PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Brucet, S; Boix, D; Nathansen, LW; Quintana, XD; Jensen, E; Balayla, D; Meerhoff, M; Jeppesen, E				Brucet, Sandra; Boix, Dani; Nathansen, Louise W.; Quintana, Xavier D.; Jensen, Elisabeth; Balayla, David; Meerhoff, Mariana; Jeppesen, Erik			Effects of Temperature, Salinity and Fish in Structuring the Macroinvertebrate Community in Shallow Lakes: Implications for Effects of Climate Change	PLOS ONE			English	Article							SPECIES RICHNESS; FEEDING ECOLOGY; AQUATIC INSECTS; DIEL MIGRATION; CHLOROPHYLL-A; ZOOPLANKTON; BRACKISH; BIODIVERSITY; PATTERNS; GRADIENT	Climate warming may lead to changes in the trophic structure and diversity of shallow lakes as a combined effect of increased temperature and salinity and likely increased strength of trophic interactions. We investigated the potential effects of temperature, salinity and fish on the plant-associated macroinvertebrate community by introducing artificial plants in eight comparable shallow brackish lakes located in two climatic regions of contrasting temperature: cold-temperate and Mediterranean. In both regions, lakes covered a salinity gradient from freshwater to oligohaline waters. We undertook day and night-time sampling of macroinvertebrates associated with the artificial plants and fish and free-swimming macroinvertebrate predators within artificial plants and in pelagic areas. Our results showed marked differences in the trophic structure between cold and warm shallow lakes. Plant-associated macroinvertebrates and free-swimming macroinvertebrate predators were more abundant and the communities richer in species in the cold compared to the warm climate, most probably as a result of differences in fish predation pressure. Submerged plants in warm brackish lakes did not seem to counteract the effect of fish predation on macroinvertebrates to the same extent as in temperate freshwater lakes, since small fish were abundant and tended to aggregate within the macrophytes. The richness and abundance of most plant-associated macroinvertebrate taxa decreased with salinity. Despite the lower densities of plant-associated macroinvertebrates in the Mediterranean lakes, periphyton biomass was lower than in cold temperate systems, a fact that was mainly attributed to grazing and disturbance by fish. Our results suggest that, if the current process of warming entails higher chances of shallow lakes becoming warmer and more saline, climatic change may result in a decrease in macroinvertebrate species richness and abundance in shallow lakes.	[Brucet, Sandra; Nathansen, Louise W.; Jensen, Elisabeth; Balayla, David; Meerhoff, Mariana; Jeppesen, Erik] Aarhus Univ, Dept Biosci, Silkeborg, Denmark; [Brucet, Sandra] European Commiss, Joint Res Ctr, Inst Environm & Sustainabil, Ispra, Italy; [Boix, Dani; Quintana, Xavier D.] Univ Girona, Fac Ciencies, Inst Aquat Ecol, Girona, Spain; [Boix, Dani; Quintana, Xavier D.] Univ Girona, Fac Ciencies, Dept Environm Sci, Girona, Spain; [Meerhoff, Mariana] Univ Republ, Fac Ciencias, CURE, Dept Ecol & Evoluc, Maldonado, Uruguay; [Jeppesen, Erik] GCRC, Greenland Inst Nat Resources, Nuuk, Greenland; [Jeppesen, Erik] Sinodanish Educ & Res Ctr, Beijing, Peoples R China	Aarhus University; European Commission Joint Research Centre; EC JRC ISPRA Site; Universitat de Girona; Universitat de Girona; Universidad de la Republica, Uruguay; Greenland Institute of Natural Resources	Brucet, S (corresponding author), Aarhus Univ, Dept Biosci, Silkeborg, Denmark.	sandra.brucet-balmana@jrc.ec.europa.eu	Jeppesen, Erik/O-2667-2019; Boix, Dani/L-5190-2014; Quintana, Xavier/L-5083-2014; Jeppesen, Erik/A-4463-2012	Boix, Dani/0000-0001-5468-2236; Quintana, Xavier/0000-0002-4070-1915; Jeppesen, Erik/0000-0002-0542-369X	European Union; Denmark from EU WISER; Denmark from Research Council for Nature and Universe [272-08-0406]; Denmark from Centre for Regional Change in the Earth System (CRES); Spain from Ministerio de Educacion y Ciencia [GL2008-05778/BOS]; Development of Basic Sciences (PEDECIBA); Uruguayan Agency for Research and Innovation (ANII) through the National System of Researchers (SNI) [FCE 2749]; Women in Science LOreal-UNESCO Uruguay; Marie Curie fellowship [MEIF-CT-2006-038366]	European Union(European Commission); Denmark from EU WISER; Denmark from Research Council for Nature and Universe; Denmark from Centre for Regional Change in the Earth System (CRES); Spain from Ministerio de Educacion y Ciencia(German Research Foundation (DFG)); Development of Basic Sciences (PEDECIBA); Uruguayan Agency for Research and Innovation (ANII) through the National System of Researchers (SNI); Women in Science LOreal-UNESCO Uruguay; Marie Curie fellowship(European Commission)	This study is a result of the project REFRESH funded by the European Union under the 7th Framework Programme. Further support was obtained in Denmark from the project EU WISER, The Research Council for Nature and Universe (272-08-0406), and the Centre for Regional Change in the Earth System (CRES), and in Spain from Ministerio de Educacion y Ciencia, Programa de Investigacion Fundamental (GL2008-05778/BOS). M. M. was supported by the Uruguayan Programme for the Development of Basic Sciences (PEDECIBA) and the Uruguayan Agency for Research and Innovation (ANII) through the National System of Researchers (SNI) and project FCE 2749, and the national award for Women in Science LOreal-UNESCO Uruguay. D. B. held a postdoctoral Marie Curie fellowship (MEIF-CT-2006-038366). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASER HF, 1995, MAR ECOL PROG SER, V127, P47, DOI 10.3354/meps127047; Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; American Public Health Association, 1989, STAND METH EX WAT WA; Behrens MD, 2007, CAN J FISH AQUAT SCI, V64, P867, DOI 10.1139/F07-063; Beklioglu M, 2007, HYDROBIOLOGIA, V584, P317, DOI 10.1007/s10750-007-0577-x; Billard, 1970, ULTRASTRUCTURE COMPA; BLABER SJM, 1976, BIOL J LINN SOC, V8, P267, DOI 10.1111/j.1095-8312.1976.tb00249.x; Blanck A, 2007, J BIOGEOGR, V34, P862, DOI 10.1111/j.1365-2699.2006.01654.x; Blanco S, 2003, HYDROBIOLOGIA, V506, P473, DOI 10.1023/B:HYDR.0000008583.05327.da; Boix D, 2008, HYDROBIOLOGIA, V597, P53, DOI 10.1007/s10750-007-9221-z; Boix D, 2007, HYDROBIOLOGIA, V584, P347, DOI 10.1007/s10750-007-0579-8; Bonada N, 2007, GLOBAL CHANGE BIOL, V13, P1658, DOI 10.1111/j.1365-2486.2007.01375.x; Brucet S, 2010, LIMNOL OCEANOGR, V55, P1697, DOI 10.4319/lo.2010.55.4.1697; Brucet S, 2009, ECOGRAPHY, V32, P692, DOI 10.1111/j.1600-0587.2009.05823.x; Burks RL, 2002, FRESHWATER BIOL, V47, P343, DOI 10.1046/j.1365-2427.2002.00824.x; CANFIELD DE, 1984, CAN J FISH AQUAT SCI, V41, P497, DOI 10.1139/f84-059; Cognetti G, 2000, MAR POLLUT BULL, V40, P7, DOI 10.1016/S0025-326X(99)00173-3; Cummins KW, 1996, INTRO AQUATIC INSECT; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Grasshoff K., 1999, METHODS SEAWATER ANA, V3rd; HART BT, 1991, HYDROBIOLOGIA, V210, P105, DOI 10.1007/BF00014327; Havens KE, 2009, HYDROBIOLOGIA, V628, P165, DOI 10.1007/s10750-009-9754-4; Jensen E, 2010, HYDROBIOLOGIA, V646, P215, DOI 10.1007/s10750-010-0172-4; JEPPESEN E, 1994, HYDROBIOLOGIA, V275, P15, DOI 10.1007/BF00026696; JEPPESEN E, 1997, STRUCTURING ROLE SUB, P369; Jeppesen E, 2007, ECOSYSTEMS, V10, P47, DOI 10.1007/s10021-006-9007-6; Jeppesen E, 2010, HYDROBIOLOGIA, V646, P73, DOI 10.1007/s10750-010-0171-5; JESPERSEN AM, 1987, ARCH HYDROBIOL, V109, P445; Jones JI, 2003, ECOLOGY, V84, P2155, DOI 10.1890/02-0422; Josefson AB, 2004, GLOBAL ECOL BIOGEOGR, V13, P273, DOI 10.1111/j.1466-822X.2004.00091.x; Kefford BJ, 2003, MAR FRESHWATER RES, V54, P755, DOI 10.1071/MF02081; Marklund O, 2001, FRESHWATER BIOL, V46, P913, DOI 10.1046/j.1365-2427.2001.00726.x; Meerhoff M, 2007, FRESHWATER BIOL, V52, P1009, DOI 10.1111/j.1365-2427.2007.01748.x; Meerhoff M, 2007, GLOBAL CHANGE BIOL, V13, P1888, DOI 10.1111/j.1365-2486.2007.01408.x; Miracle M.R., 2006, Limnetica, V25, P585; Monakov AV, 2003, FEEDING FRESHWATER I; Moss B, 2004, FRESHWATER BIOL, V49, P1633, DOI 10.1111/j.1365-2427.2004.01304.x; MUNOZ I, 1994, HYDROBIOLOGIA, V286, P65, DOI 10.1007/BF00008498; PHILLIPS GL, 1978, AQUAT BOT, V4, P103, DOI 10.1016/0304-3770(78)90012-8; Pinder A.M., 2004, Records of the Western Australian Museum Supplement, V67, P7; Pinder AC, 2001, FRESHWATER BIOL ASS, V60; Piscart C, 2005, HYDROBIOLOGIA, V551, P227, DOI 10.1007/s10750-005-4463-0; PRINCE ED, 1978, FISHERIES, V3, P5; Romo S, 2005, FRESHWATER BIOL, V50, P1706, DOI 10.1111/j.1365-2427.2005.01432.x; Schallenberg M, 2003, MAR ECOL PROG SER, V251, P181, DOI 10.3354/meps251181; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Scott W.B., 1973, Bulletin Fish Res Bd Canada, V184, P1; Tachet H., 2000, INVERTEBRES EAU DOUC; Teixeira-de Mello F, 2009, FRESHWATER BIOL, V54, P1202, DOI 10.1111/j.1365-2427.2009.02167.x; UNDERWOOD GJC, 1992, OECOLOGIA, V91, P587, DOI 10.1007/BF00650335; Vizzini S, 2005, ENVIRON BIOL FISH, V72, P259, DOI 10.1007/s10641-004-2586-1; Waterkeyn A, 2008, FRESHWATER BIOL, V53, P1808, DOI 10.1111/j.1365-2427.2008.02005.x; WILLIAMS WD, 1990, HYDROBIOLOGIA, V197, P257, DOI 10.1007/BF00026955	53	70	75	3	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e30877	10.1371/journal.pone.0030877	http://dx.doi.org/10.1371/journal.pone.0030877			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393354	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500007
J	Li, M; Tian, Y; Zhao, Y; Bu, WJ				Li, Min; Tian, Ying; Zhao, Ying; Bu, Wenjun			Higher Level Phylogeny and the First Divergence Time Estimation of Heteroptera (Insecta: Hemiptera) Based on Multiple Genes	PLOS ONE			English	Article							MOLECULAR EVOLUTION; BAYESIAN-INFERENCE; ABSOLUTE RATES; BUGS INSECTA; DNA; SYSTEMATICS; EXTINCTION; RADIATIONS; NEPOMORPHA; SEQUENCES	Heteroptera, or true bugs, are the largest, morphologically diverse and economically important group of insects with incomplete metamorphosis. However, the phylogenetic relationships within Heteroptera are still in dispute and most of the previous studies were based on morphological characters or with single gene (partial or whole 18S rDNA). Besides, so far, divergence time estimates for Heteroptera totally rely on the fossil record, while no studies have been performed on molecular divergence rates. Here, for the first time, we used maximum parsimony (MP), maximum likelihood (ML) and Bayesian inference (BI) with multiple genes (18S rDNA, 28S rDNA, 16S rDNA and COI) to estimate phylogenetic relationships among the infraorders, and meanwhile, the Penalized Likelihood (r8s) and Bayesian (BEAST) molecular dating methods were employed to estimate divergence time of higher taxa of this suborder. Major results of the present study included: Nepomorpha was placed as the most basal clade in all six trees (MP trees, ML trees and Bayesian trees of nuclear gene data and four-gene combined data, respectively) with full support values. The sister-group relationship of Cimicomorpha and Pentatomomorpha was also strongly supported. Nepomorpha originated in early Triassic and the other six infraorders originated in a very short period of time in middle Triassic. Cimicomorpha and Pentatomomorpha underwent a radiation at family level in Cretaceous, paralleling the proliferation of the flowering plants. Our results indicated that the higher-group radiations within hemimetabolous Heteroptera were simultaneously with those of holometabolous Coleoptera and Diptera which took place in the Triassic. While the aquatic habitat was colonized by Nepomorpha already in the Triassic, the Gerromorpha independently adapted to the semi-aquatic habitat in the Early Jurassic.	[Li, Min; Tian, Ying; Zhao, Ying; Bu, Wenjun] Nankai Univ, Coll Life Sci, Inst Entomol, Tianjin 300071, Peoples R China; [Tian, Ying] State Interllectual Property Off Peoples Republ C, Patent Examinat Cooperat Ctr, Beijing, Peoples R China	Nankai University	Li, M (corresponding author), Nankai Univ, Coll Life Sci, Inst Entomol, Tianjin 300071, Peoples R China.	wenjunbu@nankai.edu.cn			Natural Science Foundation of China [30725005, 31071959, J0630963]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by Natural Science Foundation of China (No. 30725005, No. 31071959 and No. J0630963). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azar D, 1998, ESTUDIOS MUSEO CIENC, V14, P217; Azar D, 2010, ANN SOC ENTOMOL FR, V46, P193, DOI 10.1080/00379271.2010.10697657; Cassis G, 2010, CLADISTICS, V26, P262, DOI 10.1111/j.1096-0031.2009.00283.x; COBBEN R. H., 1968, Evolutionary trends in Heteroptera. Part I. Eggs, architecture of the shell, gross embryology and eclosion.; Cobben RH, 1978, MEDEDLINGEN LANDBO 2, V78-5, P407; CROZIER RH, 1993, GENETICS, V133, P97; Damgaard Jakob, 2008, Acta Entomologica Musei Nationalis Pragae, V48, P251; Damgaard J, 2008, INSECT SYST EVOL, V39, P431, DOI 10.1163/187631208788784264; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dufour L, 1833, MEM SAVANTS ETRANG A, V4, P123, DOI DOI 10.5962/BHL.TITLE.12418; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FELSENSTEIN J, 2006, PHYLIP PHYLOGENY INF; Fieber F.X, 1861, EUROPAISCHEN HEMIPTE; Forero D, 2008, REV COLOMB ENTOMOL, V34, P1; Friis EM, 2006, PALAEOGEOGR PALAEOCL, V232, P251, DOI 10.1016/j.palaeo.2005.07.006; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Gillott Cedric., 2005, ENTOMOLOGY; Golub V.B., 2008, Paleontologicheskii Zhurnal, V1, P88; Grimaldi David, 2005, pi; Grimaldi David, 1993, American Museum Novitates, V3071, P1; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebsgaard MB, 2004, SYST ENTOMOL, V29, P488, DOI 10.1111/j.0307-6970.2004.00254.x; Hua JM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-134; Hua JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-610; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; JOBB G, 2008, TREEFINDER VERSION; Kaplan AI, 2003, ENCY INSECTS, P369; Knoll AH, 1996, SCIENCE, V273, P452, DOI 10.1126/science.273.5274.452; LABANDEIRA CC, 1993, SCIENCE, V261, P310, DOI 10.1126/science.11536548; Latreille P.A., 1810, CONSIDERATIONS GEN O; LATREILLE PA, 1825, FAMILLES NATURELLES, P1; Lehrmann DJ, 2006, GEOLOGY, V34, P1053, DOI 10.1130/G22827A.1; LESTON D, 1954, NATURE, V174, P91, DOI 10.1038/174091b0; Li HM, 2005, MOL PHYLOGENET EVOL, V37, P313, DOI 10.1016/j.ympev.2005.07.013; Mahner Martin, 1993, Zoologica (Stuttgart), V48, P1; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Nel A., 2004, Geologica Acta, V2, P51; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Perrichot V, 2005, CRETACEOUS RES, V26, P793, DOI 10.1016/j.cretres.2005.05.003; Popov Y.A., 1991, Geologica et Palaeontologica, V25, P215; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2010, FIGTREE V1 3 1 I EVO; Reineke A, 1998, INSECT MOL BIOL, V7, P95, DOI 10.1046/j.1365-2583.1998.71048.x; Retallack GJ, 1996, GEOL SOC AM BULL, V108, P195, DOI 10.1130/0016-7606(1996)108<0195:GCGBPT>2.3.CO;2; RIEGER C, 1976, ZOOMORPHOLOGIE, V83, P109, DOI 10.1007/BF00993483; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Schuh R. T., 1995, True bugs of the world (Hemiptera: Heteroptera): classification and natural history.; Schuh RT, 2009, SYST ENTOMOL, V34, P15, DOI 10.1111/j.1365-3113.2008.00436.x; Schuh RT, 1979, COBBEN SYST ZOOL, V28, P653; Shcherbakov D.E., 2002, HIST INSECTS, P152; Shcherbakov DE, 1996, 1996 STUDIES HEMIPTE, P31; STYS P, 1975, ACTA ENTOMOL BOHEMOS, V72, P65; SWEET MH, 1979, ANN ENTOMOL SOC AM, V72, P575, DOI 10.1093/aesa/72.5.575; Swofford David L., 1996, P407; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanner LH, 2004, EARTH-SCI REV, V65, P103, DOI 10.1016/S0012-8252(03)00082-5; TAUTZ D, 1988, MOL BIOL EVOL, V5, P366; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian XX, 2011, ZOOTAXA, P57, DOI 10.11646/zootaxa.2888.1.5; Tian Y, 2008, MOL PHYLOGENET EVOL, V47, P581, DOI 10.1016/j.ympev.2008.01.034; Weirauch C, 2011, ANNU REV ENTOMOL, V56, P487, DOI 10.1146/annurev-ento-120709-144833; WHEELER WC, 1993, ENTOMOL SCAND, V24, P121; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Wilf P, 2000, SCIENCE, V289, P291, DOI 10.1126/science.289.5477.291; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xie Q, 2008, MOL PHYLOGENET EVOL, V47, P463, DOI 10.1016/j.ympev.2008.01.024; Yang Chung-Tu, 2002, Formosan Entomologist, V22, P297; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; Yao Yunzhi, 2007, Zootaxa, V1442, P37; ZRZAVY J, 1992, ACTA ENTOMOL BOHEMOS, V89, P77; ZRZAVY J, 1990, Acta Universitatis Carolinae-Biologica, V34, P189	75	68	70	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32152	10.1371/journal.pone.0032152	http://dx.doi.org/10.1371/journal.pone.0032152			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384163	Green Submitted, Green Published, gold			2022-12-27	WOS:000302918500061
J	Mundry, M; Bornberg-Bauer, E; Sammeth, M; Feulner, PGD				Mundry, Marvin; Bornberg-Bauer, Erich; Sammeth, Michael; Feulner, Philine G. D.			Evaluating Characteristics of De Novo Assembly Software on 454 Transcriptome Data: A Simulation Approach	PLOS ONE			English	Article							GENERATION; DIVERGENCE; EXPRESSION; REVEALS; GENES	Background: The quantity of transcriptome data is rapidly increasing for non-model organisms. As sequencing technology advances, focus shifts towards solving bioinformatic challenges, of which sequence read assembly is the first task. Recent studies have compared the performance of different software to establish a best practice for transcriptome assembly. Here, we adapted a simulation approach to evaluate specific features of assembly programs on 454 data. The novelty of our study is that the simulation allows us to calculate a model assembly as reference point for comparison. Findings: The simulation approach allows us to compare basic metrics of assemblies computed by different software applications (CAP3, MIRA, Newbler, and Oases) to a known optimal solution. We found MIRA and CAP3 are conservative in merging reads. This resulted in comparably high number of short contigs. In contrast, Newbler more readily merged reads into longer contigs, while Oases produced the overall shortest assembly. Due to the simulation approach, reads could be traced back to their correct placement within the transcriptome. Together with mapping reads onto the assembled contigs, we were able to evaluate ambiguity in the assemblies. This analysis further supported the conservative nature of MIRA and CAP3, which resulted in low proportions of chimeric contigs, but high redundancy. Newbler produced less redundancy, but the proportion of chimeric contigs was higher. Conclusion: Our evaluation of four assemblers suggested that MIRA and Newbler slightly outperformed the other programs, while showing contrasting characteristics. Oases did not perform very well on the 454 reads. Our evaluation indicated that the software was either conservative (MIRA) or liberal (Newbler) about merging reads into contigs. This suggested that in choosing an assembly program researchers should carefully consider their follow up analysis and consequences of the chosen approach to gain an assembly.	[Mundry, Marvin; Bornberg-Bauer, Erich; Feulner, Philine G. D.] Univ Munster, Inst Evolut & Biodivers, Munster, Germany; [Sammeth, Michael] CNAG, Barcelona, Spain	University of Munster	Mundry, M (corresponding author), Univ Munster, Inst Evolut & Biodivers, Munster, Germany.	p.feulner@wwu.de	Sammeth, Michael/C-1157-2014; Bornberg-Bauer, Erich/A-1563-2013	Sammeth, Michael/0000-0002-6528-9883; Bornberg-Bauer, Erich/0000-0002-1826-3576; Mundry, Marvin/0000-0001-9188-6588; Feulner, Philine/0000-0002-8078-1788	German Science Foundation (DFG) [1399]; Deutsche Forschungsgemeinschaft; University of Muenster	German Science Foundation (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Muenster	MM was funded by the German Science Foundation (DFG) priority program 1399. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Muenster. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril JF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-731; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Barreto FS, 2011, MOL ECOL, V20, P560, DOI 10.1111/j.1365-294X.2010.04963.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bettencourt R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-559; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; Cabrera AR, 2011, J INSECT PHYSIOL, V57, P52, DOI 10.1016/j.jinsphys.2010.09.006; Cantacessi C, 2010, INFECT GENET EVOL, V10, P1199, DOI 10.1016/j.meegid.2010.07.024; Carvalho RA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-695; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Clark MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015919; Coppe A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-635; de Boer TE, 2011, MOL ECOL, V20, P1144, DOI 10.1111/j.1365-294X.2010.04985.x; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Desgagne-Penix I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-252; Dicker AJ, 2011, EXP PARASITOL, V127, P351, DOI 10.1016/j.exppara.2010.08.019; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Franssen SU, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-227; Furusawa C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.088102; Galindo J, 2010, J EVOLUTION BIOL, V23, P2004, DOI 10.1111/j.1420-9101.2010.02071.x; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; IYENGAR SS, 1979, COMPUT PROG BIOMED, V9, P160, DOI 10.1016/0010-468X(79)90029-1; Jeukens J, 2010, MOL ECOL, V19, P5389, DOI 10.1111/j.1365-294X.2010.04934.x; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Logacheva MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-30; Mane SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-264; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Masoudi-Nejad A, 2006, NUCLEIC ACIDS RES, V34, pW459, DOI 10.1093/nar/gkl066; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Moe KT, 2011, J INTEGR PLANT BIOL, V53, P63, DOI 10.1111/j.1744-7909.2010.01012.x; Muller L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-81; Nowack ECM, 2011, MOL BIOL EVOL, V28, P407, DOI 10.1093/molbev/msq209; Papanicolaou A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-447; Peng YH, 2010, PEST MANAG SCI, V66, P1053, DOI 10.1002/ps.2004; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Riggins CW, 2010, PEST MANAG SCI, V66, P1042, DOI 10.1002/ps.2006; Rokyta DR, 2011, TOXICON, V57, P657, DOI 10.1016/j.toxicon.2011.01.008; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Sammeth M, 2009, FLUX; Schulz M, 2010, OASES; Schwartz TS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-694; van Leeuwen H, 2007, PLANT CELL, V19, P2099, DOI 10.1105/tpc.107.050641; Whitehead A, 2006, MOL ECOL, V15, P1197, DOI 10.1111/j.1365-294X.2006.02868.x; Yang HY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-705	51	67	69	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31410	10.1371/journal.pone.0031410	http://dx.doi.org/10.1371/journal.pone.0031410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384018	Green Submitted, Green Published, gold			2022-12-27	WOS:000302918500024
J	Stepp, CE; An, Q; Matsuoka, Y				Stepp, Cara E.; An, Qi; Matsuoka, Yoky			Repeated Training with Augmentative Vibrotactile Feedback Increases Object Manipulation Performance	PLOS ONE			English	Article							SENSORY-FEEDBACK; CONTROLLED PROSTHESIS; CYBERNETIC HAND; STIMULATION; DESIGN; SYSTEM; ARM; PERCEPTION; CORTEX	Most users of prosthetic hands must rely on visual feedback alone, which requires visual attention and cognitive resources. Providing haptic feedback of variables relevant to manipulation, such as contact force, may thus improve the usability of prosthetic hands for tasks of daily living. Vibrotactile stimulation was explored as a feedback modality in ten unimpaired participants across eight sessions in a two-week period. Participants used their right index finger to perform a virtual object manipulation task with both visual and augmentative vibrotactile feedback related to force. Through repeated training, participants were able to learn to use the vibrotactile feedback to significantly improve object manipulation. Removal of vibrotactile feedback in session 8 significantly reduced task performance. These results suggest that vibrotactile feedback paired with training may enhance the manipulation ability of prosthetic hand users without the need for more invasive strategies.	[Stepp, Cara E.] Boston Univ, Dept Speech Language & Hearing Sci, Boston, MA 02215 USA; [Stepp, Cara E.] Univ Tokyo, Dept Precis Engn, Tokyo, Japan; [An, Qi; Matsuoka, Yoky] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA	Boston University; University of Tokyo; University of Washington; University of Washington Seattle	Stepp, CE (corresponding author), Boston Univ, Dept Speech Language & Hearing Sci, Boston, MA 02215 USA.	cstepp@alum.mit.edu	Stepp, Cara/AAQ-6425-2020		National Institute of Child Health and Human Development (NICHD), through the National Center for Medical Rehabilitation Research (NCMRR) [5T32HD007424]; Walter C. and Anita C. Stolov Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007424] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD), through the National Center for Medical Rehabilitation Research (NCMRR); Walter C. and Anita C. Stolov Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by grant 5T32HD007424 from the National Institute of Child Health and Human Development (NICHD), through the National Center for Medical Rehabilitation Research (NCMRR) and a grant from the Walter C. and Anita C. Stolov Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNEW PJ, 1981, AM J OCCUP THER, V35, P722, DOI 10.5014/ajot.35.11.722; Biddiss E, 2007, DISABIL REHABIL-ASSI, V2, P346, DOI 10.1080/17483100701714733; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Carrozza MC, 2006, BIOL CYBERN, V95, P629, DOI 10.1007/s00422-006-0124-2; Castro M C, 1997, IEEE Trans Rehabil Eng, V5, P140, DOI 10.1109/86.593280; Chatterjee A., 2008, J PROSTHETICS ORTHOT, V20, P27, DOI [10.1097/01.JPO.0000311041.61628.be, DOI 10.1097/01.JP0.0000311041.61628.BE]; Cranny A, 2005, MEAS SCI TECHNOL, V16, P931, DOI 10.1088/0957-0233/16/4/005; Dhillon GS, 2005, IEEE T NEUR SYS REH, V13, P468, DOI 10.1109/TNSRE.2005.856072; Geng B, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-9; KACZMAREK KA, 1991, IEEE T BIO-MED ENG, V38, P1, DOI 10.1109/10.68204; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Lanzetta M, 2004, SCAND J PLAST RECONS, V38, P106, DOI 10.1080/02844310310019860; Leung YY, 2005, J NEUROPHYSIOL, V94, P3037, DOI 10.1152/jn.00001.2005; London BM, 2008, IEEE T NEUR SYS REH, V16, P32, DOI 10.1109/TNSRE.2007.907544; MANN RW, 1970, IEEE T MAN MACHINE, VMM11, P110, DOI 10.1109/TMMS.1970.299971; Micera S, 2008, IEEE T NEUR SYS REH, V16, P453, DOI 10.1109/TNSRE.2008.2006207; Miller LA, 2008, ARCH PHYS MED REHAB, V89, P2057, DOI 10.1016/j.apmr.2008.05.016; PATTERSON PE, 1992, J REHABIL RES DEV, V29, P1, DOI 10.1682/JRRD.1992.01.0001; Pylatiuk C, 2006, J PROSTHET ORTHOT, V18, P57, DOI DOI 10.1097/00008526-200604000-00007; Pylatiuk C, 2007, PROSTHET ORTHOT INT, V31, P362, DOI 10.1080/03093640601061265; Riso R R, 1999, Technol Health Care, V7, P401; Schmidl H, 1977, Prosthet Orthot Int, V1, P21; Schultz AE, 2011, PM&R, V3, P55, DOI 10.1016/j.pmrj.2010.06.016; SCOTT RN, 1980, MED BIOL ENG COMPUT, V18, P65, DOI 10.1007/BF02442481; SHANNON GF, 1976, MED BIOL ENG, V14, P289, DOI 10.1007/BF02478123; SHANNON GF, 1979, MED BIOL ENG COMPUT, V17, P73, DOI 10.1007/BF02440956; Stepp C. E., 2010, 32 ANN INT C IEEE EN, P2089; Stepp CE, 2011, IEEE T NEUR SYS REH, V19, P677, DOI 10.1109/TNSRE.2011.2168981; Stepp CE, 2011, P 33 ANN INT C IEEE, P1061; VERRILLO RT, 1992, MUSIC PERCEPT, V9, P281; Zollo L, 2007, IEEE-ASME T MECH, V12, P418, DOI 10.1109/TMECH.2007.901936	32	33	35	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32743	10.1371/journal.pone.0032743	http://dx.doi.org/10.1371/journal.pone.0032743			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384283	gold, Green Submitted, Green Published			2022-12-27	WOS:000302918500109
J	Clements, JA; Mercer, FC; Paterno, GD; Gillespie, LL				Clements, Jaclyn A.; Mercer, F. Corinne; Paterno, Gary D.; Gillespie, Laura L.			Differential Splicing Alters Subcellular Localization of the Alpha but not Beta Isoform of the MIER1 Transcriptional Regulator in Breast Cancer Cells	PLOS ONE			English	Article							NUCLEAR EXPORT SIGNAL; TUMOR-SUPPRESSOR GENE; PROSTATE-CANCER; XENOPUS-LAEVIS; LEPTOMYCIN B; CO-REPRESSOR; SANT DOMAIN; PROTEIN; RECEPTOR; PHOSPHORYLATION	MIER1 was originally identified in a screen for novel fibroblast growth factor activated early response genes. The mier1 gene gives rise to multiple transcripts encoding protein isoforms that differ in their amino (N-) and carboxy (C-) termini. Much of the work to date has focused on the two C-terminal variants, MIER1 alpha and beta, both of which have been shown to function as transcriptional repressors. Our previous work revealed a dramatic shift in MIER1 alpha subcellular localization from nuclear in normal breast tissue to cytoplasmic in invasive breast carcinoma, suggesting that loss of nuclear MIER1 alpha may play a role in breast cancer development. In the present study, we investigated whether alternative splicing to include a cassette exon and produce an N-terminal variant of MIER1 alpha affects its subcellular localization in MCF7 breast carcinoma cells. We demonstrate that this cassette exon, exon 3A, encodes a consensus leucine-rich nuclear export signal (NES). Inclusion of this exon in MIER1 alpha to produce the MIER1-3A alpha isoform altered its subcellular distribution in MCF7 cells from 81% nuclear to 2% nuclear and this change in localization was abrogated by mutation of critical leucines within the NES. Treatment with leptomycin B (LMB), an inhibitor of the nuclear export receptor CRM1, resulted in a significant increase in the percentage of cells with nuclear MIER1-3A alpha, from 4% to 53%, demonstrating that cytoplasmic localization of this isoform was due to CRM1-dependent nuclear export. Inclusion of exon 3A in MIER1 beta to produce the N-terminal variant MIER1-3A beta however had little effect on the nuclear targeting of this isoform. Our results demonstrate that alternative splicing to include exon 3A specifically affects the localization pattern of the alpha isoform.	[Clements, Jaclyn A.; Mercer, F. Corinne; Paterno, Gary D.; Gillespie, Laura L.] Mem Univ Newfoundland, Fac Med, Terry Fox Canc Res Labs, Div Biomed Sci, St John, NF, Canada	Memorial University Newfoundland	Clements, JA (corresponding author), Univ Moncton, Ctr Format Med Nouveau Brunswick, Moncton, NB E1A 3E9, Canada.	lgillesp@mun.ca			Canadian Breast Cancer Foundation-Atlantic Chapter; Memorial University of Newfoundland	Canadian Breast Cancer Foundation-Atlantic Chapter; Memorial University of Newfoundland	Funding for this research was provided by the Canadian Breast Cancer Foundation-Atlantic Chapter (http://www.cbcf.org/atlantic/Pages/default.aspx). No grant number was assigned. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JAC was the recipient of a Memorial University of Newfoundland Dean's Fellowship.	Aasland R, 1996, TRENDS BIOCHEM SCI, V21, P87, DOI 10.1016/S0968-0004(96)30009-1; ARMSTRONG DJ, 1993, BIOCHEM BIOPH RES CO, V192, P1380, DOI 10.1006/bbrc.1993.1569; Blackmore Tina M, 2008, BMC Res Notes, V1, P68, DOI 10.1186/1756-0500-1-68; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Difeo A, 2009, DRUG RESIST UPDATE, V12, P1, DOI 10.1016/j.drup.2008.11.001; Ding ZH, 2004, J BIOL CHEM, V279, P28009, DOI 10.1074/jbc.M403793200; Ding ZH, 2003, MOL CELL BIOL, V23, P250, DOI 10.1128/MCB.23.1.250-258.2003; Fabbro M, 2003, EXP CELL RES, V282, P59, DOI 10.1016/S0014-4827(02)00019-8; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Iakoucheva LM, 2001, PROTEIN SCI, V10, P1353, DOI 10.1110/ps.40101; Jiao W, 2006, J BIOL CHEM, V281, P38098, DOI 10.1074/jbc.M605271200; Kosugi S, 2008, TRAFFIC, V9, P2053, DOI 10.1111/j.1600-0854.2008.00825.x; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Luchman HA, 1999, MECH DEVELOP, V80, P111; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; McCarthy PL, 2008, BRIT J CANCER, V99, P639, DOI 10.1038/sj.bjc.6604518; Narla G, 2005, CANCER RES, V65, P1213, DOI 10.1158/0008-5472.CAN-04-4249; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Paterno GD, 1997, J BIOL CHEM, V272, P25591, DOI 10.1074/jbc.272.41.25591; Paterno GD, 1998, GENE, V222, P77, DOI 10.1016/S0378-1119(98)00473-9; Paterno GD, 2002, GENE, V295, P79, DOI 10.1016/S0378-1119(02)00823-5; Post JN, 2001, FEBS LETT, V502, P41, DOI 10.1016/S0014-5793(01)02653-9; Rasband W.S., 1997, IMAGE J; Reynolds JN, 1996, MOL BRAIN RES, V35, P11, DOI 10.1016/0169-328X(95)00172-O; Rodriguez E., 2010, PLOS ONE, V5; RYAN PJ, 1994, DEV BIOL, V166, P101, DOI 10.1006/dbio.1994.1299; Salmena L, 2007, NAT REV CANCER, V7, P409, DOI 10.1038/nrc2145; Solari F, 1999, DEVELOPMENT, V126, P2483; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Thorne LB, 2005, DNA SEQUENCE, V16, P237, DOI 10.1080/10425170500069783; Wang L, 2008, EMBO REP, V9, P555, DOI 10.1038/embor.2008.67; Williams KL, 2011, J NEUROSCI RES, V89, P1160, DOI 10.1002/jnr.22634; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X	39	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32499	10.1371/journal.pone.0032499	http://dx.doi.org/10.1371/journal.pone.0032499			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384264	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000302916800040
J	Reed, TE; Daunt, F; Kiploks, AJ; Burthe, SJ; Granroth-Wilding, HMV; Takahashi, EA; Newell, M; Wanless, S; Cunningham, EJA				Reed, Thomas E.; Daunt, Francis; Kiploks, Adam J.; Burthe, Sarah J.; Granroth-Wilding, Hanna M. V.; Takahashi, Emi A.; Newell, Mark; Wanless, Sarah; Cunningham, Emma J. A.			Impacts of Parasites in Early Life: Contrasting Effects on Juvenile Growth for Different Family Members	PLOS ONE			English	Article							EARLY DEVELOPMENTAL STRESS; BLACK-HEADED GULLS; PASSERINE BIRD; GREAT TITS; HATCHING ASYNCHRONY; BROOD-REDUCTION; EUROPEAN SHAGS; WITHIN-CLUTCH; ZEBRA FINCHES; HOUSE MARTIN	Parasitism experienced early in ontogeny can have a major impact on host growth, development and future fitness, but whether siblings are affected equally by parasitism is poorly understood. In birds, hatching asynchrony induced by hormonal or behavioural mechanisms largely under parental control might predispose young to respond to infection in different ways. Here we show that parasites can have different consequences for offspring depending on their position in the family hierarchy. We experimentally treated European Shag (Phalacrocorax aristoteli) nestlings with the broad-spectrum anti-parasite drug ivermectin and compared their growth rates with nestlings from control broods. Average growth rates measured over the period of linear growth (10 days to 30 days of age) and survival did not differ for nestlings from treated and control broods. However, when considering individuals within broods, parasite treatment reversed the patterns of growth for individual family members: last-hatched nestlings grew significantly slower than their siblings in control nests but grew faster in treated nests. This was at the expense of their earlier-hatched brood-mates, who showed an overall growth rate reduction relative to last-hatched nestlings in treated nests. These results highlight the importance of exploring individual variation in the costs of infection and suggest that parasites could be a key factor modulating within-family dynamics, sibling competition and developmental trajectories from an early age.	[Reed, Thomas E.; Kiploks, Adam J.; Granroth-Wilding, Hanna M. V.; Takahashi, Emi A.; Cunningham, Emma J. A.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Reed, Thomas E.; Daunt, Francis; Burthe, Sarah J.; Newell, Mark; Wanless, Sarah] Ctr Ecol & Hydrol, Penicuik, Midlothian, Scotland; [Reed, Thomas E.] Netherlands Inst Ecol, Wageningen, Netherlands	University of Edinburgh; UK Centre for Ecology & Hydrology (UKCEH); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Reed, TE (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	t.reed@nioo.knaw.nl	Reed, Thomas E/A-5788-2012; Cunningham, Emma/I-9190-2012; Wanless, Sarah/K-2338-2012; Burthe, Sarah J/Q-9505-2016; Daunt, Francis/K-6688-2012; KNAW, NIOO-KNAW/A-4320-2012	Reed, Thomas E/0000-0002-2993-0477; Wanless, Sarah/0000-0002-2788-4606; Burthe, Sarah J/0000-0001-8871-3432; Daunt, Francis/0000-0003-4638-3388; KNAW, NIOO-KNAW/0000-0002-3835-159X	University of Edinburgh; Royal Society; Association for the Study of Animal Behaviour (ASAB); Natural Environment Research Council [CEH010021] Funding Source: researchfish	University of Edinburgh; Royal Society(Royal Society of London); Association for the Study of Animal Behaviour (ASAB); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was supported by a Principle's Studentship to T.E.R. from the University of Edinburgh, a fellowship to E.J.A.C. from the Royal Society and a Vacation Scholarship from the Association for the Study of Animal Behaviour (ASAB) to A.J.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abollo E, 2001, J HELMINTHOL, V75, P209; Baayen RH, 2008, R PACKAGE VERSION 09; Badyaev AV, 2006, P NATL ACAD SCI USA, V103, P14406, DOI 10.1073/pnas.0602452103; Bates D, 2005, R NEWS, V5, P27, DOI DOI 10.1111/J.1523-1739.2005.00280.X; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Becker PH, 2007, J ORNITHOL, V148, pS377, DOI 10.1007/s10336-007-0157-x; Bischoff LL, 2009, BEHAV ECOL, V20, P265, DOI 10.1093/beheco/arp012; Bize P, 2003, J ANIM ECOL, V72, P633, DOI 10.1046/j.1365-2656.2003.00734.x; Both C, 1999, P ROY SOC B-BIOL SCI, V266, P465, DOI 10.1098/rspb.1999.0660; BROWN CR, 1986, ECOLOGY, V67, P1206, DOI 10.2307/1938676; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CAMPBELL WC, 1983, SCIENCE, V221, P823, DOI 10.1126/science.6308762; Christe P, 1998, OIKOS, V83, P175, DOI 10.2307/3546559; CLARK AB, 1981, Q REV BIOL, V56, P253, DOI 10.1086/412316; Colditz IG, 2008, PARASITE IMMUNOL, V30, P63, DOI 10.1111/j.1365-3024.2007.00964.x; COOCH EG, 1991, J ANIM ECOL, V60, P483, DOI 10.2307/5293; Daunt F, 2007, FUNCT ECOL, V21, P561, DOI 10.1111/j.1365-2435.2007.01260.x; Daunt F, 2001, FUNCT ECOL, V15, P211, DOI 10.1046/j.1365-2435.2001.00515.x; Daunt F, 2001, ARDEA, V89, P449; Dawson RD, 2005, J AVIAN BIOL, V36, P127, DOI 10.1111/j.0908-8857.2005.03406.x; DIJKSTRA C, 1990, J ANIM ECOL, V59, P269, DOI 10.2307/5172; Fargallo JA, 2002, ECOL LETT, V5, P95, DOI 10.1046/j.1461-0248.2002.00290.x; Fitze PS, 2004, ECOLOGY, V85, P2018, DOI 10.1890/03-0138; Forbes S, 2009, OIKOS, V118, P1561, DOI 10.1111/j.1600-0706.2009.17702.x; FUJIOKA M, 1985, ANIM BEHAV, V33, P1228, DOI 10.1016/S0003-3472(85)80183-4; Gil D, 2004, J EXP BIOL, V207, P2215, DOI 10.1242/jeb.01013; Gluckman PD, 2005, P ROY SOC B-BIOL SCI, V272, P671, DOI 10.1098/rspb.2004.3001; GOWATY PA, 1991, CURR ORNITHOL, V8, P141; Groothuis TG, 2002, FUNCT ECOL, V16, P281; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Knowles SCL, 2010, J EVOLUTION BIOL, V23, P557, DOI 10.1111/j.1420-9101.2009.01920.x; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Lamka J, 1997, VET MED-CZECH, V42, P157; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Mainwaring MC, 2010, J EVOLUTION BIOL, V23, P1302, DOI 10.1111/j.1420-9101.2010.01997.x; MOCK DW, 1995, TRENDS ECOL EVOL, V10, P130, DOI 10.1016/S0169-5347(00)89014-X; Moller Anders Pape, 1997, P105; MOLLER AP, 1994, OECOLOGIA, V98, P263, DOI 10.1007/BF00324213; Moller AP, 1990, POPULATION BIOL PASS, P269; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Muller W, 2004, BEHAV ECOL, V15, P893, DOI 10.1093/beheco/arh091; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; Naguib M, 2005, BIOL LETT-UK, V1, P95, DOI 10.1098/rsbl.2004.0277; Naguib M, 2006, P ROY SOC B-BIOL SCI, V273, P1901, DOI 10.1098/rspb.2006.3526; O'Brien EL, 2009, OIKOS, V118, P1743, DOI 10.1111/j.1600-0706.2009.17692.x; Parejo D, 2007, J AVIAN BIOL, V38, P717, DOI 10.1111/j.2007.0908-8857.04081.x; Pastoret P.-P., 1998, HDB VERTEBRATE IMMUN; Potti J, 1996, P ROY SOC B-BIOL SCI, V263, P9, DOI 10.1098/rspb.1996.0002; Raberg L, 2005, OECOLOGIA, V145, P496, DOI 10.1007/s00442-005-0133-1; Reed TE, 2008, SCIENCE, V321, P1681, DOI 10.1126/science.1159466; RICHNER H, 1993, J ANIM ECOL, V62, P703, DOI 10.2307/5390; RICKLEFS RE, 1968, IBIS, V110, P419, DOI 10.1111/j.1474-919X.1968.tb00058.x; Ringsby TH, 1998, J AVIAN BIOL, V29, P241, DOI 10.2307/3677106; Ros AFH, 1997, AM NAT, V150, P201, DOI 10.1086/286063; Royle NJ, 2001, BEHAV ECOL, V12, P381, DOI 10.1093/beheco/12.4.381; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Saino N, 2001, J AVIAN BIOL, V32, P263, DOI 10.1111/j.0908-8857.2001.320309.x; SHARMA RL, 1990, VET PARASITOL, V37, P307, DOI 10.1016/0304-4017(90)90014-3; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; SNOW BARBARA, 1960, IBIS, V102, P554, DOI 10.1111/j.1474-919X.1960.tb07132.x; STOKLAND JN, 1988, AUK, V105, P308, DOI 10.2307/4087495; STOUFFER PC, 1991, AUK, V108, P519, DOI 10.2307/4088092; Szep T, 2000, OECOLOGIA, V125, P201, DOI 10.1007/s004420000447; Szep T, 1999, OECOLOGIA, V119, P9, DOI 10.1007/s004420050755; Tschirren B, 2003, J ANIM ECOL, V72, P839, DOI 10.1046/j.1365-2656.2003.00755.x; Velando A, 2000, ARDEA, V88, P127; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]	68	15	16	5	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32236	10.1371/journal.pone.0032236	http://dx.doi.org/10.1371/journal.pone.0032236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384190	Green Published, gold, Green Accepted			2022-12-27	WOS:000302916800031
J	Alsina, FC; Irala, D; Fontanet, PA; Hita, FJ; Ledda, F; Paratcha, G				Alsina, Fernando C.; Irala, Dolores; Fontanet, Paula A.; Hita, Francisco J.; Ledda, Fernanda; Paratcha, Gustavo			Sprouty4 Is an Endogenous Negative Modulator of TrkA Signaling and Neuronal Differentiation Induced by NGF	PLOS ONE			English	Article							TYROSINE KINASE; ERK ACTIVATION; PROTEIN-KINASE; GROWTH; ANTAGONIST; PATHWAYS; CELLS; TRANSDUCTION; DOWNSTREAM; INHIBITION	The Sprouty (Spry) family of proteins represents endogenous regulators of downstream signaling pathways induced by receptor tyrosine kinases (RTKs). Using real time PCR, we detect a significant increase in the expression of Spry4 mRNA in response to NGF, indicating that Spry4 could modulate intracellular signaling pathways and biological processes induced by NGF and its receptor TrkA. In this work, we demonstrate that overexpression of wild-type Spry4 causes a significant reduction in MAPK and Rac1 activation and neurite outgrowth induced by NGF. At molecular level, our findings indicate that ectopic expression of a mutated form of Spry4 (Y53A), in which a conserved tyrosine residue was replaced, fail to block both TrkA-mediated Erk/MAPK activation and neurite outgrowth induced by NGF, suggesting that an intact tyrosine 53 site is required for the inhibitory effect of Spry4 on NGF signaling. Downregulation of Spry4 using small interference RNA knockdown experiments potentiates PC12 cell differentiation and MAPK activation in response to NGF. Together, these findings establish a new physiological mechanism through which Spry4 regulates neurite outgrowth reducing not only the MAPK pathway but also restricting Rac1 activation in response to NGF.	[Alsina, Fernando C.; Irala, Dolores; Fontanet, Paula A.; Hita, Francisco J.; Ledda, Fernanda; Paratcha, Gustavo] Univ Buenos Aires, Div Mol & Cellular Neurosci, Inst Cellular Biol & Neurosci Prof Dr E De Robert, CONICET,Sch Med, Buenos Aires, DF, Argentina; [Ledda, Fernanda; Paratcha, Gustavo] Karolinska Inst, Dept Neurosci, Lab Mol & Cellular Neurosci, Stockholm, Sweden	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Karolinska Institutet	Alsina, FC (corresponding author), Univ Buenos Aires, Div Mol & Cellular Neurosci, Inst Cellular Biol & Neurosci Prof Dr E De Robert, CONICET,Sch Med, Buenos Aires, DF, Argentina.	gustavo.paratcha@ki.se	Hita, Francisco Javier J./G-7363-2017	Hita, Francisco Javier J./0000-0003-3576-3342; Fontanet, Paula/0000-0002-5324-6077; Paratcha, Gustavo/0000-0002-0804-4433	Argentine Agency for Promotion of Science and Technology [ANPCyT-PICT2007-01034, PICT-PRH2008-00282]; Swedish Medical Research Council [K2007-68X-20483-01-3, 33SX-14773-01A]; Karolinska Institute [2007-FoBi0594]; Argentine Medical Research Council (CONICET); J. S. Guggenheim Memorial Foundation; CONICET; ANPCyT;  [UBACyT-2010-2012-GC (20020090100227)]	Argentine Agency for Promotion of Science and Technology; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Karolinska Institute(Karolinska Institutet); Argentine Medical Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); J. S. Guggenheim Memorial Foundation; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT(ANPCyT); 	Financial support was obtained from the Argentine Agency for Promotion of Science and Technology (ANPCyT-PICT2007-01034 and PICT-PRH2008-00282), Swedish Medical Research Council (K2007-68X-20483-01-3 and 33SX-14773-01A), Karolinska Institute (2007-FoBi0594), UBACyT-2010-2012-GC (20020090100227). GP and FL were supported by an Independent Research Career Position from the Argentine Medical Research Council (CONICET). GP is additionally supported by a J. S. Guggenheim Memorial Foundation Fellowship Award. DI, PF and FH were supported by a fellowship from CONICET and FCA was supported by a fellowship from ANPCyT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbulut S, 2010, MOL BIOL CELL, V21, P3487, DOI 10.1091/mbc.E10-02-0123; Ayada T, 2009, ONCOGENE, V28, P1076, DOI 10.1038/onc.2008.464; Baudet C, 2000, DEVELOPMENT, V127, P4335; Brems H, 2007, NAT GENET, V39, P1120, DOI 10.1038/ng2113; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Ernsberger U, 2009, CELL TISSUE RES, V336, P349, DOI 10.1007/s00441-009-0784-z; Fard SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009647; Gross I, 2007, CELL DEATH DIFFER, V14, P1802, DOI 10.1038/sj.cdd.4402188; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Ishida M, 2007, CANCER SCI, V98, P815, DOI 10.1111/j.1349-7006.2007.00457.x; Kramer S, 1999, DEVELOPMENT, V126, P2515; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Ledda F, 2007, BIOMARK INSIGHTS, V2, P45; Ledda F, 2008, J NEUROSCI, V28, P39, DOI 10.1523/JNEUROSCI.2196-07.2008; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Leeksma OC, 2002, EUR J BIOCHEM, V269, P2546, DOI 10.1046/j.1432-1033.2002.02921.x; Li X, 2003, BIOCHEM SOC T, V31, P1445; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Nusser N, 2002, J BIOL CHEM, V277, P35840, DOI 10.1074/jbc.M203617200; Panagiotaki N, 2010, DEVELOPMENT, V137, P4005, DOI 10.1242/dev.053173; Poppleton HM, 2004, BIOCHEM BIOPH RES CO, V323, P98, DOI 10.1016/j.bbrc.2004.08.070; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Sasaki A, 2003, CELL CYCLE, V2, P281, DOI 10.4161/cc.2.4.418; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Spurlock G, 2009, J MED GENET, V46, P431, DOI 10.1136/jmg.2008.065474; Tsumura Y, 2005, BIOCHEM J, V387, P627, DOI 10.1042/BJ20041181; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200	39	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32087	10.1371/journal.pone.0032087	http://dx.doi.org/10.1371/journal.pone.0032087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384148	Green Submitted, Green Published, gold			2022-12-27	WOS:000302916100051
J	Dasgupta, S; Sirisha, PVS; Neelaveni, K; Anuradha, K; Reddy, BM				Dasgupta, Shilpi; Sirisha, Pisapati V. S.; Neelaveni, Kudugunti; Anuradha, Katragadda; Reddy, B. Mohan			Association of CAPN10 SNPs and Haplotypes with Polycystic Ovary Syndrome among South Indian Women	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; TYPE-2 DIABETES-MELLITUS; CALPAIN-10; GENE; POLYMORPHISMS; PREVALENCE; VARIANTS; RISK	Polycystic Ovary Syndrome (PCOS) is known to be characterized by metabolic disorder in which hyperinsulinemia and peripheral insulin resistance are central features. Given the physiological overlap between PCOS and type-2 diabetes (T2DM), and calpain 10 gene (CAPN10) being a strong candidate for T2DM, a number of studies have analyzed CAPN10 SNPs among PCOS women yielding contradictory results. Our study is first of its kind to investigate the association pattern of CAPN10 polymorphisms (UCSNP-44, 43, 56, 19 and 63) with PCOS among Indian women. 250 PCOS cases and 299 controls from Southern India were recruited for this study. Allele and genotype frequencies of the SNPs were determined and compared between the cases and controls. Results show significant association of UCSNP-44 genotype CC with PCOS (p = 0.007) with highly significant odds ratio when compared to TC (OR = 2.51, p = 0.003, 95% CI = 1.37-4.61) as well as TT (OR = 1.94, p = 0.016, 95% CI = 1.13-3.34). While the haplotype carrying the SNP-44 and SNP-19 variants (21121) exhibited a 2 fold increase in the risk for PCOS (OR = 2.37, p = 0.03), the haplotype containing SNP-56 and SNP-19 variants (11221) seems to have a protective role against PCOS (OR = 0.20, p = 0.004). Our results support the earlier evidence for a possible role of UCSNP-44 of the CAPN10 gene in the manifestation of PCOS.	[Dasgupta, Shilpi; Sirisha, Pisapati V. S.; Reddy, B. Mohan] Indian Stat Inst, Biol Anthropol Unit, Mol Anthropol Grp, Hyderabad, Andhra Pradesh, India; [Neelaveni, Kudugunti] Osmania Gen Hosp, Dept Endocrinol, Hyderabad, Andhra Pradesh, India; [Anuradha, Katragadda] Anu Test Tube Baby Ctr, Hyderabad, Andhra Pradesh, India	Indian Statistical Institute	Dasgupta, S (corresponding author), Indian Stat Inst, Biol Anthropol Unit, Mol Anthropol Grp, Hyderabad, Andhra Pradesh, India.	bmr@isical.ac.in			Indian Statistical Institute	Indian Statistical Institute	This work was supported by the Indian Statistical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adak S, 2010, DIABETES VASC DIS RE, V7, P63, DOI 10.1177/1479164109351370; Bodhini D, 2011, METABOLISM, V60, P681, DOI 10.1016/j.metabol.2010.07.001; Cassell PG, 2002, DIABETES, V51, P1622, DOI 10.2337/diabetes.51.5.1622; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Ehrmann DA, 2002, POLYCYSTIC OVARY SYNDROME, P159; Ehrmann DA, 2002, J CLIN ENDOCR METAB, V87, P1669, DOI 10.1210/jc.87.4.1669; Ehrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141; El Mkadem SA, 2001, DIABETES, V50, P2164, DOI 10.2337/diabetes.50.9.2164; Escobar-Morreale HF, 2002, FERTIL STERIL, V77, P581, DOI 10.1016/S0015-0282(01)03206-X; Evans JC, 2001, AM J HUM GENET, V69, P544, DOI 10.1086/323315; Franks S, 2001, HUM REPROD UPDATE, V7, P405, DOI 10.1093/humupd/7.4.405; Gonzalez A, 2003, J CLIN ENDOCR METAB, V88, P5529, DOI 10.1210/jc.2003-030322; Gonzalez A, 2002, J CLIN ENDOCR METAB, V87, P3971, DOI 10.1210/jc.87.8.3971; Haddad L, 2002, J CLIN ENDOCR METAB, V87, P2606, DOI 10.1210/jc.87.6.2606; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165; Mifsud A, 2000, J CLIN ENDOCR METAB, V85, P3484, DOI 10.1210/jc.85.9.3484; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sreenan SK, 2001, DIABETES, V50, P2013, DOI 10.2337/diabetes.50.9.2013; Urbanek M, 1999, P NATL ACAD SCI USA, V96, P8573, DOI 10.1073/pnas.96.15.8573; Villuendas G, 2003, FERTIL STERIL, V79, P219, DOI 10.1016/S0015-0282(02)04570-3; Vollmert C, 2007, AM J PHYSIOL-ENDOC M, V292, pE836, DOI 10.1152/ajpendo.00584.2005; Weedon MN, 2003, AM J HUM GENET, V73, P1208, DOI 10.1086/379285	23	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32192	10.1371/journal.pone.0032192	http://dx.doi.org/10.1371/journal.pone.0032192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384174	gold, Green Submitted, Green Published			2022-12-27	WOS:000302916100058
J	Li, YZ; Chigurupati, S; Holloway, HW; Mughal, M; Tweedie, D; Bruestle, DA; Mattson, MP; Wang, Y; Harvey, BK; Ray, B; Lahiri, DK; Greig, NH				Li, Yazhou; Chigurupati, Srinivasulu; Holloway, Harold W.; Mughal, Mohamed; Tweedie, David; Bruestle, Daniel A.; Mattson, Mark P.; Wang, Yun; Harvey, Brandon K.; Ray, Balmiki; Lahiri, Debomoy K.; Greig, Nigel H.			Exendin-4 Ameliorates Motor Neuron Degeneration in Cellular and Animal Models of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; TYPE-2 DIABETES-MELLITUS; TRANSGENIC MOUSE MODEL; CENTRAL-NERVOUS-SYSTEM; PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; RECEPTOR EXPRESSION; ALZHEIMERS-DISEASE; GLUCOSE-METABOLISM; PROLONGS SURVIVAL	Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by a progressive loss of lower motor neurons in the spinal cord. The incretin hormone, glucagon-like peptide-1 (GLP-1), facilitates insulin signaling, and the long acting GLP-1 receptor agonist exendin-4 (Ex-4) is currently used as an anti-diabetic drug. GLP-1 receptors are widely expressed in the brain and spinal cord, and our prior studies have shown that Ex-4 is neuroprotective in several neurodegenerative disease rodent models, including stroke, Parkinson's disease and Alzheimer's disease. Here we hypothesized that Ex-4 may provide neuroprotective activity in ALS, and hence characterized Ex-4 actions in both cell culture (NSC-19 neuroblastoma cells) and in vivo (SOD1 G93A mutant mice) models of ALS. Ex-4 proved to be neurotrophic in NSC-19 cells, elevating choline acetyltransferase (ChAT) activity, as well as neuroprotective, protecting cells from hydrogen peroxide-induced oxidative stress and staurosporine-induced apoptosis. Additionally, in both wild-type SOD1 and mutant SOD1 (G37R) stably transfected NSC-19 cell lines, Ex-4 protected against trophic factor withdrawal-induced toxicity. To assess in vivo translation, SOD1 mutant mice were administered vehicle or Ex-4 at 6-weeks of age onwards to end-stage disease via subcutaneous osmotic pump to provide steady-state infusion. ALS mice treated with Ex-4 showed improved glucose tolerance and normalization of behavior, as assessed by running wheel, compared to control ALS mice. Furthermore, Ex-4 treatment attenuated neuronal cell death in the lumbar spinal cord; immunohistochemical analysis demonstrated the rescue of neuronal markers, such as ChAT, associated with motor neurons. Together, our results suggest that GLP-1 receptor agonists warrant further evaluation to assess whether their neuroprotective potential is of therapeutic relevance in ALS.	[Li, Yazhou; Chigurupati, Srinivasulu; Holloway, Harold W.; Mughal, Mohamed; Tweedie, David; Bruestle, Daniel A.; Mattson, Mark P.; Greig, Nigel H.] NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Wang, Yun; Harvey, Brandon K.] NIDA, Mol Neuropsychiat Branch, Intramural Res Program, NIH, Baltimore, MD USA; [Ray, Balmiki; Lahiri, Debomoy K.] Indiana Univ Sch Med, Inst Psychiat Res, Dept Psychiat, Indianapolis, IN USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Indiana University System; Indiana University Bloomington	Li, YZ (corresponding author), NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	Greign@grc.nia.nih.gov	Harvey, Brandon Keith/AAY-4080-2021; Lahiri, Debomoy/AAZ-3322-2020; Harvey, Brandon K/A-5559-2010; Mattson, Mark P/F-6038-2012	Harvey, Brandon Keith/0000-0002-4036-1383; 	National Institute on Aging and National Institute on Drug Abuse, National Institutes of Health; National Institute on Aging [AG18379, AG18884]; NATIONAL INSTITUTE ON AGING [R01AG018379, ZIAAG000313, ZIAAG000314, R01AG018884, ZIAAG000333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000461, ZIADA000576, ZIADA000443, ZIADA000429] Funding Source: NIH RePORTER	National Institute on Aging and National Institute on Drug Abuse, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the Intramural Research Programs of the National Institute on Aging and National Institute on Drug Abuse, National Institutes of Health, and by the National Institute on Aging grants (AG18379 and AG18884) to D. K. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, BEHAV BRAIN RES, V205, P265, DOI 10.1016/j.bbr.2009.06.035; Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Alvarez E, 2005, J NEUROCHEM, V92, P798, DOI 10.1111/j.1471-4159.2004.02914.x; Appel S H, 2011, Acta Myol, V30, P4; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Banks WA, 2004, J PHARMACOL EXP THER, V309, P469, DOI 10.1124/jpet.103.063222; Barbeito AG, 2010, J NEURAL TRANSM, V117, P981, DOI 10.1007/s00702-010-0429-0; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bruestle DA, 2009, NEUROMOL MED, V11, P58, DOI 10.1007/s12017-009-8064-3; Calara F, 2005, CLIN THER, V27, P210, DOI 10.1016/j.clinthera.2005.02.008; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chowen JA, 1999, NEUROPEPTIDES, V33, P212, DOI 10.1054/npep.1999.0757; Cozzolino M, 2008, ANTIOXID REDOX SIGN, V10, P405, DOI 10.1089/ars.2007.1760; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Dalle S, 2011, CURR MOL PHARM; de Aguilar JLG, 2007, J NEUROCHEM, V101, P1153, DOI 10.1111/j.1471-4159.2006.04408.x; DELGADO E, 1995, PEPTIDES, V16, P225, DOI 10.1016/0196-9781(94)00175-8; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dibaj P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017910; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Fortin JP, 2010, J PHARMACOL EXP THER, V332, P274, DOI 10.1124/jpet.109.160531; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; Gallwitz B, 2011, DRUGS, V71, P1675, DOI 10.2165/11592810-000000000-00000; Gurney ME, 1997, J NEUROL SCI, V152, pS67, DOI 10.1016/S0022-510X(97)00247-5; Gurney ME, 1998, NEUROLOGY, V50, P62, DOI 10.1212/WNL.50.1.62; Gurney ME, 1996, ANN NEUROL, V39, P147, DOI 10.1002/ana.410390203; Habib AA, 2011, EXPERT OPIN EMERG DR, V16, P537, DOI 10.1517/14728214.2011.604312; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hamilton A, 2009, NEUROREPORT, V20, P1161, DOI 10.1097/WNR.0b013e32832fbf14; Harkavyi A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-19; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Holscher C, 2010, VITAM HORM, V84, P331, DOI [10.1016/B978-0-12-381517-0.00013-8, 10.1016/S0083-6729(10)84005-1]; Holst JJ, 2011, CURR MED RES OPIN, V27, P547, DOI 10.1185/03007995.2010.549466; HUBBARD RW, 1992, NEUROLOGY, V42, P1532, DOI 10.1212/WNL.42.8.1532; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Isacson R, 2011, EUR J PHARMACOL, V650, P249, DOI 10.1016/j.ejphar.2010.10.008; Iwai T, 2006, NEUROSCI RES, V55, P352, DOI 10.1016/j.neures.2006.04.008; Kastin AJ, 2003, INT J OBESITY, V27, P313, DOI 10.1038/sj.ijo.0802206; Kato S, 2008, ACTA NEUROPATHOL, V115, P97, DOI 10.1007/s00401-007-0308-4; Kim S, 2009, J ENDOCRINOL, V202, P431, DOI 10.1677/JOE-09-0132; Kim SJ, 2011, CELL DEATH DIFFER; Korner M, 2007, J NUCL MED, V48, P736, DOI 10.2967/jnumed.106.038679; Lambrechts D, 2004, TRENDS MOL MED, V10, P275, DOI 10.1016/j.molmed.2004.04.004; Lee JC, 2011, NEUROL RES, V33, P33, DOI 10.1179/016164110X12807570509899; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Li YZ, 2010, J NEUROCHEM, V113, P1621, DOI 10.1111/j.1471-4159.2010.06731.x; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Lim JG, 2010, NEUROSCI LETT, V479, P13, DOI 10.1016/j.neulet.2010.05.017; Liu WJ, 2011, BRIT J PHARMACOL, V164, P1410, DOI 10.1111/j.1476-5381.2011.01272.x; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Luque MA, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730465; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Martin LJ, 2007, REV NEUROSCIENCE, V18, P115; McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011; Merchenthaler I, 1999, J COMP NEUROL, V403, P261, DOI 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nakagawa A, 2004, AUTON NEUROSCI-BASIC, V110, P36, DOI 10.1016/j.autneu.2003.11.001; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pawlyk AC, 2010, CURR PHARM DESIGN, V16, P2053; Pedersen WA, 1999, EXP NEUROL, V155, P1, DOI 10.1006/exnr.1998.6890; Pedersen WA, 1999, BRAIN RES, V833, P117, DOI 10.1016/S0006-8993(99)01471-7; Perry T, 2003, J NEUROSCI RES, V72, P603, DOI 10.1002/jnr.10611; Perry T, 2002, J PHARMACOL EXP THER, V300, P958, DOI 10.1124/jpet.300.3.958; Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481; Perry Tracy Ann, 2005, Current Alzheimer Research, V2, P377, DOI 10.2174/1567205054367892; Perry T, 2007, EXP NEUROL, V203, P293, DOI 10.1016/j.expneurol.2006.09.028; Pradat PF, 2010, AMYOTROPH LATERAL SC, V11, P166, DOI 10.3109/17482960902822960; Ray B, 2009, BRAIN RES, V1297, P160, DOI 10.1016/j.brainres.2009.07.096; REYES ET, 1984, J NEUROL SCI, V63, P317, DOI 10.1016/0022-510X(84)90154-0; Rouaux C, 2007, J NEUROSCI, V27, P5535, DOI 10.1523/JNEUROSCI.1139-07.2007; Schiffer D, 2004, AMYOTROPH LATERAL SC, V5, P22, DOI 10.1080/14660820310016822; Shibata N, 2001, NEUROPATHOLOGY, V21, P82, DOI 10.1046/j.1440-1789.2001.00361.x; Shimizu T, 2011, AMYOTROPH LATERAL SC, V12, P379, DOI 10.3109/17482968.2010.539234; Szayna M, 2000, ENDOCRINOLOGY, V141, P1936, DOI 10.1210/en.141.6.1936; Teramoto S, 2011, J CEREBR BLOOD F MET, V31, P1696, DOI 10.1038/jcbfm.2011.51; Vucic S, 2006, CLIN NEUROPHYSIOL, V117, P1458, DOI 10.1016/j.clinph.2006.04.016; Wang YM, 2007, J NEUROSCI, V27, P304, DOI 10.1523/JNEUROSCI.4433-06.2007; Wegorzewska I, 2011, NEURODEGENER DIS, V8, P262, DOI 10.1159/000321547; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Xie XY, 2011, MED SCI MONITOR, V17, pBR35, DOI 10.12659/MSM.881383	86	86	91	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32008	10.1371/journal.pone.0032008	http://dx.doi.org/10.1371/journal.pone.0032008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384126	Green Submitted, Green Published, gold			2022-12-27	WOS:000302916100044
J	Cedervall, T; Hansson, LA; Lard, M; Frohm, B; Linse, S				Cedervall, Tommy; Hansson, Lars-Anders; Lard, Mercy; Frohm, Birgitta; Linse, Sara			Food Chain Transport of Nanoparticles Affects Behaviour and Fat Metabolism in Fish	PLOS ONE			English	Article							PLASMA-PROTEIN ADSORPTION; SOLID-LIPID-NANOPARTICLES; APOLIPOPROTEIN-A-I; ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; FIBRILLATION; INHIBITION; EXPRESSION; PATTERNS; CORONA	Nano-sized (10(-9)-10(-7) m) particles offer many technical and biomedical advances over the bulk material. The use of nanoparticles in cosmetics, detergents, food and other commercial products is rapidly increasing despite little knowledge of their effect on organism metabolism. We show here that commercially manufactured polystyrene nanoparticles, transported through an aquatic food chain from algae, through zooplankton to fish, affect lipid metabolism and behaviour of the top consumer. At least three independent metabolic parameters differed between control and test fish: the weight loss, the triglycerides:cholesterol ratio in blood serum, and the distribution of cholesterol between muscle and liver. Moreover, we demonstrate that nanoparticles bind to apolipoprotein A-I in fish serum in-vitro, thereby restraining them from properly utilising their fat reserves if absorbed through ingestion. In addition to the metabolic effects, we show that consumption of nanoparticle-containing zooplankton affects the feeding behaviour of the fish. The time it took the fish to consume 95% of the food presented to them was more than doubled for nanoparticle-exposed compared to control fish. Since many nano-sized products will, through the sewage system, end up in freshwater and marine habitats, our study provides a potential bioassay for testing new nano-sized material before manufacturing. In conclusion, our study shows that from knowledge of the molecular composition of the protein corona around nanoparticles it is possible to make a testable molecular hypothesis and bioassay of the potential biological risks of a defined nanoparticle at the organism and ecosystem level.	[Cedervall, Tommy; Frohm, Birgitta; Linse, Sara] Lund Univ, Ctr Chem, Dept Biochem & Struct Biol, Lund, Sweden; [Hansson, Lars-Anders; Lard, Mercy] Lund Univ, Dept Biol Aquat Ecol, Lund, Sweden	Lund University; Lund University	Cedervall, T (corresponding author), Lund Univ, Ctr Chem, Dept Biochem & Struct Biol, Lund, Sweden.	Sara.Linse@biochemistry.lu.se	Hansson, Lars-Anders/HCI-2735-2022; Lard, Mercy/C-4193-2011; Cedervall, Tommy/AAT-9766-2021; Lard, Mercy/R-2035-2019; Lard, Mercy/AAV-6577-2021	Lard, Mercy/0000-0001-9243-4735; Cedervall, Tommy/0000-0003-2255-8446; Lard, Mercy/0000-0001-9243-4735; Hansson, Lars-Anders/0000-0002-3035-1317; Linse, Sara/0000-0001-9629-7109	Nano Vaccin Centre (Copenhagen); Crafoord Foundation (Lund); Swedish Government to the Nanometer Structure Consortium (Lund); Swedish Research Council, VR	Nano Vaccin Centre (Copenhagen); Crafoord Foundation (Lund); Swedish Government to the Nanometer Structure Consortium (Lund); Swedish Research Council, VR(Swedish Research Council)	This work was supported by Nano Vaccin Centre (Copenhagen), the Crafoord Foundation (Lund), Swedish Government to the Nanometer Structure Consortium (Lund), and the Swedish Research Council, VR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemann E, 1997, J BIOMED MATER RES, V37, P229, DOI 10.1002/(SICI)1097-4636(199711)37:2<229::AID-JBM12>3.0.CO;2-9; Babin PJ, 1997, P NATL ACAD SCI USA, V94, P8622, DOI 10.1073/pnas.94.16.8622; Behrens S, 2011, NANOSCALE, V3, P877, DOI 10.1039/c0nr00634c; Cabaleiro-Lago C, 2010, LANGMUIR, V26, P3453, DOI 10.1021/la902980d; Cabaleiro-Lago C, 2010, ACS CHEM NEUROSCI, V1, P279, DOI 10.1021/cn900027u; Cabaleiro-Lago C, 2008, J AM CHEM SOC, V130, P15437, DOI 10.1021/ja8041806; Cedervall T, 2007, ANGEW CHEM INT EDIT, V46, P5754, DOI 10.1002/anie.200700465; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Chang C, 2010, J AUTOIMMUN, V34, pJ234, DOI 10.1016/j.jaut.2009.11.009; Dell'Orco D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010949; Diederichs JE, 1996, ELECTROPHORESIS, V17, P607, DOI 10.1002/elps.1150170332; Goppert TM, 2005, EUR J PHARM BIOPHARM, V60, P361, DOI 10.1016/j.ejpb.2005.02.006; Goppert TM, 2005, J DRUG TARGET, V13, P179, DOI 10.1080/10611860500071292; Goppert TM, 2003, J DRUG TARGET, V11, P225, DOI 10.1080/10611860310001615956; Hellstrand E, 2009, FEBS J, V276, P3372, DOI 10.1111/j.1742-4658.2009.07062.x; Jiang Y, 2010, PLOS ONE, V5; Kashiwada S, 2006, ENVIRON HEALTH PERSP, V114, P1697, DOI 10.1289/ehp.9209; Lard M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013516; Linse S, 2007, P NATL ACAD SCI USA, V104, P8691, DOI 10.1073/pnas.0701250104; Llewellyn L, 1998, BBA-GENE STRUCT EXPR, V1442, P399, DOI 10.1016/S0167-4781(98)00171-7; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lynch I., 2006, DETECTING CRYPTIC EP, V2006, DOI [10.1126/stke.3272006pe14, DOI 10.1126/STKE.3272006PE14]; Lynch I, 2009, NAT NANOTECHNOL, V4, P546, DOI 10.1038/nnano.2009.248; Oberdorster E, 2004, ENVIRON HEALTH PERSP, V112, P1058, DOI 10.1289/ehp.7021; Oslakovic C, 2011, NANOMEDICIN IN PRESS; POWELL R, 1991, GENE, V104, P155, DOI 10.1016/0378-1119(91)90245-7; Ramsden CS, 2009, ECOTOXICOLOGY, V18, P939, DOI 10.1007/s10646-009-0357-7; Salvador-Morales C, 2006, MOL IMMUNOL, V43, P193, DOI 10.1016/j.molimm.2005.02.006; Smith CJ, 2007, AQUAT TOXICOL, V82, P94, DOI 10.1016/j.aquatox.2007.02.003; Subbiah R, 2010, CURR MED CHEM, V17, P4559, DOI 10.2174/092986710794183024; Thode K, 1997, PHARMACEUT RES, V14, P905, DOI 10.1023/A:1012104017761	31	277	296	14	213	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32254	10.1371/journal.pone.0032254	http://dx.doi.org/10.1371/journal.pone.0032254			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384193	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500089
J	Nino, G; Hu, AH; Grunstein, JS; McDonough, J; Kreiger, PA; Josephson, MB; Choi, JK; Grunstein, MM				Nino, Gustavo; Hu, Aihua; Grunstein, Judith S.; McDonough, Joseph; Kreiger, Portia A.; Josephson, Maureen B.; Choi, John K.; Grunstein, Michael M.			G Protein beta gamma-Subunit Signaling Mediates Airway Hyperresponsiveness and Inflammation in Allergic Asthma	PLOS ONE			English	Article							PHOSDUCIN-LIKE PROTEIN; SMALL-MOLECULE DISRUPTION; SMOOTH-MUSCLE FUNCTION; COUPLED RECEPTOR; ADRENOCEPTOR RESPONSIVENESS; ALTERED RESPONSIVENESS; PHOSPHODIESTERASE 4D5; KINASE PATHWAY; UP-REGULATION; MURINE MODEL	Since the G beta gamma subunit of Gi protein has been importantly implicated in regulating immune and inflammatory responses, this study investigated the potential role and mechanism of action of G beta gamma signaling in regulating the induction of airway hyperresponsiveness (AHR) in a rabbit model of allergic asthma. Relative to non-sensitized animals, OVA-sensitized rabbits challenged with inhaled OVA exhibited AHR, lung inflammation, elevated BAL levels of IL-13, and increased airway phosphodiesterase-4 (PDE4) activity. These proasthmatic responses were suppressed by pretreatment with an inhaled membrane-permeable anti-G beta gamma blocking peptide, similar to the suppressive effect of glucocorticoid pretreatment. Extended mechanistic studies demonstrated that: 1) corresponding proasthmatic changes in contractility exhibited in isolated airway smooth muscle (ASM) sensitized with serum from OVA-sensitized+challenged rabbits or IL-13 were also G beta gamma-dependent and mediated by MAPK-upregulated PDE4 activity; and 2) the latter was attributed to G beta gamma-induced direct stimulation of the nonreceptor tyrosine kinase, c-Src, resulting in downstream activation of ERK1/2 and its consequent transcriptional upregulation of PDE4. Collectively, these data are the first to identify that a mechanism involving G beta gamma-induced direct activation of c-Src, leading to ERK1/2-mediated upregulation of PDE4 activity, plays a decisive role in regulating the induction of AHR and inflammation in a rabbit model of allergic airway disease.	[Nino, Gustavo; Hu, Aihua; Grunstein, Judith S.; McDonough, Joseph; Josephson, Maureen B.; Grunstein, Michael M.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Pulm Med,Res Inst, Philadelphia, PA 19104 USA; [Nino, Gustavo] Penn State Univ, Coll Med, Div Pediat Pulm & Sleep Med, Hershey, PA USA; [Kreiger, Portia A.; Choi, John K.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pathol & Lab Med,Res Inst, Philadelphia, PA 19104 USA; [Kreiger, Portia A.] Nemours AI duPont Hosp Children, Dept Pathol, Wilmington, DE USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Nemours Alfred I. duPont Hospital for Children	Nino, G (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Pulm Med,Res Inst, Philadelphia, PA 19104 USA.	grunstein@email.chop.edu	Choi, John Kim/N-7558-2018	Choi, John Kim/0000-0002-2861-0180	National Institutes of Health (NIH) [HL-061038, HL097739]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061038, R01HL097739] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grants HL-061038 and HL097739. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe W, 1998, AM J PHYSIOL-LUNG C, V275, pL990, DOI 10.1152/ajplung.1998.275.5.L990; BAI TR, 1992, AM J RESP CELL MOL, V6, P647, DOI 10.1165/ajrcmb/6.6.647; Barr AJ, 2000, BIOCHEMISTRY-US, V39, P1800, DOI 10.1021/bi992021f; Billington CK, 2008, AM J RESP CELL MOL, V38, P1, DOI 10.1165/rcmb.2007-0171OC; Casey LM, 2010, CIRC RES, V107, P532, DOI 10.1161/CIRCRESAHA.110.217075; Chang M, 2000, J BIOL CHEM, V275, P7021, DOI 10.1074/jbc.275.10.7021; Chapman RW, 2007, EUR J PHARMACOL, V571, P215, DOI 10.1016/j.ejphar.2007.05.074; Conway AM, 1999, BIOCHEM J, V337, P171, DOI 10.1042/0264-6021:3370171; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Deshpande DA, 2006, CELL SIGNAL, V18, P2105, DOI 10.1016/j.cellsig.2006.04.008; Druey KM, 2009, IMMUNOL RES, V43, P62, DOI 10.1007/s12026-008-8050-0; Duan W, 2004, J IMMUNOL, V172, P7053, DOI 10.4049/jimmunol.172.11.7053; Ferry X, 2001, J IMMUNOL, V167, P4805, DOI 10.4049/jimmunol.167.9.4805; Gerthoffer WT, 2003, RESP PHYSIOL NEUROBI, V137, P237, DOI 10.1016/S1569-9048(03)00150-2; GOLDIE RG, 1986, BRIT J CLIN PHARMACO, V22, P669, DOI 10.1111/j.1365-2125.1986.tb02956.x; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; GRUNSTEIN MM, 1984, J APPL PHYSIOL, V57, P1238, DOI 10.1152/jappl.1984.57.4.1238; Grunstein MM, 2002, AM J PHYSIOL-LUNG C, V282, pL520, DOI 10.1152/ajplung.00343.2001; Hakonarson H, 1998, AM J RESP CRIT CARE, V158, pS115, DOI 10.1164/ajrccm.158.supplement_2.13tac700; Hakonarson H, 1998, P NATL ACAD SCI USA, V95, P5257, DOI 10.1073/pnas.95.9.5257; Hakonarson H, 2003, RESP PHYSIOL NEUROBI, V137, P263, DOI 10.1016/S1569-9048(03)00152-6; HAKONARSON H, 1995, AM J PHYSIOL-LUNG C, V269, pL645, DOI 10.1152/ajplung.1995.269.5.L645; Hakonarson H, 1996, J CLIN INVEST, V97, P2593, DOI 10.1172/JCI118708; Hakonarson H, 1998, J CLIN INVEST, V102, P1732, DOI 10.1172/JCI4141; Hansen G, 2000, P NATL ACAD SCI USA, V97, P6751, DOI 10.1073/pnas.97.12.6751; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hershenson MB, 2008, ANNU REV PATHOL-MECH, V3, P523, DOI 10.1146/annurev.pathmechdis.1.110304.100213; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hu AH, 2008, AM J PHYSIOL-LUNG C, V294, pL1055, DOI 10.1152/ajplung.00021.2008; Humrich J, 2005, J BIOL CHEM, V280, P20042, DOI 10.1074/jbc.M409233200; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Kanehiro A, 2001, AM J RESP CRIT CARE, V163, P173, DOI 10.1164/ajrccm.163.1.2001118; Keir SD, 2011, J PHARMACOL TOX MET, V64, P187, DOI 10.1016/j.vascn.2011.08.003; Kinyanjui MW, 2008, CAN J PHYSIOL PHARM, V86, P1, DOI [10.1139/Y07-125, 10.1139/y07-125]; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Krymskaya VP, 2007, CURR TOP DEV BIOL, V79, P61, DOI 10.1016/S0070-2153(06)79003-2; Kuehn HS, 2007, IMMUNOL LETT, V113, P59, DOI 10.1016/j.imlet.2007.08.007; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Laporte JC, 2001, AM J RESP CRIT CARE, V164, P141, DOI 10.1164/ajrccm.164.1.2008060; Le Jeune IR, 2002, J BIOL CHEM, V277, P35980, DOI 10.1074/jbc.M204832200; Lee PJ, 2006, J CLIN INVEST, V116, P163, DOI 10.1172/JCI25711; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; McGraw DW, 2007, J CLIN INVEST, V117, P1391, DOI 10.1172/JCI30489; Mizutani N, 2011, IMMUNOL LET IN PRESS; Moynihan B, 2008, AM J PHYSIOL-LUNG C, V295, pL171, DOI 10.1152/ajplung.00457.2007; Nino G, 2010, J ALLERGY CLIN IMMUN, V125, P1020, DOI 10.1016/j.jaci.2010.02.007; Nino G, 2009, AM J PHYSIOL-LUNG C, V297, pL746, DOI 10.1152/ajplung.00079.2009; Nocker RET, 1999, INT ARCH ALLERGY IMM, V119, P45, DOI 10.1159/000024174; Ohnishi H, 2009, J ALLERGY CLIN IMMUN, V123, P249, DOI 10.1016/j.jaci.2008.10.054; Savage JR, 2000, J BIOL CHEM, V275, P30399, DOI 10.1074/jbc.M005120200; Schroder S, 2000, N-S ARCH PHARMACOL, V362, P435, DOI 10.1007/s002100000298; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Sun JG, 2006, LIFE SCI, V79, P2077, DOI 10.1016/j.lfs.2006.07.001; Tang HF, 2005, AM J RESP CRIT CARE, V171, P823, DOI 10.1164/rccm.200406-771OC; Taube C, 2003, J IMMUNOL, V170, P4301, DOI 10.4049/jimmunol.170.8.4301; Thibault C, 1997, J BIOL CHEM, V272, P12253, DOI 10.1074/jbc.272.19.12253; Trian T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020000; Trifilieff A, 2000, AM J PHYSIOL-LUNG C, V279, pL1120, DOI 10.1152/ajplung.2000.279.6.L1120; van Schalkwyk E, 2005, J ALLERGY CLIN IMMUN, V116, P292, DOI 10.1016/j.jaci.2005.04.023; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Zschauer AOA, 1999, J APPL PHYSIOL, V86, P1721, DOI 10.1152/jappl.1999.86.5.1721	69	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32078	10.1371/journal.pone.0032078	http://dx.doi.org/10.1371/journal.pone.0032078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384144	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500072
J	Souza, MS; Hansson, LA; Hylander, S; Modenutti, B; Balseiro, E				Sol Souza, Maria; Hansson, Lars-Anders; Hylander, Samuel; Modenutti, Beatriz; Balseiro, Esteban			Rapid Enzymatic Response to Compensate UV Radiation in Copepods	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; ACETYLCHOLINESTERASE ACTIVITY; PHOTOPROTECTIVE COMPOUNDS; OXIDATIVE STRESS; AMINO-ACIDS; ZOOPLANKTON; PIGMENTATION; PREDATION; DAPHNIA; APOPTOSIS	Ultraviolet radiation (UVR) causes physical damage to DNA, carboxylation of proteins and peroxidation of lipids in copepod crustaceans, ubiquitous and abundant secondary producers in most aquatic ecosystems. Copepod adaptations for long duration exposures include changes in behaviour, changes in pigmentation and ultimately changes in morphology. Adaptations to short-term exposures are little studied. Here we show that short-duration exposure to UVR causes the freshwater calanoid copepod, Eudiaptomus gracilis, to rapidly activate production of enzymes that prevent widespread collateral peroxidation (glutathione S-transferase, GST), that regulate apoptosis cell death (Caspase-3, Casp-3), and that facilitate neurotransmissions (cholinesterase-ChE). None of these enzyme systems is alone sufficient, but they act in concert to reduce the stress level of the organism. The interplay among enzymatic responses provides useful information on how organisms respond to environmental stressors acting on short time scales.	[Sol Souza, Maria; Modenutti, Beatriz; Balseiro, Esteban] INIBIOMA CONICET UNComahue, Lab Limnol, San Carlos De Bariloche, Rio Negro, Argentina; [Hansson, Lars-Anders; Hylander, Samuel] Lund Univ, Inst Biol Aquat Ecol, Lund, Sweden	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Lund University	Souza, MS (corresponding author), INIBIOMA CONICET UNComahue, Lab Limnol, San Carlos De Bariloche, Rio Negro, Argentina.	Lars-Anders.Hansson@biol.lu.se	Balseiro, Esteban/Y-2743-2019; Hansson, Lars-Anders/HCI-2735-2022	Balseiro, Esteban/0000-0002-5052-0587; Hansson, Lars-Anders/0000-0002-3035-1317; Hylander, Samuel/0000-0002-3740-5998; Modenutti, Beatriz/0000-0002-8683-5679	CONICET (Argentina); Swedish Research Council (VR) [PICT 2007-01256, PICT 2007-01258]	CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Swedish Research Council (VR)(Swedish Research Council)	This work was carried out during a stay at Lund University (Sweden) of MSS supported by CONICET (Argentina). The authors acknowledge the support of the Swedish Research Council (VR) to LAH, PICT 2007-01256 to BM and PICT 2007-01258 to EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balseiro E, 2008, LIMNOL OCEANOGR, V53, P2383, DOI 10.4319/lo.2008.53.6.2383; Bancroft BA, 2007, ECOL LETT, V10, P332, DOI 10.1111/j.1461-0248.2007.01022.x; Borgeraas J, 2000, J PLANKTON RES, V22, P1167, DOI 10.1093/plankt/22.6.1167; Borgeraas J, 2002, ARCH HYDROBIOL, V156, P83, DOI 10.1127/0003-9136/2002/0156-0083; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fischer JM, 2006, PHOTOCHEM PHOTOBIOL, V82, P547, DOI 10.1562/2005-08-30-RA-664; Forget J, 2003, AQUAT TOXICOL, V62, P195, DOI 10.1016/S0166-445X(02)00084-X; Gabriel W, 2005, J EVOLUTION BIOL, V18, P873, DOI 10.1111/j.1420-9101.2005.00959.x; Gabriel W, 2005, AM NAT, V166, P339, DOI 10.1086/432558; Gewies A, 2003, APOREVIEW, V1002, P1; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HAIRSTON NG, 1979, LIMNOL OCEANOGR, V24, P38, DOI 10.4319/lo.1979.24.1.0038; Hansson LA, 2000, P ROY SOC B-BIOL SCI, V267, P2327, DOI 10.1098/rspb.2000.1287; Hansson LA, 2004, ECOLOGY, V85, P1005, DOI 10.1890/02-0525; Hansson LA, 2007, ECOLOGY, V88, P1932, DOI 10.1890/06-2038.1; Hansson LA, 2009, PHOTOCH PHOTOBIO SCI, V8, P1266, DOI 10.1039/b908825c; Hylander S, 2009, LIMNOL OCEANOGR, V54, P1883, DOI 10.4319/lo.2009.54.6.1883; Hylander S, 2009, LIMNOL OCEANOGR, V54, P483, DOI 10.4319/lo.2009.54.2.0483; Janknegt PJ, 2009, EUR J PHYCOL, V44, P525, DOI 10.1080/09670260902943273; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Kessler K, 2008, LIMNOL OCEANOGR, V53, P2374, DOI 10.4319/lo.2008.53.6.2374; Linan-Cabello MA, 2010, REV BIOL TROP, V58, P103; Lockshin RA, 2001, NAT REV MOL CELL BIO, V2, P545, DOI 10.1038/35080097; Lopez-Martinez G, 2008, INSECT BIOCHEM MOLEC, V38, P796, DOI 10.1016/j.ibmb.2008.05.006; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacFadyen EJ, 2004, GLOBAL CHANGE BIOL, V10, P408, DOI 10.1111/j.1529-8817.2003.00750.x; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Menze MA, 2010, APOPTOSIS, V15, P293, DOI 10.1007/s10495-009-0443-6; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moeller RE, 2005, LIMNOL OCEANOGR, V50, P427, DOI 10.4319/lo.2005.50.2.0427; Murphy G, 2001, EXP DERMATOL, V10, P155, DOI 10.1034/j.1600-0625.2001.010003155.x; Persaud AD, 2007, FRESHWATER BIOL, V52, P2121, DOI 10.1111/j.1365-2427.2007.01833.x; Pigliucci M., 2001, SYN ECO EVO; Richardson H, 2002, J IMMUNOL METHODS, V265, P21, DOI 10.1016/S0022-1759(02)00068-6; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Romano G, 2003, J EXP BIOL, V206, P3487, DOI 10.1242/jeb.00580; Siebeck Otto, 1994, Advances in Limnology, V43, P101; Souza MS, 2010, PHOTOCHEM PHOTOBIOL, V86, P367, DOI 10.1111/j.1751-1097.2009.00675.x; Souza MS, 2010, LIMNOL OCEANOGR, V55, P1024, DOI 10.4319/lo.2010.55.3.1024; Souza MS, 2007, WATER AIR SOIL POLL, V183, P49, DOI 10.1007/s11270-007-9354-8; Tartarotti B, 2004, J PLANKTON RES, V26, P753, DOI 10.1093/plankt/fbh073; Tartarotti B, 2002, ARCH HYDROBIOL, V154, P691; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; West-Eberhard Mary Jane, 2003, pi; Williamson CE, 2010, SCIENCE, V329, P637, DOI 10.1126/science.1191192	48	21	23	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32046	10.1371/journal.pone.0032046	http://dx.doi.org/10.1371/journal.pone.0032046			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384136	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500067
J	Coppola, A; Tomasello, L; Pizzolanti, G; Pucci-Minafra, I; Albanese, N; Di Cara, G; Cancemi, P; Pitrone, M; Bommarito, A; Carissimi, E; Zito, G; Criscimanna, A; Galluzzo, A; Giordano, C				Coppola, Antonina; Tomasello, Laura; Pizzolanti, Giuseppe; Pucci-Minafra, Ida; Albanese, Nadia; Di Cara, Gianluca; Cancemi, Patrizia; Pitrone, Maria; Bommarito, Alessandra; Carissimi, Elvira; Zito, Giovanni; Criscimanna, Angela; Galluzzo, Aldo; Giordano, Carla			In Vitro Phenotypic, Genomic and Proteomic Characterization of a Cytokine-Resistant Murine beta-TC3 Cell Line	PLOS ONE			English	Article							NF-KAPPA-B; INSULIN-SECRETION; RAT ISLETS; INDUCED DYSFUNCTION; PROTEIN EXPRESSION; GENE-EXPRESSION; APOPTOSIS; AUTOIMMUNE; SUMO4; STRESS	Type 1 diabetes mellitus (T1DM) is caused by the selective destruction of insulin-producing beta-cells. This process is mediated by cells of the immune system through release of nitric oxide, free radicals and pro-inflammatory cytokines, which induce a complex network of intracellular signalling cascades, eventually affecting the expression of genes involved in beta-cell survival. The aim of our study was to investigate possible mechanisms of resistance to cytokine-induced beta-cell death. To this purpose, we created a cytokine-resistant beta-cell line (beta-TC3R) by chronically treating the beta-TC3 murine insulinoma cell line with IL-1 beta + IFN-gamma. beta-TC3R cells exhibited higher proliferation rate and resistance to cytokine-mediated cell death in comparison to the parental line. Interestingly, they maintained expression of beta-cell specific markers, such as PDX1, NKX6.1, GLUT2 and insulin. The analysis of the secretory function showed that beta-TC3R cells have impaired glucose-induced c-peptide release, which however was only moderately reduced after incubation with KCl and tolbutamide. Gene expression analysis showed that beta-TC3R cells were characterized by downregulation of IL-1 beta and IFN-gamma receptors and upregulation of SOCS3, the classical negative regulator of cytokines signaling. Comparative proteomic analysis showed specific upregulation of 35 proteins, mainly involved in cell death, stress response and folding. Among them, SUMO4, a negative feedback regulator in NF-kB and JAK/STAT signaling pathways, resulted hyper-expressed. Silencing of SUMO4 was able to restore sensitivity to cytokine-induced cell death in beta-TC3R cells, suggesting it may play a key role in acquired cytokine resistance by blocking JAK/STAT and NF-kB lethal signaling. In conclusion, our study represents the first extensive proteomic characterization of a murine cytokine-resistant beta-cell line, which might represent a useful tool for studying the mechanisms involved in resistance to cytokine-mediated beta-cell death. This knowledge may be of potential benefit for patients with T1DM. In particular, SUMO4 could be used as a therapeutical target.	[Coppola, Antonina; Tomasello, Laura; Pizzolanti, Giuseppe; Pitrone, Maria; Bommarito, Alessandra; Carissimi, Elvira; Zito, Giovanni; Criscimanna, Angela; Galluzzo, Aldo; Giordano, Carla] Univ Palermo, Endocrinol Sect, Dipartimento Biomed Med Interna & Specialist DIBI, Palermo, Italy; [Albanese, Nadia] Univ Palermo, Dept Phys, Ctr Oncobiol Sperimentale COBS, I-90123 Palermo, Italy; [Cancemi, Patrizia] Univ Palermo, Sect Expt Oncol, Dipartimento Biomed Med Interna & Specialist DIBI, Palermo, Italy; [Giordano, Carla] Inst Biomed & Mol Immunol A Monroy CNR IBIM, Palermo, Italy	University of Palermo; University of Palermo; University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR)	Coppola, A (corresponding author), Univ Palermo, Endocrinol Sect, Dipartimento Biomed Med Interna & Specialist DIBI, Palermo, Italy.	carla.giordano@unipa.it	Pizzolanti, Giuseppe/K-7097-2016; Coppola, Antonina/AAJ-6763-2020; GIORDANO, Carla/R-4296-2017; Zito, Giovanni/AAC-3639-2022; Tomasello, Laura/AAR-2339-2021; Coppola, Antonina/AAO-8203-2020; Coppola, Antonina/AAE-5901-2021; Albanese, Nadia/AAN-3634-2020; , Zito/O-3836-2019; Pizzolanti, Giuseppe/I-4547-2019	Pizzolanti, Giuseppe/0000-0001-6052-8438; GIORDANO, Carla/0000-0003-1731-9395; Coppola, Antonina/0000-0001-6664-8553; , Zito/0000-0002-0482-6729; CANCEMI, Patrizia/0000-0002-3951-7213; TOMASELLO, Laura/0000-0002-2304-6007				Ahmed M, 2005, DIABETOLOGIA, V48, P477, DOI 10.1007/s00125-004-1661-7; Babic I, 2006, ONCOGENE, V25, P4955, DOI 10.1038/sj.onc.1209504; Cailleau C, 1997, DIABETES, V46, P937, DOI 10.2337/diabetes.46.6.937; Cardozo AK, 2003, J PROTEOME RES, V2, P553, DOI 10.1021/pr034029o; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Chen GX, 2001, J BIOL CHEM, V276, P766, DOI 10.1074/jbc.M008330200; Chen XL, 2006, AM J PHYSIOL-HEART C, V290, pH1862, DOI 10.1152/ajpheart.00651.2005; D'Hertog W, 2007, MOL CELL PROTEOMICS, V6, P2180, DOI 10.1074/mcp.M700085-MCP200; Darville MI, 1998, DIABETOLOGIA, V41, P1101, DOI 10.1007/s001250051036; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Fernandez C, 2008, J PROTEOME RES, V7, P400, DOI 10.1021/pr070547d; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; Jacobsen MLB, 2009, DIABETOLOGIA, V52, P281, DOI 10.1007/s00125-008-1199-1; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; Kaminitz A, 2007, IMMUNOL CELL BIOL, V85, P582, DOI 10.1038/sj.icb.7100093; Karlsen AE, 2001, P NATL ACAD SCI USA, V98, P12191, DOI 10.1073/pnas.211445998; Kracklauer Martin P, 2003, Mol Cancer, V2, P39, DOI 10.1186/1476-4598-2-39; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; Larsen PM, 2001, DIABETES, V50, P1056, DOI 10.2337/diabetes.50.5.1056; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; Melloul D, 2008, BIOCHEM SOC T, V36, P334, DOI 10.1042/BST0360334; Minami K, 2000, AM J PHYSIOL-ENDOC M, V279, pE773, DOI 10.1152/ajpendo.2000.279.4.E773; NICOLETTI F, 1994, EUR J IMMUNOL, V24, P1843, DOI 10.1002/eji.1830240818; Nicoletti F, 1997, ENDOCRINOLOGY, V138, P281, DOI 10.1210/en.138.1.281; Nielsen K, 2004, DIABETOLOGIA, V47, P62, DOI 10.1007/s00125-003-1277-3; Ortis F, 2006, MOL ENDOCRINOL, V20, P1867, DOI 10.1210/me.2005-0268; Pirot P, 2006, DIABETOLOGIA, V49, P1229, DOI 10.1007/s00125-006-0214-7; Pucci-Minafra I, 2002, PROTEOMICS, V2, P919, DOI 10.1002/1615-9861(200207)2:7<919::AID-PROT919>3.0.CO;2-P; SJOHOLM A, 1991, IMMUNOL LETT, V30, P81, DOI 10.1016/0165-2478(91)90093-P; SOUTHERN C, 1990, BIOCHEM J, V272, P243, DOI 10.1042/bj2720243; Sparre T, 2002, DIABETOLOGIA, V45, P1550, DOI 10.1007/s00125-002-0953-z; Stassi G, 1995, TRANSPLANT P, V27, P3271; Stassi G, 1997, J EXP MED, V186, P1193, DOI 10.1084/jem.186.8.1193; Suk K, 2001, J IMMUNOL, V166, P4481, DOI 10.4049/jimmunol.166.7.4481; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; Wang CY, 2008, DIABETES-METAB RES, V24, P93, DOI 10.1002/dmrr.797; Wang CY, 2009, BIOCHEM BIOPH RES CO, V381, P477, DOI 10.1016/j.bbrc.2009.02.060; Watson D, 2009, BRIT J BIOMED SCI, V66, P208, DOI 10.1080/09674845.2009.11730278; WELSH N, 1991, ENDOCRINOLOGY, V129, P3167, DOI 10.1210/endo-129-6-3167; Whittle N, 2011, AMINO ACIDS, V40, P1231, DOI 10.1007/s00726-010-0758-1; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Zou YF, 2010, INT J IMMUNOGENET, V37, P345, DOI 10.1111/j.1744-313X.2010.00931.x	45	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32109	10.1371/journal.pone.0032109	http://dx.doi.org/10.1371/journal.pone.0032109			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393382	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500035
J	Kaushik, DK; Gupta, M; Kumawat, KL; Basu, A				Kaushik, Deepak Kumar; Gupta, Malvika; Kumawat, Kanhaiya Lal; Basu, Anirban			NLRP3 Inflammasome: Key Mediator of Neuroinflammation in Murine Japanese Encephalitis	PLOS ONE			English	Article							WEST NILE VIRUS; NALP3 INFLAMMASOME; MICROGLIAL ACTIVATION; OXIDATIVE STRESS; INFLUENZA-VIRUS; HOST RESPONSE; INTERLEUKIN-1-BETA; EXPRESSION; CASPASE-1; IL-1-BETA	Background: Japanese Encephalitis virus (JEV) is a common cause of acute and epidemic viral encephalitis. JEV infection is associated with microglial activation resulting in the production of pro-inflammatory cytokines including Interleukin-1 beta (IL-1 beta) and Interleukin-18 (IL-18). The Pattern Recognition Receptors (PRRs) and the underlying mechanism by which microglia identify the viral particle leading to the production of these cytokines is unknown. Methodology/Principal Findings: For our studies, we have used murine model of JEV infection as well as BV-2 mouse microglia cell line. In this study, we have identified a signalling pathway which leads to the activation of caspase-1 as the key enzyme responsible for the maturation of both IL-1 beta and IL-18 in NACHT, LRR and PYD domains-containing protein-3 (NLRP3) dependent manner. Depletion of NLRP3 results in the reduction of caspase-1 activity and subsequent production of these cytokines. Conclusion/Significance: Our results identify a mechanism mediated by Reactive Oxygen Species (ROS) production and potassium efflux as the two danger signals that link JEV infection to caspase-1 activation resulting in subsequent IL-1 beta and IL-18 maturation.	[Kaushik, Deepak Kumar; Gupta, Malvika; Kumawat, Kanhaiya Lal; Basu, Anirban] Natl Brain Res Ctr, Manesar, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Kaushik, DK (corresponding author), Natl Brain Res Ctr, Manesar, Haryana, India.	deepakkaushiik@gmail.com		Basu, Anirban/0000-0002-5200-2054	Department of Biotechnology; Indian Council of Medical Research, Government of India	Department of Biotechnology; Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	This work was supported by the core grant from the Department of Biotechnology, to the National Brain Research Centre, Government of India. DKK is the recipient of Senior Research Fellowship from Indian Council of Medical Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Barlan AU, 2011, J VIROL, V85, P146, DOI 10.1128/JVI.01265-10; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; Burns K, 2003, CURR OPIN IMMUNOL, V15, P26, DOI 10.1016/S0952-7915(02)00017-1; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Chakraborty S, 2010, J NEUROSCI RES, V88, P1615, DOI 10.1002/jnr.22343; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08; Das S, 2008, J NEUROIMMUNOL, V195, P60, DOI 10.1016/j.jneuroim.2008.01.009; Das S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017225; Das S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008134; Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034; Dinarello CA, 2006, AM J CLIN NUTR, V83, p447S; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Gupta N, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-92; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kaisho T, 2000, CRIT REV IMMUNOL, V20, P393; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kaushik DK, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-68; Kaushik DK, 2011, FRONT BIOSCI-LANDMRK, V16, P2187, DOI 10.2741/3847; Krady JK, 2002, GLIA, V40, P11, DOI 10.1002/glia.10101; KUMAR R, 1990, INDIAN J MED RES-A, V91, P321; Levison SW, 2003, DEV NEUROSCI-BASEL, V25, P184, DOI 10.1159/000072267; Lin RJ, 2004, J GEN VIROL, V85, P521, DOI 10.1099/vir.0.19496-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mishra MK, 2008, J NEUROCHEM, V105, P1582, DOI 10.1111/j.1471-4159.2008.05238.x; Mishra MK, 2009, NEUROCHEM INT, V54, P464, DOI 10.1016/j.neuint.2009.01.022; Mukherjee SB, 2002, J BIOL CHEM, V277, P24717, DOI 10.1074/jbc.M201961200; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nadiri A, 2006, J IMMUNOL, V177, P4239, DOI 10.4049/jimmunol.177.7.4239; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nazmi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021761; Nour AM, 2011, J BIOL CHEM, V286, P17921, DOI 10.1074/jbc.M110.210575; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Philpott DJ, 2000, J IMMUNOL, V165, P903, DOI 10.4049/jimmunol.165.2.903; Rajan JV, 2011, J VIROL, V85, P4167, DOI 10.1128/JVI.01687-10; Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Thongtan T, 2010, MICROBES INFECT, V12, P37, DOI 10.1016/j.micinf.2009.09.013; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; Verma D, 2008, ARTHRITIS RHEUM, V58, P888, DOI 10.1002/art.23286; WESTAWAY EG, 1985, INTERVIROLOGY, V24, P183, DOI 10.1159/000149642; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	56	100	106	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32270	10.1371/journal.pone.0032270	http://dx.doi.org/10.1371/journal.pone.0032270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393394	Green Published, gold, Green Submitted			2022-12-27	WOS:000303003500047
J	Zhang, XK; Robertson, G; Woo, S; Hoffman, BG; Gottardo, R				Zhang, Xuekui; Robertson, Gordon; Woo, Sangsoon; Hoffman, Brad G.; Gottardo, Raphael			Probabilistic Inference for Nucleosome Positioning with MNase-Based or Sonicated Short-Read Data	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; RECOGNITION; METHYLATION; OCCUPANCY; ELEMENTS	We describe a model-based method, PING, for predicting nucleosome positions in MNase-Seq and MNase- or sonicated-ChIP-Seq data. PING compares favorably to NPS and TemplateFilter in scalability, accuracy and robustness to low read density. To demonstrate that PING predictions from widely available sonicated data can have sufficient spatial resolution to be to be useful for biological inference, we use Illumina H3K4me1 ChIP-seq data to detect changes in nucleosome positioning around transcription factor binding sites due to tamoxifen stimulation, to discriminate functional and nonfunctional transcription factor binding sites more effectively than with enrichment profiles, and to confirm that the pioneer transcription factor Foxa2 associates with the accessible major groove of nucleosomal DNA.	[Zhang, Xuekui] Univ British Columbia, Dept Stat, Vancouver, BC V6T 1W5, Canada; [Robertson, Gordon] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Woo, Sangsoon; Gottardo, Raphael] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Woo, Sangsoon; Gottardo, Raphael] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Hoffman, Brad G.] Sunny Hill Hlth Ctr, Vancouver, BC, Canada; [Hoffman, Brad G.] British Columbia Childrens Hosp, Child & Family Res Inst, Vancouver, BC V6H 3V4, Canada; [Hoffman, Brad G.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada	University of British Columbia; British Columbia Cancer Agency; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; BC Childrens Hospital; Child & Family Research Institute; University of British Columbia; University of British Columbia	Zhang, XK (corresponding author), Univ British Columbia, Dept Stat, Vancouver, BC V6T 1W5, Canada.	rgottard@fhcrc.org	Gottardo, Raphael/HCH-3169-2022; Zhang, Xuekui/C-5105-2015	Zhang, Xuekui/0000-0003-4728-2343; Hoffman, Brad/0000-0002-5420-4493; Gottardo, Raphael/0000-0002-3867-0232	National Insititutes of Health [HG005692]; Natural Sciences and Engineering Research Council of Canada; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005692] Funding Source: NIH RePORTER	National Insititutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	RG was supported by National Insititutes of Health HG005692. XZ was supported by Natural Sciences and Engineering Research Council of Canada via the Alexander Graham Bell Canada Graduate Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Besag J, 1995, BIOMETRIKA, V82, P733, DOI 10.2307/2337341; Cirillo LA, 2007, J MOL BIOL, V366, P720, DOI 10.1016/j.jmb.2006.11.087; Clark DJ, 2010, J BIOMOL STRUCT DYN, V27, P781, DOI 10.1080/073911010010524945; Conerly ML, 2010, GENOME RES, V20, P1383, DOI 10.1101/gr.106542.110; Edayathumangalam RS, 2004, P NATL ACAD SCI USA, V101, P6864, DOI 10.1073/pnas.0401743101; Elsaesser SJ, 2010, CURR OPIN GENET DEV, V20, P110, DOI 10.1016/j.gde.2010.01.003; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoffman BG, 2010, GENOME RES, V20, P1037, DOI 10.1101/gr.104356.109; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kuan PF, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1454; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Lo K, 2007, BIOINFORMATICS, V23, P328, DOI 10.1093/bioinformatics/btl612; Longo A, 2007, BIOCHEMISTRY-US, V46, P2948, DOI 10.1021/bi060969l; Munzel U, 2001, BIOMETRICAL J, V43, P553, DOI 10.1002/1521-4036(200109)43:5<553::AID-BIMJ553>3.0.CO;2-N; Ong MS, 2007, J MOL BIOL, V368, P1067, DOI 10.1016/j.jmb.2007.02.062; Radman-Livaja M, 2010, DEV BIOL, V339, P258, DOI 10.1016/j.ydbio.2009.06.012; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Tong EHY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008435; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Zhang XK, 2011, BIOMETRICS, V67, P151, DOI 10.1111/j.1541-0420.2010.01441.x; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-537; Zhang ZH, 2011, CELL, V144, P175, DOI 10.1016/j.cell.2011.01.003	35	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32095	10.1371/journal.pone.0032095	http://dx.doi.org/10.1371/journal.pone.0032095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393380	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500033
J	Kraning-Rush, CM; Califano, JP; Reinhart-King, CA				Kraning-Rush, Casey M.; Califano, Joseph P.; Reinhart-King, Cynthia A.			Cellular Traction Stresses Increase with Increasing Metastatic Potential	PLOS ONE			English	Article							BREAST-CANCER; TUMOR-CELL; MATRIX STIFFNESS; SUBSTRATE STIFFNESS; EPITHELIAL-CELLS; INVASION; MIGRATION; ADHESION; CONTACT; PROGRAM	Cancer cells exist in a mechanically and chemically heterogeneous microenvironment which undergoes dynamic changes throughout neoplastic progression. During metastasis, cells from a primary tumor acquire characteristics that enable them to escape from the primary tumor and migrate through the heterogeneous stromal environment to establish secondary tumors. Despite being linked to poor prognosis, there are no direct clinical tests available to diagnose the likelihood of metastasis. Moreover, the physical mechanisms employed by metastatic cancer cells to migrate are poorly understood. Because metastasis of most solid tumors requires cells to exert force to reorganize and navigate through dense stroma, we investigated differences in cellular force generation between metastatic and non-metastatic cells. Using traction force microscopy, we found that in human metastatic breast, prostate and lung cancer cell lines, traction stresses were significantly increased compared to non-metastatic counterparts. This trend was recapitulated in the isogenic MCF10AT series of breast cancer cells. Our data also indicate that increased matrix stiffness and collagen density promote increased traction forces, and that metastatic cells generate higher forces than non-metastatic cells across all matrix properties studied. Additionally, we found that cell spreading for these cell lines has a direct relationship with collagen density, but a biphasic relationship with substrate stiffness, indicating that cell area alone does not dictate the magnitude of traction stress generation. Together, these data suggest that cellular contractile force may play an important role in metastasis, and that the physical properties of the stromal environment may regulate cellular force generation. These findings are critical for understanding the physical mechanisms of metastasis and the role of the extracellular microenvironment in metastatic progression.	[Kraning-Rush, Casey M.; Califano, Joseph P.; Reinhart-King, Cynthia A.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA	Cornell University	Kraning-Rush, CM (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.	cak57@cornell.edu	Reinhart-King, Cynthia A./A-9264-2016	Reinhart-King, Cynthia A./0000-0001-6959-3914	Cornell Center on the Microenvironment and Metastasis from the National Cancer Institute [U54CA143876]; National Science Foundation; NATIONAL CANCER INSTITUTE [U54CA143876] Funding Source: NIH RePORTER	Cornell Center on the Microenvironment and Metastasis from the National Cancer Institute; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Cornell Center on the Microenvironment and Metastasis through Award Number U54CA143876 from the National Cancer Institute to CAR-K and a National Science Foundation Graduate Research Fellowship to CMK-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EL, 2010, BIOPHYS J, V99, P2048, DOI 10.1016/j.bpj.2010.07.051; Baker EL, 2009, BIOPHYS J, V97, P1013, DOI 10.1016/j.bpj.2009.05.054; Bloom RJ, 2008, BIOPHYS J, V95, P4077, DOI 10.1529/biophysj.108.132738; Califano JP, 2010, CELL MOL BIOENG, V3, P68, DOI 10.1007/s12195-010-0102-6; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Darling EM, 2007, BIOPHYS J, V92, P1784, DOI 10.1529/biophysj.106.083097; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Dennis C, 2006, NATURE, V442, P739, DOI 10.1038/442739a; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Duffy MJ, 1996, CLIN CANCER RES, V2, P613; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Gaudet C, 2003, BIOPHYS J, V85, P3329, DOI 10.1016/S0006-3495(03)74752-3; Gjorevski N, 2010, INTEGR BIOL-UK, V2, P424, DOI 10.1039/c0ib00040j; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Huynh J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002761; Indra I, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015015; Ioachim E, 2002, EUR J CANCER, V38, P2362, DOI 10.1016/S0959-8049(02)00210-1; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kim JH, 2011, J CELL SCI, V124, P1280, DOI 10.1242/jcs.078394; Kim SH, 2009, INT J CANCER, V124, P2813, DOI 10.1002/ijc.24278; Kraning-Rush CM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015009; Kraning-Rush CM, 2012, COMPUTATION IN PRESS; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lemmon CA, 2009, BIOPHYS J, V96, P729, DOI 10.1016/j.bpj.2008.10.009; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lopez JI, 2011, INTEGR BIOL-UK, V3, P910, DOI 10.1039/c1ib00043h; Martin LJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1831; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Mierke CT, 2008, BIOPHYS J, V94, P2832, DOI 10.1529/biophysj.107.113613; Ozanne BW, 2000, EUR J CANCER, V36, P1640, DOI 10.1016/S0959-8049(00)00175-1; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pickle LW, 2007, CA-CANCER J CLIN, V57, P30, DOI 10.3322/canjclin.57.1.30; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320; Reinhart-King CA, 2008, METHOD ENZYMOL, V443, P45, DOI 10.1016/S0076-6879(08)02003-X; Rosel D, 2008, MOL CANCER RES, V6, P1410, DOI 10.1158/1541-7786.MCR-07-2174; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; Tseng QZ, 2011, LAB CHIP, V11, P2231, DOI 10.1039/c0lc00641f; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	55	256	256	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32572	10.1371/journal.pone.0032572	http://dx.doi.org/10.1371/journal.pone.0032572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389710	gold, Green Submitted, Green Published			2022-12-27	WOS:000302999600049
J	Lagemann, L; Okamoto, H; Teismann, H; Pantev, C				Lagemann, Lothar; Okamoto, Hidehiko; Teismann, Henning; Pantev, Christo			Involuntary Monitoring of Sound Signals in Noise Is Reflected in the Human Auditory Evoked N1m Response	PLOS ONE			English	Article							TONOTOPIC ORGANIZATION; NEUROMAGNETIC EVIDENCE; CORTEX; HABITUATION; FREQUENCY; FIELDS; MEMORY; BRAIN; MODULATION; PLASTICITY	Constant sound sequencing as operationalized by repeated stimulation with tones of the same frequency has multiple effects. On the one hand, it activates mechanisms of habituation and refractoriness, which are reflected in the decrease of response amplitude of evoked responses. On the other hand, the constant sequencing acts as spectral cueing, resulting in tones being detected faster and more accurately. With the present study, by means of magnetoencephalography, we investigated the impact of repeated tone stimulation on the N1m auditory evoked fields, while listeners were distracted from the test sounds. We stimulated subjects with trains of either four tones of the same frequency, or with trains of randomly assigned frequencies. The trains were presented either in a silent or in a noisy background. In silence, the patterns of source strength decline originating from repeated stimulation suggested both, refractoriness as well as habituation as underlying mechanisms. In noise, in contrast, there was no indication of source strength decline. Furthermore, we found facilitating effects of constant sequencing regarding the detection of the single tones as indexed by a shortening of N1m latency. We interpret our findings as a correlate of a bottom-up mechanism that is constantly monitoring the incoming auditory information, even when voluntary attention is directed to a different modality.	[Lagemann, Lothar; Teismann, Henning; Pantev, Christo] Univ Munster, Inst Biomagnetismus & Biosignalanal, Munster, Germany; [Okamoto, Hidehiko] Natl Inst Physiol Sci, Dept Integrat Physiol, Okazaki, Aichi 444, Japan	University of Munster; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Lagemann, L (corresponding author), Univ Munster, Inst Biomagnetismus & Biosignalanal, Munster, Germany.	L.Lagemann@uni-muenster.de	Okamoto, Hidehiko/A-7934-2008	Okamoto, Hidehiko/0000-0003-2799-3340	Tinnitus Research Initiative; Japan Society for the Promotion of Science for Young Scientists [23689070]; Strategic Research Program for Brain Sciences (Development of Biomarker Candidates for Social Behavior); Deutsche Forschungsgemeinschaft; University of Muenster	Tinnitus Research Initiative; Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Research Program for Brain Sciences (Development of Biomarker Candidates for Social Behavior); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Muenster	This work was funded by the Tinnitus Research Initiative http://www.tinnitusresearch.org/, The Japan Society for the Promotion of Science for Young Scientists (grant number 23689070) and The Strategic Research Program for Brain Sciences (Development of Biomarker Candidates for Social Behavior). The authors also acknowledge support by Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of the University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2009, EUR J NEUROSCI, V30, P132, DOI 10.1111/j.1460-9568.2009.06792.x; BARRY RJ, 1992, INT J PSYCHOPHYSIOL, V13, P9, DOI 10.1016/0167-8760(92)90014-3; Bregman A.S., 1990, AUDITORY SCENE ANAL; Budd TW, 1998, INT J PSYCHOPHYSIOL, V31, P51, DOI 10.1016/S0167-8760(98)00040-3; Chandrasekaran B, 2009, NEURON, V64, P311, DOI 10.1016/j.neuron.2009.10.006; CONDON CD, 1991, BEHAV NEUROSCI, V105, P416, DOI 10.1037/0735-7044.105.3.416; HAFTER ER, 1993, J ACOUST SOC AM, V94, P743, DOI 10.1121/1.408203; HARI R, 1988, EXP BRAIN RES, V71, P87; Hillebrand A, 2002, NEUROIMAGE, V16, P638, DOI 10.1006/nimg.2002.1102; HOLM S, 1979, SCAND J STAT, V6, P65; HUBNER R, 1995, PERCEPT PSYCHOPHYS, V57, P197, DOI 10.3758/BF03206506; Jaaskelainen IP, 2011, BRAIN RES, V1422, P66, DOI 10.1016/j.brainres.2011.09.031; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Lagemann L, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-156; Lange K, 2009, BRAIN COGNITION, V69, P127, DOI 10.1016/j.bandc.2008.06.004; Lopes da Silva FH., 2010, MEG INTRO METHODS, P1, DOI [10.1093/acprof:oso/9780195307238.003.0001, DOI 10.1093/ACPROF:OSO/9780195307238.003.0001]; Luo F, 2008, J NEUROSCI, V28, P11615, DOI 10.1523/JNEUROSCI.3972-08.2008; May P, 1999, J COMPUTATIONAL NEUR; McEvoy L, 1997, PSYCHOPHYSIOLOGY, V34, P308, DOI 10.1111/j.1469-8986.1997.tb02401.x; Morita T, 2006, BRAIN RES, V1087, P151, DOI 10.1016/j.brainres.2006.03.004; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Okamoto H, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PANTEV C, 1989, SCIENCE, V246, P486, DOI 10.1126/science.2814476; PANTEV C, 1995, ELECTROEN CLIN NEURO, V94, P26, DOI 10.1016/0013-4694(94)00209-4; RITTER W, 1968, ELECTROEN CLIN NEURO, V25, P550, DOI 10.1016/0013-4694(68)90234-4; ROMANI GL, 1982, SCIENCE, V216, P1339, DOI 10.1126/science.7079770; Rosburg T, 2010, EXP BRAIN RES, V205, P559, DOI 10.1007/s00221-010-2391-3; Salmelin R., 2009, MEG INTRO METHODS, V1st, P124; SAMS M, 1993, J COGNITIVE NEUROSCI, V5, P363, DOI 10.1162/jocn.1993.5.3.363; Scharf B, 2007, J ACOUST SOC AM, V121, P2149, DOI 10.1121/1.2537461; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; TESCHE CD, 1995, ELECTROEN CLIN NEURO, V95, P189, DOI 10.1016/0013-4694(95)00064-6; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032	36	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e31634	10.1371/journal.pone.0031634	http://dx.doi.org/10.1371/journal.pone.0031634			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389671	Green Published, gold, Green Submitted			2022-12-27	WOS:000302999600008
J	Manikkam, M; Guerrero-Bosagna, C; Tracey, R; Haque, MM; Skinner, MK				Manikkam, Mohan; Guerrero-Bosagna, Carlos; Tracey, Rebecca; Haque, Md. M.; Skinner, Michael K.			Transgenerational Actions of Environmental Compounds on Reproductive Disease and Identification of Epigenetic Biomarkers of Ancestral Exposures	PLOS ONE			English	Article							ENDOCRINE DISRUPTOR VINCLOZOLIN; JET FUELS; HEALTH; ONSET; INHIBITION; INDUCTION; PUBERTY; INSECT	Environmental factors during fetal development can induce a permanent epigenetic change in the germ line (sperm) that then transmits epigenetic transgenerational inheritance of adult-onset disease in the absence of any subsequent exposure. The epigenetic transgenerational actions of various environmental compounds and relevant mixtures were investigated with the use of a pesticide mixture (permethrin and insect repellant DEET), a plastic mixture (bisphenol A and phthalates), dioxin (TCDD) and a hydrocarbon mixture (jet fuel, JP8). After transient exposure of F0 gestating female rats during the period of embryonic gonadal sex determination, the subsequent F1-F3 generations were obtained in the absence of any environmental exposure. The effects on the F1, F2 and F3 generations pubertal onset and gonadal function were assessed. The plastics, dioxin and jet fuel were found to promote early-onset female puberty transgenerationally (F3 generation). Spermatogenic cell apoptosis was affected transgenerationally. Ovarian primordial follicle pool size was significantly decreased with all treatments transgenerationally. Differential DNA methylation of the F3 generation sperm promoter epigenome was examined. Differential DNA methylation regions (DMR) were identified in the sperm of all exposure lineage males and found to be consistent within a specific exposure lineage, but different between the exposures. Several genomic features of the DMR, such as low density CpG content, were identified. Exposure-specific epigenetic biomarkers were identified that may allow for the assessment of ancestral environmental exposures associated with adult onset disease.	[Manikkam, Mohan; Guerrero-Bosagna, Carlos; Tracey, Rebecca; Haque, Md. M.; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University	Manikkam, M (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu	Guerrero-Bosagna, Carlos/W-7319-2019	Guerrero-Bosagna, Carlos/0000-0003-1935-5875	USA Department of Defense; National Institutes of Health [NIEHS ES012974]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012974] Funding Source: NIH RePORTER	USA Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Financial support of the USA Department of Defense and National Institutes of Health (NIEHS ES012974). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2008, GENOMICS, V91, P30, DOI 10.1016/j.ygeno.2007.10.002; Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Bernal AJ, 2010, BIRTH DEFECTS RES A, V88, P938, DOI 10.1002/bdra.20685; Birnbaum LS, 2003, ENVIRON HEALTH PERSP, V111, P389, DOI 10.1289/ehp.5686; Biro FM, 2010, PEDIATRICS, V126, pE583, DOI 10.1542/peds.2009-3079; Brinkman AB, 2010, METHODS, V52, P232, DOI 10.1016/j.ymeth.2010.06.012; Bruner-Tran KL, 2011, REPROD TOXICOL, V31, P344, DOI 10.1016/j.reprotox.2010.10.003; Cesario SK, 2007, JOGNN-J OBST GYN NEO, V36, P263, DOI 10.1111/J.1552-6909.2007.00145.x; Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47; Crews D, 2007, P NATL ACAD SCI USA, V104, P5942, DOI 10.1073/pnas.0610410104; Das Parikshit C., 2008, Drug Metabolism and Drug Interactions, V23, P237; DiVall SA, 2009, CURR OPIN ENDOCRINOL, V16, P1, DOI 10.1097/MED.0b013e3283207937; Engelbregt MJT, 2000, PEDIATR RES, V48, P803, DOI 10.1203/00006450-200012000-00017; Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025; Guerrero-Bosagna C, 2011, BIOMARKERS UNPUB; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Heder AF, 2001, BIOCHEM PHARMACOL, V62, P71, DOI 10.1016/S0006-2952(01)00639-6; Honma S, 2002, REPROD TOXICOL, V16, P117, DOI 10.1016/S0890-6238(02)00006-0; Hotchkiss AK, 2007, TOXICOL SCI, V96, P335, DOI 10.1093/toxsci/kfm002; Hunt PA, 2009, BIOL REPROD, V81, P807, DOI 10.1095/biolreprod.109.077008; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kavlock R, 2005, CRIT REV TOXICOL, V35, P721, DOI 10.1080/10408440591007377; Kitchen LW, 2009, J VECTOR ECOL, V34, P50, DOI [10.1111/j.1948-7134.2009.00007.x, 10.3376/038.034.0107]; Kleiman SE, 2008, FERTIL STERIL, V89, P1728, DOI [10.1016/j.fertnstert.2007.05.068, 10.1016/j.fertnstert.2007.12.033]; Kumar S, 2004, J OCCUP HEALTH, V46, P1, DOI 10.1539/joh.46.1; Martinato F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003650; Meredith S, 2000, J REPROD FERTIL, V119, P43, DOI 10.1530/reprod/119.1.43; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Olgun S, 2004, TOXICOLOGY, V196, P181, DOI 10.1016/j.tox.2003.09.007; Pimentel D, 2007, HUM ECOL, V35, P653, DOI 10.1007/s10745-007-9128-3; Ritchie GD, 2003, J TOXICOL ENV HEAL B, V6, P357, DOI 10.1080/10937400306473; Rockett JC, 2004, ENVIRON HEALTH PERSP, V112, P105, DOI 10.1289/ehp.6265; Sadikovic B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002834; Salian S, 2009, LIFE SCI, V85, P11, DOI 10.1016/j.lfs.2009.04.005; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Skinner MK, 2005, HUM REPROD UPDATE, V11, P461, DOI 10.1093/humupd/dmi020; Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Tateno H, 2000, BIOL REPROD, V63, P341, DOI 10.1095/biolreprod63.1.341; Torres-Altoro MI, 2011, J NEUROCHEM, V119, P303, DOI 10.1111/j.1471-4159.2011.07428.x; Traggiai C, 2003, BEST PRACT RES CL OB, V17, P41, DOI 10.1053/ybeog.2003.0360; Vujovic Svetlana, 2009, Menopause Int, V15, P72, DOI 10.1258/mi.2009.009020; Ward WS, 1999, BIOL REPROD, V60, P702, DOI 10.1095/biolreprod60.3.702; Watanabe N, 2001, ENVIRON HEALTH PERSP, V109, P111; Waterland RA, 2009, HORM RES, V71, P13, DOI 10.1159/000178030; Wong SS, 2008, TOXICOLOGY, V254, P106, DOI 10.1016/j.tox.2008.09.018; Zhang WY, 2007, BIOINFORMATICS, V23, P1217, DOI 10.1093/bioinformatics/btm081	49	294	303	5	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e31901	10.1371/journal.pone.0031901	http://dx.doi.org/10.1371/journal.pone.0031901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389676	Green Published, Green Submitted, gold			2022-12-27	WOS:000302999600014
J	Poland, JA; Brown, PJ; Sorrells, ME; Jannink, JL				Poland, Jesse A.; Brown, Patrick J.; Sorrells, Mark E.; Jannink, Jean-Luc			Development of High-Density Genetic Maps for Barley and Wheat Using a Novel Two-Enzyme Genotyping-by-Sequencing Approach	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISM DISCOVERY; THROUGHPUT SNP DISCOVERY; GENOME-WIDE ASSOCIATION; LINKAGE MAP; SELECTION	Advancements in next-generation sequencing technology have enabled whole genome re-sequencing in many species providing unprecedented discovery and characterization of molecular polymorphisms. There are limitations, however, to next-generation sequencing approaches for species with large complex genomes such as barley and wheat. Genotyping-by-sequencing (GBS) has been developed as a tool for association studies and genomics-assisted breeding in a range of species including those with complex genomes. GBS uses restriction enzymes for targeted complexity reduction followed by multiplex sequencing to produce high-quality polymorphism data at a relatively low per sample cost. Here we present a GBS approach for species that currently lack a reference genome sequence. We developed a novel two-enzyme GBS protocol and genotyped bi-parental barley and wheat populations to develop a genetically anchored reference map of identified SNPs and tags. We were able to map over 34,000 SNPs and 240,000 tags onto the Oregon Wolfe Barley reference map, and 20,000 SNPs and 367,000 tags on the Synthetic W9784xOpata85 (SynOpDH) wheat reference map. To further evaluate GBS in wheat, we also constructed a de novo genetic map using only SNP markers from the GBS data. The GBS approach presented here provides a powerful method of developing high-density markers in species without a sequenced genome while providing valuable tools for anchoring and ordering physical maps and whole-genome shotgun sequence. Development of the sequenced reference genome(s) will in turn increase the utility of GBS data enabling physical mapping of genes and haplotype imputation of missing data. Finally, as a result of low per-sample costs, GBS will have broad application in genomics-assisted plant breeding programs.	[Poland, Jesse A.] ARS, Hard Winter Wheat Genet Res Unit, USDA, Manhattan, KS 66502 USA; [Poland, Jesse A.] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Brown, Patrick J.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Sorrells, Mark E.; Jannink, Jean-Luc] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [Jannink, Jean-Luc] ARS, Plant Soil & Nutr Res Unit, USDA, Ithaca, NY USA	United States Department of Agriculture (USDA); Kansas State University; University of Illinois System; University of Illinois Urbana-Champaign; Cornell University; United States Department of Agriculture (USDA)	Poland, JA (corresponding author), ARS, Hard Winter Wheat Genet Res Unit, USDA, Manhattan, KS 66502 USA.	jpoland@ksu.edu		Jannink, Jean-Luc/0000-0003-4849-628X; Poland, Jesse/0000-0002-7856-1399	United States 282 Department of Agriculture - Agricultural Research Service [5430-283 21000-005-00]; USDA NIFA 284 NRI CAP [2009-85606-05701]; Bill and Melinda Gates Foundation; USDA- NIFA NRI CAP [286 2005-05130, 287 2011-68002-30029]	United States 282 Department of Agriculture - Agricultural Research Service; USDA NIFA 284 NRI CAP; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); USDA- NIFA NRI CAP	Funding for this research was provided by United States 282 Department of Agriculture - Agricultural Research Service (Appropriation No. 5430-283 21000-005-00), the Barley Coordinated Agriculture Project (BarleyCAP - USDA NIFA 284 NRI CAP grant No. 2009-85606-05701), The Bill and Melinda Gates Foundation, the 285 Wheat Coordinated Agriculture Project (WheatCAP; USDA- NIFA NRI CAP grant No. 286 2005-05130), and the Triticeae Coordinated Agriculture Project (USDA-NIFA, NRI CAP No. 287 2011-68002-30029). The funders had no role in study design, data collection and 288 analysis, decision to publish, or preparation of the manuscript. Mention of trade names is 289 for research purposes only and does not constitute endorsement by the USDA.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Wolfe R. I., 1972, Barley Genetics Newsletter, V2, P170; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P229, DOI [10.1007/BF02672073, DOI 10.1007/BF02672073]; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Costa JM, 2001, THEOR APPL GENET, V103, P415, DOI 10.1007/s001220100622; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Deschamps S, 2010, PLANT GENOME-US, V3, P53, DOI 10.3835/plantgenome2009.09.0026; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Franckowiak J.D, 1991, BARLEY GENET NEWSL, V20, P117; GILL BS, 1991, GENOME, V34, P830, DOI 10.1139/g91-128; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-475; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Iwata H, 2006, BREEDING SCI, V56, P371, DOI 10.1270/jsbbs.56.371; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Meuwissen THE, 2001, GENETICS, V157, P1819; Miller MR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r105; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Nelson JC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-352; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Paux E, 2010, PLANT BIOTECHNOL J, V8, P196, DOI 10.1111/j.1467-7652.2009.00477.x; Sorrells ME, 2011, GENOME, V54, P875, DOI [10.1139/G11-054, 10.1139/g11-054]; Szucs P, 2009, PLANT GENOME-US, V2, P134, DOI [10.3835/plantgenome2008.01.005, 10.3835/plantgenome2008.01.0005]; van Oeveren J, 2011, GENOME RES, V21, P618, DOI 10.1101/gr.112094.110; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; You FM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-59	31	1113	1140	5	362	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32253	10.1371/journal.pone.0032253	http://dx.doi.org/10.1371/journal.pone.0032253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389690	Green Submitted, gold, Green Published			2022-12-27	WOS:000302999600028
J	Hansson, B; Tarka, M; Dawson, DA; Horsburgh, GJ				Hansson, Bengt; Tarka, Maja; Dawson, Deborah A.; Horsburgh, Gavin J.			Hybridization but No Evidence for Backcrossing and Introgression in a Sympatric Population of Great Reed Warblers and Clamorous Reed Warblers	PLOS ONE			English	Article							BIMODAL HYBRID ZONES; ACROCEPHALUS-ARUNDINACEUS; FEMALE CHOICE; SPECIATION; LOCI; DIFFERENTIATION; EFFICIENCY; PHYLOGENY; SYLVIIDAE; SELECTION	Hybridization is observed frequently in birds, but often it is not known whether the hybrids are fertile and if backcrossing occurs. The breeding ranges of the great reed warbler (Acrocephalus arundinaceus) and the clamorous reed warbler (A. stentoreus) overlap in southern Kazakhstan and a previous study has documented hybridization in a sympatric population. In the present study, we first present a large set of novel microsatellite loci isolated and characterised in great reed warblers. Secondly, we evaluate whether hybridization in the sympatric breeding population has been followed by backcrossing and introgression. We isolated 181 unique microsatellite loci in great reed warblers. Of 41 loci evaluated, 40 amplified and 30 were polymorphic. Bayesian clustering analyses based on genotype data from 23 autosomal loci recognised two well-defined genetic clusters corresponding to the two species. Individuals clustered to a very high extent to either of these clusters (admixture proportions >= 0.984) with the exception of four previously suggested arundinaceus-stentoreus hybrid birds that showed mixed ancestry (admixture proportions 0.495-0.619). Analyses of simulated hybrids and backcrossed individuals showed that the sampled birds do not correspond to first-fourth-generation backcrosses, and that fifth or higher generation backcrosses to a high extent resemble 'pure' birds at this set of markers. We conclude that these novel microsatellite loci provide a useful molecular resource for Acrocephalus warblers. The time to reach reproductive isolation is believed to be very long in birds, approximately 5 Myrs, and with an estimated divergence time of 2 Myrs between these warblers, some backcrossing and introgression could have been expected. However, there was no evidence for backcrossing and introgression suggesting that hybrids are either infertile or their progeny inviable. Very low levels of introgression cannot be excluded, which still may be an important factor as a source of new genetic variation.	[Hansson, Bengt; Tarka, Maja] Lund Univ, Dept Biol, Lund, Sweden; [Dawson, Deborah A.; Horsburgh, Gavin J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Lund University; University of Sheffield	Hansson, B (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	bengt.hansson@biol.lu.se	Hansson, Bengt/L-8874-2013; Tarka, Maja/L-8065-2013	Hansson, Bengt/0000-0001-6694-8169; Tarka, Maja/0000-0001-9651-1101	Swedish Research Council [621-2007-5381, 621-2692009-4945]; Oscar and Lili Lamm Foundation; Crafoord Foundation; BBSRC [BBS/E/D/20310000] Funding Source: UKRI; MRC [G0900740] Funding Source: UKRI; NERC [NBAF010001] Funding Source: UKRI; Medical Research Council [G0900740] Funding Source: researchfish; Natural Environment Research Council [NBAF010001] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Oscar and Lili Lamm Foundation; Crafoord Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by grants from the Swedish Research Council (621-2007-5381; 621-2692009-4945), the Oscar and Lili Lamm Foundation, and the Crafoord Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstrom P, 2006, MOL PHYLOGENET EVOL, V38, P381, DOI 10.1016/j.ympev.2005.05.015; Anderson E., 1949, INTROGRESSIVE HYBRID; ARMOUR JAL, 1994, HUM MOL GENET, V3, P599, DOI 10.1093/hmg/3.4.599; BARROWCLOUGH GF, 1980, AUK, V97, P655; Barton NH, 2001, TRENDS ECOL EVOL, V16, P325, DOI 10.1016/S0169-5347(01)02207-8; Beaumont M, 2001, MOL ECOL, V10, P319, DOI 10.1046/j.1365-294x.2001.01196.x; Beier J, 1997, J ORNITHOL, V138, P51, DOI 10.1007/BF01651651; Bensch S, 2002, MOL ECOL, V11, P473, DOI 10.1046/j.0962-1083.2001.01455.x; Cramp S., 1992, HDB BIRDS EUROPE MID; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Glutz von Blotzheim, 1985, HDB VOGEL MITTELEURO; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Grant BR, 1996, ECOLOGY, V77, P500, DOI 10.2307/2265625; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Grant PR, 2004, EVOLUTION, V58, P1588; Haas F, 2009, MOL ECOL, V18, P294, DOI 10.1111/j.1365-294X.2008.04017.x; Hansen MM, 2009, BIOL LETTERS, V5, P656, DOI 10.1098/rsbl.2009.0214; Hansson B, 2004, J ORNITHOL, V145, P159, DOI 10.1007/s10336-003-0011-8; Hansson Bengt, 2003, Avian Science, V3, P145; Hasselquist D, 1998, ECOLOGY, V79, P2376, DOI 10.2307/176829; Helbig AJ, 1999, MOL PHYLOGENET EVOL, V11, P246, DOI 10.1006/mpev.1998.0571; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; Kennerley P, 2010, REED BUSH WARBLERS; Kovshar AF, 1972, BIRDS KAZAKHSTAN Y, VIY, P75; Kronforst MR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-98; Lemaire F, 1977, BEHAVIOUR, V79, P215; Lopatin VV, 1993, FAUNA BIOLOGIYA P, P191; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mundy NI, 1996, J HERED, V87, P21, DOI 10.1093/oxfordjournals.jhered.a022948; Nielsen EE, 2006, MOL ECOL NOTES, V6, P971, DOI 10.1111/j.1471-8286.2006.01433.x; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Price T, 2008, SPECIATION BIRDS; Pritchard JK, 2000, GENETICS, V155, P945; Randler C, 2002, ANIM BEHAV, V63, P103, DOI 10.1006/anbe.2001.1884; Redenbach Z, 2003, J EVOLUTION BIOL, V16, P1135, DOI 10.1046/j.1420-9101.2003.00619.x; Richardson DS, 2000, MOL ECOL, V9, P2226; RIESEBERG LH, 1995, CONSERV BIOL, V9, P199, DOI 10.1046/j.1523-1739.1995.09010199.x; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J., 2002, MOL CLONING LAB MANU; Sanz N, 2009, CONSERV GENET, V10, P225, DOI 10.1007/s10592-008-9550-0; Secondi J, 2006, MOL ECOL, V15, P2463, DOI 10.1111/J.1365-294X.2006.02948.x; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Wirtz P, 1999, ANIM BEHAV, V58, P1, DOI 10.1006/anbe.1999.1144	51	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31667	10.1371/journal.pone.0031667	http://dx.doi.org/10.1371/journal.pone.0031667			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384052	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000302918500034
J	Myers, EM; Frankino, WA				Myers, Erin M.; Frankino, W. Anthony			Time in a Bottle: The Evolutionary Fate of Species Discrimination in Sibling Drosophila Species	PLOS ONE			English	Article							REPRODUCTIVE CHARACTER DISPLACEMENT; SEXUAL SELECTION; PREMATING ISOLATION; COURTSHIP SONGS; MATE PREFERENCE; D-PERSIMILIS; PSEUDOOBSCURA; SPECIATION; REINFORCEMENT; GENETICS	Disadvantageous hybridization favors the evolution of prezygotic isolating behaviors, generating a geographic pattern of interspecific mate discrimination where members of different species drawn from sympatric populations exhibit stronger preference for members of their own species than do individuals drawn from allopatric populations. Geographic shifts in species' boundaries can relax local selection against hybridization; under such scenarios the fate of enhanced species preference is unknown. Lineages established from populations in the region of sympatry that have been maintained as single-species laboratory cultures represent cases where allopatry has been produced experimentally. Using such cultures dating from the 1950s, we assess how Drosophila pseudoobscura and D. persimilis mate preferences respond to relaxed natural selection against hybridization. We found that the propensity to hybridize generally declines with increasing time in experimental allopatry, suggesting that maintaining enhanced preference for conspecifics may be costly. However, our data also suggest a strong role for drift in determining mating preferences once secondary allopatry has been established. Finally, we discuss the interplay between populations in establishing the presence or absence of patterns consistent with reinforcement.	[Myers, Erin M.; Frankino, W. Anthony] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Houston System; University of Houston	Myers, EM (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	myers.erinm@gmail.com			National Science Foundation [0805818]; Integrative Organismal Systems [0920720]; University of Houston; Direct For Biological Sciences [0920720] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Integrative Organismal Systems; University of Houston; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	EMM was supported by a National Science Foundation Bioinformatics Postdoctoral Fellowship. This research was supported by National Science Foundation grants Division of Environmental Biology # 0805818, Integrative Organismal Systems # 0920720, and a University of Houston Grants to Enhance and Advance Research Award to WAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2000, P NATL ACAD SCI USA, V97, P4106, DOI 10.1073/pnas.97.8.4106; Barnwell CV, 2008, J HERED, V99, P653, DOI 10.1093/jhered/esn069; Blows MW, 2002, P ROY SOC B-BIOL SCI, V269, P1113, DOI 10.1098/rspb.2002.2002; BROWN R. G. B., 1964, BEHAVIOUR, V23, P61, DOI 10.1163/156853964X00094; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; COYNE JA, 1989, EVOLUTION, V43, P362, DOI [10.2307/2409213, 10.1111/j.1558-5646.1989.tb04233.x]; Dobzhansky T, 1937, AM NAT, V71, P404, DOI 10.1086/280726; Dobzhansky T, 1936, GENETICS, V21, P113; DOBZHANSKY T, 1973, AM NAT, V107, P312, DOI 10.1086/282833; Dobzhansky T., 1937; GALIANA A, 1993, EVOLUTION, V47, P432, DOI 10.1111/j.1558-5646.1993.tb02104.x; Geyer LB, 2003, EVOLUTION, V57, P1049; Grant PR, 1996, PHILOS T ROY SOC B, V351, P765, DOI 10.1098/rstb.1996.0071; Harshman LG, 2000, TRENDS ECOL EVOL, V15, P32, DOI 10.1016/S0169-5347(99)01756-5; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Higgie M, 2008, EVOLUTION, V62, P1192, DOI 10.1111/j.1558-5646.2008.00357.x; Higgie M, 2007, AM NAT, V170, P409, DOI 10.1086/519401; Jennings JH, 2010, EVOLUTION, V64, P587, DOI 10.1111/j.1558-5646.2009.00834.x; Kalmus H, 1941, DROSOPHILA INFORM SE, V14, P56; Kitano J, 2008, BEHAVIOUR, V145, P443, DOI 10.1163/156853908792451430; KRAMER CY, 1956, BIOMETRICS, V12, P307, DOI 10.2307/3001469; Krebs RA, 2001, J EVOLUTION BIOL, V14, P75, DOI 10.1046/j.1420-9101.2001.00256.x; Kronforst MR, 2007, J EVOLUTION BIOL, V20, P278, DOI 10.1111/j.1420-9101.2006.01198.x; Lewontin R. C., 1981, DOBZHANSKYS GENETICS; LIOU LW, 1994, EVOLUTION, V48, P1451, DOI 10.1111/j.1558-5646.1994.tb02187.x; Lorch PD, 2005, EVOLUTION, V59, P1039; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; Matute DR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000341; MAYR E, 1946, P NATL ACAD SCI USA, V32, P128, DOI 10.1073/pnas.32.5.128; McPeek MA, 2006, EVOLUTION, V60, P1967, DOI 10.1111/j.0014-3820.2006.tb01835.x; MEFFERT LM, 1992, EVOLUTION, V46, P1399, DOI 10.1111/j.1558-5646.1992.tb01132.x; NOOR MA, 1995, NATURE, V375, P674, DOI 10.1038/375674a0; Noor MAF, 2006, BEHAV GENET, V36, P322, DOI 10.1007/s10519-005-9033-8; Noor MAF, 1997, J INSECT BEHAV, V10, P305, DOI 10.1007/BF02765563; Noor MAF, 1998, ANIM BEHAV, V56, P115, DOI 10.1006/anbe.1998.0779; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Noor MAF, 1996, GENET RES, V68, P117, DOI 10.1017/S0016672300034005; Noor MAF, 1999, HEREDITY, V83, P503, DOI 10.1038/sj.hdy.6886320; Nosil P, 2003, P ROY SOC B-BIOL SCI, V270, P1911, DOI 10.1098/rspb.2003.2457; Ortiz-Barrientos D, 2006, GENET RES, V87, P23, DOI 10.1017/S0016672306007932; Ortiz-Barrientos D, 2005, SCIENCE, V310, P1467, DOI 10.1126/science.1121260; Ortiz-Barrientos D, 2004, PLOS BIOL, V2, P2256, DOI 10.1371/journal.pbio.0020416; Pezzullo JC, 2010, JAVASTAT BINOMIAL PO; Pfennig DW, 2010, AM NAT, V176, pS26, DOI 10.1086/657056; Pfennig KS, 2009, Q REV BIOL, V84, P253, DOI 10.1086/605079; POWELL JR, 1983, P NATL ACAD SCI-BIOL, V80, P492, DOI 10.1073/pnas.80.2.492; PRAKASH S, 1972, GENETICS, V72, P143; Ptacek MB, 1998, ANIM BEHAV, V56, P1145, DOI 10.1006/anbe.1998.0909; Rundle HD, 1998, EVOLUTION, V52, P200, DOI 10.1111/j.1558-5646.1998.tb05153.x; RYAN MJ, 1993, EVOLUTION, V47, P647, DOI 10.1111/j.1558-5646.1993.tb02118.x; Saetre GP, 1997, NATURE, V387, P589; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Spassky B, 1943, DROS INFORM SERV, V17, P67; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tukey J, 1953, DITTOED UNPUB; Wellenreuther M, 2010, EVOLUTION, V64, P242, DOI 10.1111/j.1558-5646.2009.00815.x; Williams MA, 2001, HEREDITY, V86, P68, DOI 10.1046/j.1365-2540.2001.00811.x	57	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31759	10.1371/journal.pone.0031759	http://dx.doi.org/10.1371/journal.pone.0031759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384069	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500038
J	Aka, JA; Lin, SX				Aka, Juliette Adjo; Lin, Sheng-Xiang			Comparison of Functional Proteomic Analyses of Human Breast Cancer Cell Lines T47D and MCF7	PLOS ONE			English	Article							17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE-1; CATHEPSIN-D; 5-ALPHA-DIHYDROTESTOSTERONE; PROLIFERATION; EXPRESSION; PROFILE	T47D and MCF7 are two human hormone-dependent breast cancer cell lines which are widely used as experimental models for in vitro and in vivo (tumor xenografts) breast cancer studies. Several proteins involved in cancer development were identified in these cell lines by proteomic analyses. Although these studies reported the proteomic profiles of each cell line, until now, their differential protein expression profiles have not been established. Here, we used two-dimensional gel and mass spectrometry analyses to compare the proteomic profiles of the two cell lines, T47D and MCF7. Our data revealed that more than 164 proteins are differentially expressed between them. According to their biological functions, the results showed that proteins involved in cell growth stimulation, anti-apoptosis mechanisms and cancerogenesis are more strongly expressed in T47D than in MCF7. These proteins include G1/S-specific cyclin-D3 and prohibitin. Proteins implicated in transcription repression and apoptosis regulation, including transcriptional repressor NF-X1, nitrilase homolog 2 and interleukin-10, are, on the contrary, more strongly expressed in MCF7 as compared to T47D. Five proteins that were previously described as breast cancer biomarkers, namely cathepsin D, cathepsin B, protein S100-A14, heat shock protein beta-1 (HSP27) and proliferating cell nuclear antigen (PCNA), are found to be differentially expressed in the two cell lines. A list of differentially expressed proteins between T47D and MCF7 was generated, providing useful information for further studies of breast cancer mechanisms with these cell lines as models.	[Aka, Juliette Adjo; Lin, Sheng-Xiang] Univ Laval, CHUL Res Ctr CHUQ, Lab Endocrinol & Genom, Quebec City, PQ, Canada; [Aka, Juliette Adjo; Lin, Sheng-Xiang] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Aka, JA (corresponding author), Univ Laval, CHUL Res Ctr CHUQ, Lab Endocrinol & Genom, Quebec City, PQ, Canada.	Sheng-Xiang.Lin@crchul.ulaval.ca		Lin, Sheng-Xiang/0000-0001-9149-375X	Canadian Institutes of Health Research [FRN57892]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research with a grant to SXL (Principal Investigator for FRN57892) [www.cihr-irsc.gc.ca]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aka JA, 2010, MOL ENDOCRINOL, V24, P832, DOI 10.1210/me.2009-0468; Aspinall SR, 2004, J STEROID BIOCHEM, V88, P37, DOI 10.1016/j.jsbmb.2003.10.011; Bianchi L, 2005, PROTEOMICS, V5, P2433, DOI 10.1002/pmic.200401283; Blamey R, 2004, HUM REPROD UPDATE, V10, P281, DOI 10.1093/humupd/dmh025; Canadian Cancer Society Steering Committee, 2009, CAN CANC STAT 2009; Day JM, 2008, INT J CANCER, V122, P1931, DOI 10.1002/ijc.23350; FAUST PL, 1987, J CELL BIOL, V105, P1937, DOI 10.1083/jcb.105.5.1937; Gast MCW, 2009, BREAST CANCER RES TR, V116, P17, DOI 10.1007/s10549-008-0263-3; Greeve MA, 2004, J MOL ENDOCRINOL, V32, P793, DOI 10.1677/jme.0.0320793; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; Huber M, 2004, MOL CELL PROTEOMICS, V3, P43, DOI 10.1074/mcp.M300047-MCP200; Husen B, 2006, ENDOCRINOLOGY, V147, P5333, DOI 10.1210/en.2006-0778; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Journet A, 2004, MASS SPECTROM REV, V23, P393, DOI 10.1002/mas.20001; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Parl FF, 2000, BIOMEDICAL HLTH RES, V36; Sarvaiya HA, 2006, RAPID COMMUN MASS SP, V20, P3039, DOI 10.1002/rcm.2677; Sasco Annie J., 2003, Hormone Research (Basel), V60, P50, DOI 10.1159/000074500; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h	20	59	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31532	10.1371/journal.pone.0031532	http://dx.doi.org/10.1371/journal.pone.0031532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384035	Green Submitted, Green Published, gold			2022-12-27	WOS:000302916800016
J	Pernas, M; Casado, C; Arcones, C; Llano, A; Sanchez-Merino, V; Mothe, B; Vicario, JL; Grau, E; Ruiz, L; Sanchez, J; Telenti, A; Yuste, E; Brander, C; Lopez-Galindez, C				Pernas, Maria; Casado, Concepcion; Arcones, Carolina; Llano, Anuska; Sanchez-Merino, Victor; Mothe, Beatriz; Vicario, Jose L.; Grau, Eulalia; Ruiz, Lidia; Sanchez, Jorge; Telenti, Amalio; Yuste, Eloisa; Brander, Christian; Lopez-Galindez, Cecilio			Low-Replicating Viruses and Strong Anti-Viral Immune Response Associated with Prolonged Disease Control in a Superinfected HIV-1 LTNP Elite Controller	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEUTRALIZING ANTIBODY-RESPONSE; T-CELL RESPONSES; LONG-TERM; IN-VIVO; TYPE-1; INFECTION; GENOME; SUPPRESSORS; MECHANISMS	Objective: To study the causes for the lack of clinical progression in a superinfected HIV-1 LTNP elite controller patient. Methodology and Principal Findings: We studied host genetic, virological and immunological factors associated with viral control in a SI long term non progressor elite controller (LTNP-EC). The individual contained both viruses and maintained undetectable viral loads for >20 years and he did not express any of the described host genetic polymorphisms associated with viral control. None of four full-length gp160 recombinants derived from the LTNP-EC replicated in heterologous peripheral blood mononuclear cells. CTL responses after SI were maintained in two samples separated by 9 years and they were higher in breadth and magnitude than responses seen in most of 250 treatment naive patients and also 25 controller subjects. The LTNP-EC showed a neutralization response, against 4 of the 6 viruses analyzed, superior to other ECs. Conclusions: The study demonstrated that a strong and sustained cellular and humoral immune response and low replicating viruses are associated with viral control in the superinfected LTNP-EC.	[Pernas, Maria; Casado, Concepcion; Arcones, Carolina; Lopez-Galindez, Cecilio] Inst Salud Carlos III, Serv Virol Mol, Ctr Nacl Microbiol, Madrid, Spain; [Llano, Anuska; Mothe, Beatriz; Grau, Eulalia; Ruiz, Lidia; Brander, Christian] Hosp Badalona Germans Trias & Pujol, Inst Recerca Sida, Fundacio irsiCaixa HIVACAT, Badalona, Spain; [Sanchez-Merino, Victor; Yuste, Eloisa] Lab Retrovirol & Inmunol IDIBAPS Fac Med, Barcelona, Spain; [Vicario, Jose L.] Ctr Transfus Comunidad Madrid, Madrid, Spain; [Sanchez, Jorge] Asociac Civil IMPACTA Salud & Educ, Lima, Peru; [Telenti, Amalio] Univ Lausanne, Univ Hosp Ctr, Inst Microbiol, Lausanne, Switzerland; [Brander, Christian] ICREA, Barcelona, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Lausanne; ICREA	Pernas, M (corresponding author), Inst Salud Carlos III, Serv Virol Mol, Ctr Nacl Microbiol, Madrid, Spain.	clopez@isciii.es	Pernas, Maria/E-3998-2018; Yuste, Eloisa/R-9493-2019; Telenti, Amalio/AAY-1674-2021; Casado, Concepcion/F-3060-2016; Ruiz, Lidia/ABF-9720-2021; Lopez-Galindez, Cecilio/A-3603-2008	Pernas, Maria/0000-0003-2966-0160; Yuste, Eloisa/0000-0002-9484-9974; Casado, Concepcion/0000-0003-3412-2877; Lopez-Galindez, Cecilio/0000-0002-2324-9584; Grau, Eulalia/0000-0002-2442-9165; Brander, Christian/0000-0002-0548-5778; Mothe, Beatriz/0000-0001-9975-407X; Sanchez-Merino, Victor/0000-0001-9400-427X	Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) [36558/06, 36641/07, 36779/08, 360766/09, 360737/09]; United States National Institute of Health NIH-NIAID [N01-AI-30024]; Red Tematica Cooperativa de Investigacion en SIDA (Red de grupos) of the Fondo de Investigaciones Sanitarias de la Seguridad Social (FISss) [173];  [SAF 2007-61036];  [SAF 2010-17226]; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030024] Funding Source: NIH RePORTER	Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE); United States National Institute of Health NIH-NIAID; Red Tematica Cooperativa de Investigacion en SIDA (Red de grupos) of the Fondo de Investigaciones Sanitarias de la Seguridad Social (FISss); ; ; ICREA(ICREA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants SAF 2007-61036 and SAF 2010-17226, by Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) grants 36558/06, 36641/07, 36779/08, 360766/09 and 360737/09, and by the United States National Institute of Health NIH-NIAID contract N01-AI-30024. Support by the Red Tematica Cooperativa de Investigacion en SIDA (Red de grupos 173) of the Fondo de Investigaciones Sanitarias de la Seguridad Social (FISss) is appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Alexander L, 2000, J VIROL, V74, P4361, DOI 10.1128/JVI.74.9.4361-4376.2000; Altfeld M, 2002, NATURE, V420, P434, DOI 10.1038/nature01200; Altfeld M, 2000, CURR OPIN IMMUNOL, V12, P375, DOI 10.1016/S0952-7915(00)00103-5; Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005; Bailey JR, 2006, J VIROL, V80, P4758, DOI 10.1128/JVI.80.10.4758-4770.2006; Blankson JN, 2010, DISCOV MED, V9, P261; Blish CA, 2008, J VIROL, V82, P12094, DOI 10.1128/JVI.01730-08; Braibant M, 2010, VIROLOGY, V405, P81, DOI 10.1016/j.virol.2010.05.026; Brumme ZL, 2011, JAIDS-J ACQ IMM DEF, V56, P100, DOI 10.1097/QAI.0b013e3181fe9450; Calugi G, 2006, J VIROL, V80, P11892, DOI 10.1128/JVI.00932-06; Casado C, 2007, J INFECT DIS, V196, P895, DOI 10.1086/520885; Casado C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011079; Clerc O, 2010, J CLIN VIROL, V47, P376, DOI 10.1016/j.jcv.2010.01.013; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Fang GW, 2004, AIDS, V18, P153, DOI 10.1097/00002030-200401230-00003; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Ferre AL, 2010, J VIROL, V84, P11020, DOI 10.1128/JVI.00980-10; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; Gasser O, 2007, PLOS MED, V4, P556, DOI 10.1371/journal.pmed.0040096; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; KUSUMI K, 1992, J VIROL, V66, P875, DOI 10.1128/JVI.66.2.875-885.1992; Lambotte O, 2009, AIDS, V23, P897, DOI 10.1097/QAD.0b013e328329f97d; Lassen KG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000377; LI YX, 1991, J VIROL, V65, P3973, DOI 10.1128/JVI.65.8.3973-3985.1991; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Lotti B, 2002, J CLIN IMMUNOL, V22, P253, DOI 10.1023/A:1020066404226; Mahalanabis M, 2009, J VIROL, V83, P662, DOI 10.1128/JVI.01328-08; Mascola Jr, 1999, METH MOLEC MED, V17, P317, DOI 10.1385/0-89603-369-4:317; Medina-Ramirez M, 2011, J VIROL, V85, P5804, DOI 10.1128/JVI.02482-10; Meng ZF, 2008, AIDS RES HUM RETROV, V24, P259, DOI 10.1089/aid.2007.0128; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Miura T, 2007, 14 C RETR OPP INF LO; Miura T, 2010, J VIROL, V84, P7581, DOI 10.1128/JVI.00286-10; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; O'Connell KA, 2010, J VIROL, V84, P7018, DOI 10.1128/JVI.00548-10; Olivares I, 1997, AIDS RES HUM RETROV, V13, P979, DOI 10.1089/aid.1997.13.979; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; PERUCHO M, 1980, CELL, V22, P309, DOI 10.1016/0092-8674(80)90178-6; Powell RLR, 2010, J VIROL, V84, P9415, DOI 10.1128/JVI.02732-09; Rachinger A, 2008, CLIN INFECT DIS, V47, pE86, DOI 10.1086/592978; Sandonis V, 2009, VIROLOGY, V391, P73, DOI 10.1016/j.virol.2009.05.022; Sealy R, 2009, CURR HIV RES, V7, P497, DOI 10.2174/157016209789346255; Smith DM, 2006, VIROLOGY, V355, P1, DOI 10.1016/j.virol.2006.08.009; SPIRA AI, 1995, J VIROL, V69, P422, DOI 10.1128/JVI.69.1.422-429.1995; Voronin Y, 2007, J VIROL, V81, P10232, DOI 10.1128/JVI.01035-07; Wang B, 2002, VIROLOGY, V304, P246, DOI 10.1006/viro.2002.1706; Yang OO, 2005, J VIROL, V79, P860, DOI 10.1128/JVI.79.2.860-868.2005	56	20	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31928	10.1371/journal.pone.0031928	http://dx.doi.org/10.1371/journal.pone.0031928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384103	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916800021
J	Zelik, KE; Kuo, AD				Zelik, Karl E.; Kuo, Arthur D.			Mechanical Work as an Indirect Measure of Subjective Costs Influencing Human Movement	PLOS ONE			English	Article							TO-STEP TRANSITIONS; HUMAN WALKING; LOWER-EXTREMITY; ARTICULAR-CARTILAGE; ENERGY-DISSIPATION; LEVEL WALKING; LEG STIFFNESS; FORCE; LOCOMOTION; ENERGETICS	To descend a flight of stairs, would you rather walk or fall? Falling seems to have some obvious disadvantages such as the risk of pain or injury. But the preferred strategy of walking also entails a cost for the use of active muscles to perform negative work. The amount and distribution of work a person chooses to perform may, therefore, reflect a subjective valuation of the trade-offs between active muscle effort and other costs, such as pain. Here we use a simple jump landing experiment to quantify the work humans prefer to perform to dissipate the energy of landing. We found that healthy normal subjects (N = 8) preferred a strategy that involved performing 37% more negative work than minimally necessary (P<0.001) across a range of landing heights. This then required additional positive work to return to standing rest posture, highlighting the cost of this preference. Subjects were also able to modulate the amount of landing work, and its distribution between active and passive tissues. When instructed to land softly, they performed 76% more work than necessary (P<0.001), with a higher proportion from active muscles (89% vs. 84%, P<0.001). Stiff-legged landings, performed by one subject for demonstration, exhibited close to the minimum of work, with more of it performed passively through soft tissue deformations (at least 30% in stiff landings vs. 16% preferred). During jump landings, humans appear not to minimize muscle work, but instead choose to perform a consistent amount of extra work, presumably to avoid other subjective costs. The degree to which work is not minimized may indirectly quantify the relative valuation of costs that are otherwise difficult to measure.	[Zelik, Karl E.; Kuo, Arthur D.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Kuo, Arthur D.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zelik, KE (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	kzelik@umich.edu	Kuo, Arthur/L-3359-2013	Kuo, Arthur/0000-0001-5233-9709; Zelik, Karl/0000-0002-5054-2479	Department of Defense [DR081177]; National Institutes of Health [R44HD055706]; National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R44HD055706] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by the Department of Defense (DR081177), in part by the National Institutes of Health (R44HD055706) and in part by a National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1991, J EXP BIOL, V160, P55; ARMSTRONG CG, 1979, J BONE JOINT SURG AM, V61, P744, DOI 10.2106/00004623-197961050-00016; BAUDINETTE RV, 1987, J EXP BIOL, V129, P251; BAUDINETTE RV, 1991, J EXP BIOL, V160, P209; BENNETT MB, 1990, J ANAT, V171, P131; Bertram JEA, 2001, J THEOR BIOL, V209, P445, DOI 10.1006/jtbi.2001.2279; Bisseling RW, 2006, J BIOMECH, V39, P2438, DOI 10.1016/j.jbiomech.2005.07.021; CAVAGNA GA, 1975, J APPL PHYSIOL, V39, P174, DOI 10.1152/jappl.1975.39.1.174; CAVAGNA GA, 1963, J APPL PHYSIOL, V18, P1; Cazzola D, 2010, INVESTIGATING METABO; Dean JC, 2011, J APPL PHYSIOL, V110, P873, DOI 10.1152/japplphysiol.00505.2010; Decker MJ, 2003, CLIN BIOMECH, V18, P662, DOI 10.1016/S0268-0033(03)00090-1; DEVITA P, 1992, MED SCI SPORT EXER, V24, P108; DeVita P, 2007, J EXP BIOL, V210, P3361, DOI 10.1242/jeb.003970; Doke J, 2007, J EXP BIOL, V210, P2390, DOI 10.1242/jeb.02782; Donelan JM, 2001, P ROY SOC B-BIOL SCI, V268, P1985, DOI 10.1098/rspb.2001.1761; Donelan JM, 2002, J BIOMECH, V35, P117, DOI 10.1016/S0021-9290(01)00169-5; Eckstein F, 2001, ANAT EMBRYOL, V203, P147, DOI 10.1007/s004290000154; Ferris DP, 1998, P ROY SOC B-BIOL SCI, V265, P989, DOI 10.1098/rspb.1998.0388; Ferris DP, 1997, J APPL PHYSIOL, V82, P15, DOI 10.1152/jappl.1997.82.1.15; Gordon KE, 2009, ARCH PHYS MED REHAB, V90, P136, DOI 10.1016/j.apmr.2008.07.014; Greenwood D. T., 1988, PRINCIPLES DYNAMICS; Hsu TC, 1998, ARCH PHYS MED REHAB, V79, P1101, DOI 10.1016/S0003-9993(98)90178-2; Hunter LC, 2010, J BIOMECH, V43, P1910, DOI 10.1016/j.jbiomech.2010.03.030; Ker R F, 1989, Proc Inst Mech Eng H, V203, P191, DOI 10.1243/PIME_PROC_1989_203_038_01; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; MCNITTGRAY JL, 1993, J BIOMECH, V26, P1037, DOI 10.1016/S0021-9290(05)80003-X; Minetti AE, 1997, J THEOR BIOL, V186, P467, DOI 10.1006/jtbi.1997.0407; MINETTI AE, 1994, J BIOMECH, V27, P97, DOI 10.1016/0021-9290(94)90036-1; Minetti AE, 1998, ERGONOMICS, V41, P1771, DOI 10.1080/001401398185965; Moritz CT, 2005, J EXP BIOL, V208, P939, DOI 10.1242/jeb.01472; Ophir J, 1999, P I MECH ENG H, V213, P203, DOI 10.1243/0954411991534933; PRANGE HD, 1979, AM NAT, V113, P103, DOI 10.1086/283367; Roberts TJ, 1997, SCIENCE, V275, P1113, DOI 10.1126/science.275.5303.1113; Soo CH, 2010, J EXP BIOL, V213, P4265, DOI 10.1242/jeb.044214; Umberger BR, 2007, J EXP BIOL, V210, P3255, DOI 10.1242/jeb.000950; VIRGIN WJ, 1951, J BONE JOINT SURG BR, V33, P607, DOI 10.1302/0301-620X.33B4.607; Whittle MW, 1999, GAIT POSTURE, V10, P264, DOI 10.1016/S0966-6362(99)00041-7; Winter D, 2005, BIOMECHANICS MOTOR C; ZARRUGH MY, 1978, EUR J APPL PHYSIOL O, V38, P215, DOI 10.1007/BF00430080; Zatsiorsky VM, 1987, BIOMECHANICS B, P739; Zelik KE, 2010, J EXP BIOL, V213, P4257, DOI 10.1242/jeb.044297; Zhang SN, 2000, MED SCI SPORT EXER, V32, P812, DOI 10.1097/00005768-200004000-00014	44	48	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31143	10.1371/journal.pone.0031143	http://dx.doi.org/10.1371/journal.pone.0031143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22383998	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916800010
J	Pi, RB; Mao, XX; Chao, XJ; Cheng, ZY; Liu, MF; Duan, XL; Ye, MZ; Chen, XH; Mei, ZR; Liu, PQ; Li, WM; Han, YF				Pi, Rongbiao; Mao, Xuexuan; Chao, Xiaojuan; Cheng, Zhiyi; Liu, Mengfei; Duan, Xiaolu; Ye, Mingzhong; Chen, Xiaohong; Mei, Zhengrong; Liu, Peiqing; Li, Wenming; Han, Yifan			Tacrine-6-Ferulic Acid, a Novel Multifunctional Dimer, Inhibits Amyloid-beta-Mediated Alzheimer's Disease-Associated Pathogenesis In Vitro and In Vivo	PLOS ONE			English	Article							FERULIC ACID; OXIDATIVE STRESS; ACETYLCHOLINESTERASE INHIBITORS; COGNITIVE DEFICITS; FIBRILS; TACRINE; DERIVATIVES; TOXICITY; MICE; IMPAIRMENT	We have previously synthesized a series of hybrid compounds by linking ferulic acid to tacrine as multifunctional agents based on the hypotheses that Alzheimer's disease (AD) generates cholinergic deficiency and oxidative stress. Interestingly, we found that they may have potential pharmacological activities for treating AD. Here we report for the first time that tacrine-6-ferulic acid (T6FA), one of these compounds, can prevent amyloid-beta peptide (A beta)-induced AD-associated pathological changes in vitro and in vivo. Our results showed that T6FA significantly inhibited auto-and acetylcholinesterase (AChE)-induced aggregation of A beta(1-40) in vitro and blocked the cell death induced by A beta(1-40) in PC12 cells. In an AD mouse model by the intracerebroventricular injection of A beta(1-40), T6FA significantly improved the cognitive ability along with increasing choline acetyltransferase and superoxide dismutase activity, decreasing AChE activity and malondialdehyde level. Based on our findings, we conclude that T6FA may be a promising multifunctional drug candidate for AD.	[Pi, Rongbiao; Mao, Xuexuan; Chao, Xiaojuan; Cheng, Zhiyi; Liu, Mengfei; Duan, Xiaolu; Ye, Mingzhong; Mei, Zhengrong; Liu, Peiqing] Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Xiaohong] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Wenming; Han, Yifan] Hong Kong Polytech Univ, Inst Modern Chinese Med, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Li, Wenming] Emory Univ, Sch Med, Dept Pharmacol & Neurol, Atlanta, GA USA	Sun Yat Sen University; Sun Yat Sen University; Hong Kong Polytechnic University; Emory University	Pi, RB (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Guangzhou 510275, Guangdong, Peoples R China.	pirb@mail.sysu.edu.cn; bcwmli@pharm.emory.edu; bcyfhan@inet.polyu.edu.hk		Han, Yifan/0000-0002-5833-069X	Fundamental Research Funds for the Central Universities [10ykpy23]; National Natural Science Foundation of China/RGC Hong Kong [30731160617]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China/RGC Hong Kong	This research is supported by in part by Fundamental Research Funds for the Central Universities (No 10ykpy23) and National Natural Science Foundation of China/RGC Hong Kong Joint Research Scheme (No 30731160617) to Dr. Pi. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021954; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Bartolini M, 2003, BIOCHEM PHARMACOL, V65, P407, DOI 10.1016/S0006-2952(02)01514-9; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Byeon SR, 2007, BIOORG MED CHEM LETT, V17, P4022, DOI 10.1016/j.bmcl.2007.04.079; Castro A, 2006, CURR PHARM DESIGN, V12, P4377, DOI 10.2174/138161206778792985; Chen XH, 2010, J PHARM PHARMACOL, V62, P915, DOI 10.1211/jpp.62.07.0013; Chopra K, 2011, EXPERT OPIN PHARMACO, V12, P335, DOI 10.1517/14656566.2011.520702; Colombres M, 2004, CURR PHARM DESIGN, V10, P3123, DOI 10.2174/1381612043383359; Durairajan SSK, 2008, NEUROCHEM INT, V52, P741, DOI 10.1016/j.neuint.2007.09.006; Fang L, 2008, BIOORG MED CHEM LETT, V18, P2905, DOI 10.1016/j.bmcl.2008.03.073; Fleck C, 2010, ARZNEIMITTELFORSCH, V60, P299, DOI 10.1055/s-0031-1296291; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hiramatsu M, 2010, BRIT J PHARMACOL, V161, P1899, DOI 10.1111/j.1476-5381.2010.01014.x; Inestrosa NC, 2005, SUB CELL BIOCHEM, V38, P299; Inestrosa Nibaldo C., 2005, Current Alzheimer Research, V2, P301, DOI 10.2174/1567205054367928; Jesudason EP, 2008, MOL CELL BIOCHEM, V311, P145, DOI 10.1007/s11010-008-9705-9; Kane MD, 1999, J NEUROCHEM, V72, P1939, DOI 10.1046/j.1471-4159.1999.0721939.x; Kawabata J, 2002, J AGR FOOD CHEM, V50, P5468, DOI 10.1021/jf020347g; Lahiri DK, 1998, MOL BRAIN RES, V62, P131, DOI 10.1016/S0169-328X(98)00236-8; LEBEL CP, 1990, TOXICOL APPL PHARM, V104, P17, DOI 10.1016/0041-008X(90)90278-3; Lee KH, 2005, BIOCHEM BIOPH RES CO, V328, P816, DOI 10.1016/j.bbrc.2005.01.030; Lupp A, 2010, ARZNEIMITTEL-FORSCH, V60, P229; Munoz-Ruiz P, 2005, J MED CHEM, V48, P7223, DOI 10.1021/jm0503289; Nitsch RM, 2008, NEUROTHERAPEUTICS, V5, P415, DOI 10.1016/j.nurt.2008.05.013; Ono K, 2005, BIOCHEM BIOPH RES CO, V336, P444, DOI 10.1016/j.bbrc.2005.08.148; Ou SY, 2004, J SCI FOOD AGR, V84, P1261, DOI 10.1002/jsfa.1873; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Pi RYM, 2008, NEW TACRINE FERULIC; Prediger RDS, 2008, NEUROSCIENCE, V151, P631, DOI 10.1016/j.neuroscience.2007.11.009; Singh M, 2010, J ALZHEIMERS DIS, V21, P741, DOI 10.3233/JAD-2010-100405; Srinivasan M, 2005, FUND CLIN PHARMACOL, V19, P491, DOI 10.1111/j.1472-8206.2005.00332.x; Sultana R, 2010, J ALZHEIMERS DIS, V19, P341, DOI 10.3233/JAD-2010-1222; Takeda S, 2009, BRAIN RES, V1280, P137, DOI 10.1016/j.brainres.2009.05.035; Terry AV, 2003, J PHARMACOL EXP THER, V306, P821, DOI 10.1124/jpet.102.041616; Tumiatti V, 2010, CURR MED CHEM, V17, P1825, DOI 10.2174/092986710791111206; Van der Schyf CJ, 2006, J NEUROCHEM, V99, P1033, DOI 10.1111/j.1471-4159.2006.04141.x; Xue LB, 2008, NEUROL RES, V30, P389, DOI 10.1179/174313208X300413; Yan JJ, 2001, BRIT J PHARMACOL, V133, P89, DOI 10.1038/sj.bjp.0704047; Ye M, 2009, NOVEL TACRINE FARULI; Ye MZ, 2008, CHINESE PHARMACOL B, V24, P421	42	79	81	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31921	10.1371/journal.pone.0031921	http://dx.doi.org/10.1371/journal.pone.0031921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384101	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100040
J	Singh, AK; Singh, R; Naz, F; Chauhan, SS; Dinda, A; Shukla, AA; Gill, K; Kapoor, V; Dey, S				Singh, Abhay Kumar; Singh, Ratnakar; Naz, Farhat; Chauhan, Shyam Singh; Dinda, Amit; Shukla, Abhay Anand; Gill, Kamaldeep; Kapoor, Vaishali; Dey, Sharmistha			Structure Based Design and Synthesis of Peptide Inhibitor of Human LOX-12: In Vitro and In Vivo Analysis of a Novel Therapeutic Agent for Breast Cancer	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; CELL-LINE; LIPOXYGENASE INHIBITORS; 12-LIPOXYGENASE; GROWTH; EXPRESSION; CARCINOMA; CYCLOOXYGENASE-2; CHEMOTHERAPY; APOPTOSIS	Human breast cancer cell proliferation involves a complex interaction between growth factors, steroid hormones and peptide hormones. The interaction of growth factors, such as epidermal growth factor (EGF), with their receptors on breast cancer cells can lead to the hydrolysis of phospholipids and release of fatty acid such as arachidonic acid, which can be further metabolized by cyclooxygenase (COX) and lipoxygenase (LOX) pathways to produce prostaglandins. The high concentration of prostaglandins has been associated with chronic inflammatory diseases and several types of human cancers. This is due to the over expression COX, LOX and other inflammatory enzymes. Ten peptides were designed and synthesized by solid phase peptide synthesis and analyzed in vitro for enzyme inhibition. Out of these peptides, YWCS had shown significant inhibitory effects. The dissociation constant (K-D) was determined by surface plasmon resonance (SPR) analysis and was found to be 3.39x10(-8) M and 8.6x10(-8) M for YWCS and baicalein (positive control), respectively. The kinetic constant Ki was 72.45x10(-7) M as determined by kinetic assay. The peptide significantly reduced the cell viability of estrogen positive MCF-7 and estrogen negative MDA-MB-231 cell line with the half maximal concentration (IC50) of 75 mu M and 400 mu M, respectively. The peptide also induced 49.8% and 20.8% apoptosis in breast cancer cells MCF-7 and MDA-MB-231, respectively. The YWCS was also found to be least hemolytic at a concentration of 358 mu M. In vivo studies had shown that the peptide significantly inhibits tumor growth in mice (p<0.017). This peptide can be used as a lead compound and complement for ongoing efforts to develop differentiation therapies for breast cancer.	[Singh, Abhay Kumar; Gill, Kamaldeep; Dey, Sharmistha] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; [Singh, Ratnakar; Chauhan, Shyam Singh; Shukla, Abhay Anand] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Naz, Farhat; Dinda, Amit] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India; [Kapoor, Vaishali] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Singh, AK (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	sharmistha_d@hotmail.com	SINGH, ABHAY/P-3494-2019; Kapoor, Vaishali/I-8189-2019; Singh, Ratnakar/K-2848-2018	SINGH, ABHAY/0000-0001-8399-7974; Kapoor, Vaishali/0000-0002-7581-1487; Singh, Ratnakar/0000-0002-3226-3847	Council of Scientific and Industrial Research; Indian council of medical research	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Indian council of medical research(Indian Council of Medical Research (ICMR))	Authors acknowledge Council of Scientific and Industrial Research for financial support for purchasing the consumable items and Indian council of medical research for the fellowship of Abhay kumar Singh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avis I, 2001, FASEB J, V15, P2007, DOI 10.1096/fj.00-0866fje; Hammamieh R, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-138; Harats D, 2000, ARTERIOSCL THROM VAS, V20, P2100, DOI 10.1161/01.ATV.20.9.2100; Ikemoto S, 2004, ANTICANCER RES, V24, P733; Jiang WG, 2003, PROSTAG LEUKOTR ESS, V69, P275, DOI 10.1016/S0952-3278(03)00110-8; Kamitani H, 1999, ADV EXP MED BIOL, V469, P593; Koutsilieris M, 1999, MOL MED, V5, P86, DOI 10.1007/BF03402143; KRETSCHM.E, 1968, Z NATURFORSCH PT A, VA 23, P2135, DOI 10.1515/zna-1968-1247; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Liu XH, 1996, CLIN EXP METASTAS, V14, P145, DOI 10.1007/BF00121211; Liu XH, 1996, CANCER LETT, V109, P223, DOI 10.1016/S0304-3835(96)04462-X; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Nakano H, 2000, BIOORGAN MED CHEM, V8, P373, DOI 10.1016/S0968-0896(99)00291-6; Natarajan R, 1997, J CLIN ENDOCR METAB, V82, P1790, DOI 10.1210/jc.82.6.1790; Nie D, 1998, CANCER RES, V58, P4047; NYLANDER C, 1982, SENSOR ACTUATOR, V3, P79, DOI 10.1016/0250-6874(82)80008-5; OTTO A, 1968, Z PHYS, V216, P398, DOI 10.1007/BF01391532; Singh AK, 2011, BIOCHEM BIOPH RES CO, V414, P304, DOI 10.1016/j.bbrc.2011.09.044; Singh AK, 2011, DNA CELL BIOL, V30, P801, DOI 10.1089/dna.2011.1215; Skrzypczak-Jankun E, 2003, INT J MOL MED, V12, P17; Somvanshi RK, 2008, BBA-PROTEINS PROTEOM, V1784, P1812, DOI 10.1016/j.bbapap.2008.07.004; Steele VE, 1999, CANCER EPIDEM BIOMAR, V8, P467; Wenzel SE, 1996, ANN PHARMACOTHER, V30, P858, DOI 10.1177/106002809603000725; Whitman S, 2002, J MED CHEM, V45, P2659, DOI 10.1021/jm0201262; Wong BCY, 2001, CARCINOGENESIS, V22, P1349, DOI 10.1093/carcin/22.9.1349; Yoshimura R, 2004, INT J MOL MED, V13, P41	27	18	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32521	10.1371/journal.pone.0032521	http://dx.doi.org/10.1371/journal.pone.0032521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384268	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916100085
J	Ndiath, MO; Sougoufara, S; Gaye, A; Mazenot, C; Konate, L; Faye, O; Sokhna, C; Trape, JF				Ndiath, Mamadou O.; Sougoufara, Seynabou; Gaye, Abdoulaye; Mazenot, Catherine; Konate, Lassana; Faye, Oumar; Sokhna, Cheikh; Trape, Jean-Francois			RETRACTED: Resistance to DDT and Pyrethroids and Increased kdr Mutation Frequency in An. gambiae after the Implementation of Permethrin-Treated Nets in Senegal (Retracted article. See vol. 11, e0156195, 2016)	PLOS ONE			English	Article; Retracted Publication							ANOPHELES-GAMBIAE; INSECTICIDE RESISTANCE; MALARIA TRANSMISSION; DIPTERA-CULICIDAE; HOLOENDEMIC AREA; MOLECULAR-FORMS; WEST; SUSCEPTIBILITY; IDENTIFICATION; POPULATIONS	Introduction: The aim of this study was to evaluate the susceptibility to insecticides of An. gambiae mosquitoes sampled in Dielmo (Senegal), in 2010, 2 years after the implementation of Long Lasting Insecticide-treated Nets (LLINs) and to report the evolution of kdr mutation frequency from 2006 to 2010. Methods: WHO bioassay susceptibility tests to 6 insecticides were performed on adults F0, issuing from immature stages of An. gambiae s.l., sampled in August 2010. Species and molecular forms as well as the presence of L1014F and L1014S kdr mutations were assessed by PCR. Longitudinal study of kdr mutations was performed on adult mosquitoes sampled monthly by night landing catches from 2006 to 2010. Findings: No specimen studied presented the L1014S mutation. During the longitudinal study, L1014F allelic frequency rose from 2.4% in year before the implementation of LLINs to 4.6% 0-12 months after and 18.7% 13-30 months after. In 2010, An. gambiae were resistant to DDT, Lambda-cyhalothrin, Deltamethrin and Permethrin (mortality rates ranging from 46 to 63%) but highly susceptible to Fenitrothion and Bendiocarb (100% mortality). There was significantly more RR genotype among An. gambiae surviving exposure to DDT or Pyrethroids. An. arabiensis represented 3.7% of the sampled mosquitoes (11/300) with no kdr resistance allele detected. An. gambiae molecular form M represented 29.7% of the mosquitoes with, among them, kdr genotypes SR (18%) and SS (82%). An. gambiae molecular form S represented 66% of the population with, among them, kdr genotype SS (33.3%), SR (55.6%) and RR (11.1%). Only 2 MS hybrid mosquitoes were sampled and presented SS kdr genotype. Conclusion: Biological evidence of resistance to DDT and pyrethroids was detected among An. gambiae mosquitoes in Dielmo (Senegal) within 24 months of community use of LLINs. Molecular identification of L1014F mutation indicated that target site resistance increased after the implementation of LLINs.	[Ndiath, Mamadou O.; Sougoufara, Seynabou; Gaye, Abdoulaye; Mazenot, Catherine; Sokhna, Cheikh; Trape, Jean-Francois] Inst Rech Dev, URMITE, UMR 198, Dakar, Senegal; [Konate, Lassana; Faye, Oumar] UCAD, Lab Ecol Vectorielle & Parasitaire, Fann Dakar, Senegal	Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar	Ndiath, MO (corresponding author), Inst Rech Dev, URMITE, UMR 198, Campus Commun UCAD IRD Hann,BP 1386,CP 18524, Dakar, Senegal.	cheikh.sokhna@ird.fr			French Ministry of Research; Department Support and Formation of the south communities of the Research Institute for the Development (IRD)	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Department Support and Formation of the south communities of the Research Institute for the Development (IRD)	This work was supported by the French Ministry of Research and the Department Support and Formation of the south communities of the Research Institute for the Development (IRD). The funders had no role in study design, data collocation and analysis, decision to publish, or preparation of the manuscript.	Abate A, 2011, TROP MED INT HEALTH, V16, P486, DOI 10.1111/j.1365-3156.2011.02728.x; [Anonymous], FOC SEN PROGR IMP SE; [Anonymous], 1998, TEST PROC INS RES MO; Antonio-Nkondjio C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-154; Balkew M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-40; Betson M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-187; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Chandre F, 1999, J AM MOSQUITO CONTR, V15, P53; Czeher C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-189; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Diop A, 2010, RAPPORTS ANNUELS PRO; Diop A, 2008, RAPPORTS ANNUELS PRO; Djegbe I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-261; Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Fontenille D, 1997, AM J TROP MED HYG, V56, P247, DOI 10.4269/ajtmh.1997.56.247; Gillies MT, 1968, PUBLICATIONS S AFRIC; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hunt RH, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-107; Kelly-Hope L, 2008, LANCET INFECT DIS, V8, P387, DOI 10.1016/S1473-3099(08)70045-8; Koekemoer LL, 2011, VECTOR-BORNE ZOONOT, V11, P1193, DOI 10.1089/vbz.2010.0192; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Matowo J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-193; [Ministere de la Sante et de la Prevention Programme National de Lutte contre le Paludisme], 2010, PROGR NAT LUTT PAL; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Pages F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-178; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; Stump AD, 2004, AM J TROP MED HYG, V70, P591, DOI 10.4269/ajtmh.2004.70.591; Thwing JI, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-86; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; Trape JF, 2012, J INFECT DI IN PRESS; Vezenegho SB, 2009, MED VET ENTOMOL, V23, P326, DOI 10.1111/j.1365-2915.2009.00840.x; Vulule JM, 1999, MED VET ENTOMOL, V13, P239, DOI 10.1046/j.1365-2915.1999.00177.x; VULULE JM, 1994, MED VET ENTOMOL, V8, P71, DOI 10.1111/j.1365-2915.1994.tb00389.x; WHO, 2007, INS TREAT NETS WHO P; World Health Organisation, 2008, WORLD MAL REP 2008; World Health Organization, 2006, PEST THEIR APPL CONT; Yadouleton AW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-83; Zaim M, 2000, MED VET ENTOMOL, V14, P1, DOI 10.1046/j.1365-2915.2000.00211.x	43	36	38	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31943	10.1371/journal.pone.0031943	http://dx.doi.org/10.1371/journal.pone.0031943			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384107	Green Published, gold			2022-12-27	WOS:000302875500055
J	Narute, PS; Smithgall, TE				Narute, Purushottam S.; Smithgall, Thomas E.			Nef Alleles from All Major HIV-1 Clades Activate Src-Family Kinases and Enhance HIV-1 Replication in an Inhibitor-Sensitive Manner	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HCK TYROSINE KINASE; CD4 DOWN-REGULATION; SH3 DOMAIN; GENETIC SUBTYPES; BINDING SURFACE; TRANSGENIC MICE; C-SRC; PROTEIN; INFECTION	The HIV-1 accessory factor Nef is essential for high-titer viral replication and AIDS progression. Nef function requires interaction with many host cell proteins, including specific members of the Src kinase family. Here we explored whether Src-family kinase activation is a conserved property of Nef alleles from a wide range of primary HIV-1 isolates and their sensitivity to selective pharmacological inhibitors. Representative Nef proteins from the major HIV-1 subtypes A1, A2, B, C, F1, F2, G, H, J and K strongly activated Hck and Lyn as well as c-Src to a lesser extent, demonstrating for the first time that Src-family kinase activation is a highly conserved property of primary M-group HIV-1 Nef isolates. Recently, we identified 4-amino substituted diphenylfuropyrimidines (DFPs) that selectively inhibit Nef-dependent activation of Src-family kinases as well as HIV replication. To determine whether DFP compounds exhibit broad-spectrum Nef-dependent antiretroviral activity against HIV-1, we first constructed chimeric forms of the HIV-1 strain NL4-3 expressing each of the primary Nef alleles. The infectivity and replication of these Nef chimeras was indistinguishable from that of wild-type virus in two distinct cell lines (U87MG astroglial cells and CEM-T4 lymphoblasts). Importantly, the 4-aminopropanol and 4-aminobutanol derivatives of DFP potently inhibited the replication of all chimeric forms of HIV-1 in both U87MG and CEM-T4 cells in a Nef-dependent manner. The antiretroviral effects of these compounds correlated with inhibition of Nef-dependent activation of endogenous Src-family kinases in the HIV-infected cells. Our results demonstrate that the activation of Hck, Lyn and c-Src by Nef is highly conserved among all major clades of HIV-1 and that selective targeting of this pathway uniformly inhibits HIV-1 replication.	[Narute, Purushottam S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Narute, Purushottam S.; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Narute, PS (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA.	tsmithga@pitt.edu	Narute, Purushottam/M-5471-2015		National Institutes of Health [AI057083]; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI057083 and the Pennsylvania Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Akari H, 2000, J VIROL, V74, P2907, DOI 10.1128/JVI.74.6.2907-2912.2000; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; Bell I, 2001, VIROLOGY, V283, P148, DOI 10.1006/viro.2001.0872; Bentham M, 2006, J GEN VIROL, V87, P563, DOI 10.1099/vir.0.81200-0; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Briggs SD, 1999, J BIOL CHEM, V274, P26579, DOI 10.1074/jbc.274.37.26579; Choi HJ, 2004, J MOL BIOL, V343, P1255, DOI 10.1016/j.jmb.2004.09.015; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Coleman SH, 2006, J VIROL, V80, P1837, DOI 10.1128/JVI.80.4.1837-1849.2006; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dumitrescu TP, 2012, BMC CHEM BI IN PRESS; Emert-Sedlak L, 2009, ACS CHEM BIOL, V4, P939, DOI 10.1021/cb900195c; Engen JR, 2008, CELL MOL LIFE SCI, V65, P3058, DOI 10.1007/s00018-008-8122-2; Fackler OT, 2000, MOL CELL BIOL, V20, P2619, DOI 10.1128/MCB.20.7.2619-2627.2000; FREUND J, 1994, EUR J BIOCHEM, V223, P589, DOI 10.1111/j.1432-1033.1994.tb19029.x; Geyer M, 2002, J BIOL CHEM, V277, P28521, DOI 10.1074/jbc.M200522200; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Giese SI, 2006, VIROLOGY, V355, P175, DOI 10.1016/j.virol.2006.07.003; Greenway AL, 2002, J VIROL, V76, P2692, DOI 10.1128/JVI.76.6.2692-2702.2002; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Hanna Z, 2001, J VIROL, V75, P9378, DOI 10.1128/JVI.75.19.9378-9392.2001; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Harris M, 1999, CURR BIOL, V9, pR459, DOI 10.1016/S0960-9822(99)80282-6; HARRIS MPG, 1994, J MOL BIOL, V241, P136; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Hodge DR, 1998, J BIOL CHEM, V273, P15727, DOI 10.1074/jbc.273.25.15727; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Khan M, 2001, J VIROL, V75, P12081, DOI 10.1128/JVI.75.24.12081-12087.2001; Kim MO, 2006, J VIROL, V80, P62, DOI 10.1128/JVI.80.1.62-72.2006; KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Komuro I, 2003, J EXP MED, V198, P443, DOI 10.1084/jem.20022018; Kondo M, 2005, J INFECT DIS, V192, P56, DOI 10.1086/430739; LEE CH, 1995, EMBO J, V14, P5006, DOI 10.1002/j.1460-2075.1995.tb00183.x; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Lindwasser OW, 2007, CURR MOL MED, V7, P171; Liu LX, 2000, J VIROL, V74, P5310, DOI 10.1128/JVI.74.11.5310-5319.2000; Los Alamos National Laboratory, LOS AL NAT LAB HIV S; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; Mitchell JL, 2007, J MOL BIOL, V366, P1282, DOI 10.1016/j.jmb.2006.12.026; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Pandori MW, 1996, J VIROL, V70, P4283, DOI 10.1128/JVI.70.7.4283-4290.1996; Perrin L, 2003, LANCET INFECT DIS, V3, P22, DOI 10.1016/S1473-3099(03)00484-5; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; Poe JA, 2009, J MOL BIOL, V394, P329, DOI 10.1016/j.jmb.2009.09.047; Renkema GH, 2000, FRONT BIOSCI-LANDMRK, V5, pD268, DOI 10.2741/Renkema; Renkema GH, 1999, CURR BIOL, V9, P1407, DOI 10.1016/S0960-9822(00)80086-X; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Schreiner SJ, 2002, J BIOL CHEM, V277, P45680, DOI 10.1074/jbc.M204255200; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; Swigut T, 2001, EMBO J, V20, P1593, DOI 10.1093/emboj/20.7.1593; TERWILLIGER E, 1986, J VIROL, V60, P754, DOI 10.1128/JVI.60.2.754-760.1986; Trible RP, 2007, J MOL BIOL, V374, P121, DOI 10.1016/j.jmb.2007.09.009; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Walk SF, 2001, J VIROL, V75, P834, DOI 10.1128/JVI.75.2.834-843.2001; Wolf D, 2008, VIROLOGY, V370, P45, DOI 10.1016/j.virol.2007.08.015; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Ye HH, 2004, BIOCHEMISTRY-US, V43, P15775, DOI 10.1021/bi048712f	65	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32561	10.1371/journal.pone.0032561	http://dx.doi.org/10.1371/journal.pone.0032561			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393415	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000303003500067
J	Sharma, G; Tamang, R; Chaudhary, R; Singh, VK; Shah, AM; Anugula, S; Rani, DS; Reddy, AG; Eaaswarkhanth, M; Chaubey, G; Singh, L; Thangaraj, K				Sharma, Gunjan; Tamang, Rakesh; Chaudhary, Ruchira; Singh, Vipin Kumar; Shah, Anish M.; Anugula, Sharath; Rani, Deepa Selvi; Reddy, Alla G.; Eaaswarkhanth, Muthukrishnan; Chaubey, Gyaneshwer; Singh, Lalji; Thangaraj, Kumarasamy			Genetic Affinities of the Central Indian Tribal Populations	PLOS ONE			English	Article							HUMAN MITOCHONDRIAL-DNA; SOUTH-ASIA; MACROHAPLOGROUP-M; CASTE; DISPERSAL; ADMIXTURE; LINEAGES; HERITAGE	Background: The central Indian state Madhya Pradesh is often called as 'heart of India' and has always been an important region functioning as a trinexus belt for three major language families (Indo-European, Dravidian and Austroasiatic). There are less detailed genetic studies on the populations inhabited in this region. Therefore, this study is an attempt for extensive characterization of genetic ancestries of three tribal populations, namely; Bharia, Bhil and Sahariya, inhabiting this region using haploid and diploid DNA markers. Methodology/Principal Findings: Mitochondrial DNA analysis showed high diversity, including some of the older sublineages of M haplogroup and prominent R lineages in all the three tribes. Y-chromosomal biallelic markers revealed high frequency of Austroasiatic-specific M95-O2a haplogroup in Bharia and Sahariya, M82-H1a in Bhil and M17-R1a in Bhil and Sahariya. The results obtained by haploid as well as diploid genetic markers revealed strong genetic affinity of Bharia (a Dravidian speaking tribe) with the Austroasiatic (Munda) group. The gene flow from Austroasiatic group is further confirmed by their Y-STRs haplotype sharing analysis, where we determined their founder haplotype from the North Munda speaking tribe, while, autosomal analysis was largely in concordant with the haploid DNA results. Conclusions/Significance: Bhil exhibited largely Indo-European specific ancestry, while Sahariya and Bharia showed admixed genetic package of Indo-European and Austroasiatic populations. Hence, in a landscape like India, linguistic label doesn't unequivocally follow the genetic footprints.	[Sharma, Gunjan; Chaudhary, Ruchira] Govt Motilal Vigyan Mahavidyalaya, Dept Zool, Bhopal, India; [Tamang, Rakesh; Singh, Vipin Kumar; Shah, Anish M.; Anugula, Sharath; Rani, Deepa Selvi; Reddy, Alla G.; Eaaswarkhanth, Muthukrishnan; Singh, Lalji; Thangaraj, Kumarasamy] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Chaubey, Gyaneshwer] Univ Tartu, Dept Evolutionary Biol, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Chaubey, Gyaneshwer] Estonian Bioctr, Tartu, Estonia; [Singh, Lalji] Banaras Hindu Univ, Varanasi 221005, Uttar Pradesh, India; [Singh, Lalji] Genome Fdn, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of Tartu; Estonian Biocentre; Banaras Hindu University (BHU)	Sharma, G (corresponding author), Govt Motilal Vigyan Mahavidyalaya, Dept Zool, Bhopal, India.	ruchira_2006@yahoo.co.in; thangs@ccmb.res.in	Chaubey, Gyaneshwer/AAC-6409-2019; Muthukrishnan, Eaaswarkhanth/AAA-7106-2022; Anugula, Sharath/AAI-2443-2019; ANUGULA, SHARATH/N-8362-2015; Chaubey, Gyaneshwer/H-2753-2012	Chaubey, Gyaneshwer/0000-0003-2899-3852; Muthukrishnan, Eaaswarkhanth/0000-0001-9631-8555; Chaubey, Gyaneshwer/0000-0003-2899-3852; Chaudhary, Rubina/0000-0002-0486-1022; Thangaraj, Kumarasamy/0000-0002-0075-0106	UK-India Education and Research Initiative [RG-4772]; Indian Council of Medical Research; Council of Scientific and Industrial Research, Government of India; Department of Science and Technology, Government of India; Centre of Excellence of the Estonian Biocentre; UGC [38-76/2009]	UK-India Education and Research Initiative; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Centre of Excellence of the Estonian Biocentre; UGC(University Grants Commission, India)	KT was supported by the UK-India Education and Research Initiative (RG-4772), the Indian Council of Medical Research, and the Council of Scientific and Industrial Research, Government of India. LS was supported by a Bose Fellowship from the Department of Science and Technology, Government of India and Bhatnagar fellowship from the Council of Scientific and Industrial Research, Government of India, and GC was supported by the Centre of Excellence of the Estonian Biocentre. RC was supported by UGC grant 38-76/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Chaubey G, 2010, THESIS U TARTUENSIS, P9; Chaubey G, 2008, INT J HUM GENET, V8, P41, DOI 10.1080/09723757.2008.11886018; Chaubey G, 2007, BIOESSAYS, V29, P91, DOI 10.1002/bies.20525; Chaubey G, 2011, MOL BIOL EVOL, V28, P1013, DOI 10.1093/molbev/msq288; Chaubey G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-227; Cordaux R, 2004, CURR BIOL, V14, P231, DOI 10.1016/j.cub.2004.01.024; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Field JS, 2007, J ANTHROPOL ARCHAEOL, V26, P88, DOI 10.1016/j.jaa.2006.06.001; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kumar V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-47; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Patnaik R, 2009, J BIOSCIENCES, V34, P729, DOI 10.1007/s12038-009-0056-9; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sahoo S, 2006, P NATL ACAD SCI USA, V103, P843, DOI 10.1073/pnas.0507714103; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Shah AM, 2011, AM J HUM GENET, V89, P154, DOI 10.1016/j.ajhg.2011.05.030; Thangaraj K, 2002, J ANDROL, V23, P815; Thangaraj K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-151; Thangaraj K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015283; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	27	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32546	10.1371/journal.pone.0032546	http://dx.doi.org/10.1371/journal.pone.0032546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393414	Green Published, gold			2022-12-27	WOS:000303003500066
J	Super, H; Romeo, A				Super, Hans; Romeo, August			Masking of Figure-Ground Texture and Single Targets by Surround Inhibition: A Computational Spiking Model	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; CLASSICAL RECEPTIVE-FIELD; VISUAL-CORTEX V1; FEEDFORWARD INHIBITION; METACONTRAST MASKING; TIME-COURSE; FEEDBACK CONNECTIONS; BACKWARD-MASKING; SUPPRESSION; CELLS	A visual stimulus can be made invisible, i.e. masked, by the presentation of a second stimulus. In the sensory cortex, neural responses to a masked stimulus are suppressed, yet how this suppression comes about is still debated. Inhibitory models explain masking by asserting that the mask exerts an inhibitory influence on the responses of a neuron evoked by the target. However, other models argue that the masking interferes with recurrent or reentrant processing. Using computer modeling, we show that surround inhibition evoked by ON and OFF responses to the mask suppresses the responses to a briefly presented stimulus in forward and backward masking paradigms. Our model results resemble several previously described psychophysical and neurophysiological findings in perceptual masking experiments and are in line with earlier theoretical descriptions of masking. We suggest that precise spatiotemporal influence of surround inhibition is relevant for visual detection.	[Super, Hans] Inst Brain Cognit & Behav, Barcelona, Spain; [Super, Hans; Romeo, August] Univ Barcelona, Fac Psychol, Dept Basic Psychol, Barcelona, Spain; [Super, Hans] Catalan Inst Res & Adv Studies, Barcelona, Spain	University of Barcelona; ICREA	Super, H (corresponding author), Inst Brain Cognit & Behav, Barcelona, Spain.	hans.super@icrea.es		Super, Hans/0000-0001-9328-0096	Spanish Ministry of Education and Science (MICINN) [SAF2009-10367, PSI2010-18139]; Catalan government (AGAUR) [2009-SGR-308]; ICREA Funding Source: Custom	Spanish Ministry of Education and Science (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan government (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); ICREA(ICREA)	This work was supported by grants to HS (SAF2009-10367 & PSI2010-18139) from the Spanish Ministry of Education and Science (MICINN) and (2009-SGR-308) from the Catalan government (AGAUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitto HJ, 2008, NEURON, V57, P135, DOI 10.1016/j.neuron.2007.11.019; Almeida J, 2008, P NATL ACAD SCI USA, V105, P15214, DOI 10.1073/pnas.0805867105; Angelucci A, 2002, J NEUROSCI, V22, P8633; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Bacon-Mace N, 2005, VISION RES, V45, P1459, DOI 10.1016/j.visres.2005.01.004; Bair W, 2003, J NEUROSCI, V23, P7690; Becker MW, 2004, VISION RES, V44, P2537, DOI 10.1016/j.visres.2004.05.007; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; Block N, 2005, TRENDS COGN SCI, V9, P46, DOI 10.1016/j.tics.2004.12.006; Breitmeyer B.G., 1984, VISUAL MASKING INTEG; Breitmeyer BG, 2000, PERCEPT PSYCHOPHYS, V62, P1572, DOI 10.3758/BF03212157; Breitmeyer BG, 2008, VISION RES, V48, P2433, DOI 10.1016/j.visres.2008.08.003; BRIDGEMAN B, 1980, BRAIN RES, V196, P347, DOI 10.1016/0006-8993(80)90400-X; Bright DP, 2007, J NEUROSCI, V27, P2560, DOI 10.1523/JNEUROSCI.5100-06.2007; Carandini M, 2002, J NEUROSCI, V22, P10053; da Silva FHL, 2006, PROG BRAIN RES, V159, P3, DOI 10.1016/S0079-6123(06)59001-6; De Graaf TA, 2011, NEUROIMAGE; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Eimer M, 2008, J NEUROPSYCHOL, V2, P165, DOI 10.1348/174866407X245411; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; Fahrenfort JJ, 2007, J COGNITIVE NEUROSCI, V19, P1488, DOI 10.1162/jocn.2007.19.9.1488; Francis G, 2000, PSYCHOL REV, V107, P768, DOI 10.1037/0033-295X.107.4.768; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Izhikevich E M, 2005, DYNAMICAL SYSTEMS NE; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jackson A, 2002, J PHYSIOL-LONDON, V541, P685, DOI 10.1113/jphysiol.2001.015099; Jehee JFM, 2007, BRAIN RES, V1157, P167, DOI 10.1016/j.brainres.2007.03.090; KOVACS G, 1995, P NATL ACAD SCI USA, V92, P5587, DOI 10.1073/pnas.92.12.5587; Lakatos P, 2009, NEURON, V64, P419, DOI 10.1016/j.neuron.2009.10.014; Lamme V.A.F., 2000, BRAIN MIND, V1, P385, DOI [10.1023/A:1011569019782, DOI 10.1023/A:1011569019782]; Lamme VAF, 2002, J COGNITIVE NEUROSCI, V14, P1044, DOI 10.1162/089892902320474490; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Macknik SL, 2004, J COGNITIVE NEUROSCI, V16, P1049, DOI 10.1162/0898929041502788; Macknik SL, 2000, P NATL ACAD SCI USA, V97, P7556, DOI 10.1073/pnas.110142097; Macknik SL, 1998, NAT NEUROSCI, V1, P144, DOI 10.1038/393; Macknik SL, 2004, NEUROCOMPUTING, V58, P775, DOI 10.1016/j.neucom.2004.01.126; Macknik Stephen L, 2008, Adv Cogn Psychol, V3, P125, DOI 10.2478/v10053-008-0020-5; Macknik SL, 2006, PROG BRAIN RES, V155, P177, DOI 10.1016/S0079-6123(06)55011-3; Margolis DJ, 2007, J NEUROSCI, V27, P5994, DOI 10.1523/JNEUROSCI.0130-07.2007; MASTRONARDE DN, 1987, J NEUROPHYSIOL, V57, P381, DOI 10.1152/jn.1987.57.2.381; Mitra P, 2007, VISUAL NEUROSCI, V24, P709, DOI 10.1017/S0952523807070654; Moliadze V, 2003, J PHYSIOL-LONDON, V553, P665, DOI 10.1113/jphysiol.2003.050153; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; Ozeki H, 2004, J NEUROSCI, V24, P1428, DOI 10.1523/JNEUROSCI.3852-03.2004; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; ROLLS ET, 1994, P ROY SOC B-BIOL SCI, V257, P9, DOI 10.1098/rspb.1994.0087; Rossi AF, 1999, J NEUROSCI, V19, P6145, DOI 10.1523/JNEUROSCI.19-14-06145.1999; Saarela TP, 2008, J VISION, V8, DOI 10.1167/8.3.23; Shapiro KL, 1997, J EXP PSYCHOL HUMAN, V23, P504, DOI 10.1037/0096-1523.23.2.504; Solomon SG, 2006, J NEUROSCI, V26, P8715, DOI 10.1523/JNEUROSCI.0821-06.2006; Solomon SG, 2002, J NEUROSCI, V22, P338, DOI 10.1523/JNEUROSCI.22-01-00338.2002; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Super H, 2003, NEUROSCI LETT, V344, P75, DOI 10.1016/S0304-3940(03)00360-4; Super H, 2003, J NEUROSCI, V23, P3407; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Super H, 2007, NEUROPSYCHOLOGIA, V45, P3329, DOI 10.1016/j.neuropsychologia.2007.07.001; Super H, 2007, CEREB CORTEX, V17, P1468, DOI 10.1093/cercor/bhl058; Super H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021641; Super H, 2011, J COGNITIVE NEUROSCI, V23, P491, DOI 10.1162/jocn.2010.21512; Super H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010705; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Thompson KG, 1999, NAT NEUROSCI, V2, P283, DOI 10.1038/6398; Tse PU, 2005, P NATL ACAD SCI USA, V102, P17178, DOI 10.1073/pnas.0508010102; Vinck M, 2010, J NEUROSCI, V30, P1250, DOI 10.1523/JNEUROSCI.1623-09.2010; Webb BS, 2005, J NEUROPHYSIOL, V94, P1789, DOI 10.1152/jn.00826.2004; Yu C, 2000, NAT NEUROSCI, V3, P724, DOI 10.1038/76687; [章杰兵 ZHANG Jie-bing], 2009, [药学服务与研究, Pharmaceutical Care and Research], V9, P1; Zhu JJ, 1996, BRAIN RES BULL, V41, P281, DOI 10.1016/S0361-9230(96)00201-8	71	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31773	10.1371/journal.pone.0031773	http://dx.doi.org/10.1371/journal.pone.0031773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393370	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500023
J	Kaiser, K; Pollinger, J				Kaiser, Kristine; Pollinger, John			Batrachochytrium dendrobatidis Shows High Genetic Diversity and Ecological Niche Specificity among Haplotypes in the Maya Mountains of Belize	PLOS ONE			English	Article							AMPHIBIAN CHYTRID FUNGUS; EMERGING INFECTIOUS-DISEASE; PATHOGEN; CHYTRIDIOMYCOSIS; POPULATIONS; DECLINE; DISTRIBUTIONS; BIODIVERSITY; EMERGENCE; COMMUNITY	The amphibian pathogen Batrachochytrium dendrobatidis (Bd) has been implicated in amphibian declines around the globe. Although it has been found in most countries in Central America, its presence has never been assessed in Belize. We set out to determine the range, prevalence, and diversity of Bd using quantitative PCR (qPCR) and sequencing of a portion of the 5.8 s and ITS1-2 regions. Swabs were collected from 524 amphibians of at least 26 species in the protected areas of the Maya Mountains of Belize. We sequenced a subset of 72 samples that had tested positive for Bd by qPCR at least once; 30 samples were verified as Bd. Eight unique Bd haplotypes were identified in the Maya Mountains, five of which were previously undescribed. We identified unique ecological niches for the two most broadly distributed haplotypes. Combined with data showing differing virulence shown in different strains in other studies, the 5.8 s - ITS1-2 region diversity found in this study suggests that there may be substantial differences among populations or haplotypes. Future work should focus on whether specific haplotypes for other genomic regions and possibly pathogenicity can be associated with haplotypes at this locus, as well as the integration of molecular tools with other ecological tools to elucidate the ecology and pathogenicity of Bd.	[Kaiser, Kristine; Pollinger, John] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	University of California System; University of California Los Angeles	Kaiser, K (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	kristinekaiser@gmail.com			Critical Ecosystems Partnership Fund; Columbus Zoo and Aquarium	Critical Ecosystems Partnership Fund; Columbus Zoo and Aquarium	This work was funded in part by the Critical Ecosystems Partnership Fund, and the Columbus Zoo and Aquarium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: This work was funded in part by the Columbus Zoo and Aquarium. This does not alter their adherence to all the PLoS ONE policies on sharing data and materials.	Becker CG, 2011, P NATL ACAD SCI USA, V108, P9893, DOI 10.1073/pnas.1014497108; Berger L, 2005, DIS AQUAT ORGAN, V68, P47, DOI 10.3354/dao068047; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Bridgewater SGM, 2006, ECON BOT, V60, P265, DOI 10.1663/0013-0001(2006)60[265:CXITGM]2.0.CO;2; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Farrer RA, 2011, P NATL ACAD SCI; Federici S., 2009, HERPETOLOGY NOTES, V1, P33; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fisher MC, 2009, MOL ECOL, V18, P415, DOI 10.1111/j.1365-294X.2008.04041.x; Gaertner JP, 2009, ECOHEALTH, V6, P20, DOI 10.1007/s10393-009-0229-x; Gaertner JP, 2008, DETECTION BATRACHOCH; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Kaiser K, 2011, B ENV CONTAMINATION, P1; Kantzoura V, 2011, INT J PARASITOLOGY; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2004, BIOL CONSERV, V119, P555, DOI 10.1016/j.biocon.2004.01.017; Mendelson JR, 2004, REV BIOL TROP, V52, P991; Morehouse EA, 2003, MOL ECOL, V12, P395, DOI 10.1046/j.1365-294X.2003.01732.x; Morgan JAT, 2007, P NATL ACAD SCI USA, V104, P13845, DOI 10.1073/pnas.0701838104; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; Pauly GB, 2008, J HERPETOL, V42, P668, DOI 10.1670/07-303R1.1; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Puschendorf R, 2009, DIVERS DISTRIB, V15, P401, DOI 10.1111/j.1472-4642.2008.00548.x; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Rodriguez Edmarie Martinez, 2009, Herpetological Review, V40, P48; Rodder D, 2008, ANIM CONSERV, V11, P513, DOI 10.1111/j.1469-1795.2008.00210.x; Rohr JR, 2010, P NATL ACAD SCI USA, V107, P8269, DOI 10.1073/pnas.0912883107; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Voyles J, 2011, FUNGAL ECOLOGY	35	12	12	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32113	10.1371/journal.pone.0032113	http://dx.doi.org/10.1371/journal.pone.0032113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389681	Green Published, gold, Green Submitted			2022-12-27	WOS:000302999600019
J	Ruggenenti, P; Gaspari, F; Cannata, A; Carrara, F; Cella, C; Ferrari, S; Stucchi, N; Prandini, S; Ene-Iordache, B; Diadei, O; Perico, N; Ondei, P; Pisani, A; Buongiorno, E; Messa, P; Dugo, M; Remuzzi, G				Ruggenenti, Piero; Gaspari, Flavio; Cannata, Antonio; Carrara, Fabiola; Cella, Claudia; Ferrari, Silvia; Stucchi, Nadia; Prandini, Silvia; Ene-Iordache, Bogdan; Diadei, Olimpia; Perico, Norberto; Ondei, Patrizia; Pisani, Antonio; Buongiorno, Erasmo; Messa, Piergiorgio; Dugo, Mauro; Remuzzi, Giuseppe		GFR-ADPKD Study Grp	Measuring and Estimating GFR and Treatment Effect in ADPKD Patients: Results and Implications of a Longitudinal Cohort Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; POLYCYSTIC KIDNEY-DISEASE; PLASMA-CLEARANCE; RENAL-FUNCTION; PREDICTION EQUATIONS; INULIN CLEARANCE; SERUM CREATININE; IOHEXOL; PROGRESSION; SIROLIMUS	Trials failed to demonstrate protective effects of investigational treatments on glomerular filtration rate (GFR) reduction in Autosomal Dominant Polycystic Kidney Disease (ADPKD). To assess whether above findings were explained by unreliable GFR estimates, in this academic study we compared GFR values centrally measured by iohexol plasma clearance with corresponding values estimated by Chronic Kidney Disease Epidemiology Collaboration (CKD-Epi) and abbreviated Modification of Diet in Renal Disease (aMDRD) formulas in ADPKD patients retrieved from four clinical trials run by a Clinical Research Center and five Nephrology Units in Italy. Measured baseline GFRs and one-year GFR changes averaged 78.6 +/- 26.7 and 8.4 +/- 10.3 mL/min/1.73 m(2) in 111 and 71 ADPKD patients, respectively. CKD-Epi significantly overestimated and aMDRD underestimated baseline GFRs. Less than half estimates deviated by <10% from measured values. One-year estimated GFR changes did not detect measured changes. Both formulas underestimated GFR changes by 50%. Less than 9% of estimates deviated <10% from measured changes. Extent of deviations even exceeded that of measured one-year GFR changes. In ADPKD, prediction formulas unreliably estimate actual GFR values and fail to detect their changes over time. Direct kidney function measurements by appropriate techniques are needed to adequately evaluate treatment effects in clinics and research.	[Ruggenenti, Piero; Gaspari, Flavio; Cannata, Antonio; Carrara, Fabiola; Cella, Claudia; Ferrari, Silvia; Stucchi, Nadia; Prandini, Silvia; Ene-Iordache, Bogdan; Diadei, Olimpia; Perico, Norberto; Remuzzi, Giuseppe] Mario Negri Inst Pharmacol Res, Clin Res Ctr Rare Dis Aldo & Cele Dacco, I-24100 Bergamo, Italy; [Ruggenenti, Piero; Ondei, Patrizia; Remuzzi, Giuseppe] Osped Riuniti Bergamo, Azienda Osped, Nephrol Unit, I-24100 Bergamo, Italy; [Pisani, Antonio] Univ Naples Federico II, Azienda Osped, Naples, Italy; [Buongiorno, Erasmo] Presidio Osped V Fazzi, Lecce, Italy; [Messa, Piergiorgio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Dugo, Mauro] Azienda ULSS 9 Osped S Maria di Ca Foncello, Treviso, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Ospedali Riuniti di Bergamo; University of Naples Federico II; IRCCS Ca Granda Ospedale Maggiore Policlinico; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso	Ruggenenti, P (corresponding author), Mario Negri Inst Pharmacol Res, Clin Res Ctr Rare Dis Aldo & Cele Dacco, Via Gavazzeni 11, I-24100 Bergamo, Italy.	giuseppe.remuzzi@marionegri.it	Stucchi, Nadia/ABF-5669-2020; Perico, Norberto/ABH-3222-2020; Carrara, Fabiola/ABF-4666-2020; Ene-Iordache, Bogdan/C-6824-2018; Diadei, Olimpia/ABF-4552-2020; Prandini, Silvi/ABG-7735-2020; Ferrari, Silvia/ABF-5648-2020; Remuzzi, Giuseppe/V-9766-2017	Stucchi, Nadia/0000-0002-3739-2373; Perico, Norberto/0000-0002-3147-4327; Carrara, Fabiola/0000-0002-5799-9535; Ene-Iordache, Bogdan/0000-0002-4011-9343; Prandini, Silvi/0000-0001-9337-9512; Ferrari, Silvia/0000-0003-0769-0414; Trillini, Matias/0000-0003-1859-1729; Remuzzi, Giuseppe/0000-0002-6194-3446; PISANI, Antonio/0000-0003-0241-8323; Cella, Claudia/0000-0002-9210-0775				Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Berg UB, 2011, AM J KIDNEY DIS, V57, P55, DOI 10.1053/j.ajkd.2010.07.013; Brandstrom E, 1998, NEPHROL DIAL TRANSPL, V13, P1176, DOI 10.1093/ndt/13.5.1176; BROCHNER.J, 1969, SCAND J CLIN LAB INV, V23, P301, DOI 10.3109/00365516909081695; BROCHNER.J, 1972, SCAND J CLIN LAB INV, V30, P271, DOI 10.3109/00365517209084290; BROWN SCW, 1991, J UROLOGY, V146, P675, DOI 10.1016/S0022-5347(17)37891-6; Chudleigh RA, 2007, DIABETES CARE, V30, P300, DOI 10.2337/dc06-1688; DALGAARD O Z, 1957, Acta Med Scand Suppl, V328, P1; EFFERSOE H, 1990, INVEST RADIOL, V25, P778, DOI 10.1097/00004424-199007000-00005; Erley CM, 2001, CRIT CARE MED, V29, P1544, DOI 10.1097/00003246-200108000-00008; Fontsere N, 2006, NEPHROL DIAL TRANSPL, V21, P2152, DOI 10.1093/ndt/gfl221; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; GASPARI F, 1995, J AM SOC NEPHROL, V6, P257; Gaspari F, 1998, J AM SOC NEPHROL, V9, P310; Gaspari F, 2004, AM J TRANSPLANT, V4, P1826, DOI 10.1111/j.1600-6143.2004.00579.x; Grantham JJ, 2006, CLIN J AM SOC NEPHRO, V1, P148, DOI 10.2215/CJN.00330705; HEATH DA, 1968, LANCET, V2, P1110; King BF, 2000, J AM SOC NEPHROL, V11, P1505, DOI 10.1681/ASN.V1181505; Kuypers DRJ, 2004, TRANSPLANTATION, V78, P1204, DOI 10.1097/01.TP.0000137793.23371.42; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Orskov B, 2010, AM J NEPHROL, V31, P53, DOI 10.1159/000256657; Perico N, 2010, NAT REV NEPHROL, V6, P696, DOI 10.1038/nrneph.2010.153; Perico N, 2010, J AM SOC NEPHROL, V21, P1031, DOI 10.1681/ASN.2009121302; Poggio ED, 2005, J AM SOC NEPHROL, V16, P459, DOI 10.1681/ASN.2004060447; PRICE M, 1972, J UROLOGY, V107, P339, DOI 10.1016/S0022-5347(17)61021-8; Qian Q, 2008, J AM SOC NEPHROL, V19, P631, DOI 10.1681/ASN.2007050626; REHLING M, 1984, CLIN SCI, V66, P613, DOI 10.1042/cs0660613; Ruggenenti P, 1997, LANCET, V349, P1857; Ruggenenti P, 2005, KIDNEY INT, V68, P206, DOI 10.1111/j.1523-1755.2005.00395.x; Ruggenenti P, 2005, NEW ENGL J MED, V352, P834; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Rule AD, 2006, J AM SOC NEPHROL, V17, P854, DOI 10.1681/ASN.2005070697; Schutzer KM, 2010, EUR J CLIN PHARMACOL, V66, P903, DOI 10.1007/s00228-010-0849-7; Schwartz GJ, 2006, KIDNEY INT, V69, P2070, DOI 10.1038/sj.ki.5000385; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Stengel B, 2003, NEPHROL DIAL TRANSPL, V18, P1824, DOI 10.1093/ndt/gfg233; Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660; Torres VE, 2007, J INTERN MED, V261, P17, DOI 10.1111/j.1365-2796.2006.01743.x; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; Wu M, 2009, AM J PHYSIOL-RENAL, V297, pF1597, DOI 10.1152/ajprenal.00430.2009	43	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32533	10.1371/journal.pone.0032533	http://dx.doi.org/10.1371/journal.pone.0032533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22393413	Green Submitted, Green Published, gold			2022-12-27	WOS:000302999600046
J	Andrews, KT; Gupta, AP; Tran, TN; Fairlie, DP; Gobert, GN; Bozdech, Z				Andrews, Katherine T.; Gupta, Archna P.; Tran, Thanh N.; Fairlie, David P.; Gobert, Geoffrey N.; Bozdech, Zbynek			Comparative Gene Expression Profiling of P. falciparum Malaria Parasites Exposed to Three Different Histone Deacetylase Inhibitors	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; ANTIMALARIAL ACTIVITY; ANTIGENIC VARIATION; VIRULENCE GENES; HDAC INHIBITORS; IDENTIFICATION; ACETYLATION; PERTURBATIONS; CHLOROQUINE; PATTERNS	Histone deacetylase (HDAC) inhibitors are being intensively pursued as potential new drugs for a range of diseases, including malaria. HDAC inhibitors are also important tools for the study of epigenetic mechanisms, transcriptional control, and other important cellular processes. In this study the effects of three structurally related antimalarial HDAC inhibitors on P. falciparum malaria parasite gene expression were compared. The three hydroxamate-based compounds, trichostatin A (TSA), suberoylanilide hydroxamic acid (SAHA; Vorinostat (R)) and a 2-aminosuberic acid derivative (2-ASA-9), all caused profound transcriptional effects, with, 2-21% of genes having >2-fold altered expression following 2 h exposure to the compounds. Only two genes, alpha tubulin II and a hydrolase, were up-regulated by all three compounds after 2 h exposure in all biological replicates examined. The transcriptional changes observed after 2 h exposure to HDAC inhibitors were found to be largely transitory, with only 1-5% of genes being regulated after removing the compounds and culturing for a further 2 h. Despite some structural similarity, the three inhibitors caused quite diverse transcriptional effects, possibly reflecting subtle differences in mode of action or cellular distribution. This dataset represents an important contribution to our understanding of how HDAC inhibitors act on malaria parasites and identifies alpha tubulin II as a potential transcriptional marker of HDAC inhibition in malaria parasites that may be able to be exploited for future development of HDAC inhibitors as new antimalarial agents.	[Andrews, Katherine T.; Tran, Thanh N.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [Andrews, Katherine T.; Tran, Thanh N.; Gobert, Geoffrey N.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Gupta, Archna P.; Bozdech, Zbynek] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Fairlie, David P.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	Griffith University; QIMR Berghofer Medical Research Institute; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Queensland	Andrews, KT (corresponding author), Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia.	k.andrews@griffith.edu.au	Andrews, Katherine/F-9586-2011; Gobert, Geoffrey/V-2985-2019; Bozdech, Zbynek/A-2205-2011; Fairlie, David P/F-8865-2014	Andrews, Katherine/0000-0002-1591-8979; Fairlie, David P/0000-0002-7856-8566; Bozdech, Zbynek/0000-0002-9830-8446; Gobert, Geoffrey/0000-0001-5884-6453	Australian Research Council; Australian National Health and Medical Research Council; ARC/NHMRC Research Network for Parasitology	Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC/NHMRC Research Network for Parasitology(Australian Research CouncilNational Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the Australian Research Council, the Australian National Health and Medical Research Council, and the ARC/NHMRC Research Network for Parasitology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews KT, 2008, ANTIMICROB AGENTS CH, V52, P1454, DOI 10.1128/AAC.00757-07; Andrews KT, 2012, IMMUNOL CELL BIOL, V90, P66, DOI 10.1038/icb.2011.97; Andrews KT, 2009, CURR TOP MED CHEM, V9, P292, DOI 10.2174/156802609788085313; Auparakkitanon S, 2006, ANTIMICROB AGENTS CH, V50, P2197, DOI 10.1128/AAC.00119-06; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; BURKOT TR, 1984, T ROY SOC TROP MED H, V78, P339, DOI 10.1016/0035-9203(84)90114-7; Chaal BK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000737; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; DarkinRattray SJ, 1996, P NATL ACAD SCI USA, V93, P13143, DOI 10.1073/pnas.93.23.13143; Dow GS, 2008, ANTIMICROB AGENTS CH, V52, P3467, DOI 10.1128/AAC.00439-08; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fennell BJ, 2008, INT J PARASITOL, V38, P527, DOI 10.1016/j.ijpara.2007.09.005; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Ganesan K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000214; Garcia-Estrada C, 2010, P ROY SOC B-BIOL SCI, V277, P1777, DOI 10.1098/rspb.2009.2176; Glaser KB, 2003, MOL CANCER THER, V2, P151; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gunasekera AM, 2007, EXP PARASITOL, V117, P87, DOI 10.1016/j.exppara.2007.03.001; Hu ED, 2003, J PHARMACOL EXP THER, V307, P720, DOI 10.1124/jpet.103.055541; Hu G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-350; Hu GA, 2010, NAT BIOTECHNOL, V28, P91, DOI 10.1038/nbt.1597; Kahnberg P, 2006, J MED CHEM, V49, P7611, DOI 10.1021/jm050214x; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Le Roch KG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-513; Mai A, 2005, MED RES REV, V25, P261, DOI 10.1002/med.20024; Natalang O, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-388; NATEGHPOUR M, 1993, ANTIMICROB AGENTS CH, V37, P2337, DOI 10.1128/AAC.37.11.2337; Oakley MSM, 2007, INFECT IMMUN, V75, P2012, DOI 10.1128/IAI.01236-06; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Patel V, 2009, J MED CHEM, V52, P2185, DOI 10.1021/jm801654y; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Ridley RG, 1996, ANTIMICROB AGENTS CH, V40, P1846, DOI 10.1128/AAC.40.8.1846; Tonkin CJ, 2009, PLOS BIOL, V7, P771, DOI 10.1371/journal.pbio.1000084; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vial HJ, 2004, P NATL ACAD SCI USA, V101, P15458, DOI 10.1073/pnas.0404037101; Wheatley NC, 2010, BIOORG MED CHEM LETT, V20, P7080, DOI 10.1016/j.bmcl.2010.09.096; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang YJ, 2008, CURR MED CHEM, V15, P2840, DOI 10.2174/092986708786242796	41	50	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31847	10.1371/journal.pone.0031847	http://dx.doi.org/10.1371/journal.pone.0031847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384084	gold, Green Published, Green Submitted			2022-12-27	WOS:000302918500041
J	Aoki, W; Kitahara, N; Miura, N; Morisaka, H; Yamamoto, Y; Kuroda, K; Ueda, M				Aoki, Wataru; Kitahara, Nao; Miura, Natsuko; Morisaka, Hironobu; Yamamoto, Yoshihiro; Kuroda, Kouichi; Ueda, Mitsuyoshi			Candida albicans Possesses Sap7 as a Pepstatin A-Insensitive Secreted Aspartic Protease	PLOS ONE			English	Article							VIRULENCE FACTORS; GENE FAMILY; PROTEINASES; MODEL; DEGRADATION; EXPRESSION; INVASION; INFECTION	Background: Candida albicans, a commensal organism, is a part of the normal flora of healthy individuals. However, once the host immunity is compromised, C. albicans opportunistically causes recurrent superficial or fatal systemic candidiasis. Secreted aspartic proteases (Sap), encoded by 10 types of SAP genes, have been suggested to contribute to various virulence processes. Thus, it is important to elucidate their biochemical properties for better understanding of the molecular mechanisms that how Sap isozymes damage host tissues. Methodology/Principal Findings: The SAP7 gene was cloned from C. albicans SC5314 and heterogeneously produced by Pichia pastoris. Measurement of Sap7 proteolytic activity using the FRETS-25Ala library showed that Sap7 was a pepstatin A-insensitive protease. To understand why Sap7 was insensitive to pepstatin A, alanine substitution mutants of Sap7 were constructed. We found that M242A and T467A mutants had normal proteolytic activity and sensitivity to pepstatin A. M242 and T467 were located in close proximity to the entrance to an active site, and alanine substitution at these positions widened the entrance. Our results suggest that this alteration might allow increased accessibility of pepstatin A to the active site. This inference was supported by the observation that the T467A mutant has stronger proteolytic activity than the wild type. Conclusions/Significance: We found that Sap7 was a pepstatin A-insensitive protease, and that M242 and T467 restricted the accessibility of pepstatin A to the active site. This finding will lead to the development of a novel protease inhibitor beyond pepstatin A. Such a novel inhibitor will be an important research tool as well as pharmaceutical agent for patients suffering from candidiasis.	[Aoki, Wataru; Miura, Natsuko] Japan Soc Promot Sci, Sakyo Ku, Kyoto, Japan; [Aoki, Wataru; Kitahara, Nao; Miura, Natsuko; Morisaka, Hironobu; Kuroda, Kouichi; Ueda, Mitsuyoshi] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto, Japan; [Yamamoto, Yoshihiro] Kyoto Municipal Inst Ind Technol & Culture, Ind Technol Ctr, Simogyo Ku, Kyoto, Japan	Japan Society for the Promotion of Science; Kyoto University	Aoki, W (corresponding author), Japan Soc Promot Sci, Sakyo Ku, Kyoto, Japan.	miueda@kais.kyoto-u.ac.jp	Kuroda, Kouichi/AAQ-3678-2021; Miura, Natsuko/R-7392-2019; 航, 青木/N-7269-2013	Miura, Natsuko/0000-0002-8722-0406; Kuroda, Kouichi/0000-0002-9249-0486; Aoki, Wataru/0000-0002-3118-9390	Japan Society for the Promotion of Science for Young Scientists [22-101]; Regional Innovation Creation RD Programs [22R5005]; Grants-in-Aid for Scientific Research [10J00101, 09J02920] Funding Source: KAKEN	Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Regional Innovation Creation RD Programs; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a research fellowship from the Japan Society for the Promotion of Science for Young Scientists (grant 22-101, http://www.jsps.go.jp/j-pd/index.html); and Regional Innovation Creation R&D Programs (grant 22R5005, http://www.meti.go.jp/policy/sme_chiiki/cluster/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht A, 2006, J BIOL CHEM, V281, P688, DOI 10.1074/jbc.M509297200; Aoki W, 2011, J BIOCHEM, V150, P431, DOI 10.1093/jb/mvr073; Arnaud MB, 2005, NUCLEIC ACIDS RES, V33, pD358, DOI 10.1093/nar/gki003; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948; Borg-von Zepelin M, 1998, MOL MICROBIOL, V28, P543, DOI 10.1046/j.1365-2958.1998.00815.x; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Chen YC, 2002, MICROBIOL-SGM, V148, P3743, DOI 10.1099/00221287-148-11-3743; Colina AR, 1996, INFECT IMMUN, V64, P4514, DOI 10.1128/IAI.64.11.4514-4519.1996; CUTFIELD SM, 1995, STRUCTURE, V3, P1261, DOI 10.1016/S0969-2126(01)00261-1; DeBernardis F, 1997, INFECT IMMUN, V65, P3399, DOI 10.1128/IAI.65.8.3399-3405.1997; EDISON AM, 1988, INFECT IMMUN, V56, P1388, DOI 10.1128/IAI.56.5.1388-1390.1988; Fallon K, 1997, INFECT IMMUN, V65, P551, DOI 10.1128/IAI.65.2.551-556.1997; Fujinaga M, 2004, P NATL ACAD SCI USA, V101, P3364, DOI 10.1073/pnas.0400246101; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Gropp K, 2009, MOL IMMUNOL, V47, P465, DOI 10.1016/j.molimm.2009.08.019; Hornbach A, 2009, INFECT IMMUN, V77, P5216, DOI 10.1128/IAI.00723-09; Hube B, 1997, INFECT IMMUN, V65, P3529, DOI 10.1128/IAI.65.9.3529-3538.1997; Hube Bernhard, 1998, Revista Iberoamericana de Micologia, V15, P65; KAMINISHI H, 1995, INFECT IMMUN, V63, P984, DOI 10.1128/IAI.63.3.984-988.1995; Kretschmar M, 2002, MICROB PATHOGENESIS, V32, P61, DOI 10.1006/mpat.2001.0478; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Lermann U, 2008, MICROBIOL-SGM, V154, P3281, DOI 10.1099/mic.0.2008/022525-0; MARCINISZYN J, 1976, J BIOL CHEM, V251, P7088; Marciniszyn J Jr, 1977, Adv Exp Med Biol, V95, P199; Monod M, 1998, MICROBIOL-UK, V144, P2731, DOI 10.1099/00221287-144-10-2731; Naglik J, 2004, CELL MICROBIOL, V6, P915, DOI 10.1111/j.1462-5822.2004.00439.x; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Naglik JR, 1999, INFECT IMMUN, V67, P2482, DOI 10.1128/IAI.67.5.2482-2490.1999; Naglik JR, 2008, MICROBIOL-SGM, V154, P3266, DOI 10.1099/mic.0.2008/022293-0; Odds FC, 2008, MICROBIOL-SGM, V154, P3245, DOI 10.1099/mic.0.2008/023671-0; RUCHEL R, 1986, MICROBIOL SCI, V3, P316; Sanglard D, 1997, INFECT IMMUN, V65, P3539, DOI 10.1128/IAI.65.9.3539-3546.1997; Schaller M, 2005, MYCOSES, V48, P365, DOI 10.1111/j.1439-0507.2005.01165.x; Schaller M, 2001, J MED MICROBIOL, V50, P743, DOI 10.1099/0022-1317-50-8-743; Schaller M, 2003, INFECT IMMUN, V71, P3227, DOI 10.1128/IAI.71.6.3227-3234.2003; Schild L, 2011, EUKARYOT CELL, V10, P98, DOI 10.1128/EC.00210-10; Sims AH, 2004, FEMS MICROBIOL LETT, V239, P95, DOI 10.1016/j.femsle.2004.08.023; Smolenski G, 1997, MICROBIOL-SGM, V143, P349, DOI 10.1099/00221287-143-2-349; Sobel J D, 1988, Ann N Y Acad Sci, V544, P547, DOI 10.1111/j.1749-6632.1988.tb40450.x; SOBEL JD, 1992, CLIN INFECT DIS, V14, pS148, DOI 10.1093/clinids/14.Supplement_1.S148; Tanskul S, 2003, BIOCHEM BIOPH RES CO, V309, P547, DOI 10.1016/j.bbrc.2003.08.035; Taylor BN, 2005, INFECT IMMUN, V73, P7061, DOI 10.1128/IAI.73.10.7061-7063.2005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Villar CC, 2007, INFECT IMMUN, V75, P2126, DOI 10.1128/IAI.00054-07; WHITE TC, 1993, J BACTERIOL, V175, P6126, DOI 10.1128/JB.175.19.6126-6133.1993	46	20	22	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32513	10.1371/journal.pone.0032513	http://dx.doi.org/10.1371/journal.pone.0032513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384266	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500097
J	Hoogewijs, D; Dewilde, S; Vierstraete, A; Moens, L; Vinogradov, SN				Hoogewijs, David; Dewilde, Sylvia; Vierstraete, Andy; Moens, Luc; Vinogradov, Serge N.			A Phylogenetic Analysis of the Globins in Fungi	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; NITRIC-OXIDE DIOXYGENASE; NITROSATIVE STRESS; 2 FLAVOHEMOGLOBINS; GENOME EVOLUTION; PROTEIN FOLD; PSI-BLAST; GENE; HEMOGLOBIN; ACCURACY	Background: All globins belong to one of three families: the F (flavohemoglobin) and S (sensor) families that exhibit the canonical 3/3 alpha-helical fold, and the T (truncated 3/3 fold) globins characterized by a shortened 2/2 alpha-helical fold. All eukaryote 3/3 hemoglobins are related to the bacterial single domain F globins. It is known that Fungi contain flavohemoglobins and single domain S globins. Our aims are to provide a census of fungal globins and to examine their relationships to bacterial globins. Results: Examination of 165 genomes revealed that globins are present in > 90% of Ascomycota and similar to 60% of Basidiomycota genomes. The S globins occur in Blastocladiomycota and Chytridiomycota in addition to the phyla that have FHbs. Unexpectedly, group 1 T globins were found in one Blastocladiomycota and one Chytridiomycota genome. Phylogenetic analyses were carried out on the fungal globins, alone and aligned with representative bacterial globins. The Saccharomycetes and Sordariomycetes with two FHbs form two widely divergent clusters separated by the remaining fungal sequences. One of the Saccharomycete groups represents a new subfamily of FHbs, comprising a previously unknown N-terminal and a FHb missing the C-terminal moiety of its reductase domain. The two Saccharomycete groups also form two clusters in the presence of bacterial FHbs; the surrounding bacterial sequences are dominated by Proteobacteria and Bacilli (Firmicutes). The remaining fungal FHbs cluster with Proteobacteria and Actinobacteria. The Sgbs cluster separately from their bacterial counterparts, except for the intercalation of two Planctomycetes and a Proteobacterium between the Fungi incertae sedis and the Blastocladiomycota and Chytridiomycota. Conclusion: Our results are compatible with a model of globin evolution put forward earlier, which proposed that eukaryote F, S and T globins originated via horizontal gene transfer of their bacterial counterparts to the eukaryote ancestor, resulting from the endosymbiotic events responsible for the origin of mitochondria and chloroplasts.	[Hoogewijs, David] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Hoogewijs, David] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Dewilde, Sylvia; Moens, Luc] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Vierstraete, Andy] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium; [Vinogradov, Serge N.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI USA	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Antwerp; Ghent University; Wayne State University	Hoogewijs, D (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	david.hoogewijs@access.uzh.ch	Hoogewijs, David/L-5144-2016		Fund for Scientific Research (FWO); European Commission [PIEF-GA-2009-236157]	Fund for Scientific Research (FWO)(FWO); European Commission(European CommissionEuropean Commission Joint Research Centre)	S.D. and L. M. are supported by the Fund for Scientific Research (FWO). D.H. is a recipient of a Marie Curie Intra-European Fellowship from the European Commission (PIEF-GA-2009-236157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angelo M, 2008, METHOD ENZYMOL, V436, P131, DOI 10.1016/S0076-6879(08)36008-X; BASHFORD D, 1987, J MOL BIOL, V196, P199, DOI 10.1016/0022-2836(87)90521-3; Biesebeke RT, 2010, FUNGAL BIOL-UK, V114, P135, DOI 10.1016/j.mycres.2009.08.007; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; Chiranand W, 2008, EUKARYOT CELL, V7, P268, DOI 10.1128/EC.00240-07; Cliften PF, 2006, GENETICS, V172, P863, DOI 10.1534/genetics.105.048900; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Ebersberger I, 2012, MOL BIOL EVOL, V29, P1319, DOI 10.1093/molbev/msr285; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fitzpatrick DA, 2011, FEMS MICROBIOL  1123; Freitas TAK, 2005, J INORG BIOCHEM, V99, P23, DOI 10.1016/j.jinorgbio.2004.10.024; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Goffeau A, 2005, NATURE, V438, P1092, DOI 10.1038/4381092b; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Hoogewijs D, 2012, MOL BIOL EVOL, V29, P1105, DOI 10.1093/molbev/msr246; Hromatka BS, 2005, MOL BIOL CELL, V16, P4814, DOI 10.1091/mbc.E05-05-0435; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IWAASA H, 1992, J MOL BIOL, V227, P948, DOI 10.1016/0022-2836(92)90236-D; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keeling PJ, 2010, GENOME BIOL EVOL, V2, P304, DOI 10.1093/gbe/evq022; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; KEILIN D, 1953, NATURE, V172, P390, DOI 10.1038/172390a0; KEILIN D, 1953, NATURE, V172, P393, DOI 10.1038/172393a0; Kirk PM., 2008, DICT FUNGI, V10th ed; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Lake JA, 2009, NATURE, V460, P967, DOI 10.1038/nature08183; Lassmann T, 2005, NUCLEIC ACIDS RES, V33, P7120, DOI 10.1093/nar/gki1020; Lassmann T, 2006, NUCLEIC ACIDS RES, V34, pW596, DOI 10.1093/nar/gkl191; LESK AM, 1980, J MOL BIOL, V136, P225, DOI 10.1016/0022-2836(80)90373-3; Liggenstoffer AS, 2010, ISME J, V4, P1225, DOI 10.1038/ismej.2010.49; Liti G, 2005, ANNU REV MICROBIOL, V59, P135, DOI 10.1146/annurev.micro.59.030804.121400; Marcet-Houben M, 2010, TRENDS GENET, V26, P5, DOI 10.1016/j.tig.2009.11.007; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mueller GM, 2007, BIODIVERS CONSERV, V16, P1, DOI 10.1007/s10531-006-9117-7; Nardini M, 2007, GENE, V398, P2, DOI 10.1016/j.gene.2007.02.045; OSHINO R, 1973, EUR J BIOCHEM, V39, P581, DOI 10.1111/j.1432-1033.1973.tb03157.x; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pesce A, 2009, J MOL BIOL, V386, P246, DOI 10.1016/j.jmb.2008.12.023; Redecker D, 2006, MYCOLOGIA, V98, P885, DOI 10.3852/mycologia.98.6.885; Richards TA, 2011, CURR BIOL, V21, pR166, DOI 10.1016/j.cub.2011.01.028; Richards TA, 2009, PLANT CELL, V21, P1897, DOI 10.1105/tpc.109.065805; Salto JA, 2008, FEBS LETT, V582, P1840, DOI 10.1016/j.febslet.2008.05.004; Scannell DR, 2007, YEAST, V24, P929, DOI 10.1002/yea.1515; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Slot JC, 2011, CURR BIOL, V21, P134, DOI 10.1016/j.cub.2010.12.020; Smagghe BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002039; Stajich JE, 2009, CURR BIOL, V19, pR840, DOI 10.1016/j.cub.2009.07.004; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tuckerman JR, 2009, BIOCHEMISTRY-US, V48, P9764, DOI 10.1021/bi901409g; Van de Peer Y, 2004, NAT REV GENET, V5, P752, DOI 10.1038/nrg1449; VASUDEVAN SG, 1991, MOL GEN GENET, V226, P49, DOI 10.1007/BF00273586; Vinogradov SN, 2007, GENE, V398, P132, DOI 10.1016/j.gene.2007.02.041; Vinogradov SN, 2011, MOL PLANT, V4, P42, DOI 10.1093/mp/ssq040; Vinogradov SN, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-31; Vinogradov SN, 2005, P NATL ACAD SCI USA, V102, P11385, DOI 10.1073/pnas.0502103102; Vinogradov SN, 2011, HEMOGLOBIN RECENT DE, P231; Vuletich DA, 2006, J MOL EVOL, V62, P196, DOI 10.1007/s00239-005-0077-4; Wan XH, 2009, J MOL BIOL, V388, P262, DOI 10.1016/j.jmb.2009.03.015; Wang H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-195; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200; Wu GH, 2003, ADV MICROB PHYSIOL, V47, P255, DOI 10.1016/S0065-2911(03)47005-7; Zhou SM, 2011, FUNGAL GENET BIOL, V48, P200, DOI 10.1016/j.fgb.2010.08.011; Zhou SM, 2010, BIOCHEM BIOPH RES CO, V394, P558, DOI 10.1016/j.bbrc.2010.03.018; Zhou SM, 2009, BIOCHEM BIOPH RES CO, V381, P7, DOI 10.1016/j.bbrc.2009.01.112; ZHU H, 1992, P NATL ACAD SCI USA, V89, P5015, DOI 10.1073/pnas.89.11.5015	79	21	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31856	10.1371/journal.pone.0031856	http://dx.doi.org/10.1371/journal.pone.0031856			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384087	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000302918500042
J	Ichikawa, T; Sato, F; Terasawa, K; Tsuchiya, S; Toi, M; Tsujimoto, G; Shimizu, K				Ichikawa, Takehiro; Sato, Fumiaki; Terasawa, Kazuya; Tsuchiya, Soken; Toi, Masakazu; Tsujimoto, Gozoh; Shimizu, Kazuharu			Trastuzumab Produces Therapeutic Actions by Upregulating miR-26a and miR-30b in Breast Cancer Cells	PLOS ONE			English	Article							TAMOXIFEN RESISTANCE; 1ST-LINE TREATMENT; LIVER-CANCER; TUMOR-CELLS; PHASE-II; EXPRESSION; MICRORNAS; CYCLIN; EZH2; DOCETAXEL	Objective: Trastuzumab has been used for the treatment of HER2-positive breast cancer (BC). However, a subset of BC patients exhibited resistance to trastuzumab therapy. Thus, clarifying the molecular mechanism of trastuzumab treatment will be beneficial to improve the treatment of HER2-positive BC patients. In this study, we identified trastuzumab-responsive microRNAs that are involved in the therapeutic effects of trastuzumab. Methods and Results: RNA samples were obtained from HER2-positive (SKBR3 and BT474) and HER2-negetive (MCF7 and MDA-MB-231) cells with and without trastuzumab treatment for 6 days. Next, we conducted a microRNA profiling analysis using these samples to screen those microRNAs that were up-or down-regulated only in HER2-positive cells. This analysis identified miR-26a and miR-30b as trastuzumab-inducible microRNAs. Transfecting miR-26a and miR-30b induced cell growth suppression in the BC cells by 40% and 32%, respectively. A cell cycle analysis showed that these microRNAs induced G1 arrest in HER2-positive BC cells as trastuzumab did. An Annexin-V assay revealed that miR-26a but not miR-30b induced apoptosis in HER2-positive BC cells. Using the prediction algorithms for microRNA targets, we identified cyclin E2 (CCNE2) as a target gene of miR-30b. A luciferase-based reporter assay demonstrated that miR-30b post-transcriptionally reduced 27% (p = 0.005) of the gene expression by interacting with two binding sites in the 3'-UTR of CCNE2. Conclusion: In BC cells, trastuzumab modulated the expression of a subset of microRNAs, including miR-26a and miR-30b. The upregulation of miR-30b by trastuzumab may play a biological role in trastuzumab-induced cell growth inhibition by targeting CCNE2.	[Ichikawa, Takehiro; Sato, Fumiaki; Tsuchiya, Soken; Shimizu, Kazuharu] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Nanobio Drug Discovery, Kyoto, Japan; [Sato, Fumiaki] Kyoto Univ, Grad Sch Med, Dept Target Therapy Oncol, Kyoto, Japan; [Terasawa, Kazuya; Tsujimoto, Gozoh] Kyoto Univ, Dept Pharmacogenom, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Toi, Masakazu] Kyoto Univ, Grad Sch Med, Dept Breast Surg, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University	Ichikawa, T (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Nanobio Drug Discovery, Kyoto, Japan.	fsatoh@kuhp.kyoto-u.ac.jp			Japan Society for Promotion of Science [20390342, 20591569]; Grants-in-Aid for Scientific Research [23659610] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by two grants (#20390342 and #20591569) from the Japan Society for Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blower PE, 2008, MOL CANCER THER, V7, P1, DOI 10.1158/1535-7163.MCT-07-0573; Boominathan L, 2010, CANCER METAST REV, V29, P613, DOI 10.1007/s10555-010-9257-9; Carlomagno C, 1996, J CLIN ONCOL, V14, P2702, DOI 10.1200/JCO.1996.14.10.2702; Ciarapica R, 2009, CELL CYCLE, V8, P172, DOI 10.4161/cc.8.1.7292; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Dubska L, 2005, FEBS LETT, V579, P4149, DOI 10.1016/j.febslet.2005.06.047; Esteva FJ, 2002, J CLIN ONCOL, V20, P1800, DOI 10.1200/JCO.2002.07.058; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Gudas JM, 1999, MOL CELL BIOL, V19, P612; GUSTERSON BA, 1992, J CLIN ONCOL, V10, P1049, DOI 10.1200/JCO.1992.10.7.1049; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; Ito T, 2007, ONCOLOGY-BASEL, V73, P366, DOI 10.1159/000136156; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Kanehisa M, 2011, KEGG PATHWAY DATABAS; Kastl L, 2011, BREAST CANC RES TREA; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Le XF, 2005, CELL CYCLE, V4, P87, DOI 10.4161/cc.4.1.1360; Liang ZX, 2010, BIOCHEM PHARMACOL, V79, P817, DOI 10.1016/j.bcp.2009.10.017; Marches R, 2004, INT J CANCER, V112, P492, DOI 10.1002/ijc.20378; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Nishida N, 2011, CLIN CANCER RES, V17, P2725, DOI 10.1158/1078-0432.CCR-10-2132; Nishimura R, 2008, BREAST CANCER-TOKYO, V15, P57, DOI 10.1007/s12282-007-0014-z; Pogribny IP, 2010, INT J CANCER, V127, P1785, DOI 10.1002/ijc.25191; Qian BY, 2009, BREAST CANCER RES TR, V117, P131, DOI 10.1007/s10549-008-0219-7; ROSEN PP, 1995, CANCER, V75, P1320, DOI 10.1002/1097-0142(19950315)75:6<1320::AID-CNCR2820750614>3.0.CO;2-C; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Sato F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016435; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Scaltriti M, 2011, P NATL ACAD SCI USA, V108, P3761, DOI 10.1073/pnas.1014835108; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Terasawa K, 2009, FEBS J, V276, P3269, DOI 10.1111/j.1742-4658.2009.07041.x; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Wszolek MF, 2011, UROL ONCOL-SEMIN ORI, V29, P794, DOI 10.1016/j.urolonc.2009.08.024; Zhang B, 2011, CARCINOGENESIS, V32, P2, DOI 10.1093/carcin/bgq209; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200	39	98	104	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31422	10.1371/journal.pone.0031422	http://dx.doi.org/10.1371/journal.pone.0031422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384020	gold, Green Published, Green Submitted			2022-12-27	WOS:000302918500025
J	Liu, YC; Painter, JA; Posey, DL; Cain, KP; Weinberg, MS; Maloney, SA; Ortega, LS; Cetron, MS				Liu, Yecai; Painter, John A.; Posey, Drew L.; Cain, Kevin P.; Weinberg, Michelle S.; Maloney, Susan A.; Ortega, Luis S.; Cetron, Martin S.			Estimating the Impact of Newly Arrived Foreign-Born Persons on Tuberculosis in the United States	PLOS ONE			English	Article							IMMIGRATION STATUS; COUNTRIES; REFUGEES	Background: Among approximately 163.5 million foreign-born persons admitted to the United States annually, only 500,000 immigrants and refugees are required to undergo overseas tuberculosis (TB) screening. It is unclear what extent of the unscreened nonimmigrant visitors contributes to the burden of foreign-born TB in the United States. Methodology/Principal Findings: We defined foreign-born persons within 1 year after arrival in the United States as "newly arrived'', and utilized data from U.S. Department of Homeland Security, U.S. Centers for Disease Control and Prevention, and World Health Organization to estimate the incidence of TB among newly arrived foreign-born persons in the United States. During 2001 through 2008, 11,500 TB incident cases, including 291 multidrug-resistant TB incident cases, were estimated to occur among 20,989,738 person-years for the 1,479,542,654 newly arrived foreign-born persons in the United States. Of the 11,500 estimated TB incident cases, 41.6% (4,783) occurred among immigrants and refugees, 36.6% (4,211) among students/exchange visitors and temporary workers, 13.8% (1,589) among tourists and business travelers, and 7.3% (834) among Canadian and Mexican nonimmigrant visitors without an I-94 form (e.g., arrival-departure record). The top 3 newly arrived foreign-born populations with the largest estimated TB incident cases per 100,000 admissions were immigrants and refugees from high-incidence countries (e.g., 2008 WHO-estimated TB incidence rate of >= 100 cases/100,000 population/year; 235.8 cases/100,000 admissions, 95% confidence interval [CI], 228.3 to 243.3), students/exchange visitors and temporary workers from high-incidence countries (60.9 cases/100,000 admissions, 95% CI, 58.5 to 63.3), and immigrants and refugees from medium-incidence countries (e.g., 2008 WHO-estimated TB incidence rate of 15-99 cases/100,000 population/year; 55.2 cases/100,000 admissions, 95% CI, 51.6 to 58.8). Conclusions/Significance: Newly arrived nonimmigrant visitors contribute substantially to the burden of foreign-born TB in the United States. To achieve the goals of TB elimination, direct investment in global TB control and strategies to target nonimmigrant visitors should be considered.	[Liu, Yecai; Painter, John A.; Posey, Drew L.; Weinberg, Michelle S.; Ortega, Luis S.; Cetron, Martin S.] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA; [Cain, Kevin P.] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Maloney, Susan A.] US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Int Emerging Infect Program, Nonthaburi, Thailand	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand	Liu, YC (corresponding author), Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA.	yliu@cdc.gov						[Anonymous], WHOHTMTB2008394; [Anonymous], WHOHTMTB20103; Barr M, 2007, NONIMMIGRANT ADMISSI; Binkin NJ, 1996, CLIN INFECT DIS, V23, P1226, DOI 10.1093/clinids/23.6.1226; BLUM RN, 1993, CHEST, V103, P1670, DOI 10.1378/chest.103.6.1670; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; Cain KP, 2007, AM J RESP CRIT CARE, V175, P75, DOI 10.1164/rccm.200608-1178OC; Centers for Disease Control and Prevention, 1991, TECHN INSTR PAN PHYS; Coker R, 2006, EUR RESPIR J, V27, P801, DOI 10.1183/09031936.06.00104305; Grieco EM, 2004, ESTIMATES NONIMMIGRA; Grieco EM, 2003, LENGTH VISIT NONIMMI; Grieco EM, 2005, TEMPORARY ADMISSIONS; Hennessey KA, 1998, JAMA-J AM MED ASSOC, V280, P2008, DOI 10.1001/jama.280.23.2008; HOEFER M, 2009, ESTIMATES UNAUTHORIZ; Liu YC, 2009, NEW ENGL J MED, V360, P2406, DOI 10.1056/NEJMoa0809497; Lowenthal P, 2011, INT J TUBERC LUNG D, V15, P761, DOI 10.5588/ijtld.10.0370; Menzies D, 2001, AM J RESP CRIT CARE, V164, P914, DOI 10.1164/ajrccm.164.6.2107090b; Monger R, 2008, NONIMMIGRANT ADMISSI; Monger R., 2009, NONIMMIGRANT ADMISSI; Nolan CM, 2005, AM J RESP CRIT CARE, V172, P1169, DOI 10.1164/rccm.2508001; Public Health Agency of Canada, 2007, CAN TUB STAND; Ricks PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027405; Saraiya M, 2002, AM J PUBLIC HEALTH, V92, P826, DOI 10.2105/AJPH.92.5.826; Sciortino S, 1999, INT J TUBERC LUNG D, V3, P778; Tan L, 2001, ARCH INTERN MED, V161, P334, DOI 10.1001/archinte.161.3.334; U. S. Department of Health and Human Service Public Health Service Centers for Disease Control and Prevention, 2011, MMWR-MORBID MORTAL W, V60, P333; U. S. Department of Health and Human Service Public Health Service Centers for Disease Control and Prevention, 2008, 2008 TECHN TUB INSTR; U. S. Department of Health and Human Service Public Health Service Centers for Disease Control and Prevention, ONL TUB INF SYST; U. S. Department of Health and Human Service Public Health Service Centers for Disease Control and Prevention, TECHN INSTR TUB SCRE; U. S. Department of Health and Human Service Public Health Service Centers for Disease Control and Prevention, 2007, 2007 TUB TECHN INSTR; U. S. Department of Homeland Security, 2006, TEMP ADM NON US 2006; U. S. Department of Homeland Security Office of Immigration Statistics, 2009, 2009 YB IMM STAT; Weis SE, 2001, AM J RESP CRIT CARE, V164, P953, DOI 10.1164/ajrccm.164.6.2102132; World Health Organization, WHO TB BURDEN ESTIMA; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	35	40	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32158	10.1371/journal.pone.0032158	http://dx.doi.org/10.1371/journal.pone.0032158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384165	Green Published, gold			2022-12-27	WOS:000302918500062
J	Olesen, J; Larsson, S; Iversen, N; Yousafzai, S; Hellsten, Y; Pilegaard, H				Olesen, Jesper; Larsson, Signe; Iversen, Ninna; Yousafzai, Simi; Hellsten, Ylva; Pilegaard, Henriette			Skeletal Muscle PGC-1 alpha Is Required for Maintaining an Acute LPS-Induced TNF alpha Response	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; INSULIN-RESISTANCE; MOUSE SKELETAL; MITOCHONDRIAL BIOGENESIS; HUMAN ENDOTOXEMIA; GENE-EXPRESSION; KAPPA-B; EXERCISE; INFLAMMATION	Many lifestyle-related diseases are associated with low-grade inflammation and peroxisome proliferator activated receptor gamma coactivator (PGC)-1 alpha has been suggested to be protective against low-grade inflammation. However, whether these anti-inflammatory properties affect acute inflammation is not known. The aim of the present study was therefore to investigate the role of muscle PGC-1 alpha in acute inflammation. Quadriceps muscles were removed from 10-week old whole body PGC-1 alpha knockout (KO), muscle specific PGC-1 alpha KO (MKO) and muscle-specific PGC-1 alpha overexpression mice (TG), 2 hours after an intraperitoneal injection of either 0.8 mu g LPS/g body weight or saline. Basal TNF alpha mRNA content was lower in skeletal muscle of whole body PGC-1 alpha KO mice and in accordance TG mice showed increased TNF alpha mRNA and protein level relative to WT, indicating a possible PGC-1 alpha mediated regulation of TNF alpha. Basal p65 phosphorylation was increased in TG mice possibly explaining the elevated TNF alpha expression in these mice. Systemically, TG mice had reduced basal plasma TNF alpha levels compared with WT suggesting a protective effect against systemic low-grade inflammation in these animals. While TG mice reached similar TNF alpha levels as WT and showed more marked induction in plasma TNF alpha than WT after LPS injection, MKO PGC-1 alpha mice had a reduced plasma TNF alpha and skeletal muscle TNF alpha mRNA response to LPS. In conclusion, the present findings suggest that PGC-1 alpha enhances basal TNF alpha expression in skeletal muscle and indicate that PGC-1 alpha does not exert anti-inflammatory effects during acute inflammation. Lack of skeletal muscle PGC-1 alpha seems however to impair the acute TNF alpha response, which may reflect a phenotype more susceptible to infections as also observed in type 2 diabetes patients.	[Olesen, Jesper; Larsson, Signe; Iversen, Ninna; Yousafzai, Simi; Pilegaard, Henriette] Univ Copenhagen, Dept Biol, Ctr Inflammat & Metab, Copenhagen, Denmark; [Olesen, Jesper; Larsson, Signe; Iversen, Ninna; Yousafzai, Simi; Pilegaard, Henriette] Univ Copenhagen, Dept Biol, Copenhagen Muscle Res Ctr, Copenhagen, Denmark; [Hellsten, Ylva] Univ Copenhagen, Dept Sport Sci, Copenhagen Muscle Res Ctr, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Olesen, J (corresponding author), Univ Copenhagen, Dept Biol, Ctr Inflammat & Metab, Copenhagen, Denmark.	jolesen@bio.ku.dk	Pilegaard, Henriette/M-2315-2014; Hellsten, Ylva/B-3420-2015	Pilegaard, Henriette/0000-0002-1071-0327; Olesen, Jes/0000-0002-6712-2702; Hellsten, Ylva/0000-0002-2435-9558	Augustinus Foundation, Denmark; Danish National Research Foundation [02-512-55]; Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research [09-067009, 09-075724]; Capital Region of Denmark	Augustinus Foundation, Denmark; Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Capital Region of Denmark	The present study was supported by a grant from the Augustinus Foundation, Denmark. The Centre of Inflammation and Metabolism (CIM) is supported by a grant from the Danish National Research Foundation (# 02-512-55). CIM is part of the UNIK Project: Food, Fitness & Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology, and Innovation. CIM is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant no. 09-067009 and 09-075724). The Copenhagen Muscle Research Centre is supported by a grant from the Capital Region of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibegovic AC, 2010, AM J PHYSIOL-ENDOC M, V299, pE752, DOI 10.1152/ajpendo.00590.2009; Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080; Andreasen AS, 2008, CURR MED CHEM, V15, P1697, DOI 10.2174/092986708784872393; Andreasen AS, 2010, INTENS CARE MED, V36, P1548, DOI 10.1007/s00134-010-1845-1; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Borge BAS, 2009, AM J PHYSIOL-HEART C, V296, pH735, DOI 10.1152/ajpheart.01309.2008; Brandt C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/520258; Carpenter S, 2009, BIOCHEM J, V422, P1, DOI 10.1042/BJ20090616; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Favorite GO, 1942, J CLIN INVEST, V21, P589, DOI 10.1172/JCI101337; Frost RA, 2003, AM J PHYSIOL-REG I, V285, pR1153, DOI 10.1152/ajpregu.00164.2003; Frost RA, 2002, AM J PHYSIOL-REG I, V283, pR698, DOI 10.1152/ajpregu.00039.2002; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huey KA, 2008, J APPL PHYSIOL, V105, P1830, DOI 10.1152/japplphysiol.90955.2008; Kusuhara K, 2007, BIOL CHEM, V388, P481, DOI 10.1515/BC.2007.052; Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Schilling J, 2011, CIRC-HEART FAIL, V4, P474, DOI 10.1161/CIRCHEARTFAILURE.110.959833; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	37	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32222	10.1371/journal.pone.0032222	http://dx.doi.org/10.1371/journal.pone.0032222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384185	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500067
J	Pollack, SM; Li, YQ; Blaisdell, MJ; Farrar, EA; Chou, J; Hoch, BL; Loggers, ET; Rodler, E; Eary, JF; Conrad, EU; Jones, RL; Yee, C				Pollack, Seth M.; Li, Yonqing; Blaisdell, Megan J.; Farrar, Erik A.; Chou, Jeffrey; Hoch, Benjamin L.; Loggers, Elizabeth T.; Rodler, Eve; Eary, Janet F.; Conrad, Ernest U., III; Jones, Robin L.; Yee, Cassian			NYESO-1/LAGE-1s and PRAME Are Targets for Antigen Specific T Cells in Chondrosarcoma following Treatment with 5-Aza-2-Deoxycitabine	PLOS ONE			English	Article							ADOPTIVE IMMUNOTHERAPY; CANCER/TESTIS ANTIGEN; METASTATIC MELANOMA; EXPRESSION; CANCER; INDUCTION; NY-ESO-1; MAGE; 5-AZA-2'-DEOXYCYTIDINE; LYMPHOCYTE	Background: Chondrosarcoma has no proven systemic option in the metastatic setting. The development of a non-cross-resistant strategy, such as cellular immunotherapy using antigen-specific T cells would be highly desirable. NY-ESO-1 and PRAME are members of the Cancer Testis Antigen (CTA) family that have been identified as promising targets for T cell therapy. LAGE-1 is a cancer testis antigen 90% homologous to NY-ESO-1, sharing the 157-165 A* 0201 NY-ESO-1 epitope with its transcript variant, LAGE-1s. A number of CTA's have been induced using 5-Aza-2-Deoxycitabine (5-Aza-dC) in other cancers. We sought to evaluate the feasibility of targeting chondrosarcoma tumors using NY-ESO-1/LAGE-1s and PRAME specific T cells using 5-Aza-dC to induce antigen expression. Methods: We used 11 flash frozen tumors from the University of Washington tumor bank to test for the expression of NY-ESO-1, PRAME, LAGE-1s and LAGE-1L in chondrosarcoma tumors. Using four chondrosarcoma cell lines we tested the expression of these CTA's with and without 5-Aza-dC treatments. Finally, using NY-ESO-1/LAGE-1s and PRAME specific effectors that we generated from sarcoma patients, we evaluated the ability of these T cells to lyse A* 0201 expressing chondrosarcoma cell lines in vitro both with and without 5-Aza-dC treatment. Results: A minority (36%) of chondrosarcoma tumors expressed either NY-ESO-1 or LAGE-1s at >10% of our reference value and none expressed PRAME at that level. However, in all four of the chondrosarcoma cell lines tested, NY-ESO-1 and PRAME expression could be induced following treatment with 5-Aza-dC including in cell lines where expression was absent or barely detectable. Furthermore, NY-ESO-1/LAGE-1s and PRAME specific CD8+ effector T cells were able to specifically recognize and lyse A*0201 expressing chondrosarcoma cell lines following 5-Aza-dC treatment. Conclusion: These data suggest that adoptive immunotherapy in combination with 5-Aza-dC may be a potential strategy to treat unresectable or metastatic chondrosarcoma patients where no proven systemic therapies exist.	[Pollack, Seth M.; Li, Yonqing; Blaisdell, Megan J.; Farrar, Erik A.; Chou, Jeffrey; Loggers, Elizabeth T.; Jones, Robin L.; Yee, Cassian] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Pollack, Seth M.; Chou, Jeffrey; Loggers, Elizabeth T.; Rodler, Eve; Jones, Robin L.; Yee, Cassian] Univ Washington, Dept Oncol, Seattle, WA 98195 USA; [Hoch, Benjamin L.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Loggers, Elizabeth T.] Grp Hlth Res Inst, Seattle, WA USA; [Eary, Janet F.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Conrad, Ernest U., III] Univ Washington, Dept Orthoped & Sports Med, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Pollack, SM (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	spollac@fhcrc.org; cyee@fhcrc.org	Pollack, Seth/ABI-1013-2020; Jones, Robin L/AAO-3738-2020	Jones, Robin L/0000-0003-4173-3844	Bob and Eileen Gilman Family Sarcoma Research Program; Walker Immunotherapy Research Fellowship; Sarcoma Alliance for Research through Collaboration (SARC) Career Development Award; Burroughs Wellcome Fund Clinical Scientist Awards in Translational Research;  [RO1 CA65537-16]; NATIONAL CANCER INSTITUTE [P30CA015704, R01CA065537] Funding Source: NIH RePORTER	Bob and Eileen Gilman Family Sarcoma Research Program; Walker Immunotherapy Research Fellowship; Sarcoma Alliance for Research through Collaboration (SARC) Career Development Award; Burroughs Wellcome Fund Clinical Scientist Awards in Translational Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the Bob and Eileen Gilman Family Sarcoma Research Program as well as the Walker Immunotherapy Research Fellowship and the Sarcoma Alliance for Research through Collaboration (SARC) Career Development Award. Cassian Yee is a recipient of a Burroughs Wellcome Fund Clinical Scientist Awards in Translational Research. The University of Washington Tissue Bank is supported by RO1 CA65537-16. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstedt M, 2010, LEUKEMIA RES, V34, P899, DOI 10.1016/j.leukres.2010.02.004; Bender A, 1996, J IMMUNOL METHODS, V196, P121, DOI 10.1016/0022-1759(96)00079-8; Bergeron A, 2009, INT J CANCER, V125, P1365, DOI 10.1002/ijc.24503; BLOCK JA, 1991, J BONE JOINT SURG AM, V73A, P647, DOI 10.2106/00004623-199173050-00002; BLOCK JA, 1991, CONNECT TISSUE RES, V26, P295, DOI 10.3109/03008209109152446; Block MI, 2001, ANN THORAC SURG, V71, P301; Bluman EM, 2007, J ORTHOP RES, V25, P678, DOI 10.1002/jor.20368; Chou Jeffrey, J IMMUNOTHE IN PRESS; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; Dickey ID, 2004, J BONE JOINT SURG AM, V86A, P2412, DOI 10.2106/00004623-200411000-00008; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Figueiredo DLA, 2011, HEAD NECK-J SCI SPEC, V33, P702, DOI 10.1002/hed.21522; Gelderblom H, 2008, ONCOLOGIST, V13, P320, DOI 10.1634/theoncologist.2007-0237; Goodyear O, 2010, BLOOD, V116, P1908, DOI 10.1182/blood-2009-11-249474; Guo ZS, 2006, CANCER RES, V66, P1105, DOI 10.1158/0008-5472.CAN-05-3020; Hiraki A, 2001, BIOCHEM BIOPH RES CO, V286, P786, DOI 10.1006/bbrc.2001.5411; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Jager E, 2000, P NATL ACAD SCI USA, V97, P12198, DOI 10.1073/pnas.220413497; James SE, 2010, J IMMUNOL, V184, P4284, DOI 10.4049/jimmunol.0903701; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Li YQ, 2008, BLOOD, V111, P229, DOI 10.1182/blood-2007-05-089375; Lin CZ, 2002, GENE, V285, P269, DOI 10.1016/S0378-1119(02)00395-5; Mitchell AD, 2000, J BONE JOINT SURG BR, V82B, P55, DOI 10.1302/0301-620X.82B1.9020; Murphey MD, 2003, RADIOGRAPHICS, V23, P1245, DOI 10.1148/rg.235035134; Oi S, 2009, J NEURO-ONCOL, V92, P15, DOI 10.1007/s11060-008-9732-0; Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011; Pollack Seth M., 2011, Sarcoma, V2011, P1, DOI 10.1155/2011/438940; Quintarelli C, 2008, BLOOD, V112, P1876, DOI 10.1182/blood-2008-04-150045; RIDDELL SR, 1990, J IMMUNOL METHODS, V128, P189, DOI 10.1016/0022-1759(90)90210-M; Robbins PF, 2011, J CLIN ONCOL; Roman-Gomez O, 2007, LEUKEMIA RES, V31, P1521, DOI 10.1016/j.leukres.2007.02.016; ROSENBERG SA, 1986, SCIENCE, V233, P1318, DOI 10.1126/science.3489291; Schenk T, 2007, GENE CHROMOSOME CANC, V46, P796, DOI 10.1002/gcc.20465; Schrump DS, 2006, CLIN CANCER RES, V12, P5777, DOI 10.1158/1078-0432.CCR-06-0669; Schwab JH, 2009, CANCER IMMUNOL IMMUN, V58, P339, DOI 10.1007/s00262-008-0557-7; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Staals EL, 2006, CANCER-AM CANCER SOC, V106, P2682, DOI 10.1002/cncr.21936; Vaughan HA, 2004, CLIN CANCER RES, V10, P8396, DOI 10.1158/1078-0432.CCR-04-0809; Weiser TS, 2001, ANN THORAC SURG, V71, P295, DOI 10.1016/S0003-4975(00)02421-8; Weiser TS, 2001, J IMMUNOTHER, V24, P151, DOI 10.1097/00002371-200103000-00010; Yan MY, 2011, CANCER IMMUNOL IMMUN, V60, P1243, DOI 10.1007/s00262-011-1024-4	41	44	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32165	10.1371/journal.pone.0032165	http://dx.doi.org/10.1371/journal.pone.0032165			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384167	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500063
J	Cruaud, A; Jabbour-Zahab, R; Genson, G; Ungricht, S; Rasplus, JY				Cruaud, Astrid; Jabbour-Zahab, Roula; Genson, Gwenaelle; Ungricht, Stefan; Rasplus, Jean-Yves			Testing the Emergence of New Caledonia: Fig Wasp Mutualism as a Case Study and a Review of Evidence	PLOS ONE			English	Review							OBLIGATE POLLINATION MUTUALISM; PHYLOGENETIC-RELATIONSHIPS; HYMENOPTERA-CHALCIDOIDEA; SOLOMON-ISLANDS; PACIFIC; EVOLUTION; FICUS; BIOGEOGRAPHY; COLONIZATION; DIVERGENCE	While geologists suggest that New Caledonian main island (Grande Terre) was submerged until ca 37 Ma, biologists are struck by the presence of supposedly Gondwanan groups on the island. Among these groups are the Oreosycea fig trees (Ficus, Moraceae) and their Dolichoris pollinators (Hymenoptera, Agaonidae). These partners are distributed in the Paleotropics and Australasia, suggesting that their presence on New Caledonia could result from Gondwanan vicariance. To test this hypothesis, we obtained mitochondrial and nuclear markers (5.3 kb) from 28 species of Dolichoris, used all available sequences for Oreosycea, and conducted phylogenetic and dating analyses with several calibration strategies. All our analyses ruled out a vicariance scenario suggesting instead that New Caledonian colonization by Dolichoris and Oreosycea involved dispersal across islands from Sundaland ca 45.9-32.0 Ma. Our results show that successful long-distance dispersal of obligate mutualists may happen further suggesting that presence of intimate mutualisms on isolated islands should not be used as a priori evidence for vicariance. Comparing our results to a review of all the published age estimates for New Caledonian plant and animal taxa, we showed that support for a vicariant origin of the island biota is still lacking. Finally, as demonstrating a causal relationship between geology and biology requires independent evidence, we argue that a priori assumptions about vicariance or dispersal should not be used to constrain chronograms. This circular reasoning could lead to under or overestimation of age estimates.	[Cruaud, Astrid; Jabbour-Zahab, Roula; Genson, Gwenaelle; Rasplus, Jean-Yves] Montpellier SupAgro, CIRAD, IRD, INRA,CBGP,UMR Ctr Biol & Gest Populat, Montferrier Sur Lez, France; [Ungricht, Stefan] ETH, Zurich, Switzerland	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Swiss Federal Institutes of Technology Domain; ETH Zurich	Cruaud, A (corresponding author), Montpellier SupAgro, CIRAD, IRD, INRA,CBGP,UMR Ctr Biol & Gest Populat, Campus Int Baillarguet, Montferrier Sur Lez, France.	cruaud@supagro.inra.fr	Rasplus, Jean-Yves/O-2873-2017	Rasplus, Jean-Yves/0000-0001-8614-6665	ANR (French National Research Agency)	ANR (French National Research Agency)(French National Research Agency (ANR))	This work was supported by ANR project "BioNEOCAL" (French National Research Agency) to JYR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, P NATL ACAD SCI USA, V106, P20342, DOI 10.1073/pnas.0902213106; AITCHISON JC, 1995, GEOLOGY, V23, P161, DOI 10.1130/0091-7613(1995)023<0161:EACCIN>2.3.CO;2; [Anonymous], 2003, EVOLUTION DYNAMICS A, DOI DOI 10.1130/0-8137-2372-8.383; Berg C.C., 1992, AFRICAN FIG TREES FI, P1; Berg CC, 2002, BLUMEA, V47, P299; Berg CC, 2005, FLORA MALESIANA 1, V17; Bishop P, 1995, PROG PHYS GEOG, V19, P449, DOI 10.1177/030913339501900402; Brandley MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011375; Carpenter KJ, 2005, AM J BOT, V92, P1595, DOI 10.3732/ajb.92.10.1595; Collot J, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002612; Compton SG, 2000, BIOTROPICA, V32, P515, DOI 10.1111/j.1744-7429.2000.tb00497.x; COMPTON SG, 1988, PHILOS T ROY SOC B, V322, P459, DOI 10.1098/rstb.1988.0138; Cook LG, 2005, P ROY SOC B-BIOL SCI, V272, P2535, DOI 10.1098/rspb.2005.3219; CORNER E J H, 1985, Allertonia, V4, P125; CORNER EJH, 1970, PHILOS T ROY SOC B, V259, P383, DOI 10.1098/rstb.1970.0062; Corner EJH, 1963, PACIFIC BASIN BIOGEO, P233; Cracraft J, 2001, P ROY SOC B-BIOL SCI, V268, P459, DOI 10.1098/rspb.2000.1368; Crisp MD, 2011, TRENDS ECOL EVOL, V26, P66, DOI 10.1016/j.tree.2010.11.005; Cruaud A, 2011, J BIOGEOGR, V38, P209, DOI 10.1111/j.1365-2699.2010.02429.x; Cruaud A, 2010, CLADISTICS, V26, P359, DOI 10.1111/j.1096-0031.2009.00291.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dunn DW, 2008, J ANIM ECOL, V77, P927, DOI 10.1111/j.1365-2656.2008.01416.x; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Gillespie JJ, 2005, MOL BIOL EVOL, V22, P1593, DOI 10.1093/molbev/msi152; Grandcolas P, 2008, PHILOS T R SOC B, V363, P3309, DOI 10.1098/rstb.2008.0122; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Hall R., 1997, PETROLEUM SYSTEMS SE, P47; Harrison RD, 2005, BIOSCIENCE, V55, P1053, DOI 10.1641/0006-3568(2005)055[1053:FATDOT]2.0.CO;2; Harrison RD, 2006, J TROP ECOL, V22, P631, DOI 10.1017/S0266467406003488; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; Heads M, 2008, J BIOGEOGR, V35, P2153, DOI 10.1111/j.1365-2699.2008.01977.x; Heads M, 2010, J BIOGEOGR, V37, P1179, DOI 10.1111/j.1365-2699.2010.02311.x; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Honza E, 2004, TECTONOPHYSICS, V384, P23, DOI 10.1016/j.tecto.2004.02.006; Kawakita A, 2004, AM J BOT, V91, P410, DOI 10.3732/ajb.91.3.410; Kawakita A, 2009, P R SOC B, V276, P417, DOI 10.1098/rspb.2008.1226; Keppel G, 2009, J BIOGEOGR, V36, P1035, DOI 10.1111/j.1365-2699.2009.02095.x; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Kirchman JJ, 2007, MOL PHYLOGENET EVOL, V43, P14, DOI 10.1016/j.ympev.2006.12.013; KJELLBERG F, 1988, P K NED AKAD C BIOL, V91, P117; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Kumagai T., 2001, J FOREST RES, V6, P257, DOI [10.1007/BF02762466, DOI 10.1007/BF02762466]; Ladiges PY, 2007, AUST SYST BOT, V20, P383, DOI 10.1071/SB07018; LAMBERT FR, 1989, IBIS, V131, P521, DOI 10.1111/j.1474-919X.1989.tb04788.x; Lepage T, 2007, MOL BIOL EVOL, V24, P2669, DOI 10.1093/molbev/msm193; Lewington A, 1999, ANCIENT TREES TREES, P161; Linder M, 2011, SYST BIOL, V60, P329, DOI 10.1093/sysbio/syr009; Lopez-Vaamonde C, 2009, MOL PHYLOGENET EVOL, V52, P715, DOI 10.1016/j.ympev.2009.05.028; Lowry PP, 1998, ACAD SINICA MONOGRAP, P181; Mack KML, 2011, SELECTIVE F IN PRESS; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Marshall CR, 2008, AM NAT, V171, P726, DOI 10.1086/587523; McConkey KR, 2007, BIOTROPICA, V39, P436, DOI 10.1111/j.1744-7429.2007.00269.x; McConkey KR, 2004, EMU, V104, P369, DOI 10.1071/MU03060; Morat P, 1984, BIOGEOGRAPHY TROPICA, P71; Morat Ph., 1993, Biodiversity Letters, V1, P69, DOI 10.2307/2999749; Neall VE, 2008, PHILOS T R SOC B, V363, P3293, DOI 10.1098/rstb.2008.0119; Nobre T, 2010, P ROY SOC B-BIOL SCI, V277, P359, DOI 10.1098/rspb.2009.1373; Nylander J.A.A., 2004, MRAIC PL; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Pascal M, 2008, CONSERV BIOL, V22, P498, DOI 10.1111/j.1523-1739.2008.00889.x; Peate DW, 1997, J PETROL, V38, P1331, DOI 10.1093/petrology/38.10.1331; Pelletier B., 2006, COMPENDIUM MARINE SP, VII, P19; Pemberton CE, 1934, P HAWAIIAN ENTOMOLOG, V8, P379; Penalver E, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3541[1:FWIDAH]2.0.CO;2; Petterson MG, 1999, TECTONOPHYSICS, V301, P35, DOI 10.1016/S0040-1951(98)00214-5; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Ronsted N, 2008, SYMBIOSIS, V45, P45; Ronsted N, 2005, P ROY SOC B-BIOL SCI, V272, P2593, DOI 10.1098/rspb.2005.3249; Schellart WP, 2006, EARTH-SCI REV, V76, P191, DOI 10.1016/j.earscirev.2006.01.002; Setoguchi H, 1998, AM J BOT, V85, P1507, DOI 10.2307/2446478; Shanahan M., 2001, Journal of Biogeography, V28, P1365, DOI 10.1046/j.1365-2699.2001.00638.x; Shanahan M, 2001, BIOL REV, V76, P529, DOI 10.1017/S1464793101005760; Shilton LA, 1999, P ROY SOC B-BIOL SCI, V266, P219, DOI 10.1098/rspb.1999.0625; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Stamatakis A, 2006, INT PAR DISTR PROC S; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steadman DW, 1997, J BIOGEOGR, V24, P737, DOI 10.1046/j.1365-2699.1997.00157.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THORNE RF, 1969, PHILOS T ROY SOC B, V255, P595, DOI 10.1098/rstb.1969.0032; Trewick SA, 2007, J BIOGEOGR, V34, P1, DOI 10.1111/j.1365-2699.2006.01643.x; Ungricht S, 2004, THESIS U MONTPELLIER; UTZURRUM RCB, 1991, BIOTROPICA, V23, P311, DOI 10.2307/2388211; van Ufford AQ, 2005, AAPG BULL, V89, P119, DOI 10.1306/08300403073; Waters JM, 2006, SYST BIOL, V55, P351, DOI 10.1080/10635150600681659; Weiblen GD, 2000, AM J BOT, V87, P1342, DOI 10.2307/2656726; WIEBES JT, 1979, P K NED AKAD C BIOL, V82, P181; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024	88	40	40	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e30941	10.1371/journal.pone.0030941	http://dx.doi.org/10.1371/journal.pone.0030941			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22383982	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500007
J	Li, SM; Valo, Z; Wang, JH; Gao, HL; Bowers, CW; Singer-Sam, J				Li, Sierra M.; Valo, Zuzana; Wang, Jinhui; Gao, Hanlin; Bowers, Chauncey W.; Singer-Sam, Judith			Transcriptome-Wide Survey of Mouse CNS-Derived Cells Reveals Monoallelic Expression within Novel Gene Families	PLOS ONE			English	Article							ORIGIN ALLELIC EXPRESSION; ANNEXIN A1; ADHESION; BRAIN; CHL1; TRANSFERASES; RESOLUTION; ALCOHOL; CLUSTER; CANCER	Monoallelic expression is an integral component of regulation of a number of essential genes and gene families. To probe for allele-specific expression in cells of CNS origin, we used next-generation sequencing (RNA-seq) to analyze four clonal neural stem cell (NSC) lines derived from Mus musculus C57BL/6 (B6) x Mus musculus molossinus (JF1) adult female mice. We established a JF1 cSNP library, then ascertained transcriptome-wide expression from B6 vs. JF1 alleles in the NSC lines. Validating the assay, we found that 262 of 268 X-linked genes evaluable in at least one cell line showed monoallelic expression (at least 85% expression of the predominant allele, p-value<0.05). For autosomal genes 170 of 7,198 genes (2.4% of the total) showed monoallelic expression in at least 2 evaluable cell lines. The group included eight known imprinted genes with the expected pattern of allele-specific expression. Among the other autosomal genes with monoallelic expression were five members of the glutathione transferase gene superfamily, which processes xenobiotic compounds as well as carcinogens and cancer therapeutic agents. Monoallelic expression within this superfamily thus may play a functional role in the response to diverse and potentially lethal exogenous factors, as is the case for the immunoglobulin and olfactory receptor superfamilies. Other genes and gene families showing monoallelic expression include the annexin gene family and the Thy1 gene, both linked to inflammation and cancer, as well as genes linked to alcohol dependence (Gabrg1) and epilepsy (Kcnma1). The annotated set of genes will provide a resource for investigation of mechanisms underlying certain cases of these and other major disorders.	[Li, Sierra M.] City Hope Natl Med Ctr, Beckman Res Inst, Div Biostat, Duarte, CA 91010 USA; [Valo, Zuzana; Wang, Jinhui; Gao, Hanlin; Singer-Sam, Judith] City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, Duarte, CA 91010 USA; [Bowers, Chauncey W.] City Hope Natl Med Ctr, Beckman Res Inst, Div Computat Biol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Li, SM (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Biostat, Duarte, CA 91010 USA.	jsam@coh.org			NCI [P30 CA033572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported in part by NCI grant P30 CA033572. The work is solely the responsibility of the authors and does not represent the views of the NCI or NIH. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyeva A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012018; BEUTLER E, 1975, AM J HUM GENET, V27, P628; Bjornsson HT, 2008, GENOME RES, V18, P771, DOI 10.1101/gr.073254.107; Cedar H, 2008, CURR OPIN IMMUNOL, V20, P308, DOI 10.1016/j.coi.2008.02.002; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Covault J, 2008, NEUROPSYCHOPHARMACOL, V33, P837, DOI 10.1038/sj.npp.1301456; Deng XX, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000318; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Esumi S, 2005, NAT GENET, V37, P171, DOI 10.1038/ng1500; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Guo LY, 2005, IMMUNITY, V23, P89, DOI 10.1016/j.immuni.2005.05.008; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Henderson CJ, 1998, P NATL ACAD SCI USA, V95, P5275, DOI 10.1073/pnas.95.9.5275; Hu LL, 2011, J BIOL CHEM, V286, P3119, DOI 10.1074/jbc.M110.157842; Kahlem P, 2004, GENOME RES, V14, P1258, DOI 10.1101/gr.1951304; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; McArthur S, 2010, J IMMUNOL, V185, P6317, DOI 10.4049/jimmunol.1001095; Morellini F, 2007, MOL CELL NEUROSCI, V34, P121, DOI 10.1016/j.mcn.2006.10.006; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; Nair S, 2010, CANCER LETT, V294, P111, DOI 10.1016/j.canlet.2010.01.026; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Ray LA, 2009, ALCOHOL CLIN EXP RES, V33, P1382, DOI 10.1111/j.1530-0277.2009.00968.x; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; Tew KD, 2011, FREE RADIC BIOL MED; Wang JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001293; Wang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013843; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	37	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31751	10.1371/journal.pone.0031751	http://dx.doi.org/10.1371/journal.pone.0031751			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384067	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500037
J	Li, XX; Jiang, SW; Li, X; Mei, J; Zhong, Q; Xu, WG; Li, J; Li, WB; Liu, XQ; Zhang, H; Wang, LX				Li, Xinxu; Jiang, Shiwen; Li, Xue; Mei, Jian; Zhong, Qiu; Xu, Weiguo; Li, Jun; Li, Weibin; Liu, Xiaoqiu; Zhang, Hui; Wang, Lixia			Predictors on Delay of Initial Health-Seeking in New Pulmonary Tuberculosis Cases among Migrants Population in East China	PLOS ONE			English	Article							DIAGNOSIS; PATIENT; ETHIOPIA	Objectives: To determine the length of delay in initial health-seeking in new pulmonary tuberculosis (PTB) cases among migrant population in the eastern part of China, and factors associated with it. Methods: A cross-sectional study was conducted using a structured questionnaire in six counties in Shanghai, Guangdong and Jiangsu from May to October, 2008, to estimate the extent and factors responsible for delayed initial health-seeking of the new PTB cases. The interval between self-reported onset of TB symptoms and date of first attendance at any medical institution was determined. More than the median duration was defined as delayed health-seeking. Results: A total of 323 new migrant PTB patients participated in the study. Only 6.5% had medical insurance. The median and mean durations to initial health-seeking were respectively 10 and 31 days. There was no significant association between socio-demographic factors and delayed initial health-seeking. Average monthly working days >24 (AOR, 1.61; 95% CI, 1.03-2.51), and hemoptysis or bloody sputum (AOR, 0.48; 95% CI, 0.28-0.85) were significantly associated with delayed initial health-seeking. Conclusions: Interventions to improve health seeking behavior among the migrant population in China must focus on strengthening their labor, medical security and health education.	[Li, Xinxu; Jiang, Shiwen; Li, Xue; Li, Jun; Li, Weibin; Liu, Xiaoqiu; Zhang, Hui; Wang, Lixia] Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China; [Mei, Jian] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Zhong, Qiu] TB Res Inst Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Xu, Weiguo] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China	Chinese Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Jiangsu Provincial Center for Disease Control & Prevention	Li, XX (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China.	jiangsw@chinatb.org						Basnet R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-236; Cambanis A, 2007, TROP MED INT HEALTH, V12, P1309, DOI 10.1111/j.1365-3156.2007.01925.x; Census Office of the State Council of PRC National Bureau of Statistics of PRC, 2001, CENS DAT CHIN 2000; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P222; Chang Ching Thon, 2007, Rural Remote Health, V7, P667; Demissie M, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-23; Department of Disease Control and Department of Medical Administration of Ministry of Health of PRC Chinese Center for Disease Control and Prevention, 2009, GUID IMPL NAT TUB CO; Department of Floating Population Service and Management of National Population and Family Planning Commission of PRC, 2010, REP 2010 CHIN MIGR P; Hu LX, 2007, MODERN PREVENTIVE ME, V34, P96; Huang LQ, 2007, J CHIN ANTITUBERC, V29, P127; Legislative Affairs Office of the State Council of PRC, 2007, LAW PEOPL REP CHIN E; Li B., 2010, POPULATION RES, V34, P6; Li XX, 2010, J IMMIGR MINOR HEALT, V12, P811, DOI 10.1007/s10903-010-9336-6; Mahendradhata Y, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-393; Meintjes G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-72; Ministry of Health of PRC, 2011, NAT TUB EP SIT 2010; Mirsaeidi SM, 2007, ARCH IRAN MED, V10, P190; Ngadaya ES, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-196; Phoa LL, 2005, RESPIROLOGY, V10, P196; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Wang WB, 2007, EUR J PUBLIC HEALTH, V17, P419, DOI 10.1093/eurpub/ckm029; World Health Organization, 2010, WHOHTMTB20107; Xi HF, 2008, RES FACTORS AFFECTIN, P1; Xu L, 2008, T ROY SOC TROP MED H, V102, P797, DOI 10.1016/j.trstmh.2008.04.027; Yimer S, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-112	25	18	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31995	10.1371/journal.pone.0031995	http://dx.doi.org/10.1371/journal.pone.0031995			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384123	gold, Green Published, Green Submitted			2022-12-27	WOS:000302875500063
J	Hogstrand, K; Hejll, E; Sander, B; Rozell, B; Larsson, LG; Grandien, A				Hoegstrand, Kari; Hejll, Eduar; Sander, Birgitta; Rozell, Bjoern; Larsson, Lars-Gunnar; Grandien, Alf			Inhibition of the Intrinsic but Not the Extrinsic Apoptosis Pathway Accelerates and Drives Myc-Driven Tumorigenesis Towards Acute Myeloid Leukemia	PLOS ONE			English	Article							C-MYC; TRANSGENIC MICE; HEMATOPOIETIC-CELLS; EXPRESSION; TUMORS; DEATH; SUPPRESSOR; FLIP; OVEREXPRESSION; BCL-X(L)	Myc plays an important role in tumor development, including acute myeloid leukemia (AML). However, MYC is also a powerful inducer of apoptosis, which is one of the major failsafe programs to prevent cancer development. To clarify the relative importance of the extrinsic (death receptor-mediated) versus the intrinsic (mitochondrial) pathway of apoptosis in MYC-driven AML, we coexpressed MYC together with anti-apoptotic proteins of relevance for AML; BCL-X-L/BCL-2 (inhibiting the intrinsic pathway) or FLIPL (inhibiting the extrinsic pathway), in hematopoietic stems cells (HSCs). Transplantation of HSCs expressing MYC into syngeneic recipient mice resulted in development of AML and T-cell lymphomas within 7-9 weeks as expected. Importantly, coexpression of MYC together with BCL-X-L/BCL-2 resulted in strongly accelerated kinetics and favored tumor development towards aggressive AML. In contrast, coexpression of MYC and FLIPL did neither accelerate tumorigenesis nor change the ratio of AML versus T-cell lymphoma. However, a change in distribution of immature CD4(+)CD8(+) versus mature CD4(+) T-cell lymphoma was observed in MYC/FLIPL mice, possibly as a result of increased survival of the CD4(+) population, but this did not significantly affect the outcome of the disease. In conclusion, our findings provide direct evidence that BCL-X-L and BCL-2 but not FLIPL acts in synergy with MYC to drive AML development.	[Hoegstrand, Kari; Grandien, Alf] Karolinska Inst, Dept Med, Karolinska Univ Hosp, Ctr Infect Med, Stockholm, Sweden; [Hejll, Eduar; Larsson, Lars-Gunnar] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Sander, Birgitta; Rozell, Bjoern] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Res Ctr, Stockholm, Sweden; [Hoegstrand, Kari; Grandien, Alf] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Ctr Hematol & Regenerat Med, Stockholm, Sweden; [Sander, Birgitta; Rozell, Bjoern] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Pathol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Hogstrand, K (corresponding author), Karolinska Inst, Dept Med, Karolinska Univ Hosp, Ctr Infect Med, Stockholm, Sweden.	alf.grandien@ki.se	Larsson, Lars-Gunnar/D-9747-2012		Swedish Cancer Society; Swedish Childhood Cancer Society; Swedish Research Council; Stockholm Cancer Society; KI Foundations	Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Society; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm Cancer Society; KI Foundations	This work was funded by the Swedish Cancer Society (AG, LGL, BS), the Swedish Childhood Cancer Society (LGL, BS), the Swedish Research Council (AG, LGL, BS), the Stockholm Cancer Society (LGL, BS), KI Foundations (AG, LGL, BS), KI support to the Advanced Cancer Therapies (ACT!) consortium (LGL, BS), The County Council of Stockholm (BS), Olle Engkvist's Foundation (LGL), and Ake Olsson's Foundation for Hematology Research (AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanullah A, 2002, ONCOGENE, V21, P1600, DOI 10.1038/sj.onc.1205231; Beverly LJ, 2009, ONCOGENE, V28, P1274, DOI 10.1038/onc.2008.466; BONHAM L, 1992, ONCOGENE, V7, P2219; Cameron ER, 2000, CELL DEATH DIFFER, V7, P80, DOI 10.1038/sj.cdd.4400630; Djerbi M, 2007, SCAND J IMMUNOL, V66, P410, DOI 10.1111/j.1365-3083.2007.01957.x; Djerbi M, 1999, J EXP MED, V190, P1025, DOI 10.1084/jem.190.7.1025; Djerbi M, 2001, SCAND J IMMUNOL, V54, P180, DOI 10.1046/j.1365-3083.2001.00941.x; Dolnikov A, 1998, LEUKEMIA, V12, P542, DOI 10.1038/sj.leu.2400968; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Eischen CM, 2001, MOL CELL BIOL, V21, P5063, DOI 10.1128/MCB.21.15.5063-5070.2001; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Finnberg N, 2008, J CLIN INVEST, V118, P111, DOI 10.1172/JCI29900; Frankfurt O, 2007, CURR OPIN ONCOL, V19, P635, DOI 10.1097/CCO.0b013e3282f10e55; Gilliland DG, 2002, CANCER CELL, V1, P417, DOI 10.1016/S1535-6108(02)00081-8; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Hueber AO, 1997, SCIENCE, V278, P1305, DOI 10.1126/science.278.5341.1305; Jones L, 2010, J EXP MED, V207, P2581, DOI 10.1084/jem.20091071; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; Kataoka T, 2005, CRIT REV IMMUNOL, V25, P31, DOI 10.1615/CritRevImmunol.v25.i1.30; Kawagoe H, 2007, CANCER RES, V67, P10677, DOI 10.1158/0008-5472.CAN-07-1118; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Larramendy ML, 2002, HAEMATOLOGICA, V87, P569; Larsson LG, 2010, EXP CELL RES, V316, P1429, DOI 10.1016/j.yexcr.2010.03.025; Luo H, 2005, BLOOD, V106, P2452, DOI 10.1182/blood-2005-02-0734; Medema JP, 1999, J EXP MED, V190, P1033, DOI 10.1084/jem.190.7.1033; Meyer N, 2006, SEMIN CANCER BIOL, V16, P275, DOI 10.1016/j.semcancer.2006.07.011; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P2890, DOI 10.1128/MCB.24.7.2890-2904.2004; Nieminen AI, 2007, EMBO J, V26, P1055, DOI 10.1038/sj.emboj.7601551; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Nyakeriga AM, 2005, SCAND J IMMUNOL, V61, P545, DOI 10.1111/j.1365-3083.2005.01607.x; Persons DA, 1997, BLOOD, V90, P1777, DOI 10.1182/blood.V90.5.1777; PREISLER H D, 1987, Blood Reviews, V1, P97, DOI 10.1016/0268-960X(87)90003-8; PREISLER HD, 1987, LEUKEMIA RES, V11, P923, DOI 10.1016/0145-2126(87)90138-X; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; Schreiner S, 2001, CANCER RES, V61, P6480; Screpanti V, 2001, J IMMUNOL, V167, P2068, DOI 10.4049/jimmunol.167.4.2068; Smith DP, 2006, BLOOD, V108, P653, DOI 10.1182/blood-2006-01-0172; Smith DP, 2005, ONCOGENE, V24, P3544, DOI 10.1038/sj.onc.1208399; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Swanson PJ, 2004, J IMMUNOL, V172, P6684, DOI 10.4049/jimmunol.172.11.6684; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Testa U, 2007, HAEMATOL-HEMATOL J, V92, P81, DOI 10.3324/haematol.10279; Wang Y, 2004, CANCER CELL, V5, P501, DOI 10.1016/S1535-6108(04)00113-8; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424; ZORNIG M, 1995, ONCOGENE, V11, P2165; ZORNIG M, 1995, ONCOGENE, V10, P2397	51	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31366	10.1371/journal.pone.0031366	http://dx.doi.org/10.1371/journal.pone.0031366			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393362	Green Submitted, Green Published, gold			2022-12-27	WOS:000303003500015
J	Myllykoski, M; Raasakka, A; Han, HJ; Kursula, P				Myllykoski, Matti; Raasakka, Arne; Han, Huijong; Kursula, Petri			Myelin 2 ',3 '-Cyclic Nucleotide 3 '-Phosphodiesterase: Active-Site Ligand Binding and Molecular Conformation	PLOS ONE			English	Article							TRANSFER-RNA; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; CRYSTAL-STRUCTURE; 2'-5'-RNA LIGASE; MEMBRANE ANCHOR; PROTEIN; PHOSPHODIESTERASE; 3-PHOSPHODIESTERASE; DOMAIN	The 2'3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) is a highly abundant membrane-associated enzyme in the myelin sheath of the vertebrate nervous system. CNPase is a member of the 2H phosphoesterase family and catalyzes the formation of 2'-nucleotide products from 2',3'-cyclic substrates; however, its physiological substrate and function remain unknown. It is likely that CNPase participates in RNA metabolism in the myelinating cell. We solved crystal structures of the phosphodiesterase domain of mouse CNPase, showing the binding mode of nucleotide ligands in the active site. The binding mode of the product 2'-AMP provides a detailed view of the reaction mechanism. Comparisons of CNPase crystal structures highlight flexible loops, which could play roles in substrate recognition; large differences in the active-site vicinity are observed when comparing more distant members of the 2H family. We also studied the full-length CNPase, showing its N-terminal domain is involved in RNA binding and dimerization. Our results provide a detailed picture of the CNPase active site during its catalytic cycle, and suggest a specific function for the previously uncharacterized N-terminal domain.	[Myllykoski, Matti; Raasakka, Arne; Han, Huijong; Kursula, Petri] Univ Oulu, Dept Biochem, Oulu, Finland; [Myllykoski, Matti; Raasakka, Arne; Han, Huijong; Kursula, Petri] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Han, Huijong; Kursula, Petri] German Electron Synchrotron DESY, Ctr Struct Syst Biol, Helmholtz Ctr Infect Res CSSB HZI, Hamburg, Germany; [Kursula, Petri] Univ Hamburg, Dept Chem, Hamburg, Germany	Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Helmholtz-Center for Infection Research; University of Hamburg	Myllykoski, M (corresponding author), Univ Oulu, Dept Biochem, Oulu, Finland.	petri.kursula@oulu.fi	Kursula, Petri/AAF-4563-2020; Kursula, Petri/K-1058-2012; Raasakka, Arne/AAA-5251-2020	Kursula, Petri/0000-0001-8529-3751; Kursula, Petri/0000-0001-8529-3751; Raasakka, Arne/0000-0002-9443-9959; Han, Huijong/0000-0002-1197-3014; Myllykoski, Matti/0000-0001-6641-5856	Academy of Finland; Sigrid Juselius Foundation (Finland); Magnus Ehrnrooth Foundation (Finland); Department of Biochemistry, University of Oulu (Finland); Science and Research Foundation of the City of Hamburg (Germany); European Community [226716]	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation (Finland)(Sigrid Juselius Foundation); Magnus Ehrnrooth Foundation (Finland); Department of Biochemistry, University of Oulu (Finland); Science and Research Foundation of the City of Hamburg (Germany); European Community(European Commission)	This work was supported by grants from the Academy of Finland, the Sigrid Juselius Foundation (Finland), the Magnus Ehrnrooth Foundation (Finland), the Department of Biochemistry, University of Oulu (Finland), and the Science and Research Foundation of the City of Hamburg (Germany). The research leading to these results received funding from the European Community Seventh Framework Programme (FP7/2007-2013) under grant agreement #226716. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bekesi A, 2011, FEBS J, V278, P295, DOI 10.1111/j.1742-4658.2010.07951.x; Bifulco M, 2002, P NATL ACAD SCI USA, V99, P1807, DOI 10.1073/pnas.042678799; BRAUN PE, 1991, J NEUROSCI RES, V30, P540, DOI 10.1002/jnr.490300311; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Calvin K, 2008, CELL MOL LIFE SCI, V65, P1176, DOI 10.1007/s00018-008-7393-y; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeAngelis DA, 1996, J NEUROCHEM, V67, P943; deVries H, 1997, J NEUROSCI RES, V47, P479, DOI 10.1002/(SICI)1097-4547(19970301)47:5<479::AID-JNR3>3.0.CO;2-E; DRUMMOND GI, 1962, J BIOL CHEM, V237, P3535; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esposito C, 2008, BIOCHEMISTRY-US, V47, P308, DOI 10.1021/bi701474t; Gao YG, 2006, ACTA CRYSTALLOGR F, V62, P1196, DOI 10.1107/S1744309106046616; Gobert RP, 2009, MOL CELL BIOL, V29, P1538, DOI 10.1128/MCB.01375-08; Gold MG, 2008, J MOL BIOL, V375, P1329, DOI 10.1016/j.jmb.2007.11.037; Gravel M, 2009, J NEUROSCI RES, V87, P1069, DOI 10.1002/jnr.21939; GREER CL, 1983, CELL, V32, P537, DOI 10.1016/0092-8674(83)90473-7; Hammarstrom Martin, 2006, Journal of Structural and Functional Genomics, V7, P1, DOI 10.1007/s10969-005-9003-7; Hofmann A, 2000, EMBO J, V19, P6207, DOI 10.1093/emboj/19.22.6207; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kanai A, 2009, RNA, V15, P420, DOI 10.1261/rna.1122109; Kato M, 2003, J MOL BIOL, V329, P903, DOI 10.1016/S0022-2836(03)00448-0; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozlov G, 2003, J BIOL CHEM, V278, P46021, DOI 10.1074/jbc.M305176200; Kozlov G, 2007, FEBS J, V274, P1600, DOI 10.1111/j.1742-4658.2007.05707.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kursula P, 2001, INT J MOL MED, V8, P475; Kursula P., 2004, J APPL CRYSTALLOGR, V37, P347; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lee J, 2005, J CELL BIOL, V170, P661, DOI 10.1083/jcb.200411047; Lee J, 2001, J BIOL CHEM, V276, P14804, DOI 10.1074/jbc.M009434200; Majava V, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-10; Majava V, 2010, AMINO ACIDS, V39, P59, DOI 10.1007/s00726-009-0364-2; Margraf T, 2009, NUCLEIC ACIDS RES, V37, pW480, DOI 10.1093/nar/gkp431; Mazumder R, 2002, NUCLEIC ACIDS RES, V30, P5229, DOI 10.1093/nar/gkf645; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; MULLER HW, 1982, FEBS LETT, V144, P77, DOI 10.1016/0014-5793(82)80572-3; Muraro PA, 2002, J NEUROIMMUNOL, V130, P233, DOI 10.1016/S0165-5728(02)00229-1; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Myllykoski M, 2011, AMINO ACIDS; Myllykoski Matti, 2010, BMC Res Notes, V3, P12, DOI 10.1186/1756-0500-3-12; Sakamoto Y, 2005, J MOL BIOL, V346, P789, DOI 10.1016/j.jmb.2004.12.024; Schwer B, 2008, RNA, V14, P204, DOI 10.1261/rna.858108; Spinelli SL, 1999, J BIOL CHEM, V274, P2637, DOI 10.1074/jbc.274.5.2637; SPRINKLE TJ, 1980, J NEUROCHEM, V34, P880, DOI 10.1111/j.1471-4159.1980.tb09661.x; Stingo S, 2007, CHEM BIOL DRUG DES, V70, P502, DOI 10.1111/j.1747-0285.2007.00592.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TRAPP BD, 1988, J NEUROCHEM, V51, P859, DOI 10.1111/j.1471-4159.1988.tb01822.x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Walsh MJ, 1998, J CLIN INVEST, V101, P1923, DOI 10.1172/JCI1983	60	26	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32336	10.1371/journal.pone.0032336	http://dx.doi.org/10.1371/journal.pone.0032336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393399	Green Published, gold, Green Submitted			2022-12-27	WOS:000303003500051
J	Zhao, LQ; Morgan, TE; Mao, ZS; Lin, SR; Cadenas, E; Finch, CE; Pike, CJ; Mack, WJ; Brinton, RD				Zhao, Liqin; Morgan, Todd E.; Mao, Zisu; Lin, Sharon; Cadenas, Enrique; Finch, Caleb E.; Pike, Christian J.; Mack, Wendy J.; Brinton, Roberta D.			Continuous versus Cyclic Progesterone Exposure Differentially Regulates Hippocampal Gene Expression and Functional Profiles	PLOS ONE			English	Article							HEALTH INITIATIVE MEMORY; MILD COGNITIVE IMPAIRMENT; AMYLOID PRECURSOR PROTEIN; ESTROGEN PLUS PROGESTIN; CONJUGATED EQUINE ESTROGENS; RANDOMIZED CONTROLLED-TRIAL; MITOCHONDRIAL ATP-SYNTHASE; ALZHEIMERS-DISEASE; POSTMENOPAUSAL WOMEN; GROWTH-FACTOR	This study investigated the impact of chronic exposure to continuous (CoP4) versus cyclic progesterone (CyP4) alone or in combination with 17 beta-estradiol (E2) on gene expression profiles targeting bioenergetics, metabolism and inflammation in the adult female rat hippocampus. High-throughput qRT-PCR analyses revealed that ovarian hormonal depletion induced by ovariectomy (OVX) led to multiple significant gene expression alterations, which were to a great extent reversed by co-administration of E2 and CyP4. In contrast, co-administration of E2 and CoP4 induced a pattern highly resembling OVX. Bioinformatics analyses further revealed clear disparities in functional profiles associated with E2+CoP4 and E2+CyP4. Genes involved in mitochondrial energy (ATP synthase alpha subunit; Atp5a1), redox homeostasis (peroxiredoxin 5; Prdx5), insulin signaling (insulin-like growth factor I; Igf1), and cholesterol trafficking (liver X receptor alpha subtype; Nr1h3), differed in direction of regulation by E2+CoP4 (down-regulation relative to OVX) and E2+CyP4 (up-regulation relative to OVX). In contrast, genes involved in amyloid metabolism (beta-secretase; Bace1) differed only in degree of regulation, as both E2+CoP4 and E2+CyP4 induced down-regulation at different efficacy. E2+CyP4-induced changes could be associated with regulation of progesterone receptor membrane component 1(Pgrmc1). In summary, results from this study provide evidence at the molecular level that differing regimens of hormone therapy (HT) can induce disparate gene expression profiles in brain. From a translational perspective, confirmation of these results in a model of natural menopause, would imply that the common regimen of continuous combined HT may have adverse consequences whereas a cyclic combined regimen, which is more physiological, could be an effective strategy to maintain neurological health and function throughout menopausal aging.	[Zhao, Liqin; Mao, Zisu; Cadenas, Enrique; Brinton, Roberta D.] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Morgan, Todd E.; Lin, Sharon; Finch, Caleb E.; Pike, Christian J.] Univ So Calif, Davis Sch Gerontol, Los Angeles, CA USA; [Mack, Wendy J.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Brinton, Roberta D.] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Zhao, LQ (corresponding author), Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA.	liqinz@usc.edu; rbrinton@usc.edu	Pike, Christian J/D-4013-2018; Finch, Caleb/AAA-7250-2022	Brinton, Roberta/0000-0001-8450-772X; Pike, Christian/0000-0003-4577-7668	National Institute on Aging [1PO1 AG026572]; NATIONAL INSTITUTE ON AGING [P01AG026572, R01AG034103] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institute on Aging 1PO1 AG026572 - Progesterone in Brain Aging and Alzheimer's Disease (RDB): Project 1 to EC, Project 2 to CEF, Project 3 to RDB, Project 5 to CJP, Animal Core B to TEM and Analytic Core C to LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Bali N, 2011, ENDOCRINOLO IN PRESS; Blalock EM, 2010, J NEUROSCI, V30, P6058, DOI 10.1523/JNEUROSCI.3956-09.2010; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Brinton RD, 2003, JAMA-J AM MED ASSOC, V290, P1706, DOI 10.1001/jama.290.13.1706-a; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Carroll JC, 2007, J NEUROSCI, V27, P13357, DOI 10.1523/JNEUROSCI.2718-07.2007; Carroll JC, 2010, ENDOCRINOLOGY, V151, P2713, DOI 10.1210/en.2009-1487; Chesik D, 2010, NEUROSCI LETT, V468, P178, DOI 10.1016/j.neulet.2009.10.051; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Das AM, 2003, MOL GENET METAB, V79, P71, DOI 10.1016/S1096-7192(03)00069-6; Declercq JP, 2001, J MOL BIOL, V311, P751, DOI 10.1006/jmbi.2001.4853; Denisov V, 2008, 5761 BIOR EL; Espeland MA, 2004, JAMA-J AM MED ASSOC, V291, P2959, DOI 10.1001/jama.291.24.2959; Garcia-Segura LM, 2006, NEUROENDOCRINOLOGY, V84, P275, DOI 10.1159/000097485; Garcia-Segura LM, 2010, PROG BRAIN RES, V181, P251, DOI 10.1016/S0079-6123(08)81014-X; Goulter AB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-34; GUENNOUN R, 1990, DEV BRAIN RES, V55, P151, DOI 10.1016/0165-3806(90)90196-6; Guerra-Araiza C, 2003, J NEUROENDOCRINOL, V15, P984, DOI 10.1046/j.1365-2826.2003.01088.x; Hampel H, 2009, SCAND J CLIN LAB INV, V69, P8, DOI 10.1080/00365510701864610; Intlekofer KA, 2011, NEUROSCIENCE, V176, P86, DOI 10.1016/j.neuroscience.2010.12.033; Irwin RW, 2008, ENDOCRINOLOGY, V149, P3167, DOI 10.1210/en.2007-1227; Irwin RW, 2011, ENDOCRINOLOGY, V152, P556, DOI 10.1210/en.2010-1061; Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009; KOHAMA SG, 1989, BIOL REPROD, V41, P233, DOI 10.1095/biolreprod41.2.233; Liu LF, 2009, ENDOCRINOLOGY, V150, P3186, DOI 10.1210/en.2008-1447; Marriott LK, 2007, ENDOCRINE, V32, P317, DOI 10.1007/s12020-008-9038-1; McRory JE, 1997, DNA CELL BIOL, V16, P939, DOI 10.1089/dna.1997.16.939; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Nilsen J, 2003, P NATL ACAD SCI USA, V100, P10506, DOI 10.1073/pnas.1334098100; Patenaude A, 2005, CELL MOL LIFE SCI, V62, P1063, DOI 10.1007/s00018-005-4541-5; Peluso JJ, 2008, ENDOCRINOLOGY, V149, P534, DOI 10.1210/en.2007-1050; Quadros PS, 2008, ENDOCRINOLOGY, V149, P3054, DOI 10.1210/en.2007-1133; Rapp SR, 2003, JAMA-J AM MED ASSOC, V289, P2663, DOI 10.1001/jama.289.20.2663; Reed T, 2008, NEUROBIOL DIS, V30, P107, DOI 10.1016/j.nbd.2007.12.007; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Rohe HJ, 2009, PHARMACOL THERAPEUT, V121, P14, DOI 10.1016/j.pharmthera.2008.09.006; Rowe WB, 2007, J NEUROSCI, V27, P3098, DOI 10.1523/JNEUROSCI.4163-06.2007; Sakamoto H, 2004, NEUROSCIENCE, V126, P325, DOI 10.1016/j.neuroscience.2004.04.003; Schmidt C, 2008, MOL PSYCHIATR, V13, P953, DOI 10.1038/sj.mp.4002077; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharma S, 2008, NEUROBIOL DIS, V32, P426, DOI 10.1016/j.nbd.2008.08.002; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Smeets A, 2008, ARCH BIOCHEM BIOPHYS, V477, P98, DOI 10.1016/j.abb.2008.04.036; Szabo M, 2000, BIOL REPROD, V62, P95, DOI 10.1095/biolreprod62.1.95; Terni B, 2010, BRAIN PATHOL, V20, P222, DOI 10.1111/j.1750-3639.2009.00266.x; Torres-Aleman I, 2010, DEV NEUROBIOL, V70, P384, DOI 10.1002/dneu.20778; Vaya J, 2007, J NEUROCHEM, V102, P1727, DOI 10.1111/j.1471-4159.2007.04689.x; Viero C, 2006, CELL CALCIUM, V40, P383, DOI 10.1016/j.ceca.2006.04.007; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yao J, 2011, BRAIN RES, V1379, P2, DOI 10.1016/j.brainres.2010.11.090; Yao J, 2010, BBA-GEN SUBJECTS, V1800, P1121, DOI 10.1016/j.bbagen.2010.06.002; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271; Zhao WQ, 2009, J BIOL CHEM, V284, P18742, DOI 10.1074/jbc.M109.011015	58	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31267	10.1371/journal.pone.0031267	http://dx.doi.org/10.1371/journal.pone.0031267			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393359	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500012
J	Jiu, YM; Jin, CY; Liu, YB; Holmberg, CI; Jantti, J				Jiu, Yaming; Jin, Congyu; Liu, Yanbo; Holmberg, Carina I.; Jantti, Jussi			Exocyst Subunits Exo70 and Exo84 Cooperate with Small GTPases to Regulate Behavior and Endocytic Trafficking in C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PLASMA-MEMBRANE; SACCHAROMYCES-CEREVISIAE; POLARIZED EXOCYTOSIS; EPITHELIAL-CELLS; RAL GTPASES; COMPLEX; PROTEIN; EFFECTOR; PATHWAY	The exocyst complex is required for cell polarity regulation and the targeting and tethering of transport vesicles to the plasma membrane. The complex is structurally well conserved, however, the functions of individual subunits and their regulation is poorly understood. Here we characterize the mutant phenotypes for the exocyst complex genes exoc-7 (exo70) and exoc-8 (exo84) in Caenorhabditis elegans. The mutants display pleiotropic behavior defects that resemble those observed in cilia mutants (slow growth, uncoordinated movement, defects in chemo-, mechano- and thermosensation). However, no obvious morphological defects in cilia were observed. A targeted RNAi screen for small GTPases identified eleven genes with enhanced phenotypes when combined with exoc-7, exoc-8 single and exoc-7;exoc-8 double mutants. The screen verified previously identified functional links between the exocyst complex and small GTPases and, in addition, identified several novel potential regulators of exocyst function. The exoc-8 and exoc-7;exoc-8 mutations caused a significant size increase in the rab-10 RNAi-induced endocytic vacuoles in the intestinal epithelial cells. In addition, exoc-8 and exoc-7;exoc-8 mutations resulted in up-regulation of RAB-10 expression and affected the accumulation of endocytic marker proteins in these cells in response to rab-10 RNAi. The findings identify novel, potential regulators for exocyst function and show that exoc-7 and exoc-8 are functionally linked to rab-10 in endosomal trafficking in intestinal epithelial cells in C. elegans.	[Jiu, Yaming; Liu, Yanbo; Jantti, Jussi] Univ Helsinki, Inst Biotechnol, Res Program Cell & Mol Biol, Helsinki, Finland; [Jin, Congyu; Holmberg, Carina I.] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Jin, Congyu; Holmberg, Carina I.] Univ Helsinki, Inst Biomed, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Jiu, YM (corresponding author), Univ Helsinki, Inst Biotechnol, Res Program Cell & Mol Biol, Helsinki, Finland.	jussi.jantti@helsinki.fi		Holmberg-Still, Carina/0000-0001-9645-2009	Academy of Finland [1133552, 1131408, 113485]; Institute of Biotechnology; University of Helsinki; International Human Frontier Science Program Organization; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Institute of Biotechnology; University of Helsinki; International Human Frontier Science Program Organization(Human Frontier Science Program); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by grants from the Academy of Finland (1133552, JJ; 1131408 and 113485,CIH), Institute of Biotechnology (JJ), University of Helsinki (CIH), International Human Frontier Science Program Organization (CIH) and Sigrid Juselius Foundation (CIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; Babbey CM, 2010, AM J PHYSIOL-RENAL, V299, pF495, DOI 10.1152/ajprenal.00198.2010; BOWSER R, 1991, J CELL BIOL, V112, P1117, DOI 10.1083/jcb.112.6.1117; BRENNER S, 1974, GENETICS, V77, P71; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Camonis JH, 2005, TRENDS CELL BIOL, V15, P327, DOI 10.1016/j.tcb.2005.04.002; Chen CCH, 2006, MOL BIOL CELL, V17, P1286, DOI 10.1091/mbc.E05-08-0787; Chen XW, 2011, NAT CELL BIOL, V13, P580, DOI 10.1038/ncb2226; Das A, 2011, TRENDS CELL BIOL, V21, P383, DOI 10.1016/j.tcb.2011.03.006; Finger FP, 1998, CELL, V92, P559, DOI 10.1016/S0092-8674(00)80948-4; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Frische EW, 2007, EMBO J, V26, P5083, DOI 10.1038/sj.emboj.7601922; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029; HAN M, 1990, CELL, V63, P921, DOI 10.1016/0092-8674(90)90495-Z; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Henry L, 2008, MOL BIOL CELL, V19, P2059, DOI 10.1091/mbc.E07-09-0902; Hirotsu T, 2000, NATURE, V404, P289, DOI 10.1038/35005101; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Inglis P. N., 2007, WORMBOOK, P1, DOI [10.1895/wormbook.1.126.2, DOI 10.1895/WORMBOOK.1.126.2]; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Ishihara T, 2002, CELL, V109, P639, DOI 10.1016/S0092-8674(02)00748-1; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; Jiu YM, 2010, PROTEIN CELL, V1, P75, DOI 10.1007/s13238-010-0003-4; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kang J, 2009, DEVELOPMENT, V136, P2705, DOI 10.1242/dev.035485; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Leung B, 1999, DEV BIOL, V216, P114, DOI 10.1006/dbio.1999.9471; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; Masuda ES, 2000, FEBS LETT, V470, P61, DOI 10.1016/S0014-5793(00)01288-6; McGhee J.D., 2007, C ELEGANS INTESTINE, P1; Mello C, 1995, METHOD CELL BIOL, V48, P451; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Michaux G, 2011, J THROMB HAEMOST, V9, P392, DOI 10.1111/j.1538-7836.2010.04138.x; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Robinson NCG, 1999, MOL CELL BIOL, V19, P3580; Rogers KK, 2004, BIOCHEM BIOPH RES CO, V319, P138, DOI 10.1016/j.bbrc.2004.04.165; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Tatebe H, 2010, CURR BIOL, V20, P1975, DOI 10.1016/j.cub.2010.10.026; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Wicks SR, 2000, DEV BIOL, V221, P295, DOI 10.1006/dbio.2000.9686; Wu H, 2008, TRENDS CELL BIOL, V18, P397, DOI 10.1016/j.tcb.2008.06.007; Wu H, 2010, MOL BIOL CELL, V21, P430, DOI 10.1091/mbc.E09-06-0501; Yeaman C, 2001, J CELL BIOL, V155, P593, DOI 10.1083/jcb.200107088; Yu Y, 2011, BIOCHEM J, V434, P383, DOI 10.1042/BJ20110027; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	62	13	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32077	10.1371/journal.pone.0032077	http://dx.doi.org/10.1371/journal.pone.0032077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389680	Green Published, gold			2022-12-27	WOS:000302999600018
J	Pulicherla, N; Kota, P; Dokholyan, NV; Asokan, A				Pulicherla, Nagesh; Kota, Pradeep; Dokholyan, Nikolay V.; Asokan, Aravind			Intra- and Inter-Subunit Disulfide Bond Formation Is Nonessential in Adeno-Associated Viral Capsids	PLOS ONE			English	Article							ESCHERICHIA-COLI THIOREDOXIN; SITE CYSTEINE RESIDUES; MUTATIONAL ANALYSIS; GENE-THERAPY; VIRUS; PROTEIN; IONIZATION; REACTIVITY; VECTORS; CONFORMATION	The capsid proteins of adeno-associated viruses (AAV) have five conserved cysteine residues. Structural analysis of AAV serotype 2 reveals that Cys289 and Cys361 are located adjacent to each other within each monomer, while Cys230 and Cys394 are located on opposite edges of each subunit and juxtaposed at the pentamer interface. The Cys482 residue is located at the base of a surface loop within the trimer region. Although plausible based on molecular dynamics simulations, intra- or inter-subunit disulfides have not been observed in structural studies. In the current study, we generated a panel of Cys-to-Ser mutants to interrogate the potential for disulfide bond formation in AAV capsids. The C289S, C361S and C482S mutants were similar to wild type AAV with regard to titer and transduction efficiency. However, AAV capsid protein subunits with C230S or C394S mutations were prone to proteasomal degradation within the host cells. Proteasomal inhibition partially blocked degradation of mutant capsid proteins, but failed to rescue infectious virions. While these results suggest that the Cys230/394 pair is critical, a C394V mutant was found viable, but not the corresponding C230V mutant. Although the exact nature of the structural contribution(s) of Cys230 and Cys394 residues to AAV capsid formation remains to be determined, these results support the notion that disulfide bond formation within the Cys289/361 or Cys230/394 pair appears to be nonessential. These studies represent an important step towards understanding the role of inter-subunit interactions that drive AAV capsid assembly.	[Pulicherla, Nagesh; Asokan, Aravind] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA; [Asokan, Aravind] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Kota, Pradeep; Dokholyan, Nikolay V.; Asokan, Aravind] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Pulicherla, N (corresponding author), Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA.	aravind@med.unc.edu	Dokholyan, Nikolay/D-8081-2018; Core, Vector/CAF-4832-2022	Dokholyan, Nikolay/0000-0002-8225-4025; 	National Institutes of Health (NIH) [R01HL089221-A1]; ARRA [-S2]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089221] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health (NIH) grant R01HL089221-A1 and ARRA grant -S2 (awarded to A.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright BS, 2011, J VIROL, V85, P8616, DOI 10.1128/JVI.00123-11; Bleker S, 2006, J VIROL, V80, P810, DOI 10.1128/JVI.80.2.810-820.2006; Bleker S, 2005, J VIROL, V79, P2528, DOI 10.1128/JVI.79.4.2528-2540.2005; Bowles D.E., 2006, PARVOVIRUSES, P15; Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840; Chapman MS, 2006, PARVOVIRUSES, P107; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; DiPritmio N, 2008, J VIROL, V82, P5178, DOI 10.1128/JVI.02721-07; Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a; Govindasamy L, 2006, J VIROL, V80, P11556, DOI 10.1128/JVI.01536-06; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Li ML, 1998, J VIROL, V72, P2160, DOI 10.1128/JVI.72.3.2160-2167.1998; Li PP, 2005, J VIROL, V79, P3859, DOI 10.1128/JVI.79.6.3859-3864.2005; Li PP, 2000, J VIROL, V74, P11388, DOI 10.1128/JVI.74.23.11388-11393.2000; Mukherjee S, 2008, J MOL BIOL, V381, P229, DOI 10.1016/j.jmb.2008.05.079; Nam HJ, 2007, J VIROL, V81, P12260, DOI 10.1128/JVI.01304-07; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Ng R, 2010, J VIROL, V84, P12945, DOI 10.1128/JVI.01235-10; Perez R, 2011, J MOL BIOL, V413, P32, DOI 10.1016/j.jmb.2011.08.020; Pornillos O, 2010, J MOL BIOL, V401, P985, DOI 10.1016/j.jmb.2010.06.042; Pulicherla N, 2011, MOL THER, V19, P1070, DOI 10.1038/mt.2011.22; Raso SW, 2001, J MOL BIOL, V307, P899, DOI 10.1006/jmbi.2001.4476; Reguera J, 2004, P NATL ACAD SCI USA, V101, P2724, DOI 10.1073/pnas.0307748101; Riolobos L, 2006, J MOL BIOL, V357, P1026, DOI 10.1016/j.jmb.2006.01.019; Sapp M, 1998, J VIROL, V72, P6186, DOI 10.1128/JVI.72.7.6186-6189.1998; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Sonntag F, 2010, P NATL ACAD SCI USA, V107, P10220, DOI 10.1073/pnas.1001673107; Takahashi N, 1996, BIOCHEMISTRY-US, V35, P8342, DOI 10.1021/bi960465v; Wobus CE, 2000, J VIROL, V74, P9281, DOI 10.1128/JVI.74.19.9281-9293.2000; Wu P, 2000, J VIROL, V74, P8635, DOI 10.1128/JVI.74.18.8635-8647.2000; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899	32	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32163	10.1371/journal.pone.0032163	http://dx.doi.org/10.1371/journal.pone.0032163			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389684	Green Submitted, gold, Green Published			2022-12-27	WOS:000302999600022
J	Doss, CGP; NagaSundaram, N				Doss, C. George Priya; NagaSundaram, N.			Investigating the Structural Impacts of I64T and P311S Mutations in APE1-DNA Complex: A Molecular Dynamics Approach	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; BASE EXCISION-REPAIR; PROTEIN STABILITY CHANGES; NON-SYNONYMOUS SNPS; DNA-REPAIR; COMPUTATIONAL ANALYSIS; SOLVENT ACCESSIBILITY; GENETIC-VARIATION; SEQUENCE; PREDICTION	Background: Elucidating the molecular dynamic behavior of Protein-DNA complex upon mutation is crucial in current genomics. Molecular dynamics approach reveals the changes on incorporation of variants that dictate the structure and function of Protein-DNA complexes. Deleterious mutations in APE1 protein modify the physicochemical property of amino acids that affect the protein stability and dynamic behavior. Further, these mutations disrupt the binding sites and prohibit the protein to form complexes with its interacting DNA. Principal Findings: In this study, we developed a rapid and cost-effective method to analyze variants in APE1 gene that are associated with disease susceptibility and evaluated their impacts on APE1-DNA complex dynamic behavior. Initially, two different in silico approaches were used to identify deleterious variants in APE1 gene. Deleterious scores that overlap in these approaches were taken in concern and based on it, two nsSNPs with IDs rs61730854 (I64T) and rs1803120 (P311S) were taken further for structural analysis. Significance: Different parameters such as RMSD, RMSF, salt bridge, H-bonds and SASA applied in Molecular dynamic study reveals that predicted deleterious variants I64T and P311S alters the structure as well as affect the stability of APE1-DNA interacting functions. This study addresses such new methods for validating functional polymorphisms of human APE1 which is critically involved in causing deficit in repair capacity, which in turn leads to genetic instability and carcinogenesis.	[Doss, C. George Priya; NagaSundaram, N.] VIT Univ, Sch Biosci & Technol, Med Biotechnol Div, Ctr Nanobiotechnol, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Doss, CGP (corresponding author), VIT Univ, Sch Biosci & Technol, Med Biotechnol Div, Ctr Nanobiotechnol, Vellore, Tamil Nadu, India.	georgepriyadoss@vit.ac.in	Nagarajan, Nagasundaram/AAT-8337-2021; Alizadeh/AAK-1398-2021; C, George/ABE-4676-2021	C, George Priya Doss/0000-0002-5971-8290; Nagarajan, Nagasundaram/0000-0002-9581-4781				Abyzov A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000066; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Bairoch A, 1996, NUCLEIC ACIDS RES, V24, P21, DOI 10.1093/nar/24.1.21; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Burke DF, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-301; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Case DA, 2002, AMBER SIMULATION SOF; Chang JS, 2009, CARCINOGENESIS, V30, P78, DOI 10.1093/carcin/bgn261; Chen H, 2001, HUM MUTAT, V18, P120, DOI 10.1002/humu.1161; Chen HL, 2005, NUCLEIC ACIDS RES, V33, P3193, DOI 10.1093/nar/gki633; Chen JJ, 2009, CURR PROTEOMICS, V6, P228, DOI 10.2174/157016409789973734; CHERFILS J, 1991, PROTEINS, V11, P271, DOI 10.1002/prot.340110406; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Creighton T. E., 1993, PROTEINS STRUCTURES; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gilis D, 1997, J MOL BIOL, V272, P276, DOI 10.1006/jmbi.1997.1237; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Gromiha MM, 1999, PROTEIN ENG, V12, P549, DOI 10.1093/protein/12.7.549; GROMIHA MM, 1995, INT J PEPT PROT RES, V45, P225; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hunt DM, 2008, INFECT IMMUN, V76, P2227, DOI 10.1128/IAI.01410-07; Jeffey GA, 1997, INTRO HYDROGEN BONDI; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kouranov A, 2006, NUCLEIC ACIDS RES, V34, pD302, DOI 10.1093/nar/gkj120; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; Kumar S, 2000, J BIOMOL STRUCT DYN, P79, DOI 10.1080/07391102.2000.10506606; Kutzner C, 2007, J COMPUT CHEM, V28, P2075, DOI 10.1002/jcc.20703; Ma L, 2011, BIOCHEMISTRY-US, V50, P266, DOI 10.1021/bi101096k; MCHENRY CS, 1988, ANNU REV BIOCHEM, V57, P519; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; NOVOTNY J, 1992, PROG BIOPHYS MOL BIO, V58, P203, DOI 10.1016/0079-6107(92)90006-R; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reumers J, 2006, BIOINFORMATICS, V22, P2183, DOI 10.1093/bioinformatics/btl348; Ringe, 2004, PROTEIN STRUCTURE FU, P10; ROSE GD, 1993, ANNU REV BIOPH BIOM, V22, P381, DOI 10.1146/annurev.bb.22.060193.002121; Sarakatsannis JN, 2005, PROTEINS, V60, P732, DOI 10.1002/prot.20549; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SHIRLEY BA, 1992, BIOCHEMISTRY-US, V31, P725, DOI 10.1021/bi00118a013; SHRAKE A, 1973, J MOL BIOL, V79, P351, DOI 10.1016/0022-2836(73)90011-9; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Stitziel NO, 2004, NUCLEIC ACIDS RES, V32, pD520, DOI 10.1093/nar/gkh104; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Synowiec E, 2008, MUTAT RES-FUND MOL M, V648, P65, DOI 10.1016/j.mrfmmm.2008.09.014; Uzun A, 2007, NUCLEIC ACIDS RES, V35, pW384, DOI 10.1093/nar/gkm232; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Weiss JM, 2005, MOL CARCINOGEN, V42, P127, DOI 10.1002/mc.20067; WILSON C, 1994, STRUCTURE, V2, P713, DOI 10.1016/S0969-2126(00)00072-1; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; Xi T, 2004, GENOMICS, V83, P970, DOI 10.1016/j.ygeno.2003.12.016; Yu E, 2010, BIOCHEMISTRY-US, V49, P3786, DOI 10.1021/bi901828t; Yu ET, 2011, MUTAT RES-GEN TOX EN, V722, P140, DOI 10.1016/j.mrgentox.2010.06.015; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Yue P, 2006, J MOL BIOL, V356, P1263, DOI 10.1016/j.jmb.2005.12.025; Yue P, 2006, BMC BIOINFORMATICS, V22, P7; Zhang Z, 2010, HUM MUTAT, V31, P1043, DOI 10.1002/humu.21310	69	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31677	10.1371/journal.pone.0031677	http://dx.doi.org/10.1371/journal.pone.0031677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384055	gold, Green Submitted, Green Published			2022-12-27	WOS:000302918500035
J	Estrada-Bernal, A; Sanford, SD; Sosa, LJ; Simon, GC; Hansen, KC; Pfenninger, KH				Estrada-Bernal, Adriana; Sanford, Staci D.; Sosa, Lucas J.; Simon, Glenn C.; Hansen, Kirk C.; Pfenninger, Karl H.			Functional Complexity of the Axonal Growth Cone: A Proteomic Analysis	PLOS ONE			English	Article							LARGE GENE LISTS; FETAL-RAT-BRAIN; PROTEIN-SYNTHESIS; MESSENGER-RNA; TRANSLATIONAL REGULATION; LOCAL TRANSLATION; NEURONS; LOCALIZATION; REGENERATION; TRANSPORT	The growth cone, the tip of the emerging neurite, plays a crucial role in establishing the wiring of the developing nervous system. We performed an extensive proteomic analysis of axonal growth cones isolated from the brains of fetal Sprague-Dawley rats. Approximately 2000 proteins were identified at >= 99% confidence level. Using informatics, including functional annotation cluster and KEGG pathway analysis, we found great diversity of proteins involved in axonal pathfinding, cytoskeletal remodeling, vesicular traffic and carbohydrate metabolism, as expected. We also found a large and complex array of proteins involved in translation, protein folding, posttranslational processing, and proteasome/ubiquitination-dependent degradation. Immunofluorescence studies performed on hippocampal neurons in culture confirmed the presence in the axonal growth cone of proteins representative of these processes. These analyses also provide evidence for rough endoplasmic reticulum and reveal a reticular structure equipped with Golgi-like functions in the axonal growth cone. Furthermore, Western blot revealed the growth cone enrichment, relative to fetal brain homogenate, of some of the proteins involved in protein synthesis, folding and catabolism. Our study provides a resource for further research and amplifies the relatively recently developed concept that the axonal growth cone is equipped with proteins capable of performing a highly diverse range of functions.	[Estrada-Bernal, Adriana; Sanford, Staci D.; Sosa, Lucas J.; Simon, Glenn C.; Pfenninger, Karl H.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Estrada-Bernal, Adriana; Sanford, Staci D.; Sosa, Lucas J.; Simon, Glenn C.; Pfenninger, Karl H.] Univ Colorado, Sch Med, Colorado Intellectual & Dev Disabil Res Ctr, Aurora, CO USA; [Hansen, Kirk C.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Estrada-Bernal, A (corresponding author), Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA.	karl.pfenninger@ucdenver.edu		Sosa, Lucas/0000-0002-9153-7537	Molecular Discovery Core of the Colorado Intellectual and Developmental Disabilities Research Center (NIH/NICHD) [P30 HD004024]; National Institutes of Health (NIH) [R01 NS041029, NS061940, P30 CA046934, S1 ORR023015]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD004024] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041029, R01NS061940] Funding Source: NIH RePORTER	Molecular Discovery Core of the Colorado Intellectual and Developmental Disabilities Research Center (NIH/NICHD); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Molecular Discovery Core of the Colorado Intellectual and Developmental Disabilities Research Center (NIH/NICHD grant P30 HD004024), and by National Institutes of Health (NIH) grants R01 NS041029 and NS061940 (awarded to KHP), and by NIH grants P30 CA046934 and S1 ORR023015 (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassell GJ, 1998, J NEUROSCI, V18, P251; Bi J, 2006, P NATL ACAD SCI USA, V103, P19919, DOI 10.1073/pnas.0607394104; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DOTTI CG, 1987, NEUROSCIENCE, V23, P121, DOI 10.1016/0306-4522(87)90276-4; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Drinjakovic J, 2010, NEURON, V65, P341, DOI 10.1016/j.neuron.2010.01.017; DUNPHY WG, 1983, J CELL BIOL, V97, P270, DOI 10.1083/jcb.97.1.270; FERREIRA A, 1987, DEV BRAIN RES, V34, P9, DOI 10.1016/0165-3806(87)90191-X; Fulga TA, 2008, NEURON, V57, P339, DOI 10.1016/j.neuron.2008.01.016; Giuditta A, 2002, TRENDS NEUROSCI, V25, P400, DOI 10.1016/S0166-2236(02)02188-4; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Hengst U, 2007, SEMIN CELL DEV BIOL, V18, P209, DOI 10.1016/j.semcdb.2007.01.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; JONES SM, 1993, J CELL BIOL, V122, P775, DOI 10.1083/jcb.122.4.775; Koike M, 2010, J BIOL CHEM, V285, P21736, DOI 10.1074/jbc.M109.099283; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KOSIK KS, 1987, J NEUROSCI, V7, P3142; Letourneau PC, 1996, PERSPECT DEV NEUROBI, V4, P111; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; Lohse K, 1996, DEV BRAIN RES, V96, P83, DOI 10.1016/0165-3806(96)00076-4; Mann F, 2003, J NEUROBIOL, V57, P323, DOI 10.1002/neu.10303; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MEIRI KF, 1986, P NATL ACAD SCI USA, V83, P3537, DOI 10.1073/pnas.83.10.3537; Merianda TT, 2009, MOL CELL NEUROSCI, V40, P128, DOI 10.1016/j.mcn.2008.09.008; Murphey RK, 2002, NEURON, V36, P5, DOI 10.1016/S0896-6273(02)00943-1; Naryzhny SN, 2004, J BIOL CHEM, V279, P20194, DOI 10.1074/jbc.M312850200; NEGREAMINOU P, 1993, J NEUROCHEM, V60, P1126, DOI 10.1111/j.1471-4159.1993.tb03263.x; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Nozumi M, 2009, P NATL ACAD SCI USA, V106, P17211, DOI 10.1073/pnas.0904092106; O'Donnell M, 2009, ANNU REV NEUROSCI, V32, P383, DOI 10.1146/annurev.neuro.051508.135614; Otis KO, 2006, CURR OPIN NEUROBIOL, V16, P329, DOI 10.1016/j.conb.2006.05.001; Perry RBT, 2009, SEMIN CELL DEV BIOL, V20, P600, DOI 10.1016/j.semcdb.2009.04.014; Pertz OC, 2008, P NATL ACAD SCI USA, V105, P1931, DOI 10.1073/pnas.0706545105; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; PFENNINGER KH, 1983, CELL, V35, P573, DOI 10.1016/0092-8674(83)90191-5; PFENNINGER KH, 1981, J CELL BIOL, V89, P536, DOI 10.1083/jcb.89.3.536; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; VRIZ S, 1992, MOL CELL BIOL, V12, P3548, DOI 10.1128/MCB.12.8.3548; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Willis DE, 2006, CURR OPIN NEUROBIOL, V16, P111, DOI 10.1016/j.conb.2006.01.002; Wu CC, 2000, TRAFFIC, V1, P963, DOI 10.1034/j.1600-0854.2000.011206.x; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010	56	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31858	10.1371/journal.pone.0031858	http://dx.doi.org/10.1371/journal.pone.0031858			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384089	Green Submitted, gold, Green Published			2022-12-27	WOS:000302918500043
J	Gordon, M; Seymour, J				Gordon, Matthew; Seymour, Jamie			Growth, Development and Temporal Variation in the Onset of Six Chironex fleckeri Medusae Seasons: A Contribution to Understanding Jellyfish Ecology	PLOS ONE			English	Article							JUVENILE BANANA PRAWNS; TRIPEDALIA-CYSTOPHORA CUBOZOA; NORTHERN AUSTRALIAN ESTUARY; PENAEUS-MERGUIENSIS; ENVIRONMENTAL VARIATION; BOX-JELLYFISH; LIFE-CYCLE; FISH; METAMORPHOSIS; POSTLARVAL	Despite the worldwide distribution, toxicity and commercial, industrial and medical impacts jellyfish present, many aspects of their ecology remain poorly understood. Quantified here are important ecological parameters of Chironex fleckeri medusae, contributing not only to the understanding of an understudied taxon, the cubozoa, but also to the broader understanding of jellyfish ecology. C. fleckeri medusae were collected across seven seasons (1999, 2000, 2003, 2005-07 and 2010), with growth rates, temporal variation in the medusae season onset and differences in population structure between estuarine and coastal habitats quantified. With a mean of 2 September +/- 2 d (mean +/- 95% confidence limits), the earliest date of metamorphosis was temporally constrained between seasons, varying by only 7 d (30 August to 5 September). Juvenile medusae appeared to be added over an extended period, suggesting polyp metamorphosis was an ongoing process once it commenced. At a maximum of 3 +/- 0.2 mm d(-1) IPD, medusae growth to an asymptotic size of,190 mm IPD was rapid, yet, with the oldest medusae estimated to be, similar to 78 d in age, medusae did not appear to accumulate along the coastline. Furthermore, a greater proportion of juveniles were observed along the coastline, with estuarine populations typified by larger medusae. With key aspects of C. fleckeri's ecology now quantified, medusae season management protocols can be further developed.	[Gordon, Matthew; Seymour, Jamie] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia	James Cook University	Gordon, M (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia.	matthew.gordon@jcu.edu.au	Seymour, Jamie E/C-9748-2013	Seymour, Jamie E/0000-0002-4805-3289; Gordon, Matthew/0000-0001-8074-1295	Mission Beach Tourism Commission; Lions Foundation of Australia; National Geographic; Australian Geographic; Cairns City Council; Cardwell Shire Council; Growing the Smart State Queensland; Comalco	Mission Beach Tourism Commission; Lions Foundation of Australia; National Geographic(National Geographic Society); Australian Geographic; Cairns City Council; Cardwell Shire Council; Growing the Smart State Queensland; Comalco	Mission Beach Tourism Commission (http://www.missionbeachtourism.com/), Lions Foundation of Australia (www.lionsclubs.org.au), National Geographic (www.nationalgeographic.com.au), Australian Geographic (www.australiangeographic.com.au), Cairns City Council (www.cairns.qld.gov.au), Cardwell Shire Council (www.csc.qld.gov.au), Growing the Smart State Queensland PhD grants (www.smartstate.qld.gov.au) and Comalco (http://www.riotintoalcan.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai MN, 1997, FUNCTIONAL BIOL SCYP; Arneson A. C., 1976, COELENTERATE ECOLOGY, P227, DOI [10.1007/978-1-4757-9724-4_24, DOI 10.1007/978-1-4757-9724-4_24]; BARNES J. H., 1960, MED JOUR AUSTRALIA II, V47, P993; Barnes J. H., 1965, North Queensland Naturalist, V32, P13; BARNES J. H., 1966, SYMP ZOOL SOC LONDON, V16, P307; BLABER SJM, 1989, ESTUAR COAST SHELF S, V29, P509, DOI 10.1016/0272-7714(89)90008-5; BLABER SJM, 1995, ESTUAR COAST SHELF S, V40, P177, DOI 10.1016/S0272-7714(05)80004-6; Brown T., 1973, CHIRONEX FLECKERI DI; Burnett JW, 2001, HYDROBIOLOGIA, V451, P1, DOI 10.1023/A:1011883019506; Burnett JW, 1996, VENOMOUS POISONOUS M, P98; Carrette T, 2002, TOXICON, V40, P1547, DOI 10.1016/S0041-0101(02)00168-X; Cropp B, 1984, SCUBA DIVER, V3, P42; CYRUS DP, 1992, ESTUAR COAST SHELF S, V35, P545, DOI 10.1016/S0272-7714(05)80038-1; Fenner PJ, 1996, MED J AUSTRALIA, V165, P658, DOI 10.5694/j.1326-5377.1996.tb138679.x; Gordon M, 2004, HYDROBIOLOGIA, V530, P339, DOI 10.1007/s10750-004-2655-7; Gordon M, 1998, ECOPHYSIOLOGY TROPIC; Graham WM, 2003, BIOL INVASIONS, V5, P53, DOI 10.1023/A:1024046707234; GUEST WILLIAM C., 1959, BULL MARINE SCI GULF AND CARIBBEAN, V9, P79; Hamner WM, 1995, MAR FRESHWATER RES, V46, P985, DOI 10.1071/MF9950985; HAMNER WM, 1994, NATL GEOGR MAG, V186, P116; HARTWICK R, 1987, TOXIC PLANTS ANIMALS, P99; HARTWICK RF, 1991, HYDROBIOLOGIA, V216, P181, DOI 10.1007/BF00026460; HOFMANN DK, 1981, MAR BIOL, V65, P25, DOI 10.1007/BF00397064; Jacups S, 2010, NO TERRITORY DIS CON, V17, P25; Jacups SP, 2010, ECOHEALTH, V7, P14, DOI 10.1007/s10393-010-0306-1; KAUFMANN KW, 1981, OECOLOGIA, V49, P293, DOI 10.1007/BF00347588; Kawamura Mariko, 2003, Plankton Biology and Ecology, V50, P37; KEEN TEB, 1971, TOXICON, V9, P249, DOI 10.1016/0041-0101(71)90077-8; Kinsey BE, 1988, MORE BARNES BO UNPUB; Kinsey BE, 1986, BARNES BOX JEL UNPUB; LASKAMEHNERT G, 1985, HELGOLANDER MEERESUN, V39, P129, DOI 10.1007/BF01997447; LEONARD JL, 1980, NATURE, V284, P377, DOI 10.1038/284377a0; Liu WC, 2009, HYDROBIOLOGIA, V616, P247, DOI 10.1007/s10750-008-9597-4; Masilamoni JG, 2000, CURR SCI INDIA, V79, P567; Matsumura K, 2005, J MAR BIOL ASSOC UK, V85, P563, DOI 10.1017/S0025315405011483; Purcell JE, 2001, HYDROBIOLOGIA, V451, P27, DOI 10.1023/A:1011883905394; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2007, MAR ECOL PROG SER, V348, P183, DOI 10.3354/meps07056; Rajagopal S., 1989, Mahasagar, V22, P151; Sachlikidis NG, 2005, NEW ZEAL J MAR FRESH, V39, P305, DOI 10.1080/00288330.2005.9517310; Seymour JE, 2004, MED J AUSTRALIA, V181, P707, DOI 10.5694/j.1326-5377.2004.tb06529.x; SOUTHCOTT R V, 1971, Australian Natural History, V17, P123; Southcott R.V., 1956, AUST J MAR FRESHW RE, V7, P254, DOI DOI 10.1071/MF9560254; Stangl K, 2002, VIE MILIEU, V52, P131; Straehler-Pohl I, 2005, MAR BIOL, V147, P1271, DOI 10.1007/s00227-005-0031-4; Straehler-Pohl I, 2011, ZOOTAXA, P36; Ueno S., 1997, P491; UENO S, 1995, J PLANKTON RES, V17, P1381, DOI 10.1093/plankt/17.6.1381; Ueno S, 2003, 7 INT C COEL BIOL; Vance DJ, 1996, MAR ECOL PROG SER, V131, P115, DOI 10.3354/meps131115; VANCE DJ, 1990, ESTUAR COAST SHELF S, V31, P689, DOI 10.1016/0272-7714(90)90020-R; Vance DJ, 1998, MAR ECOL PROG SER, V163, P21, DOI 10.3354/meps163021; Vance DJ, 1996, MAR ECOL PROG SER, V135, P43, DOI 10.3354/meps135043; WERNER B, 1973, MAR BIOL, V18, P212, DOI 10.1007/BF00367987; WERNER B, 1975, HELGOLAND WISS MEER, V27, P461, DOI 10.1007/BF01611150; WERNER B, 1976, EXPERIENTIA, V32, P1047, DOI 10.1007/BF01933964; WERNER B, 1971, NATURE, V232, P582, DOI 10.1038/232582a0; Yamaguchi M., 1980, P11	58	21	21	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31277	10.1371/journal.pone.0031277	http://dx.doi.org/10.1371/journal.pone.0031277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384009	Green Accepted, Green Published, gold			2022-12-27	WOS:000302918500022
J	Sax, PE; Meyers, JL; Mugavero, M; Davis, KL				Sax, Paul E.; Meyers, Juliana L.; Mugavero, Michael; Davis, Keith L.			Adherence to Antiretroviral Treatment and Correlation with Risk of Hospitalization among Commercially Insured HIV Patients in the United States	PLOS ONE			English	Article							SINGLE-TABLET REGIMEN; INITIAL TREATMENT; MEDICATION ADHERENCE; DISOPROXIL FUMARATE; VIRAL SUPPRESSION; INHIBITOR THERAPY; SIMPLIFICATION; PROGRESSION; EFAVIRENZ; STRATEGY	Purpose: A lower daily pill burden may improve adherence to antiretroviral treatment (ART) and clinical outcomes in patients with human immunodeficiency virus (HIV). This study assessed differences in adherence using the number of pills taken per day, and evaluated how adherence correlated with hospitalization. Methodology: Commercially insured patients in the LifeLink database with an HIV diagnosis (International Classification of Diseases, 9th Revision, Clinical Modification code 042.xx) between 6/1/2006 and 12/31/2008 and receipt of a complete ART regimen were selected for inclusion. Patients were grouped according to their daily pill count and remained on ART for at least 60 days. Outcomes included adherence and rates of hospitalization. Adherence was measured as the proportion of days between the start and end of the regimen in which the patient maintained supply of all initiated ART components. Logistic regressions assessed the relationship between pills per day, adherence, and hospitalization, controlling for demographics, comorbidities, and ART-naive (vs. experienced) status. Results: 7,073 patients met the study inclusion criteria, and 33.4%, 5.8%, and 60.8% received an ART regimen comprising one, two, or three or more pills per day, respectively. Regression analysis showed patients receiving a single pill per day were significantly more likely to reach a 95% adherence threshold versus patients receiving three or more pills per day (odds ratio [OR] = 1.59; P<0.001). Regardless of the number of pills received per day, patients were over 40% less likely to have a hospitalization if they were adherent to therapy (OR = 0.57; P<0.001). Patients receiving a single pill per day were 24% less likely to have a hospitalization versus patients receiving three or more pills per day (OR = 0.76; P = 0.003). Conclusions: ART consisting of a single pill per day was associated with significantly better adherence and lower risk of hospitalization in patients with HIV compared to patients receiving three or more pills per day.	[Sax, Paul E.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Meyers, Juliana L.; Davis, Keith L.] RTI Hlth Solut, Res Triangle Pk, NC USA; [Mugavero, Michael] Univ Alabama Birmingham, Birmingham, AL USA	Harvard University; Brigham & Women's Hospital; Research Triangle Institute; University of Alabama System; University of Alabama Birmingham	Sax, PE (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	jmeyers@rti.org		Meyers, Juliana/0000-0003-2938-2957; Davis, Keith/0000-0002-0044-7107	Gilead Sciences	Gilead Sciences(Gilead Sciences)	This study was funded by Gilead Sciences. Gilead provided input on study design and analysis and reviewed the manuscript prior to submission.	Airoldi M, 2010, PATIENT PREFER ADHER, V4, P115; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; Andrews L, 2000, INFECT DIS CLIN N AM, V14, P901, DOI 10.1016/S0891-5520(05)70139-2; Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bangsberg DR, 2010, AIDS, V24, P2835, DOI 10.1097/QAD.0b013e328340a209; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; BANGSBERG DR, 2010, 17 C RETR OPP INF SA; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen C, 2010, WORLD AIDS C VIENN A; Cohen C, 2011, AIDS, V25, pF7, DOI 10.1097/QAD.0b013e328345766f; Cohen CJ, 2007, HIV CLIN TRIALS, V8, P19, DOI 10.1310/hct0801-19; Daar ES, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00316; DeJesus E, 2009, JAIDS-J ACQ IMM DEF, V51, P163, DOI 10.1097/QAI.0b013e3181a572cf; Fielden Sarah J, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P238, DOI 10.1177/1545109708323132; Hellinger FJ, 2010, PHARMACOECONOMICS, V28, P23, DOI 10.2165/11313810-000000000-00000; Hodder SL, 2010, AIDS PATIENT CARE ST, V24, P87, DOI 10.1089/apc.2009.0259; Juday T, 2011, HIV CLIN TRIALS, V12, P71, DOI 10.1310/hct1202-71; Kitahata MM, 2004, INT J STD AIDS, V15, P803, DOI 10.1258/0956462042563666; Legorreta A, 2005, AIDS CARE, V17, P938, DOI 10.1080/09540120500100692; McMahon JH, 2011, CLIN INFECT DIS, V52, P493, DOI 10.1093/cid/ciq167; Parienti JJ, 2009, CLIN INFECT DIS, V48, P484, DOI 10.1086/596482; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008	27	113	115	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31591	10.1371/journal.pone.0031591	http://dx.doi.org/10.1371/journal.pone.0031591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384040	Green Submitted, gold, Green Published			2022-12-27	WOS:000302916800017
J	Yu, TX; Chen, X; Zhang, W; Li, J; Xu, R; Wang, TC; Ai, W; Liu, CM				Yu, Tianxin; Chen, Xi; Zhang, Wen; Li, Juan; Xu, Ren; Wang, Timothy C.; Ai, Walden; Liu, Chunming			Kruppel-like Factor 4 Regulates Intestinal Epithelial Cell Morphology and Polarity	PLOS ONE			English	Article							COLORECTAL-CANCER; BETA-CATENIN; STEM-CELLS; CROSS-TALK; EXPRESSION; WNT; GENE; KRUPPEL-LIKE-FACTOR-4; IDENTIFICATION; COLON	Kruppel-like factor 4 (KLF4) is a zinc finger transcription factor that plays a vital role in regulating cell lineage differentiation during development and maintaining epithelial homeostasis in the intestine. In normal intestine, KLF4 is predominantly expressed in the differentiated epithelial cells. It has been identified as a tumor suppressor in colorectal cancer. KLF4 knockout mice demonstrated a decrease in number of goblet cells in the colon, and conditional ablation of KLF4 from the intestinal epithelium led to altered epithelial homeostasis. However, the role of KLF4 in differentiated intestinal cells and colon cancer cells, as well as the mechanism by which it regulates homeostasis and represses tumorigenesis in the intestine is not well understood. In our study, KLF4 was partially depleted in the differentiated intestinal epithelial cells by a tamoxifen-inducible Cre recombinase. We found a significant increase in the number of goblet cells in the KLF4-deleted small intestine, suggesting that KLF4 is not only required for goblet cell differentiation, but also required for maintaining goblet cell numbers through its function in inhibiting cell proliferation. The number and position of Paneth cells also changed. This is consistent with the KLF4 knockout study using villin-Cre [1]. Through immunohistochemistry (IHC) staining and statistical analysis, we found that a stem cell and/or tuft cell marker, DCAMKL1, and a proliferation marker, Ki67, are affected by KLF4 depletion, while an enteroendocrine cell marker, neurotensin (NT), was not affected. In addition, we found KLF4 depletion altered the morphology and polarity of the intestinal epithelial cells. Using a three-dimensional (3D) intestinal epithelial cyst formation assay, we found that KLF4 is essential for cell polarity and crypt-cyst formation in human colon cancer cells. These findings suggest that, as a tumor suppressor in colorectal cancer, KLF4 affects intestinal epithelial cell morphology by regulating proliferation, differentiation and polarity of the cells.	[Yu, Tianxin; Chen, Xi; Zhang, Wen; Xu, Ren; Liu, Chunming] Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40506 USA; [Yu, Tianxin] Univ Texas Med Branch, Dept Biol & Mol Biochem, Galveston, TX USA; [Li, Juan; Ai, Walden] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC USA; [Xu, Ren] Univ Kentucky, Dept Pharmacol & Toxicol, Lexington, KY USA; [Wang, Timothy C.] Columbia Univ, Dept Med, Div Digest & Liver Dis, New York, NY USA; [Wang, Timothy C.] Columbia Univ, Irving Canc Ctr, New York, NY USA; [Liu, Chunming] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY USA	University of Kentucky; University of Texas System; University of Texas Medical Branch Galveston; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Kentucky; Columbia University; Columbia University; University of Kentucky	Yu, TX (corresponding author), Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40506 USA.	cli229@uky.edu		Wang, Timothy/0000-0001-5730-3019; Xu, Ren/0000-0002-3591-9522	National Institutes of Health [R01 DK071976]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	CL was supported by R01 DK071976 from the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Chen X, 2008, ACTA BIOCH BIOPH SIN, V40, P577, DOI 10.1111/j.1745-7270.2008.00440.x; Chiambaretta F, 2004, MOL VIS, V10, P901; Cullingford TE, 2008, BBA-MOL CELL RES, V1783, P1229, DOI 10.1016/j.bbamcr.2008.03.007; Dang DT, 2001, ONCOGENE, V20, P4884, DOI 10.1038/sj.onc.1204645; Evans PM, 2010, MOL CELL BIOL, V30, P372, DOI 10.1128/MCB.00063-09; Fruman DA, 2002, P NATL ACAD SCI USA, V99, P359, DOI 10.1073/pnas.012605099; Gao N, 2010, GENE DEV, V24, P1295, DOI 10.1101/gad.1921510; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Gerbe F, 2009, GASTROENTEROLOGY, V137, P2179, DOI 10.1053/j.gastro.2009.06.072; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Ghaleb AM, 2010, DEV BIOL; Ghaleb AM, 2007, CANCER RES, V67, P7147, DOI 10.1158/0008-5472.CAN-07-1302; Ghaleb AM, 2011, DEV BIOL, V349, P310, DOI 10.1016/j.ydbio.2010.11.001; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Grainger S, 2010, DEV BIOL, V339, P155, DOI 10.1016/j.ydbio.2009.12.025; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Juan Li HZ, 2011, NEOPLASIA UNPUB; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; MAUNOURY R, 1992, DEVELOPMENT, V115, P717; May R, 2008, STEM CELLS, V26, P630, DOI 10.1634/stemcells.2007-0621; May R, 2009, STEM CELLS, V27, P2571, DOI 10.1002/stem.193; Panigada M, 1999, MECH DEVELOP, V81, P103, DOI 10.1016/S0925-4773(98)00237-8; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Pinto D, 2005, BIOL CELL, V97, P185; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Polakis P, 2000, GENE DEV, V14, P1837; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ton-That H, 1997, FEBS LETT, V419, P239, DOI 10.1016/S0014-5793(97)01465-8; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Wang QD, 2002, J BIOL CHEM, V277, P36602, DOI 10.1074/jbc.M206306200; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	41	41	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32492	10.1371/journal.pone.0032492	http://dx.doi.org/10.1371/journal.pone.0032492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384261	gold, Green Submitted, Green Published			2022-12-27	WOS:000302916800039
J	Fehlings, MG; Vaccaro, A; Wilson, JR; Singh, A; Cadotte, DW; Harrop, JS; Aarabi, B; Shaffrey, C; Dvorak, M; Fisher, C; Arnold, P; Massicotte, EM; Lewis, S; Rampersaud, R				Fehlings, Michael G.; Vaccaro, Alexander; Wilson, Jefferson R.; Singh, Anoushka; Cadotte, David W.; Harrop, James S.; Aarabi, Bizhan; Shaffrey, Christopher; Dvorak, Marcel; Fisher, Charles; Arnold, Paul; Massicotte, Eric M.; Lewis, Stephen; Rampersaud, Raja			Early versus Delayed Decompression for Traumatic Cervical Spinal Cord Injury: Results of the Surgical Timing in Acute Spinal Cord Injury Study (STASCIS)	PLOS ONE			English	Article							PHARMACOLOGICAL THERAPY; CLINICAL-TRIALS; TIME LIMITS; COMPRESSION; RECOVERY; SURGERY; STABILIZATION; METHYLPREDNISOLONE; MANAGEMENT; IMMEDIATE	Background: There is convincing preclinical evidence that early decompression in the setting of spinal cord injury (SCI) improves neurologic outcomes. However, the effect of early surgical decompression in patients with acute SCI remains uncertain. Our objective was to evaluate the relative effectiveness of early (<24 hours after injury) versus late (>= 24 hours after injury) decompressive surgery after traumatic cervical SCI. Methods: We performed a multicenter, international, prospective cohort study (Surgical Timing in Acute Spinal Cord Injury Study: STASCIS) in adults aged 16-80 with cervical SCI. Enrolment occurred between 2002 and 2009 at 6 North American centers. The primary outcome was ordinal change in ASIA Impairment Scale (AIS) grade at 6 months follow-up. Secondary outcomes included assessments of complications rates and mortality. Findings: A total of 313 patients with acute cervical SCI were enrolled. Of these, 182 underwent early surgery, at a mean of 14.2(+/- 5.4) hours, with the remaining 131 having late surgery, at a mean of 48.3(+/- 29.3) hours. Of the 222 patients with follow-up available at 6 months post injury, 19.8% of patients undergoing early surgery showed a >= 2 grade improvement in AIS compared to 8.8% in the late decompression group (OR = 2.57, 95% CI: 1.11,5.97). In the multivariate analysis, adjusted for preoperative neurological status and steroid administration, the odds of at least a 2 grade AIS improvement were 2.8 times higher amongst those who underwent early surgery as compared to those who underwent late surgery (OR = 2.83, 95% CI: 1.10,7.28). During the 30 day post injury period, there was 1 mortality in both of the surgical groups. Complications occurred in 24.2% of early surgery patients and 30.5% of late surgery patients (p = 0.21). Conclusion: Decompression prior to 24 hours after SCI can be performed safely and is associated with improved neurologic outcome, defined as at least a 2 grade AIS improvement at 6 months follow-up.	[Fehlings, Michael G.; Wilson, Jefferson R.; Singh, Anoushka; Cadotte, David W.; Massicotte, Eric M.; Lewis, Stephen; Rampersaud, Raja] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Fehlings, Michael G.; Wilson, Jefferson R.; Singh, Anoushka; Cadotte, David W.; Massicotte, Eric M.; Lewis, Stephen; Rampersaud, Raja] Univ Toronto, Dept Surg, Div Orthoped Surg, Toronto, ON, Canada; [Vaccaro, Alexander; Harrop, James S.] Thomas Jefferson Univ, Dept Neurosurg & Orthoped Surg, Div Spinal Disorders, Philadelphia, PA 19107 USA; [Aarabi, Bizhan] Univ Maryland, Dept Neurosurg, Baltimore, MD 21201 USA; [Shaffrey, Christopher] Univ Virginia, Dept Neurosurg, Charlottesville, VA USA; [Shaffrey, Christopher] Univ Virginia, Dept Orthoped Surg, Charlottesville, VA USA; [Dvorak, Marcel; Fisher, Charles] Univ British Columbia, Dept Orthoped Surg, Vancouver, BC V5Z 1M9, Canada; [Arnold, Paul] Univ Kansas, Dept Neurosurg, Kansas City, KS USA	University of Toronto; University of Toronto; Jefferson University; University System of Maryland; University of Maryland Baltimore; University of Virginia; University of Virginia; University of British Columbia; University of Kansas	Fehlings, MG (corresponding author), Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada.	michael.fehlings@uhn.on.ca		Fehlings, Michael/0000-0002-5722-6364	Krembil Foundation; Christopher and Dana Reeve Foundation; Cervical Spine Research Society; AANS/CNS Section on Disorders of the Spine and Peripheral Nerves; Rick Hansen Institute; PhDx through Medtronic Inc.	Krembil Foundation; Christopher and Dana Reeve Foundation; Cervical Spine Research Society; AANS/CNS Section on Disorders of the Spine and Peripheral Nerves; Rick Hansen Institute; PhDx through Medtronic Inc.	The authors wish to acknowledge the support of the following agencies and granting bodies who contributed to the study: Krembil Foundation; Christopher and Dana Reeve Foundation; Cervical Spine Research Society; AANS/CNS Section on Disorders of the Spine and Peripheral Nerves and the Rick Hansen Institute. The logistics of the study were supported by PhDx through an unrestricted grant to the Spine Trauma Study Group by Medtronic Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; Botel U, 1997, SPINAL CORD, V35, P420, DOI 10.1038/sj.sc.3100407; BRACKEN MB, 1984, JAMA-J AM MED ASSOC, V251, P45, DOI 10.1001/jama.251.1.45; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; BRODKEY JS, 1972, J NEUROSURG, V37, P591, DOI 10.3171/jns.1972.37.5.0591; Burns AS, 2001, SPINE, V26, pS137, DOI 10.1097/00007632-200112151-00023; Campagnolo D I, 1997, J Spinal Cord Med, V20, P331; Carlson GD, 2003, J BONE JOINT SURG AM, V85A, P86, DOI 10.2106/00004623-200301000-00014; Carlson GD, 1997, J NEUROTRAUM, V14, P951, DOI 10.1089/neu.1997.14.951; Cengiz SL, 2008, ARCH ORTHOP TRAUM SU, V128, P959, DOI 10.1007/s00402-007-0518-1; Chen L, 1997, J NEUROSURG-SPINE, V10, P3; Chipman JG, 2004, J TRAUMA, V56, P52, DOI 10.1097/01.TA.0000108630.34225.85; CLOHISY JC, 1992, SPINE, V17, pS325; Croce MA, 2001, ANN SURG, V233, P851, DOI 10.1097/00000658-200106000-00016; DELAMARTER RB, 1995, J BONE JOINT SURG AM, V77A, P1042, DOI 10.2106/00004623-199507000-00010; Dimar JR, 1999, SPINE, V24, P1623, DOI 10.1097/00007632-199908150-00002; Ditunno JF, 2004, SPINAL CORD, V42, P383, DOI 10.1038/sj.sc.3101603; DOLAN EJ, 1980, J NEUROSURG, V53, P749, DOI 10.3171/jns.1980.53.6.0749; DUH MS, 1994, NEUROSURGERY, V35, P240, DOI 10.1227/00006123-199408000-00009; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Fehlings M, CELLULAR IONIC BIOMO, P33; Fehlings MG, 1999, SPINE, V24, P605, DOI 10.1097/00007632-199903150-00023; Fehlings MG, 2010, SPINE, V35, pS166, DOI 10.1097/BRS.0b013e3181f386f6; Furlan J, 2009, J NEUROTRAUM, V27, P1; Furlan JC, 2008, J NEUROTRAUM, V25, P1273, DOI 10.1089/neu.2008.0617; Geisler F, 2001, SPINE S, V26, P87; Guest J, 2002, J NEUROSURG, V97, P25, DOI 10.3171/spi.2002.97.1.0025; GUHA A, 1987, PARAPLEGIA, V25, P324, DOI 10.1038/sc.1987.61; Hadley M, 2002, NEUROSURGERY, V50, pS58; Hadley M, 2002, NEUROSURGERY, V50, P563, DOI DOI 10.1097/00006123-200203001-00013; Hadley MN, 2002, NEUROSURGERY, V50, pS51; Kerwin AJ, 2005, J TRAUMA, V58, P15, DOI 10.1097/01.TA.0000154182.35386.7E; KOBRINE AI, 1979, J NEUROSURG, V51, P841, DOI 10.3171/jns.1979.51.6.0841; KRENGEL WF, 1993, SPINE, V18, P2080, DOI 10.1097/00007632-199310001-00027; La Rosa G, 2004, SPINAL CORD, V42, P503, DOI 10.1038/sj.sc.3101627; LEVI L, 1991, NEUROSURGERY, V29, P216, DOI 10.1227/00006123-199108000-00008; MAYNARD FM, 1979, J NEUROSURG, V50, P611, DOI 10.3171/jns.1979.50.5.0611; McKinley W, 2004, ARCH PHYS MED REHAB, V85, P1818, DOI 10.1016/j.apmr.2004.04.032; McLain RF, 1999, SPINE, V24, P1646, DOI 10.1097/00007632-199908150-00005; Mirza SK, 1999, CLIN ORTHOP RELAT R, P104, DOI 10.1097/00003086-199902000-00011; Ng W P, 1999, Neurosurg Focus, V6, pe3; NYSTROM B, 1988, ACTA NEUROL SCAND, V78, P467, DOI 10.1111/j.1600-0404.1988.tb03689.x; Papadopoulos SM, 2002, J TRAUMA, V52, P323, DOI 10.1097/00005373-200202000-00019; Pointillart V, 2000, SPINAL CORD, V38, P71, DOI 10.1038/sj.sc.3100962; Pollard ME, 2003, SPINE, V28, P33, DOI 10.1097/00007632-200301010-00009; Sapkas G S, 2007, J Orthop Surg (Hong Kong), V15, P183; Schinkel C, 2006, J TRAUMA, V61, P156, DOI 10.1097/01.ta.0000222669.09582.ec; TARLOV IM, 1954, AMA ARCH NEUROL PSY, V71, P588, DOI 10.1001/archneurpsyc.1954.02320410050004; TARLOV IM, 1954, AMA ARCH NEUROL PSY, V71, P271, DOI 10.1001/archneurpsyc.1954.02320390001001; Tator CH, 1999, J NEUROSURG, V91, P12, DOI 10.3171/spi.1999.91.1.0012; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Vaccaro AR, 1997, SPINE, V22, P2609, DOI 10.1097/00007632-199711150-00006; Waters R L, 1998, J Spinal Cord Med, V21, P195; Waters RL, 1996, SPINAL CORD, V34, P188, DOI 10.1038/sc.1996.37; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893	56	595	641	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32037	10.1371/journal.pone.0032037	http://dx.doi.org/10.1371/journal.pone.0032037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384132	gold, Green Published			2022-12-27	WOS:000302916100046
J	Tarasenko, N; Cutts, SM; Phillips, DR; Inbal, A; Nudelman, A; Kessler-Icekson, G; Rephaeli, A				Tarasenko, Nataly; Cutts, Suzanne M.; Phillips, Don R.; Inbal, Aida; Nudelman, Abraham; Kessler-Icekson, Gania; Rephaeli, Ada			Disparate Impact of Butyroyloxymethyl Diethylphosphate (AN-7), a Histone Deacetylase Inhibitor, and Doxorubicin in Mice Bearing a Mammary Tumor	PLOS ONE			English	Article							BUTYRIC-ACID; BREAST-CANCER; ANTICANCER PRODRUGS; CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD; TOPOISOMERASE-II; DNA ADDUCTS; IN-VIVO; C-KIT; EXPRESSION	The histone deacetylase inhibitor (HDACI) butyroyloxymethyl diethylphosphate (AN-7) synergizes the cytotoxic effect of doxorubicin (Dox) and anti-HER2 on mammary carcinoma cells while protecting normal cells against their insults. This study investigated the concomitant changes occurring in heart tissue and tumors of mice bearing a subcutaneous 4T1 mammary tumor following treatment with AN-7, Dox, or their combination. Dox or AN-7 alone led to inhibition of both tumor growth and lung metastases, whereas their combination significantly increased their anticancer efficacy and attenuated Doxtoxicity. Molecular analysis revealed that treatment with Dox, AN-7, and to a greater degree, AN-7 together with Dox increased tumor levels of gamma H2AX, the marker for DNA double-strand breaks and decreased the expression of Rad51, a protein needed for DNA repair. These events culminated in increased apoptosis, manifested by the appearance of cytochrome-c in the cytosol. In the myocardium, Dox-induced cardiomyopathy was associated with an increase in gamma H2AX expression and a reduction in Rad51 and MRE11 expression and increased apoptosis. The addition of AN-7 to the Dox treatment protected the heart from Dox insults as was manifested by a decrease in gamma H2AX levels, an increase in Rad51 and MRE11 expression, and a diminution of cytochrome-c release. Tumor fibrosis was high in untreated mice but diminished in Dox- and AN-7-treated mice and was almost abrogated in AN-7+Dox-treated mice. By contrast, in the myocardium, Dox alone induced a dramatic increase in fibrosis, and AN7+Dox attenuated it. The high expression levels of c-Kit, Ki-67, c-Myc, lo-FGF, and VEGF in 4T1 tumors were significantly reduced by Dox or AN-7 and further attenuated by AN-7+Dox. In the myocardium, Dox suppressed these markers, whereas AN-7+Dox restored their expression. In conclusion, the combination of AN-7 and Dox results in two beneficial effects, improved anticancer efficacy and cardioprotection.	[Tarasenko, Nataly; Inbal, Aida; Kessler-Icekson, Gania; Rephaeli, Ada] Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, Petah Tiqwa, Israel; [Tarasenko, Nataly; Inbal, Aida] Beilinson Med Ctr, Rabin Med Ctr, Thrombosis & Hemostasis Unit, Petah Tiqwa, Israel; [Cutts, Suzanne M.; Phillips, Don R.] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Nudelman, Abraham] Bar Ilan Univ, Dept Chem, Ramat Gan, Israel	Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; La Trobe University; Bar Ilan University	Tarasenko, N (corresponding author), Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, Beilinson Campus, Petah Tiqwa, Israel.	adarep@post.tau.ac.il	Cutts, Suzanne/B-2467-2012	Cutts, Suzanne/0000-0002-6055-0405	Israel Cancer Association, Israel [20092001]	Israel Cancer Association, Israel	The work was supported by Israel Cancer Association (Grant No 20092001, Israel, URL:http://ica.cancer.org.il). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashktorab H, 2009, DIGEST DIS SCI, V54, P2109, DOI 10.1007/s10620-008-0601-7; Blank-Porat D, 2007, CANCER LETT, V256, P39, DOI 10.1016/j.canlet.2007.05.011; Butt MU, 2009, J SURG RES, V156, P290, DOI 10.1016/j.jss.2009.04.012; Charpin C, 2009, BRIT J CANCER, V101, P48, DOI 10.1038/sj.bjc.6605113; Colussi C, 2010, PHARMACOL RES, V62, P3, DOI 10.1016/j.phrs.2010.02.014; Cook KL, 2010, CANCER RES, V70, P8319, DOI 10.1158/0008-5472.CAN-10-1136; Cottage CT, 2010, CIRC RES, V106, P891, DOI 10.1161/CIRCRESAHA.109.208629; Cutts SM, 2005, IUBMB LIFE, V57, P73, DOI 10.1080/15216540500079093; Cutts SM, 2001, CANCER RES, V61, P8194; De Angelis A, 2010, CIRCULATION, V121, P276, DOI 10.1161/CIRCULATIONAHA.109.895771; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Gabel Ralf, 2009, Interact Cardiovasc Thorac Surg, V9, P20, DOI 10.1510/icvts.2008.191916; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Ho CY, 2010, NEW ENGL J MED, V363, P552, DOI 10.1056/NEJMoa1002659; Jin Ke Long, 2008, J Gynecol Oncol, V19, P185, DOI 10.3802/jgo.2008.19.3.185; Kasukabe T, 1997, BRIT J CANCER, V75, P850, DOI 10.1038/bjc.1997.151; Kee HJ, 2008, CIRC RES, V103, P1259, DOI 10.1161/01.RES.0000338570.27156.84; Kessler-Icekson G, 2006, INT J BIOCHEM CELL B, V38, P358, DOI 10.1016/j.biocel.2005.10.007; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Limana F, 2011, PHARMACOL THERAPEUT, V129, P82, DOI 10.1016/j.pharmthera.2010.09.002; Lin CW, 2008, MOL CANCER THER, V7, P1195, DOI 10.1158/1535-7163.MCT-07-2199; Ling XY, 2007, CANCER RES, V67, P4210, DOI 10.1158/0008-5472.CAN-06-3629; Losordo DW, 2004, CIRCULATION, V109, P2487, DOI 10.1161/01.CIR.0000128595.79378.FA; Margosio B, 2008, INT J BIOCHEM CELL B, V40, P700, DOI 10.1016/j.biocel.2007.10.002; Mito S, 2008, HYPERTENSION, V51, P1570, DOI 10.1161/HYPERTENSIONAHA.107.102566; Nudelman A, 2005, J MED CHEM, V48, P1042, DOI 10.1021/jm049428p; Nudelman A, 2001, EUR J MED CHEM, V36, P63, DOI 10.1016/S0223-5234(00)01199-5; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Pang MY, 2010, J PHARMACOL EXP THER, V335, P266, DOI 10.1124/jpet.110.168385; Prud'homme GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013831; Rephaeli A, 2000, DRUG DEVELOP RES, V50, P379, DOI 10.1002/1098-2299(200007/08)50:3/4<379::AID-DDR20>3.0.CO;2-8; Rephaeli A, 2007, BRIT J CANCER, V96, P1667, DOI 10.1038/sj.bjc.6603781; Rephaeli A, 2006, INVEST NEW DRUG, V24, P383, DOI 10.1007/s10637-006-6213-1; Rephaeli A, 2005, INT J CANCER, V116, P226, DOI 10.1002/ijc.21030; REPHAELI A, 1991, INT J CANCER, V49, P66, DOI 10.1002/ijc.2910490113; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Rosato RR, 2004, EXPERT OPIN INV DRUG, V13, P21, DOI 10.1517/eoid.13.1.21.25283; Roussidis AE, 2007, CURR MED CHEM, V14, P735, DOI 10.2174/092986707780090963; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Swift LP, 2006, CANCER RES, V66, P4863, DOI 10.1158/0008-5472.CAN-05-3410; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Tarasenko N, 2011, INVEST NEW IN PRESS; Tarasenko N, 2008, CLIN EXP METASTAS, V25, P703, DOI 10.1007/s10585-008-9179-x; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Van den Eynden GG, 2007, HISTOPATHOLOGY, V51, P440, DOI 10.1111/j.1365-2559.2007.02761.x; Weichert W, 2009, CANCER LETT, V280, P168, DOI 10.1016/j.canlet.2008.10.047; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620	54	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31393	10.1371/journal.pone.0031393	http://dx.doi.org/10.1371/journal.pone.0031393			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384017	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916100021
J	Gomez-Pinilla, F; Ying, Z; Zhuang, YM				Gomez-Pinilla, Fernando; Ying, Zhe; Zhuang, Yumei			Brain and Spinal Cord Interaction: Protective Effects of Exercise Prior to Spinal Cord Injury	PLOS ONE			English	Article							SYNAPTIC-PLASTICITY; NEUROTROPHIC FACTOR; NERVOUS-SYSTEM; BDNF; EXPRESSION; PROTEIN; GROWTH; RATS; RECOVERY; NT-3	We have investigated the effects of a spinal cord injury on the brain and spinal cord, and whether exercise provided before the injury could organize a protective reaction across the neuroaxis. Animals were exposed to 21 days of voluntary exercise, followed by a full spinal transection (T7-T9) and sacrificed two days later. Here we show that the effects of spinal cord injury go beyond the spinal cord itself and influence the molecular substrates of synaptic plasticity and learning in the brain. The injury reduced BDNF levels in the hippocampus in conjunction with the activated forms of p-synapsin I, p-CREB and p-CaMK II, while exercise prior to injury prevented these reductions. Similar effects of the injury were observed in the lumbar enlargement region of the spinal cord, where exercise prevented the reductions in BDNF, and p-CREB. Furthermore, the response of the hippocampus to the spinal lesion appeared to be coordinated to that of the spinal cord, as evidenced by corresponding injury-related changes in BDNF levels in the brain and spinal cord. These results provide an indication for the increased vulnerability of brain centers after spinal cord injury. These findings also imply that the level of chronic activity prior to a spinal cord injury could determine the level of sensory-motor and cognitive recovery following the injury. In particular, exercise prior to the injury onset appears to foster protective mechanisms in the brain and spinal cord.	[Gomez-Pinilla, Fernando; Ying, Zhe] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA; [Gomez-Pinilla, Fernando; Zhuang, Yumei] Univ Calif Los Angeles, Dept Neurosurg, UCLA Brain Injury Res Ctr, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA.	fgomezpi@ucla.edu			National Institutes of Health [R01 NS056413]; Craig H. Neilsen Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050465, R01NS056413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Craig H. Neilsen Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health award R01 NS056413 and the Craig H. Neilsen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Anderson CJ, 2009, DEV MED CHILD NEUROL, V51, P826, DOI 10.1111/j.1469-8749.2009.03268.x; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BROCK TO, 1987, J NEUROSCI, V7, P931; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fumagalli F, 2009, NEUROSCIENCE, V159, P936, DOI 10.1016/j.neuroscience.2009.01.030; Ghiani CA, 2007, GLIA, V55, P966, DOI 10.1002/glia.20521; Gomez-Pinilla F, 2007, NEUROSCIENCE, V148, P893, DOI 10.1016/j.neuroscience.2007.05.051; Gomez-Pinilla F, 2002, J NEUROPHYSIOL, V88, P2187, DOI 10.1152/jn.00152.2002; Gomez-Pinilla F, 2004, J NEUROPHYSIOL, V92, P3423, DOI 10.1152/jn.00432.2004; Gomez-Pinilla F, 2001, EUR J NEUROSCI, V13, P1078, DOI 10.1046/j.0953-816x.2001.01484.x; Hutchinson KJ, 2004, BRAIN, V127, P1403, DOI 10.1093/brain/awh160; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Lau BYB, 2011, EXP NEUROL, V228, P283, DOI 10.1016/j.expneurol.2011.02.003; Molteni R, 2004, NEUROSCIENCE, V123, P429, DOI 10.1016/j.neuroscience.2003.09.020; Oestreicher AB, 1997, PROG NEUROBIOL, V53, P627, DOI 10.1016/S0301-0082(97)00043-9; Routtenberg A, 2000, P NATL ACAD SCI USA, V97, P7657, DOI 10.1073/pnas.97.13.7657; Seebach BS, 1999, J NEUROPHYSIOL, V81, P2398, DOI 10.1152/jn.1999.81.5.2398; Smith CM, 2011, NEUROBIOL DIS, V43, P52, DOI 10.1016/j.nbd.2010.09.014; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Wu AG, 2011, NEUROREHAB NEURAL RE, V25, P332, DOI 10.1177/1545968310397706; Ying Z, 2008, NEUROSCIENCE, V155, P1070, DOI 10.1016/j.neuroscience.2008.06.057	25	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32298	10.1371/journal.pone.0032298	http://dx.doi.org/10.1371/journal.pone.0032298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384207	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500092
J	Matsumoto, M; Ishige, A; Yazawa, Y; Kondo, M; Muramatsu, K; Watanabe, K				Matsumoto, Mitsuharu; Ishige, Atsushi; Yazawa, Yuka; Kondo, Manami; Muramatsu, Koji; Watanabe, Kenji			Promotion of Intestinal Peristalsis by Bifidobacterium spp. Capable of Hydrolysing Sennosides in Mice	PLOS ONE			English	Article							FECAL MICROBIOTA; UNITED-STATES; CONSTIPATION; METABOLISM; BACTERIA; PREVALENCE; MICROFLORA; LKM512; FLORA; RAT	Background: While there are a variety of identifiable causes of constipation, even idiopathic constipation has different possible mechanisms. Sennosides, the main laxative constituents of Daio, an ancient Kampo medicine, are prodrugs that are converted to an active principle, rheinanthrone, by intestinal microbiota. In this study, we aimed to determine the sennoside hydrolysis ability of lactic acid bacterial strains and bifidobacteria in the intestine and to investigate their effect on intestinal peristalsis in mice. Methodology/Principal Findings: A total of 88 lactic acid bacterial strains and 47 bifidobacterial strains were evaluated for their ability to hydrolyze sennosides. Our results revealed that 4 strains, all belonging to the genus Bifidobacterium, had strong sennoside hydrolysis ability, exhibiting a decrease of >70% of sennoside content. By thin-layer chromatography analysis, rheinanthrone was detected in the medium cultured with B. pseudocatenulatum LKM10070 and B. animalis subsp. lactis LKM512. The fecal sennoside contents significantly (P<0.001) decreased upon oral administration of these strains as compared with the control. Intestinal peristalsis activity was measured by the moved distance of the charcoal powder administered orally. The distance travelled by the charcoal powder in LKM512-treated mice was significantly longer than that of control (P<0.05). Intestinal microbiota were analysed by real-time PCR and terminal-restriction fragment length polymorphism. The diversity of the intestinal microbiota was reduced by kanamycin treatment and the diversity was not recovered by LKM512 treatment. Conclusion/Significance: We demonstrated that intestinal peristalsis was promoted by rheinanthrone produced by hydrolysis of sennoside by strain LKM512 and LKM10070.	[Matsumoto, Mitsuharu; Muramatsu, Koji] Kyodo Milk Ind Co Ltd, Dairy Sci & Technol Inst, Tokyo, Japan; [Ishige, Atsushi] Yokohama Coll Pharm, Sch Pharm, Lab Kampo Pharmacol, Yokohama, Kanagawa, Japan; [Yazawa, Yuka; Kondo, Manami] Kyodo Milk Ind Co Ltd, Analyt Res Ctr, Tokyo, Japan; [Watanabe, Kenji] Keio Univ, Sch Med, Ctr Kampo Med, Shinjuku Ku, Tokyo, Japan	Keio University	Matsumoto, M (corresponding author), Kyodo Milk Ind Co Ltd, Dairy Sci & Technol Inst, Hinode Machi, Tokyo, Japan.	m-matumoto@meito.co.jp	Matsumoto, Mitsuharu/AHB-4023-2022	Matsumoto, Mitsuharu/0000-0002-0378-3077	Kyodo Milk Industry Co. Ltd.	Kyodo Milk Industry Co. Ltd.	This work was funded by Kyodo Milk Industry Co. Ltd. M. Matsumoto, Y. Yazawa, M. Kondo, and K. Muramatsu are employees of Kyodo Milk Industry Co. Ltd. The funder therefore had a role in study design, data analysis, preparation of the manuscript, and decision to publish the manuscript.	AKAO T, 1994, APPL ENVIRON MICROB, V60, P1041, DOI 10.1128/AEM.60.3.1041-1043.1994; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; DREESSEN M, 1981, J PHARM PHARMACOL, V33, P679, DOI 10.1111/j.2042-7158.1981.tb13903.x; DREESSEN M, 1982, PHARM ACTA HELV, V57, P350; DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1569, DOI 10.1007/BF01303162; Ford AC, 2011, GUT, V60, P209, DOI 10.1136/gut.2010.227132; Foxx-Orenstein AE, 2008, CLEV CLIN J MED, V75, P813, DOI 10.3949/ccjm.75.11.813; HARDCASTLE JD, 1970, GUT, V11, P1038, DOI 10.1136/gut.11.12.1038; HATTORI M, 1982, CHEM PHARM BULL, V30, P1338; HATTORI M, 1988, PHARMACOLOGY, V36, P172, DOI 10.1159/000138437; KOBASHI K, 1980, PLANTA MED, V40, P225, DOI 10.1055/s-2008-1074963; Kozaki M, 1992, EXPT MANUAL LACTIC A, P6; LEMLI J, 1980, PHARMACOLOGY, V20, P50, DOI 10.1159/000137398; LEMLI J, 1988, PHARMACOLOGY, V36, P126, DOI 10.1159/000138431; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; Matsumoto M, 2004, INT J FOOD MICROBIOL, V93, P109, DOI 10.1016/j.ijfoodmicro.2003.10.009; Matsumoto M, 2002, CURR MICROBIOL, V44, P212, DOI 10.1007/s00284-001-0087-4; Matsumoto M, 2001, J INTESTINAL MICROBI, V14, P97; Matsumoto M, 2009, MICROBIOL IMMUNOL, V53, P421, DOI 10.1111/j.1348-0421.2009.00140.x; Stewart WF, 1999, AM J GASTROENTEROL, V94, P3530, DOI 10.1111/j.1572-0241.1999.01642.x; Tada T, 1996, CELL IMMUNOL, V173, P155, DOI 10.1006/cimm.1996.0261; TALLEY NJ, 1993, GASTROENTEROLOGY, V105, P781, DOI 10.1016/0016-5085(93)90896-K; Wald A, 2008, ALIMENT PHARM THER, V28, P917, DOI 10.1111/j.1365-2036.2008.03806.x; Walter S, 2002, SCAND J GASTROENTERO, V37, P911, DOI 10.1080/003655202760230865; ZWAVING JH, 1980, PHARMACOLOGY, V20, P65, DOI 10.1159/000137400	25	39	47	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31700	10.1371/journal.pone.0031700	http://dx.doi.org/10.1371/journal.pone.0031700			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384059	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500036
J	Chuquimia, OD; Petursdottir, DH; Rahman, MJ; Hartl, K; Singh, M; Fernandez, C				Chuquimia, Olga D.; Petursdottir, Dagbjort H.; Rahman, Muhammad J.; Hartl, Katharina; Singh, Mahavir; Fernandez, Carmen			The Role of Alveolar Epithelial Cells in Initiating and Shaping Pulmonary Immune Responses: Communication between Innate and Adaptive Immune Systems	PLOS ONE			English	Article							MACROPHAGE-INFLAMMATORY PROTEIN-2; MYCOBACTERIUM-TUBERCULOSIS; PRIMARY CULTURE; II CELLS; ANTIGEN; EXPRESSION; KC; MATRIX-METALLOPROTEINASE-9; CHEMOKINES; TOLERANCE	Macrophages and dendritic cells have been recognized as key players in the defense against mycobacterial infection. However, more recently, other cells in the lungs such as alveolar epithelial cells (AEC) have been found to play important roles in the defense and pathogenesis of infection. In the present study we first compared AEC with pulmonary macrophages (PuM) isolated from mice in their ability to internalize and control Bacillus Calmette-Guerin (BCG) growth and their capacity as APCs. AEC were able to internalize and control bacterial growth as well as present antigen to primed T cells. Secondly, we compared both cell types in their capacity to secrete cytokines and chemokines upon stimulation with various molecules including mycobacterial products. Activated PuM and AEC displayed different patterns of secretion. Finally, we analyzed the profile of response of AEC to diverse stimuli. AEC responded to both microbial and internal stimuli exemplified by TLR ligands and IFNs, respectively. The response included synthesis by AEC of several factors, known to have various effects in other cells. Interestingly, TNF could stimulate the production of CCL2/MCP-1. Since MCP-1 plays a role in the recruitment of monocytes and macrophages to sites of infection and macrophages are the main producers of TNF, we speculate that both cell types can stimulate each other. Also, another cell-cell interaction was suggested when IFNs (produced mainly by lymphocytes) were able to induce expression of chemokines (IP-10 and RANTES) by AEC involved in the recruitment of circulating lymphocytes to areas of injury, inflammation, or viral infection. In the current paper we confirm previous data on the capacity of AEC regarding internalization of mycobacteria and their role as APC, and extend the knowledge of AEC as a multifunctional cell type by assessing the secretion of a broad array of factors in response to several different types of stimuli.	[Chuquimia, Olga D.; Petursdottir, Dagbjort H.; Rahman, Muhammad J.; Hartl, Katharina; Fernandez, Carmen] Stockholm Univ, Dept Immunol, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Singh, Mahavir] Lionex Diagnost & Therapeut GmbH, Braunschweig, Germany	Stockholm University; Lionex Diagnostics & Therapeutics GmbH	Chuquimia, OD (corresponding author), Stockholm Univ, Dept Immunol, Wenner Gren Inst, S-10691 Stockholm, Sweden.	olga.flores@imun.su.se			European Commission [HEALTH-F3-2008-200732]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grant FP7 (HEALTH-F3-2008-200732) from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; Bousquet J., 2007, GLOBAL SURVEILLANCE, P146; CASTRANOVA V, 1988, TOXICOL APPL PHARM, V93, P472, DOI 10.1016/0041-008X(88)90051-8; Corbiere V, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-15; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; Debbabi H, 2005, AM J PHYSIOL-LUNG C, V289, pL274, DOI 10.1152/ajplung.00004.2005; deMello DE, 2000, IN VITRO CELL DEV-AN, V36, P374; Dobbs LG, 2010, CELL PHYSIOL BIOCHEM, V25, P55, DOI 10.1159/000272063; Elkington PT, 2007, AM J RESP CELL MOL, V37, P431, DOI 10.1165/rcmb.2007-0011OC; FREVERT CW, 1995, J IMMUNOL, V154, P335; Fuchs S, 2003, CELL TISSUE RES, V311, P31, DOI 10.1007/s00441-002-0653-5; Gereke M, 2009, AM J RESP CRIT CARE, V179, P344, DOI 10.1164/rccm.200804-592OC; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; HUANG S, 1992, AM J PATHOL, V141, P981; Humphreys IR, 2006, MICROBES INFECT, V8, P1339, DOI 10.1016/j.micinf.2005.12.023; Johnson MD, 2002, P NATL ACAD SCI USA, V99, P1966, DOI 10.1073/pnas.042689399; Kaufmann SHE, 2005, J EXP MED, V201, P1693, DOI 10.1084/jem.20050842; Li Q, 2003, INFECT IMMUN, V71, P4873, DOI 10.1128/IAI.71.9.4873-4882.2003; Lin YG, 1998, INFECT IMMUN, V66, P1121, DOI 10.1128/IAI.66.3.1121-1126.1998; Lo B, 2008, J IMMUNOL, V180, P881, DOI 10.4049/jimmunol.180.2.881; Marsh LM, 2009, AM J PHYSIOL-LUNG C, V296, pL442, DOI 10.1152/ajplung.00525.2007; Mio T, 1997, AM J RESP CRIT CARE, V155, P1770, DOI 10.1164/ajrccm.155.5.9154890; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Power CA, 1998, INFECT IMMUN, V66, P5743, DOI 10.1128/IAI.66.12.5743-5750.1998; Raviglione MC, 2003, TUBERCULOSIS, V83, P4, DOI 10.1016/S1472-9792(02)00071-9; RISHI AK, 1995, DEV BIOL, V167, P294, DOI 10.1006/dbio.1995.1024; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Salik E, 1999, AM J RESP CELL MOL, V21, P365, DOI 10.1165/ajrcmb.21.3.3529; Shibata T, 2006, J LEUKOCYTE BIOL, V80, P744, DOI 10.1189/jlb.0106012; Srivastava V, 2007, MICROBIOL-SGM, V153, P659, DOI 10.1099/mic.0.2006/000547-0; Taylor JL, 2006, INFECT IMMUN, V74, P6135, DOI 10.1128/IAI.02048-05; Thorley AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021827; Vanderbilt JN, 2003, AM J RESP CELL MOL, V29, P661, DOI 10.1165/rcmb.2002-0227OC; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Wickremasinghe MI, 1999, J IMMUNOL, V163, P3936; Williams MC, 2003, ANNU REV PHYSIOL, V65, P669, DOI 10.1146/annurev.physiol.65.092101.142446; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931	40	60	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32125	10.1371/journal.pone.0032125	http://dx.doi.org/10.1371/journal.pone.0032125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393384	gold, Green Published, Green Submitted			2022-12-27	WOS:000303003500037
J	Clark, JS; Soltoff, BD; Powell, AS; Read, QD				Clark, James S.; Soltoff, Benjamin D.; Powell, Amanda S.; Read, Quentin D.			Evidence from Individual Inference for High-Dimensional Coexistence: Long-Term Experiments on Recruitment Response	PLOS ONE			English	Article							CLIMATE-CHANGE VULNERABILITY; CANOPY GAPS; GROWTH-RESPONSES; FOREST RESPONSE; LIGHT GRADIENT; NEW-ENGLAND; TREE; COMPETITION; BIODIVERSITY; PERFORMANCE	Background: For competing species to coexist, individuals must compete more with others of the same species than with those of other species. Ecologists search for tradeoffs in how species might partition the environment. The negative correlations among competing species that would be indicative of tradeoffs are rarely observed. A recent analysis showed that evidence for partitioning the environment is available when responses are disaggregated to the individual scale, in terms of the covariance structure of responses to environmental variation. That study did not relate that variation to the variables to which individuals were responding. To understand how this pattern of variation is related to niche variables, we analyzed responses to canopy gaps, long viewed as a key variable responsible for species coexistence. Methodology/Principal Findings: A longitudinal intervention analysis of individual responses to experimental canopy gaps with 12 yr of pre-treatment and 8 yr post-treatment responses showed that species-level responses are positively correlated - species that grow fast on average in the understory also grow fast on average in response to gap formation. In other words, there is no tradeoff. However, the joint distribution of individual responses to understory and gap showed a negative correlation - species having individuals that respond most to gaps when previously growing slowly also have individuals that respond least to gaps when previously growing rapidly (e.g., Morus rubra), and vice versa (e.g., Quercus prinus). Conclusions/Significance: Because competition occurs at the individual scale, not the species scale, aggregated species-level parameters and correlations hide the species-level differences needed for coexistence. By disaggregating models to the scale at which the interaction occurs we show that individual variation provides insight for species differences.	[Clark, James S.; Soltoff, Benjamin D.; Powell, Amanda S.; Read, Quentin D.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Clark, James S.] Duke Univ, Dept Biol, Durham, NC USA; [Clark, James S.] Duke Univ, Dept Stat Sci, Durham, NC USA	Duke University; Duke University; Duke University	Clark, JS (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	jimclark@duke.edu			National Science Foundation [DDDAS0540347, SEII0430693, DEB0425465]; Direct For Biological Sciences [0955904, 1137309, 1137364] Funding Source: National Science Foundation; Division of Computing and Communication Foundations [0940671] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This study was funded by National Science Foundation grants DDDAS0540347, SEII0430693, DEB0425465, and the Coweeta LTER, which supported field work and analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2010, ECOL LETT, V13, P1019, DOI 10.1111/j.1461-0248.2010.01496.x; Angert AL, 2009, P NATL ACAD SCI USA, V106, P11641, DOI 10.1073/pnas.0904512106; Ashton MS, 1996, FOREST ECOL MANAG, V80, P81, DOI 10.1016/0378-1127(95)03636-9; Baltzer JL, 2007, J ECOL, V95, P1208, DOI 10.1111/j.1365-2745.2007.01286.x; Baraloto C, 2005, ECOLOGY, V86, P2461, DOI 10.1890/04-1956; Beckage B, 2000, CAN J FOREST RES, V30, P1617, DOI 10.1139/cjfr-30-10-1617; BICKEL PJ, 1975, SCIENCE, V187, P398, DOI 10.1126/science.187.4175.398; Chase J.M., 2009, ECOLOGICAL NICHES LI; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; Clark J. S, 2007, MODELS ECOLOGICAL DA; Clark JS, 2007, ECOL APPL, V17, P1942, DOI 10.1890/06-1039.1; Clark JS, 2012, PHILOS T R SOC B, V367, P236, DOI 10.1098/rstb.2011.0183; Clark JS, 2011, ECOL LETT, V14, P1273, DOI 10.1111/j.1461-0248.2011.01685.x; Clark JS, 2011, GLOBAL CHANGE BIOL, V17, P1834, DOI 10.1111/j.1365-2486.2010.02380.x; Clark JS, 2010, ECOL MONOGR, V80, P569, DOI 10.1890/09-1541.1; Clark JS, 2010, SCIENCE, V327, P1129, DOI 10.1126/science.1183506; Cooper-Ellis S, 1999, ECOLOGY, V80, P2683, DOI 10.1890/0012-9658(1999)080[2683:FRTCWR]2.0.CO;2; Dalling JW, 2004, FUNCT ECOL, V18, P725, DOI 10.1111/j.0269-8463.2004.00868.x; Dietze MC, 2008, ECOL MONOGR, V78, P331, DOI 10.1890/07-0271.1; Freedman D. A., 1998, J AM STAT ASSOC, V93, P1518, DOI DOI 10.2307/2670067; Hart JL, 2009, PLANT ECOL, V201, P131, DOI 10.1007/s11258-008-9488-9; HASTINGS A, 1980, THEOR POPUL BIOL, V18, P363, DOI 10.1016/0040-5809(80)90059-3; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; King G., 1997, SOLUTION ECOLOGICAL; Kinzig AP, 1999, AM NAT, V153, P371, DOI 10.1086/303182; Kobe RK, 1999, ECOLOGY, V80, P187, DOI 10.1890/0012-9658(1999)080[0187:LGPATT]2.0.CO;2; LATHAM RE, 1992, ECOLOGY, V73, P2129, DOI 10.2307/1941461; Mouquet N, 2002, ECOL LETT, V5, P56, DOI 10.1046/j.1461-0248.2002.00281.x; Palow DT, 2009, PLANT SOIL, V319, P25, DOI 10.1007/s11104-008-9846-3; Pedersen BS, 2004, FOREST ECOL MANAG, V196, P351, DOI 10.1016/j.foreco.2004.03.031; Poorter L, 1999, FUNCT ECOL, V13, P396, DOI 10.1046/j.1365-2435.1999.00332.x; Portsmuth A, 2007, FUNCT ECOL, V21, P61, DOI 10.1111/j.1365-2435.2006.01208.x; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238; SIPE TW, 1995, ECOLOGY, V76, P1587, DOI 10.2307/1938160; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D., 1982, Monographs in Population Biology, pi; Turnbull LA, 1999, J ECOL, V87, P899, DOI 10.1046/j.1365-2745.1999.00405.x; Valladares F, 2000, ECOLOGY, V81, P1925, DOI 10.1890/0012-9658(2000)081[1925:PPRTLO]2.0.CO;2; Wakefield J., 2005, BIOSTATISTICS, V1, P1; Wilder CM, 1999, AM MIDL NAT, V142, P201, DOI 10.1674/0003-0031(1999)142[0201:SSDAGI]2.0.CO;2; Yamamoto S.I., 2000, J FORESTRY RES, V5, P223, DOI DOI 10.1007/BF02767114	44	8	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e30050	10.1371/journal.pone.0030050	http://dx.doi.org/10.1371/journal.pone.0030050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393349	Green Published, gold			2022-12-27	WOS:000303003500002
J	Kimura-Kuroda, J; Komuta, Y; Kuroda, Y; Hayashi, M; Kawano, H				Kimura-Kuroda, Junko; Komuta, Yukari; Kuroda, Yoichiro; Hayashi, Masaharu; Kawano, Hitoshi			Nicotine-Like Effects of the Neonicotinoid Insecticides Acetamiprid and Imidacloprid on Cerebellar Neurons from Neonatal Rats	PLOS ONE			English	Article							ADOLESCENT FEMALE RATS; ACETYLCHOLINE-RECEPTOR; GRANULE CELLS; MESSENGER-RNA; IN-UTERO; ELECTRONEGATIVE PHARMACOPHORE; INTESTINAL-ABSORPTION; MATERNAL SMOKING; DIVERSE ACTIONS; NERVOUS-SYSTEM	Background: Acetamiprid (ACE) and imidacloprid (IMI) belong to a new, widely used class of pesticide, the neonicotinoids. With similar chemical structures to nicotine, neonicotinoids also share agonist activity at nicotinic acetylcholine receptors (nAChRs). Although their toxicities against insects are well established, their precise effects on mammalian nAChRs remain to be elucidated. Because of the importance of nAChRs for mammalian brain function, especially brain development, detailed investigation of the neonicotinoids is needed to protect the health of human children. We aimed to determine the effects of neonicotinoids on the nAChRs of developing mammalian neurons and compare their effects with nicotine, a neurotoxin of brain development. Methodology/Principal Findings: Primary cultures of cerebellar neurons from neonatal rats allow for examinations of the developmental neurotoxicity of chemicals because the various stages of neurodevelopment-including proliferation, migration, differentiation, and morphological and functional maturation-can be observed in vitro. Using these cultures, an excitatory Ca2+-influx assay was employed as an indicator of neural physiological activity. Significant excitatory Ca2+ influxes were evoked by ACE, IMI, and nicotine at concentrations greater than 1 mu M in small neurons in cerebellar cultures that expressed the mRNA of the alpha 3, alpha 4, and alpha 7 nAChR subunits. The firing patterns, proportion of excited neurons, and peak excitatory Ca2+ influxes induced by ACE and IMI showed differences from those induced by nicotine. However, ACE and IMI had greater effects on mammalian neurons than those previously reported in binding assay studies. Furthermore, the effects of the neonicotinoids were significantly inhibited by the nAChR antagonists mecamylamine, alpha-bungarotoxin, and dihydro-beta-erythroidine. Conclusions/Significance: This study is the first to show that ACE, IMI, and nicotine exert similar excitatory effects on mammalian nAChRs at concentrations greater than 1 mu M. Therefore, the neonicotinoids may adversely affect human health, especially the developing brain.	[Kimura-Kuroda, Junko; Komuta, Yukari; Kuroda, Yoichiro; Hayashi, Masaharu; Kawano, Hitoshi] Tokyo Metropolitan Inst Med Sci, Dept Brain Dev & Neural Regenerat, Setagaya City, Tokyo, Japan	Tokyo Metropolitan Institute of Medical Science	Kimura-Kuroda, J (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Brain Dev & Neural Regenerat, Setagaya City, Tokyo, Japan.	kuroda-jk@igakuken.or.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21510075]; Grants-in-Aid for Scientific Research [23500422] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21510075). http://www.jsps.go.jp/english/e-grants/grants.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Donia MB, 2008, J TOXICOL ENV HEAL A, V71, P119, DOI 10.1080/15287390701613140; Agulhon C, 1998, MOL BRAIN RES, V58, P123, DOI 10.1016/S0169-328X(98)00113-2; Bal R, 2010, NEUROTOXICOLOGY, V31, P113, DOI 10.1016/j.neuro.2009.10.004; Brunet JL, 2008, J ENVIRON SCI HEAL B, V43, P261, DOI 10.1080/03601230701771446; Brunet JL, 2004, TOXICOL APPL PHARM, V194, P1, DOI 10.1016/j.taap.2003.08.018; Cao JR, 2011, INT J NEUROPSYCHOPH, V14, P157, DOI 10.1017/S1461145710000179; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; DIDIER M, 1995, MOL BRAIN RES, V30, P17, DOI 10.1016/0169-328X(94)00266-H; Dwyer JB, 2009, PHARMACOL THERAPEUT, V122, P125, DOI 10.1016/j.pharmthera.2009.02.003; Eugenin J, 2008, J NEUROSCI, V28, P13907, DOI 10.1523/JNEUROSCI.4441-08.2008; Ford KA, 2006, CHEM RES TOXICOL, V19, P944, DOI 10.1021/tx0600696; Fu P, 2006, J AM SOC NEPHROL, V17, P3105, DOI 10.1681/ASN.2005121366; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Hogberg HT, 2010, TOXICOL SCI, V113, P95, DOI 10.1093/toxsci/kfp175; Huang LZ, 2007, NEUROSCIENCE, V146, P1854, DOI 10.1016/j.neuroscience.2007.03.008; Kawa K, 2002, J PHYSIOL-LONDON, V538, P87, DOI 10.1113/jphysiol.2001.012885; Kimura-Kuroda J, 2002, DEV BRAIN RES, V137, P55, DOI 10.1016/S0165-3806(02)00408-X; Lacinova L, 2005, GEN PHYSIOL BIOPHYS, V24, P3; Li P, 2011, J NEUROSCI RES, V89, P1295, DOI 10.1002/jnr.22644; de Oliveira IM, 2010, TOXICOL LETT, V192, P294, DOI 10.1016/j.toxlet.2009.11.005; Mao C, 2007, BRAZ J MED BIOL RES, V40, P735, DOI 10.1590/S0100-879X2007000500019; Mao CP, 2008, BRAIN RES, V1189, P43, DOI 10.1016/j.brainres.2007.10.089; Marchi M, 1999, NEUROCHEM INT, V34, P319, DOI 10.1016/S0197-0186(99)00015-7; Masgrau R, 2000, J NEUROCHEM, V74, P818, DOI 10.1046/j.1471-4159.2000.740818.x; Matsuda K, 2005, BIOSCI BIOTECH BIOCH, V69, P1442, DOI 10.1271/bbb.69.1442; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; Matsuda K, 2009, MOL PHARMACOL, V76, P1, DOI 10.1124/mol.109.055186; Moccia F, 2004, AM J PHYSIOL-HEART C, V286, pH486, DOI 10.1152/ajpheart.00620.2003; Moser N, 2007, J NEUROCHEM, V102, P479, DOI 10.1111/j.1471-4159.2007.04498.x; Nagata I, 2006, J COMP NEUROL, V499, P274, DOI 10.1002/cne.21102; Nagata K, 1998, J PHARMACOL EXP THER, V285, P731; Neuman RJ, 2007, BIOL PSYCHIAT, V61, P1320, DOI 10.1016/j.biopsych.2006.08.049; Oikawa H, 2005, J NEUROSCI RES, V79, P535, DOI 10.1002/jnr.20398; POCOCK JM, 1995, NEUROSCIENCE, V67, P595, DOI 10.1016/0306-4522(95)00061-M; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Rodrigues KJA, 2010, ECOTOX ENVIRON SAFE, V73, P101, DOI 10.1016/j.ecoenv.2009.04.021; Role LW, 1996, NEURON, V16, P1077, DOI 10.1016/S0896-6273(00)80134-8; Sampaio LFS, 2005, BRAZ J MED BIOL RES, V38, P603, DOI 10.1590/S0100-879X2005000400015; Shen JX, 2009, ACTA PHARMACOL SIN, V30, P673, DOI 10.1038/aps.2009.64; Shim JY, 2009, BIOPHYS J, V96, P3251, DOI 10.1016/j.bpj.2008.12.3934; Slikker W, 2005, CRIT REV TOXICOL, V35, P703, DOI 10.1080/10408440591007421; Takeda Yasuo, 2001, Keio Journal of Medicine, V50, P240; Talley TT, 2008, P NATL ACAD SCI USA, V105, P7606, DOI 10.1073/pnas.0802197105; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Tomizawa M, 1999, BRIT J PHARMACOL, V127, P115, DOI 10.1038/sj.bjp.0702526; Tomizawa M, 2003, BIOCHEMISTRY-US, V42, P7819, DOI 10.1021/bi0300130; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Ward C, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-81; Wei JX, 2011, INT J NEUROPSYCHOPH, V14, P91, DOI 10.1017/S1461145710000416; Winzer-Serhan UH, 2008, FRONT BIOSCI-LANDMRK, V13, P636, DOI 10.2741/2708; Wu J, 2006, J PHYSIOL-LONDON, V576, P103, DOI 10.1113/jphysiol.2006.114645; Zhang X, 1998, INT J DEV NEUROSCI, V16, P507, DOI 10.1016/S0736-5748(98)00044-6	52	157	168	7	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32432	10.1371/journal.pone.0032432	http://dx.doi.org/10.1371/journal.pone.0032432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393406	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500059
J	Cai, Y; Wang, JH; Ren, CX; Ittmann, M				Cai, Yi; Wang, Jianghua; Ren, Chengxi; Ittmann, Michael			Frequent Heterogeneous Missense Mutations of GGAP2 in Prostate Cancer: Implications for Tumor Biology, Clonality and Mutation Analysis	PLOS ONE			English	Article							PROGRESSION; PATHWAYS; AKT; P53; ADENOCARCINOMAS; INVASION; GTPASE; GROWTH; GENES	Prostate cancer is the most common visceral malignancy in Western men and a major cause of cancer deaths. Increased activation of the AKT and NFkB pathways have been identified as critical steps in prostate cancer initiation and progression. GGAP2 (GTP-binding and GTPase activating protein 2) is a multidomain protein that contains an N-terminal Ras homology domain (GTPase), followed by a PH domain, a C-terminal GAP domain and an ankyrin repeat domain. GGAP2 can directly activate signaling via both the AKT and NFkB pathways and acts as a node of crosstalk between these pathways. Increased GGAP2 expression is present in three quarters of prostate cancers. Mutations of GGAP2 have been reported in cell lines from other malignancies. We therefore analyzed 84 prostate cancer tissues and 43 benign prostate tissues for somatic mutations in GGAP2 by direct sequencing of individual clones derived from the GAP and GTPase domains of normal and tumor tissue. Overall, half of cancers contained mutant GAP domain clones and in 20% of cancers, 30% or more of clones were mutant in the GAP domain. Surprisingly, the mutations were heterogeneous and nonclonal, with multiple different mutations being present in many tumors. Similar findings were observed in the analysis of the GTPase domain. Mutant GGAP2 proteins had significantly higher transcriptional activity using AP-1 responsive reporter constructs when compared to wild-type protein. Furthermore, the presence of these mutations was associated with aggressive clinical behavior. The presence of high frequency nonclonal mutations of a single gene is novel and represents a new mode of genetic alteration that can promote tumor progression. Analysis of mutations in cancer has been used to predict outcome and guide therapeutic target identification but such analysis has focused on clonal mutations. Our studies indicate that in some cases high frequency nonclonal mutations may need to be assessed as well.	[Cai, Yi; Wang, Jianghua; Ren, Chengxi; Ittmann, Michael] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Cai, Yi; Wang, Jianghua; Ren, Chengxi; Ittmann, Michael] Michael E DeBakey Dept Vet Affairs, Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine	Cai, Y (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	mittmann@bcm.tmc.edu			Department of Defense [W81XWH-07-1-0023, W81 WH-07-01-0220]; National Cancer Institute [P30CA125123]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for MI was made possible via Department of Defense Prostate Cancer Research program (W81XWH-07-1-0023; http://cdmrp.army.mil), the National Cancer Institute to the Dan L. Duncan Cancer Center (P30CA125123; www.nih.gov) and by the use of the facilities of the Michael E. DeBakey Department of Veterans Affairs Medical Center (www.houston.va.gov). Support for YC was made possible via Department of Defense Prostate Cancer Research program (W81 WH-07-01-0220; http://cdmrp.army.mil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2004, J BIOL CHEM, V279, P16441, DOI 10.1074/jbc.M312175200; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Cai Y, 2009, CANCER RES, V69, P819, DOI 10.1158/0008-5472.CAN-08-2537; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dong JT, 2006, J CELL BIOCHEM, V97, P433, DOI 10.1002/jcb.20696; Hu YX, 2005, P NATL ACAD SCI USA, V102, P16853, DOI 10.1073/pnas.0507365102; ITTMANN M, 1994, AM J PATHOL, V145, P287; Liu X, 2007, ONCOGENE, V26, P4918, DOI 10.1038/sj.onc.1210290; Losi L, 2005, CARCINOGENESIS, V26, P916, DOI 10.1093/carcin/bgi044; Marchetti A, 2009, NEOPLASIA, V11, P1084, DOI 10.1593/neo.09814; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Ren ZP, 2007, J NEUROPATH EXP NEUR, V66, P944, DOI 10.1097/nen.0b013e318156bc05; Stapleton AMF, 1997, CLIN CANCER RES, V3, P1389; Steinkamp MP, 2009, CANCER RES, V69, P4434, DOI 10.1158/0008-5472.CAN-08-3605; Sun JS, 2007, PROSTATE, V67, P692, DOI 10.1002/pros.20543; Suzuki H, 1998, CANCER RES, V58, P204; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wang JH, 2004, CLIN CANCER RES, V10, P6169, DOI 10.1158/1078-0432.CCR-04-0408; Wang JH, 2006, CANCER RES, V66, P8347, DOI 10.1158/0008-5472.CAN-06-1966; Wang JH, 2011, CANCER RES, V71, P1325, DOI 10.1158/0008-5472.CAN-10-2210; Wang SI, 1998, CLIN CANCER RES, V4, P811; WHEELER TM, 1994, PROSTATE, V25, P274, DOI 10.1002/pros.2990250507; Wong OGW, 2007, P NATL ACAD SCI USA, V104, P19040, DOI 10.1073/pnas.0702544104	25	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32708	10.1371/journal.pone.0032708	http://dx.doi.org/10.1371/journal.pone.0032708			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389719	Green Published, Green Submitted, gold			2022-12-27	WOS:000302999600058
J	Ifeadi, V; Garnett-Benson, C				Ifeadi, Victoria; Garnett-Benson, Charlie			Sub-Lethal Irradiation of Human Colorectal Tumor Cells Imparts Enhanced and Sustained Susceptibility to Multiple Death Receptor Signaling Pathways	PLOS ONE			English	Article							LYMPHOTOXIN-BETA-RECEPTOR; RADIATION-THERAPY; IONIZING-RADIATION; INDUCED APOPTOSIS; NECROSIS-FACTOR; CANCER-CELLS; COMBINING RADIOTHERAPY; COLON-CARCINOMA; TNF SUPERFAMILY; CD95 EXPRESSION	Background: Death receptors (DR) of the TNF family function as anti-tumor immune effector molecules. Tumor cells, however, often exhibit DR-signaling resistance. Previous studies indicate that radiation can modify gene expression within tumor cells and increase tumor cell sensitivity to immune attack. The aim of this study is to investigate the synergistic effect of sub-lethal doses of ionizing radiation in sensitizing colorectal carcinoma cells to death receptor-mediated apoptosis. Methodology/Principal Findings: The ability of radiation to modulate the expression of multiple death receptors (Fas/CD95, TRAILR1/DR4, TRAILR2/DR5, TNF-R1 and LT beta R) was examined in colorectal tumor cells. The functional significance of sub-lethal doses of radiation in enhancing tumor cell susceptibility to DR-induced apoptosis was determined by in vitro functional sensitivity assays. The longevity of these changes and the underlying molecular mechanism of irradiation in sensitizing diverse colorectal carcinoma cells to death receptor-mediated apoptosis were also examined. We found that radiation increased surface expression of Fas, DR4 and DR5 but not LT beta R or TNF-R1 in these cells. Increased expression of DRs was observed 2 days post-irradiation and remained elevated 7-days post irradiation. Sub-lethal tumor cell irradiation alone exhibited minimal cell death, but effectively sensitized three of three colorectal carcinoma cells to both TRAIL and Fas-induced apoptosis, but not LT beta R-induced death. Furthermore, radiation-enhanced Fas and TRAIL-induced cell death lasted as long as 5-days post-irradiation. Specific analysis of intracellular sensitizers to apoptosis indicated that while radiation did reduce Bcl-X-L and c-FLIP protein expression, this reduction did not correlate with the radiation-enhanced sensitivity to Fas and/or TRAIL mediated apoptosis among the three cell types. Conclusions/Significance: Irradiation of tumor cells can overcome Fas and TRAIL resistance that is long lasting. Overall, results of these investigations suggest that non-lethal doses of radiation can be used to make human tumors more amenable to attack by anti-tumor effector molecules and cells.	[Ifeadi, Victoria; Garnett-Benson, Charlie] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University	Ifeadi, V (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA.	cgarnettbenson@gsu.edu		Garnett-Benson, Charlie/0000-0002-0238-3303	Georgia State University Office of University Research Services Administration; Georgia State University, Department of Biology	Georgia State University Office of University Research Services Administration; Georgia State University, Department of Biology	This research was supported by an Internal Research Initiation Grant (RIG) from Georgia State University Office of University Research Services & Administration. This research was supported by laboratory start-up funds from Georgia State University, Department of Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aggarwal S, 2000, GENES IMMUN, V1, P271, DOI 10.1038/sj.gene.6363674; Andersen MH, 2005, NAT REV DRUG DISCOV, V4, P399, DOI 10.1038/nrd1717; Antonia S, 2004, CURR OPIN IMMUNOL, V16, P130, DOI 10.1016/j.coi.2004.01.012; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Blattman JN, 2004, SCIENCE, V305, P200, DOI 10.1126/science.1100369; Chakraborty M, 2004, CANCER RES, V64, P4328, DOI 10.1158/0008-5472.CAN-04-0073; Chakraborty M, 2003, J IMMUNOL, V170, P6338, DOI 10.4049/jimmunol.170.12.6338; Chakraborty M, 2008, CLIN CANCER RES, V14, P4241, DOI 10.1158/1078-0432.CCR-08-0335; Chen MC, 2003, J BIOL CHEM, V278, P16073, DOI 10.1074/jbc.M208661200; Chi KW, 2005, J IMMUNOTHER, V28, P129, DOI 10.1097/01.cji.0000154248.74383.5e; Decker RH, 2008, SEMIN THORAC CARDIOV, V20, P184, DOI 10.1053/j.semtcvs.2008.09.004; Demaria S, 2005, CLIN CANCER RES, V11, P728; Demaria S, 2005, INT J RADIAT ONCOL, V63, P655, DOI 10.1016/j.ijrobp.2005.06.032; Demaria S, 2004, INT J RADIAT ONCOL, V58, P862, DOI 10.1016/j.ijrobp.2003.09.012; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Ferrara TA, 2009, CURR OPIN MOL THER, V11, P37; Formenti SC, 2008, J CLIN ONCOL, V26, P1562, DOI 10.1200/JCO.2007.15.5499; Friedman EJ, 2002, CURR PHARM DESIGN, V8, P1765, DOI 10.2174/1381612023394089; Garnett CT, 2004, CANCER RES, V64, P7985, DOI 10.1158/0008-5472.CAN-04-1525; Gelbard A, 2006, CLIN CANCER RES, V12, P1897, DOI 10.1158/1078-0432.CCR-05-1761; Gulley JL, 2005, CLIN CANCER RES, V11, P3353, DOI 10.1158/1078-0432.CCR-04-2062; Guyot F, 2005, ANN ONCOL, V16, P756, DOI 10.1093/annonc/mdi151; Hamasu T, 2005, J RADIAT RES, V46, P103, DOI 10.1269/jrr.46.103; Hodge JW, 2008, ONCOLOGY-NY, V22, P1064; Hoos A, 2010, SEMIN ONCOL, V37, P533, DOI 10.1053/j.seminoncol.2010.09.015; Houghton JA, 1997, P NATL ACAD SCI USA, V94, P8144, DOI 10.1073/pnas.94.15.8144; Huerta S, 2007, J SURG RES, V142, P184, DOI 10.1016/j.jss.2006.12.551; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kataoka T, 1998, J IMMUNOL, V161, P3936; Kimura K, 2000, J BIOL CHEM, V275, P8610, DOI 10.1074/jbc.275.12.8610; Kopetz S, 2009, CLIN CANCER RES, V15, P7451, DOI 10.1158/1078-0432.CCR-09-2523; Kufe D, 2003, CANCER BIOL THER, V2, P326, DOI 10.4161/cbt.2.4.495; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Lechleider RJ, 2008, CLIN CANCER RES, V14, P5284, DOI 10.1158/1078-0432.CCR-07-5162; Liu FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025907; Luce A, 2009, CARCINOGENESIS, V30, P432, DOI 10.1093/carcin/bgp008; Lugade AA, 2005, J IMMUNOL, V174, P7516, DOI 10.4049/jimmunol.174.12.7516; Lugade AA, 2008, J IMMUNOL, V180, P3132, DOI 10.4049/jimmunol.180.5.3132; Lukashev M, 2006, CANCER RES, V66, P9617, DOI 10.1158/0008-5472.CAN-06-0217; Marini P, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-5; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Nawrocki ST, 2007, CANCER RES, V67, P6987, DOI 10.1158/0008-5472.CAN-07-0812; Nesslinger NJ, 2007, CLIN CANCER RES, V13, P1493, DOI 10.1158/1078-0432.CCR-06-1772; Niyazi M, 2009, ONCOL REP, V21, P1455, DOI 10.3892/or_00000374; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Ravi R, 2002, CANCER RES, V62, P4180; Rigberg DA, 1999, J SURG ONCOL, V71, P91, DOI 10.1002/(SICI)1096-9098(199906)71:2<91::AID-JSO6>3.0.CO;2-7; Rosato RR, 2007, CANCER RES, V67, P9490, DOI 10.1158/0008-5472.CAN-07-0598; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Shankar S, 2004, PROSTATE, V61, P35, DOI 10.1002/pros.20069; Sharp HJ, 2007, FRONT BIOSCI-LANDMRK, V12, P4900, DOI 10.2741/2436; Sheard MA, 1999, BRIT J CANCER, V80, P1689, DOI 10.1038/sj.bjc.6690585; Sheard MA, 2003, CANCER RES, V63, P7176; Sheard MA, 1997, INT J CANCER, V73, P757, DOI 10.1002/(SICI)1097-0215(19971127)73:5<757::AID-IJC24>3.0.CO;2-1; Shibue T, 2006, EMBO J, V25, P4952, DOI 10.1038/sj.emboj.7601359; Strater J, 2005, GUT, V54, P661, DOI 10.1136/gut.2004.052696; Takamizawa S, 2000, J PEDIATR SURG, V35, P390, DOI 10.1016/S0022-3468(00)90047-2; Thorburn A, 2004, CELL SIGNAL, V16, P139, DOI 10.1016/j.cellsig.2003.08.007; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; Verbrugge I, 2009, CLIN CANCER RES, V15, P2031, DOI 10.1158/1078-0432.CCR-08-2125; Vergati M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/596432; Voelkel-Johnson C, 2005, MOL CANCER THER, V4, P1320, DOI 10.1158/1535-7163.MCT-05-0086; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang HZ, 2009, CELL RES, V19, P1388, DOI 10.1038/cr.2009.113; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Whelan M, 2003, DRUG DISCOV TODAY, V8, P253, DOI 10.1016/S1359-6446(03)02633-3; White-Gilbertson S, 2009, ONCOGENE, V28, P1132, DOI 10.1038/onc.2008.468; Xu JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010306; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Yang D, 2007, CLIN CANCER RES, V13, P5202, DOI 10.1158/1078-0432.CCR-07-1161	76	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e31762	10.1371/journal.pone.0031762	http://dx.doi.org/10.1371/journal.pone.0031762			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389673	Green Published, gold, Green Submitted			2022-12-27	WOS:000302999600010
J	Kagawa, K; Nakano, A; Miki, H; Oda, A; Amou, H; Takeuchi, K; Nakamura, S; Harada, T; Fujii, S; Yata, K; Ozaki, S; Matsumoto, T; Abe, M				Kagawa, Kumiko; Nakano, Ayako; Miki, Hirokazu; Oda, Asuka; Amou, Hiroe; Takeuchi, Kyoko; Nakamura, Shingen; Harada, Takeshi; Fujii, Shiro; Yata, Kenichiro; Ozaki, Shuji; Matsumoto, Toshio; Abe, Masahiro			Inhibition of TACE Activity Enhances the Susceptibility of Myeloma Cells to TRAIL	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; FACTOR-KAPPA-B; MULTIPLE-MYELOMA; BONE-MARROW; DEATH RECEPTORS; UP-REGULATION; C-FLIP; APOPTOSIS; GROWTH; METALLOPROTEINASES	Background: TNF-related apoptosis-inducing ligand/Apo2 ligand (TRAIL/Apo2L) selectively induces apoptosis in various cancer cells including myeloma (MM) cells. However, the susceptibility of MM cells to TRAIL is largely low in most of MM cells by yet largely unknown mechanisms. Because TNF-alpha converting enzyme (TACE) can cleave some TNF receptor family members, in the present study we explored the roles of proteolytic modulation by TACE in TRAIL receptor expression and TRAIL-mediated cytotoxicity in MM cells. Methodology/Principal Findings: MM cells preferentially expressed death receptor 4 (DR4) but not DR5 on their surface along with TACE. Conditioned media from RPMI8226 and U266 cells contained a soluble form of DR4. The DR4 levels in these conditioned media were reduced by TACE inhibition by the TACE inhibitor TAPI-0 as well as TACE siRNA. Conversely, the TACE inhibition restored surface levels of DR4 but not DR5 in these cells without affecting DR4 mRNA levels. The TACE inhibition was able to restore cell surface DR4 expression in MM cells even in the presence of bone marrow stromal cells or osteoclasts, and enhanced the cytotoxic effects of recombinant TRAIL and an agonistic antibody against DR4 on MM cells. Conclusions/Significance: These results demonstrate that MM cells post-translationally down-modulate the cell surface expression of DR4 through ectodomain shedding by endogenous TACE, and that TACE inhibition is able to restore cell surface DR4 levels and the susceptibility of MM cells to TRAIL or an agonistic antibody against DR4. Thus, TACE may protect MM cells from TRAIL-mediated death through down-modulation of cell-surface DR4. It can be envisaged that TACE inhibition augments clinical efficacy of TRAIL-based immunotherapy against MM, which eventually becomes resistant to the present therapeutic modalities.	[Kagawa, Kumiko; Nakano, Ayako; Miki, Hirokazu; Oda, Asuka; Amou, Hiroe; Takeuchi, Kyoko; Nakamura, Shingen; Harada, Takeshi; Fujii, Shiro; Yata, Kenichiro; Matsumoto, Toshio; Abe, Masahiro] Univ Tokushima, Grad Sch Med, Dept Med & Bioregulatory Sci, Tokushima 770, Japan; [Ozaki, Shuji] Tokushima Prefectural Cent Hosp, Div Internal Med, Tokushima, Japan	Tokushima University	Kagawa, K (corresponding author), Univ Tokushima, Grad Sch Med, Dept Med & Bioregulatory Sci, Tokushima 770, Japan.	masabe@clin.med.tokushima-u.ac.jp			Ministry of Health, Labor and Welfare of Japan; National Cancer Center Research and Development Fund; Japan Leukemia Research Fund	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Japan Leukemia Research Fund(Japan Leukemia Research Fund (JLRF))	This work was supported in part by Grants-in-aid for Scientific Research (A) to T.M. and (C) to M.A., a Grant-in-aid for Cancer Research to M.A. from the Ministry of Health, Labor and Welfare of Japan, National Cancer Center Research and Development Fund to M.A., and Japan Leukemia Research Fund to M.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2004, BLOOD, V104, P2484, DOI 10.1182/blood-2003-11-3839; Abe M, 2002, BLOOD, V100, P2195, DOI 10.1182/blood.V100.6.2195.h81802002195_2195_2202; Ahonen M, 2003, ONCOGENE, V22, P2121, DOI 10.1038/sj.onc.1206292; Bellail AC, 2009, REV RECENT CLIN TRIA, V4, P34, DOI 10.2174/157488709787047530; Benoit V, 2004, CANCER RES, V64, P2684, DOI 10.1158/0008-5472.CAN-03-2914; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Buchsbaum Donald J, 2007, Future Oncol, V3, P405, DOI 10.2217/14796694.3.4.405; David E, 2008, CLIN CANCER RES, V14, P5090, DOI 10.1158/1078-0432.CCR-08-0016; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Hiasa M, 2009, BLOOD, V114, P4517, DOI 10.1182/blood-2009-04-215020; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kitazoe K, 2009, INT J HEMATOL, V89, P45, DOI 10.1007/s12185-008-0226-9; Mellier G, 2010, MOL ASPECTS MED, V31, P93, DOI 10.1016/j.mam.2009.12.002; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Mitsiades CS, 2002, ONCOGENE, V21, P5673, DOI 10.1038/sj.onc.1205664; Mizrahi K, 2010, LEUKEMIA, V24, P1325, DOI 10.1038/leu.2010.97; Moretto P, 2009, EXPERT OPIN INV DRUG, V18, P311, DOI [10.1517/13543780902752463, 10.1517/13543780902752463 ]; Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498; Pratt G, 2007, BRIT J HAEMATOL, V138, P563, DOI 10.1111/j.1365-2141.2007.06705.x; Rocks N, 2008, BIOCHIMIE, V90, P369, DOI 10.1016/j.biochi.2007.08.008; Romagnoli M, 2007, CLIN CANCER RES, V13, P6010, DOI 10.1158/1078-0432.CCR-07-0140; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Secchiero P, 2008, CURR OPIN HEMATOL, V15, P42, DOI 10.1097/MOH.0b013e3282f15fa6; Shipman CM, 2003, CANCER RES, V63, P912; Tanaka Y, 2007, CLIN CANCER RES, V13, P816, DOI 10.1158/1078-0432.CCR-06-2258; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Zdzisinska B, 2008, ARCH IMMUNOL THER EX, V56, P207, DOI 10.1007/s00005-008-0022-5	29	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e31594	10.1371/journal.pone.0031594	http://dx.doi.org/10.1371/journal.pone.0031594			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389670	Green Submitted, gold, Green Published			2022-12-27	WOS:000302999600007
J	Ng, KTP; Guo, DY; Cheng, Q; Geng, W; Ling, CC; Li, CX; Liu, XB; Ma, YY; Lo, CM; Poon, RTP; Fan, ST; Man, K				Ng, Kevin T. P.; Guo, Dong Yong; Cheng, Qiao; Geng, Wei; Ling, Chang Chun; Li, Chang Xian; Liu, Xiao Bing; Ma, Yuen Yuen; Lo, Chung Mau; Poon, Ronnie T. P.; Fan, Sheung Tat; Man, Kwan			A Garlic Derivative, S-allylcysteine (SAC), Suppresses Proliferation and Metastasis of Hepatocellular Carcinoma	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; CANCER-CELLS; ORGANOSULFUR COMPOUNDS; TARGETED THERAPY; E-CADHERIN; EXPRESSION; INHIBITION; PREVENTION; INVASION; GROWTH	Background: Hepatocellular carcinoma (HCC) is highly malignant and metastatic. Currently, there is no effective chemotherapy for patients with advanced HCC leading to an urgent need to seek for novel therapeutic options. We aimed to investigate the effect of a garlic derivative, S-allylcysteine (SAC), on the proliferation and metastasis of HCC. Methodology/Principal Findings: A series of in vitro experiments including MTT, colony-forming, wound-healing, invasion, apoptosis and cell cycle assays were performed to examine the anti-proliferative and anti-metastatic effects of SAC on a metastatic HCC cell line MHCC97L. The therapeutic values of SAC single and combined with cisplatin treatments were examined in an in vivo orthotopic xenograft liver tumor model. The result showed that the proliferation rate and colony-forming abilities of MHCC97L cells were suppressed by SAC together with significant suppression of the expressions of proliferation markers, Ki-67 and proliferating cell nuclear antigen (PCNA). Moreover, SAC hindered the migration and invasion of MHCC97L cells corresponding with up-regulation of E-cadherin and down-regulation of VEGF. Furthermore, SAC significantly induced apoptosis and necrosis of MHCC97L cells through suppressing Bcl-xL and Bcl-2 as well as activating caspase-3 and caspase-9. In addition, SAC could significantly induce the S phase arrest of MHCC97L cells together with down-regulation of cdc25c, cdc2 and cyclin B1. In vivo xenograft liver tumor model demonstrated that SAC single or combined with cisplatin treatment inhibited the progression and metastasis of HCC tumor. Conclusions/Significance: Our data demonstrate the anti-proliferative and anti-metastatic effects of SAC on HCC cells and suggest that SAC may be a potential therapeutic agent for the treatment of HCC patients.	[Ng, Kevin T. P.; Guo, Dong Yong; Cheng, Qiao; Geng, Wei; Ling, Chang Chun; Li, Chang Xian; Liu, Xiao Bing; Ma, Yuen Yuen; Lo, Chung Mau; Poon, Ronnie T. P.; Fan, Sheung Tat; Man, Kwan] Univ Hong Kong, Dept Surg, LKS Fac Med, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Guo, Dong Yong] Tianjin Med Univ, Canc Hosp, Inst Canc, Dept Anesthesiol, Tianjin, Peoples R China	University of Hong Kong; Tianjin Medical University	Ng, KTP (corresponding author), Univ Hong Kong, Dept Surg, LKS Fac Med, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China.	kwanman@hku.hk	NG, Kevin Tak-Pan/J-1510-2018; Ng, Tak Pan/C-4698-2009	NG, Kevin Tak-Pan/0000-0001-9822-1335; 	Small Project Funding; University of Hong Kong	Small Project Funding; University of Hong Kong(University of Hong Kong)	This study was supported by the Small Project Funding and Seed Funding from the University of Hong Kong. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Cho SB, 2008, PATHOL INT, V58, P635, DOI 10.1111/j.1440-1827.2008.02282.x; Chu QJ, 2007, BJU INT, V99, P925, DOI 10.1111/j.1464-410X.2006.06639.x; Chu QJ, 2006, CARCINOGENESIS, V27, P2180, DOI 10.1093/carcin/bgl054; Fransvea E, 2008, HEPATOLOGY; Gapter LA, 2008, BIOCHEM BIOPH RES CO, V367, P446, DOI 10.1016/j.bbrc.2007.12.175; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herman-Antosiewicz A, 2004, MUTAT RES-FUND MOL M, V555, P121, DOI 10.1016/j.mrfmmm.2004.04.016; Ito Y, 2000, ONCOLOGY-BASEL, V59, P68, DOI 10.1159/000012140; Knowles LM, 2000, CARCINOGENESIS, V21, P1129, DOI 10.1093/carcin/21.6.1129; Lee TK, 2005, CLIN CANCER RES, V11, P8458, DOI 10.1158/1078-0432.CCR-05-0447; Li KKW, 2002, LIVER, V22, P259, DOI 10.1046/j.0106-9543.2002.01629.x; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Man K, 2010, CLIN CANCER RES, V16, P967, DOI 10.1158/1078-0432.CCR-09-1487; Murphy D, 2001, HEPATOLOGY, V33, P346, DOI 10.1053/jhep.2001.21749; Ng KTP, 2010, INT J CANCER, V127, P859, DOI 10.1002/ijc.25105; Ng KT, 2011, EUR J CANC; Pang RWC, 2008, ANN SURG ONCOL, V15, P962, DOI 10.1245/s10434-007-9730-z; Powolny AA, 2008, CANCER LETT, V269, P305, DOI 10.1016/j.canlet.2008.05.027; Rivlin RS, 2001, J NUTR, V131, p951S, DOI 10.1093/jn/131.3.951S; Shirin H, 2001, CANCER RES, V61, P725; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Stroescu C, 2008, J GASTROINTEST LIVER, V17, P411; Sundaresan S, 2008, MOL CELL BIOCHEM, V310, P209, DOI 10.1007/s11010-007-9682-4; Tanaka S, 2006, J NUTR, V136, p821S, DOI 10.1093/jn/136.3.821S; Tang F. Y., 2010, J AGR FOOD CHEM; Tang FY, 2009, J NUTR BIOCHEM, V20, P1013, DOI 10.1016/j.jnutbio.2008.09.007; Thomson M, 2003, CURR CANCER DRUG TAR, V3, P67, DOI 10.2174/1568009033333736; WELCH C, 1992, CANCER LETT, V63, P211, DOI 10.1016/0304-3835(92)90263-U; Wysocki PJ, 2010, EXPERT OPIN INV DRUG, V19, P265, DOI 10.1517/13543780903514110; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yau T, 2009, LIVER INT, V29, P10, DOI 10.1111/j.1478-3231.2008.01916.x; Zhu AX, 2011, NAT REV CLIN ONCOL	33	55	60	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e31655	10.1371/journal.pone.0031655	http://dx.doi.org/10.1371/journal.pone.0031655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389672	Green Published, gold, Green Submitted			2022-12-27	WOS:000302999600009
J	Caino, MC; Lopez-Haber, C; Kissil, JL; Kazanietz, MG				Caino, M. Cecilia; Lopez-Haber, Cynthia; Kissil, Joseph L.; Kazanietz, Marcelo G.			Non-Small Cell Lung Carcinoma Cell Motility, Rac Activation and Metastatic Dissemination Are Mediated by Protein Kinase C Epsilon	PLOS ONE			English	Article							RHO-GTPASES; PROTEOLYTIC-ENZYMES; CANCER CELLS; GROWTH; PHOSPHORYLATION; INHIBITION; MIGRATION; INVASION; DELTA; GEF	Background: Protein kinase C (PKC) epsilon, a key signaling transducer implicated in mitogenesis, survival, and cancer progression, is overexpressed in human primary non-small cell lung cancer (NSCLC). The role of PKC epsilon in lung cancer metastasis has not yet been established. Principal Findings: Here we show that RNAi-mediated knockdown of PKC epsilon in H358, H1299, H322, and A549 NSCLC impairs activation of the small GTPase Rac1 in response to phorbol 12-myristate 13-acetate (PMA), serum, or epidermal growth factor (EGF). PKC epsilon depletion markedly impaired the ability of NSCLC cells to form membrane ruffles and migrate. Similar results were observed by pharmacological inhibition of PKC epsilon with epsilon V1-2, a specific PKC epsilon inhibitor. PKC epsilon was also required for invasiveness of NSCLC cells and modulated the secretion of extracellular matrix proteases and protease inhibitors. Finally, we found that PKC epsilon-depleted NSCLC cells fail to disseminate to lungs in a mouse model of metastasis. Conclusions: Our results implicate PKC epsilon as a key mediator of Rac signaling and motility of lung cancer cells, highlighting its potential as a therapeutic target.	[Caino, M. Cecilia; Lopez-Haber, Cynthia; Kazanietz, Marcelo G.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kissil, Joseph L.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; The Wistar Institute	Caino, MC (corresponding author), Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA.	marcelog@upenn.edu		Lopez Haber, Cynthia/0000-0001-9106-543X; Caino, M. Cecilia/0000-0001-8294-8070	National Institutes of Health [R01CA74197]; NATIONAL CANCER INSTITUTE [R01CA124495, R01CA074197, R01CA139120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work in this paper has been supported by grant R01CA74197 from National Institutes of Health (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae KM, 2007, CANCER RES, V67, P6053, DOI 10.1158/0008-5472.CAN-06-4037; Barry OP, 2001, CURR PHARM DESIGN, V7, P1725, DOI 10.2174/1381612013397041; Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008; Binker MG, 2010, BIOCHEM BIOPH RES CO, V393, P371, DOI 10.1016/j.bbrc.2010.01.125; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Brantley-Sieders DM, 2009, MOL CANCER RES, V7, P615, DOI 10.1158/1541-7786.MCR-08-0401; Budas GR, 2007, BIOCHEM SOC T, V35, P1021, DOI 10.1042/BST0351021; Caino MC, 2011, J BIOL CHEM, V286, P11254, DOI 10.1074/jbc.M110.194332; Caino MC, 2009, APOPTOSIS, V14, P392, DOI 10.1007/s10495-009-0316-z; Caloca MJ, 2003, BIOCHEM J, V375, P313, DOI 10.1042/BJ20030727; Chahdi A, 2008, MOL CELL BIOL, V28, P1679, DOI 10.1128/MCB.00898-07; Chang YC, 2006, CELL DEATH DIFFER, V13, P2023, DOI 10.1038/sj.cdd.4401901; Dallol A, 2005, CANCER RES, V65, P7653, DOI 10.1158/0008-5472.CAN-05-0247; Ding L, 2002, J BIOL CHEM, V277, P35305, DOI 10.1074/jbc.M201460200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Felber M, 2007, PATHOL ONCOL RES, V13, P295, DOI 10.1007/BF02940308; Ferri N, 2007, ARTERIOSCL THROM VAS, V27, P1043, DOI 10.1161/ATVBAHA.107.139881; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Goekjian PG, 2001, EXPERT OPIN INV DRUG, V10, P2117; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Gorshkova I, 2008, J BIOL CHEM, V283, P11794, DOI 10.1074/jbc.M800250200; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Griner EM, 2010, J BIOL CHEM, V285, P16931, DOI 10.1074/jbc.M109.099036; Grossoni VC, 2007, CLIN EXP METASTAS, V24, P513, DOI 10.1007/s10585-007-9088-4; Grossoni VC, 2009, BREAST CANCER RES TR, V118, P469, DOI 10.1007/s10549-008-0299-4; Gujdar A, 2003, CELL SIGNAL, V15, P307, DOI 10.1016/S0898-6568(02)00087-6; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Huber RM, 2004, LUNG CANCER, V45, pS209, DOI 10.1016/j.lungcan.2004.07.973; Inagaki K, 2005, CIRCULATION, V111, P44, DOI 10.1161/01.CIR.0000151614.22282.F1; Ishida M, 2010, TOXICOLOGY, V275, P72, DOI 10.1016/j.tox.2010.06.005; Jansen AP, 2001, CANCER RES, V61, P808; Jiang YX, 2001, ONCOGENE, V20, P2254, DOI 10.1038/sj.onc.1204293; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Koyanagi T, 2007, J MOL CELL CARDIOL, V43, P517, DOI 10.1016/j.yjmcc.2007.06.003; Lazer G, 2009, J PATHOL, V219, P25, DOI 10.1002/path.2579; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; MELLSTROM K, 1988, EXP CELL RES, V177, P347, DOI 10.1016/0014-4827(88)90468-5; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Nakagawa M, 2005, J BIOL CHEM, V280, P33926, DOI 10.1074/jbc.M505748200; Oliva JL, 2008, J BIOL CHEM, V283, P5466, DOI 10.1074/jbc.M707576200; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; Pan Q, 2006, CANCER RES, V66, P9379, DOI 10.1158/0008-5472.CAN-06-2646; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perletti GP, 1996, ONCOGENE, V12, P847; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Price LS, 2001, SEMIN CANCER BIOL, V11, P167, DOI 10.1006/scbi.2000.0367; Ramesh R, 2001, MOL THER, V3, P337, DOI 10.1006/mthe.2001.0266; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Santibanez JF, 2010, FEBS LETT, V584, P2305, DOI 10.1016/j.febslet.2010.03.042; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Scholz RP, 2009, J CELL SCI, V122, P92, DOI 10.1242/jcs.036251; Sekido Y, 2003, ANNU REV MED, V54, P73, DOI 10.1146/annurev.med.54.101601.152202; Serova M, 2006, SEMIN ONCOL, V33, P466, DOI 10.1053/j.seminoncol.2006.04.009; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Suzuki T, 2008, J BIOL CHEM, V283, P3574, DOI 10.1074/jbc.M709141200; Tachado SD, 2002, J CELL BIOCHEM, V85, P785, DOI 10.1002/jcb.10164; Takefuji M, 2007, BIOCHEM BIOPH RES CO, V355, P788, DOI 10.1016/j.bbrc.2007.02.028; Toker A., 1998, FRONT BIOSCI-LANDMRK, V3, P1134, DOI 10.2741/A350; Tuomi S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000135; Urtreger AJ, 2005, MOL CARCINOGEN, V42, P29, DOI 10.1002/mc.20066; Xiao H, 2009, J CELL PHYSIOL, V218, P366, DOI 10.1002/jcp.21609; Yang CF, 2006, MOL CELL BIOL, V26, P831, DOI 10.1128/MCB.26.3.831-842.2006; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003	66	38	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31714	10.1371/journal.pone.0031714	http://dx.doi.org/10.1371/journal.pone.0031714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384062	gold, Green Published, Green Submitted			2022-12-27	WOS:000302918500036
J	Kumari, M; Sachar, S; Saxena, RK				Kumari, Mandavi; Sachar, Sumedha; Saxena, Rajiv K.			Loss of Proliferation and Antigen Presentation Activity following Internalization of Polydispersed Carbon Nanotubes by Primary Lung Epithelial Cells	PLOS ONE			English	Article							PULMONARY TOXICITY; BLACK PARTICLES	Interactions between poly-dispersed acid functionalized single walled carbon nanotubes (AF-SWCNTs) and primary lung epithelial (PLE) cells were studied. Peritoneal macrophages (PMs, known phagocytic cells) were used as positive controls in this study. Recovery of live cells from cultures of PLE cells and PMs was significantly reduced in the presence of AF-SWCNTs, in a time and dose dependent manner. Both PLE cells as well as PMs could take up fluorescence tagged AF-SWCNTs in a time dependent manner and this uptake was significantly blocked by cytochalasin D, an agent that blocks the activity of acto-myosin fibers and therefore the phagocytic activity of cells. Confocal microscopic studies confirmed that AF-SWCNTs were internalized by both PLE cells and PMs. Intra-trachially instilled AF-SWCNTs could also be taken up by lung epithelial cells as well as alveolar macrophages. Freshly isolated PLE cells had significant cell division activity and cell cycling studies indicated that treatment with AF-SWCNTs resulted in a marked reduction in S-phase of the cell cycle. In a previously standardized system to study BCG antigen presentation by PLE cells and PMs to sensitized T helper cells, AF-SWCNTs could significantly lower the antigen presentation ability of both cell types. These results show that mouse primary lung epithelial cells can efficiently internalize AF-SWCNTs and the uptake of nanotubes interfered with biological functions of PLE cells including their ability to present BCG antigens to sensitized T helper cells.	[Kumari, Mandavi; Sachar, Sumedha; Saxena, Rajiv K.] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Saxena, Rajiv K.] S Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India	Jawaharlal Nehru University, New Delhi	Kumari, M (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	rajivksaxena@hotmail.com			Department of Science and Technology, Government of India [SR/NM/NS-50/2008]	Department of Science and Technology, Government of India(Department of Science & Technology (India))	The study was supported bt a grant (SR/NM/NS-50/2008) from the Department of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Bianco A, 2003, ADV MATER, V15, P1765, DOI 10.1002/adma.200301646; Cui HF, 2010, CHEM RES TOXICOL, V23, P1131, DOI 10.1021/tx100050h; Debbabi H, 2005, AM J PHYSIOL-LUNG C, V289, pL274, DOI 10.1152/ajplung.00004.2005; Kam NWS, 2006, PHYS STATUS SOLIDI B, V243, P3561, DOI 10.1002/pssb.200669226; Kumari M, 2011, INFECT IMMUN, V79, P3159, DOI 10.1128/IAI.05406-11; Lam CW, 2006, CRIT REV TOXICOL, V36, P189, DOI 10.1080/10408440600570233; Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243; Mercer RR, 2008, AM J PHYSIOL-LUNG C, V294, pL87, DOI 10.1152/ajplung.00186.2007; Muller J, 2005, TOXICOL APPL PHARM, V207, P221, DOI 10.1016/j.taap.2005.01.008; Pantarotto D, 2004, CHEM COMMUN, P16, DOI 10.1039/b311254c; Sachar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022032; Saxena RK, 2007, NANOTOXICOLOGY, V1, P291, DOI 10.1080/17435390701803110; Saxena RK, 2008, BIOTECHNIQUES, V44, P799, DOI 10.2144/000112754; Shvedova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL698, DOI 10.1152/ajplung.00084.2005; Shvedova AA, 2008, AM J RESP CELL MOL, V38, P579, DOI 10.1165/rcmb.2007-0255OC; Tong HY, 2009, TOXICOL APPL PHARM, V239, P224, DOI 10.1016/j.taap.2009.05.019; Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228	18	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31890	10.1371/journal.pone.0031890	http://dx.doi.org/10.1371/journal.pone.0031890			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384094	Green Published, gold, Green Submitted			2022-12-27	WOS:000302918500044
J	Berentzen, TL; Angquist, L; Kotronen, A; Borra, R; Yki-Jarvinen, H; Iozzo, P; Parkkola, R; Nuutila, P; Ross, R; Allison, DB; Heymsfield, SB; Overvad, K; Sorensen, TIA; Jakobsen, MU				Berentzen, Tina Landsvig; Angquist, Lars; Kotronen, Anna; Borra, Ronald; Yki-Jarvinen, Hannele; Iozzo, Patricia; Parkkola, Riitta; Nuutila, Pirjo; Ross, Robert; Allison, David B.; Heymsfield, Steven B.; Overvad, Kim; Sorensen, Thorkild I. A.; Jakobsen, Marianne Uhre			Waist Circumference Adjusted for Body Mass Index and Intra-Abdominal Fat Mass	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; INSULIN-RESISTANCE; ADIPOSE-TISSUE; GLUCOSE-UPTAKE; LIVER FAT; WEIGHT-LOSS; OBESITY; EXERCISE; PREDICTION; MEN	Background: The association between waist circumference (WC) and mortality is particularly strong and direct when adjusted for body mass index (BMI). One conceivable explanation for this association is that WC adjusted for BMI is a better predictor of the presumably most harmful intra-abdominal fat mass (IAFM) than WC alone. We studied the prediction of abdominal subcutaneous fat mass (ASFM) and IAFM by WC alone and by addition of BMI as an explanatory factor. Methodology/Principal Findings: WC, BMI and magnetic resonance imaging data from 742 men and women who participated in clinical studies in Canada and Finland were pooled. Total adjusted squared multiple correlation coefficients (R-2) of ASFM and IAFM were calculated from multiple linear regression models with WC and BMI as explanatory variables. Mean BMI and WC of the participants in the pooled sample were 30 kg/m(2) and 102 cm, respectively. WC explained 29% of the variance in ASFM and 51% of the variance in IAFM. Addition of BMI to WC added 28% to the variance explained in ASFM, but only 1% to the variance explained in IAFM. Results in subgroups stratified by study center, sex, age, obesity level and type 2 diabetes status were not systematically different. Conclusion/Significance: The prediction of IAFM by WC is not improved by addition of BMI.	[Berentzen, Tina Landsvig; Angquist, Lars; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Kotronen, Anna; Yki-Jarvinen, Hannele] Univ Helsinki, Dept Med, Div Diabet, Helsinki, Finland; [Kotronen, Anna] Minerva Med Res Inst, Helsinki, Finland; [Borra, Ronald; Iozzo, Patricia; Parkkola, Riitta; Nuutila, Pirjo] Univ Turku, Turku PET Ctr, Turku, Finland; [Borra, Ronald; Parkkola, Riitta] Univ Turku, Dept Radiol, Turku, Finland; [Borra, Ronald; Parkkola, Riitta] Turku Univ Hosp, Dept Radiol, FIN-20520 Turku, Finland; [Iozzo, Patricia] CNR, Inst Clin Physiol, Pisa, Italy; [Nuutila, Pirjo] Univ Turku, Dept Med, Turku, Finland; [Nuutila, Pirjo] Turku Univ Hosp, Dept Med, FIN-20520 Turku, Finland; [Ross, Robert] Queens Univ, Dept Med, Sch Kinesiol & Hlth Studies, Div Endocrinol & Metab, Kingston, ON K7L 3N6, Canada; [Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; [Heymsfield, Steven B.] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Overvad, Kim; Jakobsen, Marianne Uhre] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Cardiovasc Res Ctr, Dept Cardiol, Aalborg, Denmark	University of Copenhagen; University of Helsinki; University of Turku; University of Turku; University of Turku; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Turku; University of Turku; Queens University - Canada; University of Alabama System; University of Alabama Birmingham; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University	Berentzen, TL (corresponding author), Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark.	tb@ipm.regionh.dk	Iozzo, P/O-2893-2015; Jakobsen, Marianne Uhre/I-8550-2018; Parkkola, Riitta/AAZ-1341-2020; Heymsfield, Steven B/N-1968-2017; Nuutila, Pirjo/J-2087-2012	Iozzo, P/0000-0001-6443-7074; Jakobsen, Marianne Uhre/0000-0001-6518-4136; Heymsfield, Steven B/0000-0003-1127-9425; Overvad, Kim/0000-0001-6429-7921; Borra, Ronald/0000-0001-8072-1243; Nuutila, Pirjo/0000-0001-9597-338X; Allison, David/0000-0003-3566-9399; Angquist, Lars/0000-0002-9516-4424	European Union [LSHM-CT-2005-018734, Health-F2-2009-241762]; Danish Obesity Research Centre (DanORC); Danish Council for Strategic Research [2101-06-0005]	European Union(European Commission); Danish Obesity Research Centre (DanORC); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was funded by and carried out as a part of two related projects supported by the European Union: Hepadip (Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome) under the 6th Framework Program (contract LSHM-CT-2005-018734) and Flip (fatty liver inhibition of progression) under the Seventh Framework Programme (FP7/2007-2013, grant agreement no Health-F2-2009-241762. This work was also supported by the Danish Obesity Research Centre (DanORC; www.danorc.dk), which is supported by the Danish Council for Strategic Research (contract 2101-06-0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 1997, AM J CLIN NUTR, V65, P403, DOI 10.1093/ajcn/65.2.403; Arner P, 1998, LANCET, V351, P1301, DOI 10.1016/S0140-6736(05)79052-8; Bigaard J, 2004, INT J OBESITY, V28, P741, DOI 10.1038/sj.ijo.0802635; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Bjorntorp P, 1997, LANCET, V350, P423, DOI 10.1016/S0140-6736(97)04503-0; Borra R, 2008, METABOLISM, V57, P1445, DOI 10.1016/j.metabol.2008.05.015; Bosy-Westphal A, 2010, J NUTR, V140, P954, DOI 10.3945/jn.109.118737; Bucci M, 2012, CARDIOVASC THER, V30, P333, DOI 10.1111/j.1755-5922.2011.00275.x; Davidson LE, 2009, ARCH INTERN MED, V169, P122, DOI 10.1001/archinternmed.2008.558; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Draper N.R., 1998, APPL REGRESSION ANAL, P79; Heitmann BL, 2010, OBES REV; Jacobs EJ, 2010, ARCH INTERN MED, V170, P1293, DOI 10.1001/archinternmed.2010.201; Janssen I, 2005, J AM GERIATR SOC, V53, P2112, DOI 10.1111/j.1532-5415.2005.00505.x; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Kanaya AM, 2003, AM J EPIDEMIOL, V158, P1161, DOI 10.1093/aje/kwg271; Kotronen A, 2007, J CLIN ENDOCR METAB, V92, P3490, DOI 10.1210/jc.2007-0482; Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005; Lautamaki R, 2006, AM J PHYSIOL-ENDOC M, V291, pE282, DOI 10.1152/ajpendo.00604.2005; Lee S, 2005, DIABETES CARE, V28, P566, DOI 10.2337/diacare.28.3.566; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Ross R, 2004, OBES RES, V12, P789, DOI 10.1038/oby.2004.95; Ross R, 2008, OBES REV, V9, P312, DOI 10.1111/j.1467-789X.2007.00411.x; Ross R, 1996, J APPL PHYSIOL, V81, P2445, DOI 10.1152/jappl.1996.81.6.2445; Ross R, 2000, ANN INTERN MED, V133, P92, DOI 10.7326/0003-4819-133-2-200007180-00008; Viljanen APM, 2009, J CLIN ENDOCR METAB, V94, P50, DOI 10.1210/jc.2008-1689; Virtanen KA, 2003, DIABETES, V52, P283, DOI 10.2337/diabetes.52.2.283; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714	30	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32213	10.1371/journal.pone.0032213	http://dx.doi.org/10.1371/journal.pone.0032213			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384179	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916800028
J	Fortmann-Roe, S; Starfield, R; Getz, WM				Fortmann-Roe, Scott; Starfield, Richard; Getz, Wayne M.			Contingent Kernel Density Estimation	PLOS ONE			English	Article							BANDWIDTH SELECTION; HOME-RANGE; DECONVOLUTION	Kernel density estimation is a widely used method for estimating a distribution based on a sample of points drawn from that distribution. Generally, in practice some form of error contaminates the sample of observed points. Such error can be the result of imprecise measurements or observation bias. Often this error is negligible and may be disregarded in analysis. In cases where the error is non-negligible, estimation methods should be adjusted to reduce resulting bias. Several modifications of kernel density estimation have been developed to address specific forms of errors. One form of error that has not yet been addressed is the case where observations are nominally placed at the centers of areas from which the points are assumed to have been drawn, where these areas are of varying sizes. In this scenario, the bias arises because the size of the error can vary among points and some subset of points can be known to have smaller error than another subset or the form of the error may change among points. This paper proposes a "contingent kernel density estimation" technique to address this form of error. This new technique adjusts the standard kernel on a point-by-point basis in an adaptive response to changing structure and magnitude of error. In this paper, equations for our contingent kernel technique are derived, the technique is validated using numerical simulations, and an example using the geographic locations of social networking users is worked to demonstrate the utility of the method.	[Fortmann-Roe, Scott; Starfield, Richard; Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa	University of California System; University of California Berkeley; University of Kwazulu Natal	Fortmann-Roe, S (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	ScottFR@berkeley.edu	Getz, Wayne/I-4521-2013	Getz, Wayne/0000-0001-8784-9354	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	Dr. Fortmann-Roe's work was partly supported by a National Science Foundation Graduate Research Fellowship. No other grants supported this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang C, 2005, IEEE SIGNAL PROC LET, V12, P242, DOI 10.1109/LSP.2004.842254; Delaigle A, 2007, STAT COMPUT, V17, P349, DOI 10.1007/s11222-007-9024-0; FAN JQ, 1991, SANKHYA SER A, V53, P97; FAN JQ, 1991, STAT SINICA, V1, P541; HALL P, 1991, BIOMETRIKA, V78, P263; Horne JS, 2007, J WILDLIFE MANAGE, V71, P996, DOI 10.2193/2005-678; Jones MC, 1996, COMPUTATION STAT, V11, P337; Jones MC, 1996, J AM STAT ASSOC, V91, P401, DOI 10.2307/2291420; JONES MC, 1991, STAT PROBABIL LETT, V12, P51, DOI 10.1016/0167-7152(91)90163-L; JONES MC, 1991, BIOMETRIKA, V78, P511; MARRON JS, 1995, J AM STAT ASSOC, V90, P499, DOI 10.2307/2291060; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; POWELL JL, 1989, ECONOMETRICA, V57, P1403, DOI 10.2307/1913713; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; Silverman B.W., 1986, DENSITY ESTIMATION S; Stefanski L.A., 1990, STATISTICS, V21, P169, DOI DOI 10.1080/02331889008802238; Team RDC, R LANG ENV STAT COMP; The Museum of Vertebrate Zoology at Berkeley, 2011, MVZ FIELDN PHOT MAP; Wand MP., 1994, KERNEL SMOOTHING; Wolfram Research Inc, 2010, MATH VERS 8 0 1; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	22	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e30549	10.1371/journal.pone.0030549	http://dx.doi.org/10.1371/journal.pone.0030549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22383966	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916800005
J	Santi-Rocca, J; Smith, S; Weber, C; Pineda, E; Hon, CC; Saavedra, E; Olivos-Garcia, A; Rousseau, S; Dillies, MA; Coppee, JY; Guillen, N				Santi-Rocca, Julien; Smith, Sherri; Weber, Christian; Pineda, Erika; Hon, Chung-Chau; Saavedra, Emma; Olivos-Garcia, Alfonso; Rousseau, Sandrine; Dillies, Marie-Agnes; Coppee, Jean-Yves; Guillen, Nancy			Endoplasmic Reticulum Stress-Sensing Mechanism Is Activated in Entamoeba histolytica upon Treatment with Nitric Oxide	PLOS ONE			English	Article							CYSTEINE; INFLAMMATION; GLYCOLYSIS; METABOLISM; EXPRESSION; TRANSPORT; VIRULENCE; SURVIVAL; GENES	The Endoplasmic Reticulum stores calcium and is a site of protein synthesis and modification. Changes in ER homeostasis lead to stress responses with an activation of the unfolded protein response (UPR). The Entamoeba histolytica endomembrane system is simple compared to those of higher eukaryotes, as a canonical ER is not observed. During amoebiasis, an infection of the human intestine and liver by E. histolytica, nitric oxide (NO) triggers an apoptotic-like event preceded by an impairment of energy production and a loss of important parasite pathogenic features. We address the question of how this ancient eukaryote responds to stress induced by immune components (i.e. NO) and whether stress leads to ER changes and subsequently to an UPR. Gene expression analysis suggested that NO triggers stress responses marked by (i) dramatic up-regulation of hsp genes although a bona fide UPR is absent; (ii) induction of DNA repair and redox gene expression and iii) up-regulation of glycolysis-related gene expression. Enzymology approaches demonstrate that NO directly inhibits glycolysis and enhance cysteine synthase activity. Using live imaging and confocal microscopy we found that NO dramatically provokes extensive ER fragmentation. ER fission in E. histolytica appears as a protective response against stress, as it has been recently proposed for neuron self-defense during neurologic disorders. Chronic ER stress is also involved in metabolic diseases including diabetes, where NO production reduces ER calcium levels and activates cell death. Our data highlighted unique cellular responses of interest to understand the mechanisms of parasite death during amoebiasis.	[Santi-Rocca, Julien; Smith, Sherri; Weber, Christian; Hon, Chung-Chau; Guillen, Nancy] Inst Pasteur, Unite Biol Cellulaire Parasitisme, Paris, France; [Santi-Rocca, Julien; Smith, Sherri; Weber, Christian; Hon, Chung-Chau; Guillen, Nancy] INSERM, U786, Paris, France; [Pineda, Erika; Saavedra, Emma] Inst Nacl Cardiol, Dept Bioquim, Mexico City, DF, Mexico; [Olivos-Garcia, Alfonso] Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Mexico City 04510, DF, Mexico; [Rousseau, Sandrine] Inst Pasteur, Bioinformat Grp Genom Anal, Genomes & Genet Dept, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); National Institute of Cardiology - Mexico; Universidad Nacional Autonoma de Mexico; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Santi-Rocca, J (corresponding author), Inst Pasteur, Unite Biol Cellulaire Parasitisme, Paris, France.	nguillen@pasteur.fr	Santi-Rocca, Julien/AAD-2448-2020; Saavedra, Emma/ABB-8989-2020; Weber, Christian/AAW-2153-2020	Santi-Rocca, Julien/0000-0002-9791-3521; Weber, Christian/0000-0003-4610-8714; Saavedra, Emma/0000-0001-8661-9813; Hon, Chung-Chau/0000-0002-3741-7577; Pineda, Erika/0000-0003-2386-1586; Moreira, Sandrine/0000-0002-4580-3566	Pasteur-Weizmann Research Council; French National Research Agency (Intestinalamibe); CONACyT, Mexico [83084]; "Ministere delegue a l'Enseignement Superieur et a la Recherche"; "Regime Social des Independants"; "Fondation pour la Recherche Medicale" in France; Pasteur Foundation; Institut Pasteur	Pasteur-Weizmann Research Council; French National Research Agency (Intestinalamibe)(French National Research Agency (ANR)); CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); "Ministere delegue a l'Enseignement Superieur et a la Recherche"; "Regime Social des Independants"; "Fondation pour la Recherche Medicale" in France(Institut National du Cancer (INCA) France); Pasteur Foundation; Institut Pasteur(European Commission)	This work is supported by grants to NG from the Pasteur-Weizmann Research Council, the French National Research Agency (Intestinalamibe) and from grant 83084 CONACyT, Mexico, to ES. JSR received a PhD fellowship from the "Ministere delegue a l'Enseignement Superieur et a la Recherche", the "Regime Social des Independants" and the "Fondation pour la Recherche Medicale" in France. SS is supported by a fellowship of the Pasteur Foundation and CCH from the Roux Fellowship of the Institut Pasteur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali V, 2004, J BIOL CHEM, V279, P16863, DOI 10.1074/jbc.M313314200; Ali V, 2007, CLIN MICROBIOL REV, V20, P164, DOI 10.1128/CMR.00019-06; Amodio G, 2009, INT J BIOCHEM CELL B, V41, P2511, DOI 10.1016/j.biocel.2009.08.006; Bachar E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004954; Benjamini Y, 2001, ANN STAT, V29, P1165; Blazquez S, 2007, INT J PARASITOL, V37, P425, DOI 10.1016/j.ijpara.2006.10.008; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Clark CG, 2007, ADV PARASIT, V65, P51, DOI 10.1016/S0065-308X(07)65002-7; DASCHER C, 1994, J BIOL CHEM, V269, P1437; DIAMOND LS, 1961, SCIENCE, V134, P336, DOI 10.1126/science.134.3475.336; Fonseca SG, 2011, TRENDS ENDOCRINOL ME; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Girard-Misguich F, 2008, MOL BIOCHEM PARASIT, V157, P236, DOI 10.1016/j.molbiopara.2007.10.014; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Gosline SJC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019118; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hostetter DR, 2007, J BIOL CHEM, V282, P27865, DOI 10.1074/jbc.M704312200; Isakov E, 2008, MOL BIOCHEM PARASIT, V158, P82, DOI 10.1016/j.molbiopara.2007.11.014; Kucharz K, 2011, J NEUROSCI RES, V89, P1150, DOI 10.1002/jnr.22646; Lee JY, 2007, INT J ONCOL, V31, P685; Mi-ichi F, 2009, P NATL ACAD SCI USA, V106, P21731, DOI 10.1073/pnas.0907106106; Nakada-Tsukui K, 2005, MOL BIOL CELL, V16, P5294, DOI 10.1091/mbc.E05-04-0283; Nepusz T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-120; Nozaki T, 1998, MOL BIOCHEM PARASIT, V97, P33, DOI 10.1016/S0166-6851(98)00129-7; Olivos-Garcia A, 2004, EXP MOL PATHOL, V77, P66, DOI 10.1016/j.yexmp.2003.09.003; Pineda E, 2010, FEBS J, V277, P3382, DOI 10.1111/j.1742-4658.2010.07743.x; Ramos E, 2007, EXP PARASITOL, V116, P257, DOI 10.1016/j.exppara.2007.01.011; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Saavedra E, 2005, FEBS J, V272, P1767, DOI 10.1111/j.1742-4658.2005.04610.x; Saavedra E, 2007, FEBS J, V274, P4922, DOI 10.1111/j.1742-4658.2007.06012.x; Santi-Rocca J, 2008, CELL MICROBIOL, V10, P202, DOI 10.1111/j.1462-5822.2007.01030.x; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Teixeira JE, 2008, EUKARYOT CELL, V7, P1222, DOI 10.1128/EC.00007-08; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Vicente JB, 2008, CELL MICROBIOL; Weber C, 2006, EUKARYOT CELL, V5, P871, DOI 10.1128/EC.5.5.871-875.2006; Weber C, 2009, MOL BIOCHEM PARASIT, V164, P165, DOI 10.1016/j.molbiopara.2008.12.005	41	46	46	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31777	10.1371/journal.pone.0031777	http://dx.doi.org/10.1371/journal.pone.0031777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384074	Green Submitted, Green Published, gold			2022-12-27	WOS:000302916800019
J	Yan, JH; Zhou, S; Li, YP				Yan, Jianhua; Zhou, Sheng; Li, Yongping			Benign Orbital Tumors with Bone Destruction in Children	PLOS ONE			English	Article							SOLITARY FIBROUS TUMOR; OF-THE-LITERATURE; INTRAOSSEOUS HEMANGIOMA; CAVERNOUS HEMANGIOMA; LEIOMYOMA; HEMANGIOPERICYTOMA; RESORPTION; EROSION	Purpose: To present rare benign orbital tumors with bone destruction in children who could not be diagnosed presurgically and may simulate malignant ones. Methods: A retrospective review of cases. Clinical, operative and pathological records in all children with a diagnosis of benign orbital tumors who showed remarkable bone destruction at a tertiary Ophthalmic Center in China between Jan 1, 2000 and Dec 31, 2009 were reviewed. All patients had definitive histopathologic diagnosis. Results: Eight patients with benign orbital tumors showed obvious bone destruction, including six cases of eosinophilic granuloma, one case of leiomyoma and one case of primary orbital intraosseous hemangioma. Among them, three patients were females and five patients were males. Tumors were unilateral in all cases, with both the right and left side affected equally. Age ranged from 3 to 7 years (mean 4.1 years). Symptom duration ranged from 1 to 5 weeks (mean 4.8 weeks). Eyelid swelling and palpable mass were the most common complaint. There was no evidence for multifocal involvement in cases with eosinophilic granuloma. Among six patients with eosinophilic granuloma, two were treated with low dose radiation (10 Gy), three received systemic corticosteroid and one was periodically observed only after incisional biopsy or subtotal curettage. There was no postoperative therapeutic intervention in the two patients with leiomyoma and intraosseous hemangioma. All eight patients regained normal vision without local recurrence after a mean follow-up time of 32.8 months. Conclusion: Benign orbital tumors such as isolated eosinophilic granuloma, leiomyoma and primary orbital intraosseous hemangioma may show remarkable bone destruction.	[Yan, Jianhua; Zhou, Sheng; Li, Yongping] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Yan, JH (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	Yan2011@tom.com		yan, jian hua/0000-0001-7564-8491				Arat YO, 2005, OPHTHAL PLAST RECONS, V21, P16, DOI 10.1097/01.IOP.0000150426.79781.54; Ben Simon GJ, 2005, OPHTHALMOLOGY, V112, P2196, DOI 10.1016/j.ophtha.2005.09.013; Bernardini FP, 2003, OPHTHALMOLOGY, V110, P1442, DOI 10.1016/S0161-6420(03)00459-7; Bidar M, 2007, OPHTHAL PLAST RECONS, V23, P87, DOI 10.1097/IOP.0b013e3180333a85; Billings SD, 2001, AM J SURG PATHOL, V25, P1134, DOI 10.1097/00000478-200109000-00003; BOCKMAN RS, 1981, J EXP MED, V154, P529, DOI 10.1084/jem.154.2.529; Calsina M, 2011, ORBIT, V30, P180, DOI 10.3109/01676830.2011.574773; Chung EM, 2008, RADIOGRAPHICS, V28, P1193, DOI 10.1148/rg.284085013; Colombo F, 2001, AM J OPHTHALMOL, V131, P151, DOI 10.1016/S0002-9394(00)00649-8; Furusato E, 2011, HUM PATHOL, V42, P120, DOI 10.1016/j.humpath.2010.05.021; Gengler C, 2006, HISTOPATHOLOGY, V48, P63, DOI 10.1111/j.1365-2559.2005.02290.x; GLOWACKI KA, 1995, J HAND SURG-AM, V20A, P1011, DOI 10.1016/S0363-5023(05)80151-0; GOWEN M, 1983, NATURE, V306, P378, DOI 10.1038/306378a0; Gunduz K, 2007, J AAPOS, V11, P506, DOI 10.1016/j.jaapos.2007.03.016; Gunduz K, 2004, SURV OPHTHALMOL, V49, P237, DOI 10.1016/j.survophthal.2003.12.010; Harris Gerald J, 2003, Trans Am Ophthalmol Soc, V101, P93; Harris GJ, 2003, T AM OPHTHAL SOC, V101, P103; Hayashi Y, 2009, CLIN NEUROL NEUROSUR, V111, P34, DOI 10.1016/j.clineuro.2008.07.010; Lin IC, 2005, OPHTHAL PLAST RECONS, V21, P451, DOI 10.1097/01.iop.0000185089.78226.15; LYON DB, 1992, OPHTHALMOLOGY, V99, P1773; Madge SN, 2009, OPHTHAL PLAST RECONS, V25, P37, DOI 10.1097/IOP.0b013e318192a27e; MARUSIC A, 1991, ENDOCRINOLOGY, V129, P2699, DOI 10.1210/endo-129-5-2699; Merani R, 2005, CLIN EXP OPHTHALMOL, V33, P408, DOI 10.1111/j.1442-9071.2005.01034.x; Mynatt CJ, 2011, HEAD NECK PATHOL, V5, P205, DOI 10.1007/s12105-011-0260-4; Rodrigues EB, 2006, OPHTHAL PLAST RECONS, V22, P292, DOI 10.1097/01.iop.0000226900.79557.cf; Rootman Jack, 2003, Orbit, V22, P103, DOI 10.1076/orbi.22.2.103.14311; Sweet C, 1997, AM J NEURORADIOL, V18, P379; Vosoghi H, 2009, OPHTHAL PLAST RECONS, V25, P430, DOI 10.1097/IOP.0b013e3181b80cad; Yan JH, 2006, GRAEF ARCH CLIN EXP, V244, P1534, DOI 10.1007/s00417-005-0188-z; Yates BJ, 2001, FOOT ANKLE INT, V22, P670, DOI 10.1177/107110070102200810	30	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32111	10.1371/journal.pone.0032111	http://dx.doi.org/10.1371/journal.pone.0032111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384155	gold, Green Submitted, Green Published			2022-12-27	WOS:000302916800025
J	Catucci, I; Colombo, M; Verderio, P; Bernard, L; Ficarazzi, F; Mariette, F; Barile, M; Peissel, B; Cattaneo, E; Manoukian, S; Radice, P; Peterlongo, P				Catucci, Irene; Colombo, Mara; Verderio, Paolo; Bernard, Loris; Ficarazzi, Filomena; Mariette, Frederique; Barile, Monica; Peissel, Bernard; Cattaneo, Elisa; Manoukian, Siranoush; Radice, Paolo; Peterlongo, Paolo			Sequencing Analysis of SLX4/FANCP Gene in Italian Familial Breast Cancer Cases	PLOS ONE			English	Article							GERMLINE MUTATIONS; MESSENGER-RNA; SUSCEPTIBILITY; PREDICTION; PROTEIN; BRCA2; SLX4	Breast cancer can be caused by germline mutations in several genes that are responsible for different hereditary cancer syndromes. Some of the genes causing the Fanconi anemia (FA) syndrome, such as BRCA2, BRIP1, PALB2, and RAD51C, are associated with high or moderate risk of developing breast cancer. Very recently, SLX4 has been established as a new FA gene raising the question of its implication in breast cancer risk. This study aimed at answering this question sequencing the entire coding region of SLX4 in 526 familial breast cancer cases from Italy. We found 81 different germline variants and none of these were clearly pathogenic. The statistical power of our sample size allows concluding that in Italy the frequency of carriers of truncating mutations of SLX4 may not exceed 0.6%. Our results indicate that testing for SLX4 germline mutations is unlikely to be relevant for the identification of individuals at risk of breast cancer, at least in the Italian population.	[Catucci, Irene; Ficarazzi, Filomena; Mariette, Frederique; Radice, Paolo; Peterlongo, Paolo] Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy; [Catucci, Irene; Colombo, Mara; Radice, Paolo; Peterlongo, Paolo] Fdn IRCCS Ist Nazl Tumori, Dept Prevent & Predict Med, Unit Mol Bases Genet Risk & Genet Testing, Milan, Italy; [Verderio, Paolo] Fdn IRCCS Ist Nazl Tumori, Unit Med Stat & Biometry, Milan, Italy; [Bernard, Loris] Ist Europeo Oncol, Dept Expt Oncol, Milan, Italy; [Barile, Monica] Ist Europeo Oncol, Div Canc Prevent & Genet, Milan, Italy; [Peissel, Bernard; Cattaneo, Elisa; Manoukian, Siranoush] Fdn IRCCS Ist Nazl Tumori, Dept Prevent & Predict Med, Unit Med Genet, Milan, Italy; [Cattaneo, Elisa] Univ Milan, Dept Med Surg & Dent, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan	Catucci, I (corresponding author), Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy.	paolo.radice@istitutotumori.mi.it	Colombo, Mara/D-2236-2017; Peissel, Bernard/E-8187-2017; Bernard, Loris/K-5953-2014; manoukian, siranoush/E-7132-2017; Verderio, Paolo/B-5034-2017; Peterlongo, Paolo/Q-4717-2018; Radice, Paolo/O-3119-2013	Colombo, Mara/0000-0001-5465-354X; Peissel, Bernard/0000-0001-9233-3571; manoukian, siranoush/0000-0002-6034-7562; Verderio, Paolo/0000-0002-9231-1281; Peterlongo, Paolo/0000-0001-6951-6855; Radice, Paolo/0000-0001-6298-4111	Fondazione Italiana per la Ricerca sul Cancro; Associazione Italiana per la Ricerca sul Cancro [4017]; Ministero della Salute [RFPS-2006-3-340203]; Ministero dell'Universita e Ricerca [RBLAO3-BETH]; Istituto Superiore di Sanita [D/41]; Fondazione IRCCS Istituto Nazionale Tumori	Fondazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute(Ministry of Health, Italy); Ministero dell'Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); Istituto Superiore di Sanita; Fondazione IRCCS Istituto Nazionale Tumori	This study was funded by grants from Fondazione Italiana per la Ricerca sul Cancro (Special Project "Hereditary tumors"), Associazione Italiana per la Ricerca sul Cancro (4017), Ministero della Salute (RFPS-2006-3-340203; Extraordinary National Cancer Program 2006, "Alleanza contro il Cancro"; "Progetto Tumori Femminili"), Ministero dell'Universita e Ricerca (RBLAO3-BETH), Istituto Superiore di Sanita (D/41), and by funds from Italian citizens who allocated the 5x1000 share of their tax payment in support of the Fondazione IRCCS Istituto Nazionale Tumori, according to Italian laws (INT-Institutional strategic projects '5x1000'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Balia C, 2010, FAM CANCER, V9, P531, DOI 10.1007/s10689-010-9382-1; Brendel V, 2004, BIOINFORMATICS, V20, P1157, DOI 10.1093/bioinformatics/bth058; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Catucci I, 2010, HUM MUTAT, V31, pE1052, DOI 10.1002/humu.21141; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Hollestelle A, 2010, CURR OPIN GENET DEV, V20, P268, DOI 10.1016/j.gde.2010.02.009; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landwehr R, 2011, BREAST CANCER RES TR, V130, P1021, DOI 10.1007/s10549-011-1681-1; Manoukian S, 2007, EUR J CANCER, V43, P601, DOI 10.1016/j.ejca.2006.09.024; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Papi L, 2010, FAM CANCER, V9, P181, DOI 10.1007/s10689-009-9295-z; Pertea M, 2001, NUCLEIC ACIDS RES, V29, P1185, DOI 10.1093/nar/29.5.1185; Peterlongo P, 2011, BREAST CANCER RES TR, V126, P825, DOI 10.1007/s10549-010-1305-1; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	26	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31038	10.1371/journal.pone.0031038	http://dx.doi.org/10.1371/journal.pone.0031038			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383991	Green Submitted, gold, Green Published			2022-12-27	WOS:000302916100013
J	Daidone, F; Montioli, R; Paiardini, A; Cellini, B; Macchiarulo, A; Giardina, G; Bossa, F; Voltattorni, CB				Daidone, Frederick; Montioli, Riccardo; Paiardini, Alessandro; Cellini, Barbara; Macchiarulo, Antonio; Giardina, Giorgio; Bossa, Francesco; Voltattorni, Carla Borri			Identification by Virtual Screening and In Vitro Testing of Human DOPA Decarboxylase Inhibitors	PLOS ONE			English	Article							3,4-DIHYDROXYPHENYLALANINE DECARBOXYLASE; BENSERAZIDE; MUTATION; PLASMA; HOMOCYSTEINE; METABOLISM; CARBIDOPA; EFFICIENT; DOCKING; LEADS	Dopa decarboxylase (DDC), a pyridoxal 5'-phosphate (PLP) enzyme responsible for the biosynthesis of dopamine and serotonin, is involved in Parkinson's disease (PD). PD is a neurodegenerative disease mainly due to a progressive loss of dopamine-producing cells in the midbrain. Co-administration of L-Dopa with peripheral DDC inhibitors (carbidopa or benserazide) is the most effective symptomatic treatment for PD. Although carbidopa and trihydroxybenzylhydrazine (the in vivo hydrolysis product of benserazide) are both powerful irreversible DDC inhibitors, they are not selective because they irreversibly bind to free PLP and PLP-enzymes, thus inducing diverse side effects. Therefore, the main goals of this study were (a) to use virtual screening to identify potential human DDC inhibitors and (b) to evaluate the reliability of our virtual-screening (VS) protocol by experimentally testing the "in vitro" activity of selected molecules. Starting from the crystal structure of the DDC-carbidopa complex, a new VS protocol, integrating pharmacophore searches and molecular docking, was developed. Analysis of 15 selected compounds, obtained by filtering the public ZINC database, yielded two molecules that bind to the active site of human DDC and behave as competitive inhibitors with K-i values >= 10 mu M. By performing in silico similarity search on the latter compounds followed by a substructure search using the core of the most active compound we identified several competitive inhibitors of human DDC with K-i values in the low micromolar range, unable to bind free PLP, and predicted to not cross the blood-brain barrier. The most potent inhibitor with a K-i value of 500 nM represents a new lead compound, targeting human DDC, that may be the basis for lead optimization in the development of new DDC inhibitors. To our knowledge, a similar approach has not been reported yet in the field of DDC inhibitors discovery.	[Daidone, Frederick; Paiardini, Alessandro; Giardina, Giorgio; Bossa, Francesco] Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, Rome, Italy; [Montioli, Riccardo; Cellini, Barbara; Voltattorni, Carla Borri] Univ Verona, Dept Life Sci & Reprod, I-37100 Verona, Italy; [Macchiarulo, Antonio] Univ Perugia, Dept Chem & Drug Technol, I-06100 Perugia, Italy	Sapienza University Rome; University of Verona; University of Perugia	Daidone, F (corresponding author), Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, Rome, Italy.	carla.borrivoltattorni@univr.it	Cellini, Barbara/AAC-6401-2019; Giardina, Giorgio/C-7529-2009; Giardina, Giorgio/M-8882-2019; Macchiarulo, Antonio/L-2846-2017	Cellini, Barbara/0000-0002-5221-9288; Giardina, Giorgio/0000-0002-0802-1370; Giardina, Giorgio/0000-0002-0802-1370; Macchiarulo, Antonio/0000-0001-9535-4183; Paiardini, Alessandro/0000-0001-9078-7545	Italian Ministero dell'Universita e della Ricerca; "Consorzio Interuniversitario per le Applicazioni di Supercalcolo per Universita e Ricerca" (CASPUR, Roma, Italy) [STD10-281]; Consorzio Interuniversitario per le Biotecnologie (CIB)	Italian Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); "Consorzio Interuniversitario per le Applicazioni di Supercalcolo per Universita e Ricerca" (CASPUR, Roma, Italy); Consorzio Interuniversitario per le Biotecnologie (CIB)	This work was supported by grants from the Italian Ministero dell'Universita e della Ricerca, from the "Consorzio Interuniversitario per le Applicazioni di Supercalcolo per Universita e Ricerca" (STD10-281; CASPUR, Roma, Italy), and by the Consorzio Interuniversitario per le Biotecnologie (CIB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN P, 1995, NEUROTOXICOLOGY, V16, P527; [Anonymous], MACCS STRUCT KEYS; BENDER DA, 1980, BIOCHEM PHARMACOL, V29, P707, DOI 10.1016/0006-2952(80)90544-4; BENDER DA, 1979, CLIN SCI MOL MED, V56, P89, DOI 10.1042/cs0560089; BENDER DA, 1980, BIOCHEM PHARMACOL, V29, P2099, DOI 10.1016/0006-2952(80)90179-3; Bertoldi M, 2002, J BIOL CHEM, V277, P36357, DOI 10.1074/jbc.M204867200; Bertoldi M, 2001, EUR J BIOCHEM, V268, P2975, DOI 10.1046/j.1432-1327.2001.02187.x; Bertoldi M, 1999, J BIOL CHEM, V274, P5514, DOI 10.1074/jbc.274.9.5514; Bertoldi M, 1996, J BIOL CHEM, V271, P23954, DOI 10.1074/jbc.271.39.23954; Bissantz C, 2000, J MED CHEM, V43, P4759, DOI 10.1021/jm001044l; BORRIVOLTATTORNI C, 1977, FEBS LETT, V75, P277, DOI 10.1016/0014-5793(77)80102-6; BORRIVOLTATTORNI C, 1977, EXPERIENTIA, V33, P158, DOI 10.1007/BF02124039; Burkhard P, 2001, NAT STRUCT BIOL, V8, P963, DOI 10.1038/nsb1101-963; CHARTERIS A, 1975, ANAL BIOCHEM, V66, P365, DOI 10.1016/0003-2697(75)90604-1; Chen Z, 2009, ACTA PHARMACOL SIN, V30, P1694, DOI 10.1038/aps.2009.159; Clark DE, 1999, J PHARM SCI, V88, P815, DOI 10.1021/js980402t; DOMINICI P, 1993, BIOCHEM J, V295, P493, DOI 10.1042/bj2950493; Dominici P, 1997, PROTEIN SCI, V6, P2007, DOI 10.1002/pro.5560060921; DOMINICI P, 1985, J BIOL CHEM, V260, P583; EBADI MS, 1968, J NEUROCHEM, V15, P659, DOI 10.1111/j.1471-4159.1968.tb08964.x; Gardian G, 2010, INT J CLIN PHARM TH, V48, P633; HARTMAN WJ, 1955, J BIOL CHEM, V216, P507; Hauser RA, 2009, EUR NEUROL, V62, P1, DOI 10.1159/000215875; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jiang XH, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-18; Kuhn W, 1998, EUR NEUROL, V40, P225, DOI 10.1159/000007984; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; MCCORMICK D, 1961, J BIOL CHEM, V236, P2085; McInnes C, 2007, CURR OPIN CHEM BIOL, V11, P494, DOI 10.1016/j.cbpa.2007.08.033; Miller JW, 2003, NEUROLOGY, V60, P1125, DOI 10.1212/01.WNL.0000055899.24594.8E; Montioli R, 2011, J INHERIT METAB DIS; Moore PS, 1997, FEBS LETT, V412, P245, DOI 10.1016/S0014-5793(97)00788-6; Moriguchi IHS, 1992, CHEM PHARM BULL, V40, P4; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; OPACKAJUFFRY J, 1995, MOVEMENT DISORD, V10, P241, DOI 10.1002/mds.870100302; Perola E, 2010, J MED CHEM, V53, P2986, DOI 10.1021/jm100118x; SCHWARTZ DE, 1978, ARZNEIMITTEL-FORSCH, V28-1, P302; SHERALD AF, 1973, ANAL BIOCHEM, V56, P300, DOI 10.1016/0003-2697(73)90194-2; Stahl M, 2001, J MED CHEM, V44, P1035, DOI 10.1021/jm0003992; Standaert DG, TREATMENT CENTRAL NE, P533; TANCINI B, 1985, ARCH BIOCHEM BIOPHYS, V238, P565, DOI 10.1016/0003-9861(85)90201-2; Tanimoto T.T., 1957, NOV, V17, P1957; Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; VOLTATTO.CB, 1971, FEBS LETT, V17, P231, DOI 10.1016/0014-5793(71)80153-9; VOLTATTORNI CB, 1981, LIFE SCI, V28, P103, DOI 10.1016/0024-3205(81)90372-6; VOLTATTORNI CB, 1983, BIOCHEMISTRY-US, V22, P2249, DOI 10.1021/bi00278a030; Wang RX, 2001, J CHEM INF COMP SCI, V41, P1422, DOI 10.1021/ci010025x	48	50	52	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31610	10.1371/journal.pone.0031610	http://dx.doi.org/10.1371/journal.pone.0031610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384042	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100026
J	Dainat, B; Evans, JD; Chen, YP; Gauthier, L; Neumann, P				Dainat, Benjamin; Evans, Jay D.; Chen, Yan Ping; Gauthier, Laurent; Neumann, Peter			Predictive Markers of Honey Bee Colony Collapse	PLOS ONE			English	Article							DEFORMED WING VIRUS; APIS-MELLIFERA L.; VARROA-DESTRUCTOR; PARALYSIS VIRUS; NOSEMA-CERANAE; WINTER LOSSES; INNATE IMMUNE; TRANSMISSION; KASHMIR; INFECTIONS	Across the Northern hemisphere, managed honey bee colonies, Apis mellifera, are currently affected by abrupt depopulation during winter and many factors are suspected to be involved, either alone or in combination. Parasites and pathogens are considered as principal actors, in particular the ectoparasitic mite Varroa destructor, associated viruses and the microsporidian Nosema ceranae. Here we used long term monitoring of colonies and screening for eleven disease agents and genes involved in bee immunity and physiology to identify predictive markers of honeybee colony losses during winter. The data show that DWV, Nosema ceranae, Varroa destructor and Vitellogenin can be predictive markers for winter colony losses, but their predictive power strongly depends on the season. In particular, the data support that V. destructor is a key player for losses, arguably in line with its specific impact on the health of individual bees and colonies.	[Dainat, Benjamin; Gauthier, Laurent; Neumann, Peter] Swiss Bee Res Ctr, Agroscope Liebefeld Posieux Res Stn ALP, Bern, Switzerland; [Evans, Jay D.; Chen, Yan Ping] ARS, Bee Res Lab, USDA, Beltsville, MD USA; [Neumann, Peter] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa	Swiss Federal Research Station Agroscope; United States Department of Agriculture (USDA); Rhodes University	Dainat, B (corresponding author), Swiss Bee Res Ctr, Agroscope Liebefeld Posieux Res Stn ALP, Bern, Switzerland.	benjamin.dainat@alp.admin.ch	Neumann, Peter/C-9964-2015; Evans, Jay D/C-8408-2012; Dainat, Benjamin/AFN-8922-2022	Neumann, Peter/0000-0001-5163-5215; Evans, Jay D/0000-0002-0036-4651; Dainat, Benjamin/0000-0002-1740-7136	Swiss Federal Veterinary Office	Swiss Federal Veterinary Office	This work was supported by a grant of the Swiss Federal Veterinary Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi A, TRENDS ECOL IN PRESS, V27; Amdam GV, 2004, EXP GERONTOL, V39, P767, DOI 10.1016/j.exger.2004.02.010; Amdam GV, 2004, J ECON ENTOMOL, V97, P741, DOI 10.1603/0022-0493(2004)097[0741:APIWHB]2.0.CO;2; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; ANDERSON DL, 1988, J GEN VIROL, V69, P1617, DOI 10.1099/0022-1317-69-7-1617; BAILEY L, 1963, VIROLOGY, V21, P390, DOI 10.1016/0042-6822(63)90200-9; Ball B.V., 1988, P457; BALL BV, 1988, ANN APPL BIOL, V113, P237, DOI 10.1111/j.1744-7348.1988.tb03300.x; Berthoud H, 2010, J APICULT RES, V49, P60, DOI 10.3896/IBRA.1.49.1.08; Boncristiani HF, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-221; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Chan QWT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-387; Chauzat MP, 2010, J APICULT RES, V49, P40, DOI 10.3896/IBRA.1.49.1.06; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2004, APIDOLOGIE, V35, P441, DOI 10.1051/apido:2004031; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dahle B, 2010, J APICULT RES, V49, P124, DOI 10.3896/IBRA.1.49.1.26; Dainat B, 2012, ENV MICROBIOL REP, V4, P123, DOI 10.1111/j.1758-2229.2011.00312.x; DALL DJ, 1985, ANN APPL BIOL, V106, P461, DOI 10.1111/j.1744-7348.1985.tb03136.x; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS30, DOI 10.1016/j.jip.2009.06.014; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; de Miranda JR, 2010, J GEN VIROL, V91, P2524, DOI 10.1099/vir.0.022434-0; Di Prisco G, 2011, J GEN VIROL, V92, P151, DOI 10.1099/vir.0.023853-0; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Fievet J, VIROLOGY J, V3, P1; Flottum K., 1997, HONEY BEE PESTS PRED, P11; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Gauthier L, 2007, APIDOLOGIE, V38, P426, DOI 10.1051/apido:2007026; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Goodwin RM, 2006, J APICULT RES, V45, P155, DOI 10.1080/00218839.2006.11101335; Govan VA, 2000, VIROLOGY, V277, P457, DOI 10.1006/viro.2000.0616; Gregory PG, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.7; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Higes M, ENV MICROBIOL, V10, P2659; Higes M, 2010, ENV MICROBIOL REP, V2, P745, DOI 10.1111/j.1758-2229.2010.00170.x; Higes M, 2010, ENV MICROBIOL REP, V2, P243, DOI 10.1111/j.1758-2229.2009.00099.x; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; Highfield AC, APPL ENV MICROBIOL, V75, P7212; IMDORF A, 1987, APIDOLOGIE, V18, P137, DOI 10.1051/apido:19870204; IMDORF A, 2003, APIACTA, V38, P258; Imdorf A, 1998, BEE BIZ, V7, P37; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; MERZ R, 1979, REV SUISSE ZOOL, V86, P663, DOI 10.5962/bhl.part.82329; Mockel N, 2011, J GEN VIROL, V92, P370, DOI 10.1099/vir.0.025940-0; Munch D, 2008, FUNCT ECOL, V22, P407, DOI 10.1111/j.1365-2435.2008.01419.x; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ribiere M., 2008, VIROLOGY HONEY BEE, P15, DOI DOI 10.1016/J.JVIROMET.2019.04.020; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Schafer MO, 2010, J ECON ENTOMOL, V103, P10, DOI 10.1603/EC09233; Schmid MR, 2008, J INSECT PHYSIOL, V54, P439, DOI 10.1016/j.jinsphys.2007.11.002; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Shen MQ, 2005, J GEN VIROL, V86, P2281, DOI 10.1099/vir.0.80824-0; Simone M, 2009, EVOLUTION, V63, P3016, DOI 10.1111/j.1558-5646.2009.00772.x; Sumpter DJT, 2004, J ANIM ECOL, V73, P51, DOI 10.1111/j.1365-2656.2004.00776.x; Tentcheva D, APPL ENV MICROBIOL, V70, P7185; Santillan-Galicia MT, 2010, J APICULT RES, V49, P141, DOI 10.3896/IBRA.1.49.2.01; TRENCZEK T, 1988, INSECT BIOCHEM, V18, P299, DOI 10.1016/0020-1790(88)90095-9; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Wilson-Rich N, 2008, J INSECT PHYSIOL, V54, P1392, DOI 10.1016/j.jinsphys.2008.07.016; Yang X, 2007, PARASITOLOGY, V134, P405, DOI 10.1017/S0031182006000710; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102	72	240	248	4	213	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32151	10.1371/journal.pone.0032151	http://dx.doi.org/10.1371/journal.pone.0032151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384162	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100055
J	Hancioglu, B; Tyson, JJ				Hancioglu, Baris; Tyson, John J.			A Mathematical Model of Mitotic Exit in Budding Yeast: The Role of Polo Kinase	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; QUANTIZED CYCLE TIMES; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; CDC14 RELEASE; FISSION YEAST; M-PHASE; PHOSPHATASE CDC14; SPINDLE CHECKPOINT; DNA-REPLICATION	Cell cycle progression in eukaryotes is regulated by periodic activation and inactivation of a family of cyclin-dependent kinases (Cdk's). Entry into mitosis requires phosphorylation of many proteins targeted by mitotic Cdk, and exit from mitosis requires proteolysis of mitotic cyclins and dephosphorylation of their targeted proteins. Mitotic exit in budding yeast is known to involve the interplay of mitotic kinases (Cdk and Polo kinases) and phosphatases (Cdc55/PP2A and Cdc14), as well as the action of the anaphase promoting complex (APC) in degrading specific proteins in anaphase and telophase. To understand the intricacies of this mechanism, we propose a mathematical model for the molecular events during mitotic exit in budding yeast. The model captures the dynamics of this network in wild-type yeast cells and 110 mutant strains. The model clarifies the roles of Polo-like kinase (Cdc5) in the Cdc14 early anaphase release pathway and in the G-protein regulated mitotic exit network.	[Hancioglu, Baris; Tyson, John J.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Hancioglu, B (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	barish@rice.edu	Tyson, John J/A-2942-2014	Tyson, John J/0000-0001-7560-6013	National Institutes of Health [R01-GM079207]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by the National Institutes of Health Grant R01-GM079207 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Barberis M, 2007, PLOS COMPUT BIOL, V3, P649, DOI 10.1371/journal.pcbi.0030064; Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6; BOURNE HR, 1995, PHILOS T R SOC B, V349, P283, DOI 10.1098/rstb.1995.0114; Calzone L, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100171; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Ciliberto A, 2003, J CELL BIOL, V163, P1243, DOI 10.1083/jcb.200306139; Ciliberto A, 2000, B MATH BIOL, V62, P37, DOI 10.1006/bulm.1999.0129; Cohen-Fix O, 1999, GENE DEV, V13, P1950, DOI 10.1101/gad.13.15.1950; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Csikasz-Nagy A, 2007, CURR GENET, V51, P245, DOI 10.1007/s00294-007-0123-4; Geymonat M, 2003, J BIOL CHEM, V278, P14591, DOI 10.1074/jbc.C300059200; Gonze D, 2001, J THEOR BIOL, V210, P167, DOI 10.1006/jtbi.2000.2294; He E, 2011, P NATL ACAD SCI USA, V108, P10016, DOI 10.1073/pnas.1102106108; Hu FH, 2001, CELL, V107, P655, DOI 10.1016/S0092-8674(01)00580-3; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Lee SE, 2001, J CELL SCI, V114, P2345; Liang FS, 2009, MOL BIOL CELL, V20, P3671, DOI 10.1091/mbc.E08-10-1049; Lopez-Aviles S, 2009, NATURE, V459, P592, DOI 10.1038/nature07984; Lu Y, 2010, CELL, V141, P268, DOI 10.1016/j.cell.2010.03.021; Lu Y, 2009, MOL BIOL CELL, V20, P1576, DOI 10.1091/mbc.E08-10-1042; Lygeros J, 2008, P NATL ACAD SCI USA, V105, P12295, DOI 10.1073/pnas.0805549105; Manzoni R, 2010, J CELL BIOL, V190, P209, DOI 10.1083/jcb.201002026; NOVAK B, 1993, J CELL SCI, V106, P1153; NOVAK B, 1995, J THEOR BIOL, V173, P283, DOI 10.1006/jtbi.1995.0063; Novak B, 1997, P NATL ACAD SCI USA, V94, P9147, DOI 10.1073/pnas.94.17.9147; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(05)00017-1; Pereira G, 2002, J CELL BIOL, V157, P367, DOI 10.1083/jcb.200112085; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Prinz S, 1998, CURR BIOL, V8, P750, DOI 10.1016/S0960-9822(98)70298-2; Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; SHIRAYAMA M, 1994, MOL CELL BIOL, V14, P7476, DOI 10.1128/MCB.14.11.7476; Shirayama M, 1996, MOL GEN GENET, V251, P176; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Shou WY, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-3; Snead JL, 2007, CHEM BIOL, V14, P1261, DOI 10.1016/j.chembiol.2007.09.011; Song SG, 2001, J CELL BIOL, V152, P451, DOI 10.1083/jcb.152.3.451; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Steuer R, 2004, J THEOR BIOL, V228, P293, DOI 10.1016/j.jtbi.2004.01.012; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Sveiczer A, 2000, P NATL ACAD SCI USA, V97, P7865, DOI 10.1073/pnas.97.14.7865; Vinod PK, 2011, J R SOC INTERFACE, V8, P1128, DOI 10.1098/rsif.2010.0649; Visintin C, 2008, GENE DEV, V22, P79, DOI 10.1101/gad.1601308; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 2003, MOL BIOL CELL; Wang YC, 2006, MOL BIOL CELL, V17, P80, DOI 10.1091/mbc.E04-12-1109; Yellman CM, 2006, MOL BIOL CELL, V17, P658, DOI 10.1091/mbc.E05-04-0336; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X; Yoshida S, 2002, BIOCHEM BIOPH RES CO, V294, P687, DOI 10.1016/S0006-291X(02)00544-2; Yoshida S, 2002, CURR BIOL, V12, P944, DOI 10.1016/S0960-9822(02)00870-9; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	62	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e30810	10.1371/journal.pone.0030810	http://dx.doi.org/10.1371/journal.pone.0030810			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383977	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916100009
J	Li, CW; Yu, S; Zhong, XL; Wu, JG; Li, XD				Li, Chengwei; Yu, Shuang; Zhong, Xiaoling; Wu, Jianguo; Li, Xiaodong			Circadian Rhythms of Fetal Liver Transcription Persist in the Absence of Canonical Circadian Clock Gene Expression Rhythms In Vivo	PLOS ONE			English	Article							RAT SUPRACHIASMATIC NUCLEUS; PERINATAL-PERIOD; OSCILLATORS; ONTOGENY; MOUSE; MICE; COORDINATION; ORGANIZATION; METABOLISM; PACEMAKER	The cellular circadian clock and systemic cues drive rhythmicity in the transcriptome of adult peripheral tissues. However, the oscillating status of the circadian clocks in fetal tissues, and their response to maternal cues, are less clear. Most clock genes do not cycle in fetal livers from mice and rats, although tissue level rhythms rapidly emerge when fetal mouse liver explants are cultured in vitro. Thus, in the fetal mouse liver, the circadian clock does not oscillate at the cellular level (but is induced to oscillate in culture). To gain a comprehensive overview of the clock status in the fetal liver during late gestation, we performed microarray analyses on fetal liver tissues. In the fetal liver we did not observe circadian rhythms of clock gene expression or many other transcripts known to be rhythmically expressed in the adult liver. Nevertheless, JTK_CYCLE analysis identified some transcripts in the fetal liver that were rhythmically expressed, albeit at low amplitudes. Upon data filtering by coefficient of variation, the expression levels for transcripts related to pancreatic exocrine enzymes and zymogen secretion were found to undergo synchronized daily fluctuations at high amplitudes. These results suggest that maternal cues influence the fetal liver, despite the fact that we did not detect circadian rhythms of canonical clock gene expression in the fetal liver. These results raise important questions on the role of the circadian clock, or lack thereof, during ontogeny.	[Li, Chengwei; Yu, Shuang; Zhong, Xiaoling; Wu, Jianguo; Li, Xiaodong] Wuhan Univ, Coll Life Sci, Natl Key Lab Virol, Wuhan 430072, Hubei Province, Peoples R China	Wuhan University	Li, CW (corresponding author), Wuhan Univ, Coll Life Sci, Natl Key Lab Virol, Wuhan 430072, Hubei Province, Peoples R China.	xiaodli@whu.edu.cn		Wu, Jianguo/0000-0002-8326-2895; Zhong, Xiaoling/0000-0003-2963-4798	National Mega Project on Major Drug Development [2011ZX09401-302-1, 2009ZX09301-014-1]; National Basic Research Program of China [2009CB918304]; China Ministry of Education [20070486102]	National Mega Project on Major Drug Development; National Basic Research Program of China(National Basic Research Program of China); China Ministry of Education(Ministry of Education, China)	This research was supported by National Mega Project on Major Drug Development (2011ZX09401-302-1 and 2009ZX09301-014-1), the National Basic Research Program of China (2009CB918304), and by the China Ministry of Education grant 20070486102. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari N, 2009, EUR J NEUROSCI, V29, P477, DOI 10.1111/j.1460-9568.2008.06605.x; BATTAGLIA FC, 1978, PHYSIOL REV, V58, P499, DOI 10.1152/physrev.1978.58.2.499; BOHME HJ, 1983, EXPERIENTIA, V39, P473; BRANNON PM, 1990, ANNU REV NUTR, V10, P85, DOI 10.1146/annurev.nu.10.070190.000505; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; Dolatshad H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009855; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; GIRARD JR, 1977, AM J PHYSIOL, V232, pE456, DOI 10.1152/ajpendo.1977.232.5.E456; Grosse D, 1998, J NEUROSCI, V18, P8032; Guo HG, 2006, J NEUROSCI, V26, P6406, DOI 10.1523/JNEUROSCI.4676-05.2006; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; REPPERT SM, 1983, SCIENCE, V220, P969, DOI 10.1126/science.6844923; Schibler U, 2009, J BIOL RHYTHM, V24, P3, DOI 10.1177/0748730408329383; Sladek M, 2004, P NATL ACAD SCI USA, V101, P6231, DOI 10.1073/pnas.0401149101; Sladek M, 2007, AM J PHYSIOL-REG I, V292, pR1224, DOI 10.1152/ajpregu.00184.2006; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Sugino H, 2007, FEBS LETT, V581, P355, DOI 10.1016/j.febslet.2006.12.039; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; VISWANATHAN N, 1994, J NEUROSCI, V14, P5393; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Vujovic N, 2008, AM J PHYSIOL-REG I, V295, pR355, DOI 10.1152/ajpregu.00498.2007; Walker JR, 2005, METHOD ENZYMOL, V393, P366, DOI 10.1016/S0076-6879(05)93016-4; Wasle B, 2005, BIOCHEM J, V385, P721; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yamazaki S, 2009, J BIOL RHYTHM, V24, P55, DOI 10.1177/0748730408328438; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368	44	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e30781	10.1371/journal.pone.0030781	http://dx.doi.org/10.1371/journal.pone.0030781			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383974	Green Submitted, gold, Green Published			2022-12-27	WOS:000302916100006
J	Bergstad, OA; Clark, L; Hansen, HO; Cousins, N				Bergstad, Odd Aksel; Clark, Laura; Hansen, Hege Overbo; Cousins, Nicola			Distribution, Population Biology, and Trophic Ecology of the Deepwater Demersal Fish Halosauropsis macrochir (Pisces: Halosauridae) on the Mid-Atlantic Ridge	PLOS ONE			English	Article							AGE-DETERMINATION; HOPLOSTETHUS-ATLANTICUS; MIDOCEAN RIDGE; ORANGE ROUGHY; VALIDATION; GROWTH; NOTACANTHIFORMES; TRACHICHTHYIDAE; STRATEGIES; DIVERSITY	Halosauropsis macrochir ranked amongst the most abundant and widespread demersal fishes on the mid-Atlantic Ridge of the North Atlantic (Iceland-Azores) with greatest abundance at 1700-3500 m. All sizes, ranging from 10-76 cm total length, occurred in the area without any apparent spatial pattern or depth trend. Using otolith sections displaying growth increments assumed to represent annuli, the age range recorded was 2-36 years, but most individuals were <20 years. Length and weight at age data were used to fit growth models. No differences between sexes in length and weight at age were observed. The majority of samples had a surplus of males. Diet analysis showed that H. macrochir feeds on Crustacea, Teleostei, Polychaeta, and Cephalopoda, but few prey could be identified to lower taxonomical levels. The mid-Atlantic Ridge constitutes a major portion of the North Atlantic living space of the abyssal halosaur where it completes its full life cycle, primarily as an actively foraging euryophagous micronekton/epibenthos and infauna feeder, becoming a partial piscivore with increasing size.	[Bergstad, Odd Aksel; Hansen, Hege Overbo] Inst Marine Res, Flodevigen, His, Norway; [Clark, Laura] Scottish Nat Heritage, Inverness, Scotland; [Cousins, Nicola] Univ Aberdeen, Aberdeen, Scotland	Institute of Marine Research - Norway; University of Aberdeen	Bergstad, OA (corresponding author), Inst Marine Res, Flodevigen, His, Norway.	oddaksel@imr.no		Bergstad, Odd Aksel/0000-0002-4096-0896	NERC [NE/C512961/1, NE/C512988/1, NE/C51297X/1, NE/C512996/1, NE/C51300X/1] Funding Source: UKRI; Natural Environment Research Council [NE/C51300X/1, NE/C512988/1, NE/C512961/1, NE/C512996/1, NE/C51297X/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Albert O. T., 2009, J NW ATLANTIC FISHER, V40, P81, DOI DOI 10.2960/J.V40.M659; Andrews AH, 1999, CAN J FISH AQUAT SCI, V56, P1339, DOI 10.1139/cjfas-56-8-1339; Bergstad OA, 2008, DEEP-SEA RES PT II, V55, P185, DOI 10.1016/j.dsr2.2007.09.005; Bergstad OA, 2008, DEEP-SEA RES PT II, V55, P1, DOI 10.1016/j.dsr2.2007.10.001; BERGSTAD OA, 1990, MAR BIOL, V107, P25, DOI 10.1007/BF01313239; Bergstad OA, 1995, NATO ASI SERIES E, V296, P267; Cailliet GM, 2001, EXP GERONTOL, V36, P739, DOI 10.1016/S0531-5565(00)00239-4; CAMPANA SE, 1990, CAN J FISH AQUAT SCI, V47, P163, DOI 10.1139/f90-017; Campana SE, 2005, MAR FRESHWATER RES, V56, P485, DOI 10.1071/MF04147; CAMPBELL RA, 1977, J PARASITOL, V63, P76, DOI 10.2307/3280106; CHANG WYB, 1982, CAN J FISH AQUAT SCI, V39, P1208, DOI 10.1139/f82-158; CRABTREE RE, 1985, B MAR SCI, V36, P235; ENGAS A, 1989, J CONSEIL, V45, P269; Felley JD, 2008, DEEP-SEA RES PT II, V55, P153, DOI 10.1016/j.dsr2.2007.09.021; FENTON GE, 1991, MAR BIOL, V109, P197, DOI 10.1007/BF01319387; Gartner John V. Jr, 1997, P115; Klimpel S, 2008, DEEP-SEA RES PT II, V55, P229, DOI 10.1016/j.dsr2.2007.09.006; Klimpel S, 2010, DEEP-SEA RES PT I, V57, P596, DOI 10.1016/j.dsr.2010.01.002; MACHIDA Y, 1988, JPN J ICHTHYOL, V35, P78; MAUCHLINE J, 1991, MAR ECOL PROG SER, V74, P109, DOI 10.3354/meps074109; MAUCHLINE J, 1985, J FISH BIOL, V26, P527, DOI 10.1111/j.1095-8649.1985.tb04293.x; Merrett N. R., 1997, FISH FISHERIES SERIE; SEDBERRY GR, 1978, MAR BIOL, V44, P357, DOI 10.1007/BF00390900; Smith DG, 2002, LIVING MARINE RESOUR, V2, P685; Sulak K.J., 1986, P593; SULAK KJ, 1977, COPEIA, P11; Sulak KJ, 1984, THESIS U MIAMI; Sulak KJ, 1990, CHECK LIST FISHES E, V1, P126; Swan S, 1996, J FISH BIOL, V49, P289; Swan SC, 2001, FISH RES, V51, P177, DOI 10.1016/S0165-7836(01)00244-2; Tracey DM, 1999, NEW ZEAL J MAR FRESH, V33, P67, DOI 10.1080/00288330.1999.9516858; Treble MA, 2008, CAN J FISH AQUAT SCI, V65, P1047, DOI 10.1139/F08-030; Wenneek TL, 2008, DEEP-SEA RES PT II, V55, P6, DOI 10.1016/j.dsr2.2007.09.017	33	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31493	10.1371/journal.pone.0031493	http://dx.doi.org/10.1371/journal.pone.0031493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384030	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500022
J	Pillet, L; Fontaine, D; Pawlowski, J				Pillet, Loic; Fontaine, Delia; Pawlowski, Jan			Intra-Genomic Ribosomal RNA Polymorphism and Morphological Variation in Elphidium macellum Suggests Inter-Specific Hybridization in Foraminifera	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; SECONDARY STRUCTURE; SMALL-SUBUNIT; SEQUENCE HETEROGENEITY; CONCERTED EVOLUTION; RDNA; GENE; DNA; ITS1; IDENTIFICATION	Elphidium macellum is a benthic foraminifer commonly found in the Patagonian fjords. To test whether its highly variable morphotypes are ecophenotypes or different genotypes, we analysed 70 sequences of the SSU rRNA gene from 25 specimens. Unexpectedly, we identified 11 distinct ribotypes, with up to 5 ribotypes co-occurring within the same specimen. The ribotypes differ by varying blocks of sequence located at the end of stem-loop motifs in the three expansion segments specific to foraminifera. These changes, distinct from typical SNPs and indels, directly affect the structure of the expansion segments. Their mosaic distribution suggests that ribotypes originated by recombination of two or more clusters of ribosomal genes. We propose that this expansion segment polymorphism (ESP) could originate from hybridization of morphologically different populations of Patagonian Elphidium. We speculate that the complex geological history of Patagonia enhanced divergence of coastal foraminiferal species and contributed to increasing genetic and morphological variation.	[Pillet, Loic; Fontaine, Delia; Pawlowski, Jan] Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland	University of Geneva	Pillet, L (corresponding author), Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland.	loic.pillet@unige.ch	Pawlowski, Jan/AAO-3306-2021	Pawlowski, Jan/0000-0003-2421-388X	Swiss National Science Foundation [31003A_125372]; Ernest Boninchi Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ernest Boninchi Foundation	This work was supported by the Swiss National Science Foundation (www.snf.ch) grant 31003A_125372 (JP) and a grant from the Ernest Boninchi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani AD, 1993, U NEW S WALES CTR MA, V5, P1; Alverson AJ, 2005, J PHYCOL, V41, P1248, DOI 10.1111/j.1529-8817.2005.00136.x; Arnold M.L., 1997, NATURAL HYBRIDIZATIO, P215; Bass D, 2009, PROTIST, V160, P483, DOI 10.1016/j.protis.2009.01.004; BOLTOVSKOY E, 1980, Journal of Foraminiferal Research, V10, P163; BOLTOVSKOY E, 1991, J PALEONTOL, V65, P175, DOI 10.1017/S0022336000020394; Bowser Samuel S., 2008, P78; BROWN DD, 1972, J MOL BIOL, V63, P57, DOI 10.1016/0022-2836(72)90521-9; BUZAS MA, 1985, J PALEONTOL, V59, P1075; BYRNE M, 1994, EVOLUTION, V48, P564, DOI 10.1111/j.1558-5646.1994.tb01344.x; Carranza S, 1996, MOL BIOL EVOL, V13, P824, DOI 10.1093/oxfordjournals.molbev.a025643; Casteleyn G, 2009, PROTIST, V160, P343, DOI 10.1016/j.protis.2008.11.002; CHAN YL, 1983, NUCLEIC ACIDS RES, V11, P7819, DOI 10.1093/nar/11.22.7819; Clapperton C. M., 1993, QUATERNARY GEOLOGY G, P779; CLARK CG, 1984, NUCLEIC ACIDS RES, V12, P6197, DOI 10.1093/nar/12.15.6197; COEN E, 1982, J MOL BIOL, V158, P17, DOI 10.1016/0022-2836(82)90448-X; Coyer JA, 2001, J PHYCOL, V37, P574, DOI 10.1046/j.1529-8817.2001.037001574.x; D'Alelio D, 2009, PROTIST, V160, P9, DOI 10.1016/j.protis.2008.07.001; d'Orbigny AD, 1839, VOYAGE AM MERIDIONAL, P86; Edvardsen B, 2003, J PHYCOL, V39, P395, DOI 10.1046/j.1529-8817.2003.01252.x; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Fama P, 2000, EUR J PHYCOL, V35, P349, DOI 10.1080/09670260010001735951; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fenton B, 1998, GENOME, V41, P337, DOI 10.1139/gen-41-3-337; Fiore-Donno AM, 2010, J EUKARYOT MICROBIOL, V57, P189, DOI 10.1111/j.1550-7408.2009.00466.x; Franceschini G, 2005, S AFR J GEOL, V108, P285, DOI 10.2113/108.2.285; Galloway J. J, 1933, MANUAL FORAMINIFERA, P483; GONZALEZ IL, 1985, P NATL ACAD SCI USA, V82, P7666, DOI 10.1073/pnas.82.22.7666; GORSKI JL, 1987, J MOL EVOL, V24, P236, DOI 10.1007/BF02111237; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HANCOCK JM, 1990, NUCLEIC ACIDS RES, V18, P5949, DOI 10.1093/nar/18.20.5949; Harper FM, 2007, INVERTEBR BIOL, V126, P373, DOI 10.1111/j.1744-7410.2007.00107.x; Harris DJ, 2000, MOL BIOL EVOL, V17, P284, DOI 10.1093/oxfordjournals.molbev.a026308; Hart MC, 2007, HARMFUL ALGAE, V6, P271, DOI 10.1016/j.hal.2006.10.001; Hartmann S, 2001, J MOL EVOL, V53, P124, DOI 10.1007/s002390010200; HASSOUNA N, 1984, NUCLEIC ACIDS RES, V12, P3563, DOI 10.1093/nar/12.8.3563; Haynes J.R., 1992, Journal of Micropalaeontology, V11, P59; HAYWARD BW, 1994, MICROPALEONTOLOGY, V40, P185, DOI 10.2307/1485816; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hollis C. J, 1997, I GEOLOGICAL NUCL SC, V16, P170; Holzmann M, 1996, J MOL EVOL, V43, P145, DOI 10.1007/BF02337359; Holzmann M, 2001, MAR MICROPALEONTOL, V43, P57, DOI 10.1016/S0377-8398(01)00021-4; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jeeps MW, 1942, J MAR BIOL ASSOC UK, V25, P612; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kita Y, 2000, PLANT SYST EVOL, V225, P1, DOI 10.1007/BF00985455; Lee J. J., 1991, BIOL FORAMINIFERA, P285; LEFFERS H, 1993, NUCLEIC ACIDS RES, V21, P1449, DOI 10.1093/nar/21.6.1449; Lena H., 1966, Ameghiniana, V4, P311; Lister JJ., 1896, PHILOSOPH TRANSACT R, V186, P401; Litaker RW, 2007, J PHYCOL, V43, P344, DOI 10.1111/j.1529-8817.2007.00320.x; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Malumian N, 2005, AMEGHINIANA, V42, P363; Malumián N., 2006, Rev. Asoc. Geol. Argent., V61, P139; Malumian N, 2011, BIOL J LINN SOC, V103, P269, DOI 10.1111/j.1095-8312.2011.01649.x; MASHKOVA TD, 1981, NUCLEIC ACIDS RES, V9, P2141, DOI 10.1093/nar/9.9.2141; McTaggart SJ, 2005, MOL BIOL EVOL, V22, P1309, DOI 10.1093/molbev/msi119; MILLER AAL, 1982, J FORAMIN RES, V12, P116, DOI 10.2113/gsjfr.12.2.116; Moreira D, 2007, MOL PHYLOGENET EVOL, V44, P255, DOI 10.1016/j.ympev.2006.11.001; Muir G, 2001, MOL BIOL EVOL, V18, P112, DOI 10.1093/oxfordjournals.molbev.a003785; Nanez C., 1990, REV ASOC GEOL ARGENT, V43, P493; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nylander JAA, 2004, MRAIC PL 1 4 3 PROGR; O'Mahony EM, 2007, J EUKARYOT MICROBIOL, V54, P103, DOI 10.1111/j.1550-7408.2006.00232.x; Pawlowski J, 2000, MICROPALEONTOLOGY, V46, P1; Pawlowski J, 2010, J EUKARYOT MICROBIOL, V57, P197, DOI 10.1111/j.1550-7408.2009.00468.x; PETERSON RC, 1980, CELL, V20, P131, DOI 10.1016/0092-8674(80)90241-X; Pillet L, 2011, PROTIST, V162, P394, DOI 10.1016/j.protis.2010.10.001; Poag CW, 1978, GULF COAST ASS GEOLO, V28, P395; Rooney AP, 2005, P NATL ACAD SCI USA, V102, P5084, DOI 10.1073/pnas.0409689102; Rooney AP, 2004, MOL BIOL EVOL, V21, P1704, DOI 10.1093/molbev/msh178; Ruggiero MV, 2004, J MOL EVOL, V58, P115, DOI 10.1007/s00239-003-2536-0; SCHNITKER D, 1974, Journal of Foraminiferal Research, V4, P217; Schweizer M, 2008, MAR MICROPALEONTOL, V66, P233, DOI 10.1016/j.marmicro.2007.10.003; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Wang Y, 1997, J BACTERIOL, V179, P3270, DOI 10.1128/jb.179.10.3270-3276.1997; WEGNEZ M, 1972, FEBS LETT, V25, P13, DOI 10.1016/0014-5793(72)80443-5; WILKINSON IP, 1979, J PALEONTOL, V53, P628; Wuyts J, 2001, NUCLEIC ACIDS RES, V29, P5017, DOI 10.1093/nar/29.24.5017	82	60	63	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32373	10.1371/journal.pone.0032373	http://dx.doi.org/10.1371/journal.pone.0032373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393402	gold, Green Published, Green Submitted			2022-12-27	WOS:000303003500055
J	Prados-Torres, A; Poblador-Plou, B; Calderon-Larranaga, A; Gimeno-Feliu, LA; Gonzalez-Rubio, F; Poncel-Falco, A; Sicras-Mainar, A; Alcala-Nalvaiz, JT				Prados-Torres, Alexandra; Poblador-Plou, Beatriz; Calderon-Larranaga, Amaia; Andres Gimeno-Feliu, Luis; Gonzalez-Rubio, Francisca; Poncel-Falco, Antonio; Sicras-Mainar, Antoni; Tomas Alcala-Nalvaiz, Jose			Multimorbidity Patterns in Primary Care: Interactions among Chronic Diseases Using Factor Analysis	PLOS ONE			English	Article							METABOLIC SYNDROME; COMORBIDITY; PREVALENCE; OBESITY; HEALTH; RISK; EPIDEMIOLOGY; LIPOTOXICITY; COMPLEXITY; MORBIDITY	Objectives: The primary objective of this study was to identify the existence of chronic disease multimorbidity patterns in the primary care population, describing their clinical components and analysing how these patterns change and evolve over time both in women and men. The secondary objective of this study was to generate evidence regarding the pathophysiological processes underlying multimorbidity and to understand the interactions and synergies among the various diseases. Methods: This observational, retrospective, multicentre study utilised information from the electronic medical records of 19 primary care centres from 2008. To identify multimorbidity patterns, an exploratory factor analysis was carried out based on the tetra-choric correlations between the diagnostic information of 275,682 patients who were over 14 years of age. The analysis was stratified by age group and sex. Results: Multimorbidity was found in all age groups, and its prevalence ranged from 13% in the 15 to 44 year age group to 67% in those 65 years of age or older. Goodness-of-fit indicators revealed sample values between 0.50 and 0.71. We identified five patterns of multimorbidity: cardio-metabolic, psychiatric-substance abuse, mechanical-obesity-thyroidal, psychogeriatric and depressive. Some of these patterns were found to evolve with age, and there were differences between men and women. Conclusions: Non-random associations between chronic diseases result in clinically consistent multimorbidity patterns affecting a significant proportion of the population. Underlying pathophysiological phenomena were observed upon which action can be taken both from a clinical, individual-level perspective and from a public health or population-level perspective.	[Prados-Torres, Alexandra; Poblador-Plou, Beatriz; Calderon-Larranaga, Amaia] Univ Zaragoza, Miguel Servet Univ Hosp, Aragon Hlth Sci Inst, IIS Aragon, Zaragoza, Spain; [Andres Gimeno-Feliu, Luis] Univ Zaragoza, San Pablo Hlth Ctr, Aragon Hlth Sci Inst, IIS Aragon, Zaragoza, Spain; [Gonzalez-Rubio, Francisca] S Delicias Hlth Ctr, IIS Aragon, Aragon Hlth Sci Inst, Zaragoza, Spain; [Poncel-Falco, Antonio] Primary Care Directorate Aragon Healthcare Serv, Aragon Hlth Sci Inst, IIS Aragon, Zaragoza, Spain; [Sicras-Mainar, Antoni] Badalona Serveis Assistencials SA, Planning Management, Badalona, Spain; [Tomas Alcala-Nalvaiz, Jose] Univ Zaragoza, Stat Methods Dept, Zaragoza, Spain	Miguel Servet University Hospital; University of Zaragoza; University of Zaragoza; University of Zaragoza	Prados-Torres, A (corresponding author), Univ Zaragoza, Miguel Servet Univ Hosp, Aragon Hlth Sci Inst, IIS Aragon, Zaragoza, Spain.	acalderon.iacs@aragon.es	Calderón-Larrañaga, Amaia/ABC-6828-2021; Gimeno-Feliu, Luis Andrés/E-5390-2016; Prados-Torres, Alexandra/P-5818-2017; Alcala, Jose Tomas/A-7358-2013; Gonzalez Rubio, Francisca/GPT-3556-2022; Poblador-Plou, Beatriz/ABC-7915-2020; Rubio, Francisca Gonzalez/ABD-1444-2020	Calderón-Larrañaga, Amaia/0000-0001-9064-9222; Gimeno-Feliu, Luis Andrés/0000-0003-2928-6623; Prados-Torres, Alexandra/0000-0002-5704-6056; Alcala, Jose Tomas/0000-0001-7549-8825; Gonzalez Rubio, Francisca/0000-0001-5939-4436; Poblador-Plou, Beatriz/0000-0002-5119-5093; Rubio, Francisca Gonzalez/0000-0001-5939-4436	Carlos III Health Institute [PI052752]; Program for the Incorporation of Research Groups into the Spanish Health System [EMER 07/020]	Carlos III Health Institute(Instituto de Salud Carlos III); Program for the Incorporation of Research Groups into the Spanish Health System	This study was funded by grant PI052752 from the Carlos III Health Institute and the Program for the Incorporation of Research Groups into the Spanish Health System (EMER 07/020). The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Abilleira S, 2009, GUIA PRACTICA CLIN P; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Barbarroja N, 2010, BIOCHEM J, V430, P141, DOI 10.1042/BJ20100285; Barbee J G, 1998, Ann Clin Psychiatry, V10, P15, DOI 10.3109/10401239809148814; Barlow DH, 2000, COMPR PSYCHIAT, V41, P55, DOI 10.1016/S0010-440X(00)80009-7; Bayliss Elizabeth A, 2003, Ann Fam Med, V1, P15, DOI 10.1370/afm.4; Bernardo F, 2003, GUIA BUENA PRACTICA; BRAND FN, 1988, AM J PREV MED, V4, P96, DOI 10.1016/S0749-3797(18)31203-0; Britt HC, 2008, MED J AUSTRALIA, V189, P72, DOI 10.5694/j.1326-5377.2008.tb01919.x; Brown T, 2009, OBES REV, V10, P627, DOI 10.1111/j.1467-789X.2009.00641.x; Choi HK, 2008, RHEUMATOLOGY, V47, P1567, DOI 10.1093/rheumatology/ken305; Coccurello R, 2010, PHARMACOL THERAPEUT, V127, P210, DOI 10.1016/j.pharmthera.2010.04.008; Cornell JE, 2007, APPL MULTIVARIATE RE, V2007, P163, DOI [10.22329/amr.v12i3.658, DOI 10.22329/AMR.V12I3.658]; DIXON L, 1991, AM J PSYCHIAT, V148, P224; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Fernandez E, 2003, EUR J CANCER PREV, V12, P57, DOI 10.1097/00008469-200302000-00009; Fortin M, 2006, ANN FAM MED, V4, P104, DOI 10.1370/afm.516; Fortin M, 2006, QUAL LIFE RES, V15, P83, DOI 10.1007/s11136-005-8661-z; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fortin Martin, 2005, Can Fam Physician, V51, P244; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Guralnik JM, 1996, ANN EPIDEMIOL, V6, P376, DOI 10.1016/S1047-2797(96)00060-9; Hansagi H, 2001, ANN EMERG MED, V37, P561, DOI 10.1067/mem.2001.111762; Hennessey James V, 2007, J Fam Pract, V56, pS31; Holden L, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-15; Informacion y Estadisticas Sanitarias-Ministerio de Sanidad y Consumo, 2008, CLASS INT ENF 9 REV; KOVACIC B, 1986, J NEURAL TRANSM, V65, P39, DOI 10.1007/BF01249610; Kubinger K., 2003, PSYCHOL SCI, V45, P106, DOI DOI 10.1177/014662169101500105; Kuepper R, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d738; Lamberts H., 1987, ICPC INT CLASSIFICAT; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; McDermott Michael T, 2009, Ann Intern Med, V151, pITC61, DOI 10.7326/0003-4819-151-11-200912010-01006; McKenney JM, 2006, AM J CARDIOL, V97, p89C, DOI 10.1016/j.amjcard.2006.02.030; Mueser KT, 1998, ADDICT BEHAV, V23, P717, DOI 10.1016/S0306-4603(98)00073-2; Nardi R, 2007, EUR J INTERN MED, V18, P359, DOI 10.1016/j.ejim.2007.05.002; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Palomo Luis, 2006, Gac Sanit, V20 Suppl 1, P182, DOI 10.1157/13086042; Pandolfino JE, 2006, GASTROENTEROLOGY, V130, P639, DOI 10.1053/j.gastro.2005.12.016; Parsons JK, 2009, J UROLOGY, V182, pS27, DOI 10.1016/j.juro.2009.07.086; Pottie P, 2006, ANN RHEUM DIS, V65, P1403, DOI 10.1136/ard.2006.061994; Rho YH, 2005, J KOREAN MED SCI, V20, P1029, DOI 10.3346/jkms.2005.20.6.1029; Richardson K, 2011, DRUG AGING, V28, P547, DOI 10.2165/11592000-000000000-00000; Safford MM, 2007, J GEN INTERN MED, V22, P382, DOI 10.1007/s11606-007-0307-0; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Schafer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014060; Schellevis FG, 1993, CHRONIC DIS GEN PRAC; Schulden JD, 2009, CURR PSYCHIAT REP, V11, P353, DOI 10.1007/s11920-009-0053-6; Skerman HM, 2009, RES NURS HEALTH, V32, P345, DOI 10.1002/nur.20323; Sociedad Espanola de Geriatria y Gerontologia (SEGG), 2006, TRAT GER RES; Sorensen TIA, 2010, BBA-MOL CELL BIOL L, V1801, P400, DOI 10.1016/j.bbalip.2009.12.011; Starfield B, 2006, ANN FAM MED, V4, P101, DOI 10.1370/afm.524; Starfield Barbara, 2011, Prim Health Care Res Dev, V12, P1, DOI 10.1017/S1463423610000484; Starfield Barbara, 2003, Ann Fam Med, V1, P8, DOI 10.1370/afm.1; Starfleld B, 2005, ANN FAM MED, V3, P215, DOI 10.1370/afm.307; Tabchnic B, 2006, USING MULTIVARIATE S; The Johns Hopkins ACG&REG;System, 2008, REF MAN VERS 8 2; Vaccarino V, 2011, CARDIOVASC RES, V90, P9, DOI 10.1093/cvr/cvq394; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; van den Akker M, 2001, J CLIN EPIDEMIOL, V54, P675, DOI 10.1016/S0895-4356(00)00358-9; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203	63	165	166	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32190	10.1371/journal.pone.0032190	http://dx.doi.org/10.1371/journal.pone.0032190			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	928SI	22393389	gold, Green Published, Green Submitted			2022-12-27	WOS:000303003500042
J	Puget, S; Philippe, C; Bax, DA; Job, B; Varlet, P; Junier, MP; Andreiuolo, F; Carvalho, D; Reis, R; Guerrini-Rousseau, L; Roujeau, T; Dessen, P; Richon, C; Lazar, V; Le Teuff, G; Sainte-Rose, C; Geoerger, B; Vassal, G; Jones, C; Grill, J				Puget, Stephanie; Philippe, Cathy; Bax, Dorine A.; Job, Bastien; Varlet, Pascale; Junier, Marie-Pierre; Andreiuolo, Felipe; Carvalho, Dina; Reis, Ricardo; Guerrini-Rousseau, Lea; Roujeau, Thomas; Dessen, Philippe; Richon, Catherine; Lazar, Vladimir; Le Teuff, Gwenael; Sainte-Rose, Christian; Geoerger, Birgit; Vassal, Gilles; Jones, Chris; Grill, Jacques			Mesenchymal Transition and PDGFRA Amplification/Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine Gliomas	PLOS ONE			English	Article							BRAIN-STEM GLIOMAS; RECURRENT MALIGNANT GLIOMAS; COPY NUMBER ABERRATIONS; GROWTH-FACTOR; STEREOTACTIC BIOPSY; IMATINIB MESYLATE; TUMOR CONSORTIUM; EXPRESSION; CELLS; CHILDREN	Diffuse intrinsic pontine glioma (DIPG) is one of the most frequent malignant pediatric brain tumor and its prognosis is universaly fatal. No significant improvement has been made in last thirty years over the standard treatment with radiotherapy. To address the paucity of understanding of DIPGs, we have carried out integrated molecular profiling of a large series of samples obtained with stereotactic biopsy at diagnosis. While chromosomal imbalances did not distinguish DIPG and supratentorial tumors on CGHarrays, gene expression profiling revealed clear differences between them, with brainstem gliomas resembling midline/thalamic tumours, indicating a closely-related origin. Two distinct subgroups of DIPG were identified. The first subgroup displayed mesenchymal and pro-angiogenic characteristics, with stem cell markers enrichment consistent with the possibility to grow tumor stem cells from these biopsies. The other subgroup displayed oligodendroglial features, and appeared largely driven by PDGFRA, in particular through amplification and/or novel missense mutations in the extracellular domain. Patients in this later group had a significantly worse outcome with an hazard ratio for early deaths, ie before 10 months, 8 fold greater that the ones in the other subgroup (p = 0.041, Cox regression model). The worse outcome of patients with the oligodendroglial type of tumors was confirmed on a series of 55 paraffin-embedded biopsy samples at diagnosis (median OS of 7.73 versus 12.37 months, p = 0.045, log-rank test). Two distinct transcriptional subclasses of DIPG with specific genomic alterations can be defined at diagnosis by oligodendroglial differentiation or mesenchymal transition, respectively. Classifying these tumors by signal transduction pathway activation and by mutation in pathway member genes may be particularily valuable for the development of targeted therapies.	[Puget, Stephanie; Roujeau, Thomas; Sainte-Rose, Christian] Univ Paris 05, Necker Sick Children Hosp, Dept Neurosurg, Paris, France; [Puget, Stephanie; Philippe, Cathy; Andreiuolo, Felipe; Guerrini-Rousseau, Lea; Geoerger, Birgit; Vassal, Gilles; Grill, Jacques] Univ Paris 11, Gustave Roussy Canc Inst, Ctr Natl Rech Sci Vectorol & Anticanc Therapeut, UMR 8203, Villejuif, France; [Bax, Dorine A.; Carvalho, Dina; Jones, Chris] Royal Marsden Hosp, Inst Canc Res, Sect Pediat Oncol, Sutton, Surrey, England; [Job, Bastien; Dessen, Philippe] Univ Paris 11, Integrated Res Canc Inst Villejuif, CNRS, Villejuif, France; [Varlet, Pascale; Junier, Marie-Pierre] Univ Paris 05, St Anne Hosp, Dept Neuropathol, Paris, France; [Varlet, Pascale; Junier, Marie-Pierre] Univ Paris 05, St Anne Hosp, INSERM, Team Glial Plast,UMR 894, Paris, France; [Carvalho, Dina] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Carvalho, Dina; Reis, Ricardo] Univ Minho, Life & Hlth Sci Res Inst, Braga, Portugal; [Richon, Catherine; Lazar, Vladimir] Univ Paris 11, Gustave Roussy Canc Inst, Funct Genom Unit, Villejuif, France; [Le Teuff, Gwenael] Univ Paris 11, Gustave Roussy Canc Inst, Dept Biostat & Epidemiol, Villejuif, France; [Geoerger, Birgit; Grill, Jacques] Univ Paris 11, Gustave Roussy Canc Inst, Dept Pediat & Adolescent Oncol, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidade de Coimbra; Universidade do Minho; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Puget, S (corresponding author), Univ Paris 05, Necker Sick Children Hosp, Dept Neurosurg, Paris, France.	grill@igr.fr	Lazar, Vladimir/AAV-2087-2020; Jones, Chris/ABE-6059-2021; Lazar, Vladimir/AAQ-2086-2020; PHILIPPE, Cathy/GRY-4381-2022	Jones, Chris/0000-0001-8118-2296; PHILIPPE, Cathy/0000-0002-3262-4390; VARLET, pascale/0000-0002-8164-1517; RICHON, Catherine/0000-0002-3556-3941; Andreiuolo, Felipe/0000-0002-2568-6155; Carvalho, Diana/0000-0001-6881-6151	Canceropole Ile de France - Institut National de Cancer (INCa); LEM-Recherche (Les Entreprises du Medicament); association "L'Etoile de Martin''; Association pour la Recherche en Neurochirurgie Pediatrique (ARNP)	Canceropole Ile de France - Institut National de Cancer (INCa); LEM-Recherche (Les Entreprises du Medicament); association "L'Etoile de Martin''; Association pour la Recherche en Neurochirurgie Pediatrique (ARNP)	The sponsors of the study were the Canceropole Ile de France - Institut National de Cancer (INCa), the LEM-Recherche (Les Entreprises du Medicament), the association "L'Etoile de Martin'' and the Association pour la Recherche en Neurochirurgie Pediatrique (ARNP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT AL, 1993, NEUROSURGERY, V33, P1026; Andreiuolo F, 2010, NEURO-ONCOLOGY, V12, P1126, DOI 10.1093/neuonc/noq074; Appolloni I, 2009, INT J CANCER, V124, P2251, DOI 10.1002/ijc.24206; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barrow J, 2011, NEURO-ONCOLOGY, V13, P212, DOI 10.1093/neuonc/noq158; Bax DA, 2010, CLIN CANCER RES, V16, P3368, DOI 10.1158/1078-0432.CCR-10-0438; Bax DA, 2009, CLIN CANCER RES, V15, P5753, DOI 10.1158/1078-0432.CCR-08-3210; Becher OJ, 2010, CANCER RES, V70, P2548, DOI 10.1158/0008-5472.CAN-09-2503; Broniscer A, 2010, CANCER-AM CANCER SOC, V116, P4632, DOI 10.1002/cncr.25405; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cao F, 2010, BIOCHEM BIOPH RES CO, V394, P843, DOI 10.1016/j.bbrc.2010.03.092; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cooper LAD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012548; De Carli E, 2009, NEW ENGL J MED, V360, P2248, DOI 10.1056/NEJMc090593; Diskin SJ, 2006, GENOME RES, V16, P1149, DOI 10.1101/gr.5076506; Donaldson SS, 2006, J CLIN ONCOL, V24, P1266, DOI 10.1200/JCO.2005.04.6599; Ducray F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-234; Ducray F, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-41; Faury D, 2007, J CLIN ONCOL, V25, P1196, DOI 10.1200/JCO.2006.07.8626; Ferletta M, 2007, MOL CANCER RES, V5, P891, DOI 10.1158/1541-7786.MCR-07-0113; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Garcia JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-454; Geoerger B, 2011, NEURO-ONCOLOGY, V13, P109, DOI 10.1093/neuonc/noq141; Geoerger B, 2009, EUR J CANCER, V45, P2342, DOI 10.1016/j.ejca.2009.03.007; Gilbertson RJ, 2007, CANCER RES, V67, P5579, DOI 10.1158/0008-5472.CAN-07-0760; Gilbertson RJ, 2003, CLIN CANCER RES, V9, P3620; Guillemot Vincent, 2008, International Conference on Biocomputation, Bioinformatics, and Biomedical Technologies (BIOTECHNO 2008), P164, DOI 10.1109/BIOTECHNO.2008.17; Hargrave D, 2008, BRIT J NEUROSURG, V22, P624, DOI 10.1080/02688690802484405; Hargrove D, 2006, LANCET ONCOL, V7, P241, DOI 10.1016/S1470-2045(06)70615-5; Herrington B, 2009, PEDIATR BLOOD CANCER, V53, P312, DOI 10.1002/pbc.21950; Holdhoff M, 2005, BLOOD CELL MOL DIS, V34, P181, DOI 10.1016/j.bcmd.2004.11.006; Holdhoff M, 2010, J NEURO-ONCOL, V97, P241, DOI 10.1007/s11060-009-0008-0; Jalali R, 2010, INT J RADIAT ONCOL, V77, P113, DOI 10.1016/j.ijrobp.2009.04.031; Kast RE, 2010, TRANSL ONCOL, V3, P13, DOI 10.1593/tlo.09280; Kessler J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-605; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Lagas JS, 2009, CLIN CANCER RES, V15, P2344, DOI 10.1158/1078-0432.CCR-08-2253; Lee JC, 2006, PLOS MED, V3, P2264, DOI 10.1371/journal.pmed.0030485; Lee Y, 2007, ONCOGENE, V26, P6442, DOI 10.1038/sj.onc.1210467; Lei L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020041; Lin Kimberly, 2010, Genes Cancer, V1, P409; Lindberg N, 2009, ONCOGENE, V28, P2266, DOI 10.1038/onc.2009.76; Liu QH, 2009, J NEURO-ONCOL, V94, P1, DOI 10.1007/s11060-009-9919-z; LOUIS DN, 1993, J NEUROPATH EXP NEUR, V52, P507, DOI 10.1097/00005072-199309000-00009; Lucas JT, 2010, ONCOGENE, V29, P4449, DOI 10.1038/onc.2010.185; Masui K, 2010, GLIA, V58, P1050, DOI 10.1002/glia.20986; Mehta S, 2011, CANCER CELL, V19, P359, DOI 10.1016/j.ccr.2011.01.035; Modena P, 2006, J CLIN ONCOL, V24, P5223, DOI 10.1200/JCO.2006.06.3701; Monje M, 2011, P NATL ACAD SCI USA, V108, P4453, DOI 10.1073/pnas.1101657108; Negri T, 2009, J PATHOL, V217, P103, DOI 10.1002/path.2450; Okada H, 2008, J NEURO-ONCOL, V88, P245, DOI 10.1007/s11060-008-9566-9; Ozawa T, 2010, GENE DEV, V24, P2205, DOI 10.1101/gad.1972310; Palm T, 2009, CANCER-AM CANCER SOC, V115, P3955, DOI 10.1002/cncr.24476; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Paulsson J, 2011, INT J CANCER, V128, P1981, DOI 10.1002/ijc.25528; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pincus DW, 2006, J NEUROSURG, V104, P108, DOI 10.3171/ped.2006.104.2.108; Pollack IF, 2007, NEURO-ONCOLOGY, V9, P145, DOI 10.1215/15228517-2006-031; Pollack IF, 2011, CHILD NERV SYST, V27, P87, DOI 10.1007/s00381-010-1264-1; Pozniak CD, 2010, P NATL ACAD SCI USA, V107, P21795, DOI 10.1073/pnas.1016485107; Puget S, 2007, J NEUROSURG, V106, P354, DOI 10.3171/ped.2007.106.5.354; Qaddoumi I, 2009, CANCER, V115, P5761, DOI 10.1002/cncr.24663; Qu HQ, 2010, NEURO-ONCOLOGY, V12, P153, DOI 10.1093/neuonc/nop001; Roujeau T, 2007, J NEUROSURG, V107, P1, DOI 10.3171/PED-07/07/001; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Russell JS, 2003, CANCER RES, V63, P7377; Salari K, 2010, BIOINFORMATICS, V26, P414, DOI 10.1093/bioinformatics/btp702; Schiffman JD, 2010, CANCER RES, V70, P512, DOI 10.1158/0008-5472.CAN-09-1851; Schumacher M, 2007, J NEUROSURG, V106, P111, DOI 10.3171/ped.2007.106.2.111; Sharma MK, 2007, CANCER RES, V67, P890, DOI 10.1158/0008-5472.CAN-06-0973; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takada N, 2010, GLIA, V58, P996, DOI 10.1002/glia.20981; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Thirant C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016375; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang Y, 2010, ONCOGENE, V29, P4658, DOI 10.1038/onc.2010.218; Wen PY, 2006, CLIN CANCER RES, V12, P4899, DOI 10.1158/1078-0432.CCR-06-0773; Zarghooni M, 2010, J CLIN ONCOL, V28, P1337, DOI 10.1200/JCO.2009.25.5463	79	168	171	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e30313	10.1371/journal.pone.0030313	http://dx.doi.org/10.1371/journal.pone.0030313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389665	Green Published, Green Submitted, gold			2022-12-27	WOS:000302999600002
J	Richardson, E; Stockwell, SR; Li, H; Aherne, W; Cuomo, ME; Mittnacht, S				Richardson, Elizabeth; Stockwell, Simon R.; Li, He; Aherne, Wynne; Cuomo, Maria Emanuela; Mittnacht, Sibylle			Mechanism-Based Screen Establishes Signalling Framework for DNA Damage-Associated G1 Checkpoint Response	PLOS ONE			English	Article							P53-DEPENDENT G(1) ARREST; SYNTHETIC LETHAL INTERACTIONS; CELL-CYCLE CHECKPOINTS; RETINOBLASTOMA PROTEIN; RADIATION RESPONSE; CANCER-CELLS; IONIZING-RADIATION; KINASE; P53; CHK1	DNA damage activates checkpoint controls which block progression of cells through the division cycle. Several different checkpoints exist that control transit at different positions in the cell cycle. A role for checkpoint activation in providing resistance of cells to genotoxic anticancer therapy, including chemotherapy and ionizing radiation, is widely recognized. Although the core molecular functions that execute different damage activated checkpoints are known, the signals that control checkpoint activation are far from understood. We used a kinome-spanning RNA interference screen to delineate signalling required for radiation-mediated retinoblastoma protein activation, the recognized executor of G(1) checkpoint control. Our results corroborate the involvement of the p53 tumour suppressor (TP53) and its downstream targets p21(CIP1/WAF1) but infer lack of involvement of canonical double strand break (DSB) recognition known for its role in activating TP53 in damaged cells. Instead our results predict signalling involving the known TP53 phosphorylating kinase PRPK/TP53RK and the JNK/p38MAPK activating kinase STK4/MST1, both hitherto unrecognised for their contribution to DNA damage G(1) checkpoint signalling. Our results further predict a network topology whereby induction of p21(CIP1/WAF1) is required but not sufficient to elicit checkpoint activation. Our experiments document a role of the kinases identified in radiation protection proposing their pharmacological inhibition as a potential strategy to increase radiation sensitivity in proliferating cancer cells.	[Richardson, Elizabeth; Stockwell, Simon R.; Cuomo, Maria Emanuela; Mittnacht, Sibylle] UCL Canc Inst, Dept Canc Biol, London, England; [Richardson, Elizabeth; Stockwell, Simon R.; Li, He; Cuomo, Maria Emanuela; Mittnacht, Sibylle] Inst Canc Res, Div Canc Biol, London SW3 6JB, England; [Aherne, Wynne] Inst Canc Res, Div Canc Therapeut, London SW3 6JB, England	University of London; University College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Richardson, E (corresponding author), UCL Canc Inst, Dept Canc Biol, London, England.	sibylle.mittnacht@cancer.ucl.ac.uk		Stockwell, Simon/0000-0002-3345-8945	Cancer Research UK [CRC278X, CRM048]	Cancer Research UK(Cancer Research UK)	This work was supported through Cancer Research UK grant numbers CRC278X and CRM048. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2001, J BIOL CHEM, V276, P44003, DOI 10.1074/jbc.M105669200; Agerbaek M, 2003, BRIT J CANCER, V89, P298, DOI 10.1038/sj.bjc.6601063; Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Assoian RK, 2008, CELL CYCLE, V7, P24, DOI 10.4161/cc.7.1.5232; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Broceno C, 2002, P NATL ACAD SCI USA, V99, P14200, DOI 10.1073/pnas.212519499; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Casanovas O, 2000, J BIOL CHEM, V275, P35091, DOI 10.1074/jbc.M006324200; Chan TA, 2000, GENE DEV, V14, P1584; Chehab NH, 2000, GENE DEV, V14, P278; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Chen ZH, 2006, INT J CANCER, V119, P2784, DOI 10.1002/ijc.22198; Chen ZH, 2003, MOL CANCER THER, V2, P543; Choo DW, 2009, BIOCHEM BIOPH RES CO, V378, P847, DOI 10.1016/j.bbrc.2008.11.132; Claudio P, 2002, GENOME BIOL, V3; Dahele M, 2010, J ROY COLL PHYS EDIN, V40, P136, DOI 10.4997/JRCPE.2010.209; DECKBAR D, CANC RES, V70, P4412; Densham RM, 2009, MOL CELL BIOL, V29, P6380, DOI 10.1128/MCB.00116-09; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; DOU QP, 1995, P NATL ACAD SCI USA, V92, P9019, DOI 10.1073/pnas.92.20.9019; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elshaikh M, 2006, ANNU REV MED, V57, P19, DOI 10.1146/annurev.med.57.121304.131431; Fasanaro P, 2006, FASEB J, V20, P1242, DOI 10.1096/fj.05-4695fje; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Gu JM, 2004, MOL BIOL CELL, V15, P3320, DOI 10.1091/mbc.E04-03-0227; HAAPAJARVI T, 1995, ONCOGENE, V11, P151; HALL M, 1995, ONCOGENE, V11, P1581; Harrington EA, 1998, P NATL ACAD SCI USA, V95, P11945, DOI 10.1073/pnas.95.20.11945; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hitomi M, 2008, MOL CELL BIOL, V28, P5478, DOI 10.1128/MCB.02047-07; JAHNSON S, 1995, EUR UROL, V28, P135; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; Jorgensen TJ, 2009, CANCER BIOL THER, V8, P665, DOI 10.4161/cbt.8.8.8304; Kalia VK, 2009, J CANCER RES THER, V5, P57, DOI 10.4103/0973-1482.55145; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Kinsella TJ, 2009, SEMIN ONCOL, V36, pS42, DOI 10.1053/j.seminoncol.2009.02.004; Knudsen ES, 2006, CURR MOL MED, V6, P749; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lin YS, 2002, J BIOL CHEM, V277, P47991, DOI 10.1074/jbc.M202630200; Lindsay KJ, 2007, BRIT J RADIOL, V80, pS2, DOI 10.1259/bjr/60507340; Liu QH, 2000, GENE DEV, V14, P1448; LUDLOW JW, 1993, ONCOGENE, V8, P331; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; Moonen L, 2001, INT J RADIAT ONCOL, V49, P1305, DOI 10.1016/S0360-3016(00)01503-0; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Pauwels B, 2010, FUTURE ONCOL, V6, P1485, DOI 10.2217/FON.10.104; Petersen L, 2010, CELL PROLIFERAT, V43, P365, DOI 10.1111/j.1365-2184.2010.00685.x; Peterson D, 1953, CANCER RES, V70, P6325; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pollack A, 1997, CLIN CANCER RES, V3, P1823; Reinhardt HC, 2010, MOL CELL, V40, P34, DOI 10.1016/j.molcel.2010.09.018; Reinhardt HC, 2009, CELL CYCLE, V8, P3112, DOI 10.4161/cc.8.19.9626; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Shieh SY, 2000, GENE DEV, V14, P289; SLEBOS RJC, 1994, P NATL ACAD SCI USA, V91, P5320, DOI 10.1073/pnas.91.12.5320; SMITH ML, 1994, EXP CELL RES, V215, P386, DOI 10.1006/excr.1994.1356; Stewart ZA, 2001, CHEM RES TOXICOL, V14, P243, DOI 10.1021/tx000199t; Swanton C, 2007, CELL CYCLE, V6, P2001, DOI 10.4161/cc.6.16.4538; Tomida A, 1996, ONCOGENE, V13, P2699; Tschop K, 2011, GENE DEV, V25, P814, DOI 10.1101/gad.2000211; Uto K, 2004, EMBO J, V23, P3386, DOI 10.1038/sj.emboj.7600328; Veech RL, 2003, P NATL ACAD SCI USA, V100, P5578, DOI 10.1073/pnas.1132039100; Ward JF, 2000, COLD SPRING HARB SYM, V65, P377, DOI 10.1101/sqb.2000.65.377; Warmerdam DO, 2010, MUTAT RES-REV MUTAT, V704, P2, DOI 10.1016/j.mrrev.2009.12.001; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang XS, 2004, MOL CELL BIOL, V24, P9207, DOI 10.1128/MCB.24.20.9207-9220.2004; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296	84	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31627	10.1371/journal.pone.0031627	http://dx.doi.org/10.1371/journal.pone.0031627			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384045	Green Published, gold, Green Submitted			2022-12-27	WOS:000302918500032
J	Chen, YT; Lee, JJ; Chiang, CY; Yang, GG; Tsai, YC; Lee, YS; Lin, CB				Chen, Yi-Ting; Lee, Jen-Jyh; Chiang, Chen-Yuan; Yang, Gee-Gow; Tsai, Yeong-Chu; Lee, Yeong-Sheng; Lin, Chih-Bin			Effective Interventions and Decline of Antituberculosis Drug Resistance in Eastern Taiwan, 2004-2008	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MEDICAL-CENTER; PATTERN	Background: The Taiwan health authority recently launched several tuberculosis (TB) control interventions, which may have an impact on the epidemic of drug-resistant TB. We conducted a population-based antituberculosis drug resistance surveillance program in Eastern Taiwan to measure the proportions of notified TB patients with anti-TB drug resistance and the trend from 2004 to 2008. Methods and Findings: All culture-positive TB patients were enrolled. Drug susceptibility testing results of the first isolate of each TB patient in each treatment course were analyzed. In total, 2688 patients were included, of which 2176 (81.0%) were new TB cases and 512 (19.0%) were previously treated cases. Among the 2176 new TB cases, 97 (4.5%) were retreated after the first episode of TB treatment within the study period. The proportion of new patients with any resistance, isoniazid resistance but not multidrug-resistant TB (resistant to at least isoniazid and rifampin, MDR-TB), and MDR-TB was 16.4%, 7.5%, and 4.0%, respectively, and that among previously treated cases was 30.9%, 7.9%, and 17.6%, respectively. The combined proportion of any resistance decreased from 23.3% in 2004 to 14.3% in 2008, and that of MDR-TB from 11.5% to 2.4%. Conclusions: The proportion of TB patients with drug-resistant TB in Eastern Taiwan remains substantial. However, an effective TB control program has successfully driven the proportion of drug resistance among TB patients downward.	[Chen, Yi-Ting; Lee, Jen-Jyh; Yang, Gee-Gow; Lin, Chih-Bin] Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Hualien, Taiwan; [Lee, Jen-Jyh; Lin, Chih-Bin] Tzu Chi Univ, Sch Med, Dept Internal Med, Hualien, Taiwan; [Chiang, Chen-Yuan] Int Union TB & Lung Dis, Paris, France; [Chiang, Chen-Yuan] Wan Fang Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Chiang, Chen-Yuan] Taipei Med Univ, Sch Med, Dept Internal Med, Taipei, Taiwan; [Tsai, Yeong-Chu] Buddhist Tzu Chi Gen Hosp, Dept Lab Med, Hualien, Taiwan; [Lee, Yeong-Sheng] Ctr Dis Control, Branch Off 4, Tainan, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Taipei Municipal WanFang Hospital; Taipei Medical University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Centers For Disease Control - Taiwan	Chen, YT (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Hualien, Taiwan.	ferlin@tzuchi.com.tw	Chen, Yi/HIR-2608-2022		Taiwan CDC	Taiwan CDC	We wish to thank Taiwan CDC for its support of the Regional Mycobacteriology Laboratory in Eastern Taiwan. We appreciate Prof. Lee Yi-Hwei for her helpful instruction on statistics.	[Anonymous], 2009, GUID SURV DRUG RES T; Armitage P, 1987, STATISTICAL METHODS, P455; Bureau of National Health Insurance Department of Health Executive Yuan, 2011, INS COV; Cheng SY, 2010, J HEALTHC QUAL, V4, P48; Department of Statistics Ministry of the Interior Executive Yuan, 2011, POP STAT YB INT; Hsu C-B, 2008, TAIWAN EPIDEMIOL B, V24, P230; Infectious Diseases Society of the Republic of China, 2004, J Microbiol Immunol Infect, V37, P382; Jou RW, 2006, EMERG INFECT DIS, V12, P871, DOI 10.3201/eid1205.051688; Kam KM, 2001, INT J TUBERC LUNG D, V5, P815; LEE JJ, 2003, TZU CHI MED J, V15, P229; Liaw YS, 2004, J FORMOS MED ASSOC, V103, P671; Liu WL, 2010, EUR J CLIN MICROBIOL, V29, P1413, DOI 10.1007/s10096-010-1019-7; Lu PL, 2003, INT J ANTIMICROB AG, V21, P239, DOI 10.1016/S0924-8579(02)00353-9; Su CT, 2010, TAIWAN EPIDEMIOLOGY, V26, P400; Van Deun A, 2004, INT J TUBERC LUNG D, V8, P23; *WHO, 2008, 4 WHO IUATLD GLOB PR; Word Health Organization, 1997, ANT DRUG RES WORLD; Yu CC, 2010, J MICROBIOL IMMUNOL, V43, P285, DOI 10.1016/S1684-1182(10)60045-X	18	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31531	10.1371/journal.pone.0031531	http://dx.doi.org/10.1371/journal.pone.0031531			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384034	gold, Green Published, Green Submitted			2022-12-27	WOS:000302916100025
J	Curtis, KA; Rudolph, DL; Nejad, I; Singleton, J; Beddoe, A; Weigl, B; LaBarre, P; Owen, SM				Curtis, Kelly A.; Rudolph, Donna L.; Nejad, Irene; Singleton, Jered; Beddoe, Andy; Weigl, Bernhard; LaBarre, Paul; Owen, S. Michele			Isothermal Amplification Using a Chemical Heating Device for Point-of-Care Detection of HIV-1	PLOS ONE			English	Article							REVERSE-TRANSCRIPTION; RAPID DETECTION; INFECTION; VIRUS; DIAGNOSIS; TUBERCULOSIS; STATE; LAMP; DNA	Background: To date, the use of traditional nucleic acid amplification tests (NAAT) for detection of HIV-1 DNA or RNA has been restricted to laboratory settings due to time, equipment, and technical expertise requirements. The availability of a rapid NAAT with applicability for resource-limited or point-of-care (POC) settings would fill a great need in HIV diagnostics, allowing for timely diagnosis or confirmation of infection status, as well as facilitating the diagnosis of acute infection, screening and evaluation of infants born to HIV-infected mothers. Isothermal amplification methods, such as reverse-transcription, loop-mediated isothermal amplification (RT-LAMP), exhibit characteristics that are ideal for POC settings, since they are typically quicker, easier to perform, and allow for integration into low-tech, portable heating devices. Methodology/Significant Findings: In this study, we evaluated the HIV-1 RT-LAMP assay using portable, non-instrumented nucleic acid amplification (NINA) heating devices that generate heat from the exothermic reaction of calcium oxide and water. The NINA heating devices exhibited stable temperatures throughout the amplification reaction and consistent amplification results between three separate devices and a thermalcycler. The performance of the NINA heaters was validated using whole blood specimens from HIV-1 infected patients. Conclusion: The RT-LAMP isothermal amplification method used in conjunction with a chemical heating device provides a portable, rapid and robust NAAT platform that has the potential to facilitate HIV-1 testing in resource-limited settings and POC.	[Curtis, Kelly A.; Rudolph, Donna L.; Nejad, Irene; Owen, S. Michele] Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Hepatitis STD & TB Prevent, Atlanta, GA 30333 USA; [Singleton, Jered; Beddoe, Andy; Weigl, Bernhard; LaBarre, Paul] PATH, Seattle, WA USA	Centers for Disease Control & Prevention - USA	Curtis, KA (corresponding author), Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Hepatitis STD & TB Prevent, Atlanta, GA 30333 USA.	czv2@cdc.gov			Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported with intramural funding from the Centers for Disease Control and Prevention. No external funding sources were used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson David A, 2011, Curr HIV/AIDS Rep, V8, P31, DOI 10.1007/s11904-010-0067-z; Boehme CC, 2007, J CLIN MICROBIOL, V45, P1936, DOI 10.1128/JCM.02352-06; Branson BM, 2007, CLIN INFECT DIS, V45, pS221, DOI 10.1086/522541; BUTERA ST, 1991, J VIROL, V65, P4645, DOI 10.1128/JVI.65.9.4645-4653.1991; Butto S, 2010, ANN I SUPER SANITA, V46, P24, DOI 10.4415/ANN_10_01_04; Campsmith ML, 2010, JAIDS-J ACQ IMM DEF, V53, P619, DOI 10.1097/QAI.0b013e3181bf1c45; Curtis KA, 2008, J VIROL METHODS, V151, P264, DOI 10.1016/j.jviromet.2008.04.011; Curtis KA, 2009, J MED VIROL, V81, P966, DOI 10.1002/jmv.21490; Enosawa M, 2003, J CLIN MICROBIOL, V41, P4359, DOI 10.1128/JCM.41.9.4359-4365.2003; Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x; Gill P, 2008, NUCLEOS NUCLEOT NUCL, V27, P224, DOI 10.1080/15257770701845204; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; Hara-Kudo Y, 2005, FEMS MICROBIOL LETT, V253, P155, DOI 10.1016/j.femsle.2005.09.032; Hutchinson AB, 2006, AIDS, V20, P1597, DOI 10.1097/01.aids.0000238405.93249.16; Ihira M, 2004, J CLIN MICROBIOL, V42, P140, DOI 10.1128/JCM.42.1.140-145.2004; Iwamoto T, 2003, J CLIN MICROBIOL, V41, P2616, DOI 10.1128/JCM.41.6.2616-2622.2003; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Kurosaki Y, 2007, J VIROL METHODS, V141, P78, DOI 10.1016/j.jviromet.2006.11.031; LaBarre P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019738; LaBarre P, 2010, IEEE ENG MED BIO, P1097, DOI 10.1109/IEMBS.2010.5627346; Liu CC, 2011, ANALYST, V136, P2069, DOI 10.1039/c1an00007a; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; MOK JYQ, 1989, ARCH DIS CHILD, V64, P1140, DOI 10.1136/adc.64.8.1140; Mori Y, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-3; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Okamoto S, 2004, J MED VIROL, V74, P677, DOI 10.1002/jmv.20223; Owen SM, 1998, J VIROL, V72, P5425, DOI 10.1128/JVI.72.7.5425-5432.1998; Pandori Mark W, 2010, Expert Rev Anti Infect Ther, V8, P631, DOI 10.1586/eri.10.48; Poon LLM, 2005, J CLIN MICROBIOL, V43, P427, DOI 10.1128/JCM.43.1.427-430.2005; Schito ML, 2010, J INFECT DIS, V201, pS1, DOI 10.1086/650394; Thai HTC, 2004, J CLIN MICROBIOL, V42, P1956, DOI 10.1128/JCM.42.5.1956-1961.2004; Wesolowski LG, 2009, CLIN VACCINE IMMUNOL, V16, P1091, DOI 10.1128/CVI.00083-09	33	94	103	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31432	10.1371/journal.pone.0031432	http://dx.doi.org/10.1371/journal.pone.0031432			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384022	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100022
J	Falcone, R; Brunamonti, E; Ferraina, S; Genovesio, A				Falcone, Rossella; Brunamonti, Emiliano; Ferraina, Stefano; Genovesio, Aldo			Monkeys Monitor Human Goals in a Nonmatch-to-Goal Interactive Task	PLOS ONE			English	Article							RHESUS-MONKEYS; CAPUCHIN MONKEYS; CEBUS-APELLA; COGNITIVE IMITATION; PREFRONTAL CORTEX; MACACA-MULATTA; GAZE; RESPONSES; NEURONS	We designed a new task, called nonmatch-to-goal, to study the ability of macaque monkeys to interact with humans in a rule-guided paradigm. In this task the monkeys were required to choose one of two targets, from a list of three. For each choice, they were required to switch from their choice on the previous trial to a different one. In a subset of trials the monkeys observed a human partner performing the task. When the human concluded his turn, the monkeys were required to switch to a new goal discarding the human's previous goal. We found that monkeys were very skillful in monitoring goals, not only of their own choice by also those of their human partner. They showed also a surprising ability to coordinate their actions, taking turns with the human partner, starting and stopping their own turn following the decision of the human partner in the task.	[Falcone, Rossella; Brunamonti, Emiliano; Ferraina, Stefano; Genovesio, Aldo] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy	Sapienza University Rome	Falcone, R (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy.	aldo.genovesio@uniroma1.it	ferraina, stefano/M-5230-2018	ferraina, stefano/0000-0001-6100-2438; FALCONE, ROSSELLA/0000-0001-5068-2984; Brunamonti, Emiliano/0000-0002-5119-6950; Genovesio, Aldo/0000-0003-2521-143X	'Sapienza' University of Rome; Ricerca dell'Ateneo Federato di Scienze delle Politiche Pubbliche e Sanitarie [P288/09]	'Sapienza' University of Rome; Ricerca dell'Ateneo Federato di Scienze delle Politiche Pubbliche e Sanitarie	This work was supported by the 'Sapienza' University of Rome, Ricerca dell'Ateneo Federato di Scienze delle Politiche Pubbliche e Sanitarie (Protocol number: P288/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2010, NEURON, V65, P752, DOI 10.1016/j.neuron.2010.03.006; ANDERSON JR, 1995, ANIM BEHAV, V49, P201, DOI 10.1016/0003-3472(95)80168-5; Anderson JR, 1996, BEHAV PROCESS, V37, P47, DOI 10.1016/0376-6357(95)00074-7; Brosnan SF, 2004, J COMP PSYCHOL, V118, P133, DOI 10.1037/0735-7036.118.2.133; Burke CJ, 2010, P NATL ACAD SCI USA, V107, P14431, DOI 10.1073/pnas.1003111107; Chang SWC, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00027; Custance D, 1999, J COMP PSYCHOL, V113, P13, DOI 10.1037/0735-7036.113.1.13; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Dushanova J, 2010, EUR J NEUROSCI, V31, P386, DOI 10.1111/j.1460-9568.2009.07067.x; Emery NJ, 1997, J COMP PSYCHOL, V111, P286, DOI 10.1037/0735-7036.111.3.286; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Fredman T, 2008, ANIM COGN, V11, P295, DOI 10.1007/s10071-007-0117-0; Fujii N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000397; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2011, PERSPECT PSYCHOL SCI, V6, P369, DOI 10.1177/1745691611413392; Genovesio A, 2005, NEURON, V47, P307, DOI 10.1016/j.neuron.2005.06.006; Genovesio A, NEUROSCIENCE RULE GU, P81; Genovesio A, 2006, J NEUROSCI, V26, P7305, DOI 10.1523/JNEUROSCI.0699-06.2006; Hauser MD, 2007, P ROY SOC B-BIOL SCI, V274, P1913, DOI 10.1098/rspb.2007.0586; Hauser MD, 2011, P ROY SOC B-BIOL SCI, V278, P158, DOI 10.1098/rspb.2010.1441; Hirata S, 2007, PRIMATES, V48, P13, DOI 10.1007/s10329-006-0022-1; Mendres KA, 2000, ANIM BEHAV, V60, P523, DOI 10.1006/anbe.2000.1512; Meunier M, 2007, NEUROBIOL LEARN MEM, V88, P243, DOI 10.1016/j.nlm.2007.04.015; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; MYERS WA, 1970, J EXP ANAL BEHAV, V14, P225, DOI 10.1901/jeab.1970.14-225; Rochat P, 2003, CONSCIOUS COGN, V12, P717, DOI 10.1016/S1053-8100(03)00081-3; Sebastian C, 2008, TRENDS COGN SCI, V12, P441, DOI 10.1016/j.tics.2008.07.008; Subiaul F, 2004, SCIENCE, V305, P407, DOI 10.1126/science.1099136; Subiaul F, 2007, ANIM COGN, V10, P369, DOI 10.1007/s10071-006-0070-3; Tomasello M, 1998, ANIM BEHAV, V55, P1063, DOI 10.1006/anbe.1997.0636; Tsujimoto S, 2010, NAT NEUROSCI, V13, P120, DOI 10.1038/nn.2453; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; van Wolkenten M, 2007, P NATL ACAD SCI USA, V104, P18854, DOI 10.1073/pnas.0707182104; VISALBERGHI E, 1989, PRIMATES, V30, P511, DOI 10.1007/BF02380877; VISALBERGHI E, 1993, TOOLS, LANGUAGE AND COGNITION IN HUMAN EVOLUTION, P138; Yoshida K, 2011, CURR BIOL, V21, P249, DOI 10.1016/j.cub.2011.01.004	36	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32209	10.1371/journal.pone.0032209	http://dx.doi.org/10.1371/journal.pone.0032209			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384177	gold, Green Published, Green Submitted			2022-12-27	WOS:000302916100059
J	Tzeng, WN; Tseng, YH; Han, YS; Hsu, CC; Chang, CW; Di Lorenzo, E; Hsieh, CH				Tzeng, Wann-Nian; Tseng, Yu-Heng; Han, Yu-San; Hsu, Chih-Chieh; Chang, Chih-Wei; Di Lorenzo, Emanuele; Hsieh, Chih-hao			Evaluation of Multi-Scale Climate Effects on Annual Recruitment Levels of the Japanese Eel, Anguilla japonica, to Taiwan	PLOS ONE			English	Article							NORTH EQUATORIAL CURRENT; TIME-SERIES; EL-NINO; INTERANNUAL VARIABILITY; LARVAL TRANSPORT; EUROPEAN EEL; SOLAR-CYCLE; COASTAL WATERS; OCEAN; FLUCTUATIONS	Long-term (1967-2008) glass eel catches were used to investigate climatic effects on the annual recruitment of Japanese eel to Taiwan. Specifically, three prevailing hypotheses that potentially explain the annual recruitment were evaluated. Hypothesis 1: high precipitation shifts the salinity front northward, resulting in favorable spawning locations. Hypothesis 2: a southward shift of the position of the North Equatorial Current (NEC) bifurcation provides a favorable larval transport route. Hypothesis 3: ocean conditions (eddy activities and productivity) along the larval migration route influence larval survival. Results of time series regression and wavelet analyses suggest that Hypothesis 1 is not supported, as the glass eel catches exhibited a negative relationship with precipitation. Hypothesis 2 is plausible. However, the catches are correlated with the NEC bifurcation with a one-year lag. Considering the time needed for larval transport (only four to six months), the one-year lag correlation does not support the direct transport hypothesis. Hypothesis 3 is supported indirectly by the results. Significant correlations were found between catches and climate indices that affect ocean productivity and eddy activities, such as the Quasi Biennial Oscillation (QBO), North Pacific Gyre Oscillation (NPGO), Pacific Decadal Oscillation (PDO), and Western Pacific Oscillation (WPO). Wavelet analysis reveals three periodicities of eel catches: 2.7, 5.4, and 10.3 years. The interannual coherence with QBO and the Nino 3.4 region suggests that the shorter-term climate variability is modulated zonally by equatorial dynamics. The low-frequency coherence with WPO, PDO, and NPGO demonstrates the decadal modulation of meridional teleconnection via ocean-atmosphere interactions. Furthermore, WPO and QBO are linked to solar activities. These results imply that the Japanese eel recruitment may be influenced by multi-timescale climate variability. Our findings call for investigation of extra-tropical ocean dynamics that affect survival of eels during transport, in addition to the existing efforts to study the equatorial system.	[Tzeng, Wann-Nian; Han, Yu-San] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Tzeng, Wann-Nian; Han, Yu-San] Natl Taiwan Univ, Inst Fisheries Sci, Taipei 10764, Taiwan; [Tzeng, Wann-Nian] Natl Taiwan Ocean Univ, Dept Environm Biol & Fisheries Sci, Keelung, Taiwan; [Tseng, Yu-Heng] Natl Taiwan Univ, Dept Atmospher Sci, Taipei 10764, Taiwan; [Hsu, Chih-Chieh] Natl Cheng Kung Univ, Earth Dynam Ctr, Tainan 70101, Taiwan; [Hsu, Chih-Chieh] Natl Changhua Univ Educ, Dept Geog, Changhua, Taiwan; [Chang, Chih-Wei] Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan; [Di Lorenzo, Emanuele] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Hsieh, Chih-hao] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; [Hsieh, Chih-hao] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan Ocean University; National Taiwan University; National Cheng Kung University; National Changhua University of Education; National Museum of Marine Biology & Aquarium; University System of Georgia; Georgia Institute of Technology; National Taiwan University; National Taiwan University	Tzeng, WN (corresponding author), Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan.	yhtseng@as.ntu.edu.tw; chsieh@ntu.edu.tw	Di Lorenzo, Emanuele/E-9107-2012; Hsieh, Chih-hao/B-3797-2008	Di Lorenzo, Emanuele/0000-0002-1935-7363; Hsieh, Chih-hao/0000-0001-5935-7272; Tseng, Yu-heng/0000-0002-4816-4974; HAN, YU-SAN/0000-0002-9236-9045	National Taiwan University; National Science Council, Taiwan	National Taiwan University(National Taiwan University); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by the National Taiwan University and the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Baldwin MP, 2001, REV GEOPHYS, V39, P179, DOI 10.1029/1999RG000073; BARNSTON AG, 1987, MON WEATHER REV, V115, P1083, DOI 10.1175/1520-0493(1987)115<1083:CSAPOL>2.0.CO;2; Bonhommeau S, 2008, MAR ECOL PROG SER, V373, P71, DOI 10.3354/meps07696; Bonhommeau S, 2008, FISH OCEANOGR, V17, P32, DOI 10.1111/j.1365-2419.2007.00453.x; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Cheng PW, 1996, MAR ECOL PROG SER, V131, P87, DOI 10.3354/meps131087; Chhak KC, 2009, J CLIMATE, V22, P1255, DOI 10.1175/2008JCLI2639.1; Dekker W, 2003, FISHERIES MANAG ECOL, V10, P365, DOI 10.1111/j.1365-2400.2003.00352.x; Dekker W., 2003, ICES NEWSLETTER, V40, P10; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; Di Lorenzo E, 2010, NAT GEOSCI, V3, P762, DOI [10.1038/NGEO984, 10.1038/ngeo984]; Durif CMF, 2011, P ROY SOC B-BIOL SCI, V278, P464, DOI 10.1098/rspb.2010.1547; FAO, 2011, CULT AQ SPEC INF PRO; Feunteun E, 2002, ECOL ENG, V18, P575, DOI 10.1016/S0925-8574(02)00021-6; Friedland KD, 2007, ICES J MAR SCI, V64, P519, DOI 10.1093/icesjms/fsm022; Gleisner H, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017129; Gray LJ, 2010, REV GEOPHYS, V48, DOI 10.1029/2009RG000282; Haigh JD, 2003, PHILOS T ROY SOC A, V361, P95, DOI 10.1098/rsta.2002.1111; Han YS, 2000, J TAIWAN FISH RES, V8, P37; Han YS, 2008, MAR BIOL, V155, P613, DOI 10.1007/s00227-008-1057-1; Han YS, 2009, ZOOL STUD, V48, P632; Hancock D, 1996, DEV SUSTAINING WORLD, P85; Hsieh CH, 2005, PROG OCEANOGR, V67, P160, DOI 10.1016/j.pocean.2005.05.002; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; Hsieh CH, 2008, CAN J FISH AQUAT SCI, V65, P947, DOI 10.1139/F08-017; Hsieh CH, 2008, AM NAT, V171, P71, DOI 10.1086/524202; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; Hsieh CH, 2006, ECOLOGY, V87, P1932, DOI 10.1890/0012-9658(2006)87[1932:BRTEFT]2.0.CO;2; Hsieh CH, 2009, GLOBAL CHANGE BIOL, V15, P2137, DOI 10.1111/j.1365-2486.2009.01875.x; Hsieh CH, 2009, FISH OCEANOGR, V18, P102, DOI 10.1111/j.1365-2419.2008.00498.x; Ives AR, 2006, ECOL APPL, V16, P20, DOI 10.1890/04-0702; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kettle AJ, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000589; Kim H, 2007, ICES J MAR SCI, V64, P1387, DOI 10.1093/icesjms/fsm091; Kimura S, 2001, FISH OCEANOGR, V10, P51, DOI 10.1046/j.1365-2419.2001.00159.x; Kimura S, 2006, DEEP-SEA RES PT II, V53, P315, DOI 10.1016/j.dsr2.2006.01.009; Klvana I, 2004, AM NAT, V164, P283, DOI 10.1086/423431; Knights B, 2003, SCI TOTAL ENVIRON, V310, P237, DOI 10.1016/S0048-9697(02)00644-7; Kotake A, 2007, ZOOL SCI, V24, P1213, DOI 10.2108/zsj.24.1213; Labitzke K, 2000, J ATMOS SOL-TERR PHY, V62, P621, DOI 10.1016/S1364-6826(00)00047-X; Lean JL, 2010, WIRES CLIM CHANGE, V1, P111, DOI 10.1002/wcc.18; Lehodey P, 2006, J CLIMATE, V19, P5009, DOI 10.1175/JCLI3898.1; Lehodey P, 1997, NATURE, V389, P715, DOI 10.1038/39575; Linkin ME, 2008, J CLIMATE, V21, P1979, DOI 10.1175/2007JCLI2048.1; Lu H, 2009, Q J ROY METEOR SOC, V135, P1030, DOI 10.1002/qj.419; Mantua N, 2004, PROG OCEANOGR, V60, P165, DOI 10.1016/j.pocean.2004.02.016; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Marcogliese Lucian A., 2009, P191; McCann KS, 2003, CAN J FISH AQUAT SCI, V60, P971, DOI 10.1139/F03-078; Meehl GA, 2009, SCIENCE, V325, P1114, DOI 10.1126/science.1172872; Menard F, 2007, FISH OCEANOGR, V16, P95, DOI 10.1111/j.1365-2419.2006.00415.x; Miller MJ, 2009, AM FISH S S, V69, P231; Ottersen G, 2001, LIMNOL OCEANOGR, V46, P1774, DOI 10.4319/lo.2001.46.7.1774; Qiu B, 1996, J GEOPHYS RES-OCEANS, V101, P12315, DOI 10.1029/95JC03204; Qiu B, 2010, J PHYS OCEANOGR, V40, P2525, DOI 10.1175/2010JPO4462.1; Qiu B, 2010, J PHYS OCEANOGR, V40, P213, DOI 10.1175/2009JPO4285.1; Rouyer T, 2008, P NATL ACAD SCI USA, V105, P5420, DOI 10.1073/pnas.0709034105; Rouyer T, 2008, MAR ECOL PROG SER, V359, P11, DOI 10.3354/meps07330; Sasaki H., 2006, J EARTH SIMULATOR, V6, P35; Sasaki H, 2008, HIGH RESOLUTION NUMERICAL MODELLING OF THE ATMOSPHERE AND OCEAN, P157, DOI 10.1007/978-0-387-49791-4_10; Schwartzlose RA, 1999, S AFR J MARINE SCI, V21, P289; Shen ML, LONG TERM VARI UNPUB; Shinoda A, 2011, REV FISH BIOL FISHER, V21, P591, DOI 10.1007/s11160-010-9195-1; SINCLAIR ARE, 1993, AM NAT, V141, P173, DOI 10.1086/285468; Tanaka H, 2003, FISH PHYSIOL BIOCHEM, V28, P493, DOI 10.1023/B:FISH.0000030638.56031.ed; Tatsukawa K, 2003, EEL BIOLOGY, P293; Tesch F. W., 1977, The eel: biology and management of anguillid eels.; Tian YJ, 2006, PROG OCEANOGR, V68, P217, DOI 10.1016/j.pocean.2006.02.009; Tian YJ, 2011, FISH RES, V112, P140, DOI 10.1016/j.fishres.2011.01.034; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Torrence C, 1999, J CLIMATE, V12, P2679, DOI 10.1175/1520-0442(1999)012<2679:ICITEM>2.0.CO;2; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; Tsukamoto K, 2009, J FISH BIOL, V74, P1833, DOI 10.1111/j.1095-8649.2009.02242.x; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; Tsukamoto K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1174; TZENG WN, 1984, B I ZOOL ACAD SINICA, V23, P173; Tzeng WN., 1985, B JAP SOC FISH OCEAN, V47, P11; Visser ME, 2009, BIOL LETTERS, V5, P739, DOI 10.1098/rsbl.2009.0429; WALLACE JM, 1981, MON WEATHER REV, V109, P784, DOI 10.1175/1520-0493(1981)109<0784:TITGHF>2.0.CO;2; Wang QY, 2009, SCI CHINA SER D, V52, P227, DOI 10.1007/s11430-009-0020-4; White WB, 1997, J GEOPHYS RES-OCEANS, V102, P3255, DOI 10.1029/96JC03549; Zenimoto K, 2009, J FISH BIOL, V74, P1878, DOI 10.1111/j.1095-8649.2009.02295.x	84	44	50	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e30805	10.1371/journal.pone.0030805	http://dx.doi.org/10.1371/journal.pone.0030805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383976	Green Submitted, gold, Green Published			2022-12-27	WOS:000302916100008
J	Choi, SH; Wiesner, P; Almazan, F; Kim, J; Miller, YI				Choi, Soo-Ho; Wiesner, Philipp; Almazan, Felicidad; Kim, Jungsu; Miller, Yury I.			Spleen Tyrosine Kinase Regulates AP-1 Dependent Transcriptional Response to Minimally Oxidized LDL	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; TOLL-LIKE RECEPTORS; KAPPA-B; MACROPHAGES; SYK; ACTIVATION; ATHEROSCLEROSIS; PHOSPHORYLATION; ACCUMULATION; OXIDATION	Oxidative modification of low-density lipoprotein (LDL) turns it into an endogenous ligand recognized by pattern-recognition receptors. We have demonstrated that minimally oxidized LDL (mmLDL) binds to CD14 and mediates TLR4/MD-2-dependent responses in macrophages, many of which are MyD88-independent. We have also demonstrated that the mmLDL activation leads to recruitment of spleen tyrosine kinase (Syk) to TLR4 and TLR4 and Syk phosphorylation. In this study, we produced a macrophage-specific Syk knockout mouse and used primary Syk(-/-) macrophages in our studies. We demonstrated that Syk mediated phosphorylation of ERK1/2 and JNK, which in turn phosphorylated c-Fos and c-Jun, respectively, as assessed by an in vitro kinase assay. c-Jun phosphorylation was also mediated by IKK epsilon. c-Jun and c-Fos bound to consensus DNA sites and thereby completed an AP-1 transcriptional complex and induced expression of CXCL2 and IL-6. These results suggest that Syk plays a key role in TLR4-mediated macrophage responses to host-generated ligands, like mmLDL, with subsequent activation of an AP-1 transcription program.	[Choi, Soo-Ho; Wiesner, Philipp; Almazan, Felicidad; Kim, Jungsu; Miller, Yury I.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Choi, SH (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	yumiller@ucsd.edu			National Institutes of Health [HL081862, HL088093]; Leducq Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088093, R01HL081862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health grants HL081862 and HL088093 as well as a grant from the Leducq Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae YS, 2009, CIRC RES, V104, P210, DOI 10.1161/CIRCRESAHA.108.181040; BENZ DJ, 1995, J BIOL CHEM, V270, P5191, DOI 10.1074/jbc.270.10.5191; Boullier A, 2006, ARTERIOSCL THROM VAS, V26, P1169, DOI 10.1161/01.ATV.0000210279.97308.9a; Choi SH, 2009, CIRC RES, V104, P1355, DOI 10.1161/CIRCRESAHA.108.192880; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Faggioli L, 2004, BBA-MOL CELL RES, V1692, P17, DOI 10.1016/j.bbamcr.2004.03.001; Harkewicz R, 2008, J BIOL CHEM, V283, P10241, DOI 10.1074/jbc.M709006200; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hilgendorf I, 2011, ARTERIOSCL THROM VAS, V31, P1991, DOI 10.1161/ATVBAHA.111.230847; Huang W, 2009, MOL CELL, V35, P48, DOI 10.1016/j.molcel.2009.05.023; Jakus Z, 2007, TRENDS CELL BIOL, V17, P493, DOI 10.1016/j.tcb.2007.09.001; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Lin YC, 2010, MOL IMMUNOL, V47, P1569, DOI 10.1016/j.molimm.2010.01.008; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Miller YI, 2005, FUTUR CARDIOL, V1, P785, DOI 10.2217/14796678.1.6.785; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Miller YI, 2009, TRENDS CARDIOVAS MED, V19, P227, DOI 10.1016/j.tcm.2010.02.001; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; Sawka-Verhelle D, 2004, J BIOL CHEM, V279, P17772, DOI 10.1074/jbc.M311991200; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; Sweeney SE, 2005, J IMMUNOL, V174, P6424, DOI 10.4049/jimmunol.174.10.6424; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; Ulanova M, 2007, J ENDOTOXIN RES, V13, P117, DOI 10.1177/0968051907079125; Wiesner P, 2010, CIRC RES, V107, P56, DOI 10.1161/CIRCRESAHA.110.218420; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; Woodside DG, 2002, J BIOL CHEM, V277, P39401, DOI 10.1074/jbc.M207657200	31	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32378	10.1371/journal.pone.0032378	http://dx.doi.org/10.1371/journal.pone.0032378			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384232	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500097
J	Guo, XG; Gao, XR; Wang, YS; Peng, LY; Zhu, YY; Wang, SM				Guo, Xiaogang; Gao, Xiuren; Wang, Yesong; Peng, Longyun; Zhu, Yingying; Wang, Shenming			I-Ks Protects from Ventricular Arrhythmia during Cardiac Ischemia and Reperfusion in Rabbits by Preserving the Repolarization Reserve	PLOS ONE			English	Article							ACTION-POTENTIAL DURATION; TORSADE-DE-POINTES; DELAYED RECTIFIER CURRENT; KCNQ1 POTASSIUM CHANNEL; EARLY AFTERDEPOLARIZATIONS; SIMULATED-ISCHEMIA; PURKINJE-FIBERS; QT PROLONGATION; LONG QT; HEART	Introduction: The function of the repolarization reserve in the prevention of ventricular arrhythmias during cardiac ischemia/reperfusion and the impact of ischemia on slowly activated delayed rectifier potassium current (I-Ks) channel subunit expression are not well understood. Methods and Results: The responses of monophasic action potential duration (MAPD) prolongation and triangulation were investigated following an L-768,673-induced blockade of I-Ks with or without ischemia/reperfusion in a rabbit model of left circumflex coronary artery occlusion/reperfusion. Ischemia/reperfusion and I-Ks blockade were found to significantly induce MAPD90 prolongation and increase triangulation at the epicardial zone at 45 min, 60 min, and 75 min after reperfusion, accompanied with an increase in premature ventricular beats (PVBs) during the same period. Additionally, I-Ks channel subunit expression was examined following transient ischemia or permanent infarction and changes in monophasic action potential (MAP) waveforms challenged by beta-adrenergic stimulation were evaluated using a rabbit model of transient or chronic cardiac ischemia. The epicardial MAP in the peri-infarct zone of hearts subjected to infarction for 2 days exhibited increased triangulation under adrenergic stimulation. KCNQ1 protein, the alpha subunit of the I-Ks channel, was downregulated in the same group. Both findings were consistent with an increased incidence of PVBs. Conclusion: Blockade of I-Ks caused MAP triangulation, which precipitated ventricular arrhythmias. Chronic ischemia increased the incidence of ventricular arrhythmias under adrenergic stimulation and was associated with increased MAP triangulation of the peri-infarct zone. Downregulation of KCNQ1 protein may be the underlying cause of these changes.	[Guo, Xiaogang; Gao, Xiuren; Wang, Yesong; Peng, Longyun] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Yingying] Cent Hosp, Intens Care Unit, Tai An, Shandong, Peoples R China; [Wang, Shenming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Vasc Surg, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Guo, XG (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China.	xiurengao@yahoo.com; shenmingwang@vip.shou.com	Guo, Xiao-gang/AAH-4293-2021		Guangdong Science and Technology Department of China [2008A030201011]; National Natural Science Foundation of China [81170172]	Guangdong Science and Technology Department of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Guangdong Science and Technology Department of China [grant number 2008A030201011] and National Natural Science Foundation of China [grant number 81170172]. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AGGARWAL R, 1995, CIRC RES, V77, P1180, DOI 10.1161/01.RES.77.6.1180; Bes S, 2005, EUR J PHARMACOL, V511, P109, DOI 10.1016/j.ejphar.2005.02.016; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; Champeroux P, 2005, BRIT J PHARMACOL, V144, P376, DOI 10.1038/sj.bjp.0706070; Chang JS, 2008, CIRC RES, V102, P905, DOI 10.1161/CIRCRESAHA.107.165308; Chen L, 2005, J BIOL CHEM, V280, P31347, DOI 10.1074/jbc.M505191200; Chouabe C, 1997, EMBO J, V16, P5472, DOI 10.1093/emboj/16.17.5472; Ducroq J, 2006, EUR J PHARMACOL, V532, P279, DOI 10.1016/j.ejphar.2005.12.083; Dun W, 2005, AM J PHYSIOL-HEART C, V289, pH667, DOI 10.1152/ajpheart.00180.2005; FRANZ MR, 1991, PROG CARDIOVASC DIS, V33, P347, DOI 10.1016/0033-0620(91)90002-4; Freeman LC, 2000, J MEMBRANE BIOL, V177, P65, DOI 10.1007/s002320001100; Ganitkevich V, 2006, CIRC RES, V99, P165, DOI 10.1161/01.RES.0000232321.89714.0e; Guerard N. C., 2008, Journal of Pharmacological and Toxicological Methods, V58, P32, DOI 10.1016/j.vascn.2008.05.129; Hondeghem LM, 2001, CIRCULATION, V103, P2004; Hondeghem LM, 2008, EUR J PHARMACOL, V584, P1, DOI 10.1016/j.ejphar.2008.01.016; Jespersen T, 2005, PHYSIOLOGY, V20, P408, DOI 10.1152/physiol.00031.2005; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Jiang M, 2000, CARDIOVASC RES, V48, P34, DOI 10.1016/S0008-6363(00)00159-0; Jost N, 2005, CIRCULATION, V112, P1392, DOI 10.1161/CIRCULATIONAHA.105.550111; Lengyel C, 2001, BRIT J PHARMACOL, V132, P101, DOI 10.1038/sj.bjp.0703777; Liu GX, 2008, PFLUG ARCH EUR J PHY, V456, P541, DOI 10.1007/s00424-007-0436-7; Liu XS, 2007, AM J PHYSIOL-HEART C, V292, pH560, DOI 10.1152/ajpheart.00616.2006; Lu HR, 2002, EUR J PHARMACOL, V452, P183, DOI 10.1016/S0014-2999(02)02246-X; Lynch JJ, 1999, CIRCULATION, V100, P1917, DOI 10.1161/01.CIR.100.18.1917; Martin RL, 2006, J CARDIOVASC PHARM, V48, P199, DOI 10.1097/01.fjc.0000246853.15926.d4; Milberg P, 2002, J PHARMACOL EXP THER, V303, P218, DOI 10.1124/jpet.102.037911; Milberg P, 2007, BASIC RES CARDIOL, V102, P42, DOI 10.1007/s00395-006-0609-0; Morales C, 2002, CARDIOVASC PATHOL, V11, P339, DOI 10.1016/S1054-8807(02)00115-1; Potet F, 2001, AM J PHYSIOL-HEART C, V280, pH2038, DOI 10.1152/ajpheart.2001.280.5.H2038; Ramakers C, 2003, CARDIOVASC RES, V57, P486, DOI 10.1016/S0008-6363(02)00717-4; Roden DM, 2005, CIRCULATION, V112, P1376, DOI 10.1161/CIRCULATIONAHA.105.562777; Rose J, 2005, AM J PHYSIOL-HEART C, V288, pH2077, DOI 10.1152/ajpheart.00526.2003; Salata JJ, 2004, CURR MED CHEM, V11, P29, DOI 10.2174/0929867043456214; Shieh RC, 1996, J PHYSIOL-LONDON, V494, P363, DOI 10.1113/jphysiol.1996.sp021498; Tsuji Y, 2006, CIRCULATION, V113, P345, DOI 10.1161/CIRCULATIONAHA.105.552968; Valverde CA, 2010, CARDIOVASC RES, V85, P671, DOI 10.1093/cvr/cvp371; Viitasalo M, 2005, PACE, V28, P219, DOI 10.1111/j.1540-8159.2005.09404.x; Volders PGA, 2003, CIRCULATION, V107, P2753, DOI 10.1161/01.CIR.0000068344.54010.B3; WALKER MJA, 1988, CARDIOVASC RES, V22, P447, DOI 10.1093/cvr/22.7.447; Watanabe I, 1997, J CARDIOVASC ELECTR, V8, P1229, DOI 10.1111/j.1540-8167.1997.tb01012.x; Zicha S, 2003, AM J PHYSIOL-HEART C, V285, pH1641, DOI 10.1152/ajpheart.00346.2003	41	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31545	10.1371/journal.pone.0031545	http://dx.doi.org/10.1371/journal.pone.0031545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384037	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500025
J	Song, LJ; Li, JH; Xie, SY; Qian, CY; Wang, J; Zhang, W; Yin, XR; Hua, ZC; Yu, CX				Song, LiJun; Li, JiaHuang; Xie, ShuYing; Qian, ChunYan; Wang, Jie; Zhang, Wei; Yin, XuRen; Hua, ZiChun; Yu, ChuanXin			Thioredoxin Glutathione Reductase as a Novel Drug Target: Evidence from Schistosoma japonicum	PLOS ONE			English	Article							CRASSICEPS METACESTODE CYSTICERCI; AFFINITY-CHROMATOGRAPHY; ANTISCHISTOSOMAL DRUGS; ESCHERICHIA-COLI; MANSONI; PRAZIQUANTEL; INFECTION; PURIFICATION; SELENIUM; SENEGAL	Background: Schistosomiasis remains a major public health concern affecting billions of people around the world. Currently, praziquantel is the only drug of choice for treatment of human schistosomiasis. The emergence of drug resistance to praziquantel in schistosomes makes the development of novel drugs an urgent task. Thioredoxin glutathione reductase (TGR) enzymes in Schistosoma mansoni and some other platyhelminths have been identified as alternative targets. The present study was designed to confirm the existense and the potential value of TGR as a target for development of novel antischistosomal agents in Schistosoma japonicum, a platyhelminth endemic in Asia. Methods and Findings: After cloning the S. japonicum TGR (SjTGR) gene, the recombinant SjTGR selenoprotein was purified and characterized in enzymatic assays as a multifunctional enzyme with thioredoxin reductase (TrxR), glutathione reductase (GR) and glutaredoxin (Grx) activities. Immunological and bioinformatic analyses confirmed that instead of having separate TrxR and GR proteins in mammalian, S. japonicum only encodes TGR, which performs the functions of both enzymes and plays a critical role in maintaining the redox balance in this parasite. These results were in good agreement with previous findings in Schistosoma mansoni and some other platyhelminths. Auranofin, a known inhibitor against TGR, caused fatal toxicity in S. japonicum adult worms in vitro and reduced worm and egg burdens in S. japonicum infected mice. Conclusions: Collectively, our study confirms that a multifunctional enzyme SjTGR selenoprotein, instead of separate TrxR and GR enzymes, exists in S. japonicum. Furthermore, TGR may be a potential target for development of novel agents against schistosomes. This assumption is strengthened by our demonstration that the SjTGR is an essential enzyme for maintaining the thiol-disulfide redox homeostasis of S. japonicum.	[Song, LiJun; Qian, ChunYan; Wang, Jie; Zhang, Wei; Yin, XuRen; Yu, ChuanXin] Jiangsu Inst Parasit Dis, Minist Hlth, Key Lab Technol Parasit Dis Prevent & Control, Wuxi, Jiangsu, Peoples R China; [Li, JiaHuang; Hua, ZiChun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Xie, ShuYing] Jiangxi Inst Parasit Dis, Dept Schistosomiasis Diag, Nanchang, Jiangxi, Peoples R China	Nanjing University	Song, LJ (corresponding author), Jiangsu Inst Parasit Dis, Minist Hlth, Key Lab Technol Parasit Dis Prevent & Control, Wuxi, Jiangsu, Peoples R China.	huazc@nju.edu.cn; chxnyu@163.com	song, lijun/ABB-7049-2021		National Natural Science Foundation of China [30972581, 50973046, 30821006]; National Key Basic Research Program in China [2007CB513100, 2011CB933502]; Natural Science Foundation of Jiangsu Province [BK2008110, BK2010046]; Special Fund for Public Interest of Science and Technology Department in Jiangsu Province [BM2007704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program in China(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Special Fund for Public Interest of Science and Technology Department in Jiangsu Province	This work was supported by the National Natural Science Foundation of China (30972581, 50973046, 30821006), the National Key Basic Research Program in China (2007CB513100, 2011CB933502), the Natural Science Foundation of Jiangsu Province (BK2008110, BK2010046) and the Special Fund for Public Interest of Science and Technology Department in Jiangsu Province (BM2007704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agorio A, 2003, J BIOL CHEM, V278, P12920, DOI 10.1074/jbc.M209266200; Alger HM, 2002, MOL BIOCHEM PARASIT, V121, P129, DOI 10.1016/S0166-6851(02)00031-2; Alonso D, 2006, AM J TROP MED HYG, V74, P342, DOI 10.4269/ajtmh.2006.74.342; Angelucci F, 2010, J BIOL CHEM, V285, P32557, DOI 10.1074/jbc.M110.141960; Angelucci F, 2009, J BIOL CHEM, V284, P28977, DOI 10.1074/jbc.M109.020701; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Becker K, 2000, EUR J BIOCHEM, V267, P6118, DOI 10.1046/j.1432-1327.2000.01703.x; BOGGARAM V, 1979, ANAL BIOCHEM, V98, P335, DOI 10.1016/0003-2697(79)90150-7; Bonilla M, 2008, J BIOL CHEM, V283, P17898, DOI 10.1074/jbc.M710609200; CARLBERG I, 1981, ANAL BIOCHEM, V116, P531, DOI 10.1016/0003-2697(81)90398-5; CIOLI D, 1995, PHARMACOL THERAPEUT, V68, P35, DOI 10.1016/0163-7258(95)00026-7; Cioli D, 2008, TRENDS PARASITOL, V24, P379, DOI 10.1016/j.pt.2008.05.006; Coura JR, 2010, MEM I OSWALDO CRUZ, V105, P598, DOI 10.1590/S0074-02762010000400040; da Silva IM, 2005, MEM I OSWALDO CRUZ, V100, P445, DOI 10.1590/S0074-02762005000400018; Danso-Appiah A, 2002, TRENDS PARASITOL, V18, P125, DOI 10.1016/S1471-4922(01)02209-7; FALLON PG, 1995, AM J TROP MED HYG, V53, P61, DOI 10.4269/ajtmh.1995.53.61; Gromer S, 2004, MED RES REV, V24, P40, DOI 10.1002/med.10051; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Guevara-Flores A, 2010, J PARASITOL RES; Guevara-Flores A, 2011, PARASITOL INT, V60, P156, DOI 10.1016/j.parint.2011.01.005; Hao Yang, 2010, Chinese Journal of Schistosomiasis Control, V22, P521; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Ismail M, 1996, AM J TROP MED HYG, V55, P214, DOI 10.4269/ajtmh.1996.55.214; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Krauth-Siegel RL, 2005, ANGEW CHEM INT EDIT, V44, P690, DOI 10.1002/anie.200300639; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; Magalhaes LG, 2010, PARASITOL RES, V106, P395, DOI 10.1007/s00436-009-1674-8; Martinez-Gonzalez JJ, 2010, PARASITOL RES, V107, P227, DOI 10.1007/s00436-010-1867-1; Melman SD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000504; Otero L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-237; Peak E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000759; Pennington JD, 2007, CURR PHARM DESIGN, V13, P3368, DOI 10.2174/138161207782360528; Rendon JL, 2004, MOL BIOCHEM PARASIT, V133, P61, DOI 10.1016/j.molbiopara.2003.09.003; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Segel IH, 1993, ENZYME KINETIC; Spiga O, 2011, BIOPOLYMERS, V95, P278, DOI 10.1002/bip.21577; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Tchuente LAT, 2001, T ROY SOC TROP MED H, V95, P65, DOI 10.1016/S0035-9203(01)90335-9; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Wang W, 2010, PARASITOLOGY, V137, P1905, DOI 10.1017/S0031182010001204; World Health Organization, 2002, WHO TRADITIONAL MED, P1; WORTHINGTON DJ, 1976, EUR J BIOCHEM, V67, P231, DOI 10.1111/j.1432-1033.1976.tb10654.x; Xiao SH, 2009, PARASITOL RES, V106, P237, DOI 10.1007/s00436-009-1656-x; YOLLES TK, 1947, J PARASITOL, V33, P419, DOI 10.2307/3273678; Zhang JS, 2003, CARCINOGENESIS, V24, P497, DOI 10.1093/carcin/24.3.497	46	56	60	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31456	10.1371/journal.pone.0031456	http://dx.doi.org/10.1371/journal.pone.0031456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384025	gold, Green Published, Green Submitted			2022-12-27	WOS:000302875500020
J	van der Veen, DR; Shao, JP; Chapman, S; Leevy, WM; Duffield, GE				van der Veen, Daan R.; Shao, Jinping; Chapman, Sarah; Leevy, W. Matthew; Duffield, Giles E.			A 24-Hour Temporal Profile of In Vivo Brain and Heart PET Imaging Reveals a Nocturnal Peak in Brain F-18-Fluorodeoxyglucose Uptake	PLOS ONE			English	Article							CEREBRAL GLUCOSE-UTILIZATION; SUPRACHIASMATIC NUCLEUS; CIRCADIAN-RHYTHMS; OLFACTORY-BULB; F-18-FDG PET; MOUSE-BRAIN; CLOCK GENES; ACCUMULATION; METABOLISM; EXPRESSION	Using positron emission tomography, we measured in vivo uptake of F-18-fluorodeoxyglucose (FDG) in the brain and heart of C57Bl/6 mice at intervals across a 24-hour light-dark cycle. Our data describe a significant, high amplitude rhythm in FDG uptake throughout the whole brain, peaking at the mid-dark phase of the light-dark cycle, which is the active phase for nocturnal mice. Under these conditions, heart FDG uptake did not vary with time of day, but did show biological variation throughout the 24-hour period for measurements within the same mice. FDG uptake was scanned at different times of day within an individual mouse, and also compared to different times of day between individuals, showing both biological and technical reproducibility of the 24-hour pattern in FDG uptake. Regional analysis of brain FDG uptake revealed especially high amplitude rhythms in the olfactory bulb and cortex, while low amplitude rhythms were observed in the amygdala, brain stem and hypothalamus. Low amplitude 24-hour rhythms in regional FDG uptake may be due to multiple rhythms with different phases in a single brain structure, quenching some of the amplitude. Our data show that the whole brain exhibits significant, high amplitude daily variation in glucose uptake in living mice. Reports applying the 2-deoxy-D[C-14]-glucose method for the quantitative determination of the rates of local cerebral glucose utilization indicate only a small number of brain regions exhibiting a day versus night variation in glucose utilization. In contrast, our data show 24-hour patterns in glucose uptake in most of the brain regions examined, including several regions that do not show a difference in glucose utilization. Our data also emphasizes a methodological requirement of controlling for the time of day of scanning FDG uptake in the brain in both clinical and pre-clinical settings, and suggests waveform normalization of FDG measurements at different times of the day.	[van der Veen, Daan R.; Shao, Jinping; Duffield, Giles E.] Univ Notre Dame, Galvin Life Sci Ctr, Dept Biol Sci, Notre Dame, IN 46556 USA; [Shao, Jinping] Nankai Univ, Sch Med, Dept Physiol, Tianjin 300071, Peoples R China; [Chapman, Sarah; Leevy, W. Matthew] Univ Notre Dame, Notre Dame Integrated Imaging Facil, Notre Dame, IN 46556 USA; [Leevy, W. Matthew] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame; Nankai University; University of Notre Dame; University of Notre Dame	van der Veen, DR (corresponding author), Univ Notre Dame, Galvin Life Sci Ctr, Dept Biol Sci, Notre Dame, IN 46556 USA.	duffield.2@nd.edu	van der Veen, Daan R/T-1013-2017	van der Veen, Daan R/0000-0001-8037-1407	American Heart Association [10SDG4030011]; National Institute of General Medical Sciences [R01-GM087508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087508] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants to GED from the American Heart Association (10SDG4030011) and the National Institute of General Medical Sciences (R01-GM087508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Abraham U, 2005, J NEUROSCI, V25, P8620, DOI 10.1523/JNEUROSCI.2225-05.2005; Aeschbach D, 1997, NEUROSCI LETT, V239, P121, DOI 10.1016/S0304-3940(97)00904-X; Amir S, 1999, NEUROSCIENCE, V92, P1165, DOI 10.1016/S0306-4522(99)00222-5; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Basu S, 2008, J NUCL MED, V49, p17N; Best JD, 1999, J NEUROSCI, V19, P828; Beyer T, 2000, J NUCL MED, V41, P1369; Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Cailotto C, 2005, EUR J NEUROSCI, V22, P2531, DOI 10.1111/j.1460-9568.2005.04439.x; Cantwell EL, 2002, BRAIN RES BULL, V57, P603, DOI 10.1016/S0361-9230(01)00753-5; CASSONE VM, 1988, BRAIN RES, V459, P178, DOI 10.1016/0006-8993(88)90301-0; Challet E, 2010, J COMP PHYSIOL B, V180, P631, DOI 10.1007/s00360-010-0451-4; CRANE PD, 1980, J NEUROCHEM, V34, P1700, DOI 10.1111/j.1471-4159.1980.tb11263.x; Davidson AJ, 2005, CLIN EXP HYPERTENS, V27, P307, DOI 10.1081/CEH-200048933; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Durgan DJ, 2005, AM J PHYSIOL-HEART C, V289, pH1530, DOI 10.1152/ajpheart.00406.2005; Fueger BJ, 2006, J NUCL MED, V47, P999; Goodwin GW, 1998, J BIOL CHEM, V273, P29530, DOI 10.1074/jbc.273.45.29530; Granados-Fuentes D, 2006, J NEUROSCI, V26, P12219, DOI 10.1523/JNEUROSCI.3445-06.2006; Green JA, 2011, COMP BIOCHEM PHYS A, V158, P287, DOI 10.1016/j.cbpa.2010.09.011; GROPLER RJ, 1990, J NUCL MED, V31, P1749; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Hamada T, 2011, BIOCHEM BIOPH RES CO, V409, P727, DOI 10.1016/j.bbrc.2011.05.076; Hjelstuen OK, 2011, EUR J PHARM BIOPHARM, V78, P307, DOI 10.1016/j.ejpb.2011.01.002; JAY TM, 1985, BRAIN RES, V342, P297, DOI 10.1016/0006-8993(85)91129-1; Kalsbeek A, 2011, FEBS LETT, V585, P1412, DOI 10.1016/j.febslet.2011.03.021; Karaganis SP, 2009, GEN COMP ENDOCR, V161, P179, DOI 10.1016/j.ygcen.2008.12.015; Kim C, 2011, NUCL MED MOLEC IMAG, V45, P169, DOI 10.1007/s13139-011-0087-7; Klein D.C., 1991, SUPRACHIASMATIC NUCL; KNUUTI MJ, 1992, J NUCL MED, V33, P1255; Kreissl M. C., 2011, EUROPEAN J NUCL MED, V1, P1; la Fleur SE, 1999, J NEUROENDOCRINOL, V11, P643; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Meyer C, 2002, AM J PHYSIOL-ENDOC M, V282, pE419, DOI 10.1152/ajpendo.00032.2001; Mirrione MM, 2007, NEUROIMAGE, V38, P34, DOI 10.1016/j.neuroimage.2007.06.032; Nanni C, 2007, NUCL MED COMMUN, V28, P547, DOI 10.1097/MNM.0b013e3281fbd42b; PAULY JE, 1967, AM J ANAT, V120, P627, DOI 10.1002/aja.1001200312; Pauwels EKJ, 1998, NUCL MED BIOL, V25, P317, DOI 10.1016/S0969-8051(97)00226-6; RIVKEES SA, 1988, J NEUROSCI, V8, P4269; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; ROOM P, 1989, BRAIN RES, V505, P321, DOI 10.1016/0006-8993(89)91460-1; Schmidt C, 2007, COGN NEUROPSYCHOL, V24, P755, DOI 10.1080/02643290701754158; Schnockel U, 2010, EUR J PHARM BIOPHARM, V74, P50, DOI 10.1016/j.ejpb.2009.05.012; SCHWARTZ WJ, 1983, BRAIN RES, V274, P184, DOI 10.1016/0006-8993(83)90538-3; Schwartz WJ, 1991, SUPRACHIASMATIC NUCL, P144; Shimoji K, 2004, J NUCL MED, V45, P665; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Taegtmeyer H, 2010, J NUCL MED, V51, p80S, DOI 10.2967/jnumed.109.068205; Toyama H, 2004, NUCL MED BIOL, V31, P251, DOI 10.1016/S0969-8051(03)00124-0; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Willich SN, 1999, VASC MED, V4, P41, DOI 10.1191/135886399670596924; Young ME, 2001, CIRC RES, V89, P1199, DOI 10.1161/hh2401.100741	56	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31792	10.1371/journal.pone.0031792	http://dx.doi.org/10.1371/journal.pone.0031792			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384076	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500042
J	Zhang, WP; Zhang, CR; Lv, ZB; Fang, DL; Wang, D; Nie, ZM; Yu, W; Lan, HL; Jiang, CY; Zhang, YZ				Zhang, Wenping; Zhang, Changrong; Lv, Zhengbing; Fang, Dailing; Wang, Dan; Nie, Zuoming; Yu, Wei; Lan, Hanglian; Jiang, Caiying; Zhang, Yaozhou			Molecular Characterization, Tissue Distribution, Subcellular Localization and Actin-Sequestering Function of a Thymosin Protein from Silkworm	PLOS ONE			English	Article							MESSENGER-RNA; GENE-PRODUCT; EXPRESSION; PEPTIDE; BINDING; ALPHA-1; THYMUS; POLYPEPTIDE-BETA-1; CHEMISTRY; EVOLUTION	We identified a novel gene encoding a Bombyx mori thymosin (BmTHY) protein from a cDNA library of silkworm pupae, which has an open reading frame (ORF) of 399 bp encoding 132 amino acids. It was found by bioinformatics that BmTHY gene consisted of three exons and two introns and BmTHY was highly homologous to thymosin betas (T beta). BmTHY has a conserved motif LKHTET with only one amino acid difference from LKKTET, which is involved in Tb binding to actin. A His-tagged BmTHY fusion protein (rBmTHY) with a molecular weight of approximately 18.4 kDa was expressed and purified to homogeneity. The purified fusion protein was used to produce anti-rBmTHY polyclonal antibodies in a New Zealand rabbit. Subcellular localization revealed that BmTHY can be found in both Bm5 cell (a silkworm ovary cell line) nucleus and cytoplasm but is primarily located in the nucleus. Western blotting and real-time RT-PCR showed that during silkworm developmental stages, BmTHY expression levels are highest in moth, followed by instar larvae, and are lowest in pupa and egg. BmTHY mRNA was universally distributed in most of fifth-instar larvae tissues (except testis). However, BmTHY was expressed in the head, ovary and epidermis during the larvae stage. BmTHY formed complexes with actin monomer, inhibited actin polymerization and cross-linked to actin. All the results indicated BmTHY might be an actin-sequestering protein and participate in silkworm development.	[Zhang, Wenping; Zhang, Changrong; Lv, Zhengbing; Fang, Dailing; Wang, Dan; Nie, Zuoming; Yu, Wei; Jiang, Caiying; Zhang, Yaozhou] Zhejiang Sci Tech Univ, Coll Life Sci, Inst Biochem, Hangzhou, Zhejiang, Peoples R China; [Lan, Hanglian] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang Sci-Tech University; Zhejiang University	Zhang, WP (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Inst Biochem, Hangzhou, Zhejiang, Peoples R China.	yaozhou@zstu.edu.cn			Zhejiang Natural Science Foundation [Y3110051]; National High-tech R&D Program of China [2011AA100603]; Zhejiang Provincial Education Department [Y201019098]; Zhejiang Sci-Tech University [1016846-Y, SWYX0915]	Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province); National High-tech R&D Program of China(National High Technology Research and Development Program of China); Zhejiang Provincial Education Department; Zhejiang Sci-Tech University(Zhejiang Sci-Tech University)	This work was supported by the financial grants from Zhejiang Natural Science Foundation (No. Y3110051), National High-tech R&D Program of China (863 Program, No. 2011AA100603), Zhejiang Provincial Education Department Program (Y201019098) and Zhejiang Sci-Tech University (No. 1016846-Y and No. SWYX0915). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2000, GENE, V260, P37, DOI 10.1016/S0378-1119(00)00452-2; BEPLER G, 1994, CANCER INVEST, V12, P491, DOI 10.3109/07357909409021409; Bodey B, 2000, INT J IMMUNOPHARMACO, V22, P261, DOI 10.1016/S0192-0561(99)00084-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brieger A, 2007, BIOCHEM BIOPH RES CO, V364, P731, DOI 10.1016/j.bbrc.2007.10.010; Carlier MF, 2007, ANN NY ACAD SCI, V1112, P67, DOI 10.1196/annals.1415.037; CASSIMERIS L, 1992, J CELL BIOL, V119, P1261, DOI 10.1083/jcb.119.5.1261; Chen JQ, 2008, CELL TISSUE RES, V331, P725, DOI 10.1007/s00441-007-0516-1; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Dhaese S, 2009, J MOL BIOL, V387, P809, DOI 10.1016/j.jmb.2009.02.026; FRASCA D, 1987, EUR J IMMUNOL, V17, P727, DOI 10.1002/eji.1830170524; Gareus R, 2006, J BIOL CHEM, V281, P2803, DOI 10.1074/jbc.M503528200; GOLDSTEI.AL, 1966, P NATL ACAD SCI USA, V56, P1010, DOI 10.1073/pnas.56.3.1010; GOLDSTEIN AL, 1994, CANCER INVEST, V12, P545, DOI 10.3109/07357909409021415; HADDEN JW, 1992, INT J IMMUNOPHARMACO, V14, P345, DOI 10.1016/0192-0561(92)90163-F; Harata M, 1999, MOL BIOL CELL, V10, P2595, DOI 10.1091/mbc.10.8.2595; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huff T, 2004, J CELL SCI, V117, P5333, DOI 10.1242/jcs.01404; Jacinto A, 2003, MECH DEVELOP, V120, P1337, DOI 10.1016/j.mod.2003.06.006; Kaur H, BIOCH BIOPHYS ACTA, V1800, P1256; Kellici Sueli, 2009, Med Arh, V63, P48; Kim YW, 2008, BIOCHEM BIOPH RES CO, V371, P664, DOI 10.1016/j.bbrc.2008.04.112; Lederer M, 2005, J CELL SCI, V118, P331, DOI 10.1242/jcs.01618; LEICHTLING KD, 1990, INT J IMMUNOPHARMACO, V12, P19, DOI 10.1016/0192-0561(90)90064-T; LOW TLK, 1979, J BIOL CHEM, V254, P987; LOW TLK, 1979, J BIOL CHEM, V254, P981; Lu ML, 1996, VIROLOGY, V218, P103, DOI 10.1006/viro.1996.0170; Moon HS, 2006, EXP CELL RES, V312, P3425, DOI 10.1016/j.yexcr.2006.07.021; Nicole M, 1991, BIOCHEMISTRY-US, V21, P523; Nie ZM, 2009, APPL BIOCHEM BIOTECH, V158, P59, DOI 10.1007/s12010-008-8302-4; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Percipalle P, 2001, J CELL BIOL, V153, P229, DOI 10.1083/jcb.153.1.229; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; SAFER D, 1991, J BIOL CHEM, V266, P4029; SAFER D, 1989, ANAL BIOCHEM, V178, P32, DOI 10.1016/0003-2697(89)90351-5; SAFER D, 1990, P NATL ACAD SCI USA, V87, P2536, DOI 10.1073/pnas.87.7.2536; Shen YF, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/416040; Skare P, 2003, EXP CELL RES, V286, P12, DOI 10.1016/S0014-4827(03)00102-2; Turrini P, 1998, J NEUROIMMUNOL, V82, P64, DOI 10.1016/S0165-5728(97)00189-6; Windmill KF, 1999, J REPROD IMMUNOL, V44, P29, DOI 10.1016/S0165-0378(99)00006-6; YU FX, 1993, J BIOL CHEM, V268, P502; ZATZ MM, 1985, J IMMUNOL, V134, P1032; Zhang YZ, 2007, APPL BIOCHEM BIOTECH, V136, P327, DOI 10.1007/s12010-007-9029-3; Zimin AV, 2008, BIOINFORMATICS, V24, P42, DOI 10.1093/bioinformatics/btm542; Zoubek RE, 2007, ANN NY ACAD SCI, V1112, P442, DOI 10.1196/annals.1415.031	45	9	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31040	10.1371/journal.pone.0031040	http://dx.doi.org/10.1371/journal.pone.0031040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22383992	gold, Green Published, Green Submitted			2022-12-27	WOS:000302875500011
J	Navarrete, P; Magne, F; Araneda, C; Fuentes, P; Barros, L; Opazo, R; Espejo, R; Romero, J				Navarrete, Paola; Magne, Fabien; Araneda, Cristian; Fuentes, Pamela; Barros, Luis; Opazo, Rafael; Espejo, Romilio; Romero, Jaime			PCR-TTGE Analysis of 16S rRNA from Rainbow Trout (Oncorhynchus mykiss) Gut Microbiota Reveals Host-Specific Communities of Active Bacteria	PLOS ONE			English	Article							ATLANTIC SALMON; SOYBEAN-MEAL; INTESTINAL MICROBIOTA; PHYLOGENETIC ANALYSIS; MOLECULAR ANALYSIS; FISH-MEAL; ZEBRAFISH; DIVERSITY; MUCOSA; REPLACEMENT	This study assessed the relative contributions of host genetics and diet in shaping the gut microbiota of rainbow trout. Full sibling fish from four unrelated families, each consisting of individuals derived from the mating of one male and one female belonging to a breeding program, were fed diets containing either vegetable proteins or vegetable oils for two months in comparison to a control diet consisting of only fish protein and fish oil. Two parallel approaches were applied on the same samples: transcriptionally active bacterial populations were examined based on RNA analysis and were compared with bacterial populations obtained from DNA analysis. Comparison of temporal temperature gradient gel electrophoresis (TTGE) profiles from DNA and RNA showed important differences, indicating that active bacterial populations were better described by RNA analysis. Results showed that some bacterial groups were significantly (P<0.05) associated with specific families, indicating that microbiota composition may be influenced by the host. In addition, the effect of diet on microbiota composition was dependent on the trout family.	[Navarrete, Paola; Fuentes, Pamela; Barros, Luis; Opazo, Rafael; Espejo, Romilio; Romero, Jaime] Univ Chile, Inst Nutr & Tecnol Alimentos, Santiago, Region Metropol, Chile; [Magne, Fabien] Conservatoire Natl Arts & Metiers, Biol Lab, Paris, Ile De France, France; [Araneda, Cristian] Univ Chile, Fac Ciencias Agron, Santiago, Region Metropol, Chile	Universidad de Chile; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Universidad de Chile	Navarrete, P (corresponding author), Univ Chile, Inst Nutr & Tecnol Alimentos, Santiago, Region Metropol, Chile.	pnavarre@inta.cl	navarrete, paola/B-5371-2014; Magne, Fabien/F-1393-2014; Espejo, Romilio T/J-3183-2015; Romero, Jaime/I-2816-2013; Araneda, Cristian M/H-4036-2013	navarrete, paola/0000-0003-0692-2324; Magne, Fabien/0000-0002-8210-4561; Espejo, Romilio T/0000-0003-0495-4576; Romero, Jaime/0000-0001-9614-2393; Araneda, Cristian M/0000-0002-9986-5340	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [3100075, 1110253]; INNOVA [07CN13PBT-41]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); INNOVA	This study was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT N<SUP>o</SUP>3100075, N<SUP>o</SUP>1110253) and INNOVA 07CN13PBT-41. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakke-McKellep AM, 2007, BRIT J NUTR, V97, P699, DOI 10.1017/S0007114507381397; Bates JM, 2006, DEV BIOL, V297, P374, DOI 10.1016/j.ydbio.2006.05.006; Bell JG, 2001, J NUTR, V131, P1535, DOI 10.1093/jn/131.5.1535; Clayton D, 2007, HDB STAT GENETICS, P1216; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Heikkinen J, 2006, AQUACULTURE, V261, P259, DOI 10.1016/j.aquaculture.2006.07.012; Holben WE, 2002, MICROB ECOL, V44, P175, DOI 10.1007/s00248-002-1011-6; Huber I, 2004, J APPL MICROBIOL, V96, P117, DOI 10.1046/j.1365-2672.2003.02109.x; Kapatral V, 2003, GENOME RES, V13, P1180, DOI 10.1101/gr.566003; Kim DH, 2007, J APPL MICROBIOL, V102, P1654, DOI 10.1111/j.1365-2672.2006.03185.x; Kovacs A, 2011, MICROB ECOL, V61, P423, DOI 10.1007/s00248-010-9787-2; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Mansfield GS, 2010, AQUACULTURE, V307, P95, DOI 10.1016/j.aquaculture.2010.07.014; Merrifield DL, 2009, J FISH DIS, V32, P755, DOI 10.1111/j.1365-2761.2009.01052.x; Merrifield DL, 2009, AQUAC RES, V40, P1064, DOI 10.1111/j.1365-2109.2009.02200.x; Navarrete P, 2009, MICROB ECOL, V57, P550, DOI 10.1007/s00248-008-9448-x; Navarrete P, 2010, AQUAC RES, V41, pe667, DOI 10.1111/j.1365-2109.2010.02590.x; Navarrete P, 2010, FEMS MICROBIOL ECOL, V71, P148, DOI 10.1111/j.1574-6941.2009.00769.x; Nayak SK, 2010, AQUAC RES, V41, P1553, DOI 10.1111/j.1365-2109.2010.02546.x; Penn MH, 2011, AQUACULTURE, V310, P267, DOI 10.1016/j.aquaculture.2010.10.040; Pond MJ, 2006, AQUACULTURE, V261, P194, DOI 10.1016/j.aquaculture.2006.06.037; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ringo E, 1998, J APPL MICROBIOL, V85, P855, DOI 10.1046/j.1365-2672.1998.00595.x; Ringo E, 2006, AQUACULTURE, V261, P829, DOI 10.1016/j.aquaculture.2006.06.030; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Romero J, 2001, J SHELLFISH RES, V20, P1235; Romero J, 2006, MICROB ECOL, V51, P422, DOI 10.1007/s00248-006-9037-9; Sales J, 2009, BRIT J NUTR, V102, P1709, DOI 10.1017/S0007114509991279; Sharifuzzaman SM, 2010, FISH SHELLFISH IMMUN, V29, P212, DOI 10.1016/j.fsi.2010.03.008; Smith VJ, 2010, MAR DRUGS, V8, P1213, DOI 10.3390/md8041213; Smriga S, 2010, FEMS MICROBIOL ECOL, V73, P31, DOI 10.1111/j.1574-6941.2010.00879.x; Sokol H, 2006, J CLIN MICROBIOL, V44, P3172, DOI 10.1128/JCM.02600-05; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Uran PA, 2009, J FISH DIS, V32, P733, DOI 10.1111/j.1365-2761.2009.01049.x; vandePeer Y, 1997, COMPUT APPL BIOSCI, V13, P227; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Ward NL, 2009, EXTREMOPHILES, V13, P679, DOI 10.1007/s00792-009-0252-4; Zar JH, 1974, BIOSTATISTICAL ANAL; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	45	110	120	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31335	10.1371/journal.pone.0031335	http://dx.doi.org/10.1371/journal.pone.0031335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393360	gold, Green Published, Green Submitted			2022-12-27	WOS:000303003500013
J	Seelke, AMH; Dooley, JC; Krubitzer, LA				Seelke, Adele M. H.; Dooley, James C.; Krubitzer, Leah A.			The Emergence of Somatotopic Maps of the Body in S1 in Rats: The Correspondence Between Functional and Anatomical Organization	PLOS ONE			English	Article							BARREL-FIELD CORTEX; PRIMARY SOMATOSENSORY CORTEX; 2/3 PYRAMIDAL NEURONS; CEREBRAL-CORTEX; POSTNATAL-DEVELOPMENT; CRITICAL PERIOD; NEONATAL-RAT; IN-VIVO; THALAMOCORTICAL SYNAPSES; SYNAPTIC PLASTICITY	Most of what we know about cortical map development and plasticity comes from studies in mice and rats, and for the somatosensory cortex, almost exclusively from the whisker-dominated posteromedial barrel fields. Whiskers are the main effector organs of mice and rats, and their representation in cortex and subcortical pathways is a highly derived feature of murine rodents. This specialized anatomical organization may therefore not be representative of somatosensory cortex in general, especially for species that utilize other body parts as their main effector organs, like the hands of primates. For these reasons, we examined the emergence of whole body maps in developing rats using electrophysiological recording techniques. In P5, P10, P15, P20 and adult rats, multiple recordings were made in the medial portion of S1 in each animal. Subsequently, these functional maps were related to anatomical parcellations of S1 based on a variety of histological stains. We found that at early postnatal ages (P5) medial S1 was composed almost exclusively of the representation of the vibrissae. At P10, other body part representations including the hindlimb and forelimb were present, although these were not topographically organized. By P15, a clear topographic organization began to emerge coincident with a reduction in receptive field size. By P20, body maps were adult-like. This study is the first to describe how topography of the body develops in S1 in any mammal. It indicates that anatomical parcellations and functional maps are initially incongruent but become tightly coupled by P15. Finally, because anatomical and functional specificity of developing barrel cortex appears much earlier in postnatal life than the rest of the body, the entire primary somatosensory cortex should be considered when studying general topographic map formation in development.	[Seelke, Adele M. H.; Dooley, James C.; Krubitzer, Leah A.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Krubitzer, Leah A.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Seelke, AMH (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	lakrubitzer@ucdavis.edu		Dooley, James/0000-0002-9868-9840; Seelke, Adele/0000-0002-2867-0335	National Institutes of Health [5R21NS071225-02, 1F32NS064792-01A2, 5T32EY015387- 05, T32DC8072]; NATIONAL EYE INSTITUTE [T32EY015387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071225, F32NS064792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC008072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported in part by a grant to Leah Krubitzer (5R21NS071225-02), a grant to Adele Seelke (1F32NS064792-01A2), and by training grants (5T32EY015387- 05 and T32DC8072), all grants were from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts JR., 2005, BEHAV LABORATOTY RAT, P266; ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; Armentano M, 2007, NAT NEUROSCI, V10, P1277, DOI 10.1038/nn1958; ARMSTRONGJAMES M, 1975, J PHYSIOL-LONDON, V246, P501, DOI 10.1113/jphysiol.1975.sp010902; Ben-Ari Y, 2004, TRENDS NEUROSCI, V27, P422, DOI 10.1016/j.tins.2004.05.002; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENNETTCLARKE CA, 1991, NEUROSCIENCE, V43, P163, DOI 10.1016/0306-4522(91)90425-N; BERRY M, 1965, J ANAT, V99, P691; Blue ME, 1991, CEREB CORTEX, V1, P380, DOI 10.1093/cercor/1.5.380; BOLLES RC, 1964, ANIM BEHAV, V12, P427, DOI 10.1016/0003-3472(64)90062-4; Campi KL, 2011, BRAIN BEHAV EVOLUT, V77, P116, DOI 10.1159/000324862; Campi KL, 2010, J COMP NEUROL, V518, P4491, DOI 10.1002/cne.22466; CATALANO SM, 1991, P NATL ACAD SCI USA, V88, P2999, DOI 10.1073/pnas.88.8.2999; Catania KC, 2000, BRAIN BEHAV EVOLUT, V55, P311, DOI 10.1159/000006666; Catania KC, 2006, CURR OPIN NEUROBIOL, V16, P467, DOI 10.1016/j.conb.2006.06.010; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; Cooke DF, 2011, FUNCTIONAL ORG CORTE; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; DAMATO RJ, 1987, P NATL ACAD SCI USA, V84, P4322, DOI 10.1073/pnas.84.12.4322; DAWSON DR, 1987, J COMP NEUROL, V256, P246, DOI 10.1002/cne.902560205; De Felipe J, 1997, CEREBRAL CORTEX, P7; DONATELLE JM, 1977, J COMP NEUROL, V175, P207, DOI 10.1002/cne.901750205; EAYRS JT, 1959, J ANAT, V93, P385; Erzurumlu R, 2008, SENSES COMPREHENSIVE, P171; ERZURUMLU RS, 1990, DEV BRAIN RES, V56, P229; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Fox K, 2008, BARREL CORTEX, P1, DOI 10.1017/CBO9780511541636.003; FUJIMIYA M, 1986, J COMP NEUROL, V246, P191, DOI 10.1002/cne.902460205; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Gallyas F, 1979, Neurol Res, V1, P203; HICKS SP, 1968, ANAT REC, V160, P619, DOI 10.1002/ar.1091600311; Inan M, 2007, NEUROSCIENTIST, V13, P49, DOI 10.1177/1073858406296257; Jain N, 2003, J NEUROSCI, V23, P10321; JEANMONOD D, 1981, NEUROSCIENCE, V6, P1503, DOI 10.1016/0306-4522(81)90222-0; JHAVERI S, 1991, P NATL ACAD SCI USA, V88, P4489, DOI 10.1073/pnas.88.10.4489; Jones L, 2002, DEVELOPMENT, V129, P5041; Karlen SJ, 2006, J COMP NEUROL, V499, P990, DOI 10.1002/cne.21156; KILLACKEY HP, 1979, J COMP NEUROL, V183, P285, DOI 10.1002/cne.901830206; KILLACKEY HP, 1994, J NEUROSCI, V14, P1496, DOI 10.1523/JNEUROSCI.14-03-01496.1994; Krubitzer L, 2011, ALL RODENTS ARE NOT; LAND PW, 1985, J COMP NEUROL, V238, P225, DOI 10.1002/cne.902380209; Larsen DD, 2008, BRAIN RES BULL, V75, P391, DOI 10.1016/j.brainresbull.2007.10.041; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Li H, 2011, ANN NY ACAD SCI, V1225, P119, DOI 10.1111/j.1749-6632.2011.06024.x; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Maier DL, 1999, P NATL ACAD SCI USA, V96, P9397, DOI 10.1073/pnas.96.16.9397; Maravall M, 2004, J NEUROPHYSIOL, V92, P144, DOI 10.1152/jn.00598.2003; Maravall M, 2004, CEREB CORTEX, V14, P655, DOI 10.1093/cercor/bhh026; MARKUS EJ, 1987, EXP NEUROL, V96, P262, DOI 10.1016/0014-4886(87)90045-8; MCCANDLISH C, 1989, EXP BRAIN RES, V77, P425, DOI 10.1007/BF00275001; MCCANDLISH CA, 1993, EXP BRAIN RES, V92, P369; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; MILLER MW, 1988, CEREB CORTEX, V7, P133; Molnar Z, 1998, J NEUROSCI, V18, P5723; MUNGER BL, 1986, J COMP NEUROL, V252, P404, DOI 10.1002/cne.902520309; Nakagawa Y, 1999, J NEUROSCI, V19, P10877, DOI 10.1523/JNEUROSCI.19-24-10877.1999; O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Ohsaki K, 2002, DEV BRAIN RES, V137, P159, DOI 10.1016/S0165-3806(02)00462-5; OLEARY DDM, 1981, DEV BRAIN RES, V1, P607, DOI 10.1016/0165-3806(81)90012-2; Pallas SL, 2001, TRENDS NEUROSCI, V24, P417, DOI 10.1016/S0166-2236(00)01853-1; PARNAVELAS JG, 1980, BRAIN RES, V193, P373, DOI 10.1016/0006-8993(80)90171-7; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; Ragsdale CW, 2001, CURR OPIN NEUROBIOL, V11, P50, DOI 10.1016/S0959-4388(00)00173-2; Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010; RHOADES RW, 1990, J COMP NEUROL, V293, P190, DOI 10.1002/cne.902930204; RICE FL, 1977, J COMP NEUROL, V171, P545, DOI 10.1002/cne.901710408; RICE FL, 1985, J COMP NEUROL, V236, P477, DOI 10.1002/cne.902360405; RICE FL, 1985, J COMP NEUROL, V236, P496, DOI 10.1002/cne.902360406; RICHMOND G, 1980, BEHAVIOUR, V75, P82, DOI 10.1163/156853980X00573; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Seelke AMH, 2008, SLEEP, V31, P691, DOI 10.1093/sleep/31.5.691; Seelke AMH, 2010, BRAIN RES, V1324, P34, DOI 10.1016/j.brainres.2010.01.088; Shoykhet M, 2008, J NEUROPHYSIOL, V99, P356, DOI 10.1152/jn.01063.2007; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; SUR M, 1990, TRENDS NEUROSCI, V13, P227, DOI 10.1016/0166-2236(90)90165-7; Sur M, 2001, NAT REV NEUROSCI, V2, P251, DOI 10.1038/35067562; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Uziel D, 2006, ANAT REC PART A, V288A, P135, DOI 10.1002/ar.a.20286; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; VANDERLOOS H, 1978, NEUROSCI LETT, V7, P23, DOI 10.1016/0304-3940(78)90107-6; VANEDEN CG, 1985, J COMP NEUROL, V241, P253, DOI 10.1002/cne.902410302; Vercelli A, 1999, EXP NEUROL, V156, P294, DOI 10.1006/exnr.1999.7025; WALLACE JA, 1982, BRAIN RES BULL, V9, P117, DOI 10.1016/0361-9230(82)90127-7; WATERS RS, 1995, EXP BRAIN RES, V103, P183; WELKER C, 1971, BRAIN RES, V26, P259, DOI 10.1016/S0006-8993(71)80004-5; WELKER C, 1976, J COMP NEUROL, V166, P173, DOI 10.1002/cne.901660205; WELKER E, 1986, J NEUROSCI, V6, P3355; WELLER WL, 1972, BRAIN RES, V43, P11; WHISHAW IQ, 1992, BEHAV BRAIN RES, V48, P113, DOI 10.1016/S0166-4328(05)80147-0; WHISHAW IQ, 1994, BEHAV BRAIN RES, V60, P15, DOI 10.1016/0166-4328(94)90058-2; Whishaw IQ, 1996, BEHAV BRAIN RES, V77, P135, DOI 10.1016/0166-4328(95)00209-X; WISE SP, 1978, J COMP NEUROL, V178, P187, DOI 10.1002/cne.901780202; WONGRILEY MTT, 1984, J COMP NEUROL, V222, P18, DOI 10.1002/cne.902220103; Woolsey T.A., 1990, P461; WOOLSEY TA, 1975, J COMP NEUROL, V164, P79, DOI 10.1002/cne.901640107; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	102	48	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32322	10.1371/journal.pone.0032322	http://dx.doi.org/10.1371/journal.pone.0032322			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393398	Green Submitted, Green Published, gold			2022-12-27	WOS:000303003500050
J	Derraik, JGB; Reed, PW; Jefferies, C; Cutfield, SW; Hofman, PL; Cutfield, WS				Derraik, Jose G. B.; Reed, Peter W.; Jefferies, Craig; Cutfield, Samuel W.; Hofman, Paul L.; Cutfield, Wayne S.			Increasing Incidence and Age at Diagnosis among Children with Type 1 Diabetes Mellitus over a 20-Year Period in Auckland (New Zealand)	PLOS ONE			English	Article							ACCELERATOR HYPOTHESIS; INCIDENCE TRENDS; YOUNGER AGE; BODY-MASS; CHILDHOOD; WEIGHT; WORLDWIDE; COHORT; ONSET; BORN	Background: We aimed to evaluate the incidence of type 1 diabetes mellitus in children <15 years of age (yr) in the Auckland region (New Zealand) over 20 years (1990-2009). Methods: We performed a retrospective review of all patients <15 yr diagnosed with type 1 diabetes, from an unselected complete regional cohort. Results: There were 884 new cases of type 1 diabetes, and age at diagnosis rose from 7.6 yr in 1990/1 to 8.9 yr in 2008/9 (r(2) = 0.31, p = 0.009). There was a progressive increase in type 1 diabetes incidence among children <15 yr (p<0.0001), reaching 22.5 per 100,000 in 2009. However, the rise in incidence did not occur evenly among age groups, being 2.5-fold higher in older children (10-14 yr) than in the youngest group (0-4 yr). The incidence of new cases of type 1 diabetes was highest in New Zealand Europeans throughout the study period in all age groups (p<0.0001), but the rate of increase was similar in New Zealand Europeans and Non-Europeans. Type 1 diabetes incidence and average annual increase were similar in both sexes. There was no change in BMI SDS shortly after diagnosis, and no association between BMI SDS and age at diagnosis. Conclusions: There has been a steady increase in type 1 diabetes incidence among children <15 yr in Auckland over 20 years. Contrary to other studies, age at diagnosis has increased and the greatest rise in incidence occurred in children 10-14 yr. There was little change in BMI SDS in this population, providing no support for the 'accelerator hypothesis'.	[Derraik, Jose G. B.; Jefferies, Craig; Cutfield, Samuel W.; Hofman, Paul L.; Cutfield, Wayne S.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Reed, Peter W.; Jefferies, Craig] Auckland Dist Hlth Board, Auckland, New Zealand; [Hofman, Paul L.; Cutfield, Wayne S.] Univ Auckland, Natl Res Ctr Growth & Dev, Auckland 1, New Zealand	University of Auckland; Auckland District Health Board; University of Auckland	Derraik, JGB (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	w.cutfield@auckland.ac.nz	Derraik, José Guilherme Behrensdorf/A-1925-2008; Jefferies, craig/ABA-1921-2021	Derraik, José Guilherme Behrensdorf/0000-0003-1226-1956; Jefferies, Craig/0000-0002-0541-6094				Australian Institute of Health and Welfare, 2010, INC TYPE 1 DIAB AUST; Banin Patrizia, 2010, Acta Biomed, V81, P35; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Betts P, 2005, DIABETIC MED, V22, P144, DOI 10.1111/j.1464-5491.2004.01368.x; Cadario F, 2004, J ENDOCRINOL INVEST, V27, P913, DOI 10.1007/BF03347532; Campbell-Stokes PL, 2005, DIABETOLOGIA, V48, P643, DOI 10.1007/s00125-005-1697-3; Delli AJ, 2010, PEDIATR DIABETES, V11, P513, DOI 10.1111/j.1399-5448.2010.00637.x; Douglas NM, 2007, J PAEDIATR CHILD H, V43, P173, DOI 10.1111/j.1440-1754.2007.01038.x; ELLIOTT RB, 1985, NEW ZEAL MED J, V98, P922; ELLIOTT RB, 1992, PEDIAT AD E, V21, P66; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Gale EAM, 2007, DIABETOLOGIA, V50, P1571, DOI 10.1007/s00125-007-0726-9; Harjutsalo V, 2008, LANCET, V371, P1777, DOI 10.1016/S0140-6736(08)60765-5; Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; Kibirige M, 2003, DIABETES CARE, V26, P2865, DOI 10.2337/diacare.26.10.2865; Knerr I, 2005, DIABETOLOGIA, V48, P2501, DOI 10.1007/s00125-005-0033-2; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Pundziute-Lycka A, 2002, DIABETOLOGIA, V45, P783, DOI 10.1007/s00125-002-0845-2; SCOTT RS, 1992, DIABETES CARE, V15, P895, DOI 10.2337/diacare.15.7.895; Sella T, 2011, DIABETIC MED, V28, P48, DOI 10.1111/j.1464-5491.2010.03174.x; Statistics New Zealand, 2010, 2006 CENS POP DWELLI; Wilkin TJ, 2006, DIABETES CARE, V29, P1462, DOI 10.2337/dc06-0345; Wilkin TJ, 2001, DIABETOLOGIA, V44, P914, DOI 10.1007/s001250100548; Wu Denise, 2005, N Z Med J, V118, pU1557	25	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32640	10.1371/journal.pone.0032640	http://dx.doi.org/10.1371/journal.pone.0032640			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389717	Green Submitted, Green Published, gold			2022-12-27	WOS:000302999600056
J	Karasov, WH; Caviedes-Vidal, E; Bakken, BH; Izhaki, I; Samuni-Blank, M; Arad, Z				Karasov, William H.; Caviedes-Vidal, Enrique; Bakken, Bradley Hartman; Izhaki, Ido; Samuni-Blank, Michal; Arad, Zeev			Capacity for Absorption of Water-Soluble Secondary Metabolites Greater in Birds than in Rodents	PLOS ONE			English	Article							INTESTINAL PASSIVE ABSORPTION; VERTEBRATE-DISPERSED FRUITS; TRANSEPITHELIAL TRANSPORT; IN-VITRO; PHYSIOLOGICAL REGULATION; PARACELLULAR ABSORPTION; GLOMERULAR-FILTRATION; EPITHELIAL-CELLS; CHLOROGENIC ACID; MOLECULAR-BASIS	Plant secondary metabolites (SMs) are pervasive in animal foods and potentially influence feeding behavior, interspecies interactions, and the distribution and abundance of animals. Some of the major classes of naturally occurring SMs in plants include many water-soluble compounds in the molecular size range that could cross the intestinal epithelium via the paracellular space by diffusion or solvent drag. There are differences among species in paracellular permeability. Using Middle Eastern rodent and avian consumers of fruits containing SMs, we tested the hypothesis that avian species would have significantly higher paracellular permeability than rodent species. Permeability in intact animals was assessed using standard pharmacological methodology to measure absorption of two radiolabeled, inert, neutral water-soluble probes that do not interact with intestinal nutrient transporters, L-arabinose (M-r = 150.1 Da) and lactulose (M-r = 342.3 Da). We also measured absorption of labeled 3-O-methyl-D-glucose (3OMD-glucose; M-r = 194.2 Da), which is a nonmetabolized analogue of D-glucose that is passively absorbed through the paracellular space but also transported across the enterocyte membranes. Most glucose was absorbed by all species, but arabinose fractional absorption (f) was nearly three times higher in birds (1.03 +/- 0.17, n = 15 in two species) compared to rodents (0.37 +/- 0.06, n = 10 in two species) (P < 0.001). Surprisingly, the apparent rates of absorption in birds of arabinose exceeded those of 3OMD-glucose. Our findings are in agreement with previous work showing that the paracellular pathway is more prominent in birds relative to nonflying mammals, and suggests that birds may be challenged by greater absorption of water-soluble, dietary SMs. The increased expression of the paracellular pathway in birds hints at a tradeoff: the free energy birds gain by absorbing water-soluble nutrients passively may be offset by the metabolic demands placed on them to eliminate concomitantly absorbed SMs.	[Karasov, William H.; Bakken, Bradley Hartman] Univ Wisconsin, Dept Forest & Wildlife Ecol, Russell Labs, Madison, WI 53706 USA; [Caviedes-Vidal, Enrique] Univ Nacl San Luis, Dept Bioquim & Ciencias Biol, San Luis, Argentina; [Caviedes-Vidal, Enrique] Consejo Nacl Invest Cient & Tecn, Inst Multidisciplinario Invest Biol San Luis, Chacabuco, San Luis, Argentina; [Izhaki, Ido] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Samuni-Blank, Michal; Arad, Zeev] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel	University of Wisconsin System; University of Wisconsin Madison; Universidad Nacional de San Luis; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Haifa; Technion Israel Institute of Technology	Karasov, WH (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Russell Labs, Madison, WI 53706 USA.	wkarasov@wisc.edu	Izhaki, Ido/I-9712-2019; Izhaki, Ido/D-5586-2011; Caviedes-Vidal, Enrique/J-9204-2013	Izhaki, Ido/0000-0002-4525-4683; Izhaki, Ido/0000-0002-4525-4683; Caviedes-Vidal, Enrique/0000-0003-4526-4969	United States-Israel Binational Science Foundation [2006043, 2008124T]; Israel Science Foundation [189/08]; United States National Science Foundation [IOS-1025886]; Division Of Integrative Organismal Systems [1025886] Funding Source: National Science Foundation	United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); United States National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the United States-Israel Binational Science Foundation (#2006043 and #2008124T) to BHB, Israel Science Foundation (#189/08) to II, and United States National Science Foundation (#IOS-1025886) to WHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altestein O, 2005, FLESHY FRUITED PLANT; Ayrton A, 2001, XENOBIOTICA, V31, P469, DOI 10.1080/00498250110060969; Bakken BH, 2004, J EXP BIOL, V207, P4383, DOI 10.1242/jeb.01238; Barbehenn RV, 1998, ARCH INSECT BIOCHEM, V39, P109, DOI 10.1002/(SICI)1520-6327(1998)39:3&lt;109::AID-ARCH3&gt;3.0.CO;2-B; BIJLSMA PB, 1995, GASTROENTEROLOGY, V108, P687, DOI 10.1016/0016-5085(95)90440-9; Brody T., 1999, NUTR BIOCH, V2nd ed., P1; Cai KH, 2006, BIOCHEM PHARMACOL, V72, P974, DOI 10.1016/j.bcp.2006.06.026; Cai KH, 2006, BIOCHEM PHARMACOL, V71, P1570, DOI 10.1016/j.bcp.2006.02.013; Caviedes-Vidal E, 2007, P NATL ACAD SCI USA, V104, P19132, DOI 10.1073/pnas.0703159104; Chang MH, 2004, ZOOLOGY, V107, P121, DOI 10.1016/j.zool.2004.03.001; Chang MH, 2004, J EXP BIOL, V207, P3109, DOI 10.1242/jeb.01154; CHANG RLS, 1975, BIOPHYS J, V15, P861, DOI 10.1016/S0006-3495(75)85862-0; Chediack JG, 2006, J COMP PHYSIOL B, V176, P303, DOI 10.1007/s00360-005-0052-9; Chediack JG, 2003, J COMP PHYSIOL B, V173, P187, DOI 10.1007/s00360-002-0314-8; Chediack JG, 2001, AM ZOOL, V41, P1410; Cipollini ML, 1997, AM NAT, V150, P346, DOI 10.1086/286069; Cipollini ML, 1997, ECOLOGY, V78, P782; Cipollini ML, 2000, REV CHIL HIST NAT, V73, P421; Deprez S, 2001, ANTIOXID REDOX SIGN, V3, P957, DOI 10.1089/152308601317203503; FINE KD, 1993, GASTROENTEROLOGY, V105, P1117, DOI 10.1016/0016-5085(93)90957-E; Foley WJ, 2005, CURR OPIN PLANT BIOL, V8, P430, DOI 10.1016/j.pbi.2005.05.009; GIBALDI M, 1982, PHARMACOKINETICS, P1; Gilbert ER, 2007, POULTRY SCI, V86, P1739, DOI 10.1093/ps/86.8.1739; HAMILTON I, 1987, CLIN SCI, V73, P189, DOI 10.1042/cs0730189; Harborne JB, 1993, INTRO ECOLOGICAL BIO, P1; He YL, 1998, J PHARM SCI, V87, P626, DOI 10.1021/js970120d; Hem A, 1998, LAB ANIM-UK, V32, P364, DOI 10.1258/002367798780599866; Janzen D. H., 1975, ECOLOGY PLANTS TROPI; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Karasov W. H., 2007, PHYSL ECOLOGY ANIMAL; Karasov WH, 2011, AM J PHYSL IN PRESS; Karasov WH, 2011, ANNU REV PHYSIOL, V73, P69, DOI 10.1146/annurev-physiol-012110-142152; Kavimandan NJ, 2008, INT J PHARMACEUT, V354, P143, DOI 10.1016/j.ijpharm.2007.12.014; Konishi Y, 2005, BIOSCI BIOTECH BIOCH, V69, P583, DOI 10.1271/bbb.69.583; Konishi Y, 2004, J AGR FOOD CHEM, V52, P2527, DOI 10.1021/jf035366k; Konishi Y, 2004, J AGR FOOD CHEM, V52, P2518, DOI 10.1021/jf035407c; Konishi Y, 2003, J AGR FOOD CHEM, V51, P7296, DOI 10.1021/jf034894t; Konishi Y, 2003, BIOSCI BIOTECH BIOCH, V67, P2317, DOI 10.1271/bbb.67.2317; Kuhn J, 2004, P NATL ACAD SCI USA, V101, P13808, DOI 10.1073/pnas.0402576101; Lafay S, 2006, BRIT J NUTR, V96, P39, DOI 10.1079/BJN20061714; Lane JS, 1999, AM J PHYSIOL-GASTR L, V276, pG789, DOI 10.1152/ajpgi.1999.276.3.G789; Lavin SR, 2007, J EXP BIOL, V210, P2754, DOI 10.1242/jeb.006114; LEAHY DE, 1994, J PHARMACOKINET BIOP, V22, P411, DOI 10.1007/BF02353863; Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525; Li H, 2008, ANIM GENET, V39, P407, DOI 10.1111/j.1365-2052.2008.01744.x; LOBLEY RW, 1990, CLIN SCI, V79, P175, DOI 10.1042/cs0790175; Lohner K, 2007, MOL NUTR FOOD RES, V51, P293, DOI 10.1002/mnfr.200600225; LOO JCK, 1968, J PHARM SCI, V57, P918, DOI 10.1002/jps.2600570602; MA TY, 1993, J LAB CLIN MED, V122, P590; McWhorter TJ, 2010, PHYSIOL BIOCHEM ZOOL, V83, P376, DOI 10.1086/597524; McWhorter TJ, 2009, BIOL REV, V84, P533, DOI 10.1111/j.1469-185X.2009.00086.x; Morris ME, 2006, LIFE SCI, V78, P2116, DOI 10.1016/j.lfs.2005.12.003; Mott CR, 2008, POULTRY SCI, V87, P2215, DOI 10.3382/ps.2008-00101; MOTULSKY HJ, 1987, FASEB J, V1, P365, DOI 10.1096/fasebj.1.5.3315805; Nielsen HM, 2002, EUR J PHARM SCI, V16, P151, DOI 10.1016/S0928-0987(02)00083-0; PAPPENHEIMER JR, 1990, AM J PHYSIOL, V259, pG290, DOI 10.1152/ajpgi.1990.259.2.G290; PAPPENHEIMER JR, 1987, J MEMBRANE BIOL, V100, P123, DOI 10.1007/BF02209145; Ritschel WA, 1999, HDB BASIC PHARMACOKI, P1; Riviere JE, 1999, COMP PHARMACOKINETIC; SADOWSKI DC, 1993, CAN J PHYSIOL PHARM, V71, P835, DOI 10.1139/y93-125; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Skopec MM, 2010, J CHEM ECOL, V36, P236, DOI 10.1007/s10886-010-9747-9; SMULDERS AP, 1971, J MEMBRANE BIOL, V5, P297, DOI 10.1007/BF01957348; Sokal RR.RohlfFJ, 1981, BIOMETRY, P1; Sorensen JS, 2006, J CHEM ECOL, V32, P1181, DOI 10.1007/s10886-006-9079-y; Spiegel O, 2007, ECOL LETT, V10, P718, DOI 10.1111/j.1461-0248.2007.01062.x; Struempf HM, 1999, AUK, V116, P749, DOI 10.2307/4089335; Tewksbury JJ, 2001, NATURE, V412, P403, DOI 10.1038/35086653; Tian XJ, 2009, INT J PHARMACEUT, V367, P58, DOI 10.1016/j.ijpharm.2008.09.023; TURNER JR, 1995, GASTROENTEROLOGY, V109, P1391, DOI 10.1016/0016-5085(95)90605-3; UHING MR, 1995, J CLIN INVEST, V95, P2799, DOI 10.1172/JCI117984; WELLING PG, 1986, PHARMACOKINETICS PRO; YOKOTA SD, 1985, RENAL PHYSIOL BIOCH, V8, P193	73	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32417	10.1371/journal.pone.0032417	http://dx.doi.org/10.1371/journal.pone.0032417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389702	Green Published, Green Submitted, gold			2022-12-27	WOS:000302999600040
J	Pasquo, A; Consalvi, V; Knapp, S; Alfano, I; Ardini, M; Stefanini, S; Chiaraluce, R				Pasquo, Alessandra; Consalvi, Valerio; Knapp, Stefan; Alfano, Ivan; Ardini, Matteo; Stefanini, Simonetta; Chiaraluce, Roberta			Structural Stability of Human Protein Tyrosine Phosphatase rho Catalytic Domain: Effect of Point Mutations	PLOS ONE			English	Article							SOMATIC MUTATIONS; RECEPTOR-T; CANCER; IDENTIFICATION; DISEASE; SUBSTRATE; CATALOG; GENOME; GENES; SNPS	Protein tyrosine phosphatase rho (PTP rho) belongs to the classical receptor type IIB family of protein tyrosine phosphatase, the most frequently mutated tyrosine phosphatase in human cancer. There are evidences to suggest that PTP rho may act as a tumor suppressor gene and dysregulation of Tyr phosphorylation can be observed in diverse diseases, such as diabetes, immune deficiencies and cancer. PTP rho variants in the catalytic domain have been identified in cancer tissues. These natural variants are nonsynonymous single nucleotide polymorphisms, variations of a single nucleotide occurring in the coding region and leading to amino acid substitutions. In this study we investigated the effect of amino acid substitution on the structural stability and on the activity of the membrane-proximal catalytic domain of PTP rho. We expressed and purified as soluble recombinant proteins some of the mutants of the membrane-proximal catalytic domain of PTP rho identified in colorectal cancer and in the single nucleotide polymorphisms database. The mutants show a decreased thermal and thermodynamic stability and decreased activation energy relative to phosphatase activity, when compared to wild-type. All the variants show three-state equilibrium unfolding transitions similar to that of the wild-type, with the accumulation of a folding intermediate populated at similar to 4.0 M urea.	[Pasquo, Alessandra] UT BIORAD FARM CR Casaccia ENEA, Rome, Italy; [Consalvi, Valerio; Ardini, Matteo; Stefanini, Simonetta; Chiaraluce, Roberta] Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, Rome, Italy; [Knapp, Stefan; Alfano, Ivan] Univ Oxford, Struct Genom Consortium, Oxford, England	Italian National Agency New Technical Energy & Sustainable Economics Development; Sapienza University Rome; University of Oxford	Pasquo, A (corresponding author), UT BIORAD FARM CR Casaccia ENEA, Rome, Italy.	roberta.chiaraluce@uniroma1.it	Ardini, Matteo/V-1884-2018; Knapp, Stefan/AAG-2347-2019; consalvi, valerio/F-1918-2011	Ardini, Matteo/0000-0002-9044-3352; Knapp, Stefan/0000-0001-5995-6494; 	Department of Biochemical Sciences; Uniroma1	Department of Biochemical Sciences; Uniroma1	Department of Biochemical Sciences; Uniroma1, www.uniroma1.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allali-Hassani A, 2009, BIOCHEM J, V424, P15, DOI 10.1042/BJ20090723; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Benjwal S, 2006, PROTEIN SCI, V15, P635, DOI 10.1110/ps.051917406; Bromberg Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S8; Burgoyne AM, 2009, CANCER RES, V69, P6960, DOI 10.1158/0008-5472.CAN-09-0863; Cheng TMK, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000135; Craig SEL, 2011, CANCER RES, V71, P303, DOI 10.1158/0008-5472.CAN-10-2301; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; Ervin J, 2002, BIOPHYS J, V83, P473, DOI 10.1016/S0006-3495(02)75183-7; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Geierhaas CD, 2007, PROTEIN SCI, V16, P125, DOI 10.1110/ps.062383807; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Rowling PJE, 2010, J BIOL CHEM, V285, P20080, DOI 10.1074/jbc.M109.088922; ROYER CA, 1993, PROTEIN SCI, V2, P1844, DOI 10.1002/pro.5560021106; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Scott A, 2011, BIOSCIENCE REP, V31, P303, DOI 10.1042/BSR20100134; Stenson PD, 2008, J MED GENET, V45, P124, DOI 10.1136/jmg.2007.055210; Teng S, 2008, CURR PHARM BIOTECHNO, V9, P123, DOI 10.2174/138920108783955164; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Yue P, 2006, J MOL BIOL, V356, P1263, DOI 10.1016/j.jmb.2005.12.025; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020; Zhang XD, 2007, P NATL ACAD SCI USA, V104, P4060, DOI 10.1073/pnas.0611665104; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616; Zhao YQ, 2010, P NATL ACAD SCI USA, V107, P2592, DOI 10.1073/pnas.0914884107; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	34	14	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32555	10.1371/journal.pone.0032555	http://dx.doi.org/10.1371/journal.pone.0032555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389709	Green Submitted, Green Published, gold			2022-12-27	WOS:000302999600048
J	Saffarzadeh, M; Juenemann, C; Queisser, MA; Lochnit, G; Barreto, G; Galuska, SP; Lohmeyer, J; Preissner, KT				Saffarzadeh, Mona; Juenemann, Christiane; Queisser, Markus A.; Lochnit, Guenter; Barreto, Guillermo; Galuska, Sebastian P.; Lohmeyer, Juergen; Preissner, Klaus T.			Neutrophil Extracellular Traps Directly Induce Epithelial and Endothelial Cell Death: A Predominant Role of Histones	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RECOMBINANT HUMAN DNASE; CYSTIC-FIBROSIS; NETTING NEUTROPHILS; MEDICAL PROGRESS; MYELOPEROXIDASE; LIPOPOLYSACCHARIDE; ENDOTOXIN	Neutrophils play an important role in innate immunity by defending the host organism against invading microorganisms. Antimicrobial activity of neutrophils is mediated by release of antimicrobial peptides, phagocytosis as well as formation of neutrophil extracellular traps (NET). These structures are composed of DNA, histones and granular proteins such as neutrophil elastase and myeloperoxidase. This study focused on the influence of NET on the host cell functions, particularly on human alveolar epithelial cells as the major cells responsible for gas exchange in the lung. Upon direct interaction with epithelial and endothelial cells, NET induced cytotoxic effects in a dose-dependent manner, and digestion of DNA in NET did not change NET-mediated cytotoxicity. Pre-incubation of NET with antibodies against histones, with polysialic acid or with myeloperoxidase inhibitor but not with elastase inhibitor reduced NET-mediated cytotoxicity, suggesting that histones and myeloperoxidase are responsible for NET-mediated cytotoxicity. Although activated protein C (APC) did decrease the histone-induced cytotoxicity in a purified system, it did not change NET-induced cytotoxicity, indicating that histone-dependent cytotoxicity of NET is protected against APC degradation. Moreover, in LPS-induced acute lung injury mouse model, NET formation was documented in the lung tissue as well as in the bronchoalveolar lavage fluid. These data reveal the important role of protein components in NET, particularly histones, which may lead to host cell cytotoxicity and may be involved in lung tissue destruction.	[Saffarzadeh, Mona; Juenemann, Christiane; Queisser, Markus A.; Lochnit, Guenter; Galuska, Sebastian P.; Preissner, Klaus T.] Univ Giessen, Sch Med, Inst Biochem, Giessen, Germany; [Queisser, Markus A.] Northwestern Univ, Chicago, IL 60611 USA; [Barreto, Guillermo] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Lohmeyer, Juergen] Univ Giessen, Dept Internal Med 2, Giessen, Germany	Justus Liebig University Giessen; Northwestern University; Max Planck Society; Justus Liebig University Giessen	Saffarzadeh, M (corresponding author), Univ Giessen, Sch Med, Inst Biochem, Giessen, Germany.	klaus.t.preissner@biochemie.med.uni-giessen.de	Barreto, Guillermo/U-5718-2017	Barreto, Guillermo/0000-0002-7777-4712	Bundesministerium fur Bildung und Forschung (Berlin, Germany); Clinical Research Group "Pneumonia" [01-KI-1004]; "Excellence Cluster Cardio-Pulmonary System" (ECCPS), Deutsche Forschungsgemeinschaft (Bonn, Germany)	Bundesministerium fur Bildung und Forschung (Berlin, Germany)(Federal Ministry of Education & Research (BMBF)); Clinical Research Group "Pneumonia"; "Excellence Cluster Cardio-Pulmonary System" (ECCPS), Deutsche Forschungsgemeinschaft (Bonn, Germany)	This work was supported in part by the Bundesministerium fur Bildung und Forschung (Berlin, Germany), Clinical Research Group "Pneumonia" (01-KI-1004), and the "Excellence Cluster Cardio-Pulmonary System" (ECCPS), Deutsche Forschungsgemeinschaft (Bonn, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Bergmann C, 2008, CLIN CANCER RES, V14, P3706, DOI 10.1158/1078-0432.CCR-07-5126; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; BOTHA AJ, 1995, J TRAUMA, V39, P411; Bozinovski S, 2004, AM J PHYSIOL-LUNG C, V286, pL877, DOI 10.1152/ajplung.00275.2003; BRANDT T, 1995, THORAX, V50, P880, DOI 10.1136/thx.50.8.880; BRIGHAM KL, 1986, AM REV RESPIR DIS, V133, P913; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cabanski M, 2009, AM J PHYSIOL-LUNG C, V297, pL608, DOI 10.1152/ajplung.90433.2008; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Costa D, 2006, FREE RADICAL BIO MED, V40, P632, DOI 10.1016/j.freeradbiomed.2005.09.017; DeCoursey TE, 2005, CELL MOL LIFE SCI, V62, P2173, DOI 10.1007/s00018-005-5177-1; Douda DN, 2011, J IMMUNOL, V187, P1856, DOI 10.4049/jimmunol.1004201; Faffe DS, 2000, EUR RESPIR J, V15, P85, DOI 10.1183/09031936.00.15108500; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; FUJISHIMA S, 1995, INTENS CARE MED, V21, P277, DOI 10.1007/BF01701489; Gong Q, 2008, INT IMMUNOPHARMACOL, V8, P792, DOI 10.1016/j.intimp.2008.01.026; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Gupta A, 2006, ANN NY ACAD SCI, V1075, P118, DOI 10.1196/annals.1368.015; Gupta AK, 2010, FEBS LETT, V584, P3193, DOI 10.1016/j.febslet.2010.06.006; Haegens A, 2008, EUR RESPIR J, V31, P252, DOI 10.1183/09031936.00029307; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Hamutcu R, 2002, AM J RESP CRIT CARE, V165, P1172, DOI 10.1164/ajrccm.165.8.2104090; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jones A, 2007, FASEB J, V21, P345, DOI 10.1096/fj.06-6675com; Kanthack A. A., 1894, J PHYSL, V17, P80; KANTHACK AA, 1894, J PHYSL, V17, P81; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Klebanoff SJ, 1999, P ASSOC AM PHYSICIAN, V111, P383, DOI 10.1111/paa.1999.111.5.383; KOLLEF MH, 1995, NEW ENGL J MED, V332, P27, DOI 10.1056/NEJM199501053320106; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Lee JS, 2005, AM J PHYSIOL-LUNG C, V289, pL731, DOI 10.1152/ajplung.00196.2005; Lim MB, 2011, J LEUKOC BIOL; Liu M, 1997, INTENS CARE MED, V23, P718, DOI 10.1007/s001340050400; Liu MY, 2005, AM J RESP CRIT CARE, V171, P298, DOI 10.1164/rccm.2412002; Manicone AM, 2009, EXPERT REV CLIN IMMU, V5, P63, DOI 10.1586/1744666X.5.1.63; Manzenreiter R, 2011, J CYST FIBROS; Marcos V, 2010, NAT MED, V16, P1018, DOI 10.1038/nm.2209; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Medina E, 2009, J INNATE IMMUN, V1, P176, DOI 10.1159/000203699; Mishra B, 2010, J NEUROSCI, V30, P12400, DOI 10.1523/JNEUROSCI.6407-09.2010; Myzak MC, 2002, REDOX REP, V7, P47, DOI 10.1179/135100002125000181; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Patel S, 2010, NITRIC OXIDE-BIOL CH, V22, P226, DOI 10.1016/j.niox.2010.01.001; Perl M, 2008, MOL MED, V14, P465, DOI 10.2119/2008-00011.Perl; RAPTIS L, 1980, J CLIN INVEST, V66, P1391, DOI 10.1172/JCI109992; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Rotta AT, 1998, CRIT CARE MED, V26, P1707, DOI 10.1097/00003246-199810000-00026; Segel GB, 2011, J LEUKOCYTE BIOL, V89, P359, DOI 10.1189/jlb.0910538; Steinmuller M, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-30; Szarka RJ, 1997, J IMMUNOL METHODS, V202, P49, DOI 10.1016/S0022-1759(96)00236-0; Tasaka S, 2003, AM J RESP CELL MOL, V29, P252, DOI 10.1165/rcmb.2002-0132OC; Thulke S, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-77; Ullrich O, 1999, P NATL ACAD SCI USA, V96, P6223, DOI 10.1073/pnas.96.11.6223; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Valeva A, 2008, MED MICROBIOL IMMUN, V197, P285, DOI 10.1007/s00430-007-0061-2; van der Vliet A, 2000, AM J PHYSIOL-LUNG C, V279, pL537, DOI 10.1152/ajplung.2000.279.3.L537; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Zhang D, 2001, J BIOL CHEM, V276, P3683, DOI 10.1074/jbc.M005390200	73	764	813	5	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32366	10.1371/journal.pone.0032366	http://dx.doi.org/10.1371/journal.pone.0032366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389696	Green Published, Green Submitted, gold			2022-12-27	WOS:000302999600034
J	Edwards, DRV; Tacconelli, A; Wejse, C; Hill, PC; Morris, GAJ; Edwards, TL; Gilbert, JR; Myers, JL; Park, YS; Stryjewski, ME; Abbate, E; Estevan, R; Rabna, P; Novelli, G; Hamilton, CD; Adegbola, R; Ostergaard, L; Williams, SM; Scott, WK; Sirugo, G				Edwards, Digna R. Velez; Tacconelli, Alessandra; Wejse, Christian; Hill, Philip C.; Morris, Gerard A. J.; Edwards, Todd L.; Gilbert, John R.; Myers, Jamie L.; Park, Yo Son; Stryjewski, Martin E.; Abbate, Eduardo; Estevan, Rosa; Rabna, Paulo; Novelli, Giuseppe; Hamilton, Carol D.; Adegbola, Richard; Ostergaard, Lars; Williams, Scott M.; Scott, William K.; Sirugo, Giorgio			MCP1 SNPs and Pulmonary Tuberculosis in Cohorts from West Africa, the USA and Argentina: Lack of Association or Epistasis with IL12B Polymorphisms	PLOS ONE			English	Article							HUMAN GENETIC SUSCEPTIBILITY; MYCOBACTERIUM-TUBERCULOSIS; PROMOTER POLYMORPHISM; RISK-FACTORS; GENOTYPE; PROTECTION	The monocyte chemotactic protein-1 (MCP-1) is a chemokine that plays an important role in the recruitment of monocytes to M. tuberculosis infection sites, and previous studies have reported that genetic variants in MCP1 are associated with differential susceptibility to pulmonary tuberculosis (PTB). We examined eight MCP1 single nucleotide polymorphisms (SNPs) in a multi-ethnic, case-control design that included: 321 cases and 346 controls from Guinea-Bissau, 258 cases and 271 controls from The Gambia, 295 cases and 179 controls from the U. S. (African-Americans), and an additional set of 237 cases and 144 controls of European ancestry from the U. S. and Argentina. Two locus interactions were also examined for polymorphisms in MCP1 and interleukin 12B (IL12B), another gene implicated in PTB risk. Examination of previously associated MCP1 SNPs rs1024611 (-2581A/G), rs2857656 (-362G/C) and rs4586 (+900C/T) did not show evidence for association. One interaction between rs2857656 and IL12B SNP rs2288831 was observed among Africans but the effect was in the opposite direction in Guineans (OR = 1.90, p = 0.001) and Gambians (OR = 0.64, p = 0.024). Our data indicate that the effect of genetic variation within MCP1 is not clear cut and additional studies will be needed to elucidate its role in TB susceptibility.	[Edwards, Digna R. Velez; Edwards, Todd L.; Gilbert, John R.; Myers, Jamie L.; Park, Yo Son; Scott, William K.] Univ Miami, Dr John T Macdonald Fdn Dept Human Genet, Miami, FL 33152 USA; [Edwards, Digna R. Velez; Edwards, Todd L.; Gilbert, John R.; Myers, Jamie L.; Park, Yo Son; Scott, William K.] Univ Miami, Miami Inst Human Genom, Miami, FL USA; [Edwards, Digna R. Velez; Williams, Scott M.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA; [Edwards, Digna R. Velez] Vanderbilt Univ, Med Ctr, Vanderbilt Epidemiol Ctr, Inst Med & Publ Hlth, Nashville, TN USA; [Edwards, Digna R. Velez] Vanderbilt Univ, Med Ctr, Dept Obstet & Gynecol, Nashville, TN 37232 USA; [Tacconelli, Alessandra; Novelli, Giuseppe; Sirugo, Giorgio] Osped San Pietro FBF, Ctr Ric Sci, Ctr Genet, Rome, Italy; [Wejse, Christian; Rabna, Paulo] Danish Epidemiol Sci Ctr, Bandim Hlth Project, Bissau, Guinea Bissau; [Wejse, Christian; Rabna, Paulo] Statens Serum Inst, Bissau, Guinea Bissau; [Wejse, Christian; Ostergaard, Lars] Aarhus Univ, Dept Infect Dis, Skejby, Denmark; [Wejse, Christian] Aarhus Univ, Sch Publ Hlth, Ctr Global Hlth, Skejby, Denmark; [Hill, Philip C.; Morris, Gerard A. J.; Adegbola, Richard; Sirugo, Giorgio] MRC Labs, Fajara, Gambia; [Hill, Philip C.] Univ Otago, Sch Med, Ctr Int Hlth, Dunedin, New Zealand; [Edwards, Todd L.] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Dept Med,Div Epidemiol, Nashville, TN 37212 USA; [Stryjewski, Martin E.] Ctr Educ Med & Invest Clin Norberto Quirno CEMIC, Dept Med, Div Infect Dis, Buenos Aires, DF, Argentina; [Abbate, Eduardo; Estevan, Rosa] Hosp FJ Muniz, Dept Med, Buenos Aires, DF, Argentina; [Novelli, Giuseppe] Univ Tor Vergata, Dipartimento Biopatol & Diagnost Immagini, Rome, Italy; [Hamilton, Carol D.] Family Hlth Int 360, Res Triangle Pk, NC USA; [Hamilton, Carol D.] Duke Univ, Med Ctr, Durham, NC USA; [Adegbola, Richard] Bill & Melinda Gates Fdn, Seattle, WA USA	University of Miami; University of Miami; Vanderbilt University; Vanderbilt University; Vanderbilt University; Aarhus University; Statens Serum Institut; Aarhus University; Aarhus University; MRC Laboratory Molecular Biology; University of Otago; Vanderbilt University; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); University of Buenos Aires; University of Rome Tor Vergata; Duke University; Bill & Melinda Gates Foundation	Edwards, DRV (corresponding author), Univ Miami, Dr John T Macdonald Fdn Dept Human Genet, Miami, FL 33152 USA.	BScott@med.miami.edu; sirugo.giorgio@fbfrm.it	Williams, Scott/B-9491-2012; Williams, Scott/Q-4812-2019; Velez Edwards, Digna/C-1090-2012; Novelli, Giuseppe/T-8822-2019; Novelli, Giuseppe/A-5195-2013; Wejse, Christian/C-8468-2014; Sirugo, Giorgio/N-9056-2019; Ostergaard, Lars/AAA-3020-2020; Sirugo, Giorgio/L-1628-2016; Novelli, Giuseppe/GQB-3329-2022	Williams, Scott/0000-0002-4835-9544; Novelli, Giuseppe/0000-0002-7781-602X; Wejse, Christian/0000-0002-2534-2942; Ostergaard, Lars/0000-0003-2459-0511; Novelli, Giuseppe/0000-0002-7781-602X; , YoSon/0000-0002-0465-4744; Scott, William/0000-0001-9336-6404; Stryjewski, Martin/0000-0002-4986-6564; Ostergaard, Lars/0000-0002-7619-605X	Medical Research Council UK (MRC) [G0000690]; MRC (UK) The Gambia Unit; Danish Medical Research Council; Danish Society of Respiratory Medicine; Danish Council of Development Research; United States National Institutes of Health [R01 HL68534]; MRC [MC_UP_A900_1122, MC_U190071468] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068534] Funding Source: NIH RePORTER	Medical Research Council UK (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC (UK) The Gambia Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Society of Respiratory Medicine; Danish Council of Development Research; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the Medical Research Council UK (MRC) award G0000690 to GS; MRC (UK) The Gambia Unit core-funding to PCH and RA; grants from the Danish Medical Research Council, the Danish Society of Respiratory Medicine, the Danish Council of Development Research to CW and LO, and by the United States National Institutes of Health grant R01 HL68534 to WKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Arji N, 2012, J INFECT DEV COUNTR, V6, P73; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Ben-Selma W, 2011, MOL BIOL REP, V38, P5413, DOI 10.1007/s11033-011-0695-4; Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; Blackwell JM, 1997, PHILOS T R SOC B, V352, P1331, DOI 10.1098/rstb.1997.0118; Buijtels PCAM, 2008, INT J TUBERC LUNG D, V12, P1485; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Feng WX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014652; Feng WX, 2011, INT J TUBERC LUNG DI; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ganachari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008881; Gustafson P, 2004, INT J EPIDEMIOL, V33, P163, DOI 10.1093/ije/dyh026; Hancock DB, 2007, GENET EPIDEMIOL, V31, P883, DOI 10.1002/gepi.20249; Hasan Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008459; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Intemann CD, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-34; Jensen LE, 2006, AM J MED GENET A, V140A, P1114, DOI 10.1002/ajmg.a.31212; Lienhardt C, 2002, AM J EPIDEMIOL, V155, P1066, DOI 10.1093/aje/155.11.1066; Modi WS, 2003, AIDS, V17, P2357, DOI 10.1097/00002030-200311070-00011; Moller M, 2010, FEMS IMMUNOL MED MIC, V58, P3, DOI 10.1111/j.1574-695X.2009.00600.x; Morris GAJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016656; Olesen R, 2007, GENES IMMUN, V8, P456, DOI 10.1038/sj.gene.6364410; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Sirugo G, 2004, NAT GENET, V36, P785, DOI 10.1038/ng0804-785; Sirugo G, 2008, HUM GENET, V123, P557, DOI 10.1007/s00439-008-0511-y; Stein CM, 2011, MAMM GENOME, V22, P91, DOI 10.1007/s00335-010-9301-7; Szalai C, 2001, ATHEROSCLEROSIS, V158, P233, DOI 10.1016/S0021-9150(01)00423-3; Thye T, 2009, HUM MOL GENET, V18, P381, DOI 10.1093/hmg/ddn352; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Vannberg FO, 2011, IMMUNOL REV, V240, P105, DOI 10.1111/j.1600-065X.2010.00996.x; Velez DR, 2009, INT J TUBERC LUNG D, V13, P1068; World Health Organization, 2010, GLOB TUB CONTR	37	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32275	10.1371/journal.pone.0032275	http://dx.doi.org/10.1371/journal.pone.0032275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384203	Green Submitted, Green Published, gold			2022-12-27	WOS:000302918500072
J	Ghodrati, M; Khaligh-Razavi, SM; Ebrahimpour, R; Rajaei, K; Pooyan, M				Ghodrati, Masoud; Khaligh-Razavi, Seyed-Mahdi; Ebrahimpour, Reza; Rajaei, Karim; Pooyan, Mohammad			How Can Selection of Biologically Inspired Features Improve the Performance of a Robust Object Recognition Model?	PLOS ONE			English	Article							RECEPTIVE-FIELDS; FUNCTIONAL ARCHITECTURE; CORTEX; NEOCOGNITRON; ALGORITHMS; BRAIN	Humans can effectively and swiftly recognize objects in complex natural scenes. This outstanding ability has motivated many computational object recognition models. Most of these models try to emulate the behavior of this remarkable system. The human visual system hierarchically recognizes objects in several processing stages. Along these stages a set of features with increasing complexity is extracted by different parts of visual system. Elementary features like bars and edges are processed in earlier levels of visual pathway and as far as one goes upper in this pathway more complex features will be spotted. It is an important interrogation in the field of visual processing to see which features of an object are selected and represented by the visual cortex. To address this issue, we extended a hierarchical model, which is motivated by biology, for different object recognition tasks. In this model, a set of object parts, named patches, extracted in the intermediate stages. These object parts are used for training procedure in the model and have an important role in object recognition. These patches are selected indiscriminately from different positions of an image and this can lead to the extraction of nondiscriminating patches which eventually may reduce the performance. In the proposed model we used an evolutionary algorithm approach to select a set of informative patches. Our reported results indicate that these patches are more informative than usual random patches. We demonstrate the strength of the proposed model on a range of object recognition tasks. The proposed model outperforms the original model in diverse object recognition tasks. It can be seen from the experiments that selected features are generally particular parts of target images. Our results suggest that selected features which are parts of target objects provide an efficient set for robust object recognition.	[Ghodrati, Masoud; Pooyan, Mohammad] Shahed Univ, Dept Biomed Engn, Fac Engn, Tehran, Iran; [Ghodrati, Masoud; Ebrahimpour, Reza] Inst Res Fundamental Sci IPM, SCS, Tehran, Iran; [Khaligh-Razavi, Seyed-Mahdi; Ebrahimpour, Reza] Shahid Rajaee Teacher Training Univ, Brain & Intelligent Syst Res Lab BISLab, Dept Elect & Comp Engn, Tehran, Iran; [Khaligh-Razavi, Seyed-Mahdi] Univ Tehran, Dept Math Stat & Comp Sci, Tehran, Iran; [Rajaei, Karim] Amirkabir Univ Technol, Dept Math & Comp Sci, Tehran, Iran	Shahed University; Shahid Rajaee Teacher Training University (SRTTU); University of Tehran; Amirkabir University of Technology	Ghodrati, M (corresponding author), Shahed Univ, Dept Biomed Engn, Fac Engn, Tehran, Iran.	Masoud.ghodrati@ipm.ir	Ebrahimpour, Reza/AAH-8531-2019; Ebrahimpour, Reza/A-9721-2009	Ebrahimpour, Reza/0000-0002-7013-8078; Ghodrati, Masoud/0000-0002-4006-2578; Khaligh-Razavi, Seyed-Mahdi/0000-0002-5700-1704	MRC [MC_U105597120] Funding Source: UKRI; Medical Research Council [MC_U105597120] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Berg AC, 2001, PROC CVPR IEEE, P607; Fergus R, 2003, PROC CVPR IEEE, P264; Fukushima K, 2003, NEUROCOMPUTING, V51, P161, DOI 10.1016/S0925-2312(02)00614-8; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; Grossberg S, 1997, TRENDS NEUROSCI, V20, P106, DOI 10.1016/S0166-2236(96)01002-8; Grossberg S, 2007, PROG BRAIN RES, V165, P79, DOI 10.1016/S0079-6123(06)65006-1; He XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020002; Holland JH., 1975, Q REV BIOL; Huang Y, 2011, IEEE T SYSTEMS MAN B; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Krupka E, 2008, J MACH LEARN RES, V9, P2349; Lazebnik S., 2009, OBJECT CATEGORIZATIO; Li FF, 2007, COMPUT VIS IMAGE UND, V106, P59, DOI 10.1016/j.cviu.2005.09.012; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mel BW, 1997, NEURAL COMPUT, V9, P777, DOI 10.1162/neco.1997.9.4.777; Meyers E, 2008, INT J COMPUT VISION, V76, P93, DOI 10.1007/s11263-007-0058-8; Ming-Yeong Teo, 1997, Neural Network World, V7, P293; Mutch J, 2008, INT J COMPUT VISION, V80, P45, DOI 10.1007/s11263-007-0118-0; Opelt A, 2006, IEEE T PATTERN ANAL, V28, P416, DOI 10.1109/TPAMI.2006.54; Pan Z, 1999, EV COMP 1999 CEC 99, V3; Pinto  N., 2011, IEEE WORKSH APPL COM, P463, DOI [10.1109/WACV.2011.5711540, DOI 10.1109/WACV.2011.5711540]; Pinto N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040027; Polk TA, 2007, J NEUROSCI, V27, P13921, DOI 10.1523/JNEUROSCI.4001-07.2007; Ponce J, 2006, DATASET ISSUES OBJEC, P29; Raymer ML, 2000, IEEE T EVOLUT COMPUT, V4, P164, DOI 10.1109/4235.850656; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rolls ET, 2000, PROG NEUROBIOL, V61, P557, DOI 10.1016/S0301-0082(99)00066-0; Rowe JE, 2010, EVOL COMPUT, V18, P635, DOI 10.1162/EVCO_a_00007; Rudolph G, 1996, IEEE C EVOL COMPUTAT, P50, DOI 10.1109/ICEC.1996.542332; Salcedo-Sanz S, 2002, ARTIFICIAL NEURAL NE, V2002, P144; Schneider G, 2005, IEEE T SYST MAN CY B, V35, P426, DOI 10.1109/TSMCB.2005.846649; Serre T., 2005, ARTIF INTELL, P1; Serre T, 2002, BIOL MOTIVATED COMPU, P209; Serre T, 2007, PROG BRAIN RES, V165, P33, DOI 10.1016/S0079-6123(06)65004-8; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Shi D, 1999, Int J Neural Syst, V9, P497, DOI 10.1142/S012906579900054X; SIEDLECKI W, 1989, PATTERN RECOGN LETT, V10, P335, DOI 10.1016/0167-8655(89)90037-8; Sivanandam S. N., 2007, INTRO GENETIC ALGORI; Stringer SM, 2006, BIOL CYBERN, V94, P128, DOI 10.1007/s00422-005-0030-z; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Varma M, 2007, IEEE I CONF COMP VIS, P369; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Weber M, 2000, LECT NOTES COMPUT SC, V1842, P18; Weber M, 2000, THESIS CALTECH PASAD; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yang JH, 1998, IEEE INTELL SYST APP, V13, P44, DOI 10.1109/5254.671091; Zhang H., 2006, 2006 IEEE COMP SOC C, V2, P2126, DOI [DOI 10.1109/CVPR.2006.301, 10.1109/CVPR.2006.301]	51	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32357	10.1371/journal.pone.0032357	http://dx.doi.org/10.1371/journal.pone.0032357			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384229	gold, Green Published			2022-12-27	WOS:000302918500081
J	Jiang, WH; Ghosh, D				Jiang, Wenhua; Ghosh, Debashis			Motion and Flexibility in Human Cytochrome P450 Aromatase	PLOS ONE			English	Article							NORMAL-MODE ANALYSIS; PROTEIN FLEXIBILITY; LIPID-COMPOSITION; CONFORMATIONAL-CHANGE; MOLECULAR-DYNAMICS; ANALYSIS SUGGESTS; SINGLE-PARAMETER; MECHANISM; MACROMOLECULES; ELECTROSTATICS	The crystal structures of human placental aromatase in complex with the substrate androstenedione and exemestane have revealed an androgen-specific active site and the structural basis for higher order organization. However, X-ray structures do not provide accounts of movements due to short-range fluctuations, ligand binding and protein-protein association. In this work, we conduct normal mode analysis (NMA) revealing the intrinsic fluctuations of aromatase, deduce the internal modes in membrane-free and membrane-integrated monomers as well as the intermolecular modes in oligomers, and propose a quaternary organization for the endoplasmic reticulum (ER) membrane integration. Dynamics of the crystallographic oligomers from NMA is found to be in agreement with the isotropic thermal factors from the X-ray analysis. Calculations of the root mean square fluctuations of the C-alpha atoms from their equilibrium positions confirm that the rigid-core structure of aromatase is intrinsic regardless of the changes in steroid binding interactions, and that aromatase self-association does not deteriorate the rigidity of the catalytic cleft. Furthermore, NMA on membrane-integrated aromatase shows that the internal modes in all likelihood contribute to breathing of the active site access channel. The collective intermolecular hinge bending and twisting modes provide the flexibility in the quaternary association necessary for membrane integration of the aromatase oligomers. Taken together, fluctuations of the active site, the access channel, and the heme-proximal cavity, and a dynamic quaternary organization could all be essential components of the functional aromatase in its role as an ER membrane-embedded steroidogenic enzyme.	[Jiang, Wenhua; Ghosh, Debashis] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Jiang, WH (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY USA.	ghoshd@upstate.edu			National Institutes of Health [GM086893]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by National Institutes of Health Grant GM086893. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Bahar I, 2010, CHEM REV, V110, P1463, DOI 10.1021/cr900095e; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BROOKS B, 1985, P NATL ACAD SCI USA, V82, P4995, DOI 10.1073/pnas.82.15.4995; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROWN DJ, 1989, PLANT PHYSIOL, V90, P955, DOI 10.1104/pp.90.3.955; Catalano S, 2009, MOL ENDOCRINOL, V23, P1634, DOI 10.1210/me.2009-0039; DAVISON SC, 1974, BIOCHEMISTRY-US, V140, P461, DOI 10.1042/bj1400461; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dobbins SE, 2008, P NATL ACAD SCI USA, V105, P10390, DOI 10.1073/pnas.0802496105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fogolari F, 2002, J MOL RECOGNIT, V15, P377, DOI 10.1002/jmr.577; Forman-Kay JD, 1999, NAT STRUCT BIOL, V6, P1086, DOI 10.1038/70008; Ghosh D, 2011, STEROIDS, V76, P753, DOI 10.1016/j.steroids.2011.02.030; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; GO N, 1983, P NATL ACAD SCI-BIOL, V80, P3696, DOI 10.1073/pnas.80.12.3696; Gohlke H, 2004, PROTEINS, V56, P322, DOI 10.1002/prot.20116; Hong YY, 2010, J STEROID BIOCHEM, V118, P203, DOI 10.1016/j.jsbmb.2009.11.010; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kovacs JA, 2004, PROTEINS, V56, P661, DOI 10.1002/prot.20151; Ma JP, 1998, P NATL ACAD SCI USA, V95, P8502, DOI 10.1073/pnas.95.15.8502; Ma JP, 2004, CURR PROTEIN PEPT SC, V5, P119, DOI 10.2174/1389203043486892; Phan G, 2010, STRUCTURE, V18, P507, DOI 10.1016/j.str.2010.01.018; Poulos TL, 2003, P NATL ACAD SCI USA, V100, P13121, DOI 10.1073/pnas.2336095100; Praporski S, 2009, J BIOL CHEM, V284, P33224, DOI 10.1074/jbc.M109.006064; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Shattuck T W., 2009, MOL OPERATING ENV; Soheilifard R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026008; STEINBERG IZ, 1963, J BIOL CHEM, V238, P172; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Tama F, 2000, PROTEINS, V41, P1; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Van Wynsberghe A, 2004, BIOCHEMISTRY-US, V43, P13083, DOI 10.1021/bi049738+; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	36	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32565	10.1371/journal.pone.0032565	http://dx.doi.org/10.1371/journal.pone.0032565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384274	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500101
J	Koren, L; Ng, ESM; Soma, KK; Wynne-Edwards, KE				Koren, Lee; Ng, Ella S. M.; Soma, Kiran K.; Wynne-Edwards, Katherine E.			Sample Preparation and Liquid Chromatography-Tandem Mass Spectrometry for Multiple Steroids in Mammalian and Avian Circulation	PLOS ONE			English	Article							TESTOSTERONE; IMMUNOASSAY; CORTICOSTERONE; INTERFERENCE; EXTRACTION; ESTROGENS; SONGBIRD; CORTISOL; PLASMA; BRAIN	Blood samples from wild mammals and birds are often limited in volume, allowing researchers to quantify only one or two steroids from a single sample by immunoassays. In addition, wildlife serum or plasma samples are often lipemic, necessitating stringent sample preparation. Here, we validated sample preparation for simultaneous liquid chromatography -tandem mass spectrometry (LC-MS/MS) quantitation of cortisol, corticosterone, 11-deoxycortisol, dehydroepiandrosterone (DHEA), 17b-estradiol, progesterone, 17 alpha-hydroxyprogesterone and testosterone from diverse mammalian (7 species) and avian (5 species) samples. Using 100 mL of serum or plasma, we quantified (signal-to-noise (S/N) ratio >= 10) 4-7 steroids depending on the species and sample, without derivatization. Steroids were extracted from serum or plasma using automated solid-phase extraction where samples were loaded onto C18 columns, washed with water and hexane, and then eluted with ethyl acetate. Quantitation by LC-MS/MS was done in positive ion, multiple reaction-monitoring (MRM) mode with an atmospheric pressure chemical ionization (APCI) source and heated nebulizer (500 degrees C). Deuterated steroids served as internal standards and run time was 15 minutes. Extraction recoveries were 87-101% for the 8 analytes, and all intra-and inter-run CVs were <= 8.25%. This quantitation method yields good recoveries with variable lipid-content samples, avoids antibody cross-reactivity issues, and delivers results for multiple steroids. Thus, this method can enrich datasets by providing simultaneous quantitation of multiple steroids, and allow researchers to reimagine the hypotheses that could be tested with their volume-limited, lipemic, wildlife samples.	[Koren, Lee; Ng, Ella S. M.; Wynne-Edwards, Katherine E.] Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, Calgary, AB, Canada; [Koren, Lee; Ng, Ella S. M.; Wynne-Edwards, Katherine E.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Soma, Kiran K.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of Calgary; University of Calgary; University of British Columbia	Koren, L (corresponding author), Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, Calgary, AB, Canada.	k.wynne-edwards@ucalgary.ca	Wynne-Edwards, Katherine/P-2326-2019; Wynne-Edwards, Katherine/D-9036-2012; Soma, Kiran K/B-9772-2012	Wynne-Edwards, Katherine/0000-0002-2944-4516; Soma, Kiran K/0000-0003-2169-8092	Natural Sciences and Engineering Research Council of Canada; Canadian Foundation for Innovation; Alberta Education and Technology; Faculty of Veterinary Medicine at the University of Calgary (KEWE); CIHR; University of Calgary Faculty of Veterinary Medicine (LK/KEWE)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Alberta Education and Technology; Faculty of Veterinary Medicine at the University of Calgary (KEWE); CIHR(Canadian Institutes of Health Research (CIHR)); University of Calgary Faculty of Veterinary Medicine (LK/KEWE)	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada, the Canadian Foundation for Innovation, Alberta Education and Technology, and the Faculty of Veterinary Medicine at the University of Calgary (KEWE). In addition, support was provided by CIHR (KKS) plus a postdoctoral award from the University of Calgary Faculty of Veterinary Medicine (LK/KEWE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blasco M, 2009, J CHROMATOGR B, V877, P1509, DOI 10.1016/j.jchromb.2009.03.028; Bock JL, 2000, AM J CLIN PATHOL, V113, P628, DOI 10.1309/DUDM-3Y6L-3R1L-QP15; Ceglarek U, 2010, J STEROID BIOCHEM, V121, P479, DOI 10.1016/j.jsbmb.2010.07.002; Charlier TD, 2010, GEN COMP ENDOCR, V167, P18, DOI 10.1016/j.ygcen.2010.02.002; Fanelli F, 2011, STEROIDS, V76, P244, DOI 10.1016/j.steroids.2010.11.005; Guo TD, 2004, ARCH PATHOL LAB MED, V128, P469; Guo TD, 2008, CLIN BIOCHEM, V41, P736, DOI 10.1016/j.clinbiochem.2008.02.009; Guo TD, 2006, CLIN CHIM ACTA, V372, P76, DOI 10.1016/j.cca.2006.03.034; Harwood DT, 2009, CLIN CHIM ACTA, V409, P78, DOI 10.1016/j.cca.2009.09.003; Ismail AAA, 2002, ANN CLIN BIOCHEM, V39, P366, DOI 10.1258/000456302760042128; Lee C, 1998, CLIN BIOCHEM, V31, P229, DOI 10.1016/S0009-9120(98)00025-3; Newman AEM, 2008, GEN COMP ENDOCR, V155, P503, DOI 10.1016/j.ygcen.2007.08.007; Newman AEM, 2008, ENDOCRINOLOGY, V149, P2537, DOI 10.1210/en.2007-1363; Penning TM, 2010, J STEROID BIOCHEM, V121, P546, DOI 10.1016/j.jsbmb.2010.01.005; Rossi C, 2010, CLIN CHIM ACTA, V411, P222, DOI 10.1016/j.cca.2009.11.007; Schmidt G, 2002, FOOD CHEM, V76, P83, DOI 10.1016/S0308-8146(01)00237-0; Schmidt KL, 2010, BRAIN BEHAV IMMUN, V24, P908, DOI 10.1016/j.bbi.2010.02.008; Shackleton C, 2010, J STEROID BIOCHEM, V121, P481, DOI 10.1016/j.jsbmb.2010.02.017; Soldin SJ, 2009, CLIN CHEM, V55, P1061, DOI 10.1373/clinchem.2007.100008; Stanczyk FZ, 2010, J STEROID BIOCHEM, V121, P491, DOI 10.1016/j.jsbmb.2010.05.001; Stanczyk FZ, 2003, STEROIDS, V68, P1173, DOI 10.1016/j.steroids.2003.08.012; Taves MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015727; Taves MD, 2011, FRONTIERS ENDOCRINOL, V2; WINGFIELD JC, 1994, ANIM BEHAV, V47, P77, DOI 10.1006/anbe.1994.1009	24	51	51	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32496	10.1371/journal.pone.0032496	http://dx.doi.org/10.1371/journal.pone.0032496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384262	gold, Green Published			2022-12-27	WOS:000302918500096
J	Lifjeld, JT; Laskemoen, T; Kleven, O; Pedersen, ATM; Lampe, HM; Rudolfsen, G; Schmoll, T; Slagsvold, T				Lifjeld, Jan T.; Laskemoen, Terje; Kleven, Oddmund; Pedersen, A. Tiril M.; Lampe, Helene M.; Rudolfsen, Geir; Schmoll, Tim; Slagsvold, Tore			No Evidence for Pre-Copulatory Sexual Selection on Sperm Length in a Passerine Bird	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; PIED FLYCATCHERS; FICEDULA-HYPOLEUCA; COMPETITION; MALES; MATE; HYPOTHESIS; MORPHOLOGY; FERTILITY; EVOLUTION	There is growing evidence that post-copulatory sexual selection, mediated by sperm competition, influences the evolution of sperm phenotypes. Evidence for pre-copulatory sexual selection effects on sperm traits, on the other hand, is rather scarce. A recent paper on the pied flycatcher, Ficedula hypoleuca, reported phenotypic associations between sperm length and two sexually selected male traits, i.e. plumage colour and arrival date, thus invoking pre-copulatory sexual selection for longer sperm. We were unable to replicate these associations with a larger data set from the same and two additional study populations; sperm length was not significantly related to either male plumage colour or arrival date. Furthermore, there was no significant difference in sperm length between populations despite marked differences in male plumage colour. We also found some evidence against the previously held assumption of longer sperm being qualitatively superior; longer sperm swam at the same speed as shorter sperm, but were less able to maintain speed over time. We argue that both empirical evidence and theoretical considerations suggest that the evolution of sperm morphology is not primarily associated with pre-copulatory sexual selection on male secondary sexual traits in this or other passerine bird species. The relatively large between-male variation in sperm length in this species is probably due to relaxed post-copulatory sexual selection.	[Lifjeld, Jan T.; Laskemoen, Terje; Kleven, Oddmund] Univ Oslo, Nat Hist Museum, NCB, Oslo, Norway; [Pedersen, A. Tiril M.] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway; [Lampe, Helene M.; Slagsvold, Tore] Univ Oslo, Dept Biol, CEES, Oslo, Norway; [Rudolfsen, Geir] Norwegian Radiat Protect Author, Dept Environm Radioact, Tromso, Norway; [Schmoll, Tim] Univ Bielefeld, D-33615 Bielefeld, Germany	University of Oslo; Norwegian University of Life Sciences; University of Oslo; University of Bielefeld	Lifjeld, JT (corresponding author), Univ Oslo, Nat Hist Museum, NCB, Oslo, Norway.	j.t.lifjeld@nhm.uio.no	Kleven, Oddmund/A-6116-2009; Rudolfsen, Geir/ABD-7777-2020; Lifjeld, Jan T/B-1978-2008	Kleven, Oddmund/0000-0003-0267-6795; Lifjeld, Jan T/0000-0002-9172-9985; Rudolfsen, Geir/0000-0001-7984-8458	Research Council of Norway [170853/V40, 196554/V40]	Research Council of Norway(Research Council of Norway)	The work was funded by two grants (170853/V40 and 196554/V40) from the Research Council of Norway. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1986, NATURE, V323, P152, DOI 10.1038/323152a0; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bates D, 2005, R NEWS, V5, P27, DOI DOI 10.1111/J.1523-1739.2005.00280.X; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Birkhead TR, SPERM COMPETITION SE; Birkhead TR, SPERM BIOL EVOLUTION; Calhim S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000413; Calhim S, 2009, BIOL LETTERS, V5, P58, DOI 10.1098/rsbl.2008.0544; Chek AA, 1996, ETHOLOGY, V102, P134; Drost R, 1936, VOGELZUG, V6, P179; Ellegren H, 1995, MOL ECOL, V4, P739, DOI 10.1111/j.1365-294X.1995.tb00274.x; Gelman A., 2007, DATA ANAL USING REGR; GOMENDIO M, 1991, P ROY SOC B-BIOL SCI, V243, P181, DOI 10.1098/rspb.1991.0029; Gomendio M, 2007, REPRODUCTION, V134, P19, DOI 10.1530/REP-07-0143; Helfenstein F, 2010, BEHAV ECOL SOCIOBIOL, V64, P557, DOI 10.1007/s00265-009-0871-x; KELLER L, 1995, ADV STUD BEHAV, V24, P291, DOI 10.1016/S0065-3454(08)60397-6; Kelly CD, 2006, Q REV BIOL, V81, P221, DOI 10.1086/506236; Kleven O, 2008, EVOLUTION, V62, P494, DOI 10.1111/j.1558-5646.2007.00287.x; Kleven O, 2009, EVOLUTION, V63, P2466, DOI 10.1111/j.1558-5646.2009.00725.x; Laskemoen T, 2010, BEHAV ECOL SOCIOBIOL, V64, P1473, DOI 10.1007/s00265-010-0962-8; Lehtonen PK, 2009, ANIM BEHAV, V77, P1103, DOI 10.1016/j.anbehav.2009.01.014; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lifjeld JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013456; Lifjeld JT, 1997, AUK, V114, P112, DOI 10.2307/4089072; LIFJELD JT, 1991, BEHAV ECOL SOCIOBIOL, V29, P95, DOI 10.1007/BF00166483; Lifjeld JT, 1997, ANIM BEHAV, V53, P1225, DOI 10.1006/anbe.1996.0430; Lubjuhn T, 2000, BEHAV ECOL SOCIOBIOL, V48, P12, DOI 10.1007/s002650000208; PARKER GA, 1982, J THEOR BIOL, V96, P281, DOI 10.1016/0022-5193(82)90225-9; Pizzari T, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P207, DOI 10.1016/B978-0-12-372568-4.00006-9; POMIANKOWSKI A, 1995, P ROY SOC B-BIOL SCI, V260, P21, DOI 10.1098/rspb.1995.0054; RATTI O, 1995, BEHAV ECOL SOCIOBIOL, V37, P419, DOI 10.1007/BF00170590; ROSKAFT E, 1992, J ZOOL, V228, P521, DOI 10.1111/j.1469-7998.1992.tb04452.x; SAETRE GP, 1995, J ANIM ECOL, V64, P21, DOI 10.2307/5824; Saetre GP, 1997, NATURE, V387, P589; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; SLAGSVOLD T, 1986, ORNIS SCAND, V17, P210, DOI 10.2307/3676829; Slagsvold T, 2001, BEHAV ECOL, V12, P412, DOI 10.1093/beheco/12.4.412; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011	38	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32611	10.1371/journal.pone.0032611	http://dx.doi.org/10.1371/journal.pone.0032611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384277	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000302918500104
J	Monaco, S; Fiorini, M; Farinazzo, A; Ferrari, S; Gelati, M; Piccardo, P; Zanusso, G; Ghetti, B				Monaco, Salvatore; Fiorini, Michele; Farinazzo, Alessia; Ferrari, Sergio; Gelati, Matteo; Piccardo, Pedro; Zanusso, Gianluigi; Ghetti, Bernardino			Allelic Origin of Protease-Sensitive and Protease-Resistant Prion Protein Isoforms in Gerstmann-Straussler-Scheinker Disease with the P102L Mutation	PLOS ONE			English	Article							PHENOTYPIC HETEROGENEITY; SYNTHETIC PEPTIDE; TRUNCATED FORMS; WILD-TYPE; PRP; NEURODEGENERATION; IDENTIFICATION; VARIABILITY; FRAGMENTS; FAMILY	Gerstmann-Straussler-Scheinker (GSS) disease is a dominantly inherited prion disease associated with point mutations in the Prion Protein gene. The most frequent mutation associated with GSS involves a proline-to-leucine substitution at residue 102 of the prion protein, and is characterized by marked variability at clinical, pathological and molecular levels. Previous investigations of GSS P102L have shown that disease-associated pathological prion protein, or PrPSc, consists of two main conformers, which under exogenous proteolysis generates a core fragment of 21 kDa and an internal fragment of 8 kDa. Both conformers are detected in subjects with spongiform degeneration, whereas only the 8 kDa fragment is recovered in cases lacking spongiosis. Several studies have reported an exclusive derivation of protease-resistant PrPSc isoforms from the mutated allele; however, more recently, the propagation of protease-resistant wild-type PrPSc has been described. Here we analyze the molecular and pathological phenotype of six GSS P102L cases characterized by the presence of 21 and 8 kDa PrP fragments and two subjects with only the 8 kDa PrP fragment. Using sensitive protein separation techniques and Western blots with antibodies differentially recognizing wild-type and mutant PrP we observed a range of PrPSc allelic conformers, either resistant or sensitive to protease treatment in all investigated subjects. Additionally, tissue deposition of protease-sensitive wild-type PrPSc molecules was seen by conventional PrP immunohistochemistry and paraffin-embedded tissue blot. Our findings enlarge the spectrum of conformational allelic PrPSc quasispecies propagating in GSS P102L thus providing a molecular support to the spectrum of disease phenotypes, and, in addition, impact the diagnostic role of PrP immunohistochemistry in prion diseases.	[Monaco, Salvatore; Fiorini, Michele; Farinazzo, Alessia; Ferrari, Sergio; Gelati, Matteo; Zanusso, Gianluigi] Univ Verona, Dept Neurol Neuropsychol Morphol & Motor Sci, I-37100 Verona, Italy; [Piccardo, Pedro] US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA; [Piccardo, Pedro; Ghetti, Bernardino] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA	University of Verona; US Food & Drug Administration (FDA); Indiana University System; Indiana University Bloomington	Monaco, S (corresponding author), Univ Verona, Dept Neurol Neuropsychol Morphol & Motor Sci, I-37100 Verona, Italy.	salvatore.monaco@univr.it	Gelati, Matteo/AAR-1692-2020; Monaco, Salvatore/K-4659-2018; Zanusso, Gianluigi/K-2823-2018; Ferrari, Sergio/AAE-5649-2019	Monaco, Salvatore/0000-0003-3191-8597; Zanusso, Gianluigi/0000-0001-5199-6264; ferrari, sergio/0000-0003-3855-5135; Fiorini, Michele/0000-0002-5339-8716	National Institute of Neurological Disease and Stroke (NINDS), National Institutes of Health [R01 NS029822]; National Institute on Aging (NIA), National Institutes of Health [P30 AG010133]; Fondazione Cariverona; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251968, BBS/E/D/20251967] Funding Source: researchfish; BBSRC [BBS/E/D/20251967, BBS/E/D/20251968] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010133] Funding Source: NIH RePORTER	National Institute of Neurological Disease and Stroke (NINDS), National Institutes of Health; National Institute on Aging (NIA), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Fondazione Cariverona(Fondazione Cariverona); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants R01 NS029822 to BG from National Institute of Neurological Disease and Stroke (NINDS), P30 AG010133 from National Institute on Aging (NIA) to BG (both Institutes are part of the National Institutes of Health) and by the grant "Disabilita cognitiva e comportamentale nelle demenze e nelle psicosi" from Fondazione Cariverona to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbanti P, 1996, NEUROLOGY, V47, P734, DOI 10.1212/WNL.47.3.734; Bergstrom AL, 2009, CLIN NEUROPATHOL, V28, P321, DOI 10.2379/NPX07098; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Colucci M, 2006, J NEUROPATH EXP NEUR, V65, P642, DOI 10.1097/01.jnen.0000228198.81797.4d; DeArmond SJ, 1999, COLD SPRING HARBOR M, V38, P585; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; HAINFELLNER JA, 1995, BRAIN PATHOL, V5, P201, DOI 10.1111/j.1750-3639.1995.tb00596.x; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Hill AF, 2003, BRAIN, V126, P1333, DOI 10.1093/brain/awg125; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Jimenez-Huete A, 1998, AM J PATHOL, V153, P1561, DOI 10.1016/S0002-9440(10)65744-6; Kaneko K, 2000, J MOL BIOL, V295, P997, DOI 10.1006/jmbi.1999.3386; MCKINLEY MP, 1991, J VIROL, V65, P1340, DOI 10.1128/JVI.65.3.1340-1351.1991; Parchi P, 1998, P NATL ACAD SCI USA, V95, P8322, DOI 10.1073/pnas.95.14.8322; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Piccardo P, 1998, J NEUROPATH EXP NEUR, V57, P979, DOI 10.1097/00005072-199810000-00010; Piccardo P, 2007, P NATL ACAD SCI USA, V104, P4712, DOI 10.1073/pnas.0609241104; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; PRUSINER SB, 1992, BIOCHEMISTRY-US, V31, P12277, DOI 10.1021/bi00164a001; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; Tremblay P, 2004, J VIROL, V78, P2088, DOI 10.1128/JVI.78.4.2088-2099.2004; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Wadsworth JDF, 2006, BRAIN, V129, P1557, DOI 10.1093/brain/awl076; Webb TEF, 2008, BRAIN, V131, P2632, DOI 10.1093/brain/awn202; Zanusso G, 2004, J BIOL CHEM, V279, P38936, DOI 10.1074/jbc.M405468200; Zanusso G, 2003, NEW ENGL J MED, V348, P711, DOI 10.1056/NEJMoa022043; ZANUSSO G, 2005, DRUG DISCOV TODAY, V2, P511; Zou WQ, 2010, ANN NEUROL, V68, P162, DOI 10.1002/ana.22094; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200	33	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32382	10.1371/journal.pone.0032382	http://dx.doi.org/10.1371/journal.pone.0032382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384235	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100076
J	Guo, W; Zou, LF; Li, YR; Cui, YP; Ji, ZY; Cai, LL; Zou, HS; Hutchins, WC; Yang, CH; Chen, GY				Guo, Wei; Zou, Li-fang; Li, Yu-rong; Cui, Yi-ping; Ji, Zhi-yuan; Cai, Lu-lu; Zou, Hua-song; Hutchins, William C.; Yang, Ching-hong; Chen, Gong-you			Fructose-Bisphophate Aldolase Exhibits Functional Roles between Carbon Metabolism and the hrp System in Rice Pathogen Xanthomonas oryzae pv. oryzicola	PLOS ONE			English	Article							ACTING REGULATORY ELEMENT; HYPERSENSITIVE-RESPONSE; TRANSCRIPTIONAL INDUCTION; BACTERIAL PATHOGENS; GENOME SEQUENCE; GENE HRPG; CAMPESTRIS; PLANT; EXPRESSION; VESICATORIA	Fructose-bisphophate aldolase (FbaB), is an enzyme in glycolysis and gluconeogenesis in living organisms. The mutagenesis in a unique fbaB gene of Xanthomonas oryzae pv. oryzicola, the causal agent of rice bacterial leaf streak, led the pathogen not only unable to use pyruvate and malate for growth and delayed its growth when fructose was used as the sole carbon source, but also reduced extracellular polysaccharide (EPS) production and impaired bacterial virulence and growth in rice. Intriguingly, the fbaB promoter contains an imperfect PIP-box (plant-inducible promoter) (TTCGT-N-9-TTCGT). The expression of fbaB was negatively regulated by a key hrp regulatory HrpG and HrpX cascade. Base substitution in the PIP-box altered the regulation of fbaB with the cascade. Furthermore, the expression of fbaB in X. oryzae pv. oryzicola RS105 strain was inducible in planta rather than in a nutrient-rich medium. Except other hrp-hrc-hpa genes, the expression of hrpG and hrpX was repressed and the transcripts of hrcC, hrpE and hpa3 were enhanced when fbaB was deleted. The mutation in hrcC, hrpE or hpa3 reduced the ability of the pathogen to acquire pyruvate and malate. In addition, bacterial virulence and growth in planta and EPS production in R Delta fbaB mutant were completely restored to the wild-type level by the presence of fbaB in trans. This is the first report to demonstrate that carbohydrates, assimilated by X. oryzae pv. oryzicola, play critical roles in coordinating hrp gene expression through a yet unknown regulator.	[Zou, Li-fang; Li, Yu-rong; Ji, Zhi-yuan; Cai, Lu-lu; Zou, Hua-song; Chen, Gong-you] Shanghai Jiao Tong Univ, Sch Agr & Biol, Minist Agr, Key Lab Urban South, Shanghai 200030, Peoples R China; [Guo, Wei; Cui, Yi-ping; Chen, Gong-you] Nanjing Agr Univ, Coll Plant Protect, Minist Educ China, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Peoples R China; [Hutchins, William C.; Yang, Ching-hong] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA	Ministry of Agriculture & Rural Affairs; Shanghai Jiao Tong University; Ministry of Education, China; Nanjing Agricultural University; University of Wisconsin System; University of Wisconsin Milwaukee	Guo, W (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Minist Agr, Key Lab Urban South, Shanghai 200030, Peoples R China.	chyang@uwm.edu; gyouchen@sjtu.edu.cn	Zou, Huasong/GLN-3569-2022; CHEN, Gongyou/AAA-9694-2019; Cai, Lulu/AAN-1269-2021	CHEN, Gongyou/0000-0003-1979-2880; Cai, Lulu/0000-0002-4830-4105; Zou, Huasong/0000-0001-5758-1975	State Key Basic Research and Development Project of China [2011CB16141]; National Natural Science Foundation of China [31071656, 31000071]; Foundation of Ministry of Education of China [20100073110045]	State Key Basic Research and Development Project of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by the State Key Basic Research and Development Project of China (2011CB16141), the National Natural Science Foundation of China (31071656 to Dr. Chen and 31000071 to Zou) and the Ph.D. Programs Foundation of Ministry of Education of China (20100073110045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldon D, 2000, EMBO J, V19, P2304, DOI 10.1093/emboj/19.10.2304; ANKENBAUER RG, 1990, J BACTERIOL, V172, P6442, DOI 10.1128/jb.172.11.6442-6446.1990; Brito B, 2002, MOL PLANT MICROBE IN, V15, P109, DOI 10.1094/MPMI.2002.15.2.109; Buttner D, 2002, EMBO J, V21, P5313, DOI 10.1093/emboj/cdf536; Buttner D, 2002, TRENDS MICROBIOL, V10, P186, DOI 10.1016/S0966-842X(02)02331-4; Buttner D, 2002, J BACTERIOL, V184, P2389, DOI 10.1128/JB.184.9.2389-2398.2002; Cunnac S, 2004, J BACTERIOL, V186, P2309, DOI 10.1128/JB.186.8.2309-2318.2004; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; DENNY TP, 1995, ANNU REV PHYTOPATHOL, V33, P173, DOI 10.1146/annurev.py.33.090195.001133; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Furutani A, 2006, FEMS MICROBIOL LETT, V259, P133, DOI 10.1111/j.1574-6968.2006.00265.x; Furutani A, 2004, J BACTERIOL, V186, P1374, DOI 10.1128/JB.186.5.1374-1380.2004; Guo Xiaoxia, 2010, Wei Sheng Wu Xue Bao, V50, P1155; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; He YW, 2007, MOL MICROBIOL, V64, P281, DOI 10.1111/j.1365-2958.2007.05670.x; HOCHSTER RM, 1958, CAN J BIOCHEM PHYS, V36, P669; Huang DL, 2009, MOL PLANT MICROBE IN, V22, P321, DOI 10.1094/MPMI-22-3-0321; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Islam MR, 2009, J GEN PLANT PATHOL, V75, P66, DOI 10.1007/s10327-008-0124-2; Jiang Jia, 2009, Wei Sheng Wu Xue Bao, V49, P1018; Kim SY, 2010, BIOTECHNOL LETT, V32, P527, DOI 10.1007/s10529-009-0193-0; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; Lee SW, 2008, J BACTERIOL, V190, P2183, DOI 10.1128/JB.01406-07; Letisse F, 2002, J BIOTECHNOL, V99, P307, DOI 10.1016/S0168-1656(02)00221-3; Li YR, 2011, MOL PLANT MICROBE IN, V24, P1086, DOI 10.1094/MPMI-09-10-0205; Lu GT, 2009, MICROBIOL-SGM, V155, P1602, DOI 10.1099/mic.0.023762-0; Mellgren EM, 2009, J BACTERIOL, V191, P3132, DOI 10.1128/JB.01570-08; Noel L, 2002, J BACTERIOL, V184, P1340, DOI 10.1128/JB.184.5.1340-1348.2002; Oku Takashi, 2004, Journal of General Plant Pathology, V70, P159, DOI 10.1007/s10327-004-0106-y; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; RAHME LG, 1992, J BACTERIOL, V174, P3499, DOI 10.1128/JB.174.11.3499-3507.1992; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; SCHULTE R, 1992, J BACTERIOL, V174, P815, DOI 10.1128/jb.174.3.815-823.1992; Seo YS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-99; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Sugio A, 2005, MOL PLANT MICROBE IN, V18, P546, DOI 10.1094/MPMI-18-0546; Tamir-Ariel D, 2007, J BACTERIOL, V189, P6359, DOI 10.1128/JB.00320-07; Tamir-Ariel D, 2011, MOL PLANT PATHOL, V12, P57, DOI 10.1111/j.1364-3703.2010.00652.x; Tang DJ, 2005, J BACTERIOL, V187, P6231, DOI 10.1128/JB.187.17.6231-6237.2005; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; Tsuge S, 2005, J BACTERIOL, V187, P2308, DOI 10.1128/JB.187.7.2308-2314.2005; Tsuge S, 2006, J BACTERIOL, V188, P4158, DOI 10.1128/JB.00006-06; Tung SY, 1999, APPL ENVIRON MICROB, V65, P5564; Turner PE, 2004, GENETICS, V167, P9, DOI 10.1534/genetics.167.1.9; Wang L, 2007, APPL ENVIRON MICROB, V73, P8023, DOI 10.1128/AEM.01414-07; Wang LF, 2008, MOL PLANT MICROBE IN, V21, P555, DOI 10.1094/MPMI-21-5-0555; Wang YinPeng, 2009, Acta Phytopathologica Sinica, V39, P392; Watt TF, 2009, J BIOTECHNOL, V140, P59, DOI 10.1016/j.jbiotec.2008.12.003; Weber E, 2005, J BACTERIOL, V187, P6175, DOI 10.1128/JB.187.17.6175-6186.2005; Wengelnik K, 1999, J BACTERIOL, V181, P6828, DOI 10.1128/JB.181.21.6828-6831.1999; Wengelnik K, 1996, MOL PLANT MICROBE IN, V9, P704, DOI 10.1094/MPMI-9-0704; Wengelnik K, 1996, J BACTERIOL, V178, P3462, DOI 10.1128/jb.178.12.3462-3469.1996; WINANS SC, 1990, J BACTERIOL, V172, P2433, DOI 10.1128/jb.172.5.2433-2438.1990; Xiao You-lun, 2007, Weishengwu Xuebao, V47, P396; Yang WF, 2007, CURR MICROBIOL, V54, P307, DOI 10.1007/s00284-006-0485-8; Yoshimochi T, 2009, J BACTERIOL, V191, P3424, DOI 10.1128/JB.01113-08; ZAGALLO AC, 1967, J BACTERIOL, V93, P970, DOI 10.1128/JB.93.3.970-975.1967; Zhang SS, 2008, RES MICROBIOL, V159, P569, DOI 10.1016/j.resmic.2008.06.010; Zou HS, 2011, CURR MICROBIOL, V62, P908, DOI 10.1007/s00284-010-9804-1; Zou LF, 2006, APPL ENVIRON MICROB, V72, P6212, DOI 10.1128/AEM.00511-06	65	17	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31855	10.1371/journal.pone.0031855	http://dx.doi.org/10.1371/journal.pone.0031855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384086	gold, Green Published, Green Submitted			2022-12-27	WOS:000302875500048
J	Riaz, A; Zeller, KS; Johansson, S				Riaz, Anjum; Zeller, Kathrin Stephanie; Johansson, Staffan			Receptor-Specific Mechanisms Regulate Phosphorylation of AKT at Ser473: Role of RICTOR in beta 1 Integrin-Mediated Cell Survival	PLOS ONE			English	Article							PROTEIN-KINASE-B/AKT; LINKED KINASE; HYDROPHOBIC MOTIF; CANCER-CELLS; SUBSTRATE-SPECIFICITY; P21-ACTIVATED KINASE; SIGNALING PATHWAYS; MTOR COMPLEX; MICE REVEALS; ACTIVATION	A tight control over AKT/PKB activation is essential for cells, and they realise this in part by regulating the phosphorylation of Ser473 in the "hydrophobic motif" of the AKT carboxy-terminal region. The RICTOR-mTOR complex (TORC2) is a major kinase for AKT Ser473 phosphorylation after stimulation by several growth factors, in a reaction proposed to require p21-activated kinase (PAK) as a scaffold. However, other kinases may catalyse this reaction in stimuli-specific manners. Here we characterised the requirement of RICTOR, ILK, and PAK for AKT Ser473 phosphorylation downstream of selected family members of integrins, G protein-coupled receptors, and tyrosine-kinase receptors and analysed the importance of this phosphorylation site for adhesion-mediated survival. siRNA-mediated knockdown in HeLa and MCF7 cells showed that RICTOR-mTOR was required for phosphorylation of AKT Ser473, and for efficient phosphorylation of the downstream AKT targets FOXO1 Thr24 and BAD Ser136, in response to beta 1 integrin-stimulation. ILK and PAK1/2 were dispensable for these reactions. RICTOR knockdown increased the number of apoptotic MCF7 cells on beta 1 integrin ligands up to 2-fold after 24 h in serum-free conditions. beta 1 integrin-stimulation induced phosphorylation of both AKT1 and AKT2 but markedly preferred AKT2. RICTOR-mTOR was required also for LPA-induced AKT Ser473 phosphorylation in MCF7 cells, but, interestingly, not in HeLa cells. PAK was needed for the AKT Ser473 phosphorylation in response to LPA and PDGF, but not to EGF. These results demonstrate that different receptors utilise different enzyme complexes to phosphorylate AKT at Ser473, and that AKT Ser473 phosphorylation significantly contributes to beta 1 integrin-mediated anchorage-dependent survival of cells.	[Riaz, Anjum; Zeller, Kathrin Stephanie; Johansson, Staffan] Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden	Uppsala University	Riaz, A (corresponding author), Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden.	staffan.johansson@imbim.uu.se			Swedish Research Council [7147]; Swedish Cancer Foundation; Swedish Childhood Cancer Foundation; Higher Education Commission, Pakistan	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Swedish Childhood Cancer Foundation(European Commission); Higher Education Commission, Pakistan(Higher Education Commission of Pakistan)	Economic support was obtained from the Swedish Research Council (Grant No. 7147), Swedish Cancer Foundation, and Swedish Childhood Cancer Foundation. Anjum Riaz was supported by a scholarship from the Higher Education Commission, Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Arias-Romero LE, 2010, ONCOGENE, V29, P5839, DOI 10.1038/onc.2010.318; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Baudhuin LM, 2002, MOL PHARMACOL, V62, P660, DOI 10.1124/mol.62.3.660; Beeser A, 2005, J BIOL CHEM, V280, P36609, DOI 10.1074/jbc.M502306200; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Caporali S, 2008, MOL PHARMACOL, V74, P173, DOI 10.1124/mol.107.044743; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Conus NM, 2002, J BIOL CHEM, V277, P38021, DOI 10.1074/jbc.M203387200; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Dibble CC, 2009, CANCER CELL, V16, P178, DOI 10.1016/j.ccr.2009.08.011; Dong LQ, 2005, AM J PHYSIOL-ENDOC M, V289, pE187, DOI 10.1152/ajpendo.00011.2005; Dufour G, 2004, J BIOL CHEM, V279, P44113, DOI 10.1074/jbc.M405323200; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Farias E, 2005, BIOCHEM BIOPH RES CO, V329, P305, DOI 10.1016/j.bbrc.2005.01.125; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Fukuda K, 2011, J BIOL CHEM, V286, P21886, DOI 10.1074/jbc.M111.240093; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huynh N, 2010, BBA-MOL CELL RES, V1803, P1106, DOI 10.1016/j.bbamcr.2010.05.007; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim D, 2005, FRONT BIOSCI-LANDMRK, V10, P975, DOI 10.2741/1592; Liao Y, 2010, AM J TRANSL RES, V2, P19; Mao K, 2008, J MOL CELL CARDIOL, V44, P429, DOI 10.1016/j.yjmcc.2007.10.016; Maydan M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012356; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; Nakamura A, 2008, MOL CELL BIOL, V28, P5996, DOI 10.1128/MCB.00114-08; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Park J, 2009, J BIOL CHEM, V284, P6169, DOI 10.1074/jbc.C800210200; Partovian C, 2004, CELL SIGNAL, V16, P951, DOI 10.1016/j.cellsig.2004.01.008; Persad S, 2000, P NATL ACAD SCI USA, V97, P3207, DOI 10.1073/pnas.060579697; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Santi SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014614; Santi SA, 2010, AM J PHYSIOL-CELL PH, V298, pC580, DOI 10.1152/ajpcell.00375.2009; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Surucu B, 2008, J BIOL CHEM, V283, P30025, DOI 10.1074/jbc.M803053200; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; Uesugi A, 2011, CANCER RES, V71, P5765, DOI 10.1158/0008-5472.CAN-11-0368; Vachon P. H., 2011, J SIGNAL TRANSDUCT, V2011; Velling T, 2008, EXP CELL RES, V314, P309, DOI 10.1016/j.yexcr.2007.08.018; Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Zeller KS, 2010, CELL SIGNAL, V22, P1838, DOI 10.1016/j.cellsig.2010.07.011; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007	59	41	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32081	10.1371/journal.pone.0032081	http://dx.doi.org/10.1371/journal.pone.0032081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384145	gold, Green Submitted, Green Published			2022-12-27	WOS:000302875500073
J	Satoh, M; Andoh, Y; Clingan, CS; Ogura, H; Fujii, S; Eshima, K; Nakayama, T; Taniguchi, M; Hirata, N; Ishimori, N; Tsutsui, H; Onoe, K; Iwabuchi, K				Satoh, Masashi; Andoh, Yasuhiro; Clingan, Christopher Stuart; Ogura, Hisako; Fujii, Satoshi; Eshima, Koji; Nakayama, Toshinori; Taniguchi, Masaru; Hirata, Noriyuki; Ishimori, Naoki; Tsutsui, Hiroyuki; Onoe, Kazunori; Iwabuchi, Kazuya			Type II NKT Cells Stimulate Diet-Induced Obesity by Mediating Adipose Tissue Inflammation, Steatohepatitis and Insulin Resistance	PLOS ONE			English	Article							KILLER T-CELLS; GUT MICROBIOTA; GLUCOSE-INTOLERANCE; METABOLIC SYNDROME; PPAR-GAMMA; INKT CELLS; OB/OB MICE; FAT; LYMPHOCYTES; ACTIVATION	The progression of obesity is accompanied by a chronic inflammatory process that involves both innate and acquired immunity. Natural killer T (NKT) cells recognize lipid antigens and are also distributed in adipose tissue. To examine the involvement of NKT cells in the development of obesity, C57BL/6 mice (wild type; WT), and two NKT-cell-deficient strains, J alpha 18(-/-) mice that lack the type I subset and CD1d(-/-) mice that lack both the type I and II subsets, were fed a high fat diet (HFD). CD1d(-/-) mice gained the least body weight with the least weight in perigonadal and brown adipose tissue as well as in the liver, compared to WT or J alpha 18(-/-) mice fed an HFD. Histologically, CD1d(-/-) mice had significantly smaller adipocytes and developed significantly milder hepatosteatosis than WT or J alpha 8(-/-) mice. The number of NK1.1(+)TCR beta(+) cells in adipose tissue increased when WT mice were fed an HFD and were mostly invariant V alpha 14J alpha 18-negative. CD11b(+) macrophages (M phi) were another major subset of cells in adipose tissue infiltrates, and they were divided into F4/80(high) and F4/80(low) cells. The F4/80(low)-M phi subset in adipose tissue was increased in CD1d(-/-) mice, and this population likely played an anti-inflammatory role. Glucose intolerance and insulin resistance in CD1d(-/-) mice were not aggravated as in WT or J alpha 18(-/-) mice fed an HFD, likely due to a lower grade of inflammation and adiposity. Collectively, our findings provide evidence that type II NKT cells initiate inflammation in the liver and adipose tissue and exacerbate the course of obesity that leads to insulin resistance.	[Satoh, Masashi; Eshima, Koji; Iwabuchi, Kazuya] Kitasato Univ, Sch Med, Dept Immunol, Sagamihara, Japan; [Satoh, Masashi; Andoh, Yasuhiro; Clingan, Christopher Stuart; Ogura, Hisako; Hirata, Noriyuki; Onoe, Kazunori; Iwabuchi, Kazuya] Hokkaido Univ, Inst Med Genet, Res Sect Pathophysiol, Div Immunobiol, Sapporo, Hokkaido, Japan; [Andoh, Yasuhiro; Ishimori, Naoki; Tsutsui, Hiroyuki] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan; [Clingan, Christopher Stuart] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA; [Fujii, Satoshi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pathobiol & Therapeut, Nagoya, Aichi, Japan; [Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan; [Taniguchi, Masaru] RIKEN, Res Ctr Allergy & Immunol, Yokohama, Kanagawa, Japan; [Hirata, Noriyuki] Hokkaido Univ, Inst Med Genet, Res Sect Pathophysiol, Div Canc Biol, Sapporo, Hokkaido, Japan	Kitasato University; Hokkaido University; Hokkaido University; Vanderbilt University; Nagoya City University; Chiba University; RIKEN; Hokkaido University	Satoh, M (corresponding author), Kitasato Univ, Sch Med, Dept Immunol, Sagamihara, Japan.	akimari@kitasato-u.ac.jp	Ishimori, Naoki/A-8015-2012; Taniguchi, Masaru/N-7932-2015; Ishimori, Naoki/AAP-2349-2020; Nakayama, Toshinori/E-1067-2017; Tsutsui, Hiroyuki/A-4070-2012	Taniguchi, Masaru/0000-0001-7821-7179; Nakayama, Toshinori/0000-0002-1434-2007; 	Japan Society for the Promotion of Science (JSPS) [20390106]; Establishment of International Collaboration Center for Zoonosis Control; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Ministry of Health, Labor and Welfare of Japan; Heisei Ijuku Tomakomai East Hospital; Parent's Association (Keyaki Kai) Grant of Kitasa; Grants-in-Aid for Scientific Research [24390192, 23591096, 23592073] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Establishment of International Collaboration Center for Zoonosis Control; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Heisei Ijuku Tomakomai East Hospital; Parent's Association (Keyaki Kai) Grant of Kitasa; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research(#B: #20390106) by the Japan Society for the Promotion of Science (JSPS), Global COE Program, Establishment of International Collaboration Center for Zoonosis Control, by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, a Health and Labor Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases) from the Ministry of Health, Labor and Welfare of Japan, and a Grant by Heisei Ijuku Tomakomai East Hospital. MS is a recipient of a Parent's Association (Keyaki Kai) Grant of Kitasa to University School of Medicine. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bassaganya-Riera J, 2009, CELL IMMUNOL, V258, P138, DOI 10.1016/j.cellimm.2009.04.003; Caspar-Bauguil S, 2005, FEBS LETT, V579, P3487, DOI 10.1016/j.febslet.2005.05.031; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Elinav E, 2006, J PATHOL, V209, P121, DOI 10.1002/path.1950; Exley MA, 2004, HEPATOLOGY, V40, P1033, DOI 10.1002/hep.20433; Exley MA, 2008, EUR J IMMUNOL, V38, P1756, DOI 10.1002/eji.200737389; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Guri AJ, 2008, J NUTR BIOCHEM, V19, P216, DOI 10.1016/j.jnutbio.2007.02.010; Hammond KJL, 1999, EUR J IMMUNOL, V29, P3768, DOI 10.1002/(SICI)1521-4141(199911)29:11<3768::AID-IMMU3768>3.3.CO;2-7; Hansen TH, 2007, NAT IMMUNOL, V8, P563, DOI 10.1038/ni1475; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Lalazar G, 2008, MOL IMMUNOL, V45, P3517, DOI 10.1016/j.molimm.2008.05.009; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lynch L, 2009, EUR J IMMUNOL, V39, P1893, DOI 10.1002/eji.200939349; Major AS, 2004, ARTERIOSCL THROM VAS, V24, P2351, DOI 10.1161/01.ATV.0000147112.84168.87; Mantell BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019831; Margalit M, 2006, J PHARMACOL EXP THER, V319, P105, DOI 10.1124/jpet.106.104950; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Miyazaki Y, 2008, SCAND J IMMUNOL, V67, P230, DOI 10.1111/j.1365-3083.2007.02062.x; Nakai Y, 2004, BLOOD, V104, P2051, DOI 10.1182/blood-2003-10-3485; Nieuwenhuis EES, 2009, J CLIN INVEST, V119, P1241, DOI 10.1172/JCI36509; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ogawa Y, 1999, DIABETES, V48, P1822, DOI 10.2337/diabetes.48.9.1822; Ohmura K, 2010, ARTERIOSCL THROM VAS, V30, P193, DOI 10.1161/ATVBAHA.109.198614; Roy KC, 2008, J IMMUNOL, V180, P2942, DOI 10.4049/jimmunol.180.5.2942; Schumann J, 2003, J IMMUNOL, V170, P5815, DOI 10.4049/jimmunol.170.12.5815; Tupin E, 2004, J EXP MED, V199, P417, DOI 10.1084/jem.20030997; Van Kaer L, 2007, CURR OPIN IMMUNOL, V19, P354, DOI 10.1016/j.coi.2007.03.001; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859; WATANABE H, 1992, J IMMUNOL METHODS, V146, P145, DOI 10.1016/0022-1759(92)90223-G; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	43	76	79	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e30568	10.1371/journal.pone.0030568	http://dx.doi.org/10.1371/journal.pone.0030568			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22383967	gold, Green Published			2022-12-27	WOS:000302875500005
J	Shi, C; Hu, N; Huang, H; Gao, J; Zhao, YJ; Gao, LZ				Shi, Chao; Hu, Na; Huang, Hui; Gao, Ju; Zhao, You-Jie; Gao, Li-Zhi			An Improved Chloroplast DNA Extraction Procedure for Whole Plastid Genome Sequencing	PLOS ONE			English	Article							RESOLVES; GENES	Background: Chloroplast genomes supply valuable genetic information for evolutionary and functional studies in plants. The past five years have witnessed a dramatic increase in the number of completely sequenced chloroplast genomes with the application of second-generation sequencing technology in plastid genome sequencing projects. However, costeffective high-throughput chloroplast DNA (cpDNA) extraction becomes a major bottleneck restricting the application, as conventional methods are difficult to make a balance between the quality and yield of cpDNAs. Methodology/Principal Findings: We first tested two traditional methods to isolate cpDNA from the three species, Oryza brachyantha, Leersia japonica and Prinsepia utihis. Both of them failed to obtain properly defined cpDNA bands. However, we developed a simple but efficient method based on sucrose gradients and found that the modified protocol worked efficiently to isolate the cpDNA from the same three plant species. We sequenced the isolated DNA samples with Illumina (Solexa) sequencing technology to test cpDNA purity according to aligning sequence reads to the reference chloroplast genomes, showing that the reference genome was properly covered. We show that 40-50% cpDNA purity is achieved with our method. Conclusion: Here we provide an improved method used to isolate cpDNA from angiosperms. The Illumina sequencing results suggest that the isolated cpDNA has reached enough yield and sufficient purity to perform subsequent genome assembly. The cpDNA isolation protocol thus will be widely applicable to the plant chloroplast genome sequencing projects.	[Shi, Chao; Hu, Na; Huang, Hui; Gao, Ju; Zhao, You-Jie; Gao, Li-Zhi] Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Kunming, Peoples R China; [Shi, Chao; Hu, Na] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, LZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Kunming, Peoples R China.	lgao@mail.kib.ac.cn		You-jie, Zhao/0000-0002-3198-0465	National Science Foundation of China [U0936603]; Natural Science Foundation of Yunnan Province [2008CC016]; Chinese Academy of Sciences (CAS) [KSCX2-YW-N-029]; Talent Program of Yunnan Province [20080A009]; Chinese Department of Science and Technology [2007CB815703]; Kunming Institute of Botany, CAS [672705232515]; Kunming Institute of Botany, CAS	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Talent Program of Yunnan Province; Chinese Department of Science and Technology; Kunming Institute of Botany, CAS(Chinese Academy of Sciences); Kunming Institute of Botany, CAS(Chinese Academy of Sciences)	This work was supported by National Science Foundation of China (U0936603), Key Project of Natural Science Foundation of Yunnan Province (2008CC016), the Hundreds Talents Program of the Chinese Academy of Sciences (CAS), Talent Program of Yunnan Province (20080A009), a grant from the Chinese Academy of Science (KSCX2-YW-N-029), a grant from Chinese Department of Science and Technology (973 Program 2007CB815703), Frontier Grant of Kunming Institute of Botany, CAS (672705232515), and a start-up grant from Kunming Institute of Botany, CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton RA, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-22; BOOKJANS G, 1984, ANAL BIOCHEM, V141, P244, DOI 10.1016/0003-2697(84)90452-4; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Diekmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002813; DRUMMOND AJ, 2009, GENEIOUS V4 7; Heinze B, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-4; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; KOLODNER R, 1979, P NATL ACAD SCI USA, V76, P41, DOI 10.1073/pnas.76.1.41; Lang BF, 2007, NAT PROTOC, V2, P652, DOI 10.1038/nprot.2007.58; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Nock CJ, 2010, PLANT BIOTECHNOL J, P1; PALMER JD, 1986, METHOD ENZYMOL, V118, P167; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Shaffer C, 2007, NAT BIOTECHNOL, V25, P149, DOI 10.1038/nbt0207-149; Sugiura M, 1995, ESSAYS BIOCHEM, V30, P49; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025	20	117	125	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31468	10.1371/journal.pone.0031468	http://dx.doi.org/10.1371/journal.pone.0031468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384027	Green Submitted, gold, Green Published			2022-12-27	WOS:000302875500021
J	Aldrich, C; Magini, A; Emiliani, C; Dottorini, T; Bistoni, F; Crisanti, A; Spaccapelo, R				Aldrich, Cassandra; Magini, Alessandro; Emiliani, Carla; Dottorini, Tania; Bistoni, Francesco; Crisanti, Andrea; Spaccapelo, Roberta			Roles of the Amino Terminal Region and Repeat Region of the Plasmodium berghei Circumsporozoite Protein in Parasite Infectivity	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; SALIVARY-GLANDS; FALCIPARUM SPOROZOITES; ANOPHELES-STEPHENSI; MALARIA PARASITE; MONOCLONAL-ANTIBODIES; PROTECTIVE ANTIBODIES; CELL INVASION; AEDES-AEGYPTI; II-PLUS	The circumsporozoite protein (CSP) plays a key role in malaria sporozoite infection of both mosquito salivary glands and the vertebrate host. The conserved Regions I and II have been well studied but little is known about the immunogenic central repeat region and the N-terminal region of the protein. Rodent malaria Plasmodium berghei parasites, in which the endogenous CS gene has been replaced with the avian Plasmodium gallinaceum CS (PgCS) sequence, develop normally in the A. stephensi mosquito midgut but the sporozoites are not infectious. We therefore generated P. berghei transgenic parasites carrying the PgCS gene, in which the repeat region was replaced with the homologous region of P. berghei CS (PbCS). A further line, in which both the N-terminal region and repeat region were replaced with the homologous regions of PbCS, was also generated. Introduction of the PbCS repeat region alone, into the PgCS gene, did not rescue sporozoite species-specific infectivity. However, the introduction of both the PbCS repeat region and the N-terminal region into the PgCS gene completely rescued infectivity, in both the mosquito vector and the mammalian host. Immunofluorescence experiments and western blot analysis revealed correct localization and proteolytic processing of CSP in the chimeric parasites. The results demonstrate, in vivo, that the repeat region of P. berghei CSP, alone, is unable to mediate sporozoite infectivity in either the mosquito or the mammalian host, but suggest an important role for the N-terminal region in sporozoite host cell invasion.	[Aldrich, Cassandra; Magini, Alessandro; Emiliani, Carla; Dottorini, Tania; Bistoni, Francesco; Crisanti, Andrea; Spaccapelo, Roberta] Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy; [Aldrich, Cassandra] Univ Oxford, Keble Coll, Oxford, England; [Aldrich, Cassandra; Crisanti, Andrea] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England	University of Perugia; University of Oxford; Imperial College London	Aldrich, C (corresponding author), Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy.	roberta.spaccapelo@unipg.it	Magini, Alessandro/P-1201-2019; Emiliani, Carla/G-3738-2010; Magini, Alessandro/L-9175-2015	Emiliani, Carla/0000-0002-6368-1515; Magini, Alessandro/0000-0002-2750-6226; Crisanti, Andrea/0000-0002-2406-4426; Dottorini, Tania/0000-0001-7733-906X; Spaccapelo, Roberta/0000-0003-2100-6172	Italian Ministry of Research [2005065913]	Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the Italian Ministry of Research PRIN (Research Programmes of National Interest) n. 2005065913. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancsin JB, 2004, J BIOL CHEM, V279, P21824, DOI 10.1074/jbc.M401979200; Ballou WR, 2009, PARASITE IMMUNOL, V31, P492, DOI 10.1111/j.1365-3024.2009.01143.x; BALLOU WR, 1987, LANCET, V1, P1277; Birkett A, 2002, INFECT IMMUN, V70, P6860, DOI 10.1128/IAI.70.12.6860-6870.2002; Bongfen SE, 2009, VACCINE, V27, P328, DOI 10.1016/j.vaccine.2008.09.097; BOULANGER N, 1995, PARASITOL RES, V81, P58, DOI 10.1007/BF00932418; Capurro MD, 2000, AM J TROP MED HYG, V62, P427, DOI 10.4269/ajtmh.2000.62.427; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; CERAMI C, 1994, J EXP MED, V179, P695, DOI 10.1084/jem.179.2.695; Cerede O, 2002, EMBO J, V21, P2526, DOI 10.1093/emboj/21.11.2526; COCHRANE AH, 1982, P NATL ACAD SCI-BIOL, V79, P5651, DOI 10.1073/pnas.79.18.5651; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Coppi A, 2011, J EXP MED, V208, P341, DOI 10.1084/jem.20101488; FREVERT U, 1993, J EXP MED, V177, P1287, DOI 10.1084/jem.177.5.1287; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; GODSON GN, 1983, NATURE, V305, P29, DOI 10.1038/305029a0; Gonzalez-Ceron L, 1998, EXP PARASITOL, V90, P203, DOI 10.1006/expr.1998.4334; HERRINGTON DA, 1987, NATURE, V328, P257, DOI 10.1038/328257a0; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Myung JM, 2004, MOL BIOCHEM PARASIT, V133, P53, DOI 10.1016/j.molbiopara.2003.09.002; NAGASAWA H, 1987, INFECT IMMUN, V55, P2928, DOI 10.1128/IAI.55.12.2928-2932.1987; Nardin E, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P397; NUSSENZWEIG V, 1989, ADV IMMUNOL, V45, P283, DOI 10.1016/S0065-2776(08)60695-1; Persson C, 2002, J IMMUNOL, V169, P6681, DOI 10.4049/jimmunol.169.12.6681; Pinzon-Ortiz C, 2001, J BIOL CHEM, V276, P26784, DOI 10.1074/jbc.M104038200; POSTHUMA G, 1988, EUR J CELL BIOL, V46, P18; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; Rathore D, 2000, MOL BIOCHEM PARASIT, V108, P253, DOI 10.1016/S0166-6851(00)00214-0; Rathore D, 2005, J BIOL CHEM, V280, P20524, DOI 10.1074/jbc.M414254200; Rathore D, 2002, J BIOL CHEM, V277, P7092, DOI 10.1074/jbc.M106862200; Rathore D, 2001, BIOCHEMISTRY-US, V40, P11518, DOI 10.1021/bi0105476; Robson KJH, 1997, MOL BIOCHEM PARASIT, V84, P1, DOI 10.1016/S0166-6851(96)02774-0; SANTORO F, 1983, J BIOL CHEM, V258, P3341; Sidjanski SP, 1997, MOL BIOCHEM PARASIT, V90, P33, DOI 10.1016/S0166-6851(97)00124-2; SIMONETTI AB, 1993, J EUKARYOT MICROBIOL, V40, P569, DOI 10.1111/j.1550-7408.1993.tb06109.x; SINNIS P, 1994, J EXP MED, V180, P297, DOI 10.1084/jem.180.1.297; Spaccapelo R, 1997, LANCET, V350, P335, DOI 10.1016/S0140-6736(97)24031-6; STEWART MJ, 1986, INFECT IMMUN, V51, P859, DOI 10.1128/IAI.51.3.859-864.1986; STEWART MJ, 1988, J PROTOZOOL, V35, P389, DOI 10.1111/j.1550-7408.1988.tb04115.x; Tewari R, 2005, CELL MICROBIOL, V7, P699, DOI 10.1111/j.1462-5822.2005.00503.x; Tewari R, 2002, J BIOL CHEM, V277, P47613, DOI 10.1074/jbc.M208453200; VANDERBERG JP, 1975, J PARASITOL, V61, P43, DOI 10.2307/3279102; WARBURG A, 1992, EXP PARASITOL, V75, P303, DOI 10.1016/0014-4894(92)90215-V; Wengelnik K, 1999, EMBO J, V18, P5195, DOI 10.1093/emboj/18.19.5195; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Ying P, 1997, EXP PARASITOL, V85, P168, DOI 10.1006/expr.1996.4134; YOSHIDA N, 1981, J EXP MED, V154, P1225, DOI 10.1084/jem.154.4.1225; YOSHIDA N, 1980, SCIENCE, V207, P71, DOI 10.1126/science.6985745	49	31	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32524	10.1371/journal.pone.0032524	http://dx.doi.org/10.1371/journal.pone.0032524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393411	Green Submitted, Green Published, gold			2022-12-27	WOS:000303003500064
J	Chi, JW; Li, L; Liu, MJ; Tan, JQ; Tang, CY; Pan, Q; Wang, DL; Zhang, ZH				Chi, Jingwei; Li, Li; Liu, Mujun; Tan, Jieqiong; Tang, Chengyuan; Pan, Qian; Wang, Danling; Zhang, Zhuohua			Pathogenic Connexin-31 Forms Constitutively Active Hemichannels to Promote Necrotic Cell Death	PLOS ONE			English	Article							GAP-JUNCTION HEMICHANNELS; ICHTHYOSIS-DEAFNESS SYNDROME; TUMOR-NECROSIS-FACTOR; ERYTHROKERATODERMIA VARIABILIS; OXIDATIVE STRESS; SKIN-DISEASE; HELA-CELLS; ER STRESS; MUTATIONS; CALCIUM	Mutations in Connexin-31 (Cx31) are associated with multiple human diseases including erythrokeratodermia variabilis (EKV). The molecular action of Cx31 pathogenic mutants remains largely elusive. We report here that expression of EKV pathogenic mutant Cx31R42P induces cell death with necrotic characteristics. Inhibition of hemichannel activity by a connexin hemichannel inhibitor or high extracellular calcium suppresses Cx31R42P-induced cell death. Expression of Cx31R42P induces ER stress resulting in reactive oxygen species (ROS) production, in turn, to regulate gating of Cx31R42P hemichannels and Cx31R42P induced cell death. Moreover, Cx31R42P hemichannels play an important role in mediating ATP release from the cell. In contrast, no hemichannel activity was detected with cells expressing wildtype Cx31. Together, the results suggest that Cx31R42P forms constitutively active hemichannels to promote necrotic cell death. The Cx31R42P active hemichannels are likely resulted by an ER stress mediated ROS overproduction. The study identifies a mechanism of EKV pathogenesis induced by a Cx31 mutant and provides a new avenue for potential treatment strategy of the disease.	[Chi, Jingwei; Li, Li; Tan, Jieqiong; Tang, Chengyuan; Pan, Qian; Wang, Danling; Zhang, Zhuohua] Cent S Univ, State Key Lab Med Genet, Xiangya Med Sch, Changsha, Hunan, Peoples R China; [Liu, Mujun] Cent S Univ, Sch Biol Sci & Technol, Changsha, Hunan, Peoples R China	Central South University; Central South University	Chi, JW (corresponding author), Cent S Univ, State Key Lab Med Genet, Xiangya Med Sch, Changsha, Hunan, Peoples R China.	zhangzhuohua@sklmg.edu.cn			Natural Science Foundation of China [30730052, 30971469, 30600334, 30900801]; Ministry of Sciences and Technology of China [2011CB510002]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Sciences and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from Natural Science Foundation of China (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm) (30730052 to Z.Z., 30971469 to D.W., 30600334 to Q.P. and 30900801 to M.L.) and a grant from Ministry of Sciences and Technology of China (http://www.most.cn/eng/) (2011CB510002 to Z.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams CK, 2002, P NATL ACAD SCI USA, V99, P3980, DOI 10.1073/pnas.261713499; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Burrell HE, 2003, J INVEST DERMATOL, V120, P440, DOI 10.1046/j.1523-1747.2003.12050.x; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Di WL, 2002, HUM MOL GENET, V11, P2005, DOI 10.1093/hmg/11.17.2005; Diestel S, 2002, BIOCHEM BIOPH RES CO, V296, P721, DOI 10.1016/S0006-291X(02)00929-4; Essenfelder GM, 2004, HUM MOL GENET, V13, P1703, DOI 10.1093/hmg/ddh191; Fuchs-Telem D, 2011, CLIN EXP DERMATOL, V36, P406, DOI 10.1111/j.1365-2230.2010.03986.x; Gerido DA, 2007, AM J PHYSIOL-CELL PH, V293, pC337, DOI 10.1152/ajpcell.00626.2006; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Gomez-Hernandez JM, 2003, P NATL ACAD SCI USA, V100, P16030, DOI 10.1073/pnas.2530348100; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; He LQ, 2005, ACTA BIOCH BIOPH SIN, V37, P547, DOI 10.1111/j.1745-7270.2005.00080.x; Hunzeker Christopher M, 2008, Dermatol Online J, V14, P13; Lee JR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001276; Li HY, 1996, J CELL BIOL, V134, P1019, DOI 10.1083/jcb.134.4.1019; Lopez-Bigas N, 2001, HUM MOL GENET, V10, P947, DOI 10.1093/hmg/10.9.947; Mese G, 2011, MOL BIOL CELL, V22, P4776, DOI 10.1091/mbc.E11-09-0778; Montgomery JR, 2004, J AM ACAD DERMATOL, V51, P377, DOI 10.1016/j.jaad.2003.12.042; Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365; Orellana JA, 2011, J NEUROSCI, V31, P4962, DOI 10.1523/JNEUROSCI.6417-10.2011; Pearson RA, 2005, NEURON, V46, P731, DOI 10.1016/j.neuron.2005.04.024; PILLAI S, 1992, J CLIN INVEST, V90, P42, DOI 10.1172/JCI115854; Rajagopalan B, 1999, CLIN EXP DERMATOL, V24, P173; Retamal MA, 2006, P NATL ACAD SCI USA, V103, P4475, DOI 10.1073/pnas.0511118103; Richard G, 2003, J INVEST DERMATOL, V120, P601, DOI 10.1046/j.1523-1747.2003.12080.x; Richard G, 1998, NAT GENET, V20, P366, DOI 10.1038/3840; Saez JC, 2010, EXP CELL RES, V316, P2377, DOI 10.1016/j.yexcr.2010.05.026; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Stong BC, 2006, LARYNGOSCOPE, V116, P2205, DOI 10.1097/01.mlg.0000241944.77192.d2; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Tattersall D, 2009, HUM MOL GENET, V18, P4734, DOI 10.1093/hmg/ddp436; Thimm J, 2005, J BIOL CHEM, V280, P10646, DOI 10.1074/jbc.M412749200; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wilgoss A, 1999, J INVEST DERMATOL, V113, P1119, DOI 10.1046/j.1523-1747.1999.00792.x; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845; Xia K, 2010, PROTEIN CELL, V1, P935, DOI 10.1007/s13238-010-0118-7; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617; Zhao HB, 2005, P NATL ACAD SCI USA, V102, P18724, DOI 10.1073/pnas.0506481102	42	35	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32531	10.1371/journal.pone.0032531	http://dx.doi.org/10.1371/journal.pone.0032531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393412	gold, Green Published, Green Submitted			2022-12-27	WOS:000303003500065
J	Li, CG; Chu, N; Wang, BB; Wang, J; Luan, J; Han, L; Meng, DM; Wang, YL; Suo, PS; Cheng, LF; Ma, X; Miao, ZM; Liu, SG				Li, Changgui; Chu, Nan; Wang, Binbin; Wang, Jing; Luan, Jian; Han, Lin; Meng, Dongmei; Wang, Yunlong; Suo, Peisu; Cheng, Longfei; Ma, Xu; Miao, Zhimin; Liu, Shiguo			Polymorphisms in the Presumptive Promoter Region of the SLC2A9 Gene Are Associated with Gout in a Chinese Male Population	PLOS ONE			English	Article							URIC-ACID LEVELS; HUMAN ARTICULAR CHONDROCYTES; GENOME-WIDE ASSOCIATION; COMMON POLYMORPHISMS; SERUM URATE; GLUT9; HYPERURICEMIA; SUSCEPTIBILITY; PREVALENCE; DISEASE	Background: Glucose transporter 9 (GLUT9) is a high-capacity/low-affinity urate transporter. To date, several recent genome-wide association studies (GWAS) and follow-up studies have identified genetic variants of SLC2A9 associated with urate concentrations and susceptibility to gout. We therefore investigated associations between gout and polymorphisms and haplotypes in the presumptive promoter region of GLUT9 in Chinese males. Methodology/Principal Findings: The approximately 2000 bp presumptive promoter region upstream of the start site of exon 1 of GLUT9 was sequenced and subjected to genetic analysis. A genotype-phenotype correlation was performed and polymorphisms-induced changes in transcription factor binding sites were predicted. Of 21 SNPs identified in GLUT9, five had not been previously reported. Two of the SNPs (rs13124007 and rs6850166) were associated with susceptibility to gout (p = 0.009 and p = 0.042, respectively). The C allele of rs13124007 appeared to be the risk allele for predisposition to gout (p = 0.006, OR 1.709 [95% CI 1.162-2.514]). For rs6850166, an increased risk of gout was associated with the A allele (p = 0.029, OR 1.645 [95% CI 1.050-2.577]). After Bonferroni correction, there was statistically difference in rs13124007 allele frequencies between gout cases and controls (P = 0.042). Haplotype analyses showed that haplotype GG was a protective haplotype (p = 0.0053) and haplotype CA was associated with increased risk of gout (p = 0.0326). Genotype-phenotype analysis among gout patients revealed an association of rs13124007 with serum triglycerides levels (P = 0.001). The C to G substitution in polymorphism rs13124007 resulted in a loss of a binding site for transcription factor interferon regulatory factor 1 (IRF-1). Conclusions/Significance: Polymorphisms rs13124007 and rs6850166 are associated with susceptibility to gout in Chinese males.	[Li, Changgui; Chu, Nan; Han, Lin; Meng, Dongmei; Wang, Yunlong; Miao, Zhimin; Liu, Shiguo] Qingdao Univ, Coll Med, Affiliated Hosp, Qingdao 266071, Peoples R China; [Wang, Binbin; Wang, Jing; Suo, Peisu; Cheng, Longfei; Ma, Xu] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Wang, Binbin; Wang, Jing; Suo, Peisu; Cheng, Longfei; Ma, Xu] Natl Res Inst Family Planning, Beijing, Peoples R China; [Luan, Jian] Qingdao Municipal Hosp, Qingdao, Peoples R China; [Ma, Xu] WHO, Collaborating Ctr Res Human Reprod, Beijing, Peoples R China	Qingdao University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Research Institute for Family Planning - China; Qingdao Municipal Hospital; World Health Organization	Li, CG (corresponding author), Qingdao Univ, Coll Med, Affiliated Hosp, Qingdao 266071, Peoples R China.	lichanggui@medmail.com.cn; liushiguo2002@126.com		Wang, Binbin/0000-0002-1597-5930	National Basic Research Program of China [2010CB534902]; National Science Foundation of China (NSFC) [30570890, 30871192]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China 2010CB534902) and National Science Foundation of China (NSFC: 30570890 and 30871192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai N, 2008, J BIOL CHEM, V283, P26834, DOI 10.1074/jbc.C800156200; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bibert S, 2009, AM J PHYSIOL-RENAL, V297, pF612, DOI 10.1152/ajprenal.00139.2009; Brandstatter A, 2008, DIABETES CARE, V31, P1662, DOI 10.2337/dc08-0349; Brandstatter A, 2010, ATHEROSCLEROSIS, V210, P474, DOI 10.1016/j.atherosclerosis.2009.12.013; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Choi HK, 2008, RHEUMATOLOGY, V47, P1567, DOI 10.1093/rheumatology/ken305; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Choi HK, 2007, ARTHRIT RHEUM-ARTHR, V57, P109, DOI 10.1002/art.22466; Cummings N, 2010, EUR J HUM GENET, V18, P1243, DOI 10.1038/ejhg.2010.97; Dalbeth N, 2009, RHEUMATOLOGY, V48, P222, DOI 10.1093/rheumatology/ken460; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Dinour D, 2010, J AM SOC NEPHROL, V21, P64, DOI 10.1681/ASN.2009040406; Doege H, 2000, BIOCHEM J, V350, P771, DOI 10.1042/0264-6021:3500771; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Hollis-Moffatt JE, 2009, ARTHRITIS RHEUM-US, V60, P3485, DOI 10.1002/art.24938; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; McArdle PF, 2008, ARTHRITIS RHEUM-US, V58, P2874, DOI 10.1002/art.23752; Miao ZM, 2008, J RHEUMATOL, V35, P1859; Mikuls TR, 2005, ANN RHEUM DIS, V64, P267, DOI 10.1136/ard.2004.024091; Mobasheri A, 2002, CELL BIOL INT, V26, P297, DOI 10.1006/cbir.2001.0850; Polasek O, 2010, CROAT MED J, V51, P48, DOI 10.3325/cmj.2010.51.48; Richardson S, 2003, OSTEOARTHR CARTILAGE, V11, P92, DOI 10.1053/joca.2002.0858; Schumacher HR, 2005, J RHEUMATOL, V32, P2368; Stark K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001948; Stark K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007729; Terkeltaub RA, 2003, NEW ENGL J MED, V349, P1647, DOI 10.1056/NEJMcp030733; Terkeltaub R, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1909; Tu HP, 2010, ANN RHEUM DIS, V69, P887, DOI 10.1136/ard.2009.113357; Urano W, 2010, ANN RHEUM DIS, V69, P932, DOI 10.1136/ard.2009.111096; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Zemunik T, 2009, CROAT MED J, V50, P23, DOI 10.3325/cmj.2009.50.23; Zhang W, 2006, ANN RHEUM DIS, V65, P1301, DOI 10.1136/ard.2006.055251	38	12	15	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e24561	10.1371/journal.pone.0024561	http://dx.doi.org/10.1371/journal.pone.0024561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393348	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500001
J	Sinha, AU; Armstrong, SA				Sinha, Amit U.; Armstrong, Scott A.			iCanPlot: Visual Exploration of High-Throughput Omics Data Using Interactive Canvas Plotting	PLOS ONE			English	Article								Increasing use of high throughput genomic scale assays requires effective visualization and analysis techniques to facilitate data interpretation. Moreover, existing tools often require programming skills, which discourages bench scientists from examining their own data. We have created iCanPlot, a compelling platform for visual data exploration based on the latest technologies. Using the recently adopted HTML5 Canvas element, we have developed a highly interactive tool to visualize tabular data and identify interesting patterns in an intuitive fashion without the need of any specialized computing skills. A module for geneset overlap analysis has been implemented on the Google App Engine platform: when the user selects a region of interest in the plot, the genes in the region are analyzed on the fly. The visualization and analysis are amalgamated for a seamless experience. Further, users can easily upload their data for analysis-which also makes it simple to share the analysis with collaborators. We illustrate the power of iCanPlot by showing an example of how it can be used to interpret histone modifications in the context of gene expression.	[Sinha, Amit U.; Armstrong, Scott A.] Childrens Hosp, Dana Farber Canc Inst, Dept Pediat Oncol, Div Hematol Oncol, Boston, MA 02115 USA; [Sinha, Amit U.; Armstrong, Scott A.] Harvard Univ, Sch Med, Boston, MA USA; [Armstrong, Scott A.] Harvard Stem Cell Inst, Boston, MA USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University	Sinha, AU (corresponding author), Childrens Hosp, Dana Farber Canc Inst, Dept Pediat Oncol, Div Hematol Oncol, Boston, MA 02115 USA.	amit.sinha@childrens.harvard.edu; scott.armstrong@childrens.harvard.edu			Charles H. Hood Foundation; Leukemia and Lymphoma Society	Charles H. Hood Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society)	This work was supported in part by the Charles H. Hood Foundation and the Leukemia and Lymphoma Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2009, BIOINFORMATICS, V25, P1475, DOI 10.1093/bioinformatics/btp274; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bostock M, 2009, IEEE T VIS COMPUT GR, V15, P1121, DOI 10.1109/TVCG.2009.174; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sinha AU, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-82; Sinha AU, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-452; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102	10	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31690	10.1371/journal.pone.0031690	http://dx.doi.org/10.1371/journal.pone.0031690			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393367	Green Submitted, gold, Green Published			2022-12-27	WOS:000303003500020
J	Lapchak, PH; Ioannou, A; Kannan, L; Rani, P; Lucca, JJD; Tsokos, GC				Lapchak, Peter H.; Ioannou, Antonis; Kannan, Lakshmi; Rani, Poonam; Lucca, Jurandir J. Dalle; Tsokos, George C.			Platelet-Associated CD40/CD154 Mediates Remote Tissue Damage after Mesenteric Ischemia/Reperfusion Injury	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ANTIGEN-INDUCED ARTHRITIS; ISCHEMIC-STROKE; P-SELECTIN; REPERFUSION INJURY; ENDOTHELIAL-CELLS; COMPLEMENT; LINK; ACTIVATION; MICE	Several innate and adaptive immune cell types participate in ischemia/reperfusion induced tissue injury. Amongst them, platelets have received little attention as contributors in the process of tissue damage after ischemia reperfusion (I/R) injury. It is currently unknown whether platelets participate through the immunologically important molecules including, CD40 and when activated, CD154 (CD40L), in the pathogenesis of I/R injury. We hypothesized that constitutive expression of CD40 and activation-induced expression of CD154 on platelets mediate local mesenteric and remote lung tissue damage after I/R injury. Wild type (WT; C57BL/6J), CD40 and CD154 deficient mice underwent mesenteric ischemia for 30 minutes followed by reperfusion for 3 hours. WT mice subjected to mesenteric I/R injury displayed both local intestinal and remote lung damage. In contrast, there was significantly less intestinal damage and no remote lung injury in CD40 and CD154 deficient mice when compared to WT mice. Platelet-depleted WT mice transfused with platelets from CD40 or CD154 deficient mice failed to reconstitute remote lung damage. In contrast, when CD40 or CD154 deficient mice were transfused with WT platelets lung tissue damage was re-established. Together, these findings suggest that multiple mechanisms are involved in local and remote tissue injury and also identify platelet-expressed CD40 and/or CD154 as mediators of remote tissue damage.	[Lapchak, Peter H.; Ioannou, Antonis; Kannan, Lakshmi; Rani, Poonam; Tsokos, George C.] Beth Israel Deaconess Med Ctr, Dept Med, Div Rheumatol, Boston, MA 02215 USA; [Lapchak, Peter H.; Ioannou, Antonis; Kannan, Lakshmi; Rani, Poonam; Tsokos, George C.] Harvard Univ, Sch Med, Boston, MA USA; [Lucca, Jurandir J. Dalle] USA, Inst Surg Res, San Antonio, TX USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Lapchak, PH (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Rheumatol, Boston, MA 02215 USA.	aioannou@bicmc.harvard.edu; gtsokos@bidmc.harvard.edu	Lapchak, Peter H./B-3559-2009; tsokos, george C/O-3360-2013	tsokos, george C/0000-0001-9589-2360; Lapchak, Peter/0000-0001-8597-088X; Ioannou, Antonis/0000-0003-0064-5004	Medical Research and Material Command of the Department of the Army [W81XWH-09-1-0530, W81XWH-09-1-0536]	Medical Research and Material Command of the Department of the Army	The research presented herein was supported by grant numbers W81XWH-09-1-0530 and W81XWH-09-1-0536 from Medical Research and Material Command of the Department of the Army. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh A, 2006, J GASTROENTEROL, V41, P47, DOI 10.1007/s00535-005-1721-x; Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; Baldwin WM, 2010, CURR OPIN ORGAN TRAN; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Chen J, 2009, J AUTOIMMUN, V32, P195, DOI 10.1016/j.jaut.2009.02.021; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Collins CE, 1997, ALIMENT PHARM THER, V11, P237, DOI 10.1046/j.1365-2036.1997.153328000.x; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Diepenhorst GMP, 2009, ANN SURG, V249, P889, DOI 10.1097/SLA.0b013e3181a38f45; Dole VS, 2007, THROMB HAEMOSTASIS, V98, P806, DOI 10.1160/TH07-03-0207; Duffau P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001001; Edgerton C, 2009, CLIN IMMUNOL, V130, P313, DOI 10.1016/j.clim.2008.09.019; Elzey BD, 2003, IMMUNITY, V19, P9, DOI 10.1016/S1074-7613(03)00177-8; Fleming SD, 2003, CLIN IMMUNOL, V106, P55, DOI 10.1016/S1521-6616(02)00021-9; Fleming SD, 2002, J IMMUNOL, V169, P2126, DOI 10.4049/jimmunol.169.4.2126; Franks ZG, 2010, ANN NY ACAD SCI, V1207, P11, DOI 10.1111/j.1749-6632.2010.05733.x; Fujimi S, 2006, BLOOD, V107, P4399, DOI 10.1182/blood-2005-09-3776; Gushiken FC, 2009, J THROMB HAEMOST, V7, P865, DOI 10.1111/j.1538-7836.2009.03334.x; HERD CM, 1994, EUR RESPIR J, V7, P1145; Ioannou A, 2011, CLIN IMMUNOL, V141, P3, DOI 10.1016/j.clim.2011.07.001; Irving PM, 2008, EUR J GASTROEN HEPAT, V20, P283, DOI 10.1097/MEG.0b013e3282f246c2; Irving PM, 2004, INFLAMM BOWEL DIS, V10, P361, DOI 10.1097/00054725-200407000-00007; Kirk AD, 2009, AM J TRANSPLANT, V9, P14, DOI 10.1111/j.1600-6143.2008.02473.x; Lapchak PH, 2012, AM J PHYSL IN PRESS; Lievens D, 2010, BLOOD, V116, P4317, DOI 10.1182/blood-2010-01-261206; Marquardt L, 2009, CEREBROVASC DIS, V28, P276, DOI 10.1159/000228710; Matthijsen RA, 2007, AM J PATHOL, V171, P1743, DOI 10.2353/ajpath.2007.070184; May AE, 2002, CIRCULATION, V106, P2111, DOI 10.1161/01.CIR.0000033597.45947.0F; May AE, 2008, ARTERIOSCL THROM VAS, V28, pS5, DOI 10.1161/ATVBAHA.107.158915; Mehta N, 2008, STROKE, V39, P3236, DOI 10.1161/STROKEAHA.108.514687; Peerschke EI, 2010, MOL IMMUNOL, V47, P2170, DOI 10.1016/j.molimm.2010.05.009; Prodan CI, 2008, INT J STROKE, V3, P249, DOI 10.1111/j.1747-4949.2008.00223.x; Rahman M, 2009, ANN SURG, V250, P783, DOI 10.1097/SLA.0b013e3181bd95b7; Ramesh N, 1998, SPRINGER SEMIN IMMUN, V19, P383, DOI 10.1007/BF00792598; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; Rizvi M, 2008, TRENDS MOL MED, V14, P530, DOI 10.1016/j.molmed.2008.09.006; Schmitt-Sody M, 2007, SCAND J RHEUMATOL, V36, P311, DOI 10.1080/03009740701218741; Schmitt-Sody M, 2007, PLATELETS, V18, P365, DOI 10.1080/09537100701191315; Seizer P, 2008, CURR MED CHEM, V15, P1976, DOI 10.2174/092986708785132852; Slotta JE, 2009, PLATELETS, V20, P505, DOI 10.3109/09537100903215417; Wang F, 2007, CLIN RHEUMATOL, V26, P768, DOI 10.1007/s10067-007-0550-0; Williams JP, 1999, J APPL PHYSIOL, V86, P938, DOI 10.1152/jappl.1999.86.3.938; Williams KT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000159; Yoshida H, 2009, INFLAMM BOWEL DIS, V15, P1245, DOI 10.1002/ibd.20896; Yoshiya K, 2011, AM J PHYSIOL-GASTR L, V301, pG1020, DOI 10.1152/ajpgi.00239.2011	46	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32260	10.1371/journal.pone.0032260	http://dx.doi.org/10.1371/journal.pone.0032260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384195	Green Submitted, gold, Green Published			2022-12-27	WOS:000302918500069
J	Pelletier, D; Leleu, K; Mallet, D; Mou-Tham, G; Herve, G; Boureau, M; Guilpart, N				Pelletier, Dominique; Leleu, Kevin; Mallet, Delphine; Mou-Tham, Gerard; Herve, Gilles; Boureau, Matthieu; Guilpart, Nicolas			Remote High-Definition Rotating Video Enables Fast Spatial Survey of Marine Underwater Macrofauna and Habitats	PLOS ONE			English	Article							REEF FISH ASSEMBLAGES; STEREO-VIDEO; VISUAL CENSUS; BAITED VIDEO; RELATIVE DENSITY; NEW-CALEDONIA; STATIONS; BIODIVERSITY; SYSTEM; COMMUNITIES	Observing spatial and temporal variations of marine biodiversity from non-destructive techniques is central for understanding ecosystem resilience, and for monitoring and assessing conservation strategies, e.g. Marine Protected Areas. Observations are generally obtained through Underwater Visual Censuses (UVC) conducted by divers. The problems inherent to the presence of divers have been discussed in several papers. Video techniques are increasingly used for observing underwater macrofauna and habitat. Most video techniques that do not need the presence of a diver use baited remote systems. In this paper, we present an original video technique which relies on a remote unbaited rotating remote system including a high definition camera. The system is set on the sea floor to record images. These are then analysed at the office to quantify biotic and abiotic sea bottom cover, and to identify and count fish species and other species like marine turtles. The technique was extensively tested in a highly diversified coral reef ecosystem in the South Lagoon of New Caledonia, based on a protocol covering both protected and unprotected areas in major lagoon habitats. The technique enabled to detect and identify a large number of species, and in particular fished species, which were not disturbed by the system. Habitat could easily be investigated through the images. A large number of observations could be carried out per day at sea. This study showed the strong potential of this non obtrusive technique for observing both macrofauna and habitat. It offers a unique spatial coverage and can be implemented at sea at a reasonable cost by non-expert staff. As such, this technique is particularly interesting for investigating and monitoring coastal biodiversity in the light of current conservation challenges and increasing monitoring needs.	[Pelletier, Dominique; Mallet, Delphine] IFREMER, Unite Rech Lagons Ecosyst & Aquaculture Durable N, Noumea, New Caledonia; [Pelletier, Dominique; Leleu, Kevin; Mou-Tham, Gerard; Guilpart, Nicolas] Inst Rech Pour Dev, Unite Rech CoReUs, Noumea, New Caledonia; [Leleu, Kevin; Boureau, Matthieu; Guilpart, Nicolas] IFREMER, Lab Biol Halieut, Plouzane, France; [Herve, Gilles] IFREMER, Lab Environm & Ressources PACA, La Seyne Sur Mer, France	Ifremer; Ifremer; Ifremer	Pelletier, D (corresponding author), IFREMER, Unite Rech Lagons Ecosyst & Aquaculture Durable N, Noumea, New Caledonia.	dpellet@ifremer.fr	Pelletier, Dominique/A-1649-2011	Pelletier, Dominique/0000-0003-2420-1942	GAIUS; French National Research Agency; ZONECO of New Caledonia; Coral Reef Initiative for the South Pacific program (CRISP); French Agency for Development	GAIUS; French National Research Agency(French National Research Agency (ANR)); ZONECO of New Caledonia; Coral Reef Initiative for the South Pacific program (CRISP); French Agency for Development(French National Research Agency (ANR))	This work was made possible through grants of the ZONECO program of the New Caledonia (http://www.zoneco.nc), the Coral Reef Initiative for the South Pacific program (CRISP, http://www.crisponline.net/) funded by the French Agency for Development, and the GAIUS project funded by the French National Research Agency (http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bohnsack JA, 1986, NOAA TECHNICAL REPOR, V41, P15; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M., 2003, AQUATIC PROTECTED AR, P455; Cappo M, 2007, MAR ECOL PROG SER, V350, P209, DOI 10.3354/meps07189; Christie P, 2007, CORAL REEFS, V26, P1047, DOI 10.1007/s00338-007-0235-9; Clua E, 2006, J EXP MAR BIOL ECOL, V333, P219, DOI 10.1016/j.jembe.2005.12.010; Convention on Biological Diversity, 2011, 10 M C PART CBD; Dickens LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018965; Ferraris J, 2005, MAR ECOL PROG SER, V292, P271, DOI 10.3354/meps292271; Goetze JS, 2011, CORAL REEFS, V30, P507, DOI 10.1007/s00338-011-0732-8; HARMELIN-VIVIEN M L, 1985, Revue d'Ecologie la Terre et la Vie, V40, P467; Harvey E, 2004, MAR FRESHWATER RES, V55, P573, DOI 10.1071/MF03130; Harvey E, 2002, FISH RES, V57, P255, DOI 10.1016/S0165-7836(01)00356-3; Harvey E, 1995, MAR TECHNOL SOC J, V29, P10; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; Harvey ES, 2010, MAR TECHNOL SOC J, V44, P75, DOI 10.4031/MTSJ.44.1.3; Heagney EC, 2007, MAR ECOL PROG SER, V350, P255, DOI 10.3354/meps07193; Hill JJ, 2004, METHODS ECOLOGICAL M; Kulbicki M, 1996, PEUPLEMENTS POISSONS; Kulbicki M, 2010, J EXP MAR BIOL ECOL, V387, P15, DOI 10.1016/j.jembe.2010.03.003; Langlois TJ, 2010, AQUAT BIOL, V9, P155, DOI 10.3354/ab00235; Lebart L., 1984, MULTIVARIATE DESCRIP; MacNeill MA, 2008, MAR ECOL PROG SER, V367, P249, DOI 10.3354/meps07580; Malcolm HA, 2007, MAR ECOL PROG SER, V350, P277, DOI 10.3354/meps07195; Pelletier D, 2000, CAN J FISH AQUAT SCI, V57, P51, DOI 10.1139/cjfas-57-1-51; Pelletier D, 2011, FISH RES, V107, P84, DOI 10.1016/j.fishres.2010.10.011; Preuss B, 2009, ICES J MAR SCI, V66, P170, DOI 10.1093/icesjms/fsn204; Shackleton CM, 2010, ENVIRON CONSERV, V37, P1, DOI 10.1017/S0376892910000366; Shortis M, 2009, OCEANOGR MAR BIOL, V47, P257; Walters C., 1986, ADAPTIVE MANAGEMENT; Wantiez L, 1997, CORAL REEFS, V16, P215, DOI 10.1007/s003380050077; Watson DL, 2007, MAR FRESHW BEHAV PHY, V40, P85, DOI 10.1080/10236240701393263; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; Williams ID, 2006, MAR ECOL PROG SER, V310, P185, DOI 10.3354/meps310185; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Willis TJ, 2000, MAR ECOL PROG SER, V198, P249, DOI 10.3354/meps198249; Willis TJ, 2001, J FISH BIOL, V59, P1408, DOI 10.1006/jfbi.2001.1721; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	40	38	38	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e30536	10.1371/journal.pone.0030536	http://dx.doi.org/10.1371/journal.pone.0030536			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383965	gold, Green Published			2022-12-27	WOS:000302918500011
J	Zheng, LN; Zhou, X; Zhang, HD; Ji, XF; Li, L; Huang, L; Bai, LQ; Zhang, HJ				Zheng, Lina; Zhou, Xiang; Zhang, Huaidong; Ji, Xiaofeng; Li, Lei; Huang, Lin; Bai, Linquan; Zhang, Houjin			Structural and Functional Analysis of Validoxylamine A 7 '-phosphate Synthase ValL Involved in Validamycin A Biosynthesis	PLOS ONE			English	Article							GENE-CLUSTER; STREPTOMYCES; GLUCOSYLTRANSFERASE; INHIBITOR; PROTEIN	Validamycin A (Val-A) is an effective antifungal agent widely used in Asian countries as crop protectant. Validoxylamine A, the core structure and intermediate of Val-A, consists of two C7-cyclitol units connected by a rare C-N bond. In the Val-A biosynthetic gene cluster in Streptomyces hygroscopicus 5008, the ORF valL was initially annotated as a validoxylamine A 7'-phosphate(V7P) synthase, whose encoded 497-aa protein shows high similarity with trehalose 6-phosphate(T6P) synthase. Gene inactivation of valL abolished both validoxylamine A and validamycin A productivity, and complementation with a cloned valL recovered 10% production of the wild-type in the mutant, indicating the involvement of ValL in validoxylamine A biosynthesis. Also we determined the structures of ValL and ValL/trehalose complex. The structural data indicates that ValL adopts the typical fold of GT-B protein family, featuring two Rossmann-fold domains and an active site at domain junction. The residues in the active site are arranged in a manner homologous to that of Escherichia coli (E. coli) T6P synthase OtsA. However, a significant discrepancy is found in the active-site loop region. Also noticeable structural variance is found around the active site entrance in the apo ValL structure while the region takes an ordered configuration upon binding of product analog trehalose. Furthermore, the modeling of V7P in the active site of ValL suggests that ValL might have a similar SNi-like mechanism as OtsA.	[Zheng, Lina; Zhang, Huaidong; Huang, Lin; Zhang, Houjin] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biotechnol, Wuhan 430074, Hubei, Peoples R China; [Zhou, Xiang; Li, Lei; Bai, Linquan] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Zhou, Xiang; Li, Lei; Bai, Linquan] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Ji, Xiaofeng] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Shandong, Peoples R China	Huazhong University of Science & Technology; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS	Zhang, HJ (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biotechnol, Wuhan 430074, Hubei, Peoples R China.	bailq@sjtu.edu.cn; hjzhang@mail.hust.edu.cn	BAI, Linquan/AAI-9833-2020	Zhang, Huaidong/0000-0001-6572-4737	National Natural Science Foundation of China [31000326, 31070070]; Ministry of Science Technology [2009CB118901]; Ministry of Education [20100142120002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science Technology; Ministry of Education	This research was financially supported by National Natural Science Foundation of China (No. 31000326 and 31070070), the 973 Program from Ministry of Science & Technology (No. 2009CB118901), and the Ph.D. Training Fund of the Ministry of Education (No. 20100142120002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Asamizu S, 2011, J AM CHEM SOC, V133, P12124, DOI 10.1021/ja203574u; ASANO N, 1987, J ANTIBIOT, V40, P526, DOI 10.7164/antibiotics.40.526; Bai L, 2006, CHEM BIOL, V13, P387, DOI 10.1016/j.chembiol.2006.02.002; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bell W, 1998, J BIOL CHEM, V273, P33311, DOI 10.1074/jbc.273.50.33311; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dong HJ, 2001, J AM CHEM SOC, V123, P2733, DOI 10.1021/ja003643n; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errey JC, 2010, ANGEW CHEM INT EDIT, V49, P1234, DOI 10.1002/anie.200905096; Gibson RP, 2004, J BIOL CHEM, V279, P1950, DOI 10.1074/jbc.M307643200; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Iwasa T., 1970, J ANTIBIOT, V23, P595, DOI DOI 10.7164/ANTIBIOTICS.23.595; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawamura N, 1996, J ANTIBIOT, V49, P651, DOI 10.7164/antibiotics.49.651; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]; Mahmud T, 2003, NAT PROD REP, V20, P137, DOI 10.1039/b205561a; Mahmud T, 2009, CURR OPIN CHEM BIOL, V13, P161, DOI 10.1016/j.cbpa.2009.02.030; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minagawa K, 2007, CHEMBIOCHEM, V8, P632, DOI 10.1002/cbic.200600528; Morera S, 2001, J MOL BIOL, V311, P569, DOI 10.1006/jmbi.2001.4905; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Paget MSB, 1999, J BACTERIOL, V181, P204, DOI 10.1128/JB.181.1.204-211.1999; Singh D, 2006, GENE, V376, P13, DOI 10.1016/j.gene.2005.12.035; SMOKVINA T, 1990, GENE, V94, P53, DOI 10.1016/0378-1119(90)90467-6; SUAMI T, 1980, J ANTIBIOT, V33, P98, DOI 10.7164/antibiotics.33.98; Sun YH, 2009, APPL MICROBIOL BIOT, V82, P303, DOI 10.1007/s00253-008-1793-7; Wehmeier UF, 2004, APPL MICROBIOL BIOT, V63, P613, DOI 10.1007/s00253-003-1477-2; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu H, 2009, CHEM BIOL, V16, P567, DOI 10.1016/j.chembiol.2009.04.006; YOKOSE K, 1983, J ANTIBIOT, V36, P1166, DOI 10.7164/antibiotics.36.1166; Yu Y, 2005, APPL ENVIRON MICROB, V71, P5066, DOI 10.1128/AEM.71.9.5066-5076.2005	35	8	10	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32033	10.1371/journal.pone.0032033	http://dx.doi.org/10.1371/journal.pone.0032033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384130	Green Submitted, Green Published, gold			2022-12-27	WOS:000302918500055
J	Henkel, CV; Burgerhout, E; de Wijze, DL; Dirks, RP; Minegishi, Y; Jansen, HJ; Spaink, HP; Dufour, S; Weltzien, FA; Tsukamoto, K; van den Thillart, GEEJM				Henkel, Christiaan V.; Burgerhout, Erik; de Wijze, Danielle L.; Dirks, Ron P.; Minegishi, Yuki; Jansen, Hans J.; Spaink, Herman P.; Dufour, Sylvie; Weltzien, Finn-Arne; Tsukamoto, Katsumi; van den Thillart, Guido E. E. J. M.			Primitive Duplicate Hox Clusters in the European Eel's Genome	PLOS ONE			English	Article							ANGUILLA-JAPONICA; EVOLUTION; GENE; ORIGIN; BODY; TRANSCRIPTION; PHYSIOLOGY	The enigmatic life cycle and elongated body of the European eel (Anguilla anguilla L., 1758) have long motivated scientific enquiry. Recently, eel research has gained in urgency, as the population has dwindled to the point of critical endangerment. We have assembled a draft genome in order to facilitate advances in all provinces of eel biology. Here, we use the genome to investigate the eel's complement of the Hox developmental transcription factors. We show that unlike any other teleost fish, the eel retains fully populated, duplicate Hox clusters, which originated at the teleost-specific genome duplication. Using mRNA-sequencing and in situ hybridizations, we demonstrate that all copies are expressed in early embryos. Theories of vertebrate evolution predict that the retention of functional, duplicate Hox genes can give rise to additional developmental complexity, which is not immediately apparent in the adult. However, the key morphological innovation elsewhere in the eel's life history coincides with the evolutionary origin of its Hox repertoire.	[Henkel, Christiaan V.; Burgerhout, Erik; Dirks, Ron P.; Jansen, Hans J.] ZF Screens BV, Leiden, Netherlands; [de Wijze, Danielle L.; Minegishi, Yuki; Spaink, Herman P.; van den Thillart, Guido E. E. J. M.] Leiden Univ, Inst Biol, Leiden, Netherlands; [Dufour, Sylvie] Museum Natl Hist Nat, UMR BOREA, CNRS 7208, F-75231 Paris, France; [Weltzien, Finn-Arne] Norwegian Sch Vet Sci, Oslo, Norway; [Tsukamoto, Katsumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan	Leiden University; Leiden University - Excl LUMC; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Norwegian University of Life Sciences; University of Tokyo	Henkel, CV (corresponding author), ZF Screens BV, Leiden, Netherlands.	henkel@zfscreens.com	Spaink, Herman P./S-3586-2017; Burgerhout, Erik/AAI-4527-2020	Spaink, Herman P./0000-0003-4128-9501; Henkel, Christiaan/0000-0001-9838-8215; Jansen, Hans/0000-0002-8563-4146; weltzien, finn-arne/0000-0002-5111-1558	Norwegian School of Veterinary Science; Research Council of Norway [184851]; Centre National de la Recherche Scientifique; L'Agence Nationale de la Recherche [08-BLAN-0173]; ZF-screens B.V., Leiden University; University of Tokyo	Norwegian School of Veterinary Science; Research Council of Norway(Research Council of Norway); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); L'Agence Nationale de la Recherche(French National Research Agency (ANR)); ZF-screens B.V., Leiden University; University of Tokyo	This work was supported by the Norwegian School of Veterinary Science and the Research Council of Norway (184851), by Centre National de la Recherche Scientifique and L'Agence Nationale de la Recherche (08-BLAN-0173), and by private resources from ZF-screens B.V., Leiden University and The University of Tokyo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup K, 2009, SCIENCE, V325, P1660, DOI 10.1126/science.1178120; Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Als TD, 2011, MOL ECOL, V20, P1333, DOI 10.1111/j.1365-294X.2011.05011.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; AVISE JC, 1990, EVOLUTION, V44, P1254, DOI [10.2307/2409286, 10.1111/j.1558-5646.1990.tb05229.x]; Bishop RE, 1999, J EXP BIOL, V202, P2485; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Burgerhout E, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-16; Crow KD, 2006, MOL BIOL EVOL, V23, P121, DOI 10.1093/molbev/msj020; Cunningham JT, 1897, NATURE, V55, P467; Di-Poi N, 2010, NATURE, V464, P99, DOI 10.1038/nature08789; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Freyhof J, 2010, ANGUILLA ANGUILLA IU; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Greenwood P. H., 1966, Bulletin of the American Museum of Natural History, V131, P339; Guo BC, 2010, J EXP ZOOL PART B, V314B, P135, DOI 10.1002/jez.b.21318; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; He XJ, 2011, DEV BIOL, V357, P463, DOI 10.1016/j.ydbio.2011.07.014; Hiroi J, 2004, DEV GENES EVOL, V214, P176, DOI 10.1007/s00427-004-0397-1; HOLLAND PWH, 1994, DEVELOPMENT, P125; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Inoue JG, 2005, GENE, V349, P227, DOI 10.1016/j.gene.2005.01.008; Inoue JG, 2004, MOL PHYLOGENET EVOL, V32, P274, DOI 10.1016/j.ympev.2003.11.009; Inoue JG, 2010, BIOL LETTERS, V6, P363, DOI 10.1098/rsbl.2009.0989; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuraku S, 2009, INT J DEV BIOL, V53, P765, DOI 10.1387/ijdb.072533km; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lynch VJ, 2008, EVOLUTION, V62, P2131, DOI 10.1111/j.1558-5646.2008.00440.x; Mainguy G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000356; Matschiner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018911; Mehta RS, 2010, INTEGR COMP BIOL, V50, P1091, DOI 10.1093/icb/icq075; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Miller Michael J., 2009, Aqua-Bioscience Monographs, V2, P1; Minegishi Y, 2005, MOL PHYLOGENET EVOL, V34, P134, DOI 10.1016/j.ympev.2004.09.003; Mungpakdee S, 2008, MOL BIOL EVOL, V25, P1333, DOI 10.1093/molbev/msn097; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Oliveira K, 2010, CAN J ZOOL, V88, P1121, DOI 10.1139/Z10-081; Otake T, 2003, EEL BIOLOGY, P61; Pfeiler E, 1999, COMP BIOCHEM PHYS A, V123, P113, DOI 10.1016/S1095-6433(99)00028-8; Raff RA, 2008, PHILOS T R SOC B, V363, P1473, DOI 10.1098/rstb.2007.2237; Raincrow JD, 2011, J EXP ZOOL PART B, V316B, P451, DOI 10.1002/jez.b.21420; Schmidt J, 1923, NATURE, V111, P51, DOI 10.1038/111051a0; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Tanaka H, 2003, FISH PHYSIOL BIOCHEM, V28, P493, DOI 10.1023/B:FISH.0000030638.56031.ed; Tesch F-W., 2003, EEL; Van den Thillart G, SPAWNING MIGRATION E; Wagner GP, 2003, P NATL ACAD SCI USA, V100, P14603, DOI 10.1073/pnas.2536656100; Woltering JM, 2006, NAT GENET, V38, P601, DOI 10.1038/ng0606-601; Woltering JM, 2009, DEV BIOL, V332, P82, DOI 10.1016/j.ydbio.2009.04.031; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400	54	107	108	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32231	10.1371/journal.pone.0032231	http://dx.doi.org/10.1371/journal.pone.0032231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384188	gold, Green Published, Green Submitted			2022-12-27	WOS:000302916800030
J	Huang, RB; Eniola-Adefeso, O				Huang, Ryan B.; Eniola-Adefeso, Omolola			Shear Stress Modulation of IL-1 beta-Induced E-Selectin Expression in Human Endothelial Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; IN-VITRO; INFLAMMATION; INTERLEUKIN-1; FLOW; DYSFUNCTION; REPERFUSION; RESPONSES; ISCHEMIA	Background: Endothelial cells (ECs) are continuously exposed to hemodynamic forces imparted by blood flow. While it is known that endothelial behavior can be influenced by cytokine activation or fluid shear, the combined effects of these two independent agonists have yet to be fully elucidated. Methodology: We investigated EC response to long-term inflammatory cues under physiologically relevant shear conditions via E-selectin expression where monolayers of human umbilical vein ECs were simultaneously exposed to laminar fluid shear and interleukin-1 beta (shear-cytokine activation) in a parallel plate flow chamber. Results and Conclusion: Naive ECs exposed to shear-cytokine activation display significantly higher E-selectin expression for up to 24 hr relative to ECs activated in static (static-cytokine). Peak E-selectin expression occurred after 8-12 hr of continuous shear-cytokine activation contrary to the commonly observed 4-6 hr peak expression in ECs exposed to static-cytokine activation. Cells with some history of high shear conditioning exhibited either high or muted E-selectin expression depending on the durations of the shear pre-conditioning and the ensuing shear-cytokine activation. Overall, the presented data suggest that a high laminar shear enhances acute EC response to interleukin-1 beta in naive or shear-conditioned ECs as may be found in the pathological setting of ischemia/reperfusion injury while conferring rapid E-selectin downregulation to protect against chronic inflammation.	[Huang, Ryan B.; Eniola-Adefeso, Omolola] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Huang, RB (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	lolaa@umich.edu		Eniola-Adefeso, Omolola/0000-0002-8728-6608	American Heart Association [0735043N]; University of Michigan COPE	American Heart Association(American Heart Association); University of Michigan COPE	This work was supported by a grant from the American Heart Association (0735043N) to OEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This article was made available as Open Access with the support of the University of Michigan COPE Fund, http://lib.umich.edu/cope.	Aird WC, 2008, PHARMACOL REP, V60, P139; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Amberger A, 1997, CELL STRESS CHAPERON, V2, P94, DOI 10.1379/1466-1268(1997)002<0094:CEOIVE>2.3.CO;2; Boutin H, 2001, J NEUROSCI, V21, P5528, DOI 10.1523/JNEUROSCI.21-15-05528.2001; Burns AR, 2000, J CELL SCI, V113, P45; CARDEN DL, 1990, CIRC RES, V66, P1436, DOI 10.1161/01.RES.66.5.1436; Charoenphol P, 2011, ATHEROSCLEROSIS, V217, P364, DOI 10.1016/j.atherosclerosis.2011.04.016; Charoenphol P, 2010, BIOMATERIALS, V31, P1392, DOI 10.1016/j.biomaterials.2009.11.007; Chiu JJ, 2004, ARTERIOSCL THROM VAS, V24, P73, DOI 10.1161/01.ATV.0000106321.63667.24; Cicha I, 2009, ATHEROSCLEROSIS, V207, P93, DOI 10.1016/j.atherosclerosis.2009.04.034; Conway DE, 2010, AM J PHYSIOL-HEART C, V298, pH367, DOI 10.1152/ajpheart.00565.2009; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Davies PF, 2001, ANN NY ACAD SCI, V947, P7; Davies PF, 2001, ANN NY ACAD SCI, P947; DEPAOLA N, 1992, ARTERIOSCLER THROMB, V12, P1254, DOI 10.1161/01.ATV.12.11.1254; DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276; Dinarello CA, 2011, J INTERN MED, V269, P16, DOI 10.1111/j.1365-2796.2010.02313.x; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Eniola-Adefeso O, 2009, ANN BIOMED ENG, V37, P737, DOI 10.1007/s10439-009-9647-8; Erdman SE, 2010, INT J CANCER, V127, P768, DOI 10.1002/ijc.25430; Ferrario CM, 2006, AM J CARDIOL, V98, P121, DOI 10.1016/j.amjcard.2006.01.059; Galkina E, 2007, CURR DRUG TARGETS, V8, P1239, DOI 10.2174/138945007783220650; Gimbrone MA, 2000, ANN NY ACAD SCI, V902, P230; Griffin WST, 2002, J LEUKOCYTE BIOL, V72, P233; Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6; Haring HP, 1996, STROKE, V27, P1386, DOI 10.1161/01.STR.27.8.1386; Henninger DD, 1997, J IMMUNOL, V158, P1825; Imberti B, 2002, ENDOTHELIUM-NEW YORK, V9, P11, DOI 10.1080/10623320210714; INAUEN W, 1990, FREE RADICAL BIO MED, V9, P219, DOI 10.1016/0891-5849(90)90031-D; IVES CL, 1986, IN VITRO CELL DEV B, V22, P500; JANG IK, 1993, EUR HEART J, V14, P2; Ji JY, 2008, ANN BIOMED ENG, V36, P586, DOI 10.1007/s10439-008-9465-4; Kluger MS, 2002, J IMMUNOL, V168, P2091, DOI 10.4049/jimmunol.168.5.2091; Kluger MS, 1997, J IMMUNOL, V158, P887; Kraiss LW, 2003, J VASC SURG, V37, P161, DOI 10.1067/mva.2003.67; KUIJPERS TW, 1994, J IMMUNOL, V152, P5060; LANGILLE BL, 1991, ARTERIOSCLER THROMB, V11, P1814, DOI 10.1161/01.ATV.11.6.1814; Lei YP, 2008, J NUTR, V138, P996, DOI 10.1093/jn/138.6.996; LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li M, 2009, ANN BIOMED ENG, V37, P1082, DOI 10.1007/s10439-009-9684-3; Libby P, 2007, NUTR REV, V65, pS140, DOI [10.1111/j.1753-4887.2007.tb00352.x, 10.1301/nr.2007.dec.S140-S146]; Maedler K, 2011, HANDB EXP PHARMACOL, V203, P257, DOI 10.1007/978-3-642-17214-4_11; Malek AM, 1996, J CELL SCI, V109, P713; Matharu NM, 2008, J CELL PHYSIOL, V216, P732, DOI 10.1002/jcp.21457; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; MORIGI M, 1995, BLOOD, V85, P1696, DOI 10.1182/blood.V85.7.1696.bloodjournal8571696; NAGEL T, 1994, J CLIN INVEST, V94, P885, DOI 10.1172/JCI117410; Noria S, 1999, CIRC RES, V85, P504, DOI 10.1161/01.RES.85.6.504; PAREKH RB, 1994, TRENDS BIOTECHNOL, V12, P339, DOI 10.1016/0167-7799(94)90034-5; PARKS DA, 1986, AM J PHYSIOL, V250, pG749, DOI 10.1152/ajpgi.1986.250.6.G749; Partridge J, 2007, FASEB J, V21, P3553, DOI 10.1096/fj.06-8059com; POBER JS, 1986, J IMMUNOL, V136, P1680; Pries A. R., 2006, V176, P1; REMUZZI A, 1984, BIORHEOLOGY, V21, P617; Rodrigues SF, 2010, CARDIOVASC RES, V87, P291, DOI 10.1093/cvr/cvq090; Roldan V, 2003, THROMB HAEMOSTASIS, V90, P1007, DOI 10.1160/TH02-09-0083; Rouleau L, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001217; Sheikh S, 2003, BLOOD, V102, P2828, DOI 10.1182/blood-2003-01-0080; Shimokawa H, 1999, J MOL CELL CARDIOL, V31, P23, DOI 10.1006/jmcc.1998.0841; Thorin E, 1998, PHARMACOL THERAPEUT, V78, P155, DOI 10.1016/S0163-7258(98)00005-9; Tiong AY, 2005, AM HEART J, V150, P11, DOI 10.1016/j.ahj.2004.12.019; Yamawaki H, 2003, CIRCULATION, V108, P1619, DOI 10.1161/01.CIR.0000089373.49941.C4; Yee A, 2006, ANN BIOMED ENG, V34, P593, DOI 10.1007/s10439-006-9078-8; Zhang RL, 1996, J CEREBR BLOOD F MET, V16, P1126, DOI 10.1097/00004647-199611000-00006	65	39	40	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31874	10.1371/journal.pone.0031874	http://dx.doi.org/10.1371/journal.pone.0031874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384091	gold, Green Published, Green Submitted			2022-12-27	WOS:000302916800020
J	Kuznetsova, IM; Sulatskaya, AI; Uversky, VN; Turoverov, KK				Kuznetsova, Irina M.; Sulatskaya, Anna I.; Uversky, Vladimir N.; Turoverov, Konstantin K.			Analyzing Thioflavin T Binding to Amyloid Fibrils by an Equilibrium Microdialysis-Based Technique	PLOS ONE			English	Article							MOLECULAR-MECHANISM; BETA-SHEET; AFFINITY; AGENTS; SITES	A new approach for the determination of the amyloid fibril - thioflavin T (ThT) binding parameters (the number of binding modes, stoichiometry, and binding constants of each mode) is proposed. This approach is based on the absorption spectroscopy determination of the concentration of free and bound to fibril dye in solutions, which are prepared by equilibrium microdialysis. Furthermore, the proposed approach allowed us, for the first time, to determine the absorption spectrum, molar extinction coefficient, and fluorescence quantum yield of the ThT bound to fibril by each binding modes. This approach is universal and can be used for determining the binding parameters of any dye interaction with a receptor, such as ANS binding to proteins in the molten globule state or to protein amorphous aggregates.	[Kuznetsova, Irina M.; Sulatskaya, Anna I.; Turoverov, Konstantin K.] Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia; [Uversky, Vladimir N.] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Moscow Region, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; State University System of Florida; University of South Florida; Russian Academy of Sciences	Kuznetsova, IM (corresponding author), Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia.	vuversky@health.usf.edu; kkt@incras.ru	Uversky, Vladimir N./F-4515-2011; Kuznetsova, Irina M./R-9844-2017; Sulatskaya, Anna/I-6042-2014; Turoverov, Konstantin/S-2079-2016	Uversky, Vladimir N./0000-0002-4037-5857; Kuznetsova, Irina M./0000-0002-3336-4834; Sulatskaya, Anna/0000-0002-1207-3384; Turoverov, Konstantin/0000-0002-6977-1896	Russian Academy of Sciences; Russian Foundation of Basic Research [12-04-90022_Bel]; Dmitry Zimin's Russian Charitable Foundation "Dynasty"	Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Dmitry Zimin's Russian Charitable Foundation "Dynasty"	This work was supported in part by the Russian Academy of Sciences "Molecular and Cell Biology" Program (KKT, VNU), Russian Foundation of Basic Research, grant 12-04-90022_Bel (KKT) and Dmitry Zimin's Russian Charitable Foundation "Dynasty" (AIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; De Ferrari GV, 2001, J BIOL CHEM, V276, P23282, DOI 10.1074/jbc.M009596200; Dzwolak W, 2005, FEBS LETT, V579, P6601, DOI 10.1016/j.febslet.2005.10.048; Goers J, 2002, BIOCHEMISTRY-US, V41, P12546, DOI 10.1021/bi0262698; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; Henriksen G, 2007, J MED CHEM, V50, P1087, DOI 10.1021/jm061466g; Klunk WE, 2003, J NEUROSCI, V23, P2086; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lockhart A, 2005, J BIOL CHEM, V280, P7677, DOI 10.1074/jbc.M412056200; Loksztejn A, 2008, J MOL BIOL, V379, P9, DOI 10.1016/j.jmb.2008.03.057; Maskevich AA, 2007, J PROTEOME RES, V6, P1392, DOI 10.1021/pr0605567; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; Morimoto K, 2009, J BIOCHEM, V145, P677, DOI 10.1093/jb/mvp025; Ono M, 2009, CHEM PHARM BULL, V57, P1029, DOI 10.1248/cpb.57.1029; Qiang W, 2011, J AM CHEM SOC, V133, P4018, DOI 10.1021/ja109679q; Sabate R, 2008, J STRUCT BIOL, V162, P387, DOI 10.1016/j.jsb.2008.02.002; Sen P, 2009, SPECTROCHIM ACTA A, V74, P94, DOI 10.1016/j.saa.2009.05.010; Stsiapura VI, 2007, J PHYS CHEM A, V111, P4829, DOI 10.1021/jp070590o; Sulatskaya AI, 2011, J PHYS CHEM B, V115, P11519, DOI 10.1021/jp207118x; Sulatskaya AI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015385; Sutharsan J, 2010, CHEMMEDCHEM, V5, P56, DOI 10.1002/cmdc.200900440; Turoverov K K, 1998, Tsitologiia, V40, P806; Turoverov KK, 2007, P SOC PHOTO-OPT INS, V6733, P1; Tycko R, 2004, CURR OPIN STRUC BIOL, V14, P96, DOI 10.1016/j.sbi.2003.12.002; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Voropai E. S., 2003, Journal of Applied Spectroscopy, V70, P868, DOI 10.1023/B:JAPS.0000016303.37573.7e; Wu C, 2009, J MOL BIOL, V394, P627, DOI 10.1016/j.jmb.2009.09.056; Ye L, 2008, J NEUROCHEM, V105, P1428, DOI 10.1111/j.1471-4159.2008.05245.x	31	45	46	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e30724	10.1371/journal.pone.0030724	http://dx.doi.org/10.1371/journal.pone.0030724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22383971	Green Submitted, gold, Green Published			2022-12-27	WOS:000302916800006
J	Ardeshirpour, Y; Chernomordik, V; Zielinski, R; Capala, J; Griffiths, G; Vasalatiy, O; Smirnov, AV; Knutson, JR; Lyakhov, I; Achilefu, S; Gandjbakhche, A; Hassan, M				Ardeshirpour, Yasaman; Chernomordik, Victor; Zielinski, Rafal; Capala, Jacek; Griffiths, Gary; Vasalatiy, Olga; Smirnov, Aleksandr V.; Knutson, Jay R.; Lyakhov, Ilya; Achilefu, Samuel; Gandjbakhche, Amir; Hassan, Moinuddin			In Vivo Fluorescence Lifetime Imaging Monitors Binding of Specific Probes to Cancer Biomarkers	PLOS ONE			English	Article							BREAST-CANCER; EXPRESSION; AGENTS	One of the most important factors in choosing a treatment strategy for cancer is characterization of biomarkers in cancer cells. Particularly, recent advances in Monoclonal Antibodies (MAB) as primary-specific drugs targeting tumor receptors show that their efficacy depends strongly on characterization of tumor biomarkers. Assessment of their status in individual patients would facilitate selection of an optimal treatment strategy, and the continuous monitoring of those biomarkers and their binding process to the therapy would provide a means for early evaluation of the efficacy of therapeutic intervention. In this study we have demonstrated for the first time in live animals that the fluorescence lifetime can be used to detect the binding of targeted optical probes to the extracellular receptors on tumor cells in vivo. The rationale was that fluorescence lifetime of a specific probe is sensitive to local environment and/or affinity to other molecules. We attached Near-InfraRed (NIR) fluorescent probes to Human Epidermal Growth Factor 2 (HER2/neu)-specific Affibody molecules and used our time-resolved optical system to compare the fluorescence lifetime of the optical probes that were bound and unbound to tumor cells in live mice. Our results show that the fluorescence lifetime changes in our model system delineate HER2 receptor bound from the unbound probe in vivo. Thus, this method is useful as a specific marker of the receptor binding process, which can open a new paradigm in the "image and treat" concept, especially for early evaluation of the efficacy of the therapy.	[Ardeshirpour, Yasaman; Chernomordik, Victor; Gandjbakhche, Amir; Hassan, Moinuddin] NICHHD, NIH, Bethesda, MD 20892 USA; [Zielinski, Rafal; Capala, Jacek; Lyakhov, Ilya] NCI, NIH, Bethesda, MD 20892 USA; [Zielinski, Rafal] John Paul II Catholic Univ Lublin, Dept Mol Biol, Lublin, Poland; [Griffiths, Gary; Vasalatiy, Olga] NIH, Imaging Probe Dev Ctr, Rockville, MD USA; [Smirnov, Aleksandr V.; Knutson, Jay R.] NHLBI, NIH, Bethesda, MD 20892 USA; [Achilefu, Samuel] Washington Univ, Dept Radiol, St Louis, MO USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Catholic University of Lublin; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Washington University (WUSTL)	Ardeshirpour, Y (corresponding author), NICHHD, NIH, Bethesda, MD 20892 USA.	amir@helix.nih.gov	Capala, Jacek/S-3553-2019; Achilefu, Samuel/AAC-2401-2019	Achilefu, Samuel/0000-0002-3133-6717	Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute, Imaging Probe Development Center, National Heart, Lung and Blood Institute, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000261] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006065, ZIAHL006067, ZICHL005090, ZIAHL001452] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute, Imaging Probe Development Center, National Heart, Lung and Blood Institute, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research is supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development and by the National Cancer Institute, Imaging Probe Development Center, National Heart, Lung and Blood Institute, National Institutes of Health. As YA, RF, VC, JC, GG, OV, AS, JK, IL, AG and MH are employees of the National Institutes of Health; this funder played a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers W, 2007, MOL IMAGING, V6, P237, DOI 10.2310/7290.2007.00020; Alford R, 2010, CONTRAST MEDIA MOL I, V5, P1, DOI 10.1002/cmmi.360; Allison M, 2010, NAT BIOTECHNOL, V28, P117, DOI 10.1038/nbt0210-117; Amiot CL, 2008, SENSORS-BASEL, V8, P3082, DOI 10.3390/s8053082; [Anonymous], 1999, PRINCIPLES FLUORESCE; [Anonymous], R PROJECT STAT COMPU; Ardeshirpour Y, 2011, TECHNOL CANCER RES T, V10, P549, DOI 10.1177/153303461101000605; Baum RP, 2010, J NUCL MED, V51, P892, DOI 10.2967/jnumed.109.073239; Berezin MY, 2010, CHEM REV, V110, P2641, DOI 10.1021/cr900343z; Bloch S, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2070148; Bremer C, 2003, EUR RADIOL, V13, P231, DOI 10.1007/s00330-002-1610-0; Cheng Z, 2010, J BIOMEDICAL OPTICS, V15; Chernomordik V, 2010, MOL IMAGING, V9, P192, DOI 10.2310/7290.2010.00018; Christian NA, 2009, MOL IMAGING BIOL, V11, P167, DOI 10.1007/s11307-008-0184-x; Corlu A, 2007, OPT EXPRESS, V15, P6696, DOI 10.1364/OE.15.006696; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Gannot I, 2004, LASER SURG MED, V35, P342, DOI 10.1002/lsm.20101; Ghoroghchian PP, 2005, P NATL ACAD SCI USA, V102, P2922, DOI 10.1073/pnas.0409394102; Goldshaid L, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2579; Gurfinkel M, 2003, DIS MARKERS, V19, P107; Hall D, 2004, OPT LETT, V29, P2258, DOI 10.1364/OL.29.002258; Hassan M, 2007, MOL IMAGING, V6, P229, DOI 10.2310/7290.2007.00019; Hillman EMC, 2007, NAT PHOTONICS, V1, P526, DOI 10.1038/nphoton.2007.146; Leblond F, 2010, J PHOTOCH PHOTOBIO B, V98, P77, DOI 10.1016/j.jphotobiol.2009.11.007; Lee SB, 2008, CLIN CANCER RES, V14, P3840, DOI 10.1158/1078-0432.CCR-07-4076; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; Lyakhov I, 2010, CHEMBIOCHEM, V11, P345, DOI 10.1002/cbic.200900532; Mathejczyk JE, 2011, MOL IMAGING; Nutt R, 2007, CLIN PHARMACOL THER, V81, P792, DOI 10.1038/sj.clpt.6100213; OLeary MA, 1996, OPT LETT, V21, P158, DOI 10.1364/OL.21.000158; Paithankar DY, 1997, APPL OPTICS, V36, P2260, DOI 10.1364/AO.36.002260; Pogue BW, 2010, J BIOMEDICAL OPTICS, V15; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smirnov A, 2009, 3 DIMENSIONAL MULTID, V7184, p71841D1; Szmacinski H., 1994, TOPICS FLUORESCENCE; VAUPEL P, 1989, CANCER RES, V49, P6449; Welsher K, 2011, P NATL ACAD SCI USA, V108, P8943, DOI 10.1073/pnas.1014501108; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; ZIMMERMAN HE, 1982, P NATL ACAD SCI USA, V79, P2128, DOI 10.1073/pnas.79.6.2128	40	26	26	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31881	10.1371/journal.pone.0031881	http://dx.doi.org/10.1371/journal.pone.0031881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384092	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916100037
J	Demidova-Rice, TN; Wolf, L; Deckenback, J; Hamblin, MR; Herman, IM				Demidova-Rice, Tatiana N.; Wolf, Lindsey; Deckenback, Jeffry; Hamblin, Michael R.; Herman, Ira M.			Human Platelet-Rich Plasma- and Extracellular Matrix-Derived Peptides Promote Impaired Cutaneous Wound Healing In Vivo	PLOS ONE			English	Article							GROWTH-FACTORS; CELLS; MICE; ANGIOGENESIS; CYTOKINES; INJURY; VITRO	Previous work in our laboratory has described several pro-angiogenic short peptides derived from endothelial extracellular matrices degraded by bacterial collagenase. Here we tested whether these peptides could stimulate wound healing in vivo. Our experiments demonstrated that a peptide created as combination of fragments of tenascin X and fibrillin 1 (comb1) applied into cranial dermal wounds created in mice treated with cyclophosphamide to impair wound healing, can improve the rate of wound closure. Furthermore, we identify and characterize a novel peptide (UN3) created and modified from two naturally-occurring peptides, which are present in human platelet-rich plasma. In vitro testing of UN3 demonstrates that it causes a 50% increase in endothelial proliferation, 250% increase in angiogenic response and a tripling of epithelial cell migration in response to injury. Results of in vivo experiments where comb1 and UN3 peptides were added together to cranial wounds in cyclophosphamide-treated mice leads to improvement of wound vascularization as shown by an increase of the number of blood vessels present in the wound beds. Application of the peptides markedly promotes cellular responses to injury and essentially restores wound healing dynamics to those of normal, acute wounds in the absence of cyclophosphamide impairment. Our current work is aimed at understanding the mechanisms underlying the stimulatory effects of these peptides as well as identification of the cellular receptors mediating these effects.	[Demidova-Rice, Tatiana N.; Wolf, Lindsey; Deckenback, Jeffry; Herman, Ira M.] Tufts Univ, Sch Med, Ctr Innovat Wound Healing Res, Grad Program Cellular & Mol Physiol,Sackler Sch G, Boston, MA 02111 USA; [Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Hamblin, Michael R.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Tufts University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT)	Demidova-Rice, TN (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab Tumor Biol, Boston, MA 02114 USA.	ira.herman@tufts.edu	Hamblin, Michael R/H-2758-2019; Hamblin, Mike/AAB-2511-2022	Hamblin, Michael R/0000-0001-6431-4605; 	National Institutes of Heatlh [EY15125, EY19533]; Wound Care Partners, LLC; NATIONAL EYE INSTITUTE [K08EY019533, R01EY015125] Funding Source: NIH RePORTER	National Institutes of Heatlh; Wound Care Partners, LLC; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Heatlh EY15125, EY19533, and Wound Care Partners, LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Belmont Philip J, 2010, J Surg Orthop Adv, V19, P2; Borzini P, 2005, CURR OPIN HEMATOL, V12, P473, DOI 10.1097/01.moh.0000177831.70657.e8; Burkatovskaya M, 2008, WOUND REPAIR REGEN, V16, P425, DOI 10.1111/j.1524-475X.2008.00382.x; Chung TY, 2010, PHOTOMED LASER SURG, V28, P251, DOI 10.1089/pho.2009.2493; Coppinger JA, 2007, BLOOD, V109, P4786, DOI 10.1182/blood-2006-07-038539; Demidova-Rice TN, 2011, WOUND REPAIR REGEN, V19, P59, DOI 10.1111/j.1524-475X.2010.00642.x; Durham JT, 2009, MICROVASC RES, V77, P281, DOI 10.1016/j.mvr.2008.12.003; Fonder MA, 2008, J AM ACAD DERMATOL, V58, P185, DOI 10.1016/j.jaad.2007.08.048; HAWRYLOWICZ CM, 1991, J EXP MED, V174, P785, DOI 10.1084/jem.174.4.785; HEALY AM, 1992, EXP EYE RES, V55, P663, DOI 10.1016/0014-4835(92)90171-N; Horn P, 2010, CYTOTHERAPY, V12, P888, DOI 10.3109/14653249.2010.501788; Hostetler SG, 2006, WOUNDS, V18, P340; Imegwu Obi, 1997, Wound Repair and Regeneration, V5, P364, DOI 10.1046/j.1460-9568.1997.50411.x; Liu L, 2006, INVEST OPHTH VIS SCI, V47, P2438, DOI 10.1167/iovs.05-0876; Malinda KM, 2008, INT J BIOCHEM CELL B, V40, P2771, DOI 10.1016/j.biocel.2008.05.025; Nurden AT, 2011, THROMB HAEMOST S1; O'Connor R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/107859; Reid RR, 2004, J AM COLL SURGEONS, V199, P578, DOI 10.1016/j.jamcollsurg.2004.05.262; Rhee JS, 2004, THROMB HAEMOSTASIS, V92, P394, DOI 10.1160/TH03-04-0213; Roedersheimer M, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-4; Sharma A, 2006, J INVEST DERMATOL, V126, P2323, DOI 10.1038/sj.jid.5700428; Shuster CB, 1996, CELL MOTIL CYTOSKEL, V35, P175; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Ye J, 2008, GRAEF ARCH CLIN EXP, V246, P217, DOI 10.1007/s00417-007-0716-0	25	51	56	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32146	10.1371/journal.pone.0032146	http://dx.doi.org/10.1371/journal.pone.0032146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384158	Green Submitted, Green Published, gold			2022-12-27	WOS:000302916100054
J	Endo, Y; Zhang, MJ; Yamaji, S; Cang, Y				Endo, Yoko; Zhang, Mingjun; Yamaji, Sachie; Cang, Yong			Genetic Abolishment of Hepatocyte Proliferation Activates Hepatic Stem Cells	PLOS ONE			English	Article							LIVER-REGENERATION; PROGENITOR CELLS; MOUSE-LIVER; OVAL CELLS; SURFACE-MARKERS; DNA-DAMAGE; RAT-LIVER; DEGRADATION; EXPRESSION; DIFFERENTIATION	Quiescent hepatic stem cells (HSCs) can be activated when hepatocyte proliferation is compromised. Chemical injury rodent models have been widely used to study the localization, biomarkers, and signaling pathways in HSCs, but these models usually exhibit severe promiscuous toxicity and fail to distinguish damaged and non-damaged cells. Our goal is to establish new animal models to overcome these limitations, thereby providing new insights into HSC biology and application. We generated mutant mice with constitutive or inducible deletion of Damaged DNA Binding protein 1 (DDB1), an E3 ubiquitin ligase, in hepatocytes. We characterized the molecular mechanism underlying the compensatory activation and the properties of oval cells (OCs) by methods of mouse genetics, immuno-staining, cell transplantation and gene expression profiling. We show that deletion of DDB1 abolishes self-renewal capacity of mouse hepatocytes in vivo, leading to compensatory activation and proliferation of DDB1-expressing OCs. Partially restoring proliferation of DDB1-deficient hepatocytes by ablation of p21, a substrate of DDB1 E3 ligase, alleviates OC proliferation. Purified OCs express both hepatocyte and cholangiocyte markers, form colonies in vitro, and differentiate to hepatocytes after transplantation. Importantly, the DDB1 mutant mice exhibit very minor liver damage, compared to a chemical injury model. Microarray analysis reveals several previously unrecognized markers, including Reelin, enriched in oval cells. Here we report a genetic model in which irreversible inhibition of hepatocyte duplication results in HSC-driven liver regeneration. The DDB1 mutant mice can be broadly applied to studies of HSC differentiation, HSC niche and HSCs as origin of liver cancer.	[Endo, Yoko; Zhang, Mingjun; Yamaji, Sachie; Cang, Yong] Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA USA; [Cang, Yong] Zhejiang Univ, Inst Life Sci, Hangzhou 310027, Peoples R China	Sanford Burnham Prebys Medical Discovery Institute; Zhejiang University	Endo, Y (corresponding author), Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA USA.	ycang@sanfordburnham.org		Cang, Yong/0000-0002-1148-7008; Zhang, Mingjun/0000-0002-0641-1877	Japan Society for the Promotion of Science for Young Scientists; V Foundation for Cancer Research	Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); V Foundation for Cancer Research	This work was supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists (Y.E.) and V Foundation for Cancer Research (Y.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Akhurst B, 2001, HEPATOLOGY, V34, P519, DOI 10.1053/jhep.2001.26751; Alison MR, 2009, J PATHOL, V217, P282, DOI 10.1002/path.2453; Balzar M, 1999, J MOL MED, V77, P699, DOI 10.1007/s001099900038; Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Braun S, 2011, CELL, V144, P41, DOI 10.1016/j.cell.2010.11.051; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Cang Y, 2006, CELL, V127, P929, DOI 10.1016/j.cell.2006.09.045; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; ENGELHARDT NV, 1993, DIFFERENTIATION, V55, P19, DOI 10.1111/j.1432-0436.1993.tb00029.x; FACTOR VM, 1993, EXP TOXICOL PATHOL, V45, P239, DOI 10.1016/S0940-2993(11)80399-4; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; Fonia O, 1996, HEPATOLOGY, V24, P697, DOI 10.1053/jhep.1996.v24.pm0008781345; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Jackson S, 2009, TRENDS BIOCH SCI; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Kobold D, 2002, J HEPATOL, V36, P607, DOI 10.1016/S0168-8278(02)00050-8; Kofman AV, 2005, HEPATOLOGY, V41, P1252, DOI 10.1002/hep.20696; LAISHES BA, 1981, CANCER RES, V41, P1731; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mishra L, 2009, HEPATOLOGY, V49, P318, DOI 10.1002/hep.22704; Ochsner SA, 2007, STEM CELLS, V25, P2476, DOI 10.1634/stemcells.2007-0101; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Preisegger KH, 1999, LAB INVEST, V79, P103; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rountree CB, 2007, STEM CELLS, V25, P2419, DOI 10.1634/stemcells.2007-0176; Sell S, 2001, HEPATOLOGY, V33, P738, DOI 10.1053/jhep.2001.21900; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Suzuki A, 2008, HEPATOLOGY, V48, P1964, DOI 10.1002/hep.22558; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Van den Heuvel MC, 2001, HEPATOLOGY, V33, P1387, DOI 10.1053/jhep.2001.24453; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Yamaji S, 2010, P NATL ACAD SCI USA, V107, P22237, DOI 10.1073/pnas.1015793108; Yovchev MI, 2008, HEPATOLOGY, V47, P636, DOI 10.1002/hep.22047; Yovchev MI, 2007, HEPATOLOGY, V45, P139, DOI 10.1002/hep.21448; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431	43	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31846	10.1371/journal.pone.0031846	http://dx.doi.org/10.1371/journal.pone.0031846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384083	gold, Green Published, Green Submitted			2022-12-27	WOS:000302916100035
J	Kiss, J; Nagy, B; Olasz, F				Kiss, Janos; Nagy, Bela; Olasz, Ferenc			Stability, Entrapment and Variant Formation of Salmonella Genomic Island 1	PLOS ONE			English	Article							MULTIPLE-ANTIBIOTIC-RESISTANCE; ENTERICA SEROVAR KENTUCKY; TYPHIMURIUM DT104; GENE-CLUSTER; SGI1; REGION; SEQUENCE; SALMONELLA-GENOMIC-ISLAND-1; AGONA; RECOMBINATION	Background: The Salmonella genomic island 1 (SGI1) is a 42.4 kb integrative mobilizable element containing several antibiotic resistance determinants embedded in a complex integron segment In104. The numerous SGI1 variants identified so far, differ mainly in this segment and the explanations of their emergence were mostly based on comparative structure analyses. Here we provide experimental studies on the stability, entrapment and variant formation of this peculiar gene cluster originally found in S. Typhimurium. Methodology/Principal Findings: Segregation and conjugation tests and various molecular techniques were used to detect the emerging SGI1 variants in Salmonella populations of 17 Salmonella enterica serovar Typhimurium DT104 isolates from Hungary. The SGI1s in these isolates proved to be fully competent in excision, conjugal transfer by the IncA/C helper plasmid R55, and integration into the E. coli chromosome. A trap vector has been constructed and successfully applied to capture the island on a plasmid. Monitoring of segregation of SGI1 indicated high stability of the island. SGI1-free segregants did not accumulate during long-term propagation, but several SGI1 variants could be obtained. Most of them appeared to be identical to SGI1-B and SGI1-C, but two new variants caused by deletions via a short-homology-dependent recombination process have also been detected. We have also noticed that the presence of the conjugation helper plasmid increased the formation of these deletion variants considerably. Conclusions/Significance: Despite that excision of SGI1 from the chromosome was proven in SGI1(+) Salmonella populations, its complete loss could not be observed. On the other hand, we demonstrated that several variants, among them two newly identified ones, arose with detectable frequencies in these populations in a short timescale and their formation was promoted by the helper plasmid. This reflects that IncA/C helper plasmids are not only involved in the horizontal spreading of SGI1, but may also contribute to its evolution.	[Kiss, Janos; Olasz, Ferenc] Agr Biotechnol Ctr, H-2101 Godollo, Hungary; [Nagy, Bela] Hungarian Acad Sci, Vet Med Res Inst, H-1581 Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute	Kiss, J (corresponding author), Agr Biotechnol Ctr, H-2101 Godollo, Hungary.	kissj@abc.hu		Kiss, Janos/0000-0002-0506-5474	EU [MedVetNet FP6-506122, WP21, CRAB LSH-2004-2.1.2-4]; Stipendium Bolyai of the Hungarian Academy of Sciences [BO/00326/09]	EU(European Commission); Stipendium Bolyai of the Hungarian Academy of Sciences	This work was supported by the EU FP6 program (MedVetNet FP6-506122, WP21 and CRAB LSH-2004-2.1.2-4). JK was also supported by the Stipendium Bolyai of the Hungarian Academy of Sciences (BO/00326/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2007, J ANTIMICROB CHEMOTH, V59, P184, DOI 10.1093/jac/dkl471; ALBERTINI AM, 1982, CELL, V29, P319, DOI 10.1016/0092-8674(82)90148-9; Boyd D, 2002, ANTIMICROB AGENTS CH, V46, P1714, DOI 10.1128/AAC.46.6.1714-1722.2002; Boyd D, 2001, J BACTERIOL, V183, P5725, DOI 10.1128/JB.183.19.5725-5732.2001; Boyd DA, 2000, FEMS MICROBIOL LETT, V189, P285, DOI 10.1111/j.1574-6968.2000.tb09245.x; Boyd DA, 2008, ANTIMICROB AGENTS CH, V52, P340, DOI 10.1128/AAC.00902-07; Cloeckaert A, 2006, ANTIMICROB AGENTS CH, V50, P3944, DOI 10.1128/AAC.00697-06; DALENCON E, 1994, EMBO J, V13, P2725, DOI 10.1002/j.1460-2075.1994.tb06563.x; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Djordjevic SP, 2009, ANTIMICROB AGENTS CH, V53, P2319, DOI 10.1128/AAC.01532-08; Douard G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015302; Doublet B, 2004, ANTIMICROB AGENTS CH, V48, P2510, DOI 10.1128/AAC.48.7.2510-2517.2004; Doublet B, 2005, MOL MICROBIOL, V55, P1911, DOI 10.1111/j.1365-2958.2005.04520.x; Doublet B, 2003, EMERG INFECT DIS, V9, P585, DOI 10.3201/eid0905.020609; Doublet B, 2004, ANTIMICROB AGENTS CH, V48, P3806, DOI 10.1128/AAC.48.10.3806-3812.2004; Doublet B, 2008, ANTIMICROB AGENTS CH, V52, P3745, DOI 10.1128/AAC.00525-08; Doublet B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002060; Fekete PZ, 2008, ACTA VET HUNG, V56, P5, DOI 10.1556/AVet.56.2008.1.2; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; GIBSON T, 1984, THESIS U CAMBRIDGE U; Golding GR, 2007, MICROBES INFECT, V9, P21, DOI 10.1016/j.micinf.2006.10.004; GONZYTREBOUL G, 1992, J MOL BIOL, V224, P967, DOI 10.1016/0022-2836(92)90463-T; Imre A, 2011, FEMS MICROBIOL LETT, V317, P52, DOI 10.1111/j.1574-6968.2011.02210.x; Kiss J, 1999, MOL MICROBIOL, V34, P37, DOI 10.1046/j.1365-2958.1999.01567.x; Levings RS, 2008, ANTIMICROB AGENTS CH, V52, P2529, DOI 10.1128/AAC.00189-08; Levings RS, 2007, ANTIMICROB AGENTS CH, V51, P317, DOI 10.1128/AAC.01229-06; Levings RS, 2005, J BACTERIOL, V187, P4401, DOI 10.1128/JB.187.13.4401-4409.2005; Lovett ST, 2002, GENETICS, V160, P851; Mather AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027220; Middendorf B, 2004, J BACTERIOL, V186, P3086, DOI 10.1128/JB.186.10.3086-3096.2004; Mulvey MR, 2006, MICROBES INFECT, V8, P1915, DOI 10.1016/j.micinf.2005.12.028; Partridge SR, 2003, ANTIMICROB AGENTS CH, V47, P342, DOI 10.1128/AAC.47.1.342-349.2003; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Quiroz TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026031; Sambrook J., 2002, MOL CLONING LAB MANU; Siebor E, 2011, J ANTIMICROB CHEMOTH, V66, P2513, DOI 10.1093/jac/dkr335; Szabo M, 1999, PLASMID, V42, P192, DOI 10.1006/plas.1999.1425; Threlfall EJ, 2000, J ANTIMICROB CHEMOTH, V46, P7, DOI 10.1093/jac/46.1.7; Vo ATT, 2007, J ANTIMICROB CHEMOTH, V59, P594, DOI 10.1093/jac/dkl531; Weill FX, 2005, ANTIMICROB AGENTS CH, V49, P2793, DOI 10.1128/AAC.49.7.2793-2801.2005; WESTONHAFER K, 1991, GENETICS, V127, P649; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000786	42	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32497	10.1371/journal.pone.0032497	http://dx.doi.org/10.1371/journal.pone.0032497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384263	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916100084
J	Ledford, JG; Mukherjee, S; Kislan, MM; Nugent, JL; Hollingsworth, JW; Wright, JR				Ledford, Julie G.; Mukherjee, Sambuddho; Kislan, Michele M.; Nugent, Julia L.; Hollingsworth, John W.; Wright, Jo Rae			Surfactant Protein-A Suppresses Eosinophil-Mediated Killing of Mycoplasma pneumoniae in Allergic Lungs	PLOS ONE			English	Article							B GENETIC-VARIANTS; RESPIRATORY-DISTRESS-SYNDROME; CHRONIC ASTHMA; INFLAMMATION; INFECTION; MICE; DEGRANULATION; PEROXIDASE; EXPRESSION; CHILDREN	Surfactant protein-A (SP-A) has well-established functions in reducing bacterial and viral infections but its role in chronic lung diseases such as asthma is unclear. Mycoplasma pneumoniae (Mp) frequently colonizes the airways of chronic asthmatics and is thought to contribute to exacerbations of asthma. Our lab has previously reported that during Mp infection of non-allergic airways, SP-A aides in maintaining airway homeostasis by inhibiting an overzealous TNF-alpha mediated response and, in allergic mice, SP-A regulates eosinophilic infiltration and inflammation of the airway. In the current study, we used an in vivo model with wild type (WT) and SP-A(-/-) allergic mice challenged with the model antigen ovalbumin (Ova) that were concurrently infected with Mp (Ova+Mp) to test the hypothesis that SP-A ameliorates Mp-induced stimulation of eosinophils. Thus, SP-A could protect allergic airways from injury due to release of eosinophil inflammatory products. SP-A deficient mice exhibit significant increases in inflammatory cells, mucus production and lung damage during concurrent allergic airway disease and infection (Ova+Mp) as compared to the WT mice of the same treatment group. In contrast, SP-A deficient mice have significantly decreased Mp burden compared to WT mice. The eosinophil specific factor, eosinophil peroxidase (EPO), which has been implicated in pathogen killing and also in epithelial dysfunction due to oxidative damage of resident lung proteins, is enhanced in samples from allergic/infected SP-A(-/-) mice as compared to WT mice. In vitro experiments using purified eosinophils and human SP-A suggest that SP-A limits the release of EPO from Mp-stimulated eosinophils thereby reducing their killing capacity. These findings are the first to demonstrate that although SP-A interferes with eosinophil-mediated biologic clearance of Mp by mediating the interaction of Mp with eosinophils, SP-A simultaneously benefits the airway by limiting inflammation and damage.	[Ledford, Julie G.; Mukherjee, Sambuddho; Kislan, Michele M.; Nugent, Julia L.; Wright, Jo Rae] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Ledford, Julie G.; Hollingsworth, John W.] Duke Univ, Med Ctr, Dept Pulm Allergy & Crit Care Med, Durham, NC USA; [Hollingsworth, John W.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA	Duke University; Duke University; Duke University	Ledford, JG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	j.ledford@cellbio.duke.edu			NIH [P01-AI81672, ES016126]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL091642, K99HL111151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI081672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016126] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by NIH grant to Jo Rae Wright, P01-AI81672, and ES016126 to John Hollingsworth. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Allergy A and Immunology (1996- 2011) Asthma Stastics, 1996, ASTHM STAST; Biscardi S, 2004, CLIN INFECT DIS, V38, P1341, DOI 10.1086/392498; Borelli V, 2003, INFECT IMMUN, V71, P605, DOI 10.1128/IAI.71.2.605-613.2003; Chu HW, 2005, J IMMUNOL, V174, P5713, DOI 10.4049/jimmunol.174.9.5713; Chu HW, 2003, CHEST, V123, p390S, DOI 10.1378/chest.123.3_suppl.390S; Chu HW, 2003, INFECT IMMUN, V71, P1520, DOI 10.1128/IAI.71.3.1520-1526.2003; Denzler KL, 2001, J IMMUNOL, V167, P1672, DOI 10.4049/jimmunol.167.3.1672; Erpenbeck VJ, 2009, N-S ARCH PHARMACOL, V379, P217, DOI 10.1007/s00210-008-0354-z; Erpenbeck VJ, 2006, ALLERGY, V61, P598, DOI 10.1111/j.1398-9995.2006.01062.x; Floros J, 2001, BIOL NEONATE, V80, P22, DOI 10.1159/000047173; Forbes E, 2004, J IMMUNOL, V172, P5664, DOI 10.4049/jimmunol.172.9.5664; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; GLEICH GJ, 1990, J ALLERGY CLIN IMMUN, V85, P422, DOI 10.1016/0091-6749(90)90151-S; Kannan TR, 2005, INFECT IMMUN, V73, P2828, DOI 10.1128/IAI.73.5.2828-2834.2005; Korfhagen TR, 1996, P NATL ACAD SCI USA, V93, P9594, DOI 10.1073/pnas.93.18.9594; Korsgren M, 1997, J EXP MED, V185, P885, DOI 10.1084/jem.185.5.885; Kraft M, 1998, AM J RESP CRIT CARE, V158, P998, DOI 10.1164/ajrccm.158.3.9711092; Kraft M, 2002, CHEST, V121, P1782, DOI 10.1378/chest.121.6.1782; Kraft M, 2006, J ALLERGY CLIN IMMUN, V117, P1197, DOI 10.1016/j.jaci.2006.03.001; Ledford JG, 2010, J IMMUNOL, V185, P3884, DOI 10.4049/jimmunol.1000387; Ledford JG, 2010, INNATE IMMUN-LONDON, V16, P183, DOI 10.1177/1753425910368446; Ledford JG, 2009, J IMMUNOL, V182, P7818, DOI 10.4049/jimmunol.0900452; Lee NA, 1997, J IMMUNOL, V158, P1332; Malherbe DC, 2005, AM J PHYSIOL-LUNG C, V289, pL856, DOI 10.1152/ajplung.00009.2005; Martin RJ, 2001, J ALLERGY CLIN IMMUN, V107, P595, DOI 10.1067/mai.2001.113563; Marttila R, 2003, AM J RESP CRIT CARE, V168, P1216, DOI 10.1164/rccm.200304-524OC; McIntosh JC, 1996, AM J PHYSIOL-LUNG C, V271, pL310, DOI 10.1152/ajplung.1996.271.2.L310; Ou Chun-Yen, 2008, Acta Paediatrica Taiwanica, V49, P14; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; Pastva AM, 2011, J IMMUNOL, V186, P2842, DOI 10.4049/jimmunol.0904190; Pegorier S, 2006, J IMMUNOL, V177, P4861, DOI 10.4049/jimmunol.177.7.4861; Pelaia G, 2006, RESP MED, V100, P775, DOI 10.1016/j.rmed.2005.08.025; Persson T, 2001, INFECT IMMUN, V69, P3591, DOI 10.1128/IAI.69.6.3591-3596.2001; Piboonpocanun S, 2005, J BIOL CHEM, V280, P9, DOI 10.1074/jbc.M411570200; Prevention CfDCa (2009-2010) Asthma, 2009, ASTHM; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Schagat TL, 2003, AM J PHYSIOL-LUNG C, V284, pL140, DOI 10.1152/ajplung.00125.2002; Schagat TL, 2001, J IMMUNOL, V166, P2727, DOI 10.4049/jimmunol.166.4.2727; Schmiedl A, 2009, INT ARCH ALLERGY IMM, V148, P118, DOI 10.1159/000155742; Selman M, 2003, HUM GENET, V113, P542, DOI 10.1007/s00439-003-1015-4; Thomas NJ, 2009, PEDIATR RES, V66, P70, DOI 10.1203/PDR.0b013e3181a1d768; Tino MJ, 1999, AM J RESP CELL MOL, V20, P759, DOI 10.1165/ajrcmb.20.4.3439; Verjan Garcia N, 2011, J IMMUNOL; von Bredow C, 2006, CLIN EXP ALLERGY, V36, P1566, DOI 10.1111/j.1365-2222.2006.02598.x; Wang Y, 2011, AM J PHYSL LUNG CELL	46	25	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32436	10.1371/journal.pone.0032436	http://dx.doi.org/10.1371/journal.pone.0032436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384248	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100080
J	Trowbridge, AM; Asensio, D; Eller, ASD; Way, DA; Wilkinson, MJ; Schnitzler, JP; Jackson, RB; Monson, RK				Trowbridge, Amy M.; Asensio, Dolores; Eller, Allyson S. D.; Way, Danielle A.; Wilkinson, Michael J.; Schnitzler, Joerg-Peter; Jackson, Robert B.; Monson, Russell K.			Contribution of Various Carbon Sources Toward Isoprene Biosynthesis in Poplar Leaves Mediated by Altered Atmospheric CO2 Concentrations	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; EMISSION RATE; PHOSPHATE TRANSLOCATORS; INTACT LEAVES; ASPEN LEAVES; PTR-MS; (CO2)-C-13; PLANTS; METABOLISM; PATHWAY	Biogenically released isoprene plays important roles in both tropospheric photochemistry and plant metabolism. We performed a (CO2)-C-13-labeling study using proton-transfer-reaction mass spectrometry (PTR-MS) to examine the kinetics of recently assimilated photosynthate into isoprene emitted from poplar (Populus x canescens) trees grown and measured at different atmospheric CO2 concentrations. This is the first study to explicitly consider the effects of altered atmospheric CO2 concentration on carbon partitioning to isoprene biosynthesis. We studied changes in the proportion of labeled carbon as a function of time in two mass fragments, M41(+), which represents, in part, substrate derived from pyruvate, and M69(+), which represents the whole unlabeled isoprene molecule. We observed a trend of slower C-13 incorporation into isoprene carbon derived from pyruvate, consistent with the previously hypothesized origin of chloroplastic pyruvate from cytosolic phosphenolpyruvate (PEP). Trees grown under sub-ambient CO2 (190 ppmv) had rates of isoprene emission and rates of labeling of M41(+) and M69(+) that were nearly twice those observed in trees grown under elevated CO2 (590 ppmv). However, they also demonstrated the lowest proportion of completely labeled isoprene molecules. These results suggest that under reduced atmospheric CO2 availability, more carbon from stored/older carbon sources is involved in isoprene biosynthesis, and this carbon most likely enters the isoprene biosynthesis pathway through the pyruvate substrate. We offer direct evidence that extra-chloroplastic rather than chloroplastic carbon sources are mobilized to increase the availability of pyruvate required to up-regulate the isoprene biosynthesis pathway when trees are grown under sub-ambient CO2.	[Trowbridge, Amy M.; Asensio, Dolores; Eller, Allyson S. D.; Wilkinson, Michael J.; Monson, Russell K.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Eller, Allyson S. D.; Monson, Russell K.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Schnitzler, Joerg-Peter] Helmholtz Zentrum Munchen, Inst Biochem Plant Pathol, Res Unit Environm Simulat, Neuherberg, Germany; [Jackson, Robert B.] Duke Univ, Dept Biol, Nicholas Sch Environm, Durham, NC USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Duke University	Trowbridge, AM (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	amy.m.trowbridge@gmail.com	Asensio, Dolores/I-3383-2016; Schnitzler, Joerg-Peter/C-5268-2011; Way, Danielle/AAY-6395-2021; Way, Danielle A/N-1867-2014; Eller, Allyson/I-7021-2012	Asensio, Dolores/0000-0002-7622-1200; Schnitzler, Joerg-Peter/0000-0002-9825-867X; Way, Danielle/0000-0003-4801-5319; Way, Danielle A/0000-0003-4801-5319; Eller, Allyson/0000-0003-3125-5658; Trowbridge, Amy/0000-0001-8993-2530; Jackson, Robert/0000-0001-8846-7147	Human Frotiers in Science Program in Strasbourg, France; U.S. Department of Energy [ER64242]	Human Frotiers in Science Program in Strasbourg, France; U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by Human Frotiers in Science Program in Strasbourg, France http://www.hfsp.org/, and the U.S. Department of Energy (Program in Ecosystem Research #ER64242) http://per.ornl.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behnke K, 2007, PLANT J, V51, P485, DOI 10.1111/j.1365-313X.2007.03157.x; Brilli F, 2007, NEW PHYTOL, V175, P244, DOI 10.1111/j.1469-8137.2007.02094.x; Cegelski L, 2006, J MAGN RESON, V178, P1, DOI 10.1016/j.jmr.2005.10.010; DELWICHE CF, 1993, PLANT CELL ENVIRON, V16, P587, DOI 10.1111/j.1365-3040.1993.tb00907.x; Fehsenfeld F, 1992, GLOBAL BIOGEOCHEM CY, V6, P389, DOI 10.1029/92GB02125; Fischer K, 1997, PLANT CELL, V9, P453, DOI 10.1105/tpc.9.3.453; Flugge UI, 1999, ANNU REV PLANT PHYS, V50, P27, DOI 10.1146/annurev.arplant.50.1.27; Fuentes JD, 2000, B AM METEOROL SOC, V81, P1537, DOI 10.1175/1520-0477(2000)081<1537:BHITAB>2.3.CO;2; Funk JL, 2004, PLANT CELL ENVIRON, V27, P747, DOI 10.1111/j.1365-3040.2004.01177.x; Ghirardo A, 2010, PLANT CELL ENVIRON, V33, P781, DOI 10.1111/j.1365-3040.2009.02104.x; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Guenther A., 2006, ATMOS CHEM PHYS, V6, P3181, DOI [10.5194/acp-6-3181-2006, DOI 10.5194/ACP-6-3181-2006, DOI 10.5194/ACPD-6-107-2006]; Guenther A.B., 1993, J GEOPHYS RES, V98, P609, DOI DOI 10.1029/93JD00527; GUENTHER AB, 1991, J GEOPHYS RES-ATMOS, V96, P10799, DOI 10.1029/91JD00960; Harley PC, 1999, OECOLOGIA, V118, P109, DOI 10.1007/s004420050709; Hasunuma T, 2010, J EXP BOT, V61, P1041, DOI 10.1093/jxb/erp374; Heald CL, 2009, GLOBAL CHANGE BIOL, V15, P1127, DOI 10.1111/j.1365-2486.2008.01802.x; Karl T, 2002, PLANTA, V215, P894, DOI 10.1007/s00425-002-0825-2; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Lindinger W, 1998, CHEM SOC REV, V27, P347, DOI 10.1039/a827347z; Logan BA, 2000, TRENDS PLANT SCI, V5, P477, DOI 10.1016/S1360-1385(00)01765-9; LORETO F, 1990, PLANTA, V182, P523, DOI 10.1007/BF02341027; Loreto F, 1996, PLANT PHYSIOL, V110, P1317, DOI 10.1104/pp.110.4.1317; Loreto F, 2007, PLANT CELL ENVIRON, V30, P662, DOI 10.1111/j.1365-3040.2007.01648.x; MONSON RK, 1989, PLANT PHYSIOL, V90, P267, DOI 10.1104/pp.90.1.267; Monson RK, 2007, PHILOS T R SOC A, V365, P1677, DOI 10.1098/rsta.2007.2038; Possell M, 2011, GLOBAL CHANGE BIOL, V17, P1595, DOI 10.1111/j.1365-2486.2010.02306.x; Rasulov B, 2009, PLANT PHYSIOL, V151, P448, DOI 10.1104/pp.109.141978; Rasulov B, 2009, PLANT PHYSIOL, V149, P1609, DOI 10.1104/pp.108.133512; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Rontein D, 2002, J BIOL CHEM, V277, P43948, DOI 10.1074/jbc.M206366200; Rosenstiel TN, 2004, PLANT BIOLOGY, V6, P12, DOI 10.1055/s-2003-44722; Rosenstiel TN, 2003, NATURE, V421, P256, DOI 10.1038/nature01312; Sanadze GA, 1964, PHOTOSYNTH RES, V2, P701; Schnitzler JP, 2004, PLANT PHYSIOL, V135, P152, DOI 10.1104/pp.103.037374; Scholefield PA, 2004, PLANT CELL ENVIRON, V27, P393, DOI 10.1111/j.1365-3040.2003.01155.x; Sharkey TD, 2001, ANNU REV PLANT PHYS, V52, P407, DOI 10.1146/annurev.arplant.52.1.407; Wilkinson MJ, 2009, GLOBAL CHANGE BIOL, V15, P1189, DOI 10.1111/j.1365-2486.2008.01803.x	38	35	38	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32387	10.1371/journal.pone.0032387	http://dx.doi.org/10.1371/journal.pone.0032387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384238	Green Submitted, Green Published, gold			2022-12-27	WOS:000302916100077
J	Williams, PT				Williams, Paul T.			Attenuating Effect of Vigorous Physical Activity on the Risk for Inherited Obesity: A Study of 47,691 Runners	PLOS ONE			English	Article							BODY-MASS INDEX; WEIGHT-GAIN; WAIST CIRCUMFERENCE; EXERCISE; FAT; ASSOCIATION; ADIPOSITY; AGE; LIPOPROTEINS; METAANALYSIS	Objective: Physical activity has been shown to attenuate the effect of the FTO polymorphism on body weight, and the heritability of body weight in twin and in family studies. The dose-response relationship between activity and the risk for inherited obesity is not well known, particularly for higher doses of vigorous exercise. Such information is needed to best prescribe an exercise dose for obesity prevention in those at risk due to their family history. Design: We therefore analyzed self-reported usual running distance, body mass index (BMI), waist circumference, and mother's and father's adiposity (1 = lean, 2 = normal, 3 = overweight, and 4 = very overweight) from survey data collected on 33,480 male and 14,211 female runners. Age-, education-, and alcohol-adjusted regression analyses were used to estimate the contribution of parental adiposities to the BMI and waist circumferences in runners who ran an average of <3, 3-6, 6-9, >= 9 km/day. Results: BMI and waist circumferences of runners who ran <3 km/day were significantly related to their parents adiposity (P<10(-15) and P<10(-11), respectively). These relationships (i.e., kg/m(2) or cm per increment in parental adiposity) diminished significantly with increasing running distance for both BMI (inheritancexexercise interaction, males: P<10(-10); females: P<10 25) and waist circumference (inheritancexexercise interaction, males: P<10(-9); females: P = 0.004). Compared to <3 km/day, the parental contribution to runners who averaged >= 9 km/day was diminished by 48% for male BMI, 58% for female BMI, 55% for male waist circumference, and 58% for female waist circumference. These results could not be attributed to self-selection. Conclusions: Exceeding the minimum exercise dose currently recommended for general health benefits (energy equivalent to running 2-3 km/day) may substantially diminish the risk for inherited obesity. The results are consistent with other research suggesting the physical activity dose required to prevent unhealthy weight gain is greater than that recommended for other health benefits.	Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Donner Lab, Div Life Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Williams, PT (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Donner Lab, Div Life Sci, Berkeley, CA 94720 USA.	ptwilliams@lbl.gov			National Heart, Lung, and Blood Institute [HL094717]; Institute of Aging [AG032004]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG032004] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Institute of Aging; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grant HL094717 from the National Heart, Lung, and Blood Institute and AG032004 from the Institute of Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Bjorntorp P, 1999, DRUGS, V58, P13; BORAHGIDDENS J, 1993, J NUTR EDUC, V25, P102; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; Erlichman J, 2002, Obes Rev, V3, P273, DOI 10.1046/j.1467-789X.2002.00078.x; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Francis LA, 2003, OBES RES, V11, P143, DOI 10.1038/oby.2003.23; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Institute of Medicine, 2005, DIET REF INT EN CARB, P880; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Juhan-Vague I, 2002, PATHOPHYSIOL HAEMO T, V32, P269, DOI 10.1159/000073579; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Martins C, 2008, P NUTR SOC, V67, P28, DOI 10.1017/S0029665108005995; McCaffery JM, 2009, AM J CLIN NUTR, V89, P1011, DOI 10.3945/ajcn.2008.27170; OLIVERIA SA, 1992, AM J CLIN NUTR, V56, P593, DOI 10.1093/ajcn/56.3.593; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; POULIOT MC, 1989, METABOLISM, V38, P1244, DOI 10.1016/0026-0495(89)90166-2; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; ROMIJN JA, 1993, J APPL PHYSIOL, V75, P108, DOI 10.1152/jappl.1993.75.1.108; Samaras K, 1997, INT J OBESITY, V21, P839, DOI 10.1038/sj.ijo.0800502; Scott RA, 2010, EUR J HUM GENET, V18, P1339, DOI 10.1038/ejhg.2010.131; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spiegelman D, 2005, STAT MED, V24, P1657, DOI 10.1002/sim.2055; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Sudi KM, 2000, J PEDIATR ENDOCR MET, V13, P505; Summerbell CD, 2009, INT J OBESITY, V33, pS1, DOI 10.1038/ijo.2009.80; Vimaleswaran KS, 2009, AM J CLIN NUTR, V90, P425, DOI 10.3945/ajcn.2009.27652; Waller K, 2008, INT J OBESITY, V32, P353, DOI 10.1038/sj.ijo.0803692; Williams PT, 2007, INT J OBESITY, V31, P652, DOI 10.1038/sj.ijo.0803457; Williams P. T., 2011, Medicine and Science in Sports & Exercise, V43, P2120, DOI 10.1249/MSS.0b013e31821cd128; Williams PT, 2008, MED SCI SPORT EXER, V40, P296, DOI 10.1249/mss.0b013e31815b6475; Williams PT, 2007, ARTERIOSCL THROM VAS, V27, P1811, DOI 10.1161/ATVBAHA.107.141853; Williams PT, 2007, MED SCI SPORT EXER, V39, P801, DOI 10.1249/mss.0b013e31803349b1; Williams PT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027657; Williams PT, 2009, OBESITY, V17, P1428, DOI 10.1038/oby.2008.680; Williams PT, 2005, OBES RES, V13, P1370, DOI 10.1038/oby.2005.166; Williams PT, 2005, MED SCI SPORT EXER, V37, P1329, DOI 10.1249/01.mss.0000174894.05236.45; Williams PT, 2005, CIRCULATION, V112, P350, DOI 10.1161/CIRCULATIONAHA.105.534578; Williams PT, 2004, INT J OBESITY, V28, P120, DOI 10.1038/sj.ijo.0802480; Williams PT, 2011, OBESITY SILVER SPRIN, DOI [10.1038/oby.2011.313, DOI 10.1038/OBY.2011.313.]	44	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31436	10.1371/journal.pone.0031436	http://dx.doi.org/10.1371/journal.pone.0031436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384023	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100023
J	Jacobs, RHAH; Renken, R; Cornelissen, FW				Jacobs, Richard H. A. H.; Renken, Remco; Cornelissen, Frans W.			Neural Correlates of Visual Aesthetics - Beauty as the Coalescence of Stimulus and Internal State	PLOS ONE			English	Article							TACTILE PERCEPTION; MINDS EYE; CORTEX; FMRI; SELF; NEUROSCIENCE; JUDGMENT; REGIONS; TOUCH; FORM	How do external stimuli and our internal state coalesce to create the distinctive aesthetic pleasures that give vibrance to human experience? Neuroaesthetics has so far focused on the neural correlates of observing beautiful stimuli compared to neutral or ugly stimuli, or on neural correlates of judging for beauty as opposed to other judgments. Our group questioned whether this approach is sufficient. In our view, a brain region that assesses beauty should show beauty-level-dependent activation during the beauty judgment task, but not during other, unrelated tasks. We therefore performed an fMRI experiment in which subjects judged visual textures for beauty, naturalness and roughness. Our focus was on finding brain activation related to the rated beauty level of the stimuli, which would take place exclusively during the beauty judgment. An initial whole-brain analysis did not reveal such interactions, yet a number of the regions showing main effects of the judgment task or the beauty level of stimuli were selectively sensitive to beauty level during the beauty task. Of the regions that were more active during beauty judgments than roughness judgments, the frontomedian cortex and the amygdala demonstrated the hypothesized interaction effect, while the posterior cingulate cortex did not. The latter region, which only showed a task effect, may play a supporting role in beauty assessments, such as attending to one's internal state rather than the external world. Most of the regions showing interaction effects of judgment and beauty level correspond to regions that have previously been implicated in aesthetics using different stimulus classes, but based on either task or beauty effects alone. The fact that we have now shown that task-stimulus interactions are also present during the aesthetic judgment of visual textures implies that these areas form a network that is specifically devoted to aesthetic assessment, irrespective of the stimulus type.	[Jacobs, Richard H. A. H.; Renken, Remco; Cornelissen, Frans W.] Univ Groningen, Univ Med Ctr Groningen, Sch Behav & Cognit Neurosci, Lab Expt Ophthalmol, Groningen, Netherlands; [Jacobs, Richard H. A. H.; Renken, Remco; Cornelissen, Frans W.] Univ Groningen, Univ Med Ctr Groningen, Sch Behav & Cognit Neurosci, BCN NeuroImaging Ctr, Groningen, Netherlands	University of Groningen; University of Groningen	Jacobs, RHAH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Sch Behav & Cognit Neurosci, Lab Expt Ophthalmol, Groningen, Netherlands.	richardjacobs01@hotmail.com		Renken, Remco Jan/0000-0002-7777-9484	European Commission [043157]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by a grant from the European Commission, under contract #043157 (Syntex). http://cordis.europa.eu/home_en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Calvo-Merino B, 2008, CONSCIOUS COGN, V17, P911, DOI 10.1016/j.concog.2007.11.003; Cant JS, 2007, CEREB CORTEX, V17, P713, DOI 10.1093/cercor/bhk022; Cant JS, 2009, EXP BRAIN RES, V192, P391, DOI 10.1007/s00221-008-1573-8; Cunningham WA, 2008, PSYCHOL SCI, V19, P152, DOI 10.1111/j.1467-9280.2008.02061.x; Di Dio C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001201; Fiedler K, 2011, PERSPECT PSYCHOL SCI, V6, P163, DOI 10.1177/1745691611400237; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hofel L, 2003, PERCEPT MOTOR SKILL, V96, P30, DOI 10.2466/pms.2003.96.1.30; Ishizu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021852; Jacobs RHAH, 2012, AESTHETICS NUM UNPUB; Jacobsen T, 2006, NEUROIMAGE, V29, P276, DOI 10.1016/j.neuroimage.2005.07.010; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Merabet L, 2004, NEURON, V42, P173, DOI 10.1016/S0896-6273(04)00147-3; Merabet LB, 2007, J NEUROPHYSIOL, V97, P1633, DOI 10.1152/jn.00806.2006; MORDKOFF AM, 1963, J VERB LEARN VERB BE, V2, P504, DOI 10.1016/S0022-5371(63)80057-2; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rolls ET, 2003, CEREB CORTEX, V13, P308, DOI 10.1093/cercor/13.3.308; Sathian K, 1997, NEUROREPORT, V8, P3877, DOI 10.1097/00001756-199712220-00008; Sathian K, 2002, BEHAV BRAIN RES, V135, P127, DOI 10.1016/S0166-4328(02)00141-9; Sathian K, 2005, DEV PSYCHOBIOL, V46, P279, DOI 10.1002/dev.20056; Vartanian O, 2004, NEUROREPORT, V15, P893, DOI 10.1097/00001756-200404090-00032; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Zhang MM, 2004, COGN AFFECT BEHAV NE, V4, P251, DOI 10.3758/CABN.4.2.251; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	30	42	44	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31248	10.1371/journal.pone.0031248	http://dx.doi.org/10.1371/journal.pone.0031248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZZ	22384006	gold, Green Published, Green Submitted			2022-12-27	WOS:000302875500016
J	Magee, DA; Taraktsoglou, M; Killick, KE; Nalpas, NC; Browne, JA; Park, SDE; Conlon, KM; Lynn, DJ; Hokamp, K; Gordon, SV; Gormley, E; MacHugh, DE				Magee, David A.; Taraktsoglou, Maria; Killick, Kate E.; Nalpas, Nicolas C.; Browne, John A.; Park, Stephen D. E.; Conlon, Kevin M.; Lynn, David J.; Hokamp, Karsten; Gordon, Stephen V.; Gormley, Eamonn; MacHugh, David E.			Global Gene Expression and Systems Biology Analysis of Bovine Monocyte-Derived Macrophages in Response to In Vitro Challenge with Mycobacterium bovis	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; INNATE IMMUNITY; INTERFERON-GAMMA; 19-KDA LIPOPROTEIN; ADAPTIVE IMMUNITY; IFN-GAMMA; TUBERCULOSIS; INHIBITION; INFECTION; MECHANISM	Background: Mycobacterium bovis, the causative agent of bovine tuberculosis, is a major cause of mortality in global cattle populations. Macrophages are among the first cell types to encounter M. bovis following exposure and the response elicited by these cells is pivotal in determining the outcome of infection. Here, a functional genomics approach was undertaken to investigate global gene expression profiles in bovine monocyte-derived macrophages (MDM) purified from seven age-matched non-related females, in response to in vitro challenge with M. bovis (multiplicity of infection 2:1). Total cellular RNA was extracted from non-challenged control and M. bovis-challenged MDM for all animals at intervals of 2 hours, 6 hours and 24 hours post-challenge and prepared for global gene expression analysis using the Affymetrix (R) GeneChip (R) Bovine Genome Array. Results: Comparison of M. bovis-challenged MDM gene expression profiles with those from the non-challenged MDM controls at each time point identified 3,064 differentially expressed genes 2 hours post-challenge, with 4,451 and 5,267 differentially expressed genes detected at the 6 hour and 24 hour time points, respectively (adjusted P-value threshold <= 0.05). Notably, the number of downregulated genes exceeded the number of upregulated genes in the M. bovis-challenged MDM across all time points; however, the fold-change in expression for the upregulated genes was markedly higher than that for the downregulated genes. Systems analysis revealed enrichment for genes involved in: (1) the inflammatory response; (2) cell signalling pathways, including Toll-like receptors and intracellular pathogen recognition receptors; and (3) apoptosis. Conclusions: The increased number of downregulated genes is consistent with previous studies showing that M. bovis infection is associated with the repression of host gene expression. The results also support roles for MyD88-independent signalling and intracellular PRRs in mediating the host response to M. bovis.	[Magee, David A.; Taraktsoglou, Maria; Killick, Kate E.; Nalpas, Nicolas C.; Browne, John A.; Park, Stephen D. E.; Gordon, Stephen V.; MacHugh, David E.] Univ Coll Dublin, UCD Sch Agr & Food Sci, Anim Genom Lab, Dublin 2, Ireland; [Gormley, Eamonn] Univ Coll Dublin, UCD Sch Vet Med, TB Diagnost & Immunol Res Ctr, Dublin 2, Ireland; [Lynn, David J.] TEAGASC, Anim Biosci Ctr, Dunsany, Meath, Ireland; [Hokamp, Karsten] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Gordon, Stephen V.; MacHugh, David E.] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Dublin 2, Ireland	University College Dublin; University College Dublin; Teagasc; Trinity College Dublin; University College Dublin	Magee, DA (corresponding author), Univ Coll Dublin, UCD Sch Agr & Food Sci, Anim Genom Lab, Dublin 2, Ireland.	david.machugh@ucd.ie	Conlon, Kevin M/G-2533-2013; Gormley, Eamonn/AAU-6678-2020	Conlon, Kevin M/0000-0002-4365-3955; Gormley, Eamonn/0000-0003-3900-0393; Browne, John/0000-0002-7698-9834; Nalpas, Nicolas/0000-0002-7255-6214; Gordon, Stephen/0000-0002-4833-5542; Lynn, David/0000-0003-4664-1404; MacHugh, David/0000-0002-8112-4704; Hokamp, Karsten/0000-0001-7464-2370	Science Foundation Ireland [SFI/01/F.1/B028, SFI/08/IN.1/B2038]; Department of Agriculture, Fisheries and Food [RSF 06 405]; European Union [KBBE-211602-MACROSYS]; Irish Research Council for Science, Engineering and Technology (IRCSET); Bioinformatics and Systems Biology	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Department of Agriculture, Fisheries and Food; European Union(European Commission); Irish Research Council for Science, Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); Bioinformatics and Systems Biology	This work was funded by the following sources: Science Foundation Ireland (www.sfi.ie) Investigator grants (Nos: SFI/01/F.1/B028 and SFI/08/IN.1/B2038); Department of Agriculture, Fisheries and Food (www.agriculture.ie) Research Stimulus Grant (No: RSF 06 405); European Union Framework 7 (http://cordis.europa.eu/fp7) Project Grant (No: KBBE-211602-MACROSYS); Irish Research Council for Science, Engineering and Technology (IRCSET) funded Bioinformatics and Systems Biology PhD Programme (http://bioinfo-casl.ucd.ie/PhD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergeron A, 1997, J IMMUNOL, V159, P3034; Bezuidenhout J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004228; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brooks MN, 2011, CELL MICROBIOL, V13, P402, DOI 10.1111/j.1462-5822.2010.01544.x; Cheallaigh CN, 2011, CLIN EXP IMMUNOL, V164, P291, DOI 10.1111/j.1365-2249.2011.04381.x; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Dasgupta A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012225; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; Denis M, 2007, TUBERCULOSIS, V87, P53, DOI 10.1016/j.tube.2006.03.005; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Dhiman R, 2011, J IMMUNOL, V186, P1638, DOI 10.4049/jimmunol.1003146; Ding AH, 2005, IMMUNOLOGY, V116, P381, DOI 10.1111/j.1365-2567.2005.02238.x; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Ferrer NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012978; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Fortune SM, 2004, J IMMUNOL, V172, P6272, DOI 10.4049/jimmunol.172.10.6272; Galindo RC, 2009, VET IMMUNOL IMMUNOP, V129, P119, DOI 10.1016/j.vetimm.2008.12.012; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Haddad JJ, 2003, CELL SIGNAL, V15, P255, DOI 10.1016/S0898-6568(02)00075-X; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hestvik ALK, 2005, FEMS MICROBIOL REV, V29, P1041, DOI 10.1016/j.femsre.2005.04.013; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; JACOBSEN CN, 1993, VET IMMUNOL IMMUNOP, V39, P461, DOI 10.1016/0165-2427(93)90075-F; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Jozefowski S, 2008, BIOESSAYS, V30, P943, DOI 10.1002/bies.20815; Kabara E, 2010, BRIEF FUNCT GENOMICS, V9, P220, DOI 10.1093/bfgp/elq009; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelly DM, 2008, INFECT IMMUN, V76, P351, DOI 10.1128/IAI.00614-07; Killick KE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-611; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Li AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011066; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lukey PT, 2001, MYCOBACTERIUM TUBERC, P403; MASAKI S, 1990, MICROBIOL IMMUNOL, V34, P653, DOI 10.1111/j.1348-0421.1990.tb01041.x; Meade KG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-400; Monroe KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000665; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Nagabhushanam V, 2003, J IMMUNOL, V171, P4750, DOI 10.4049/jimmunol.171.9.4750; Netea MG, 2004, TRENDS MICROBIOL, V12, P484, DOI 10.1016/j.tim.2004.09.004; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Okamura H, 1998, CURR OPIN IMMUNOL, V10, P259, DOI 10.1016/S0952-7915(98)80163-5; Pai RK, 2003, J IMMUNOL, V171, P175, DOI 10.4049/jimmunol.171.1.175; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Pollock JM, 2005, VET IMMUNOL IMMUNOP, V108, P37, DOI 10.1016/j.vetimm.2005.08.012; Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016; Rad R, 2009, GASTROENTEROLOGY, V136, P2247, DOI 10.1053/j.gastro.2009.02.066; Rivero-Lezcano OM, 2010, CLIN EXP IMMUNOL, V162, P289, DOI 10.1111/j.1365-2249.2010.04168.x; Rolland SG, 2010, CURR OPIN CELL BIOL, V22, P852, DOI 10.1016/j.ceb.2010.07.014; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SAFRAN M, 2010, GENECARDS VERSION 3, pAQ20; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; SATTLER TH, 1948, J BACTERIOL, V56, P235, DOI 10.1128/JB.56.2.235-243.1948; Saukkonen JJ, 2002, INFECT IMMUN, V70, P1684, DOI 10.1128/IAI.70.4.1684-1693.2002; Shi SAP, 2003, J EXP MED, V198, P987, DOI 10.1084/jem.20030603; Silver RF, 2009, AM J RESP CELL MOL, V40, P491, DOI 10.1165/rcmb.2008-0219OC; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Talloen W, 2007, BIOINFORMATICS, V23, P2897, DOI 10.1093/bioinformatics/btm478; Taraktsoglou M, 2011, VET IMMUNOL IMMUNOP, V140, P130, DOI 10.1016/j.vetimm.2010.12.002; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tourneur L, 2010, TRENDS IMMUNOL, V31, P260, DOI 10.1016/j.it.2010.05.005; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; VanHeyningen TK, 1997, J IMMUNOL, V158, P330; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wang Y, 2011, FEMS MICROBIOL LETT, V321, P30, DOI 10.1111/j.1574-6968.2011.02304.x; Waters W Ray, 2011, Clin Dev Immunol, V2011, P768542, DOI 10.1155/2011/768542; Weiss DJ, 2008, VET PATHOL, V45, P829, DOI 10.1354/vp.45-6-829; Welin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020302; Widdison S, 2006, CLIN EXP IMMUNOL, V144, P281, DOI 10.1111/j.1365-2249.2006.03053.x; Widdison S, 2007, VET IMMUNOL IMMUNOP, V117, P302, DOI 10.1016/j.vetimm.2007.01.016; Widdison S, 2011, DEV COMP IMMUNOL, V35, P580, DOI 10.1016/j.dci.2011.01.001; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Xu Y, 2008, AUTOPHAGY, V4, P110, DOI 10.4161/auto.5225	90	38	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32034	10.1371/journal.pone.0032034	http://dx.doi.org/10.1371/journal.pone.0032034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384131	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500066
J	Nielsen, N; Odum, N; Urso, B; Lanier, LL; Spee, P				Nielsen, Natasja; Odum, Niels; Urso, Birgitte; Lanier, Lewis L.; Spee, Pieter			Cytotoxicity of CD56(bright) NK Cells towards Autologous Activated CD4(+) T Cells Is Mediated through NKG2D, LFA-1 and TRAIL and Dampened via CD94/NKG2A	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DENDRITIC CELLS; LIGAND EXPRESSION; IN-VIVO; DEPENDENT ACTIVATION; MULTIPLE-SCLEROSIS; ARTHRITIS PATIENTS; PERIPHERAL-BLOOD; RAPID INDUCTION; CUTTING EDGE	In mouse models of chronic inflammatory diseases, Natural Killer (NK) cells can play an immunoregulatory role by eliminating chronically activated leukocytes. Indirect evidence suggests that NK cells may also be immunoregulatory in humans. Two subsets of human NK cells can be phenotypically distinguished as CD16(+)CD56(dim) and CD16(dim/-)D56(bright). An expansion in the CD56(bright) NK cell subset has been associated with clinical responses to therapy in various autoimmune diseases, suggesting an immunoregulatory role for this subset in vivo. Here we compared the regulation of activated human CD4(+) T cells by CD56(dim) and CD56(bright) autologous NK cells in vitro. Both subsets efficiently killed activated, but not resting, CD4(+) T cells. The activating receptor NKG2D, as well as the integrin LFA-1 and the TRAIL pathway, played important roles in this process. Degranulation by NK cells towards activated CD4(+) T cells was enhanced by IL-2, IL-15, IL-12+IL-18 and IFN-alpha. Interestingly, IL-7 and IL-21 stimulated degranulation by CD56(bright) NK cells but not by CD56(dim) NK cells. NK cell killing of activated CD4(+) T cells was suppressed by HLA-E on CD4(+) T cells, as blocking the interaction between HLA-E and the inhibitory CD94/NKG2A NK cell receptor enhanced NK cell degranulation. This study provides new insight into CD56(dim) and CD56(bright) NK cell-mediated elimination of activated autologous CD4(+) T cells, which potentially may provide an opportunity for therapeutic treatment of chronic inflammation.	[Nielsen, Natasja; Spee, Pieter] Novo Nordisk AS, Translat Immunol, Malov, Denmark; [Urso, Birgitte] Novo Nordisk AS, Inflammat Biol, Monocyte Biol, Malov, Denmark; [Odum, Niels] Univ Copenhagen, Fac Sci, Dept Biol, Copenhagen, Denmark; [Nielsen, Natasja; Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Nielsen, Natasja; Lanier, Lewis L.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA	Novo Nordisk; Novo Nordisk; University of Copenhagen; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nielsen, N (corresponding author), Novo Nordisk AS, Translat Immunol, Malov, Denmark.	spee@novonordisk.com	Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952	Novo Nordisk A/S; Danish Agency for Science, Technology and Innovation; National Institutes of Health [AI066897]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI066897] Funding Source: NIH RePORTER	Novo Nordisk A/S(Novo Nordisk); Danish Agency for Science, Technology and Innovation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Novo Nordisk A/S, the Danish Agency for Science, Technology and Innovation (http://en.fi.dk/research/industrial-phd-programme), and the National Institutes of Health (grant AI066897). LLL is an American Cancer Society Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen L, 2009, J IMMUNOL, V183, P897, DOI 10.4049/jimmunol.0803014; Ardolino M, 2011, BLOOD, V117, P4778, DOI 10.1182/blood-2010-08-300954; Barber DF, 2004, J IMMUNOL, V173, P3653, DOI 10.4049/jimmunol.173.6.3653; Becknell B, 2005, ADV IMMUNOL, V86, P209, DOI 10.1016/S0065-2776(04)86006-1; Betts MR, 2004, METHOD CELL BIOL, V75, P497; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; BIRON CA, 1984, J LEUKOCYTE BIOL, V35, P31, DOI 10.1002/jlb.35.1.31; Brooks CR, 2006, J IMMUNOL, V176, P1141, DOI 10.4049/jimmunol.176.2.1141; Bryceson YT, 2009, BLOOD, V114, P2657, DOI 10.1182/blood-2009-01-201632; Carrega P, 2008, CANCER-AM CANCER SOC, V112, P863, DOI 10.1002/cncr.23239; Cerboni C, 2007, BLOOD, V110, P606, DOI 10.1182/blood-2006-10-052720; Chen SH, 2005, J EXP MED, V202, P1679, DOI 10.1084/jem.20051473; Chiesa MD, 2003, EUR J IMMUNOL, V33, P1657, DOI 10.1002/eji.200323986; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; DADMARZ R, 1994, LYMPHOKINE CYTOK RES, V13, P349; Dalbeth N, 2004, J IMMUNOL, V173, P6418, DOI 10.4049/jimmunol.173.10.6418; Dalbeth Nicola, 2007, V136, P149; de Matos CT, 2007, IMMUNOLOGY, V122, P291, DOI 10.1111/j.1365-2567.2007.02638.x; Eagle RA, 2006, HUM IMMUNOL, V67, P159, DOI 10.1016/j.humimm.2006.02.015; Eagle Robert A., 2009, Current Immunology Reviews, V5, P22; El-Sherbiny YM, 2007, CANCER RES, V67, P8444, DOI 10.1158/0008-5472.CAN-06-4230; ELLIS TM, 1989, J IMMUNOL, V142, P2949; Fehniger TA, 2000, J CLIN INVEST, V106, P117, DOI 10.1172/JCI6218; Ferlazzo G, 2003, EUR J IMMUNOL, V33, P306, DOI 10.1002/immu.200310004; Fort MM, 1998, J IMMUNOL, V161, P3256; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Girart MV, 2007, J IMMUNOL, V179, P3472, DOI 10.4049/jimmunol.179.6.3472; Gracie JA, 1999, J CLIN INVEST, V104, P1393, DOI 10.1172/JCI7317; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Hayakawa Y, 2004, J IMMUNOL, V172, P123, DOI 10.4049/jimmunol.172.1.123; Helander TS, 1998, CURR TOP MICROBIOL, V230, P89; Jacobs R, 2001, EUR J IMMUNOL, V31, P3121, DOI 10.1002/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4; Kastrukoff LF, 1998, J NEUROIMMUNOL, V86, P123, DOI 10.1016/S0165-5728(98)00014-9; Kastrukoff LF, 2003, J NEUROIMMUNOL, V145, P103, DOI 10.1016/j.jneuroim.2003.10.001; Katchar K, 2005, EUR RESPIR J, V26, P77, DOI 10.1183/09031936.05.00030805; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LANIER LL, 1986, J IMMUNOL, V136, P4480; Leavenworth JW, 2011, P NATL ACAD SCI USA, V108, P14584, DOI 10.1073/pnas.1112188108; Leavenworth JW, 2010, P NATL ACAD SCI USA, V107, P2562, DOI 10.1073/pnas.0914732107; Li ZQ, 2005, J IMMUNOL, V174, P5187, DOI 10.4049/jimmunol.174.9.5187; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Molinero LL, 2006, HUM IMMUNOL, V67, P170, DOI 10.1016/j.humimm.2006.02.010; Lu LR, 2007, IMMUNITY, V26, P593, DOI 10.1016/j.immuni.2007.03.017; Lunemann A, 2008, J IMMUNOL, V181, P6170, DOI 10.4049/jimmunol.181.9.6170; Magri G, 2011, BLOOD, V117, P848, DOI 10.1182/blood-2010-08-301374; Marcenaro S, 2006, BLOOD, V108, P2316, DOI 10.1182/blood-2006-04-015693; Mittendorf EA, 2005, BREAST CANCER RES TR, V92, P85, DOI 10.1007/s10549-005-0988-1; Mottonen M, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar589; NAGLER A, 1989, J IMMUNOL, V143, P3183; Nilsson N, 1999, CLIN EXP IMMUNOL, V117, P63; Niu XY, 2010, HUM IMMUNOL, V71, P334, DOI 10.1016/j.humimm.2010.01.010; Ottaviani C, 2006, EUR J IMMUNOL, V36, P118, DOI 10.1002/eji.200535243; Rabinovich BA, 2003, J IMMUNOL, V170, P3572, DOI 10.4049/jimmunol.170.7.3572; Roy S, 2008, J IMMUNOL, V180, P1729, DOI 10.4049/jimmunol.180.3.1729; Saraste M, 2007, NEUROL SCI, V28, P121, DOI 10.1007/s10072-007-0803-3; Schierloh P, 2005, J IMMUNOL, V175, P6852, DOI 10.4049/jimmunol.175.10.6852; Schulz U, 2010, SCAND J IMMUNOL, V72, P319, DOI 10.1111/j.1365-3083.2010.02435.x; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; TAK PP, 1994, ARTHRITIS RHEUM, V37, P1735, DOI 10.1002/art.1780371205; Takao S, 2010, J IMMUNOL, V185, P6031, DOI 10.4049/jimmunol.1000176; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vales-Gomez M, 2008, CANCER RES, V68, P1546, DOI 10.1158/0008-5472.CAN-07-2973; van Roon JAG, 2005, ARTHRITIS RHEUM, V52, P1700, DOI 10.1002/art.21045; Vandenbark AA, 2009, J NEUROIMMUNOL, V215, P125, DOI 10.1016/j.jneuroim.2009.08.007; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wilson JL, 1999, J IMMUNOL, V163, P6365; Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375; Zhang BN, 1997, J EXP MED, V186, P1677, DOI 10.1084/jem.186.10.1677; Zwirner NW, 2010, BIOFACTORS, V36, P274, DOI 10.1002/biof.107	70	107	113	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31959	10.1371/journal.pone.0031959	http://dx.doi.org/10.1371/journal.pone.0031959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384114	gold, Green Published, Green Submitted			2022-12-27	WOS:000302875500059
J	Williams, SM; Nast, A; Coleman, MJ				Williams, Shayna M.; Nast, Alexis; Coleman, Melissa J.			Characterization of Synaptically Connected Nuclei in a Potential Sensorimotor Feedback Pathway in the Zebra Finch Song System	PLOS ONE			English	Article							WHITE-CROWNED SPARROW; VOCAL CONTROL NUCLEUS; AUDITORY RESPONSES; PARALLEL PATHWAYS; AUTOGENOUS SONG; BASAL GANGLIA; MOTOR PATHWAY; FOREBRAIN; NEURONS; SONGBIRDS	Birdsong is a learned behavior that is controlled by a group of identified nuclei, known collectively as the song system. The cortical nucleus HVC (used as a proper name) is a focal point of many investigations as it is necessary for song production, song learning, and receives selective auditory information. HVC receives input from several sources including the cortical area MMAN (medial magnocellular nucleus of the nidopallium). The MMAN to HVC connection is particularly interesting as it provides potential sensorimotor feedback to HVC. To begin to understand the role of this connection, we investigated the physiological relation between MMAN and HVC activity with simultaneous multiunit extracellular recordings from these two nuclei in urethane anesthetized zebra finches. As previously reported, we found similar timing in spontaneous bursts of activity in MMAN and HVC. Like HVC, MMAN responds to auditory playback of the bird's own song (BOS), but had little response to reversed BOS or conspecific song. Stimulation of MMAN resulted in evoked activity in HVC, indicating functional excitation from MMAN to HVC. However, inactivation of MMAN resulted in no consistent change in auditory responses in HVC. Taken together, these results indicate that MMAN provides functional excitatory input to HVC but does not provide significant auditory input to HVC in anesthetized animals. We hypothesize that MMAN may play a role in motor reinforcement or coordination, or may provide modulatory input to the song system about the internal state of the animal as it receives input from the hypothalamus.	[Nast, Alexis; Coleman, Melissa J.] Scripps Coll, Claremont, CA 91711 USA; [Coleman, Melissa J.] Pitzer Coll, Claremont McKenna Coll, WM Keck Sci Dept, Claremont, CA 91711 USA	Claremont Colleges; Scripps College; Claremont Colleges; Claremont Graduate School; Claremont McKenna College; Pitzer College	Williams, SM (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Neuroendocrinol Lab, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA.	mcoleman@kecksci.claremont.edu		Williams-Burris, Shayna/0000-0002-9644-0136	institutional start-up funds; Rose Hills Foundation	institutional start-up funds; Rose Hills Foundation	This work was supported by institutional start-up funds (MJC) and by the Rose Hills Foundation (SMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar E, 2003, CEREB CORTEX, V13, P53, DOI 10.1093/cercor/13.1.53; Bauer EE, 2008, J NEUROSCI, V28, P1509, DOI 10.1523/JNEUROSCI.3838-07.2008; Bottjer SW, 2010, NAT NEUROSCI, V13, P153, DOI 10.1038/nn.2472; Cardin JA, 2005, J NEUROPHYSIOL, V93, P2157, DOI 10.1152/jn.01001.2004; Coleman MJ, 2007, J NEUROSCI, V27, P10024, DOI 10.1523/JNEUROSCI.2215-07.2007; Coleman MJ, 2005, J NEUROBIOL, V63, P70, DOI 10.1002/neu.20122; Coleman MJ, 2004, J NEUROSCI, V24, P7251, DOI 10.1523/JNEUROSCI.0947-04.2004; Coleman MJ, 2008, 2008 NEUR M PLANN WA, V15; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; FORTUNE ES, 1995, J COMP NEUROL, V360, P413, DOI 10.1002/cne.903600305; Foster EF, 1997, J COMP NEUROL, V382, P364, DOI 10.1002/cne.903820305; Foster EF, 2001, J NEUROBIOL, V46, P142, DOI 10.1002/1097-4695(20010205)46:2<142::AID-NEU60>3.0.CO;2-R; Goller F, 2004, ANN NY ACAD SCI, V1016, P130, DOI 10.1196/annals.1298.009; Green D.M., 1966, SIGNAL DETECTION THE, V11, P455; Green DM, 1966, SIGNAL DETECTION THE; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hamaguchi K, 2010, 2010 NEUR M PLANN SA; KATZ LC, 1981, BRAIN RES, V221, P192, DOI 10.1016/0006-8993(81)91073-8; Kubikova L, 2007, EUR J NEUROSCI, V25, P2145, DOI 10.1111/j.1460-9568.2007.05368.x; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; MARGOLIASH D, 1985, P NATL ACAD SCI USA, V82, P5997, DOI 10.1073/pnas.82.17.5997; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MCCASLAND JS, 1987, J NEUROSCI, V7, P23; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Schmidt MF, 2004, ANN NY ACAD SCI, V1016, P171, DOI 10.1196/annals.1298.014; Schmidt MF, 1998, NAT NEUROSCI, V1, P513, DOI 10.1038/2232; Seki Y, 2008, NEUROREPORT, V19, P679, DOI 10.1097/WNR.0b013e3282fb7dae; Solis MM, 2005, J NEUROSCI, V25, P2811, DOI 10.1523/JNEUROSCI.5285-04.2005; Solis MM, 1997, J NEUROSCI, V17, P6447; Striedter GF, 1998, J NEUROBIOL, V34, P27, DOI 10.1002/(SICI)1097-4695(199801)34:1<27::AID-NEU3>3.0.CO;2-E; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Thode C, 2008, NEUROSCIENCE, V157, P143, DOI 10.1016/j.neuroscience.2008.08.057; Vates GE, 1997, J COMP NEUROL, V380, P275; VICARIO DS, 1993, J NEUROBIOL, V24, P488, DOI 10.1002/neu.480240407; Vu E, 2001, 2001 NEUR M PLANN SA; VU ET, 1994, J NEUROSCI, V14, P6924; Wild JM, 2004, ANN NY ACAD SCI, V1016, P438, DOI 10.1196/annals.1298.016; Williams SM, 2008, 2008 NEUR M PLANN WA, V14; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	41	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32178	10.1371/journal.pone.0032178	http://dx.doi.org/10.1371/journal.pone.0032178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384172	gold, Green Published, Green Submitted			2022-12-27	WOS:000302875500083
J	Heenan, CB; Seymour, RS				Heenan, Caragh B.; Seymour, Roger S.			The Effect of Wind on the Rate of Heat Loss from Avian Cup-Shaped Nests	PLOS ONE			English	Article							NESTLING CACTUS WRENS; SITE SELECTION; METABOLIC-RATE; TEMPERATURE REGULATION; RELATIVE IMPORTANCE; MICROCLIMATE; INCUBATION; ORIENTATION; SPARROW; DESIGN	Forced convection can significantly influence the heat loss from birds and their offspring but effects may be reduced by using sheltered micro-sites such as cavities or constructing nests. The structural and thermal properties of the nests of two species, the spiny-cheeked honeyeater (Acanthagenys rufogularis) and yellow-throated miner (Manorina flavigula), were measured in relation to three wind speeds. Nest dimensions differ between the two species, despite the similar body mass of the incubating adults, however nest conductance is comparable. As wind speed increases, so does the rate of heat loss from the nests of both species, and further still during incubation recesses. The significance of forced convection through the nest is a near-doubling in heat production required by the parent, even when incubating at relatively low wind speeds. This provides confirmation that selecting a sheltered nest site is important for avian reproductive success.	[Heenan, Caragh B.; Seymour, Roger S.] Univ Adelaide, Dept Ecol Evolut & Landscape Sci, Adelaide, SA, Australia	University of Adelaide	Heenan, CB (corresponding author), Univ Adelaide, Dept Ecol Evolut & Landscape Sci, Adelaide, SA, Australia.	caragh.heenan@adelaide.edu.au	Heenan, Caragh/C-8566-2013	Heenan, Caragh/0000-0002-5368-7606	University of Adelaide	University of Adelaide	The work was funded by the University of Adelaide postgraduate research student support scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaby M, 2002, ENCY WEATHER CLIMATE; Ar A, 2002, OX ORN SER, V13, P143; AUSTIN GT, 1976, AUK, V93, P245; AUSTIN GT, 1974, CONDOR, V76, P216, DOI 10.2307/1366737; BAKKEN GS, 1990, AUK, V107, P587; BENNETT PM, 1987, J ZOOL, V213, P327, DOI 10.1111/j.1469-7998.1987.tb03708.x; BIEBACH H, 1986, PHYSIOL ZOOL, V59, P69, DOI 10.1086/physzool.59.1.30156092; Bradshaw P., 1964, PROG AEROSP SCI, V5, P1, DOI DOI 10.1016/0376-0421(64)90003-X; BUTTEMER WA, 1986, PHYSIOL ZOOL, V59, P131, DOI 10.1086/physzool.59.2.30156027; BUTTEMER WA, 1985, OECOLOGIA, V68, P126, DOI 10.1007/BF00379484; Cahill JRA, 2008, WILSON J ORNITHOL, V120, P545, DOI 10.1676/07-066.1; CALDER W A, 1973, Ecology (Washington D C), V54, P127, DOI 10.2307/1934381; Calder W.A., 1974, AVIAN BIOL, V4, P259; Carey C, 2002, OX ORN SER, V13, P238; CONNER RN, 1975, AUK, V92, P371, DOI 10.2307/4084566; Cooper SJ, 1999, CONDOR, V101, P863, DOI 10.2307/1370077; D'Alba L, 2009, J THERM BIOL, V34, P93, DOI 10.1016/j.jtherbio.2008.11.005; Deeming D.C., 1991, P147, DOI 10.1017/CBO9780511585739.011; Eikenaar C, 2003, J AVIAN BIOL, V34, P419, DOI 10.1111/j.0908-8857.2003.03147.x; GOLDSTEIN DL, 1983, PHYSIOL ZOOL, V56, P485, DOI 10.1086/physzool.56.4.30155871; HADLEY N F, 1969, Arctic and Alpine Research, V1, P121, DOI 10.2307/1550018; HAGGERTY TM, 1995, SOUTHWEST NAT, V40, P62; Hansell M.H., 2000, BIRD NESTS CONSTRUCT, DOI [10.1017/CBO9781139106788, DOI 10.1017/CBO9781139106788]; Heenan C. B., EFFECT WATER S UNPUB; Heenan CB, 2011, P ROY SOC B-BIOL SCI, V278, P2924, DOI 10.1098/rspb.2010.2798; Hilton GM, 2004, AUK, V121, P777, DOI 10.1642/0004-8038(2004)121[0777:UANTTI]2.0.CO;2; INOUYE RS, 1981, CONDOR, V83, P88, DOI 10.2307/1367613; KERN MD, 1984, CONDOR, V86, P455, DOI 10.2307/1366826; KERN MD, 1993, J FIELD ORNITHOL, V64, P367; Kim SY, 2005, J ORNITHOL, V146, P176, DOI 10.1007/s10336-005-0077-6; Kristjansson TO, 2011, POLAR BIOL, V34, P985, DOI 10.1007/s00300-010-0956-z; Long AM, 2009, CONDOR, V111, P395, DOI 10.1525/cond.2009.080076; Lundy H., 1969, FERTILITY HATCHABILI, P143; Marchant S., 1990, P1; MAYER L, 1982, INT J BIOMETEOROL, V26, P231, DOI 10.1007/BF02184939; MEHTA RD, 1979, AERONAUT J, V83, P443; MITCHELL JW, 1976, BIOPHYS J, V16, P561, DOI 10.1016/S0006-3495(76)85711-6; MITCHELL MA, 1985, BRIT POULTRY SCI, V26, P413, DOI 10.1080/00071668508416830; MOLLER AP, 1991, ORNIS SCAND, V22, P396, DOI 10.2307/3676514; Olson CR, 2006, PHYSIOL BIOCHEM ZOOL, V79, P927, DOI 10.1086/506003; ORR Y, 1970, CONDOR, V72, P476, DOI 10.2307/1366401; Palmgren M., 1939, Ornis Fennica Helsingfors, V16, P1; Pennycuick CJ, 1997, J EXP BIOL, V200, P1441; Pinowski J, 2006, J THERM BIOL, V31, P573, DOI 10.1016/j.jtherbio.2006.05.007; Reid JM, 2000, P ROY SOC B-BIOL SCI, V267, P37, DOI 10.1098/rspb.2000.0963; Reid JM, 2002, FUNCT ECOL, V16, P305, DOI 10.1046/j.1365-2435.2002.00632.x; Reid JM, 2002, OX ORN SER, V13, P314; RELLER AW, 1972, AM MIDL NAT, V88, P270, DOI 10.2307/2424354; RICKLEFS RE, 1969, CONDOR, V71, P32, DOI 10.2307/1366045; RICKLEFS RE, 1968, CONDOR, V70, P121, DOI 10.2307/1365955; Southwick E.E., 1975, Ecological Stud, V12, P417; Tieleman BI, 2008, CONDOR, V110, P116, DOI 10.1525/cond.2008.110.1.116; TRACY CR, 1972, BIOSCIENCE, V22, P656, DOI 10.2307/1296267; VLECK CM, 1981, CONDOR, V83, P229, DOI 10.2307/1367313; Wachob DG, 1996, J FIELD ORNITHOL, V67, P525; Walsberg G.E., 1985, P389; WALSBERG GE, 1986, AUK, V103, P1; WEBB DR, 1983, PHYSIOL ZOOL, V56, P493, DOI 10.1086/physzool.56.4.30155872; WEBB DR, 1983, J THERM BIOL, V8, P301, DOI 10.1016/0306-4565(83)90013-X; WEBB DR, 1993, J THERM BIOL, V18, P117, DOI 10.1016/0306-4565(93)90024-N; WEBSTER MD, 1988, PHYSIOL ZOOL, V61, P543, DOI 10.1086/physzool.61.6.30156163; WITH KA, 1993, CONDOR, V95, P401, DOI 10.2307/1369363; Wolf BO, 1996, ECOLOGY, V77, P2228, DOI 10.2307/2265716	63	32	33	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32252	10.1371/journal.pone.0032252	http://dx.doi.org/10.1371/journal.pone.0032252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389689	gold, Green Published, Green Submitted			2022-12-27	WOS:000302999600027
J	Hall, KC; Blobel, CP				Hall, Katherine C.; Blobel, Carl P.			Interleukin-1 Stimulates ADAM17 through a Mechanism Independent of its Cytoplasmic Domain or Phosphorylation at Threonine 735	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR-ALPHA; CONVERTING-ENZYME; TNF-ALPHA; ENDOTHELIAL-CELLS; DISINTEGRIN; ECTODOMAIN; EGFR; TACE; METALLOPROTEINASE	ADAM17 (a disintegrin and metalloproteinase) is a membrane-anchored metalloproteinase that regulates the release of EGFR-ligands, TNF alpha and other membrane proteins from cells. ADAM17 can be rapidly activated by a variety of signaling pathways, yet little is known about the underlying mechanism. Several studies have demonstrated that the cytoplasmic domain of ADAM17 is not required for its rapid activation by a variety of stimuli, including phorbol esters, tyrosine kinases and some G-protein coupled receptors. However, phosphorylation of cytoplasmic residue T735 was recently reported as a crucial step for activation of ADAM17 by IL-1 beta and by the p38 MAP-kinase pathway. One possible mechanism to reconcile these results would be that T735 has an inhibitory role and that it must be phosphorylated as a pre-requisite for the activation of ADAM17, which would then proceed via a mechanism that is independent of its cytoplasmic domain. To test this hypothesis, we performed rescue experiments of Adam17(-/-) cells with wild type and mutant forms of ADAM17. However, these experiments showed that an inactivating mutation (T735A) or an activating mutation (T735D) of cytoplasmic residue T735 or the removal of the cytoplasmic domain of ADAM17 did not significantly affect the stimulation of ADAM17 by IL-1 beta or by activation of MAP-kinase with anisomycin. Moreover, we found that the MAP-kinase inhibitor SB203580 blocked activation of cytoplasmic tail-deficient ADAM17 and of the T735A mutant by IL-1 beta or by anisomycin, providing further support for a model in which the activation mechanism of ADAM17 does not rely on its cytoplasmic domain or phosphorylation of T735.	[Hall, Katherine C.; Blobel, Carl P.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Hall, Katherine C.; Blobel, Carl P.] Cornell Univ, Weill Med Coll, Cell Biol & Genet Program, New York, NY 10021 USA; [Blobel, Carl P.] Cornell Univ, Weill Med Coll, Biophys & Syst Biol Program, Dept Physiol & Med, New York, NY 10021 USA	Cornell University; Cornell University	Hall, KC (corresponding author), Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA.	blobelc@hss.edu			National Institutes of Health (NIH) [R01GM64750, 5T32AR007281-28]; National Center for Research Resources, National Institutes of Health [C06-RR12538-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064750] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health (NIH) to CPB [R01GM64750], and by an NIH training grant in Musculoskeletal Research to KCH [5T32AR007281-28]. This investigation was conducted in a facility constructed with support from Research Facilities Improvement Program Grant Number C06-RR12538-01 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIBAS J, 1995, J CELL BIOL, V128, P433, DOI 10.1083/jcb.128.3.433; Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; Bell J, 2007, J LEUKOC BIOL, V82; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; Fan HZ, 2003, J BIOL CHEM, V278, P18617, DOI 10.1074/jbc.M300331200; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Hart S, 2004, CANCER RES, V64, P1943, DOI 10.1158/0008-5472.CAN-03-3720; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Li Xiaojin, 2011, World J Biol Chem, V2, P246, DOI 10.4331/wjbc.v2.i11.246; Li XJ, 2004, J BIOL CHEM, V279, P27365, DOI 10.1074/jbc.M401690200; Maretzky T, 2011, ONCOGENE, V30, P611, DOI 10.1038/onc.2010.443; Maretzky T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1232; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Ohtsu H, 2006, ARTERIOSCL THROM VAS, V26, pE133, DOI 10.1161/01.ATV.0000236203.90331.d0; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin Umut, 2006, V327, P99; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schlondorff J, 2001, J BIOL CHEM, V276, P14665, DOI 10.1074/jbc.M010741200; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Wang SE, 2008, MOL CELL BIOL, V28, P5605, DOI 10.1128/MCB.00787-08; Weskamp G, 1996, J CELL BIOL, V132, P717, DOI 10.1083/jcb.132.4.717; Weskamp G, 2010, CIRC RES, V106, P932, DOI 10.1161/CIRCRESAHA.109.207415; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Zhang Q, 2006, P NATL ACAD SCI USA, V103, P6901, DOI 10.1073/pnas.0509719103; Zheng YF, 2004, J BIOL CHEM, V279, P42898, DOI 10.1074/jbc.M403193200; Zheng YF, 2002, J BIOL CHEM, V277, P42463, DOI 10.1074/jbc.M207459200	40	50	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31600	10.1371/journal.pone.0031600	http://dx.doi.org/10.1371/journal.pone.0031600			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384041	Green Submitted, Green Published, gold			2022-12-27	WOS:000302918500030
J	Li, S; Hao, BX; Lu, YY; Yu, PL; Lee, HC; Yue, JB				Li, Sen; Hao, Baixia; Lu, Yingying; Yu, Peilin; Lee, Hon-Cheung; Yue, Jianbo			Intracellular Alkalinization Induces Cytosolic Ca2+ Increases by Inhibiting Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA)	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; PANCREATIC ACINAR-CELLS; CALCIUM-PUMP; SARCOPLASMIC-RETICULUM; NA+/H+ EXCHANGER; EXTRACELLULAR PH; LEAK CHANNELS; FERTILIZATION; STORES; ENTRY	Intracellular pH (pHi) and Ca2+ regulate essentially all aspects of cellular activities. Their inter-relationship has not been mechanistically explored. In this study, we used bases and acetic acid to manipulate the pHi. We found that transient pHi rise induced by both organic and inorganic bases, but not acidification induced by acid, produced elevation of cytosolic Ca2+. The sources of the Ca2+ increase are from the endoplasmic reticulum (ER) Ca2+ pools as well as from Ca2+ influx. The store-mobilization component of the Ca2+ increase induced by the pHi rise was not sensitive to antagonists for either IP3-receptors or ryanodine receptors, but was due to inhibition of the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), leading to depletion of the ER Ca2+ store. We further showed that the physiological consequence of depletion of the ER Ca2+ store by pHi rise is the activation of store-operated channels (SOCs) of Orai1 and Stim1, leading to increased Ca2+ influx. Taken together, our results indicate that intracellular alkalinization inhibits SERCA activity, similar to thapsigargin, thereby resulting in Ca2+ leak from ER pools followed by Ca2+ influx via SOCs.	[Li, Sen; Hao, Baixia; Lu, Yingying; Yu, Peilin; Lee, Hon-Cheung; Yue, Jianbo] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Li, S (corresponding author), Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China.	jyue@hku.hk	Lee, Hon Cheung/C-4329-2009; Yue, Jianbo/AAC-4588-2019; Yue, Jianbo/K-8002-2015	Hao, Helen Baixia/0000-0002-5648-3705; Li, Sen/0000-0003-4496-5050; Lu, Yingying/0000-0002-5423-9522; Yue, Jianbo/0000-0001-6384-5447	Research Grant Council (RGC) [HKU 784710M, HKU 782709M, HKU 785911M]; National Natural Science Foundation of China (NSFC)/RGC from Hong Kong [N_HKU 737/09]; Leukemia and Lymphoma Society of America	Research Grant Council (RGC)(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)/RGC from Hong Kong; Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society)	This work was supported by Research Grant Council (RGC) grants (HKU 784710M, HKU 782709M, HKU 785911M), a National Natural Science Foundation of China (NSFC)/RGC grant from Hong Kong (N_HKU 737/09), and a Special Fellow Award from the Leukemia and Lymphoma Society of America (Dr. Yue). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso A, 2000, BRIT J PHARMACOL, V130, P1809, DOI 10.1038/sj.bjp.0703490; ANDERSEN JP, 1985, J BIOL CHEM, V260, P371; Austin C, 1996, BIOCHEM BIOPH RES CO, V222, P537, DOI 10.1006/bbrc.1996.0779; Cabado AG, 2000, CELL SIGNAL, V12, P573, DOI 10.1016/S0898-6568(00)00101-7; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; COHEN PG, 1984, MED HYPOTHESES, V15, P135, DOI 10.1016/0306-9877(84)90118-X; Crepin A, 2007, BIOCHEM J, V401, P49, DOI 10.1042/BJ20060870; DANTHULURI NR, 1990, J BIOL CHEM, V265, P19071; Dhaka A, 2009, J NEUROSCI, V29, P153, DOI 10.1523/JNEUROSCI.4901-08.2009; Epel D., 1978, Current Topics in Developmental Biology, V12, P185, DOI 10.1016/S0070-2153(08)60597-9; Epel D, 1978, Birth Defects Orig Artic Ser, V14, P377; Fujita F, 2008, J CLIN INVESTIGATION; Heppner TJ, 2002, AM J PHYSIOL-HEART C, V283, pH2169, DOI 10.1152/ajpheart.00603.2002; Jadot M, 2001, EUR J BIOCHEM, V268, P1392, DOI 10.1046/j.1432-1327.2001.02006.x; Kapur N, 2007, AM J PHYSIOL-CELL PH, V292, pC1510, DOI 10.1152/ajpcell.00181.2006; Kargacin GJ, 2005, PFLUG ARCH EUR J PHY, V449, P356, DOI 10.1007/s00424-004-1345-7; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; KLOCKNER U, 1994, J GEN PHYSIOL, V103, P647, DOI 10.1085/jgp.103.4.647; Lajas AI, 2001, CELL SIGNAL, V13, P451, DOI 10.1016/S0898-6568(01)00161-9; Lang S, 2011, CHANNELS, V5, P228, DOI 10.4161/chan.5.3.15314; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; Leffler CW, 1999, AM J PHYSIOL-HEART C, V277, pH1878, DOI 10.1152/ajpheart.1999.277.5.H1878; LYALL V, 1994, AM J PHYSIOL, V266, pF685, DOI 10.1152/ajprenal.1994.266.5.F685; Marumo M, 2001, THROMB RES, V104, P353, DOI 10.1016/S0049-3848(01)00374-7; Mogyoros I, 1997, BRAIN, V120, P317, DOI 10.1093/brain/120.2.317; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Nitschke R, 1996, PFLUG ARCH EUR J PHY, V433, P98, DOI 10.1007/s004240050254; NUCCITELLI R, 1981, P NATL ACAD SCI-BIOL, V78, P4421, DOI 10.1073/pnas.78.7.4421; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Paradiso A, 2004, BREAST CANCER RES, V6, pR616, DOI 10.1186/bcr922; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Poteser M, 2003, CIRC RES, V92, P888, DOI 10.1161/01.RES.0000069216.80612.66; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Reshkin SJ, 2000, FASEB J, V14, P2185, DOI 10.1096/fj.00-0029com; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Speake T, 1998, J PHYSIOL-LONDON, V506, P415, DOI 10.1111/j.1469-7793.1998.415bw.x; Srikanth S, 2010, NAT CELL BIOL, V12, P436, DOI 10.1038/ncb2045; Srinivas SP, 2002, INVEST OPHTH VIS SCI, V43, P2341; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Tengholm A, 2000, CELL CALCIUM, V27, P43, DOI 10.1054/ceca.1999.0087; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; TSUKIOKA M, 1994, J PHYSIOL-LONDON, V475, P369, DOI 10.1113/jphysiol.1994.sp020078; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Wakabayashi I, 2006, J VASC RES, V43, P238, DOI 10.1159/000091235; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; Yue JB, 2009, J BIOL CHEM, V284, P29335, DOI 10.1074/jbc.M109.049767	52	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31905	10.1371/journal.pone.0031905	http://dx.doi.org/10.1371/journal.pone.0031905			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384096	Green Submitted, Green Published, gold			2022-12-27	WOS:000302918500045
J	Miniati, M; Cenci, C; Monti, S; Poli, D				Miniati, Massimo; Cenci, Caterina; Monti, Simonetta; Poli, Daniela			Clinical Presentation of Acute Pulmonary Embolism: Survey of 800 Cases	PLOS ONE			English	Article							CT ANGIOGRAPHY; COR-PULMONALE; PROBABILITY; DIAGNOSIS; PERFUSION; THROMBOSIS; SURVIVAL; MODEL	Background: Pulmonary embolism (PE) is a common and potentially fatal disease that is still underdiagnosed. The objective of our study was to reappraise the clinical presentation of PE with emphasis on the identification of the symptoms and signs that prompt the patients to seek medical attention. Methodology/Principal Findings: We studied 800 patients with PE from two different clinical settings: 440 were recruited in Pisa (Italy) as part of the Prospective Investigative Study of Acute Pulmonary Embolism Diagnosis (PISAPED); 360 were diagnosed with and treated for PE in seven hospitals of central Tuscany, and evaluated at the Atherothrombotic Disorders Unit, Firenze (Italy), shortly after hospital discharge. We interviewed the patients directly using a standardized, self-administered questionnaire originally utilized in the PISAPED. The two samples differed significantly as regards age, proportion of outpatients, prevalence of unprovoked PE, and of active cancer. Sudden onset dyspnea was the most frequent symptom in both samples (81 and 78%), followed by chest pain (56 and 39%), fainting or syncope (26 and 22%), and hemoptysis (7 and 5%). At least one of the above symptoms was reported by 756 (94%) of 800 patients. Isolated symptoms and signs of deep vein thrombosis occurred in 3% of the cases. Only 7 (1%) of 800 patients had no symptoms before PE was diagnosed. Conclusions/Significance: Most patients with PE feature at least one of four symptoms which, in decreasing order of frequency, are sudden onset dyspnea, chest pain, fainting (or syncope), and hemoptysis. The occurrence of such symptoms, if not explained otherwise, should alert the clinicians to consider PE in differential diagnosis, and order the appropriate objective test.	[Miniati, Massimo] Univ Florence, Dipartimento Area Crit Med Chirurg, Florence, Italy; [Miniati, Massimo; Cenci, Caterina; Poli, Daniela] Univ Careggi, Azienda Osped, Struttura Operat Dipartimentale SOD Malattie Ater, Florence, Italy; [Monti, Simonetta] CNR, Ist Fisiol Clin, I-56100 Pisa, Italy; [Monti, Simonetta] Fdn CNR Reg Toscana G Monasterio, Pisa, Italy	University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; Consiglio Nazionale delle Ricerche (CNR)	Miniati, M (corresponding author), Univ Florence, Dipartimento Area Crit Med Chirurg, Florence, Italy.	massimo.miniati@unifi.it	MONTI, SIMONETTA/A-9766-2016	MONTI, SIMONETTA/0000-0001-7825-6987; Miniati, Massimo/0000-0002-6977-8916	Department of Medical and Surgical Critical Care, University of Firenze (Italy)	Department of Medical and Surgical Critical Care, University of Firenze (Italy)	This work was supported in part by funds from the Department of Medical and Surgical Critical Care, University of Firenze (Italy). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bajc M, 2009, EUR J NUCL MED MOL I, V36, P1528, DOI 10.1007/s00259-009-1169-y; Bajc M, 2009, EUR J NUCL MED MOL I, V36, P1356, DOI 10.1007/s00259-009-1170-5; FLEISCHNER FG, 1967, NEW ENGL J MED, V276, P1213, DOI 10.1056/NEJM196706012762201; Heit JA, 1999, ARCH INTERN MED, V159, P445, DOI 10.1001/archinte.159.5.445; Hurwitz LM, 2007, RADIOLOGY, V245, P742, DOI 10.1148/radiol.2453062046; Larson DB, 2011, RADIOLOGY, V258, P164, DOI 10.1148/radiol.10100640; Mamlouk MD, 2010, RADIOLOGY, V256, P625, DOI 10.1148/radiol.10091624; McGinn SS, 1935, J AMER MED ASSOC, V104, P1473, DOI 10.1001/jama.1935.02760170011004; MEYER G, 1990, EUR J NUCL MED, V17, P315, DOI 10.1007/BF01268022; Miniati M, 2003, AM J MED, V114, P173, DOI 10.1016/S0002-9343(02)01478-X; Miniati M, 2001, AM J MED, V110, P528, DOI 10.1016/S0002-9343(01)00693-3; Miniati M, 1999, AM J RESP CRIT CARE, V159, P864, DOI 10.1164/ajrccm.159.3.9806130; Miniati M, 1996, AM J RESP CRIT CARE, V154, P1387, DOI 10.1164/ajrccm.154.5.8912753; Miniati M, 2008, AM J RESP CRIT CARE, V178, P290, DOI 10.1164/rccm.200802-207OC; Miniati M, 2006, MEDICINE, V85, P253, DOI 10.1097/01.md.0000236952.87590.c8; Pineda LA, 2001, CHEST, V120, P791, DOI 10.1378/chest.120.3.791; Pistolesi M, 2010, RADIOLOGY, V256, P334, DOI 10.1148/radiol.10100662; Stein PD, 2007, AM J MED, V120, P871, DOI 10.1016/j.amjmed.2007.03.024; Stein PD, 2010, AM J MED, V123, P426, DOI 10.1016/j.amjmed.2009.09.037; Stein PD, 2007, PULMONARY EMBOLISM, 2ND EDITION, P3; STEIN PD, 1975, PROG CARDIOVASC DIS, V17, P247, DOI 10.1016/S0033-0620(75)80016-8; STEIN PD, 1979, AM J CARDIOL, V43, P669, DOI 10.1016/0002-9149(79)90031-6; The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) endorsed by the International Society of Heart and Lung Transplantation (ISHLT), 2009, EUR HEART J, V30, P2495; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416	24	55	61	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e30891	10.1371/journal.pone.0030891	http://dx.doi.org/10.1371/journal.pone.0030891			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383978	Green Submitted, Green Published, gold			2022-12-27	WOS:000302918500015
J	Sainz, J; Lupianez, CB; Segura-Catena, J; Vazquez, L; Rios, R; Oyonarte, S; Hemminki, K; Forsti, A; Jurado, M				Sainz, Juan; Belen Lupianez, Carmen; Segura-Catena, Juana; Vazquez, Lourdes; Rios, Rafael; Oyonarte, Salvador; Hemminki, Kari; Forsti, Asta; Jurado, Manuel			Dectin-1 and DC-SIGN Polymorphisms Associated with Invasive Pulmonary Aspergillosis Infection	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; BETA-GLUCAN RECEPTOR; MULTIFACTOR DIMENSIONALITY REDUCTION; VIRUS TYPE-1 INFECTION; GENE-GENE INTERACTIONS; PROMOTER POLYMORPHISM; DENDRITIC CELLS; FUMIGATUS CONIDIA; IMMUNE-RESPONSES; MCP-1 EXPRESSION	The recognition of pathogen-derived structures by C-type lectins and the chemotactic activity mediated by the CCL2/CCR2 axis are critical steps in determining the host immune response to fungi. The present study was designed to investigate whether the presence of single nucleotide polymorphisms (SNPs) within DC-SIGN, Dectin-1, Dectin-2, CCL2 and CCR2 genes influence the risk of developing Invasive Pulmonary Aspergillosis (IPA). Twenty-seven SNPs were selected using a hybrid functional/tagging approach and genotyped in 182 haematological patients, fifty-seven of them diagnosed with proven or probable IPA according to the 2008 EORTC/MSG criteria. Association analysis revealed that carriers of the Dectin-1(rs3901533) (T/T) and Dectin-1(rs7309123) (G/G) genotypes and DC-SIGN(rs4804800) (G), DC-SIGN(rs11465384) T, DC-SIGN(7248637 A) and DC-SIGN(7252229) (C) alleles had a significantly increased risk of IPA infection (OR = 5.59 95% CI 1.37-22.77; OR = 4.91 95% CI 1.52-15.89; OR = 2.75 95% CI 1.27-5.95; OR = 2.70 95% CI 1.24-5.90; OR = 2.39 95% CI 1.09-5.22 and OR = 2.05 95% CI 1.00-4.22, respectively). There was also a significantly increased frequency of galactomannan positivity among patients carrying the Dectin-1(rs3901533_T) allele and Dectin-1(rs7309123_G/G) genotype. In addition, healthy individuals with this latter genotype showed a significantly decreased level of Dectin-1 mRNA expression compared to C-allele carriers, suggesting a role of the Dectin-1(rs7309123) polymorphism in determining the levels of Dectin-1 and, consequently, the level of susceptibility to IPA infection. SNP-SNP interaction (epistasis) analysis revealed significant interactions models including SNPs in Dectin-1, Dectin-2, CCL2 and CCR2 genes, with synergistic genetic effects. Although these results need to be further validated in larger cohorts, they suggest that Dectin-1, DC-SIGN, Dectin-2, CCL2 and CCR2 genetic variants influence the risk of IPA infection and might be useful in developing a risk-adapted prophylaxis.	[Sainz, Juan; Belen Lupianez, Carmen; Segura-Catena, Juana; Rios, Rafael; Jurado, Manuel] Genyo Pfizer Univ Granada Andalusian Govt Ctr Gen, Genom Oncol Area, Granada, Spain; [Sainz, Juan; Hemminki, Kari; Forsti, Asta] German Canc Res Ctr, Mol Genet Epidemiol Dept, D-6900 Heidelberg, Germany; [Sainz, Juan; Belen Lupianez, Carmen; Segura-Catena, Juana; Rios, Rafael; Jurado, Manuel] Univ Hosp Virgen de las Nieves, Dept Haematol, Granada, Spain; [Vazquez, Lourdes] Univ Hosp Salamanca, Dept Hematol, Salamanca, Spain; [Oyonarte, Salvador] Blood Transfus Reg Ctr, Granada, Spain; [Oyonarte, Salvador] Sectorial Tissue Bank, Granada, Spain; [Hemminki, Kari; Forsti, Asta] Clin Res Ctr, Ctr Primary Hlth Care Res, Malmo, Sweden	Pfizer; University of Granada; Helmholtz Association; German Cancer Research Center (DKFZ); Hospital Universitario Virgen de las Nieves; University of Salamanca	Sainz, J (corresponding author), Genyo Pfizer Univ Granada Andalusian Govt Ctr Gen, Genom Oncol Area, Granada, Spain.	juan.sainz@genyo.es	Rios-Tamayo, Rafael/AAA-3204-2019; Segura-Catena, Juana/G-1242-2016; Juan, Sainz/Y-6473-2019; VAZQUEZ, LOURDES/A-2839-2019	Segura-Catena, Juana/0000-0002-1190-0368; Juan, Sainz/0000-0002-9355-2423; Oyonarte, Salvador/0000-0002-5888-430X; VAZQUEZ, LOURDES/0000-0001-8191-0046	Consejeria de Salud de la Junta de Andalucia (Sevilla, Spain) [P08-CVI-4116]; Fondo de Investigaciones Sanitarias (Madrid, Spain) [PI081051]	Consejeria de Salud de la Junta de Andalucia (Sevilla, Spain); Fondo de Investigaciones Sanitarias (Madrid, Spain)	This study was supported by grants P08-CVI-4116 from Consejeria de Salud de la Junta de Andalucia (Sevilla, Spain) and PI081051 from Fondo de Investigaciones Sanitarias (Madrid, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EL, 2008, J PHARMACOL EXP THER, V325, P115, DOI 10.1124/jpet.107.133124; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Asakura Y, 2009, NEW ENGL J MED, P360; Asakura Y, 2009, NEW ENGL J MED, V360, P635; Barreiro LB, 2006, PLOS MED, V3, P230, DOI 10.1371/journal.pmed.0030020; Bochud PY, 2008, NEW ENGL J MED, V359, P1766, DOI 10.1056/NEJMoa0802629; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; Carvalho A, 2008, J INFECT DIS, V197, P618, DOI 10.1086/526500; Chai LYA, 2011, J INFECT DIS, V203, P736, DOI 10.1093/infdis/jiq102; Chan KYK, 2010, HUM IMMUNOL, V71, P702, DOI 10.1016/j.humimm.2010.03.006; Chen Bowang, 2009, BMC Res Notes, V2, P214, DOI 10.1186/1756-0500-2-214; Cunha C, 2010, BLOOD, V116, P5394, DOI 10.1182/blood-2010-04-279307; de Boer MGJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018403; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; den Dunnen J, 2009, CANCER IMMUNOL IMMUN, V58, P1149, DOI 10.1007/s00262-008-0615-1; Dennehy KM, 2007, J LEUKOCYTE BIOL, V82, P253, DOI 10.1189/jlb.1206753; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ganachari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008881; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Kashima S, 2009, J GEN VIROL, V90, P927, DOI 10.1099/vir.0.008367-0; Kesh S, 2005, ANN NY ACAD SCI, V1062, P95, DOI 10.1196/annals.1358.012; Koizumi Y, 2007, AIDS RES HUM RETROV, V23, P713, DOI 10.1089/aid.2006.0225; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; Maertens J, 2002, J INFECT DIS, V186, P1297, DOI 10.1086/343804; Maertens J, 2004, BRIT J HAEMATOL, V126, P852, DOI 10.1111/j.1365-2141.2004.05140.x; Marr KA, 2004, J INFECT DIS, V190, P641, DOI 10.1086/422009; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Martin MP, 2004, J VIROL, V78, P14053, DOI 10.1128/JVI.78.24.14053-14056.2004; McDermott DH, 2005, CIRCULATION, V112, P1113, DOI 10.1161/CIRCULATIONAHA.105.543579; Mezger M, 2008, CLIN MICROBIOL INFEC, V14, P228, DOI 10.1111/j.1469-0691.2007.01902.x; Mezger M, 2008, J INFECT DIS, V197, P924, DOI 10.1086/528694; Mezger M, 2008, BLOOD, V111, P534, DOI 10.1182/blood-2007-05-090928; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Muhlbauer M, 2003, GASTROENTEROLOGY, V125, P1085, DOI 10.1016/S0016-5085(03)01213-7; Ok M, 2011, INT J MED MICROBIOL, V301, P445, DOI 10.1016/j.ijmm.2011.04.013; Park BL, 2006, EXP MOL MED, V38, P694, DOI 10.1038/emm.2006.82; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Ryan EJ, 2010, HUM IMMUNOL, V71, P829, DOI 10.1016/j.humimm.2010.05.007; Saijo S, 2011, INT IMMUNOL; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sainz J, 2008, J CLIN IMMUNOL, V28, P473, DOI 10.1007/s10875-008-9197-0; Sainz J, 2010, Methods Find Exp Clin Pharmacol, V32 Suppl A, P9; Sainz J, 2010, INT J IMMUNOPATH PH, V23, P423, DOI 10.1177/039463201002300205; Sainz J, 2007, HUM IMMUNOL, V68, P41, DOI 10.1016/j.humimm.2006.10.011; Sainz J, 2007, IMMUNOL LETT, V109, P76, DOI 10.1016/j.imlet.2007.01.005; Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550; Seo KW, 2005, BONE MARROW TRANSPL, V36, P1089, DOI 10.1038/sj.bmt.1705181; Serrano-Gomez D, 2004, J IMMUNOL, V173, P5635, DOI 10.4049/jimmunol.173.9.5635; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Soubani AO, 2002, CHEST, V121, P1988, DOI 10.1378/chest.121.6.1988; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Vannberg FO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001388; Werner JL, 2011, INFECT IMMUN; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zaas AK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000101	64	101	107	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32273	10.1371/journal.pone.0032273	http://dx.doi.org/10.1371/journal.pone.0032273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384201	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500071
J	Sola, R; Valls, RM; Godas, G; Perez-Busquets, G; Ribalta, J; Girona, J; Heras, M; Cabre, A; Castro, A; Domenech, G; Torres, F; Masana, L; Angles, N; Reguant, J; Ramirez, B; Barriach, JM				Sola, Rosa; Valls, Rosa M.; Godas, Gemma; Perez-Busquets, Gloria; Ribalta, Josep; Girona, Josefa; Heras, Mercedes; Cabre, Anna; Castro, Antoni; Domenech, Gema; Torres, Ferran; Masana, Lluis; Angles, Neus; Reguant, Jordi; Ramirez, Bartolome; Barriach, Joaquim M.			Cocoa, Hazelnuts, Sterols and Soluble Fiber Cream Reduces Lipids and Inflammation Biomarkers in Hypertensive Patients: A Randomized Controlled Trial	PLOS ONE			English	Article							CHOLESTEROL-LOWERING FOODS; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; ENDOTHELIAL FUNCTION; DIETARY PORTFOLIO; PLANT STEROLS; HEART-DISEASE; SERUM-LIPIDS; 52 COUNTRIES	Background: Cocoa, mixed with other food ingredients, intake can have beneficial effects on cardiovascular disease (CVD) biomarkers. We compared the effects of 4 cocoa cream products on some of these biomarkers. Methods and Findings: In this multi-centered, randomized, controlled, double-blind, parallel trial, volunteers (n = 113; age range: 43-65 years) who were pre-hypertensive, stage-1 hypertensive and hypercholesterolemic received one of 4 cocoa cream products (13 g/unit; 1 g cocoa/unit, 6 units/d; 465 Kcal/d) added to a low saturated fat diet for 4 weeks. The groups were: A) (n = 28), cocoa cream considered as control; B) (n = 28), cocoa+hazelnut cream (30 g/d hazelnuts); C) (n = 30), cocoa+hazelnuts+phytosterols (2 g/d); and D) (n = 27), cocoa+hazelnuts+ phytosterols+soluble fiber (20 g/d) the patented "LMN product''. Primary outcome measures were BP, LDL-c, apolipoprotein B-100 (Apo B), ApoB/ApoA ratio, oxidized LDL (oxLDL) and high-sensitive C-reactive protein (hsCRP) determined at baseline and post-cocoa cream product intake. Statistical analysis used was ANCOVA or mixed models (in case of repeated measurements), with baseline observation included as a covariate. After 4 weeks, compared to product A, product C reduced LDL-c by 11.2%, Apo B by 8.1% and ApoB/ApoA ratio by 7.8% (P = 0.01). LMN decreased LDL-c by 9.2%, Apo B-100 by 8.5%, ApoB/ApoA ratio by 10.5%, hsCRP by 33.4% and oxLDL by 5.9% (P = 0.01). Surprisingly, even "control'' product A reduced systolic BP (-7.89 mmHg; 95% CI: -11.45 to -4.3) and diastolic BP (-5.54 mmHg; 95% CI: -7.79 to -3.29). The BP reductions were similar with the other 3 products. Limitations of the study are that the trial period was relatively short and that a better "BP control'' product would have been preferable. Conclusion: The creams (particularly the LMN) have anti-inflammatory and antioxidant effects in addition to lowering LDL-c, Apo B and ApoB/ApoA ratio. Thus, the soluble fiber effects amplified with sterols (as contained in the cocoa creams) provide new dietary therapeutic perspectives.	[Sola, Rosa; Valls, Rosa M.; Godas, Gemma; Perez-Busquets, Gloria; Ribalta, Josep; Girona, Josefa; Heras, Mercedes; Cabre, Anna; Castro, Antoni; Masana, Lluis] Univ Rovira & Virgili, Hosp Univ St Joan Reus, CIBERDEM, URLA,IISPV, E-43201 Reus, Spain; [Torres, Ferran] Univ Autonoma Barcelona, Biostat Unit, Stat & Methodol Support Unit USEM, IDIBAPS Hosp Clin,Sch Med, E-08193 Barcelona, Spain; [Angles, Neus; Reguant, Jordi; Ramirez, Bartolome; Barriach, Joaquim M.] La Morella Nuts, Castellvell Del Camp, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Autonomous University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Sola, R (corresponding author), Univ Rovira & Virgili, Hosp Univ St Joan Reus, CIBERDEM, URLA,IISPV, C St Llorenc 21, E-43201 Reus, Spain.	rosa.sola@urv.cat	Valls, Rosa M/AAB-1163-2019; SOLÀ, Rosa/N-5919-2014; MASANA, LUIS/M-7002-2019; Ribalta, Josep/AAD-4859-2020; Castro, Antoni/AAI-4431-2021; Torres, Ferran/D-1296-2011; Girona, Josefa/U-3489-2018	Valls, Rosa M/0000-0002-3351-0942; MASANA, LUIS/0000-0002-0789-4954; Ribalta, Josep/0000-0002-8879-4719; Castro, Antoni/0000-0001-5441-6333; Torres, Ferran/0000-0002-7355-7913; Girona, Josefa/0000-0002-6267-8779; SOLA, Rosa/0000-0002-8359-235X; Heras, Mercedes/0000-0002-5285-154X	CENIT; Spanish Ministry of Industry; Ministry of Education and Science [Ministerio de Educacion y Ciencia]; La Morella Nuts S.A., Spain [CDTI FIT-060000-2002-73]; Universitat Rovira i Virgili	CENIT; Spanish Ministry of Industry(Spanish Government); Ministry of Education and Science [Ministerio de Educacion y Ciencia](German Research Foundation (DFG)); La Morella Nuts S.A., Spain; Universitat Rovira i Virgili	Rosa Sola received a research grant support from CENIT program (MET-DEV-FUN) from the Spanish Ministry of Industry and by a consortium of companies headed by La Morella Nuts (Castellvell del Camp, Tarragona, Spain), and from the Ministry of Education and Science [Ministerio de Educacion y Ciencia] in the form of a research grant PROFIT 2005-2007 and additional support was from La Morella Nuts S. A. Additional support was from La Morella Nuts S. A. (CDTI FIT-060000-2002-73, Spain) in the form of grants made available directly to the Universitat Rovira i Virgili. Ferran Torres and Gema Domenech of the Universitat Autonoma de Barcelona received financial support from Universitat Rovira i Virgili to perform the statistical analyses. Joaquim-M Barriach, Bartolome Ramirez, Jordi Reguant and Neus Angles are employees of La Morella Nuts S. A., Spain. This funding body therefore had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba S, 2007, AM J CLIN NUTR, V85, P709, DOI 10.1093/ajcn/85.3.709; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Desch S, 2010, AM J HYPERTENS, V23, P97, DOI 10.1038/ajh.2009.213; Elmadfa I, 2009, ANN NUTR METAB, V54, P8, DOI 10.1159/000220822; Favier JC, 1995, REPERTOIRE GEN ALIME; Ferri N, 2006, CURR OPIN LIPIDOL, V17, P495, DOI 10.1097/01.mol.0000245254.33011.de; Fraley AE, 2006, CURR OPIN LIPIDOL, V17, P502, DOI 10.1097/01.mol.0000245255.40634.b5; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Grassi D, 2005, HYPERTENSION, V46, P398, DOI 10.1161/01.HYP.0000174990.46027.70; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Jenkins DJA, 2008, METABOLISM, V57, P130, DOI 10.1016/j.metabol.2007.08.016; Jenkins DJA, 2010, CAN MED ASSOC J, V182, P1961, DOI 10.1503/cmaj.092128; Jenkins David J A, 2007, Curr Atheroscler Rep, V9, P501, DOI 10.1007/s11883-007-0067-7; Jenkins DJA, 2003, JAMA-J AM MED ASSOC, V290, P502, DOI 10.1001/jama.290.4.502; Jia L, 2010, AM J CLIN NUTR, V92, P218, DOI 10.3945/ajcn.2009.28202; Kim JE, 2010, BRIT J NUTR, V104, P957, DOI 10.1017/S0007114510001704; Matsuzawa Y, 2010, J AM COLL CARDIOL, V55, P1688, DOI 10.1016/j.jacc.2009.10.073; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Mursu J, 2004, FREE RADICAL BIO MED, V37, P1351, DOI 10.1016/j.freeradbiomed.2004.06.002; Ried K, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-39; Sola R, 2010, ATHEROSCLEROSIS, V211, P630, DOI 10.1016/j.atherosclerosis.2010.03.010; Taubert D, 2007, JAMA-J AM MED ASSOC, V298, P49, DOI 10.1001/jama.298.1.49; Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570; Verbeke G, 2000, LINEAR MIXED MODELS; Volpe R, 2001, BRIT J NUTR, V86, P233, DOI 10.1079/BJN2001395; Walldius G, 2006, J INTERN MED, V259, P259, DOI 10.1111/j.1365-2796.2005.01610.x; Walldius G, 2004, J INTERN MED, V255, P188, DOI 10.1046/j.1365-2796.2003.01276.x; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	30	31	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31103	10.1371/journal.pone.0031103	http://dx.doi.org/10.1371/journal.pone.0031103			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383996	gold, Green Published			2022-12-27	WOS:000302918500018
J	Leuchter, AF; Cook, IA; Hunter, AM; Cai, CC; Horvath, S				Leuchter, Andrew F.; Cook, Ian A.; Hunter, Aimee M.; Cai, Chaochao; Horvath, Steve			Resting-State Quantitative Electroencephalography Reveals Increased Neurophysiologic Connectivity in Depression	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; FRONTAL EEG ASYMMETRY; FUNCTIONAL CONNECTIVITY; MAJOR DEPRESSION; SLEEP MICROARCHITECTURE; ALPHA OSCILLATIONS; THETA-OSCILLATIONS; BRAIN ACTIVITY; COHERENCE; SYNCHRONIZATION	Symptoms of Major Depressive Disorder (MDD) are hypothesized to arise from dysfunction in brain networks linking the limbic system and cortical regions. Alterations in brain functional cortical connectivity in resting-state networks have been detected with functional imaging techniques, but neurophysiologic connectivity measures have not been systematically examined. We used weighted network analysis to examine resting state functional connectivity as measured by quantitative electroencephalographic (qEEG) coherence in 121 unmedicated subjects with MDD and 37 healthy controls. Subjects with MDD had significantly higher overall coherence as compared to controls in the delta (0.5-4 Hz), theta (4-8 Hz), alpha (8-12 Hz), and beta (12-20 Hz) frequency bands. The frontopolar region contained the greatest number of "hub nodes" (surface recording locations) with high connectivity. MDD subjects expressed higher theta and alpha coherence primarily in longer distance connections between frontopolar and temporal or parietooccipital regions, and higher beta coherence primarily in connections within and between electrodes overlying the dorsolateral prefrontal cortical (DLPFC) or temporal regions. Nearest centroid analysis indicated that MDD subjects were best characterized by six alpha band connections primarily involving the prefrontal region. The present findings indicate a loss of selectivity in resting functional connectivity in MDD. The overall greater coherence observed in depressed subjects establishes a new context for the interpretation of previous studies showing differences in frontal alpha power and synchrony between subjects with MDD and normal controls. These results can inform the development of qEEG state and trait biomarkers for MDD.	[Leuchter, Andrew F.; Cook, Ian A.; Hunter, Aimee M.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Lab Brain Behav & Pharmacol, Los Angeles, CA 90024 USA; [Leuchter, Andrew F.; Cook, Ian A.; Hunter, Aimee M.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, Depress Res & Clin Program, Los Angeles, CA 90024 USA; [Cai, Chaochao; Horvath, Steve] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Gonda Goldschmied Neurosci & Genet Res Ctr, Los Angeles, CA 90095 USA; [Cai, Chaochao; Horvath, Steve] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Leuchter, AF (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Lab Brain Behav & Pharmacol, Los Angeles, CA 90024 USA.	AFL@UCLA.EDU			Eli Lilly and Company; Wyeth Pharmaceuticals; Pfizer	Eli Lilly and Company(Eli Lilly); Wyeth Pharmaceuticals(Wyeth); Pfizer(Pfizer)	Eli Lilly and Company (www.lilly.com), Wyeth Pharmaceuticals (now owned by Pfizer), and Pfizer (www.Pfizer.com) contributed to the funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JJB, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00232; Andersen SB, 2009, INT J PSYCHOPHYSIOL, V71, P156, DOI 10.1016/j.ijpsycho.2008.09.004; Armitage R, 2006, CLIN EEG NEUROSCI, V37, P1; Armitage R, 2002, INT J NEUROPSYCHOPH, V5, P217, DOI 10.1017/S1461145702002948; Babiloni C, 2006, CLIN NEUROPHYSIOL, V117, P1000, DOI 10.1016/j.clinph.2005.12.028; Balconi M, 2009, INT J PSYCHOPHYSIOL, V74, P158, DOI 10.1016/j.ijpsycho.2009.08.006; Bluhm R, 2009, PSYCHIAT CLIN NEUROS, V63, P754, DOI 10.1111/j.1440-1819.2009.02030.x; Britz J, 2010, NEUROIMAGE, V52, P1162, DOI 10.1016/j.neuroimage.2010.02.052; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bruder GE, 1997, BIOL PSYCHIAT, V41, P939, DOI 10.1016/S0006-3223(96)00260-0; BULLOCK TH, 1995, ELECTROEN CLIN NEURO, V95, P161, DOI 10.1016/0013-4694(95)93347-A; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G., 2006, RHYTHMS BRAIN; Coan JA, 2004, BIOL PSYCHOL, V67, P7, DOI 10.1016/j.biopsycho.2004.03.002; Crespo-Garcia M, 2010, NEUROIMAGE, V50, P1258, DOI 10.1016/j.neuroimage.2010.01.018; Cullen KR, 2009, NEUROSCI LETT, V460, P227, DOI 10.1016/j.neulet.2009.05.022; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Debener S, 2000, NEUROPSYCHOBIOLOGY, V41, P31, DOI 10.1159/000026630; Del Percio C, 2011, NEUROSCIENCE, V175, P198, DOI 10.1016/j.neuroscience.2010.11.031; Diamond Adele, ANNU REV PSYCHOL, V64, P135, DOI [DOI 10.1146/annurev-clinpsy-032813-153724, 10.1146/annurev-psych-113011-143750, DOI 10.1146/ANNUREV-PSYCH-113011-143750]; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dzirasa K, 2010, J NEUROSCI, V30, P6387, DOI 10.1523/JNEUROSCI.0764-10.2010; Elliott R, 2002, ARCH GEN PSYCHIAT, V59, P597, DOI 10.1001/archpsyc.59.7.597; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Epstein J, 2011, PSYCHIAT RES-NEUROIM, V193, P144, DOI 10.1016/j.pscychresns.2011.01.012; Fales CL, 2008, BIOL PSYCHIAT, V63, P377, DOI 10.1016/j.biopsych.2007.06.012; Feige B, 2005, J NEUROPHYSIOL, V93, P2864, DOI 10.1152/jn.00721.2004; FEIN G, 1988, ELECTROEN CLIN NEURO, V69, P581, DOI 10.1016/0013-4694(88)90171-X; Fingelkurts AA, 2006, NEUROSCI RES, V56, P133, DOI 10.1016/j.neures.2006.06.006; Fingelkurts AA, 2007, HUM BRAIN MAPP, V28, P247, DOI 10.1002/hbm.20275; First MB, 2002, STRUCTURED CLIN INTE; Fulton MK, 2000, BIOL PSYCHIAT, V47, P618, DOI 10.1016/S0006-3223(99)00163-8; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Grimm S, 2009, NEUROPSYCHOPHARMACOL, V34, P932, DOI 10.1038/npp.2008.81; Hajos M, 2003, NEUROPSYCHOPHARMACOL, V28, P857, DOI 10.1038/sj.npp.1300116; Hamilton JP, 2011, MOL PSYCHIATR, V16, P763, DOI 10.1038/mp.2010.46; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Heller W, 1998, COGNITION EMOTION, V12, P421; HENRIQUES JB, 1991, J ABNORM PSYCHOL, V100, P535, DOI 10.1037/0021-843X.100.4.535; Herrera-Guzman I, 2010, J AFFECT DISORDERS, V123, P341, DOI 10.1016/j.jad.2009.10.009; Hinrikus H, 2009, MED BIOL ENG COMPUT, V47, P1291, DOI 10.1007/s11517-009-0554-9; Hlinka J, 2010, NEUROIMAGE, V53, P239, DOI 10.1016/j.neuroimage.2010.06.002; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Hyvarinen A, 2010, NEUROIMAGE, V49, P257, DOI 10.1016/j.neuroimage.2009.08.028; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Jann K, 2009, NEUROIMAGE, V45, P903, DOI 10.1016/j.neuroimage.2009.01.001; Joormann J, 2006, BEHAV THER, V37, P269, DOI 10.1016/j.beth.2006.01.002; Kaplan AY, 1997, ZH VYSSH NERV DEYAT+, V47, P32; Kemp AH, 2010, BIOL PSYCHOL, V85, P350, DOI 10.1016/j.biopsycho.2010.08.001; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Knott V, 2001, PSYCHIAT RES-NEUROIM, V106, P123, DOI 10.1016/S0925-4927(00)00080-9; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; Kostandov E A, 2010, Neurosci Behav Physiol, V40, P197, DOI 10.1007/s11055-009-9239-y; Kudina T A, 2004, Neurosci Behav Physiol, V34, P929, DOI 10.1023/B:NEAB.0000042576.39132.f5; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; LEUCHTER AF, 1992, BRAIN, V115, P1543, DOI 10.1093/brain/115.5.1543; Leuchter AF, 2008, CLIN EEG NEUROSCI, V39, P175, DOI 10.1177/155005940803900405; Linkenkaer-Hansen K, 2005, J NEUROSCI, V25, P10131, DOI 10.1523/JNEUROSCI.3244-05.2005; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Marchand W, 2011, PROG NEUROPSYCHOPHAR; Mu Y, 2010, NEUROIMAGE, V53, P757, DOI 10.1016/j.neuroimage.2010.07.008; Musso F, 2010, NEUROIMAGE, V52, P1149, DOI 10.1016/j.neuroimage.2010.01.093; Nunez P.L., 1995, NEOCORTICAL DYNAMICS; Nunez PL, 2001, HUM BRAIN MAPP, V13, P125, DOI 10.1002/hbm.1030; Nunez PL, 1999, CLIN NEUROPHYSIOL, V110, P469, DOI 10.1016/S1388-2457(98)00043-1; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; OCONNOR KP, 1979, BRIT J PSYCHIAT, V135, P156, DOI 10.1192/bjp.135.2.156; Ottowitz WE, 2002, HARVARD REV PSYCHIAT, V10, P86, DOI 10.1093/hrp/10.2.86; Park CA, 2007, IFMBE PROC, V14, P1095; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pizzagalli DA, 2005, PSYCHOL SCI, V16, P805, DOI 10.1111/j.1467-9280.2005.01618.x; Pizzagalli DA, 2011, NEUROPSYCHOPHARMACOL, V36, P183, DOI 10.1038/npp.2010.166; Puig M, 2011, MOL NEUROBIOL; RAPPELSBERGER P, 1988, Brain Topography, V1, P46, DOI 10.1007/BF01129339; Regier DA, 2009, AM J PSYCHIAT, V166, P645, DOI 10.1176/appi.ajp.2009.09020279; Rengachary J, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00029, 10.3389/fnhum.2011.00069]; ROEMER R A, 1992, Brain Topography, V4, P285, DOI 10.1007/BF01135566; Sadaghiani S, 2010, J NEUROSCI, V30, P10243, DOI 10.1523/JNEUROSCI.1004-10.2010; Sauseng P, 2006, EXP BRAIN RES, V170, P295, DOI 10.1007/s00221-005-0211-y; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; Savitz JB, 2009, NEUROSCIENCE, V164, P300, DOI 10.1016/j.neuroscience.2009.03.082; Schyns PG, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001064; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Segrave RA, 2010, J AFFECT DISORDERS, V127, P191, DOI 10.1016/j.jad.2010.05.022; SHAW JC, 1984, INT J PSYCHOPHYSIOL, V1, P255, DOI 10.1016/0167-8760(84)90045-X; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Srinivasan R, 1996, BRAIN TOPOGR, V8, P355, DOI 10.1007/BF01186911; Srinivasan R, 1998, IEEE T BIO-MED ENG, V45, P814, DOI 10.1109/10.686789; Srinivasan R, 2007, J NEUROSCI METH, V166, P41, DOI 10.1016/j.jneumeth.2007.06.026; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; Stewart JL, 2011, J AFFECT DISORDERS, V129, P167, DOI 10.1016/j.jad.2010.08.029; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Sun Y, 2008, BRAIN RES BULL, V76, P559, DOI 10.1016/j.brainresbull.2008.05.001; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Tcheslavski GV, 2006, BIOMED SIGNAL PROCES, V1, P151, DOI 10.1016/j.bspc.2006.08.001; THATCHER RW, 1986, ELECTROEN CLIN NEURO, V64, P123, DOI 10.1016/0013-4694(86)90107-0; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; van Wingen GA, 2010, PSYCHOL MED, V8, P1; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Winterer G, 2003, ACTA PSYCHIAT SCAND, V108, P51, DOI 10.1034/j.1600-0447.2003.00060.x; Womelsdorf T, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00210; Zakzanis KK, 1998, NEUROPSY NEUROPSY BE, V11, P111; Zhang Y, 2008, NEUROSCIENCE, V156, P238, DOI 10.1016/j.neuroscience.2008.06.061; Zhou Y, 2010, J AFFECT DISORDERS, V121, P220, DOI 10.1016/j.jad.2009.05.029	109	137	141	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32508	10.1371/journal.pone.0032508	http://dx.doi.org/10.1371/journal.pone.0032508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384265	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916800041
J	Yang, JJ; Cho, LY; Ko, KP; Shin, A; Ma, SH; Choi, BY; Han, DS; Song, KS; Kim, YS; Lee, JY; Han, BG; Chang, SH; Shin, HR; Kang, D; Yoo, KY; Park, SK				Yang, Jae Jeong; Cho, Lisa Y.; Ko, Kwang-Pil; Shin, Aesun; Ma, Seung Hyun; Choi, Bo Youl; Han, Dong Soo; Song, Kyu Sang; Kim, Yong Sung; Lee, Jong-Young; Han, Bok Ghee; Chang, Soung-Hoon; Shin, Hai-Rim; Kang, Daehee; Yoo, Keun-Young; Park, Sue K.			Genetic Susceptibility on CagA-Interacting Molecules and Gene-Environment Interaction with Phytoestrogens: A Putative Risk Factor for Gastric Cancer	PLOS ONE			English	Article							HELICOBACTER-PYLORI CAGA; PROTEIN; MET; KINASE; CELLS; SRC; ASSOCIATION; EXPRESSION; RECEPTOR; FAMILY	Objectives: To evaluate whether genes that encode CagA-interacting molecules (SRC, PTPN11, CRK, CRKL, CSK, c-MET and GRB2) are associated with gastric cancer risk and whether an interaction between these genes and phytoestrogens modify gastric cancer risk. Methods: In the discovery phase, 137 candidate SNPs in seven genes were analyzed in 76 incident gastric cancer cases and 322 matched controls from the Korean Multi-Center Cancer Cohort. Five significant SNPs in three genes (SRC, c-MET and CRK) were re-evaluated in 386 cases and 348 controls in the extension phase. Odds ratios (ORs) for gastric cancer risk were estimated adjusted for age, smoking, H. pylori seropositivity and CagA strain positivity. Summarized ORs in the total study population (462 cases and 670 controls) were presented using pooled-and meta-analysis. Plasma concentrations of phytoestrogens (genistein, daidzein, equol and enterolactone) were measured using the time-resolved fluoroimmunoassay. Results: SRC rs6122566, rs6124914, c-MET rs41739, and CRK rs7208768 showed significant genetic effects for gastric cancer in both the pooled and meta-analysis without heterogeneity (pooled OR = 3.96 [95% CI 2.05-7.65], 1.24 [95% CI = 1.01-1.53], 1.19 [95% CI = 1.01-1.41], and 1.37 [95% CI = 1.15-1.62], respectively; meta OR = 4.59 [95% CI 2.74-7.70], 1.36 [95% CI = 1.09-1.70], 1.20 [95% CI = 1.00-1.44], and 1.32 [95% CI = 1.10-1.57], respectively). Risk allele of CRK rs7208768 had a significantly increased risk for gastric cancer at low phytoestrogen levels (p interaction<0.05). Conclusions: Our findings suggest that SRC, c-MET and CRK play a key role in gastric carcinogenesis by modulating CagA signal transductions and interaction between CRK gene and phytoestrogens modify gastric cancer risk.	[Yang, Jae Jeong; Cho, Lisa Y.; Ma, Seung Hyun; Kang, Daehee; Yoo, Keun-Young; Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Yang, Jae Jeong; Cho, Lisa Y.; Ma, Seung Hyun; Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Ko, Kwang-Pil] Gachon Univ Med & Sci, Dept Prevent Med, Inchon, South Korea; [Shin, Aesun; Shin, Hai-Rim] Natl Canc Ctr, Canc Epidemiol Branch, Goyang Si, South Korea; [Choi, Bo Youl] Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea; [Han, Dong Soo] Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea; [Song, Kyu Sang] Chungnam Natl Univ, Dept Pathol, Coll Med, Taejon, South Korea; [Kim, Yong Sung] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon, South Korea; [Lee, Jong-Young; Han, Bok Ghee] Korea Natl Inst Hlth, Ctr Genome Sci, Osong, South Korea; [Chang, Soung-Hoon] Konkuk Univ, Dept Prevent Med, Chungju, South Korea; [Shin, Hai-Rim] Western Pacific Reg Off, World Hlth Org, Manila, Philippines; [Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Gachon University; National Cancer Center - Korea (NCC); Hanyang University; Hanyang University; Chungnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Konkuk University; Konkuk University Medical Center; World Health Organization; Seoul National University (SNU)	Yang, JJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	suepark@snu.ac.kr	Park, Sue Kyung/J-2757-2012; Shin, Aesun/E-9145-2014; Yoo, Keun-Young/J-5548-2012; Han, Dong Soo/P-1753-2015; Han, Dong Soo/AHD-6285-2022; Kang, Dae Hee/E-8631-2012; Lee, Jong-Young/M-6319-2013	Shin, Aesun/0000-0002-6426-1969; Han, Dong Soo/0000-0001-7103-3318; Lee, Jong-Young/0000-0002-0092-9958; Kang, Daehee/0000-0003-4031-5878	Ministry of Health and Welfare, Republic of Korea [0520140]; National Research Foundation of Korea; Ministry of Education, Science and Technology [2011-0001564]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (0520140), and the Basic Research Laboratory (BRL) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2011-0001564). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T., 2007, Inflammopharmacology, V15, P10, DOI 10.1007/s10787-006-1556-y; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Blaser MJ, 1998, BRIT MED J, V316, P1507, DOI 10.1136/bmj.316.7143.1507; BLASER MJ, 1995, CANCER RES, V55, P2111; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Chen YC, 2006, WORLD J GASTROENTERO, V12, P5972, DOI 10.3748/wjg.v12.i37.5972; Cho LY, 2009, ANN EPIDEMIOL, V19, P644, DOI 10.1016/j.annepidem.2009.04.011; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; Goto Y, 2006, INT J CANCER, V118, P203, DOI 10.1002/ijc.21338; Gual P, 2000, ONCOGENE, V19, P1509, DOI 10.1038/sj.onc.1203514; Gwack J, 2006, BRIT J CANCER, V95, P639, DOI 10.1038/sj.bjc.6603309; Handa O, 2007, BIOCHEM PHARMACOL, V73, P1697, DOI 10.1016/j.bcp.2006.10.022; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; Hatakeyama M, 2005, CANCER SCI, V96, P835, DOI 10.1111/j.1349-7006.2005.00130.x; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2003, MICROBES INFECT, V5, P143, DOI 10.1016/S1286-4579(02)00085-0; Hatakeyama M, 2006, INT J HEMATOL, V84, P301, DOI 10.1532/IJH97.06166; Herynk MH, 2007, J EXP THER ONCOL, V6, P205; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; Hong HK, 2006, J BASIC MICROB, V46, P329, DOI 10.1002/jobm.200510073; IARC, 1994, IARC MON EV CARC RIS, V61, P177; Inoue T, 2004, CANCER SCI, V95, P803, DOI 10.1111/j.1349-7006.2004.tb02185.x; Ko KP, 2010, CANCER EPIDEM BIOMAR, V19, P1292, DOI 10.1158/1055-9965.EPI-09-1004; Kobashigawa Y, 2007, NAT STRUCT MOL BIOL, V14, P503, DOI 10.1038/nsmb1241; KUNIYASU H, 1992, BIOCHEM BIOPH RES CO, V189, P227, DOI 10.1016/0006-291X(92)91548-5; Lin Charles H., 2009, V496, P129, DOI 10.1007/978-1-59745-553-4_10; Ma PC, 2008, GENE CHROMOSOME CANC, V47, P1025, DOI 10.1002/gcc.20604; MATSUKAWA Y, 1993, CANCER RES, V53, P1328; Miller CT, 2003, ONCOGENE, V22, P7950, DOI 10.1038/sj.onc.1206529; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Nishihara H, 2002, CANCER LETT, V180, P55, DOI 10.1016/S0304-3835(01)00763-7; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Park CY, 2002, J CLIN MICROBIOL, V40, P4753, DOI 10.1128/JCM.40.12.4753-4756.2002; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Porter J, 2010, EXPERT OPIN THER PAT, V20, P159, DOI 10.1517/13543770903514137; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Rohde M, 2003, MOL MICROBIOL, V49, P219, DOI 10.1046/j.1365-2958.2003.03549.x; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Shin A, 2005, BRIT J CANCER, V92, P1273, DOI 10.1038/sj.bjc.6602467; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; Takeuchi H, 2003, CLIN CANCER RES, V9, P1480; Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200; Wen SC, 2009, CANCER LETT, V282, P1, DOI 10.1016/j.canlet.2008.11.016; Yoo Keun Young, 2002, Asian Pac J Cancer Prev, V3, P85; Zhou HB, 2004, WORLD J GASTROENTERO, V10, P1822	49	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31020	10.1371/journal.pone.0031020	http://dx.doi.org/10.1371/journal.pone.0031020			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22383989	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916800008
J	Antonov, A; Stokke, BG; Fossoy, F; Ranke, PS; Liang, W; Yang, CC; Moksnes, A; Shykoff, J; Roskaft, E				Antonov, Anton; Stokke, Bard G.; Fossoy, Frode; Ranke, Peter S.; Liang, Wei; Yang, Canchao; Moksnes, Arne; Shykoff, Jacqui; Roskaft, Eivin			Are Cuckoos Maximizing Egg Mimicry by Selecting Host Individuals with Better Matching Egg Phenotypes?	PLOS ONE			English	Article							WARBLERS ACROCEPHALUS-PALUSTRIS; CUCULUS-CANORUS PARASITISM; GREAT REED WARBLERS; COMMON CUCKOOS; COLOR PATTERNS; REJECTION BEHAVIOR; BROOD PARASITISM; NESTS; EVOLUTION; BIRDS	Background: Avian brood parasites and their hosts are involved in complex offence-defense coevolutionary arms races. The most common pair of reciprocal adaptations in these systems is egg discrimination by hosts and egg mimicry by parasites. As mimicry improves, more advanced host adaptations evolve such as decreased intra-and increased interclutch variation in egg appearance to facilitate detection of parasitic eggs. As interclutch variation increases, parasites able to choose hosts matching best their own egg phenotype should be selected, but this requires that parasites know their own egg phenotype and select host nests correspondingly. Methodology/Principal Findings: We compared egg mimicry of common cuckoo Cuculus canorus eggs in naturally parasitized marsh warbler Acrocephalus palustris nests and their nearest unparasitized conspecific neighbors having similar laying dates and nest-site characteristics. Modeling of avian vision and image analyses revealed no evidence that cuckoos parasitize nests where their eggs better match the host eggs. Cuckoo eggs were as good mimics, in terms of background and spot color, background luminance, spotting pattern and egg size, of host eggs in the nests actually exploited as those in the neighboring unparasitized nests. Conclusions/Significance: We reviewed the evidence for brood parasites selecting better-matching host egg phenotypes from several relevant studies and argue that such selection probably cannot exist in host-parasite systems where host interclutch variation is continuous and overall low or moderate. To date there is also no evidence that parasites prefer certain egg phenotypes in systems where it should be most advantageous, i.e., when both hosts and parasites lay polymorphic eggs. Hence, the existence of an ability to select host nests to maximize mimicry by brood parasites appears unlikely, but this possibility should be further explored in cuckoo-host systems where the host has evolved discrete egg phenotypes.	[Antonov, Anton; Stokke, Bard G.; Fossoy, Frode; Ranke, Peter S.; Moksnes, Arne; Roskaft, Eivin] Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway; [Liang, Wei; Yang, Canchao] Hainan Normal Univ, Coll Life Sci, Haikou, Peoples R China; [Shykoff, Jacqui] Univ Paris 11, CNRS, AgroParisTech, Lab Ecol Systemat & Evolut,UMR 8079, F-91405 Orsay, France	Norwegian University of Science & Technology (NTNU); Hainan Normal University; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay	Antonov, A (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway.	liangwei@hainnu.edu.cn	Fossoy, Frode/O-3073-2017; Røskaft, Eivin/N-7476-2019	Fossoy, Frode/0000-0002-7535-9574; Røskaft, Eivin/0000-0003-0262-8443; Ranke, Peter S./0000-0003-3757-8626	National Natural Science Foundation of China [31071938]; Program for New Century Excellent Talents in University [NCET-10-0111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Natural Science Foundation of China (No 31071938 to WL, BGS and AA), and by Program for New Century Excellent Talents in University (NCET-10-0111 to WL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonov A, 2006, BEHAV ECOL SOCIOBIOL, V60, P11, DOI 10.1007/s00265-005-0132-6; Antonov A, 2010, J EVOLUTION BIOL, V23, P1170, DOI 10.1111/j.1420-9101.2010.01982.x; Antonov A, 2007, J AVIAN BIOL, V38, P390, DOI 10.1111/j.2007.0908-8857.03813.x; Antonov A, 2006, AUK, V123, P419, DOI 10.1642/0004-8038(2006)123[419:ERIMWA]2.0.CO;2; Aviles JM, 2006, J EVOLUTION BIOL, V19, P1901, DOI 10.1111/j.1420-9101.2006.01166.x; Aviles JM, 2011, J EVOLUTION BIOL, V24, P314, DOI 10.1111/j.1420-9101.2010.02168.x; Aviles JM, 2010, J EVOLUTION BIOL, V23, P293, DOI 10.1111/j.1420-9101.2009.01898.x; Aviles JM, 2008, AM NAT, V171, P327, DOI 10.1086/527493; Aviles JM, 2011, BEHAV ECOL SOCIOBIOL, V65, P1721, DOI 10.1007/s00265-011-1180-8; Aviles JM, 2009, AUK, V126, P431, DOI 10.1525/auk.2009.08162; Banks AJ, 2001, BEHAV ECOL, V12, P31, DOI 10.1093/oxfordjournals.beheco.a000375; Cassey P, 2008, BIOL LETTERS, V4, P515, DOI 10.1098/rsbl.2008.0279; Cassey P, 2009, IBIS, V151, P689, DOI 10.1111/j.1474-919X.2009.00953.x; Cherry MI, 2007, J EVOLUTION BIOL, V20, P1218, DOI 10.1111/j.1420-9101.2007.01308.x; Cherry MI, 2001, P ROY SOC B-BIOL SCI, V268, P565, DOI 10.1098/rspb.2000.1414; Cuthill IC, 1999, AM NAT, V153, P183, DOI 10.1086/303160; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; DAVIES NB, 1989, J ANIM ECOL, V58, P207, DOI 10.2307/4995; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Goldsmith TH, 2005, J COMP PHYSIOL A, V191, P933, DOI 10.1007/s00359-005-0024-2; Gomez D., 2006, AVICOL PROGRAM ANAL, V1; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; Honza M, 2002, ANIM BEHAV, V64, P861, DOI 10.1006/anbe.2002.1969; Hoyt OF, 1979, AUK, V96, P73; Kilner RM, 2006, BIOL REV, V81, P383, DOI 10.1017/S1464793106007044; MOKSNES A, 1995, J ZOOL, V236, P625, DOI 10.1111/j.1469-7998.1995.tb02736.x; Moksnes A, 2000, IBIS, V142, P247, DOI 10.1111/j.1474-919X.2000.tb04864.x; Moskat C, 2002, IBIS, V144, P614, DOI 10.1046/j.1474-919X.2002.00085.x; OIEN IJ, 1995, BEHAV ECOL, V6, P166, DOI 10.1093/beheco/6.2.166; Polacikova L, 2009, EVOL ECOL, V23, P879, DOI 10.1007/s10682-008-9278-9; Roskaft E, 2002, BEHAV ECOL, V13, P163, DOI 10.1093/beheco/13.2.163; Rothstein SI, 1998, PARASITIC BIRDS THEI; SOLER JJ, 1995, BEHAV ECOL SOCIOBIOL, V36, P201, DOI 10.1007/BF00177797; Spottiswoode CN, 2010, P NATL ACAD SCI USA, V107, P8672, DOI 10.1073/pnas.0910486107; Stokke BG, 2007, EVOLUTION, V61, P2212, DOI 10.1111/j.1558-5646.2007.00176.x; Stokke Bard G., 2005, Ornithological Science, V4, P17, DOI 10.2326/osj.4.17; Stokke BG, 2002, EVOLUTION, V56, P199; Takasu F, 2003, EVOL ECOL RES, V5, P345; Vikan JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019288; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Wyllie I., 1981, CUCKOO; Yang CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010816	43	23	30	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31704	10.1371/journal.pone.0031704	http://dx.doi.org/10.1371/journal.pone.0031704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384060	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100029
J	Baselga, A; Gomez-Rodriguez, C; Lobo, JM				Baselga, Andres; Gomez-Rodriguez, Carola; Lobo, Jorge M.			Historical Legacies in World Amphibian Diversity Revealed by the Turnover and Nestedness Components of Beta Diversity	PLOS ONE			English	Article							SPECIES RICHNESS; GLOBAL PATTERNS; LATITUDINAL GRADIENTS; NICHE CONSERVATISM; CLIMATE-CHANGE; SCALE; EVOLUTIONARY; ENERGY; WATER; ENDEMISM	Historic processes are expected to influence present diversity patterns in combination with contemporary environmental factors. We hypothesise that the joint use of beta diversity partitioning methods and a threshold-based approach may help reveal the effect of large-scale historic processes on present biodiversity. We partitioned intra-regional beta diversity into its turnover (differences in composition caused by species replacements) and nestedness-resultant (differences in species composition caused by species losses) components. We used piecewise regressions to show that, for amphibian beta diversity, two different world regions can be distinguished. Below parallel 37, beta diversity is dominated by turnover, while above parallel 37, beta diversity is dominated by nestedness. Notably, these regions are revealed when the piecewise regression method is applied to the relationship between latitude and the difference between the Last Glacial Maximum (LGM) and the present temperature but not when present energy-water factors are analysed. When this threshold effect of historic climatic change is partialled out, current energy-water variables become more relevant to the nestedness-resultant dissimilarity patterns, while mountainous areas are associated with higher spatial turnover. This result suggests that nested patterns are caused by species losses that are determined by physiological constraints, whereas turnover is associated with speciation and/or Pleistocene refugia. Thus, the new threshold-based view may help reveal the role of historic factors in shaping present amphibian beta diversity patterns.	[Baselga, Andres; Gomez-Rodriguez, Carola] Univ Santiago de Compostela, Fac Biol, Dept Zool, Santiago De Compostela, Spain; [Lobo, Jorge M.] CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolutiva, E-28006 Madrid, Spain	Universidade de Santiago de Compostela; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Baselga, A (corresponding author), Univ Santiago de Compostela, Fac Biol, Dept Zool, Santiago De Compostela, Spain.	andres.baselga@usc.es	Lobo, Jorge M/E-2309-2013; Gómez-Rodríguez, Carola/B-6823-2016; Baselga, Andres/A-6740-2008	Lobo, Jorge M/0000-0002-3152-4769; Gómez-Rodríguez, Carola/0000-0002-2019-7176; Baselga, Andres/0000-0001-7914-7109	Spanish Ministry of Science and Innovation [CGL2009-10111]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	AB is funded by the Spanish Ministry of Science and Innovation (grant CGL2009-10111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn C-H, 1994, J JAPANESE SOC PHOTO, V33, P12, DOI DOI 10.4287/JSPRS.33.2_12; Araujo MB, 2008, ECOGRAPHY, V31, P8, DOI 10.1111/j.2007.0906-7590.05318.x; Bahn V, 2007, GLOBAL ECOL BIOGEOGR, V16, P733, DOI 10.1111/j.1466-8238.2007.00331.x; Baselga A, 2012, GLOBAL ECOL IN PRESS; Baselga A, 2008, ECOGRAPHY, V31, P263, DOI 10.1111/j.0906-7590.2008.5335.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Buckley LB, 2007, P ROY SOC B-BIOL SCI, V274, P1167, DOI 10.1098/rspb.2006.0436; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Clark Labs, 2000, GLOB CHANG DAT ARCH, V3; Crawley M.J., 2007, R BOOK; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Dobrovolski R, 2012, GLOBAL ECOL BIOGEOGR, V21, P191, DOI 10.1111/j.1466-8238.2011.00671.x; Dutilleul P, 1993, BIOMETRICS, V6, P46; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Ehlers J, 2004, EXTENT CHRONOLOGY GL, V2; Ehlers J, 2004, EXTENT CHRONOLOGY GL, V3; Ehlers J, 2004, EXTENT CHRONOLOGY GL, V1; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Fjeldsa J, 1999, ECOGRAPHY, V22, P63, DOI 10.1111/j.1600-0587.1999.tb00455.x; Gaston KJ, 2007, P ROY SOC B-BIOL SCI, V274, P1567, DOI 10.1098/rspb.2007.0236; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Hawkins BA, 2006, J BIOGEOGR, V33, P770, DOI 10.1111/j.1365-2699.2006.01452.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2003, ECOL ENTOMOL, V28, P678, DOI 10.1111/j.1365-2311.2003.00551.x; Hawkins BA, 2003, GLOBAL ECOL BIOGEOGR, V12, P475, DOI 10.1046/j.1466-822X.2003.00060.x; Hawkins BA, 2010, J BIOGEOGR, V37, P647, DOI 10.1111/j.1365-2699.2009.02250.x; Heaney LR, 2005, J BIOGEOGR, V32, P229, DOI 10.1111/j.1365-2699.2004.01120.x; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hortal J, 2011, ECOL LETT, V14, P741, DOI 10.1111/j.1461-0248.2011.01634.x; IUCN, 2014, IUCN RED LIST THREAT; Jansson R, 2003, P ROY SOC B-BIOL SCI, V270, P583, DOI 10.1098/rspb.2002.2283; Kerr JT, 1999, ECOSCIENCE, V6, P329, DOI 10.1080/11956860.1999.11682546; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Latham Roger Earl, 1993, P294; Legendre P., 2012, NUMERICAL ECOLOGY; Leprieur F, 2011, ECOL LETT, V14, P325, DOI 10.1111/j.1461-0248.2011.01589.x; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Melo AS, 2009, ECOGRAPHY, V32, P226, DOI 10.1111/j.1600-0587.2008.05502.x; Montoya D, 2007, ECOGRAPHY, V30, P173, DOI 10.1111/j.0906-7590.2007.04873.x; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Qian H, 2007, ECOL LETT, V10, P737, DOI 10.1111/j.1461-0248.2007.01066.x; Qian H, 2010, ECOL RES, V25, P629, DOI 10.1007/s11284-010-0695-1; R Core Team, 2020, R LANG ENV STAT COMP; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Ricklefs RE, 1999, OIKOS, V86, P369, DOI 10.2307/3546454; Ricklefs RE, 2006, ECOLOGY, V87, pS3, DOI 10.1890/0012-9658(2006)87[3:EDATOO]2.0.CO;2; Ruggiero A, 2008, ECOGRAPHY, V31, P306, DOI 10.1111/j.0906-7590.2008.05333.x; Sastre P, 2009, J BIOGEOGR, V36, P568, DOI 10.1111/j.1365-2699.2008.02070.x; Smith MA, 2005, ECOGRAPHY, V28, P110; Svenning JC, 2004, ECOLOGY, V85, P2526, DOI 10.1890/03-0396; Svenning JC, 2007, ECOL LETT, V10, P453, DOI 10.1111/j.1461-0248.2007.01038.x; Svenning JC, 2011, J ANIM ECOL, V80, P393, DOI 10.1111/j.1365-2656.2010.01771.x; Tello JS, 2012, GLOBAL ECOL BIOGEOGR, V21, P212, DOI 10.1111/j.1466-8238.2011.00661.x; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Whittaker RJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P76, DOI 10.1111/j.1466-8238.2006.00268.x; Whitton FJS, 2012, GLOBAL ECOL BIOGEOGR, V21, P179, DOI 10.1111/j.1466-8238.2011.00660.x; Wiens JJ, 2007, AM NAT, V170, pS86, DOI 10.1086/519396; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109; Zobel M, 2011, GLOBAL ECOL BIOGEOGR, V20, P251, DOI 10.1111/j.1466-8238.2010.00593.x	63	106	108	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32341	10.1371/journal.pone.0032341	http://dx.doi.org/10.1371/journal.pone.0032341			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384222	gold, Green Published, Green Submitted			2022-12-27	WOS:000302916100070
J	Delaney, JT; Jeff, JM; Brown, NJ; Pretorius, M; Okafor, HE; Darbar, D; Roden, DM; Crawford, DC				Delaney, Jessica T.; Jeff, Janina M.; Brown, Nancy J.; Pretorius, Mias; Okafor, Henry E.; Darbar, Dawood; Roden, Dan M.; Crawford, Dana C.			Characterization of Genome-Wide Association-Identified Variants for Atrial Fibrillation in African Americans	PLOS ONE			English	Article							SAMPLE-SIZE REQUIREMENTS; BREAST-CANCER RISK; ATHEROSCLEROSIS RISK; EUROPEAN ANCESTRY; GENETIC ANCESTRY; UNITED-STATES; POPULATION; PREVALENCE; SUSCEPTIBILITY; DISEASE	Background: Despite a greater burden of risk factors, atrial fibrillation (AF) is less common among African Americans than European-descent populations. Genome-wide association studies (GWAS) for AF in European-descent populations have identified three predominant genomic regions associated with increased risk (1q21, 4q25, and 16q22). The contribution of these loci to AF risk in African American is unknown. Methodology/Principal Findings: We studied 73 African Americans with AF from the Vanderbilt-Meharry AF registry and 71 African American controls, with no history of AF including after cardiac surgery. Tests of association were performed for 148 SNPs across the three regions associated with AF, and 22 SNPs were significantly associated with AF (P<0.05). The SNPs with the strongest associations in African Americans were both different from the index SNPs identified in European-descent populations and independent from the index European-descent population SNPs (r(2)<0.40 in HapMap CEU): 1q21 rs4845396 (odds ratio [OR] 0.30, 95% confidence interval [CI] 0.13-0.67, P = 0.003), 4q25 rs4631108 (OR 3.43, 95% CI 1.59-7.42, P = 0.002), and 16q22 rs16971547 (OR 8.1, 95% CI 1.46-45.4, P = 0.016). Estimates of European ancestry were similar among cases (23.6%) and controls (23.8%). Accordingly, the probability of having two copies of the European derived chromosomes at each region did not differ between cases and controls. Conclusions/Significance: Variable European admixture at known AF loci does not explain decreased AF susceptibility in African Americans. These data support the role of 1q21, 4q25, and 16q22 variants in AF risk for African Americans, although the index SNPs differ from those identified in European-descent populations.	[Delaney, Jessica T.; Brown, Nancy J.; Darbar, Dawood; Roden, Dan M.] Vanderbilt Univ, Dept Med, Nashville, TN 37235 USA; [Jeff, Janina M.; Crawford, Dana C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Jeff, Janina M.; Crawford, Dana C.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA; [Brown, Nancy J.; Roden, Dan M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Pretorius, Mias] Vanderbilt Univ, Dept Anesthesiol, Nashville, TN USA; [Okafor, Henry E.] Meharry Med Coll, Dept Med, Nashville, TN 37208 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Meharry Medical College	Delaney, JT (corresponding author), Vanderbilt Univ, Dept Med, Nashville, TN 37235 USA.	dana.crawford@chgr.mc.vanderbilt.edu	Crawford, Dana/C-1054-2012; Crawford, Dana/O-5578-2019; Roden, Dan/ABD-5412-2021; Darbar, Dawood/C-9079-2015	Crawford, Dana/0000-0002-6437-6248; Darbar, Dawood/0000-0002-4103-5977; Pretorius, Mias/0000-0002-8777-3940	National Institutes of Health Pharmacogenetics Research Network [U01 HL65962, U01 HL92217]; NIH [GM007569, R01 HL092217]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092217, U01HL065962, U19HL065962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459, T32GM080178, T32GM007569] Funding Source: NIH RePORTER	National Institutes of Health Pharmacogenetics Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by the National Institutes of Health Pharmacogenetics Research Network (U01 HL65962 and U01 HL92217), NIH training grant (GM007569), NIH grant R01 HL092217, and an American Heart Association Established Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Behar DM, 2010, HUM MOL GENET, V19, P1816, DOI 10.1093/hmg/ddq040; Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; Bock CH, 2009, HUM GENET, V126, P637, DOI 10.1007/s00439-009-0712-z; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Cheng CY, 2010, OBESITY, V18, P563, DOI 10.1038/oby.2009.282; Cheng CY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000490; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Darbar D, 2007, HEART RHYTHM, V4, P743, DOI 10.1016/j.hrthm.2007.02.006; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Fejerman L, 2008, CANCER RES, V68, P9723, DOI 10.1158/0008-5472.CAN-08-2039; Fejerman L, 2010, CANCER EPIDEM BIOMAR, V19, P1074, DOI 10.1158/1055-9965.EPI-09-1193; Fejerman L, 2009, CANCER EPIDEM BIOMAR, V18, P3110, DOI 10.1158/1055-9965.EPI-09-0464; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Grady BJ, 2010, BIOCOMPUT-PAC SYM, P315; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417; Hughes LB, 2008, ARTHRITIS RHEUM-US, V58, P349, DOI 10.1002/art.23166; Kaab S, 2009, EUR HEART J, V30, P813, DOI 10.1093/eurheartj/ehn578; Keebler ME, 2010, CIRC-CARDIOVASC GENE, V3, P358, DOI 10.1161/CIRCGENETICS.109.914267; Kirchhof P, 2011, CIRC-CARDIOVASC GENE, V4, P123, DOI 10.1161/CIRCGENETICS.110.958058; Lai CQ, 2009, HUM GENET, V125, P199, DOI 10.1007/s00439-008-0612-7; LaRosa JC, 2005, AM J MED, V118, P1314, DOI 10.1016/j.amjmed.2005.04.041; Li C, 2011, HUM GENET, V129, P239, DOI 10.1007/s00439-010-0912-6; Lubitz SA, 2010, CIRCULATION, V122, P976, DOI 10.1161/CIRCULATIONAHA.109.886440; Marcus GM, 2010, CIRCULATION, V122, P2009, DOI 10.1161/CIRCULATIONAHA.110.958306; Milan DJ, 2010, HEART RHYTHM, V7, P1141, DOI 10.1016/j.hrthm.2010.04.021; Motsinger Alison A, 2006, Pac Symp Biocomput, P584, DOI 10.1142/9789812701626_0054; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ozgen N, 2007, CARDIOVASC RES, V75, P758, DOI 10.1016/j.cardiores.2007.05.008; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Postma AV, 2011, CARDIOVASC RES, V91, P243, DOI 10.1093/cvr/cvr134; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiner AP, 2007, HUM GENET, V121, P565, DOI 10.1007/s00439-007-0350-2; Rice TK, 2008, ADV GENET, V60, P293, DOI 10.1016/S0065-2660(07)00412-9; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Ruiz-Narvaez EA, 2010, HUM GENET, V127, P629, DOI 10.1007/s00439-010-0803-x; Ruiz-Narvaez EA, 2010, CANCER EPIDEM BIOMAR, V19, P1320, DOI 10.1158/1055-9965.EPI-09-1250; Ruo B, 2004, J AM COLL CARDIOL, V43, P429, DOI 10.1016/j.jacc.2003.09.035; Rybicki BA, 2002, HUM HERED, V53, P187, DOI 10.1159/000066193; Tsai CT, 2008, HEART RHYTHM, V5, P1285, DOI 10.1016/j.hrthm.2008.05.012; Udler MS, 2009, HUM MOL GENET, V18, P1692, DOI 10.1093/hmg/ddp078; Vergara C, 2009, HUM GENET, V125, P565, DOI 10.1007/s00439-009-0649-2; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	50	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32338	10.1371/journal.pone.0032338	http://dx.doi.org/10.1371/journal.pone.0032338			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384221	gold, Green Published, Green Submitted			2022-12-27	WOS:000302916100069
J	Paraschiv-Ionescu, A; Perruchoud, C; Buchser, E; Aminian, K				Paraschiv-Ionescu, Anisoara; Perruchoud, Christophe; Buchser, Eric; Aminian, Kamiar			Barcoding Human Physical Activity to Assess Chronic Pain Conditions	PLOS ONE			English	Article							LOW-BACK-PAIN; SPINAL-CORD STIMULATION; DWELLING OLDER-ADULTS; FRACTAL DYNAMICS; AMBULATORY SYSTEM; ACTIVITY PATTERNS; DISEASE; GAIT; COMPLEXITY; MOVEMENT	Background: Modern theories define chronic pain as a multidimensional experience - the result of complex interplay between physiological and psychological factors with significant impact on patients' physical, emotional and social functioning. The development of reliable assessment tools capable of capturing the multidimensional impact of chronic pain has challenged the medical community for decades. A number of validated tools are currently used in clinical practice however they all rely on self-reporting and are therefore inherently subjective. In this study we show that a comprehensive analysis of physical activity (PA) under real life conditions may capture behavioral aspects that may reflect physical and emotional functioning. Methodology: PA was monitored during five consecutive days in 60 chronic pain patients and 15 pain-free healthy subjects. To analyze the various aspects of pain-related activity behaviors we defined the concept of PA 'barcoding'. The main idea was to combine different features of PA (type, intensity, duration) to define various PA states. The temporal sequence of different states was visualized as a 'barcode' which indicated that significant information about daily activity can be contained in the amount and variety of PA states, and in the temporal structure of sequence. This information was quantified using complementary measures such as structural complexity metrics (information and sample entropy, Lempel-Ziv complexity), time spent in PA states, and two composite scores, which integrate all measures. The reliability of these measures to characterize chronic pain conditions was assessed by comparing groups of subjects with clinically different pain intensity. Conclusion: The defined measures of PA showed good discriminative features. The results suggest that significant information about pain-related functional limitations is captured by the structural complexity of PA barcodes, which decreases when the intensity of pain increases. We conclude that a comprehensive analysis of daily-life PA can provide an objective appraisal of the intensity of pain.	[Paraschiv-Ionescu, Anisoara; Aminian, Kamiar] Ecole Polytech Fed Lausanne, Lab Movement Anal & Measurement, Lausanne, Switzerland; [Perruchoud, Christophe; Buchser, Eric] Hosp Morges, EHC, Anesthesia & Pain Management Dept, Morges, Switzerland; [Perruchoud, Christophe; Buchser, Eric] Univ Hosp Ctr, Dept Anesthesiol, Lausanne, Switzerland; [Perruchoud, Christophe; Buchser, Eric] Univ Lausanne, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne	Paraschiv-Ionescu, A (corresponding author), Ecole Polytech Fed Lausanne, Lab Movement Anal & Measurement, Lausanne, Switzerland.	anisoara.ionescu@epfl.ch	Aminian, Kamiar/H-4568-2011	Aminian, Kamiar/0000-0002-6582-5375	Swiss Innovation Promotion Agency (CTI) [6579.2MTS-LS]	Swiss Innovation Promotion Agency (CTI)	This study was supported by the Swiss Innovation Promotion Agency (CTI) under grant number 6579.2MTS-LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjoro K, 2008, CLIN GERIATR MED, V24, P237, DOI 10.1016/j.cger.2007.12.001; Breivik H, 2008, BRIT J ANAESTH, V101, P17, DOI 10.1093/bja/aen103; Buchser E, 2005, NEUROMODULATION, V8, P40, DOI 10.1111/j.1094-7159.2005.05219.x; Bussmann JBJ, 1998, PAIN, V74, P153, DOI 10.1016/S0304-3959(97)00161-9; Cavanaugh JT, 2010, J GERONTOL A-BIOL, V65, P197, DOI 10.1093/gerona/glp144; Chou SW, 2003, AM J PHYS MED REHAB, V82, P42, DOI 10.1097/01.PHM.0000043769.93584.4D; Cohen J, 1987, STAT POWER ANAL BEHA; Cote JN, 2010, CLIN J PAIN, V26, P754, DOI 10.1097/AJP.0b013e3181e0174f; Cover Thomas M., 2001, FRONTMATTER INDEX EL, pi; Crombez G, 1999, PAIN, V80, P329, DOI 10.1016/S0304-3959(98)00229-2; Cysarz D, 2000, AM J PHYSIOL-HEART C, V278, pH2163, DOI 10.1152/ajpheart.2000.278.6.H2163; Davis MG, 2007, EUR J APPL PHYSIOL, V100, P581, DOI 10.1007/s00421-006-0320-8; Duhn Lenora J, 2004, Adv Neonatal Care, V4, P126, DOI 10.1016/j.adnc.2004.04.005; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Ferenets R, 2006, IEEE T BIO-MED ENG, V53, P1067, DOI 10.1109/TBME.2006.873543; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Griffin DW, PHYSIOTHERAPY IN PRE; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Hodges PW, 2011, J ELECTROMYOGR KINES, V21, P220, DOI 10.1016/j.jelekin.2011.01.002; Hodges PW, 2011, PAIN, V152, pS90, DOI 10.1016/j.pain.2010.10.020; Hu K, 2004, PHYSICA A, V337, P307, DOI 10.1016/j.physa.2004.01.042; Hu K, 2009, P NATL ACAD SCI USA, V106, P2490, DOI 10.1073/pnas.0806087106; Jamison RN, 2006, J PAIN, V7, P192, DOI 10.1016/j.jpain.2005.10.006; Karantonis DM, 2006, IEEE T INF TECHNOL B, V10, P156, DOI 10.1109/TITB.2005.856864; KASPAR F, 1987, PHYS REV A, V36, P842, DOI 10.1103/PhysRevA.36.842; Landmark T, 2011, PAIN, V152, P2241, DOI 10.1016/j.pain.2011.04.029; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; LIPSITZ LA, 2004, SCI AGING KNOWLEDGE, pPE16; Lord S, 2011, AGE AGEING, V40, P205, DOI 10.1093/ageing/afq166; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; Nagarajan R, 2002, IEEE T BIO-MED ENG, V49, P1371, DOI 10.1109/TBME.2002.804582; Najafi B, 2003, IEEE T BIO-MED ENG, V50, P711, DOI 10.1109/TBME.2003.812189; Nang EEK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-644; Ohashi K, 2004, METHOD INFORM MED, V43, P26; Paraschiv-Ionescu A, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.021913; Paraschiv-Ionescu A, 2004, GAIT POSTURE, V20, P113, DOI 10.1016/j.gaitpost.2003.07.005; Park CH, 2008, PATTERN RECOGN, V41, P1083, DOI 10.1016/j.patcog.2007.07.022; Rapp PE, 2007, COGN NEURODYNAMICS, V1, P287, DOI 10.1007/s11571-007-9027-8; Rapp PE, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016209; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Ryan CG, 2009, AUST J PHYSIOTHER, V55, P53, DOI 10.1016/S0004-9514(09)70061-3; Schenkman ML, 2001, PHYS THER, V81, P1400, DOI 10.1093/ptj/81.8.1400; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Stolee P, 2005, J AM GERIATR SOC, V53, P319, DOI 10.1111/j.1532-5415.2005.53121.x; Sullivan MJL, 2008, CLIN J PAIN, V24, P281, DOI 10.1097/AJP.0b013e318164bb15; van Weering MGH, 2009, EUR J PAIN, V13, P649, DOI 10.1016/j.ejpain.2008.07.005; Verbunt JA, 2001, ARCH PHYS MED REHAB, V82, P726, DOI 10.1053/apmr.2001.23182; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; WYNER AD, 1989, IEEE T INFORM THEORY, V35, P1250, DOI 10.1109/18.45281; Yang CC, 2009, TELEMED J E-HEALTH, V15, P62, DOI 10.1089/tmj.2008.0060; Younger J, 2009, CURR PAIN HEADACHE R, V13, P39, DOI 10.1007/s11916-009-0009-x; ZIV J, 1978, IEEE T INFORM THEORY, V24, P530, DOI 10.1109/TIT.1978.1055934	58	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32239	10.1371/journal.pone.0032239	http://dx.doi.org/10.1371/journal.pone.0032239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384191	Green Submitted, Green Published, gold			2022-12-27	WOS:000302916100061
J	Rattanama, P; Thompson, JR; Kongkerd, N; Srinitiwarawong, K; Vuddhakul, V; Mekalanos, JJ				Rattanama, Pimonsri; Thompson, Janelle R.; Kongkerd, Natthawan; Srinitiwarawong, Kanchana; Vuddhakul, Varaporn; Mekalanos, John J.			Sigma E Regulators Control Hemolytic Activity and Virulence in a Shrimp Pathogenic Vibrio harveyi	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; ESCHERICHIA-COLI; PENAEUS-MONODON; GENE-EXPRESSION; SUICIDE VECTOR; CHOLERAE; RPOE; PHOSPHOLIPASE; CONSTRUCTION; CLONING	Members of the genus Vibrio are important marine and aquaculture pathogens. Hemolytic activity has been identified as a virulence factor in many pathogenic vibrios including V. cholerae, V. parahaemolyticus, V. alginolyticus, V. harveyi and V. vulnificus. We have used transposon mutagenesis to identify genes involved in the hemolytic activity of shrimp-pathogenic V. harveyi strain PSU3316. Out of 1,764 mutants screened, five mutants showed reduced hemolytic activity on sheep blood agar and exhibited virulence attenuation in shrimp (Litopenaeus vannamei). Mutants were identified by comparing transposon junction sequences to a draft of assembly of the PSU3316 genome. Surprisingly none of the disrupted open reading frames or gene neighborhoods contained genes annotated as hemolysins. The gene encoding RseB, a negative regulator of the sigma factor (sigma(E)), was interrupted in 2 out of 5 transposon mutants, in addition, the transcription factor CytR, a threonine synthetase, and an efflux-associated cytoplasmic protein were also identified. Knockout mutations introduced into the rpoE operon at the rseB gene exhibited low hemolytic activity in sheep blood agar, and were 3- to 7-fold attenuated for colonization in shrimp. Comparison of whole cell extracted proteins in the rseB mutant (PSU4030) to the wild-type by 2-D gel electrophoresis revealed 6 differentially expressed proteins, including two down-regulated porins (OmpC-like and OmpN) and an upregulated protease (DegQ) which have been associated with sigma(E) in other organisms. Our study is the first report linking hemolytic activity to the sigma(E) regulators in pathogenic Vibrio species and suggests expression of this virulence-linked phenotype is governed by multiple regulatory pathways within the V. harveyi.	[Rattanama, Pimonsri; Kongkerd, Natthawan; Srinitiwarawong, Kanchana; Vuddhakul, Varaporn] Prince Songkla Univ, Fac Sci, Dept Microbiol, Hat Yai, Songkhla, Thailand; [Rattanama, Pimonsri] Prince Songkla Univ, Fac Med, Dept Biomed Sci, Hat Yai, Songkhla, Thailand; [Thompson, Janelle R.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Mekalanos, John J.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Prince of Songkla University; Prince of Songkla University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Rattanama, P (corresponding author), Prince Songkla Univ, Fac Sci, Dept Microbiol, Hat Yai, Songkhla, Thailand.	john_mekalanos@hms.harvard.edu	Thompson, Janelle/AAJ-8225-2020	Thompson, Janelle/0000-0003-0445-3720; Mittraparp-arthorn, Pimonsri/0000-0003-2474-5229	Thailand Research Fund through the Royal Golden Jubilee Ph.D. program [HD/0153/2547]; Harvard University; Massachusetts Institute of Technology	Thailand Research Fund through the Royal Golden Jubilee Ph.D. program(Thailand Research Fund (TRF)); Harvard University; Massachusetts Institute of Technology	Thailand Research Fund provided financial support through the Royal Golden Jubilee Ph.D. program (Grant No. HD/0153/2547) and financial support also came from Harvard University and the Massachusetts Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JD, 1998, J FISH DIS, V21, P313, DOI 10.1046/j.1365-2761.1998.00101.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bag PK, 2008, APPL ENVIRON MICROB, V74, P5635, DOI 10.1128/AEM.00029-08; Brown RN, 2009, INFECT IMMUN, V77, P3768, DOI 10.1128/IAI.00205-09; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; CHI E, 1995, MOL MICROBIOL, V17, P713, DOI 10.1111/j.1365-2958.1995.mmi_17040713.x; Chiang SL, 2002, GENE, V296, P179, DOI 10.1016/S0378-1119(02)00856-9; Dasgupta N, 2006, INFECT IMMUN, V74, P3334, DOI 10.1128/IAI.00090-06; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; ERICKSON JW, 1989, GENE DEV, V3, P1462, DOI 10.1101/gad.3.9.1462; Fiore AE, 1997, INFECT IMMUN, V65, P3112, DOI 10.1128/IAI.65.8.3112-3117.1997; Gorham HC, 1996, MOL MICROBIOL, V19, P171, DOI 10.1046/j.1365-2958.1996.360888.x; Hannan TJ, 2008, MOL MICROBIOL, V67, P116, DOI 10.1111/j.1365-2958.2007.06025.x; Harris LJ, 1997, AUSTASIA AQUACULT, V11, P59; Hiratsu, 1995, J BACTERIOL, V177, P2918; HONDA T, 1979, INFECT IMMUN, V26, P1020, DOI 10.1128/IAI.26.3.1020-1027.1979; Ilg K, 2009, INFECT IMMUN, V77, P2568, DOI 10.1128/IAI.01537-08; Jiravanichpaisal P., 1994, Journal of Aquatic Animal Health, V6, P27, DOI 10.1577/1548-8667(1994)006&lt;0027:HBAPOV&gt;2.3.CO;2; Kabir MS, 2005, MICROBIOL-SGM, V151, P2721, DOI 10.1099/mic.0.28004-0; Kang JH, 1998, BBA-LIPID LIPID MET, V1394, P85, DOI 10.1016/S0005-2760(98)00100-3; Kautsky N, 2000, AQUACULTURE, V191, P145, DOI 10.1016/S0044-8486(00)00424-5; Kolmar H, 1996, J BACTERIOL, V178, P5925, DOI 10.1128/jb.178.20.5925-5929.1996; Leano EM, 1998, AQUACULTURE, V164, P367, DOI 10.1016/S0044-8486(98)00201-4; Liu PC, 1996, LETT APPL MICROBIOL, V22, P413, DOI 10.1111/j.1472-765X.1996.tb01192.x; Liu PC, 1996, CURR MICROBIOL, V33, P129, DOI 10.1007/s002849900087; MECSAS J, 1993, GENE DEV, V7, P2618, DOI 10.1101/gad.7.12b.2618; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Missiakas D, 1997, J BACTERIOL, V179, P2465, DOI 10.1128/jb.179.8.2465-2471.1997; Moreno MLG, 1998, J APPL MICROBIOL, V84, P747, DOI 10.1046/j.1365-2672.1998.00404.x; NIKAIDO H, 1994, J BIOL CHEM, V269, P3905; PIZZUTTO M, 1995, DIS AQUAT ORGAN, V21, P61, DOI 10.3354/dao021061; Rattanama P, 2009, DIS AQUAT ORGAN, V86, P113, DOI 10.3354/dao02119; ROUVIERE PE, 1995, EMBO J, V14, P1032, DOI 10.1002/j.1460-2075.1995.tb07084.x; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; SHINODA S, 1991, J GEN MICROBIOL, V137, P2705, DOI 10.1099/00221287-137-12-2705; Sun BG, 2007, J BACTERIOL, V189, P2575, DOI 10.1128/JB.01650-06; Thaithongnum S, 2006, AQUACULTURE, V261, P1, DOI 10.1016/j.aquaculture.2006.07.001; Zhang WW, 2008, APPL ENVIRON MICROB, V74, P6254, DOI 10.1128/AEM.00109-08; Zhang XH, 2001, APPL ENVIRON MICROB, V67, P3161, DOI 10.1128/AEM.67.7.3161-3167.2001	42	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32523	10.1371/journal.pone.0032523	http://dx.doi.org/10.1371/journal.pone.0032523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384269	Green Submitted, Green Published, gold			2022-12-27	WOS:000302916100086
J	Vasudev, M; Cheung, DS; Pincsak, H; Li, SH; Yan, K; Simpson, P; Dasu, T; Grayson, MH				Vasudev, Monica; Cheung, Dorothy S.; Pincsak, Hannah; Li, Shun-Hwa; Yan, Ke; Simpson, Pippa; Dasu, Trivikram; Grayson, Mitchell H.			Expression of High-Affinity IgE Receptor on Human Peripheral Blood Dendritic Cells in Children	PLOS ONE			English	Article							FC-EPSILON-RI; ASTHMA; DIFFERENTIATION; BRONCHIOLITIS; POPULATIONS; INFECTION; ALLERGY	Background: In a mouse model of viral induced atopic disease, expression of FceRI on dendritic cells is critical. While adult human conventional (cDC) and plasmacytoid (pDC) dendritic cells have been shown to express FceRI, it is not known if this receptor is expressed in childhood and how its expression is governed by IgE. Methods: Following informed consent of subjects (n = 27, aged 12-188 months), peripheral blood was stained for surface expression of CD19, ILT7, CD1c, IgE, FceRI and analyzed by flow cytometry (cDC: CD19(-) ILT7(-) CD1c(+); pDC: CD19(-) ILT7(+) CD1c(-)). Total and specific serum IgE levels to food and inhalant allergens were determined by ImmunoCAP, and the relationship between FceRI expression on dendritic cells and sensitization, free IgE, cell bound IgE, and age was determined. Results: Independent of sensitization status, FceRI expression was noted on cDC and pDC as early as 12 months of age. Serum IgE level correlated with expression of FceRI on cDC, but not pDC. Based on the concentration of IgE, a complex relationship was found between surface bound IgE and expression of FceRI on cDC. pDC exhibited a linear relationship of FceRI expression and bound IgE that was consistent through all IgE concentrations. Conclusions: In children, FceRI expression on cDC and pDC is modulated differently by serum and cell bound IgE. IgE governance of FceRI expression on cDC depends upon a complex relationship. Further studies are needed to determine the functional roles of FceRI on cDC and pDC.	[Vasudev, Monica; Cheung, Dorothy S.; Pincsak, Hannah; Li, Shun-Hwa; Yan, Ke; Simpson, Pippa; Dasu, Trivikram; Grayson, Mitchell H.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Vasudev, M (corresponding author), Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	wheeze@allergist.com	Grayson, Mitchell H/A-3693-2008; simpson, pippa/AAI-8172-2020; Grayson, Mitchell/AAX-3674-2020	Grayson, Mitchell H/0000-0002-4673-2122; simpson, pippa/0000-0003-1458-3748; Grayson, Mitchell/0000-0002-4673-2122	Genentech; National Institutes of Health [HL087778]; Children's Research Institute of the Children's Hospital of Wisconsin; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087778] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Research Institute of the Children's Hospital of Wisconsin; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by Genentech (www.gene.com), National Institutes of Health grant HL087778 (www.nih.gov), and the Children's Research Institute of the Children's Hospital of Wisconsin (www.chw.org/display/PPF/DocID/30477/router.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Cao W, 2010, IMMUNOL REV, V234, P163, DOI 10.1111/j.0105-2896.2009.00867.x; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Chen Xiuxu, 2011, Open Immunol J, V4, P22; Cheung DS, 2010, ANN ALLERG ASTHMA IM, V105, P437, DOI 10.1016/j.anai.2010.09.010; Cheung DS, 2010, J IMMUNOL, V185, P4983, DOI 10.4049/jimmunol.1002456; Dehlink E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012204; Escobar GJ, 2010, ARCH PEDIAT ADOL MED, V164, P915, DOI 10.1001/archpediatrics.2010.177; Foster B, 2003, J ALLERGY CLIN IMMUN, V112, P1132, DOI 10.1016/j.jaci.2003.09.011; Grayson MH, 2006, ANN ALLERG ASTHMA IM, V96, P643, DOI 10.1016/S1081-1206(10)61061-7; Grayson MH, 2007, J EXP MED, V204, P2759, DOI 10.1084/jem.20070360; Johnston SL, 1996, AM J RESP CRIT CARE, V154, P654, DOI 10.1164/ajrccm.154.3.8810601; JURGENS M, 1995, J IMMUNOL, V155, P5184; Khan SH, 2010, J ALLERGY CLIN IMMUN, V125, P265, DOI 10.1016/j.jaci.2009.09.038; Kirsche H, 2010, ALLERGY, V65, P24, DOI 10.1111/j.1398-9995.2009.02174.x; Lundberg K, 2010, HUM IMMUNOL, V71, P931, DOI 10.1016/j.humimm.2010.07.008; Patterson S, 2005, J IMMUNOL, V174, P8200, DOI 10.4049/jimmunol.174.12.8200; Prussin C, 2003, J ALLERGY CLIN IMMUN, V112, P1147, DOI 10.1016/j.jaci.2003.10.003; Rissoan MC, 2002, BLOOD, V100, P3295, DOI 10.1182/blood-2002-02-0638; Saini S, 1997, J ALLERGY CLIN IMMUN, V99, P417; Schroeder JT, 2010, J ALLERGY CLIN IMMUN, V125, P896, DOI 10.1016/j.jaci.2009.10.021; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Silver E, 2009, PEDIAT ALLERG IMM-UK, V20, P471, DOI 10.1111/j.1399-3038.2008.00818.x; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; THOMPSON HL, 1990, J CLIN INVEST, V85, P1227, DOI 10.1172/JCI114557	26	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32556	10.1371/journal.pone.0032556	http://dx.doi.org/10.1371/journal.pone.0032556			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384272	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100087
J	Trepel, M; Martens, V; Doll, C; Rahlff, J; Gosch, B; Loges, S; Binder, M				Trepel, Martin; Martens, Victoria; Doll, Christian; Rahlff, Janina; Goesch, Barbara; Loges, Sonja; Binder, Mascha			Phenotypic Detection of Clonotypic B Cells in Multiple Myeloma by Specific Immunoglobulin Ligands Reveals their Rarity in Multiple Myeloma	PLOS ONE			English	Article							CIRCULATING CLONAL LYMPHOCYTES; HIGH-DOSE THERAPY; PERIPHERAL-BLOOD; BONE-MARROW; PLASMA-CELLS; MONOCLONAL GAMMOPATHY; ADENOASSOCIATED VIRUS; PEPTIDE LIBRARIES; RAS MUTATIONS; PHAGE DISPLAY	In multiple myeloma, circulating "clonotypic" B cells, that express the immunoglobulin rearrangement of the malignant plasma cell clone, can be indirectly detected by PCR. Their role as potential "feeder" cells for the malignant plasma cell pool remains controversial. Here we established for the first time an approach that allows direct tracking of such clonotypic cells by labeling with patient-specific immunoglobulin ligands in 15 patients with myeloma. Fifty percent of patients showed evidence of clonotypic B cells in blood or bone marrow by PCR. Epitope-mimicking peptides from random libraries were selected on each patient's individual immunoglobulin and used as ligands to trace cells expressing the idiotypic immunoglobulin on their surface. We established a flow cytometry and immunofluorescence protocol to track clonotypic B cells and validated it in two independent monoclonal B cell systems. Using this method, we found clonotypic B cells in only one out of 15 myeloma patients. In view of the assay's validated sensitivity level of 10(-3), this surprising data suggests that the abundance of such cells has been vastly overestimated in the past and that they apparently represent a very rare population in myeloma. Our novel tracing approach may open perspectives to isolate and analyze clonotypic B cells and determine their role in myeloma pathobiology.	[Trepel, Martin; Martens, Victoria; Rahlff, Janina; Goesch, Barbara; Loges, Sonja; Binder, Mascha] Univ Canc Ctr Hamburg, Hubertus Wald Tumorzentrum, Univ Med Ctr Hamburg Eppendorf, Dept Oncol & Hematol,BMT Sect Pneumol, Hamburg, Germany; [Doll, Christian] Univ Med Ctr Freiburg, Dept Hematol & Oncol, Freiburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg	Trepel, M (corresponding author), Univ Canc Ctr Hamburg, Hubertus Wald Tumorzentrum, Univ Med Ctr Hamburg Eppendorf, Dept Oncol & Hematol,BMT Sect Pneumol, Hamburg, Germany.	m.trepel@uke.de; m.binder@uke.de	Loges, Sonja/ABE-9868-2021; Rahlff, Janina/H-9952-2019	Loges, Sonja/0000-0002-7650-8527; Rahlff, Janina/0000-0002-2132-2709; Doll, Christian/0000-0002-0439-759X; Binder, Mascha/0000-0003-0663-3004	Wilhelm Sander-Stiftung [2009.035.1]; Hamburger Krebsgesellschaft; Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft [TR448/6-1]	Wilhelm Sander-Stiftung; Hamburger Krebsgesellschaft; Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Wilhelm Sander-Stiftung (grant # 2009.035.1 to MB and MT), the Hamburger Krebsgesellschaft (scholarship to MB), the Deutsche Krebshilfe (Max-Eder group leader program to SL) and the Deutsche Forschungsgemeinschaft (grant # TR448/6-1 to MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkus MHC, 2001, LEUKEMIA, V15, P1127, DOI 10.1038/sj.leu.2402164; Basak GW, 2010, BIOL BLOOD MARROW TR, V16, P587, DOI 10.1016/j.bbmt.2009.10.024; BERENSON JR, 1990, BLOOD, V75, P2107; BERGSAGEL PL, 1995, BLOOD, V85, P436, DOI 10.1182/blood.V85.2.436.bloodjournal852436; Bertinetti C, 2006, EUR J HAEMATOL, V77, P395, DOI 10.1111/j.1600-0609.2006.00740.x; Billadeau D, 1996, BLOOD, V88, P289; BILLADEAU D, 1993, J EXP MED, V178, P1023, DOI 10.1084/jem.178.3.1023; Binder M, 2007, CANCER RES, V67, P3518, DOI 10.1158/0008-5472.CAN-06-3919; Binder M, 2006, BLOOD, V108, P1975, DOI 10.1182/blood-2006-04-014639; Brennan SK, 2009, J MOL MED, V87, P1079, DOI 10.1007/s00109-009-0531-7; BROWN R, 1995, BRIT J HAEMATOL, V90, P113, DOI 10.1111/j.1365-2141.1995.tb03388.x; Chen BZJ, 1996, BLOOD, V87, P1972, DOI 10.1182/blood.V87.5.1972.bloodjournal8751972; CORRADINI P, 1993, LEUKEMIA, V7, P1879; CORRADINI P, 1993, J EXP MED, V178, P1091, DOI 10.1084/jem.178.3.1091; Ghosh N, 2009, CANCER LETT, V277, P1, DOI 10.1016/j.canlet.2008.08.005; Huff CA, 2008, J CLIN ONCOL, V26, P2895, DOI 10.1200/JCO.2007.15.8428; Jager S, 2007, LEUKEMIA, V21, P411, DOI 10.1038/sj.leu.2404548; Joshua DE, 1996, BLOOD, V88, P1125; Kiel K, 1999, BONE MARROW TRANSPL, V23, P1019, DOI 10.1038/sj.bmt.1701767; KIYOTAKI M, 1987, J IMMUNOL, V138, P4150; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; McSweeney PA, 1996, BLOOD, V88, P622, DOI 10.1182/blood.V88.2.622.bloodjournal882622; Michelfelder S, 2007, EXP HEMATOL, V35, P1766, DOI 10.1016/j.exphem.2007.07.018; Michelfelder S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005122; Muller OJ, 2003, NAT BIOTECHNOL, V21, P1040, DOI 10.1038/nbt856; Osterroth F, 1999, J IMMUNOL METHODS, V229, P141, DOI 10.1016/S0022-1759(99)00111-8; Pfeifer S, 2011, LEUKEMIA, V25, P1213, DOI 10.1038/leu.2011.70; Pilarski LM, 2000, CLIN CANCER RES, V6, P585; Pilarski LM, 2002, EXP HEMATOL, V30, P221, DOI 10.1016/S0301-472X(01)00788-3; Pilarski LM, 1999, LEUKEMIA LYMPHOMA, V32, P199, DOI 10.3109/10428199909167381; Pilarski LM, 1996, LEUKEMIA LYMPHOMA, V22, P375, DOI 10.3109/10428199609054775; Pilarski LM, 2000, BLOOD, V95, P1056, DOI 10.1182/blood.V95.3.1056.003k26_1056_1065; Rasmussen T, 2000, BLOOD, V96, P4357; Rasmussen T, 2005, BLOOD, V105, P317, DOI 10.1182/blood-2004-03-0833; Rasmussen T, 2010, HAEMATOL-HEMATOL J, V95, P1730, DOI 10.3324/haematol.2010.024778; Rottenburger C, 1999, BRIT J HAEMATOL, V106, P545, DOI 10.1046/j.1365-2141.1999.01548.x; Santonocito AM, 2004, LEUKEMIA RES, V28, P469, DOI 10.1016/j.leukres.2003.09.015; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Szczepek AJ, 1998, BLOOD, V92, P2844, DOI 10.1182/blood.V92.8.2844.420k17_2844_2855; Taylor BJ, 2002, CLIN CANCER RES, V8, P502; Taylor BJ, 2008, BLOOD, V112, P1894, DOI 10.1182/blood-2008-01-129221; Trepel M, 2002, CURR OPIN CHEM BIOL, V6, P399, DOI 10.1016/S1367-5931(02)00336-8; Trepel M, 2001, CANCER RES, V61, P8110; Turesson I, 2010, J CLIN ONCOL, V28, P830, DOI 10.1200/JCO.2009.25.4177; Wehr C, 2011, INT J CANC; Yaccoby S, 1999, BLOOD, V94, P3576, DOI 10.1182/blood.V94.10.3576.422k01_3576_3582; Yata K, 2004, LEUKEMIA, V18, P1891, DOI 10.1038/sj.leu.2403513; Zojer N, 2002, BRIT J HAEMATOL, V117, P852, DOI 10.1046/j.1365-2141.2002.03529.x	51	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31998	10.1371/journal.pone.0031998	http://dx.doi.org/10.1371/journal.pone.0031998			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384124	gold, Green Published, Green Submitted			2022-12-27	WOS:000302875500064
J	Cegan, R; Vyskot, B; Kejnovsky, E; Kubat, Z; Blavet, H; Safar, J; Dolezel, J; Blavet, N; Hobza, R				Cegan, Radim; Vyskot, Boris; Kejnovsky, Eduard; Kubat, Zdenek; Blavet, Hana; Safar, Jan; Dolezel, Jaroslav; Blavet, Nicolas; Hobza, Roman			Genomic Diversity in Two Related Plant Species with and without Sex Chromosomes - Silene latifolia and S. vulgaris	PLOS ONE			English	Article							Y-CHROMOSOME; DNA-SEQUENCES; TRANSPOSABLE ELEMENTS; REPETITIVE DNA; SIZE; EVOLUTION; GENE; ACCUMULATION; RETROTRANSPOSONS; AMPLIFICATION	Background: Genome size evolution is a complex process influenced by polyploidization, satellite DNA accumulation, and expansion of retroelements. How this process could be affected by different reproductive strategies is still poorly understood. Methodology/Principal Findings: We analyzed differences in the number and distribution of major repetitive DNA elements in two closely related species, Silene latifolia and S. vulgaris. Both species are diploid and possess the same chromosome number (2n = 24), but differ in their genome size and mode of reproduction. The dioecious S. latifolia (1C = 2.70 pg DNA) possesses sex chromosomes and its genome is 2.5 x larger than that of the gynodioecious S. vulgaris (1C = 1.13 pg DNA), which does not possess sex chromosomes. We discovered that the genome of S. latifolia is larger mainly due to the expansion of Ogre retrotransposons. Surprisingly, the centromeric STAR-C and TR1 tandem repeats were found to be more abundant in S. vulgaris, the species with the smaller genome. We further examined the distribution of major repetitive sequences in related species in the Caryophyllaceae family. The results of FISH (fluorescence in situ hybridization) on mitotic chromosomes with the Retand element indicate that large rearrangements occurred during the evolution of the Caryophyllaceae family. Conclusions/Significance: Our data demonstrate that the evolution of genome size in the genus Silene is accompanied by the expansion of different repetitive elements with specific patterns in the dioecious species possessing the sex chromosomes.	[Cegan, Radim; Vyskot, Boris; Kejnovsky, Eduard; Kubat, Zdenek; Blavet, Hana; Hobza, Roman] Acad Sci Czech Republ, Inst Biophys, Dept Plant Dev Genet, Vvi, CS-61265 Brno, Czech Republic; [Cegan, Radim] Mendel Univ Brno, Fac Agron, Dept Plant Biol, Brno, Czech Republic; [Safar, Jan; Dolezel, Jaroslav] Inst Expt Bot, Ctr Reg Hana Biotechnol Agr Res, Olomouc, Czech Republic; [Blavet, Nicolas] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Mendel University in Brno; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Swiss Federal Institutes of Technology Domain; ETH Zurich	Cegan, R (corresponding author), Acad Sci Czech Republ, Inst Biophys, Dept Plant Dev Genet, Vvi, Kralovopolska 135, CS-61265 Brno, Czech Republic.	hobza@ibp.cz	Kejnovsky, Eduard/D-8878-2012; Vyskot, Boris/H-1962-2014; Hobza, Roman/I-4297-2014; Safar, Jan/G-1038-2014; Dolezel, Jaroslav/B-7716-2008; Blavet, Nicolas/S-5594-2019; Kubát, Zdeněk/D-9221-2012; Blavet, Hana/G-1988-2014; Blavet, Nicolas/F-8148-2014; Hobza, Roman/G-3119-2014; Čegan, Radim/H-1892-2014	Dolezel, Jaroslav/0000-0002-6263-0492; Blavet, Nicolas/0000-0003-2199-9119; Kubát, Zdeněk/0000-0001-8278-9495; Blavet, Nicolas/0000-0003-2199-9119; Čegan, Radim/0000-0002-6789-6564; Hobza, Roman/0000-0003-3062-2962	Internal Grant Agency at Mendel University, Faculty of Agronomy, Brno, Czech Republic [DP7/2009]; Grant Agency of AS CR [KJB600040901]; Czech Science Foundation [P501/10/P483, P501/10/0102, 204/09/H002, P305/10/0930, 522/09/0083]; Academy of Sciences of the Czech Republic [AV0Z50040507, AV0Z50040702]	Internal Grant Agency at Mendel University, Faculty of Agronomy, Brno, Czech Republic; Grant Agency of AS CR(Grant Agency of the Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	The work was supported by the Internal Grant Agency at Mendel University, Faculty of Agronomy, Brno, Czech Republic (grant no. DP7/2009), the Grant Agency of AS CR (KJB600040901), Czech Science Foundation (grant nos. P501/10/P483, P501/10/0102, 204/09/H002, P305/10/0930 and 522/09/0083) and the Academy of Sciences of the Czech Republic (grant nos. AV0Z50040507 and AV0Z50040702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Bergero R, 2008, GENETICS, V178, P1085, DOI 10.1534/genetics.107.081745; Bouzidi MF, 2006, THEOR APPL GENET, V113, P81, DOI 10.1007/s00122-006-0274-6; Brodie R, 2004, BIOINFORMATICS, V20, P279, DOI 10.1093/bioinformatics/btg406; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Buzek J, 1997, CHROMOSOME RES, V5, P57, DOI 10.1023/A:1011693603279; Cegan R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-180; Cermak T, 2008, CHROMOSOME RES, V16, P961, DOI 10.1007/s10577-008-1254-2; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Cohen S, 2009, CYTOGENET GENOME RES, V124, P327, DOI 10.1159/000218136; Dong H, 2011, ACTA BIOCH BIOPH SIN, V43, P496, DOI 10.1093/abbs/gmr030; Drummond AJ, 2010, GENEIOUS V5 3; Duret L, 1996, COMPUT APPL BIOSCI, V12, P507; Field D, 2006, NAT BIOTECHNOL, V24, P801, DOI 10.1038/nbt0706-801; FIGUEIRA A, 1992, J AM SOC HORTIC SCI, V117, P673, DOI 10.21273/JASHS.117.4.673; Filatov DA, 2009, GENETICS, V181, P811, DOI 10.1534/genetics.108.099267; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; Greilhuber J, 2006, PLANT BIOLOGY, V8, P770, DOI 10.1055/s-2006-924101; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Heslop-Harrison JS, 2003, CHROMOSOME RES, V11, P241, DOI 10.1023/A:1022998709969; Hobza R, 2007, MOL GENET GENOMICS, V278, P633, DOI 10.1007/s00438-007-0279-0; Hobza R, 2006, CHROMOSOMA, V115, P376, DOI 10.1007/s00412-006-0065-5; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kazama Y, 2003, J PLANT RES, V116, P317, DOI 10.1007/s10265-003-0106-6; Kazama Y, 2006, GENOME, V49, P520, DOI 10.1139/G05-130; Kejnovsky E, 2009, HEREDITY, V102, P533, DOI 10.1038/hdy.2009.17; Kejnovsky E, 2006, GENETICA, V128, P167, DOI 10.1007/s10709-005-5701-0; Kejnovsky E, 2006, MOL GENET GENOMICS, V276, P254, DOI 10.1007/s00438-006-0140-x; Kejnovsky E, 2009, TRENDS ECOL EVOL, V24, P572, DOI 10.1016/j.tree.2009.04.010; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kubat Z, 2008, GENOME, V51, P350, DOI 10.1139/G08-024; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Leitch IJ, 1997, TRENDS PLANT SCI, V2, P470, DOI 10.1016/S1360-1385(97)01154-0; Lengerova M, 2004, THEOR APPL GENET, V108, P1193, DOI 10.1007/s00122-003-1568-6; Ma JX, 2004, GENOME RES, V14, P860, DOI 10.1101/gr.1466204; Macas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027335; Marais GAB, 2008, CURR BIOL, V18, P545, DOI 10.1016/j.cub.2008.03.023; Matsunaga S, 2002, GENOME, V45, P745, DOI 10.1139/G02-026; Morse AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004332; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Neumann P, 2006, GENETICS, V173, P1047, DOI 10.1534/genetics.106.056259; Nicolas M, 2005, PLOS BIOL, V3, P47, DOI 10.1371/journal.pbio.0030004; Obara M, 2002, GENES GENET SYST, V77, P393, DOI 10.1266/ggs.77.393; Pellicer J, 2010, BOT J LINN SOC, V164, P10, DOI 10.1111/j.1095-8339.2010.01072.x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Petrov Dmitri, 2006, P144; Pritham EJ, 2003, GENETICS, V165, P799; Renny-Byfield S, 2011, MOL BIOL EVOL, V28, P2843, DOI 10.1093/molbev/msr112; Siroky J, 2001, CHROMOSOME RES, V9, P387, DOI 10.1023/A:1016783501674; Siroky J, 1999, ANN BOT-LONDON, V84, P633, DOI 10.1006/anbo.1999.0958; Smit A, 1996, REPEATMASKER OPEN 30; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Taylor DR, 2001, GENETICS, V158, P833; THOMAS CA, 1971, ANNU REV GENET, V5, P237, DOI 10.1146/annurev.ge.05.120171.001321; Vyskot B, 2004, TRENDS GENET, V20, P432, DOI 10.1016/j.tig.2004.06.006; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286	62	16	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31898	10.1371/journal.pone.0031898	http://dx.doi.org/10.1371/journal.pone.0031898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393373	gold, Green Published, Green Submitted			2022-12-27	WOS:000303003500026
J	del Pozo, JSG; Solera, J				Garcia del Pozo, Julian Solis; Solera, Javier			Systematic Review and Meta-Analysis of Randomized Clinical Trials in the Treatment of Human Brucellosis	PLOS ONE			English	Article							DOXYCYCLINE PLUS STREPTOMYCIN; TETRACYCLINE-STREPTOMYCIN; RETROSPECTIVE EVALUATION; ANTIMICROBIAL REGIMENS; THERAPEUTIC REGIMENS; RIFAMPIN; EFFICACY; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN	Background: Brucellosis is a persistent health problem in many developing countries throughout the world, and the search for simple and effective treatment continues to be of great importance. Methods and Findings: A search was conducted in MEDLINE and in the Cochrane Central Register of Controlled Trials (CENTRAL). Clinical trials published from 1985 to present that assess different antimicrobial regimens in cases of documented acute uncomplicated human brucellosis were included. The primary outcomes were relapse, therapeutic failure, combined variable of relapse and therapeutic failure, and adverse effect rates. A meta-analysis with a fixed effect model was performed and odds ratio with 95% confidence intervals were calculated. A random effect model was used when significant heterogeneity between studies was verified. Comparison of combined doxycycline and rifampicin with a combination of doxycycline and streptomycin favors the latter regimen (OR = 3.17; CI95% = 2.05-4.91). There were no significant differences between combined doxycycline-streptomycin and combined doxycycline-gentamicin (OR = 1.89; CI95% = 0.81-4.39). Treatment with rifampicin and quinolones was similar to combined doxycycline-rifampicin (OR = 1.23; CI95% = 0.63-2.40). Only one study assessed triple therapy with aminoglycoside-doxycycline-rifampicin and only included patients with uncomplicated brucellosis. Thus this approach cannot be considered the therapy of choice until further studies have been performed. Combined doxycycline/co-trimoxazole or doxycycline monotherapy could represent a cost-effective alternative in certain patient groups, and further studies are needed in the future. Conclusions: Although the preferred treatment in uncomplicated human brucellosis is doxycycline-aminoglycoside combination, other treatments based on oral regimens or monotherapy should not be rejected until they are better studied. Triple therapy should not be considered the current treatment of choice.	[Garcia del Pozo, Julian Solis] Villarrobledo Hosp, Dept Internal Med, Villarrobledo, Spain; [Solera, Javier] Albacete Univ Hosp, Dept Internal Med, Albacete, Spain		del Pozo, JSG (corresponding author), Villarrobledo Hosp, Dept Internal Med, Villarrobledo, Spain.	julianeloysolis@gmail.com	del Pozo, Julián Solís García/Q-4917-2016; Solís García del Pozo, Julián/I-3133-2019	del Pozo, Julián Solís García/0000-0002-8361-2090; Solís García del Pozo, Julián/0000-0002-8361-2090; Solera Santos, Jose Javier/0000-0001-9517-3083				Abramson O, 1997, ANTIMICROB AGENTS CH, V41, P1621, DOI 10.1128/AAC.41.7.1621; ACOCELLA G, 1989, J ANTIMICROB CHEMOTH, V23, P433, DOI 10.1093/jac/23.3.433; Afifi S, 2005, AM J TROP MED HYG, V73, P392, DOI 10.4269/ajtmh.2005.73.392; Agalar C, 1999, EUR J CLIN MICROBIOL, V18, P535, DOI 10.1007/s100960050344; AKOVA M, 1993, ANTIMICROB AGENTS CH, V37, P1831, DOI 10.1128/AAC.37.9.1831; Al Shaalan Mohammed, 2002, International Journal of Infectious Diseases, V6, P182, DOI 10.1016/S1201-9712(02)90108-6; Alavi SM, 2007, PAK J MED SCI, V23, P889; ALIDRISSI HY, 1989, J INT MED RES, V17, P363, DOI 10.1177/030006058901700409; Alp E, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-72; ALSIBAI MB, 1992, ANTIMICROB AGENTS CH, V36, P150, DOI 10.1128/AAC.36.1.150; Andriopoulos P, 2007, INT J INFECT DIS, V11, P52, DOI 10.1016/j.ijid.2005.10.011; ARIZA J, 1985, J INFECT DIS, V152, P1358, DOI 10.1093/infdis/152.6.1358; Ariza J, 2002, MED CLIN-BARCELONA, V119, P339, DOI 10.1016/S0025-7753(02)73409-X; ARIZA J, 1995, CLIN INFECT DIS, V20, P1241, DOI 10.1093/clinids/20.5.1241; ARIZA J, 1992, ANN INTERN MED, V117, P25, DOI 10.7326/0003-4819-117-1-25; ARIZA J, 1985, ANTIMICROB AGENTS CH, V28, P548, DOI 10.1128/AAC.28.4.548; Ariza J, 2007, PLOS MED, V4, P1872, DOI 10.1371/journal.pmed.0040317; Aygen B, 2002, MED MALADIES INFECT, V32, P485, DOI 10.1016/S0399-077X(02)00403-1; Bayindir Y, 2003, J CHEMOTHERAPY, V15, P466, DOI 10.1179/joc.2003.15.5.466; Bosilkovski M, 2007, INT J INFECT DIS, V11, P342, DOI 10.1016/j.ijid.2006.10.002; Buzgan T, 2010, INT J INFECT DIS, V14, pE469, DOI 10.1016/j.ijid.2009.06.031; Cascio A, 2003, J CHEMOTHERAPY, V15, P248, DOI 10.1179/joc.2003.15.3.248; CASTILLO JDC, 1989, CHEMOTHERAPY, V35, P146; CISNEROS JM, 1990, ANTIMICROB AGENTS CH, V34, P881, DOI 10.1128/AAC.34.5.881; Colmenero JD, 1996, MEDICINE, V75, P195, DOI 10.1097/00005792-199607000-00003; COLMENERO JD, 1994, ANTIMICROB AGENTS CH, V38, P2798, DOI 10.1128/AAC.38.12.2798; Demirtuerk N, 2008, TROP DOCT, V38, P59, DOI 10.1258/td.2006.006266; DOGANAY M, 1992, EUR J CLIN MICROBIOL, V11, P74; El Miedany YM, 2003, J RHEUMATOL, V30, P2666; Ersoy Y, 2005, TROP DOCT, V35, P210, DOI 10.1258/004947505774938765; Falagas ME, 2006, ANTIMICROB AGENTS CH, V50, P22, DOI 10.1128/AAC.50.1.22-33.2006; Feiz J M, 1973, Br J Clin Pract, V27, P410; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Garcia PB, 2002, REV CLIN ESP, V202, P577, DOI 10.1016/S0014-2565(02)71152-1; Grasso E, 1987, Minerva Med, V78, P1443; HALL WH, 1990, REV INFECT DIS, V12, P1060; Kalo T, 1996, MED MALADIES INFECT, V26, P587, DOI 10.1016/S0399-077X(96)80077-1; Karabay O, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-18; Keramat F, 2009, TROP DOCT, V39, P207, DOI 10.1258/td.2009.090030; KHURIBULOS N, 1991, J INFECTION, V22, P302, DOI 10.1016/S0163-4453(05)80021-0; LANG R, 1992, CLIN INFECT DIS, V14, P506, DOI 10.1093/clinids/14.2.506; LANG R, 1990, J ANTIMICROB CHEMOTH, V26, P841, DOI 10.1093/jac/26.6.841; LUBANI MM, 1989, PEDIATR INFECT DIS J, V8, P75; Malik GM, 1998, AM J TROP MED HYG, V58, P190, DOI 10.4269/ajtmh.1998.58.190; Memish Z, 2000, J INFECTION, V40, P59, DOI 10.1053/jinf.1999.0586; MONTEJO JM, 1993, CLIN INFECT DIS, V16, P671, DOI 10.1093/clind/16.5.671; Pappas G, 2007, J CHEMOTHERAPY, V19, P243, DOI 10.1179/joc.2007.19.3.243; Pappas G, 2007, J INFECTION, V54, P459, DOI 10.1016/j.jinf.2006.09.015; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pappas G, 2005, INT J ANTIMICROB AG, V26, P101, DOI 10.1016/j.ijantimicag.2005.06.001; Pappas G, 2006, EXPERT OPIN INV DRUG, V15, P1141, DOI 10.1517/13543784.15.10.1141; Ranjbar M, 2007, INT J INFECT DIS, V11, P152, DOI 10.1016/j.ijid.2005.11.007; Rodriguez Zapata M, 1987, Chemioterapia, V6, P360; Roushan MRH, 2010, J ANTIMICROB CHEMOTH, V65, P1028, DOI 10.1093/jac/dkq064; Roushan MRH, 2006, PEDIATR INFECT DIS J, V25, P544, DOI 10.1097/01.inf.0000219403.91975.ce; Roushan MRH, 2006, CLIN INFECT DIS, V42, P1075, DOI 10.1086/501359; Roushan MRH, 2004, SWISS MED WKLY, V134, P564; Saltoglu N, 2002, SAUDI MED J, V23, P921; Savas L, 2007, INFECT DIS CLIN PRAC, V15, P83, DOI 10.1097/01.idc.0000240863.82188.95; SHEHABI A, 1990, J INFECTION, V20, P5, DOI 10.1016/S0163-4453(90)92214-6; Skalsky K, 2008, BMJ-BRIT MED J, V336, P701, DOI 10.1136/bmj.39497.500903.25; Solera J, 1996, CLIN INFECT DIS, V22, P441, DOI 10.1093/clinids/22.3.441; SOLERA J, 1994, MED CLIN-BARCELONA, V102, P731; Solera J, 1998, J INFECTION, V36, P85, DOI 10.1016/S0163-4453(98)93342-4; Solera J, 2001, CLIN INFECT DIS, V32, P506, DOI 10.1086/318503; SOLERA J, 1991, MED CLIN-BARCELONA, V96, P649; Solera J, 2004, CLIN INFECT DIS, V39, P1776, DOI 10.1086/426024; Solera J, 1997, ANTIMICROB AGENTS CH, V41, P80, DOI 10.1128/AAC.41.1.80; SOLERA J, 1995, ANTIMICROB AGENTS CH, V39, P2061, DOI 10.1128/AAC.39.9.2061; Straight T. M., 2002, Current Treatment Options in Infectious Diseases, V4, P447; Villa LF, 2010, MEDIMECUM GUIA TERAP; *WHO, 1986, WHO TECH REP SER, V740, P1	72	68	71	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32090	10.1371/journal.pone.0032090	http://dx.doi.org/10.1371/journal.pone.0032090			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393379	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500032
J	Harney, AS; Meade, TJ; LaBonne, C				Harney, Allison S.; Meade, Thomas J.; LaBonne, Carole			Targeted Inactivation of Snail Family EMT Regulatory Factors by a Co(III)-Ebox Conjugate	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; REPRESSES E-CADHERIN; HUMAN ALPHA-THROMBIN; NEURAL CREST; TRANSCRIPTION FACTOR; SLUG; XENOPUS; CELLS; METASTASIS; INHIBITION	Snail family proteins are core EMT (epithelial-mesenchymal transition) regulatory factors that play essential roles in both development and disease processes and have been associated with metastasis in carcinomas. Snail factors are required for the formation of neural crest stem cells in most vertebrate embryos, as well as for the migratory invasive behavior of these cells. Snail factors have recently been linked to the formation of cancer stem cells, and expression of Snail proteins may be associated with tumor recurrence and resistance to chemotherapy and radiotherapy. We report that Co(III)-Ebox is a potent inhibitor of Snail-mediated transcriptional repression in breast cancer cells and in the neural crest of Xenopus. We further show that the activity of Co(III)-Ebox can be modulated by temperature, increasing the utility of this conjugate as a Snail inhibitor in model organisms. We exploit this feature to further delineate the requirements for Snail function during neural crest development, showing that in addition to the roles that Snail factors play in neural crest precursor formation and neural crest EMT/migration, inhibition of Snail function after the onset of neural crest migration leads to a loss of neural crest derived melanocytes. Co(III)-Ebox-mediated inhibition therefore provides a powerful tool for analysing the function of these core EMT factors with unparalleled temporal resolution. Moreover, the potency of Co(III)-Ebox as a Snail inhibitor in breast cancer cells suggests its potential as a therapeutic inhibitor of tumor progression and metastasis.	[Harney, Allison S.; Meade, Thomas J.; LaBonne, Carole] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Harney, Allison S.; Meade, Thomas J.] Northwestern Univ, Dept Chem, Evanston, IL USA; [Harney, Allison S.; Meade, Thomas J.] Northwestern Univ, Dept Neurobiol, Evanston, IL USA; [Harney, Allison S.; Meade, Thomas J.] Northwestern Univ, Dept Radiol, Evanston, IL USA; [Meade, Thomas J.; LaBonne, Carole] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Harney, AS (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	clabonne@northwestern.edu			NIH [R01CA114058, U54CA151880]; Rosenberg Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA114058, U54CA151880] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosenberg Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants R01CA114058 (CL) and U54CA151880 (TJM), and the Rosenberg Cancer Foundation. A. S. H. is a fellow of the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Alves CC, 2007, J PATHOL, V211, P507, DOI 10.1002/path.2138; Aoki Y, 2003, DEV BIOL, V259, P19, DOI 10.1016/S0012-1606(03)00161-1; Asbell PA, 1998, CORNEA, V17, P550; Aybar MJ, 2003, DEVELOPMENT, V130, P483, DOI 10.1242/dev.00238; Baygi ME, 2010, TUMOR BIOL, V31, P297, DOI 10.1007/s13277-010-0037-5; Bellmeyer A, 2003, DEV CELL, V4, P827, DOI 10.1016/S1534-5807(03)00160-6; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Carl TF, 1999, DEV BIOL, V213, P101, DOI 10.1006/dbio.1999.9320; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Chandler HL, 2007, EXP EYE RES, V84, P400, DOI 10.1016/j.exer.2006.10.010; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Elloul S, 2005, CANCER-AM CANCER SOC, V103, P1631, DOI 10.1002/cncr.20946; Epstein Seth P, 2006, BMC Ophthalmol, V6, P22, DOI 10.1186/1471-2415-6-22; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Foubert E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2585; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; Geradts J, 2011, HUMAN PATHO IN PRESS; Goswami S, 2009, CLIN EXP METASTAS, V26, P153, DOI 10.1007/s10585-008-9225-8; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hajra KM, 2002, CANCER RES, V62, P1613; Harney AS, 2009, P NATL ACAD SCI USA, V106, P13667, DOI 10.1073/pnas.0906423106; Hemavathy K, 2004, DEV BIOL, V269, P411, DOI 10.1016/j.ydbio.2004.01.029; Honore SM, 2003, DEV BIOL, V260, P79, DOI 10.1016/S0012-1606(03)00247-1; Hwang WL, 2011, GASTROENTEROLOGY, V141, P279, DOI 10.1053/j.gastro.2011.04.008; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Kuphal S, 2005, MELANOMA RES, V15, P305, DOI 10.1097/00008390-200508000-00012; LaBonne C, 1998, J NEUROBIOL, V36, P175, DOI 10.1002/(SICI)1097-4695(199808)36:2<175::AID-NEU6>3.0.CO;2-Z; LaBonne C, 2000, DEV BIOL, V221, P195, DOI 10.1006/dbio.2000.9609; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; Louie AY, 1998, P NATL ACAD SCI USA, V95, P6663, DOI 10.1073/pnas.95.12.6663; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Murray SA, 2007, DEVELOPMENT, V134, P1789, DOI 10.1242/dev.02837; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Olmeda D, 2007, CANCER RES, V67, P11721, DOI 10.1158/0008-5472.CAN-07-2318; Schwartz JA, 2001, J VIROL, V75, P4117, DOI 10.1128/JVI.75.9.4117-4128.2001; Takeuchi T, 1998, J AM CHEM SOC, V120, P8555, DOI 10.1021/ja981191x; Takeuchi T, 1999, BIOORGAN MED CHEM, V7, P815, DOI 10.1016/S0968-0896(98)00272-7; Taylor KM, 2005, DEV CELL, V9, P593, DOI 10.1016/j.devcel.2005.09.016; Thomas AJ, 2009, DEVELOPMENT, V136, P1849, DOI 10.1242/dev.031989; Tucker RP, 2004, INT J BIOCHEM CELL B, V36, P173, DOI 10.1016/S1357-2725(03)00243-7; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Vernon AE, 2004, CURR BIOL, V14, pR719, DOI 10.1016/j.cub.2004.08.048; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yang ZB, 2005, CANCER RES, V65, P3179, DOI 10.1158/0008-5472.CAN-04-3480	50	45	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32318	10.1371/journal.pone.0032318	http://dx.doi.org/10.1371/journal.pone.0032318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393397	Green Published, gold, Green Submitted			2022-12-27	WOS:000303003500049
J	Verspoor, KM; Cohn, JD; Ravikumar, KE; Wall, ME				Verspoor, Karin M.; Cohn, Judith D.; Ravikumar, Komandur E.; Wall, Michael E.			Text Mining Improves Prediction of Protein Functional Sites	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; LIGAND-BINDING; MYCOBACTERIUM-TUBERCULOSIS; INFORMATION EXTRACTION; SINGLE-PARAMETER; CLASSIFICATION; FLUCTUATIONS; ANNOTATION; RETRIEVAL; EFFICIENT	We present an approach that integrates protein structure analysis and text mining for protein functional site prediction, called LEAP-FS (Literature Enhanced Automated Prediction of Functional Sites). The structure analysis was carried out using Dynamics Perturbation Analysis (DPA), which predicts functional sites at control points where interactions greatly perturb protein vibrations. The text mining extracts mentions of residues in the literature, and predicts that residues mentioned are functionally important. We assessed the significance of each of these methods by analyzing their performance in finding known functional sites (specifically, small-molecule binding sites and catalytic sites) in about 100,000 publicly available protein structures. The DPA predictions recapitulated many of the functional site annotations and preferentially recovered binding sites annotated as biologically relevant vs. those annotated as potentially spurious. The text-based predictions were also substantially supported by the functional site annotations: compared to other residues, residues mentioned in text were roughly six times more likely to be found in a functional site. The overlap of predictions with annotations improved when the text-based and structure-based methods agreed. Our analysis also yielded new high-quality predictions of many functional site residues that were not catalogued in the curated data sources we inspected. We conclude that both DPA and text mining independently provide valuable high-throughput protein functional site predictions, and that integrating the two methods using LEAP-FS further improves the quality of these predictions.	[Verspoor, Karin M.; Ravikumar, Komandur E.] Univ Colorado, Sch Med, Aurora, CO USA; [Cohn, Judith D.; Wall, Michael E.] Los Alamos Natl Lab, Comp Computat & Stat Sci Div, Los Alamos, NM USA; [Wall, Michael E.] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Verspoor, KM (corresponding author), Univ Colorado, Sch Med, Aurora, CO USA.	karin.verspoor@ucdenver.edu; mewall@lanl.gov	Verspoor, Karin/G-6034-2016	Verspoor, Karin/0000-0002-8661-1544; Wall, Michael/0000-0003-1000-688X; Cohn, Judith/0000-0002-1333-3395	National Institutes of Health [5R01LM010120-02, 3R01LM010120-02S1]; Los Alamos National Laboratory LDRD [20110435DR, 20060700DR]; NATIONAL LIBRARY OF MEDICINE [R01LM010120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Los Alamos National Laboratory LDRD(United States Department of Energy (DOE)Los Alamos National Laboratory); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors acknowledge the support of National Institutes of Health grants 5R01LM010120-02 and 3R01LM010120-02S1 to KMV. MEW also received support from Los Alamos National Laboratory LDRD grant 20110435DR. JDC and MEW received additional support from Los Alamos National Laboratory LDRD grant 20060700DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlers CB, 2007, PAC S BIOC; Ankerst M, 1999, SIGMOD RECORD, VOL 28, NO 2 - JUNE 1999, P49; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Baker CJO, 2006, INFORM SYST FRONT, V8, P47, DOI 10.1007/s10796-006-6103-2; Baumgartner WA, 2007, BIOINFORMATICS, V23, pI41, DOI 10.1093/bioinformatics/btm229; Benson ML, 2008, NUCLEIC ACIDS RES, V36, pD674, DOI 10.1093/nar/gkm911; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bourne PE, 1997, METHOD ENZYMOL, V277, P571, DOI 10.1016/S0076-6879(97)77032-0; Caporaso JG, 2007, BIOINFORMATICS, V23, P1862, DOI 10.1093/bioinformatics/btm235; Caporaso J Gregory, 2008, Pac Symp Biocomput, P640; Card GL, 2005, J BIOL CHEM, V280, P13978, DOI 10.1074/jbc.M413904200; Chim N, 2011, TUBERCULOSIS, V91, P155, DOI 10.1016/j.tube.2010.11.009; Choe JY, 2000, BIOCHEMISTRY-US, V39, P8565, DOI 10.1021/bi000574g; Cohen K.B., 2010, BMC BIOINFORMATICS, V11; Cohn JD, 2008, AFP BIOSAPIENS; Damm KL, 2008, BIOPOLYMERS, V89, P643, DOI 10.1002/bip.20993; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Earhart CA, 1998, BIOCHEMISTRY-US, V37, P7194, DOI 10.1021/bi9721896; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferrucci D., 2004, Natural Language Engineering, V10, P327, DOI 10.1017/S1351324904003523; Gaizauskas R, 2003, BIOINFORMATICS, V19, P135, DOI 10.1093/bioinformatics/19.1.135; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Greer DS, 2002, BIOINFORMATICS, V18, P1280, DOI 10.1093/bioinformatics/18.9.1280; Hinsen K, 1998, PROTEINS, V33, P417, DOI 10.1002/(SICI)1097-0134(19981115)33:3<417::AID-PROT10>3.0.CO;2-8; Horn F, 2004, BIOINFORMATICS, V20, P557, DOI 10.1093/bioinformatics/btg449; Hu LG, 2005, PROTEINS, V60, P333, DOI 10.1002/prot.20512; Huang LL, 2005, ACTA CRYSTALLOGR D, V61, P316, DOI 10.1107/S0907444904033189; Hurley JK, 1997, BIOCHEMISTRY-US, V36, P11100, DOI 10.1021/bi9709001; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; Jez JM, 2001, BIOCHEMISTRY-US, V40, P14829, DOI 10.1021/bi015621z; Koussounadis A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-129; Krallinger M, 2010, METHODS MOL BIOL, V593, P341, DOI 10.1007/978-1-60327-194-3_16; Krallinger M, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s8, 10.1186/gb-2008-9-S2-S8]; Laurie ATR, 2006, CURR PROTEIN PEPT SC, V7, P395; Laurila JB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S24; Leitner F, 2010, IEEE ACM T COMPUT BI, V7, P385, DOI 10.1109/TCBB.2010.61; Ming D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.198103; Ming D, METHODS MOL IN PRESS; Ming D, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-5; Ming DM, 2006, J MOL BIOL, V358, P213, DOI 10.1016/j.jmb.2006.01.097; Ming DM, 2005, PROTEINS, V59, P697, DOI 10.1002/prot.20440; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nagel K, 2009, AUTOMATIC FUNCTIONAL; Nagel K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S4; Nam HJ, 1999, CELL, V97, P449, DOI 10.1016/S0092-8674(00)80755-2; Nunn CM, 2002, J BIOL CHEM, V277, P20033, DOI 10.1074/jbc.M200864200; Oliver DE, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-146; Ory J, 1997, J BIOL CHEM, V272, P9793; Perot S, 2010, DRUG DISCOV TODAY, V15, P656, DOI 10.1016/j.drudis.2010.05.015; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Ravikumar KE, 2011, 10 INT C MACH LEARN; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Schwartz TW, 2007, TRENDS PHARMACOL SCI, V28, P366, DOI 10.1016/j.tips.2007.06.008; Sokolov A, 2011, AUT FUNCT PRED SIG W, P53; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Verspoor K, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S20; Verspoor K, 2011, P AFP CAFA SIG ISMB, P43; Verspoor K, 2010, P INT SYST MOL BIOL; Verspoor K, 2010, IEEE ACM T COMPUT BI, V7, P462, DOI 10.1109/TCBB.2010.48; Wall ME, 2006, AIP CONF PROC, V851, P16, DOI 10.1063/1.2345620; WEAVER LH, 1995, J MOL BIOL, V245, P54, DOI 10.1016/S0022-2836(95)80038-7; Witte Rene, 2007, J Bioinform Comput Biol, V5, P1339, DOI 10.1142/S0219720007003193; Xie L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S9; Zhou D, 2008, J BIOMED INFORM, V41, P393, DOI 10.1016/j.jbi.2007.11.008	65	22	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32171	10.1371/journal.pone.0032171	http://dx.doi.org/10.1371/journal.pone.0032171			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393388	Green Published, gold, Green Submitted			2022-12-27	WOS:000303003500041
J	Li, CL; Jiang, ZG; Li, LL; Li, ZQ; Fang, HX; Li, CW; Beauchamp, G				Li, Chunlin; Jiang, Zhigang; Li, Linlin; Li, Zhongqiu; Fang, Hongxia; Li, Chunwang; Beauchamp, Guy			Effects of Reproductive Status, Social Rank, Sex and Group Size on Vigilance Patterns in Przewalski's Gazelle	PLOS ONE			English	Article							PREDATION RISK; BIGHORN SHEEP; PROCAPRA-PRZEWALSKII; HUMAN DISTURBANCE; DIURNAL ACTIVITY; NATIONAL-PARK; TIME BUDGET; ELK; BEHAVIOR; RUT	Background: Quantifying vigilance and exploring the underlying mechanisms has been the subject of numerous studies. Less attention has focused on the complex interplay between contributing factors such as reproductive status, social rank, sex and group size. Reproductive status and social rank are of particular interest due to their association with mating behavior. Mating activities in rutting season may interfere with typical patterns of vigilance and possibly interact with social rank. In addition, balancing the tradeoff between vigilance and life maintenance may represent a challenge for gregarious ungulate species rutting under harsh winter conditions. We studied vigilance patterns in the endangered Przewalski's gazelle (Procapra przewalskii) during both the rutting and non-rutting seasons to examine these issues. Methodology/Principal Findings: Field observations were carried out with focal sampling during rutting and non-rutting season in 2008-2009. Results indicated a complex interplay between reproductive status, social rank, sex and group size in determining vigilance in this species. Vigilance decreased with group size in female but not in male gazelles. Males scanned more frequently and thus spent more time vigilant than females. Compared to non-rutting season, gazelles increased time spent scanning at the expense of bedding in rutting season. During the rutting season, territorial males spent a large proportion of time on rutting activities and were less vigilant than non-territorial males. Although territorial males may share collective risk detection with harem females, we suggest that they are probably more vulnerable to predation because they seemed reluctant to leave rut stands under threats. Conclusions/Significance: Vigilance behavior in Przewalski's gazelle was significantly affected by reproductive status, social rank, sex, group size and their complex interactions. These findings shed light on the mechanisms underlying vigilance patterns and the tradeoff between vigilance and other crucial activities.	[Li, Chunlin; Jiang, Zhigang; Li, Linlin; Fang, Hongxia; Li, Chunwang] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Li, Chunlin; Jiang, Zhigang; Li, Linlin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Li, Zhongqiu] Nanjing Univ, Coll Life Sci, Nanjing 210008, Peoples R China; [Beauchamp, Guy] Univ Montreal, Fac Vet Med, Quebec City, PQ, Canada	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanjing University; Universite de Montreal	Li, CL (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	jiangzg@ioz.ac.cn	Jiang, Zhigang/E-4598-2014; Li, Zhong-qiu/A-1748-2011	Jiang, Zhigang/0000-0003-2154-8588; Li, Zhong-qiu/0000-0003-2004-293X	Ministry of Science and Technology, China [2008BAC39B04]; Chinese Academy of Sciences [KSCX2-EW-Z-4]; National Natural Sciences Foundation of China [31070469]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Science and Technology Supporting Project, Ministry of Science and Technology, China (Monitoring of Important Biological Species and Demonstration of Key Conservation Technology Application in China, 2008BAC39B04, http://program.most.gov.cn/), Key Program of Knowledge Innovation Program of Chinese Academy of Sciences (KSCX2-EW-Z-4, http://www.bio.cas.cn/xmyj/yzscxzdxm/) and National Natural Sciences Foundation of China (Population patterns and structure of Przewalski's gazelle in anthropogenic landscape, No. 31070469, http://www.nsfc.gov.cn/nsfc/cen/xxgk/slzz.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage KB, 1996, ETHOL ECOL EVOL, V8, P67, DOI 10.1080/08927014.1996.9522936; BALMFORD A, 1992, ANIM BEHAV, V44, P117, DOI 10.1016/S0003-3472(05)80761-4; Bateson P., 1983, MATE CHOICE; Beauchamp G, 2001, BEHAV ECOL SOCIOBIOL, V51, P47, DOI 10.1007/s002650100413; Beauchamp G, 2003, BEHAV PROCESS, V63, P111, DOI 10.1016/S0376-6357(03)00002-0; Beauchamp G, 2003, AM NAT, V161, P672, DOI 10.1086/368225; Beauchamp G, 1997, CAN J ZOOL, V75, P1526, DOI 10.1139/z97-776; Beauchamp G, 2008, BEHAV ECOL, V19, P1361, DOI 10.1093/beheco/arn096; Caro T., 2005, ANTIPREDATOR DEFENSE; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1993, ANIM BEHAV, V46, P1121, DOI 10.1006/anbe.1993.1302; Fairbanks B, 2007, ANIM BEHAV, V73, P115, DOI 10.1016/j.anbehav.2006.07.002; Favreau FR, 2010, P ROY SOC B-BIOL SCI, V277, P2089, DOI 10.1098/rspb.2009.2337; FESTABIANCHET M, 1988, OECOLOGIA, V75, P580, DOI 10.1007/BF00776423; Fortin D, 2004, OIKOS, V107, P172, DOI 10.1111/j.0030-1299.2004.12976.x; Frid A, 1997, ANIM BEHAV, V53, P799, DOI 10.1006/anbe.1996.0345; Guillemain M, 2003, BEHAV ECOL, V14, P724, DOI 10.1093/beheco/arg060; Gutzwiller KJ, 1998, CONDOR, V100, P519, DOI 10.2307/1369718; ILLIUS AW, 1994, ANIM BEHAV, V47, P481, DOI 10.1006/anbe.1994.1067; Inger R, 2006, ANIM BEHAV, V71, P1335, DOI 10.1016/j.anbehav.2005.08.015; IUCN SSC ANTELOPE SPECIALIST GROUP, 2008, IUCN RED LIST THREAT; JACOBSEN OW, 1994, ANIM BEHAV, V47, P488, DOI 10.1006/anbe.1994.1069; Jiang Z.G., 2004, CHINAS PRZEWALSKIS G; Jiang Zhi-Gang, 2004, Acta Zoologica Sinica, V50, P706; Jiang Zhi-Gang, 2003, Chinese Journal of Zoology, V38, P129; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; Lei RH, 2001, J ZOOL, V255, P175, DOI 10.1017/S0952836901001248; Leslie David M. Jr., 2010, Mammalian Species, P124, DOI 10.1644/860.1; Li C, 2010, CURRENT STA IN PRESS; Li C, 2007, ZOO BIOL, V26, P461, DOI 10.1002/zoo.20132; Li CW, 2009, WILDLIFE RES, V36, P379, DOI 10.1071/WR08117; Li CW, 2001, HORM BEHAV, V40, P518, DOI 10.1006/hbeh.2001.1711; Li Z, 2008, THESIS I ZOOLOGY CHI; Li Z, 2009, J ZOOL LOND; Li ZQ, 2010, J MAMMAL, V91, P674, DOI 10.1644/09-MAMM-A-203.1; Liley S, 2008, BEHAV ECOL, V19, P245, DOI 10.1093/beheco/arm116; Lima SL, 1999, ANIM BEHAV, V58, P537, DOI 10.1006/anbe.1999.1182; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Liu Bing-wan, 2009, Zoological Research, V30, P694, DOI 10.3724/SP.J.1141.2009.06694; Lung MA, 2007, BEHAV ECOL, V18, P12, DOI [10.1093/beheco/ar1066, 10.1093/beheco/arl066]; Marino A, 2008, ETHOLOGY, V114, P413, DOI 10.1111/j.1439-0310.2008.01485_1.x; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; McElligott AG, 2003, EVOL ECOL RES, V5, P1239; Mooring MS, 2006, ANIM BEHAV, V72, P737, DOI 10.1016/j.anbehav.2006.02.006; Mooring MS, 2004, HORM BEHAV, V46, P392, DOI 10.1016/j.yhbeh.2004.03.008; Pelletier F, 2009, ETHOLOGY, V115, P141, DOI 10.1111/j.1439-0310.2008.01589.x; Pepin D, 2001, APPL ANIM BEHAV SCI, V74, P233, DOI 10.1016/S0168-1591(01)00172-1; REALE D, 1996, CAN J ZOOL, V74, P1812; Reboreda JC, 1997, ETHOLOGY, V103, P198; Richard E, 2008, BEHAV PROCESS, V79, P28, DOI 10.1016/j.beproc.2008.04.008; Rieucau G, 2008, OIKOS, V117, P501, DOI 10.1111/j.0030-1299.2008.16274.x; Rieucau G, 2009, BEHAV ECOL, V20, P421, DOI 10.1093/beheco/arn144; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; Shih Hsi-Te, 2000, Acta Zoologica Taiwanica, V11, P47; Shorrocks B, 2005, AFR J ECOL, V43, P91, DOI 10.1111/j.1365-2028.2005.00541.x; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; Sundaresan SR, 2007, BEHAV ECOL, V18, P860, DOI 10.1093/beheco/arm055; Taylor AR, 2003, ECOL APPL, V13, P951, DOI 10.1890/1051-0761(2003)13[951:WRTRAA]2.0.CO;2; Tchabovsky AV, 2001, J ETHOL, V19, P105, DOI 10.1007/s101640170006; Treves A, 2000, ANIM BEHAV, V60, P711, DOI 10.1006/anbe.2000.1528; UNDERWOOD R, 1982, BEHAVIOUR, V79, P81, DOI 10.1163/156853982X00193; Willisch CS, 2007, ETHOLOGY, V113, P97, DOI 10.1111/j.1439-0310.2006.01301.x; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; Wolff JO, 2003, CAN J ZOOL, V81, P266, DOI 10.1139/Z03-011; Wolff JO, 1998, OIKOS, V83, P529, DOI 10.2307/3546680; Yang Ji, 2011, PLoS One, V6, pe20144, DOI 10.1371/journal.pone.0020144; Yoccoz NG, 2002, P ROY SOC B-BIOL SCI, V269, P1523, DOI 10.1098/rspb.2002.2047; You Zhang-Qiang, 2005, Acta Zoologica Sinica, V51, P187; You ZQ, 2011, CURR ZOOL, V57, P701, DOI 10.1093/czoolo/57.6.701; Li ZQ, 2008, BEHAV PROCESS, V78, P25, DOI 10.1016/j.beproc.2007.11.011; [No title captured]	72	42	49	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32607	10.1371/journal.pone.0032607	http://dx.doi.org/10.1371/journal.pone.0032607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389714	gold, Green Published, Green Submitted			2022-12-27	WOS:000302999600053
J	Mavhu, W; Hatzold, K; Laver, SM; Sherman, J; Tengende, BR; Mangenah, C; Langhaug, LF; Hart, G; Cowan, FM				Mavhu, Webster; Hatzold, Karin; Laver, Susan M.; Sherman, Judith; Tengende, Brenda R.; Mangenah, Collin; Langhaug, Lisa F.; Hart, Graham; Cowan, Frances M.			Acceptability of Early Infant Male Circumcision as an HIV Prevention Intervention in Zimbabwe: A Qualitative Perspective	PLOS ONE			English	Article							INFECTION; HARARE; MEN	Background: Early infant male circumcision (EIMC) is simpler, safer and more cost-effective than adult circumcision. In sub-Saharan Africa, there are concerns about acceptability of EIMC which could affect uptake. In 2009 a quantitative survey of 2,746 rural Zimbabweans (aged 18-44) indicated that 60% of women and 58% of men would be willing to have their newborn son circumcised. Willingness was associated with knowledge of HIV and male circumcision. This qualitative study was conducted to better understand this issue. Methods: In 2010, 24 group discussions were held across Zimbabwe with participants from seven ethnic groups. Additionally, key informant interviews were held with private paediatricians who offer EIMC (n = 2) plus one traditional leader. Discussions were audio-recorded, transcribed, translated into English (where necessary), coded using NVivo 8 and analysed using grounded theory principles. Results: Knowledge of the procedure was poor. Despite this, acceptability of EIMC was high among parents from most ethnic groups. Discussions suggested that fathers would make the ultimate decision regarding EIMC although mothers and extended family can have (often covert) influence. Participants' concerns centred on: safety, motive behind free service provision plus handling and disposal of the discarded foreskin. Older men from the dominant traditionally circumcising population strongly opposed EIMC, arguing that it separates circumcision from adolescent initiation, as well as allowing women (mothers) to nurse the wound, considered taboo. Conclusions: EIMC is likely to be an acceptable HIV prevention intervention for most populations in Zimbabwe, if barriers to uptake are appropriately addressed and fathers are specifically targeted by the programme.	[Mavhu, Webster; Tengende, Brenda R.; Mangenah, Collin; Cowan, Frances M.] Univ Zimbabwe, Zimbabwe AIDS Prevent Project, Dept Community Med, Harare, Zimbabwe; [Hatzold, Karin] Populat Serv Int, Harare, Zimbabwe; [Laver, Susan M.] UNICEF, CCORE, Harare, Zimbabwe; [Mavhu, Webster; Langhaug, Lisa F.; Hart, Graham; Cowan, Frances M.] UCL, Res Dept Infect & Populat Hlth, Ctr Sexual Hlth & HIV Res, London, England	University of Zimbabwe; University of London; University College London	Mavhu, W (corresponding author), Univ Zimbabwe, Zimbabwe AIDS Prevent Project, Dept Community Med, Harare, Zimbabwe.	wmavhu@gmail.com		Hart, Graham/0000-0001-9676-6577; Langhaug, Lisa/0000-0002-9131-8158; Cowan, Frances/0000-0003-3087-4422; Mavhu, Webster/0000-0003-1881-4398	PSI-Zimbabwe; SIDA-Zimbabwe; UKaid-Zimbabwe; UNICEF-Zimbabwe	PSI-Zimbabwe; SIDA-Zimbabwe; UKaid-Zimbabwe; UNICEF-Zimbabwe	This study was funded through several funders including PSI-Zimbabwe, SIDA-Zimbabwe, UKaid-Zimbabwe and UNICEF-Zimbabwe (no grant numbers used). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey R. C., 2010, 18 INT AIDS C VIENN; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bassett MT, 1996, J ACQ IMMUN DEF SYND, V13, P287, DOI 10.1097/00042560-199611010-00012; Binagwaho A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000211; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Chirawu P, 2010, AIDS CARE, V22, P81, DOI 10.1080/09540120903012577; El Bcheraoui C, 2010, 18 INT AIDS C VIENN; Fritz K, 2011, AIDS BEHAV, V15, P1732, DOI 10.1007/s10461-011-9922-1; Glaser B.G., 1968, DISCOV GROUNDED THEO; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Kalichman SC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000219; Kong X, 2011, 18 C RETR OPP INF M; Lukobo MD, 2007, AIDS CARE, V19, P471, DOI 10.1080/09540120601163250; Madhivanan P, 2008, AIDS, V22, P983, DOI 10.1097/QAD.0b013e3282ffde52; Manji KP, 2000, ANN TROP PAEDIATR, V20, P101, DOI 10.1080/02724936.2000.11748116; Mavhu W, 2011, TROP MED INT HEALTH, V16, P589, DOI 10.1111/j.1365-3156.2011.02744.x; Mavhu W, 2010, TROP MED INT HEALTH, V15, P574, DOI 10.1111/j.1365-3156.2010.02493.x; Mavundla TR, 2009, J TRANSCULT NURS, V20, P395, DOI 10.1177/1043659609340801; Ministry of Health, 2010, STRAT SAF MED MAL CI; Ngalande RC, 2006, AIDS BEHAV, V10, P377, DOI 10.1007/s10461-006-9076-8; Plank RM, 2010, AIDS BEHAV, V14, P1198, DOI 10.1007/s10461-009-9632-0; Skovdal M, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-13; UNICEF, 2011, MED MAL CIRC E SO AF MED MAL CIRC E SO AF; Waters E, 2011, AIDS CARE       0628; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; WISWELL TE, 1989, PEDIATRICS, V83, P1011; World Health Organization, 2007, NEW DAT MAL CIRC HIV	29	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32475	10.1371/journal.pone.0032475	http://dx.doi.org/10.1371/journal.pone.0032475			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384258	Green Submitted, Green Published, gold			2022-12-27	WOS:000302918500094
J	Stoffberg, S; Schoeman, MC; Matthee, CA				Stoffberg, Samantha; Schoeman, M. Corrie; Matthee, Conrad A.			Correlated Genetic and Ecological Diversification in a Widespread Southern African Horseshoe Bat	PLOS ONE			English	Article							ECHOLOCATION CALL FREQUENCIES; SPECIES IDENTIFICATION; CLIMATE-CHANGE; EVOLUTION; CHIROPTERA; MORPHOLOGY; SPECIATION; DISTRIBUTIONS; PLEISTOCENE; ECOREGIONS	The analysis of molecular data within a historical biogeographical framework, coupled with ecological characteristics can provide insight into the processes driving diversification. Here we assess the genetic and ecological diversity within a widespread horseshoe bat Rhinolophus clivosus sensu lato with specific emphasis on the southern African representatives which, although not currently recognized, were previously described as a separate species R. geoffroyi comprising four subspecies. Sequence divergence estimates of the mtDNA control region show that the southern African representatives of R. clivosus s.l. are as distinct from samples further north in Africa than they are from R. ferrumequinum, the sister-species to R. clivosus. Within South Africa, five genetically supported geographic groups exist and these groups are corroborated by echolocation and wing morphology data. The groups loosely correspond to the distributions of the previously defined subspecies and Maxent modelling shows a strong correlation between the detected groups and ecoregions. Based on molecular clock calibrations, it is evident that climatic cycling and related vegetation changes during the Quaternary may have facilitated diversification both genetically and ecologically.	[Stoffberg, Samantha; Matthee, Conrad A.] Univ Stellenbosch, Dept Bot & Zool, Evolutionary Genom Grp, ZA-7600 Stellenbosch, South Africa; [Schoeman, M. Corrie] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa	Stellenbosch University; University of Kwazulu Natal	Stoffberg, S (corresponding author), Univ Stellenbosch, Dept Bot & Zool, Evolutionary Genom Grp, ZA-7600 Stellenbosch, South Africa.	samanthastoffberg@gmail.com	Matthee, Conrad A./B-1620-2012; Schoeman, Corrie/G-2616-2010	Matthee, Conrad A./0000-0002-6836-069X; Schoeman, Corrie/0000-0003-3736-0264	University of KwaZulu-Natal; National Research Foundation (NRF); Claude Leon Foundation	University of KwaZulu-Natal; National Research Foundation (NRF); Claude Leon Foundation	This research was supported by grants from the University of KwaZulu-Natal to MCS and the National Research Foundation (NRF) to CAM, and Claude Leon Foundation Postdoctoral Fellowships to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2005, TRENDS ECOL EVOL, V20, P278, DOI 10.1016/j.tree.2005.04.001; ALDRIDGE HDJN, 1987, J ANIM ECOL, V56, P763, DOI 10.2307/4947; Alpers DL, 2004, MOL ECOL, V13, P1771, DOI 10.1111/j.1365-294X.2004.02204.x; Anthony E.L.P., 1988, P47; Beheregaray Luciano B, 2007, J Biol, V6, P9, DOI 10.1186/jbiol60; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Branch WR, 1998, FIELD GUIDE SNAKES O; Brown DM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-57; Carruthers V., 2001, FROGS FROGGING SO AF; Ceballos G, 2009, P NATL ACAD SCI USA, V106, P3841, DOI 10.1073/pnas.0812419106; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022648; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021460; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Compton JS, 2011, QUATERNARY SCI REV, V30, P506, DOI 10.1016/j.quascirev.2010.12.012; Cotterill FPD, 2002, J ZOOL, V256, P165, DOI 10.1017/S0952836902000201; Cowling R. M., 1997, VEGETATION SO AFRICA, P615; Csorba G., 2003, HORSESHOE BATS WORLD; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Faulkes CG, 2004, MOL ECOL, V13, P613, DOI 10.1046/j.1365-294X.2004.02099.x; FENTON MB, 1990, CAN J ZOOL, V68, P411, DOI 10.1139/z90-061; Flagstad O, 2001, P ROY SOC B-BIOL SCI, V268, P667, DOI 10.1098/rspb.2000.1416; Flanders J, 2011, J BIOGEOGR, V38, P439, DOI 10.1111/j.1365-2699.2010.02411.x; Francis CM, 2007, ACTA CHIROPTEROL, V9, P1, DOI 10.3161/1733-5329(2007)9[1:ANSOKC]2.0.CO;2; Francis CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012575; Goodman SM, 2011, ZOOTAXA, P1; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HELLER KG, 1989, OECOLOGIA, V80, P178, DOI 10.1007/BF00380148; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt Godfrey M, 2004, Front Zool, V1, P4; Hockey P.A.R., 2005, ROBERTSBIRDS SO AFRI, V7th; HOELZEL AR, 1991, MOL BIOL EVOL, V8, P475; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; JONES G, 1993, P ROY SOC B-BIOL SCI, V252, P125, DOI 10.1098/rspb.1993.0055; Jones G, 2003, BAT ECOLOGY, P301; Jones G, 2011, J COMP PHYSIOL A, V197, P447, DOI 10.1007/s00359-010-0565-x; Jones G, 1997, ADV STUD BEHAV, V26, P317, DOI 10.1016/S0065-3454(08)60383-6; Kingston T, 2004, NATURE, V429, P654, DOI 10.1038/nature02487; Kruskop SV, 2008, RUSSIAN J THERIOL, V7, P71; Lawes MJ, 2007, J BIOGEOGR, V34, P1246, DOI 10.1111/j.1365-2699.2007.01696.x; Linder HP, 2010, CURR OPIN ENV SUST, V2, P109, DOI 10.1016/j.cosust.2010.02.001; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Mao XG, 2010, MOL ECOL, V19, P2754, DOI 10.1111/j.1365-294X.2010.04704.x; Mao XG, 2010, MOL ECOL, V19, P1352, DOI 10.1111/j.1365-294X.2010.04560.x; Matthee C. A., 1997, Journal of Mammalian Evolution, V4, P53, DOI 10.1023/A:1027331727034; Mayer F, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-4; Miller JM, 2011, CONSERV GENET, V12, P423, DOI 10.1007/s10592-010-0149-x; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Miller-Butterworth CM, 2003, NATURE, V424, P187, DOI 10.1038/nature01742; Monadjem A., 2010, BATS SO CENTRAL AFRI, P596; Mugo DN, 1995, S AFR J ZOOL, V30, P115; Muwanika VB, 2003, HEREDITY, V91, P361, DOI 10.1038/sj.hdy.6800341; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Partridge TC, 1999, QUATERN INT, V57-8, P207, DOI 10.1016/S1040-6182(98)00061-5; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambau RV, 2003, MOL PHYLOGENET EVOL, V28, P564, DOI 10.1016/S1055-7903(03)00058-7; Reeder DeeAnn M., 2007, Occasional Papers Museum of Texas Tech University, V269, P1; Roberts A., 1951, MAMMALS S AFRICA; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Russo D, 2007, J BIOGEOGR, V34, P2129, DOI 10.1111/j.1365-2699.2007.01762.x; SAUNDERS MB, 1992, ECOLOGY, V73, P1335, DOI 10.2307/1940680; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Schoeman MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003715; Schuchmann M, 2010, AM NAT, V176, P72, DOI 10.1086/652993; Shi LM, 2009, ACTA THERIOL, V54, P371, DOI 10.4098/j.at.0001-7051.099.2008; SMITHERS RHN, 1983, MAMMALS SO AFRICAN S, P736; Stoffberg S, 2004, CAN J ZOOL, V82, P1854, DOI 10.1139/Z04-172; Stoffberg S, 2007, THESIS U CAPE TOWN S; Stoffberg S, 2010, MOL PHYLOGENET EVOL, V54, P1, DOI 10.1016/j.ympev.2009.09.021; Swart BL, 2009, J BIOGEOGR, V36, P78, DOI 10.1111/j.1365-2699.2008.01988.x; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thabah A, 2006, BIOL J LINN SOC, V88, P119, DOI 10.1111/j.1095-8312.2006.00602.x; Tolley KA, 2009, MOL PHYLOGENET EVOL, V51, P120, DOI 10.1016/j.ympev.2008.11.017; TRAPPE M, 1982, NATURWISSENSCHAFTEN, V69, P193, DOI 10.1007/BF00364902; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; WOLOSZYN B W, 1987, Acta Palaeontologica Polonica, V32, P207	88	25	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31946	10.1371/journal.pone.0031946	http://dx.doi.org/10.1371/journal.pone.0031946			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384108	Green Published, gold			2022-12-27	WOS:000302918500049
J	Valles, SM; Oi, DH; Yu, FH; Tan, XX; Buss, EA				Valles, Steven M.; Oi, David H.; Yu, Fahong; Tan, Xin-Xing; Buss, Eileen A.			Metatranscriptomics and Pyrosequencing Facilitate Discovery of Potential Viral Natural Enemies of the Invasive Caribbean Crazy Ant, Nylanderia pubens	PLOS ONE			English	Article							IMPORTED FIRE ANT; STRAND RNA VIRUS; SOLENOPSIS-INVICTA; GENOME SEQUENCE; DRAFT GENOME; HYMENOPTERA; FORMICIDAE; EVOLUTION; PATHOGENS; TAXONOMY	Background: Nylanderia pubens (Forel) is an invasive ant species that in recent years has developed into a serious nuisance problem in the Caribbean and United States. A rapidly expanding range, explosive localized population growth, and control difficulties have elevated this ant to pest status. Professional entomologists and the pest control industry in the United States are urgently trying to understand its biology and develop effective control methods. Currently, no known biological-based control agents are available for use in controlling N. pubens. Methodology and Principal Findings: Metagenomics and pyrosequencing techniques were employed to examine the transcriptome of field-collected N. pubens colonies in an effort to identify virus infections with potential to serve as control agents against this pest ant. Pyrosequencing (454-platform) of a non-normalized N. pubens expression library generated 1,306,177 raw sequence reads comprising 450 Mbp. Assembly resulted in generation of 59,017 non-redundant sequences, including 27,348 contigs and 31,669 singlets. BLAST analysis of these non-redundant sequences identified 51 of potential viral origin. Additional analyses winnowed this list of potential viruses to three that appear to replicate in N. pubens. Conclusions: Pyrosequencing the transcriptome of field-collected samples of N. pubens has identified at least three sequences that are likely of viral origin and, in which, N. pubens serves as host. In addition, the N. pubens transcriptome provides a genetic resource for the scientific community which is especially important at this early stage of developing a knowledgebase for this new pest.	[Valles, Steven M.; Oi, David H.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL USA; [Yu, Fahong] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Tan, Xin-Xing] SeqWright, Houston, TX USA; [Buss, Eileen A.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA	United States Department of Agriculture (USDA); State University System of Florida; University of Florida; State University System of Florida; University of Florida	Valles, SM (corresponding author), USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL USA.	steven.valles@ars.usda.gov			USDA-NIFA [2010-34135-21096]	USDA-NIFA(United States Department of Agriculture (USDA))	This research was funded by the USDA-NIFA Tropical and Subtropical Agricultural Research Award # 2010-34135-21096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Calibeo D., 2011, INTEGRATED PEST MANA; Craggs JK, 2001, J VIROL METHODS, V94, P111, DOI 10.1016/S0166-0934(01)00281-6; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Drees BM, 2009, CURRENT STATUS INVAS, P129; Drezen JM, 2003, J INSECT PHYSIOL, V49, P407, DOI 10.1016/S0022-1910(03)00058-1; Farmerie WG, 2005, DATA KNOWL ENG, V53, P75, DOI 10.1016/j.datak.2004.06.014; Fort P, 2012, MOL BIOL EVOL, V29, P381, DOI 10.1093/molbev/msr226; Fuxa JR, 1987, EPIZOOTIOLOGY INSECT, P555; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Hartley CJ, 2005, J VIROL, V79, P13385, DOI 10.1128/JVI.79.21.13385-13398.2005; Hashimoto Y, 2008, J INVERTEBR PATHOL, V98, P243, DOI 10.1016/j.jip.2008.02.002; Hunnicutt LE, 2006, VIROLOGY, V350, P67, DOI 10.1016/j.virol.2006.02.034; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; JOUVENAZ DP, 1977, FLA ENTOMOL, V60, P275, DOI 10.2307/3493922; JOUVENAZ DP, 1983, FLA ENTOMOL, V66, P111, DOI 10.2307/3494557; JOUVENAZ DP, 1990, APPL MYRMECOLOGY WOR, P623; Kaya, 1993, INSECT PATHOLOGY; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Kroemer JA, 2004, ANNU REV ENTOMOL, V49, P431, DOI 10.1146/annurev.ento.49.072103.120132; Lacey LA, 2001, BIOL CONTROL, V21, P230, DOI 10.1006/bcon.2001.0938; LaPolla JS, 2010, SYST ENTOMOL, V35, P118, DOI 10.1111/j.1365-3113.2009.00492.x; MacGown J., 2010, Midsouth Entomologist, V3, P44; Meyers J., 2008, IDENTIFICATION DISTR; Oi David H., 2009, V6, P237; Oi DH, 2003, ENVIRON ENTOMOL, V32, P1171, DOI 10.1603/0046-225X-32.5.1171; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; TRAGER JC, 1984, SOCIOBIOLOGY, V9, P51; Valles S. M., 2012, Psyche: A Journal of Entomology, V2012, P821591, DOI 10.1155/2012/821591; Valles SM, 2004, VIROLOGY, V328, P151, DOI 10.1016/j.virol.2004.07.016; Valles SM, 2008, J INVERTEBR PATHOL, V99, P74, DOI 10.1016/j.jip.2008.01.004; Valles SM, 2007, VIROLOGY, V365, P457, DOI 10.1016/j.virol.2007.03.043; Valles SM, 2009, VIROLOGY, V388, P354, DOI 10.1016/j.virol.2009.03.028; van Regenmortel M. H. V., 2000, VIRUS TAXONOMY CLASS; WARNER J, 2010, CARIBBEAN CRAZY ANT; Webb BA, 1998, VIRUSES, P105; Wetterer JK, 2008, FLA ENTOMOL, V91, P423, DOI 10.1653/0015-4040(2008)91[423:PEOTHC]2.0.CO;2; Wojcik D.P., 1987, P627; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108	43	33	36	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31828	10.1371/journal.pone.0031828	http://dx.doi.org/10.1371/journal.pone.0031828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384082	Green Published, gold			2022-12-27	WOS:000302918500040
J	Hauser, A; Sewangi, J; Mbezi, P; Dugange, F; Lau, I; Ziske, J; Theuring, S; Kuecherer, C; Harms, G; Kunz, A				Hauser, Andrea; Sewangi, Julius; Mbezi, Paulina; Dugange, Festo; Lau, Inga; Ziske, Judith; Theuring, Stefanie; Kuecherer, Claudia; Harms, Gundel; Kunz, Andrea			Emergence of Minor Drug-Resistant HIV-1 Variants after Triple Antiretroviral Prophylaxis for Prevention of Vertical HIV-1 Transmission	PLOS ONE			English	Article							SINGLE-DOSE NEVIRAPINE; IMMUNODEFICIENCY-VIRUS TYPE-1; TO-CHILD TRANSMISSION; LONG-TERM PERSISTENCE; VIROLOGICAL FAILURE; ZIDOVUDINE RESISTANCE; TREATMENT-NAIVE; PREGNANT-WOMEN; VIRAL LOAD; THERAPY	Background: WHO-guidelines for prevention of mother-to-child transmission of HIV-1 in resource-limited settings recommend complex maternal antiretroviral prophylaxis comprising antenatal zidovudine (AZT), nevirapine single-dose (NVP-SD) at labor onset and AZT/lamivudine (3TC) during labor and one week postpartum. Data on resistance development selected by this regimen is not available. We therefore analyzed the emergence of minor drug-resistant HIV-1 variants in Tanzanian women following complex prophylaxis. Method: 1395 pregnant women were tested for HIV-1 at Kyela District Hospital, Tanzania. 87/202 HIV-positive women started complex prophylaxis. Blood samples were collected before start of prophylaxis, at birth and 1-2, 4-6 and 12-16 weeks postpartum. Allele-specific real-time PCR assays specific for HIV-1 subtypes A, C and D were developed and applied on samples of mothers and their vertically infected infants to quantify key resistance mutations of AZT (K70R/T215Y/T215F), NVP (K103N/Y181C) and 3TC (M184V) at detection limits of <1%. Results: 50/87 HIV-infected women having started complex prophylaxis were eligible for the study. All women took AZT with a median duration of 53 days (IQR 39-64); all women ingested NVP-SD, 86% took 3TC. HIV-1 resistance mutations were detected in 20/50 (40%) women, of which 70% displayed minority species. Variants with AZT-resistance mutations were found in 11/50 (22%), NVP-resistant variants in 9/50 (18%) and 3TC-resistant variants in 4/50 women (8%). Three women harbored resistant HIV-1 against more than one drug. 49/50 infants, including the seven vertically HIV-infected were breastfed, 3/7 infants exhibited drug-resistant virus. Conclusion: Complex prophylaxis resulted in lower levels of NVP-selected resistance as compared to NVP-SD, but AZT-resistant HIV-1 emerged in a substantial proportion of women. Starting AZT in pregnancy week 14 instead of 28 as recommended by the current WHO-guidelines may further increase the frequency of AZT-resistance mutations. Given its impact on HIV-transmission rate and drug-resistance development, HAART for all HIV-positive pregnant women should be considered.	[Hauser, Andrea; Lau, Inga; Ziske, Judith; Theuring, Stefanie; Harms, Gundel; Kunz, Andrea] Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany; [Hauser, Andrea; Kuecherer, Claudia] Robert Koch Inst, Ctr HIV & Retrovirol, Berlin, Germany; [Sewangi, Julius] Minist Hlth & Social Welf, Reg AIDS Control Program Mbeya Reg, Dar Es Salaam, Tanzania; [Mbezi, Paulina] Minist Hlth & Social Welf, PMTCT Serv Mbeya Reg, Dar Es Salaam, Tanzania; [Dugange, Festo] Kyela Dist Hosp, Minist Hlth & Social Welf, Dar Es Salaam, Tanzania	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute	Hauser, A (corresponding author), Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany.	andrea.hauser@charite.de			German Ministry for Economic Cooperation and Development [01.2029.5]; H.W. & J. Hector Stiftung, Germany	German Ministry for Economic Cooperation and Development; H.W. & J. Hector Stiftung, Germany	The work was supported by the German Ministry for Economic Cooperation and Development through project 01.2029.5 (Prevention of Mother-to Child Transmission of HIV) and by a grant of the H.W. & J. Hector Stiftung, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT J, 1992, J VIROL, V66, P5627, DOI 10.1128/JVI.66.9.5627-5630.1992; [Anonymous], HIV DRUG RESISTANCE; [Anonymous], BIOEDIT VERSION 7 0; Arrive E, 2007, INT J EPIDEMIOL, V36, P1009, DOI 10.1093/ije/dym104; Arroyo MA, 2005, AIDS, V19, P1517, DOI 10.1097/01.aids.0000183515.14642.76; BOUCHER CAB, 1992, J INFECT DIS, V165, P105, DOI 10.1093/infdis/165.1.105; BOUCHER CAB, 1993, ANTIMICROB AGENTS CH, V37, P1525, DOI 10.1128/AAC.37.7.1525; Charpentier C, 2004, J VIROL, V78, P4234, DOI 10.1128/JVI.78.8.4234-4247.2004; Clarke JR, 1999, J MED VIROL, V59, P364, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;364::AID-JMV17&gt;3.0.CO;2-V; Coffie PA, 2008, CLIN INFECT DIS, V46, P611, DOI 10.1086/526780; Coovadia A, 2009, CLIN INFECT DIS, V48, P462, DOI 10.1086/596486; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Dykes C, 2004, J INFECT DIS, V189, P1091, DOI 10.1086/382033; Eastman PS, 1998, J INFECT DIS, V177, P557, DOI 10.1086/514228; Ekpini RA, 2002, AIDS, V16, P625, DOI 10.1097/00002030-200203080-00015; Ellis RJ, 2011, AIDS, V25, P1747, DOI 10.1097/QAD.0b013e32834a40cd; Eshleman SH, 2005, JAIDS-J ACQ IMM DEF, V40, P24, DOI 10.1097/01.qai.0000174656.71276.d6; Farr SL, 2010, JAIDS-J ACQ IMM DEF, V54, P515, DOI 10.1097/QAI.0b013e3181e3a70e; Flys T, 2005, J INFECT DIS, V192, P24, DOI 10.1086/430742; Flys TS, 2007, J INFECT DIS, V195, P711, DOI 10.1086/511433; Fox Z, 2008, AIDS, V22, P2279, DOI 10.1097/QAD.0b013e328311d16f; Frank M, 2011, ANTIMICROB AGENTS CH, V55, P5529, DOI 10.1128/AAC.00741-11; Gianella S, 2010, J INFECT DIS, V202, P657, DOI 10.1086/655397; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Halvas EK, 2006, J CLIN MICROBIOL, V44, P2612, DOI 10.1128/JCM.00449-06; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Hauser A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020357; Hauser A, 2009, ANTIMICROB AGENTS CH, V53, P2965, DOI 10.1128/AAC.01672-08; Heidari S, 2011, JAIDS-J ACQ IMM DEF, V57, P290, DOI 10.1097/QAI.0b013e318221c56a; Johnson JA, 2005, J INFECT DIS, V192, P16, DOI 10.1086/430741; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Joint United Nations Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; Katzenstein TL, 2008, HIV MED, V9, P445, DOI 10.1111/j.1468-1293.2008.00593.x; Kirsten I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021020; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kunz A, 2009, J ANTIMICROB CHEMOTH, V63, P170, DOI 10.1093/jac/dkn441; LAND S, 1992, J INFECT DIS, V166, P1139, DOI 10.1093/infdis/166.5.1139; Lecossier D, 2005, JAIDS-J ACQ IMM DEF, V38, P37, DOI 10.1097/00126334-200501010-00007; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Loubser S, 2006, AIDS, V20, P995, DOI 10.1097/01.aids.0000222071.60620.1d; MacLeod IJ, 2010, J CLIN VIROL, V48, P162, DOI 10.1016/j.jcv.2010.03.017; Marazzi MC, 2011, AIDS, V25, P1611, DOI 10.1097/QAD.0b013e3283493ed0; Marazzi MC, 2010, AIDS, V24, P2819, DOI 10.1097/QAD.0b013e32833ff58c; McIntyre JA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000172; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Metzner KJ, 2011, J CLIN VIROL, V50, P156, DOI 10.1016/j.jcv.2010.10.001; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Metzner KJ, 2005, AIDS, V19, P1819, DOI 10.1097/01.aids.0000189878.97480.ed; Mirochnick M, 1998, J INFECT DIS, V178, P368, DOI 10.1086/515641; NIELSEN C, 1992, ANTIVIR RES, V18, P303, DOI 10.1016/0166-3542(92)90063-B; Palmer S, 2006, P NATL ACAD SCI USA, V103, P7094, DOI 10.1073/pnas.0602033103; Paredes R, 2007, J VIROL METHODS, V146, P136, DOI 10.1016/j.jviromet.2007.06.012; Phillips AN, 2007, AIDS, V21, P1717; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; RICHMAN DD, 1990, J ACQ IMMUN DEF SYND, V3, P743; Roquebert B, 2006, AIDS, V20, P287, DOI 10.1097/01.aids.0000202650.03279.69; Ross LL, 2010, J ANTIMICROB CHEMOTH, V65, P307, DOI 10.1093/jac/dkp419; Rowley CF, 2008, J VIROL METHODS, V149, P69, DOI 10.1016/j.jviromet.2008.01.005; Rowley CF, 2010, AIDS RES HUM RETROV, V26, P293, DOI 10.1089/aid.2009.0082; SCHENKER S, 1990, AM J MED SCI, V299, P16, DOI 10.1097/00000441-199001000-00005; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; SMITH MS, 1994, LEUKEMIA, V8, pS179; Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201; Stringer JSA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000233; The United Republic of Tanzania Ministry of Health and Social Welfare, 2007, PREV MOTH TO CHILD T; Welles SL, 2000, AIDS, V14, P263, DOI 10.1097/00002030-200002180-00008; WHO, 2006, ANT DRUGS TREAT PREG	70	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32055	10.1371/journal.pone.0032055	http://dx.doi.org/10.1371/journal.pone.0032055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384138	Green Submitted, Green Published, gold			2022-12-27	WOS:000302916100049
J	Schulte, DM; Muller, N; Neumann, K; Oberhauser, F; Faust, M; Gudelhofer, H; Brandt, B; Krone, W; Laudes, M				Schulte, Dominik M.; Mueller, Nike; Neumann, Katrin; Oberhaeuser, Frank; Faust, Michael; Guedelhoefer, Heike; Brandt, Burkhard; Krone, Wilhelm; Laudes, Matthias			Pro-Inflammatory wnt5a and Anti-Inflammatory sFRP5 Are Differentially Regulated by Nutritional Factors in Obese Human Subjects	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; INSULIN-RESISTANCE; ADIPOGENESIS; ANTAGONIST; PREADIPOCYTES; MACROPHAGES; MECHANISMS; RECEPTORS; WNT-5A; GENE	Background: Obesity is associated with macrophage infiltration of adipose tissue. These inflammatory cells affect adipocytes not only by classical cytokines but also by the secreted glycopeptide wnt5a. Healthy adipocytes are able to release the wnt5a inhibitor sFRP5. This protective effect, however, was found to be diminished in obesity. The aim of the present study was to examine (1) whether obese human subjects exhibit increased serum concentrations of wnt5a and (2) whether wnt5a and/or sFRP5 serum concentrations in obese subjects can be influenced by caloric restriction. Methodology: 23 obese human subjects (BMI 44.1 +/- 1.1 kg/m(2)) and 12 age-and sex-matched lean controls (BMI 22.3 +/- 0.4 kg/m(2)) were included in the study. Obese subjects were treated with a very low-calorie diet (approximately 800 kcal/d) for 12 weeks. Body composition was assessed by impedance analysis, insulin sensitivity was estimated by HOMA-IR and the leptin-to-adiponectin ratio and wnt5a and sFRP5 serum concentrations were measured by ELISA. sFRP5 expression in human adipose tissue biopsies was further determined on protein level by immunohistology. Principal Findings: Pro-inflammatory wnt5a was not measurable in any serum sample of lean control subjects. In patients with obesity, however, wnt5a became significantly detectable consistent with low grade inflammation in such subjects. Caloric restriction resulted in a weight loss from 131.9 +/- 4.0 to 112.3 +/- 3.2 kg in the obese patients group. This was accompanied by a significant decrease of HOMA-IR and leptin-to-adiponectin ratio, indicating improved insulin sensitivity. Interestingly, these metabolic improvements were associated with a significant increase in serum concentrations of the anti-inflammatory factor and wnt5a-inhibitor sFRP5. Conclusions/Significance: Obesity is associated with elevated serum levels of pro-inflammatory wnt5a in humans. Furthermore, caloric restriction beneficially affects serum concentrations of anti-inflammatory sFRP5 in such subjects. These findings suggest a novel regulatory system in low grade inflammation in obesity, which can be influenced by nutritional therapy.	[Schulte, Dominik M.; Mueller, Nike; Neumann, Katrin; Laudes, Matthias] Univ Kiel, Dept Internal Med 1, Kiel, Germany; [Oberhaeuser, Frank; Faust, Michael; Guedelhoefer, Heike; Krone, Wilhelm] Univ Cologne, Ctr Endocrinol Diabet & Prevent Med, D-50931 Cologne, Germany; [Brandt, Burkhard] Univ Kiel, Inst Clin Chem, Kiel, Germany	University of Kiel; University of Cologne; University of Kiel	Schulte, DM (corresponding author), Univ Kiel, Dept Internal Med 1, Kiel, Germany.	matthias.laudes@uk-sh.de	Laudes, Matthias/C-8885-2011; Biguzzi, Felipe A/E-4724-2015; Schulte, Dominik M/G-8653-2013	Schulte, Dominik M/0000-0002-4622-6051				Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Bilkovski R, 2011, INT J OBESITY, V35, P1450, DOI 10.1038/ijo.2011.6; Bilkovski R, 2010, J BIOL CHEM, V285, P6170, DOI 10.1074/jbc.M109.054338; Christodoulides C, 2006, DIABETOLOGIA, V49, P678, DOI 10.1007/s00125-006-0144-4; Christodoulides C, 2006, J CELL SCI, V119, P2613, DOI 10.1242/jcs.02975; Dominguez H, 2005, J VASC RES, V42, P517, DOI 10.1159/000088261; Finucane FM, 2009, DIABETOLOGIA, V52, P2345, DOI 10.1007/s00125-009-1508-3; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Lagathu C, 2010, INT J OBESITY, V34, P1695, DOI 10.1038/ijo.2010.107; Lagathu C, 2009, DIABETES, V58, P609, DOI 10.2337/db08-1180; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Laudes M, 2011, J MOL ENDOCRINOL, V46, pR65, DOI 10.1530/JME-10-0169; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Rosenvinge A, 2007, SCAND J RHEUMATOL, V36, P91, DOI 10.1080/03009740601179605; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Schertzer JD, 2011, DIABETES, V60, P2206, DOI 10.2337/db11-0004; Schultz O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014328; Sethi JK, 2000, FEBS LETT, V469, P77, DOI 10.1016/S0014-5793(00)01250-3; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Wang Chao-Ping, 2007, Rev Diabet Stud, V4, P77, DOI 10.1900/RDS.2007.4.77; Wright WS, 2007, DIABETES, V56, P295, DOI 10.2337/db06-1339; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhao L, 2011, AM J PHYSIOL-ENDOC M, V301, pE587, DOI 10.1152/ajpendo.00709.2010	27	101	116	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32437	10.1371/journal.pone.0032437	http://dx.doi.org/10.1371/journal.pone.0032437			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384249	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916100081
J	Amoureux, MC; Nicolas, S; Rougon, G				Amoureux, Marie-Claude; Nicolas, Stephane; Rougon, Genevieve			NCAM180 Regulates Ric8A Membrane Localization and Potentiates beta-Adrenergic Response	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; HETEROTRIMERIC G-PROTEINS; NULL MUTANT MICE; IMMUNOGLOBULIN SUPERFAMILY; LIPID RAFTS; RIC-8 SYNEMBRYN; PLASMA-MEMBRANE; POLYSIALIC ACID; DENTATE GYRUS; GS-ALPHA	Cooperation between receptors allows integrated intracellular signaling leading to appropriate physiological responses. The Neural Cell Adhesion Molecule (NCAM) has three main isoforms of 120, 140 and 180 kDa, with adhesive and signaling properties, but their respective functions remains to be fully identified. Here we show that the human NCAM180 intracellular domain is a novel interactor of the human guanosine exchange factor (GEF) Ric8A using the yeast two hybrid system and immunoprecipitation. Furthermore, NCAM, Ric8A and G(alpha s) form a tripartite complex. Colocalization experiments by confocal microscopy revealed that human NCAM180 specifically induces the recruitment of Ric8A to the membrane. In addition, using an in vitro recombinant system, and in vivo by comparing NCAM knock-out mouse brain to NCAM heterozygous and wild type brains, we show that NCAM expression dose dependently regulates Ric8A redistribution in detergent resistent membrane microdomains (DRM). Previous studies have demonstrated essential roles for Ric8 in G(alpha) protein activity at G protein coupled receptors (GPCR), during neurotransmitter release and for asymmetric cell division. We observed that inhibition of Ric8A by siRNA or its overexpression, decreases or increases respectively, cAMP production following beta-adrenergic receptor stimulation. Furthermore, in human HEK293T recombinant cells, NCAM180 potentiates the G(alpha s) coupled beta-adrenergic receptor response, in a Ric8A dependent manner, whereas NCAM120 or NCAM140 do not. Finally, in mouse hippocampal neurons expressing endogenously NCAM, NCAM is required for the agonist isoproterenol to induce cAMP production, and this requirement depends on Ric8A. These data illustrate a functional crosstalk between a GPCR and an IgCAM in the nervous system.	[Amoureux, Marie-Claude; Nicolas, Stephane; Rougon, Genevieve] Aix Marseille Univ, CNRS 6216, Inst Biol Dev Marseille Luminy, Marseille, France; [Amoureux, Marie-Claude] Eurobio Abcys, Les Ulis, France	UDICE-French Research Universities; Aix-Marseille Universite	Amoureux, MC (corresponding author), Aix Marseille Univ, CNRS 6216, Inst Biol Dev Marseille Luminy, Marseille, France.	Marie-Claude.Amoureux@ibdml.univmed.fr	ROUGON, Genevieve/G-2578-2013	ROUGON, Genevieve/0000-0003-1316-8200	Canceropole PACA; Federation de Recherche sur le Cerveau (FRC); CNRS	Canceropole PACA(Region Grand-Est); Federation de Recherche sur le Cerveau (FRC); CNRS(Centre National de la Recherche Scientifique (CNRS))	The Canceropole PACA (www.canceropole-paca.fr), Federation de Recherche sur le Cerveau (FRC-www.frc.asso.fr) and institutional grants from CNRS (www.cnrs.fr) provided funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar K, 2005, DEVELOPMENT, V132, P4449, DOI 10.1242/dev.02039; Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Amoureux MC, 2000, J NEUROSCI, V20, P3631, DOI 10.1523/JNEUROSCI.20-10-03631.2000; Brock JA, 1997, BRIT J PHARMACOL, V120, P769, DOI 10.1038/sj.bjp.0700959; Catapano LA, 2007, BBA-BIOMEMBRANES, V1768, P976, DOI 10.1016/j.bbamem.2006.09.025; Conchonaud F, 2007, J BIOL CHEM, V282, P26266, DOI 10.1074/jbc.M608590200; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; DOHERTY P, 1991, CELL, V67, P21, DOI 10.1016/0092-8674(91)90569-K; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; HIRN M, 1981, BRAIN RES, V214, P433, DOI 10.1016/0006-8993(81)91208-7; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Klattenhoff C, 2003, J CELL PHYSIOL, V195, P151, DOI 10.1002/jcp.10300; Leshchyns'ka I, 2003, J CELL BIOL, V161, P625, DOI 10.1083/jcb.200303020; Ma L, 2003, J NEUROSCI, V23, P3164; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Marino P, 2009, EXP NEUROL, V219, P163, DOI 10.1016/j.expneurol.2009.05.009; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; MURRAY BA, 1986, J CELL BIOL, V103, P1431, DOI 10.1083/jcb.103.4.1431; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; POLLERBERG GE, 1987, CELL TISSUE RES, V250, P227, DOI 10.1007/BF00214676; Polo-Parada L, 2005, NEURON, V46, P917, DOI 10.1016/j.neuron.2005.05.018; Polo-Parada L, 2004, J NEUROSCI, V24, P1852, DOI 10.1523/JNEUROSCI.4406-03.2004; Revest JM, 1999, EUR J NEUROSCI, V11, P1134, DOI 10.1046/j.1460-9568.1999.00521.x; Romo X, 2008, J CELL PHYSIOL, V214, P673, DOI 10.1002/jcp.21257; Rougon G, 2003, ANNU REV NEUROSCI, V26, P207, DOI 10.1146/annurev.neuro.26.041002.131014; Schade MA, 2005, GENETICS, V169, P631, DOI 10.1534/genetics.104.032334; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Stoenica L, 2006, EUR J NEUROSCI, V23, P2255, DOI 10.1111/j.1460-9568.2006.04771.x; Stork O, 1999, J NEUROBIOL, V40, P343, DOI 10.1002/(SICI)1097-4695(19990905)40:3<343::AID-NEU6>3.0.CO;2-S; Stork O, 2000, EUR J NEUROSCI, V12, P3291, DOI 10.1046/j.1460-9568.2000.00197.x; Straube T, 2003, J PHYSIOL-LONDON, V552, P953, DOI 10.1113/jphysiol.2003.049452; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tonissoo T, 2006, BEHAV BRAIN RES, V167, P42, DOI 10.1016/j.bbr.2005.08.025; Touzet O, 2010, AIDS, V24, P1437, DOI 10.1097/QAD.0b013e32833a6114; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10	39	6	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32216	10.1371/journal.pone.0032216	http://dx.doi.org/10.1371/journal.pone.0032216			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384181	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500086
J	Brusegan, C; Pistocchi, A; Frassine, A; Della Noce, I; Schepis, F; Cotelli, F				Brusegan, Chiara; Pistocchi, Anna; Frassine, Andrea; Della Noce, Isabella; Schepis, Filippo; Cotelli, Franco			ccdc80-l1 Is Involved in Axon Pathfinding of Zebrafish Motoneurons	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; IDENTIFIED MOTONEURONS; HEDGEHOG ACTIVITY; SKELETAL-MUSCLE; SONIC-HEDGEHOG; CELL-MIGRATION; MOTOR AXONS; IN-VIVO; NO TAIL; EXPRESSION	Axon pathfinding is a subfield of neural development by which neurons send out axons to reach the correct targets. In particular, motoneurons extend their axons toward skeletal muscles, leading to spontaneous motor activity. In this study, we identified the zebrafish Ccdc80 and Ccdc80-like1 (Ccdc80-l1) proteins in silico on the basis of their high aminoacidic sequence identity with the human CCDC80 (Coiled-Coil Domain Containing 80). We focused on ccdc80-l1 gene that is expressed in nervous and non-nervous tissues, in particular in territories correlated with axonal migration, such as adaxial cells and muscle pioneers. Loss of ccdc80-l1 in zebrafish embryos induced motility issues, although somitogenesis and myogenesis were not impaired. Our results strongly suggest that ccdc80-l1 is involved in axon guidance of primary and secondary motoneurons populations, but not in their proper formation. ccdc80-l1 has a differential role as regards the development of ventral and dorsal motoneurons, and this is consistent with the asymmetric distribution of the transcript. The axonal migration defects observed in ccdc80-l1 loss-of-function embryos are similar to the phenotype of several mutants with altered Hedgehog activity. Indeed, we reported that ccdc80-l1 expression is positively regulated by the Hedgehog pathway in adaxial cells and muscle pioneers. These findings strongly indicate ccdc80-l1 as a down-stream effector of the Hedgehog pathway.	[Brusegan, Chiara; Pistocchi, Anna; Frassine, Andrea; Cotelli, Franco] Univ Milan, Dipartimento Biol, Milan, Italy; [Pistocchi, Anna] Ist Sci San Raffaele, DiBiT, Dipartimento Med Rigenerativa, Milan, Italy; [Della Noce, Isabella; Schepis, Filippo] Univ Modena & Reggio Emilia, Dipartimento Med, Modena, Italy	University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universita di Modena e Reggio Emilia	Brusegan, C (corresponding author), Univ Milan, Dipartimento Biol, Milan, Italy.	anna.pistocchi@guest.unimi.it; filippo.schepis@unimore.it; franco.cotelli@unimi.it	Pistocchi, Anna/A-6228-2014; Schepis, Filippo/H-9417-2014	Pistocchi, Anna/0000-0001-9467-2542; Schepis, Filippo/0000-0001-6549-5102				Aoki K, 2002, BIOCHEM BIOPH RES CO, V290, P1282, DOI 10.1006/bbrc.2002.6337; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; Barresi MJF, 2001, CURR BIOL, V11, P1432, DOI 10.1016/S0960-9822(01)00428-6; Beattie CE, 1997, DEV BIOL, V187, P171, DOI 10.1006/dbio.1997.8604; Beattie CE, 2000, BRAIN RES BULL, V53, P489, DOI 10.1016/S0361-9230(00)00382-8; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; Bommer GT, 2005, J BIOL CHEM, V280, P7962, DOI 10.1074/jbc.M412593200; Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; Chen WB, 2001, DEVELOPMENT, V128, P2385; de Castro F, 2003, NEWS PHYSIOL SCI, V18, P130, DOI 10.1152/nips.01414.2002; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Eisen JS, 1999, TRENDS NEUROSCI, V22, P321, DOI 10.1016/S0166-2236(98)01370-8; EISEN JS, 1991, DEVELOPMENT, P141; Elworthy S, 2008, DEVELOPMENT, V135, P2115, DOI 10.1242/dev.015719; Fashena D, 1999, J COMP NEUROL, V406, P415, DOI 10.1002/(SICI)1096-9861(19990412)406:3<415::AID-CNE9>3.0.CO;2-2; FELSENFELD AL, 1991, DEV BIOL, V148, P23, DOI 10.1016/0012-1606(91)90314-S; Ferragud J, 2011, FEBS LETT, V585, P3041, DOI 10.1016/j.febslet.2011.08.025; GOMEZ TM, 1994, J NEUROSCI, V14, P5959; GRIFFIN K, 1995, DEVELOPMENT, V121, P2983; Haffter P, 1996, INT J DEV BIOL, V40, P221; Haslett JN, 2003, NEUROGENETICS, V4, P163, DOI 10.1007/s10048-003-0148-x; HATTA K, 1991, DEVELOPMENT, V112, P821; Holley SA, 2007, DEV DYNAM, V236, P1422, DOI 10.1002/dvdy.21162; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; JOWETT T, 1994, TRENDS GENET, V10, P73, DOI 10.1016/0168-9525(94)90220-8; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lauderdale JD, 1997, MOL CELL NEUROSCI, V9, P293, DOI 10.1006/mcne.1997.0624; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lewis KE, 2001, DEVELOPMENT, V128, P3485; LIU DWC, 1990, J NEUROSCI, V10, P3947, DOI 10.1523/JNEUROSCI.10-12-03947.1990; Liu Y, 2004, BIOCHEM BIOPH RES CO, V322, P497, DOI 10.1016/j.bbrc.2004.07.161; McKerracher L, 1996, MOL NEUROBIOL, V12, P95, DOI 10.1007/BF02740648; Melancon E, 1997, J NEUROSCI, V17, P7796; Melby AE, 1996, DEVELOPMENT, V122, P2225; Menelaou E, 2008, EUR J NEUROSCI, V28, P1080, DOI 10.1111/j.1460-9568.2008.06418.x; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Pawlowski K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-590; PIKE SH, 1992, DEVELOPMENT, V114, P825; Rescan PY, 2001, COMP BIOCHEM PHYS B, V130, P1, DOI 10.1016/S1096-4959(01)00412-2; Roos M, 1999, MECH DEVELOP, V87, P103, DOI 10.1016/S0925-4773(99)00153-7; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Sato-Maeda M, 2006, DEVELOPMENT, V133, P937, DOI 10.1242/dev.02268; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Schnapp E, 2009, J CELL SCI, V122, P481, DOI 10.1242/jcs.038356; Stickney HL, 2000, DEV DYNAM, V219, P287; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tremblay F, 2009, J BIOL CHEM, V284, P8136, DOI 10.1074/jbc.M809535200; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; Tseng BS, 2002, J APPL PHYSIOL, V93, P537, DOI 10.1152/japplphysiol.00202.2002; Visconti R, 2003, ONCOGENE, V22, P1087, DOI 10.1038/sj.onc.1206194; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; Westerfield M., ZEBRAFISH BOOK GUIDE; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Zeller J, 1999, DEVELOPMENT, V126, P3461	57	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31851	10.1371/journal.pone.0031851	http://dx.doi.org/10.1371/journal.pone.0031851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384085	Green Submitted, Green Published, gold			2022-12-27	WOS:000302875500047
J	Chen, TH; Chang, CH; Lin, CY; Jenq, CC; Chang, MY; Tian, YC; Hung, CC; Fang, JT; Yang, CW; Wen, MS; Lin, FC; Chen, YC				Chen, Tien-Hsing; Chang, Chih-Hsiang; Lin, Chan-Yu; Jenq, Chang-Chyi; Chang, Ming-Yang; Tian, Ya-Chung; Hung, Cheng-Chieh; Fang, Ji-Tseng; Yang, Chih-Wei; Wen, Ming-Shien; Lin, Fun-Chung; Chen, Yung-Chang			Acute Kidney Injury Biomarkers for Patients in a Coronary Care Unit: A Prospective Cohort Study	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ACUTE-RENAL-FAILURE; SERUM CYSTATIN-C; INTERLEUKIN-18; MARKER; IL-18; RISK; CREATININE; PROGNOSIS; DIAGNOSIS	Background: Renal dysfunction is an established predictor of all-cause mortality in intensive care units. This study analyzed the outcomes of coronary care unit (CCU) patients and evaluated several biomarkers of acute kidney injury (AKI), including neutrophil gelatinase-associated lipocalin (NGAL), interleukin-18 (IL-18) and cystatin C (CysC) on the first day of CCU admission. Methodology/Principal Findings: Serum and urinary samples collected from 150 patients in the coronary care unit of a tertiary care university hospital between September 2009 and August 2010 were tested for NGAL, IL-18 and CysC. Prospective demographic, clinical and laboratory data were evaluated as predictors of survival in this patient group. The most common cause of CCU admission was acute myocardial infarction (80%). According to Acute Kidney Injury Network criteria, 28.7% (43/150) of CCU patients had AKI of varying severity. Cumulative survival rates at 6-month follow-up following hospital discharge differed significantly (p<0.05) between patients with AKI versus those without AKI. For predicting AKI, serum CysC displayed an excellent areas under the receiver operating characteristic curve (AUROC) (0.895 +/- 0.031, p<0.001). The overall 180-day survival rate was 88.7% (133/150). Multiple Cox logistic regression hazard analysis revealed that urinary NGAL, serum IL-18, Acute Physiology, Age and Chronic Health Evaluation II (APACHE II) and sodium on CCU admission day one were independent risk factors for 6-month mortality. In terms of 6-month mortality, urinary NGAL had the best discriminatory power, the best Youden index, and the highest overall correctness of prediction. Conclusions: Our data showed that serum CysC has the best discriminative power for predicting AKI in CCU patients. However, urinary NGAL and serum IL-18 are associated with short-term mortality in these critically ill patients.	[Chen, Tien-Hsing; Wen, Ming-Shien; Lin, Fun-Chung] Chang Gung Mem Hosp, Sect Cardiol 2, Taipei 10591, Taiwan; [Chang, Chih-Hsiang; Lin, Chan-Yu; Jenq, Chang-Chyi; Chang, Ming-Yang; Tian, Ya-Chung; Hung, Cheng-Chieh; Fang, Ji-Tseng; Yang, Chih-Wei; Chen, Yung-Chang] Chang Gung Mem Hosp, Dept Nephrol, Taipei 10591, Taiwan; [Jenq, Chang-Chyi; Chang, Ming-Yang; Tian, Ya-Chung; Hung, Cheng-Chieh; Fang, Ji-Tseng; Yang, Chih-Wei; Wen, Ming-Shien; Lin, Fun-Chung; Chen, Yung-Chang] Chang Gung Univ, Coll Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chen, TH (corresponding author), Chang Gung Mem Hosp, Sect Cardiol 2, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	cyc2356@adm.cgmh.org.tw	Chang, Jason Chih-Hsiang/P-8662-2017; Chang, Ming-Yang/AGH-5397-2022	Chang, Jason Chih-Hsiang/0000-0002-7342-335X; Chang, Ming-Yang/0000-0001-8899-0376	National Science Council of Taiwan (NSC) [99-2314-B-182A-009-MY3]	National Science Council of Taiwan (NSC)(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council of Taiwan (NSC 99-2314-B-182A-009-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Blankenberg S, 2003, CIRCULATION, V108, P2453, DOI 10.1161/01.CIR.0000099509.76044.A2; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bu DX, 2006, AM J PATHOL, V169, P2245, DOI 10.2353/ajpath.2006.050706; Cadnapaphornchai MA, 2001, CARDIOLOGY, V96, P122, DOI 10.1159/000047396; Carlson M, 2002, GUT, V50, P501, DOI 10.1136/gut.50.4.501; Chen YC, 2011, ANN THORAC SURG, V91, P137, DOI 10.1016/j.athoracsur.2010.08.063; Coca SG, 2008, KIDNEY INT, V73, P1008, DOI 10.1038/sj.ki.5002729; Damman K, 2008, EUR J HEART FAIL, V10, P997, DOI 10.1016/j.ejheart.2008.07.001; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Hall IE, 2010, J AM SOC NEPHROL, V21, P189, DOI 10.1681/ASN.2009030264; Heise D, 2011, EUR J CARDIO-THORAC, V39, P38, DOI 10.1016/j.ejcts.2010.05.044; Hemdahl AL, 2006, ARTERIOSCL THROM VAS, V26, P136, DOI 10.1161/01.ATV.0000193567.88685.f4; Herget-Rosenthal S, 2007, CLIN BIOCHEM, V40, P153, DOI 10.1016/j.clinbiochem.2006.10.014; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Hoste EAJ, 2010, NEPHROL DIAL TRANSPL, V25, P747, DOI 10.1093/ndt/gfp389; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Koyner JL, 2010, CLIN J AM SOC NEPHRO, V5, P2154, DOI 10.2215/CJN.00740110; Krawczeski CD, 2010, CLIN J AM SOC NEPHRO, V5, P1552, DOI 10.2215/CJN.02040310; Lee JK, 2004, P NATL ACAD SCI USA, V101, P8815, DOI 10.1073/pnas.0402800101; Li SX, 2003, BRAIN RES, V992, P76, DOI 10.1016/j.brainres.2003.08.033; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Matsumoto S, 1997, BIOCHEM BIOPH RES CO, V234, P454, DOI 10.1006/bbrc.1997.6665; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; McCullough PA, 2000, J AM COLL CARDIOL, V36, P679, DOI 10.1016/S0735-1097(00)00774-9; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mishra J, 2005, LANCET, V365, P1231, DOI 10.1016/s0140-6736(05)74811-x; Netea MG, 2000, CLIN INFECT DIS, V31, pS178, DOI 10.1086/317513; Parikh CR, 2008, CRIT CARE MED, V36, pS159, DOI 10.1097/CCM.0b013e318168c652; Perianayagam MC, 2009, AM J KIDNEY DIS, V54, P1025, DOI 10.1053/j.ajkd.2009.05.022; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; Siew ED, 2011, J AM SOC NEPHROL, V22, P810, DOI 10.1681/ASN.2010080796; Thompson SR, 2007, CLIN CHEM, V53, P2078, DOI 10.1373/clinchem.2007.092692; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Tiret L, 2005, CIRCULATION, V112, P643, DOI 10.1161/CIRCULATIONAHA.104.519702; TOMLANOVICH S, 1986, AM J KIDNEY DIS, V8, P332, DOI 10.1016/S0272-6386(86)80107-X; Westhuyzen J, 2006, ANN CLIN LAB SCI, V36, P387; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	39	45	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32328	10.1371/journal.pone.0032328	http://dx.doi.org/10.1371/journal.pone.0032328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384218	gold, Green Submitted, Green Published			2022-12-27	WOS:000302875500095
J	Ma, Q; Zhang, WW; Zhang, L; Qiao, B; Pan, CS; Yi, H; Wang, LL; Yuan, YJ				Ma, Qian; Zhang, Weiwen; Zhang, Lu; Qiao, Bin; Pan, Chensong; Yi, Hong; Wang, Lili; Yuan, Ying-jin			Proteomic Analysis of Ketogulonicigenium vulgare under Glutathione Reveals High Demand for Thiamin Transport and Antioxidant Protection	PLOS ONE			English	Article							INTRACYTOPLASMIC MEMBRANE FORMATION; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; COG DATABASE; PROTEIN; CELL; PYROPHOSPHATE; OXIDATION	Ketogulonicigenium vulgare, though grows poorly when mono-cultured, has been widely used in the industrial production of the precursor of vitamin C with the coculture of Bacillus megaterium. Various efforts have been made to clarify the synergic pattern of this artificial microbial community and to improve the growth and production ability of K. vulgare, but there is still no sound explanation. In previous research, we found that the addition of reduced glutathione into K. vulgare monoculture could significantly improve its growth and productivity. By performing SEM and TEM, we observed that after adding GSH into K. vulgare monoculture, cells became about 4-6 folds elongated, and formed intracytoplasmic membranes (ICM). To explore the molecular mechanism and provide insights into the investigation of the synergic pattern of the coculture system, we conducted a comparative iTRAQ-2-D-LC-MS/MS-based proteomic analysis of K. vulgare grown under reduced glutathione. Principal component analysis of proteomic data showed that after the addition of glutathione, proteins for thiamin/thiamin pyrophosphate (TPP) transport, glutathione transport and the maintenance of membrane integrity, together with several membrane-bound dehydrogenases had significant up-regulation. Besides, several proteins participating in the pentose phosphate pathway and tricarboxylic acid cycle were also up-regulated. Additionally, proteins combating intracellular reactive oxygen species were also up-regulated, which similarly occurred in K. vulgare when the cocultured B. megaterium cells lysed from our former research results. This study reveals the demand for transmembrane transport of substrates, especially thiamin, and the demand for antioxidant protection of K. vulgare.	[Ma, Qian; Zhang, Weiwen; Zhang, Lu; Qiao, Bin; Yuan, Ying-jin] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China; [Ma, Qian; Zhang, Weiwen; Zhang, Lu; Qiao, Bin; Yuan, Ying-jin] Tianjin Univ, Dept Pharmaceut Engn, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China; [Pan, Chensong] Bruker Daltonics Inc, Beijing Off, Beijing, Peoples R China; [Yi, Hong; Wang, Lili] Hebei Univ Sci & Technol, Coll Biol Sci & Engn, Shijiazhuang, Hebei, Peoples R China	Tianjin University; Tianjin University; Nokia Corporation; Pfizer; Hebei University of Science & Technology	Ma, Q (corresponding author), Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn	wang, lili/HDL-7210-2022	Zhang, Weiwen/0000-0001-8305-5653	National Basic Research Program of China ("973'' Program) [2011CBA00802]; National Natural Science Foundation of China [20736006, 21020102040]	National Basic Research Program of China ("973'' Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are grateful for the financial support from the National Basic Research Program of China ("973'' Program: 2011CBA00802), and the National Natural Science Foundation of China (Key Program: 20736006, Major International Joint Research Project: 21020102040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUDRANT J, 1990, ENZYME MICROB TECH, V12, P322, DOI 10.1016/0141-0229(90)90159-N; Bozdech Z, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-17; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bremus C, 2006, J BIOTECHNOL, V124, P196, DOI 10.1016/j.jbiotec.2006.01.010; Cheng JS, 2009, APPL MICROBIOL BIOT, V83, P909, DOI 10.1007/s00253-009-2037-1; CLAUS GW, 1975, J BACTERIOL, V123, P1169, DOI 10.1128/JB.123.3.1169-1183.1975; Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3; EATON MW, 1974, BIOCHEM J, V144, P327, DOI 10.1042/bj1440327; Fu SL, 2007, APPL MICROBIOL BIOT, V75, P1127, DOI 10.1007/s00253-007-0930-z; Germon P, 2001, J BACTERIOL, V183, P4110, DOI 10.1128/JB.183.14.4110-4114.2001; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; Hancock Robert D, 2009, Recent Pat Food Nutr Agric, V1, P39; HEEFNER DL, 1976, J BACTERIOL, V125, P1163, DOI 10.1128/JB.125.3.1163-1171.1976; Lazzaroni JC, 2002, BIOCHIMIE, V84, P391, DOI 10.1016/S0300-9084(02)01419-0; Leduc S, 2004, APPL MICROBIOL BIOT, V65, P163, DOI 10.1007/s00253-004-1562-1; Li Y, 2003, APPL ENVIRON MICROB, V69, P5739, DOI 10.1128/AEM.69.10.5739-5745.2003; Li ZJ, 2010, ADV BIOCHEM ENG BIOT, V122, P1, DOI 10.1007/10_2010_76; Lin FM, 2009, PROTEOMICS, V9, P5471, DOI 10.1002/pmic.200900100; Lin FM, 2009, APPL ENVIRON MICROB, V75, P3765, DOI 10.1128/AEM.02594-08; Lushchak VI, 2001, BIOCHEMISTRY-MOSCOW+, V66, P476, DOI 10.1023/A:1010294415625; Ma Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026108; MCCANDLESS DW, 1982, ANN NY ACAD SCI, V378, P355, DOI 10.1111/j.1749-6632.1982.tb31210.x; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Miyazaki T, 2006, APPL ENVIRON MICROB, V72, P1487, DOI 10.1128/AEM.72.2.1487-1495.2006; MULLER MM, 1993, J BACTERIOL, V175, P6059, DOI 10.1128/JB.175.18.6059-6061.1993; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; RIDGWAY HF, 1981, APPL ENVIRON MICROB, V41, P274, DOI 10.1128/AEM.41.1.274-287.1981; RINDI G, 1966, J NUTR, V89, P197, DOI 10.1093/jn/89.2.197; SAUBERLICH HE, 1994, ANNU REV NUTR, V14, P371, DOI 10.1146/annurev.nu.14.070194.002103; Smirnova GV, 2000, FREE RADICAL BIO MED, V28, P1009, DOI 10.1016/S0891-5849(99)00256-7; Solomon J, 2003, J BACTERIOL, V185, P6425, DOI 10.1128/JB.185.21.6425-6433.2003; Sudarsan N, 2005, CHEM BIOL, V12, P1325, DOI 10.1016/j.chembiol.2005.10.007; Szent-Gyorgyi A, 1928, BIOCHEM J, V22, P1387, DOI 10.1042/bj0221387; Takagi Y, 2010, APPL MICROBIOL BIOT, V86, P469, DOI 10.1007/s00253-009-2312-1; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; TYNKKYNEN S, 1993, J BACTERIOL, V175, P7523, DOI 10.1128/JB.175.23.7523-7532.1993; Urbance JW, 2001, INT J SYST EVOL MICR, V51, P1059, DOI 10.1099/00207713-51-3-1059; Webb E, 1998, J BIOL CHEM, V273, P8946, DOI 10.1074/jbc.273.15.8946; WHITE SA, 1982, J BACTERIOL, V150, P934, DOI 10.1128/JB.150.2.934-943.1982; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Yin GL, 1990, United States Patent, Patent No. 4935359; Yuan YJ, 2009, China Patent, Patent No. [CN200910069697.7, 2009100696977]; Zangen A, 1997, BIOCHEM PHARMACOL, V54, P575, DOI 10.1016/S0006-2952(97)00178-0; Zhang J, 2011, BIORESOURCE TECHNOL, V102, P4807, DOI 10.1016/j.biortech.2010.10.124; Zhang WC, 2003, China Patent, Patent No. [CN03102060.7, 031020607]; Zhou J, 2011, APPL ENVIRON MICROB, V77, P7023, DOI 10.1128/AEM.05123-11	48	28	36	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32156	10.1371/journal.pone.0032156	http://dx.doi.org/10.1371/journal.pone.0032156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384164	gold, Green Published, Green Submitted			2022-12-27	WOS:000302875500078
J	Donoghue, JF; McGavigan, CJ; Lederman, FL; Cann, LM; Fu, L; Dimitriadis, E; Girling, JE; Rogers, PAW				Donoghue, Jacqueline F.; McGavigan, C. Jay; Lederman, Fiona L.; Cann, Leonie M.; Fu, Lulu; Dimitriadis, Eva; Girling, Jane E.; Rogers, Peter A. W.			Dilated Thin-Walled Blood and Lymphatic Vessels in Human Endometrium: A Potential Role for VEGF-D in Progestin-Induced Break-Through Bleeding	PLOS ONE			English	Article							GROWTH FACTOR-D; INTRAUTERINE SYSTEM; MICROVASCULAR DENSITY; ONLY CONTRACEPTIVES; NORPLANT(R) USERS; GENE-TRANSFER; TUMOR-CELLS; MOUSE MODEL; LEVONORGESTREL; WOMEN	Progestins provide safe, effective and cheap options for contraception as well as the treatment of a variety of gynaecological disorders. Episodes of irregular endometrial bleeding or breakthrough bleeding (BTB) are a major unwanted side effect of progestin treatment, such that BTB is the leading cause for discontinued use of an otherwise effective and popular medication. The cellular mechanisms leading to BTB are poorly understood. In this study, we make the novel finding that the large, dilated, thin walled vessels characteristic of human progestin-treated endometrium include both blood and lymphatic vessels. Increased blood and lymphatic vessel diameter are features of VEGF-D action in other tissues and we show by immunolocalisation and Western blotting that stromal cell decidualisation results in a significant increase in VEGF-D protein production, particularly of the proteolytically processed 21 kD form. Using a NOD/scid mouse model with xenografted human endometrium we were able to show that progestin treatment causes decidualisation, VEGF-D production and endometrial vessel dilation. Our results lead to a novel hypothesis to explain BTB, with stromal cell decidualisation rather than progestin treatment per se being the proposed causative event, and VEGF-D being the proposed effector agent.	[Donoghue, Jacqueline F.] Monash Univ, Monash Inst Med Res, Oncogen Signalling Lab, Clayton, Vic, Australia; [Donoghue, Jacqueline F.; McGavigan, C. Jay] Monash Univ, Dept Obstet & Gynaecol, Ctr Womens Hlth Res, Clayton, Vic 3168, Australia; [Lederman, Fiona L.; Cann, Leonie M.; Fu, Lulu; Girling, Jane E.] Univ Melbourne, Royal Womens Hosp, Gynaecol Res Ctr, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Dimitriadis, Eva] Monash Med Ctr, Embryo Implantat Lab, Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia	Monash University; Monash University; University of Melbourne; Monash University; Prince Henry's Institute of Medical Research	Donoghue, JF (corresponding author), Monash Univ, Monash Inst Med Res, Oncogen Signalling Lab, Clayton, Vic, Australia.	parogers@unimelb.edu.au	dimitriadis, e/AAD-7601-2021; Rogers, Peter AW/C-2651-2008	Rogers, Peter AW/0000-0002-7399-8997; Girling, Jane/0000-0002-8154-2068; Donoghue, Jacqueline/0000-0003-1370-2469; dimitriadis, eva/0000-0003-1425-950X	Australian Postgraduate Award; National Health and Medical Research Council [384195, 550911, 334063]	Australian Postgraduate Award(Australian Government); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	JFD was supported by an Australian Postgraduate Award. This study was funded by National Health and Medical Research Council Grant No. 384195 to PAWR and JEG. ED salary paid by National Health and Medical Research Council Career Development Award Grant No. 550911. PAWR salary paid by National Health and Medical Research Council Fellowship Grant No. 334063. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Byzova TV, 2002, BLOOD, V99, P4434, DOI 10.1182/blood.V99.12.4434; Clark DA, 1996, HUM REPROD, V11, P1438; COHEN PE, 1993, J REPROD FERTIL, V99, P219, DOI 10.1530/jrf.0.0990219; Critchley HOD, 1998, HUM REPROD, V13, P1210, DOI 10.1093/humrep/13.5.1210; d'Arcangues C, 2000, HUM REPROD, V15, P24, DOI 10.1093/humrep/15.suppl_3.24; Donoghue JF, 2007, HUM REPROD, V22, P1705, DOI 10.1093/humrep/dem037; Findlay JK, 1996, HUM REPROD, V11, P179, DOI 10.1093/humrep/11.suppl_2.179; Fraser IS, 2000, STEROIDS, V65, P665, DOI 10.1016/S0039-128X(00)00188-4; Girling JE, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-84; Gonzalez MLA, 2009, HUM REPROD, V24, P2217, DOI 10.1093/humrep/dep203; Gonzalez MLA, 2009, HUM REPROD, V24, P697, DOI 10.1093/humrep/den437; Hickey M, 1998, HUM REPROD, V13, P3190, DOI 10.1093/humrep/13.11.3190; Hickey M, 1996, HUM REPROD, V11, P35, DOI 10.1093/humrep/11.suppl_2.35; Hickey M, 2000, HUM REPROD, V15, P1509, DOI 10.1093/humrep/15.7.1509; Irvine GA, 1998, BRIT J OBSTET GYNAEC, V105, P592, DOI 10.1111/j.1471-0528.1998.tb10172.x; Jones RL, 2000, HUM REPROD, V15, P162, DOI 10.1093/humrep/15.suppl_3.162; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Kholova I, 2007, HUM GENE THER, V18, P232, DOI 10.1089/hum.2006.100; MARKEE JE, 1978, AM J OBSTET GYNECOL, V131, P558; McColl BK, 2003, J EXP MED, V198, P863, DOI 10.1084/jem.20030361; McGavigan CJ, 2003, HUM REPROD, V18, P77, DOI 10.1093/humrep/deg023; Menkhorst E, 2010, J REPROD IMMUNOL, V84, P124, DOI 10.1016/j.jri.2009.12.001; Morison NB, 2007, REPRODUCTION, V133, P309, DOI 10.1530/rep.1.01171; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Rodgers AK, 2008, EXPERT OPIN PHARMACO, V9, P243, DOI [10.1517/14656566.9.2.243, 10.1517/14656566.9.2.243 ]; Rodriguez MI, 2010, AM J OBSTET GYNECOL, V202, P420, DOI 10.1016/j.ajog.2009.10.863; Rogers PAW, 2005, HUM REPROD, V20, P3341, DOI 10.1093/humrep/dei239; Rogers PAW, 1996, HUM REPROD, V11, P45, DOI 10.1093/humrep/11.suppl_2.45; ROGERS PAW, 1993, HUM REPROD, V8, P1396, DOI 10.1093/oxfordjournals.humrep.a138268; Rogers PAW, 2000, HUM REPROD, V15, P78, DOI 10.1093/humrep/15.suppl_3.78; Runic R, 2000, J CLIN ENDOCR METAB, V85, P3853, DOI 10.1210/jc.85.10.3853; Rutanen J, 2004, CIRCULATION, V109, P1029, DOI 10.1161/01.CIR.0000115519.03688.A2; Song J Y, 1995, Obstet Gynecol Surv, V50, P385; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Stephanie R, 2007, HUM REPROD, V22, P3084, DOI 10.1093/humrep/dem238; Stewart A, 2001, BRIT J OBSTET GYNAEC, V108, P74, DOI 10.1016/S0306-5456(00)00020-6; Veikkola T, 2000, CANCER RES, V60, P203; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; Vincent AJ, 2002, HUM REPROD, V17, P1189, DOI 10.1093/humrep/17.5.1189; Volchek M, 2010, HUM REPROD, V25, P2455, DOI 10.1093/humrep/deq224; Wonodirekso S, 2000, HUM REPROD, V15, P189, DOI 10.1093/humrep/15.suppl_3.189; Wulff C, 2003, REPRODUCTION, V126, P569, DOI 10.1530/rep.0.1260569; Yu J, 2011, MOL CELL ENDOCRINOL, V344, P25, DOI 10.1016/j.mce.2011.04.011	46	12	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30916	10.1371/journal.pone.0030916	http://dx.doi.org/10.1371/journal.pone.0030916			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22383980	gold, Green Published			2022-12-27	WOS:000302853600088
J	Ghosh, P; Hsu, CY; Alyamani, EJ; Shehata, MM; Al-Dubaib, MA; Al-Naeem, A; Hashad, M; Mahmoud, OM; Alharbi, KBJ; Al-Busadah, K; Al-Swailem, AM; Talaat, AM				Ghosh, Pallab; Hsu, Chungyi; Alyamani, Essam J.; Shehata, Maher M.; Al-Dubaib, Musaad A.; Al-Naeem, Abdulmohsen; Hashad, Mahmoud; Mahmoud, Osama M.; Alharbi, Khalid B. J.; Al-Busadah, Khalid; Al-Swailem, Abdulaziz M.; Talaat, Adel M.			Genome-Wide Analysis of the Emerging Infection with Mycobacterium avium Subspecies paratuberculosis in the Arabian Camels (Camelus dromedarius)	PLOS ONE			English	Article							JOHNES-DISEASE; SEQUENCE; POLYMORPHISMS; PATHOLOGY; INSERTION; IDENTIFICATION; RESTRICTION; CULTURE; EPITOPE; CLONES	Mycobacterium avium subspecies paratuberculosis (M. ap) is the causative agent of paratuberculosis or Johne's disease (JD) in herbivores with potential involvement in cases of Crohn's disease in humans. JD is spread worldwide and is economically important for both beef and dairy industries. Generally, pathogenic ovine strains (M. ap-S) are mainly found in sheep while bovine strains (M. ap-C) infect other ruminants (e.g. cattle, goat, deer), as well as sheep. In an effort to characterize this emerging infection in dromedary/Arabian camels, we successfully cultured M. ap from several samples collected from infected camels suffering from chronic, intermittent diarrhea suggestive of JD. Gene-based typing of isolates indicated that all isolates belong to sheep lineage of strains of M. ap (M. ap-S), suggesting a putative transmission from infected sheep herds. Screening sheep and goat herds associated with camels identified the circulation of this type in sheep but not goats. The current genome-wide analysis recognizes these camel isolates as a sub-lineage of the sheep strain with a significant number of single nucleotide polymorphisms (SNPs) between sheep and camel isolates (similar to 1000 SNPs). Such polymorphism could represent geographical differences among isolates or host adaptation of M. ap during camel infection. To our knowledge, this is the first attempt to examine the genomic basis of this emerging infection in camels with implications on the evolution of this important pathogen. The sequenced genomes of M. ap isolates from camels will further assist our efforts to understand JD pathogenesis and the dynamic of disease transmission across animal species.	[Ghosh, Pallab; Hsu, Chungyi; Talaat, Adel M.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Alyamani, Essam J.; Shehata, Maher M.; Al-Swailem, Abdulaziz M.] King Abdulaziz City Sci & Technol, Natl Biotechnol Ctr, Riyadh, Saudi Arabia; [Al-Dubaib, Musaad A.; Hashad, Mahmoud; Mahmoud, Osama M.; Alharbi, Khalid B. J.] Qassim Univ, Coll Agr & Vet Med, Qasim, Saudi Arabia; [Al-Naeem, Abdulmohsen; Al-Busadah, Khalid] King Faisal Univ, Coll Vet Med & Anim Resources, Al Hasa, Saudi Arabia; [Talaat, Adel M.] Univ Wisconsin, Lab Bacterial Genom, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; King Abdulaziz City for Science & Technology; Qassim University; King Faisal University; University of Wisconsin System; University of Wisconsin Madison	Ghosh, P (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.	alswailem@kacst.edu.sa; atalaat@wisc.edu	Ghosh, Pallab/I-6140-2018; Alharbi, Khalid Khalaf/GYV-3906-2022	Ghosh, Pallab/0000-0002-1346-407X; Alharbi, Khalid Khalaf/0000-0001-8355-5033; Alharbi, Khaled/0000-0003-4083-8644; Al-Swailem, Abdulaziz/0000-0002-9484-5973	King Abdulaziz City of Science and Technology (KACST), Saudi Arabia; United States Department of Agriculture (USDA) [NRI 2007-35204-18400]; U.S.-Egypt Joint Board on Scientific and Technological Cooperation [1937]	King Abdulaziz City of Science and Technology (KACST), Saudi Arabia; United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); U.S.-Egypt Joint Board on Scientific and Technological Cooperation(Science and Technology Development Fund (STDF)United States Agency for International Development (USAID)US-Egypt Science and Technology Joint Fund)	This work was supported by funds from King Abdulaziz City of Science and Technology (KACST), Saudi Arabia, NRI 2007-35204-18400 from the United States Department of Agriculture (USDA) and U.S.-Egypt Joint Board on Scientific and Technological Cooperation, grant # 1937. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hizab FA, 2010, J CAMEL PRACT RES, V17, P31; Alexander DC, 2009, J BACTERIOL, V191, P1018, DOI 10.1128/JB.01340-08; Alharbi KB, 2012, TROP ANIM HEALTH PRO, V44, P173, DOI 10.1007/s11250-011-9905-2; Alhebabi A. M., 2010, Open Veterinary Science Journal, V4, P41, DOI 10.2174/1874318801004010041; Almubarak AI, 2007, J ANIM VET ADV, V6, P33; Amand W. B., 1974, American Association of Zoo Veterinarians. Annual proceedings, 1974., P150; [Anonymous], 2003, CODE PRACTICE CAMELS; Bannantine JP, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00163; Bannantine JP, 2011, CLIN VACCINE IMMUNOL, V18, P105, DOI 10.1128/CVI.00297-10; Begg DJ, 2011, IMMUNOBIOLOGY, V216, P840, DOI 10.1016/j.imbio.2010.12.004; BUERGELT CD, 1978, VET PATHOL, V15, P196, DOI 10.1177/030098587801500206; Bush RD, 2006, AUST VET J, V84, P246, DOI 10.1111/j.1751-0813.2006.00001.x; Castellanos E, 2007, J CLIN MICROBIOL, V45, P3439, DOI 10.1128/JCM.01411-07; Castellanos E, 2009, APPL ENVIRON MICROB, V75, P676, DOI 10.1128/AEM.01683-08; CHIODINI RJ, 1984, CORNELL VET, V74, P218; Clarke CJ, 1997, J COMP PATHOL, V116, P217, DOI 10.1016/S0021-9975(97)80001-1; Clarke CJ, 1996, J COMP PATHOL, V114, P419, DOI 10.1016/S0021-9975(96)80017-X; COLLINS MT, 1991, J AM VET MED ASSOC, V199, P1724; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; de Juan L, 2006, APPL ENVIRON MICROB, V72, P5927, DOI 10.1128/AEM.00451-06; GREEN EP, 1989, NUCLEIC ACIDS RES, V17, P9063, DOI 10.1093/nar/17.22.9063; Harboe M, 2004, SCAND J IMMUNOL, V59, P190, DOI 10.1111/j.0300-9475.2004.01383.x; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; Li YJ, 2005, CELL MICROBIOL, V7, P539, DOI 10.1111/j.1462-5822.2004.00484.x; Losinger WC, 2005, J DAIRY RES, V72, P425, DOI 10.1017/S0022029905001007; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; National Animal Health Monitoring System, 2008, JOHN DIS US DAIR 199; NEI M, 1986, MOL BIOL EVOL, V3, P418; PALING RW, 1988, J WILDLIFE DIS, V24, P308, DOI 10.7589/0090-3558-24.2.308; Pasricha R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-41; Ramadan R.O., 1994, SURG RADIOLOGY DROME, V1; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; SAXEGAARD F, 1990, J COMP PATHOL, V102, P149, DOI 10.1016/S0021-9975(08)80120-X; Semret M, 2005, J CLIN MICROBIOL, V43, P3704, DOI 10.1128/JCM.43.8.3704-3712.2005; Sivakumar P, 2006, VET PATHOL, V43, P455, DOI 10.1354/vp.43-4-455; Skjot RLV, 2002, INFECT IMMUN, V70, P5446, DOI 10.1128/IAI.70.10.5446-5453.2002; Smole SC, 2002, J CLIN MICROBIOL, V40, P3374, DOI 10.1128/JCM.40.9.3374-3380.2002; Stevenson K, 2002, J CLIN MICROBIOL, V40, P1798, DOI 10.1128/JCM.40.5.1798-1804.2002; Talaat AM, 1998, INFECT IMMUN, V66, P2938, DOI 10.1128/IAI.66.6.2938-2942.1998; Talaat AM, 1997, VET MICROBIOL, V58, P229, DOI 10.1016/S0378-1135(97)00120-X; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAYLOR AW, 1953, J COMP PATHOL THERAP, V63, P368, DOI 10.1016/S0368-1742(53)80038-X; Turenne CY, 2008, J BACTERIOL, V190, P2479, DOI 10.1128/JB.01691-07; Whittington R, 1998, MOL CELL PROBE, V12, P349, DOI 10.1006/mcpr.1998.0194; Whittington RJ, 1999, J CLIN MICROBIOL, V37, P1077, DOI 10.1128/JCM.37.4.1077-1083.1999; Whittington RJ, 2001, AUST VET J, V79, P267, DOI 10.1111/j.1751-0813.2001.tb11980.x; Wu CW, 2007, J BACTERIOL, V189, P7877, DOI 10.1128/JB.00780-07; Wu CW, 2007, INFECT IMMUN, V75, P2110, DOI 10.1128/IAI.01739-06; Wu CW, 2006, J BACTERIOL, V188, P711, DOI 10.1128/JB.188.2.711-723.2006; Wynne JW, 2010, J BACTERIOL, V192, P6319, DOI 10.1128/JB.00972-10	50	42	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31947	10.1371/journal.pone.0031947	http://dx.doi.org/10.1371/journal.pone.0031947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393374	Green Submitted, Green Published, gold			2022-12-27	WOS:000303003500027
J	Katz, AM; Amankulor, NM; Pitter, K; Helmy, K; Squatrito, M; Holland, EC				Katz, Amanda M.; Amankulor, Nduka M.; Pitter, Ken; Helmy, Karim; Squatrito, Massimo; Holland, Eric C.			Astrocyte-Specific Expression Patterns Associated with the PDGF-Induced Glioma Microenvironment	PLOS ONE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; ADULT MAMMALIAN BRAIN; MOLECULE TENASCIN-C; VASCULAR NICHE; ANTIGEN PRESENTATION; SUBVENTRICULAR ZONE; REACTIVE GLIOSIS; PRECURSOR CELLS; GLIOBLASTOMA	Background: The tumor microenvironment contains normal, non-neoplastic cells that may contribute to tumor growth and maintenance. Within PDGF-driven murine gliomas, tumor-associated astrocytes (TAAs) are a large component of the tumor microenvironment. The function of non-neoplastic astrocytes in the glioma microenvironment has not been fully elucidated; moreover, the differences between these astrocytes and normal astrocytes are unknown. We therefore sought to identify genes and pathways that are increased in TAAs relative to normal astrocytes and also to determine whether expression of these genes correlates with glioma behavior. Methodology/Principal Findings: We compared the gene expression profiles of TAAs to normal astrocytes and found the Antigen Presentation Pathway to be significantly increased in TAAs. We then identified a gene signature for glioblastoma (GBM) TAAs and validated the expression of some of those genes within the tumor. We also show that TAAs are derived from the non-tumor, stromal environment, in contrast to the Olig2+ tumor cells that constitute the neoplastic elements in our model. Finally, we validate this GBM TAA signature in patients and show that a TAA-derived gene signature predicts survival specifically in the human proneural subtype of glioma. Conclusions/Significance: Our data identifies unique gene expression patterns between populations of TAAs and suggests potential roles for stromal astrocytes within the glioma microenvironment. We show that certain stromal astrocytes in the tumor microenvironment express a GBM-specific gene signature and that the majority of these stromal astrocyte genes can predict survival in the human disease.	[Katz, Amanda M.; Pitter, Ken] Cornell Univ, Biochem Cell & Mol Biol Program, Weill Med Coll, New York, NY 10021 USA; [Katz, Amanda M.; Amankulor, Nduka M.; Pitter, Ken; Helmy, Karim; Squatrito, Massimo; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Katz, Amanda M.; Amankulor, Nduka M.; Pitter, Ken; Helmy, Karim; Squatrito, Massimo; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10021 USA; [Amankulor, Nduka M.; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Amankulor, Nduka M.; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA; [Amankulor, Nduka M.; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Katz, AM (corresponding author), Cornell Univ, Biochem Cell & Mol Biol Program, Weill Med Coll, New York, NY 10021 USA.	hollande@mskcc.org	Squatrito, Massimo/F-4149-2016; Amankulor, Nduka/CAJ-3564-2022	Squatrito, Massimo/0000-0002-4593-3790; Pitter, Kenneth/0000-0002-9450-313X	National Institutes of Health (NIH) [U54 CA163167, U01 CA141502, U54 CA143798, RO1 CA100688]; NATIONAL CANCER INSTITUTE [R01CA100688, U01CA141502, U54CA143798, U54CA163167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS076028] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants U54 CA163167, U01 CA141502, U54 CA143798, and RO1 CA100688. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009; Barker Alison J, 2008, Commun Integr Biol, V1, P207; Becher OJ, 2008, CANCER RES, V68, P2241, DOI 10.1158/0008-5472.CAN-07-6350; Becher OJ, 2010, CANCER RES, V70, P2548, DOI 10.1158/0008-5472.CAN-09-2503; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; FIERZ W, 1985, J IMMUNOL, V134, P3785; Fomchenko EI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020605; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Garcion E, 2001, DEVELOPMENT, V128, P2485; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Glass R, 2005, J NEUROSCI, V25, P2637, DOI 10.1523/JNEUROSCI.5118-04.2005; Gonda TA, 2010, SEMIN CELL DEV BIOL, V21, P2, DOI 10.1016/j.semcdb.2009.10.001; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Huse JT, 2011, GLIA, V59, P1190, DOI 10.1002/glia.21165; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Kazanis I, 2007, J NEUROSCI, V27, P13991, DOI 10.1523/JNEUROSCI.3279-07.2007; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lang B, 2004, NEUROSCIENCE, V128, P775, DOI 10.1016/j.neuroscience.2004.06.033; Lim DA, 2007, NEUROSURG CLIN N AM, V18, P81, DOI 10.1016/j.nec.2006.10.002; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; McCarthy BJ, 2005, NEURO-ONCOLOGY, V7, P196, DOI 10.1215/S115285170400050X; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; MUCKE L, 1993, FASEB J, V7, P1226, DOI 10.1096/fasebj.7.13.8405808; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Preusser M, 2007, HISTOPATHOLOGY, V50, P365, DOI 10.1111/j.1365-2559.2007.02614.x; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Shrikant P, 1996, J IMMUNOL, V157, P1819; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vivanco I, 2010, P NATL ACAD SCI USA, V107, P6459, DOI 10.1073/pnas.0911188107; YONG VW, 1991, J NEUROPATH EXP NEUR, V50, P16, DOI 10.1097/00005072-199101000-00002; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	50	55	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32453	10.1371/journal.pone.0032453	http://dx.doi.org/10.1371/journal.pone.0032453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393407	Green Published, gold, Green Submitted			2022-12-27	WOS:000303003500060
J	Tobaly-Tapiero, J; Zamborlini, A; Bittoun, P; Saib, A				Tobaly-Tapiero, Joelle; Zamborlini, Alessia; Bittoun, Patricia; Saib, Ali			Investigating the Intercellular Spreading Properties of the Foamy Virus Gag Protein	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; HUMAN IMMUNODEFICIENCY VIRUS; VP22-GFP FUSION PROTEINS; STRUCTURAL PROTEIN; NUCLEAR-LOCALIZATION; TRANSDUCTION; TRAFFICKING; CHROMATIN; DELIVERY; DOMAINS	Small regions called protein transduction domains (PTDs), identified in cellular and viral proteins, have been reported to efficiently cross biological membranes. Here we show that the structural Gag protein of the prototypic foamy virus (PFV) is apparently able to move from cell to cell and to transport the green fluorescent protein (GFP) from few transfected cells to the nuclei of the entire monolayer. Deletion studies showed that this property lies within the second glycine/arginine (GRII) box in the C-terminus of the protein. We also found that uptake and nuclear accumulation of Gag GRII expressed as GFP-fusion protein in recipient cells was observed only following methanol fixation, but never in living cells or when cells were fixed with glutaraldehyde or treated with trichloroacetic acid prior to methanol fixation. Absence of intercellular spreading in vivo was further confirmed using a sensitive luciferase activity assay based on transactivation of the PFV long terminal repeats. Thus, we conclude that intercellular spreading of PFV Gag represents an artificial diffusion event occurring during cell fixation, followed by nuclear retention mediated by the chromatin-binding sequence within the Gag GRII box. In light of these results, we advise caution before defining a peptide as PTD on the basis of intercellular spreading observed by fluorescence microscopy.	[Tobaly-Tapiero, Joelle; Zamborlini, Alessia; Bittoun, Patricia; Saib, Ali] Univ Paris 07, CNRS, INSERM, U944,Inst Univ Hematol,UMR7212, Paris, France; [Zamborlini, Alessia; Saib, Ali] Conservatoire Natl Arts & Metiers, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; heSam Universite; Conservatoire National Arts & Metiers (CNAM)	Tobaly-Tapiero, J (corresponding author), Univ Paris 07, CNRS, INSERM, U944,Inst Univ Hematol,UMR7212, Paris, France.	ali.saib@cnam.fr	Zamborlini, Alessia/ABE-2256-2021	Zamborlini, Alessia/0000-0002-8902-1996; Tobaly-Tapiero, Joelle/0000-0001-6318-8627	Association de recherche contre le Cancer (ARC) [5981]; Agence Nationale de Recherches sur le side et les hepatites virales (ANRS); Sidaction	Association de recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de Recherches sur le side et les hepatites virales (ANRS); Sidaction	This work was supported by Association de recherche contre le Cancer (ARC) (#5981), Agence Nationale de Recherches sur le side et les hepatites virales (ANRS) and Sidaction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brewis N, 2000, J VIROL, V74, P1051, DOI 10.1128/JVI.74.2.1051-1056.2000; Delelis O, 2004, CURR OPIN MICROBIOL, V7, P400, DOI 10.1016/j.mib.2004.06.009; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Duchardt F, 2009, J BIOL CHEM, V284, P36099, DOI 10.1074/jbc.M109.036426; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; Elliott G, 2000, J VIROL, V74, P2131, DOI 10.1128/JVI.74.5.2131-2141.2000; Elliott G, 1999, J VIROL, V73, P4110, DOI 10.1128/JVI.73.5.4110-4119.1999; Elliott G, 1999, GENE THER, V6, P149, DOI 10.1038/sj.gt.3300850; Fang B, 1998, GENE THER, V5, P1420, DOI 10.1038/sj.gt.3300741; Fonseca SB, 2009, ADV DRUG DELIVER REV, V61, P953, DOI 10.1016/j.addr.2009.06.001; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Ingvarsdottir K, 2010, BBA-GENE REGUL MECH, V1799, P200, DOI 10.1016/j.bbagrm.2009.08.002; Jarver P, 2004, DRUG DISCOV TODAY, V9, P395, DOI 10.1016/S1359-6446(04)03042-9; Kiernan JA, 2000, FORMALDEHYDE FORMALI, P8; Lecellier CH, 2002, J VIROL, V76, P7220, DOI 10.1128/JVI.76.14.7220-7227.2002; Lopez MR, 2008, VIRUS RES, V136, P175, DOI 10.1016/j.virusres.2008.05.010; Lundberg M, 2003, MOL THER, V8, P143, DOI 10.1016/S1525-0016(03)00135-7; Lundberg M, 2002, BIOCHEM BIOPH RES CO, V291, P367, DOI 10.1006/bbrc.2002.6450; Lundberg M, 2001, NAT BIOTECHNOL, V19, P713, DOI 10.1038/90741; MELAN MA, 1992, J CELL SCI, V101, P731; Mullers E, 2011, J VIROL, V85, P9276, DOI 10.1128/JVI.00663-11; Mullers E, 2011, J VIROL, V85, P1452, DOI 10.1128/JVI.01731-10; Petit C, 2003, J CELL SCI, V116, P3433, DOI 10.1242/jcs.00613; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Saib A, 1997, J VIROL, V71, P1155; SCHLIEPHAKE AW, 1994, J VIROL, V68, P4946, DOI 10.1128/JVI.68.8.4946-4954.1994; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Schwarze SR, 2000, TRENDS PHARMACOL SCI, V21, P45, DOI 10.1016/S0165-6147(99)01429-7; Tobaly-Tapiero J, 2001, J VIROL, V75, P4367, DOI 10.1128/JVI.75.9.4367-4375.2001; Tobaly-Tapiero J, 2008, TRAFFIC, V9, P1717, DOI 10.1111/j.1600-0854.2008.00792.x; Yu SF, 1996, J VIROL, V70, P8255, DOI 10.1128/JVI.70.12.8255-8262.1996; Yu SYF, 2006, TRAFFIC, V7, P966, DOI 10.1111/j.1600-0854.2006.00448.x	36	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31108	10.1371/journal.pone.0031108	http://dx.doi.org/10.1371/journal.pone.0031108			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393357	gold, Green Submitted, Green Published			2022-12-27	WOS:000303003500010
J	Duerschmied, D; Ahrens, I; Mauler, M; Brandt, C; Weidner, S; Bode, C; Moser, M				Duerschmied, Daniel; Ahrens, Ingo; Mauler, Maximilian; Brandt, Christoph; Weidner, Stefanie; Bode, Christoph; Moser, Martin			Serotonin Antagonism Improves Platelet Inhibition in Clopidogrel Low-Responders after Coronary Stent Placement: An In Vitro Pilot Study	PLOS ONE			English	Article							CYCLIC FLOW VARIATIONS; LIGHT TRANSMISSION AGGREGOMETRY; RECEPTOR ANTAGONIST; REUPTAKE INHIBITOR; BLOOD-FLOW; AGGREGATION; ACTIVATION; SARPOGRELATE; THROMBOXANE-A2; MECHANISMS	Increased residual platelet reactivity remains a burden for coronary artery disease (CAD) patients who received a coronary stent and do not respond sufficiently to treatment with acetylsalicylic acid and clopidogrel. We hypothesized that serotonin antagonism reduces high on-treatment platelet reactivity. Whole blood impedance aggregometry was performed with arachidonic acid (AA, 0.5 mM) and adenosine diphosphate (ADP, 6.5 mu M) in addition to different concentrations of serotonin (1-100 mu M) in whole blood from 42 CAD patients after coronary stent placement and 10 healthy subjects. Serotonin increased aggregation dose-dependently in CAD patients who responded to clopidogrel treatment: After activation with ADP, aggregation increased from 33.7 +/- 1.3% to 40.9 +/- 2.0% in the presence of 50 mu M serotonin (p<0.05) and to 48.2 +/- 2.0% with 100 mu M serotonin (p<0.001). The platelet serotonin receptor antagonist ketanserin decreased ADP-induced aggregation significantly in clopidogrel low-responders (from 59.9 +/- 3.1% to 37.4 +/- 3.5, p<0.01), but not in clopidogrel responders. These results were confirmed with light transmission aggregometry in platelet-rich plasma in a subset of patients. Serotonin hence increased residual platelet reactivity in patients who respond to clopidogrel after coronary stent placement. In clopidogrel low-responders, serotonin receptor antagonism improved platelet inhibition, almost reaching responder levels. This may justify further investigation of triple antiplatelet therapy with anti-serotonergic agents.	[Duerschmied, Daniel; Ahrens, Ingo; Mauler, Maximilian; Brandt, Christoph; Weidner, Stefanie; Bode, Christoph; Moser, Martin] Univ Med Ctr Freiburg, Dept Cardiol & Angiol, Freiburg, Germany	University of Freiburg	Duerschmied, D (corresponding author), Univ Med Ctr Freiburg, Dept Cardiol & Angiol, Freiburg, Germany.	daniel.duerschmied@uniklinik-freiburg.de	Duerschmied, D./K-8182-2015; Duerschmied, D./AAB-5139-2021	Duerschmied, D./0000-0001-5249-4012; Duerschmied, D./0000-0001-5249-4012	University Medical Center of Freiburg	University Medical Center of Freiburg	This pilot study was investigator initiated and financed by the University Medical Center of Freiburg. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 2009, J PHARMACOL EXP THER, V331, P96, DOI 10.1124/jpet.109.153189; Ahrens I, 2009, CURR OPIN INVEST DR, V10, P902; Andrade C, 2010, J CLIN PSYCHIAT, V71, P1565, DOI 10.4088/JCP.09r05786blu; ASHTON JH, 1986, CIRCULATION, V73, P572, DOI 10.1161/01.CIR.73.3.572; ASHTON JH, 1987, CIRCULATION, V76, P952, DOI 10.1161/01.CIR.76.4.952; ASHTON JH, 1989, J AM COLL CARDIOL, V13, P755, DOI 10.1016/0735-1097(89)90622-0; BENEDICT CR, 1986, CIRC RES, V58, P58, DOI 10.1161/01.RES.58.1.58; Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047; BUSH LR, 1984, CIRC RES, V55, P642, DOI 10.1161/01.RES.55.5.642; Cattaneo M, 2009, SEMIN THROMB HEMOST, V35, P158, DOI 10.1055/s-0029-1220324; Dale GL, 2002, NATURE, V415, P175, DOI 10.1038/415175a; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Duerschmied D, 2009, HAMOSTASEOLOGIE, V29, P356; Duerschmied D, 2009, J THROMB HAEMOST, V7, P1163, DOI 10.1111/j.1538-7836.2009.03476.x; Duerschmied D, 2010, EXPERT REV CARDIOVAS, V8, P1215, DOI [10.1586/erc.10.104, 10.1586/ERC.10.104]; Francischetti IMB, 2000, J BIOL CHEM, V275, P12639, DOI 10.1074/jbc.275.17.12639; Fujita M, 2003, AM HEART J, V145, DOI 10.1067/mhj.2003.176; Galan AM, 2009, THROMB HAEMOSTASIS, V102, P511, DOI 10.1160/TH08-12-0810; Gilles M, 2005, PSYCHOSOM MED, V67, P748, DOI 10.1097/01.psy.0000174994.91245.34; GOLINO P, 1994, NEW ENGL J MED, V330, P523, DOI 10.1056/NEJM199402243300802; GOLINO P, 1989, CIRCULATION, V79, P154, DOI 10.1161/01.CIR.79.1.154; GOLINO P, 1991, NEW ENGL J MED, V324, P641, DOI 10.1056/NEJM199103073241001; GOLINO P, 1988, CIRCULATION, V77, P678, DOI 10.1161/01.CIR.77.3.678; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Hamm CW, 2011, EUR HEART J; Hochholzer W, 2006, J AM COLL CARDIOL, V48, P1742, DOI 10.1016/j.jacc.2006.06.065; HOLDRINET A, 1969, SCAND J HAEMATOL, V6, P354; Horibe E, 2004, CIRC J, V68, P68, DOI 10.1253/circj.68.68; Kokubu N, 2006, CIRC J, V70, P1451, DOI 10.1253/circj.70.1451; Kuliczkowski W, 2009, EUR HEART J, V30, P426, DOI 10.1093/eurheartj/ehn562; Leon C, 1999, J CLIN INVEST, V104, P1731, DOI 10.1172/JCI8399; Levine GN, 2016, CIRCULATION; Lopez-Vilchez I, 2009, CARDIOVASC RES, V84, P309, DOI 10.1093/cvr/cvp205; McNicol A, 1999, THROMB RES, V95, P1, DOI 10.1016/S0049-3848(99)00015-8; Nishihira K, 2006, J THROMB HAEMOST, V4, P247, DOI 10.1111/j.1538-7836.2005.01702.x; Przyklenk K, 2010, J THROMB HAEMOST, V8, P331, DOI 10.1111/j.1538-7836.2009.03693.x; Shimizu Y, 2002, J AM COLL CARDIOL, V40, P1347, DOI 10.1016/S0735-1097(02)02158-7; Shinohara Y, 2008, STROKE, V39, P1827, DOI 10.1161/STROKEAHA.107.505131; Sibbing D, 2008, THROMB HAEMOSTASIS, V99, P121, DOI 10.1160/TH07-07-0478; Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030; Siller-Matula JM, 2010, J THROMB HAEMOST, V8, P351, DOI 10.1111/j.1538-7836.2009.03699.x; Storey RF, 2007, J AM COLL CARDIOL, V50, P1852, DOI 10.1016/j.jacc.2007.07.058; Tseng YL, 2010, THROMB RES, V126, P517, DOI 10.1016/j.thromres.2010.09.017; VERSTRAETE M, 1989, BRIT MED J, V298, P424; Wallentin L, 2008, EUR HEART J, V29, P21, DOI 10.1093/eurheartj/ehm545; Wallentin L, 2009, EUR HEART J, V30, P1964, DOI 10.1093/eurheartj/ehp296; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Wiviott SD, 2007, CIRCULATION, V116, P2923, DOI 10.1161/CIRCULATIONAHA.107.740324	48	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32656	10.1371/journal.pone.0032656	http://dx.doi.org/10.1371/journal.pone.0032656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384279	gold, Green Published, Green Submitted			2022-12-27	WOS:000302918500106
J	Zhang, RK; Fang, H; Chen, YX; Shen, J; Lu, HD; Zeng, C; Ren, JH; Zeng, H; Li, ZF; Chen, SM; Cai, DZ; Zhao, Q				Zhang, RongKai; Fang, Hang; Chen, YuXian; Shen, Jun; Lu, HuaDing; Zeng, Chun; Ren, JianHua; Zeng, Hua; Li, Zhifu; Chen, ShaoMing; Cai, DaoZhang; Zhao, Qing			Gene Expression Analyses of Subchondral Bone in Early Experimental Osteoarthritis by Microarray	PLOS ONE			English	Article							CRUCIATE LIGAMENT TRANSECTION; C-C CHEMOKINES; MATRIX METALLOPROTEINASES; RHEUMATOID-ARTHRITIS; INDIAN HEDGEHOG; INFLAMMATORY ARTHRITIS; CARTILAGE DEGENERATION; ARTICULAR-CARTILAGE; CONDYLAR CARTILAGE; HUMAN CHONDROCYTES	Osteoarthritis (OA) is a degenerative joint disease that affects both cartilage and bone. A better understanding of the early molecular changes in subchondral bone may help elucidate the pathogenesis of OA. We used microarray technology to investigate the time course of molecular changes in the subchondral bone in the early stages of experimental osteoarthritis in a rat model. We identified 2,234 differentially expressed (DE) genes at 1 week, 1,944 at 2 weeks and 1,517 at 4 weeks post-surgery. Further analyses of the dysregulated genes indicated that the events underlying subchondral bone remodeling occurred sequentially and in a time-dependent manner at the gene expression level. Some of the identified dysregulated genes that were identified have suspected roles in bone development or remodeling; these genes include Alp, Igf1, Tgf beta 1, Postn, Mmp3, Tnfsf11, Acp5, Bmp5, Aspn and Ihh. The differences in the expression of these genes were confirmed by real-time PCR, and the results indicated that our microarray data accurately reflected gene expression patterns characteristic of early OA. To validate the results of our microarray analysis at the protein level, immunohistochemistry staining was used to investigate the expression of Mmp3 and Aspn protein in tissue sections. These analyses indicate that Mmp3 protein expression completely matched the results of both the microarray and real-time PCR analyses; however, Aspn protein expression was not observed to differ at any time. In summary, our study demonstrated a simple method of separation of subchondral bone sample from the knee joint of rat, which can effectively avoid bone RNA degradation. These findings also revealed the gene expression profiles of subchondral bone in the rat OA model at multiple time points post-surgery and identified important DE genes with known or suspected roles in bone development or remodeling. These genes may be novel diagnostic markers or therapeutic targets for OA.	[Zhang, RongKai; Fang, Hang; Chen, YuXian; Shen, Jun; Lu, HuaDing; Zeng, Chun; Ren, JianHua; Zeng, Hua; Li, Zhifu; Cai, DaoZhang] Sun Yat Sen Univ, Dept Orthopaed, Affiliated Hosp 3, Guangzhou, Peoples R China; [Zhang, RongKai; Chen, ShaoMing; Zhao, Qing] Sun Yat Sen Univ, Dept Orthopaed, Affiliated Hosp 5, Zhuhai, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, RK (corresponding author), Sun Yat Sen Univ, Dept Orthopaed, Affiliated Hosp 3, Guangzhou, Peoples R China.	caidaozhang@gmail.com			Chinese National Natural Science Foundation [2008AA02Z437]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the 863 Scientific Research of the Chinese National Natural Science Foundation (2008AA02Z437). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2009, OSTEOARTHR CARTILAGE, V17, P1049, DOI 10.1016/j.joca.2009.02.008; Aigner T, 2006, ARTHRITIS RHEUM-US, V54, P3533, DOI 10.1002/art.22174; Anandarajah AP, 2009, TRENDS ENDOCRIN MET, V20, P88, DOI 10.1016/j.tem.2008.10.007; Appleton CTG, 2007, ARTHRITIS RHEUM-US, V56, P1854, DOI 10.1002/art.22711; Bailey AJ, 2002, INT J BIOCHEM CELL B, V34, P176, DOI 10.1016/S1357-2725(01)00107-8; Bailey AJ, 1997, GERONTOLOGY, V43, P296; BLAVIER L, 1995, J CELL SCI, V108, P3649; Bogoch ER, 1998, CAN J SURG, V41, P264; Bord S, 1997, J ANAT, V191, P39, DOI 10.1046/j.1469-7580.1997.19110039.x; Borzi RM, 2000, ARTHRITIS RHEUM, V43, P1734, DOI 10.1002/1529-0131(200008)43:8<1734::AID-ANR9>3.0.CO;2-B; Botter SM, 2009, OSTEOARTHR CARTILAGE, V17, P636, DOI 10.1016/j.joca.2008.09.018; Brandt KD, 2002, BIORHEOLOGY, V39, P221; Brown TD, 2006, J ORTHOP TRAUMA, V20, P739, DOI 10.1097/01.bot.0000246468.80635.ef; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Couchourel D, 2009, ARTHRITIS RHEUM-US, V60, P1438, DOI 10.1002/art.24489; de Andres MC, 2011, BIOCHEM BIOPH RES CO, V407, P54, DOI 10.1016/j.bbrc.2011.02.101; Dew G, 2000, CELL TISSUE RES, V299, P385, DOI 10.1007/s004419900166; Einhorn TA, 2003, J BONE JOINT SURG AM, V85A, P82, DOI 10.2106/00004623-200300003-00014; Endres M, 2010, OSTEOARTHR CARTILAGE, V18, P1458, DOI 10.1016/j.joca.2010.08.003; Felson DT, 2004, ARTHRITIS RHEUM-US, V50, P341, DOI 10.1002/art.20051; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; Gillan L, 2002, CANCER RES, V62, P5358; Glaser DL, 2003, J BONE JOINT SURG AM, V85A, P2332, DOI 10.2106/00004623-200312000-00010; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hanada T, CYTOKINE GROWTH FACT, V13, P413, DOI 16/S1359-6101(02)00026-6; Haringman JJ, 2006, ANN RHEUM DIS, V65, P294, DOI 10.1136/ard.2005.037176; Hayami T, 2006, BONE, V38, P234, DOI 10.1016/j.bone.2005.08.007; Hayami T, 2004, ARTHRITIS RHEUM-US, V50, P1193, DOI 10.1002/art.20124; Hilal G, 1998, ARTHRITIS RHEUM, V41, P891, DOI 10.1002/1529-0131(199805)41:5<891::AID-ART17>3.0.CO;2-X; HILL PA, 1994, J CELL SCI, V107, P3055; Hopwood B, 2005, BONE, V36, P635, DOI 10.1016/j.bone.2005.02.003; Hopwood B, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2301; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Karam MC, 2011, J NEUROIMMUNOL, V234, P49, DOI 10.1016/j.jneuroim.2011.02.003; KING JA, 1994, DEV BIOL, V166, P112, DOI 10.1006/dbio.1994.1300; Klatt AR, 2009, J ORTHOP RES, V27, P65, DOI 10.1002/jor.20716; Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338; Lande R, 2004, J IMMUNOL, V173, P2815, DOI 10.4049/jimmunol.173.4.2815; Li XL, 2006, ANN NY ACAD SCI, V1068, P26, DOI 10.1196/annals.1346.006; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Lindner V, 2005, ARTERIOSCL THROM VAS, V25, P77, DOI 10.1161/01.ATV.0000149141.81230.c6; Lisignoli G, 2006, J CELL PHYSIOL, V206, P78, DOI 10.1002/jcp.20435; Lisignoli G, 2002, CYTOKINE, V20, P231, DOI 10.1006/cyto.2002.2006; Lisignoli G, 1999, CLIN EXP IMMUNOL, V116, P371; Logar DB, 2007, J BONE MINER METAB, V25, P219, DOI 10.1007/s00774-007-0753-0; Lohmander LS, 2000, ARTHRITIS RES, V2, P95, DOI 10.1186/ar74; Ma DD, 2011, J BIOL CHEM, V286, P4302, DOI 10.1074/jbc.M110.140202; Madry H, 2010, KNEE SURG SPORT TR A, V18, P419, DOI 10.1007/s00167-010-1054-z; Mailhot G, 2008, J CELL PHYSIOL, V214, P56, DOI 10.1002/jcp.21164; Malemud CJ, 2010, DRUG AGING, V27, P95, DOI 10.2165/11319950-000000000-00000; Manacu CA, 2005, ARTHRITIS RES THER, V7, pR324, DOI 10.1186/ar1489; Mansell JP, 1998, J CLIN INVEST, V101, P1596, DOI 10.1172/JCI867; Matyas JR, 1997, OSTEOARTHR CARTILAGE, V5, P99, DOI 10.1016/S1063-4584(97)80003-9; MEIKLE MC, 1992, J CELL SCI, V103, P1093; Ng TCS, 2006, FRONT BIOSCI-LANDMRK, V11, P943; Pastoureau PC, 1999, OSTEOARTHR CARTILAGE, V7, P466, DOI 10.1053/joca.1999.0241; RADIN EL, 1986, CLIN ORTHOP RELAT R, P34; Lamas JR, 2010, ANN RHEUM DIS, V69, P1880, DOI 10.1136/ard.2009.122564; REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rountree RB, 2004, PLOS BIOL, V2, P1815, DOI 10.1371/journal.pbio.0020355; Sakao K, 2009, J BONE MINER METAB, V27, P412, DOI 10.1007/s00774-009-0058-6; Sanchez C, 2005, OSTEOARTHR CARTILAGE, V13, P988, DOI 10.1016/j.joca.2005.07.012; Sanchez C, 2005, OSTEOARTHR CARTILAGE, V13, P979, DOI 10.1016/j.joca.2005.03.008; Sanchez C, 2008, ARTHRITIS RHEUM-US, V58, P442, DOI 10.1002/art.23159; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sanchez-Sabate E, 2009, OSTEOARTHR CARTILAGE, V17, P1106, DOI 10.1016/j.joca.2009.01.010; Shibakawa A, 2005, OSTEOARTHR CARTILAGE, V13, P679, DOI 10.1016/j.joca.2005.04.010; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; So JS, 2011, LIFE SCI, V88, P358, DOI 10.1016/j.lfs.2010.12.013; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Tang GH, 2004, J DENT RES, V83, P434, DOI 10.1177/154405910408300516; Urist MR, 2002, CLIN ORTHOP RELAT R, P5; Vergunst CE, 2005, SCAND J RHEUMATOL, V34, P415, DOI 10.1080/03009740500439159; Westacott CI, 1997, ARTHRITIS RHEUM, V40, P1282, DOI 10.1002/art.1780400713; Wu QQ, 2001, J BIOL CHEM, V276, P35290, DOI 10.1074/jbc.M101055200; Yuan GH, 2001, ARTHRITIS RHEUM-US, V44, P1056, DOI 10.1002/1529-0131(200105)44:5<1056::AID-ANR186>3.3.CO;2-L	79	38	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32356	10.1371/journal.pone.0032356	http://dx.doi.org/10.1371/journal.pone.0032356			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384228	gold, Green Submitted, Green Published			2022-12-27	WOS:000302918500080
J	Acerbi, I; Luque, T; Gimenez, A; Puig, M; Reguart, N; Farre, R; Navajas, D; Alcaraz, J				Acerbi, Irene; Luque, Tomas; Gimenez, Alicia; Puig, Marta; Reguart, Noemi; Farre, Ramon; Navajas, Daniel; Alcaraz, Jordi			Integrin-Specific Mechanoresponses to Compression and Extension Probed by Cylindrical Flat-Ended AFM Tips in Lung Cells	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; ADHESION; CONTRACTION; STIFFNESS; RIGIDITY; TENSION; ACTIN	Cells from lung and other tissues are subjected to forces of opposing directions that are largely transmitted through integrin-mediated adhesions. How cells respond to force bidirectionality remains ill defined. To address this question, we nanofabricated flat-ended cylindrical Atomic Force Microscopy (AFM) tips with similar to 1 mu m(2) cross-section area. Tips were uncoated or coated with either integrin-specific (RGD) or non-specific (RGE/BSA) molecules, brought into contact with lung epithelial cells or fibroblasts for 30 s to form focal adhesion precursors, and used to probe cell resistance to deformation in compression and extension. We found that cell resistance to compression was globally higher than to extension regardless of the tip coating. In contrast, both tip-cell adhesion strength and resistance to compression and extension were the highest when probed at integrin-specific adhesions. These integrin-specific mechanoresponses required an intact actin cytoskeleton, and were dependent on tyrosine phosphatases and Ca2+ signaling. Cell asymmetric mechanoresponse to compression and extension remained after 5 minutes of tip-cell adhesion, revealing that asymmetric resistance to force directionality is an intrinsic property of lung cells, as in most soft tissues. Our findings provide new insights on how lung cells probe the mechanochemical properties of the microenvironment, an important process for migration, repair and tissue homeostasis.	[Acerbi, Irene; Luque, Tomas; Gimenez, Alicia; Puig, Marta; Farre, Ramon; Navajas, Daniel; Alcaraz, Jordi] Univ Barcelona, Fac Med, Unitat Biofis & Bioengn, Barcelona 7, Spain; [Acerbi, Irene] Politecn Milan, Dipartimento Bioingn, Lab Tecnol Biomed, I-20133 Milan, Italy; [Acerbi, Irene; Luque, Tomas; Navajas, Daniel] Inst Bioengn Catalunya IBEC, Barcelona, Spain; [Puig, Marta; Farre, Ramon] IDIBAPS, Barcelona, Spain; [Reguart, Noemi; Farre, Ramon; Navajas, Daniel; Alcaraz, Jordi] CIBER Enfermedades Resp CIBERES, Bunyola, Spain	University of Barcelona; Polytechnic University of Milan; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Acerbi, I (corresponding author), Univ Barcelona, Fac Med, Unitat Biofis & Bioengn, Barcelona 7, Spain.	jalcaraz@ub.edu	Alcaraz, Jordi/AAE-3632-2020; Alcaraz, Jordi/F-5513-2016; Acerbi, Irene/AAA-3120-2019; Farre, Ramon/L-2664-2017; Navajas, Daniel/E-4233-2010	Alcaraz, Jordi/0000-0001-7898-1599; Alcaraz, Jordi/0000-0001-7898-1599; Farre, Ramon/0000-0002-9084-7824; Navajas, Daniel/0000-0001-7150-9363	Ministerio de Ciencia e Innovacion [SAF2009-13243, SAF2008-02991]; Ministerio de Sanidad y Politica Social [PI081908, PS09/01377]; Asociacion Espanola Contra el Cancer; Fundacio Privada Cellex; UBB	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Sanidad y Politica Social(Spanish Government); Asociacion Espanola Contra el Cancer; Fundacio Privada Cellex(Foundation CELLEX); UBB	This work was supported by grants from the Ministerio de Ciencia e Innovacion (SAF2009-13243 to JA, SAF2008-02991 to RF www.micinn.es), Ministerio de Sanidad y Politica Social (PI081908 to DN, PS09/01377 to NR www.msps.es), Asociacion Espanola Contra el Cancer (to NR and JA www.aecc.es), and pre-doctoral fellowships from the Ministerio de Ciencia e Innovacion (to IA, TL and AG), and from the Fundacio Privada Cellex (to MP). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank F Rico (Inst. Curie) for critical reading of the manuscript, X Trepat (IBEC) and X Gasull (UB) for helpful discussions, R Nieto and MA Rodriguez (Unitat de Biofisica i Bioenginyeria -UBB-, UB), and MJ Lopez (Plataforma de Nanotec., UB) for technical assistance, and other members of the UBB for support.	Alcaraz J, 2004, J MAMMARY GLAND BIOL, V9, P361, DOI 10.1007/s10911-004-1406-8; Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Alcaraz J, 2002, LANGMUIR, V18, P716, DOI 10.1021/la0110850; Alcaraz J, 2008, EMBO J, V27, P2829, DOI 10.1038/emboj.2008.206; Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Callies C, 2011, J CELL SCI, V124, P1936, DOI 10.1242/jcs.084657; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Curran-Everett D, 2009, ADV PHYSIOL EDUC, V33, P81, DOI 10.1152/advan.90218.2008; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; Deng LH, 2005, J APPL PHYSIOL, V99, P634, DOI 10.1152/japplphysiol.00025.2005; DEPASQUALE JA, 1987, J CELL BIOL, V105, P2803, DOI 10.1083/jcb.105.6.2803; Discher D, 2009, ANN BIOMED ENG, V37, P847, DOI 10.1007/s10439-009-9661-x; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Fernandez P, 2006, BIOPHYS J, V90, P3796, DOI 10.1529/biophysj.105.072215; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Fung Y.C., 1993, BIOMECHANICS MECH PR; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Glogauer M, 1997, J CELL SCI, V110, P11; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Johnson K. L., 1985, CONTACT MECH, DOI 10.1201/b17110-2; Kendall K, 1971, J PHYS D, V4, P10; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Li FY, 2003, BIOPHYS J, V84, P1252, DOI 10.1016/S0006-3495(03)74940-6; Lystvet SM, 2011, NANOSCALE, V3, P1788, DOI 10.1039/c0nr00948b; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; McKee CT, 2011, TISSUE ENG PART B-RE, V17, P155, DOI 10.1089/ten.teb.2010.0520; Mio T, 2001, AM J PHYSIOL-LUNG C, V281, pL164, DOI 10.1152/ajplung.2001.281.1.L164; Nakano N, 2006, J BIOCHEM, V139, P821, DOI 10.1093/jb/mvj092; NAVAJAS D, 1995, J APPL PHYSIOL, V79, P348, DOI 10.1152/jappl.1995.79.1.348; Nilsson BO, 1999, INFLAMM RES, V48, P509, DOI 10.1007/s000110050495; Paszek MJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000604; PLOPPER G, 1993, BIOCHEM BIOPH RES CO, V193, P571, DOI 10.1006/bbrc.1993.1662; Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127; Rico F, 2007, J MOL RECOGNIT, V20, P459, DOI 10.1002/jmr.829; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Roca-Cusachs P, 2008, BIOPHYS J, V94, P4984, DOI 10.1529/biophysj.107.116863; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Scallan J., 2010, FLUID EXCHANGE REGUL; Tschumperlin DJ, 2010, J BIOMECH, V43, P99, DOI 10.1016/j.jbiomech.2009.09.015; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wolfenson H, 2011, J CELL SCI, V124, P1425, DOI 10.1242/jcs.077388	50	26	26	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32261	10.1371/journal.pone.0032261	http://dx.doi.org/10.1371/journal.pone.0032261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384196	Green Submitted, Green Published, gold			2022-12-27	WOS:000302916100063
J	Garrido-Sanchez, L; Vendrell, J; Fernandez-Garcia, D; Ceperuelo-Mallafre, V; Chacon, MR; Ocana-Wilhelmi, L; Alcaide, J; Tinahones, FJ; Garcia-Fuentes, E				Garrido-Sanchez, Lourdes; Vendrell, Joan; Fernandez-Garcia, Diego; Ceperuelo-Mallafre, Victoria; Chacon, Matilde R.; Ocana-Wilhelmi, Luis; Alcaide, Juan; Tinahones, Francisco J.; Garcia-Fuentes, Eduardo			De Novo Lipogenesis in Adipose Tissue Is Associated with Course of Morbid Obesity after Bariatric Surgery	PLOS ONE			English	Article							COENZYME-A SYNTHETASE; FATTY-ACID SYNTHESIS; INSULIN-RESISTANCE; PHOSPHOENOLPYRUVATE CARBOXYKINASE; WEIGHT-LOSS; ENZYME; GLYCERONEOGENESIS; OVEREXPRESSION; PROTECTS; ACETATE	Objective: De novo lipogenesis is involved in fatty acid biosynthesis and could be involved in the regulation of the triglyceride storage capacity of adipose tissue. However, the association between lipogenic and lipolytic genes and the evolution of morbidly obese subjects after bariatric surgery remains unknown. In this prospective study we analyze the association between the improvement in the morbidly obese patients as a result of bariatric surgery and the basal expression of lipogenic and lipolytic genes. Methods: We study 23 non diabetic morbidly obese patients who were studied before and 7 months after bariatric surgery. Also, we analyze the relative basal mRNA expression levels of lipogenic and lipolytic genes in epiploic visceral adipose tissue (VAT) and abdominal subcutaneous adipose tissue (SAT). Results: When the basal acetyl-CoA carboxylase 1 (ACC1), acetyl-CoA synthetase 2 (ACSS2) and ATP citrate lyase (ACL) expression in SAT was below percentile-50, there was a greater decrease in weight (P = 0.006, P = 0.034, P = 0.026), body mass index (P = 0.008, P = 0.033, P = 0.034) and hip circumference (P = 0.033, P = 0.021, P = 0.083) after bariatric surgery. In VAT, when the basal ACSS2 expression was below percentile-50, there was a greater decrease in hip circumference (P = 0.006). After adjusting for confounding variables in logistic regression models, only the morbidly obese patients with SAT or VAT ACSS2 expression >= P50 before bariatric surgery had a lower percentage hip circumference loss (<P50) after bariatric surgery (SAT: P = 0.039; VAT: P = 0.033). Conclusions: A lower basal ACSS2, ACC1 and ACL expression, genes involved in de novo lipogenesis, is associated with a better evolution of anthropometric variables after bariatric surgery. Thus, the previous state of the pathways involved in fatty acid metabolism may have repercussions on the improvement of these patients.	[Garrido-Sanchez, Lourdes; Vendrell, Joan; Chacon, Matilde R.] Hosp Univ Joan XXIII, IISPV, CIBERDEM, Tarragona, Spain; [Fernandez-Garcia, Diego; Ceperuelo-Mallafre, Victoria; Tinahones, Francisco J.] Hosp Clin Virgen de la Victoria, Serv Endocrinol & Nutr, Malaga, Spain; [Fernandez-Garcia, Diego; Tinahones, Francisco J.; Garcia-Fuentes, Eduardo] Ciber Fisiopatol Obesidad & Nutr CIBEROB, Malaga, Spain; [Ocana-Wilhelmi, Luis] Hosp Clin Virgen de la Victoria, Serv Cirugia, Malaga, Spain; [Alcaide, Juan; Garcia-Fuentes, Eduardo] Fdn IMABIS, Malaga, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Hospital Virgen de la Victoria; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; FIMABIS	Garrido-Sanchez, L (corresponding author), Hosp Univ Joan XXIII, IISPV, CIBERDEM, Tarragona, Spain.	fjtinahones@hotmail.com; edugf1@gmail.com	Vendrell, Joan j/V-4034-2018; Chacón, Matilde R./E-5574-2019; Garcia-Fuentes, Eduardo/AAB-1607-2020; Tinahones, Francisco José/AAB-2882-2020; Ceperuelo-Mallafré, Victòria/A-4615-2017	Vendrell, Joan j/0000-0002-6994-6115; Chacón, Matilde R./0000-0003-1531-2165; Ceperuelo-Mallafré, Victòria/0000-0002-4460-9761; Tinahones, Francisco J/0000-0001-6871-4403; GARCIA-FUENTES, EDUARDO/0000-0002-3491-2724	Instituto de Salud Carlos III [PS09/01060, PS09/00997, PI08/0733, CP06/00119, JCI-2009-04086, JCI-2010-06395]; Servicio Andaluz de Salud [PI0255/2007]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Servicio Andaluz de Salud	This work was supported in part by grants from the Instituto de Salud Carlos III (PS09/01060, PS09/00997, PI08/0733, CP06/00119, JCI-2009-04086 and JCI-2010-06395) and Servicio Andaluz de Salud (PI0255/2007). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELFIORE F, 1995, BIOCHEM MOL MED, V54, P19, DOI 10.1006/bmme.1995.1003; Benedetti G, 2000, J AM COLL NUTR, V19, P270, DOI 10.1080/07315724.2000.10718926; COLEMAN PS, 1986, ANN NY ACAD SCI, V488, P451; Forest C, 2003, BIOCHEM SOC T, V31, P1125; Franckhauser S, 2006, DIABETES, V55, P273, DOI 10.2337/diabetes.55.02.06.db05-0482; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Garcia-Fuentes E, 2007, OBESITY, V15, P2391, DOI 10.1038/oby.2007.284; Garcia-Fuentes E, 2006, OBES SURG, V16, P1179, DOI 10.1381/096089206778392383; Garrido-Sanchez L, 2011, SURG OBES RELAT 0331; Garrido-Sanchez L, 2008, DIABETES CARE, V31, P2258, DOI 10.2337/dc08-0930; Hall KD, 2008, INT J OBESITY, V32, P619; HOWARD BV, 1974, J BIOL CHEM, V249, P7912; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Kreuz S, 2009, DIABETES-METAB RES, V25, P577, DOI 10.1002/dmrr.997; Leroyer SN, 2006, J BIOL CHEM, V281, P13141, DOI 10.1074/jbc.M512943200; Luong A, 2000, J BIOL CHEM, V275, P26458, DOI 10.1074/jbc.M004160200; Macias-Gonzalez M, 2009, EUR J CLIN INVEST, V39, P972, DOI 10.1111/j.1365-2362.2009.02198.x; Mao JQ, 2009, P NATL ACAD SCI USA, V106, P17576, DOI 10.1073/pnas.0909055106; Mao JQ, 2003, P NATL ACAD SCI USA, V100, P7515, DOI 10.1073/pnas.1332670100; Murri M, 2010, OBES SURG, V20, P363, DOI 10.1007/s11695-009-0021-6; Peinado JR, 2010, PROTEOMICS, V10, P3356, DOI 10.1002/pmic.201000350; Sone H, 2002, AM J PHYSIOL-ENDOC M, V282, pE222, DOI 10.1152/ajpendo.00189.2001; Soriguer F, 2009, OBESITY, V17, P10, DOI 10.1038/oby.2008.475; Soriguer F, 2009, OBES SURG, V19, P1574, DOI 10.1007/s11695-009-9955-y; STEINER G, 1966, CAN J BIOCHEM CELL B, V44, P1587, DOI 10.1139/o66-181; Swierczynski J, 2000, METABOLISM, V49, P594, DOI 10.1016/S0026-0495(00)80033-5; Swierczynski J, 2003, MOL CELL BIOCHEM, V254, P55, DOI 10.1023/A:1027332523114; Tinahones FJ, 2010, OBES SURG, V20, P1559, DOI 10.1007/s11695-010-0194-z; Vendrell J, 2010, J CLIN ENDOCR METAB, V95, P2983, DOI 10.1210/jc.2009-2481; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Wang YL, 2004, OBES RES, V12, P1781, DOI 10.1038/oby.2004.221; Zhao LF, 2010, ENDOCR J, V57, P317, DOI 10.1507/endocrj.K09E-298	33	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31280	10.1371/journal.pone.0031280	http://dx.doi.org/10.1371/journal.pone.0031280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384010	Green Submitted, Green Published, gold			2022-12-27	WOS:000302916100017
J	Liu, TS; Pinheiro, A; Zhao, ZX; Nestor, PG; McCarley, RW; Niznikiewicz, MA				Liu, Taosheng; Pinheiro, Ana; Zhao, Zhongxin; Nestor, Paul G.; McCarley, Robert W.; Niznikiewicz, Margaret A.			Emotional Cues during Simultaneous Face and Voice Processing: Electrophysiological Insights	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; FACIAL AFFECT RECOGNITION; TIME-COURSE; BRAIN POTENTIALS; AUDIOVISUAL INTEGRATION; COMBINED PERCEPTION; VISUAL-STIMULI; EXPRESSIONS; ATTENTION; ERP	Both facial expression and tone of voice represent key signals of emotional communication but their brain processing correlates remain unclear. Accordingly, we constructed a novel implicit emotion recognition task consisting of simultaneously presented human faces and voices with neutral, happy, and angry valence, within the context of recognizing monkey faces and voices task. To investigate the temporal unfolding of the processing of affective information from human face-voice pairings, we recorded event-related potentials (ERPs) to these audiovisual test stimuli in 18 normal healthy subjects; N100, P200, N250, P300 components were observed at electrodes in the frontal-central region, while P100, N170, P270 were observed at electrodes in the parietal-occipital region. Results indicated a significant audiovisual stimulus effect on the amplitudes and latencies of components in frontal-central (P200, P300, and N250) but not the parietal occipital region (P100, N170 and P270). Specifically, P200 and P300 amplitudes were more positive for emotional relative to neutral audiovisual stimuli, irrespective of valence, whereas N250 amplitude was more negative for neutral relative to emotional stimuli. No differentiation was observed between angry and happy conditions. The results suggest that the general effect of emotion on audiovisual processing can emerge as early as 200 msec (P200 peak latency) post stimulus onset, in spite of implicit affective processing task demands, and that such effect is mainly distributed in the frontal-central region.	[Liu, Taosheng] Second Mil Med Univ, Dept Psychol, Shanghai, Peoples R China; [Liu, Taosheng; Pinheiro, Ana; Nestor, Paul G.; McCarley, Robert W.; Niznikiewicz, Margaret A.] Boston VA Healthcare Syst, Brockton Div, Dept Psychiat, Neurosci Lab,Clin Neurosci Div, Brockton, MA USA; [Liu, Taosheng; Pinheiro, Ana; Nestor, Paul G.; McCarley, Robert W.; Niznikiewicz, Margaret A.] Harvard Univ, Sch Med, Brockton, MA 02401 USA; [Pinheiro, Ana] Univ Minho, Sch Psychol, CiPsi, Neuropsychophysiol Lab, Braga, Portugal; [Zhao, Zhongxin] Second Mil Med Univ, Changzheng Hosp, Dept Neurol, Neurosci Res Ctr, Shanghai, Peoples R China; [Nestor, Paul G.] Univ Massachusetts, Boston, MA 02125 USA	Naval Medical University; Harvard University; Universidade do Minho; Naval Medical University; University of Massachusetts System; University of Massachusetts Boston	Liu, TS (corresponding author), Second Mil Med Univ, Dept Psychol, Shanghai, Peoples R China.	Zhongxinzhao@smmu.edu.cn; Margaret_Niznikiewicz@hms.harvard.edu	McCarley, Robert W/N-5562-2014; Shenton, Martha/V-8780-2019	McCarley, Robert W/0000-0001-5705-7495; Pinheiro, Ana/0000-0002-7981-3682	China Scholarship Council [2009658022]; Fundacao para a Ciencia e a Tecnologia - FCT (Portugal) [SFRH/BPD/68967/2010]; National Institute of Mental Health - NIMH [RO1 MH 040799, RO3 MH 078036]; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH078036, R01MH040799] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); Fundacao para a Ciencia e a Tecnologia - FCT (Portugal)(Portuguese Foundation for Science and Technology); National Institute of Mental Health - NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a joint PhD student scholarship (2009658022) from China Scholarship Council awarded to T.S.L., a Post-Doctoral Grant (SFRH/BPD/68967/2010) from Fundacao para a Ciencia e a Tecnologia - FCT (Portugal) awarded to A.P.P., and by the National Institute of Mental Health - NIMH (RO1 MH 040799 grant awarded to R.W.M.; RO3 MH 078036 grant awarded to M.A.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SK, 2003, SCHIZOPHR RES, V64, P125, DOI 10.1016/S0920-9964(02)00347-X; Ashley V, 2004, NEUROREPORT, V15, P211, DOI 10.1097/00001756-200401190-00041; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bolognini N, 2005, EXP BRAIN RES, V160, P273, DOI 10.1007/s00221-004-2005-z; Bradley M.M., 2007, INT AFFECTIVE DIGITI, V2nd; Brefczynski-Lewis J, 2009, BRAIN TOPOGR, V21, P193, DOI 10.1007/s10548-009-0093-6; Carretie L, 1997, BRAIN COGNITION, V34, P207, DOI 10.1006/brcg.1997.0895; Carretie L, 1997, ELECTROEN CLIN NEURO, V103, P298, DOI 10.1016/S0013-4694(96)96565-7; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.3.CO;2-Q; Crowley KE, 2004, CLIN NEUROPHYSIOL, V115, P732, DOI 10.1016/j.clinph.2003.11.021; Curran T, 2002, COGN AFFECT BEHAV NE, V2, P1, DOI 10.3758/CABN.2.1.1; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; de Gelder B, 1999, NEUROSCI LETT, V260, P133, DOI 10.1016/S0304-3940(98)00963-X; Delplanque S, 2005, BIOL PSYCHOL, V68, P107, DOI 10.1016/j.biopsycho.2004.04.006; Dolcos F, 2002, COGN AFFECT BEHAV NE, V2, P252, DOI 10.3758/CABN.2.3.252; Dominguez-Borras J, 2008, EUR J NEUROSCI, V28, P1199, DOI 10.1111/j.1460-9568.2008.06411.x; Eimer M, 1999, NEUROREPORT, V10, P255, DOI 10.1097/00001756-199902050-00010; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Eimer M, 2003, COGN AFFECT BEHAV NE, V3, P97, DOI 10.3758/CABN.3.2.97; Ethofer T, 2006, HUM BRAIN MAPP, V27, P707, DOI 10.1002/hbm.20212; Everhart D Erik, 2006, Behav Cogn Neurosci Rev, V5, P92, DOI 10.1177/1534582306289665; Focker J, 2011, ACTA PSYCHOL, V137, P36, DOI 10.1016/j.actpsy.2011.02.004; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; GARCIALARREA L, 1992, NEUROPSYCHOLOGIA, V30, P723, DOI 10.1016/0028-3932(92)90042-K; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; JOHNSTON VS, 1986, PSYCHOPHYSIOLOGY, V23, P684, DOI 10.1111/j.1469-8986.1986.tb00694.x; Kayser C, 2010, CURR BIOL, V20, P19, DOI 10.1016/j.cub.2009.10.068; Kotz SA, 2006, PROG BRAIN RES, V156, P285, DOI 10.1016/S0079-6123(06)56015-7; Kreifelts B, 2007, NEUROIMAGE, V37, P1445, DOI 10.1016/j.neuroimage.2007.06.020; Lang P.J., 2008, A8 U FLOR; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Lebib R, 2004, NEUROSCI LETT, V372, P74, DOI 10.1016/j.neulet.2004.09.039; Lenz D, 2007, INT J PSYCHOPHYSIOL, V64, P31, DOI 10.1016/j.ijpsycho.2006.07.008; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Liu TS, 2012, NEUROREPORT, V23, P108, DOI 10.1097/WNR.0b013e32834ea757; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Massaro DW, 1996, PSYCHON B REV, V3, P215, DOI 10.3758/BF03212421; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; Mishra J, 2009, VISION RES, V49, P1073, DOI 10.1016/j.visres.2008.02.018; Muller VI, 2011, NEUROIMAGE, V54, P2257, DOI 10.1016/j.neuroimage.2010.10.047; Munte TF, 1998, NEUROSCI RES, V30, P25, DOI 10.1016/S0168-0102(97)00118-1; NOVAK G, 1992, PSYCHOPHYSIOLOGY, V29, P412, DOI 10.1111/j.1469-8986.1992.tb01714.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Paulmann S, 2008, BRAIN LANG, V105, P59, DOI 10.1016/j.bandl.2007.11.005; Paulmann S, 2008, NEUROREPORT, V19, P209, DOI 10.1097/WNR.0b013e3282f454db; Paulmann S, 2010, SOC NEUROSCI-UK, V5, P59, DOI 10.1080/17470910903135668; Paulmann S, 2009, NEUROREPORT, V20, P1603, DOI 10.1097/WNR.0b013e3283320e3f; Pizzagalli DA, 2002, NEUROIMAGE, V16, P663, DOI 10.1006/nimg.2002.1126; Polich J, 1999, EEG CL N SU, V50, P281; Posamentier MT, 2003, NEUROPSYCHOL REV, V13, P113, DOI 10.1023/A:1025519712569; Pourtois G, 2000, NEUROREPORT, V11, P1329, DOI 10.1097/00001756-200004270-00036; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Pourtois G, 2002, COGNITIVE BRAIN RES, V14, P99, DOI 10.1016/S0926-6410(02)00064-2; Puce A, 2007, NEUROPSYCHOLOGIA, V45, P93, DOI 10.1016/j.neuropsychologia.2006.04.017; Saint-Amour D, 2007, NEUROPSYCHOLOGIA, V45, P587, DOI 10.1016/j.neuropsychologia.2006.03.036; Sauter DA, 2010, J COGNITIVE NEUROSCI, V22, P474, DOI 10.1162/jocn.2009.21215; Schutter DJLG, 2004, INT J PSYCHOPHYSIOL, V53, P29, DOI 10.1016/j.ijpsycho.2004.01.003; Spreckelmeyer KN, 2006, BRAIN RES, V1070, P160, DOI 10.1016/j.brainres.2005.11.075; Streit M, 1999, COGNITIVE BRAIN RES, V7, P481, DOI 10.1016/S0926-6410(98)00048-2; Streit M, 2001, SCHIZOPHR RES, V49, P145, DOI 10.1016/S0920-9964(00)00041-4; Streit M, 2000, NEUROSCI LETT, V278, P13, DOI 10.1016/S0304-3940(99)00884-8; Thierry G, 2007, NEUROREPORT, V18, P245, DOI 10.1097/WNR.0b013e328011dc95; Turetsky BI, 2007, SCHIZOPHR RES, V94, P253, DOI 10.1016/j.schres.2007.05.001; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; WEINSTEIN AM, 1995, BIOL PSYCHIAT, V37, P847, DOI 10.1016/0006-3223(94)00249-3; Werner S, 2010, J NEUROSCI, V30, P2662, DOI 10.1523/JNEUROSCI.5091-09.2010; Wildgruber D, 2006, PROG BRAIN RES, V156, P249, DOI 10.1016/S0079-6123(06)56013-3; Williams LM, 2006, NEUROIMAGE, V31, P458, DOI 10.1016/j.neuroimage.2005.12.009; Woods DL, 1995, EEG CL N SU, P102; Wynn JK, 2008, SCHIZOPHRENIA BULL, V34, P679, DOI 10.1093/schbul/sbn047	75	63	64	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31001	10.1371/journal.pone.0031001	http://dx.doi.org/10.1371/journal.pone.0031001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZZ	22383987	gold, Green Submitted, Green Published			2022-12-27	WOS:000302875500009
J	Matsen, FA; Hoffman, NG; Gallagher, A; Stamatakis, A				Matsen, Frederick A.; Hoffman, Noah G.; Gallagher, Aaron; Stamatakis, Alexandros			A Format for Phylogenetic Placements	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; DNA-SEQUENCES; READS	We have developed a unified format for phylogenetic placements, that is, mappings of environmental sequence data (e.g., short reads) into a phylogenetic tree. We are motivated to do so by the growing number of tools for computing and post-processing phylogenetic placements, and the lack of an established standard for storing them. The format is lightweight, versatile, extensible, and is based on the JSON format, which can be parsed by most modern programming languages. Our format is already implemented in several tools for computing and post-processing parsimony- and likelihood-based phylogenetic placements and has worked well in practice. We believe that establishing a standard format for analyzing read placements at this early stage will lead to a more efficient development of powerful and portable post-analysis tools for the growing applications of phylogenetic placement.	[Matsen, Frederick A.; Hoffman, Noah G.; Gallagher, Aaron] Fred Hutchinson Canc Res Ctr, Program Computat Biol, Seattle, WA 98104 USA; [Hoffman, Noah G.] Univ Washington, Seattle, WA USA; [Stamatakis, Alexandros] Heidelberg Inst Theoret Studies, Heidelberg, Germany	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Heidelberg Institute for Theoretical Studies	Matsen, FA (corresponding author), Fred Hutchinson Canc Res Ctr, Program Computat Biol, 1124 Columbia St, Seattle, WA 98104 USA.	matsen@fhcrc.org	Stamatakis, Alexandros/B-8740-2009	Stamatakis, Alexandros/0000-0003-0353-0691	National Institutes of Health [HG005966-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	FAM, NGH, and AG were supported in part by National Institutes of Health grant HG005966-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Berger SA, 2011, BIOINFORMATICS, V27, P2068, DOI 10.1093/bioinformatics/btr320; Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Crockford D., 2006, APPL JSON MEDIA TYPE; Evans S, 2010, ARXIV10051699; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Matsen F, 2011, ARXIV11075095V1; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Mirarab S, 2012, PAC S BIOC PSB 2012; Monier A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r106; Pirrung M, 2011, BIOINFORMATICS, V27, P3067, DOI 10.1093/bioinformatics/btr517; Stark M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-461; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Westesson O, 2011, ARXIV11034347; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151	16	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31009	10.1371/journal.pone.0031009	http://dx.doi.org/10.1371/journal.pone.0031009			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22383988	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500010
J	Montagne, M; Beaudoin, N; Fortin, D; Lavoie, CL; Klinck, R; Lavigne, P				Montagne, Martin; Beaudoin, Nicolas; Fortin, David; Lavoie, Christine L.; Klinck, Roscoe; Lavigne, Pierre			The Max b-HLH-LZ Can Transduce into Cells and Inhibit c-Myc Transcriptional Activities	PLOS ONE			English	Article							DNA-BINDING; PROTEIN; GENE; EXPRESSION; REPRESSION; MIZ-1; COMPLEX; ZIPPER	The inhibition of the functions of c-Myc (endogenous and oncogenic) was recently shown to provide a spectacular therapeutic index in cancer mouse models, with complete tumor regression and minimal side-effects in normal tissues. This was achieved by the systemic and conditional expression of omomyc, the cDNA of a designed mutant of the b-HLH-LZ of c-Myc named Omomyc. The overall mode of action of Omomyc consists in the sequestration of Max and the concomitant competition of the Omomyc/Max complex with the endogenous c-Myc/Max heterodimer. This leads to the inhibition of the transactivation of Myc target genes involved in proliferation and metabolism. While this body of work has provided extraordinary insights to guide the future development of new cancer therapies that target c-Myc, Omomyc itself is not a therapeutic agent. In this context, we sought to exploit the use of a b-HLH-LZ to inhibit c-Myc in a cancer cell line in a more direct fashion. We demonstrate that the b-HLH-LZ domain of Max (Max*) behaves as a bona fide protein transduction domain (PTD) that can efficiently transduce across cellular membrane via through endocytosis and translocate to the nucleus. In addition, we show that the treatment of HeLa cells with Max* leads to a reduction of metabolism and proliferation rate. Accordingly, we observe a decrease of the population of HeLa cells in S phase, an accumulation in G1/G0 and the induction of apoptosis. In agreement with these phenotypic changes, we show by q-RT-PCR that the treatment of HeLa cells with Max* leads to the activation of the transcription c-Myc repressed genes as well as the repression of the expression of c-Myc activated genes. In addition to the novel discovery that the Max b-HLH-LZ is a PTD, our findings open up new avenues and strategies for the direct inhibition of c-Myc with b-HLH-LZ analogs.	[Montagne, Martin; Lavoie, Christine L.; Lavigne, Pierre] Univ Sherbrooke, Fac Med & Sci Sante, Dept Pharmacol, Quebec City, PQ, Canada; [Beaudoin, Nicolas; Fortin, David] Univ Sherbrooke, Fac Med & Sci Sante, Dept Chirurg, Quebec City, PQ, Canada; [Klinck, Roscoe] Univ Sherbrooke, Dept Microbiol & Infectiol, Quebec City, PQ, Canada; [Klinck, Roscoe] Univ Sherbrooke, Lab Genom Fonct, Quebec City, PQ, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Montagne, M (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Pharmacol, Quebec City, PQ, Canada.	Pierre.Lavigne@USherbrooke.ca			Canadian Cancer Society Research Institute [20208]	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was supported by a grant from the Canadian Cancer Society Research Institute (Grant #20208). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Bowen H, 2002, J BIOL CHEM, V277, P34997, DOI 10.1074/jbc.M204232200; Cole MD, 2006, CURR TOP MICROBIOL, V302, P33; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; GU W, 1993, P NATL ACAD SCI USA, V90, P2935, DOI 10.1073/pnas.90.7.2935; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jean-Francois N, 2003, J MOL BIOL, V326, P1577, DOI 10.1016/S0022-2836(03)00029-9; Jiao CY, 2009, J BIOL CHEM, V284, P33957, DOI 10.1074/jbc.M109.056309; KATO GJ, 1992, GENE DEV, V6, P81, DOI 10.1101/gad.6.1.81; Kime L, 2003, BIOCHEM J, V370, P291, DOI 10.1042/BJ20021679; Kleine-Kohlbrecher D, 2006, CURR TOP MICROBIOL, V302, P51; LINDEMAN GJ, 1995, ONCOGENE, V10, P1013; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Noguchi H, 2005, DIABETES, V54, P2859, DOI 10.2337/diabetes.54.10.2859; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Rottmann S, 2006, CURR TOP MICROBIOL, V302, P63; Savino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022284; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Sodir NM, 2011, GENE DEV, V25, P907, DOI 10.1101/gad.2038411; Song BD, 2004, MOL BIOL CELL, V15, P2243, DOI 10.1091/mbc.E04-01-0015; Song BD, 2004, J BIOL CHEM, V279, P40431, DOI 10.1074/jbc.M407007200; Soucek L, 2002, CANCER RES, V62, P3507; Soucek L, 1998, ONCOGENE, V17, P2463, DOI 10.1038/sj.onc.1202199; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Soucek L, 2010, CURR OPIN GENET DEV, V20, P91, DOI 10.1016/j.gde.2009.11.001; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; van den Berg A, 2011, CURR OPIN BIOTECH, V22, P888, DOI 10.1016/j.copbio.2011.03.008; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Yap CS, 2011, CELL CYCLE, V10, P2184, DOI 10.4161/cc.10.13.16249; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A	37	18	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32172	10.1371/journal.pone.0032172	http://dx.doi.org/10.1371/journal.pone.0032172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384171	Green Submitted, Green Published, gold			2022-12-27	WOS:000302875500082
J	Harrell, L; Wang, YW; Antonopoulos, D; Young, V; Lichtenstein, L; Huang, Y; Hanauer, S; Chang, E				Harrell, Laura; Wang, Yunwei; Antonopoulos, Dionysios; Young, Vincent; Lichtenstein, Lev; Huang, Yong; Hanauer, Stephen; Chang, Eugene			Standard Colonic Lavage Alters the Natural State of Mucosal-Associated Microbiota in the Human Colon	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; FECAL MICROBIOTA; DIVERSITY; COMMUNITIES; DISEASE	Background & Aims: Past studies of the human intestinal microbiota are potentially confounded by the common practice of using bowel-cleansing preparations. We examined if colonic lavage changes the natural state of enteric mucosal-adherent microbes in healthy human subjects. Methods: Twelve healthy individuals were divided into three groups; experimental group, control group one, and control group two. Subjects in the experimental group underwent an un-prepped flexible sigmoidoscopy with biopsies. Within two weeks, subjects were given a standard polyethylene glycol-based bowel cleansing preparation followed by a second flexible sigmoidoscopy. Subjects in control group one underwent two un-prepped flexible sigmoidoscopies within one week. Subjects in the second control group underwent an un-prepped flexible sigmoidoscopy followed by a second flexible sigmoidoscopy after a 24-hour clear liquid diet within one week. The mucosa-associated microbial communities from the two procedures in each subject were compared using 16S rRNA gene based terminal restriction fragment length polymorphism (T-RFLP), and library cloning and sequencing. Results: Clone library sequencing analysis showed that there were changes in the composition of the mucosa-associated microbiota in subjects after colonic lavage. These changes were not observed in our control groups. Standard bowel preparation altered the diversity of mucosa-associated microbiota. Taxonomic classification did not reveal significant changes at the phylum level, but there were differences observed at the genus level. Conclusion: Standard bowel cleansing preparation altered the mucosal-adherent microbiota in all of our subjects, although the degree of change was variable. These findings underscore the importance of considering the confounding effects of bowel preparation when designing experiments exploring the gut microbiota.	[Harrell, Laura; Wang, Yunwei; Antonopoulos, Dionysios; Huang, Yong; Hanauer, Stephen; Chang, Eugene] Univ Chicago, Dept Med, Gastroenterol Sect, Med Ctr, Chicago, IL 60637 USA; [Young, Vincent] Univ Michigan, Dept Med, Div Infect Dis, Ann Arbor, MI 48109 USA; [Lichtenstein, Lev] Rabin Med Ctr, Gastroenterol Inst, Petah Tiqwa, Israel	University of Chicago; University of Chicago Medical Center; University of Michigan System; University of Michigan; Rabin Medical Center	Harrell, L (corresponding author), Univ Chicago, Dept Med, Gastroenterol Sect, Med Ctr, Chicago, IL 60637 USA.	echang@medicine.bsd.uchicago.edu	Young, Vincent B/B-3179-2009; Lichtenstein, Lev/AFP-2119-2022; Antonopoulos, Dionysios/ABE-6212-2020	Young, Vincent B/0000-0003-3687-2364; Antonopoulos, Dionysios/0000-0002-2238-5031	Gastrointestinal Research Foundation, Chicago, IL, USA; Digestive Diseases Research Core Center [DK-42086]; Crohn's and Colitis Foundation of America; Human Microbiome Project [DK083993, HG004858, R37 DK47722]; Sinai-Helmsley Alliance for Research Excellence; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH3DK083993, P30DK042086, R37DK047722, UH2DK083993] Funding Source: NIH RePORTER	Gastrointestinal Research Foundation, Chicago, IL, USA; Digestive Diseases Research Core Center; Crohn's and Colitis Foundation of America; Human Microbiome Project; Sinai-Helmsley Alliance for Research Excellence; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Gastrointestinal Research Foundation, Chicago, IL, USA, and grants from Digestive Diseases Research Core Center (DK-42086), Research Fellowship Award (YW) from the Crohn's and Colitis Foundation of America, Human Microbiome Project (DK083993, HG004858), R37 DK47722 (EBC) and Sinai-Helmsley Alliance for Research Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Hu SE, 2010, AM J PHYSIOL-GASTR L, V299, pG1266, DOI 10.1152/ajpgi.00357.2010; Komanduri S, 2007, CLIN GASTROENTEROL H, V5, P352, DOI 10.1016/j.cgh.2007.01.001; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mai V, 2006, GUT, V55, P1822, DOI 10.1136/gut.2006.108266; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Rajilic-Stojanovic M, 2007, ENVIRON MICROBIOL, V9, P2125, DOI 10.1111/j.1462-2920.2007.01369.x; Wang YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013607; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Young VB, 2004, J CLIN MICROBIOL, V42, P1203, DOI 10.1128/JCM.42.3.1203-1206.2004; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	18	101	103	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32545	10.1371/journal.pone.0032545	http://dx.doi.org/10.1371/journal.pone.0032545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389708	Green Published, gold, Green Submitted			2022-12-27	WOS:000302999600047
J	Shohat, M; Ben-Meir, D; Lavi, S				Shohat, Meytal; Ben-Meir, Daniella; Lavi, Sara			Protein Phosphatase Magnesium Dependent 1A (PPM1A) Plays a Role in the Differentiation and Survival Processes of Nerve Cells	PLOS ONE			English	Article							AKT/PROTEIN KINASE-B; PC12 CELLS; NEURONAL DIFFERENTIATION; CYCLE PROGRESSION; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; MAMMALIAN-CELLS; GROWTH ARREST; 2C; APOPTOSIS	The serine/threonine phosphatase type 2C (PPM1A) has a broad range of substrates, and its role in regulating stress response is well established. We have investigated the involvement of PPM1A in the survival and differentiation processes of PC6-3 cells, a subclone of the PC12 cell line. This cell line can differentiate into neuron like cells upon exposure to nerve growth factor (NGF). Overexpression of PPM1A in naive PC6-3 cells caused cell cycle arrest at the G2/M phase followed by apoptosis. Interestingly, PPM1A overexpression did not affect fully differentiated cells. Using PPM1A overexpressing cells and PPM1A knockdown cells, we show that this phosphatase affects NGF signaling in PC6-3 cells and is engaged in neurite outgrowth. In addition, the ablation of PPM1A interferes with NGF-induced growth arrest during differentiation of PC6-3 cells.	[Shohat, Meytal; Ben-Meir, Daniella; Lavi, Sara] Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Shohat, M (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	saralav@tauex.tau.ac.il			David Kane Foundation; Ela Kodesz Institute for Research on Cancer Development and Prevention; Ministry of Science and Technology, Israel; DKFZ (Deutsches Krebsforschungs Zentrum); Ministry of Health; Israel Cancer Association	David Kane Foundation; Ela Kodesz Institute for Research on Cancer Development and Prevention; Ministry of Science and Technology, Israel(Ministry of Science, Technology and Space (MOST), Israel); DKFZ (Deutsches Krebsforschungs Zentrum); Ministry of Health; Israel Cancer Association	This work was supported by research grants from the David Kane Foundation, the Ela Kodesz Institute for Research on Cancer Development and Prevention, the Ministry of Science and Technology, Israel and the DKFZ (Deutsches Krebsforschungs Zentrum), the Ministry of Health and Israel Cancer Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 1992, MOL BRAIN RES, V13, P283, DOI 10.1016/0169-328X(92)90211-S; Bang OS, 2001, J CELL SCI, V114, P81; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; BARTON GJ, 1994, EUR J BIOCHEM, V220, P225, DOI 10.1111/j.1432-1033.1994.tb18618.x; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cheng AY, 2000, J BIOL CHEM, V275, P34744, DOI 10.1074/jbc.M006210200; Cheng AY, 1999, GENE DEV, V13, P2946, DOI 10.1101/gad.13.22.2946; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Eaton MJ, 2004, MOL CELL ENDOCRINOL, V228, P39, DOI 10.1016/j.mce.2003.02.001; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Guthridge MA, 1997, MOL CELL BIOL, V17, P5485, DOI 10.1128/MCB.17.9.5485; Hanada M, 2001, J BIOL CHEM, V276, P5753, DOI 10.1074/jbc.M007773200; Hanada M, 1998, FEBS LETT, V437, P172, DOI 10.1016/S0014-5793(98)01229-0; Katayama K, 2005, MOL CELL BIOL, V25, P5725, DOI 10.1128/MCB.25.13.5725-5737.2005; Klesse LJ, 1999, MICROSC RES TECHNIQ, V45, P210, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<210::AID-JEMT4>3.3.CO;2-6; Klumpp S, 2006, BIOCHEM SOC T, V34, P1370, DOI 10.1042/BST0341370; Klumpp S, 2002, NEUROCHEM INT, V41, P251, DOI 10.1016/S0197-0186(02)00020-7; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Lammers T, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-65; Lee SR, 2005, J CELL PHYSIOL, V205, P270, DOI 10.1002/jcp.20395; Li MG, 2003, J BIOL CHEM, V278, P12013, DOI 10.1074/jbc.M211474200; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Lifschitz-Mercer B, 2001, HISTOCHEM CELL BIOL, V116, P31; Luo HR, 2003, P NATL ACAD SCI USA, V100, P11712, DOI 10.1073/pnas.1634990100; Marino S, 2002, DEVELOPMENT, V129, P3513; Martin D, 2002, J BIOL CHEM, V277, P42943, DOI 10.1074/jbc.M201070200; MCGOWAN CH, 1988, METHOD ENZYMOL, V159, P416; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; Musatov S, 2004, P NATL ACAD SCI USA, V101, P3627, DOI 10.1073/pnas.0308289101; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; Ofek P, 2003, METHOD ENZYMOL, V366, P338; Ofek P, 2003, J BIOL CHEM, V278, P14299, DOI 10.1074/jbc.M211699200; Price NE, 1999, CURR OPIN NEUROBIOL, V9, P336, DOI 10.1016/S0959-4388(99)80049-X; Schwarz S, 2006, APOPTOSIS, V11, P1111, DOI 10.1007/s10495-006-6982-1; Seroussi E, 2001, J MOL BIOL, V312, P439, DOI 10.1006/jmbi.2001.4967; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Stern A, 2007, J MOL EVOL, V64, P61, DOI 10.1007/s00239-006-0033-y; Strack S, 2002, J BIOL CHEM, V277, P41525, DOI 10.1074/jbc.M203767200; Szeberenyi J., 1996, Neurobiology (Budapest), V4, P1; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Tong Y, 1998, J BIOL CHEM, V273, P35282, DOI 10.1074/jbc.273.52.35282; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Xiao JN, 2003, J NEUROCHEM, V86, P1516, DOI 10.1046/j.1471-4159.2003.01961.x; Yoshizaki T, 2004, J BIOL CHEM, V279, P22715, DOI 10.1074/jbc.M313745200	46	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32438	10.1371/journal.pone.0032438	http://dx.doi.org/10.1371/journal.pone.0032438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384250	Green Published, gold, Green Submitted			2022-12-27	WOS:000302918500089
J	Cao, H; Chu, YK; Lv, X; Qiu, PB; Liu, C; Zhang, HR; Li, D; Peng, S; Dou, ZY; Hua, JL				Cao, Hui; Chu, Yuankui; Lv, Xiao; Qiu, Pubin; Liu, Chao; Zhang, Huiru; Li, Dan; Peng, Sha; Dou, Zhongying; Hua, Jinlian			GSK3 Inhibitor-BIO Regulates Proliferation of Immortalized Pancreatic Mesenchymal Stem Cells (iPMSCs)	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; BETA-CELLS; C-MYC; PHOSPHORYLATION; LITHIUM; PROTEIN; MAINTENANCE; GENERATION; SURVIVAL; INSULIN	Background: The small molecule 6-bromoindirubin-30-oxime (BIO), a glycogen synthase kinase 3 (GSK3) inhibitor, is a pharmacological agent known to maintain self-renewal in human and mouse embryonic stem cells (ESCs). However, the precise role of GSK3 in immortalized pancreatic mesenchymal stem cells (iPMSCs) growth and survival is not completely understood at present. Results: To determine whether this molecule is involved in controlling the proliferation of iPMSCs, we examined the effect of BIO on iPMSCs. We found that the inactivation of GSK3 by BIO can robustly stimulate iPMSCs proliferation and mass formation as shown by QRT-PCR, western blotting, 5-Bromo-2-deoxyuridine (BrdU) immunostaining assay and tunel assay. However, we did not find the related roles of BIO on beta cell differentiation by immunostaining, QRT-PCR assay, glucose-stimulated insulin release and C-peptide content analysis. Conclusions: These results suggest that BIO plays a key role in the regulation of cell mass proliferation and maintenance of the undifferentiated state of iPMSCs.	[Cao, Hui; Chu, Yuankui; Lv, Xiao; Qiu, Pubin; Liu, Chao; Peng, Sha; Dou, Zhongying; Hua, Jinlian] NW A&F Univ, Coll Vet Med, Shaanxi Ctr Stem Cells Engn & Technol, Key Lab Anim Biotechnol,Agr Minist China, Yangling, Shaanxi, Peoples R China; [Cao, Hui] Hope Biotechnol Su Zhou Co Ltd, Suzhou, Jiangsu, Peoples R China; [Zhang, Huiru; Li, Dan] Henan Univ Technol, Coll Bioengn, Zhengzhou 450000, Henan, Peoples R China	Northwest A&F University - China; Henan University of Technology	Cao, H (corresponding author), NW A&F Univ, Coll Vet Med, Shaanxi Ctr Stem Cells Engn & Technol, Key Lab Anim Biotechnol,Agr Minist China, Yangling, Shaanxi, Peoples R China.	jinlianhua@nwsuaf.edu.cn		zhang, hui ru/0000-0002-9030-1514	National Natural Science Foundation of China [30972097]; State Education Ministry [109148]; Program for New Century Excellent Talents in University [NCET-09-0654]; Scientific Research Program of Shaanxi Province [2008K02-05]; Fund for the Doctoral Program of Higher Education (SRFDP) [20100204120020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Education Ministry; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Scientific Research Program of Shaanxi Province; Fund for the Doctoral Program of Higher Education (SRFDP)	This work is supported by grants from National Natural Science Foundation of China (Program 30972097), Key Program of State Education Ministry (109148), Program for New Century Excellent Talents in University (NCET-09-0654), the Scientific Research Program of Shaanxi Province (2008K02-05), and Fund for the Doctoral Program of Higher Education (SRFDP, 20100204120020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton S, 2007, CELL SIGNAL, V19, P378, DOI 10.1016/j.cellsig.2006.07.008; Boucher MJ, 2006, J BIOL CHEM, V281, P6395, DOI 10.1074/jbc.M511597200; Cao H, 2011, CELL PROLIFERAT, V44, P19, DOI 10.1111/j.1365-2184.2010.00714.x; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; DENIS N, 1991, ONCOGENE, V6, P1453; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093; Elliott R B, 2008, United States Patent Application, Patent No. 20080070301; Feng RuoPeng, 2007, Agricultural Sciences in China, V6, P742, DOI 10.1016/S1671-2927(07)60107-2; Golestaneh N, 2009, STEM CELLS DEV, V18, P1115, DOI 10.1089/scd.2008.0347; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Guo TX, 2009, ENDOCR REV, V30, P214, DOI 10.1210/er.2009-0004; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Klein PS, 1996, PNAS, V3, P8455; List JF, 2004, AM J PHYSIOL-ENDOC M, V286, pE875, DOI 10.1152/ajpendo.00007.2004; Maher MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010184; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Mussmann R, 2007, J BIOL CHEM, V282, P12030, DOI 10.1074/jbc.M609637200; Rocques N, 2007, MOL CELL, V28, P584, DOI 10.1016/j.molcel.2007.11.009; Rogers SA, 2007, XENOTRANSPLANTATION, V14, P591, DOI 10.1111/j.1399-3089.2007.00429.x; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Schmidt MM, 2001, INT J DEV BIOL, V45, P421; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Silva AK, 2010, MOL VIS, V16, P36; Sineva GS, 2010, BIOL CELL, V102, P549, DOI 10.1042/BC20100016; Suzuki S, 2004, DIABETES, V53, pA214, DOI 10.2337/diabetes.53.8.2143; Wang Q, 2011, CELL RES, V21, P1424, DOI 10.1038/cr.2011.108; Wang WD, 2009, P NATL ACAD SCI USA, V106, P1427, DOI 10.1073/pnas.0811848106; Wen J, 2010, REPRODUCTION, V139, P1039, DOI 10.1530/REP-09-0539; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wrobel KH, 1996, CELL TISSUE RES, V283, P191, DOI 10.1007/s004410050529; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042	36	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31502	10.1371/journal.pone.0031502	http://dx.doi.org/10.1371/journal.pone.0031502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384031	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100024
J	Kumar, R; Tran, LSP; Neelakandan, AK; Nguyen, HT				Kumar, Rajesh; Lam-Son Phan Tran; Neelakandan, Anjanasree K.; Nguyen, Henry T.			Higher Plant Cytochrome b5 Polypeptides Modulate Fatty Acid Desaturation	PLOS ONE			English	Article							OLEATE DESATURASE; LINOLENIC ACID; HETEROLOGOUS EXPRESSION; MICROSOMAL PREPARATIONS; DIFFERENT ISOFORMS; DEVELOPING SEEDS; B(5) REDUCTASE; BIOSYNTHESIS; GENES; IDENTIFICATION	Background: Synthesis of polyunsaturated fatty acids (PUFAs) in the endoplasmic reticulum of plants typically involves the fatty acid desaturases FAD2 and FAD3, which use cytochrome b(5) (Cb5) as an electron donor. Higher plants are reported to have multiple isoforms of Cb5, in contrast to a single Cb5 in mammals and yeast. Despite the wealth of information available on the roles of FAD2 and FAD3 in PUFA synthesis, information regarding the contributions of various Cb5 isoforms in desaturase-mediated reactions is limited. Results: The present functional characterization of Cb5 polypeptides revealed that all Arabidopsis Cb5 isoforms are not similarly efficient in omega-6 desaturation, as evidenced by significant variation in their product outcomes in yeast-based functional assays. On the other hand, characterization of Cb5 polypeptides of soybean (Glycine max) suggested that similar omega-6 desaturation efficiencies were shared by various isoforms. With regard to omega-3 desaturation, certain Cb5 genes of both Arabidopsis and soybean were shown to facilitate the accumulation of more desaturation products than others when co-expressed with their native FAD3. Additionally, similar trends of differential desaturation product accumulation were also observed with most Cb5 genes of both soybean and Arabidopsis even if co-expressed with non-native FAD3. Conclusions: The present study reports the first description of the differential nature of the Cb5 genes of higher plants in fatty acid desaturation and further suggests that omega-3/omega-6 desaturation product outcome is determined by the nature of both the Cb5 isoform and the fatty acid desaturases.	Univ Missouri, Div Plant Sci, Columbia, MO USA; Univ Missouri, Natl Ctr Soybean Biotechnol, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Kumar, R (corresponding author), NBPGR, Natl Res Ctr DNA Fingerprinting, New Delhi, India.	kraj.pgr@gmail.com; nguyenhenry@missouri.edu	Tran, Lam-Son P/A-1346-2009	Tran, Lam-Son P/0000-0001-9883-9768	Missouri Soybean Merchandising Council (MSMC)	Missouri Soybean Merchandising Council (MSMC)	This work was supported by a grant from Missouri Soybean Merchandising Council (MSMC) to the soybean genomics research program at the University of Missouri-Columbia. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILAR F, 1991, PLANT MOL BIOL, V17, P351, DOI 10.1007/BF00040630; Altuve A, 2004, BIOCHEM BIOPH RES CO, V314, P602, DOI 10.1016/j.bbrc.2003.12.138; Anai T, 2005, PLANT SCI, V168, P1615, DOI 10.1016/j.plantsci.2005.02.016; Bilyeu KD, 2003, CROP SCI, V43, P1833, DOI 10.2135/cropsci2003.1833; Broadwater JA, 2002, J BIOL CHEM, V277, P15613, DOI 10.1074/jbc.M200231200; Broun P, 1998, SCIENCE, V282, P1315, DOI 10.1126/science.282.5392.1315; BROWSE J, 1991, ANNU REV PLANT PHYS, V42, P467, DOI 10.1146/annurev.pp.42.060191.002343; Cahoon EB, 2001, J BIOL CHEM, V276, P2637, DOI 10.1074/jbc.M009188200; Covello PS, 1996, PLANT PHYSIOL, V111, P223, DOI 10.1104/pp.111.1.223; Damude HG, 2006, P NATL ACAD SCI USA, V103, P9446, DOI 10.1073/pnas.0511079103; de Vetten N, 1999, P NATL ACAD SCI USA, V96, P778, DOI 10.1073/pnas.96.2.778; Dyer JM, 2002, PLANT PHYSIOL, V130, P2027, DOI 10.1104/pp.102.010835; Dyer JM, 2001, BIOCHEM BIOPH RES CO, V282, P1019, DOI 10.1006/bbrc.2001.4667; Dyer JM, 2008, PHYSIOL PLANTARUM, V132, P11, DOI 10.1111/j.1399-3054.2007.01021.x; Fan RC, 2009, PLANT PHYSIOL, V150, P1880, DOI 10.1104/pp.109.141374; Fukuchi-Mizutani M, 1999, PLANT PHYSIOL, V119, P353, DOI 10.1104/pp.119.1.353; Hwang YT, 2004, PLANT CELL, V16, P3002, DOI 10.1105/tpc.104.026039; Kajiwara S, 1996, APPL ENVIRON MICROB, V62, P4309, DOI 10.1128/AEM.62.12.4309-4313.1996; Kumar R, 2006, PLANT J, V48, P920, DOI 10.1111/j.1365-313X.2006.02925.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee M, 1998, SCIENCE, V280, P915, DOI 10.1126/science.280.5365.915; LU GG, 1995, J MOL BIOL, V248, P931, DOI 10.1006/jmbi.1995.0273; Maggio C, 2007, J EXP BOT, V58, P1365, DOI 10.1093/jxb/erl303; MIQUEL M, 1992, J BIOL CHEM, V267, P1502; MITCHELL AG, 1995, J BIOL CHEM, V270, P29766; NAGANO M, 2009, PLANT J; Nam JW, 2007, J EXP BOT, V58, P1421, DOI 10.1093/jxb/erm005; Napier JA, 2003, PROSTAG LEUKOTR ESS, V68, P135, DOI 10.1016/S0952-3278(02)00263-6; NAPIER JA, 1995, PLANTA, V197, P200, DOI 10.1007/BF00239957; Napier JA, 1997, BIOCHEM J, V328, P717; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Pedrazzini E, 2009, J PLANT BIOL, V52, P88, DOI 10.1007/s12374-009-9014-1; Petrini GA, 2004, EUR J BIOCHEM, V271, P1079, DOI 10.1111/j.1432-1033.2004.04005.x; Rahier A, 1997, BIOCHEM BIOPH RES CO, V236, P434, DOI 10.1006/bbrc.1997.6974; Reed DW, 2000, PLANT PHYSIOL, V122, P715, DOI 10.1104/pp.122.3.715; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Sayanova O, 1997, P NATL ACAD SCI USA, V94, P4211, DOI 10.1073/pnas.94.8.4211; Shockey JM, 2005, PLANT SCI, V169, P375, DOI 10.1016/j.plantsci.2005.03.023; Shoemaker R, 2002, GENOME, V45, P329, DOI 10.1139/g01-150; Shoemaker RC, 2006, CURR OPIN PLANT BIOL, V9, P104, DOI 10.1016/j.pbi.2006.01.007; SMITH MA, 1994, PLANT MOL BIOL, V25, P527, DOI 10.1007/BF00043880; Smith MA, 2003, PLANTA, V217, P507, DOI 10.1007/s00425-003-1015-6; SMITH MA, 1990, BIOCHEM J, V272, P23, DOI 10.1042/bj2720023; SMITH MA, 1992, BIOCHEM J, V287, P141, DOI 10.1042/bj2870141; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang GQ, 2005, PLANT J, V44, P433, DOI 10.1111/j.1365-313X.2005.02535.x; Vrinten P, 2005, PLANT PHYSIOL, V139, P79, DOI 10.1104/pp.105.064451	47	26	27	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31370	10.1371/journal.pone.0031370	http://dx.doi.org/10.1371/journal.pone.0031370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384013	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916100019
J	Borkosky, SS; Whitley, C; Kopp-Schneider, A; zur Hausen, H; de Villiers, EM				Borkosky, Silvia S.; Whitley, Corinna; Kopp-Schneider, Annette; zur Hausen, Harald; de Villiers, Ethel-Michele			Epstein-Barr Virus Stimulates Torque Teno Virus Replication: A Possible Relationship to Multiple Sclerosis	PLOS ONE			English	Article							HERPES-SIMPLEX VIRUS; VARICELLA-ZOSTER-VIRUS; TT-VIRUS; MOLECULAR MIMICRY; CEREBROSPINAL-FLUID; CELL-LINE; JC VIRUS; INTRAGENOMIC REARRANGEMENT; ENDOGENOUS RETROVIRUS; HUMAN HERPESVIRUS-6	Viral infections have been implicated in the pathogenesis of multiple sclerosis. Epstein-Barr virus (EBV) has frequently been investigated as a possible candidate and torque teno virus (TTV) has also been discussed in this context. Nevertheless, mechanistic aspects remain unresolved. We report viral replication, as measured by genome amplification, as well as quantitative PCR of two TTV-HD14 isolates isolated from multiple sclerosis brain in a series of EBV-positive and -negative lymphoblastoid and Burkitt's lymphoma cell lines. Our results demonstrate the replication of both transfected TTV genomes up to day 21 post transfection in all the evaluated cell lines. Quantitative amplification indicates statistically significant enhanced TTV replication in the EBV-positive cell lines, including the EBV-converted BJAB line, in comparison to the EBV-negative Burkitt's lymphoma cell line BJAB. This suggests a helper effect of EBV infections in the replication of TTV. The present study provides information on a possible interaction of EBV and TTV in the etiology and progression of multiple sclerosis.	[Borkosky, Silvia S.; Whitley, Corinna; zur Hausen, Harald; de Villiers, Ethel-Michele] Deutsch Krebsforschungszentrum DKFZ, Div Characterizat Tumorviruses, Heidelberg, Germany; [Kopp-Schneider, Annette] Deutsch Krebsforschungszentrum, Div Biostat, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Borkosky, SS (corresponding author), Deutsch Krebsforschungszentrum DKFZ, Div Characterizat Tumorviruses, Heidelberg, Germany.	e.devilliers@dkfz.de		Kopp-Schneider, Annette/0000-0002-1810-0267	Oryx, Munchen	Oryx, Munchen	Partial funding by Oryx, Munchen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alvarez-Lafuente R, 2007, MULT SCLER J, V13, P590, DOI 10.1177/1352458506073116; Ascherio A, 2008, SEMIN NEUROL, V28, P17, DOI 10.1055/s-2007-1019126; Ascherio A, 2010, J NEUROIMMUNE PHARM, V5, P271, DOI 10.1007/s11481-010-9201-3; Banwell B, 2007, LANCET NEUROL, V6, P773, DOI 10.1016/S1474-4422(07)70196-5; Banwell B, 2011, LANCET NEUROL, V10, P436, DOI 10.1016/S1474-4422(11)70045-X; Bernasconi M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-43; Biagini P, 2010, VIROLOGIE, V14, P3, DOI 10.1684/vir.2010.0279; Blazsek A, 2008, EXP DERMATOL, V17, P446, DOI 10.1111/j.1600-0625.2007.00663.x; Bornkamm GW, 2001, PHILOS T R SOC B, V356, P437, DOI 10.1098/rstb.2000.0781; Brudek T, 2007, J NEUROIMMUNOL, V187, P147, DOI 10.1016/j.jneuroim.2007.04.003; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Canaan A, 2009, P NATL ACAD SCI USA, V106, P22421, DOI 10.1073/pnas.0911676106; Cassiani-Ingoni R, 2005, GLIA, V52, P252, DOI 10.1002/glia.20219; Castellazzi M, 2010, MULT SCLER J, V16, P883, DOI 10.1177/1352458510368051; CHALLONER PB, 1995, P NATL ACAD SCI USA, V92, P7440, DOI 10.1073/pnas.92.16.7440; Chitnis T, 2011, NEUROL CLIN, V29, P481, DOI 10.1016/j.ncl.2011.01.004; Christensen T, 2005, REV MED VIROL, V15, P179, DOI 10.1002/rmv.465; Clark Duncan, 2004, Herpes, V11 Suppl 2, p112A; Comabella M, 2010, MULT SCLER, V16, P355, DOI 10.1177/1352458509357066; Croxford JL, 2005, J VIROL, V79, P8581, DOI 10.1128/JVI.79.13.8581-8590.2005; d'Herouel AF, 2010, VIROLOGY, V405, P524, DOI 10.1016/j.virol.2010.06.040; de Villiers EM, 2009, CURR TOP MICROBIOL, V331, P91; de Villiers EM, 2007, INT J CANCER, V121, P2109, DOI 10.1002/ijc.22931; de Villiers EM, 2011, J VIROL, V85, P7284, DOI 10.1128/JVI.02472-10; Delbue S, 2007, J NEUROVIROL, V13, P73, DOI 10.1080/13550280601094563; Feederle R, 2009, J VIROL, V83, P4952, DOI 10.1128/JVI.00170-09; Figueiredo CP, 2007, LEUKEMIA LYMPHOMA, V48, P731, DOI 10.1080/10428190701203954; FRESEN KO, 1976, INT J CANCER, V17, P161, DOI 10.1002/ijc.2910170203; FRESEN KO, 1978, INT J CANCER, V22, P378, DOI 10.1002/ijc.2910220403; Garbuglia AR, 2003, INT J IMMUNOPATH PH, V16, P109, DOI 10.1177/039463200301600204; GEORGFRIES B, 1984, VIROLOGY, V134, P64, DOI 10.1016/0042-6822(84)90272-1; Gergely P, 2006, AUTOIMMUN REV, V6, P5, DOI 10.1016/j.autrev.2006.03.002; Germi R, 2004, CLIN CHEM, V50, P1814, DOI 10.1373/clinchem.2004.034363; Granieri E, 2001, NEUROL SCI, V22, P179, DOI 10.1007/s100720170021; Handel AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012496; HEILBRONN R, 1989, J VIROL, V63, P3683, DOI 10.1128/JVI.63.9.3683-3692.1989; HEILBRONN R, 1993, P NATL ACAD SCI USA, V90, P11406, DOI 10.1073/pnas.90.23.11406; Hinuma Y, 1967, J Virol, V1, P1045; Hosking MP, 2010, CRIT REV IMMUNOL, V30, P119, DOI 10.1615/CritRevImmunol.v30.i2.20; Jelcic I, 2004, J VIROL, V78, P7498, DOI 10.1128/JVI.78.14.7498-7507.2004; Kakalacheva K, 2011, BBA-MOL BASIS DIS, V1812, P132, DOI 10.1016/j.bbadis.2010.06.012; Kakkola L, 2007, FEBS J, V274, P4719, DOI 10.1111/j.1742-4658.2007.06020.x; Kanda Y, 1999, BLOOD, V93, P2485, DOI 10.1182/blood.V93.8.2485.408k06_2485_2490; KLEIN G, 1975, INTERVIROLOGY, V5, P319, DOI 10.1159/000149930; Kuppers R, 2003, NAT REV IMMUNOL, V3, P801, DOI 10.1038/nri1201; Kuusisto H, 2008, MULT SCLER J, V14, P54, DOI 10.1177/1352458507080063; LAUER K, 1994, J CLIN EPIDEMIOL, V47, P43, DOI 10.1016/0895-4356(94)90032-9; LEINBACH SS, 1979, J VIROL, V30, P248, DOI 10.1128/JVI.30.1.248-254.1979; Leppik L, 2007, J VIROL, V81, P9346, DOI 10.1128/JVI.00781-07; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; Levin LI, 2010, ANN NEUROL, V67, P824, DOI 10.1002/ana.21978; Libbey JE, 2007, INT REV NEUROBIOL, V79, P127, DOI 10.1016/S0074-7742(07)79006-2; Libbey JE, 2010, RESULTS PROBL CELL D, V51, P21, DOI 10.1007/400_2008_12; Lunemann JD, 2008, NEUROLOGY, V71, P1033, DOI 10.1212/01.wnl.0000326576.91097.87; Lunemann JD, 2008, J EXP MED, V205, P1763, DOI 10.1084/jem.20072397; Lunemann JD, 2010, ANN NEUROL, V67, P159, DOI 10.1002/ana.21886; Lunemann JD, 2009, TRENDS IMMUNOL, V30, P243, DOI 10.1016/j.it.2009.03.007; Lunemann JD, 2006, BRAIN, V129, P1493, DOI 10.1093/brain/awl067; Maggi F, 2007, RHEUMATOLOGY, V46, P885, DOI 10.1093/rheumatology/kem032; Maggi F, 2001, J MED VIROL, V64, P190, DOI 10.1002/jmv.1035; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Mameli G, 2007, J GEN VIROL, V88, P264, DOI 10.1099/vir.0.81890-0; Mancuso R, 2007, J MED VIROL, V79, P192, DOI 10.1002/jmv.20777; McLaughlin KA, 2009, J IMMUNOL, V183, P4067, DOI 10.4049/jimmunol.0801888; Mechelli R, 2011, MULT SCLER J, V17, P1290, DOI 10.1177/1352458511410515; MENEZES J, 1975, BIOMEDICINE, V22, P276; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; Munz C, 2000, J EXP MED, V191, P1649, DOI 10.1084/jem.191.10.1649; Ninomiya M, 2008, J CLIN MICROBIOL, V46, P507, DOI 10.1128/JCM.01703-07; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; Okamoto H, 2000, J VIROL, V74, P10236, DOI 10.1128/JVI.74.21.10236-10239.2000; Okamoto H, 2000, BIOCHEM BIOPH RES CO, V270, P657, DOI 10.1006/bbrc.2000.2481; Okamoto H, 2009, CURR TOP MICROBIOL, V331, P1, DOI 10.1007/978-3-540-70972-5_1; Okamoto H, 1999, J MED VIROL, V57, P252, DOI 10.1002/(SICI)1096-9071(199903)57:3&lt;252::AID-JMV7&gt;3.0.CO;2-Q; Oleszak EL, 2004, CLIN MICROBIOL REV, V17, P174, DOI 10.1128/CMR.17.1.174-207.2004; Peferoen LAN, 2010, BRAIN, V133, DOI 10.1093/brain/awp296; Peng YH, 2002, ARCH VIROL, V147, P21, DOI 10.1007/s705-002-8301-7; Pohl D, 2006, NEUROLOGY, V67, P2063, DOI 10.1212/01.wnl.0000247665.94088.8d; Ponsonby AL, 2005, LANCET NEUROL, V4, P793, DOI 10.1016/S1474-4422(05)70233-7; Sargsyan SA, 2010, NEUROLOGY, V74, P1127, DOI 10.1212/WNL.0b013e3181d865a1; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; SCHLEHOFER JR, 1986, VIROLOGY, V152, P110, DOI 10.1016/0042-6822(86)90376-4; SCHLEHOFER JR, 1983, INT J CANCER, V32, P99, DOI 10.1002/ijc.2910320116; Sips GJ, 2007, REV MED VIROL, V17, P223, DOI 10.1002/rmv.526; Soldan SS, 1997, NAT MED, V3, P1394, DOI 10.1038/nm1297-1394; Sospedra M, 2006, AUTOIMMUNITY, V39, P3, DOI 10.1080/08916930500484922; Sospedra Mireia, 2005, PLoS Pathog, V1, pe41; Sotelo J, 2007, J NEUROL, V254, P493, DOI 10.1007/s00415-006-0402-x; Sugawara Y, 1999, EMBO J, V18, P5755, DOI 10.1093/emboj/18.20.5755; Tejada-Simon MV, 2003, ANN NEUROL, V53, P189, DOI 10.1002/ana.10425; Thacker EL, 2006, ANN NEUROL, V59, P499, DOI 10.1002/ana.20820; Thomas T, 2008, SEMIN NEUROL, V28, P69, DOI 10.1055/s-2007-1019129; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; Torkildsen O, 2008, EUR J NEUROL, V15, P106, DOI 10.1111/j.1468-1331.2007.02009.x; von Herrath MG, 2003, NAT REV MICROBIOL, V1, P151, DOI 10.1038/nrmicro754; Waubant E, 2011, NEUROLOGY, V76, P1989, DOI 10.1212/WNL.0b013e31821e552a; Weller B, 2008, VIROLOGY, V381, P36, DOI 10.1016/j.virol.2008.08.017; Willis SN, 2009, BRAIN, V132, P3318, DOI 10.1093/brain/awp200; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; zur Hausen H, 1987, ACCOMPLISHMENTS ONCO, P126; zur Hausen H, 2009, INT J CANCER, V125, P1764, DOI 10.1002/ijc.24365	101	28	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32160	10.1371/journal.pone.0032160	http://dx.doi.org/10.1371/journal.pone.0032160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384166	gold, Green Published, Green Submitted			2022-12-27	WOS:000302875500079
J	de Souza, TA; Soprano, AS; de Lira, NPV; Quaresma, AJC; Pauletti, BA; Leme, AFP; Benedetti, CE				de Souza, Tiago Antonio; Soprano, Adriana Santos; Vieira de Lira, Nayara Patricia; Christino Quaresma, Alexandre Jose; Pauletti, Bianca Alves; Paes Leme, Adriana Franco; Benedetti, Celso Eduardo			The TAL Effector PthA4 Interacts with Nuclear Factors Involved in RNA-Dependent Processes Including a HMG Protein That Selectively Binds Poly(U) RNA	PLOS ONE			English	Article							MESSENGER-RNA; XANTHOMONAS-CITRI; TRANSCRIPTION FACTOR; DNA-BINDING; PATHOGENICITY GENE; RECOGNITION; COMPLEX; MECHANISM; SPECIFICITY; AVIRULENCE	Plant pathogenic bacteria utilize an array of effector proteins to cause disease. Among them, transcriptional activator-like (TAL) effectors are unusual in the sense that they modulate transcription in the host. Although target genes and DNA specificity of TAL effectors have been elucidated, how TAL proteins control host transcription is poorly understood. Previously, we showed that the Xanthomonas citri TAL effectors, PthAs 2 and 3, preferentially targeted a citrus protein complex associated with transcription control and DNA repair. To extend our knowledge on the mode of action of PthAs, we have identified new protein targets of the PthA4 variant, required to elicit canker on citrus. Here we show that all the PthA4-interacting proteins are DNA and/or RNA-binding factors implicated in chromatin remodeling and repair, gene regulation and mRNA stabilization/modification. The majority of these proteins, including a structural maintenance of chromosomes protein (CsSMC), a translin-associated factor X (CsTRAX), a VirE2-interacting protein (CsVIP2), a high mobility group (CsHMG) and two poly(A)-binding proteins (CsPABP1 and 2), interacted with each other, suggesting that they assemble into a multiprotein complex. CsHMG was shown to bind DNA and to interact with the invariable leucine-rich repeat region of PthAs. Surprisingly, both CsHMG and PthA4 interacted with PABP1 and 2 and showed selective binding to poly(U) RNA, a property that is novel among HMGs and TAL effectors. Given that homologs of CsHMG, CsPABP1, CsPABP2, CsSMC and CsTRAX in other organisms assemble into protein complexes to regulate mRNA stability and translation, we suggest a novel role of TAL effectors in mRNA processing and translational control.	[de Souza, Tiago Antonio; Soprano, Adriana Santos; Vieira de Lira, Nayara Patricia; Christino Quaresma, Alexandre Jose; Pauletti, Bianca Alves; Paes Leme, Adriana Franco; Benedetti, Celso Eduardo] CNPEM, Lab Nacl Biociencias LNBio, Campinas, SP, Brazil		de Souza, TA (corresponding author), CNPEM, Lab Nacl Biociencias LNBio, Campinas, SP, Brazil.	celso.benedetti@lnbio.org.br	Leme, Adriana F Paes/C-9679-2012; Quaresma, Alexandre Jose Christino/E-4229-2010; de Souza, Tiago Antonio/C-1039-2012; Citros, Inct/I-2442-2013	Leme, Adriana F Paes/0000-0001-7959-147X; de Souza, Tiago Antonio/0000-0001-6283-4359; Christino Quaresma, Alexandre Jose/0000-0002-1810-0400; Santos Soprano, Adriana/0000-0001-7117-927X; Benedetti, Celso/0000-0002-4602-0256	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [2010/00634-1, 470410/2008-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (www.fapesp.br) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (www.cnpq.br), grant numbers 2010/00634-1 and 470410/2008-6, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saadi A, 2007, MOL PLANT MICROBE IN, V20, P934, DOI 10.1094/MPMI-20-8-0934; Anand A, 2007, PLANT CELL, V19, P1695, DOI 10.1105/tpc.106.042903; Balatsos NAA, 2006, J BIOL CHEM, V281, P4517, DOI 10.1074/jbc.M508590200; Bell AJ, 2008, BIOCHEM BIOPH RES CO, V377, P262, DOI 10.1016/j.bbrc.2008.09.131; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Chen ES, 2004, P NATL ACAD SCI USA, V101, P8078, DOI 10.1073/pnas.0307976101; Cheng YL, 2003, DEV CELL, V4, P53, DOI 10.1016/S1534-5807(02)00399-4; Cunha JL, 2011, BRAZ J MED BIOL RES, V44, P361, DOI 10.1590/S0100-879X2011007500017; Das D, 2001, J BIOL CHEM, V276, P32597, DOI 10.1074/jbc.M011792200; Dasgupta A, 2003, BBA-GENE STRUCT EXPR, V1627, P101, DOI 10.1016/S0167-4781(03)00080-0; Deng Dong, 2012, Science, V335, P720, DOI 10.1126/science.1215670; Dias SMG, 2010, NUCLEUS-PHILA, V1, P139, DOI 10.4161/nucl.1.2.10919; Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; Domingues MN, 2010, MOL PLANT PATHOL, V11, P663, DOI [10.1111/J.1364-3703.2010.00636.X, 10.1111/j.1364-3703.2010.00636.x]; Duan YP, 1999, MOL PLANT MICROBE IN, V12, P556, DOI 10.1094/MPMI.1999.12.6.556; Erdemir T, 2002, MOL MICROBIOL, V46, P947, DOI 10.1046/j.1365-2958.2002.03224.x; Erdemir T, 2002, J CELL SCI, V115, P207; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Grasser KD, 2007, BBA-GENE STRUCT EXPR, V1769, P346, DOI 10.1016/j.bbaexp.2006.12.004; Grosset C, 2000, CELL, V103, P29, DOI 10.1016/S0092-8674(00)00102-1; Hirano M, 2002, EMBO J, V21, P5733, DOI 10.1093/emboj/cdf575; Hou X, 2009, P NATL ACAD SCI USA, V106, P6410, DOI 10.1073/pnas.0901940106; Huntzinger E, 2010, EMBO J, V29, P4146, DOI 10.1038/emboj.2010.274; Jones L, 2006, PLANT PHYSIOL, V141, P598, DOI 10.1104/pp.105.076109; Kahvejian A, 2001, COLD SPRING HARB SYM, V66, P293, DOI 10.1101/sqb.2001.66.293; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kay S, 2009, PLANT J, V59, P859, DOI 10.1111/j.1365-313X.2009.03922.x; Krohn NM, 2002, J BIOL CHEM, V277, P32438, DOI 10.1074/jbc.M203814200; Lange SS, 2009, MOL CARCINOGEN, V48, P571, DOI 10.1002/mc.20544; Launholt D, 2006, PLANT CELL, V18, P2904, DOI 10.1105/tpc.106.047274; Lemay JF, 2010, RNA BIOL, V7, P291, DOI 10.4161/rna.7.3.11649; Lildballe DL, 2008, J MOL BIOL, V384, P9, DOI 10.1016/j.jmb.2008.09.014; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Mansfield JW, 2009, MOL PLANT PATHOL, V10, P721, DOI 10.1111/j.1364-3703.2009.00576.x; Miyoshi K, 2003, PLANT J, V36, P532, DOI 10.1046/j.1365-313X.2003.01897.x; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Murakami MT, 2010, PROTEINS, V78, P3386, DOI 10.1002/prot.22846; Ogram SA, 2010, VIROLOGY, V397, P14, DOI 10.1016/j.virol.2009.11.006; Pedersen DS, 2010, PLANT PHYSIOL, V154, P1831, DOI 10.1104/pp.110.163055; de Oliveira MLP, 2009, PLANT CELL REP, V28, P387, DOI 10.1007/s00299-008-0646-2; Pfalz J, 2009, EMBO J, V28, P2042, DOI 10.1038/emboj.2009.121; Prasad R, 2007, MOL CELL, V27, P829, DOI 10.1016/j.molcel.2007.06.029; Prikryl J, 2011, P NATL ACAD SCI USA, V108, P415, DOI 10.1073/pnas.1012076108; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Romer P, 2009, PLANT PHYSIOL, V150, P1697, DOI 10.1104/pp.109.139931; Sato H, 2009, GENE DEV, V23, P2537, DOI 10.1101/gad.1817109; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Sutrias-Grau M, 1999, J BIOL CHEM, V274, P1628, DOI 10.1074/jbc.274.3.1628; SWARUP S, 1992, MOL PLANT MICROBE IN, V5, P204, DOI 10.1094/MPMI-5-204; SWARUP S, 1991, PHYTOPATHOLOGY, V81, P802, DOI 10.1094/Phyto-81-802; Ueda T, 2010, BBA-GENE REGUL MECH, V1799, P114, DOI 10.1016/j.bbagrm.2009.11.005; Wang ZR, 1999, MOL CELL BIOL, V19, P4552; Williams-Carrier R, 2008, RNA, V14, P1930, DOI 10.1261/rna.1077708; Yanagisawa S, 1997, EUR J BIOCHEM, V250, P403, DOI 10.1111/j.1432-1033.1997.0403a.x; Ye XC, 2011, NAT STRUCT MOL BIOL, V18, P650, DOI 10.1038/nsmb.2032; Yeap BB, 2002, J BIOL CHEM, V277, P27183, DOI 10.1074/jbc.M202883200; Yuan T, 2011, MOL PLANT, V4, P300, DOI 10.1093/mp/ssq076	64	24	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32305	10.1371/journal.pone.0032305	http://dx.doi.org/10.1371/journal.pone.0032305			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384209	gold, Green Published, Green Submitted			2022-12-27	WOS:000302875500093
J	Dehmer, M; Grabner, M; Varmuza, K				Dehmer, Matthias; Grabner, Martin; Varmuza, Kurt			Information Indices with High Discriminative Power for Graphs	PLOS ONE			English	Article							COMPLEX NETWORKS; ENTROPY; BOUNDS	In this paper, we evaluate the uniqueness of several information-theoretic measures for graphs based on so-called information functionals and compare the results with other information indices and non-information-theoretic measures such as the well-known Balaban J index. We show that, by employing an information functional based on degree-degree associations, the resulting information index outperforms the Balaban J index tremendously. These results have been obtained by using nearly 12 million exhaustively generated, non-isomorphic and unweighted graphs. Also, we obtain deeper insights on these and other topological descriptors when exploring their uniqueness by using exhaustively generated sets of alkane trees representing connected and acyclic graphs in which the degree of a vertex is at most four.	[Dehmer, Matthias; Grabner, Martin] UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria; [Varmuza, Kurt] Univ Vienna, Inst Chem Engn, Lab Chemometr, Vienna, Austria	University of Vienna	Dehmer, M (corresponding author), UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria.	matthias.dehmer@umit.at			Austrian Science Funds [P22029-N13]; Austrian Science Fund (FWF) [P 22029] Funding Source: researchfish	Austrian Science Funds(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Matthias Dehmer, Martin Grabner and Kurt Varmuza thank the Austrian Science Funds for supporting this work (project P22029-N13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALABAN AT, 1991, J MATH CHEM, V8, P383, DOI 10.1007/BF01166951; BALABAN AT, 1982, CHEM PHYS LETT, V89, P399, DOI 10.1016/0009-2614(82)80009-2; Bertz S. H., 1981, J AM CHEM SOC, V103, P3241; BONCHEV D, 1981, J COMPUT CHEM, V2, P127, DOI 10.1002/jcc.540020202; BONCHEV D, 1977, J CHEM PHYS, V67, P4517, DOI 10.1063/1.434593; Bonchev D., 2005, COMPLEXITY CHEM BIOL, DOI 10.1007/b136300; Bonchev D, 2009, ENCY COMPLEXITY SYST, V5, P4820, DOI [10.1007/978-0-387-30440-3_285, DOI 10.1007/978-0-387-30440-3_285]; Bonchev D, 1983, INFORM THEORETIC IND; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Dehmer M, 2011, QUANTUM FRONTIERS AT, P479; Dehmer M, 2008, APPL MATH COMPUT, V201, P82, DOI 10.1016/j.amc.2007.12.010; Dehmer M, 2008, SYMMETRY, V19, P269; Dehmer M, 2011, INFORM SCIENCES, V181, P57, DOI 10.1016/j.ins.2010.08.041; Dehmer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008057; Dehmer M, 2009, J CHEM INF MODEL, V49, P1655, DOI 10.1021/ci900060x; Dehmer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003079; Dehmer MM, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-18; Devillers J., 1999, TOPOLOGICAL INDICES; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Diudea MV, 2011, COMPLEXITY, V16, P32, DOI 10.1002/cplx.20363; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Emmert-Streib F, 2007, APPL MATH COMPUT, V190, P1783, DOI 10.1016/j.amc.2007.02.095; Harary F., 1969, GRAPH THEORY; Hu CY, 1996, J CHEM INF COMP SCI, V36, P82, DOI 10.1021/ci9501150; Kim J, 2008, PHYSICA A, V387, P2637, DOI 10.1016/j.physa.2008.01.015; Konstantinova EV, 1996, J CHEM INF COMP SCI, V36, P54, DOI 10.1021/ci9502461; Konstantinova EV, 2003, INDIAN J CHEM A, V42, P1227; Konstantinova EV, 1990, VYCHISL SISTEMY, V136, P38; Li X., 2006, MATH CHEM MONOGRAPHS; McKay BD, 1998, J ALGORITHM, V26, P306, DOI 10.1006/jagm.1997.0898; Mehler A, 2010, ENTROPY-SWITZ, V12, P1440, DOI 10.3390/e12061440; Molgen isomer generator software, 2000, MOLG IS GEN SOFTW; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; Mueller LAJ, 2011, BIOINFORMATICS, V27, P140, DOI 10.1093/bioinformatics/btq606; R software a language and environment for statistical computing, 2011, R SOFTW LANG ENV STA; RANDIC M, 1975, J AM CHEM SOC, V97, P6609, DOI 10.1021/ja00856a001; RASHEVSKY N., 1955, BULL MATH BIOPHYS, V17, P229, DOI 10.1007/BF02477860; RAYCHAUDHURY C, 1984, J COMPUT CHEM, V5, P581, DOI 10.1002/jcc.540050612; Shannon C. E., 1949, MATH THEORY COMMUNIC; Skorobogatov VA, 1988, MATCH-COMMUN MATH CO, V23, P105; Todeschini R., 2002, HDB MOL DESCRIPTORS; Trinajstic N., 2018, CHEM GRAPH THEORY; Vukicevic D, 2005, INTERNET ELECT J MOL, V4, P491; WIENER H, 1947, J AM CHEM SOC, V69, P17, DOI 10.1021/ja01193a005; Zhou B, 2008, CROAT CHEM ACTA, V81, P319	45	55	55	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31214	10.1371/journal.pone.0031214	http://dx.doi.org/10.1371/journal.pone.0031214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393358	Green Submitted, Green Published, gold			2022-12-27	WOS:000303003500011
J	Jonckheere, N; Skrypek, N; Merlin, J; Dessein, AF; Dumont, P; Leteurtre, E; Harris, A; Desseyn, JL; Susini, C; Frenois, F; Van Seuningen, I				Jonckheere, Nicolas; Skrypek, Nicolas; Merlin, Johann; Dessein, Anne Frederique; Dumont, Patrick; Leteurtre, Emmanuelle; Harris, Ann; Desseyn, Jean-Luc; Susini, Christiane; Frenois, Frederic; Van Seuningen, Isabelle			The Mucin MUC4 and Its Membrane Partner ErbB2 Regulate Biological Properties of Human CAPAN-2 Pancreatic Cancer Cells via Different Signalling Pathways	PLOS ONE			English	Article							CHROMOSOMAL LOCALIZATION; TUMOR MICROENVIRONMENT; COLON-CANCER; BILE-ACIDS; GENE MUC4; TGF-BETA; PROGRESSION; EXPRESSION; PROMOTER; SURVIVAL	The mucin MUC4 and its membrane partner the ErbB2 oncogenic receptor are potential interacting partners in human pancreatic tumour development. However, the way they function is still largely unknown. In this work, we aimed to identify the cellular mechanisms and the intracellular signalling pathways under the control of both ErbB2 and MUC4 in a human pancreatic adenocarcinomatous cell line. Using co-immunoprecipitation and GST pull-down, we show that MUC4 and ErbB2 interact in the human pancreatic adenocarcinomatous cell line CAPAN-2 via the EGF domains of MUC4. Stable cell clones were generated in which either MUC4 or ErbB2 were knocked down (KD) by a shRNA approach. Biological properties of these cells were then studied in vitro and in vivo. Our results show that ErbB2-KD cells are more apoptotic and less proliferative (decreased cyclin D1 and increased p27kip1 expression) while migration and invasive properties were not altered. MUC4-KD clones were less proliferative with decreased cyclin D1 expression, G1 cell cycle arrest and altered ErbB2/ErbB3 expression. Their migration properties were reduced whereas invasive properties were increased. Importantly, inhibition of ErbB2 and MUC4 expression did not impair the same signalling pathways (inhibition of MUC4 expression affected the JNK pathway whereas that of ErbB2 altered the MAPK pathway). Finally, ErbB2-KD and MUC4-KD cells showed impaired tumour growth in vivo. Our results show that ErbB2 and MUC4, which interact physically, activate different intracellular signalling pathways to regulate biological properties of CAPAN-2 pancreatic cancer cells.	[Jonckheere, Nicolas; Skrypek, Nicolas; Merlin, Johann; Dessein, Anne Frederique; Leteurtre, Emmanuelle; Frenois, Frederic; Van Seuningen, Isabelle] INSERM, UMR837, Jean Pierre Aubert Res Ctr, Team Mucins Epithelial Differentiat & Carcinogene, F-59045 Lille, France; [Jonckheere, Nicolas; Skrypek, Nicolas; Merlin, Johann; Dessein, Anne Frederique; Leteurtre, Emmanuelle; Desseyn, Jean-Luc; Frenois, Frederic; Van Seuningen, Isabelle] Univ Lille Nord France, Lille, France; [Dumont, Patrick] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, Inst Biol Lille,UMR8161, F-59019 Lille, France; [Leteurtre, Emmanuelle] Ctr Hosp Reg & Univ Lille, Ctr Biol Pathol, F-59037 Lille, France; [Harris, Ann] Northwestern Univ, Human Mol Genet Program, Childrens Mem Res Ctr, Chicago, IL 60611 USA; [Harris, Ann] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA; [Desseyn, Jean-Luc] INSERM, U995, F-59045 Lille, France; [Susini, Christiane] Fac Med Toulouse, INSERM, U858, Inst Med Mol Rangueil, F-31073 Toulouse, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Northwestern University; Northwestern University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Jonckheere, N (corresponding author), INSERM, UMR837, Jean Pierre Aubert Res Ctr, Team Mucins Epithelial Differentiat & Carcinogene, F-59045 Lille, France.	nicolas.jonckheere@inserm.fr	VAN SEUNINGEN, Isabelle/N-6176-2016; Jonckheere, Nicolas/J-6028-2013; Desseyn, Jean-Luc/M-5070-2018	VAN SEUNINGEN, Isabelle/0000-0002-3131-2694; Jonckheere, Nicolas/0000-0002-0496-0661; Desseyn, Jean-Luc/0000-0001-6876-8049	Institut National du Cancer (INCa); Ligue Nationale contre le Cancer (LNCC); Centre Hospitalier Regional Universitaire (CHRU) de Lille/region Nord-Pas de Calais; Fondation pour la Recherche Medicale (FRM); Universite de Lille 2 and Region Nord-Pas de Calais; la Ligue Nationale contre le Cancer (Equipe Labellisee Ligue, IVS)	Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Ligue Nationale contre le Cancer (LNCC)(Ligue nationale contre le cancer); Centre Hospitalier Regional Universitaire (CHRU) de Lille/region Nord-Pas de Calais(Region Hauts-de-France); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Universite de Lille 2 and Region Nord-Pas de Calais(Region Hauts-de-France); la Ligue Nationale contre le Cancer (Equipe Labellisee Ligue, IVS)	Dr. Nicolas Jonckheere is a recipient of a postdoctoral fellowship from the Institut National du Cancer (INCa) and Ligue Nationale contre le Cancer (LNCC). Nicolas Skrypek is a recipient of a PhD fellowship of Centre Hospitalier Regional Universitaire (CHRU) de Lille/region Nord-Pas de Calais. Dr Frederic Frenois is a recipient of a postdoctoral fellowship from the Fondation pour la Recherche Medicale (FRM). Johann Merlin is the recipient of a PhD fellowship from the Universite de Lille 2 and Region Nord-Pas de Calais. This work is supported by a grant from la Ligue Nationale contre le Cancer (Equipe Labellisee Ligue 2010, IVS). Isabelle Van Seuningen is the recipient of a "Contrat Hospitalier de Recherche Translationnelle"/CHRT 2010, AVIESAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artis D, 2000, EUR J IMMUNOL, V30, P1656, DOI 10.1002/1521-4141(200006)30:6&lt;1656::AID-IMMU1656&gt;3.0.CO;2-Z; BREUSS JM, 1995, J CELL SCI, V108, P2241; Carraway KL, 2009, FUTURE ONCOL, V5, P1631, DOI 10.2217/FON.09.125; Carraway KL, 2007, CURR TOP DEV BIOL, V78, P1, DOI 10.1016/S0070-2153(06)78001-2; Carraway KL, 2003, BIOESSAYS, V25, P66, DOI 10.1002/bies.10201; CHANG SK, 1994, GASTROENTEROLOGY, V107, P28, DOI 10.1016/0016-5085(94)90057-4; Chaturvedi P, 2008, CANCER RES, V68, P2065, DOI 10.1158/0008-5472.CAN-07-6041; Cheon DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004675; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Desseyn JL, 2002, EUR J BIOCHEM, V269, P3150, DOI 10.1046/j.1432-1033.2002.02988.x; Erkan M., 2010, Experimental Oncology, V32, P128; Farrow B, 2008, J SURG RES, V149, P319, DOI 10.1016/j.jss.2007.12.757; FOGH J, 1980, EXP CELL BIOL, V48, P229; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hruban RH, 2007, GASTROENTEROL CLIN N, V36, P831, DOI 10.1016/j.gtc.2007.08.012; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Jonckheere N, 2004, ONCOGENE, V23, P5729, DOI 10.1038/sj.onc.1207769; Jonckheere N, 2009, BRIT J CANCER, V101, P637, DOI 10.1038/sj.bjc.6605190; Jonckheere N, 2008, EPITHELIAL MUCINS ST, P17; Jonckheere Nicolas, 2010, Cancers (Basel), V2, P1794, DOI 10.3390/cancers2041794; Jonckheere N, 2010, BIOCHIMIE, V92, P1, DOI 10.1016/j.biochi.2009.09.018; Jonckheere Nicolas, 2008, Critical Reviews in Oncogenesis, V14, P177; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kielosto M, 2009, INT J CANCER, V125, P1065, DOI 10.1002/ijc.24391; KIM YW, 1989, PANCREAS, V4, P353, DOI 10.1097/00006676-198906000-00013; Komoto M, 2009, CANCER SCI, V100, P1243, DOI 10.1111/j.1349-7006.2009.01176.x; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Mariette C, 2004, BIOCHEM J, V377, P701, DOI 10.1042/BJ20031132; Merlin J, 2011, ONCOGENE, V30, P2514, DOI 10.1038/onc.2010.631; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Moniaux N, 2007, BRIT J CANCER, V97, P345, DOI 10.1038/sj.bjc.6603868; Moniaux N, 1999, BIOCHEM J, V338, P325, DOI 10.1042/0264-6021:3380325; Moniaux N, 2001, FRONT BIOSCI-LANDMRK, V6, pD1192, DOI 10.2741/Moniaux; Nollet S, 1998, BIOCHEM J, V332, P739, DOI 10.1042/bj3320739; Perrais M, 2001, J BIOL CHEM, V276, P30923, DOI 10.1074/jbc.M104204200; Piessen G, 2007, BIOCHEM J, V402, P81, DOI 10.1042/BJ20061461; Pirollo KF, 2007, CANCER RES, V67, P2938, DOI 10.1158/0008-5472.CAN-06-4535; PORCHET N, 1991, BIOCHEM BIOPH RES CO, V175, P414, DOI 10.1016/0006-291X(91)91580-6; Porchet Nicole, 1999, Journal de la Societe de Biologie, V193, P85; Ramsauer VP, 2003, J BIOL CHEM, V278, P30142, DOI 10.1074/jbc.M303220200; Rhodes JM, 2008, BIOCHEM SOC T, V36, P1482, DOI 10.1042/BST0361482; Senapati S, 2011, CLIN CANCER RES, V17, P267, DOI 10.1158/1078-0432.CCR-10-1937; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Theodoropoulos G, 2009, J CELL BIOCHEM, V107, P112, DOI 10.1002/jcb.22106; Tidswell M, 1997, J IMMUNOL, V159, P1497; van der Sluis M, 2004, BIOCHEM BIOPH RES CO, V325, P952, DOI 10.1016/j.bbrc.2004.10.108; Van Seuningen I, 2000, BIOCHEM J, V348, P675; Van Seuningen I., 2008, EPITHELIAL MUCINS ST, P233; VANSEUNINGEN I, 1995, J BIOL CHEM, V270, P26976, DOI 10.1074/jbc.270.45.26976; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Walsh N, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-140; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154	52	42	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32232	10.1371/journal.pone.0032232	http://dx.doi.org/10.1371/journal.pone.0032232			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393391	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500044
J	Kanao, T; Sawada, T; Davies, SA; Ichinose, H; Hasegawa, K; Takahashi, R; Hattori, N; Imai, Y				Kanao, Tomoko; Sawada, Tomoyo; Davies, Shireen-Anne; Ichinose, Hiroshi; Hasegawa, Kazuko; Takahashi, Ryosuke; Hattori, Nobutaka; Imai, Yuzuru			The Nitric Oxide-Cyclic GMP Pathway Regulates FoxO and Alters Dopaminergic Neuron Survival in Drosophila	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; COLON-CANCER CELLS; PARKINSONS-DISEASE; NERVOUS-SYSTEM; CGMP; EXPRESSION; LRRK2; SYNTHASE; PHOSPHORYLATION; LOCALIZATION	Activation of the forkhead box transcription factor FoxO is suggested to be involved in dopaminergic (DA) neurodegeneration in a Drosophila model of Parkinson's disease (PD), in which a PD gene product LRRK2 activates FoxO through phosphorylation. In the current study that combines Drosophila genetics and biochemical analysis, we show that cyclic guanosine monophosphate (cGMP)-dependent kinase II (cGKII) also phosphorylates FoxO at the same residue as LRRK2, and Drosophila orthologues of cGKII and LRRK2, DG2/For and dLRRK, respectively, enhance the neurotoxic activity of FoxO in an additive manner. Biochemical assays using mammalian cGKII and FoxO1 reveal that cGKII enhances the transcriptional activity of FoxO1 through phosphorylation of the FoxO1 S319 site in the same manner as LRRK2. A Drosophila FoxO mutant resistant to phosphorylation by DG2 and dLRRK (dFoxO S259A corresponding to human FoxO1 S319A) suppressed the neurotoxicity and improved motor dysfunction caused by co-expression of FoxO and DG2. Nitric oxide synthase (NOS) and soluble guanylyl cyclase (sGC) also increased FoxO's activity, whereas the administration of a NOS inhibitor L-NAME suppressed the loss of DA neurons in aged flies co-expressing FoxO and DG2. These results strongly suggest that the NO-FoxO axis contributes to DA neurodegeneration in LRRK2-linked PD.	[Kanao, Tomoko] Juntendo Univ, Grad Sch Med, Res Inst Dis Old Age, Tokyo, Japan; [Hattori, Nobutaka] Juntendo Univ, Grad Sch Med, Dept Neurol, Tokyo, Japan; [Imai, Yuzuru] Juntendo Univ, Grad Sch Med, Dept Neurosci Neurodegenerat Disorders, Tokyo, Japan; [Sawada, Tomoyo; Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto, Japan; [Sawada, Tomoyo; Takahashi, Ryosuke; Hattori, Nobutaka] JST, Saitama, Japan; [Davies, Shireen-Anne] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland; [Ichinose, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Life Sci, Yokohama, Kanagawa 227, Japan; [Hasegawa, Kazuko] Sagamihara Natl Hosp, Natl Hosp Org, Dept Neurol, Sagamihara, Kanagawa, Japan	Juntendo University; Juntendo University; Juntendo University; Kyoto University; University of Glasgow; Tokyo Institute of Technology	Kanao, T (corresponding author), Juntendo Univ, Grad Sch Med, Res Inst Dis Old Age, Tokyo, Japan.	yzimai@juntendo.ac.jp	Imai, Yuzuru/AAA-6472-2019; Hattori, Nobutaka/ACR-0069-2022; Sawada, Tomoyo/C-3610-2017; Ichinose, Hiroshi/D-8986-2015	Imai, Yuzuru/0000-0003-2924-5231; Ichinose, Hiroshi/0000-0001-6008-6860	Inamori Foundation; Uehara Memorial Foundation; Dainippon Sumitomo Pharma; Program for Young Researchers from Special Coordination Funds for Promoting Science and Technology; MEXT in Japan; Biotechnology and Biological Sciences Research Council [BB/G020620/1, BB/C000633/1, BB/E011438/1] Funding Source: researchfish; BBSRC [BB/E011438/1, BB/G020620/1] Funding Source: UKRI; Grants-in-Aid for Scientific Research [23790973, 23890206, 21500305] Funding Source: KAKEN	Inamori Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); Program for Young Researchers from Special Coordination Funds for Promoting Science and Technology; MEXT in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by funding from the Inamori Foundation, the Uehara Memorial Foundation, Dainippon Sumitomo Pharma, and the Program for Young Researchers from Special Coordination Funds for Promoting Science and Technology commissioned by MEXT in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilano K, 2008, NEUROCHEM RES, V33, P2416, DOI 10.1007/s11064-008-9697-6; Berger Z, 2010, BIOCHEMISTRY-US, V49, P5511, DOI 10.1021/bi100157u; Bicker G, 2007, ARCH INSECT BIOCHEM, V64, P43, DOI 10.1002/arch.20161; Bois PRJ, 2005, MOL CELL BIOL, V25, P7645, DOI 10.1128/MCB.25.17.7645-7656.2005; Davies SA, 2006, CELL SIGNAL, V18, P409, DOI 10.1016/j.cellsig.2005.08.011; Davies SA, 2000, INSECT BIOCHEM MOLEC, V30, P1123, DOI 10.1016/S0965-1748(00)00118-1; De Vente J, 2001, NEUROSCIENCE, V108, P27, DOI 10.1016/S0306-4522(01)00401-8; Dreyer J, 2004, J NEUROSCI, V24, P10454, DOI 10.1523/JNEUROSCI.2265-04.2004; Eve DJ, 1998, MOL BRAIN RES, V63, P62, DOI 10.1016/S0169-328X(98)00259-9; Feil R, 2005, REV NEUROSCIENCE, V16, P23; Feil S, 2005, NEUROSCIENCE, V135, P863, DOI 10.1016/j.neuroscience.2005.06.051; Foley E, 2003, GENE DEV, V17, P115, DOI 10.1101/gad.1018503; Geiselhoringer A, 2004, FEBS LETT, V575, P19, DOI 10.1016/j.febslet.2004.08.030; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Hong YK, 2009, BIOCHEM BIOPH RES CO, V384, P160, DOI 10.1016/j.bbrc.2009.04.112; Hunot S, 1996, NEUROSCIENCE, V72, P355, DOI 10.1016/0306-4522(95)00578-1; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; JARCHAU T, 1994, P NATL ACAD SCI USA, V91, P9426, DOI 10.1073/pnas.91.20.9426; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; KALDERON D, 1989, J BIOL CHEM, V264, P10738; Kanao T, 2010, HUM MOL GENET, V19, P3747, DOI 10.1093/hmg/ddq289; Kulaksiz H, 2002, AM J PATHOL, V161, P655, DOI 10.1016/S0002-9440(10)64221-6; Kwon IK, 2010, ONCOGENE, V29, P3423, DOI 10.1038/onc.2010.91; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Lee KS, 2009, J BIOL CHEM, V284, P29454, DOI 10.1074/jbc.M109.028027; Lessing D, 2009, NAT REV GENET, V10, P359, DOI 10.1038/nrg2563; Liberatore GT, 1999, NAT MED, V5, P1403; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; MacPherson MR, 2004, J BIOL CHEM, V279, P40026, DOI 10.1074/jbc.M405619200; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; McGettigan J, 2005, INSECT BIOCHEM MOLEC, V35, P741, DOI 10.1016/j.ibmb.2005.02.017; Muller D, 2005, GENETICS, V171, P1137, DOI 10.1534/genetics.105.044453; Muramatsu Y, 2003, J NEURAL TRANSM, V110, P1129, DOI 10.1007/s00702-003-0021-y; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Roodveldt C, 2008, J CELL MOL MED, V12, P1820, DOI 10.1111/j.1582-4934.2008.00450.x; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Soh JW, 2008, MOL CARCINOGEN, V47, P519, DOI 10.1002/mc.20409; Steinert JR, 2010, NEUROSCIENTIST, V16, P435, DOI 10.1177/1073858410366481; Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654; Tseng KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027187; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Venderova K, 2009, HUM MOL GENET, V18, P4390, DOI 10.1093/hmg/ddp394; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wang X, 1997, J NEUROCHEM, V68, P443; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00055; Yakubovich N, 2010, CURR BIOL, V20, pR141, DOI 10.1016/j.cub.2009.12.011; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yuasa K, 2000, FEBS LETT, V466, P175, DOI 10.1016/S0014-5793(99)01786-X; Yuasa K, 2008, BIOCHEM BIOPH RES CO, V374, P522, DOI 10.1016/j.bbrc.2008.07.071; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	62	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e30958	10.1371/journal.pone.0030958	http://dx.doi.org/10.1371/journal.pone.0030958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393355	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000303003500008
J	Yu, XY; Lu, RJ; Wang, Z; Zhu, N; Wang, W; Julian, D; Chris, B; Lv, JX; Tan, WJ				Yu, Xiaoyan; Lu, Roujian; Wang, Zhong; Zhu, Na; Wang, Wen; Julian, Druce; Chris, Birch; Lv, Jianxin; Tan, Wenjie			Etiology and Clinical Characterization of Respiratory Virus Infections in Adult Patients Attending an Emergency Department in Beijing	PLOS ONE			English	Article							HUMAN CORONAVIRUSES; TRACT INFECTIONS; PCR; DIAGNOSIS; CHILDREN; IDENTIFICATION; ASSAY; HKU1	Background: Acute respiratory tract infections (ARTIs) represent a serious global health burden. To date, few reports have addressed the prevalence of respiratory viruses (RVs) in adults with ARTIs attending an emergency department (ED). Therefore, the potential impact of respiratory virus infections on such patients remains unknown. Methodology/Principal Findings: To determine the epidemiological and clinical profiles of common and recently discovered respiratory viruses in adults with ARTIs attending an ED in Beijing, a 1-year consecutive study was conducted from May, 2010, to April, 2011. Nose and throat swab samples from 416 ARTI patients were checked for 13 respiratory viruses using multiple reverse transcription polymerase chain reaction(RT-PCR) assays for common respiratory viruses, including influenza viruses (Flu) A, B, and adenoviruses (ADVs), picornaviruses (PICs), respiratory syncytial virus (RSV), parainfluenza viruses (PIVs) 1-3, combined with real-time RT-PCR for human metapneumovirus (HMPV) and human coronaviruses (HCoVs, -OC43, -229E, -NL63, and -HKU1). Viral pathogens were detected in 52.88% (220/416) of patient samples, and 7.21% (30/416) of patients tested positive for more than one virus. PICs (17.79%) were the dominant agents detected, followed by FluA (16.11%), HCoVs (11.78%), and ADV (11.30%). HMPV, PIVs, and FluB were also detected (<3%), but not RSV. The total prevalence and the dominant virus infections detected differed significantly between ours and a previous report. Co-infection rates were high for HCoV-229E (12/39, 30.76%), PIC (22/74, 29.73%), ADV (12/47, 25.53%) and FluA (15/67, 22.39%). Different patterns of clinical symptoms were associated with different respiratory viruses. Conclusions: The pattern of RV involvement in adults with ARTIs attending an ED in China differs from that previously reported. The high prevalence of viruses (PIC, FluA, HCoVs and ADV) reported here strongly highlight the need for the development of safe and effective therapeutic approaches for these viruses.	[Yu, Xiaoyan; Lv, Jianxin; Tan, Wenjie] Wenzhou Med Coll, Inst Med Virol, Minist Educ, Key Lab Lab Med, Wenzhou, Zhejiang, Peoples R China; [Yu, Xiaoyan; Lu, Roujian; Zhu, Na; Wang, Wen; Tan, Wenjie] China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Wang, Zhong] CAMS, Peking Union Med Coll Hosp, Beijing, Peoples R China; [Julian, Druce; Chris, Birch] Victorian Infect Dis Reference Lab, Dept Virol, Melbourne, Vic, Australia	Wenzhou Medical University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Victorian Infectious Diseases Reference Laboratory	Yu, XY (corresponding author), Wenzhou Med Coll, Inst Med Virol, Minist Educ, Key Lab Lab Med, Wenzhou, Zhejiang, Peoples R China.	jxlu313@163.com; tanwj28@yahoo.cn		Druce, Julian/0000-0002-3521-3298	China-Australia Health and HIV/AIDSFacility [EID07]; 973 Program of China [2011CB504704]; National Science Foundation [81100062]; 863 Hi-Tech Research and Development Program of China [2007AA02Z463, 2007AA02Z-464]	China-Australia Health and HIV/AIDSFacility; 973 Program of China(National Basic Research Program of China); National Science Foundation(National Science Foundation (NSF)); 863 Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This study was supported by a grant provided by the China-Australia Health and HIV/AIDSFacility program (Item no. EID07), 973 Program of China (Grant numbers: 2011CB504704), National Science Foundation Program of China (81100062) and the 863 Hi-Tech Research and Development Program of China (2007AA02Z463,2007AA02Z-464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Beck ET, 2010, FUTURE MICROBIOL, V5, P901, DOI [10.2217/fmb.10.48, 10.2217/FMB.10.48]; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Bharaj P, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-89; Brittain-Long R, 2011, SCAN J INFE IN PRESS; Brittain-Long R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-44; Brittain-Long R, 2010, J CLIN VIROL, V47, P263, DOI 10.1016/j.jcv.2009.12.010; Druce J, 2005, J MED VIROL, V75, P122, DOI 10.1002/jmv.20246; Esposito S, 2006, J MED VIROL, V78, P1609, DOI 10.1002/jmv.20745; Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Greenberg SB, 2011, SEMIN RESP CRIT CARE, V32, P433, DOI 10.1055/s-0031-1283283; Greer RM, 2009, J CLIN VIROL, V45, P10, DOI 10.1016/j.jcv.2009.03.008; He J, 2011, J MICROBES INFECT, V6, P90; Kim C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021610; Lam WY, 2007, J CLIN MICROBIOL, V45, P3631, DOI 10.1128/JCM.00280-07; Linde A, 2009, EUROSURVEILLANCE, V14, P2; Maertzdorf J, 2004, J CLIN MICROBIOL, V42, P981, DOI 10.1128/JCM.42.3.981-986.2004; Mahony JB, 2010, EXPERT REV ANTI-INFE, V8, P1273, DOI [10.1586/eri.10.121, 10.1586/ERI.10.121]; Ren L, 2009, CLIN MICROBIOL INFEC, V15, P1146, DOI 10.1111/j.1469-0691.2009.02746.x; Ren LL, 2011, J CLIN VIROL, V51, P209, DOI 10.1016/j.jcv.2011.05.001; Ren LL, 2011, J MED VIROL, V83, P291, DOI 10.1002/jmv.21956; Schildgen V, 2011, CLIN MICROBIOL REV, V24, P734, DOI 10.1128/CMR.00015-11; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005	27	47	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32174	10.1371/journal.pone.0032174	http://dx.doi.org/10.1371/journal.pone.0032174			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389685	Green Published, Green Submitted, gold			2022-12-27	WOS:000302999600023
J	Tachikawa, M; Ikeda, S; Fujinawa, J; Hirose, S; Akanuma, S; Hosoya, K				Tachikawa, Masanori; Ikeda, Saori; Fujinawa, Jun; Hirose, Shirou; Akanuma, Shin-ichi; Hosoya, Ken-ichi			gamma-Aminobutyric Acid Transporter 2 Mediates the Hepatic Uptake of Guanidinoacetate, the Creatine Biosynthetic Precursor, in Rats	PLOS ONE			English	Article							METHYLTRANSFERASE DEFICIENCY; MESSENGER-RNAS; INBORN ERROR; BETA-ALANINE; LIVER; BRAIN; HETEROGENEITY; LOCALIZATION; HEPATOCYTES; METABOLISM	Guanidinoacetic acid (GAA) is the biosynthetic precursor of creatine which is involved in storage and transmission of phosphate-bound energy. Hepatocytes readily convert GAA to creatine, raising the possibility that the active uptake of GAA by hepatocytes is a regulatory factor. The purpose of this study is to investigate and identify the transporter responsible for GAA uptake by hepatocytes. The characteristics of [C-14] GAA uptake by hepatocytes were elucidated using the in vivo liver uptake method, freshly isolated rat hepatocytes, an expression system of Xenopus laevis oocytes, gene knockdown, and an immunohistochemical technique. In vivo injection of [C-14] GAA into the rat femoral vein and portal vein results in the rapid uptake of [C-14] GAA by the liver. The uptake was markedly inhibited by c-aminobutyric acid (GABA) and nipecotinic acid, an inhibitor of GABA transporters (GATs). The characteristics of Na+- and Cl--dependent [C-14] GAA uptake by freshly isolated rat hepatocytes were consistent with those of GAT2. The Km value of the GAA uptake (134 mM) was close to that of GAT2-mediated GAA transport (78.9 mM). GABA caused a marked inhibition with an IC50 value of 8.81 mM. The [C-14] GAA uptake exhibited a significant reduction corresponding to the reduction in GAT2 protein expression. GAT2 was localized on the sinusoidal membrane of the hepatocytes predominantly in the periportal region. This distribution pattern was consistent with that of the creatine biosynthetic enzyme, S-adenosylmethionine: guanidinoacetate N-methyltransferase. GAT2 makes a major contribution to the sinusoidal GAA uptake by periportal hepatocytes, thus regulating creatine biosynthesis in the liver.	[Tachikawa, Masanori; Ikeda, Saori; Fujinawa, Jun; Hirose, Shirou; Akanuma, Shin-ichi; Hosoya, Ken-ichi] Toyama Univ, Dept Pharmaceut, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [Tachikawa, Masanori] Tohoku Univ, Grad Sch Pharmaceut Sci, Div Membrane Transport & Drug Targeting, Sendai, Miyagi 980, Japan	University of Toyama; Tohoku University	Tachikawa, M (corresponding author), Toyama Univ, Dept Pharmaceut, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan.	hosoyak@pha.u-toyama.ac.jp			Ministry of Education, Science, Sports, and Culture; Japan Society for the Promotion of Science, Japan	Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported, in part, by a Grant-in Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture, and the Japan Society for the Promotion of Science, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrue A, 2010, NEUROCHEM RES, V35, P247, DOI 10.1007/s11064-009-0048-z; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; BORDEN LA, 1992, J BIOL CHEM, V267, P21098; Braissant O, 2011, AMINO ACIDS, V40, P1315, DOI 10.1007/s00726-011-0852-z; BURGER HJ, 1989, HEPATOLOGY, V9, P22, DOI 10.1002/hep.1840090105; da Silva RP, 2009, AM J PHYSIOL-ENDOC M, V296, pE256, DOI 10.1152/ajpendo.90547.2008; Fujita M, 2009, AM J PHYSIOL-GASTR L, V297, pG681, DOI 10.1152/ajpgi.00238.2009; GROOTHUIS GMM, 1982, AM J PHYSIOL, V243, pG455, DOI 10.1152/ajpgi.1982.243.6.G455; Harris RC, 2006, AMINO ACIDS, V30, P279, DOI 10.1007/s00726-006-0299-9; Liu MP, 1999, AM J PHYSIOL-GASTR L, V276, pG206, DOI 10.1152/ajpgi.1999.276.1.G206; Madon J, 2000, MOL PHARMACOL, V57, P634, DOI 10.1124/mol.57.3.634; MARESCAU B, 1992, METABOLISM, V41, P526, DOI 10.1016/0026-0495(92)90213-T; MCGUIRE DM, 1986, J HISTOCHEM CYTOCHEM, V34, P429, DOI 10.1177/34.4.3512696; Nasrallah F, 2010, PEDIATR NEUROL, V42, P163, DOI 10.1016/j.pediatrneurol.2009.07.015; NOEL H, 1984, BIOCHEM J, V220, P701, DOI 10.1042/bj2200701; Ohtsuki S, 2002, J CEREBR BLOOD F MET, V22, P1327, DOI 10.1097/01.WCB.0000033966.83623.7D; PARDRIDGE WM, 1979, AM J PHYSIOL, V237, pE367, DOI 10.1152/ajpendo.1979.237.4.E367; PAYNE RM, 1991, BIOCHIM BIOPHYS ACTA, V1089, P352, DOI 10.1016/0167-4781(91)90176-M; PETZINGER E, 1989, AM J PHYSIOL, V256, pG78, DOI 10.1152/ajpgi.1989.256.1.G78; Reichel C, 1999, GASTROENTEROLOGY, V117, P688, DOI 10.1016/S0016-5085(99)70463-4; Schmidt A, 2004, HUM MOL GENET, V13, P905, DOI 10.1093/hmg/ddh112; SORA I, 1994, BIOCHEM BIOPH RES CO, V204, P419, DOI 10.1006/bbrc.1994.2475; Stockler S, 1997, METABOLISM, V46, P1189, DOI 10.1016/S0026-0495(97)90215-8; Stockler S, 1996, AM J HUM GENET, V58, P914; STOLL B, 1991, HEPATOLOGY, V13, P247, DOI 10.1002/hep.1840130208; Tachikawa M, 2004, EUR J NEUROSCI, V20, P144, DOI 10.1111/j.1460-9568.2004.03478.x; Tachikawa M, 2008, J NEUROCHEM, V107, P768, DOI 10.1111/j.1471-4159.2008.05652.x; Tachikawa M, 2009, J NEUROCHEM, V111, P499, DOI 10.1111/j.1471-4159.2009.06332.x; TRASK RV, 1990, BIOCHIM BIOPHYS ACTA, V1049, P182, DOI 10.1016/0167-4781(90)90039-5; Warskulat U, 2006, FASEB J, V20, P574, DOI 10.1096/fj.05-5016fje; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879, DOI 10.1248/bpb1978.4.879; ZHANG RW, 1992, DRUG METAB DISPOS, V20, P113	33	26	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32557	10.1371/journal.pone.0032557	http://dx.doi.org/10.1371/journal.pone.0032557			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384273	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500100
J	Toedling, J; Servant, N; Ciaudo, C; Farinelli, L; Voinnet, O; Heard, E; Barillot, E				Toedling, Joern; Servant, Nicolas; Ciaudo, Constance; Farinelli, Laurent; Voinnet, Olivier; Heard, Edith; Barillot, Emmanuel			Deep-Sequencing Protocols Influence the Results Obtained in Small-RNA Sequencing	PLOS ONE			English	Article							GENE-EXPRESSION; IDENTIFICATION; DATABASE; UPDATE	Second-generation sequencing is a powerful method for identifying and quantifying small-RNA components of cells. However, little attention has been paid to the effects of the choice of sequencing platform and library preparation protocol on the results obtained. We present a thorough comparison of small-RNA sequencing libraries generated from the same embryonic stem cell lines, using different sequencing platforms, which represent the three major second-generation sequencing technologies, and protocols. We have analysed and compared the expression of microRNAs, as well as populations of small RNAs derived from repetitive elements. Despite the fact that different libraries display a good correlation between sequencing platforms, qualitative and quantitative variations in the results were found, depending on the protocol used. Thus, when comparing libraries from different biological samples, it is strongly recommended to use the same sequencing platform and protocol in order to ensure the biological relevance of the comparisons.	[Toedling, Joern; Servant, Nicolas; Ciaudo, Constance; Heard, Edith; Barillot, Emmanuel] Inst Curie, Paris, France; [Toedling, Joern; Servant, Nicolas; Barillot, Emmanuel] INSERM, U900, Paris, France; [Toedling, Joern; Servant, Nicolas; Barillot, Emmanuel] Mines ParisTech, Fontainebleau, France; [Toedling, Joern; Ciaudo, Constance; Heard, Edith] CNRS, UMR3215, Paris, France; [Toedling, Joern; Ciaudo, Constance; Heard, Edith] INSERM, U934, Paris, France; [Ciaudo, Constance; Voinnet, Olivier] Swiss Fed Inst Technol Zurich, Dept Biol, Zurich, Switzerland; [Voinnet, Olivier] Univ Strasbourg, CNRS, UPR2357, Inst Biol Mol Plantes, Strasbourg, France; [Farinelli, Laurent] Fasteris, Plan Les Ouates, Switzerland	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Toedling, J (corresponding author), Inst Curie, Paris, France.	nicolas.servant@curie.fr; cciaudo@ethz.ch	Heard, Edith/D-7197-2017; Ciaudo, Constance/A-2014-2012	Heard, Edith/0000-0001-8052-7117; Ciaudo, Constance/0000-0002-0857-4506; Toedling, Joern/0000-0003-1471-1295; Voinnet, Olivier/0000-0001-6982-9544; BARILLOT, Emmanuel/0000-0003-2724-2002; Servant, Nicolas/0000-0003-1678-7410	Institut Curie, INCa; ANR; European Research Council [ERC 210890]; FEBS: Federation of European Biochemical Societies	Institut Curie, INCa; ANR(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); FEBS: Federation of European Biochemical Societies	This research was funded by Institut Curie, INCa "Gepig", by a grant from the ANR "RNA ES" to both EH and OV, and by a starting grant from the European Research Council "Frontiers of RNAi" ERC 210890 to OV. CC was supported by a post-doctoral fellowship (FEBS: Federation of European Biochemical Societies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Chow JC, 2010, CELL, V141, P956, DOI 10.1016/j.cell.2010.04.042; Ciaudo C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000620; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hafner M, 2011, RNA, V17, P1697, DOI 10.1261/rna.2799511; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; McCormick KP, 2010, SILENCE, V2, P2; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Pfeffer S, 2007, METHOD ENZYMOL, V427, P51, DOI 10.1016/S0076-6879(07)27003-X; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tian G, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-64; Toedling J, 2010, BIOINFORMATICS, V26, P2902, DOI 10.1093/bioinformatics/btq531; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	27	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32724	10.1371/journal.pone.0032724	http://dx.doi.org/10.1371/journal.pone.0032724			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384282	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500108
J	Zhang, Y; Zhang, HT; Yao, XG; Shen, H; Chen, J; Li, CJ; Chen, LL; Zheng, MY; Ye, JM; Hu, LH; Shen, X; Jiang, HL				Zhang, Yu; Zhang, Haitao; Yao, Xin-gang; Shen, Hong; Chen, Jing; Li, Chenjing; Chen, Lili; Zheng, Mingyue; Ye, Jiming; Hu, Lihong; Shen, Xu; Jiang, Hualiang			(+)-Rutamarin as a Dual Inducer of Both GLUT4 Translocation and Expression Efficiently Ameliorates Glucose Homeostasis in Insulin-Resistant Mice	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; ACTIVATED RECEPTOR-GAMMA; PPAR-GAMMA; TRANSPORTER EXPRESSION; MUSCLE-CELLS; MECHANISM; ADIPOCYTES; 3T3-L1; GENE; INHIBITION	Glucose transporter 4 (GLUT4) is a principal glucose transporter in response to insulin, and impaired translocation or decreased expression of GLUT4 is believed to be one of the major pathological features of type 2 diabetes mellitus (T2DM). Therefore, induction of GLUT4 translocation or/and expression is a promising strategy for anti-T2DM drug discovery. Here we report that the natural product (+)-Rutamarin (Rut) functions as an efficient dual inducer on both insulin-induced GLUT4 translocation and expression. Rut-treated 3T3-L1 adipocytes exhibit efficiently enhanced insulin-induced glucose uptake, while diet-induced obese (DIO) mice based assays further confirm the Rut-induced improvement of glucose homeostasis and insulin sensitivity in vivo. Subsequent investigation of Rut acting targets indicates that as a specific protein tyrosine phosphatase 1B (PTP1B) inhibitor Rut induces basal GLUT4 translocation to some extent and largely enhances insulin-induced GLUT4 translocation through PI3 kinase-AKT/PKB pathway, while as an agonist of retinoid X receptor alpha (RXR alpha), Rut potently increases GLUT4 expression. Furthermore, by using molecular modeling and crystallographic approaches, the possible binding modes of Rut to these two targets have been also determined at atomic levels. All our results have thus highlighted the potential of Rut as both a valuable lead compound for anti-T2DM drug discovery and a promising chemical probe for GLUT4 associated pathways exploration.	[Zhang, Yu; Zhang, Haitao; Yao, Xin-gang; Shen, Hong; Chen, Jing; Li, Chenjing; Chen, Lili; Zheng, Mingyue; Hu, Lihong; Shen, Xu; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Ye, Jiming] RMIT Univ, Sch Hlth Sci, Melbourne, Vic, Australia	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Royal Melbourne Institute of Technology (RMIT)	Zhang, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	simmhulh@mail.shcnc.ac.cn; xshen@mail.shcnc.ac.cn; hljiang@mail.shcnc.ac.cn	Zheng, Mingyue/B-4860-2010; Zhang, Yu/J-5225-2014; Zheng, Mingyue/AAJ-8027-2020; Zhang, Haitao/L-7612-2015; Zhang, Yu/AAV-5722-2021; shen, hong/M-2727-2015; Zheng, Mingyue/HHZ-4062-2022; shen, hong/I-6179-2016; Zheng, Mingyue/Z-3582-2019	Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092; Zhang, Haitao/0000-0003-4879-2951; Zhang, Yu/0000-0002-1778-8389; Zheng, Mingyue/0000-0002-3323-3092; 	State Key Program of Basic Research of China [2010CB912501, 2009CB918502]; National Natural Science Foundation of China [90713046, 30890044, 10979072]; Science Foundation of Shanghai [11XD1406100, 11ZR1444500]; Foundation of Chinese Academy of Sciences [KSCX2-EW-Q-3]	State Key Program of Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Foundation of Chinese Academy of Sciences(Chinese Academy of Sciences)	This work is supported by the State Key Program of Basic Research of China (grants 2010CB912501, 2009CB918502); the National Natural Science Foundation of China (grants 90713046, 30890044, 10979072); Science Foundation of Shanghai (11XD1406100,11ZR1444500); and Foundation of Chinese Academy of Sciences (grants KSCX2-EW-Q-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Armoni M, 2003, J BIOL CHEM, V278, P30614, DOI 10.1074/jbc.M304654200; Armoni M, 2007, TRENDS ENDOCRIN MET, V18, P100, DOI 10.1016/j.tem.2007.02.001; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Buhl ES, 2001, DIABETES, V50, P12, DOI 10.2337/diabetes.50.1.12; Cao XH, 2004, MOL CELL BIOL, V24, P9705, DOI 10.1128/MCB.24.22.9705-9725.2004; Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/endo.143.3.8662; Dalen KT, 2003, J BIOL CHEM, V278, P48283, DOI 10.1074/jbc.M302287200; Davies PJA, 2001, MOL PHARMACOL, V59, P170, DOI 10.1124/mol.59.2.170; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FROST SC, 1985, J BIOL CHEM, V260, P2646; GIBBS EM, 1995, J CLIN INVEST, V95, P1512, DOI 10.1172/JCI117823; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Kim J, 2005, CANCER RES, V65, P6189, DOI 10.1158/0008-5472.CAN-04-4439; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Lampson MA, 2000, J CELL SCI, V113, P4065; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JO, 2011, J CELL PHYSIOL, V226, P974, DOI 10.1002/jcp.22410; Leick L, 2010, AM J PHYSIOL-ENDOC M, V299, pE456, DOI 10.1152/ajpendo.00648.2009; Liu F, 2009, BIOCHEM J, V418, P413, DOI 10.1042/BJ20082051; Liu G, 2004, CURR OPIN MOL THER, V6, P331; Montessuit C, 2006, BASIC RES CARDIOL, V101, P27, DOI 10.1007/s00395-005-0567-y; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Navaza J, 1994, ACTA CRYSTALLOGR D, V50, P760; Needham M, 2000, J STEROID BIOCHEM, V72, P35, DOI 10.1016/S0960-0760(00)00027-3; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Picard F, 2002, ANNU REV NUTR, V22, P167, DOI 10.1146/annurev.nutr.22.010402.102808; Pinaire JA, 2007, PPAR RES, V2007, DOI 10.1155/2007/94156; Puius YA, 1997, P NATL ACAD SCI USA, V94, P13420, DOI 10.1073/pnas.94.25.13420; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shen H, 2008, CELL PHYSIOL BIOCHEM, V22, P1, DOI 10.1159/000149779; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; SLEEMAN MW, 1995, MOL CELL ENDOCRINOL, V108, P161, DOI 10.1016/0303-7207(95)03473-K; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; Tsiani E, 1998, DIABETES, V47, P1676, DOI 10.2337/diabetes.47.11.1676; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Ye F, 2006, CHEMBIOCHEM, V7, P74, DOI 10.1002/cbic.200500186; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zhang S, 2007, DRUG DISCOV TODAY, V12, P373, DOI 10.1016/j.drudis.2007.03.011; Zhang YN, 2008, ADV SYNTH CATAL, V350, P2373, DOI 10.1002/adsc.200800396; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693; Zorzano A, 2005, ACTA PHYSIOL SCAND, V183, P43, DOI 10.1111/j.1365-201X.2004.01380.x	53	18	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31811	10.1371/journal.pone.0031811	http://dx.doi.org/10.1371/journal.pone.0031811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384078	Green Submitted, Green Published, gold			2022-12-27	WOS:000302918500039
J	Hayasaka, N; Nagai, N; Kawao, N; Niwa, A; Yoshioka, Y; Mori, Y; Shigeta, H; Kashiwagi, N; Miyazawa, M; Satou, T; Higashino, H; Matsuo, O; Murakami, T				Hayasaka, Naoto; Nagai, Nobuo; Kawao, Naoyuki; Niwa, Atsuko; Yoshioka, Yoshichika; Mori, Yuki; Shigeta, Hiroshi; Kashiwagi, Nobuo; Miyazawa, Masaaki; Satou, Takao; Higashino, Hideaki; Matsuo, Osamu; Murakami, Takamichi			In Vivo Diagnostic Imaging Using Micro-CT: Sequential and Comparative Evaluation of Rodent Models for Hepatic/Brain Ischemia and Stroke	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; BRAIN; PLASMINOGEN; INFARCTION; RAT; THROMBOSIS; INJURY	Background: There is an increasing need for animal disease models for pathophysiological research and efficient drug screening. However, one of the technical barriers to the effective use of the models is the difficulty of non-invasive and sequential monitoring of the same animals. Micro-CT is a powerful tool for serial diagnostic imaging of animal models. However, soft tissue contrast resolution, particularly in the brain, is insufficient for detailed analysis, unlike the current applications of CT in the clinical arena. We address the soft tissue contrast resolution issue in this report. Methodology: We performed contrast-enhanced CT (CECT) on mouse models of experimental cerebral infarction and hepatic ischemia. Pathological changes in each lesion were quantified for two weeks by measuring the lesion volume or the ratio of high attenuation area (%HAA), indicative of increased vascular permeability. We also compared brain images of stroke rats and ischemic mice acquired with micro-CT to those acquired with 11.7-T micro-MRI. Histopathological analysis was performed to confirm the diagnosis by CECT. Principal Findings: In the models of cerebral infarction, vascular permeability was increased from three days through one week after surgical initiation, which was also confirmed by Evans blue dye leakage. Measurement of volume and %HAA of the liver lesions demonstrated differences in the recovery process between mice with distinct genetic backgrounds. Comparison of CT and MR images acquired from the same stroke rats or ischemic mice indicated that accuracy of volumetric measurement, as well as spatial and contrast resolutions of CT images, was comparable to that obtained with MRI. The imaging results were also consistent with the histological data. Conclusions: This study demonstrates that the CECT scanning method is useful in rodents for both quantitative and qualitative evaluations of pathologic lesions in tissues/organs including the brain, and is also suitable for longitudinal observation of the same animals.	[Hayasaka, Naoto] Kinki Univ, Sch Med, Dept Anat & Neurobiol, Osaka 589, Japan; [Nagai, Nobuo; Kawao, Naoyuki; Matsuo, Osamu] Kinki Univ, Sch Med, Dept Physiol, Osaka 589, Japan; [Niwa, Atsuko; Higashino, Hideaki] Kinki Univ, Sch Med, Dept Pharmacol, Osaka 589, Japan; [Yoshioka, Yoshichika; Mori, Yuki] Osaka Univ, Immunol Frontier Res Ctr, Biofunct Imaging Lab, Suita, Osaka, Japan; [Shigeta, Hiroshi] Hitachi Aloka Med Co Ltd, Suita, Osaka, Japan; [Kashiwagi, Nobuo; Murakami, Takamichi] Kinki Univ, Sch Med, Dept Radiol, Osaka 589, Japan; [Miyazawa, Masaaki] Kinki Univ, Sch Med, Dept Immunol, Osaka 589, Japan; [Satou, Takao] Kinki Univ, Sch Med, Dept Pathol, Osaka 589, Japan; [Hayasaka, Naoto] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama, Japan	Kindai University (Kinki University); Kindai University (Kinki University); Kindai University (Kinki University); Osaka University; Kindai University (Kinki University); Kindai University (Kinki University); Kindai University (Kinki University); Japan Science & Technology Agency (JST)	Hayasaka, N (corresponding author), Kinki Univ, Sch Med, Dept Anat & Neurobiol, Osaka 589, Japan.	hayasaka@med.kindai.ac.jp; murakami@med.kindai.ac.jp	Mori, Yuki/AAH-9283-2020; Miyazawa, Masaaki/AAA-3916-2020; MATSUO, OSAMU/AAM-9703-2020	Mori, Yuki/0000-0003-4208-0005; Miyazawa, Masaaki/0000-0002-7300-119X; Matsuo, Osamu/0000-0002-9806-2204; Kawao, Naoyuki/0000-0002-4148-5476	Japan Society for the Promotion of Science [19590235, 21590264]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grant-in-Aid for Scientific Research: No. 19590235 and 21590264 from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PROPHYLACTIC APPROAC; Beckmann N, 2007, NMR BIOMED, V20, P154, DOI 10.1002/nbm.1153; de Crespigny A, 2008, J NEUROSCI METH, V171, P207, DOI 10.1016/j.jneumeth.2008.03.006; Engelhorn T, 2009, NEUROSCI LETT, V458, P28, DOI 10.1016/j.neulet.2009.04.033; Higashino H, 2009, J NEURAL TRANSM, V116, P1209, DOI 10.1007/s00702-009-0278-x; Kawao N, 2010, J THROMB HAEMOST, V8, P1555, DOI 10.1111/j.1538-7836.2010.03870.x; Kawao N, 2010, THROMB RES, V125, pE214, DOI 10.1016/j.thromres.2009.12.009; Kim GW, 2000, J CEREBR BLOOD F MET, V20, P1690, DOI 10.1097/00004647-200012000-00008; Korner P, 2007, ESSENTIAL HYPERTENSI, P501; Langheinrich AC, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-36; Langheinrich AC, 2010, NEURORADIOLOGY, V52, P815, DOI 10.1007/s00234-009-0617-5; Martiniova L, 2009, J MAGN RESON IMAGING, V29, P685, DOI 10.1002/jmri.21654; Nagai N, 2005, J THROMB HAEMOST, V3, P1379, DOI 10.1111/j.1538-7836.2005.01466.x; Nagai N, 1999, CIRCULATION, V99, P2440, DOI 10.1161/01.CIR.99.18.2440; Nagai N, 2010, BRAIN RES, V1322, P109, DOI 10.1016/j.brainres.2010.01.077; OKAMOTO K, 1974, CIRC RES, V34, pI143; Okamoto K, 1975, CLIN SCI MOL MED, V2, p161s; Ritman EL, 2004, ANNU REV BIOMED ENG, V6, P185, DOI 10.1146/annurev.bioeng.6.040803.140130; Ritman EL, 2007, NUCL INSTRUM METH A, V580, P968, DOI 10.1016/j.nima.2007.06.040; Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007; Schambach SJ, 2010, METHODS, V50, P26, DOI 10.1016/j.ymeth.2009.09.003; Seo Y, 2008, PHYS MED BIOL, V53, pN99, DOI 10.1088/0031-9155/53/7/N01; Suckow CE, 2008, MOL IMAGING BIOL, V10, P114, DOI 10.1007/s11307-007-0128-x; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513	24	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32342	10.1371/journal.pone.0032342	http://dx.doi.org/10.1371/journal.pone.0032342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384223	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916100071
J	Liu, Y; Chen, XH; Si, YJ; Li, ZJ; Gao, L; Gao, L; Zhang, C; Zhang, X				Liu, Yao; Chen, Xing-hua; Si, Ying-jian; Li, Zhong-jun; Gao, Lei; Gao, Li; Zhang, Cheng; Zhang, Xi			Reconstruction of Hematopoietic Inductive Microenvironment after Transplantation of VCAM-1-Modified Human Umbilical Cord Blood Stromal Cells	PLOS ONE			English	Article							BONE-MARROW; STEM-CELLS; PROGENITOR CELLS; IN-VITRO; MICE; ENGRAFTMENT; ADHESION; LIGAND	The hematopoietic inductive microenvironment (HIM) is where hematopoietic stem/progenitor cells grow and develop. Hematopoietic stromal cells were the key components of the HIM. In our previous study, we had successfully cultured and isolated human cord blood-derived stromal cells (HUCBSCs) and demonstrated that they could secret hemopoietic growth factors such as GM-CSF, TPO, and SCF. However, it is still controversial whether HUCBSCs can be used for reconstruction of HIM. In this study, we first established a co-culture system of HUCBSCs and cord blood CD34(+) cells and then determined that using HUCBSCs as the adherent layer had significantly more newly formed colonies of each hematopoietic lineage than the control group, indicating that HUCBSCs had the ability to promote the proliferation of hematopoietic stem cells/progenitor cells. Furthermore, the number of colonies was significantly higher in vascular cell adhesion molecule-1 (VCAM-1)-modified HUCBSCs, suggesting that the ability of HUCBSCs in promoting the proliferation of hematopoietic stem cells/progenitor cells was further enhanced after having been modified with VCAM-1. Next, HUCBSCs were infused into a radiation-damaged animal model, in which the recovery of hematopoiesis was observed. The results demonstrate that the transplanted HUCBSCs were "homed in" to bone marrow and played roles in promoting the recovery of irradiation-induced hematopoietic damage and repairing HIM. Compared with the control group, the HUCBSC group had significantly superior effectiveness in terms of the recovery time for hemogram and myelogram, CFU-F, CFU-GM, BFU-E, and CFU-Meg. Such differences were even more significant in VCAM-1-modified HUCBSCs group. We suggest that HUCBSCs are able to restore the functions of HIM and promote the recovery of radiation-induced hematopoietic damage. VCAM-1 plays an important role in supporting the repair of HIM damage.	[Liu, Yao; Chen, Xing-hua; Si, Ying-jian; Gao, Lei; Gao, Li; Zhang, Cheng; Zhang, Xi] Third Mil Med Univ, Xinqiao Hosp, Dept Hematol, Chongqing, Peoples R China; [Li, Zhong-jun] Third Mil Med Univ, Xinqiao Hosp, Dept Blood Transfus, Chongqing, Peoples R China; [Si, Ying-jian] Mil Gen Hosp Beijing, BaYi Childrens Hosp, Dept Pediat Hematol Oncol, Beijing, Peoples R China	Army Medical University; Army Medical University	Liu, Y (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Hematol, Chongqing, Peoples R China.	zhangxxi@sina.com			National Natural Science Foundation of China [30500220, 81070388, 81000194, 30670890]; Chongqing Key Discipline of Natural Science [2009BA5056, 2009BA5011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Key Discipline of Natural Science	This work was supported in part by the National Natural Science Foundation of China (No. 30500220 (to XZ), 81070388 (to XZ), 81000194 (to YL), 30670890 (to XHC)) and Chongqing Key Discipline of Natural Science (No. 2009BA5056 (to ZX), 2009BA5011 (to XHC)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basak Pratima, 2010, Chin J Cancer, V29, P969; Dorshkind K, 2007, GENE DEV, V21, P2249, DOI 10.1101/gad.1600307; FUKUSHIMA N, 1995, CRIT REV ONCOL HEMAT, V20, P255, DOI 10.1016/1040-8428(94)00163-N; Gao L, 2006, BLOOD CELL MOL DIS, V36, P322, DOI 10.1016/j.bcmd.2005.12.036; Gao L, 2010, CELL CYCLE, V9, P1342, DOI 10.4161/cc.9.7.11146; Gillette Jennifer M, 2009, Commun Integr Biol, V2, P305; Gottschling S, 2007, STEM CELLS, V25, P798, DOI 10.1634/stemcells.2006-0513; Hao Jing, 2001, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V9, P56; Hao L, 2009, CROAT MED J, V50, P351, DOI 10.3325/cmj.2009.50.351; Isomura H, 2003, J MED VIROL, V70, P444, DOI 10.1002/jmv.10415; Jones EA, 2006, CYTOM PART B-CLIN CY, V70B, P391, DOI 10.1002/cyto.b.20118; Konstandin MH, 2006, J IMMUNOL METHODS, V310, P67, DOI 10.1016/j.jim.2005.12.005; Lee YH, 2004, J KOREAN MED SCI, V19, P523, DOI 10.3346/jkms.2004.19.4.523; Liu Y, 2011, CANCER BIOL THER, V11, P84, DOI 10.4161/cbt.11.1.13956; Lo Celso C, 2009, J BIOPHOTONICS, V2, P619, DOI 10.1002/jbio.200910072; OFLAHERTY E, 1995, BONE MARROW TRANSPL, V15, P207; Papayannopoulou T, 1998, BLOOD, V91, P2231, DOI 10.1182/blood.V91.7.2231.2231_2231_2239; PERKINS S, 1988, J CLIN INVEST, V81, P1072, DOI 10.1172/JCI113419; Ramakrishnan A, 2009, EXPERT OPIN BIOL TH, V9, P21, DOI [10.1517/14712590802603093, 10.1517/14712590802603093 ]; Schmitz N, 2002, SEMIN HEMATOL, V39, P3, DOI 10.1053/shem.2002.29245; Shipounova IN, 2009, CTS-CLIN TRANSL SCI, V2, P67, DOI 10.1111/j.1752-8062.2008.00074.x; Tada T, 2008, EXP ANIM TOKYO, V57, P347, DOI 10.1538/expanim.57.347; Wagner W, 2007, EXP HEMATOL, V35, P314, DOI 10.1016/j.exphem.2006.10.003; WOLF NS, 1982, EXP HEMATOL, V10, P108; Yanai N, 2000, BLOOD, V96, P139, DOI 10.1182/blood.V96.1.139.013k15_139_144; Zhang C, 2011, J BIOL CHEM, V286, P13723, DOI 10.1074/jbc.M110.144691; Zhang Xi, 2008, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V16, P598	27	10	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31741	10.1371/journal.pone.0031741	http://dx.doi.org/10.1371/journal.pone.0031741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384064	gold, Green Published, Green Submitted			2022-12-27	WOS:000302916100032
J	Mimeault, M; Johansson, SL; Batra, SK				Mimeault, Murielle; Johansson, Sonny L.; Batra, Surinder K.			Pathobiological Implications of the Expression of EGFR, pAkt, NF-kappa B and MIC-1 in Prostate Cancer Stem Cells and Their Progenies	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MACROPHAGE INHIBITORY CYTOKINE-1; METASTASIS-INITIATING CELLS; STEM/PROGENITOR CELLS; SIDE POPULATION; ANDROGEN; PROGRESSION; DOCETAXEL; GEFITINIB; ADENOCARCINOMA	The progression of prostate cancers (PCs) to locally invasive, androgen-independent and metastatic disease states is generally associated with treatment resistance and disease relapse. The present study was undertaken to establish the possibility of using a combination of specific oncogenic products, including epidermal growth factor receptor (EGFR), pAkt, nuclear factor-kappaB (NF-kappa B) and macrophage inhibitory cytokine-1 (MIC-1) as biomarkers and therapeutic targets for optimizing the management of patients with localized PC at earlier disease stages. The immunohistochemical and immunofluorescence data have revealed that the expression levels of EGFR, Ser(473)-pAkt, NF-kappa B p65 and MIC-1 proteins were significantly enhanced in the same subset of 76 cases of prostatic adenocarcinoma specimens during the disease progression and these biomarkers were expressed in a small subpopulation of CD133(+) PC cells and the bulk tumor mass of CD133(-) PC cells. Importantly, all of these biomarkers were also overexpressed in 80-100% of 30 PC metastasis bone tissue specimens. Moreover, the results have indicated that the EGF-EGFR signaling pathway can provide critical functions for the self-renewal of side population (SP) cells endowed with stem cell-like features from highly invasive WPE1-NB26 cells. Of therapeutic interest, the targeting of EGFR, pAkt, NF-kappa B or MIC-1 was also effective at suppressing the basal and EGF-promoted prostasphere formation by SP WPE1-NB26 cells, inducing disintegration of SP cell-derived prostaspheres and decreasing the viability of SP and non-SP WPE1-NB26 cell fractions. Also, the targeting of these oncogenic products induced the caspase-dependent apoptosis in chemoresistant SP WPE1-NB26 cells and enhanced their sensibility to the cytotoxic effects induced by docetaxel. These findings suggest that the combined use of EGFR, pAkt, NF-kappa B and/or MIC-1 may represent promising strategies for improving the accuracy of current diagnostic and prognostic methods and efficacy of treatments of PC patients in considering the disease heterogeneity, thereby preventing PC progression to metastatic and lethal disease states.	[Mimeault, Murielle; Batra, Surinder K.] Univ Nebraska Med Ctr, Coll Med, Dept Biochem & Mol Biol, Omaha, NE USA; [Johansson, Sonny L.; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Coll Med, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Mimeault, M (corresponding author), Univ Nebraska Med Ctr, Coll Med, Dept Biochem & Mol Biol, Omaha, NE USA.	mmimeault@unmc.edu; sbatra@unmc.edu			National Institutes of Health [R01CA138791]; NATIONAL CANCER INSTITUTE [R01CA138791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors of this work are supported by the National Institutes of Health grant (R01CA138791) for prostate cancer research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelucci A, 2006, ENDOCR-RELAT CANCER, V13, P197, DOI 10.1677/erc.1.01100; Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477; Ayala GE, 2004, CANCER RES, V64, P6082, DOI 10.1158/0008-5472.CAN-04-0838; Bae KM, 2010, J UROLOGY, V183, P2045, DOI 10.1016/j.juro.2009.12.092; Banach-Petrosky W, 2007, CANCER RES, V67, P9089, DOI 10.1158/0008-5472.CAN-07-2887; Birnie R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r83; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Bostwick DG, 2004, CANCER-AM CANCER SOC, V101, P2371, DOI 10.1002/cncr.20408; Brown DA, 2006, CLIN CANCER RES, V12, P89, DOI 10.1158/1078-0432.CCR-05-1331; Brown DA, 2009, CLIN CANCER RES, V15, P6658, DOI 10.1158/1078-0432.CCR-08-3126; Cao DL, 2011, PROSTATE, V71, P700, DOI 10.1002/pros.21286; Chauchereau A, 2011, EXP CELL RES, V317, P262, DOI 10.1016/j.yexcr.2010.10.012; Chen SJ, 2007, PROSTATE, V67, P557, DOI 10.1002/pros.20551; Dalfior D, 2010, PATHOLOGY, V42, P1, DOI 10.3109/00313020903434447; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; De Visschere P, 2010, JBR-BTR, V93, P62, DOI 10.5334/jbr-btr.121; Di Lorenzo G, 2002, CLIN CANCER RES, V8, P3438; Domingo-Domenech J, 2006, CLIN CANCER RES, V12, P5578, DOI 10.1158/1078-0432.CCR-05-2767; Donovan MJ, 2012, BJU INT, V109, P207, DOI 10.1111/j.1464-410X.2011.10316.x; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Duhagon MA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-324; Ellem SJ, 2009, AM J PATHOL, V175, P1187, DOI 10.2353/ajpath.2009.081107; Epstein JI, 2004, MODERN PATHOL, V17, P307, DOI 10.1038/modpathol.3800050; Fan X, 2011, UROL ONCOL; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Freedland SJ, 2010, CANCER, V117, P1123; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Graff JN, 2011, CANCER-AM CANCER SOC, V117, P3882, DOI 10.1002/cncr.25986; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Guzman-Ramirez N, 2009, PROSTATE, V69, P1683, DOI 10.1002/pros.21018; Haas GP, 2008, CAN J UROL, V15, P3866; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; HARVEY P., 2009, BMC UROLOGY, V9, P9; Huang CY, 2007, CLIN CANCER RES, V13, P5825, DOI 10.1158/1078-0432.CCR-07-1037; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kawasaki BT, 2009, PROSTATE, V69, P827, DOI 10.1002/pros.20931; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Lakhey M, 2010, Kathmandu Univ Med J (KUMJ), V8, P158; Le Page C, 2005, PROSTATE, V65, P130, DOI 10.1002/pros.20234; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Lieberman Ronald, 2004, Am J Ther, V11, P501; Liu T, 2010, MOL CELL BIOCHEM, V340, P265, DOI 10.1007/s11010-010-0426-5; Maitland NJ, 2007, ERNST SCHERING FOUND, V5, P155, DOI 10.1007/2789_2007_050; Merseburger AS, 2006, ONCOL REP, V16, P79; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mimeault M, 2006, INT J CANCER, V118, P1022, DOI 10.1002/ijc.21440; Mimeault M, 2006, CARCINOGENESIS, V27, P1, DOI 10.1093/carcin/bgi229; Mimeault M, 2007, GROWTH FACTORS, V25, P400, DOI 10.1080/08977190801930935; Mimeault M, 2008, ENDOCR REV, V29, P234, DOI 10.1210/er.2007-0040; Mimeault M, 2007, MOL CANCER THER, V6, P967, DOI 10.1158/1535-7163.MCT-06-0648; Mimeault M, 2007, INT J CANCER, V120, P160, DOI 10.1002/ijc.22268; Mimeault M, 2011, MOL MED, V17, P949, DOI 10.2119/molmed.2011.00115; Mimeault M, 2011, BBA-REV CANCER, V1816, P25, DOI 10.1016/j.bbcan.2011.03.001; Mimeault M, 2010, CANCER LETT, V295, P69, DOI 10.1016/j.canlet.2010.02.015; Mimeault M, 2010, MOL CANCER THER, V9, P617, DOI 10.1158/1535-7163.MCT-09-1013; Mimeault M, 2009, METHODS MOL BIOL, V568, P139, DOI 10.1007/978-1-59745-280-9_8; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Peraldo-Neia C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-31; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Ross JS, 2004, CLIN CANCER RES, V10, P2466, DOI 10.1158/1078-0432.CCR-0543-3; Rowehl Rebecca A., 2008, Cancer Genomics & Proteomics, V5, P301; Schafer W, 2006, J UROLOGY, V176, P532, DOI 10.1016/j.juro.2006.03.033; Schlomm T, 2007, CLIN CANCER RES, V13, P6579, DOI 10.1158/1078-0432.CCR-07-1257; Selander KS, 2007, CANCER EPIDEM BIOMAR, V16, P532, DOI 10.1158/1055-9965.EPI-06-0841; Senapati S, 2010, ONCOGENE, V29, P1293, DOI 10.1038/onc.2009.420; Shah RB, 2006, PROSTATE, V66, P1437, DOI 10.1002/pros.20460; Shanmugam R, 2006, PROSTATE, V66, P1498, DOI 10.1002/pros.20482; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Sweeney C, 2004, CLIN CANCER RES, V10, P5501, DOI 10.1158/1078-0432.CCR-0571-03; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Torring N, 2003, PROSTATE, V56, P142, DOI 10.1002/pros.10245; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Wakchoure S, 2009, PROSTATE, V69, P652, DOI 10.1002/pros.20913; Wei C, 2007, CANCER BIOL THER, V6, P763, DOI 10.4161/cbt.6.5.3996; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; Xie C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-43; Zellweger T, 2005, INT J CANCER, V113, P619, DOI 10.1002/ijc.20615; Zhao LL, 2009, CANCER RES, V69, P7696, DOI 10.1158/0008-5472.CAN-08-4901	80	41	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31919	10.1371/journal.pone.0031919	http://dx.doi.org/10.1371/journal.pone.0031919			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384099	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100039
J	O'Dwyer, L; Lamberton, F; Bokde, ALW; Ewers, M; Faluyi, YO; Tanner, C; Mazoyer, B; O'Neill, D; Bartley, M; Collins, DR; Coughlan, T; Prvulovic, D; Hampel, H				O'Dwyer, Laurence; Lamberton, Franck; Bokde, Arun L. W.; Ewers, Michael; Faluyi, Yetunde O.; Tanner, Colby; Mazoyer, Bernard; O'Neill, Desmond; Bartley, Mairead; Collins, D. Ronan; Coughlan, Tara; Prvulovic, David; Hampel, Harald			Using Support Vector Machines with Multiple Indices of Diffusion for Automated Classification of Mild Cognitive Impairment	PLOS ONE			English	Article							DIMENSIONAL PATTERN-CLASSIFICATION; PRODROMAL ALZHEIMERS-DISEASE; WHITE-MATTER; BRAIN ATROPHY; SPATIAL STATISTICS; MCI PATIENTS; DEMENTIA; MRI; DIAGNOSIS; DECLINE	Few studies have looked at the potential of using diffusion tensor imaging (DTI) in conjunction with machine learning algorithms in order to automate the classification of healthy older subjects and subjects with mild cognitive impairment (MCI). Here we apply DTI to 40 healthy older subjects and 33 MCI subjects in order to derive values for multiple indices of diffusion within the white matter voxels of each subject. DTI measures were then used together with support vector machines (SVMs) to classify control and MCI subjects. Greater than 90% sensitivity and specificity was achieved using this method, demonstrating the potential of a joint DTI and SVM pipeline for fast, objective classification of healthy older and MCI subjects. Such tools may be useful for large scale drug trials in Alzheimer's disease where the early identification of subjects with MCI is critical.	[O'Dwyer, Laurence; Prvulovic, David; Hampel, Harald] Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany; [Lamberton, Franck; Mazoyer, Bernard] Univ Caen & Paris Descartes, CEA, CNRS, Ctr Imaging Neurosci & Applicat Pathol,UMR 6232, F-14032 Caen, France; [Bokde, Arun L. W.] Trinity Coll Dublin, Cognit Syst Grp, Discipline Psychiat, Sch Med, Dublin, Ireland; [Bokde, Arun L. W.] Trinity Coll Dublin, TCIN, Dublin, Ireland; [Ewers, Michael] Univ Calif San Francisco, Dept Radiol, VA Med Ctr, San Francisco, CA USA; [Faluyi, Yetunde O.] Addenbrookes Hosp, Liaison Psychiat Serv, Cambridge, England; [Faluyi, Yetunde O.] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England; [Tanner, Colby] Trinity Coll Dublin, Dept Zool, Dublin, Ireland; [Mazoyer, Bernard] Ctr Hosp Univ, Caen, France; [Mazoyer, Bernard] Inst Univ France, Paris, France; [O'Neill, Desmond; Bartley, Mairead; Coughlan, Tara] Trinity Coll Dublin, Dept Med Gerontol, Dublin, Ireland	Goethe University Frankfurt; CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; Trinity College Dublin; Trinity College Dublin; University of California System; University of California San Francisco; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Trinity College Dublin; CHU de Caen NORMANDIE; Institut Universitaire de France; Trinity College Dublin	O'Dwyer, L (corresponding author), Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany.	larodwyer@gmail.com	Mazoyer, Bernard M/B-6303-2012; Tanner, Colby/H-4653-2012; Lamberton, Franck/GRO-7517-2022; mazoyer, bernard m/A-5369-2009; O'Dwyer, Laurence/J-1699-2012; O'Neill, Desmond/D-1486-2013	Mazoyer, Bernard M/0000-0003-0970-2837; mazoyer, bernard m/0000-0003-0970-2837; Bokde, Arun/0000-0003-0114-4914; collins, Ronan/0000-0003-0404-8266; Hampel, Harald/0000-0003-0894-8982; O'Neill, Desmond/0000-0002-5542-9897; Lamberton, Franck/0000-0002-4655-4397	Science Foundation Ireland (SFI) [08/IN.1/B1846]; School of Medicine, Goethe University, Frankfurt, Germany; LOEWE; Irish Research Council for Science Engineering and Technology (IRCSET)	Science Foundation Ireland (SFI)(Science Foundation Ireland); School of Medicine, Goethe University, Frankfurt, Germany; LOEWE; Irish Research Council for Science Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology)	This work was supported by the Science Foundation Ireland (SFI) investigator neuroimaging program award 08/IN.1/B1846 to H. H. and institutional research funds of the School of Medicine, Goethe University, Frankfurt, Germany to H. H. This work was also supported by the Neurodegeneration & Alzheimer's disease research grant of the LOEWE program "Neuronal Coordination Research Focus Frankfurt" (NeFF) to H. H. and D. P. C.J.T. was supported by a fellowship from the Irish Research Council for Science Engineering and Technology (IRCSET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Beaulieu C., 2009, BIOL BASIS DIFFUSION, P105; Bischkopf J, 2002, ACTA PSYCHIAT SCAND, V106, P403, DOI 10.1034/j.1600-0447.2002.01417.x; Bosch B, 2010, NEUROBIOL AGING; BRUN A, 1986, ANN NEUROL, V19, P253, DOI 10.1002/ana.410190306; Choo IH, 2010, NEUROBIOL AGING, V31, P772, DOI 10.1016/j.neurobiolaging.2008.06.015; Cui Y, 2011, NEUROIMAGE; Davatzikos C, 2008, NEUROBIOL AGING, V29, P514, DOI 10.1016/j.neurobiolaging.2006.11.010; DEFIGUEIREDO RJP, 1995, P NATL ACAD SCI USA, V92, P5530, DOI 10.1073/pnas.92.12.5530; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Fan Y, 2008, NEUROIMAGE, V41, P277, DOI 10.1016/j.neuroimage.2008.02.043; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Grana M, 2011, NEUROSCI LETT, V502, P225, DOI 10.1016/j.neulet.2011.07.049; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Haller S, 2010, J ALZHEIMERS DIS, V22, P315, DOI 10.3233/JAD-2010-100840; Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208; Hua X, 2008, NEUROIMAGE, V43, P458, DOI 10.1016/j.neuroimage.2008.07.013; Huang H, 2005, NEUROIMAGE, V26, P195, DOI 10.1016/j.neuroimage.2005.01.019; Jack CR, 2002, NEUROLOGY, V58, P750, DOI 10.1212/WNL.58.5.750; Kaye JA, 1997, NEUROLOGY, V48, P1297, DOI 10.1212/WNL.48.5.1297; Kiuchi K, 2009, BRAIN RES, V1287, P184, DOI 10.1016/j.brainres.2009.06.052; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; Lerch JP, 2008, NEUROBIOL AGING, V29, P23, DOI 10.1016/j.neurobiolaging.2006.09.013; Magnin B, 2009, NEURORADIOLOGY, V51, P73, DOI 10.1007/s00234-008-0463-x; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; O'Dwyer L, 2011, J ALZHEIMERS DIS; O'Dwyer L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021745; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Pievani M, 2010, HUM BRAIN MAPP; Plant C, 2010, NEUROIMAGE, V50, P162, DOI 10.1016/j.neuroimage.2009.11.046; PLATT J, 1999, ADV KERNEL METHODS S, V208, P98; Rakotomamonjy A, 2003, VARIABLE SELECTION U; Reese LC, 2011, J NEUROCHEM, V119, P791, DOI 10.1111/j.1471-4159.2011.07447.x; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Scholkopf B, 1997, IEEE T SIGNAL PROCES, V45, P2758, DOI 10.1109/78.650102; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Takahashi S, 2002, NEUROSCI LETT, V332, P45, DOI 10.1016/S0304-3940(02)00914-X; Teipel SJ, 2007, NEUROIMAGE, V38, P13, DOI 10.1016/j.neuroimage.2007.07.008; Teipel SJ, 2011, HUM BRAIN MAPP, V32, P1349, DOI 10.1002/hbm.21111; Wee CY, 2011, NEUROIMAGE, V54, P1812, DOI 10.1016/j.neuroimage.2010.10.026; Witten IH, 2011, MOR KAUF D, P1; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068	54	72	72	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32441	10.1371/journal.pone.0032441	http://dx.doi.org/10.1371/journal.pone.0032441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384251	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100082
J	Heeg, D; Burns, DA; Cartman, ST; Minton, NP				Heeg, Daniela; Burns, David A.; Cartman, Stephen T.; Minton, Nigel P.			Spores of Clostridium difficile Clinical Isolates Display a Diverse Germination Response to Bile Salts	PLOS ONE			English	Article							BACILLUS-SUBTILIS; INCREASED SPORULATION; TOXIN PRODUCTION; EPIDEMIC; STRAINS; TAUROCHOLATE; INFECTION; PROTEINS; NUTRIENT; SEQUENCE	Clostridium difficile spores play a pivotal role in the transmission of infectious diarrhoea, but in order to cause disease spores must complete germination and return to vegetative cell growth. While the mechanisms of spore germination are well understood in Bacillus, knowledge of C. difficile germination remains limited. Previous studies have shown that bile salts and amino acids play an important role in regulating the germination response of C. difficile spores. Taurocholate, in combination with glycine, can stimulate germination, whereas chenodeoxycholate has been shown to inhibit spore germination in a C. difficile clinical isolate. Our recent studies of C. difficile sporulation characteristics have since pointed to substantial diversity among different clinical isolates. Consequently, in this study we investigated how the germination characteristics of different C. difficile isolates vary in response to bile salts. By analysing 29 isolates, including 16 belonging to the BI/NAP1/027 type, we show that considerable diversity exists in both the rate and extent of C. difficile germination in response to rich medium containing both taurocholate and glycine. Strikingly, we also show that although a potent inhibitor of germination for some isolates, chenodeoxycholate does not inhibit the germination, or outgrowth, of all C. difficile strains. Finally, we provide evidence that components of rich media may induce the germination of C. difficile spores, even in the absence of taurocholate. Taken together, these data suggest that the mechanisms of C. difficile spore germination in response to bile salts are complex and require further study. Furthermore, we stress the importance of studying multiple isolates in the future when analysing the nutrients or chemicals that either stimulate or inhibit C. difficile spore germination.	[Heeg, Daniela; Burns, David A.; Cartman, Stephen T.; Minton, Nigel P.] Univ Nottingham, Sch Mol Med Sci, Clostridia Res Grp, Ctr Biomol Sci, Nottingham NG7 2RD, England	University of Nottingham	Heeg, D (corresponding author), Univ Nottingham, Sch Mol Med Sci, Clostridia Res Grp, Ctr Biomol Sci, Nottingham NG7 2RD, England.	nigel.minton@nottingham.ac.uk		Minton, Nigel/0000-0002-9277-1261	UK Medical Research Council [G0601176]; European Community [PEOPLE-ITN-2008-237942, HEALTH-F3-2008-223585]; MRC [G0601176] Funding Source: UKRI; Medical Research Council [G0601176] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research leading to these results received funding from the UK Medical Research Council (Grant G0601176) and the European Community's Seventh Framework Programmes 'CLOSTNET' (PEOPLE-ITN-2008-237942) and 'HYPERDIFF' (HEALTH-F3-2008-223585). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; Broussolle V, 2002, ANAEROBE, V8, P89, DOI 10.1006/anae.2002.0424; Burns DA, 2011, J MICROBIOL METH, V87, P133, DOI 10.1016/j.mimet.2011.07.017; Burns DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024894; Burns DA, 2010, ANAEROBE, V16, P618, DOI 10.1016/j.anaerobe.2010.10.001; Burns DA, 2010, RES MICROBIOL, V161, P730, DOI 10.1016/j.resmic.2010.09.007; Burns DA, 2010, J BACTERIOL, V192, P657, DOI 10.1128/JB.01209-09; Cheng VCC, 2011, ENVIRON MODELL SOFTW, P1; Fawley WN, 2007, INFECT CONT HOSP EP, V28, P920, DOI 10.1086/519201; Howerton A, 2011, J BACTERIOL, V193, P274, DOI 10.1128/JB.00980-10; Hudson KD, 2001, J BACTERIOL, V183, P4317, DOI 10.1128/JB.183.14.4317-4322.2001; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kuijper EJ, 2007, CURR OPIN INFECT DIS, V20, P376; MEKHJIAN HS, 1979, DIGEST DIS SCI, V24, P545, DOI 10.1007/BF01489324; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Moir A, 2002, CELL MOL LIFE SCI, V59, P403, DOI 10.1007/s00018-002-8432-8; NORTHFIE.TC, 1973, GUT, V14, P513, DOI 10.1136/gut.14.7.513; Paidhungat M, 2000, J BACTERIOL, V182, P2513, DOI 10.1128/JB.182.9.2513-2519.2000; Paredes-Sabja D, 2009, J BACTERIOL, V191, P2711, DOI 10.1128/JB.01832-08; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Popham DL, 1996, J BACTERIOL, V178, P6451, DOI 10.1128/jb.178.22.6451-6458.1996; Poxton IR, 2001, CLIN MICROBIOL INFEC, V7, P421, DOI 10.1046/j.1198-743x.2001.00287.x; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; SEKIGUCHI J, 1995, J BACTERIOL, V177, P5582, DOI 10.1128/jb.177.19.5582-5589.1995; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Sorg JA, 2010, J BACTERIOL, V192, P4983, DOI 10.1128/JB.00610-10; Sorg JA, 2009, J BACTERIOL, V191, P1115, DOI 10.1128/JB.01260-08; Vohra P, 2011, MICROBIOL-SGM, V157, P1343, DOI 10.1099/mic.0.046243-0; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wheeldon LJ, 2008, J APPL MICROBIOL, V105, P2223, DOI 10.1111/j.1365-2672.2008.03965.x; Wilcox MH, 2000, LANCET, V356, P1324, DOI 10.1016/S0140-6736(00)02819-1; WILSON KH, 1982, J CLIN MICROBIOL, V15, P443, DOI 10.1128/JCM.15.3.443-446.1982; WILSON KH, 1983, J CLIN MICROBIOL, V18, P1017, DOI 10.1128/JCM.18.4.1017-1019.1983; Xiao YH, 2011, FOOD MICROBIOL, V28, P266, DOI 10.1016/j.fm.2010.03.016	38	88	96	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32381	10.1371/journal.pone.0032381	http://dx.doi.org/10.1371/journal.pone.0032381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384234	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500098
J	Homaira, N; Luby, SP; Petri, WA; Vainionpaa, R; Rahman, M; Hossain, K; Snider, CB; Rahman, M; Alamgir, ASM; Zesmin, F; Alam, M; Gurley, ES; Zaman, RU; Azim, T; Erdman, DD; Fry, AM; Bresee, J; Widdowson, MA; Haque, R; Azziz-Baumgartner, E				Homaira, Nusrat; Luby, Stephen P.; Petri, William A.; Vainionpaa, Raija; Rahman, Mustafizur; Hossain, Kamal; Snider, Cynthia B.; Rahman, Mahmudur; Alamgir, A. S. M.; Zesmin, Farzina; Alam, Masud; Gurley, Emily S.; Zaman, Rashid Uz; Azim, Tasnim; Erdman, Dean D.; Fry, Alicia M.; Bresee, Joseph; Widdowson, Marc-Alain; Haque, Rashidul; Azziz-Baumgartner, Eduardo			Incidence of Respiratory Virus-Associated Pneumonia in Urban Poor Young Children of Dhaka, Bangladesh, 2009-2011	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RISK-FACTORS; INFECTION; EPIDEMIOLOGY; ETIOLOGY; COHORT	Background: Pneumonia is the leading cause of childhood death in Bangladesh. We conducted a longitudinal study to estimate the incidence of virus-associated pneumonia in children aged <2 years in a low-income urban community in Dhaka, Bangladesh. Methods: We followed a cohort of children for two years. We collected nasal washes when children presented with respiratory symptoms. Study physicians diagnosed children with cough and age-specific tachypnea and positive lung findings as pneumonia case-patients. We tested respiratory samples for respiratory syncytial virus (RSV), rhinoviruses, human metapneumovirus (HMPV), influenza viruses, human parainfluenza viruses (HPIV 1, 2, 3), and adenoviruses using real-time reverse transcription polymerase chain reaction assays. Results: Between April 2009-March 2011, we followed 515 children for 730 child-years. We identified a total of 378 pneumonia episodes, 77% of the episodes were associated with a respiratory viral pathogen. The overall incidence of pneumonia associated with a respiratory virus infection was 40/100 child-years. The annual incidence of pneumonia/100 child-years associated with a specific respiratory virus in children aged <2years was 12.5 for RSV, 6 for rhinoviruses, 6 for HMPV, 4 for influenza viruses, 3 for HPIV and 2 for adenoviruses. Conclusion: Young children in Dhaka are at high risk of childhood pneumonia and the majority of these episodes are associated with viral pathogens. Developing effective low-cost strategies for prevention are a high priority.	[Homaira, Nusrat; Luby, Stephen P.; Rahman, Mustafizur; Hossain, Kamal; Zesmin, Farzina; Alam, Masud; Gurley, Emily S.; Zaman, Rashid Uz; Azim, Tasnim; Haque, Rashidul; Azziz-Baumgartner, Eduardo] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Luby, Stephen P.; Erdman, Dean D.; Fry, Alicia M.; Bresee, Joseph; Widdowson, Marc-Alain; Azziz-Baumgartner, Eduardo] Ctr Dis Control & Prevent CDC, Atlanta, GA USA; [Petri, William A.; Snider, Cynthia B.] Univ Virginia, Jack Jouett, VA USA; [Vainionpaa, Raija] Univ Turku, Turku, Finland; [Rahman, Mahmudur; Alamgir, A. S. M.] Inst Epidemiol Dis Control & Res, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); Centers for Disease Control & Prevention - USA; University of Virginia; University of Turku	Homaira, N (corresponding author), Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh.	nhomaira@icddrb.org	Petri, William A./D-3639-2019; Gurley, Emily S/B-7903-2010; rahman, mustafizur/E-6918-2010; Petri, William/AAL-3642-2020; Homaira, Nusrat/U-4526-2019; Zaman, Rashid/AAM-5209-2020	Gurley, Emily S/0000-0002-8648-9403; Petri, William/0000-0002-7268-1218; Homaira, Nusrat/0000-0003-3341-7964; Zaman, Rashid/0000-0002-8556-4993; Widdowson, Marc-Alain/0000-0002-0682-6933	Influenza Division of Centers for Disease Control and Prevention (CDC), Atlanta [1U01CI000628-01]; University of Virginia (UVA) under the NIH [RO1 AI043596]; National Center for Preparedness, Detection, and Control of Infectious Diseases [U01CI000628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007046, R01AI043596] Funding Source: NIH RePORTER	Influenza Division of Centers for Disease Control and Prevention (CDC), Atlanta; University of Virginia (UVA) under the NIH; National Center for Preparedness, Detection, and Control of Infectious Diseases(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the Influenza Division of Centers for Disease Control and Prevention (CDC), Atlanta under the co-operative agreement number 1U01CI000628-01 and University of Virginia (UVA) under the NIH grant RO1 AI043596 to WAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4490; AUSINA V, 1988, EUR J CLIN MICROBIOL, V7, P343, DOI 10.1007/BF01962334; Bangladesh Bureau of Statistics, 2009, 2008 STAT YB BANGL; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; BORRERO I, 1990, REV INFECT DIS, V12, pS950; Brooks WA, 2009, PEDIATR INFECT DIS J, V9, P1; Broor S, 2001, Indian Pediatr, V38, P1361; Calegari Tatiany, 2005, Braz J Infect Dis, V9, P156, DOI 10.1590/S1413-86702005000200006; Centers for Disease Control and Prevention (CDC), 2003, SEASONAL FLU; Centers for Disease Control and Prevention (CDC), 2007, SEASONAL FLU; Cilla G, 2008, J MED VIROL, V80, P1843, DOI 10.1002/jmv.21271; COLLINS PL, 2001, FIELDS VIROLOGY, P1443; Darville T, 1998, PEDIAT REV, V19; Ekalaksananan Tipaya, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P513; Forgie IM, 1991, PEDIAT INFECT DIS J, V10; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Halder AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008145; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hasan K, 2006, SCAND J INFECT DIS, V38, P690, DOI 10.1080/00365540600606473; Henrickson Kelly J, 1998, Semin Pediatr Infect Dis, V9, P217, DOI 10.1016/S1045-1870(98)80035-6; Huq F, 1990, REV INFECT DIS, V12; ICDDRB, 2009, HLTH SCI B, V7, P1; Jartti T, 2004, J MED VIROLOGY, V72; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; KORPPI M, 1993, EUR J PEDIATR, V152, P24, DOI 10.1007/BF02072512; Luby SP, 2009, CLIN INFECT DIS, V48, pS97, DOI 10.1086/596487; Meissner HC, 2005, PEDIATR CLIN N AM, V52, P695, DOI 10.1016/j.pcl.2005.02.010; National Institute of population Research and training (NIPORT), 2009, BANGL DEM HLTH SURV; Nokes DJ, 2004, J INFECT DIS, V190, P1828, DOI 10.1086/425040; O'Brien KL, 2000, CLIN INFECT DIS, V30, P784, DOI 10.1086/313772; Peng D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-155; RobertsonI SE, 2004, B WHO, V82; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Savitha MR, 2007, INDIAN J PEDIATR, V74, P477, DOI 10.1007/s12098-007-0081-3; Sinaniotis C A, 2004, Paediatr Respir Rev, V5 Suppl A, pS197, DOI 10.1016/S1526-0542(04)90037-1; Sinaniotis CA, 2005, CURR OPIN PULM MED, V11, P218, DOI 10.1097/01.mcp.0000159831.82529.85; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; Smyth A, 2002, BRIT MED BULL, V61, P247, DOI 10.1093/bmb/61.1.247; Tsai HP, 2001, J CLIN MICROBIOL, V39, P111, DOI 10.1128/JCM.39.1.111-118.2001; VATHANOPHAS K, 1990, REV INFECT DIS, V12, pS957; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; Weber MW, 1999, INT J EPIDEMIOL, V28, P157, DOI 10.1093/ije/28.1.157; WHO, 2007, WORLD HLTH STAT; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; World Health Organization, 2008, WHO STAT INF SYST WH; World Health Organization, 2000, MAN CHILD SER INF SE; World Health Organization, 2008, CHILD MORT; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; Zaman RU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008452	49	61	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32056	10.1371/journal.pone.0032056	http://dx.doi.org/10.1371/journal.pone.0032056			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384139	Green Submitted, Green Published, gold			2022-12-27	WOS:000302875500068
J	Smets, PMY; Lefebvre, HP; Aresu, L; Croubels, S; Haers, H; Piron, K; Meyer, E; Daminet, S				Smets, Pascale M. Y.; Lefebvre, Herve P.; Aresu, Luca; Croubels, Siska; Haers, Hendrik; Piron, Koen; Meyer, Evelyne; Daminet, Sylvie			Renal Function and Morphology in Aged Beagle Dogs Before and after Hydrocortisone Administration	PLOS ONE			English	Article							PITUITARY-DEPENDENT HYPERADRENOCORTICISM; GLOMERULAR-FILTRATION-RATE; RETINOL-BINDING-PROTEIN; CUSHINGS-DISEASE; URINE PROTEIN; EXOGENOUS CREATININE; GEL-ELECTROPHORESIS; ARTERIAL-PRESSURE; KIDNEY-DISEASE; BLOOD-PRESSURE	Objectives of this study were to evaluate glomerular filtration rate (GFR), renal structural changes and proteinuria in aged Beagle dogs before and after hydrocortisone (HC) administration. Eleven Beagle dogs >= 10 years old were treated with either hydrocortisone (HC group, n = 6) or placebo (control group, n = 5). Urinary markers, GFR and kidney biopsies were evaluated before (T0), during (T16 wks) and after discontinuing HC administration (T24 wks). Results indicate that HC administration causes a significant increase in GFR. At all time points except T16 wks, proteinuria was higher in the control group than in the HC group, and there was no significant difference in urinary markers between groups. At T16 wks, proteinuria, urinary albumin-to-creatinine (c) ratio, immunoglobulin G/c and retinol-binding protein/c were higher compared to baseline in the HC group. At T0, rare to mild renal lesions were detected in all HC dogs and rare to moderate changes in all control dogs. Glomerulosclerosis progressed in both groups until T24 wks. Tubular atrophy was detected in three HC dogs at T16 wks and T24 wks, but also in five control dogs throughout the study. At every time point, five HC dogs and all control dogs had rare to moderate interstitial inflammation. Rare to mild interstitial fibrosis was found in up to three HC dogs at T16 wks and T24 wks, and severe fibrosis in one HC dog at T24 wks. Up to four control dogs had rare to mild fibrosis at all time points. These findings indicate that clinically healthy, aged Beagle dogs may have considerable renal lesions and proteinuria, which could have implications for experimental or toxicological studies. Additional research is needed to elucidate glucocorticoid effects on renal structure, but functional changes such as hyperfiltration and proteinuria warrant attention to kidney function of canine patients with Cushing's syndrome or receiving exogenous glucocorticoids.	[Smets, Pascale M. Y.; Piron, Koen; Daminet, Sylvie] Univ Ghent, Fac Vet Med, Dept Small Anim Med & Clin Biol, Salisburylaan, Merelbeke, Belgium; [Lefebvre, Herve P.] Univ Toulouse, INP, Ecole Natl Vet Toulouse, Unite Rech Clin, Toulouse, France; [Lefebvre, Herve P.] Univ Toulouse, INP, Ecole Natl Vet Toulouse, Dept Clin Sci, Toulouse, France; [Aresu, Luca] Univ Padua, Fac Vet Med, Dept Publ Hlth Comparat Pathol & Vet Hyg, Agripolis Legnaro Pd, Italy; [Croubels, Siska; Meyer, Evelyne] Univ Ghent, Fac Vet Med, Dept Pharmacol Toxicol & Biochem, Salisburylaan, Merelbeke, Belgium; [Haers, Hendrik] Univ Ghent, Fac Vet Med, Dept Med Imaging, Salisburylaan, Merelbeke, Belgium	Ghent University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; University of Padua; Ghent University; Ghent University	Smets, PMY (corresponding author), Univ Ghent, Fac Vet Med, Dept Small Anim Med & Clin Biol, Salisburylaan, Merelbeke, Belgium.	Pascale.Smets@Ugent.be	; Aresu, Luca/J-9788-2018	Daminet, Sylvie/0000-0001-6733-7925; Croubels, Siska/0000-0001-6357-3517; Aresu, Luca/0000-0002-7893-1740	Fund for Scientific Research Flanders, Belgium [17800]	Fund for Scientific Research Flanders, Belgium(FWO)	This manuscript was supported by the Fund for Scientific Research Flanders, Belgium (grant nr. 17800, www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aresu L, 2008, VET REC, V163, P679; BAYLIS C, 1990, SEMIN NEPHROL, V10, P320; CASTAGNARO M, 1987, SCHWEIZ ARCH TIERH, V129, P545; CONNELL JMC, 1987, J HYPERTENS, V5, P425; de Bruin C, 2009, HORM RES, V71, P140, DOI 10.1159/000178058; Esposito C, 2007, J NEPHROL, V20, P617; FINCO DR, 1994, AM J VET RES, V55, P1282; Fuiano G, 2001, KIDNEY INT, V59, P1052; Goy-Thollot I, 2002, J SMALL ANIM PRACT, V43, P489, DOI 10.1111/j.1748-5827.2002.tb00019.x; GRAUER GF, 1985, AM J VET RES, V46, P2116; Groman RP, 2004, VET RADIOL ULTRASOUN, V45, P62, DOI 10.1111/j.1740-8261.2004.04010.x; Haentjens P, 2005, EUR J ENDOCRINOL, V153, P819, DOI 10.1530/eje.1.02040; Haers H, 2011, VET RADIOL ULTRASOUN, V52, P640, DOI 10.1111/j.1740-8261.2011.01843.x; HALL JE, 1980, HYPERTENSION, V2, P139, DOI 10.1161/01.HYP.2.2.139; Heiene R, 2007, ACTA VET SCAND, V49, DOI 10.1186/1751-0147-49-13; Hsieh CK, 2007, CLIN NEPHROL, V67, P109; Hurley KJ, 1998, J AM VET MED ASSOC, V212, P369; IKEDA H, 1985, MECH AGEING DEV, V33, P77, DOI 10.1016/0047-6374(85)90110-1; KAPLAN C, 1975, AM J PATHOL, V80, P227; Koh JM, 2000, CLIN ENDOCRINOL, V52, P349; Kubota E, 2001, CLIN EXP NEPHROL, V5, P186, DOI [10.1007/s101570170009, DOI 10.1007/S101570170009]; Le Garreres A, 2007, J FELINE MED SURG, V9, P89, DOI 10.1016/j.jfms.2006.08.003; Lees GE, 2005, J VET INTERN MED, V19, P377, DOI 10.1892/0891-6640(2005)19[377:AAMOPI]2.0.CO;2; Lees GE, 2011, TOP COMPANION ANIM M, V26, P143, DOI 10.1053/j.tcam.2011.04.006; LINDEMAN R D, 1986, Comprehensive Therapy, V12, P43; Maddens B, 2010, J VET INTERN MED, V24, P1263, DOI 10.1111/j.1939-1676.2010.0603.x; Maddens BEJ, 2010, VET IMMUNOL IMMUNOP, V134, P259, DOI 10.1016/j.vetimm.2009.09.003; MANNING RD, 1987, AM J PHYSIOL, V252, pF403, DOI 10.1152/ajprenal.1987.252.3.F403; Martin JE, 2007, J PATHOL, V211, P198, DOI 10.1002/path.2111; Mathieu M, 2006, AM J VET RES, V67, P1236, DOI 10.2460/ajvr.67.7.1236; MCLACHLAN MSF, 1977, J PATHOL, V121, P65, DOI 10.1002/path.1711210202; Nishida E, 1996, EXP ANIM TOKYO, V45, P339, DOI 10.1538/expanim.45.339; ORTH DN, 1995, NEW ENGL J MED, V332, P791, DOI 10.1056/NEJM199503233321207; Pomeroy MJ, 2004, TOXICOL PATHOL, V32, P237, DOI 10.1080/01926230490274407; Pugliese A, 2005, VET RES COMMUN, V29, P57, DOI 10.1007/s11259-005-0012-6; Raila J, 2003, AM J VET RES, V64, P874, DOI 10.2460/ajvr.2003.64.874; Raila J, 2010, AM J VET RES, V71, P1387, DOI 10.2460/ajvr.71.11.1387; RIJNBERK A, 1968, J ENDOCRINOL, V41, P397, DOI 10.1677/joe.0.0410397; Schellenberg S, 2008, J VET INTERN MED, V22, P273, DOI 10.1111/j.1939-1676.2007.0039.x; Silva Fred G., 2005, International Urology and Nephrology, V37, P419, DOI 10.1007/s11255-004-0874-5; Silva Fred G., 2005, International Urology and Nephrology, V37, P185, DOI 10.1007/s11255-004-0873-6; Smets PMY, 2010, J VET INTERN MED, V24, P65, DOI 10.1111/j.1939-1676.2009.0426.x; STUART BP, 1975, VET PATHOL, V12, P125, DOI 10.1177/030098587501200205; Stuart S, 2001, AM J KIDNEY DIS, V37, DOI 10.1053/ajkd.2001.22865; TATSUMI T, 1995, INTERNAL MED, V34, P10, DOI 10.2169/internalmedicine.34.10; Torng S, 2001, TRANSPLANTATION, V72, P1453, DOI 10.1097/00007890-200110270-00021; Vaden SL, 2005, CLIN TECH SMALL AN P, V20, P11, DOI 10.1053/j.ctsap.2004.12.003; van Hoek I, 2007, J VET INTERN MED, V21, P950, DOI 10.1892/0891-6640(2007)21[950:CAROPC]2.0.CO;2; VANACKER BAC, 1993, NEPHRON, V65, P254, DOI 10.1159/000187484; Vinge L, 2010, NEPHROL DIAL TRANSPL, V25, P2458, DOI 10.1093/ndt/gfq044; Waters CB, 1997, J VET INTERN MED, V11, P172, DOI 10.1111/j.1939-1676.1997.tb00086.x; Watson ADJ, 2002, J VET INTERN MED, V16, P22, DOI 10.1892/0891-6640(2002)016&lt;0022:PECCTI&gt;2.3.CO;2; Yalcin A, 2004, REV MED VET-TOULOUSE, V155, P104; Zaragoza C, 2003, J COMP PATHOL, V129, P169, DOI 10.1016/S0021-9975(03)00029-X; Zini E, 2004, AM J VET RES, V65, P964, DOI 10.2460/ajvr.2004.65.964	55	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31702	10.1371/journal.pone.0031702	http://dx.doi.org/10.1371/journal.pone.0031702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393368	Green Submitted, gold, Green Published			2022-12-27	WOS:000303003500021
J	Hou, LF; He, SJ; Li, X; Wan, CP; Yang, Y; Zhang, XH; He, PL; Zhou, Y; Zhu, FH; Yang, YF; Li, Y; Tang, W; Zuo, JP				Hou, Li-Fei; He, Shi-Jun; Li, Xin; Wan, Chun-Ping; Yang, Yang; Zhang, Xiao-Hui; He, Pei-Lan; Zhou, Yu; Zhu, Feng-Hua; Yang, Yi-Fu; Li, Ying; Tang, Wei; Zuo, Jian-Ping			SM934 Treated Lupus-Prone NZBxNZW F-1 Mice by Enhancing Macrophage Interleukin-10 Production and Suppressing Pathogenic T Cell Development	PLOS ONE			English	Article							MURINE LUPUS; AUTOANTIBODY PRODUCTION; THERAPEUTIC TARGETS; DISEASE-ACTIVITY; MRL/LPR MICE; ERYTHEMATOSUS; RESPONSES; GAMMA; ARTEMISININ; IL-17	Background: Artemisinin and its derivatives were reported to possess strong regulatory effects on inflammation and autoimmune diseases. This study was designed to examine the therapeutic effects and underlying mechanisms of SM934, a water-soluble artemisinin analogue, on lupus-prone female NZBxNZW F-1 mice. Methodology/Principal Findings: NZB/W F-1 mice were treated orally with SM934 for 3 or 6 months respectively to investigate the effect on clinical manifestations and immunological correlates. To further explore the mechanisms of SM934, ovalbumin (OVA)-immunized or interferon (IFN)-gamma-elicited C57BL/6 mice were used. In vivo, treatment with SM934 for 3 or 6 months significantly delayed the progression of glomerulonephritis and increased the survival rate of NZB/W F1 mice. Clinical improvement was accompanied with decreased Th1-related anti-double-strand DNA (dsDNA) IgG2a and IgG3 Abs, serum interleukin (IL)-17, and increased Th2-related anti-dsDNA IgG1 Ab, serum IL-10 and IL-4. SM934 treatment also suppressed the accumulation of effector/memory T cells, induced the apoptosis of CD4(+) T cells, while enhancing the development of regulatory T cells in NZB/W F-1 mice. In addition, SM934 treatment promoted the IL-10 production of macrophages from NZB/W F-1 mice, OVA-immunized C57BL/6 mice and IFN-gamma-elicited C57BL/6 mice. In vitro, SM934 enhanced IL-10 production from primary macrophages stimulated with IFN-gamma. Conclusions/Significance: The results of this study demonstrated that artemisinin analogue SM934 had therapeutic effects on lupus-prone female NZB/W F-1 mice by inhibiting the pathogenic helper T cell development and enhancing anti-inflammatory cytokine IL-10 production.	[Hou, Li-Fei; He, Shi-Jun; Li, Xin; He, Pei-Lan; Zhou, Yu; Zhu, Feng-Hua; Tang, Wei; Zuo, Jian-Ping] Chinese Acad Sci, Shanghai Inst Mat Med, Lab Immunopharmacol, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Wan, Chun-Ping; Yang, Yang; Zhang, Xiao-Hui; Yang, Yi-Fu; Zuo, Jian-Ping] Shanghai Univ Tradit Chinese Med, Lab Immunol & Virol, Shanghai, Peoples R China; [Li, Ying] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Synthet Chem, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai University of Traditional Chinese Medicine; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Hou, LF (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Lab Immunopharmacol, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	jpzuo@mail.shcnc.ac.cn		Hou, Lifei/0000-0001-8975-7795	Science & Technology Commission of Shanghai Municipality, China [08XD14053]; National Science & Technology Major Project "New Drug Creation and Manufacturing Program", China [2009ZX09301-001, 2009ZX09102-019]	Science & Technology Commission of Shanghai Municipality, China(Science & Technology Commission of Shanghai Municipality (STCSM)); National Science & Technology Major Project "New Drug Creation and Manufacturing Program", China	This work was supported by the grants of Science & Technology Commission of Shanghai Municipality, China (No. 08XD14053), and National Science & Technology Major Project "New Drug Creation and Manufacturing Program", China (2009ZX09301-001, 2009ZX09102-019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahoshi M, 1999, ARTHRITIS RHEUM, V42, P1644, DOI 10.1002/1529-0131(199908)42:8<1644::AID-ANR12>3.0.CO;2-L; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Blenman KRM, 2006, LAB INVEST, V86, P1136, DOI 10.1038/labinvest.3700468; Boross P, 2011, J IMMUNOL, V187, P1304, DOI 10.4049/jimmunol.1101194; Brian LK, 1996, CELL, V85, P303; Crispin JC, 2010, CURR OPIN RHEUMATOL, V22, P499, DOI 10.1097/BOR.0b013e32833c62b0; Crispin JC, 2010, NAT REV RHEUMATOL, V6, P317, DOI 10.1038/nrrheum.2010.60; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Feng T, 2011, J IMMUNOL, V186, P6313, DOI 10.4049/jimmunol.1001454; Garrett-Sinha LA, 2008, CURR OPIN RHEUMATOL, V20, P519, DOI 10.1097/BOR.0b013e328304b6b5; Gergely P, 2002, J IMMUNOL, V169, P1092, DOI 10.4049/jimmunol.169.2.1092; Haas C, 1998, J IMMUNOL, V160, P3713; He DG, 2009, J IMMUNOL, V183, P1463, DOI 10.4049/jimmunol.0804108; Hou LF, 2011, ARTHRITIS RHEUM-US, V63, P2445, DOI 10.1002/art.30392; Hou LF, 2009, INT IMMUNOPHARMACOL, V9, P1509, DOI 10.1016/j.intimp.2009.09.003; HOUSSIAU FA, 1995, LUPUS, V4, P393, DOI 10.1177/096120339500400510; Hughes GC, 2009, ARTHRITIS RHEUM, V60, P1775, DOI 10.1002/art.24548; Humrich JY, 2010, P NATL ACAD SCI USA, V107, P204, DOI 10.1073/pnas.0903158107; ISHIDA H, 1994, J EXP MED, V179, P305, DOI 10.1084/jem.179.1.305; Jin OY, 2009, CELL MOL IMMUNOL, V6, P461, DOI 10.1038/cmi.2009.58; Kaneko Y, 2006, J EXP MED, V203, P789, DOI 10.1084/jem.20051900; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Llorente L, 2000, ARTHRITIS RHEUM, V43, P1790, DOI 10.1002/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2; Llorente L, 2003, J AUTOIMMUN, V20, P287, DOI 10.1016/S0896-8411(03)00043-X; Lu Lan, 2002, Zhongguo Zhong Xi Yi Jie He Za Zhi, V22, P169; Masutani K, 2001, ARTHRITIS RHEUM, V44, P2097, DOI 10.1002/1529-0131(200109)44:9<2097::AID-ART360>3.0.CO;2-6; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Miyara M, 2005, J IMMUNOL, V175, P8392, DOI 10.4049/jimmunol.175.12.8392; Monk CR, 2005, ARTHRITIS RHEUM, V52, P1180, DOI 10.1002/art.20976; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Park YB, 1998, CLIN EXP RHEUMATOL, V16, P283; Peng SL, 1997, J CLIN INVEST, V99, P1936, DOI 10.1172/JCI119361; Reilly CM, 2002, IMMUNOL RES, V25, P143, DOI 10.1385/IR:25:2:143; Renno T, 1998, EUR J IMMUNOL, V28, P540, DOI 10.1002/(SICI)1521-4141(199802)28:02<540::AID-IMMU540>3.3.CO;2-P; Renno T, 1996, J EXP MED, V183, P431, DOI 10.1084/jem.183.2.431; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Sanz I, 2010, NAT REV RHEUMATOL, V6, P326, DOI 10.1038/nrrheum.2010.68; Scalapino KJ, 2006, J IMMUNOL, V177, P1451, DOI 10.4049/jimmunol.177.3.1451; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Wang JX, 2008, BRIT J PHARMACOL, V153, P1303, DOI 10.1038/bjp.2008.11; Wang JX, 2007, BRIT J PHARMACOL, V150, P652, DOI 10.1038/sj.bjp.0707137; Wang JX, 2009, ACTA PHARMACOL SIN, V30, P1428, DOI 10.1038/aps.2009.138; Wang L, 2008, NAT IMMUNOL, V9, P186, DOI 10.1038/ni1548; Wu XL, 2010, ACTA BIOCH BIOPH SIN, V42, P916, DOI 10.1093/abbs/gmq101; Yin ZN, 2002, J IMMUNOL, V169, P2148, DOI 10.4049/jimmunol.169.4.2148; Yuan WJ, 2011, ARTHRITIS RHEUM-US, V63, P212, DOI 10.1002/art.30083; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	49	49	59	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32424	10.1371/journal.pone.0032424	http://dx.doi.org/10.1371/journal.pone.0032424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389703	gold, Green Submitted, Green Published			2022-12-27	WOS:000302999600041
J	Kategaya, LS; Hilliard, A; Zhang, LY; Asara, JM; Ptacek, LJ; Fu, YH				Kategaya, Lorna S.; Hilliard, Aisha; Zhang, Louying; Asara, John M.; Ptacek, Louis J.; Fu, Ying-Hui			Casein Kinase 1 Proteomics Reveal Prohibitin 2 Function in Molecular Clock	PLOS ONE			English	Article								Throughout the day, clock proteins synchronize changes in animal physiology (e.g., wakefulness and appetite) with external cues (e.g., daylight and food). In vertebrates, both casein kinase 1 delta and epsilon (CK1 delta and CK1 epsilon) regulate these circadian changes by phosphorylating other core clock proteins. In addition, CK1 can regulate circadian-dependent transcription in a non-catalytic manner, however, the mechanism is unknown. Furthermore, the extent of functional redundancy between these closely related kinases is debated. To further advance knowledge about CK1 delta and CK1 epsilon mechanisms of action in the biological clock, we first carried out proteomic analysis of both kinases in human cells. Next, we tested interesting candidates in a cell-based circadian readout which resulted in the discovery of PROHIBITIN 2 (PHB2) as a modulator of period length. Decreasing the expression of PHB2 increases circadian-driven transcription, thus revealing PHB2 acts as an inhibitor in the molecular clock. While stable binding of PHB2 to either kinase was not detected, knocking down CK1 epsilon expression increases PHB2 protein levels and, unexpectedly, knocking down CK1 delta decreases PHB2 transcript levels. Thus, isolating CK1 protein complexes led to the identification of PHB2 as an inhibitor of circadian transcription. Furthermore, we show that CK1 delta and CK1 epsilon differentially regulate the expression of PHB2.	[Kategaya, Lorna S.; Hilliard, Aisha; Zhang, Louying; Ptacek, Louis J.; Fu, Ying-Hui] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Ptacek, Louis J.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Asara, John M.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Signal Transduct, Boston, MA 02215 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Kategaya, LS (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	ljp@ucsf.edu; ying-hui.fu@ucsf.edu			National Institutes of Health [GM079180, HL059596]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079180] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health grant GM079180 and HL059596 to LP and YF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Brown SA, 2005, SCIENCE, V308, P693, DOI 10.1126/science.1107373; Hogenesch JB, 2000, J NEUROSCI, V20, part. no.; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Kim JW, 2009, CANCER SCI, V100, P1468, DOI 10.1111/j.1349-7006.2009.01209.x; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Ko CH, 2006, HUM MOL GENET, V89, P184; Koch A, 2010, EUR J CELL BIOL, pR271; MATTSON G, 1993, MOL BIOL REP, V17, P167, DOI 10.1007/BF00986726; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Volkel P, 2010, BIOCHEM SOC T, V38, P883, DOI 10.1042/BST0380883; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yu WJ, 2009, MOL CELL BIOL, V29, P1452, DOI 10.1128/MCB.01777-08; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zhao J, 2003, CELL, V113, P755, DOI 10.1016/S0092-8674(03)00400-8	16	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31987	10.1371/journal.pone.0031987	http://dx.doi.org/10.1371/journal.pone.0031987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384121	Green Published, gold, Green Submitted			2022-12-27	WOS:000302918500052
J	Niclasen, J; Teasdale, TW; Andersen, AMN; Skovgaard, AM; Elberling, H; Obel, C				Niclasen, Janni; Teasdale, Thomas William; Andersen, Anne-Marie Nybo; Skovgaard, Anne Mette; Elberling, Hanne; Obel, Carsten			Psychometric Properties of the Danish Strength and Difficulties Questionnaire: The SDQ Assessed for More than 70,000 Raters in Four Different Cohorts	PLOS ONE			English	Article							CHILD MENTAL-HEALTH; PSYCHIATRIC-DISORDERS; NORMATIVE DATA; RISK-FACTORS; PREVALENCE; COUNTRIES; BEHAVIOR; VERSION	Background: The Strength and Difficulties Questionnaire (SDQ) is a brief behavioural five factor instrument developed to assess emotional and behavioural problems in children and adolescents. The aim of the current study was to evaluate the psychometric properties for parent and teacher ratings in the Danish version of SDQ for different age groups of boys and girls. Methods: The Danish versions of the SDQ were distributed to a total of 71,840 parent and teacher raters of 5-, 7- and 10- to 12-year-old children included in four large scale Danish cohorts. The internal reliability was assessed and exploratory factor analyses were carried out to replicate the originally proposed five factor structure. Mean scores and percentiles were examined in order to differentiate between low, medium and high levels of emotional and behavioural difficulties. Results: The original five factor structure could be substantially confirmed. The Conduct items however did not solely load on the proposed Conduct scale and the Conduct scale was further contaminated by non-conduct items. Positively worded items tended to load on the Prosocial scale. This was more so the case for teachers than for parents. Parent and teacher means and percentiles were found to be lower compared to British figures but similar to or only slightly lower than those found in the other Nordic countries. The percentiles for girls were generally lower than for boys, markedly so for the teacher hyperactivity ratings. Conclusions: The study supports the usefulness of the SDQ as a screening tool for boys and girls across age groups and raters in the general Danish population.	[Niclasen, Janni; Teasdale, Thomas William] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Andersen, Anne-Marie Nybo] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Skovgaard, Anne Mette; Elberling, Hanne] Copenhagen Univ Hosp, Child & Adolescent Psychiat Ctr Glostrup, Copenhagen, Denmark; [Obel, Carsten] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Aarhus University	Niclasen, J (corresponding author), Univ Copenhagen, Dept Psychol, Copenhagen, Denmark.	Janni.niclasen@psy.ku.dk	Andersen, Anne-Marie Nybo/E-4993-2013; Nybo Andersen, Anne-Marie/AAA-1997-2022; Obel, Carsten/H-9605-2016	Andersen, Anne-Marie Nybo/0000-0002-4296-8488; Nybo Andersen, Anne-Marie/0000-0002-4296-8488; Obel, Carsten/0000-0001-5004-1933; Skovgaard, Anne Mette/0000-0002-8793-8303	Department of Psychology, University of Copenhagen; Ludvig og Sara Elsass Foundation; Aase og Ejnar Danielsens Foundation; Carl J. Becker's Foundation; Lundbeck Foundation; Borne- og Ungdomspsykiatrisk Selskab i Danmark; Dagmar Marshalls Foundation; Fonden til Laegevidenskabens Fremme; Direktor Jakob Madsens Legat	Department of Psychology, University of Copenhagen; Ludvig og Sara Elsass Foundation; Aase og Ejnar Danielsens Foundation; Carl J. Becker's Foundation; Lundbeck Foundation(Lundbeckfonden); Borne- og Ungdomspsykiatrisk Selskab i Danmark; Dagmar Marshalls Foundation; Fonden til Laegevidenskabens Fremme; Direktor Jakob Madsens Legat	This work was supported by the Department of Psychology, University of Copenhagen; Ludvig og Sara Elsass Foundation; Aase og Ejnar Danielsens Foundation; Carl J. Becker's Foundation; Lundbeck Foundation; Borne- og Ungdomspsykiatrisk Selskab i Danmark; Dagmar Marshalls Foundation; Fonden til Laegevidenskabens Fremme; Direktor Jakob Madsens Legat. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 2008, J CHILD PSYCHOL PSYC, V49, P251, DOI 10.1111/j.1469-7610.2007.01867.x; [Anonymous], AARHUS BIRTH COHORT; Bilenberg N, 2005, ACTA PSYCHIAT SCAND, V111, P59, DOI 10.1111/j.1600-0447.2004.00432.x; Bourdon KH, 2005, J AM ACAD CHILD PSY, V44, P557, DOI 10.1097/01.chi.0000159157.57075.c8; Christensen E., 2004, 0413 SOC, V04, P13; Dickey WC, 2004, J AM ACAD CHILD PSY, V43, P1159, DOI 10.1097/01.chi.0000132808.36708.a9; DU Y, 2008, CHILD ADOL PSYCH CL, V29, P8; Elberling H, 2010, EUR CHILD ADOLES PSY, V19, P725, DOI 10.1007/s00787-010-0110-z; Ford T, 2003, J AM ACAD CHILD PSY, V42, P1203, DOI 10.1097/00004583-200310000-00011; Goodman A, 2010, J ABNORM CHILD PSYCH, V38, P1179, DOI 10.1007/s10802-010-9434-x; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Goodman R, 2005, EUR CHILD ADOLES PSY, V14, P28, DOI 10.1007/s00787-005-0420-8; Goodman R, 2005, SOC PSYCH PSYCH EPID, V40, P11, DOI 10.1007/s00127-005-0851-z; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Heiervang E, 2007, J AM ACAD CHILD PSY, V46, P438, DOI 10.1097/chi.0b013e31803062bf; Jackson DA, 2004, J ABNORM CHILD PSYCH, V32, P215, DOI 10.1023/B:JACP.0000019772.71251.ff; Jacobsen TN, 2010, EUR J EPIDEMIOL, V25, P349, DOI 10.1007/s10654-010-9448-2; Marzocchi GM, 2004, EUR CHILD ADOLES PSY, V13, P40, DOI 10.1007/s00787-004-2007-1; Mellor D, 2004, PSYCHOL ASSESSMENT, V16, P396, DOI 10.1037/1040-3590.16.4.396; Meltzer H, 2003, INT REV PSYCHIATR, V15, P185, DOI 10.1080/0954026021000046155; Mullick MSI, 2005, SOC PSYCH PSYCH EPID, V40, P663, DOI 10.1007/s00127-005-0939-5; Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60; Obel C, 2004, EUR CHILD ADOLES PSY, V13, P32, DOI 10.1007/s00787-004-2006-2; Obel C., 2003, DAN MED BULL, V27, P462; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Sanne B, 2009, PSYCHOL ASSESSMENT, V21, P352, DOI 10.1037/a0016317; Shojaei T, 2009, SOC PSYCH PSYCH EPID, V44, P740, DOI 10.1007/s00127-008-0489-8; Skovgaard AM, 2005, SCAND J PUBLIC HEALT, V33, P197, DOI 10.1080/14034940510005662; Smedje H, 1999, EUR CHILD ADOLES PSY, V8, P63, DOI 10.1007/s007870050086; Stone LL, 2010, CLIN CHILD FAM PSYCH, V13, P254, DOI 10.1007/s10567-010-0071-2; van Widenfelt BM, 2003, EUR CHILD ADOLES PSY, V12, P281, DOI 10.1007/s00787-003-0341-3; Woerner W, 2004, EUR CHILD ADOLES PSY, V13, P3, DOI 10.1007/s00787-004-2002-6	34	135	135	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32025	10.1371/journal.pone.0032025	http://dx.doi.org/10.1371/journal.pone.0032025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	927OV	22384129	Green Published, gold, Green Submitted			2022-12-27	WOS:000302918500054
J	Miller, MA; Stabenow, JM; Parvathareddy, J; Wodowski, AJ; Fabrizio, TP; Bina, XWR; Zalduondo, L; Bina, JE				Miller, Mark A.; Stabenow, Jennifer M.; Parvathareddy, Jyothi; Wodowski, Andrew J.; Fabrizio, Thomas P.; Bina, Xiaowen R.; Zalduondo, Lillian; Bina, James E.			Visualization of Murine Intranasal Dosing Efficiency Using Luminescent Francisella tularensis: Effect of Instillation Volume and Form of Anesthesia	PLOS ONE			English	Article							ENDOTRACHEAL INTUBATION; PSEUDOMONAS-AERUGINOSA; TISSUE DISTRIBUTION; TULAREMIA VACCINE; INFECTION; MICE; MOUSE; DELIVERY; MODEL; LIVE	Intranasal instillation is a widely used procedure for pneumonic delivery of drugs, vaccine candidates, or infectious agents into the respiratory tract of research mice. However, there is a paucity of published literature describing the efficiency of this delivery technique. In this report we have used the murine model of tularemia, with Francisella tularensis live vaccine strain (FTLVS) infection, to evaluate the efficiency of pneumonic delivery via intranasal dosing performed either with differing instillation volumes or different types of anesthesia. FTLVS was rendered luminescent via transformation with a reporter plasmid that constitutively expressed the Photorhabdus luminescens lux operon from a Francisella promoter. We then used an IVIS Spectrum whole animal imaging system to visualize FT dissemination at various time points following intranasal instillation. We found that instillation of FT in a dose volume of 10 mu l routinely resulted in infection of the upper airways but failed to initiate infection of the pulmonary compartment. Efficient delivery of FT into the lungs via intranasal instillation required a dose volume of 50 mu l or more. These studies also demonstrated that intranasal instillation was significantly more efficient for pneumonic delivery of FTLVS in mice that had been anesthetized with inhaled (isoflurane) vs. parenteral (ketamine/xylazine) anesthesia. The collective results underscore the need for researchers to consider both the dose volume and the anesthesia type when either performing pneumonic delivery via intranasal instillation, or when comparing studies that employed this technique.	[Miller, Mark A.; Stabenow, Jennifer M.; Parvathareddy, Jyothi; Wodowski, Andrew J.; Fabrizio, Thomas P.; Bina, Xiaowen R.; Zalduondo, Lillian; Bina, James E.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA; [Fabrizio, Thomas P.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA	University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Miller, MA (corresponding author), Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA.	mamiller@uthsc.edu	Fabrizio, Thomas/J-9935-2013; Bina, Xiaowen/AAE-9100-2022	Fabrizio, Thomas/0000-0002-8960-0728; 	National Institutes of Health (NIH) from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense [U54 AI057157]; NIH [AI074582, AI079482, AI061260]; Department of Defense Army [W81XHW-05-1-0227]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157, R21AI074582, R21AI079482] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Army(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by National Institutes of Health (NIH) grant #U54 AI057157 from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense (www.serceb.org/), by NIH (www.niaid.nih.gov/) grants AI074582 and AI079482 (to JEB) and AI061260 (to MAM), and by Department of Defense Army grant W81XHW-05-1-0227 (usacehr.amedd.army.mil/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN SD, 1994, J ANTIMICROB CHEMOTH, V34, P1001, DOI 10.1093/jac/34.6.1001; Asensio CJA, 2011, VACCINE, V29, P1649, DOI 10.1016/j.vaccine.2010.12.068; Ayala VI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019016; Balogh EP, 2011, INT J MED MICROBIOL, V301, P252, DOI 10.1016/j.ijmm.2010.08.020; Bina XR, 2010, PLASMID, V64, P156, DOI 10.1016/j.plasmid.2010.07.001; Chapoval SP, 1999, J CLIN INVEST, V103, P1707, DOI 10.1172/JCI6175; Cheng CM, 2011, VACCINE, V29, P2437, DOI 10.1016/j.vaccine.2011.01.031; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Easton A, 2011, J INFECT DIS, V204, P636, DOI 10.1093/infdis/jir301; Ebino K, 1999, INHAL TOXICOL, V11, P171, DOI 10.1080/089583799197131; EIGELSBACH H, 1961, J IMMUNOL, V87, P415; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; Eyles JE, 2001, J PHARM PHARMACOL, V53, P601, DOI 10.1211/0022357011775929; Ezoe H, 2011, VACCINE, V29, P1754, DOI 10.1016/j.vaccine.2010.12.117; Flecknell PA., 2009, LAB ANIMAL ANESTHESI, V3rd edition; Fox J, 2007, MOUSE BIOMEDICAL RES, DOI DOI 10.1016/B978-012369454-6/50094-7; Gabryszewski SJ, 2011, J IMMUNOL, V186, P1151, DOI 10.4049/jimmunol.1001751; Gonzalez A, 2011, MICROB PATHOGENESIS, V51, P161, DOI 10.1016/j.micpath.2011.03.013; Hamacher J, 2008, LAB ANIM-UK, V42, P222, DOI 10.1258/la.2007.006068; He XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020846; Hilliard JJ, 2011, ANTIMICROB AGENTS CH, V55, P836, DOI 10.1128/AAC.00670-10; Hoogendijk AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018519; Hrvacic B, 2006, PHARM RES-DORDR, V23, P1765, DOI 10.1007/s11095-006-9029-y; Kadioglu A, 2011, J IMMUNOL, V186, P5907, DOI 10.4049/jimmunol.1001533; Kamei A, 2011, INFECT IMMUN, V79, P1289, DOI 10.1128/IAI.01139-10; KuoLee R, 2011, MICROBES INFECT, V13, P447, DOI 10.1016/j.micinf.2011.01.010; Lange M, 2011, BIOCHEM BIOPH RES CO, V404, P877, DOI 10.1016/j.bbrc.2010.12.078; Lee LN, 2011, INFECT IMMUN, V79, P3328, DOI 10.1128/IAI.01133-10; MacDonald KD, 2009, J APPL PHYSIOL, V106, P984, DOI 10.1152/japplphysiol.91376.2008; Mares CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014088; Margolis DA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-71; Matsuo K, 2000, VACCINE, V18, P1344, DOI 10.1016/S0264-410X(99)00401-6; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Mendez MP, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-12; Mijares LA, 2011, J IMMUNOL, V186, P7080, DOI 10.4049/jimmunol.1003687; Onischuk AA, 2009, J AEROSOL MED PULM D, V22, P245, DOI 10.1089/jamp.2008.0721; Pore D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022663; Rivera B, 2005, CONTEMP TOP LAB ANIM, V44, P52; Rouf R, 2011, MICROBIOL-SGM, V157, P2133, DOI 10.1099/mic.0.048157-0; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; SASLAW S, 1961, ARCH INTERN MED, V107, P689, DOI 10.1001/archinte.1961.03620050055006; SCHOOK LB, 1977, CAN J MICROBIOL, V23, P823, DOI 10.1139/m77-120; Smee DF, 2008, INT J ANTIMICROB AG, V31, P352, DOI 10.1016/j.ijantimicag.2007.11.013; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; Spoelstra EN, 2007, LAB ANIM-UK, V41, P128, DOI 10.1258/002367707779399400; Stabenow J, 2010, J VIROL, V84, P3909, DOI 10.1128/JVI.02012-09; Su X, 2004, EXP LUNG RES, V30, P479, DOI 10.1080/01902140490476382; Surendran N, 2011, VACCINE, V29, P2749, DOI 10.1016/j.vaccine.2011.01.090; Thomas RJ, 2008, APPL ENVIRON MICROB, V74, P6437, DOI 10.1128/AEM.01194-08; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; van den Boogaard FE, 2011, J THROMB HAEMOST, V9, P122, DOI 10.1111/j.1538-7836.2010.04089.x; Vergari A, 2003, LAB ANIM-UK, V37, P204, DOI 10.1258/002367703766453047; Visweswaraiah A, 2002, VACCINE, V20, P3209, DOI 10.1016/S0264-410X(02)00247-5; Weber SE, 2011, J IMMUNOL, V186, P432, DOI 10.4049/jimmunol.1001963; Zhao L, 2011, INT IMMUNOPHARMACOL, V11, P1378, DOI 10.1016/j.intimp.2011.03.024	55	50	51	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31359	10.1371/journal.pone.0031359	http://dx.doi.org/10.1371/journal.pone.0031359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384012	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916800013
J	Syed, F; Thomas, AN; Singh, S; Kolluru, V; Hart, SGE; Bayat, A				Syed, Farhatullah; Thomas, Alexis N.; Singh, Subir; Kolluru, Venkatesh; Hart, Susan G. Emeigh; Bayat, Ardeshir			In Vitro Study of Novel Collagenase (XIAFLEX (R)) on Dupuytren's Disease Fibroblasts Displays Unique Drug Related Properties	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; GROWTH-FACTOR GENE; CLOSTRIDIUM-HISTOLYTICUM; CONNECTIVE-TISSUE; NONSURGICAL TREATMENT; FREE-RADICALS; CONTRACTURE; EXPRESSION; MATRIX; SKIN	Dupuytren's disease (DD) is a benign, fibroproliferative disease of the palmar fascia, with excessive extracellular matrix (ECM) deposition and over-production of cytokines and growth factors, resulting in digital fixed flexion contractures limiting hand function and patient quality of life. Surgical fasciectomy is the gold standard treatment but is invasive and has associated morbidity without limiting disease recurrence. Injectable Collagenase Clostridium histolyticum (CCH) - Xiaflex(R) - is a novel, nonsurgical option with clinically proven in vivo reduction of DD contractures but with limited in vitro data demonstrating its cellular and molecular effects. The aim of this study was to delineate the effects of CCH on primary fibroblasts isolated from DD and non-DD anatomical sites (using RTCA, LDH, WST-1, FACS, qRT-PCR, ELISA and In-Cell Quantitative Western Blotting) to compare the efficacy of varying concentrations of Xiaflex(R) against a reagent grade Collagenase, Collagenase A. Results demonstrated that DD nodule and cord fibroblasts had greater proliferation than those from fat and skin. Xiaflex(R) exposure resulted in dose-and time-dependent inhibition of cellular spreading, attachment and proliferation, with cellular recovery after enzyme removal. Unlike Collagenase A, Xiaflex(R) did not cause apoptosis. Collagen expression patterns were significantly (p<0.05) different in DD fibroblasts across anatomical sites - the highest levels of collagen I and III were detected in DD nodule, with DD cord and fat fibroblasts demonstrating a smaller increase in both collagen expression relative to DD skin. Xiaflex(R) significantly (p<0.05) down-regulated ECM components, cytokines and growth factors in a dose-dependent manner. An in vitro scratch wound assay model demonstrated that, at low concentrations, Xiaflex(R) enabled a faster fibroblast reparatory migration into the wound, whereas, at high concentrations, this process was significantly (p<0.05) inhibited. This is the first report elucidating potential mechanisms of action of Xiaflex(R) on Dupuytren fibroblasts, offering a greater insight and a better understanding of its effect in DD.	[Syed, Farhatullah; Thomas, Alexis N.; Singh, Subir; Kolluru, Venkatesh; Bayat, Ardeshir] Univ Manchester, Manchester Interdisciplinary Bioctr, Sch Translat Med, Manchester, Lancs, England; [Syed, Farhatullah; Bayat, Ardeshir] Univ Manchester, Sch Translat Med, Inflammat Sci Grp, Manchester, Lancs, England; [Bayat, Ardeshir] Wythenshawe Hosp, Univ Hosp S Manchester NHS Fdn Trust, Dept Plast & Reconstruct Surg, Manchester M23 9LT, Lancs, England; [Bayat, Ardeshir] Univ Manchester, Wythenshawe Hosp, Manchester Acad Hlth Sci Ctr, Univ Hosp S Manchester NHS Fdn Trust, Manchester, Lancs, England; [Hart, Susan G. Emeigh] Auxilium Pharmaceut Inc, Malvern, PA USA	University of Manchester; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Syed, F (corresponding author), Univ Manchester, Manchester Interdisciplinary Bioctr, Sch Translat Med, Manchester, Lancs, England.	Ardeshir.Bayat@manchester.ac.uk	Kolluru, Venkatesh/AAJ-7912-2020	Kolluru, Venkatesh/0000-0002-7318-2090; Thomas, Alexis/0000-0002-9112-9904; BAYAT, ARDESHIR/0000-0002-4116-6491				Al-Qattan MM, 2006, J HAND SURG-AM, V31A, P1527, DOI 10.1016/j.jhsa.2006.08.012; AN HS, 1988, J HAND SURG-AM, V13A, P872, DOI 10.1016/0363-5023(88)90262-6; Arkkila PET, 1997, J RHEUMATOL, V24, P153; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; ATKINSON RK, 1992, COMP BIOCHEM PHYS C, V102, P125, DOI 10.1016/0742-8413(92)90053-A; ATTALI P, 1987, ARCH INTERN MED, V147, P1065, DOI 10.1001/archinte.147.6.1065; Badalamente MA, 2000, J HAND SURG-AM, V25A, P629, DOI 10.1053/jhsu.2000.6918; BADALAMENTE MA, 1992, J HAND SURG-AM, V17A, P317, DOI 10.1016/0363-5023(92)90414-K; Badalamente MA, 2002, J HAND SURG-AM, V27A, P788, DOI 10.1053/jhsu.2002.35299; Badalamente MA, 2007, J HAND SURG-AM, V32A, P767, DOI 10.1016/j.jhsa.2007.04.002; BAIRD KS, 1993, J CLIN PATHOL, V46, P425, DOI 10.1136/jcp.46.5.425; BATEMAN JF, 1984, BIOCHEM J, V217, P103, DOI 10.1042/bj2170103; Bayat A, 2006, ANN ROY COLL SURG, V88, P3, DOI 10.1308/003588406X83104; Bayat A, 2002, J BONE JOINT SURG BR, V84B, P211, DOI 10.1302/0301-620X.84B2.12083; Bayat A, 2010, NAT REV RHEUMATOL, V6, P7, DOI 10.1038/nrrheum.2009.255; BAZIN S, 1980, EUR J CLIN INVEST, V10, P9, DOI 10.1111/j.1365-2362.1980.tb00317.x; Bisson MA, 2003, J HAND SURG-BRIT EUR, V28B, P351, DOI 10.1016/S0266-7681(03)00135-9; BRICKLEYPARSONS D, 1981, J BONE JOINT SURG AM, V63, P787, DOI 10.2106/00004623-198163050-00014; Caufield RJ, 2008, CURR ORTHOP PRACT, V19, P499, DOI 10.1097/BCO.0b013e3283025e78; Chen HX, 2005, ANAL BIOCHEM, V338, P136, DOI 10.1016/j.ab.2004.11.015; Dave SA, 2001, EXP MOL PATHOL, V71, P147, DOI 10.1006/exmp.2001.2385; Degreef I, 2008, ACTA ORTHOP BELG, V74, P456; Del Carlo M, 2009, J UROLOGY, V181, P279, DOI 10.1016/S0022-5347(09)60794-1; Desai SS, 2010, EXPERT OPIN BIOL TH, V10, P1395, DOI 10.1517/14712598.2010.510509; Duong HS, 2005, CELLS TISSUES ORGANS, V181, P89, DOI 10.1159/000091098; Dupuytren B, 1834, LANCET, V2, P222; French M F, 1992, Matrix Suppl, V1, P134; Gabbiani GaM D, 1985, DUPUYTRENS DISEASE, P86; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Gudmundsson KG, 2000, J CLIN EPIDEMIOL, V53, P291, DOI 10.1016/S0895-4356(99)00145-6; Hannoush RN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003498; Hart MG, 2005, POSTGRAD MED J, V81, P425, DOI 10.1136/pgmj.2004.027425; HERRMANN H, 1980, EUR J BIOCHEM, V105, P63, DOI 10.1111/j.1432-1033.1980.tb04474.x; Hindman HB, 2003, J BONE JOINT SURG BR, V85B, P448, DOI 10.1302/0301-620X.85B3.13219; Hindocha S, 2006, J HAND SURG-AM, V31A, P204, DOI 10.1016/j.jhsa.2005.09.018; Hindocha S, 2011, BRIT J SURG, V98, P308, DOI 10.1002/bjs.7307; Howard JC, 2004, J SURG RES, V117, P232, DOI 10.1016/j.jss.2004.01.013; Hurst LC, 2009, NEW ENGL J MED, V361, P2579; Hurst LC, 2009, NEW ENGL J MED, V361, P968, DOI 10.1056/NEJMoa0810866; Igarashi A, 1996, J INVEST DERMATOL, V106, P729, DOI 10.1111/1523-1747.ep12345771; Jung CM, 1999, J BACTERIOL, V181, P2816, DOI 10.1128/JB.181.9.2816-2822.1999; Kim HA, 2001, J RHEUMATOL, V28, P2038; Liss GM, 1996, AM J IND MED, V29, P521; Livingstone JA, 1999, J HAND SURG-BRIT EUR, V24B, P199, DOI 10.1054/jhsb.1998.0011; Lu ZF, 2007, EXP DERMATOL, V16, P37, DOI 10.1111/j.1600-0625.2006.00510.x; MALLYA SK, 1992, J PROTEIN CHEM, V11, P99, DOI 10.1007/BF01025096; Matsushita O, 1999, J BACTERIOL, V181, P923, DOI 10.1128/JB.181.3.923-933.1999; Matsushita O, 2001, J BIOL CHEM, V276, P8761, DOI 10.1074/jbc.M003450200; Mookhtiar K A, 1992, Matrix Suppl, V1, P116; MURRELL GAC, 1987, BMJ-BRIT MED J, V295, P1373, DOI 10.1136/bmj.295.6610.1373; MURRELL GAC, 1990, AUST NZ J SURG, V60, P247, DOI 10.1111/j.1445-2197.1990.tb07362.x; MURRELL GAC, 1991, J HAND SURG-BRIT EUR, V16B, P263, DOI 10.1016/0266-7681(91)90050-X; MURRELL GAC, 1990, BIOCHEM J, V265, P659, DOI 10.1042/bj2650659; MURRELL GAC, 1989, J BONE JOINT SURG BR, V71, P367, DOI 10.1302/0301-620X.71B3.2722922; Olive DM, 2004, EXPERT REV PROTEOMIC, V1, P327, DOI 10.1586/14789450.1.3.327; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Rayan Ghazi M, 2007, Instr Course Lect, V56, P101; Rehman S, 2008, J HAND SURG-AM, V33A, P359, DOI 10.1016/j.jhsa.2007.11.010; Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024; Riley Kathleen N, 2005, J Burns Wounds, V4, pe8; SANDERSON PL, 1992, J BONE JOINT SURG BR, V74, P923, DOI 10.1302/0301-620X.74B6.1447259; Sebastian A, 2011, EXP DERMATOL, V20, P64, DOI 10.1111/j.1600-0625.2010.01150.x; Shi L, 2010, INT WOUND J, V7, P87, DOI 10.1111/j.1742-481X.2010.00659.x; Shih B, 2010, NAT REV RHEUMATOL, V6, P715, DOI 10.1038/nrrheum.2010.180; Shih B, 2009, J HAND SURG-AM, V34A, P124, DOI 10.1016/j.jhsa.2008.09.017; Starkweather KD, 1996, J HAND SURG-AM, V21A, P490, DOI 10.1016/S0363-5023(96)80368-6; STEINBRINK DR, 1985, J BIOL CHEM, V260, P2771; Syed F, 2011, BRIT J DERMATOL, V164, P83, DOI 10.1111/j.1365-2133.2010.10048.x; TEREK RM, 1995, J BONE JOINT SURG AM, V77A, P1; Thomas A, 2010, THER CLIN RISK MANAG, V6, P557, DOI 10.2147/TCRM.S8591; Thurston AJ, 2003, J BONE JOINT SURG BR, V85B, P469, DOI 10.1302/0301-620X.85B4.14215; Tomasek JJ, 1999, HAND CLIN, V15, P21; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; Verjee LS, 2010, J CELL PHYSIOL, V224, P681, DOI 10.1002/jcp.22167; Verjee LS, 2009, J HAND SURG-AM, V34A, P1785, DOI 10.1016/j.jhsa.2009.08.005; Watt AJ, 2010, J HAND SURG-AM, V35A, P534, DOI 10.1016/j.jhsa.2010.01.003; Xing JZ, 2005, CHEM RES TOXICOL, V18, P154, DOI 10.1021/tx049721s; Zhang AY, 2008, J HAND SURG-EUR VOL, V33E, P783, DOI 10.1177/1753193408091352	80	37	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31430	10.1371/journal.pone.0031430	http://dx.doi.org/10.1371/journal.pone.0031430			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384021	gold, Green Published, Green Submitted			2022-12-27	WOS:000302916800014
J	Reemers, SSN; van Haarlem, DA; Sijts, AJAM; Vervelde, L; Jansen, CA				Reemers, Sylvia S. N.; van Haarlem, Daphne A.; Sijts, Alice J. A. M.; Vervelde, Lonneke; Jansen, Christine A.			Identification of Novel Avian Influenza Virus Derived CD8+T-Cell Epitopes	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; T-CELL RESPONSES; CLASS-I MOLECULE; A VIRUS; INFECTION; CHICKEN; IMMUNITY; MEMORY; MHC; HEMAGGLUTININ	Avian influenza virus (AIV) infection is a continuing threat to both humans and poultry. Influenza virus specific CD8+ T cells are associated with protection against homologous and heterologous influenza strains. In contrast to what has been described for humans and mice, knowledge on epitope-specific CD8+ T cells in chickens is limited. Therefore, we set out to identify AIV-specific CD8+ T-cell epitopes. Epitope predictions based on anchor residues resulted in 33 candidate epitopes. MHC I inbred chickens were infected with a low pathogenic AIV strain and sacrificed at 5, 7, 10 and 14 days post infection (dpi). Lymphocytes isolated from lung, spleen and blood were stimulated ex vivo with AIV-specific pooled or individual peptides and the production of IFN gamma was determined by ELIspot. This resulted in the identification of 12 MHC B12-restricted, 3 B4-restricted and 1 B19-restricted AIV-specific CD8+ T-cell epitopes. In conclusion, we have identified novel AIV-derived CD8+ T-cell epitopes for several inbred chicken strains. This knowledge can be used to study the role of CD8+ T cells against AIV infection in a natural host for influenza, and may be important for vaccine development.	[Reemers, Sylvia S. N.; van Haarlem, Daphne A.; Sijts, Alice J. A. M.; Vervelde, Lonneke; Jansen, Christine A.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands	Utrecht University	Reemers, SSN (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands.	c.a.jansen@uu.nl	Vervelde, Lonneke/C-7707-2013	Vervelde, Lonneke/0000-0003-2241-1743; Sijts, Alice/0000-0003-3815-4788	EU [04220]; Dutch Ministery of Agriculture, Nature and Food Quality	EU(European Commission); Dutch Ministery of Agriculture, Nature and Food Quality	This study was financially supported by the EU sixth framework program Flupath (grant 04220) and Programme "Impulse Veterinary Avian Influenza Research" in The Netherlands, Dutch Ministery of Agriculture, Nature and Food Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariaans MP, 2008, DEV COMP IMMUNOL, V32, P1398, DOI 10.1016/j.dci.2008.05.007; BEDNAREK MA, 1991, J IMMUNOL, V147, P4047; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; BRILES WE, 1950, GENETICS, V35, P633; Brown IH, 2010, AVIAN DIS, V54, P187, DOI 10.1637/8949-053109-Reg.1; Chen GL, 2009, NAT MED, V15, P1251, DOI 10.1038/nm1109-1251; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; Davison F, 2008, AVIAN IMMUNOLOGY, P1; de Bree GJ, 2005, J EXP MED, V202, P1433, DOI 10.1084/jem.20051365; EFFROS RB, 1977, J EXP MED, V145, P557, DOI 10.1084/jem.145.3.557; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Flynn KJ, 1999, P NATL ACAD SCI USA, V96, P8597, DOI 10.1073/pnas.96.15.8597; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; GOBEL TWF, 1994, EUR J IMMUNOL, V24, P1685, DOI 10.1002/eji.1830240734; GOTCH F, 1987, J EXP MED, V165, P408, DOI 10.1084/jem.165.2.408; Graham MB, 1997, J EXP MED, V186, P2063, DOI 10.1084/jem.186.12.2063; GUILLEMOT F, 1988, EMBO J, V7, P2775, DOI 10.1002/j.1460-2075.1988.tb03132.x; He XS, 2003, J INFECT DIS, V187, P1075, DOI 10.1086/368218; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; JOHANSSON BE, 1989, J VIROL, V63, P1239, DOI 10.1128/JVI.63.3.1239-1246.1989; Kapczynski Darrell R, 2011, BMC Proc, V5 Suppl 4, pS13, DOI 10.1186/1753-6561-5-S4-S13; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; KAUFMAN J, 1995, IMMUNOL REV, V143, P63, DOI 10.1111/j.1600-065X.1995.tb00670.x; Kern F, 1999, J VIROL, V73, P8179, DOI 10.1128/JVI.73.10.8179-8184.1999; KILBOURNE ED, 1968, J VIROL, V2, P281, DOI 10.1128/JVI.2.4.281-288.1968; Koch M, 2007, IMMUNITY, V27, P885, DOI 10.1016/j.immuni.2007.11.007; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Pang KC, 2006, J IMMUNOL, V177, P7680, DOI 10.4049/jimmunol.177.11.7680; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; PINK JRL, 1985, IMMUNOGENETICS, V21, P293, DOI 10.1007/BF00375381; Rebel JMJ, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-10; Reemers SS, 2010, VACCINE, V28, P6351, DOI 10.1016/j.vaccine.2010.06.099; Rimmelzwaan GF, 2007, CURR OPIN BIOTECH, V18, P529, DOI 10.1016/j.copbio.2007.11.002; SCHULMAN JL, 1968, J VIROL, V2, P778, DOI 10.1128/JVI.2.8.778-786.1968; Senne DA, 2010, AVIAN DIS, V54, P179, DOI 10.1637/8921-050809-Review.1; Seo SH, 2002, J VIROL, V76, P4886, DOI 10.1128/JVI.76.10.4886-4890.2002; Seo SH, 2001, J VIROL, V75, P2516, DOI 10.1128/JVI.75.6.2516-2525.2001; Sijts AJAM, 2000, J IMMUNOL, V164, P4500, DOI 10.4049/jimmunol.164.9.4500; Singh S, 2010, VIROLOGY, V405, P62, DOI 10.1016/j.virol.2010.05.002; Singh S, 2010, VIROLOGY, V399, P231, DOI 10.1016/j.virol.2009.12.029; TOWNSEND ARM, 1984, J EXP MED, V160, P552, DOI 10.1084/jem.160.2.552; VAINIO O, 1984, IMMUNOGENETICS, V19, P131, DOI 10.1007/BF00387856; VAINIO O, 1988, J IMMUNOL, V140, P2864; VIRELIZIER JL, 1975, J IMMUNOL, V115, P434; Wallny HJ, 2006, P NATL ACAD SCI USA, V103, P1434, DOI 10.1073/pnas.0507386103; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA	50	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31953	10.1371/journal.pone.0031953	http://dx.doi.org/10.1371/journal.pone.0031953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384112	Green Published, gold			2022-12-27	WOS:000302916100041
J	Fode, P; Larsen, AR; Feenstra, B; Jespersgaard, C; Skov, RL; Stegger, M; Fowler, VG; Andersen, PS				Fode, Peder; Larsen, Anders Rhod; Feenstra, Bjarke; Jespersgaard, Cathrine; Skov, Robert Leo; Stegger, Marc; Fowler, Vance G., Jr.; Andersen, Paal Skytt		Danish SAB Study Grp Consortium	Genetic Variability in Beta-Defensins Is Not Associated with Susceptibility to Staphylococcus aureus Bacteremia	PLOS ONE			English	Article							COPY NUMBER VARIATION; GENOME-WIDE ASSOCIATION; BETA-DEFENSIN-1; PSORIASIS; PEPTIDE; DEFB1; HBD-1	Introduction: Human beta-defensins are key components of human innate immunity to a variety of pathogens, including Staphylococcus aureus. The aim of the present study was to investigate a potential association between gene variations in DEFB1 and DEFB103/DEFB4 and the development of S. aureus bacteremia (SAB) employing a case-control design. Methods: Cases were unique patients with documented SAB, identified with the National S. aureus Bacteremia Register, a comprehensive dataset of all episodes of community associated-SABs (CA-SAB) occurring in children (<= 20 yrs) in Denmark from 1990 to 2006. Controls were age-matched healthy individuals with no history of SAB. DNA obtained from cases and controls using the Danish Newborn Screening Biobank were genotyped for functional polymorphisms of DEFB1 by Sanger sequencing and copy number variation of the DEFB103 and DEFB4 genes using Pyrosequencing-based Paralogue Ratio Test (P-PRT). Results: 193 ethnic Danish SAB cases with 382 age-matched controls were used for this study. S. aureus isolates represented a variety of bacterial (i.e., different spa types) types similar to SAB isolates in general. DEFB1 minor allele frequencies of rs11362 (cases vs. controls 0.47/0.44), rs1800972 (0.21/0.24), and rs1799946 (0.32/0.33) were not significantly different in cases compared with controls. Also, DEFB4/DEFB103 gene copy numbers (means 4.83/4.92) were not significantly different in cases compared with controls. Conclusions: Using a large, unique cohort of pediatric CA-SAB, we found no significant association between DEFB1 genetic variation or DEFB4/DEFB103 gene copy number and susceptibility for SAB.	[Fode, Peder; Larsen, Anders Rhod; Skov, Robert Leo; Stegger, Marc; Andersen, Paal Skytt] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark; [Feenstra, Bjarke] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Jespersgaard, Cathrine] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Fowler, Vance G., Jr.] Duke Med Ctr, Dept Infect Dis, Durham, NC USA	Statens Serum Institut; Statens Serum Institut; Statens Serum Institut; Duke University	Fode, P (corresponding author), Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark.	psa@ssi.dk	Andersen, Paal S/H-2087-2015; Skov, Robert/ABB-3105-2020; Fowler, Vance/AAW-2017-2021	Andersen, Paal S/0000-0001-5656-0427; Skov, Robert/0000-0002-6079-5381; Larsen, Anders Rhod/0000-0002-1713-8765; Feenstra, Bjarke/0000-0003-1478-649X; Stegger, Marc/0000-0003-0321-1180	Danish Medical Research Council; Idella Foundation; Lundbeck Foundation; NIH [R01-AI068804]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068804] Funding Source: NIH RePORTER	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Idella Foundation; Lundbeck Foundation(Lundbeckfonden); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by Danish Medical Research Council; Idella Foundation; and The Lundbeck Foundation. Dr. Fowler was supported by NIH grant R01-AI068804. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001088; Aldhous MC, 2010, HUM MOL GENET, V19, P4930, DOI 10.1093/hmg/ddq411; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; Baker MW, 2009, J ALLERGY CLIN IMMUN, V124, P522, DOI 10.1016/j.jaci.2009.04.007; Chen QX, 2007, GENES IMMUN, V8, P439, DOI 10.1038/sj.gene.6364401; CHRISTOPHERS E, 1987, ARCH DERMATOL RES, V279, pS48, DOI 10.1007/BF00585919; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Fode P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016768; Harder J, 2004, J INVEST DERMATOL, V123, P522, DOI 10.1111/j.0022-202X.2004.23234.x; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Hill PC, 2001, INTERN MED J, V31, P97, DOI 10.1111/j.1444-0903.2001.00029.x; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Morrison G, 2002, INFECT IMMUN, V70, P3053, DOI 10.1128/IAI.70.6.3053-3060.2002; Norgaard-Pedersen B, 2007, J INHERIT METAB DIS, V30, P530, DOI 10.1007/s10545-007-0631-x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ruimy R, 2010, J INFECT DIS, V202, P924, DOI 10.1086/655901; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Skov R, 2008, 2008112 STAT SER I; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang FR, 2011, NAT GENET, V43, P1247, DOI 10.1038/ng.973; Zhao CQ, 1996, FEBS LETT, V396, P319, DOI 10.1016/0014-5793(96)01123-4	25	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32315	10.1371/journal.pone.0032315	http://dx.doi.org/10.1371/journal.pone.0032315			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384213	gold, Green Submitted, Green Published			2022-12-27	WOS:000302875500094
J	Morley, AP; Narayanan, M; Mines, R; Molokhia, A; Baxter, S; Craig, G; Lewis, CM; Craig, I				Morley, Andrew P.; Narayanan, Madan; Mines, Rebecca; Molokhia, Ashraf; Baxter, Sebastian; Craig, Gavin; Lewis, Cathryn M.; Craig, Ian			AVPR1A and SLC6A4 Polymorphisms in Choral Singers and Non-Musicians: A Gene Association Study	PLOS ONE			English	Article							SEROTONIN-TRANSPORTER GENE; OBSESSIVE-COMPULSIVE DISORDER; STIN2 VNTR POLYMORPHISM; ANTIDEPRESSANT RESPONSE; PERSONALITY-TRAITS; IMMUNOGLOBULIN-A; COMPLEX TRAITS; MIGRAINE; DEPRESSION; VARIANTS	Amateur choral singing is a common pastime and worthy of study, possibly conferring benefits to health and social behaviour. Participants might be expected to possess musical ability and share some behavioural characteristics. Polymorphisms in genes concerned with serotonergic neurotransmission are associated with both behaviour and musical aptitude. Those investigated previously include the variable number tandem repeats RS1, RS3 and AVR in the AVPR1A (arginine vasopressin receptor 1a) gene and STin2 in the SLC6A4 (solute carrier family 6 [ neurotransmitter transporter, serotonin], member 4) gene, as well as the SLC6A4 promoter region polymorphism, 5-HTTLPR. We conducted a genetic association study on 523 participants to establish whether alleles at these polymorphisms occur more commonly in choral singers than in those not regularly participating in organised musical activity (non-musicians). We also analysed tagging single nucleotide polymorphisms (SNPs) for AVPR1A and SLC6A4 to determine whether other variants in these genes were associated with singer/non-musician status. At the STin2 polymorphism, overall association with singer/non-musician status was evident at P = 0.006. The 9-repeat (P = 0.04) and 12-repeat (P = 0.04) alleles were more common in singers and the 10-repeat allele less so (P = 0.009). Odds ratios were 0.73 (95% Cl 0.57-0.94) for the 10-repeat allele and 2.47 (95% Cl 0.88-6.94) for the rarer 9-repeat allele. No overall association was detected at P<0.05 between any other polymorphism and singer/non-musician status. Our null findings with respect to RS3, RS1 and AVR, polymorphisms associated with musical ability by other authors, suggest that choir membership may depend partly on factors other than musical ability. In a related musical project involving one participating choir, a new 40-part unaccompanied choral work, "Allele'', was composed and broadcast on national radio. In the piece, each singer's part incorporated their personal RS3 genotype.	[Morley, Andrew P.; Narayanan, Madan; Mines, Rebecca; Molokhia, Ashraf; Baxter, Sebastian] Kings Hlth Partners Acad Hlth Sci Ctr, London, England; [Craig, Gavin; Lewis, Cathryn M.; Craig, Ian] Kings Coll London, Inst Psychiat, Med Res Council Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Lewis, Cathryn M.] Kings Coll London, Div Genet & Mol Med, London WC2R 2LS, England	King's Health Partners; University of London; King's College London; University of London; King's College London	Morley, AP (corresponding author), Kings Hlth Partners Acad Hlth Sci Ctr, London, England.	andrew.morley@gstt.nhs.uk	Craig, Ian/AAF-9167-2019; Lewis, Cathryn/M-8766-2019; Lewis, Cathryn M/A-5225-2010	Lewis, Cathryn/0000-0002-8249-8476; Lewis, Cathryn M/0000-0002-8249-8476; Craig, Ian/0000-0002-4063-1005	Wellcome Trust Arts Award [WT089550A, WT089550Z]; Medical Research Council [G9817803B] Funding Source: researchfish	Wellcome Trust Arts Award(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by a Wellcome Trust Arts Award and a related Extension Award, respectively WT089550A and WT089550Z (http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Saiz PA, 2010, PSYCHIAT GENET, V20, P171, DOI 10.1097/YPG.0b013e32833a20b9; Ali FR, 2010, J NEUROCHEM, V112, P296, DOI 10.1111/j.1471-4159.2009.06453.x; Bachner-Melman R, 2005, PLOS GENET, V1, P394, DOI 10.1371/journal.pgen.0010042; Bah J, 2008, PSYCHIAT RES-NEUROIM, V162, P221, DOI 10.1016/j.pscychresns.2007.07.004; Bellivier F, 2002, NEUROSCI LETT, V334, P17, DOI 10.1016/S0304-3940(02)01029-7; Bloch MH, 2008, AM J MED GENET B, V147B, P850, DOI 10.1002/ajmg.b.30699; Clift SM, 2001, J R SOC PROMO HEALTH, V121, P248, DOI 10.1177/146642400112100409; Coutinho AM, 2004, MOL PSYCHIATR, V9, P264, DOI 10.1038/sj.mp.4001409; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Drago Antonio, 2009, Human Genomics, V3, P257; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Fan JB, 2005, MOL PSYCHIATR, V10, P928, DOI 10.1038/sj.mp.4001690; Fiskerstrand CE, 1999, FEBS LETT, V458, P171, DOI 10.1016/S0014-5793(99)01150-3; Freeman B, 2003, BEHAV GENET, V33, P67, DOI 10.1023/A:1021055617738; GREEN RG, 1987, PSYCHOL REP, V61, P623, DOI 10.2466/pr0.1987.61.2.623; Harrison PA, 2003, J SCHOOL HEALTH, V73, P113, DOI 10.1111/j.1746-1561.2003.tb03585.x; Hranilovic D, 2004, BIOL PSYCHIAT, V55, P1090, DOI 10.1016/j.biopsych.2004.01.029; Huang CH, 2008, AM J MED GENET B, V147B, P903, DOI 10.1002/ajmg.b.30720; Huezo-Diaz P, 2009, BRIT J PSYCHIAT, V195, P30, DOI 10.1192/bjp.bp.108.062521; Israel S, 2008, PROG BRAIN RES, V170, P435, DOI 10.1016/S0079-6123(08)00434-2; Kato M, 2010, MOL PSYCHIATR, V15, P473, DOI 10.1038/mp.2008.116; Kazantseva AV, 2008, PSYCHIAT GENET, V18, P167, DOI 10.1097/YPG.0b013e328304deb8; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; Kohen R, 2008, ARCH GEN PSYCHIAT, V65, P1296, DOI 10.1001/archpsyc.65.11.1296; Kreutz G, 2004, J BEHAV MED, V27, P623, DOI 10.1007/s10865-004-0006-9; Li J, 2007, AM J MED GENET B, V144B, P14, DOI 10.1002/ajmg.b.30373; Lopez de LC, 2006, BIOL PSYCHIAT, V59, P114; MacKenzie A, 1999, P NATL ACAD SCI USA, V96, P15251, DOI 10.1073/pnas.96.26.15251; MARTIN RA, 1988, INT J PSYCHIAT MED, V18, P93, DOI 10.2190/724B-3V06-QC5N-6587; Min WJ, 2009, PSYCHOPHARMACOLOGY, V205, P409, DOI 10.1007/s00213-009-1550-3; Newton-Cheh C, 2005, MUTAT RES-FUND MOL M, V573, P54, DOI 10.1016/j.mrfmmm.2005.01.006; Niesler B, 2010, EUR J GASTROEN HEPAT, V22, P856, DOI 10.1097/MEG.0b013e32832e9d6b; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ogilvie AD, 1996, LANCET, V347, P731, DOI 10.1016/S0140-6736(96)90079-3; Park JW, 2006, HEADACHE, V46, P991, DOI 10.1111/j.1526-4610.2006.00439.x; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pritchard AL, 2007, DEMENT GERIATR COGN, V24, P201, DOI 10.1159/000107081; Proitsi P, 2012, NEUROBIOL A IN PRESS; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Safarinejad MR, 2010, BJU INT, V105, P73, DOI 10.1111/j.1464-410X.2009.08714.x; Saiz PA, 2008, PROG NEURO-PSYCHOPH, V32, P765, DOI 10.1016/j.pnpbp.2007.12.005; Sanjuan J, 2008, BRIT J PSYCHIAT, V193, P383, DOI 10.1192/bjp.bp.107.045427; Sarosi A, 2008, PROG NEURO-PSYCHOPH, V32, P1667, DOI 10.1016/j.pnpbp.2008.06.014; Schurks M, 2010, J HEADACHE PAIN, V11, P317, DOI 10.1007/s10194-010-0230-3; Smits KM, 2004, MOL PSYCHIATR, V9, P433, DOI 10.1038/sj.mp.4001488; Szilagyi A, 2006, HEADACHE, V46, P478, DOI 10.1111/j.1526-4610.2006.00379.x; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Terrazzino S, 2010, EUR J PHARMACOL, V641, P82, DOI 10.1016/j.ejphar.2010.04.049; Ukkola LT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005534; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; Wendland JR, 2007, NEUROPSYCHOPHARMACOL, V32, P2543, DOI 10.1038/sj.npp.1301394; Yue WH, 2008, SLEEP, V31, P1535, DOI 10.1093/sleep/31.11.1535; Zhong SF, 2009, P ROY SOC B-BIOL SCI, V276, P4181, DOI 10.1098/rspb.2009.1312	54	21	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31763	10.1371/journal.pone.0031763	http://dx.doi.org/10.1371/journal.pone.0031763			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384070	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500038
J	Brush, GS; Najor, NA; Dombkowski, AA; Cukovic, D; Sawarynski, KE				Brush, George S.; Najor, Nicole A.; Dombkowski, Alan A.; Cukovic, Daniela; Sawarynski, Kara E.			Yeast IME2 Functions Early in Meiosis Upstream of Cell Cycle-Regulated SBF and MBF Targets	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; S-PHASE; DNA-REPLICATION; PROTEIN-KINASE; BUDDING YEAST; G1-SPECIFIC TRANSCRIPTION; GENE-EXPRESSION; G1 CYCLINS; PHOSPHORYLATION; INHIBITOR	Background: In Saccharomyces cerevisiae, the G1 cyclin/cyclin-dependent kinase (CDK) complexes Cln1,-2,-3/Cdk1 promote S phase entry during the mitotic cell cycle but do not function during meiosis. It has been proposed that the meiosis-specific protein kinase Ime2, which is required for normal timing of pre-meiotic DNA replication, is equivalent to Cln1,-2/Cdk1. These two CDK complexes directly catalyze phosphorylation of the B-type cyclin/CDK inhibitor Sic1 during the cell cycle to enable its destruction. As a result, Clb5,-6/Cdk1 become activated and facilitate initiation of DNA replication. While Ime2 is required for Sic1 destruction during meiosis, evidence now suggests that Ime2 does not directly catalyze Sic1 phosphorylation to target it for destabilization as Cln1,-2/Cdk1 do during the cell cycle. Methodology/Principal Findings: We demonstrated that Sic1 is eventually degraded in meiotic cells lacking the IME2 gene (ime2 Delta), supporting an indirect role of Ime2 in Sic1 destruction. We further examined global RNA expression comparing wild type and ime2D cells. Analysis of these expression data has provided evidence that Ime2 is required early in meiosis for normal transcription of many genes that are also periodically expressed during late G1 of the cell cycle. Conclusions/Significance: Our results place Ime2 at a position in the early meiotic pathway that lies upstream of the position occupied by Cln1,-2/Cdk1 in the analogous cell cycle pathway. Thus, Ime2 may functionally resemble Cln3/Cdk1 in promoting S phase entry, or it could play a role even further upstream in the corresponding meiotic cascade.	[Brush, George S.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Brush, George S.] Barbara Ann Karmanos Canc Inst, Program Mol Biol & Genet, Detroit, MI USA; [Brush, George S.; Sawarynski, Kara E.] Wayne State Univ, Sch Med, Canc Biol Grad Program, Detroit, MI USA; [Brush, George S.; Najor, Nicole A.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Dombkowski, Alan A.; Cukovic, Daniela] Wayne State Univ, Sch Med, Dept Pediat, Childrens Hosp Michigan,Div Clin Pharmacol & Toxi, Detroit, MI 48201 USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Children's Hospital of Michigan; Wayne State University	Brush, GS (corresponding author), Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA.	brushg@karmanos.org	Sawarynski, Kara/AAE-3069-2021	Sawarynski, Kara/0000-0003-3008-0884; Dombkowski, Alan/0000-0002-0312-8750	National Institutes of Health (NIH) [T32CA009531]; NIH Center [P30CA22453]; Perinatology Research Branch of the National Institute of Child Health and Human Development, Wayne State University; NATIONAL CANCER INSTITUTE [T32CA009531, P30CA022453] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perinatology Research Branch of the National Institute of Child Health and Human Development, Wayne State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NAN and KES were supported by the Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant T32CA009531 from the National Institutes of Health (NIH). The Microscopy, Imaging and Cytometry Resources Core is supported, in part, by NIH Center Grant P30CA22453 to the Karmanos Cancer Institute, Wayne State University, and by the Perinatology Research Branch of the National Institute of Child Health and Human Development, Wayne State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NT, 2009, MOL CELL BIOL, V29, P4352, DOI 10.1128/MCB.00305-09; ANDREWS BJ, 1989, CELL, V57, P21, DOI 10.1016/0092-8674(89)90168-2; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Clifford DM, 2004, J BIOL CHEM, V279, P6163, DOI 10.1074/jbc.M306943200; Colomina N, 1999, EMBO J, V18, P320, DOI 10.1093/emboj/18.2.320; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; DAHMANN C, 1995, CURR BIOL, V5, P1257, DOI 10.1016/S0960-9822(95)00252-1; Day A, 2004, CELL CYCLE, V3, P1433, DOI 10.4161/cc.3.11.1205; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; de Bruin RAM, 2006, MOL CELL, V23, P483, DOI 10.1016/j.molcel.2006.06.025; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; Dirick L, 1998, SCIENCE, V281, P1854, DOI 10.1126/science.281.5384.1854; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Ferrezuelo F, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r67; Ferrezuelo F, 2009, CELL CYCLE, V8, P239, DOI 10.4161/cc.8.2.7543; Foat BC, 2005, P NATL ACAD SCI USA, V102, P17675, DOI 10.1073/pnas.0503803102; FOIANI M, 1995, MOL CELL BIOL, V15, P883; Foiani M, 1996, MOL GEN GENET, V253, P278, DOI 10.1007/s004380050323; Guttmann-Raviv N, 2002, MOL CELL BIOL, V22, P2047, DOI 10.1128/MCB.22.7.2047-2056.2002; Holt LJ, 2007, MOL CELL, V25, P689, DOI 10.1016/j.molcel.2007.02.012; Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Leem SH, 1998, NUCLEIC ACIDS RES, V26, P3154, DOI 10.1093/nar/26.13.3154; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LOWNDES NF, 1992, NATURE, V357, P505, DOI 10.1038/357505a0; Mallory MJ, 2007, MOL CELL, V27, P951, DOI 10.1016/j.molcel.2007.08.019; Mendes ND, 2006, BIOINFORMATICS, V22, P2996, DOI 10.1093/bioinformatics/btl537; MITCHELL AP, 1990, MOL CELL BIOL, V10, P2104, DOI 10.1128/MCB.10.5.2104; MITCHELL AP, 1994, MICROBIOL REV, V58, P56, DOI 10.1128/MMBR.58.1.56-70.1994; Monteiro PT, 2008, NUCLEIC ACIDS RES, V36, pD132, DOI 10.1093/nar/gkm976; Moore M, 2007, BIOCHEMISTRY-US, V46, P271, DOI 10.1021/bi061858p; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; NASMYTH K, 1991, CELL, V66, P995, DOI 10.1016/0092-8674(91)90444-4; OGAS J, 1991, CELL, V66, P1015, DOI 10.1016/0092-8674(91)90445-5; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Pak J, 2002, MOL CELL BIOL, V22, P6417, DOI 10.1128/MCB.22.18.6417-6429.2002; Raithatha SA, 2005, GENETICS, V169, P1329, DOI 10.1534/genetics.104.036103; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; Sawarynski KE, 2007, BBA-MOL CELL RES, V1773, P450, DOI 10.1016/j.bbamcr.2006.10.003; Sawarynski KE, 2009, P NATL ACAD SCI USA, V106, P232, DOI 10.1073/pnas.0809731105; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schneider BL, 1996, SCIENCE, V272, P560, DOI 10.1126/science.272.5261.560; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Sclafani RA, 2000, J CELL SCI, V113, P2111; Sedgwick C, 2006, BIOCHEM J, V399, P151, DOI 10.1042/BJ20060363; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Sopko R, 2002, MOL CELL BIOL, V22, P7024, DOI 10.1128/MCB.22.20.7024-7040.2002; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; STUART D, 1995, GENE DEV, V9, P2780, DOI 10.1101/gad.9.22.2780; Stuart D, 1998, GENE DEV, V12, P2698, DOI 10.1101/gad.12.17.2698; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tyers M, 1996, P NATL ACAD SCI USA, V93, P7772, DOI 10.1073/pnas.93.15.7772; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; Valentin G, 2006, J BIOL CHEM, V281, P2828, DOI 10.1074/jbc.M510626200; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Wan LH, 2006, GENETICS, V174, P1767, DOI 10.1534/genetics.106.064303; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	63	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31575	10.1371/journal.pone.0031575	http://dx.doi.org/10.1371/journal.pone.0031575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393365	gold, Green Published, Green Submitted			2022-12-27	WOS:000303003500018
J	Chung, MY; Kim, YW; Bae, SM; Kwon, EH; Chaturvedi, PK; Battogtokh, G; Ahn, WS				Chung, Mee Young; Kim, Yong-Wan; Bae, Su Mi; Kwon, Eun Hye; Chaturvedi, Pankaj Kumar; Battogtokh, Gantumur; Ahn, Woong Shick			Development of a Bead-Based Multiplex Genotyping Method for Diagnostic Characterization of HPV Infection	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; POLYMERASE-CHAIN-REACTION; CERVICAL INTRAEPITHELIAL NEOPLASIA; FRAGMENT-LENGTH-POLYMORPHISM; LINE PROBE ASSAY; HIGH-RISK HPV; DNA CHIP; CANCER; WOMEN; LESIONS	The accurate genotyping of human papillomavirus (HPV) is clinically important because the oncogenic potential of HPV is dependent on specific genotypes. Here, we described the development of a bead-based multiplex HPV genotyping (MPG) method which is able to detect 20 types of HPV (15 high-risk HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68 and 5 low-risk HPV types 6, 11, 40, 55, 70) and evaluated its accuracy with sequencing. A total of 890 clinical samples were studied. Among these samples, 484 were HPV positive and 406 were HPV negative by consensus primer (PGMY09/11) directed PCR. The genotyping of 484 HPV positive samples was carried out by the bead-based MPG method. The accuracy was 93.5% (95% CI, 91.0-96.0), 80.1% (95% CI, 72.3-87.9) for single and multiple infections, respectively, while a complete type mismatch was observed only in one sample. The MPG method indiscriminately detected dysplasia of several cytological grades including 71.8% (95% CI, 61.5-82.3) of ASCUS (atypical squamous cells of undetermined significance) and more specific for high grade lesions. For women with HSIL (high grade squamous intraepithelial lesion) and SCC diagnosis, 32 women showed a PPV (positive predictive value) of 77.3% (95% CI, 64.8-89.8). Among women > 40 years of age, 22 women with histological cervical cancer lesions showed a PPV of 88% (95% CI, 75.3-100). Of the highest risk HPV types including HPV-16, 18 and 31 positive women of the same age groups, 34 women with histological cervical cancer lesions showed a PPV of 77.3% (95% CI, 65.0-89.6). Taken together, the bead-based MPG method could successfully detect high-grade lesions and high-risk HPV types with a high degree of accuracy in clinical samples.	[Chung, Mee Young] Catholic Univ Korea, Coll Med, Dept Anesthesiol, Seoul, South Korea; [Kim, Yong-Wan; Bae, Su Mi; Kwon, Eun Hye; Chaturvedi, Pankaj Kumar; Battogtokh, Gantumur] Catholic Univ Korea, Canc Res Inst Med Sci, Seoul, South Korea; [Ahn, Woong Shick] Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Chung, MY (corresponding author), Catholic Univ Korea, Coll Med, Dept Anesthesiol, Seoul, South Korea.	ahnlab1@catholic.ac.kr			Small and Medium Business Administration, Seoul, Republic of Korea [2008-22-S1040034]	Small and Medium Business Administration, Seoul, Republic of Korea	The study was supported by a 2008 grant from the Small and Medium Business Administration, Seoul, Republic of Korea (Grant #2008-22-S1040034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asato T, 2004, J INFECT DIS, V189, P1829, DOI 10.1086/382896; Bae JH, 2008, J MICROBIOL BIOTECHN, V18, P788; Berkhof J, 2006, CANCER EPIDEM BIOMAR, V15, P1268, DOI 10.1158/1055-9965.EPI-05-0764; Boulet GAV, 2008, CANCER EPIDEM BIOMAR, V17, P810, DOI 10.1158/1055-9965.EPI-07-2865; Brink AATP, 2007, DIS MARKERS, V23, P273, DOI 10.1155/2007/147429; Bulkmans NWJ, 2007, BRIT J CANCER, V96, P1419, DOI 10.1038/sj.bjc.6603653; Carvalho ND, 2010, MEM I OSWALDO CRUZ, V105, P73, DOI 10.1590/S0074-02762010000100011; Chan PKS, 1999, J MED VIROL, V59, P232, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt;232::AID-JMV18&gt;3.0.CO;2-7; Choi YD, 2005, GYNECOL ONCOL, V98, P369, DOI 10.1016/j.ygyno.2005.04.044; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Datta NR, 2006, GYNECOL ONCOL, V103, P100, DOI 10.1016/j.ygyno.2006.01.058; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Gasperov NM, 2008, PATHOL ONCOL RES, V14, P355, DOI 10.1007/s12253-008-9084-2; Geraets DT, 2009, J CLIN VIROL, V46, pS21, DOI 10.1016/S1386-6532(09)70297-5; Gharizadeh B, 2001, LAB INVEST, V81, P673, DOI 10.1038/labinvest.3780276; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Hubbard RA, 2003, ARCH PATHOL LAB MED, V127, P940; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kim KH, 2006, GYNECOL ONCOL, V100, P38, DOI 10.1016/j.ygyno.2005.08.024; Kleter B, 1999, J CLIN MICROBIOL, V37, P2508, DOI 10.1128/JCM.37.8.2508-2517.1999; Lehtinen M, 2001, J CLIN VIROL, V22, P117, DOI 10.1016/S1386-6532(01)00172-X; Liaw KL, 2001, J INFECT DIS, V183, P8, DOI 10.1086/317638; Lowy DR, 2008, CANCER-AM CANCER SOC, V113, P1980, DOI 10.1002/cncr.23704; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nobre RJ, 2008, J CLIN VIROL, V42, P13, DOI 10.1016/j.jcv.2007.11.021; Oh Y, 2007, CANCER SCI, V98, P549, DOI 10.1111/j.1349-7006.2007.00427.x; Park JY, 2007, GYNECOL ONCOL, V107, P39, DOI 10.1016/j.ygyno.2007.05.014; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Spinillo A, 2009, VIRUS RES, V142, P154, DOI 10.1016/j.virusres.2009.02.004; Trottier H, 2006, CANCER EPIDEM BIOMAR, V15, P1274, DOI 10.1158/1055-9965.EPI-06-0129; Vernon SD, 2000, J CLIN MICROBIOL, V38, P651, DOI 10.1128/JCM.38.2.651-655.2000; Wallace J, 2005, J MOL DIAGN, V7, P72, DOI 10.1016/S1525-1578(10)60011-6; Wheeler CM, 2006, J INFECT DIS, V194, P1291, DOI 10.1086/507909; Zhao YW, 2008, PATHOL INT, V58, P643, DOI 10.1111/j.1440-1827.2008.02283.x	34	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32259	10.1371/journal.pone.0032259	http://dx.doi.org/10.1371/journal.pone.0032259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393393	Green Published, gold, Green Submitted			2022-12-27	WOS:000303003500046
J	Ku, WL; Duggal, G; Li, Y; Girvan, M; Ott, E				Ku, Wai Lim; Duggal, Geet; Li, Yuan; Girvan, Michelle; Ott, Edward			Interpreting Patterns of Gene Expression: Signatures of Coregulation, the Data Processing Inequality, and Triplet Motifs	PLOS ONE			English	Article							REGULATORY NETWORKS; MUTUAL INFORMATION; INFERENCE; ARACNE	Various methods of reconstructing transcriptional regulatory networks infer transcriptional regulatory interactions (TRIs) between strongly coexpressed gene pairs (as determined from microarray experiments measuring mRNA levels). Alternatively, however, the coexpression of two genes might imply that they are coregulated by one or more transcription factors (TFs), and do not necessarily share a direct regulatory interaction. We explore whether and under what circumstances gene pairs with a high degree of coexpression are more likely to indicate TRIs, coregulation or both. Here we use established TRIs in combination with microarray expression data from both Escherichia coli (a prokaryote) and Saccharomyces cerevisiae (a eukaryote) to assess the accuracy of predictions of coregulated gene pairs and TRIs from coexpressed gene pairs. We find that coexpressed gene pairs are more likely to indicate coregulation than TRIs for Saccharomyces cerevisiae, but the incidence of TRIs in highly coexpressed gene pairs is higher for Escherichia coli. The data processing inequality (DPI) has previously been applied for the inference of TRIs. We consider the case where a transcription factor gene is known to regulate two genes (one of which is a transcription factor gene) that are known not to regulate one another. According to the DPI, the non-interacting gene pairs should have the smallest mutual information among all pairs in the triplets. While this is sometimes the case for Escherichia coli, we find that it is almost always not the case for Saccharomyces cerevisiae. This brings into question the usefulness of the DPI sometimes employed to infer TRIs from expression data. Finally, we observe that when a TF gene is known to regulate two other genes, it is rarely the case that one regulatory interaction is positively correlated and the other interaction is negatively correlated. Typically both are either positively or negatively correlated.	[Ku, Wai Lim; Girvan, Michelle; Ott, Edward] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Ku, Wai Lim; Girvan, Michelle; Ott, Edward] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Duggal, Geet] Univ Maryland, Inst Adv Comp Studies, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Duggal, Geet] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; [Li, Yuan] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Ku, WL (corresponding author), Univ Maryland, Dept Phys, College Pk, MD 20742 USA.	wlku@umd.edu	O, E/F-1630-2015; Girvan, Michelle/E-3982-2016; Ku, Wai Lim/R-7170-2016; Ott, Edward/F-5609-2017	Girvan, Michelle/0000-0003-0299-0784; Ku, Wai Lim/0000-0002-8859-6771; Ott, Edward/0000-0002-9395-5062; Girvan, Michelle/0000-0001-7519-2842	Office of Naval Research (ONR) [N0001H-07-1-0734]	Office of Naval Research (ONR)(Office of Naval Research)	This work was supported by the Office of Naval Research (ONR) grant N0001H-07-1-0734. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Alon U, 2007, INTRO SYSTEMS BIOL D; Balaji S, 2008, TRENDS GENET, V24, P319, DOI 10.1016/j.tig.2008.04.006; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; Daub CO, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-118; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; FISHER LD, 1993, BIOSTATISTICS; Gama-Castro S, 2010, NUCL ACIDS RES; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Kim DC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S3-S9; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Liang KC, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/253894; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Margolin AA, 2007, ANN NY ACAD SCI, V1115, P51, DOI 10.1196/annals.1407.019; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mordelet F, 2008, BIOINFORMATICS, V24, pI76, DOI 10.1093/bioinformatics/btn273; Olsen C, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/308959; Paninski L, 2003, NEURAL COMPUT, V15, P1191, DOI 10.1162/089976603321780272; Slonim Noam, 2005, ARXIVCS0502017; Veiga DFT, 2007, GENET MOL RES, V6, P730; Watkinson J, 2009, ANN NY ACAD SCI, V1158, P302, DOI 10.1111/j.1749-6632.2008.03757.x; Zoppoli P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-154	26	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31969	10.1371/journal.pone.0031969	http://dx.doi.org/10.1371/journal.pone.0031969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393375	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500028
J	Hennessey, PT; Sanford, T; Choudhary, A; Mydlarz, WW; Brown, D; Adai, AT; Ochs, MF; Ahrendt, SA; Mambo, E; Califano, JA				Hennessey, Patrick T.; Sanford, Tiffany; Choudhary, Ashish; Mydlarz, Wojciech W.; Brown, David; Adai, Alex Tamas; Ochs, Michael F.; Ahrendt, Steven A.; Mambo, Elizabeth; Califano, Joseph A.			Serum microRNA Biomarkers for Detection of Non-Small Cell Lung Cancer	PLOS ONE			English	Article							CIRCULATING MICRORNAS; EXPRESSION; SIGNATURES; PROGNOSIS; PLASMA	Non small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality world-wide and the majority of cases are diagnosed at late stages of disease. There is currently no cost-effective screening test for NSCLC, and the development of such a test is a public health imperative. Recent studies have suggested that chest computed tomography screening of patients at high risk of lung cancer can increase survival from disease, however, the cost effectiveness of such screening has not been established. In this Phase I/II biomarker study we examined the feasibility of using serum miRNA as biomarkers of NSCLC using RT-qPCR to examine the expression of 180 miRNAs in sera from 30 treatment naive NSCLC patients and 20 healthy controls. Receiver operating characteristic curves (ROC) and area under the curve were used to identify differentially expressed miRNA pairs that could distinguish NSCLC from healthy controls. Selected miRNA candidates were further validated in sera from an additional 55 NSCLC patients and 75 healthy controls. Examination of miRNA expression levels in serum from a multi-institutional cohort of 50 subjects (30 NSCLC patients and 20 healthy controls) identified differentially expressed miRNAs. A combination of two differentially expressed miRNAs miR-15b and miR-27b, was able to discriminate NSCLC from healthy controls with sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 100% in the training set. Upon further testing on additional 130 subjects (55 NSCLC and 75 healthy controls), this miRNA pair predicted NSCLC with a specificity of 84% (95% CI 0.73-0.91), sensitivity of 100% (95% CI; 0.93-1.0), NPV of 100%, and PPV of 82%. These data provide evidence that serum miRNAs have the potential to be sensitive, cost-effective biomarkers for the early detection of NSCLC. Further testing in a Phase III biomarker study in is necessary for validation of these results.	[Hennessey, Patrick T.; Mydlarz, Wojciech W.; Califano, Joseph A.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Sanford, Tiffany; Choudhary, Ashish; Adai, Alex Tamas; Mambo, Elizabeth] Asuragen Inc, Austin, TX USA; [Brown, David] MiRNA Therapeut Inc, Austin, TX USA; [Ochs, Michael F.] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; [Ochs, Michael F.] Johns Hopkins Med Inst, Div Biostat & Bioinformat, Baltimore, MD 21205 USA; [Ahrendt, Steven A.] Univ Pittsburgh, Med Ctr, Div Surg Oncol, Pittsburgh, PA USA; [Califano, Joseph A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Asuragen; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Greater Baltimore Medical Center	Hennessey, PT (corresponding author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	jcalifa@jhmi.edu		Ahrendt, Steven/0000-0002-3029-2126	National Institute of Health SBIR [1R43CA141786-01]; National Institute of Health [T32DC000027]; Asuragen, Inc.; NATIONAL CANCER INSTITUTE [R43CA141786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000027] Funding Source: NIH RePORTER	National Institute of Health SBIR; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Asuragen, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was funded in part by National Institute of Health SBIR grant #1R43CA141786-01 and by National Institute of Health grant # T32DC000027. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was also funded in part by Asuragen, Inc. The researchers at Asuragen, Inc. who participated in this study were not influenced by management or parties outside of their research group and had exclusive control over study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal C, 2010, J NATL COMPR CANC NE, V8, P822, DOI 10.6004/jnccn.2010.0059; Bach PB, 2007, JAMA-J AM MED ASSOC, V297, P953, DOI 10.1001/jama.297.9.953; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Bellomi Massimo, 2006, Cancer Imaging, V6, pS9, DOI 10.1102/1470-7330.2006.9001; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Brenner DJ, 2004, RADIOLOGY, V231, P440, DOI 10.1148/radiol.2312030880; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Foss KM, 2011, J THORAC ONCOL, V6, P482, DOI 10.1097/JTO.0b013e318208c785; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Keller A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-353; Komatsu S, 2011, BRIT J CANCER, V105, P104, DOI 10.1038/bjc.2011.198; Kuehbacher A, 2008, TRENDS PHARMACOL SCI, V29, P12, DOI 10.1016/j.tips.2007.10.014; Lin PY, 2010, BRIT J CANCER, V103, P1144, DOI 10.1038/sj.bjc.6605901; Liu B, 2009, LUNG CANCER, V66, P169, DOI 10.1016/j.lungcan.2009.01.010; Miettinen OS, 2000, CAN MED ASSOC J, V162, P1431; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; New York Early Cancer Action Inv, 2007, RADIOLOGY, V243, P239, DOI 10.1148/radiol.2431060467; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Rock V. J., 2007, Morbidity and Mortality Weekly Report, V56, P1157; Russi EW, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13185; Shen J, 2011, LAB INVEST, V91, P579, DOI 10.1038/labinvest.2010.194; Subramanian J, 2010, J THORAC ONCOL, V5, P1116, DOI 10.1097/JTO.0b013e3181e76159; Sun YQ, 2010, BIOCHEM BIOPH RES CO, V391, P1483, DOI 10.1016/j.bbrc.2009.12.098; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Wang YF, 2009, J BIOL CHEM, V284, P23094, DOI 10.1074/jbc.M109.012617; Welch HG, 2007, ARCH INTERN MED, V167, P2289, DOI 10.1001/archinte.167.21.2289; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	32	147	162	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32307	10.1371/journal.pone.0032307	http://dx.doi.org/10.1371/journal.pone.0032307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389695	gold, Green Published, Green Accepted			2022-12-27	WOS:000302999600033
J	Kota, S; Takahashi, V; Ni, F; Snyder, JK; Strosberg, AD				Kota, Smitha; Takahashi, Virginia; Ni, Feng; Snyder, John K.; Strosberg, A. Donny			Direct Binding of a Hepatitis C Virus Inhibitor to the Viral Capsid Protein	PLOS ONE			English	Article							INFECTION IN-VITRO; CORE PROTEIN; LIPID DROPLETS; CELL-CULTURE; NS3 HELICASE; DIMERIZATION; REPLICATION; ASSAY; EPIDEMIOLOGY; POLYMERASE	Over 130 million people are infected chronically with hepatitis C virus (HCV), which, together with HBV, is the leading cause of liver disease. Novel small molecule inhibitors of Hepatitis C virus (HCV) are needed to complement or replace current treatments based on pegylated interferon and ribavirin, which are only partially successful and plagued with side-effects. Assembly of the virion is initiated by the oligomerization of core, the capsid protein, followed by the interaction with NS5A and other HCV proteins. By screening for inhibitors of core dimerization, we previously discovered peptides and drug-like compounds that disrupt interactions between core and other HCV proteins, NS3 and NS5A, and block HCV production. Here we report that a biotinylated derivative of SL209, a prototype small molecule inhibitor of core dimerization (IC50 of 2.80 mu M) that inhibits HCV production with an EC50 of 3.20 mu M, is capable of penetrating HCV-infected cells and tracking with core. Interaction between the inhibitors, core and other viral proteins was demonstrated by SL209-mediated affinity-isolation of HCV proteins from lysates of infected cells, or of the corresponding recombinant HCV proteins. SL209-like inhibitors of HCV core may form the basis of novel treatments of Hepatitis C in combination with other target-specific HCV drugs such as inhibitors of the NS3 protease, the NS5B polymerase, or the NS5A regulatory protein. More generally, our work supports the hypothesis that inhibitors of viral capsid formation might constitute a new class of potent antiviral agents, as was recently also shown for HIV capsid inhibitors.	[Kota, Smitha; Takahashi, Virginia; Strosberg, A. Donny] Scripps Res Inst, Dept Infectol, Jupiter, FL 33458 USA; [Strosberg, A. Donny] Univ Paris 07, CNRS, Paris, France; [Strosberg, A. Donny] Inst Cochin, INSERM, Paris, France; [Ni, Feng; Snyder, John K.] Boston Univ, Dept Chem, Boston, MA 02215 USA	Scripps Research Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Boston University	Kota, S (corresponding author), Scripps Res Inst, Dept Infectol, Jupiter, FL 33458 USA.	strosber@scripps.edu			TSRI; Factor Foundation (Florida); NIH [1R21NS066411, RNS073933A]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066411] Funding Source: NIH RePORTER	TSRI; Factor Foundation (Florida); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by start-up funds from TSRI, by a donation from The Factor Foundation (Florida), and by NIH grants 1R21NS066411 and RNS073933A (to ADS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Blair WS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001220; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; Boulant S, 2005, J VIROL, V79, P11353, DOI 10.1128/JVI.79.17.11353-11365.2005; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Chen KX, 2009, CURR OPIN INVEST DR, V10, P821; Cheng G, 2008, P NATL ACAD SCI USA, V105, P3088, DOI 10.1073/pnas.0712380105; Courcambeck J, 2006, ANTIVIR THER, V11, P847; Cristina J, 2007, VIRUS RES, V127, P185, DOI 10.1016/j.virusres.2007.02.023; Curreli F, 2011, BIOORGAN MED CHEM, V19, P77, DOI 10.1016/j.bmc.2010.11.045; De Francesco R, 2007, ADV DRUG DELIVER REV, V59, P1242, DOI 10.1016/j.addr.2007.04.016; Fader LD, 2011, BIOORG MED CHEM LETT, V21, P398, DOI 10.1016/j.bmcl.2010.10.131; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Gentile I, 2010, EXPERT OPIN INV DRUG, V19, P151, DOI 10.1517/13543780903501505; Klein KC, 2005, J VIROL, V79, P6814, DOI 10.1128/JVI.79.11.6814-6826.2005; Kota S, 2009, J GEN VIROL, V90, P1319, DOI 10.1099/vir.0.008565-0; Kota S, 2010, ASSAY DRUG DEV TECHN, V8, P96, DOI 10.1089/adt.2009.0217; Lalezari J, 2013, ANTIVIRAL ACTIVITY P; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Meurs EF, 2007, WORLD J GASTROENTERO, V13, P2446, DOI 10.3748/wjg.v13.i17.2446; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Mousseau G, 2011, J GEN VIROL, V92, P101, DOI 10.1099/vir.0.023325-0; Ni F, 2011, BIOORG MED CHEM LETT, V21, P2198, DOI 10.1016/j.bmcl.2011.03.014; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Peppard J, 2003, J BIOMOL SCREEN, V8, P149, DOI 10.1177/1087057103252308; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Prevelige PE, 2011, J MOL BIOL, V410, P634, DOI 10.1016/j.jmb.2011.03.074; Ruebsam F, 2009, BIOORG MED CHEM LETT, V19, P451, DOI 10.1016/j.bmcl.2008.11.048; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Strosberg AD, 2010, VIRUSES-BASEL, V2, P1734, DOI 10.3390/v2081734; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang PY, 2009, J ORG CHEM, V74, P6819, DOI 10.1021/jo901345j; Wei WG, 2009, BIOORG MED CHEM LETT, V19, P6926, DOI 10.1016/j.bmcl.2009.10.070; Zhang HT, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-28; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zlotnick A, 2002, J VIROL, V76, P4848, DOI 10.1128/JVI.76.10.4848-4854.2002	45	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32207	10.1371/journal.pone.0032207	http://dx.doi.org/10.1371/journal.pone.0032207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389688	gold, Green Submitted, Green Published			2022-12-27	WOS:000302999600026
J	Sun, J; Liu, SF; Zhang, CS; Yu, LN; Bi, J; Zhu, F; Yang, QL				Sun, Jie; Liu, Shao-fang; Zhang, Chu-shu; Yu, Li-na; Bi, Jie; Zhu, Feng; Yang, Qing-li			Chemical Composition and Antioxidant Activities of Broussonetia papyrifera Fruits	PLOS ONE			English	Article							INHIBITORS; EXTRACTS; CONSTITUENTS; PEPTIDE	Fruits of Broussonetia papyrifera from South China were analyzed for their total chemical composition, and antioxidant activities in ethanol and aqueous extracts. In the fruit of this plant, the crude protein, crude fat and carbohydrates was 7.08%, 3.72% and 64.73% of dry weight, respectively. The crude protein, crude fat and carbohydrates were 15.71%, 20.51% and 36.09% of dry weight, respectively. Fatty acid and amino acid composition of the fruit were analyzed. Unsaturated fatty acid concentration was 70.6% of the total fatty acids. The percentage of the essential amino acids (EAAs) was 40.60% of the total amino acids. Furthermore, B. papyrifera fruit are rich in many mineral elements and vitamins. Total phenolic content was assessed using the Folin-Ciocalteau assay, whereas antioxidant activities were assessed by measuring the ability of the two extracts to scavenge DPPH radicals, inhibit peroxidation, and chelate ferric ions. Their reducing power was also assessed. Results indicated that the aqueous extract of B. papyrifera was a more potent reducing agent and radical-scavenger than the ethanol extract. GC-MS analysis of the ethanol extract showed the presence of some acid-containing compounds. The changes in total phenolic content and antioxidant capacity in B. papyrifera from four different regions grown under normal conditions were assessed. The antioxidant activity of different extracts was positively associated with their total phenolic content. These results suggest that the fruit of B. papyrifera could be used in dietary supplement preparations, or as a food additive, for nutritional gain, or to prevent oxidation in food products.	[Sun, Jie; Liu, Shao-fang; Zhang, Chu-shu; Yu, Li-na; Bi, Jie; Zhu, Feng; Yang, Qing-li] Shandong Peanut Res Inst, Qingdao, Peoples R China		Sun, J (corresponding author), Shandong Peanut Res Inst, Qingdao, Peoples R China.	rice407@sohu.com			National Natural Science Foundation of China [31100205, 31000728]; China Agriculture Research System [CARS- 14]; Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province [BS2010NY023]; Natural Science Fund of Shangdong Province [ZR2009DQ004, ZR2011CQ036]; Qingdao Municipal Science and Technology Plan Project [11-2-3-26-nsh, 11-2-4-9-(3)-jch]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province; Natural Science Fund of Shangdong Province; Qingdao Municipal Science and Technology Plan Project	This study was supported by grants from the National Natural Science Foundation of China (31100205; 31000728), the China Agriculture Research System (CARS- 14), the Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province (BS2010NY023), the Natural Science Fund of Shangdong Province (ZR2009DQ004; ZR2011CQ036), Qingdao Municipal Science and Technology Plan Project (11-2-3-26-nsh; 11-2-4-9-(3)-jch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalbasit AM, 2009, J AM OIL CHEM SOC, V86, P749; Abdalbasit AM, 2009, J AM OIL CHEM SOC, V86, P1181; [Anonymous], 1993, OFF METH REC PRACT; [Anonymous], 1995, OFFICIAL METHODS ANA; BALZ M, 1992, FETT WISS TECHNOL, V94, P209, DOI 10.1002/lipi.19920940604; Chen RM, 2002, BIOORG MED CHEM LETT, V12, P3387, DOI 10.1016/S0960-894X(02)00757-6; Chen XH, 2010, J AGR FOOD CHEM, V58, P6966, DOI 10.1021/jf1011775; DINIS TCP, 1994, ARCH BIOCHEM BIOPHYS, V315, P161, DOI 10.1006/abbi.1994.1485; El-Adawy TA, 2001, FOOD CHEM, V74, P47, DOI 10.1016/S0308-8146(00)00337-X; Emma MM, 1994, FOOD CHEM, V51, P125; Ensminger M.E., 1990, FEEDS NUTR DIGEST, Vsecond; Esenowo G, 2002, J FOOD SCI TECHNOLOG, V39, P435; FAO/WHO, 1990, PROT QUAL EV, P23; Farvin KHS, 2010, FOOD CHEM, V123, P1081, DOI 10.1016/j.foodchem.2010.05.067; Hu XR, 2011, ELECTROCHIM ACTA, V56, P2919, DOI 10.1016/j.electacta.2010.12.086; IRENE D, 2008, FOOD CHEM, V107, P613; Jose M, 2008, PHYTOCHEMISTRY, V69, P451; Ko FN, 1998, FREE RADICAL BIO MED, V25, P160, DOI 10.1016/S0891-5849(98)00031-8; Ko HH, 1997, J NAT PROD, V60, P1008, DOI 10.1021/np970186o; Kumaran A, 2007, FITOTERAPIA, V78, P46, DOI 10.1016/j.fitote.2006.09.031; Lee D, 2001, J NAT PROD, V64, P1286, DOI 10.1021/np010288l; Lin CN, 1996, J NAT PROD, V59, P834, DOI 10.1021/np960376j; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; Qian ZJ, 2008, BIORESOURCE TECHNOL, V99, P3365, DOI 10.1016/j.biortech.2007.08.018; Rajapakse N, 2005, FOOD RES INT, V38, P175, DOI 10.1016/j.foodres.2004.10.002; Razali N, 2008, FOOD CHEM, V111, P38, DOI 10.1016/j.foodchem.2008.03.024; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Son KH, 2001, FITOTERAPIA, V72, P456, DOI 10.1016/S0367-326X(00)00329-4; Tuberoso CIG, 2007, FOOD CHEM, V101, P806, DOI 10.1016/j.foodchem.2006.02.039; Tuberoso CIG, 2010, FOOD CHEM, V123, P1242, DOI 10.1016/j.foodchem.2010.05.094; You LJ, 2011, FOOD CHEM, V124, P188, DOI 10.1016/j.foodchem.2010.06.007	31	12	16	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32021	10.1371/journal.pone.0032021	http://dx.doi.org/10.1371/journal.pone.0032021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389678	gold, Green Published, Green Submitted			2022-12-27	WOS:000302999600016
J	Victor, KG; Rady, JM; Cross, JV; Templeton, DJ				Victor, Ken G.; Rady, Joshua M.; Cross, Janet V.; Templeton, Dennis J.			Proteomic Profile of Reversible Protein Oxidation Using PROP, Purification of Reversibly Oxidized Proteins	PLOS ONE			English	Article							TYROSINE PHOSPHATASES; HYDROGEN-PEROXIDE; IDENTIFICATION; INACTIVATION; QUANTITATION; ACTIVATION	Signal transduction pathways that are modulated by thiol oxidation events are beginning to be uncovered, but these discoveries are limited by the availability of relatively few analytical methods to examine protein oxidation compared to other signaling events such as protein phosphorylation. We report here the coupling of PROP, a method to purify reversibly oxidized proteins, with the proteomic identification of the purified mixture using mass spectrometry. A gene ontology (GO), KEGG enrichment and Wikipathways analysis of the identified proteins indicated a significant enrichment in proteins associated with both translation and mRNA splicing. This methodology also enabled the identification of some of the specific cysteine residue targets within identified proteins that are reversibly oxidized by hydrogen peroxide treatment of intact cells. From these identifications, we determined a potential consensus sequence motif associated with oxidized cysteine residues. Furthermore, because we identified proteins and specific sites of oxidation from both abundant proteins and from far less abundant signaling proteins (e. g. hepatoma derived growth factor, prostaglandin E synthase 3), the results suggest that the PROP procedure was efficient. Thus, this PROP-proteomics methodology offers a sensitive means to identify biologically relevant redox signaling events that occur within intact cells.	[Victor, Ken G.; Rady, Joshua M.; Cross, Janet V.; Templeton, Dennis J.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia	Victor, KG (corresponding author), Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA.	kgv7g@virginia.edu; dtempleton@virginia.edu	Cross, Janet V/F-8276-2011; Templeton, Dennis J/F-7695-2011	Rady, Joshua/0000-0002-7806-136X	National Institutes of Health, NCI [CA126101]; NATIONAL CANCER INSTITUTE [R01CA126101] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant CA126101, part of the Clinical Proteomics Technologies in Cancer program of the NCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardwell J, 2005, NAT BIOTECHNOL, V23, P42, DOI 10.1038/nbt0105-42; Boivin B, 2008, P NATL ACAD SCI USA, V105, P9959, DOI 10.1073/pnas.0804336105; Chu F, 2003, CARCINOGENESIS, V24, P317, DOI 10.1093/carcin/24.2.317; Collier TS, 2010, ANAL CHEM, V82, P8696, DOI 10.1021/ac101978b; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; Cross JV, 2004, BIOCHEM J, V381, P675, DOI 10.1042/BJ20040591; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Fu CX, 2009, MOL CELL PROTEOMICS, V8, P1674, DOI 10.1074/mcp.M800580-MCP200; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Hagglund P, 2008, J PROTEOME RES, V7, P5270, DOI 10.1021/pr800633y; Held JM, 2010, MOL CELL PROTEOMICS, V9, P1400, DOI 10.1074/mcp.M900643-MCP200; Hendrickson EL, 2006, ANALYST, V131, P1335, DOI 10.1039/b610957h; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Klemke M, 2008, IMMUNITY, V29, P404, DOI 10.1016/j.immuni.2008.06.016; Klomsiri C, 2010, METHOD ENZYMOL, V473, P77, DOI 10.1016/S0076-6879(10)73003-2; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lyons CE, 2011, ANAL CHEM, V83, P856, DOI 10.1021/ac102461e; Nadeau PJ, 2009, MOL BIOL CELL, V20, P3628, DOI 10.1091/mbc.E09-03-0211; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Salsbury FR, 2008, PROTEIN SCI, V17, P299, DOI 10.1110/ps.073096508; Sethuraman M, 2004, J PROTEOME RES, V3, P1228, DOI 10.1021/pr049887e; Sethuraman M, 2004, MOL CELL PROTEOMICS, V3, P273, DOI 10.1074/mcp.T300011-MCP200; Templeton DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015012; Usaite R, 2008, J PROTEOME RES, V7, P266, DOI 10.1021/pr700580m; Victor KG, 2010, J AM SOC MASS SPECTR, V21, P80, DOI 10.1016/j.jasms.2009.09.007; Wani R, 2011, P NATL ACAD SCI USA, V108, P10550, DOI 10.1073/pnas.1011665108; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yamaoka K, 1996, J BIOCHEM-TOKYO, V119, P878; Zander T, 1998, METHOD ENZYMOL, V290, P59, DOI 10.1016/S0076-6879(98)90007-6; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	34	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32527	10.1371/journal.pone.0032527	http://dx.doi.org/10.1371/journal.pone.0032527			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389707	Green Published, gold, Green Submitted			2022-12-27	WOS:000302999600045
J	Wever, KE; Menting, TP; Rovers, M; van der Vliet, JA; Rongen, GA; Masereeuw, R; Ritskes-Hoitinga, M; Hooijmans, CR; Warle, M				Wever, Kimberley E.; Menting, Theo P.; Rovers, Maroeska; van der Vliet, J. Adam; Rongen, Gerard A.; Masereeuw, Rosalinde; Ritskes-Hoitinga, Merel; Hooijmans, Carlijn R.; Warle, Michiel			Ischemic Preconditioning in the Animal Kidney, a Systematic Review and Meta-Analysis	PLOS ONE			English	Review							DELAYED GRAFT FUNCTION; ACUTE-RENAL-FAILURE; REPERFUSION INJURY; CARDIAC-SURGERY; SEARCH FILTER; TRANSPLANTATION; HYPOTHERMIA; MYOCARDIUM; MECHANISMS; PROTECTS	Ischemic preconditioning (IPC) is a potent renoprotective strategy which has not yet been translated successfully into clinical practice, in spite of promising results in animal studies. We performed a unique systematic review and meta-analysis of animal studies to identify factors modifying IPC efficacy in renal ischemia/reperfusion injury (IRI), in order to enhance the design of future (clinical) studies. An electronic literature search for animal studies on IPC in renal IRI yielded fifty-eight studies which met our inclusion criteria. We extracted data for serum creatinine, blood urea nitrogen and histological renal damage, as well as study quality indicators. Meta-analysis showed that IPC reduces serum creatinine (SMD 1.54 [95% CI 1.16, 1.93]), blood urea nitrogen (SMD 1.42 [95% CI 0.97, 1.87]) and histological renal damage (SMD 1.12 [95% CI 0.89, 1.35]) after IRI as compared to controls. Factors influencing IPC efficacy were the window of protection (<24 h = early vs. >= 24 h = late) and animal species (rat vs. mouse). No difference in efficacy between local and remote IPC was observed. In conclusion, our findings show that IPC effectively reduces renal damage after IRI, with higher efficacy in the late window of protection. However, there is a large gap in study data concerning the optimal window of protection, and IPC efficacy may differ per animal species. Moreover, current clinical trials on RIPC may not be optimally designed, and our findings identify a need for further standardization of animal experiments.	[Wever, Kimberley E.; Rongen, Gerard A.; Masereeuw, Rosalinde] Radboud Univ Nijmegen, Med Ctr, Dept Pharmacol & Toxicol, NL-6525 ED Nijmegen, Netherlands; [Wever, Kimberley E.; Menting, Theo P.; van der Vliet, J. Adam; Warle, Michiel] Radboud Univ Nijmegen, Med Ctr, Dept Surg, NL-6525 ED Nijmegen, Netherlands; [Rovers, Maroeska] Radboud Univ Nijmegen, Med Ctr, Dept Operating Rooms & Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands; [Rovers, Maroeska; Ritskes-Hoitinga, Merel; Hooijmans, Carlijn R.] Radboud Univ Nijmegen, Med Ctr, Cent Anim Lab, NL-6525 ED Nijmegen, Netherlands; [Rovers, Maroeska; Ritskes-Hoitinga, Merel; Hooijmans, Carlijn R.] Radboud Univ Nijmegen, Med Ctr, Res Ctr 3R, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Wever, KE (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Pharmacol & Toxicol, NL-6525 ED Nijmegen, Netherlands.	k.wever@chir.umcn.nl	Ritskes-Hoitinga, Merel/GLT-8517-2022; Rongen, Gerard/AAJ-9694-2021; Wever, Kimberley/D-9705-2016; Hooijmans, Carlijn R/L-4390-2015; Rovers, Maroeska/F-2969-2014	Ritskes-Hoitinga, Merel/0000-0001-5315-284X; Wever, Kimberley/0000-0003-3635-3660; Masereeuw, Rosalinde/0000-0002-1560-1074; Hooijmans, Carlijn R/0000-0001-6435-5714; Rovers, Maroeska/0000-0002-3095-170X	Netherlands Heart Foundation [2006T035]	Netherlands Heart Foundation(Netherlands Heart Foundation)	This work was partially funded by the Netherlands Heart Foundation (grant #2006T035). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ZA, 2007, CIRCULATION, V116, pI98, DOI 10.1161/circulationaha.106.679167; Chen X, 2009, AM J NEPHROL, V30, P287, DOI 10.1159/000225928; Choi YS, 2011, J THORAC CARDIOV SUR, V142, P148, DOI 10.1016/j.jtcvs.2010.11.018; Cochrane J, 1999, RENAL FAILURE, V21, P135, DOI 10.3109/08860229909066978; de Vries RBM, 2011, LAB ANIM-UK, V45, P268, DOI 10.1258/la.2011.011056; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eisner C, 2010, KIDNEY INT, V77, P519, DOI 10.1038/ki.2009.501; Grenz A, 2007, J AM SOC NEPHROL, V18, P833, DOI 10.1681/ASN.2006101141; Hausenloy DJ, 2011, NAT REV CARDIOL, V8, P619, DOI 10.1038/nrcardio.2011.85; Hausenloy DJ, 2009, ATHEROSCLEROSIS, V204, P334, DOI 10.1016/j.atherosclerosis.2008.10.029; Hooijmans CR, 2010, LAB ANIM-UK, V44, P170, DOI 10.1258/la.2010.009117; Hooijmans CR, 2010, ATLA-ALTERN LAB ANIM, V38, P167, DOI 10.1177/026119291003800208; JABLONSKI P, 1983, TRANSPLANTATION, V35, P198, DOI 10.1097/00007890-198303000-00002; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nigwekar SU, 2009, AM J KIDNEY DIS, V54, P413, DOI 10.1053/j.ajkd.2009.01.267; Obal D, 2006, EUR J ANAESTH, V23, P319, DOI 10.1017/S0265021505002000; Ojo AO, 1997, TRANSPLANTATION, V63, P968, DOI 10.1097/00007890-199704150-00011; Ojo AO, 2003, NEW ENGL J MED, V349, P931, DOI 10.1056/NEJMoa021744; Park KM, 2003, J BIOL CHEM, V278, P27256, DOI 10.1074/jbc.M301778200; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Pitcher JM, 2005, J SURG RES, V129, P202, DOI 10.1016/j.jss.2005.04.015; Pound P, 2004, BMJ-BRIT MED J, V328, P514, DOI 10.1136/bmj.328.7438.514; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Przyklenk K, 2011, DRUG AGING, V28, P331, DOI 10.2165/11587190-000000000-00000; Safian RD, 2001, NEW ENGL J MED, V344, P431, DOI 10.1056/NEJM200102083440607; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; van der Worp HB, 2010, J CEREBR BLOOD F MET, V30, P1079, DOI 10.1038/jcbfm.2010.44; Walsh SR, 2010, VASC ENDOVASC SURG, V44, P334, DOI 10.1177/1538574410370788; Walsh SR, 2008, EUR J CARDIO-THORAC, V34, P985, DOI 10.1016/j.ejcts.2008.07.062; Waring WS, 2011, CLIN TOXICOL, V49, P720, DOI 10.3109/15563650.2011.615319; Wever KE, 2011, NEPHROL DIAL TRANSPL, V26, P3108, DOI 10.1093/ndt/gfr103; Yin DP, 1998, TRANSPLANTATION, V66, P152, DOI 10.1097/00007890-199807270-00002; Zimmerman RF, 2011, KIDNEY INT, V80, P861, DOI 10.1038/ki.2011.156	35	128	138	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32296	10.1371/journal.pone.0032296	http://dx.doi.org/10.1371/journal.pone.0032296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389693	Green Published, gold, Green Submitted			2022-12-27	WOS:000302999600031
J	Cheng, CP; Lee, PF; Liu, WC; Wu, IC; Chin, CY; Chang, TT; Tseng, VS				Cheng, Chun-Pei; Lee, Pei-Fen; Liu, Wen-Chun; Wu, I-Chin; Chin, Chu-Yu; Chang, Ting-Tsung; Tseng, Vincent S.			Analysis of Precore/Core Covariances Associated with Viral Kinetics and Genotypes in Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients	PLOS ONE			English	Article							VIRUS CORE GENE; HEPATOCELLULAR-CARCINOMA; MOLECULAR EPIDEMIOLOGY; NATURAL COURSE; LIVER-DISEASE; MUTATIONS; RISK; IMMUNOLOGY; MANAGEMENT; INFECTION	Hepatitis B virus (HBV) is one of the most common DNA viruses that can cause aggressive hepatitis, cirrhosis and hepatocellular carcinoma. Although many people are persistently infected with HBV, the kinetics in serum levels of viral loads and the host immune responses vary from person to person. HBV precore/core open reading frame (ORF) encoding proteins, hepatitis B e antigen (HBeAg) and core antigen (HBcAg), are two indicators of active viral replication. The aim of this study was to discover a variety of amino acid covariances in responses to viral kinetics, seroconversion and genotypes during the course of HBV infection. A one year follow-up study was conducted with a total number of 1,694 clones from 23 HBeAg-positive chronic hepatitis B patients. Serum alanine aminotransferase, HBV DNA and HBeAg levels were measured monthly as criteria for clustering patients into several different subgroups. Monthly derived multiple precore/core ORFs were directly sequenced and translated into amino acid sequences. For each subgroup, time-dependent covariances were identified from their time-varying sequences over the entire follow-up period. The fluctuating, wavering, HBeAg-nonseroconversion and genotype C subgroups showed greater degrees of covariances than the stationary, declining, HBeAg-seroconversion and genotype B. Referring to literature, mutation hotspots within our identified covariances were associated with the infection process. Remarkably, hotspots were predominant in genotype C. Moreover, covariances were also identified at early stage (spanning from baseline to a peak of serum HBV DNA) in order to determine the intersections with aforementioned time-dependent covariances. Preserved covariances, namely representative covariances, of each subgroup are visually presented using a tree-based structure. Our results suggested that identified covariances were strongly associated with viral kinetics, seroconversion and genotypes. Moreover, representative covariances may benefit clinicians to prescribe a suitable treatment for patients even if they have no obvious symptoms at the early stage of HBV infection.	[Cheng, Chun-Pei; Chin, Chu-Yu; Tseng, Vincent S.] Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan 70101, Taiwan; [Lee, Pei-Fen; Tseng, Vincent S.] Natl Cheng Kung Univ, Inst Med Informat, Tainan 70101, Taiwan; [Liu, Wen-Chun] Ming Dao Univ, Dept Biotechnol, Changhua, Taiwan; [Wu, I-Chin; Chang, Ting-Tsung] Natl Cheng Kung Univ, Dept Internal Med, Tainan 70101, Taiwan; [Wu, I-Chin] Natl Cheng Kung Univ, Grad Inst Clin Med, Tainan 70101, Taiwan; [Chang, Ting-Tsung] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Wu, I-Chin; Chang, Ting-Tsung] Natl Cheng Kung Univ, Infect Dis & Signaling Res Ctr, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; Mingdao University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Cheng, CP (corresponding author), Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan 70101, Taiwan.	tsengsm@mail.ncku.edu.tw			National Science Council (NSC) of the Republic of China (Taiwan) [NSC100-2314-B-006-073-]; National Science Council of Taiwan (R.O.C.); Advanced Biomedical ICT Research Center at the National Cheng Kung University	National Science Council (NSC) of the Republic of China (Taiwan)(Ministry of Science and Technology, Taiwan); National Science Council of Taiwan (R.O.C.)(Ministry of Science and Technology, Taiwan); Advanced Biomedical ICT Research Center at the National Cheng Kung University	The authors would like to thank the National Science Council (NSC, http://web1.nsc.gov.tw/mp.aspx?mp=7) of the Republic of China (Taiwan) for financial support of this research under contract number "NSC100-2314-B-006-073-". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the National Science Council of Taiwan (R.O.C.) and the Advanced Biomedical ICT Research Center at the National Cheng Kung University. We would also like to thank the collaboration from research fellow Dr. Mi-Hua Tao in the Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan (R.O.C.).	AKARCA US, 1995, HEPATOLOGY, V22, P50, DOI 10.1002/hep.1840220109; Alexopoulou A, 2009, J MED VIROL, V81, P34, DOI 10.1002/jmv.21337; Asim M, 2010, J MED VIROL, V82, P1115, DOI 10.1002/jmv.21774; Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Bozkaya H, 1996, HEPATOLOGY, V24, P32, DOI 10.1053/jhep.1996.v24.pm0008707278; Chan HLY, 2009, CLIN GASTROENTEROL H, V7, P1361, DOI 10.1016/j.cgh.2009.08.004; Chan HLY, 2003, J CLIN MICROBIOL, V41, P1277, DOI 10.1128/JCM.41.3.1277-1279.2003; Chang S, 2010, MINING MUTATION CHAI, P473; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chu CJ, 2002, GASTROENTEROLOGY, V122, P1756, DOI 10.1053/gast.2002.33588; CHUANG WL, 1993, GASTROENTEROLOGY, V104, P263, DOI 10.1016/0016-5085(93)90861-6; Dahari H, 2009, GASTROENTEROLOGY, V136, P1402, DOI 10.1053/j.gastro.2008.12.060; EHATA T, 1992, J CLIN INVEST, V89, P332, DOI 10.1172/JCI115581; Eyal E, 2007, PROTEINS, V67, P142, DOI 10.1002/prot.21223; Frenkel-Morgenstern M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S5-S6; GOWANS EJ, 1985, INTERVIROLOGY, V24, P220, DOI 10.1159/000149646; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; HOSONO S, 1995, VIROLOGY, V212, P151, DOI 10.1006/viro.1995.1463; HSU HC, 1987, J HEPATOL, V5, P45, DOI 10.1016/S0168-8278(87)80060-0; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Kao JH, 2007, HEPATOL INT, V1, P415, DOI 10.1007/s12072-007-9033-2; Kim H, 2007, J MICROBIOL BIOTECHN, V17, P701; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Krishnan SM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001072; Lee BC, 2008, PROTEINS, V72, P863, DOI 10.1002/prot.21972; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lin YJ, 2010, P NATL ACAD SCI USA, V107, P9340, DOI 10.1073/pnas.1004762107; Liu WC, 2006, J CLIN MICROBIOL, V44, P4491, DOI 10.1128/JCM.01375-06; Liu Z, 2005, J VIRAL HEPATITIS, V12, P146, DOI 10.1111/j.1365-2893.2005.00552.x; Livingston SE, 2007, J INFECT DIS, V195, P5, DOI 10.1086/509894; Luciani F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000565; Luo K X, 1994, Zhonghua Nei Ke Za Zhi, V33, P763; MARGOLIS HS, 1991, SEMIN LIVER DIS, V11, P84, DOI 10.1055/s-2008-1040427; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; MISSALE G, 1993, J EXP MED, V177, P751, DOI 10.1084/jem.177.3.751; Mohamadkhani A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-209; NORDER H, 1992, J GEN VIROL, V73, P3141, DOI 10.1099/0022-1317-73-12-3141; PENNA A, 1992, ARCH VIROL, P23; Pumpens P, 2002, INTERVIROLOGY, V45, P218, DOI 10.1159/000067915; Pumpens P, 2001, INTERVIROLOGY, V44, P98, DOI 10.1159/000050037; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Shinkai N, 2007, J CLIN MICROBIOL, V45, P3191, DOI 10.1128/JCM.00411-07; Thakur V, 2003, J MED VIROL, V70, P520, DOI 10.1002/jmv.10426; Tsai Sun-Lung, 1994, Journal of Biomedical Science, V1, P105, DOI 10.1007/BF02257984; Wang Yaoyu E, 2006, Genome Inform, V17, P23; Wu IC, 2007, J MED VIROL, V79, P663, DOI 10.1002/jmv.20822; Xu Z, 2010, J GASTROENTEROL; Yin JH, 2011, AM J GASTROENTEROL, V106, P81, DOI 10.1038/ajg.2010.399; Yin JH, 2010, CANCER EPIDEM BIOMAR, V19, P777, DOI 10.1158/1055-9965.EPI-09-1001; Yuen MF, 2007, J VIRAL HEPATITIS, V14, P269, DOI 10.1111/j.1365-2893.2006.00799.x	51	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32553	10.1371/journal.pone.0032553	http://dx.doi.org/10.1371/journal.pone.0032553			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384271	Green Published, gold, Green Submitted			2022-12-27	WOS:000302918500099
J	Ribeiro, PL; Camacho, A; Navas, CA				Ribeiro, Pedro Leite; Camacho, Agustin; Navas, Carlos Arturo			Considerations for Assessing Maximum Critical Temperatures in Small Ectothermic Animals: Insights from Leaf-Cutting Ants	PLOS ONE			English	Article							CRITICAL THERMAL LIMITS; HEAT-SHOCK PROTEINS; CLIMATE-CHANGE; GEOGRAPHIC-VARIATION; SPECIES RESPONSES; TOLERANCE; ACCLIMATION; ADAPTATION; EVOLUTIONARY; DROSOPHILA	The thermal limits of individual animals were originally proposed as a link between animal physiology and thermal ecology. Although this link is valid in theory, the evaluation of physiological tolerances involves some problems that are the focus of this study. One rationale was that heating rates shall influence upper critical limits, so that ecological thermal limits need to consider experimental heating rates. In addition, if thermal limits are not surpassed in experiments, subsequent tests of the same individual should yield similar results or produce evidence of hardening. Finally, several non-controlled variables such as time under experimental conditions and procedures may affect results. To analyze these issues we conducted an integrative study of upper critical temperatures in a single species, the ant Atta sexdens rubropiosa, an animal model providing large numbers of individuals of diverse sizes but similar genetic makeup. Our specific aims were to test the 1) influence of heating rates in the experimental evaluation of upper critical temperature, 2) assumptions of absence of physical damage and reproducibility, and 3) sources of variance often overlooked in the thermal-limits literature; and 4) to introduce some experimental approaches that may help researchers to separate physiological and methodological issues. The upper thermal limits were influenced by both heating rates and body mass. In the latter case, the effect was physiological rather than methodological. The critical temperature decreased during subsequent tests performed on the same individual ants, even one week after the initial test. Accordingly, upper thermal limits may have been overestimated by our (and typical) protocols. Heating rates, body mass, procedures independent of temperature and other variables may affect the estimation of upper critical temperatures. Therefore, based on our data, we offer suggestions to enhance the quality of measurements, and offer recommendations to authors aiming to compile and analyze databases from the literature.	[Ribeiro, Pedro Leite; Camacho, Agustin; Navas, Carlos Arturo] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil	Universidade de Sao Paulo	Ribeiro, PL (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil.	pedrolribeiro@gmail.com	Navas, Carlos/B-2138-2013; Camacho, Agustín/AAA-7104-2021	Navas, Carlos/0000-0002-9859-0568; Camacho, Agustín/0000-0003-2978-792X	State of Sao Paulo Science Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP) [08/57687-0, 2009/54235-3]	State of Sao Paulo Science Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the State of Sao Paulo Science Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP - 08/57687-0 and 2009/54235-3; URL: http://www.fapesp.br/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000258; Angilletta MJ, THERMAL ADAPTATION; Bernardo J, 2006, BIOL LETTERS, V2, P135, DOI 10.1098/rsbl.2005.0417; Bilyk KT, 2011, COMP BIOCHEM PHYS A, V158, P382, DOI 10.1016/j.cbpa.2010.12.010; BRATTSTROM BH, 1963, ECOLOGY, V44, P238, DOI 10.2307/1932171; Britton JR, 2010, FRESHWATER BIOL, V55, P1130, DOI 10.1111/j.1365-2427.2010.02396.x; Calosi P, 2008, BIOL LETTERS, V4, P99, DOI 10.1098/rsbl.2007.0408; Chapperon C, 2011, GLOBAL CHANGE BIOL, V17, P1740, DOI 10.1111/j.1365-2486.2010.02356.x; Chown SL, 2009, FUNCT ECOL, V23, P133, DOI 10.1111/j.1365-2435.2008.01481.x; Clusella-Trullas S, 2011, AM NAT, V177, P738, DOI 10.1086/660021; Compton TJ, 2007, J EXP MAR BIOL ECOL, V352, P200, DOI 10.1016/j.jembe.2007.07.010; Cowles Raymond Bridgman, 1944, BULL AMER MUS NAT HIST, V83, P261; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Duarte H, 2011, GLOBAL CHANGE BIOL; Edgerly JS, 2005, FUNCT ECOL, V19, P255, DOI 10.1111/j.1365-2435.2005.00957.x; Eliason EJ, 2011, SCIENCE, V332, P109, DOI 10.1126/science.1199158; Eme J, 2011, J EXP MAR BIOL ECOL, V399, P35, DOI 10.1016/j.jembe.2011.01.009; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Folk DG, 2007, J EXP BIOL, V210, P2649, DOI 10.1242/jeb.003350; Garbuz DG, 2008, MOL ECOL, V17, P4763, DOI 10.1111/j.1365-294X.2008.03947.x; Garcia-Berthou E, 2001, J ANIM ECOL, V70, P708, DOI 10.1046/j.1365-2656.2001.00524.x; Gilman SE, 2006, P NATL ACAD SCI USA, V103, P9560, DOI 10.1073/pnas.0510992103; Gonzalez RA, 2010, J THERM BIOL, V35, P218, DOI 10.1016/j.jtherbio.2010.05.004; Hazell SP, 2010, J INSECT PHYSIOL, V56, P123, DOI 10.1016/j.jinsphys.2009.08.022; HEATWOLE H, 1968, COMP BIOCHEM PHYSIOL, V27, P807, DOI 10.1016/0010-406X(68)90620-8; Hochachka P. W., 2002, BIOCH ADAPTATION; Hoffmann AA, 2010, J EXP BIOL, V213, P870, DOI 10.1242/jeb.037630; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Holldobler B., 1990, pi; Hopkin RS, 2006, J EXP MAR BIOL ECOL, V331, P74, DOI 10.1016/j.jembe.2005.10.007; Huang SP, 2008, J THERM BIOL, V33, P48, DOI 10.1016/j.jtherbio.2007.09.007; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; Jumbam KR, 2008, POLAR BIOL, V31, P215, DOI 10.1007/s00300-007-0349-0; Jumbam KR, 2008, J INSECT PHYSIOL, V54, P1008, DOI 10.1016/j.jinsphys.2008.03.011; KIVIVUORI L, 1990, ANN ZOOL FENN, V27, P287; Klok CJ, 2003, BIOL J LINN SOC, V78, P401, DOI 10.1046/j.1095-8312.2003.00154.x; Kumlu M, 2010, J THERM BIOL, V35, P305, DOI 10.1016/j.jtherbio.2010.06.009; Lighton JRB, 2004, J EXP BIOL, V207, P1903, DOI 10.1242/jeb.00970; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1553, DOI 10.1139/z97-782; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1561, DOI 10.1139/z97-783; Manly BFJ, 1997, RANDOMIZATION BOOTST; Marshall DJ, 2010, BIOL LETTERS, V6, P669, DOI 10.1098/rsbl.2010.0233; Martins EG, 2011, GLOBAL CHANGE BIOL, V17, P99, DOI 10.1111/j.1365-2486.2010.02241.x; Mercader RJ, 2008, ECOL ENTOMOL, V33, P537, DOI 10.1111/j.1365-2311.2008.01001.x; Monahan WB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007921; Mora C, 2006, J THERM BIOL, V31, P337, DOI 10.1016/j.jtherbio.2006.01.005; Navas CA, 2007, COMP BIOCHEM PHYS A, V147, P647, DOI 10.1016/j.cbpa.2006.04.035; Nyamukondiwa C, 2010, PHYSIOL ENTOMOL, V35, P255, DOI 10.1111/j.1365-3032.2010.00736.x; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Peck LS, 2008, MAR ECOL PROG SER, V358, P181, DOI 10.3354/meps07336; Peck LS, 2009, FUNCT ECOL, V23, P248, DOI 10.1111/j.1365-2435.2008.01537.x; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2006, POLAR BIOL, V29, P688, DOI 10.1007/s00300-005-0106-1; Portner HO, 2008, CLIM RES, V37, P253, DOI 10.3354/cr00766; Rensing L, 1996, CHRONOBIOL INT, V13, P239, DOI 10.3109/07420529609020904; Rensing L, 1997, CHRONOBIOL INT, V14, P481, DOI 10.3109/07420529709001470; Rezende EL, 2011, FUNCT ECOL, V25, P111, DOI 10.1111/j.1365-2435.2010.01778.x; Santos M, 2011, FUNCT ECOL, V25, P1169, DOI 10.1111/j.1365-2435.2011.01908.x; Sarma K, 2010, FISH PHYSIOL BIOCHEM, V36, P85, DOI 10.1007/s10695-008-9293-3; Seebacher F, 2011, J EXP BIOL, V214, P1437, DOI 10.1242/jeb.053124; Sgro CM, 2010, J EVOLUTION BIOL, V23, P2484, DOI 10.1111/j.1420-9101.2010.02110.x; Sherman E, 2003, J THERM BIOL, V28, P373, DOI 10.1016/S0306-4565(03)00014-7; Silva A, 2003, J INSECT PHYSIOL, V49, P307, DOI 10.1016/S0022-1910(03)00004-0; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Stenseng E, 2005, BIOL BULL-US, V208, P138, DOI 10.2307/3593122; Stillman JH, 2000, PHYSIOL BIOCHEM ZOOL, V73, P200, DOI 10.1086/316738; Stillman JH, 2005, INT CONGR SER, P267; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; Terblanche JS, 2006, AM J TROP MED HYG, V74, P786, DOI 10.4269/ajtmh.2006.74.786; Terblanche JS, 2011, J EXP BIOL, V214, P3713, DOI 10.1242/jeb.061283; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Willett CS, 2010, EVOLUTION, V64, P2521, DOI 10.1111/j.1558-5646.2010.01008.x; WILLHITE C, 1982, COMP BIOCHEM PHYS A, V72, P255, DOI 10.1016/0300-9629(82)90042-1; Yoder JA, 2006, INT J ACAROL, V32, P417, DOI 10.1080/01647950608684490	78	85	86	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32083	10.1371/journal.pone.0032083	http://dx.doi.org/10.1371/journal.pone.0032083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384147	Green Submitted, Green Published, gold			2022-12-27	WOS:000302916800023
J	Hunnicutt, BJ; Chaverra, M; George, L; Lefcort, F				Hunnicutt, Barbara J.; Chaverra, Marta; George, Lynn; Lefcort, Frances			IKAP/Elp1 Is Required In Vivo for Neurogenesis and Neuronal Survival, but Not for Neural Crest Migration	PLOS ONE			English	Article							DORSAL ROOT-GANGLIA; FAMILIAL DYSAUTONOMIA; ELONGATOR COMPLEX; MOUSE IKBKAP; DIFFERENTIATION; EXPRESSION; PROTEIN; GENES; CELLS; PROLIFERATION	Familial Dysautonomia (FD; Hereditary Sensory Autonomic Neuropathy; HSAN III) manifests from a failure in development of the peripheral sensory and autonomic nervous systems. The disease results from a point mutation in the IKBKAP gene, which encodes the IKAP protein, whose function is still unresolved in the developing nervous system. Since the neurons most severely depleted in the disease derive from the neural crest, and in light of data identifying a role for IKAP in cell motility and migration, it has been suggested that FD results from a disruption in neural crest migration. To determine the function of IKAP during development of the nervous system, we (1) first determined the spatial-temporal pattern of IKAP expression in the developing peripheral nervous system, from the onset of neural crest migration through the period of programmed cell death in the dorsal root ganglia, and (2) using RNAi, reduced expression of IKBKAP mRNA in the neural crest lineage throughout the process of dorsal root ganglia (DRG) development in chick embryos in ovo. Here we demonstrate that IKAP is not expressed by neural crest cells and instead is expressed as neurons differentiate both in the CNS and PNS, thus the devastation of the PNS in FD could not be due to disruptions in neural crest motility or migration. In addition, we show that alterations in the levels of IKAP, through both gain and loss of function studies, perturbs neuronal polarity, neuronal differentiation and survival. Thus IKAP plays pleiotropic roles in both the peripheral and central nervous systems.	[Hunnicutt, Barbara J.; Chaverra, Marta; George, Lynn; Lefcort, Frances] Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Hunnicutt, BJ (corresponding author), Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA.	lefcort@montana.edu		George, Lynn/0000-0002-8125-2319	NIH-NINDS [NS35714]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035714, R29NS035714] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by NIH-NINDS NS35714. This grant paid the salary for every author on this study and for the reagents used for the experiments summarized here. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Axelrod FB, 2006, CLIN AUTON RES, V16, P90, DOI 10.1007/s10286-006-0326-7; Boone N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015590; CARR VM, 1978, J COMP NEUROL, V182, P727; Cheishvili D, 2007, HUM MOL GENET, V16, P2097, DOI 10.1093/hmg/ddm157; Cheishvili D, 2011, HUM MOL GENET, V20, P1585, DOI 10.1093/hmg/ddr036; Chen YT, 2009, MOL CELL BIOL, V29, P736, DOI 10.1128/MCB.01313-08; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Coles EG, 2007, DEV BIOL, V312, P533, DOI 10.1016/j.ydbio.2007.09.056; Cornez I, 2008, BIOCHEM PHARMACOL, V75, P2122, DOI 10.1016/j.bcp.2008.03.006; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Cuajungco MP, 2001, DNA CELL BIOL, V20, P579, DOI 10.1089/104454901317094990; Dietrich P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027015; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; Gardiner J, 2007, TRAFFIC, V8, P1145, DOI 10.1111/j.1600-0854.2007.00605.x; George L, 2010, J COMP NEUROL, V518, P405, DOI 10.1002/cne.22248; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hapner SJ, 2006, DEV BIOL, V297, P182, DOI 10.1016/j.ydbio.2006.05.007; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Holmberg C, 2002, J BIOL CHEM, V277, P31918, DOI 10.1074/jbc.M200719200; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Keren H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015884; LAHAT E, 1992, DEV MED CHILD NEUROL, V34, P690; LALLIER TE, 1988, DEV BIOL, V127, P99, DOI 10.1016/0012-1606(88)90192-3; Le Douarin N.M., 1982, NEURAL CREST; Le Douarin NM, 1998, NEURAL CREST; LORING JF, 1987, DEV BIOL, V121, P220, DOI 10.1016/0012-1606(87)90154-0; MAHLOUDJI M, 1970, J NEUROL SCI, V11, P383, DOI 10.1016/0022-510X(70)90083-3; MCKUSICK VA, 1967, ISRAEL J MED SCI, V3, P372; Mezey E, 2003, BRAIN RES, V983, P209, DOI 10.1016/S0006-8993(03)03090-7; Nakagawa S, 1998, DEVELOPMENT, V125, P2963; Naumanen T, 2008, CELL ADHES MIGR, V2, P236, DOI 10.4161/cam.2.4.6630; Nelissen H, 2005, P NATL ACAD SCI USA, V102, P7754, DOI 10.1073/pnas.0502600102; Nelson BR, 2004, DEV DYNAM, V229, P618, DOI 10.1002/dvdy.20030; Nguyen L, 2010, TRENDS MOL MED, V16, P1, DOI 10.1016/j.molmed.2009.11.002; Nielsen KM, 2004, MOL CELL NEUROSCI, V25, P629, DOI 10.1016/j.mcn.2003.12.004; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Park KS, 2010, DEVELOPMENT, V137, P2691, DOI 10.1242/dev.050096; PEARSON J, 1978, J NEUROL SCI, V39, P47, DOI 10.1016/0022-510X(78)90187-9; PEARSON J, 1978, J NEUROL SCI, V35, P77, DOI 10.1016/0022-510X(78)90103-X; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Rifkin JT, 2000, DEV BIOL, V227, P465, DOI 10.1006/dbio.2000.9841; RILEY C M, 1957, Adv Pediatr, V9, P157; Shafikhani SH, 2008, CELL CYCLE, V7, P2868, DOI 10.4161/cc.7.18.6674; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Solinger JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000820; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Svejstrup JQ, 2007, CURR OPIN CELL BIOL, V19, P331, DOI 10.1016/j.ceb.2007.04.005; TOSNEY KW, 1978, DEV BIOL, V62, P317, DOI 10.1016/0012-1606(78)90219-1; Weston J A, 1970, Adv Morphog, V8, P41	52	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32050	10.1371/journal.pone.0032050	http://dx.doi.org/10.1371/journal.pone.0032050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384137	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100048
J	Kikuchi, O; Kobayashi, M; Amano, K; Sasaki, T; Kitazumi, T; Kim, HJ; Lee, YS; Yokota-Hashimoto, H; Kitamura, YI; Kitamura, T				Kikuchi, Osamu; Kobayashi, Masaki; Amano, Kosuke; Sasaki, Tsutomu; Kitazumi, Tomoya; Kim, Hye-Jin; Lee, Yong-Soo; Yokota-Hashimoto, Hiromi; Kitamura, Yukari-Ido; Kitamura, Tadahiro			FoxO1 Gain of Function in the Pancreas Causes Glucose Intolerance, Polycystic Pancreas, and Islet Hypervascularization	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXO1; BETA-CELL GROWTH; INSULIN-RECEPTOR; FACTOR-A; MICE; DIFFERENTIATION; RESISTANCE; PATHWAY; REVASCULARIZATION; VASCULARIZATION	Genetic studies revealed that the ablation of insulin/IGF-1 signaling in the pancreas causes diabetes. FoxO1 is a downstream transcription factor of insulin/IGF-1 signaling. We previously reported that FoxO1 haploinsufficiency restored beta cell mass and rescued diabetes in IRS2 knockout mice. However, it is still unclear whether FoxO1 dysregulation in the pancreas could be the cause of diabetes. To test this hypothesis, we generated transgenic mice overexpressing constitutively active FoxO1 specifically in the pancreas (TG). TG mice had impaired glucose tolerance and some of them indeed developed diabetes due to the reduction of beta cell mass, which is associated with decreased Pdx1 and MafA in beta cells. We also observed increased proliferation of pancreatic duct epithelial cells in TG mice and some mice developed a polycystic pancreas as they aged. Furthermore, TG mice exhibited islet hypervascularities due to increased VEGF-A expression in beta cells. We found FoxO1 binds to the VEGF-A promoter and regulates VEGF-A transcription in beta cells. We propose that dysregulation of FoxO1 activity in the pancreas could account for the development of diabetes and pancreatic cysts.	[Kikuchi, Osamu; Kobayashi, Masaki; Amano, Kosuke; Sasaki, Tsutomu; Kitazumi, Tomoya; Kim, Hye-Jin; Lee, Yong-Soo; Yokota-Hashimoto, Hiromi; Kitamura, Yukari-Ido; Kitamura, Tadahiro] Gunma Univ, Inst Mol & Cellular Regulat, Metab Signal Res Ctr, Maebashi, Gunma 371, Japan	Gunma University	Kikuchi, O (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Metab Signal Res Ctr, Maebashi, Gunma 371, Japan.	kitamura@gunma-u.ac.jp	Lee, Yong-Soo/AAI-7059-2020	Sasaki, Tsutomu/0000-0001-8041-1915	Naito Memorial Foundation; Pancreas Research Foundation of Japan; Uehara Memorial Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Naito Memorial Foundation(Naito Memorial Foundation); Pancreas Research Foundation of Japan(Pancreas Research Foundation of Japan); Uehara Memorial Foundation(Uehara Memorial Foundation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-Aid for Scientific Research (B) (T.K.), Naito Memorial Foundation (T.K.), Pancreas Research Foundation of Japan (T.K.), The Uehara Memorial Foundation (T.K.), and Global Centers of Excellence program (T.K.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Basturk O, 2009, ARCH PATHOL LAB MED, V133, P423, DOI 10.1043/1543-2165-133.3.423; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Elli L, 2006, AM J GASTROENTEROL, V101, P2655, DOI 10.1111/j.1572-0241.2006.00737.x; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Iwashita N, 2007, DIABETOLOGIA, V50, P380, DOI 10.1007/s00125-006-0512-0; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kawamori D, 2005, J BIOL CHEM; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2001, MOL CELL BIOL, V21, P5624, DOI 10.1128/MCB.21.16.5624-5630.2001; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kitamura T, 2009, MOL CELL BIOL, V29, P4417, DOI 10.1128/MCB.01622-08; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kushner JA, 2010, CELL METAB, V11, P2, DOI 10.1016/j.cmet.2009.12.005; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Schiekofer S, 2005, ARTERIOSCL THROM VAS, V25, P1603, DOI 10.1161/01.ATV.0000171994.89106.ca; Tsunekawa S, 2011, DIABETES, V60, P2883, DOI 10.2337/db11-0340; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116	31	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32249	10.1371/journal.pone.0032249	http://dx.doi.org/10.1371/journal.pone.0032249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384192	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916100062
J	Kim, SU; Kim, JK; Park, YN; Han, KH				Kim, Seung Up; Kim, Ja Kyung; Park, Young Nyun; Han, Kwang-Hyub			Discordance between Liver Biopsy and FibroScan (R) in Assessing Liver Fibrosis in Chronic Hepatitis B: Risk Factors and Influence of Necroinflammation	PLOS ONE			English	Article							TRANSIENT ELASTOGRAPHY FIBROSCAN; STIFFNESS MEASUREMENT; ACCURACY; VARIABILITY; PERFORMANCE; CIRRHOSIS	Background: Few studies have investigated predictors of discordance between liver biopsy (LB) and liver stiffness measurement (LSM) using FibroScan (R). We assessed predictors of discordance between LB and LSM in chronic hepatitis B (CHB) and investigated the effects of necroinflammatory activity. Methods: In total, 150 patients (107 men, 43 women) were prospectively enrolled. Only LSM with >= 10 valid measurements was considered reliable. Liver fibrosis was evaluated using the Laennec system. LB specimens <15 mm in length were considered ineligible. Reference cutoff LSM values to determine discordance were calculated from our cohort (6.0 kPa for >= F2, 7.5 kPa for >= F3, and 9.4 kPa for F4). Results: A discordance, defined as a discordance of at least two stages between LB and LSM, was identified in 21 (14.0%) patients. In multivariate analyses, fibrosis stages F3-4 and F4 showed independent negative associations with discordance (P = 0.002; hazard ratio [HR], 0.073; 95% confidence interval [CI], 0.014-0.390 for F3-4 and P = 0.014; HR, 0.067; 95% CI, 0.008-0.574 for F4). LSM values were not significantly different between maximal activity grades 1-2 and 3-4 in F1 and F2 fibrosis stages, whereas LSM values were significantly higher in maximal activity grade 3-4 than 1-2 in F3 and F4 fibrosis stage (median 8.6 vs. 11.3 kPa in F3, P = 0.049; median 11.9 vs. 19.2 kPa in F4, P = 0.009). Conclusion: Advanced fibrosis stage (F3-4) or cirrhosis (F4) showed a negative correlation with discordance between LB and LSM in patients with CHB, and maximal activity grade 3-4 significantly influenced LSM values in F3 and F4.	[Kim, Seung Up; Kim, Ja Kyung; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Seung Up; Kim, Ja Kyung; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Ctr Chron Metab Dis, Seoul, South Korea; [Kim, Ja Kyung; Park, Young Nyun; Han, Kwang-Hyub] Liver Cirrhosis Clin Res Ctr, Seoul, South Korea; [Park, Young Nyun; Han, Kwang-Hyub] Brain Korea 21 Project Med Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, SU (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	young0608@yuhs.ac; gihankhys@yuhs.ac		KIM, JA KYUNG/0000-0001-5025-6846; Han, Kwang-Hyub/0000-0003-3960-6539; Park, Young Nyun/0000-0003-0357-7967; Kim, Seung Up/0000-0002-9658-8050	Ministry of Health, Welfare and Family Affairs, Republic of Korea [A050021]; National Research Foundation [R13-2002-054-03004-0]; Korea government (MOST)	Ministry of Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation; Korea government (MOST)(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government)	This study was supported by the grant of the Good Health R & D Project from the Ministry of Health, Welfare and Family Affairs, Republic of Korea (A050021) and the National Research Foundation grant (R13-2002-054-03004-0) funded by the Korea government (MOST) (to YNP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Chan HLY, 2009, J VIRAL HEPATITIS, V16, P36, DOI 10.1111/j.1365-2893.2008.01037.x; Cho HJ, 2011, J GASTROEN HEPATOL, V26, P492, DOI 10.1111/j.1440-1746.2010.06419.x; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Fung J, 2011, AM J GASTROENTEROL, V106, P492, DOI 10.1038/ajg.2010.463; Fung J, 2010, HEPATOL INT, V4, P716, DOI 10.1007/s12072-010-9189-z; Kim MY, 2011, J HEPATOL, V55, P1004, DOI 10.1016/j.jhep.2011.02.012; Kim SU, 2010, ALIMENT PHARM THER, V32, P498, DOI 10.1111/j.1365-2036.2010.04353.x; Kim SU, 2010, HEPATO-GASTROENTEROL, V57, P832; Kim SU, 2010, MAGN RESON IMAGING, V28, P802, DOI 10.1016/j.mri.2010.03.018; Kim SU, 2008, HEPATOL INT, V2, P471, DOI 10.1007/s12072-008-9091-0; Kim SU, 2010, J CLIN GASTROENTEROL, V44, P66, DOI 10.1097/MCG.0b013e3181a95c7f; Kim SU, 2009, LIVER INT, V29, P810, DOI 10.1111/j.1478-3231.2008.01894.x; Lucidarme D, 2009, HEPATOLOGY, V49, P1083, DOI 10.1002/hep.22748; Millonig G, 2008, HEPATOLOGY, V48, P1718, DOI 10.1002/hep.22577; Millonig G, 2010, J HEPATOL, V52, P206, DOI 10.1016/j.jhep.2009.11.018; Myers RP, 2010, LIVER INT, V30, P1471, DOI 10.1111/j.1478-3231.2010.02331.x; Rousselet MC, 2005, HEPATOLOGY, V41, P257, DOI 10.1002/hep.20535; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Wanless IR, 2002, BLOOD, V100, P1566, DOI 10.1182/blood-2002-01-0306; Wright TL, 2006, AM J GASTROENTEROL, V101, pS1, DOI 10.1111/j.1572-0241.2006.00469.x; Yun MH, 2011, J VIRAL HEPATITIS, V18, P631, DOI 10.1111/j.1365-2893.2010.01376.x	27	39	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32233	10.1371/journal.pone.0032233	http://dx.doi.org/10.1371/journal.pone.0032233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384189	Green Submitted, gold, Green Published			2022-12-27	WOS:000302916100060
J	Chen, YL; Chen, YS; Chan, H; Tseng, YH; Yang, SR; Tsai, HY; Liu, HY; Sun, DS; Chang, HH				Chen, Ya-Lei; Chen, Yao-Shen; Chan, Hao; Tseng, Yao-Hsuan; Yang, Shu-Ru; Tsai, Hsin-Ying; Liu, Hong-Yi; Sun, Der-Shan; Chang, Hsin-Hou			The Use of Nanoscale Visible Light-Responsive Photocatalyst TiO2-Pt for the Elimination of Soil-Borne Pathogens	PLOS ONE			English	Article							BURKHOLDERIA-CEPACIA COMPLEX; PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; CENOCEPACIA; PSEUDOMALLEI; MELIOIDOSIS; WATER; COLONIZATION; DISINFECTION; PENETRATION	Exposure to the soil-borne pathogens Burkholderia pseudomallei and Burkholderia cenocepacia can lead to severe infections and even mortality. These pathogens exhibit a high resistance to antibiotic treatments. In addition, no licensed vaccine is currently available. A nanoscale platinum-containing titania photocatalyst (TiO2-Pt) has been shown to have a superior visible light-responsive photocatalytic ability to degrade chemical contaminants like nitrogen oxides. The antibacterial activity of the catalyst and its potential use in soil pathogen control were evaluated. Using the plating method, we found that TiO2-Pt exerts superior antibacterial performance against Escherichia coli compared to other commercially available and laboratory prepared ultraviolet/ visible light-responsive titania photocatalysts. TiO2-Pt-mediated photocatalysis also affectively eliminates the soil-borne bacteria B. pseudomallei and B. cenocepacia. An air pouch infection mouse model further revealed that TiO2-Pt-mediated photocatalysis could reduce the pathogenicity of both strains of bacteria. Unexpectedly, water containing up to 10% w/v dissolved soil particles did not reduce the antibacterial potency of TiO2-Pt, suggesting that the TiO2-Pt photocatalyst is suitable for use in soil-contaminated environments. The TiO2-Pt photocatalyst exerted superior antibacterial activity against a broad spectrum of human pathogens, including B. pseudomallei and B. cenocepacia. Soil particles (<10% w/v) did not significantly reduce the antibacterial activity of TiO2-Pt in water. These findings suggest that the TiO2-Pt photocatalyst may have potential applications in the development of bactericides for soilborne pathogens.	[Chen, Ya-Lei; Yang, Shu-Ru; Tsai, Hsin-Ying; Liu, Hong-Yi] Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Div Infect Dis, Kaohsiung, Taiwan; [Chan, Hao] Tzu Chi Univ, Grad Inst Med Sci, Hualien, Taiwan; [Tseng, Yao-Hsuan] Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei, Taiwan; [Sun, Der-Shan; Chang, Hsin-Hou] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Chen, Yao-Shen] Natl Yung Ming Univ, Dept Internal Med, Taipei, Taiwan	National Kaohsiung Normal University; Kaohsiung Veterans General Hospital; Tzu Chi University; National Taiwan University of Science & Technology; Tzu Chi University; National Yang Ming Chiao Tung University	Chen, YL (corresponding author), Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan.	hhchang@mail.tcu.edu.tw	Chang, Hsin-Hou/B-6225-2012	Chang, Hsin-Hou/0000-0002-8731-3485	National Science Council, Taiwan, People's Republic of China [95-2314-B-320-009-MY3, 98-2320-B-0.17-001-MY3, 99-2320-B-017-002-MY3]; Ministry of Economic Affairs, Taiwan, People's Republic of China [98-EC-17-A-19-S2-0111]; Tzu-Chi University [TCIRP 95002-02, TCIRP 98001-01, TCRPP 99020, TCRPP 100003]	National Science Council, Taiwan, People's Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Economic Affairs, Taiwan, People's Republic of China(Ministry of Economic Affairs, Taiwan); Tzu-Chi University	This work is supported by the National Science Council, Taiwan, People's Republic of China, under grant numbers 95-2314-B-320-009-MY3, 98-2320-B-0.17-001-MY3 and 99-2320-B-017-002-MY3, by the Ministry of Economic Affairs, Taiwan, People's Republic of China, under grant number 98-EC-17-A-19-S2-0111 and by Tzu-Chi University under grant numbers TCIRP 95002-02, TCIRP 98001-01, TCRPP 99020 and TCRPP 100003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTERTHUM F, 1989, APPL ENVIRON MICROB, V55, P1943, DOI 10.1128/AEM.55.8.1943-1948.1989; Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051; BENVENUTI S, 1995, WEED SCI, V43, P389, DOI 10.1017/S0043174500081376; Bevivino A, 2005, RES MICROBIOL, V156, P974, DOI 10.1016/j.resmic.2005.05.007; Brett PJ, 2000, ACTA TROP, V74, P201, DOI 10.1016/S0001-706X(99)00071-6; Chang HH, 1999, EXP CELL RES, V250, P387, DOI 10.1006/excr.1999.4547; Chang WK, 2012, NANOMEDICIN IN PRESS, V8; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Chen YS, 2010, J CLIN MICROBIOL, V48, P1432, DOI 10.1128/JCM.01720-09; Chen YS, 2009, JPN J INFECT DIS, V62, P155; Chen YS, 2009, MICROBIOL IMMUNOL, V53, P184, DOI 10.1111/j.1348-0421.2009.00105.x; Chen YS, 2003, FOLIA MICROBIOL, V48, P253, DOI 10.1007/BF02930965; Cheng CL, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-7; Chou PW, 2006, OBSERVATION CA UNPUB; Cunha MV, 2004, J CLIN MICROBIOL, V42, P3052, DOI 10.1128/JCM.42.7.3052-3058.2004; Currie BJ, 2003, EMERG INFECT DIS, V9, P1538, DOI 10.3201/eid0912.020750; Dance DAB, 2000, ACTA TROP, V74, P159, DOI 10.1016/S0001-706X(99)00066-2; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; Elkins JG, 1999, APPL ENVIRON MICROB, V65, P4594; Frojd V, 2011, BMC ORAL HEALTH, V11, DOI 10.1186/1472-6831-11-8; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Graindorge A, 2010, DIAGN MICR INFEC DIS, V66, P29, DOI 10.1016/j.diagmicrobio.2009.06.008; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; Hassett DJ, 1999, MOL MICROBIOL, V34, P1082, DOI 10.1046/j.1365-2958.1999.01672.x; Hearing VJ, 2005, J DERMATOL SCI, V37, P3, DOI 10.1016/j.jdermsci.2004.08.014; Iwasaki M, 2000, J COLLOID INTERF SCI, V224, P202, DOI 10.1006/jcis.1999.6694; Jin X, 1996, SOIL SCI, V161, P509, DOI 10.1097/00010694-199608000-00006; Kaiser K, 2000, SOIL SCI, V165, P305, DOI 10.1097/00010694-200004000-00002; Kau JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004167; Kuo CF, 1998, INFECT IMMUN, V66, P3931, DOI 10.1128/IAI.66.8.3931-3935.1998; LEELARASAMEE A, 1989, REV INFECT DIS, V11, P413; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Li QL, 2008, WATER RES, V42, P4591, DOI 10.1016/j.watres.2008.08.015; Lin HH, 2007, J HAZARD MATER, V145, P431, DOI 10.1016/j.jhazmat.2006.11.043; Lin HH, 2006, J CLIN MICROBIOL, V44, P4596, DOI 10.1128/JCM.01531-06; Lin YM, 2006, ENVIRON SCI TECHNOL, V40, P1616, DOI 10.1021/es051007p; Liou JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019982; LO SJ, 1979, BIOCHEM BIOPH RES CO, V86, P748, DOI 10.1016/0006-291X(79)91776-5; Loutet SA, 2010, INFECT IMMUN, V78, P4088, DOI 10.1128/IAI.00212-10; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Mann T, 2010, INFECTION, V38, P187, DOI 10.1007/s15010-010-0017-0; Matsuzawa S, 2008, APPL CATAL B-ENVIRON, V83, P39, DOI 10.1016/j.apcatb.2008.01.036; Njoroge J, 2009, EMBO MOL MED, V1, P201, DOI 10.1002/emmm.200900032; Peeters E, 2008, J HOSP INFECT, V70, P361, DOI 10.1016/j.jhin.2008.08.015; Rajagopal G, 2006, COLLOID SURFACE B, V51, P107, DOI 10.1016/j.colsurfb.2006.06.003; Russell AD, 2003, LANCET INFECT DIS, V3, P794, DOI 10.1016/S1473-3099(03)00833-8; Saiman L, 2003, INFECT CONT HOSP EP, V24, pS6, DOI 10.1086/503485; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sano T, 2008, J MOL CATAL A-CHEM, V284, P127, DOI 10.1016/j.molcata.2008.01.014; Slominski A, 1998, CLIN DERMATOL, V16, P503, DOI 10.1016/S0738-081X(98)00023-6; Stone R, 2007, SCIENCE, V317, P1022, DOI 10.1126/science.317.5841.1022; Su HP, 2007, J CLIN MICROBIOL, V45, P2599, DOI 10.1128/JCM.00228-07; Wattanaphon HT, 2008, J APPL MICROBIOL, V105, P416, DOI 10.1111/j.1365-2672.2008.03755.x; Wong MS, 2006, APPL ENVIRON MICROB, V72, P6111, DOI 10.1128/AEM.02580-05; Wong MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010394; WOOLLEY JT, 1978, PLANT PHYSIOL, V61, P597, DOI 10.1104/pp.61.4.597; Yue QL, 2008, J FLUORESC, V18, P11, DOI 10.1007/s10895-007-0228-7	58	26	27	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31212	10.1371/journal.pone.0031212	http://dx.doi.org/10.1371/journal.pone.0031212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384003	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500014
J	Kaiser, TS; Heckel, DG				Kaiser, Tobias S.; Heckel, David G.			Genetic Architecture of Local Adaptation in Lunar and Diurnal Emergence Times of the Marine Midge Clunio marinus (Chironomidae, Diptera)	PLOS ONE			English	Article							DROSOPHILA CIRCADIAN CLOCK; GENOME SIZE; TIMELESS; PROTEIN; TRANSCRIPTION; MELANOGASTER; POPULATIONS; VRILLE; PERIOD; DNA	Circadian rhythms pre-adapt the physiology of most organisms to predictable daily changes in the environment. Some marine organisms also show endogenous circalunar rhythms. The genetic basis of the circalunar clock and its interaction with the circadian clock is unknown. Both clocks can be studied in the marine midge Clunio marinus (Chironomidae, Diptera), as different populations have different local adaptations in their lunar and diurnal rhythms of adult emergence, which can be analyzed by crossing experiments. We investigated the genetic basis of population variation in clock properties by constructing the first genetic linkage map for this species, and performing quantitative trait locus (QTL) analysis on variation in both lunar and diurnal timing. The genome has a genetic length of 167-193 centimorgans based on a linkage map using 344 markers, and a physical size of 95-140 megabases estimated by flow cytometry. Mapping the sex determining locus shows that females are the heterogametic sex, unlike most other Chironomidae. We identified two QTL each for lunar emergence time and diurnal emergence time. The distribution of QTL confirms a previously hypothesized genetic basis to a correlation of lunar and diurnal emergence times in natural populations. Mapping of clock genes and light receptors identified ciliary opsin 2 (cOps2) as a candidate to be involved in both lunar and diurnal timing; cryptochrome 1 (cry1) as a candidate gene for lunar timing; and two timeless (tim2, tim3) genes as candidate genes for diurnal timing. This QTL analysis of lunar rhythmicity, the first in any species, provides a unique entree into the molecular analysis of the lunar clock.	[Kaiser, Tobias S.; Heckel, David G.] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany	Max Planck Society	Kaiser, TS (corresponding author), Max F Perutz Labs, Vienna, Austria.	tobias.kaiser@univie.ac.at	Heckel, David G/K-2138-2013	Heckel, David G/0000-0001-8991-2150; Kaiser, Tobias/0000-0002-4126-0533	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	TSK held a scholarship of the International Max Planck Research School. The study was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Bachleitner W, 2007, P NATL ACAD SCI USA, V104, P3538, DOI 10.1073/pnas.0606870104; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; BASTEN CJ, 2002, QTL CARTOGRAPHER REF; BEERMANN W., 1955, BIOL ZENTRALBL, V74, P525; Benna C, 2010, CURR BIOL, V20, P346, DOI 10.1016/j.cub.2009.12.048; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fishman L, 2001, GENETICS, V159, P1701; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Gotter AL, 1999, NEURON, V24, P953, DOI 10.1016/S0896-6273(00)81042-9; Gregory TR, 2008, HEREDITY, V101, P228, DOI 10.1038/hdy.2008.49; Hardin PE, 2009, SLEEP BIOL RHYTHMS, V7, P235, DOI 10.1111/j.1479-8425.2009.00412.x; Hirota T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000559; Huang YM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001107; Kaiser TS, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-49; Kaiser TS, 2010, MOL ECOL, V19, P2845, DOI 10.1111/j.1365-294X.2010.04706.x; Kaiser TS, 2009, MOL ECOL RESOUR, V9, P195, DOI 10.1111/j.1755-0998.2008.02340.x; Kojima S, 2007, P NATL ACAD SCI USA, V104, P1859, DOI 10.1073/pnas.0607567104; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Korringa P, 1957, MEM GEOL SOC AM, V67, P917; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lee H, 2009, P NATL ACAD SCI USA, V106, P21359, DOI 10.1073/pnas.0906651106; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Markus MA, 2006, DNA CELL BIOL, V25, P457, DOI 10.1089/dna.2006.25.457; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; MENG XL, 1993, BIOMETRIKA, V80, P267, DOI 10.2307/2337198; MICHAILOVA P, 1980, ZOOL ANZ, V205, P417; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; Nardon C, 2005, MOL ECOL, V14, P869, DOI 10.1111/j.1365-294X.2005.02457.x; Naylor E, 2001, EARTH MOON PLANETS, V85-6, P291, DOI 10.1023/A:1017088504226; NEUMANN D, 1988, J COMP PHYSIOL A, V163, P671, DOI 10.1007/BF00603851; NEUMANN D, 1967, HELGOLAND WISS MEER, V15, P163, DOI 10.1007/BF01618620; NEUMANN D, 1966, Z VERGL PHYSIOL, V53, P1, DOI 10.1007/BF00343045; NEUMANN D, 1995, NATURWISSENSCHAFTEN, V82, P310, DOI 10.1007/BF01131527; NEUMANN D, 1981, HDB BEHAVIOURAL NEUR, V4, P351; Neumann D, 1990, ATLAS PHASE RESPONSE, P715; Reineke A, 1998, INSECT MOL BIOL, V7, P95, DOI 10.1046/j.1365-2583.1998.71048.x; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rosato E, 2001, PHILOS T R SOC B, V356, P1769, DOI 10.1098/rstb.2001.0961; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; Stanewsky R, 2002, CELL TISSUE RES, V309, P11, DOI 10.1007/s00441-002-0569-0; Sugama N, 2008, J PINEAL RES, V45, P133, DOI 10.1111/j.1600-079X.2008.00566.x; THOMPSON PE, 1971, CAN ENTOMOL, V103, P369, DOI 10.4039/Ent103369-3; Tsuchiya Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000305; Velarde RA, 2005, INSECT BIOCHEM MOLEC, V35, P1367, DOI 10.1016/j.ibmb.2005.09.001; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; Wang S, 2012, WINDOWS QTL CARTOGRA; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; ZENG ZB, 1994, GENETICS, V136, P1457; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	63	13	14	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32092	10.1371/journal.pone.0032092	http://dx.doi.org/10.1371/journal.pone.0032092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384150	Green Published, gold			2022-12-27	WOS:000302875500075
J	Klinke, T; Daboul, A; Maron, J; Gredes, T; Puls, R; Jaghsi, A; Biffar, R				Klinke, Thomas; Daboul, Amro; Maron, Juliane; Gredes, Tomasz; Puls, Ralf; Jaghsi, Ahmad; Biffar, Reiner			Artifacts In Magnetic Resonance Imaging and Computed Tomography Caused By Dental Materials	PLOS ONE			English	Article							METALLIC OBJECTS; MR-IMAGES; CT; SUSCEPTIBILITY; IMPLANTS; DEVICES; ALLOYS; PET/CT; IMPACT	Background: Artifacts caused by dental restorations, such as dental crowns, dental fillings and orthodontic appliances, are a common problem in MRI and CT scans of the head and neck. The aim of this in-vitro study was to identify and evaluate the artifacts produced by different dental restoration materials in CT and MRI images. Methods: Test samples of 44 materials (Metal and Non-Metal) commonly used in dental restorations were fabricated and embedded with reference specimens in gelatin moulds. MRI imaging of 1.5T and CT scan were performed on the samples and evaluated in two dimensions. Artifact size and distortions were measured using a digital image analysis software. Results: In MRI, 13 out of 44 materials produced artifacts, while in CT 41 out of 44 materials showed artifacts. Artifacts produced in both MRI and CT images were categorized according to the size of the artifact. Significance: Metal based restoration materials had strong influence on CT and less artifacts in MRI images. Rare earth elements such as Ytterbium trifluoride found in composites caused artifacts in both MRI and CT. Recognizing these findings would help dental materials manufacturers and developers to produce materials which can cause less artifacts in MRI and CT images.	[Klinke, Thomas; Daboul, Amro; Maron, Juliane; Jaghsi, Ahmad; Biffar, Reiner] Ernst Moritz Arndt Univ Greifswald, Polyclin Prosthodont & Biomat, Greifswald, Germany; [Gredes, Tomasz] Ernst Moritz Arndt Univ Greifswald, Polyclin Orthodont, Greifswald, Germany; [Puls, Ralf] Ernst Moritz Arndt Univ Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Klinke, T (corresponding author), Ernst Moritz Arndt Univ Greifswald, Polyclin Prosthodont & Biomat, Greifswald, Germany.	daboulamro@gmail.com	Gredes, Tomasz/AAR-1180-2021	Gredes, Tomasz/0000-0002-0492-3422; Al Jaghsi, Ahmad/0000-0002-7888-1149				Abbaszadeh K, 2000, ORAL SURG ORAL MED O, V89, P759, DOI 10.1067/moe.2000.105942; Allen F, 2000, CLIN ORAL IMPLAN RES, V11, P34, DOI 10.1034/j.1600-0501.2000.011001034.x; Baek CH, 2008, J NUCL MED, V49, P1422, DOI 10.2967/jnumed.108.051649; Bartels LW, 2001, J VASC INTERV RADIOL, V12, P365, DOI 10.1016/S1051-0443(07)61918-6; Behr M, 1996, Eur J Prosthodont Restor Dent, V4, P111; BEUF O, 1994, DENT MATER, V10, P265, DOI 10.1016/0109-5641(94)90072-8; BouSerhal Charbel, 2002, Clin Implant Dent Relat Res, V4, P156, DOI 10.1111/j.1708-8208.2002.tb00167.x; Bui FM, 2000, J MED ENG TECHNOL, V24, P20, DOI 10.1080/030919000294003; CAMACHO CR, 1995, JMRI-J MAGN RESON IM, V5, P75, DOI 10.1002/jmri.1880050115; Cao Zheng, 2008, Zhonghua Yi Xue Za Zhi, V88, P1855; Carlsson A, 2009, THESIS U GOTHENBURG, P5; Destine Darline, 2008, Nihon Hotetsu Shika Gakkai Zasshi, V52, P205, DOI 10.2186/jjps.52.205; Eggers G, 2005, MAGN RESON MATER PHY, V18, P103, DOI 10.1007/s10334-005-0101-0; FACHE JS, 1987, AM J NEURORADIOL, V8, P837; FIALA TGS, 1993, PLAST RECONSTR SURG, V92, P1227; HINSHAW DB, 1988, RADIOLOGY, V166, P777, DOI 10.1148/radiology.166.3.3340777; Hopper TAJ, 2006, MAGN RESON IMAGING, V24, P1077, DOI 10.1016/j.mri.2006.04.019; Hubalkova H, 2006, INT DENT J, V56, P135; Hubalkova Hana, 2002, Eur J Prosthodont Restor Dent, V10, P125; Kamel EM, 2003, EUR RADIOL, V13, P724, DOI 10.1007/s00330-002-1564-2; Lee MJ, 2007, RADIOGRAPHICS, V27, P791, DOI 10.1148/rg.273065087; NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719; Odlum O, 2001, Spec Care Dentist, V21, P72; Shafiei F, 2003, J DENT RES, V82, P602, DOI 10.1177/154405910308200806; Starcukova J, 2008, DENT MATER, V24, P715, DOI 10.1016/j.dental.2007.07.002; Stradiotti P, 2009, EUR SPINE J, V18, pS102, DOI 10.1007/s00586-009-0998-5	26	72	76	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31766	10.1371/journal.pone.0031766	http://dx.doi.org/10.1371/journal.pone.0031766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384071	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500039
J	Qi, YC; Ma, MJ; Li, DJ; Chen, MJ; Lu, QB; Li, XJ; Li, JL; Liu, W; Cao, WC				Qi, Ying-Cheng; Ma, Mai-Juan; Li, Dong-Jun; Chen, Mei-Juan; Lu, Qing-Bin; Li, Xiu-Jun; Li, Jun-Lian; Liu, Wei; Cao, Wu-Chun			Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Multi-Ethnic Region, Xinjiang Uygur Autonomous Region, China	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; XDR TUBERCULOSIS; SOUTH-AFRICA; SHANGHAI; TB	Background: The multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) has emerged as a global threat. Xinjiang is a multi-ethnic region and suffered second highest incidence of TB in China. However, epidemiological information on MDR and XDR TB is scarcely investigated. Methodology/Principal Findings: A prospective study was conducted to analyze the prevalence of MDR and XDR TB and the differences of drug resistance TB between Chinese Han and other nationalities population at Chest Hospital of Xinjiang Uygur Autonomous Region, China. We performed in vitro drug susceptibility testing of Mycobacterium tuberculosis to first- and second-line anti-tuberculosis drugs for all 1893 culture confirmed positive TB cases that were diagnosed between June 2009 and June 2011. Totally 1117 (59.0%, 95% CI, 56.8%-61.2%) clinical isolates were resistant to >= 1 first-line drugs; the prevalence of MDR TB was 13.2% (95% CI, 11.7%-14.7%), of which, 77 (30.8%; 95% CI, 25.0%-36.6%) and 31 (12.8%; 95% CI, 8.6%-17.0%) isolates were pre-XDR and XDR TB respectively. Among the MDR/XDR TB, Chinese Han patients were significantly less likely to be younger with an odds ratio 0.42 for age 20-29 years and 0.52 for age 40-49 years; P-trend = 0.004), and Chinese Han patients has a lower prevalence of XDR TB (9.6%) than all the other nationality (14.9%). Conclusions/Significance: The burden of drug resistance TB cases is sizeable, which highlights an urgent need to reinforce the control, detection and treatment strategies for drug resistance TB. However, the difference of MDR and XDR TB between Chinese Han and other nationalities was not observed.	[Qi, Ying-Cheng; Chen, Mei-Juan; Li, Jun-Lian] Chest Hosp Xinjiang Uygur Autonomous Reg, Dept TB, Urumqi, Peoples R China; [Ma, Mai-Juan; Lu, Qing-Bin; Li, Xiu-Jun; Liu, Wei; Cao, Wu-Chun] Beijing Inst Microbiol & Epidemiol, Dept Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Li, Dong-Jun] Red Cross Aid Ctr Urumqi, Emergency Ctr, Urumqi, Peoples R China; [Lu, Qing-Bin; Li, Xiu-Jun] Shandong Univ, Dept Epidemiol & Hlth Stat, Jinan 250100, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Shandong University	Qi, YC (corresponding author), Chest Hosp Xinjiang Uygur Autonomous Reg, Dept TB, Urumqi, Peoples R China.	ljunl2007@163.com; liu_weis@sohu.com; caowc@nic.bmi.ac.cn	li, xiu/GXV-1745-2022	Ma, Mai-Juan/0000-0002-8105-462X; Lu, Qing-Bin/0000-0002-2804-0827	National Science Fund for Distinguished Young Scholars [30725032]; Research Funds of academy of military medical sciences [2008ZD006]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Research Funds of academy of military medical sciences	This study was supported by the grants of National Science Fund for Distinguished Young Scholars (30725032) and Innovation Research Funds of academy of military medical sciences (2008ZD006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2008, CLIN INFECT DIS, V47, P450, DOI 10.1086/590009; Blower S, 2007, LANCET INFECT DIS, V7, P443, DOI 10.1016/S1473-3099(07)70143-3; Bureau of Health XUAR, 2011, B HLTH XUAR B; Deng YF, 2011, EMERG INFECT DIS, V17, P495, DOI 10.3201/eid1703.100812; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Health CMo, 2010, NAT BAS SURV DRUG RE; Jin X, 2002, XINJIANG MED J, V32, P25; Lonnroth K, 2000, INT J TUBERC LUNG D, V4, P1052; Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99; Murase Y, 2010, EMERG INFECT DIS, V16, P948, DOI 10.3201/eid1606.091844; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Raviglione M, 2006, INT J TUBERC LUNG D, V10, P1185; Sun ZG, 2008, J CLIN MICROBIOL, V46, P4075, DOI 10.1128/JCM.00822-08; Tang SJ, 2011, SCAND J INFECT DIS, V43, P280, DOI 10.3109/00365548.2010.548080; Tang SJ, 2011, EMERG INFECT DIS, V17, P558, DOI 10.3201/eid1703.100919; WHO, 2008, ANT DRUG RES WORLD W; WHO, 2004, WHO NEWS, V82, P716; WHO, 2011, GLOB TTUB CONTR 2010; WHO, 2007, WHOHTMTB2007376; WHOStopTBPartnership, 2006, WHOHTMSTB200635; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Yang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020343; Zhao M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004370	25	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32103	10.1371/journal.pone.0032103	http://dx.doi.org/10.1371/journal.pone.0032103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384153	gold, Green Submitted, Green Published			2022-12-27	WOS:000302875500076
J	Zafeiropoulou, K; Bita, T; Polykratis, A; Karabina, S; Vlachojannis, J; Katsoris, P				Zafeiropoulou, Kalliopi; Bita, Theodora; Polykratis, Apostolos; Karabina, Stella; Vlachojannis, John; Katsoris, Panagiotis			Hemodialysis Removes Uremic Toxins That Alter the Biological Actions of Endothelial Cells	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; ISCHEMIA-REPERFUSION INJURY; GLYCATION END-PRODUCTS; MYOCARDIAL-INFARCTION; VASCULAR ENDOTHELIUM; REGULATORY FUNCTIONS; MATRIX METALLOPROTEINASES; CAROTID ATHEROSCLEROSIS; PARACRINE FUNCTIONS	Chronic kidney disease is linked to systemic inflammation and to an increased risk of ischemic heart disease and atherosclerosis. Endothelial dysfunction associates with hypertension and vascular disease in the presence of chronic kidney disease but the mechanisms that regulate the activation of the endothelium at the early stages of the disease, before systemic inflammation is established remain obscure. In the present study we investigated the effect of serum derived from patients with chronic kidney disease either before or after hemodialysis on the activation of human endothelial cells in vitro, as an attempt to define the overall effect of uremic toxins at the early stages of endothelial dysfunction. Our results argue that uremic toxins alter the biological actions of endothelial cells and the remodelling of the extracellular matrix before signs of systemic inflammatory responses are observed. This study further elucidates the early events of endothelial dysfunction during toxic uremia conditions allowing more complete understanding of the molecular events as well as their sequence during progressive renal failure.	[Zafeiropoulou, Kalliopi; Polykratis, Apostolos; Karabina, Stella; Katsoris, Panagiotis] Univ Patras, Dept Biol, Patras, Achaia, Greece; [Bita, Theodora; Vlachojannis, John] Univ Hosp Patras, Dept Internal Med Nephrol, Patras, Achaia, Greece	University of Patras; University of Patras	Zafeiropoulou, K (corresponding author), Univ Patras, Dept Biol, Patras, Achaia, Greece.	katsopan@upatras.gr		Polykratis, Apostolos/0000-0001-6720-3302				Andrews KL, 2000, AM J PATHOL, V157, P303, DOI 10.1016/S0002-9440(10)64541-5; ANGGARD EE, 1992, JPN J PHARMACOL, V58, pP200; Annuk M, 2003, KIDNEY INT, V63, pS50, DOI 10.1046/j.1523-1755.63.s84.2.x; Baradaran A, 2005, SAUDI J KIDNEY DIS T, V16, P288; Bolton CH, 2001, NEPHROL DIAL TRANSPL, V16, P1189, DOI 10.1093/ndt/16.6.1189; Brodsky SV, 2002, AM J PHYSIOL-RENAL, V282, pF1140, DOI 10.1152/ajprenal.00329.2001; Caramelo C, 1996, CIRC RES, V79, P1031, DOI 10.1161/01.RES.79.5.1031; Caron A, 2005, CAN J PHYSIOL PHARM, V83, P287, DOI 10.1139/Y05-011; Chappey O, 1997, Rev Prat, V47, P2223; Chen HJ, 2003, AM J PHYSIOL-HEART C, V284, pH1612, DOI 10.1152/ajpheart.00992.2002; Cheng S, 2006, FASEB J, V20, P1898, DOI 10.1096/fj.06-5898fje; Chung TW, 2004, J GASTROEN HEPATOL, V19, P565, DOI 10.1111/j.1440-1746.2004.03344.x; Costa-Hong V, 2009, ARQ BRAS CARDIOL, V92, P381; Cross J, 2002, BLOOD PURIFICAT, V20, P459, DOI 10.1159/000063552; de Nooijer R, 2006, ARTERIOSCL THROM VAS, V26, P340, DOI 10.1161/01.ATV.0000197795.56960.64; Djuric T, 2008, CLIN BIOCHEM, V41, P1326, DOI 10.1016/j.clinbiochem.2008.08.081; Fleming I, 1996, MOL CELL BIOCHEM, V157, P137; Florys Bozena, 2006, Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw, V12, P184; Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016; GUERRA R, 1989, BLOOD VESSELS, V26, P300; Hansson G, 1997, Lakartidningen, V94, P852; HANSSON GK, 1987, ACTA MED SCAND, P11; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hansson J, 2009, EUR J CARDIOV PREV R, V16, P297, DOI 10.1097/HJR.0b013e3283213108; Hayakawa H, 1999, J HYPERTENS, V17, P611, DOI 10.1097/00004872-199917050-00004; Hayashidani S, 2003, AM J PHYSIOL-HEART C, V285, pH1229, DOI 10.1152/ajpheart.00207.2003; Ho FM, 2007, J CELL BIOCHEM, V101, P442, DOI 10.1002/jcb.21192; Ishikawa M, 2001, AM J CARDIOL, V88, P1203, DOI 10.1016/S0002-9149(01)02064-1; Jaconbson SH, 2002, AM J NEPHROL, V22, P42, DOI 10.1159/000046673; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jefferis BJ, 2010, ATHEROSCLEROSIS, V208, P557, DOI 10.1016/j.atherosclerosis.2009.08.018; Johnson TS, 2002, EXP NEPHROL, V10, P182; Kandalam V, 2010, AM J PHYSIOL-HEART C, V299, pH1012, DOI 10.1152/ajpheart.00246.2010; Kandalam V, 2010, CIRC RES, V106, P796, DOI 10.1161/CIRCRESAHA.109.209189; Karbowska A, 2009, TRANSPL P, V41, P3052, DOI 10.1016/j.transproceed.2009.07.080; Kelly D, 2008, EUR J HEART FAIL, V10, P133, DOI 10.1016/j.ejheart.2007.12.009; Kharbanda RK, 2001, CORONARY ARTERY DIS, V12, P485, DOI 10.1097/00019501-200109000-00007; KITAGAWA S, 1994, LIFE SCI, V55, P491, DOI 10.1016/0024-3205(94)00741-1; KORNERUP HJ, 1976, ACTA MED SCAND, V200, P257; Kunz K, 1999, NEPHROL DIAL TRANSPL, V14, P1934, DOI 10.1093/ndt/14.8.1934; LAZARUS JM, 1974, ARCH INTERN MED, V133, P1059, DOI 10.1001/archinte.133.6.1059; Lee WY, 2011, BIOMATERIALS, V32, P5558, DOI 10.1016/j.biomaterials.2011.04.031; Lehrke M, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-50; Libby P, 2006, Handb Exp Pharmacol, P285; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Linden E, 2008, CLIN J AM SOC NEPHRO, V3, P691, DOI 10.2215/CJN.04291007; Lindsey ML, 2004, HEART FAIL REV, V9, P7, DOI 10.1023/B:HREV.0000011390.44039.b7; Luttun A, 2004, CIRCULATION, V109, P1408, DOI 10.1161/01.CIR.0000121728.14930.DE; Maier JAM, 2004, BBA-MOL BASIS DIS, V1689, P13, DOI 10.1016/j.bbadis.2004.01.002; Matsuda H, 2004, HYPERTENSION, V43, P603, DOI 10.1161/01.HYP.0000118053.42262.71; Matsumura S, 2005, J CLIN INVEST, V115, P599, DOI 10.1172/JCI200522304; Matsusaka H, 2005, AM J PHYSIOL-HEART C, V289, pH1858, DOI 10.1152/ajpheart.00216.2005; Ruilope LM, 2007, VASC HEALTH RISK MAN, V3, P1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Musial K, 2011, CELL STRESS CHAPERON, V16, P97, DOI 10.1007/s12192-010-0214-x; Mysliwiec M, 2004, Rocz Akad Med Bialymst, V49, P151; Napoli C, 2002, STROKE, V33, P2864; Nin JWM, 2009, DIABETOLOGIA, V52, P705, DOI 10.1007/s00125-009-1263-5; Pawlak K, 2011, CLIN BIOCHEM, V44, P838, DOI 10.1016/j.clinbiochem.2011.03.143; Polykratis A, 2005, J BIOL CHEM, V280, P22454, DOI 10.1074/jbc.M414407200; Pradhan-Palikhe P, 2010, SCAND J IMMUNOL, V72, P150, DOI 10.1111/j.1365-3083.2010.02418.x; RYAN JW, 1982, ADV VET SCI COMP MED, V26, P79; Sahin G, 2007, BLOOD PURIFICAT, V25, P309, DOI 10.1159/000106103; Schaefer L, 1996, KIDNEY INT, V49, P75, DOI 10.1038/ki.1996.10; Schwedler SB, 2002, KIDNEY INT, V62, P301, DOI 10.1046/j.1523-1755.2002.00423.x; Seimon T, 2009, J LIPID RES, V50, pS382, DOI 10.1194/jlr.R800032-JLR200; Song GD, 2010, WOUND REPAIR REGEN, V18, P426, DOI 10.1111/j.1524-475X.2010.00595.x; Szczepanska Maria, 2005, Pol Merkur Lekarski, V18, P17; Tabas I, 2007, CURR DRUG TARGETS, V8, P1288, DOI 10.2174/138945007783220623; TAKAGI M, 1994, BLOOD COAGUL FIBRIN, V5, P713, DOI 10.1097/00001721-199410000-00006; Tarin C, 2009, ARTERIOSCL THROM VAS, V29, P27, DOI 10.1161/ATVBAHA.108.169623; Thorp E, 2009, J LEUKOCYTE BIOL, V86, P1089, DOI 10.1189/jlb.0209115; VANE JR, 1990, NEW ENGL J MED, V323, P27; VANHINSBERGH VWM, 1992, MOL CELL BIOCHEM, V116, P163, DOI 10.1007/BF01270584; Wakatsuki S, 2008, EXPERT OPIN THER TAR, V12, P1469, DOI 10.1517/14728220802551140 ; Wang Chang-qian, 2005, Zhonghua Xinxueguanbing Zazhi, V33, P405; Zoccali C, 2006, J AM SOC NEPHROL, V17, pS64, DOI 10.1681/ASN.2005121345; Zureik M, 2005, J HYPERTENS, V23, P2263, DOI 10.1097/01.hjh.0000191245.68443.24	78	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e30975	10.1371/journal.pone.0030975	http://dx.doi.org/10.1371/journal.pone.0030975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22383985	gold, Green Submitted, Green Published			2022-12-27	WOS:000302875500008
J	Di Maio, S; Polizzotto, G; Di Gangi, E; Foresta, G; Genna, G; Verzera, A; Scacco, A; Amore, G; Oliva, D				Di Maio, Sabina; Polizzotto, Giuseppe; Di Gangi, Enrico; Foresta, Giusy; Genna, Giuseppe; Verzera, Antonella; Scacco, Antonio; Amore, Gabriele; Oliva, Daniele			Biodiversity of Indigenous Saccharomyces Populations from Old Wineries of South-Eastern Sicily (Italy): Preservation and Economic Potential	PLOS ONE			English	Article							AROMA COMPOUNDS; WHITE WINE; CEREVISIAE STRAINS; YEAST POPULATION; FERMENTATION; GRAPE; IDENTIFICATION; DIVERSITY; AREAS; FLORA	In recent years, the preservation of biodiversity has become an important issue. Despite much public discussion, however, current practices in the food industry seldom take account of its potential economic importance: on the contrary, the introduction of industrialized agriculture practices over large areas has often resulted in a dramatic reduction in biodiversity. In this paper, we report on the remarkable degree of biodiversity in the wine yeast populations naturally present in a small area of Sicily (Italy) where traditional (non-industrial) winery practices are still in place. Out of more than 900 Saccharomyces yeast isolates recovered from late spontaneous fermentations, we detected at least 209 strains. Most interestingly, when evaluated at the fermentation and technological level, a number of isolates were found to be superior to industrial yeast strains. Out of a selected group, isolates from two strains were used for experimental fermentations in a winery environment and the quality of the wines produced was assessed at the technological, quality and sensory levels. Given that the characteristics of the wines produced were found to be industrially appealing, the study demonstrated the economic potential of preserving the patrimony of Sicilian yeast biodiversity and highlighted the importance of maintaining traditional wine making practices.	[Di Maio, Sabina; Polizzotto, Giuseppe; Di Gangi, Enrico; Foresta, Giusy; Genna, Giuseppe; Scacco, Antonio; Amore, Gabriele; Oliva, Daniele] Ist Reg Vite & Vino, Palermo, Italy; [Verzera, Antonella; Scacco, Antonio; Amore, Gabriele] Univ Messina, Dipartimento Chim Organ & Biol, Messina, Italy; [Scacco, Antonio; Amore, Gabriele] Univ Catania, Dipartimento Sci Agr & Alimentari, Catania, Italy; [Amore, Gabriele] Staz Zool Anton Dohrn Napoli, Anim Physiol & Evolut Lab, Naples, Italy	University of Messina; University of Catania; Stazione Zoologica Anton Dohrn di Napoli	Di Maio, S (corresponding author), Ist Reg Vite & Vino, Palermo, Italy.	d.oliva@vitevino.it	Oliva, Daniele/E-8718-2017	Oliva, Daniele/0000-0002-1718-8906; VERZERA, Antonella/0000-0002-6162-9297	IRVV-Palermo Italy	IRVV-Palermo Italy	Support for this study was provided through an intramural funding of the IRVV-Palermo Italy. www.IRVV(www.vitevino.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, 4121 UNI ISO; [Anonymous], 2003, 10957 UNI; [Anonymous], 1977, 3591 ISO; [Anonymous], DIV DAT FING SOFTW U; [Anonymous], 2007, 8589 UNI ISO; Barnett RWP., 2001, PEDIATR DERMATOL, V18, P547, DOI [10.1046/j.1525-1470.2001.1862020a.x, DOI 10.1046/J.1525-1470.2001.1862020A.X]; Capece A, 2010, INT J FOOD MICROBIOL, V144, P187, DOI 10.1016/j.ijfoodmicro.2010.09.009; Caridi A, 2002, J GEN APPL MICROBIOL, V48, P261, DOI 10.2323/jgam.48.261; Cavazza A., 1998, VIGNEVINO, V25, P42; Ciani M, 2004, ANTON LEEUW INT J G, V85, P159, DOI 10.1023/B:ANTO.0000020284.05802.d7; Clarke R. J., 2004, WINE FLAVOR CHEM; Clavijo A, 2011, ANTON LEEUW INT J G, V99, P727, DOI 10.1007/s10482-010-9514-5; Csoma H, 2010, INT J FOOD MICROBIOL, V140, P239, DOI 10.1016/j.ijfoodmicro.2010.03.024; Csoma H, 2008, FEMS YEAST RES, V8, P328, DOI 10.1111/j.1567-1364.2007.00339.x; Dalby A., 2000, EMPIRE PLEASURES LUX; Di Maio S., 2006, ENOLOGO, V42, P93; EEC 2676, 1990, 2676 EEC; Fleet GH, 2003, INT J FOOD MICROBIOL, V86, P11, DOI 10.1016/S0168-1605(03)00245-9; Ganga MA, 2004, J APPL MICROBIOL, V96, P76, DOI 10.1046/j.1365-2672.2003.02080.x; Giudici P., 1992, VIGNEVINI, V9, P29; Granchi L, 1999, J APPL MICROBIOL, V87, P949, DOI 10.1046/j.1365-2672.1999.00600.x; Gump BH, 2002, AM J ENOL VITICULT, V53, P325; Guth H, 1997, J AGR FOOD CHEM, V45, P3027, DOI 10.1021/jf970280a; International Standard Organization, 1993, 85861 ISO; Josepa S, 2000, FEMS MICROBIOL LETT, V193, P255, DOI 10.1016/S0378-1097(00)00458-4; Kotseridis Y, 1998, AM J ENOL VITICULT, V49, P44; Legras JL, 2003, FEMS MICROBIOL LETT, V221, P249, DOI 10.1016/S0378-1097(03)00205-2; Li H, 2008, EUR FOOD RES TECHNOL, V227, P287, DOI 10.1007/s00217-007-0722-9; Lilly M, 2000, APPL ENVIRON MICROB, V66, P744, DOI 10.1128/AEM.66.2.744-753.2000; Martini A, 1993, J WINE RES, V4, P165, DOI DOI 10.1080/09571269308717966; Meral R., 2008, Trakia Journal of Sciences, V6, P57; Mercado L, 2007, FOOD MICROBIOL, V24, P403, DOI 10.1016/j.fm.2006.06.005; Mndez-Vilas A, 2010, CURRENT RES TECHNOLO; Mortimer R, 1999, RES MICROBIOL, V150, P199, DOI 10.1016/S0923-2508(99)80036-9; NESS F, 1993, J SCI FOOD AGR, V62, P89, DOI 10.1002/jsfa.2740620113; NICKERSON WJ, 1953, J INFECT DIS, V93, P43, DOI 10.1093/infdis/93.1.43; Oliva D., 2006, ENOLOGO, V42, P85; Pallmann CL, 2001, AM J ENOL VITICULT, V52, P198; Pastena B, 2009, CULTURE WINE SICILY; Petka J, 2006, J AGR FOOD CHEM, V54, P909, DOI 10.1021/jf0518397; Pino JA, 2011, FOOD CHEM, V125, P1141, DOI 10.1016/j.foodchem.2010.09.056; Pramateftaki PV, 2000, J APPL MICROBIOL, V89, P236, DOI 10.1046/j.1365-2672.2000.01102.x; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; QUEROL A, 1992, APPL ENVIRON MICROB, V58, P2948, DOI 10.1128/AEM.58.9.2948-2953.1992; Ribereau-Gayon P., 1998, TRAITE OENOLOGIE; Romancino DP, 2008, J APPL MICROBIOL, V105, P2248, DOI 10.1111/j.1365-2672.2008.03894.x; Romano P., 2005, MICROBIOLOGIA VINO, P101; Romano P, 2008, WORLD J MICROB BIOT, V24, P1797, DOI 10.1007/s11274-008-9672-z; ROSI I, 1994, J APPL BACTERIOL, V77, P519, DOI 10.1111/j.1365-2672.1994.tb04396.x; ROSINI G, 1984, J GEN APPL MICROBIOL, V30, P249, DOI 10.2323/jgam.30.249; Ruberto G, 2008, BIORESOURCE TECHNOL, V99, P260, DOI 10.1016/j.biortech.2006.12.025; Santamaria P, 2005, INT J FOOD MICROBIOL, V103, P49, DOI 10.1016/j.ijfoodmicro.2004.11.024; Scacco A, 2010, AM J ENOL VITICULT, V61, P498, DOI 10.5344/ajev.2010.10003; Scacco A, 2010, AM J ENOL VITICULT, V61, P260; Schaeffer A B, 1933, Science, V77, P194, DOI 10.1126/science.77.1990.194; Schuller D, 2004, FEMS MICROBIOL LETT, V231, P19, DOI 10.1016/S0378-1097(03)00928-5; Strauss MLA, 2001, J APPL MICROBIOL, V91, P182, DOI 10.1046/j.1365-2672.2001.01379.x; Torija MJ, 2001, ANTON LEEUW INT J G, V79, P345, DOI 10.1023/A:1012027718701; Valero E, 2005, FEMS YEAST RES, V5, P959, DOI 10.1016/j.femsyr.2005.04.007; VAUGHANMARTINI A, 1995, J IND MICROBIOL, V14, P514, DOI 10.1007/BF01573967; Verzera A, 2008, FOOD ANAL METHOD, V1, P144, DOI 10.1007/s12161-008-9027-2; Yong-Sheng Tao, 2009, Health, V1, P176, DOI 10.4236/health.2009.13028; Zalacain A, 2007, TALANTA, V71, P1610, DOI 10.1016/j.talanta.2006.07.051; ZAMBONELLI C, 1998, MICROBIOLOGIA BIOTEC; [No title captured]	65	37	38	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e30428	10.1371/journal.pone.0030428	http://dx.doi.org/10.1371/journal.pone.0030428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393353	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500006
J	Halasi, M; Gartel, AL				Halasi, Marianna; Gartel, Andrei L.			Suppression of FOXM1 Sensitizes Human Cancer Cells to Cell Death Induced by DNA-Damage	PLOS ONE			English	Article							N-TERMINAL KINASE; FORKHEAD BOX M1; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; IONIZING-RADIATION; GAMMA-RADIATION; EXPRESSION; APOPTOSIS; INVASION; RESISTANCE	Irradiation and DNA-damaging chemotherapeutic agents are commonly used in anticancer treatments. Following DNA damage FOXM1 protein levels are often elevated. In this study, we sought to investigate the potential role of FOXM1 in programmed cell death induced by DNA-damage. Human cancer cells after FOXM1 suppression were subjected to doxorubicin or gamma-irradiation treatment. Our findings indicate that FOXM1 downregulation by stable or transient knockdown using RNAi or by treatment with proteasome inhibitors that target FOXM1 strongly sensitized human cancer cells of different origin to DNA-damage-induced apoptosis. We showed that FOXM1 suppresses the activation of pro-apoptotic JNK and positively regulates anti-apoptotic Bcl-2, suggesting that JNK activation and Bcl-2 down-regulation could mediate sensitivity to DNA-damaging agent-induced apoptosis after targeting FOXM1. Since FOXM1 is widely expressed in human cancers, our data further support the fact that it is a valid target for combinatorial anticancer therapy.	[Halasi, Marianna; Gartel, Andrei L.] Univ Illinois, Dept Med, Chicago, IL 60680 USA; [Halasi, Marianna; Gartel, Andrei L.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA; [Gartel, Andrei L.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Halasi, M (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60680 USA.	agartel@uic.edu			National Institutes of Health (NIH) [1RO1CA1294414, 1R21CA134615]; NATIONAL CANCER INSTITUTE [R21CA134615] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grants 1RO1CA1294414 and 1R21CA134615 to Dr. Gartel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2010, BREAST CANCER RES TR, V122, P337, DOI 10.1007/s10549-009-0572-1; Alvarez-Fernandez M, 2010, EMBO REP, V11, P452, DOI 10.1038/embor.2010.46; Barsotti AM, 2009, ONCOGENE, V28, P4295, DOI 10.1038/onc.2009.282; Behren A, 2010, ONCOGENE, V29, P1519, DOI 10.1038/onc.2009.436; Bhat UG, 2008, CELL CYCLE, V7, P1851, DOI 10.4161/cc.7.12.6032; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006593; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; Burdak-Rothkamm S, 2009, EUR J PHARMACOL, V625, P151, DOI 10.1016/j.ejphar.2009.09.068; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Chen CH, 2009, ONCOGENE, V28, P2723, DOI 10.1038/onc.2009.128; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Chetty C, 2009, INT J CANCER, V124, P2468, DOI 10.1002/ijc.24209; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Dai B, 2007, ONCOGENE, V26, P6212, DOI 10.1038/sj.onc.1210443; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Gartel AL, 2008, EXPERT OPIN THER TAR, V12, P663, DOI 10.1517/14728222.12.6.663 ; Halasi M, 2010, CELL CYCLE, V9, P1214, DOI 10.4161/cc.9.6.10955; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Kim CH, 2010, BIOCHEM BIOPH RES CO, V391, P1182, DOI 10.1016/j.bbrc.2009.12.012; Kim MJ, 2008, MOL CANCER RES, V6, P1718, DOI 10.1158/1541-7786.MCR-08-0032; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Laoukili J, 2006, BIOCH BIOPH IN PRESS; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li YR, 2011, CLIN CANCER RES, V17, P4414, DOI 10.1158/1078-0432.CCR-11-0431; Llambi F, 2011, CURR OPIN GENET DEV, V21, P12, DOI 10.1016/j.gde.2010.12.001; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Pandit B, 2009, CELL CYCLE, V8, P3425, DOI 10.4161/cc.8.20.9628; Park HJ, 2011, EMBO MOL MED, V3, P21, DOI 10.1002/emmm.201000107; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Radhakrishnan Senthil K, 2008, Nat Rev Cancer, V8, pc2, DOI 10.1038/nrc2223-c1; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Radhakrishnan SK, 2006, ONCOGENE, V25, P1812, DOI 10.1038/sj.onc.1209195; Stevenson HS, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1766; Su ZZ, 2006, ONCOGENE, V25, P2339, DOI 10.1038/sj.onc.1209271; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Teh MT, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-45; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wang IC, 2008, J BIOL CHEM, V283, P20770, DOI 10.1074/jbc.M709892200; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang M, 2011, MOL CANCER THER, V10, P2287, DOI 10.1158/1535-7163.MCT-11-0536; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Wu QF, 2010, ACTA PHARMACOL SIN, V31, P361, DOI 10.1038/aps.2010.4; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Zhou FF, 2011, FEBS J, V278, P403, DOI 10.1111/j.1742-4658.2010.07965.x	46	65	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31761	10.1371/journal.pone.0031761	http://dx.doi.org/10.1371/journal.pone.0031761			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393369	Green Published, gold, Green Submitted			2022-12-27	WOS:000303003500022
J	Balmaceda-Aguilera, C; Cortes-Campos, C; Cifuentes, M; Peruzzo, B; Mack, L; Tapia, JC; Oyarce, K; Garcia, MA; Nualart, F				Balmaceda-Aguilera, Carolina; Cortes-Campos, Christian; Cifuentes, Manuel; Peruzzo, Bruno; Mack, Lauren; Tapia, Juan Carlos; Oyarce, Karina; Angeles Garcia, Maria; Nualart, Francisco			Glucose Transporter 1 and Monocarboxylate Transporters 1, 2, and 4 Localization within the Glial Cells of Shark Blood-Brain-Barriers	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; FACILITATIVE GLUCOSE TRANSPORTERS; CHOROID-PLEXUS; ENERGY-METABOLISM; SKELETAL-MUSCLE; RADIAL GLIA; CORTICAL ASTROCYTES; ACID TRANSPORTERS; SQUALUS-ACANTHIAS; GENE-EXPRESSION	Although previous studies showed that glucose is used to support the metabolic activity of the cartilaginous fish brain, the distribution and expression levels of glucose transporter (GLUT) isoforms remained undetermined. Optic/ultrastructural immunohistochemistry approaches were used to determine the expression of GLUT1 in the glial blood-brain barrier (gBBB). GLUT1 was observed solely in glial cells; it was primarily located in end-feet processes of the gBBB. Western blot analysis showed a protein with a molecular mass of 50 kDa, and partial sequencing confirmed GLUT1 identity. Similar approaches were used to demonstrate increased GLUT1 polarization to both apical and basolateral membranes in choroid plexus epithelial cells. To explore monocarboxylate transporter (MCT) involvement in shark brain metabolism, the expression of MCTs was analyzed. MCT1, 2 and 4 were expressed in endothelial cells; however, only MCT1 and MCT4 were present in glial cells. In neurons, MCT2 was localized at the cell membrane whereas MCT1 was detected within mitochondria. Previous studies demonstrated that hypoxia modified GLUT and MCT expression in mammalian brain cells, which was mediated by the transcription factor, hypoxia inducible factor-1. Similarly, we observed that hypoxia modified MCT1 cellular distribution and MCT4 expression in shark telencephalic area and brain stem, confirming the role of these transporters in hypoxia adaptation. Finally, using three-dimensional ultrastructural microscopy, the interaction between glial end-feet and leaky blood vessels of shark brain was assessed in the present study. These data suggested that the brains of shark may take up glucose from blood using a different mechanism than that used by mammalian brains, which may induce astrocyte-neuron lactate shuttling and metabolic coupling as observed in mammalian brain. Our data suggested that the structural conditions and expression patterns of GLUT1, MCT1, MCT2 and MCT4 in shark brain may establish the molecular foundation of metabolic coupling between glia and neurons.	[Balmaceda-Aguilera, Carolina; Mack, Lauren; Oyarce, Karina; Nualart, Francisco] Univ Concepcion, Lab Neurobiol & Stem Cells, Dept Cellular Biol, Concepcion, Chile; [Cortes-Campos, Christian; Angeles Garcia, Maria] Univ Concepcion, Lab Cellular Biol, Dept Cellular Biol, Concepcion, Chile; [Cifuentes, Manuel] Univ Malaga, Dept Cellular Biol Genet & Physiol, Fac Sci, E-29071 Malaga, Spain; [Peruzzo, Bruno] Univ Austral Chile, Anat Histol & Pathol Inst, Fac Med, Valdivia, Chile; [Tapia, Juan Carlos] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA; [Tapia, Juan Carlos] Columbia Univ, Dept Neurosci, New York, NY USA	Universidad de Concepcion; Universidad de Concepcion; Universidad de Malaga; Universidad Austral de Chile; Columbia University; Columbia University	Balmaceda-Aguilera, C (corresponding author), Univ Concepcion, Lab Neurobiol & Stem Cells, Dept Cellular Biol, Concepcion, Chile.	frnualart@udec.cl	Cortes Campos, Christian/Q-4096-2016; Garcia-Robles, Maria/F-4900-2014; Cifuentes, Manuel/I-6922-2018; Nualart, Francisco/AAB-9342-2021	Cortes Campos, Christian/0000-0002-2532-9035; Cifuentes, Manuel/0000-0003-1414-469X; Garcia-Robles, Maria/0000-0001-8482-0361; Oyarce, Karina/0000-0002-9591-3149	Fondo de Ciencia y Tecnologia (FONDECYT) [1100396, 1100705]; Ring of Research (PBCT) [ACT-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	Fondo de Ciencia y Tecnologia (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Ring of Research (PBCT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/PBCT); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by grants from Fondo de Ciencia y Tecnologia (FONDECYT 1100396 and 1100705) to FN and MAG, Ring of Research (PBCT ACT-02) to FN and MAG.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abbott NJ, 2005, CELL MOL NEUROBIOL, V25, P5, DOI 10.1007/s10571-004-1374-y; AGNEW WF, 1980, CELL TISSUE RES, V208, P261; Alkemade A, 2005, J CLIN ENDOCR METAB, V90, P4322, DOI 10.1210/jc.2004-2567; Ari C, 2008, BRAIN BEHAV EVOLUT, V71, P305, DOI 10.1159/000129654; Aubert A, 2007, GLIA, V55, P1272, DOI 10.1002/glia.20360; Badr GA, 1999, MOL BRAIN RES, V64, P24, DOI 10.1016/S0169-328X(98)00301-5; Bergersen L, 2002, NEUROCHEM RES, V27, P89, DOI 10.1023/A:1014806723147; Bergersen L, 2001, EXP BRAIN RES, V136, P523, DOI 10.1007/s002210000600; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; Broer S, 1999, BIOCHEM J, V341, P529, DOI 10.1042/0264-6021:3410529; Brooks GA, 1999, J APPL PHYSIOL, V87, P1713, DOI 10.1152/jappl.1999.87.5.1713; BUNDGAARD M, 1981, BRAIN RES, V226, P61, DOI 10.1016/0006-8993(81)91083-0; Bundgaard M, 2008, GLIA, V56, P699, DOI 10.1002/glia.20642; Chiba A, 2000, NEUROSCI LETT, V279, P65, DOI 10.1016/S0304-3940(99)00949-0; Chiry O, 2006, BRAIN RES, V1070, P65, DOI 10.1016/j.brainres.2005.11.064; Cortes-Campos C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016411; CSERR HF, 1984, AM J PHYSIOL, V246, pR277, DOI 10.1152/ajpregu.1984.246.3.R277; DEROOS R, 1985, GEN COMP ENDOCR, V58, P28, DOI 10.1016/0016-6480(85)90133-9; DICK APK, 1984, P NATL ACAD SCI-BIOL, V81, P7233, DOI 10.1073/pnas.81.22.7233; Doege H, 2000, J BIOL CHEM, V275, P16275, DOI 10.1074/jbc.275.21.16275; FARRELL CL, 1992, J HISTOCHEM CYTOCHEM, V40, P193, DOI 10.1177/40.2.1552163; FARRELL CL, 1991, P NATL ACAD SCI USA, V88, P5779, DOI 10.1073/pnas.88.13.5779; FENSTERMACHER JD, 1980, FED PROC, V39, P3201; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Garcia-Verdugo JM, 2002, BRAIN RES BULL, V57, P765, DOI 10.1016/S0361-9230(01)00769-9; Gerhart DZ, 1997, AM J PHYSIOL-ENDOC M, V273, pE207, DOI 10.1152/ajpendo.1997.273.1.E207; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2002, BRAIN RES BULL, V57, P777, DOI 10.1016/S0361-9230(01)00777-8; GRONDONA JM, 1994, MOL BRAIN RES, V26, P299, DOI 10.1016/0169-328X(94)90103-1; HACKER HJ, 1991, HISTOCHEMISTRY, V96, P435, DOI 10.1007/BF00316001; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hanu R, 2000, AM J PHYSIOL-CELL PH, V278, pC921, DOI 10.1152/ajpcell.2000.278.5.C921; Hashimoto T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002915; Ibberson M, 2000, J BIOL CHEM, V275, P4607, DOI 10.1074/jbc.275.7.4607; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jolivet Renaud, 2009, Front Neuroenergetics, V1, P4, DOI 10.3389/neuro.14.004.2009; Juel C, 1999, J PHYSIOL-LONDON, V517, P633, DOI 10.1111/j.1469-7793.1999.0633s.x; Kalman M, 2001, INT J DEV NEUROSCI, V19, P101, DOI 10.1016/S0736-5748(00)00058-7; Kimelberg HK, 2004, NEUROCHEM INT, V45, P191, DOI 10.1016/j.neuint.2003.08.015; Kono T, 2005, BRIT POULTRY SCI, V46, P510, DOI 10.1080/00071660500181289; Lagana G, 2006, PHYSIOL RES, V55, P675, DOI 10.33549/physiolres.930897; Lazzari M, 2006, ANAT EMBRYOL, V211, P497, DOI 10.1007/s00429-006-0101-5; Lin T, 2005, J TRAUMA, V59, P1191, DOI 10.1097/01.ta.0000188646.86995.9d; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; MAHER F, 1994, MOL CELL NEUROSCI, V5, P369, DOI 10.1006/mcne.1994.1044; MAHER F, 1991, Molecular and Cellular Neuroscience, V2, P351, DOI 10.1016/1044-7431(91)90066-W; Malatesta P, 2008, CELL TISSUE RES, V331, P165, DOI 10.1007/s00441-007-0481-8; McVie-Wylie AJ, 2001, GENOMICS, V72, P113, DOI 10.1006/geno.2000.6457; Mobasheri A, 2005, HISTOL HISTOPATHOL, V20, P1327, DOI 10.14670/HH-20.1327; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Ngan AK, 2009, COMP BIOCHEM PHYS B, V154, P396, DOI 10.1016/j.cbpb.2009.08.003; Nualart F, 1999, BRAIN RES, V824, P97, DOI 10.1016/S0006-8993(99)01078-1; Nunez-Parra A, 2011, CHEM SENSES; OPPELT WW, 1966, COMP BIOCHEM PHYSIOL, V17, P857, DOI 10.1016/0010-406X(66)90126-5; PARDRIDGE WM, 1990, J BIOL CHEM, V265, P18035; Pellerin L, 2005, J NEUROSCI RES, V79, P55, DOI 10.1002/jnr.20307; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Peruzzo B, 2000, EXP BRAIN RES, V132, P10, DOI 10.1007/s002219900289; Phay JE, 2000, GENOMICS, V66, P217, DOI 10.1006/geno.2000.6195; Philp NJ, 2001, AM J PHYSIOL-CELL PH, V280, pC1319, DOI 10.1152/ajpcell.2001.280.5.C1319; Pierre K, 2000, NEUROSCIENCE, V100, P617, DOI 10.1016/S0306-4522(00)00294-3; Planas JV, 2000, FEBS LETT, V481, P266, DOI 10.1016/S0014-5793(00)02020-2; Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541; Ren BF, 2008, JOINT BONE SPINE, V75, P176, DOI 10.1016/j.jbspin.2007.05.012; Renshaw GMC, 2002, COMP BIOCHEM PHYS B, V131, P133, DOI 10.1016/S1096-4959(01)00484-5; Richards JG, 2003, J COMP PHYSIOL B, V173, P463, DOI 10.1007/s00360-003-0354-8; Segal MB, 2001, MICROSC RES TECHNIQ, V52, P38, DOI 10.1002/1097-0029(20010101)52:1<38::AID-JEMT6>3.3.CO;2-A; Skipor J, 2008, ACTA NEUROBIOL EXP, V68, P414; SWANSON RA, 1992, CAN J PHYSIOL PHARM, V70, pS138, DOI 10.1139/y92-255; SWANSON RA, 1992, NEUROSCIENCE, V51, P451, DOI 10.1016/0306-4522(92)90329-Z; Teerijoki H, 2000, BBA-GENE STRUCT EXPR, V1494, P290, DOI 10.1016/S0167-4781(00)00216-5; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; van der Meer DLM, 2005, AM J PHYSIOL-REG I, V289, pR1512, DOI 10.1152/ajpregu.00089.2005; Vannucci SJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE1127, DOI 10.1152/ajpendo.00187.2003; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Vega C, 2006, J NEUROCHEM, V97, P872, DOI 10.1111/j.1471-4159.2006.03790.x; WANG MY, 1994, ARCH BIOCHEM BIOPHYS, V310, P172, DOI 10.1006/abbi.1994.1154; Yu S, 1998, BRAIN RES, V797, P65, DOI 10.1016/S0006-8993(98)00372-2; Zoll J, 2006, J APPL PHYSIOL, V100, P1258, DOI 10.1152/japplphysiol.00359.2005	84	22	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32409	10.1371/journal.pone.0032409	http://dx.doi.org/10.1371/journal.pone.0032409			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389700	Green Published, gold, Green Submitted			2022-12-27	WOS:000302999600038
J	Hishida, H; Suzuki, H; Michikawa, T; Ohtake, Y; Oota, S				Hishida, Hiroyuki; Suzuki, Hiromasa; Michikawa, Takashi; Ohtake, Yutaka; Oota, Satoshi			CT Image Segmentation Using FEM with Optimized Boundary Condition	PLOS ONE			English	Article							BONE; REGION; CUTS	The authors propose a CT image segmentation method using structural analysis that is useful for objects with structural dynamic characteristics. Motivation of our research is from the area of genetic activity. In order to reveal the roles of genes, it is necessary to create mutant mice and measure differences among them by scanning their skeletons with an X-ray CT scanner. The CT image needs to be manually segmented into pieces of the bones. It is a very time consuming to manually segment many mutant mouse models in order to reveal the roles of genes. It is desirable to make this segmentation procedure automatic. Although numerous papers in the past have proposed segmentation techniques, no general segmentation method for skeletons of living creatures has been established. Against this background, the authors propose a segmentation method based on the concept of destruction analogy. To realize this concept, structural analysis is performed using the finite element method (FEM), as structurally weak areas can be expected to break under conditions of stress. The contribution of the method is its novelty, as no studies have so far used structural analysis for image segmentation. The method's implementation involves three steps. First, finite elements are created directly from the pixels of a CT image, and then candidates are also selected in areas where segmentation is thought to be appropriate. The second step involves destruction analogy to find a single candidate with high strain chosen as the segmentation target. The boundary conditions for FEM are also set automatically. Then, destruction analogy is implemented by replacing pixels with high strain as background ones, and this process is iterated until object is decomposed into two parts. Here, CT image segmentation is demonstrated using various types of CT imagery.	[Hishida, Hiroyuki; Ohtake, Yutaka] Univ Tokyo, Dept Precis Engn, Sch Engn, Bunkyo Ku, Tokyo, Japan; [Suzuki, Hiromasa; Michikawa, Takashi] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo, Japan; [Oota, Satoshi] RIKEN BioResouce Ctr, Tsukuba, Ibaraki, Japan	University of Tokyo; University of Tokyo; RIKEN	Hishida, H (corresponding author), Univ Tokyo, Dept Precis Engn, Sch Engn, Bunkyo Ku, Tokyo, Japan.	hishida@den.rcast.u-tokyo.ac.jp		Michikawa, Takashi/0000-0002-0606-668X	MEXT [1201]; JSPS [22246018]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was funded by MEXT Global COE Program "GlobalCenter of Excellence for Mechanical Systems Innovation", JSPS Grant-in-Aid for Scientific Research (A), 22246018, and MEXT Grant-in-Aid for Scientific Research on Innovative Areas, 1201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; Auer M, 2010, IEEE T MED IMAGING, V29, P1022, DOI 10.1109/TMI.2009.2039579; Azar FS, 2002, MED IMAGE ANAL, V6, P1, DOI 10.1016/S1361-8415(01)00053-6; BENDSOE MP, 1988, COMPUT METHOD APPL M, V71, P197, DOI 10.1016/0045-7825(88)90086-2; Boykov Y, 2006, INT J COMPUT VISION, V70, P109, DOI 10.1007/s11263-006-7934-5; Campadelli P, 2009, ARTIF INTELL MED, V45, P185, DOI 10.1016/j.artmed.2008.07.020; CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954, DOI 10.2106/00004623-197759070-00021; ELIAS P, 1956, IRE T INFORM THEOR, V2, P117, DOI 10.1109/TIT.1956.1056816; Grau V, 2004, IEEE T MED IMAGING, V23, P447, DOI 10.1109/TMI.2004.824224; Hahn HK, 2006, LECT NOTES COMPUT SC, V4241, P178; Hishida H, 2010, LECT NOTES COMPUT SC, V6455, P39; JOLIOT M, 1993, IEEE T MED IMAGING, V12, P269, DOI 10.1109/42.232255; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Mat-Isa N. A., 2005, INT J COMPUTER INTER, V13; MULLER R, 1995, MED ENG PHYS, V17, P126, DOI 10.1016/1350-4533(95)91884-J; Pardo XM, 2001, IMAGE VISION COMPUT, V19, P461, DOI 10.1016/S0262-8856(00)00092-5; Press W. H., 1992, ART SCI COMPUTING; Quint Corporation, VOX; Rao SS, 2005, FINITE ELEMENT METHOD IN ENGINEERING, 4TH EDITION, P1; Roettger S.., VOLUME LIB; Schnorr C, 1998, J MATH IMAGING VIS, V8, P271, DOI 10.1023/A:1008278718907; Sebastian TB, 2003, MED IMAGE ANAL, V7, P21, DOI 10.1016/S1361-8415(02)00065-8; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Zhang J, 2010, COMPUT BIOL MED, V40, P231, DOI 10.1016/j.compbiomed.2009.11.020	25	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e31116	10.1371/journal.pone.0031116	http://dx.doi.org/10.1371/journal.pone.0031116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389668	Green Published, Green Submitted, gold			2022-12-27	WOS:000302999600005
J	Seto, WK; Lai, CL; Ip, PPC; Fung, J; Wong, DKH; Yuen, JCH; Hung, IFN; Yuen, MF				Seto, Wai-Kay; Lai, Ching-Lung; Ip, Philip P. C.; Fung, James; Wong, Danny Ka-Ho; Yuen, John Chi-Hang; Hung, Ivan Fan-Ngai; Yuen, Man-Fung			A Large Population Histology Study Showing the Lack of Association between ALT Elevation and Significant Fibrosis in Chronic Hepatitis B	PLOS ONE			English	Article							HBV DNA LEVELS; ALANINE AMINOTRANSFERASE LEVELS; PERSISTENTLY NORMAL ALT; LIVER HISTOLOGY; NATURAL-HISTORY; VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; PREDICTIVE MODEL; GENOTYPE-C; PREVALENCE	Objective: We determined the association between various clinical parameters and significant liver injury in both hepatitis B e antigen (HBeAg)-positive and HBeAg-negative patients. Methods: From 1994 to 2008, liver biopsy was performed on 319 treatment-naive CHB patients. Histologic assessment was based on the Knodell histologic activity index for necroinflammation and the Ishak fibrosis staging for fibrosis. Results: 211 HBeAg-positive and 108 HBeAg-negative patients were recruited, with a median age of 31 and 46 years respectively. 9 out of 40 (22.5%) HBeAg-positive patients with normal ALT had significant histologic abnormalities (necroinflammation grading >= 7 or fibrosis score >= 3). There was a significant difference in fibrosis scores among HBeAg-positive patients with an ALT level within the Prati criteria (30 U/L for men, 19 U/L for women) and patients with a normal ALT but exceeding the Prati criteria (p = 0.024). Age, aspartate aminotransferase and platelet count were independent predictors of significant fibrosis in HBeAg-positive patients with an elevated ALT by multivariate analysis (p = 0.007, 0.047 and 0.045 respectively). HBV DNA and platelet count were predictors of significant fibrosis in HBeAg-negative disease (p = 0.020 and 0.015 respectively). An elevated ALT was not predictive of significant fibrosis for HBeAg-positive (p = 0.345) and -negative (p = 0.544) disease. There was no significant difference in fibrosis staging among ALT 1-2x upper limit of normal (ULN) and > x2 ULN for both HBeAg-positive (p = 0.098) and -negative (p = 0.838) disease. Conclusion: An elevated ALT does not accurately predict significant liver injury. Decisions on commencing antiviral therapy should not be heavily based on a particular ALT threshold.	[Seto, Wai-Kay; Lai, Ching-Lung; Fung, James; Wong, Danny Ka-Ho; Yuen, John Chi-Hang; Hung, Ivan Fan-Ngai; Yuen, Man-Fung] Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Ip, Philip P. C.] Univ Hong Kong, Dept Pathol, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Lai, Ching-Lung] Univ Hong Kong, State Key Lab Liver Res, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Seto, WK (corresponding author), Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China.	mfyuen@hkucc.hku.hk	Ip, Philip/AAV-5995-2021; Hung, Ivan FN/ABD-5916-2021; SETO, Wai-Kay/H-4452-2012; Fung, James/AAG-4832-2020; Wong, Danny/H-6819-2016; Wong, Danny/S-6230-2019	Ip, Philip/0000-0002-0493-9838; Hung, Ivan FN/0000-0002-1556-2538; SETO, Wai-Kay/0000-0002-9012-313X; Lai, Ching-Lung/0000-0002-5927-2436; /0000-0001-9078-5005; Fung, James/0000-0002-1286-8902				Andreani T, 2007, CLIN GASTROENTEROL H, V5, P636, DOI 10.1016/j.cgh.2007.01.005; Chan HLY, 2002, AM J GASTROENTEROL, V97, P406; Chang TT, 2010, HEPATOLOGY, V51, P422, DOI 10.1002/hep.23327; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chu CJ, 2002, HEPATOLOGY, V36, P1408, DOI 10.1053/jhep.2002.36949; Dufour DR, 2000, CLIN CHEM, V46, P2050; Fung J, 2008, LIVER INT, V28, P1408, DOI 10.1111/j.1478-3231.2008.01784.x; Fung J, 2008, AM J GASTROENTEROL, V103, P1421, DOI 10.1111/j.1572-0241.2007.01751.x; Huang JF, 2007, GUT, V56, P736, DOI 10.1136/gut.2006.115410; Hui AY, 2005, AM J GASTROENTEROL, V100, P616, DOI 10.1111/j.1572-0241.2005.41289.x; Iloeje UH, 2007, CLIN GASTROENTEROL H, V5, P921, DOI 10.1016/j.cgh.2007.06.015; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Kumada T, 2007, GUT, V56, P738, DOI 10.1136/gut.2006.118455; Kumada T, 2010, J MED VIROL, V82, P539, DOI 10.1002/jmv.21686; Kumar M, 2008, GASTROENTEROLOGY, V134, P1376, DOI 10.1053/j.gastro.2008.02.075; Lai CL, 2007, ANN INTERN MED, V147, P58, DOI 10.7326/0003-4819-147-1-200707030-00010; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Lee JK, 2010, HEPATOLOGY, V51, P1577, DOI 10.1002/hep.23505; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Mani H, 2009, HEPATOLOGY, V49, pS61, DOI 10.1002/hep.22930; Manno M, 2004, GASTROENTEROLOGY, V127, P756, DOI 10.1053/j.gastro.2004.06.021; Martinot-Peignoux M, 2002, J HEPATOL, V36, P543, DOI 10.1016/S0168-8278(02)00004-1; Mohamadnejad M, 2006, AM J GASTROENTEROL, V101, P2537, DOI 10.1111/j.1572-0241.2006.00788.x; Park JY, 2008, J VIRAL HEPATITIS, V15, P615, DOI 10.1111/j.1365-2893.2008.00989.x; Peng DD, 2008, J GASTROEN HEPATOL, V23, P1082, DOI 10.1111/j.1440-1746.2008.05478.x; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Seto WK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023077; Shi JP, 2008, J GASTROEN HEPATOL, V23, P1419, DOI 10.1111/j.1440-1746.2008.05531.x; Tai DI, 2009, HEPATOLOGY, V49, P1859, DOI 10.1002/hep.22878; ter Borg F, 2000, J CLIN PATHOL, V53, P541, DOI 10.1136/jcp.53.7.541; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Yuen MF, 2007, J GASTROEN HEPATOL, V22, P973, DOI 10.1111/j.1440-1746.2007.04938.x; Yuen MF, 2005, GUT, V54, P1610, DOI 10.1136/gut.2005.065136; Yuen MF, 2005, J VIRAL HEPATITIS, V12, P513, DOI 10.1111/j.1365-2893.2005.00629.x; Yuen MF, 2005, ALIMENT PHARM THERAP, V21, P841, DOI 10.1111/j.1365-2036.2005.02410.x; Yuen MF, 2004, AM J GASTROENTEROL, V99, P2032, DOI 10.1111/j.1572-0241.2004.40440.x; Zacharakis G, 2008, J HEPATOL, V49, P884, DOI 10.1016/j.jhep.2008.06.009	40	55	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32622	10.1371/journal.pone.0032622	http://dx.doi.org/10.1371/journal.pone.0032622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389715	Green Submitted, gold, Green Published			2022-12-27	WOS:000302999600054
J	Chan, KH; Lee, KM; Wong, KB				Chan, Kwok-Ho; Lee, Ka-Man; Wong, Kam-Bo			Interaction between Hydrogenase Maturation Factors HypA and HypB Is Required for [NiFe]-Hydrogenase Maturation	PLOS ONE			English	Article							ESCHERICHIA-COLI; ACTIVE-SITE; BRADYRHIZOBIUM-JAPONICUM; PROTEINS HYPA; NICKEL; CYANIDE; FE; ISOENZYMES; SUBUNIT; UREASE	The active site of [NiFe]-hydrogenase contains nickel and iron coordinated by cysteine residues, cyanide and carbon monoxide. Metal chaperone proteins HypA and HypB are required for the nickel insertion step of [NiFe]-hydrogenase maturation. How HypA and HypB work together to deliver nickel to the catalytic core remains elusive. Here we demonstrated that HypA and HypB from Archaeoglobus fulgidus form 1: 1 heterodimer in solution and HypA does not interact with HypB dimer preloaded with GMPPNP and Ni. Based on the crystal structure of A. fulgidus HypB, mutants were designed to map the HypA binding site on HypB. Our results showed that two conserved residues, Tyr-4 and Leu-6, of A. fulgidus HypB are required for the interaction with HypA. Consistent with this observation, we demonstrated that the corresponding residues, Leu-78 and Val-80, located at the N-terminus of the GTPase domain of Escherichia coli HypB were required for HypA/HypB interaction. We further showed that L78A and V80A mutants of HypB failed to reactivate hydrogenase in an E. coli Delta hypB strain. Our results suggest that the formation of the HypA/HypB complex is essential to the maturation process of hydrogenase. The HypA binding site is in proximity to the metal binding site of HypB, suggesting that the HypA/HypB interaction may facilitate nickel transfer between the two proteins.	[Chan, Kwok-Ho; Lee, Ka-Man; Wong, Kam-Bo] Chinese Univ Hong Kong, Ctr Prot Sci & Crystallog, Sch Life Sci, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Chan, KH (corresponding author), Chinese Univ Hong Kong, Ctr Prot Sci & Crystallog, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	kbwong@cuhk.edu.hk	Wong, Kam-Bo/G-4258-2013; Wong, Kam-Bo/AAU-9364-2021	Wong, Kam-Bo/0000-0002-6984-5373; Wong, Kam-Bo/0000-0002-6984-5373; Chan, Kwok Ho/0000-0002-6693-2682	CUHK [4610/06M]; Research Grants Council of Hong Kong [HKU1/07C]	CUHK(Chinese University of Hong Kong); Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work is supported by a General Research Fund (CUHK 4610/06M) and a Collaborative Research Fund (HKU1/07C) from Research Grants Council of Hong Kong (http://www.ugc.edu.hk/eng/rgc/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanassova A, 2005, J BACTERIOL, V187, P4689, DOI 10.1128/JB.187.14.4689-4697.2005; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BALLANTINE SP, 1985, J BACTERIOL, V163, P454, DOI 10.1128/JB.163.2.454-459.1985; Blokesch M, 2002, J MOL BIOL, V324, P287, DOI 10.1016/S0022-2836(02)01070-7; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Cai F, 2011, J BIOL INORG CHEM, V16, P857, DOI 10.1007/s00775-011-0782-y; Chan K-H, 2011, PLOS ONE IN PRESS; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dias AV, 2008, BIOCHEMISTRY-US, V47, P11981, DOI 10.1021/bi801337x; Forzi L, 2007, FEBS LETT, V581, P3317, DOI 10.1016/j.febslet.2007.06.028; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; Hoffmann D, 2006, FEBS J, V273, P4516, DOI 10.1111/j.1742-4658.2006.05460.x; Hube M, 2002, J BACTERIOL, V184, P3879, DOI 10.1128/JB.184.14.3879-3885.2002; JACOBI A, 1992, ARCH MICROBIOL, V158, P444; Leach MR, 2005, BIOCHEMISTRY-US, V44, P12229, DOI 10.1021/bi050993j; Lenz O, 2007, FEBS LETT, V581, P3322, DOI 10.1016/j.febslet.2007.06.027; Loscher S, 2005, FEBS LETT, V579, P4287, DOI 10.1016/j.febslet.2005.06.063; MAIER T, 1993, J BACTERIOL, V175, P630, DOI 10.1128/JB.175.3.630-635.1993; MAIER T, 1995, EUR J BIOCHEM, V230, P133, DOI 10.1111/j.1432-1033.1995.tb20543.x; Mehta N, 2003, J BACTERIOL, V185, P726, DOI 10.1128/JB.185.3.726-734.2003; Olson JW, 1997, MOL MICROBIOL, V24, P119, DOI 10.1046/j.1365-2958.1997.3251690.x; Olson JW, 2001, MOL MICROBIOL, V39, P176, DOI 10.1046/j.1365-2958.2001.02244.x; Olson JW, 2000, J BACTERIOL, V182, P1702, DOI 10.1128/JB.182.6.1702-1705.2000; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Paschos A, 2001, FEBS LETT, V488, P9, DOI 10.1016/S0014-5793(00)02408-X; Reissmann S, 2003, SCIENCE, V299, P1067, DOI 10.1126/science.1080972; Roseboom W, 2005, FEBS LETT, V579, P469, DOI 10.1016/j.febslet.2004.12.013; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Theodoratou E, 2005, BIOCHEM SOC T, V33, P108, DOI 10.1042/BST0330108; Watanabe S, 2009, J MOL BIOL, V394, P448, DOI 10.1016/j.jmb.2009.09.030; WAUGH R, 1986, BIOCHIMIE, V68, P157, DOI 10.1016/S0300-9084(86)81080-X; Winter G, 2005, FEBS LETT, V579, P4292, DOI 10.1016/j.febslet.2005.06.064; Xia W, 2011, J BIOL CHEM; Xia W, 2009, J AM CHEM SOC, V131, P10031, DOI 10.1021/ja900543y; Zhang JW, 2005, J BIOL CHEM, V280, P4360, DOI 10.1074/jbc.M411799200	36	26	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32592	10.1371/journal.pone.0032592	http://dx.doi.org/10.1371/journal.pone.0032592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384275	gold, Green Published, Green Submitted			2022-12-27	WOS:000302918500102
J	Costello, DA; Claret, M; Al-Qassab, H; Plattner, F; Irvine, EE; Choudhury, AI; Giese, KP; Withers, DJ; Pedarzani, P				Costello, Derek A.; Claret, Marc; Al-Qassab, Hind; Plattner, Florian; Irvine, Elaine E.; Choudhury, Agharul I.; Giese, K. Peter; Withers, Dominic J.; Pedarzani, Paola			Brain Deletion of Insulin Receptor Substrate 2 Disrupts Hippocampal Synaptic Plasticity and Metaplasticity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; PROTEIN-KINASE-C; STREPTOZOTOCIN-DIABETIC RATS; GROWTH-FACTOR-I; CENTRAL-NERVOUS-SYSTEM; PHOSPHATIDYLINOSITOL 3-KINASE; XENOPUS OOCYTES; NMDA RECEPTORS; CA1 REGION	Objective: Diabetes mellitus is associated with cognitive deficits and an increased risk of dementia, particularly in the elderly. These deficits and the corresponding neurophysiological structural and functional alterations are linked to both metabolic and vascular changes, related to chronic hyperglycaemia, but probably also defects in insulin action in the brain. To elucidate the specific role of brain insulin signalling in neuronal functions that are relevant for cognitive processes we have investigated the behaviour of neurons and synaptic plasticity in the hippocampus of mice lacking the insulin receptor substrate protein 2 (IRS-2). Research Design and Methods: To study neuronal function and synaptic plasticity in the absence of confounding factors such as hyperglycaemia, we used a mouse model with a central nervous system-(CNS)-restricted deletion of IRS-2 (NesCreIrs2KO). Results: We report a deficit in NMDA receptor-dependent synaptic plasticity in the hippocampus of NesCreIrs2KO mice, with a concomitant loss of metaplasticity, the modulation of synaptic plasticity by the previous activity of a synapse. These plasticity changes are associated with reduced basal phosphorylation of the NMDA receptor subunit NR1 and of downstream targets of the PI3K pathway, the protein kinases Akt and GSK-3 beta. Conclusions: These findings reveal molecular and cellular mechanisms that might underlie cognitive deficits linked to specific defects of neuronal insulin signalling.	[Costello, Derek A.; Pedarzani, Paola] UCL, Res Dept Neurosci, London, England; [Claret, Marc; Al-Qassab, Hind; Irvine, Elaine E.; Choudhury, Agharul I.; Withers, Dominic J.] UCL, Dept Med, London, England; [Plattner, Florian; Irvine, Elaine E.; Giese, K. Peter] UCL, Wolfson Inst Biomed Res, London, England; [Irvine, Elaine E.; Choudhury, Agharul I.; Withers, Dominic J.] Univ London Imperial Coll Sci Technol & Med, Metab Signalling Grp, MRC Clin Sci Ctr, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Imperial College London	Costello, DA (corresponding author), Trinity Coll Dublin, Dept Physiol, Inst Neurosci, Dublin, Ireland.	p.pedarzani@ucl.ac.uk	Giese, Karl P/A-3112-2011; Withers, Dominic J/D-7671-2014	Giese, Karl P/0000-0003-4503-7344; Withers, Dominic J/0000-0002-8009-7521; Claret, Marc/0000-0001-7766-9296; Irvine, Elaine/0000-0001-5508-8140; Costello, Derek/0000-0002-5449-6166; Plattner, Florian/0000-0002-3150-1866	Biotechnology and Biological Sciences Research Council (BBSRC) [BBS/B/16143]; Medical Research Council (MRC) [G0100066]; European Neuroscience Institute Network (ENI-Net); Wellcome Trust [WT081394MA]; MRC [G0100066, MC_U120097114] Funding Source: UKRI; Alzheimers Research UK [ART-PG2003-2] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BBS/B/16143] Funding Source: researchfish; Medical Research Council [MC_U120097114, G0100066] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Neuroscience Institute Network (ENI-Net); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) Grant BBS/B/16143 to Dr. Withers, Dr. Pedarzani and Dr. Giese. Dr. Pedarzani acknowledges additional support by the Medical Research Council (MRC) (Career Establishment Grant G0100066) and European Neuroscience Institute Network (ENI-Net). Dr. Withers was also supported by a Wellcome Trust Strategic Award WT081394MA (awarded to Professor's Partridge, Withers and Thornton and Dr. Gems). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 1997, PROG NEUROBIOL, V52, P303, DOI 10.1016/S0301-0082(97)00018-X; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Artola A, 2005, EUR J NEUROSCI, V22, P169, DOI 10.1111/j.1460-9568.2005.04205.x; Artola A, 2008, EUR J PHARMACOL, V585, P153, DOI 10.1016/j.ejphar.2007.11.084; BASKIN DG, 1994, ENDOCRINOLOGY, V134, P1952, DOI 10.1210/en.134.4.1952; Biessels GJ, 1998, BRAIN RES, V800, P125, DOI 10.1016/S0006-8993(98)00510-1; Biessels GJ, 1996, DIABETES, V45, P1259, DOI 10.2337/diabetes.45.9.1259; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Blair LAC, 1997, NEURON, V19, P421, DOI 10.1016/S0896-6273(00)80950-2; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 2005, BIOL PSYCHIAT, V57, P113, DOI 10.1016/j.biopsych.2004.02.031; BONDY C, 1992, NEUROSCIENCE, V46, P909, DOI 10.1016/0306-4522(92)90193-6; Bruning JC, 1997, MOL CELL BIOL, V17, P1513; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Christie JM, 1999, J NEUROCHEM, V72, P1523, DOI 10.1046/j.1471-4159.1999.721523.x; Conejo R, 2001, J CELL PHYSIOL, V187, P96, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1058>3.0.CO;2-V; Di Luca M, 1999, DIABETOLOGIA, V42, P693, DOI 10.1007/s001250051217; DURAND GM, 1992, P NATL ACAD SCI USA, V89, P9359, DOI 10.1073/pnas.89.19.9359; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Fadool DA, 2000, J NEUROPHYSIOL, V83, P2332, DOI 10.1152/jn.2000.83.4.2332; FLOOD JF, 1990, DIABETES, V39, P1391, DOI 10.2337/diabetes.39.11.1391; FOLLI F, 1994, J NEUROSCI, V14, P6412; Freude S, 2008, J NEUROCHEM, V107, P907, DOI 10.1111/j.1471-4159.2008.05631.x; Gao L, 2006, J NEUROSCI, V26, P6259, DOI 10.1523/JNEUROSCI.0481-06.2006; Gardoni F, 2002, J NEUROCHEM, V80, P438, DOI 10.1046/j.0022-3042.2001.00713.x; Giese KP, 2009, IUBMB LIFE, V61, P516, DOI 10.1002/iub.187; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; HERRON CE, 1986, NATURE, V322, P265, DOI 10.1038/322265a0; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Hooper C, 2007, EUR J NEUROSCI, V25, P81, DOI 10.1111/j.1460-9568.2006.05245.x; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; Huang CC, 2004, J NEUROCHEM, V89, P217, DOI 10.1111/j.1471-4159.2003.02307.x; Huang CC, 2003, MOL CELL NEUROSCI, V24, P831, DOI 10.1016/S1044-7431(03)00238-0; Irvine EE, 2011, LEARN MEMORY, V18, P375, DOI 10.1101/lm.2111311; Izumi Y, 2003, DIABETOLOGIA, V46, P1007, DOI 10.1007/s00125-003-1144-2; Jin Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016188; Jones ML, 2005, J NEUROCHEM, V92, P1431, DOI 10.1111/j.1471-4159.2004.02985.x; Kamal A, 1999, NEUROSCIENCE, V90, P737, DOI 10.1016/S0306-4522(98)00485-0; Karpova A, 2006, NEUROSCIENCE, V137, P833, DOI 10.1016/j.neuroscience.2005.10.012; KELLER BU, 1991, J PHYSIOL-LONDON, V435, P275, DOI 10.1113/jphysiol.1991.sp018510; Kelly A, 2000, NEUROPHARMACOLOGY, V39, P643, DOI 10.1016/S0028-3908(99)00169-0; Killick R, 2009, BIOCHEM BIOPH RES CO, V386, P257, DOI 10.1016/j.bbrc.2009.06.032; Kneussel M, 2002, BRAIN RES REV, V39, P74, DOI 10.1016/S0165-0173(02)00159-5; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; Kubota T, 2003, CIRCULATION, V107, P3073, DOI 10.1161/01.CIR.0000070937.52035.25; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; Liao GY, 1999, J NEUROCHEM, V73, P1510, DOI 10.1046/j.1471-4159.1999.0731510.x; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; LIU LF, 1995, NEUROSCI LETT, V192, P5, DOI 10.1016/0304-3940(95)11593-L; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Ma XH, 2003, J NEUROSCI, V23, P1159, DOI 10.1523/JNEUROSCI.23-04-01159.2003; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Martin ED, 2011, CEREB CORTEX; Messier C, 2005, NEUROBIOL AGING, V26, pS26, DOI 10.1016/j.neurobiolaging.2005.09.014; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; Nguyen PV, 1997, LEARN MEMORY, V4, P230, DOI 10.1101/lm.4.2.230; O'Malley D, 2003, NEUROPHARMACOLOGY, V44, P855, DOI 10.1016/S0028-3908(03)00081-9; O'Malley D, 2004, MOL PHARMACOL, V65, P1352, DOI 10.1124/mol.65.6.1352; O'Malley D, 2007, EUR J NEUROSCI, V25, P673, DOI 10.1111/j.1460-9568.2007.05347.x; Opazo P, 2003, J NEUROSCI, V23, P3679; Pardini AW, 2006, BRAIN RES, V1112, P169, DOI 10.1016/j.brainres.2006.06.109; Pasquier F, 2006, DIABETES METAB, V32, P403, DOI 10.1016/S1262-3636(07)70298-7; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Raman IM, 1996, NEURON, V16, P415, DOI 10.1016/S0896-6273(00)80059-8; Ramsey MM, 2005, J NEUROPHYSIOL, V94, P247, DOI 10.1152/jn.00768.2004; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Sanna PP, 2002, J NEUROSCI, V22, P3359; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Skeberdis VA, 2001, P NATL ACAD SCI USA, V98, P3561, DOI 10.1073/pnas.051634698; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Stranahan AM, 2008, HIPPOCAMPUS, V18, P1085, DOI 10.1002/hipo.20470; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; Sun XJ, 1997, MOL ENDOCRINOL, V11, P251, DOI 10.1210/me.11.2.251; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Thiagarajan TC, 2007, NEUROPHARMACOLOGY, V52, P156, DOI 10.1016/j.neuropharm.2006.07.030; THOMAS KL, 1994, NEUROREPORT, V6, P119, DOI 10.1097/00001756-199412300-00031; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; URUSHIHARA H, 1992, J BIOL CHEM, V267, P11697; van der Heide LP, 2005, J NEUROCHEM, V94, P1158, DOI 10.1111/j.1471-4159.2005.03269.x; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; WANG LM, 1993, P NATL ACAD SCI USA, V90, P4032, DOI 10.1073/pnas.90.9.4032; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Winocur G, 2005, BEHAV NEUROSCI, V119, P1389, DOI 10.1037/0735-7044.119.5.1389; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Xing CH, 2006, BRAIN RES, V1072, P30, DOI 10.1016/j.brainres.2005.10.091; Xing CH, 2007, EXP NEUROL, V205, P222, DOI 10.1016/j.expneurol.2007.01.029	104	50	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31124	10.1371/journal.pone.0031124	http://dx.doi.org/10.1371/journal.pone.0031124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383997	gold, Green Submitted, Green Published			2022-12-27	WOS:000302918500019
J	Gabrielsen, M; Beckham, KSH; Feher, VA; Zetterstrom, CE; Wang, D; Muller, S; Elofsson, M; Amaro, RE; Byron, O; Roe, AJ				Gabrielsen, Mads; Beckham, Katherine S. H.; Feher, Victoria A.; Zetterstrom, Caroline E.; Wang, Dai; Mueller, Sylke; Elofsson, Mikael; Amaro, Rommie E.; Byron, Olwyn; Roe, Andrew J.			Structural Characterisation of Tpx from Yersinia pseudotuberculosis Reveals Insights into the Binding of Salicylidene Acylhydrazide Compounds	PLOS ONE			English	Article							X-RAY SOLUTION; THIOL PEROXIDASE; BIOLOGICAL MACROMOLECULES; PROTEIN INTERACTIONS; SOLUTION SCATTERING; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PURIFICATION; ASSEMBLIES; INHIBITORS	Thiol peroxidase, Tpx, has been shown to be a target protein of the salicylidene acylhydrazide class of antivirulence compounds. In this study we present the crystal structures of Tpx from Y. pseudotuberculosis (ypTpx) in the oxidised and reduced states, together with the structure of the C61S mutant. The structures solved are consistent with previously solved atypical 2-Cys thiol peroxidases, including that for "forced'' reduced states using the C61S mutant. In addition, by investigating the solution structure of ypTpx using small angle X-ray scattering (SAXS), we have confirmed that reduced state ypTpx in solution is a homodimer. The solution structure also reveals flexibility around the dimer interface. Notably, the conformational changes observed between the redox states at the catalytic triad and at the dimer interface have implications for substrate and inhibitor binding. The structural data were used to model the binding of two salicylidene acylhydrazide compounds to the oxidised structure of ypTpx. Overall, the study provides insights into the binding of the salicylidene acylhydrazides to ypTpx, aiding our long-term strategy to understand the mode of action of this class of compounds.	[Gabrielsen, Mads; Beckham, Katherine S. H.; Wang, Dai; Roe, Andrew J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Immunol, Glasgow, Lanark, Scotland; [Feher, Victoria A.; Amaro, Rommie E.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA USA; [Feher, Victoria A.; Amaro, Rommie E.] Univ Calif Irvine, Dept Comp Sci, Irvine, CA USA; [Feher, Victoria A.; Amaro, Rommie E.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA; [Zetterstrom, Caroline E.; Elofsson, Mikael] Umea Univ, Umea Ctr Microbial Res, Umea, Sweden; [Zetterstrom, Caroline E.; Elofsson, Mikael] Umea Univ, Dept Chem, Umea, Sweden; [Mueller, Sylke] Univ Glasgow, Inst Infect Immun & Immunol, Coll Med Vet & Life Sci, Wellcome Ctr Mol Parasitol, Glasgow, Lanark, Scotland; [Byron, Olwyn] Univ Glasgow, Coll Med Vet & Life Sci, Sch Life Sci, Glasgow, Lanark, Scotland	University of Glasgow; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Umea University; Umea University; University of Glasgow; University of Glasgow	Gabrielsen, M (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Immunol, Glasgow, Lanark, Scotland.	Olwyn.Byron@glasgow.ac.uk; Andrew.Roe@glasgow.ac.uk		Gabrielsen, Mads/0000-0002-9848-2276; Byron, Olwyn/0000-0001-7857-4520; Beckham, Kate/0000-0002-4929-6119; Elofsson, Mikael/0000-0002-3219-4669; roe, andrew/0000-0003-3698-6134	Biotechnology and Biological Sciences Research Council [BB/G011389/1]; Medical Research Scotland grant [223 ORG G 0709]; Wellcome Trust; Swedish Research Council; National Institutes of Health (NIH) [1-DP2-OD007237]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007237] Funding Source: NIH RePORTER; BBSRC [BB/G011389/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Scotland grant; Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a grant from the Biotechnology and Biological Sciences Research Council to AJR and MG (BB/G011389/1) and a Medical Research Scotland grant (ref. 223 ORG G 0709) to AJR and DW. KSHB is supported by a Wellcome Trust studentship. CZ and ME are supported by the Swedish Research Council. This work was supported in part by the National Institutes of Health (NIH) through the NIH Director's New Innovator Award Program, 1-DP2-OD007237 to REA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphey MS, 2000, J MOL BIOL, V300, P903, DOI 10.1006/jmbi.2000.3881; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker LMS, 2003, J BIOL CHEM, V278, P9203, DOI 10.1074/jbc.M209888200; Baron C, 2010, CURR OPIN MICROBIOL, V13, P100, DOI 10.1016/j.mib.2009.12.003; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bricogne G., 2011, BUSTER VERSION 2 8 0; Cao ZB, 2005, STRUCTURE, V13, P1661, DOI 10.1016/j.str.2005.07.021; CHA MK, 1995, J BIOL CHEM, V270, P28635, DOI 10.1074/jbc.270.48.28635; Choi J, 2005, PROTEINS, V61, P1146, DOI 10.1002/prot.20704; Choi JK, 2003, J BIOL CHEM, V278, P49478, DOI 10.1074/jbc.M309015200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gabrielsen M, 2010, ACTA CRYSTALLOGR F, V66, P1606, DOI 10.1107/S1744309110039679; Hall A, 2009, J MOL BIOL, V393, P867, DOI 10.1016/j.jmb.2009.08.040; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Horst SA, 2010, J BACTERIOL, V192, P2929, DOI 10.1128/JB.01652-09; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Karplus P. Andrew, 2007, V44, P41; Keyser P, 2008, J INTERN MED, V264, P17, DOI 10.1111/j.1365-2796.2008.01941.x; KIM KW, 1988, J BIOL CHEM, V263, P4704; Kleywegt G.J., 1994, PROTEIN CRYSTALLOGR, V31, P9; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lu J, 2008, BIOCHEM BIOPH RES CO, V373, P414, DOI 10.1016/j.bbrc.2008.06.051; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; Pan JL, 2006, PROTEIN SCI, V15, P2217, DOI 10.1110/ps.062268106; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rho BS, 2006, J MOL BIOL, V361, P850, DOI 10.1016/j.jmb.2006.05.076; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stehr M, 2006, ACTA CRYSTALLOGR D, V62, P563, DOI 10.1107/S0907444906008249; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tao K, 2008, FEMS MICROBIOL LETT, V289, P41, DOI 10.1111/j.1574-6968.2008.01372.x; Tree JJ, 2009, INFECT IMMUN, V77, P4209, DOI 10.1128/IAI.00562-09; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wan XY, 1997, FEBS LETT, V407, P32, DOI 10.1016/S0014-5793(97)00302-5; Wang D, 2011, J BIOL CHEM, V286, P29922, DOI 10.1074/jbc.M111.233858; Wang H, 2011, NAT CHEM BIOL, V7, P720, DOI [10.1038/NCHEMBIO.643, 10.1038/nchembio.643]; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459	53	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32217	10.1371/journal.pone.0032217	http://dx.doi.org/10.1371/journal.pone.0032217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384182	Green Published, Green Accepted, gold			2022-12-27	WOS:000302918500066
J	Ma, Z; Zhang, H; Zheng, JX; Li, Y; Yi, L; Fan, HJ; Lu, CP				Ma, Zhe; Zhang, Hui; Zheng, Junxi; Li, Yue; Yi, Li; Fan, Hongjie; Lu, Chengping			Interaction between M-Like Protein and Macrophage Thioredoxin Facilitates Antiphagocytosis for Streptococcus equi ssp zooepidemicus	PLOS ONE			English	Article							GROUP-A STREPTOCOCCI; COMPLEMENT-RESISTANCE MECHANISMS; UP-REGULATED PROTEIN-1; FACTOR-H; SUBSP ZOOEPIDEMICUS; SPLIT-UBIQUITIN; IN-VIVO; PHAGOCYTOSIS; BINDING; ADHERENCE	Streptococcus equi ssp. zooepidemicus (S. zooepidemicus, S.z) is one of the common pathogens that can cause septicemia, meningitis, and mammitis in domesticated species. M-like protein (SzP) is an important virulence factor of S. zooepidemicus and contributes to bacterial infection and antiphagocytosis. The interaction between SzP of S. zooepidemicus and porcine thioredoxin (TRX) was identified by the yeast two-hybrid and further confirmed by co-immunoprecipitation. SzP interacted with both reduced and the oxidized forms of TRX without inhibiting TRX activity. Membrane anchored SzP was able to recruit TRX to the surface, which would facilitate the antiphagocytosis of the bacteria. Further experiments revealed that TRX regulated the alternative complement pathway by inhibiting C3 convertase activity and associating with factor H (FH). TRX alone inhibited C3 cleavage and C3a production, and the inhibitory effect was additive when FH was also present. TRX inhibited C3 deposition on the bacterial surface when it was recruited by SzP. These new findings indicated that S. zooepidemicus used SzP to recruit TRX and regulated the alternative complement pathways to evade the host immune phagocytosis.	[Ma, Zhe; Zhang, Hui; Zheng, Junxi; Li, Yue; Yi, Li; Fan, Hongjie; Lu, Chengping] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Fan, HJ (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	fhj@njau.edu.cn			National Basic Research Program (973) of China [2012CB518804]; National Natural Science Foundation of China [31172319]; key Technology R&D Program of Jiangsu [BE2009388]; Fundamental Research Funds for the Central Universities [KYT 201003]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Basic Research Program (973) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key Technology R&D Program of Jiangsu; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by Program from the National Basic Research Program (973) of China (2012CB518804), the National Natural Science Foundation of China (31172319), the key Technology R & D Program of Jiangsu (BE2009388), the Fundamental Research Funds for the Central Universities (KYT 201003), and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions	Abbott Y, 2009, J MED MICROBIOL; Andersen JF, 1997, BIOCHEMISTRY-US, V36, P13979, DOI 10.1021/bi971004s; Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; BARTELT MA, 1978, INFECT IMMUN, V20, P200, DOI 10.1128/IAI.20.1.200-208.1978; Billiet L, 2005, J BIOL CHEM, V280, P40310, DOI 10.1074/jbc.M503644200; BISNO AL, 1979, INFECT IMMUN, V26, P1172, DOI 10.1128/IAI.26.3.1172-1176.1979; Bruckner A, 2009, INT J MOL SCI, V10, P2763, DOI 10.3390/ijms10062763; CAMPBELL JR, 1991, INFECT IMMUN, V59, P1978, DOI 10.1128/IAI.59.6.1978-1983.1991; CAMPO RE, 1995, J INFECT DIS, V171, P601, DOI 10.1093/infdis/171.3.601; Carlsson F, 2003, J EXP MED, V198, P1057, DOI 10.1084/jem.20030543; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; Dave S, 2001, INFECT IMMUN, V69, P3435, DOI 10.1128/IAI.69.5.3435-3437.2001; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Ernst JD, 2000, CELL MICROBIOL, V2, P379, DOI 10.1046/j.1462-5822.2000.00075.x; Eyre DW, 2010, EUR J CLIN MICROBIOL; Fan HJ, 2009, VACCINE, V27, P56, DOI 10.1016/j.vaccine.2008.10.037; Fan HJ, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-170; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; HEATH DG, 1989, P NATL ACAD SCI USA, V86, P4741, DOI 10.1073/pnas.86.12.4741; Hoe NP, 2002, P NATL ACAD SCI USA, V99, P7646, DOI 10.1073/pnas.112039899; Holden MTG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000346; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Inomata Y, 2008, INVEST OPHTH VIS SCI, V49, P5118, DOI 10.1167/iovs.07-1659; Jarva H, 2003, MOL IMMUNOL, V40, P95, DOI 10.1016/S0161-5890(03)00108-1; Johnsson E, 1996, J IMMUNOL, V157, P3021; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; JOINER KA, 1988, ANNU REV MICROBIOL, V42, P201, DOI 10.1146/annurev.mi.42.100188.001221; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; KANTOR FS, 1965, J EXP MED, V121, P849, DOI 10.1084/jem.121.5.849; Kondo N, 2004, J IMMUNOL, V172, P442, DOI 10.4049/jimmunol.172.1.442; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; McRae JL, 2005, J IMMUNOL, V174, P6250, DOI 10.4049/jimmunol.174.10.6250; MOORE BO, 1969, J AM VET MED ASSOC, V155, P416; Nakamura H, 2008, NOVART FDN SYMP, V291, P221; Nakamura H, 2008, NOVART FDN SYMP, V291, P192; Nakamura Hajime, 2008, Novartis Found Symp, V291, P184; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Rautemaa R, 1999, MICROBES INFECT, V1, P785, DOI 10.1016/S1286-4579(99)80081-1; Staali L, 2003, CELL MICROBIOL, V5, P253, DOI 10.1046/j.1462-5822.2003.00272.x; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; TIMONEY JF, 1995, INFECT IMMUN, V63, P1440, DOI 10.1128/IAI.63.4.1440-1445.1995; Timoney JF, 1997, INFECT IMMUN, V65, P3600, DOI 10.1128/IAI.65.9.3600-3605.1997; Tiwari R, 2007, VET MICROBIOL, V121, P105, DOI 10.1016/j.vetmic.2006.11.023; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; WESSELS MR, 1991, P NATL ACAD SCI USA, V88, P8317, DOI 10.1073/pnas.88.19.8317; Wibawan IWT, 1999, RES VET SCI, V67, P131, DOI 10.1053/rvsc.1998.0287	47	16	19	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32099	10.1371/journal.pone.0032099	http://dx.doi.org/10.1371/journal.pone.0032099			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384152	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500059
J	Orloff, MS; Zhang, L; Bebek, G; Eng, C				Orloff, Mohammed S.; Zhang, Li; Bebek, Gurkan; Eng, Charis			Integrative Genomic Analysis Reveals Extended Germline Homozygosity with Lung Cancer Risk in the PLCO Cohort	PLOS ONE			English	Article							GENETIC PREDISPOSITION; SUSCEPTIBILITY LOCUS; ASSOCIATION; VARIANTS; SMOKING; DISPLAY; BREAST; TOOL	Susceptibility to common cancers is multigenic resulting from low-to-high penetrance predisposition-factors and environmental exposure. Genomic studies suggest germline homozygosity as a novel low-penetrance factor contributing to common cancers. We hypothesized that long homozygous regions (tracts-of-homozygosity [TOH]) harbor tobacco-dependent and independent lung-cancer predisposition (or protection) genes. We performed in silico genome-wide SNP-array-based analysis of lung-cancer patients of European-ancestry from the PLCO screening-trial cohort to identify TOH regions amongst 788 cancer-cases and 830 ancestry-matched controls. Association analyses was then performed between presence of lung cancer and common(c) TOHs (operationally defined as 10 or more subjects sharing >= 100 identical homozygous calls), aTOHs (allelically-matched groups within a cTOH), demographics and tobacco-exposure. Finally, integration of significant c/aTOH with transcriptome was performed to functionally-map lung-cancer risk-genes. After controlling for demographics and smoking, we identified 7 cTOHs and 5 aTOHs associated with lung cancer (adjusted p<0.01). Three cTOHs were over-represented in cases over controls (OR = 1.75-2.06, p = 0.007-0.001), whereas 4 were under-represented (OR = 0.28-0.69, p = 0.006-0.001). Interaction between smoking status and cTOH3/aTOH2 (2p16.3-2p16.1) was observed (adjusted p<0.03). The remaining significant aTOHs have ORs 0.23-0.50 (p = 0.004-0.006) and 2.95-3.97 (p = 0.008-0.001). After integrating significant cTOH/aTOHs with publicly-available lung-cancer transcriptome datasets followed by filtering based on lung cancer and its relevant pathways revealed 9 putative predisposing genes (p<0.0001). In conclusion, differentially-distributed cTOH/aTOH genomic variants between cases and controls harbor sets of plausible differentially-expressed genes accounting for the complexity of lung-cancer predisposition.	[Orloff, Mohammed S.; Zhang, Li; Bebek, Gurkan; Eng, Charis] Cleveland Clin, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44106 USA; [Zhang, Li] Lerner Res Inst, Dept Quantitat Hlth Sci, Cleveland, OH USA; [Orloff, Mohammed S.; Eng, Charis] Taussig Canc Inst, Cleveland, OH USA; [Eng, Charis] Cleveland Clin, Stanley Shalom Zielony Inst Nursing Excellence, Cleveland, OH 44106 USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Bebek, Gurkan; Eng, Charis] Case Western Reserve Univ, Sch Med, CASE Comprehens Canc Ctr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University	Orloff, MS (corresponding author), Cleveland Clin, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44106 USA.	engc@ccf.org		Eng, Charis/0000-0002-3693-5145	Cleveland Clinic; American Cancer Society	Cleveland Clinic; American Cancer Society(American Cancer Society)	CE holds the Sondra J. and Stephen R. Hardis Endowed Chair of Cancer Genomic Medicine at the Cleveland Clinic, and the American Cancer Society Clinical Research Professorship. These Chair funds have supported in part some of the authors' FTE to perform this study (including MO and CE's time). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Assie G, 2008, JAMA-J AM MED ASSOC, V299, P1437, DOI 10.1001/jama.299.12.1437; Bacolod MD, 2008, CANCER RES, V68, P2610, DOI 10.1158/0008-5472.CAN-07-5250; Bhattacharya P, 2002, CANCER LETT, V188, P207, DOI 10.1016/S0304-3835(02)00430-5; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Frank SA, 2004, NAT REV GENET, V5, P764, DOI 10.1038/nrg1450; Fusby JS, 2010, INHAL TOXICOL, V22, P785, DOI 10.3109/08958378.2010.483258; Gao Y, 2009, INT J CANCER, V125, P146, DOI 10.1002/ijc.24283; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; HUANG RTC, 1978, NATURE, V276, P624, DOI 10.1038/276624a0; Jupiter D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-332; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Le Roy F, 2007, CELL DEATH DIFFER, V14, P1406, DOI 10.1038/sj.cdd.4402130; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Li XJ, 2004, INT J CANCER, V112, P451, DOI 10.1002/ijc.20436; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Mincey BA, 2003, ONCOLOGIST, V8, P466, DOI 10.1634/theoncologist.8-5-466; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pradhan D, 2002, IMMUNITY, V17, P303, DOI 10.1016/S1074-7613(02)00396-5; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rudan I, 2003, J MED GENET, V40, P925, DOI 10.1136/jmg.40.12.925; Rudan I, 1999, HUM BIOL, V71, P173; SHAMI SA, 1991, LANCET, V338, P954, DOI 10.1016/0140-6736(91)91828-I; SIMPSON JL, 1981, AM J OBSTET GYNECOL, V141, P629, DOI 10.1016/S0002-9378(15)33302-0; Steiner E, 2006, J CELL SCI, V119, P459, DOI 10.1242/jcs.02773; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Turnbull C, 2005, CLIN MED, V5, P491, DOI 10.7861/clinmedicine.5-5-491; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Yue W, 2007, CLIN CANCER RES, V13, P4336, DOI 10.1158/1078-0432.CCR-07-0015	37	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31975	10.1371/journal.pone.0031975	http://dx.doi.org/10.1371/journal.pone.0031975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384118	gold, Green Published, Green Submitted			2022-12-27	WOS:000302918500051
J	Sampson, JH; Schmittling, RJ; Archer, GE; Congdon, KL; Nair, SK; Reap, EA; Desjardins, A; Friedman, AH; Friedman, HS; Herndon, JE; Coan, A; McLendon, RE; Reardon, DA; Vredenburgh, JJ; Bigner, DD; Mitchell, DA				Sampson, John H.; Schmittling, Robert J.; Archer, Gary E.; Congdon, Kendra L.; Nair, Smita K.; Reap, Elizabeth A.; Desjardins, Annick; Friedman, Allan H.; Friedman, Henry S.; Herndon, James E., II; Coan, April; McLendon, Roger E.; Reardon, David A.; Vredenburgh, James J.; Bigner, Darell D.; Mitchell, Duane A.			A Pilot Study of IL-2R alpha Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; GROWTH-FACTOR-BETA; MONOCLONAL-ANTIBODY; METASTATIC MELANOMA; PERIPHERAL-BLOOD; AUTOIMMUNE-DISEASE; HUMAN CYTOMEGALOVIRUS; CANCER-PATIENTS; SELF-TOLERANCE; IN-VIVO	Background: Preclinical studies in mice have demonstrated that the prophylactic depletion of immunosuppressive regulatory T-cells (T-Regs) through targeting the high affinity interleukin-2 (IL-2) receptor (IL-2R alpha/CD25) can enhance antitumor immunotherapy. However, therapeutic approaches are complicated by the inadvertent inhibition of IL-2R alpha expressing anti-tumor effector T-cells. Objective: To determine if changes in the cytokine milieu during lymphopenia may engender differential signaling requirements that would enable unarmed anti-IL-2R alpha monoclonal antibody (MAbs) to selectively deplete T-Regs while permitting vaccine-stimulated immune responses. Methodology: A randomized placebo-controlled pilot study was undertaken to examine the ability of the anti-IL-2R alpha MAb daclizumab, given at the time of epidermal growth factor receptor variant III (EGFRvIII) targeted peptide vaccination, to safely and selectively deplete T-Regs in patients with glioblastoma (GBM) treated with lymphodepleting temozolomide (TMZ). Results and Conclusions: Daclizumab treatment (n = 3) was well-tolerated with no symptoms of autoimmune toxicity and resulted in a significant reduction in the frequency of circulating CD4+Foxp3+ TRegs in comparison to saline controls (n = 3)( p = 0.0464). A significant (p < 0.0001) inverse correlation between the frequency of TRegs and the level of EGFRvIII specific humoral responses suggests the depletion of TRegs may be linked to increased vaccine-stimulated humoral immunity. These data suggest this approach deserves further study. Trial Registration:	[Sampson, John H.; Schmittling, Robert J.; Archer, Gary E.; Congdon, Kendra L.; Reap, Elizabeth A.; Desjardins, Annick; Friedman, Allan H.; Friedman, Henry S.; Vredenburgh, James J.; Bigner, Darell D.; Mitchell, Duane A.] Duke Univ, Med Ctr, Dept Surg, Div Neurosurg, Durham, NC 27710 USA; [Sampson, John H.; Friedman, Henry S.; McLendon, Roger E.; Bigner, Darell D.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Nair, Smita K.] Duke Univ, Med Ctr, Dept Surg, Div Surg Sci, Durham, NC 27710 USA; [Herndon, James E., II; Coan, April] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA; [Reardon, David A.] Dana Farber Canc Inst, Boston, MA 02115 USA	Duke University; Duke University; Duke University; Duke University; Harvard University; Dana-Farber Cancer Institute	Sampson, JH (corresponding author), Duke Univ, Med Ctr, Dept Surg, Div Neurosurg, Durham, NC 27710 USA.	john.sampson@duke.edu	Sykes, April/N-4407-2018; Nair, Smita/GYR-2993-2022; Nair Jain, Smita/M-2765-2018	Sykes, April/0000-0002-7667-8155; Nair, Smita/0000-0001-5615-7056; Nair Jain, Smita/0000-0002-1542-9913; Sampson, John/0000-0002-0104-7658	National Institutes of Health (NIH) [RO1-CA097222, R21-NS067980, R21-CA132891]; NIH/National Institute of Neurological Disorders and Stroke SRC on Primary and Metastatic Tumors of the Central Nervous System [P50-NS020023]; Specialized Program of Research Excellence in Brain Cancer [P50-CA108786]; Duke University from National Center for Research Resources/NIH [1UL2-RR024128]; NATIONAL CANCER INSTITUTE [R01CA097222, R21CA132891, P50CA108786] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067980, P50NS020023] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Neurological Disorders and Stroke SRC on Primary and Metastatic Tumors of the Central Nervous System; Specialized Program of Research Excellence in Brain Cancer; Duke University from National Center for Research Resources/NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health (NIH) grants RO1-CA097222 (JHS), R21-NS067980 (JHS) and R21-CA132891 (JHS), grants from the NIH/National Institute of Neurological Disorders and Stroke SRC on Primary and Metastatic Tumors of the Central Nervous System P50-NS020023 (DAR, JHS and DDB) and Specialized Program of Research Excellence in Brain Cancer P50-CA108786 (DDB and JHS) and by Duke University's CTSA grant 1UL2-RR024128 from National Center for Research Resources/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Consultant or Advisory Role: JHS, Celldex Therapeutics (C); DDB, Celldex Therapeutics (C) Honoraria: JHS, Celldex Therapeutics; DDB, Celldex Therapeutics Research Funding: JHS. The designation (C) indicates a compensated position. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. CDX-110 is a Celldex product. There are no patents, products in development or other marketed products to declare.	Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Attia P, 2006, J IMMUNOTHER, V29, P208, DOI 10.1097/01.cji.0000187959.45803.0c; Attia P, 2005, J CLIN ONCOL, V23, P6043, DOI 10.1200/JCO.2005.06.205; Attia P, 2005, J IMMUNOTHER, V28, P582, DOI 10.1097/01.cji.0000175468.19742.10; Bagavant H, 2002, INT IMMUNOL, V14, P1397, DOI 10.1093/intimm/dxf105; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Binder M, 2007, CANCER RES, V67, P3518, DOI 10.1158/0008-5472.CAN-06-3919; Blansfield JA, 2005, J IMMUNOTHER, V28, P593, DOI 10.1097/01.cji.0000178913.41256.06; Boissonnas A, 2010, IMMUNITY, V32, P266, DOI 10.1016/j.immuni.2009.11.015; Cobbs CS, 2002, CANCER RES, V62, P3347; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curtin JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001983; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Fecci PE, 2006, CANCER RES, V66, P3294, DOI 10.1158/0008-5472.CAN-05-3773; Fecci PE, 2006, CLIN CANCER RES, V12, P4294, DOI 10.1158/1078-0432.CCR-06-0053; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Goebel J, 2000, TRANSPL IMMUNOL, V8, P153, DOI 10.1016/S0966-3274(00)00021-6; GREEN DR, 1993, IMMUNOL TODAY, V14, P523, DOI 10.1016/0167-5699(93)90180-S; HUMPHREY PA, 1990, P NATL ACAD SCI USA, V87, P4207, DOI 10.1073/pnas.87.11.4207; Ichihara F, 2003, CLIN CANCER RES, V9, P4404; Jaber SH, 2006, ARCH DERMATOL, V142, P166, DOI 10.1001/archderm.142.2.166; Jacobs JFM, 2010, CLIN CANCER RES, V16, P5067, DOI 10.1158/1078-0432.CCR-10-1757; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kohm AP, 2006, J IMMUNOL, V176, P3301, DOI 10.4049/jimmunol.176.6.3301; Koyama K, 2008, CLIN CANCER RES, V14, P6770, DOI 10.1158/1078-0432.CCR-08-1156; Liau LM, 2005, CLIN CANCER RES, V11, P5515, DOI 10.1158/1078-0432.CCR-05-0464; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Maloy KJ, 2005, NAT IMMUNOL, V6, P1071, DOI 10.1038/ni1105-1071; Martin JF, J IMMUNOL, V185, P1311; Mitchell DA, 2011, BLOOD; Mitchell DA, 2008, NEURO-ONCOLOGY, V10, P10, DOI 10.1215/15228517-2007-035; Morse MA, 2008, BLOOD, V112, P610, DOI 10.1182/blood-2008-01-135319; Nair S, 2007, CANCER RES, V67, P371, DOI 10.1158/0008-5472.CAN-06-2903; Neujahr DC, 2006, J IMMUNOL, V176, P4632, DOI 10.4049/jimmunol.176.8.4632; Onizuka S, 1999, CANCER RES, V59, P3128; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Powell DJ, 2008, J IMMUNOTHER, V31, P189, DOI 10.1097/CJI.0b013e31815dc0e8; Powell DJ, 2007, J IMMUNOL, V179, P4919, DOI 10.4049/jimmunol.179.7.4919; Prins RM, 2008, NEW ENGL J MED, V359, P539, DOI 10.1056/NEJMc0804818; Purev E, 2004, J IMMUNOL, V173, P6472, DOI 10.4049/jimmunol.173.10.6472; Quezada SA, 2008, J EXP MED, V205, P2125, DOI 10.1084/jem.20080099; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sampson JH, 2011, NEURO-ONCOLOGY, V13, P324, DOI 10.1093/neuonc/noq157; Sampson JH, 2010, J CLIN ONCOL, V28, P4722, DOI 10.1200/JCO.2010.28.6963; Sampson JH, 2009, MOL CANCER THER, V8, P2773, DOI 10.1158/1535-7163.MCT-09-0124; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Scheurer ME, 2008, ACTA NEUROPATHOL, V116, P79, DOI 10.1007/s00401-008-0359-1; Schmittling RJ, 2008, J IMMUNOL METHODS, V339, P74, DOI 10.1016/j.jim.2008.08.004; Seddon B, 1999, J EXP MED, V189, P877, DOI 10.1084/jem.189.5.877; Seddon B, 1999, J EXP MED, V189, P279, DOI 10.1084/jem.189.2.279; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sok JC, 2006, CLIN CANCER RES, V12, P5064, DOI 10.1158/1078-0432.CCR-06-0913; Somasundaram R, 2002, CANCER RES, V62, P5267; Stephens LA, 2000, J IMMUNOL, V165, P3105, DOI 10.4049/jimmunol.165.6.3105; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; TAGUCHI O, 1994, IMMUNOLOGY, V82, P365; TAGUCHI O, 1987, J EXP MED, V165, P146, DOI 10.1084/jem.165.1.146; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Van Assche G, 2006, GUT, V55, P1568, DOI 10.1136/gut.2005.089854; Vincenti F, 1998, TRANSPLANT P, V30, P2155, DOI 10.1016/S0041-1345(98)00571-5; Wainwright DA, 2011, NEURO-ONCOLOGY, V13, P1308, DOI 10.1093/neuonc/nor134; WIKSTRAND CJ, 1995, CANCER RES, V55, P3140; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wolf AM, 2003, CLIN CANCER RES, V9, P606; Woo EY, 2001, CANCER RES, V61, P4766; Wrzesinski C, 2007, J CLIN INVEST, V117, P492, DOI 10.1172/JCI30414; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	76	78	89	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31046	10.1371/journal.pone.0031046	http://dx.doi.org/10.1371/journal.pone.0031046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383993	gold, Green Published, Green Submitted			2022-12-27	WOS:000302918500017
J	Guo, YL; Tomlinson, B; Chu, TY; Fang, YJ; Gui, HS; Tang, CS; Yip, BH; Cherny, SS; Hur, YM; Sham, PC; Lam, TH; Thomas, NG				Guo, Youling; Tomlinson, Brian; Chu, Tanya; Fang, Yu Jing; Gui, Hongsheng; Tang, Clara S.; Yip, Benjamin H.; Cherny, Stacey S.; Hur, Yoon-Mi; Sham, Pak Chung; Lam, Tai Hing; Thomas, Neil G.			A Genome-Wide Linkage and Association Scan Reveals Novel Loci for Hypertension and Blood Pressure Traits	PLOS ONE			English	Article							FACTOR GDNF GENE; QUANTITATIVE TRAITS; CHINESE POPULATION; PAIR ANALYSIS; PHOSDUCIN; PROTEIN; HERITABILITY; POLYMORPHISM; SCHIZOPHRENIA; PHENOTYPES	Hypertension is caused by the interaction of environmental and genetic factors. The condition which is very common, with about 18% of the adult Hong Kong Chinese population and over 50% of older individuals affected, is responsible for considerable morbidity and mortality. To identify genes influencing hypertension and blood pressure, we conducted a combined linkage and association study using over 500,000 single nucleotide polymorphisms (SNPs) genotyped in 328 individuals comprising 111 hypertensive probands and their siblings. Using a family-based association test, we found an association with SNPs on chromosome 5q31.1 (rs6596140; P<9 x 10(-8)) for hypertension. One candidate gene, PDC, was replicated, with rs3817586 on 1q31.1 attaining P = 2.5 x 10(-4) and 2.9 x 10(-5) in the within-family tests for DBP and MAP, respectively. We also identified regions of significant linkage for systolic and diastolic blood pressure on chromosomes 2q22 and 5p13, respectively. Further family-based association analysis of the linkage peak on chromosome 5 yielded a significant association (rs1605685, P<7 x 10(-5)) for DBP. This is the first combined linkage and association study of hypertension and its related quantitative traits with Chinese ancestry. The associations reported here account for the action of common variants whereas the discovery of linkage regions may point to novel targets for rare variant screening.	[Guo, Youling; Gui, Hongsheng; Tang, Clara S.; Yip, Benjamin H.; Cherny, Stacey S.; Sham, Pak Chung] Univ Hong Kong, Dept Psychiat, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Tomlinson, Brian; Chu, Tanya; Fang, Yu Jing] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Hur, Yoon-Mi] Mokpo Natl Univ, Seoul, South Korea; [Thomas, Neil G.] Univ Birmingham, Unit Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England	University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Mokpo National University; University of Birmingham	Guo, YL (corresponding author), Univ Hong Kong, Dept Psychiat, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China.	cherny@hku.hk; hrmrlth@hkucc.hku.hk; g.n.thomas@bham.ac.uk	Gui, Hongsheng/D-1063-2013; Tomlinson, Brian/P-5365-2015; YIP, Benjamin HK/I-2336-2013; Thomas, G. Neil/A-1879-2013; Tomlinson, Brian/AAD-9404-2019; Cherny, Stacey S/B-3315-2008; Yip, Benjamin/AAC-7845-2019; Lam, Tai Hing/C-4317-2009	Gui, Hongsheng/0000-0002-0460-7446; Thomas, G. Neil/0000-0002-2777-1847; Tomlinson, Brian/0000-0001-6717-5444; Cherny, Stacey S/0000-0002-0269-3352; Yip, Benjamin/0000-0002-4749-7611; Lam, Tai Hing/0000-0002-2033-9971; Tang, Clara/0000-0003-0265-2638	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK 4095/00M, CUHK 4438/03M, HKU 7672/06M]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	The work described in this paper was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region, China (Projects no. CUHK 4095/00M, CUHK 4438/03M, HKU 7672/06M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Baker PRS, 2004, AM J PHYSIOL-CELL PH, V287, pC1359, DOI 10.1152/ajpcell.00238.2004; BAUER PH, 1992, NATURE, V358, P73, DOI 10.1038/358073a0; Beetz N, 2009, J CLIN INVEST, V119, P3597, DOI 10.1172/JCI38433; Bell JT, 2006, HUM MOL GENET, V15, P1365, DOI 10.1093/hmg/ddl058; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cardon LR, 2000, BEHAV GENET, V30, P235, DOI 10.1023/A:1001970425822; Cho Kelly, 2007, BMC Proc, V1 Suppl 1, pS161; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Fang YJ, 2005, INT J CARDIOL, V102, P111, DOI 10.1016/j.ijcard.2004.05.010; Fang YJ, 2010, J HYPERTENS, V28, P1203, DOI 10.1097/HJH.0b013e3283384b07; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gong ML, 2003, HUM MOL GENET, V12, P1273, DOI 10.1093/hmg/ddg135; Gu DF, 2007, HYPERTENSION, V50, P116, DOI 10.1161/HYPERTENSIONAHA.107.088310; Gu DF, 2006, HYPERTENSION, V47, P1147, DOI 10.1161/01.HYP.0000219041.66702.45; Hamet P, 1998, J HYPERTENS, V16, P397, DOI 10.1097/00004872-199816040-00001; Hiura Y, 2010, CIRC J, V74, P2353, DOI 10.1253/circj.CJ-10-0353; Hong KW, J HUM GENET, V55, P336; Kardia SLR, 2003, AM J HYPERTENS, V16, P154, DOI 10.1016/S0895-7061(02)03249-1; Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/00004872-200401000-00003; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lee KB, 2001, PSYCHIAT RES, V104, P11, DOI 10.1016/S0165-1781(01)00294-3; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Luke MM, 2009, STROKE, V40, P363, DOI 10.1161/STROKEAHA.108.521328; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Michelato A, 2004, NEUROSCI LETT, V357, P235, DOI 10.1016/j.neulet.2003.12.089; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Munroe PB, 2006, HYPERTENSION, V48, P105, DOI 10.1161/01.HYP.0000228324.74255.f1; Newton-Cheh C., 2009, NAT GENET, V41, P666, DOI [10.1038/ng.361, DOI 10.1038/NG.361]; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ranade K, 2003, AM J HYPERTENS, V16, P158, DOI 10.1016/S0895-7061(02)03245-4; Seoh ML, 2003, FEBS LETT, V539, P131, DOI 10.1016/S0014-5793(03)00213-8; Sesso HD, 2000, HYPERTENSION, V36, P801, DOI 10.1161/01.HYP.36.5.801; Sham PC, 2002, AM J HUM GENET, V71, P238, DOI 10.1086/341560; Snieder H, 2003, HYPERTENSION, V41, P1196, DOI 10.1161/01.HYP.0000072269.19820.0D; SPARKES RS, 1993, GENOMICS, V18, P426, DOI 10.1006/geno.1993.1490; St-Pierre J, 2001, MOL GENET METAB, V72, P209, DOI 10.1006/mgme.2000.3144; Thomas GN, 2007, CLIN ENDOCRINOL, V66, P666, DOI 10.1111/j.1365-2265.2007.02798.x; Thomas GN, 1999, CLIN EXP HYPERTENS, V21, P1161, DOI 10.3109/10641969909052195; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; Wang XL, 2006, CIRCULATION, V114, P2780, DOI 10.1161/CIRCULATIONAHA.106.643940; Wang Y, 2009, P NATL ACAD SCI USA, V106, P226, DOI 10.1073/pnas.0808358106; Watanabe Y, 2010, HYPERTENS RES, V33, P129, DOI 10.1038/hr.2009.193; Yang HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005459; Zhu DL, 2001, J HYPERTENS, V19, P55, DOI 10.1097/00004872-200101000-00008	52	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31489	10.1371/journal.pone.0031489	http://dx.doi.org/10.1371/journal.pone.0031489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384028	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916800015
J	Matulova, M; Stepanova, H; Sisak, F; Havlickova, H; Faldynova, M; Kyrova, K; Volf, J; Rychlik, I				Matulova, Marta; Stepanova, Hana; Sisak, Frantisek; Havlickova, Hana; Faldynova, Marcela; Kyrova, Kamila; Volf, Jiri; Rychlik, Ivan			Cytokine Signaling in Splenic Leukocytes from Vaccinated and Non-Vaccinated Chickens after Intravenous Infection with Salmonella Enteritidis	PLOS ONE			English	Article							ENTERICA SEROVAR ENTERITIDIS; IMMUNE-RESPONSE; PATHOGENICITY ISLANDS; T-CELLS; TYPHIMURIUM; EXPRESSION; RECHALLENGE; CECUM	In order to design a new Salmonella enterica vaccine, one needs to understand how naive and immune chickens interact differently when exposed to S. enterica. In this study we therefore determined the immune response of vaccinated and non-vaccinated chickens after intravenous infection with Salmonella enterica serovar Enteritidis (S. Enteritidis). Using flow cytometry we showed that 4 days post infection (DPI), counts of CD4 and B-lymphocytes did not change, CD8 and gamma delta T-lymphocytes decreased and macrophages and heterophils increased in the spleen. When vaccinated and non-vaccinated chickens were compared, only macrophages and heterophils were found in significantly higher counts in the spleens of the non-vaccinated chickens. The non-vaccinated chickens also expressed higher anti-LPS antibodies than the vaccinated chickens. The expression of interleukin (IL) 1 beta, IL6, IL8, IL18, LITAF, IFN gamma and iNOS did not exhibit any clear pattern in the cells sorted from the spleens of vaccinated or non-vaccinated chickens. Only IL17 and IL22 showed a differential expression in the CD4 T-lymphocytes of the vaccinated and non-vaccinated chickens at 4 DPI, both being expressed at a higher level in the non-vaccinated chickens. Due to a similar IFN gamma expression in the CD4 T-lymphocytes in both the vaccinated and non-vaccinated chickens, and a variable IL17 expression oscillating around IFN gamma expression levels, the IL17: IFN gamma ratio in CD4 T-lymphocytes was found to be central for the outcome of the immune response. When IL17 was expressed at higher levels than IFN gamma in the non-vaccinated chickens, the Th17 immune response with a higher macrophage and heterophil infiltration in the spleen dominated. However, when the expression of IL17 was lower than that of IFN gamma as in the vaccinated chickens, the Th1 response with a higher resistance to S. Enteritidis infection dominated.	[Matulova, Marta; Stepanova, Hana; Sisak, Frantisek; Havlickova, Hana; Faldynova, Marcela; Kyrova, Kamila; Volf, Jiri; Rychlik, Ivan] Vet Res Inst, CS-62132 Brno, Czech Republic	Czech Veterinary Research Institute	Matulova, M (corresponding author), Vet Res Inst, CS-62132 Brno, Czech Republic.	rychlik@vri.cz	, Ivan/GPS-9674-2022; kyrova, kamila/H-4024-2016; Štěpánová, Hana/GPG-3735-2022; Bendickova, Kamila/D-1544-2017	, Ivan/0000-0001-7995-6483; kyrova, kamila/0000-0001-5627-3305; Bendickova, Kamila/0000-0001-7767-1003	Czech Ministry of Agriculture [MZE0002716202]; Czech Ministry of Education [CZ.1.05/2.1.00/01.0006 - ED0006/01/01]; Czech Science Foundation [524/09/0215]	Czech Ministry of Agriculture(Ministry of Agriculture, Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	This work has been supported by the projects MZE0002716202 of the Czech Ministry of Agriculture, AdmireVet project CZ.1.05/2.1.00/01.0006 - ED0006/01/01 from the Czech Ministry of Education and project 524/09/0215 from the Czech Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beal RK, 2004, VET IMMUNOL IMMUNOP, V100, P151, DOI 10.1016/j.vetimm.2004.04.005; Berndt A, 2001, VET IMMUNOL IMMUNOP, V78, P143, DOI 10.1016/S0165-2427(00)00264-6; Berndt A, 2007, INFECT IMMUN, V75, P5993, DOI 10.1128/IAI.00695-07; Berndt A, 2006, INFECT IMMUN, V74, P3967, DOI 10.1128/IAI.01128-05; Carvajal BG, 2008, VACCINE, V26, P5423, DOI 10.1016/j.vaccine.2008.07.088; Crhanova M, 2011, INFECT IMMUN, V79, P2755, DOI 10.1128/IAI.01375-10; Karasova D, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-75; Kolesarova M, 2011, VET MED-CZECH, V56, P325, DOI 10.17221/1586-VETMED; Matulova M, 2012, VACCINE IN PRESS, DOI [10.1016/j.vaccine.2012.01.050, DOI 10.1016/J.VACCINE.2012.01.050]; Pieper J, 2011, INFECT IMMUN, V79, P822, DOI 10.1128/IAI.00788-10; Rychlik I, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-268; Sadeyen JR, 2004, MICROBES INFECT, V6, P1278, DOI 10.1016/j.micinf.2004.07.005; Santos RL, 2009, TRENDS MICROBIOL, V17, P498, DOI 10.1016/j.tim.2009.08.008; Van Dijk A, 2009, MOL IMMUNOL, V46, P1517, DOI 10.1016/j.molimm.2008.12.015; Withanage GSK, 2005, INFECT IMMUN, V73, P5173, DOI 10.1128/IAI.73.8.5173-5182.2005; Zuckermann FA, 1999, VET IMMUNOL IMMUNOP, V72, P55, DOI 10.1016/S0165-2427(99)00118-X	16	17	18	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32346	10.1371/journal.pone.0032346	http://dx.doi.org/10.1371/journal.pone.0032346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384225	gold, Green Published, Green Submitted			2022-12-27	WOS:000302916800037
J	Usami, S; Nishio, S; Nagano, M; Abe, S; Yamaguchi, T				Usami, Shin-ichi; Nishio, Shin-ya; Nagano, Makoto; Abe, Satoko; Yamaguchi, Toshikazu		Deafness Gene Study Consortium	Simultaneous Screening of Multiple Mutations by Invader Assay Improves Molecular Diagnosis of Hereditary Hearing Loss: A Multicenter Study	PLOS ONE			English	Article							ENLARGED VESTIBULAR AQUEDUCT; CLINICAL-FEATURES; PENDRED-SYNDROME; GJB2 MUTATIONS; DEAFNESS; SPECTRUM; JAPANESE; SLC26A4	Although etiological studies have shown genetic disorders to be a common cause of congenital/early-onset sensorineural hearing loss, there have been no detailed multicenter studies based on genetic testing. In the present report, 264 Japanese patients with bilateral sensorineural hearing loss from 33 ENT departments nationwide participated. For these patients, we first applied the Invader assay for screening 47 known mutations of 13 known deafness genes, followed by direct sequencing as necessary. A total of 78 (29.5%) subjects had at least one deafness gene mutation. Mutations were more frequently found in the patients with congenital or early-onset hearing loss, i.e., in those with an awareness age of 0-6 years, mutations were significantly higher (41.8%) than in patients with an older age of awareness (16.0%). Among the 13 genes, mutations in GJB2 and SLC26A4 were mainly found in congenital or early-onset patients, in contrast with mitochondrial mutations (12S rRNA m.1555A>G, tRNA(Leu(UUR)) m.3243A>G), which were predominantly found in older-onset patients. The present method of simultaneous screening of multiple deafness mutations by Invader assay followed by direct sequencing will enable us to detect deafness mutations in an efficient and practical manner for clinical use.	[Usami, Shin-ichi; Nishio, Shin-ya] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Asahi Ku, Matsumoto, Nagano 390, Japan; [Nagano, Makoto; Abe, Satoko; Yamaguchi, Toshikazu] Biomed Labs Inc, Dept Clin Genom, Kawagoe, Saitama, Japan	Shinshu University	Usami, S (corresponding author), Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Asahi Ku, Matsumoto, Nagano 390, Japan.	usami@shinshu-u.ac.jp	Ito, Tsukasa/R-7201-2016	Ito, Tsukasa/0000-0002-4237-3564; Nishio, Shin-ya/0000-0001-6640-2297	Ministry of Health and Welfare, Japan; Ministry of Education, Science and Culture of Japan	Ministry of Health and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the (then) Ministry of Health and Welfare, Japan (http://www.mhlw.go.jp/english/) (S. U.) and a Grant-in-Aid for Scientific Research from the (then) Ministry of Education, Science and Culture of Japan (http://www.mext.go.jp/english/) (S. U.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 1997, ANN OTO RHINOL LARYN, V106, P1063, DOI 10.1177/000348949710601210; Abe S, 2007, GENET TEST, V11, P333, DOI 10.1089/gte.2007.0002; Azaiez H, 2004, HUM MUTAT, V24, P305, DOI 10.1002/humu.20084; den Ouweland JM, 1992, NAT GENET, V1, P368; Fukushima K, 2002, INT J PEDIATR OTORHI, V62, P151, DOI 10.1016/S0165-5876(01)00619-X; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403; Kimberling WJ, 2005, HUM MUTAT, V26, P462, DOI 10.1002/humu.20221; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Oguchi T, 2005, J HUM GENET, V50, P76, DOI 10.1007/s10038-004-0223-7; Ohtsuka A, 2003, HUM GENET, V112, P329, DOI 10.1007/s00439-002-0889-x; Oshima T, 1996, LARYNGOSCOPE, V106, P43, DOI 10.1097/00005537-199601000-00009; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Snoeckx RL, 2005, AM J HUM GENET, V77, P945, DOI 10.1086/497996; Suzuki H, 2000, ACTA OTO-LARYNGOL, V127, P1292; Tsukada K, 2010, CLIN GENET, V78, P464, DOI 10.1111/j.1399-0004.2010.01407.x; Tsukamoto K, 2003, EUR J HUM GENET, V11, P916, DOI 10.1038/sj.ejhg.5201073; Usami S, 1997, LARYNGOSCOPE, V107, P483, DOI 10.1097/00005537-199704000-00011; Usami S, 2000, J MED GENET, V37, P38, DOI 10.1136/jmg.37.1.38; Usami S, 1999, HUM GENET, V104, P188, DOI 10.1007/s004390050933; Usami SI, 2008, ACTA OTO-LARYNGOL, V128, P446, DOI 10.1080/00016480701785046; Yang T, 2007, AM J HUM GENET, V80, P1055, DOI 10.1086/518314	22	44	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31276	10.1371/journal.pone.0031276	http://dx.doi.org/10.1371/journal.pone.0031276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384008	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916800012
J	Ruppert, SM; Chehtane, M; Zhang, G; Hu, HY; Li, XM; Khaled, AR				Ruppert, Shannon M.; Chehtane, Mounir; Zhang, Ge; Hu, Haiyan; Li, Xiaoman; Khaled, Annette R.			JunD/AP-1-Mediated Gene Expression Promotes Lymphocyte Growth Dependent on Interleukin-7 Signal Transduction	PLOS ONE			English	Article							T-CELL PROLIFERATION; JUND MESSENGER-RNA; C-JUN; FAMILY-MEMBERS; PROTEIN-KINASE; IL-7; ACTIVATION; RECEPTOR; MOUSE; SURVIVAL	Interleukin-7 (IL-7) is an essential cytokine for lymphocyte growth that has the potential for promoting immune reconstitution. This feature makes IL-7 an ideal candidate for therapeutic development. As with other cytokines, signaling through the IL-7 receptor induces the JAK/STAT pathway. However, the broad scope of IL-7 regulatory targets likely necessitates the use of other signaling components whose identities remain poorly defined. To this end, we used an IL-7 dependent T-cell line to examine how expression of the glycolytic enzyme, Hexokinase II (HXKII) was regulated by IL-7 in a STAT5-independent manner. Our studies revealed that IL-7 promoted the activity of JNK (Jun N-terminal Kinase), and that JNK, in turn, drove the expression of JunD, a component of the Activating Protein 1 (AP-1) transcription factors. Gel shifts showed that the AP-1 complex induced by IL-7 contained JunD but not c-Fos or c-Jun. Inhibition of JNK/JunD blocked glucose uptake and HXKII gene expression, indicating that this pathway was responsible for promoting HXKII expression. Because others had shown that JunD was a negative regulator of cell growth, we performed a bioinformatics analysis to uncover possible JunD-regulated gene targets. Our search revealed that JunD could control the expression of proteins involved in signal transduction, cell survival and metabolism. One of these growth promoters was the oncogene, Pim-1. Pim-1 is an IL-7-induced protein that was inhibited when the activities of JNK or JunD were blocked, showing that in IL-7 dependent T-cells JunD can promote positive signals transduced through Pim-1. This was confirmed when the IL-7-induced proliferation of CD8 T-cells was impaired upon JunD inhibition. These results show that engagement of the IL-7 receptor drives a signal that is more complex than the JAK/STAT pathway, activating JNK and JunD to induce rapid growth stimulation through the expression of metabolic and signaling factors like HXKII and Pim-1.	[Ruppert, Shannon M.; Chehtane, Mounir; Zhang, Ge; Li, Xiaoman; Khaled, Annette R.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Hu, Haiyan] Univ Cent Florida, Dept Elect Engn & Comp Sci, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Ruppert, SM (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	akhaled@mail.ucf.edu			NIH/NCI [CA109524RO1]; NATIONAL CANCER INSTITUTE [R01CA109524] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by an NIH/NCI Grant CA109524RO1 (Khaled) from the National Institutes of Health (NIH) (www.cancer.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpdogan O, 2003, J CLIN INVEST, V112, P1095, DOI 10.1172/JCI200317865; Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; CASTELLAZZI M, 1991, P NATL ACAD SCI USA, V88, P8890, DOI 10.1073/pnas.88.20.8890; Cen B, 2010, J BIOL CHEM, V285, P29128, DOI 10.1074/jbc.M110.137240; Chehtane M, 2010, AM J PHYSL CELL PHYS; Crawley JB, 1996, EUR J IMMUNOL, V26, P2717, DOI 10.1002/eji.1830261125; Crawley JB, 1997, J BIOL CHEM, V272, P15023, DOI 10.1074/jbc.272.23.15023; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Gao YF, 2005, J IMMUNOL, V175, P5783, DOI 10.4049/jimmunol.175.9.5783; Goetz CA, 2004, J IMMUNOL, V172, P4770, DOI 10.4049/jimmunol.172.8.4770; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; Heikkinen S, 2000, MAMM GENOME, V11, P91, DOI 10.1007/s003350010019; Hernandez JM, 2008, ONCOGENE, V27, P4757, DOI 10.1038/onc.2008.120; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Jacobs H, 1999, J EXP MED, V190, P1059, DOI 10.1084/jem.190.8.1059; Jaganathan S, 2010, J PHARMACOL EXP THER, V333, P373, DOI 10.1124/jpet.109.162669; Jiang Q, 2004, MOL CELL BIOL, V24, P6501, DOI 10.1128/MCB.24.14.6501-6513.2004; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Kang JS, 2004, J IMMUNOL, V173, P2307, DOI 10.4049/jimmunol.173.4.2307; Khaled AR, 2005, J CELL BIOL, V169, P755, DOI 10.1083/jcb.200409099; Khaled AR, 2003, IMMUNOL REV, V193, P48, DOI 10.1034/j.1600-065X.2003.00050.x; Khaled AR, 2002, IMMUNITY, V17, P561, DOI 10.1016/S1074-7613(02)00450-8; Khaled AR, 2001, MOL CELL BIOL, V21, P7545, DOI 10.1128/MCB.21.22.7545-7557.2001; Khaled AR, 1999, P NATL ACAD SCI USA, V96, P14476, DOI 10.1073/pnas.96.25.14476; Kim K, 2003, J IMMUNOL METHODS, V274, P177, DOI 10.1016/S0022-1759(02)00513-6; Kittipatarin C, 2007, CYTOKINE, V39, P75, DOI 10.1016/j.cyto.2007.07.183; Kittipatarin C, 2010, IMMUNOL LETT, V131, P170, DOI 10.1016/j.imlet.2010.04.007; Kittipatarin C, 2009, J IMMUNOL METHODS, V344, P45, DOI 10.1016/j.jim.2009.03.001; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; Li WQ, 2010, MOL CELL BIOL, V30, P590, DOI 10.1128/MCB.01006-09; Li WQ, 2004, J BIOL CHEM, V279, P29160, DOI 10.1074/jbc.M401656200; Li WQ, 2006, J EXP MED, V203, P573, DOI 10.1084/jem.20051520; Mazzucchelli RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007637; Meixner A, 2004, EMBO J, V23, P1325, DOI 10.1038/sj.emboj.7600133; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Morcinek JC, 2002, ONCOGENE, V21, P1668, DOI 10.1038/sj.onc.1205148; Musti AM, 1996, BIOL CHEM, V377, P619, DOI 10.1515/bchm3.1996.377.10.619; Pellegrini M, 2004, J EXP MED, V200, P1189, DOI 10.1084/jem.20041328; PFARR CM, 1994, CELL, V76, P747, DOI 10.1016/0092-8674(94)90513-4; Rahman Z, 2001, IMMUNOL LETT, V75, P199, DOI 10.1016/S0165-2478(00)00322-9; Rajnavolgyi E, IL 7 WITHDRAWAL INDU; Repass JF, 2009, GENESIS; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; SAKATA T, 1990, J LEUKOCYTE BIOL, V48, P205, DOI 10.1002/jlb.48.3.205; Sasson SC, 2006, CURR DRUG TARGETS, V7, P1571, DOI 10.2174/138945006779025365; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; SCHUTTE J, 1989, P NATL ACAD SCI USA, V86, P2257, DOI 10.1073/pnas.86.7.2257; SECKINGER P, 1994, J IMMUNOL, V153, P97; Seddon B, 2002, J IMMUNOL, V169, P3752, DOI 10.4049/jimmunol.169.7.3752; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Short JD, 2002, J BIOL CHEM, V277, P32697, DOI 10.1074/jbc.M204553200; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Unsinger J, 2010, J IMMUNOL, V184, P3768, DOI 10.4049/jimmunol.0903151; VENKITARAMAN AR, 1992, P NATL ACAD SCI USA, V89, P12083, DOI 10.1073/pnas.89.24.12083; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; Weitzman JB, 2000, MOL CELL, V6, P1109, DOI 10.1016/S1097-2765(00)00109-X; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Xiao L, 2007, BIOCHEM J, V403, P573, DOI 10.1042/BJ20061436; Yazgan O, 2002, J BIOL CHEM, V277, P29710, DOI 10.1074/jbc.M204552200; Zou TT, 2010, MOL CELL BIOL, V30, P5021, DOI 10.1128/MCB.00807-10	67	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32262	10.1371/journal.pone.0032262	http://dx.doi.org/10.1371/journal.pone.0032262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384197	Green Published, gold			2022-12-27	WOS:000302916100064
J	Simmons, T; Appel, B				Simmons, Timothy; Appel, Bruce			Mutation of pescadillo Disrupts Oligodendrocyte Formation in Zebrafish	PLOS ONE			English	Article							INSERTIONAL MUTAGENESIS; EMBRYONIC-DEVELOPMENT; RIBOSOME BIOGENESIS; CELL-PROLIFERATION; SPECIFICATION; PROTEIN; MIGRATION; GENES; EYE	Background: In vertebrates, the myelin sheath is essential for efficient propagation of action potentials along the axon shaft. Oligodendrocytes are the cells of the central nervous system that create myelin sheaths. During embryogenesis, ventral neural tube precursors give rise to oligodendrocyte progenitor cells, which divide and migrate throughout the central nervous system. This study aimed to investigate mechanisms that regulate oligodendrocyte progenitor cell formation. Methodology/Principal Findings: By conducting a mutagenesis screen in transgenic zebrafish, we identified a mutation, designated vu166, by an apparent reduction in the number of oligodendrocyte progenitor cells in the dorsal spinal cord. We subsequently determined that vu166 is an allele of pescadillo, a gene known to play a role in ribosome biogenesis and cell proliferation. We found that pescadillo function is required for both the proper number of oligodendrocyte progenitors to form, by regulating cell cycle progression, and for normal levels of myelin gene expression. Conclusions/Significance: Our data provide evidence that neural precursors require pes function to progress through the cell cycle and produce oligodendrocyte progenitor cells and for oligodendrocyte differentiation.	[Simmons, Timothy] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Appel, Bruce] Univ Colorado, Dept Pediat, Aurora, CO USA	Vanderbilt University; University of Colorado System; University of Colorado Anschutz Medical Campus	Simmons, T (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	Bruce.Appel@UCDenver.edu	Appel, Bruce/X-6418-2019	Appel, Bruce/0000-0003-4500-0672	NIH [NS046668, NS048154]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046668, P30NS048154] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by grants NS046668 (B.A) and NS048154 (University of Colorado Denver Zebrafish Core Facility) from the NIH (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank members of the Appel lab for discussions. The anti-BrdU antibody, developed by S. J. Kaufman, was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA. Confocal microscopy was performed using equipment provided by the Gates Frontiers Fund.	Adams CC, 2002, RNA, V8, P150, DOI 10.1017/S1355838202010026; Allende ML, 1996, GENE DEV, V10, P3141, DOI 10.1101/gad.10.24.3141; de Castro F, 2005, BRAIN RES REV, V49, P227, DOI 10.1016/j.brainresrev.2004.12.034; Du YCN, 2002, CELL, V109, P835, DOI 10.1016/S0092-8674(02)00773-0; Gaiano N, 1996, NATURE, V383, P829, DOI 10.1038/383829a0; Gessert S, 2007, DEV BIOL, V310, P99, DOI 10.1016/j.ydbio.2007.07.037; Hauptmann G, 2000, METH MOL B, V137, P139; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kinoshita Y, 2001, J BIOL CHEM, V276, P6656, DOI 10.1074/jbc.M008536200; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Lerch-Gaggl A, 2002, J BIOL CHEM, V277, P45347, DOI 10.1074/jbc.M208338200; Li J, 2009, CANCER SCI, V100, P2255, DOI 10.1111/j.1349-7006.2009.01325.x; Maiorana A, 2004, ONCOGENE, V23, P7116, DOI 10.1038/sj.onc.1207916; Megason Sean G., 2009, V546, P317, DOI 10.1007/978-1-60327-977-2_19; Park HC, 2005, J NEUROSCI, V25, P6836, DOI 10.1523/JNEUROSCI.0981-05.2005; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Raper J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001933; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Sikorski EM, 2006, J BIOL CHEM, V281, P24423, DOI 10.1074/jbc.M602287200; TEMPLE S, 1985, NATURE, V313, P223, DOI 10.1038/313223a0	24	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32317	10.1371/journal.pone.0032317	http://dx.doi.org/10.1371/journal.pone.0032317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384214	Green Submitted, Green Published, gold			2022-12-27	WOS:000302916100068
J	Zhang, EY; Xiong, Q; Ye, L; Suntharalingam, P; Wang, XH; Astle, CM; Zhang, JY; Harrison, DE				Zhang, Eric Y.; Xiong, Qiang; Ye, Lei; Suntharalingam, Piradeep; Wang, Xiaohong; Astle, C. Michael; Zhang, Jianyi; Harrison, David E.			Fetal Myocardium in the Kidney Capsule: An In Vivo Model of Repopulation of Myocytes by Bone Marrow Cells	PLOS ONE			English	Article							CARDIAC STEM-CELLS; INFARCTED MYOCARDIUM; GENETIC-REGULATION; HEART-FAILURE; REGENERATION; DIFFERENTIATION; TRANSPLANTATION; SENESCENCE; GROWTH; POPULATION	Debate surrounds the question of whether the heart is a post-mitotic organ in part due to the lack of an in vivo model in which myocytes are able to actively regenerate. The current study describes the first such mouse model - a fetal myocardial environment grafted into the adult kidney capsule. Here it is used to test whether cells descended from bone marrow can regenerate cardiac myocytes. One week after receiving the fetal heart grafts, recipients were lethally irradiated and transplanted with marrow from green fluorescent protein (GFP)-expressing C57Bl/6J (B6) donors using normal B6 recipients and fetal donors. Levels of myocyte regeneration from GFP marrow within both fetal myocardium and adult hearts of recipients were evaluated histologically. Fetal myocardium transplants had rich neovascularization and beat regularly after 2 weeks, continuing at checkpoints of 1, 2, 4, 6, 8 and 12 months after transplantation. At each time point, GFP-expressing rod-shaped myocytes were found in the fetal myocardium, but only a few were found in the adult hearts. The average count of repopulated myocardium with green rod-shaped myocytes was 996.8 cells per gram of fetal myocardial tissue, and 28.7 cells per adult heart tissue, representing a thirty-five fold increase in fetal myocardium compared to the adult heart at 12 months (when numbers of green rod-shaped myocytes were normalized to per gram of myocardial tissue). Thus, bone marrow cells can differentiate to myocytes in the fetal myocardial environment. The novel in vivo model of fetal myocardium in the kidney capsule appears to be valuable for testing repopulating abilities of potential cardiac progenitors.	[Zhang, Eric Y.; Astle, C. Michael; Harrison, David E.] Jackson Lab, Bar Harbor, ME 04609 USA; [Xiong, Qiang; Ye, Lei; Suntharalingam, Piradeep; Wang, Xiaohong; Zhang, Jianyi] Univ Minnesota, Sch Med, Dept Med, Div Cardiol, Minneapolis, MN 55455 USA	Jackson Laboratory; University of Minnesota System; University of Minnesota Twin Cities	Zhang, EY (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	zhang047@umn.edu; david.harrison@.jax.org	Zhang, Jianyi/N-1949-2018	Zhang, Jianyi/0000-0002-3955-6554; Ye, Lei/0000-0001-5039-6224	National Institutes of Health (NIH) [R01 HL-95077]; American Heart Association (AHA)-Jon DeHaan Myogenesis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100407, R01HL095077] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)-Jon DeHaan Myogenesis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health (NIH) grant R01 HL-95077 and the American Heart Association (AHA)-Jon DeHaan Myogenesis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anversa P, 2004, CIRCULATION, V109, P2832, DOI 10.1161/01.CIR.0000132469.85026.46; Anversa P, 1998, CIRC RES, V83, P1, DOI 10.1161/01.RES.83.1.1; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bittner RE, 1999, ANAT EMBRYOL, V199, P391, DOI 10.1007/s004290050237; Chen JC, 2000, EXP HEMATOL, V28, P442, DOI 10.1016/S0301-472X(99)00157-5; Chimenti C, 2003, CIRC RES, V93, P604, DOI 10.1161/01.RES.0000093985.76901.AF; Ertl RP, 2008, BLOOD, V111, P1709, DOI 10.1182/blood-2007-01-069807; HARRISON DE, 1993, EXP HEMATOL, V21, P206; HARRISON DE, 1991, EXP HEMATOL, V19, P374; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; Hosoda T, 2011, CIRCULATION, V123, P1287, DOI 10.1161/CIRCULATIONAHA.110.982918; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Kajstura J, 2008, J MOL CELL CARDIOL, V45, P505, DOI 10.1016/j.yjmcc.2008.05.025; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; Leri A, 2011, CIRC RES, V109, P941, DOI 10.1161/CIRCRESAHA.111.243154; Liu JB, 2004, AM J PHYSIOL-HEART C, V287, pH501, DOI 10.1152/ajpheart.00019.2004; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; MacLellan WR, 2000, ANNU REV PHYSIOL, V62, P289, DOI 10.1146/annurev.physiol.62.1.289; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nadal-Ginard B, 2003, CIRC RES, V92, P139, DOI 10.1161/01.RES.0000053618.86362.DF; Nakamura Y, 2007, STEM CELLS, V25, P612, DOI 10.1634/stemcells.2006-0168; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Rota M, 2007, P NATL ACAD SCI USA, V104, P17783, DOI 10.1073/pnas.0706406104; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Sussman MA, 2004, ANNU REV PHYSIOL, V66, P29, DOI 10.1146/annurev.physiol.66.032102.140723; Urbanek K, 2005, P NATL ACAD SCI USA, V102, P8692, DOI 10.1073/pnas.0500169102; Wang XH, 2006, STEM CELLS, V24, P1779, DOI 10.1634/stemcells.2005-0386; Xiong QA, 2011, STEM CELLS, V29, P367, DOI 10.1002/stem.580; Yuan R, 2005, EXP HEMATOL, V33, P243, DOI 10.1016/j.exphem.2004.10.014; Zeng LP, 2007, CIRCULATION, V115, P1866, DOI 10.1161/CIRCULATIONAHA.106.659730; Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289	38	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31099	10.1371/journal.pone.0031099	http://dx.doi.org/10.1371/journal.pone.0031099			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383995	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100014
J	Rayson, S; Arciga-Reyes, L; Wootton, L; Zabala, MD; Truman, W; Graham, N; Grant, M; Davies, B				Rayson, Samantha; Arciga-Reyes, Luis; Wootton, Lucie; Zabala, Marta De Torres; Truman, William; Graham, Neil; Grant, Murray; Davies, Brendan			A Role for Nonsense-Mediated mRNA Decay in Plants: Pathogen Responses Are Induced in Arabidopsis thaliana NMD Mutants	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; EXON JUNCTION COMPLEX; SYRINGAE PV. TOMATO; OPEN READING FRAMES; SALICYLIC-ACID; PSEUDOMONAS-SYRINGAE; DEFENSE RESPONSES; CAENORHABDITIS-ELEGANS; DISEASE RESISTANCE; GENE-EXPRESSION	Nonsense-mediated mRNA decay (NMD) is a conserved mechanism that targets aberrant mRNAs for destruction. NMD has also been found to regulate the expression of large numbers of genes in diverse organisms, although the biological role for this is unclear and few evolutionarily conserved targets have been identified. Expression analyses of three Arabidopsis thaliana lines deficient in NMD reveal that the vast majority of NMD-targeted transcripts are associated with response to pathogens. Congruently, NMD mutants, in which these transcripts are elevated, confer partial resistance to Pseudomonas syringae. These findings suggest a biological rationale for the regulation of gene expression by NMD in plants and suggest that manipulation of NMD could offer a new approach for crop protection. Amongst the few non-pathogen responsive NMD-targeted genes, one potential NMD targeted signal, the evolutionarily conserved upstream open reading frame (CuORF), was found to be hugely over-represented, raising the possibility that this feature could be used to target specific physiological mRNAs for control by NMD.	[Rayson, Samantha; Arciga-Reyes, Luis; Wootton, Lucie; Davies, Brendan] Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds, W Yorkshire, England; [Zabala, Marta De Torres; Truman, William; Grant, Murray] Univ Exeter, Sch Biosci, Exeter, Devon, England; [Graham, Neil] Univ Nottingham, Nottingham Arabidopsis Stock Ctr, Loughborough, Leics, England	University of Leeds; University of Exeter; University of Nottingham	Rayson, S (corresponding author), Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds, W Yorkshire, England.	b.h.davies@leeds.ac.uk	Graham, Neil/C-5489-2008; Truman, William/D-7823-2015	Graham, Neil/0000-0001-9080-8967; Truman, William/0000-0002-9840-2539; Davies, Brendan/0000-0002-9282-3789	BBSRC; BBSRC [BB/E010334/1, BB/D007046/1, BB/H00775X/1, BB/F005903/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F005903/1, BB/D007046/1, BB/E010334/1, BB/H00775X/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Anders KR, 2003, EMBO J, V22, P641, DOI 10.1093/emboj/cdg056; Arciga-Reyes L, 2006, PLANT J, V47, P480, DOI 10.1111/j.1365-313X.2006.02802.x; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Behm-Ansmant I, 2007, EMBO J, V26, P1591, DOI 10.1038/sj.emboj.7601588; BENDER CL, 1987, PHYSIOL MOL PLANT P, V30, P273, DOI 10.1016/0885-5765(87)90040-3; Biles CL, 2001, BIOS, V72, P67; Bruno IG, 2011, MOL CELL, V42, P500, DOI 10.1016/j.molcel.2011.04.018; Chan WK, 2007, EMBO J, V26, P1820, DOI 10.1038/sj.emboj.7601628; Chiu SY, 2003, RNA, V9, P77, DOI 10.1261/rna.2137903; Clarke JD, 2000, PLANT CELL, V12, P2175, DOI 10.1105/tpc.12.11.2175; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; Da Cunha L, 2007, CURR OPIN PLANT BIOL, V10, P349, DOI 10.1016/j.pbi.2007.04.018; de Torres-Zabala M, 2007, EMBO J, V26, P1434, DOI 10.1038/sj.emboj.7601575; Denning G, 2001, J BIOL CHEM, V276, P22709, DOI 10.1074/jbc.C100144200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Devadas SK, 2002, PLANT J, V30, P467, DOI 10.1046/j.1365-313X.2002.01300.x; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P1908, DOI 10.1073/pnas.020367497; Eberle AB, 2008, PLOS BIOL, V6, P849, DOI 10.1371/journal.pbio.0060092; Fukuhara N, 2005, MOL CELL, V17, P537, DOI 10.1016/j.molcel.2005.01.010; Gaba A, 2005, MOL CELL, V20, P449, DOI 10.1016/j.molcel.2005.09.019; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Gonzalez CI, 2000, MOL CELL, V5, P489, DOI 10.1016/S1097-2765(00)80443-8; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; Grimson A, 2004, MOL CELL BIOL, V24, P7483, DOI 10.1128/MCB.24.17.7483-7490.2004; Guan QN, 2006, PLOS GENET, V2, P1924, DOI 10.1371/journal.pgen.0020203; Hamid R, 2010, CLIN GENET, V77, P280, DOI 10.1111/j.1399-0004.2009.01311.x; Hayden CA, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-32; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Heidel AJ, 2004, GENETICS, V168, P2197, DOI 10.1534/genetics.104.032193; HIRANO SS, 1990, ANNU REV PHYTOPATHOL, V28, P155, DOI 10.1146/annurev.py.28.090190.001103; Hori K, 2005, PLANT J, V43, P530, DOI 10.1111/j.1365-313X.2005.02473.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imai A, 2005, PLANT CELL PHYSIOL, V46, pS30; Imai A, 2006, DEVELOPMENT, V133, P3575, DOI 10.1242/dev.02535; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivanov PV, 2008, EMBO J, V27, P736, DOI 10.1038/emboj.2008.17; Jennings MD, 2010, NATURE, V465, P378, DOI 10.1038/nature09003; Jin JB, 2008, PLANT J, V53, P530, DOI 10.1111/j.1365-313X.2007.03359.x; Jing HC, 2007, J EXP BOT, V58, P3885, DOI 10.1093/jxb/erm237; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kerenyi Z, 2008, EMBO J, V27, P1585, DOI 10.1038/emboj.2008.88; Kertesz S, 2006, NUCLEIC ACIDS RES, V34, P6147, DOI 10.1093/nar/gkl737; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Knott JM, 2007, FEBS LETT, V581, P3081, DOI 10.1016/j.febslet.2007.05.074; Kurihara Y, 2009, P NATL ACAD SCI USA, V106, P2453, DOI 10.1073/pnas.0808902106; Lamba JK, 2003, HUM MOL GENET, V12, P99, DOI 10.1093/hmg/ddg011; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lee J, 2007, PLANT J, V49, P79, DOI 10.1111/j.1365-313X.2006.02947.x; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Li YJ, 2009, PHYSIOL PLANTARUM, V136, P19, DOI 10.1111/j.1399-3054.2009.01209.x; Liu GS, 2010, PLANT CELL, V22, P3845, DOI 10.1105/tpc.110.079392; Malanin SY, 2010, RUSS J PLANT PHYSL+, V57, P267, DOI 10.1134/S1021443710020159; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; McGlincy NJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-565; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Mohr TJ, 2010, MOL PLANT MICROBE IN, V23, P1303, DOI 10.1094/MPMI-01-10-0022; Mosher S, 2010, PLANT PHYSIOL, V152, P1901, DOI 10.1104/pp.109.152603; Nibbe M, 2002, PLANTA, V216, P120, DOI 10.1007/s00425-002-0907-1; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Nyiko T, 2009, PLANT MOL BIOL, V71, P367, DOI 10.1007/s11103-009-9528-4; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Pal M, 2001, RNA, V7, P5, DOI 10.1017/S1355838201000127; Palusa SG, 2010, NEW PHYTOL, V185, P83, DOI 10.1111/j.1469-8137.2009.03065.x; PELTZ SW, 1993, GENE DEV, V7, P1737, DOI 10.1101/gad.7.9.1737; Ramani AK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r101; Rehwinkel A, 2005, RNA, V11, P1530, DOI 10.1261/rna.2160905; Riehs N, 2008, J CELL SCI, V121, P2208, DOI 10.1242/jcs.027862; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Rodriguez-Gabriel MA, 2006, MOL CELL BIOL, V26, P6347, DOI 10.1128/MCB.00286-06; Ruiz-Echevarria MJ, 2000, CELL, V101, P741, DOI 10.1016/S0092-8674(00)80886-7; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Schoning JC, 2008, NUCLEIC ACIDS RES, V36, P6977, DOI 10.1093/nar/gkn847; Scholl RL, 2000, PLANT PHYSIOL, V124, P1477, DOI 10.1104/pp.124.4.1477; Serin G, 2001, MOL CELL BIOL, V21, P209, DOI 10.1128/MCB.21.1.209-223.2001; Shashikanth M, 2008, PLANT BIOTECHNOL-NAR, V25, P553, DOI 10.5511/plantbiotechnology.25.553; Shirano Y, 2002, PLANT CELL, V14, P3149, DOI 10.1105/tpc.005348; Singh G, 2008, PLOS BIOL, V6, P860, DOI 10.1371/journal.pbio.0060111; Song HR, 2009, PLANT CELL, V21, P1195, DOI 10.1105/tpc.108.064774; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Truman WM, 2010, PLANT PHYSIOL, V152, P1562, DOI 10.1104/pp.109.152173; Venugopal SC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000545; Viegas MH, 2007, NUCLEIC ACIDS RES, V35, P4542, DOI 10.1093/nar/gkm461; Vincill ED, 2005, PLANT PHYSIOL, V137, P1435, DOI 10.1104/pp.104.051953; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wada KC, 2010, J PLANT PHYSIOL, V167, P447, DOI 10.1016/j.jplph.2009.10.006; Ward JL, 2010, PLANT J, V63, P443, DOI 10.1111/j.1365-313X.2010.04254.x; Wawrzynska A, 2010, MOL PLANT MICROBE IN, V23, P578, DOI 10.1094/MPMI-23-5-0578; Wittkopp N, 2009, MOL CELL BIOL, V29, P3517, DOI 10.1128/MCB.00177-09; Xu SH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002159; Yamashita A, 2005, BBA-PROTEINS PROTEOM, V1754, P305, DOI 10.1016/j.bbapap.2005.10.002; Yi H, 2007, PLANT CELL, V19, P2929, DOI 10.1105/tpc.107.051821; Yoine M, 2006, PLANT J, V47, P49, DOI 10.1111/j.1365-313X.2006.02771.x; Yoine M, 2006, PLANT CELL PHYSIOL, V47, P572, DOI 10.1093/pcp/pcj035; Zabala MD, 2009, PLANT J, V59, P375, DOI 10.1111/j.1365-313X.2009.03875.x; Zetoune AB, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-83; Zhang XC, 2003, PLANT CELL, V15, P2333, DOI 10.1105/tpc.013474; Zhang XC, 2007, PLANT PHYSIOL, V145, P1577, DOI 10.1104/pp.107.108720	109	95	96	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31917	10.1371/journal.pone.0031917	http://dx.doi.org/10.1371/journal.pone.0031917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384098	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500052
J	Dingari, NC; Horowitz, GL; Kang, JW; Dasari, RR; Barman, I				Dingari, Narahara Chari; Horowitz, Gary L.; Kang, Jeon Woong; Dasari, Ramachandra R.; Barman, Ishan			Raman Spectroscopy Provides a Powerful Diagnostic Tool for Accurate Determination of Albumin Glycation	PLOS ONE			English	Article							HUMAN-SERUM-ALBUMIN; NONENZYMATIC GLYCOSYLATION; HEMODIALYSIS-PATIENTS; CALIBRATION MODELS; DIABETIC SUBJECTS; GLYCEMIC CONTROL; PLASMA-GLUCOSE; IN-VIVO; HEMOGLOBIN; FRUCTOSAMINE	We present the first demonstration of glycated albumin detection and quantification using Raman spectroscopy without the addition of reagents. Glycated albumin is an important marker for monitoring the long-term glycemic history of diabetics, especially as its concentrations, in contrast to glycated hemoglobin levels, are unaffected by changes in erythrocyte life times. Clinically, glycated albumin concentrations show a strong correlation with the development of serious diabetes complications including nephropathy and retinopathy. In this article, we propose and evaluate the efficacy of Raman spectroscopy for determination of this important analyte. By utilizing the pre-concentration obtained through drop-coating deposition, we show that glycation of albumin leads to subtle, but consistent, changes in vibrational features, which with the help of multivariate classification techniques can be used to discriminate glycated albumin from the unglycated variant with 100% accuracy. Moreover, we demonstrate that the calibration model developed on the glycated albumin spectral dataset shows high predictive power, even at substantially lower concentrations than those typically encountered in clinical practice. In fact, the limit of detection for glycated albumin measurements is calculated to be approximately four times lower than its minimum physiological concentration. Importantly, in relation to the existing detection methods for glycated albumin, the proposed method is also completely reagent-free, requires barely any sample preparation and has the potential for simultaneous determination of glycated hemoglobin levels as well. Given these key advantages, we believe that the proposed approach can provide a uniquely powerful tool for quantification of glycation status of proteins in biopharmaceutical development as well as for glycemic marker determination in routine clinical diagnostics in the future.	[Dingari, Narahara Chari; Kang, Jeon Woong; Dasari, Ramachandra R.; Barman, Ishan] MIT, Laser Biomed Res Ctr, GR Harrison Spect Lab, Cambridge, MA 02139 USA; [Horowitz, Gary L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Clin Pathol, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Dingari, NC (corresponding author), MIT, Laser Biomed Res Ctr, GR Harrison Spect Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ishan@mit.edu			NIH National Center for Research Resources at the MIT Laser Biomedical Research Center [P41-RR02594]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002594] Funding Source: NIH RePORTER	NIH National Center for Research Resources at the MIT Laser Biomedical Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors research work is funded by the NIH National Center for Research Resources (http://www.ncrr.nih.gov/) for their grant P41-RR02594, at the MIT Laser Biomedical Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI E, 1995, LANGMUIR, V11, P1057, DOI 10.1021/la00004a003; ANDERSON DJ, 1989, CLIN CHEM, V35, P2152; [Anonymous], 2010, DIABETES CARE S1, V33, pS4, DOI DOI 10.2337/DC10-S004; Arnold MA, 1998, ANAL CHEM, V70, P1773, DOI 10.1021/ac9710801; Barman I, 2011, J BIOMED OPT, V16; Barman I, 2010, ANAL CHEM, V82, P9719, DOI 10.1021/ac101754n; Barman I, 2010, ANAL CHEM, V82, P6104, DOI 10.1021/ac100810e; Barone PW, 2006, ANGEW CHEM INT EDIT, V45, P8138, DOI 10.1002/anie.200603138; Bouma B, 2003, J BIOL CHEM, V278, P41810, DOI 10.1074/jbc.M303925200; Brereton R.G., 2003, CHEMOMETRICS DATA AN; Brewster VL, 2011, ANAL CHEM, V83, P6074, DOI 10.1021/ac2012009; Burtis CA, 2001, TIETZ FUNDAMENTALS C; Cameron B D, 1999, Diabetes Technol Ther, V1, P135, DOI 10.1089/152091599317341; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Chaiken J, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1922147; CHEN MC, 1976, J AM CHEM SOC, V98, P990, DOI 10.1021/ja00420a021; Chesne S, 2006, BIOCHIMIE, V88, P1467, DOI 10.1016/j.biochi.2006.05.011; Cohen RM, 2008, BLOOD, V112, P4284, DOI 10.1182/blood-2008-04-154112; Crow P, 2005, BRIT J CANCER, V92, P2166, DOI 10.1038/sj.bjc.6602638; Currie LA, 1999, ANAL CHIM ACTA, V391, P103, DOI 10.1016/S0003-2670(99)00103-8; Dati F, 1996, EUR J CLIN CHEM CLIN, V34, P517; Davidson J, 1986, CLIN DIABETES MELLIT, P198; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; Dingari NC, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3611006; Dingari NC, 2011, ANAL BIOANAL CHEM, V400, P2871, DOI 10.1007/s00216-011-5004-5; Esmonde-White KA, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3130338; Filik J, 2007, ANALYST, V132, P544, DOI 10.1039/b701541k; FITZGIBBONS JF, 1976, J CLIN INVEST, V58, P820, DOI 10.1172/JCI108534; Freedman BI, 2010, PERITON DIALYSIS INT, V30, P72, DOI 10.3747/pdi.2008.00243; GABER BP, 1974, J AM CHEM SOC, V96, P6868, DOI 10.1021/ja00829a010; GARLICK RL, 1983, J BIOL CHEM, V258, P6142; Geddes CD, 2006, TOPICS FLUORESCENCE; Gugliucci Alejandro, 2000, Journal of the American Osteopathic Association, V100, P621; GUTHROW CE, 1979, P NATL ACAD SCI USA, V76, P4258, DOI 10.1073/pnas.76.9.4258; Haka AS, 2005, P NATL ACAD SCI USA, V102, P12371, DOI 10.1073/pnas.0501390102; HELLER A, 1992, J PHYS CHEM-US, V96, P3579, DOI 10.1021/j100188a007; Hom FG, 1998, ACTA DIABETOL, V35, P48, DOI 10.1007/s005920050100; IBERG N, 1986, J BIOL CHEM, V261, P3542; Ichikawa H, 1996, Nihon Jinzo Gakkai Shi, V38, P305; Inaba M, 2007, J AM SOC NEPHROL, V18, P896, DOI 10.1681/ASN.2006070772; Joy MS, 2002, AM J KIDNEY DIS, V39, P297, DOI 10.1053/ajkd.2002.30549; Kang JW, 2011, BIOMED OPT EXPRESS, V2, P2484, DOI 10.1364/BOE.2.002484; Khan MWA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P146, DOI 10.1134/S0006297907020034; Ko GTC, 1998, DIABETES CARE, V21, P1221, DOI 10.2337/diacare.21.8.1221; Kocisova E, 2011, J RAMAN SPECTROSC, V42, P1606, DOI 10.1002/jrs.2915; Koga M, 2009, DIABETES RES CLIN PR, V84, P163, DOI 10.1016/j.diabres.2009.01.013; Koga M, 2008, DIABETES RES CLIN PR, V81, P258, DOI 10.1016/j.diabres.2008.04.012; Kopecky V, 2006, VIB SPECTROSC, V42, P184, DOI 10.1016/j.vibspec.2006.04.019; Kosecki SM, 2005, ANN PHARMACOTHER, V39, P1557, DOI 10.1345/aph.1G010; Kumeda Y, 2008, CLIN ENDOCRINOL, V69, P556, DOI 10.1111/j.1365-2265.2008.03202.x; Lieber CA, 2003, APPL SPECTROSC, V57, P1363, DOI 10.1366/000370203322554518; LIN VJC, 1976, BIOPOLYMERS, V15, P203, DOI 10.1002/bip.1976.360150114; Liu W, 1997, BIOCHEM MOL BIOL INT, V42, P277; Matousek P, 2006, APPL SPECTROSC, V60, P758, DOI 10.1366/000370206777886955; OHE Y, 1987, CLIN CHIM ACTA, V169, P229, DOI 10.1016/0009-8981(87)90323-8; Okumura A, 2007, JPN J OPHTHALMOL, V51, P236, DOI 10.1007/s10384-007-0431-8; Ortiz C, 2006, ANAL BIOCHEM, V353, P157, DOI 10.1016/j.ab.2006.03.025; Peacock TP, 2008, KIDNEY INT, V73, P1062, DOI 10.1038/ki.2008.25; Peng CS, 2011, J AM CHEM SOC, V133, P15650, DOI 10.1021/ja205636h; PEZOLET M, 1976, BIOCHIM BIOPHYS ACTA, V453, P502, DOI 10.1016/0005-2795(76)90146-X; Rondeau P, 2011, BIOCHIMIE, V93, P645, DOI 10.1016/j.biochi.2010.12.003; Rondeau P, 2010, BBA-PROTEINS PROTEOM, V1804, P789, DOI 10.1016/j.bbapap.2009.12.003; Sacks DB, 2002, CLIN CHEM, V48, P436; Sacks DB, 2001, CARBOHYDRATES; Saha A, 2011, BIOMED OPT EXPRESS, V2, P2792, DOI 10.1364/BOE.2.002792; Saha A, 2010, J BIOPHOTONICS, V3, P670, DOI 10.1002/jbio.201000044; Saha A, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3246792; SAKURAI T, 1984, FEBS LETT, V176, P27, DOI 10.1016/0014-5793(84)80905-9; Sardesai V, 2011, INTRO CLIN NUTR, P346; Saudek CD, 2008, J CLIN ENDOCR METAB, V93, P2447, DOI 10.1210/jc.2007-2174; Shafer-Peltier KE, 2003, J AM CHEM SOC, V125, P588, DOI 10.1021/ja028255v; SHAKLAI N, 1984, J BIOL CHEM, V259, P3812; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stefek M, 1996, ACTA DIABETOL, V33, P35, DOI 10.1007/BF00571938; Tu A.T., 1982, RAMAN SPECTROSCOPY B; VANHAEVERBEEK M, 1994, ACTA DIABETOL, V31, P43, DOI 10.1007/BF00580760; Wang Y, 2007, CLIN CHEM, V53, P1394, DOI 10.1373/clinchem.2006.082917; Wold S, 1983, LECT NOTES MATH; Xu YJ, 2002, CLIN CHIM ACTA, V325, P127, DOI 10.1016/S0009-8981(02)00277-2; Yoshiuchi K, 2008, ENDOCR J, V55, P503, DOI 10.1507/endocrj.K07E-089; Zhang DM, 2003, ANAL CHEM, V75, P5703, DOI 10.1021/ac0345087	81	114	121	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32406	10.1371/journal.pone.0032406	http://dx.doi.org/10.1371/journal.pone.0032406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393405	Green Published, gold, Green Submitted			2022-12-27	WOS:000303003500058
J	Dong, D; Jin, K; Wu, XL; Zhong, Y				Dong, Dong; Jin, Ke; Wu, Xiaoli; Zhong, Yang			CRDB: Database of Chemosensory Receptor Gene Families in Vertebrate	PLOS ONE			English	Article							LINEAGE-SPECIFIC EXPANSIONS; EVOLUTIONARY DYNAMICS; MAMMALIAN EVOLUTION; GIANT PANDA; REPERTOIRES; SEQUENCE; PROTEIN; MOUSE; COW; PRIMATES	Chemosensory receptors (CR) are crucial for animals to sense the environmental changes and survive on earth. The emergence of whole-genome sequences provides us an opportunity to identify the entire CR gene repertoires. To completely gain more insight into the evolution of CR genes in vertebrates, we identified the nearly all CR genes in 25 vertebrates using homology-based approaches. Among these CR gene repertoires, nearly half of them were identified for the first time in those previously uncharacterized species, such as the guinea pig, giant panda and elephant, etc. Consistent with previous findings, we found that the numbers of CR genes vary extensively among different species, suggesting an extreme form of 'birth-and-death' evolution. For the purpose of facilitating CR gene analysis, we constructed a database with the goals to provide a resource for CR genes annotation and a web tool for exploring their evolutionary patterns. Besides a search engine for the gene extraction from a specific chromosome region, an easy-to-use phylogenetic analysis tool was also provided to facilitate online phylogeny study of CR genes. Our work can provide a rigorous platform for further study on the evolution of CR genes in vertebrates.	[Dong, Dong] E China Normal Univ, iAIR, Inst Mol Ecol & Evolut, Shanghai 200062, Peoples R China; [Jin, Ke; Wu, Xiaoli; Zhong, Yang] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Jin, Ke] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Zhong, Yang] Tibet Univ, Inst Biodivers Sci & Geobiol, Lhasa, Peoples R China	East China Normal University; Fudan University; University of Toronto; Tibet University	Dong, D (corresponding author), E China Normal Univ, iAIR, Inst Mol Ecol & Evolut, Shanghai 200062, Peoples R China.	ddong.ecnu@gmail.com			East China Normal University [79633006]	East China Normal University	This work is supported by Key Construction Program of the National '985' project of East China Normal University to Dong Dong, and the funding No. is 79633006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIGNETTI E, 1985, EUR J BIOCHEM, V149, P227, DOI 10.1111/j.1432-1033.1985.tb08916.x; BLAZQUEZ NB, 1988, VET REC, V123, P49, DOI 10.1136/vr.123.2.49; Dong D, 2009, GENOME BIOL EVOL, V1, P258, DOI 10.1093/gbe/evp026; Dong D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-12; Endo H, 2002, J VET MED SCI, V64, P1153, DOI 10.1292/jvms.64.1153; Fischer A, 2005, MOL BIOL EVOL, V22, P432, DOI 10.1093/molbev/msi027; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Gilad Y, 2003, P NATL ACAD SCI USA, V100, P3324, DOI 10.1073/pnas.0535697100; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; Glendinning JI, 1999, BEHAV NEUROSCI, V113, P840, DOI 10.1037/0735-7044.113.4.840; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Go Y, 2006, MOL BIOL EVOL, V23, P964, DOI 10.1093/molbev/msj106; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hashiguchi Y, 2007, MOL BIOL EVOL, V24, P2099, DOI 10.1093/molbev/msm140; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KRATZING JE, 1975, CELL TISSUE RES, V156, P239; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Niimura Y, 2005, P NATL ACAD SCI USA, V102, P6039, DOI 10.1073/pnas.0501922102; Niimura Y, 2005, GENE, V346, P13, DOI 10.1016/j.gene.2004.09.025; Niimura Y, 2003, P NATL ACAD SCI USA, V100, P12235, DOI 10.1073/pnas.1635157100; Niimura Y, 2006, J HUM GENET, V51, P505, DOI 10.1007/s10038-006-0391-8; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Niimura Y, 2009, GENOME BIOL EVOL, V1, P34, DOI 10.1093/gbe/evp003; Rouquier S, 1999, MAMM GENOME, V10, P1172, DOI 10.1007/s003359901185; Rouquier S, 1998, HUM MOL GENET, V7, P1337, DOI 10.1093/hmg/7.9.1337; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; Rouquier S, 2007, MUTAT RES-FUND MOL M, V616, P95, DOI 10.1016/j.mrfmmm.2006.11.012; Shi P, 2006, MOL BIOL EVOL, V23, P292, DOI 10.1093/molbev/msj028; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Shi P, 2007, GENOME RES, V17, P166, DOI 10.1101/gr.6040007; Steiger SS, 2008, P ROY SOC B-BIOL SCI, V275, P2309, DOI 10.1098/rspb.2008.0607; Steiger SS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-446; Yamate J, 2006, J VET MED SCI, V68, P495, DOI 10.1292/jvms.68.495; Yang H, 2005, GENOMICS, V86, P306, DOI 10.1016/j.ygeno.2005.05.012; Young JM, 2007, TRENDS GENET, V23, P212, DOI 10.1016/j.tig.2007.03.004; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zozulya S, 2001, GENOME BIOL, V2	40	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31540	10.1371/journal.pone.0031540	http://dx.doi.org/10.1371/journal.pone.0031540			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393364	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500017
J	Hsu, KC; Cheng, WC; Chen, YF; Wang, HJ; Li, LT; Wang, WC; Yang, JM				Hsu, Kai-Cheng; Cheng, Wen-Chi; Chen, Yen-Fu; Wang, Hung-Jung; Li, Ling-Ting; Wang, Wen-Ching; Yang, Jinn-Moon			Core Site-Moiety Maps Reveal Inhibitors and Binding Mechanisms of Orthologous Proteins by Screening Compound Libraries	PLOS ONE			English	Article							FACTOR-I RECEPTOR; SHIKIMATE KINASE; CRYSTAL-STRUCTURE; ACID; DISCOVERY; RESIDUES; RESOURCE; SEQUENCE; COMPLEX; GENE	Members of protein families often share conserved structural subsites for interaction with chemically similar moieties despite low sequence identity. We propose a core site-moiety map of multiple proteins (called CoreSiMMap) to discover inhibitors and mechanisms by profiling subsite-moiety interactions of immense screening compounds. The consensus anchor, the subsite-moiety interactions with statistical significance, of a CoreSiMMap can be regarded as a "hot spot" that represents the conserved binding environments involved in biological functions. Here, we derive the CoreSiMMap with six consensus anchors and identify six inhibitors (IC50 < 8.0 mu M) of shikimate kinases (SKs) of Mycobacterium tuberculosis and Helicobacter pylori from the NCI database (236,962 compounds). Studies of site-directed mutagenesis and analogues reveal that these conserved interacting residues and moieties contribute to pocket-moiety interaction spots and biological functions. These results reveal that our multi-target screening strategy and the CoreSiMMap can increase the accuracy of screening in the identification of novel inhibitors and subsite-moiety environments for elucidating the binding mechanisms of targets.	[Hsu, Kai-Cheng; Chen, Yen-Fu; Li, Ling-Ting; Yang, Jinn-Moon] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Cheng, Wen-Chi; Wang, Hung-Jung; Wang, Wen-Ching] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Dept Life Sci, Hsinchu, Taiwan; [Yang, Jinn-Moon] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Tsing Hua University; National Yang Ming Chiao Tung University	Hsu, KC (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.	wcwang@mx.nthu.edu.tw; moon@faculty.nctu.edu.tw	Wang, Wen-Ching/ABI-2253-2020; Yang, Jinn-Moon/AAU-4400-2021	Yang, Jinn-Moon/0000-0002-3205-4391; Wang, Wen-Ching/0000-0002-7422-3667	National Core Facility Program for Biotechnology; National Science Council [NSC98-2313-B-007-005-MY3, NSC98-3112-B-007-004]; National Science Council; Ministry of Education and National Health Research Institutes [NHRI-EX100-10009PI]	National Core Facility Program for Biotechnology; National Science Council(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education and National Health Research Institutes	The authors are grateful to Core Facility for Protein Structural Analysis supported by National Core Facility Program for Biotechnology. Dr. Wen-Ching Wang was supported by a grant from National Science Council (NSC98-2313-B-007-005-MY3, NSC98-3112-B-007-004). Dr. Yang was supported by National Science Council, partial supports of Ministry of Education and National Health Research Institutes (NHRI-EX100-10009PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Bajorath F, 2002, NAT REV DRUG DISCOV, V1, P882, DOI 10.1038/nrd941; Bisson WH, 2007, P NATL ACAD SCI USA, V104, P11927, DOI 10.1073/pnas.0609752104; Blum G, 2003, J BIOL CHEM, V278, P40442, DOI 10.1074/jbc.M305490200; CARHART RE, 1985, J CHEM INF COMP SCI, V25, P64, DOI 10.1021/ci00046a002; Chen YF, 2010, NUCLEIC ACIDS RES, V38, pW424, DOI 10.1093/nar/gkq480; Cheng WC, 2005, J BACTERIOL, V187, P8156, DOI 10.1128/JB.187.23.8156-8163.2005; Chin KH, 2010, J MOL BIOL, V396, P646, DOI 10.1016/j.jmb.2009.11.076; Chiu WC, 2006, J MOL BIOL, V359, P741, DOI 10.1016/j.jmb.2006.03.063; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Freire E, 2002, NAT BIOTECHNOL, V20, P15, DOI 10.1038/nbt0102-15; Gan JH, 2006, BIOCHEMISTRY-US, V45, P8539, DOI 10.1021/bi0606290; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; Gu YJ, 2002, J MOL BIOL, V319, P779, DOI 10.1016/S0022-2836(02)00339-X; Hallak H, 2002, HEPATOLOGY, V36, P1509, DOI 10.1053/jhep.2002.37138; Hartmann MD, 2006, J MOL BIOL, V364, P411, DOI 10.1016/j.jmb.2006.09.001; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hung HC, 2009, ANTIVIR RES, V81, P123, DOI 10.1016/j.antiviral.2008.10.006; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Johnson KA, 2001, BIOCHEMISTRY-US, V40, P618, DOI 10.1021/bi0016422; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lock RL, 2008, NAT REV DRUG DISCOV, V7, P324, DOI 10.1038/nrd2510; Lyne PD, 2002, DRUG DISCOV TODAY, V7, P1047, DOI 10.1016/S1359-6446(02)02483-2; MILLAR G, 1986, BIOCHEM J, V237, P427, DOI 10.1042/bj2370427; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Shoichet BK, 2002, CURR OPIN CHEM BIOL, V6, P439, DOI 10.1016/S1367-5931(02)00339-3; Wei DG, 2008, J MED CHEM, V51, P7882, DOI 10.1021/jm8010096; WHO, 2008, GLOBAL TUBERCULOSIS; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Wolber G, 2008, DRUG DISCOV TODAY, V13, P23, DOI 10.1016/j.drudis.2007.09.007; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Yang JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000428; Yang JM, 2005, J CHEM INF MODEL, V45, P1134, DOI 10.1021/ci050034w; Yang JM, 2005, PROTEINS, V59, P205, DOI 10.1002/prot.20387; Yang JM, 2004, PROTEINS, V55, P288, DOI 10.1002/prot.20035; Yang MC, 2008, CRYST GROWTH DES, V8, P4268, DOI 10.1021/cg800697s; Zahradka P, 2004, ENDOCRINOLOGY, V145, P2978, DOI 10.1210/en.2004-0029; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	43	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32142	10.1371/journal.pone.0032142	http://dx.doi.org/10.1371/journal.pone.0032142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393385	gold, Green Published, Green Submitted			2022-12-27	WOS:000303003500038
J	Sueur, C; Deneubourg, JL; Petit, O				Sueur, Cedric; Deneubourg, Jean-Louis; Petit, Odile			From Social Network (Centralized vs. Decentralized) to Collective Decision-Making (Unshared vs. Shared Consensus)	PLOS ONE			English	Article							GROUP-SIZE; REPRODUCTIVE STATUS; ANIMAL GROUPS; LEADERSHIP; EVOLUTION; FISSION; ORGANIZATION; EGALITARIAN; DOMINANCE; BEHAVIOR	Relationships we have with our friends, family, or colleagues influence our personal decisions, as well as decisions we make together with others. As in human beings, despotism and egalitarian societies seem to also exist in animals. While studies have shown that social networks constrain many phenomena from amoebae to primates, we still do not know how consensus emerges from the properties of social networks in many biological systems. We created artificial social networks that represent the continuum from centralized to decentralized organization and used an agent-based model to make predictions about the patterns of consensus and collective movements we observed according to the social network. These theoretical results showed that different social networks and especially contrasted ones - star network vs. equal network led to totally different patterns. Our model showed that, by moving from a centralized network to a decentralized one, the central individual seemed to lose its leadership in the collective movement's decisions. We, therefore, showed a link between the type of social network and the resulting consensus. By comparing our theoretical data with data on five groups of primates, we confirmed that this relationship between social network and consensus also appears to exist in animal societies.	[Sueur, Cedric; Deneubourg, Jean-Louis; Petit, Odile] Univ Libre Bruxelles, Unit Social Ecol, Brussels, Belgium; [Sueur, Cedric; Petit, Odile] Ctr Natl Rech Sci, Dept Ecol Physiol & Ethol, Strasbourg, France; [Sueur, Cedric; Petit, Odile] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France	Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sueur, C (corresponding author), Univ Libre Bruxelles, Unit Social Ecol, Campus Plaine,Bd Triomphe, Brussels, Belgium.	cedric.sueur@iphc.cnrs.fr	Sueur, Cédric/A-4020-2011	Sueur, Cédric/0000-0001-8206-2739	Wallonia Brussels International; Belgian National Fund for Scientific Research; Franco-American Commission; Alsace Region; Fyssen Foundation	Wallonia Brussels International; Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Franco-American Commission; Alsace Region(Region Grand-Est); Fyssen Foundation	This work was supported by Wallonia Brussels International, the Belgian National Fund for Scientific Research, the Franco-American Commission, the Alsace Region and the Fyssen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2007, RANGELAND J, V29, P65, DOI 10.1071/RJ06036; Bode NWF, 2011, ANIM BEHAV, V82, P29, DOI 10.1016/j.anbehav.2011.04.011; Bode NWF, 2011, BEHAV ECOL SOCIOBIOL, V65, P117, DOI 10.1007/s00265-010-1111-0; BOINSKI S, 1995, BEHAVIOUR, V132, P875, DOI 10.1163/156853995X00054; Boinski S., 2000, MOVE WHY ANIMALS TRA; Bonnie KE, 2006, PRIMATES, V47, P27, DOI 10.1007/s10329-005-0141-0; Borgatti S. P., 2002, UCINET 6 WINDOWS SOF; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; Butler Z, 2006, INT J ROBOT RES, V25, P485, DOI 10.1177/0278364906065375; Camazine S., 2003, SELF ORG BIOL SYSTEM; CHEPKOSADE BD, 1989, SOC NETWORKS, V11, P293, DOI 10.1016/0378-8733(89)90007-5; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Croft DP, 2005, OECOLOGIA, V143, P211, DOI 10.1007/s00442-004-1796-8; DENEUBOURG JL, 1989, ETHOL ECOL EVOL, V1, P295, DOI 10.1080/08927014.1989.9525500; DEWAAL FBM, 1989, AM J PRIMATOL, V19, P83, DOI 10.1002/ajp.1350190203; FEIST JD, 1976, Z TIERPSYCHOL, V41, P337; Fischhoff IR, 2009, BEHAV ECOL SOCIOBIOL, V63, P1035, DOI 10.1007/s00265-009-0723-8; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Franks NR, 2003, P ROY SOC B-BIOL SCI, V270, P2457, DOI 10.1098/rspb.2003.2527; Gautrais J, 2007, ANIM BEHAV, V74, P1443, DOI 10.1016/j.anbehav.2007.02.020; Hemelrijk CK, 1999, P ROY SOC B-BIOL SCI, V266, P361, DOI 10.1098/rspb.1999.0646; Hemelrijk CK, 2005, BEHAV ECOL, V16, P178, DOI 10.1093/beheco/arh149; Hemelrijk CK, 2000, ANIM BEHAV, V59, P1035, DOI 10.1006/anbe.2000.1400; Hockings KJ, 2006, CURR BIOL, V16, pR668, DOI 10.1016/j.cub.2006.08.019; Jackson MO, 2005, GROUP FORMATION IN ECONOMICS: NETWORKS, CLUBS, AND COALITIONS, P11, DOI 10.1017/CBO9780511614385.002; Jacobs A, 2008, BEHAV PROCESS, V79, P111, DOI 10.1016/j.beproc.2008.05.004; Jacobs A, 2011, INT J PRIMATOL, V32, P721, DOI 10.1007/s10764-011-9497-8; Kanngiesser P, 2011, AM J PRIMATOL, V73, P758, DOI 10.1002/ajp.20914; Kasper C, 2009, PRIMATES, V50, P343, DOI 10.1007/s10329-009-0153-2; King AJ, 2011, INT J PRIMATOL, V32, P1245, DOI 10.1007/s10764-011-9526-7; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; King AJ, 2008, CURR BIOL, V18, P1833, DOI 10.1016/j.cub.2008.10.048; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Krause J, 2002, LIVING GROUPS; Leca JB, 2003, ANIM BEHAV, V66, P1045, DOI 10.1006/anbe.2003.2276; Leca JB, 2002, INT J PRIMATOL, V23, P979, DOI 10.1023/A:1019641830918; Lehmann J, 2007, ANIM BEHAV, V74, P1617, DOI 10.1016/j.anbehav.2006.10.025; List C, 2004, TRENDS ECOL EVOL, V19, P168, DOI 10.1016/j.tree.2004.02.004; Lockwood M, 1999, NATURE, V399, P437, DOI 10.1038/20867; Lusseau D, 2009, BEHAV ECOL SOCIOBIOL, V63, P1067, DOI 10.1007/s00265-009-0740-7; Matsumura S, 1999, PRIMATES, V40, P23, DOI 10.1007/BF02557699; McCowan B, 2008, APPL ANIM BEHAV SCI, V109, P396, DOI 10.1016/j.applanim.2007.02.009; Mech D., 2003, WOLVES BEHAV ECOLOGY; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Nunn CL, 2006, INFECT DIS PRIMATES; Peterson RO, 2002, CAN J ZOOL, V80, P1405, DOI 10.1139/Z02-124; Petit O, 2009, P ROY SOC B-BIOL SCI, V276, P3495, DOI 10.1098/rspb.2009.0983; Qiu FS, 2010, SIMUL MODEL PRACT TH, V18, P190, DOI 10.1016/j.simpat.2009.10.005; Ramos-Fernandez G, 2009, BEHAV ECOL SOCIOBIOL, V63, P999, DOI 10.1007/s00265-009-0719-4; RASA OAE, 1983, BEHAV ECOL SOCIOBIOL, V12, P181; RHINE RJ, 1987, AM J PRIMATOL, V13, P119, DOI 10.1002/ajp.1350130203; RHINE RJ, 1981, FOLIA PRIMATOL, V35, P77, DOI 10.1159/000155968; Seppa P, 2008, BEHAV ECOL SOCIOBIOL, V62, P589, DOI 10.1007/s00265-007-0483-2; Stueckle S, 2008, ANIM BEHAV, V75, P1995, DOI 10.1016/j.anbehav.2007.12.012; Sueur C, 2008, BEHAV PROCESS, V78, P84, DOI 10.1016/j.beproc.2008.01.004; Sueur C, 2011, ANIM BEHAV, V82, P845, DOI 10.1016/j.anbehav.2011.07.020; Sueur C, 2011, P ROY SOC B-BIOL SCI, V278, P1697, DOI 10.1098/rspb.2010.2084; Sueur C, 2010, J EXP BIOL, V213, P1338, DOI 10.1242/jeb.039016; Sueur C, 2009, ANIM BEHAV, V78, P1087, DOI 10.1016/j.anbehav.2009.07.029; Sueur C, 2010, INFLUENCE RELATIONS; Sueur C, 2008, INT J PRIMATOL, V29, P1085, DOI 10.1007/s10764-008-9262-9; Sueur C, 2011, INT J PRIMATOL, V32, P1413, DOI 10.1007/s10764-011-9520-0; Sueur C, 2011, J THEOR BIOL, V273, P156, DOI 10.1016/j.jtbi.2010.12.035; Sueur C, 2011, AM J PRIMATOL, V73, P703, DOI 10.1002/ajp.20915; Thierry B., 2004, MACAQUE SOC MODEL ST; Tisue S., 2004, NETLOGO SIMPLE ENV M; Van Horn RC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1823, DOI 10.1007/s00265-007-0415-1; Van Vugt M, 2008, AM PSYCHOL, V63, P182, DOI 10.1037/0003-066X.63.3.182; VEHRENCAMP SL, 1983, ANIM BEHAV, V31, P667, DOI 10.1016/S0003-3472(83)80222-X; Voelkl B, 2008, J THEOR BIOL, V252, P77, DOI 10.1016/j.jtbi.2008.02.002; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Watts DP, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P351; Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Wilensky U., 1999, NETLOGO	80	61	61	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32566	10.1371/journal.pone.0032566	http://dx.doi.org/10.1371/journal.pone.0032566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	928SI	22393416	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500068
J	Weiner, ZP; Boyer, AE; Gallegos-Candela, M; Cardani, AN; Barr, JR; Glomski, IJ				Weiner, Zachary P.; Boyer, Anne E.; Gallegos-Candela, Maribel; Cardani, Amber N.; Barr, John R.; Glomski, Ian J.			Debridement Increases Survival in a Mouse Model of Subcutaneous Anthrax	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; LETHAL TOXIN; EDEMA TOXIN; DENDRITIC CELLS; LYMPH-NODES; INHALATIONAL ANTHRAX; INJECTIONAL ANTHRAX; INFECTION; MACROPHAGES; MANAGEMENT	Anthrax is caused by infection with Bacillus anthracis, a spore-forming Gram-positive bacterium. A major virulence factor for B. anthracis is an immunomodulatory tripartite exotoxin that has been reported to alter immune cell chemotaxis and activation. It has been proposed that B. anthracis infections initiate through entry of spores into the regional draining lymph nodes where they germinate, grow, and disseminate systemically via the efferent lymphatics. If this model holds true, it would be predicted that surgical removal of infected tissues, debridement, would have little effect on the systemic dissemination of bacteria. This model was tested through the development of a mouse debridement model. It was found that removal of the site of subcutaneous infection in the ear increased the likelihood of survival and reduced the quantity of spores in the draining cervical lymph nodes (cLN). At the time of debridement 12 hours post-injection measurable levels of exotoxins were present in the ear, cLN, and serum, yet leukocytes within the cLN were activated; countering the concept that exotoxins inhibit the early inflammatory response to promote bacterial growth. We conclude that the initial entry of spores into the draining lymph node of cutaneous infections alone is not sufficient to cause systemic disease and that debridement should be considered as an adjunct to antibiotic therapy.	[Weiner, Zachary P.; Cardani, Amber N.; Glomski, Ian J.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Boyer, Anne E.; Gallegos-Candela, Maribel; Barr, John R.] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA	University of Virginia; Centers for Disease Control & Prevention - USA	Weiner, ZP (corresponding author), Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA.	iglomski@virginia.edu			University of Virginia School of Medicine; NIH NIAID [1R21AI082046, 5T32AI704634]; Jeffress Memorial Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082046, T32AI007046] Funding Source: NIH RePORTER	University of Virginia School of Medicine; NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Jeffress Memorial Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research described in this manuscript was funded by The University of Virginia School of Medicine Dean's allocated funds (IJG, ZPW), NIH NIAID grants 1R21AI082046 (IJG, ZPW) and 5T32AI704634 Infectious Diseases Training Program (ZPW), and The Jeffress Memorial Trust Research Award (IJG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Agrawal A, 2003, NATURE, V424, P329, DOI 10.1038/nature01794; Beaumont G, 2010, J FORENSIC LEG MED, V17, P443, DOI 10.1016/j.jflm.2010.09.008; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Boyer AE, 2007, ANAL CHEM, V79, P8463, DOI 10.1021/ac701741s; Brookmeyer R, 2002, SCIENCE, V295, P1861, DOI 10.1126/science.1068474; Chand HS, 2009, INFECT IMMUN, V77, P429, DOI 10.1128/IAI.00647-08; Chou PJ, 2008, DNA CELL BIOL, V27, P637, DOI 10.1089/dna.2008.0760; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Cote CK, 2006, INFECT IMMUN, V74, P469, DOI 10.1128/IAI.74.1.469-480.2006; Crawford MA, 2006, J IMMUNOL, V176, P7557, DOI 10.4049/jimmunol.176.12.7557; Dumetz F, 2011, AM J PATHOL, V178, P2523, DOI 10.1016/j.ajpath.2011.02.027; Fiole D, 2009, 2009 ASM BAC A UNPUB; Fontes R A Jr, 2000, J Am Acad Orthop Surg, V8, P151; Glomski IJ, 2007, PLOS PATHOG, V3, P699, DOI 10.1371/journal.ppat.0030076; Glomski IJ, 2007, INFECT IMMUN, V75, P4754, DOI 10.1128/IAI.00575-07; Glomski IJ, 2007, CELL MICROBIOL, V9, P502, DOI 10.1111/j.1462-5822.2006.00806.x; Glomski IJ, 2011, BACILLUS ANTHRACIS A, P227; Goossens PL, 2009, MOL ASPECTS MED, V30, P467, DOI 10.1016/j.mam.2009.07.005; Guidi-Rontani C, 2002, TRENDS MICROBIOL, V10, P405, DOI 10.1016/S0966-842X(02)02422-8; Hirsh MI, 2007, LAB INVEST, V87, P182, DOI 10.1038/labinvest.3700505; Hu HJ, 2007, FEMS MICROBIOL LETT, V272, P245, DOI 10.1111/j.1574-6968.2007.00766.x; Jallali N, 2011, J PLAST RECONSTR AES, V64, P276, DOI 10.1016/j.bjps.2010.06.003; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Kim C, 2008, P NATL ACAD SCI USA, V105, P6150, DOI 10.1073/pnas.0800105105; Koch R, 1876, BEITR BIOL PFLANZ, V2, P277; Loving CL, 2007, INFECT IMMUN, V75, P2689, DOI 10.1128/IAI.01875-06; Lyons CR, 2004, INFECT IMMUN, V72, P4801, DOI 10.1128/IAI.72.8.4801-4809.2004; Maldonado-Arocho FJ, 2009, INFECT IMMUN, V77, P2036, DOI 10.1128/IAI.01329-08; McGovern TW, 2002, NEW ENGL J MED, V346, P943; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Paccani SR, 2007, CELL MICROBIOL, V9, P924, DOI 10.1111/j.1462-5822.2006.00840.x; Ramsay CN, 2010, EURO SURVEILL, V15, P19465; Ribot WJ, 2006, INFECT IMMUN, V74, P5029, DOI 10.1128/IAI.00275-06; Ringertz SH, 2000, LANCET, V356, P1574, DOI 10.1016/S0140-6736(00)03133-0; Saadia R, 2000, WORLD J SURG, V24, P1146, DOI 10.1007/s002680010188; SIRARD JC, 1994, J BACTERIOL, V176, P5188, DOI 10.1128/jb.176.16.5188-5192.1994; Spencer RC, 2003, J CLIN PATHOL, V56, P182, DOI 10.1136/jcp.56.3.182; Swartz MN, 2001, NEW ENGL J MED, V345, P1621, DOI 10.1056/NEJMra012892; Tournier JN, 2007, CELL MICROBIOL, V9, P555, DOI 10.1111/j.1462-5822.2006.00866.x; Tournier JN, 2005, J IMMUNOL, V174, P4934, DOI 10.4049/jimmunol.174.8.4934; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; WELKOS SL, 1993, MICROB PATHOGENESIS, V14, P381, DOI 10.1006/mpat.1993.1037; WHO, 2008, ANTHRAX HUMANS ANIMA; Yang J, 2009, MOL IMMUNOL, V46, P3261, DOI 10.1016/j.molimm.2009.08.005	47	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e30201	10.1371/journal.pone.0030201	http://dx.doi.org/10.1371/journal.pone.0030201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393351	gold, Green Published, Green Submitted			2022-12-27	WOS:000303003500004
J	Dan, S; Chen, F; Choy, KW; Jiang, FM; Lin, JR; Xuan, ZL; Wang, W; Chen, SP; Li, XC; Jiang, H; Leung, TY; Lau, TK; Su, Y; Zhang, WY; Zhang, XQ				Dan, Shan; Chen, Fang; Choy, Kwong Wai; Jiang, Fuman; Lin, Jingrong; Xuan, Zhaoling; Wang, Wei; Chen, Shengpei; Li, Xuchao; Jiang, Hui; Leung, Tak Yeung; Lau, Tze Kin; Su, Yue; Zhang, Weiyuan; Zhang, Xiuqing			Prenatal Detection of Aneuploidy and Imbalanced Chromosomal Arrangements by Massively Parallel Sequencing	PLOS ONE			English	Article								Fetal chromosomal abnormalities are the most common reasons for invasive prenatal testing. Currently, G-band karyotyping and several molecular genetic methods have been established for diagnosis of chromosomal abnormalities. Although these testing methods are highly reliable, the major limitation remains restricted resolutions or can only achieve limited coverage on the human genome at one time. The massively parallel sequencing (MPS) technologies which can reach single base pair resolution allows detection of genome-wide intragenic deletions and duplication challenging karyotyping and microarrays as the tool for prenatal diagnosis. Here we reported a novel and robust MPS-based method to detect aneuploidy and imbalanced chromosomal arrangements in amniotic fluid (AF) samples. We sequenced 62 AF samples on Illumina GAIIx platform and with averagely 0.01 x whole genome sequencing data we detected 13 samples with numerical chromosomal abnormalities by z-test. With up to 26 whole genome sequencing data we were able to detect microdeletion/microduplication (ranged from 1.4 Mb to 37.3 Mb of 5 samples from chorionic villus sampling (CVS) using SeqSeq algorithm. Our work demonstrated MPS is a robust and accurate approach to detect aneuploidy and imbalanced chromosomal arrangements in prenatal samples.	[Dan, Shan; Su, Yue; Zhang, Weiyuan] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Perinatal Med, Beijing, Peoples R China; [Chen, Fang; Jiang, Fuman; Lin, Jingrong; Xuan, Zhaoling; Wang, Wei; Chen, Shengpei; Li, Xuchao; Jiang, Hui; Zhang, Xiuqing] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China; [Choy, Kwong Wai; Leung, Tak Yeung; Lau, Tze Kin] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynecol, Fetal Med Unit, Hong Kong, Hong Kong, Peoples R China	Capital Medical University; Beijing Genomics Institute (BGI); Chinese University of Hong Kong; Prince of Wales Hospital	Dan, S (corresponding author), Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Perinatal Med, Beijing, Peoples R China.	sd_bao@sina.com; zhangxq@genomics.org.cn	Choy, Richard/AAW-8230-2020	Choy, Richard/0000-0002-3616-6200; Lau, Tze Kin/0000-0002-0242-1410	Beijing Nova Program [2006B08]; Beijing Municipal Science and Technology Commission [Z09090300830909]; Hong Kong General Research Fund (GRF) [463710]; Chinese University [2041573]; Shenzhen City Key Laborabory [CXB200903110066A]	Beijing Nova Program(Beijing Municipal Science & Technology Commission); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Hong Kong General Research Fund (GRF); Chinese University; Shenzhen City Key Laborabory	The study was supported by Beijing Nova Program (2006B08) and Beijing Municipal Science and Technology Commission (Z09090300830909). Choy KW and Lau TK were supported by Hong Kong General Research Fund (GRF) grant project number 463710. Leung TY was supported by Chinese University Direct grant project number 2041573. The study was also supported by Shenzhen City Key Laborabory Project (CXB200903110066A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V110, P1459; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Driscoll DA, 2009, NEW ENGL J MED, V360, P2556, DOI 10.1056/NEJMcp0900134; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; HOOK EB, 1981, OBSTET GYNECOL, V58, P282; Irving C, 2011, J MATERN-FETAL NEO M, V24, P137, DOI 10.3109/14767051003758879; Korteweg FJ, 2008, OBSTET GYNECOL, V111, P865, DOI 10.1097/AOG.0b013e31816a4ee3; Leung TY, 2011, ULTRASOUND OBST GYN, V38, P314, DOI 10.1002/uog.8988; Leung TY, 2011, ULTRASOUND OBSTET GY; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Morris JK, 2003, PRENATAL DIAG, V23, P252, DOI 10.1002/pd.568; Vermeesch JR, 2007, EUR J HUM GENET, V15, P1105, DOI 10.1038/sj.ejhg.5201896; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wapner RJ, 2010, CLIN OBSTET GYNECOL, V53, P628, DOI 10.1097/GRF.0b013e3181ee2793; Williams ES, 2011, METHODS MOL BIOL, V735, P113, DOI 10.1007/978-1-61779-092-8_11	15	20	37	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e27835	10.1371/journal.pone.0027835	http://dx.doi.org/10.1371/journal.pone.0027835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389664	Green Submitted, gold, Green Published			2022-12-27	WOS:000302999600001
J	An, S; Chen, LL; Wei, JF; Yang, XN; Ma, DY; Xu, XM; Xu, XQ; He, SH; Lu, J; Laiz, R				An, Su; Chen, Lingling; Wei, Ji-Fu; Yang, Xuening; Ma, Dongying; Xu, Xuemei; Xu, Xueqing; He, Shaoheng; Lu, Jia; Laiz, Ren			Purification and Characterization of Two New Allergens from the Venom of Vespa magnifica	PLOS ONE			English	Article							ANTIGENIC CROSS-REACTIVITY; HORSEFLY SALIVARY-GLANDS; HYMENOPTERA VENOM; WASP VENOM; HONEYBEE VENOM; PROTEIN; HYALURONIDASE; ANAPHYLAXIS; DIPTERA; BIOLOGY	Due to poor diagnostic facilities and a lack of medical alertness, allergy to Vespa wasps may be underestimated. Few allergens have been identified from Vespa wasps. Possible native allergen proteins were purified from the wasp venoms (WV) (Vespa magnifica Smith) by gel filtration, ion exchange chromatography, respectively. Their sequences were determined by Edman degradation and cDNA cloning. Their allergenicities were assayed by enzyme-linked immunosorbent assay inhibition tests (ELISA-IT), immunoblots, and skin prick tests (SPTs). Their cross allergencities with Tab y 2 and Tab y 5 purified from the horsefly (Tabanus yao Macquart) were also determined. Two native allergens were identified from the WV, respectively. They are a 25-KDa antigen 5 protein (Ag5) (Vesp ma 5) and a 35-KDa hyaluronidase (Vesp ma 2). They represented major allergens in Vespa magnifica by immunoblots and SPTs. ELISA inhibition of pooled sera IgE reactivity to both the WV and the horsefly salivary gland extracts (HSGE) using four purified allergens (Vesp ma 2, Vesp ma 5 and previously purified Tab y 2 and Tab y 5) was significant. Their cross allergenicities were confirmed by ELISA-IT, immunoblots, and SPTs. They represented the cross reactive allergens from wasp and horsefly and proved the so called wasp-horsefly syndrome.	[An, Su; Yang, Xuening; Ma, Dongying; Xu, Xueqing; Lu, Jia; Laiz, Ren] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Biotoxin Units, Kunming, Yunnan, Peoples R China; [An, Su] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Wei, Ji-Fu; He, Shaoheng] Nanjing Med Univ, Affiliated Hosp 1, Clin Res Ctr, Nanjing, Jiangsu, Peoples R China; [Chen, Lingling; Xu, Xuemei] Kunming Med Coll, Affiliated Hosp 1, Clin Lab, Kunming, Yunnan, Peoples R China; [Chen, Lingling; Xu, Xuemei] Kunming Med Coll, Affiliated Hosp 1, Dept Otolaryngol, Kunming, Yunnan, Peoples R China; [An, Su; Yang, Xuening] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Nanjing Medical University; Kunming Medical University; Kunming Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	An, S (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Biotoxin Units, Kunming, Yunnan, Peoples R China.	shaohenghe@hotmail.com; lujia1979@gmail.com; rlai@mail.kiz.ac.cn	Chen, Ling-Ling/AAY-3547-2021; ma, dongying/D-8623-2012		Chinese National Natural Science Foundation [30830021, 30800185, 30972822, 31025025]; Ministry of Science and Technology [2010CB529800, 2009ZX09103-1/091]; Ministry of Agriculture	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	This work was supported by Chinese National Natural Science Foundation (30830021, 30800185, 30972822, 31025025), the Ministry of Science and Technology (2010CB529800, 2009ZX09103-1/091) and the Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An S, 2011, ALLERGY, V66, P1420, DOI 10.1111/j.1398-9995.2011.02683.x; de Graaf DC, 2009, J PROTEOMICS, V72, P145, DOI 10.1016/j.jprot.2009.01.017; Freye HB, 1996, ANN ALLERG ASTHMA IM, V76, P270, DOI 10.1016/S1081-1206(10)63440-0; Galvao CES, 2006, J ALLERGY CLIN IMMUN, V117, pS308, DOI 10.1016/j.jaci.2005.12.1216; Han JY, 2008, TOXICON, V51, P914, DOI 10.1016/j.toxicon.2008.01.002; Hemmer W, 1998, J ALLERGY CLIN IMMUN, V101, P134, DOI 10.1016/S0091-6749(98)70208-8; Hoffman DR, 2008, CURR OPIN ALLERGY CL, V8, P338, DOI 10.1097/ACI.0b013e3283036a7d; HOFFMAN DR, 1993, J ALLERGY CLIN IMMUN, V92, P707, DOI 10.1016/0091-6749(93)90014-7; Hoffman DR, 2006, CLIN REV ALLERG IMMU, V30, P109, DOI 10.1385/CRIAI:30:2:109; HOFFMAN DR, 1987, INT ARCH ALLER A IMM, V84, P25, DOI 10.1159/000234394; Jin C, 2010, J ALLERGY CLIN IMMUN, V125, P184, DOI 10.1016/j.jaci.2009.08.037; Kemparaju K, 2006, CELL BIOCHEM FUNCT, V24, P7, DOI 10.1002/cbf.1261; King TP, 1997, J ALLERGY CLIN IMMUN, V99, P630, DOI 10.1016/S0091-6749(97)70025-3; King TP, 2000, INT ARCH ALLERGY IMM, V123, P99, DOI 10.1159/000024440; LU G, 1993, J IMMUNOL, V150, P2823; Ma D, 2011, ALLERGY, V66, P101, DOI 10.1111/j.1398-9995.2010.02435.x; Ma DY, 2009, MOL CELL PROTEOMICS, V8, P2071, DOI 10.1074/mcp.M900186-MCP200; Monsalve RI, 1999, PROTEIN EXPRES PURIF, V16, P410, DOI 10.1006/prep.1999.1082; Pantera B, 2003, BBA-GEN SUBJECTS, V1623, P72, DOI 10.1016/j.bbagen.2003.07.001; Peiren N, 2005, BBA-PROTEINS PROTEOM, V1752, P1, DOI 10.1016/j.bbapap.2005.07.017; Peng Z, 2006, ALLERGY, V61, P485, DOI 10.1111/j.1398-9995.2006.00985.x; Peng ZK, 2007, CURR OPIN ALLERGY CL, V7, P350, DOI 10.1097/ACI.0b013e328259c313; Peng ZK, 1998, J ALLERGY CLIN IMMUN, V101, P498, DOI 10.1016/S0091-6749(98)70357-4; Quercia O, 2008, EUR ANN ALLERGY CLIN, V40, P61; Seppala U, 2009, MOL IMMUNOL, V46, P2014, DOI 10.1016/j.molimm.2009.03.005; Skov LK, 2006, ACTA CRYSTALLOGR D, V62, P595, DOI 10.1107/S0907444906010687; SOBOTKA AK, 1976, J ALLERGY CLIN IMMUN, V57, P29, DOI 10.1016/0091-6749(76)90076-2; Suck R, 2000, INT ARCH ALLERGY IMM, V121, P284, DOI 10.1159/000024341; WILBUR RD, 1975, J ALLERGY CLIN IMMUN, V55, P72; Xu XQ, 2006, TOXICON, V47, P249, DOI 10.1016/j.toxicon.2005.10.015; Xu XQ, 2008, MOL CELL PROTEOMICS, V7, P582, DOI 10.1074/mcp.M700497-MCP200; Xu XQ, 2006, PEPTIDES, V27, P3053, DOI 10.1016/j.peptides.2006.09.003; Yang H, 2008, TOXICON, V51, P289, DOI 10.1016/j.toxicon.2007.10.003; Yu HN, 2007, TOXICON, V50, P377, DOI 10.1016/j.toxicon.2007.04.023; Zhou ZH, 2006, BIOCHEM BIOPH RES CO, V347, P1099, DOI 10.1016/j.bbrc.2006.07.024	35	73	81	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31920	10.1371/journal.pone.0031920	http://dx.doi.org/10.1371/journal.pone.0031920			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384100	Green Submitted, Green Published, gold			2022-12-27	WOS:000302918500046
J	Parma, V; Tirindelli, R; Bisazza, A; Massaccesi, S; Castiello, U				Parma, Valentina; Tirindelli, Roberto; Bisazza, Angelo; Massaccesi, Stefano; Castiello, Umberto			Subliminally Perceived Odours Modulate Female Intrasexual Competition: An Eye Movement Study	PLOS ONE			English	Article							FACIAL ATTRACTIVENESS; HUMAN PHEROMONES; MENSTRUAL-CYCLE; EVOLUTIONARY PSYCHOLOGY; STEROID ANDROSTADIENONE; PUTATIVE PHEROMONES; HUMAN CHEMOSIGNAL; SEX-DIFFERENCES; BRAIN RESPONSE; MALE FACES	Background: Evidence suggests that subliminal odorants influence human perception and behavior. It has been hypothesized that the human sex-steroid derived compound 4,16-androstadien-3-one (androstadienone) functions as a human chemosignal. The most intensively studied steroid compound, androstadienone is known to be biologically relevant since it seems to convey information about male mate quality to women. It is unclear if the effects of androstadienone are menstrual cycle related. Methodology/Principal Findings: In the first experiment, heterosexual women were exposed to androstadienone or a control compound and asked to view stimuli such as female faces, male faces and familiar objects while their eye movements were recorded. In the second experiment the same women were asked to rate the level of stimuli attractiveness following exposure to the study or control compound. The results indicated that women at high conception risk spent more time viewing the female than the male faces regardless of the compound administered. Women at a low conception risk exhibited a preference for female faces only following exposure to androstadienone. Conclusions/Significance: We contend that a woman's level of fertility influences her evaluation of potential competitors (e.g., faces of other women) during times critical for reproduction. Subliminally perceived odorants, such as androstadienone, might similarly enhance intrasexual competition strategies in women during fertility phases not critical for conception. These findings offer a substantial contribution to the current debate about the effects that subliminally perceived body odors might have on behavior.	[Parma, Valentina; Bisazza, Angelo; Massaccesi, Stefano; Castiello, Umberto] Univ Padua, Dept Gen Psychol, Padua, Italy; [Tirindelli, Roberto] Univ Parma, Dept Neurosci, I-43100 Parma, Italy	University of Padua; University of Parma	Parma, V (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	umberto.castiello@unipd.it	Parma, Valentina/AAR-7176-2020; Parma, Valentina/K-3268-2016	Castiello, Umberto/0000-0003-0629-1286; Bisazza, Angelo/0000-0003-0209-7638; Parma, Valentina/0000-0003-0276-7072				Barber N, 1995, ETHOL SOCIOBIOL, V16, P395, DOI 10.1016/0162-3095(95)00068-2; Bensafi M, 2004, PSYCHONEUROENDOCRINO, V29, P1290, DOI 10.1016/j.psyneuen.2004.03.007; Bensafi M, 2003, BEHAV NEUROSCI, V117, P1125, DOI 10.1037/0735-7044.117.6.1125; Berglund H, 2008, CEREB CORTEX, V18, P1900, DOI 10.1093/cercor/bhm216; Berglund H, 2006, P NATL ACAD SCI USA, V103, P8269, DOI 10.1073/pnas.0600331103; BERNSTEIN IH, 1982, PERCEPT PSYCHOPHYS, V32, P495, DOI 10.3758/BF03204202; BIRD S, 1983, EXPERIENTIA, V39, P790, DOI 10.1007/BF01990330; Boulkroune N, 2007, NEUROPSYCHOPHARMACOL, V32, P1822, DOI 10.1038/sj.npp.1301303; BROOKSBANK BW, 1972, J ENDOCRINOL, V52, P239, DOI 10.1677/joe.0.0520239; Buss DM, 1997, CLIN PSYCHOL REV, V17, P605, DOI 10.1016/S0272-7358(97)00037-8; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; BUSS DM, 1990, J SOC PERS RELAT, V7, P395, DOI 10.1177/0265407590073006; Chopra A, 2008, NEUROIMAGE, V40, P1257, DOI 10.1016/j.neuroimage.2008.01.015; Cornwell RE, 2004, P ROY SOC B-BIOL SCI, V271, P635, DOI 10.1098/rspb.2003.2649; Dematte ML, 2007, CHEM SENSES, V32, P603, DOI 10.1093/chemse/bjm030; Doty R., 2010, GREAT PHEROMONE MYTH; DOTY RL, 1985, NEUROPSYCHOLOGIA, V23, P667, DOI 10.1016/0028-3932(85)90067-3; Farroni T, 2007, COGNITION, V102, P396, DOI 10.1016/j.cognition.2006.01.007; Fehring RJ, 2006, JOGNN-J OBST GYN NEO, V35, P376, DOI 10.1111/j.1552-6909.2006.00051.x; Feinberg DR, 2006, HORM BEHAV, V49, P215, DOI 10.1016/j.yhbeh.2005.07.004; Fisher ML, 2004, P ROY SOC B-BIOL SCI, V271, pS283, DOI 10.1098/rsbl.2004.0160; Garver-Apgar CE, 2008, EVOL HUM BEHAV, V29, P223, DOI 10.1016/j.evolhumbehav.2007.12.007; GOWER DB, 1994, J STEROID BIOCHEM, V48, P409, DOI 10.1016/0960-0760(94)90082-5; Grammer K, 2005, EUR J OBSTET GYN R B, V118, P135, DOI 10.1016/j.ejogrb.2004.08.010; Grosser BI, 2000, PSYCHONEUROENDOCRINO, V25, P289, DOI 10.1016/S0306-4530(99)00056-6; Gulyas B, 2004, NEUROCHEM INT, V44, P595, DOI 10.1016/j.neuint.2003.10.003; Havlicek J, 2010, VITAM HORM, V83, P47, DOI 10.1016/S0083-6729(10)83003-1; Hays WST, 2003, BEHAV ECOL SOCIOBIOL, V54, P89, DOI 10.1007/s00265-003-0613-4; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummer TA, 2009, HORM BEHAV, V55, P548, DOI 10.1016/j.yhbeh.2009.01.002; Jacob S, 2002, HORM BEHAV, V42, P274, DOI 10.1006/hbeh.2002.1826; Jacob S, 2001, PHYSIOL BEHAV, V74, P15, DOI 10.1016/S0031-9384(01)00537-6; Jacob S, 2000, HORM BEHAV, V37, P57, DOI 10.1006/hbeh.1999.1559; Jacob S, 2001, NEUROREPORT, V12, P2391, DOI 10.1097/00001756-200108080-00021; Johnston VS, 2001, EVOL HUM BEHAV, V22, P251, DOI 10.1016/S1090-5138(01)00066-6; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; KWAN TK, 1992, J STEROID BIOCHEM, V43, P549, DOI 10.1016/0960-0760(92)90243-C; Lundstrom JN, 2006, NEUROIMAGE, V30, P1340, DOI 10.1016/j.neuroimage.2005.10.040; Lundstrom JN, 2005, BIOL PSYCHOL, V70, P197, DOI 10.1016/j.biopsycho.2005.01.008; Lundstrom JN, 2003, CHEM SENSES, V28, P643, DOI 10.1093/chemse/bjg057; Lundstrom JN, 2003, HORM BEHAV, V44, P395, DOI 10.1016/j.yhbeh.2003.06.004; Mazzatenta A, 2010, THERMAL SIGNATURES H; NIXON A, 1988, J STEROID BIOCHEM, V29, P505, DOI 10.1016/0022-4731(88)90185-9; Pause BM, 2004, PHYSIOL BEHAV, V83, P21, DOI 10.1016/j.physbeh.2004.07.019; Pawlowski B, 2008, COLLEGIUM ANTROPOL, V32, P457; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; Penton-Voak IS, 2000, EVOL HUM BEHAV, V21, P39, DOI 10.1016/S1090-5138(99)00033-1; Peters M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004138; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2005, EVOL HUM BEHAV, V26, P186, DOI 10.1016/j.evolhumbehav.2004.08.014; Richardson DC, 2000, COGNITION, V76, P269, DOI 10.1016/S0010-0277(00)00084-6; Savic I, 2005, P NATL ACAD SCI USA, V102, P7356, DOI 10.1073/pnas.0407998102; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Saxton TK, 2008, HORM BEHAV, V54, P597, DOI 10.1016/j.yhbeh.2008.06.001; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Schmitt DP, 1996, J PERS SOC PSYCHOL, V70, P1185, DOI 10.1037/0022-3514.70.6.1185; Stanley D, 2008, CURR DIR PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-8721.2008.00568.x; Stowers L, 2005, NEURON, V46, P699, DOI 10.1016/j.neuron.2005.04.032; Tirindelli R, 2009, PHYSIOL REV, V89, P921, DOI 10.1152/physrev.00037.2008; VANTOLLER C, 1983, BIOL PSYCHOL, V16, P85, DOI 10.1016/0301-0511(83)90056-X; Villemure C, 2007, EUR J PAIN, V11, P181, DOI 10.1016/j.ejpain.2006.02.005; World Medical Association Declaration of Helsinki, ETH PRIC MED RES INV; Wyart C, 2007, J NEUROSCI, V27, P1261, DOI 10.1523/JNEUROSCI.4430-06.2007; Wyatt TD, 2009, NATURE, V457, P262, DOI 10.1038/457262a; Wysocki CJ, 2004, ANAT REC PART A, V281A, P1201, DOI 10.1002/ar.a.20125; ZAJONC RB, 1984, AM PSYCHOL, V39, P117, DOI 10.1037/0003-066X.39.2.117; [No title captured]	67	42	44	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e30645	10.1371/journal.pone.0030645	http://dx.doi.org/10.1371/journal.pone.0030645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383968	gold, Green Published			2022-12-27	WOS:000302918500012
J	Roberts, SB; Hauser, L; Seeb, LW; Seeb, JE				Roberts, Steven B.; Hauser, Lorenz; Seeb, Lisa W.; Seeb, James E.			Development of Genomic Resources for Pacific Herring through Targeted Transcriptome Pyrosequencing	PLOS ONE			English	Article							PRINCE-WILLIAM-SOUND; HEMORRHAGIC SEPTICEMIA VIRUS; RESOLUTION MELTING ANALYSIS; VALDEZ OIL-SPILL; CLUPEA-PALLASI; POPULATION-GENETICS; SNP DISCOVERY; ALASKA; DISEASE; MODELS	Pacific herring (Clupea pallasii) support commercially and culturally important fisheries but have experienced significant additional pressure from a variety of anthropogenic and environmental sources. In order to provide genomic resources to facilitate organismal and population level research, high-throughput pyrosequencing (Roche 454) was carried out on transcriptome libraries from liver and testes samples taken in Prince William Sound, the Bering Sea, and the Gulf of Alaska. Over 40,000 contigs were identified with an average length of 728 bp. We describe an annotated transcriptome as well as a workflow for single nucleotide polymorphism (SNP) discovery and validation. A subset of 96 candidate SNPs chosen from 10,933 potential SNPs, were tested using a combination of Sanger sequencing and high-resolution melt-curve analysis. Five SNPs supported between-ocean-basin differentiation, while one SNP associated with immune function provided high differentiation between Prince William Sound and Kodiak Island within the Gulf of Alaska. These genomic resources provide a basis for environmental physiology studies and opportunities for marker development and subsequent population structure analysis.	[Roberts, Steven B.; Hauser, Lorenz; Seeb, Lisa W.; Seeb, James E.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Roberts, SB (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	sr320@uw.edu	Seeb, Lisa W/GSN-3076-2022; Hauser, Lorenz/E-4365-2010	Roberts, Steven/0000-0001-8302-1138	Exxon Valdez Oil Spill Trustee Council [10100165-A]	Exxon Valdez Oil Spill Trustee Council(Exxon Mobil Corporation)	The research described in this paper was supported by the Exxon Valdez Oil Spill Trustee Council project 10100165-A (http://www.evostc.state.ak.us/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Boshra H, 2006, FISH SHELLFISH IMMUN, V20, P239, DOI 10.1016/j.fsi.2005.04.004; Carls MG, 2002, CAN J FISH AQUAT SCI, V59, P153, DOI 10.1139/F01-200; Deriso RB, 2008, ECOL APPL, V18, P1270, DOI 10.1890/07-0708.1; Elston RA, 2009, DIS AQUAT ORGAN, V83, P223, DOI 10.3354/dao02005; Everett MV, 2011, MOL ECOL RESOUR, V11, P93, DOI 10.1111/j.1755-0998.2010.02969.x; EVOSTC, 2008, PRINC WILL SOUND INT; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Goetz F, 2010, MOL ECOL, V19, P176, DOI 10.1111/j.1365-294X.2009.04481.x; GRANT WS, 1984, CAN J FISH AQUAT SCI, V41, P856, DOI 10.1139/f84-102; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Hulson PJF, 2008, ICES J MAR SCI, V65, P25, DOI 10.1093/icesjms/fsm162; Marty GD, 2010, DIS AQUAT ORGAN, V90, P1, DOI 10.3354/dao02210; Marty GD, 2003, CAN J FISH AQUAT SCI, V60, P1258, DOI [10.1139/f03-109, 10.1139/F03-109]; Marty GD, 1998, DIS AQUAT ORGAN, V32, P15, DOI 10.3354/dao032015; McGlauflin MT, 2010, T AM FISH SOC, V139, P676, DOI 10.1577/T09-103.1; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; O'Connell M, 1998, J FISH BIOL, V53, P150; Roberts SB, 2012, HERRING HEPATIC TRAN; Roberts SB, 2012, HERRING TESTICULAR T; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Seeb JE, 2011, MOL ECOL RESOUR, V11, P335, DOI 10.1111/j.1755-0998.2010.02936.x; Seeb JE, 1999, GENETIC DISCRIMINATI; Stegeman JJ, 1993, AQUATIC TOXICOLOGY M, P87; Thorne RE, 2008, ICES J MAR SCI, V65, P44, DOI 10.1093/icesjms/fsm176; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; WHITEHEAD AS, 1985, IMMUNOL REV, V87, P185, DOI 10.1111/j.1600-065X.1985.tb01150.x; Wu SB, 2008, THEOR APPL GENET, V118, P1, DOI 10.1007/s00122-008-0870-8	33	17	17	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e30908	10.1371/journal.pone.0030908	http://dx.doi.org/10.1371/journal.pone.0030908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383979	gold, Green Published, Green Submitted			2022-12-27	WOS:000302918500016
J	Rong, J; Zhang, W; Wang, XH; Fan, HJ; Lu, CP; Yao, HC				Rong, Jie; Zhang, Wei; Wang, Xiaohui; Fan, Hongjie; Lu, Chengping; Yao, Huochun			Identification of Candidate Susceptibility and Resistance Genes of Mice Infected with Streptococcus suis Type 2	PLOS ONE			English	Article							LONG PENTRAXIN PTX3; MATRIX METALLOPROTEINASES; UP-REGULATION; PROSTAGLANDIN E-2; INNATE IMMUNITY; ACTIVATION; MENINGITIS; PROTEINS; STRAINS; INFLAMMATION	Streptococcus suis type 2 (SS2) is an important swine pathogen and zoonosis agent. A/J mice are significantly more susceptible than C57BL/6 (B6) mice to SS2 infection, but the genetic basis is largely unknown. Here, alterations in gene expression in SS2 (strain HA9801)-infected mice were identified using Illumina mouse BeadChips. Microarray analysis revealed 3,692 genes differentially expressed in peritoneal macrophages between A/J and B6 mice due to SS2 infection. Between SS2-infected A/J and control A/J mice, 2646 genes were differentially expressed (1469 upregulated; 1177 downregulated). Between SS2-infected B6 and control B6 mice, 1449 genes were differentially expressed (778 upregulated; 671 downregulated). These genes were analyzed for significant Gene Ontology (GO) categories and signaling pathways using the Kyoto Encylopedia of Genes and Genomes (KEGG) database to generate a signaling network. Upregulated genes in A/J and B6 mice were related to response to bacteria, immune response, positive regulation of B cell receptor signaling pathway, type I interferon biosynthesis, defense and inflammatory responses. Additionally, upregulated genes in SS2-infected B6 mice were involved in antigen processing and presentation of exogenous peptides, peptide antigen stabilization, lymphocyte differentiation regulation, positive regulation of monocyte differentiation, antigen receptor-mediated signaling pathway and positive regulation of phagocytosis. Downregulated genes in SS2-infected B6 mice played roles in glycolysis, carbohydrate metabolic process, amino acid metabolism, behavior and muscle regulation. Microarray results were verified by quantitative real-time PCR (qRT-PCR) of 14 representative deregulated genes. Four genes differentially expressed between SS2-infected A/J and B6 mice, toll-like receptor 2 (Tlr2), tumor necrosis factor (Tnf), matrix metalloproteinase 9 (Mmp9) and pentraxin 3 (Ptx3), were previously implicated in the response to S. suis infection. This study identified candidate genes that may influence susceptibility or resistance to SS2 infection in A/J and B6 mice, providing further validation of these models and contributing to understanding of S. suis pathogenic mechanisms.	[Rong, Jie; Zhang, Wei; Wang, Xiaohui; Fan, Hongjie; Lu, Chengping; Yao, Huochun] Nanjing Agr Univ, Minist Agr, Key Lab Anim Bacteriol, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Rong, J (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Anim Bacteriol, Nanjing, Jiangsu, Peoples R China.	yaohch@njau.edu.cn			Cloning and Identification of the Resistance Genes of Swine Against Major Pathogenic Picroorganism [2009ZX08009-1546]; Foundation of National Natural Science Foundation of China [30671558]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Cloning and Identification of the Resistance Genes of Swine Against Major Pathogenic Picroorganism; Foundation of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by Cloning and Identification of the Resistance Genes of Swine Against Major Pathogenic Picroorganism (2009ZX08009-1546), The Foundation of National Natural Science Foundation of China (No. 30671558), and The Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Numani D, 2003, CLIN EXP IMMUNOL, V133, P67, DOI 10.1046/j.1365-2249.2003.02189.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BEAUDOIN M, 1992, FEMS MICROBIOL LETT, V99, P111, DOI 10.1111/j.1574-6968.1992.tb05552.x; Chabot-Roy G, 2006, MICROB PATHOGENESIS, V41, P21, DOI 10.1016/j.micpath.2006.04.001; Chemnitz JM, 2006, CANCER RES, V66, P1114, DOI 10.1158/0008-5472.CAN-05-3252; Cotena A, 2007, J IMMUNOL, V179, P6311, DOI 10.4049/jimmunol.179.9.6311; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Deban L, 2008, J IMMUNOL, V181, P8433, DOI 10.4049/jimmunol.181.12.8433; Dias AAM, 2001, J LEUKOCYTE BIOL, V69, P928; Diniz SN, 2004, J LEUKOCYTE BIOL, V75, P649, DOI 10.1189/jlb.0803371; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Dominguez-Punaro MD, 2008, INFECT IMMUN, V76, P3901, DOI 10.1128/IAI.00350-08; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Fittipaldi N, 2007, APPL ENVIRON MICROB, V73, P4359, DOI 10.1128/AEM.00258-07; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Graveline R, 2007, INT IMMUNOL, V19, P375, DOI 10.1093/intimm/dxm003; Hill JE, 2005, VET MICROBIOL, V107, P63, DOI 10.1016/j.vetmic.2005.01.003; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Jobin MC, 2006, MICROB PATHOGENESIS, V40, P29, DOI 10.1016/j.micpath.2005.10.003; KATAOKA Y, 1991, J VET MED SCI, V53, P1043, DOI 10.1292/jvms.53.1043; Kolb SA, 1998, J NEUROIMMUNOL, V84, P143, DOI 10.1016/S0165-5728(97)00247-6; Leib SL, 2000, INFECT IMMUN, V68, P615, DOI 10.1128/IAI.68.2.615-620.2000; Lemay AM, 2005, PHYSIOL GENOMICS, V23, P54, DOI 10.1152/physiolgenomics.00095.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Ravizza T, 2001, NEUROSCIENCE, V105, P43, DOI 10.1016/S0306-4522(01)00177-4; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Segura M, 1999, INFECT IMMUN, V67, P4646, DOI 10.1128/IAI.67.9.4646-4654.1999; Segura M, 2002, CLIN EXP IMMUNOL, V127, P243, DOI 10.1046/j.1365-2249.2002.01768.x; Segura M, 2006, FEMS IMMUNOL MED MIC, V47, P92, DOI 10.1111/j.1574-695X.2006.00067.x; Soares AC, 2006, MICROBES INFECT, V8, P1321, DOI 10.1016/j.micinf.2005.12.017; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; Tenenbaum T, 2006, BRAIN RES, V1100, P1, DOI 10.1016/j.brainres.2006.05.041; Vanier G, 2009, MICROB PATHOGENESIS, V46, P13, DOI 10.1016/j.micpath.2008.10.003; Wang KC, 2007, BERL MUNCH TIERARZTL, V120, P207, DOI 10.2376/0005-9366-120-207; WILLIAMS AE, 1988, RES VET SCI, V45, P394, DOI 10.1016/S0034-5288(18)30972-X; Wu ZF, 2010, MICROB PATHOGENESIS, V48, P178, DOI 10.1016/j.micpath.2010.02.007; Wu ZF, 2008, MICROB PATHOGENESIS, V45, P159, DOI 10.1016/j.micpath.2008.04.009; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zhang W, 2007, ZOONOSES PUBLIC HLTH, V54, P253, DOI 10.1111/j.1863-2378.2007.01056.x; Zhang W, 2007, PROTEOMICS, V7, P4468, DOI 10.1002/pmic.200700294	48	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32150	10.1371/journal.pone.0032150	http://dx.doi.org/10.1371/journal.pone.0032150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384161	gold, Green Submitted, Green Published			2022-12-27	WOS:000302918500060
J	Wallstrom, P; Sonestedt, E; Hlebowicz, J; Ericson, U; Drake, I; Persson, M; Gullberg, B; Hedblad, B; Wirfalt, E				Wallstrom, Peter; Sonestedt, Emily; Hlebowicz, Joanna; Ericson, Ulrika; Drake, Isabel; Persson, Margaretha; Gullberg, Bo; Hedblad, Bo; Wirfalt, Elisabet			Dietary Fiber and Saturated Fat Intake Associations with Cardiovascular Disease Differ by Sex in the Malmo Diet and Cancer Cohort: A Prospective Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; FOOD HABIT CHANGE; MYOCARDIAL-INFARCTION; POOLED ANALYSIS; HISTORY METHOD; BREAST-CANCER; RISK; MORTALITY; TIME; MEN	Background: The aim of the study was to examine associations between intake of macronutrients and dietary fiber and incident ischemic cardiovascular disease (iCVD) in men and women. Methods: We used data from 8,139 male and 12,535 female participants (aged 44-73 y) of the Swedish population-based Malmo Diet and Cancer cohort. The participants were without history of CVD and diabetes mellitus, and had reported stable dietary habits in the study questionnaire. Diet was assessed by a validated modified diet history method, combining a 7-d registration of cooked meals and cold beverages, a 168-item food questionnaire (covering other foods and meal patterns), and a 1-hour diet interview. Sociodemographic and lifestyle data were collected by questionnaire. iCVD cases, which included coronary events (myocardial infarctions or deaths from chronic ischemic heart disease) and ischemic strokes, were ascertained via national and local registries. Nutrient-disease associations were examined by multivariate Cox regressions. Results: During a mean follow-up of 13.5 years, we identified 1,089 male and 687 female iCVD cases. High fiber intakes were associated with lower incidence rates of iCVD in women and of ischemic stroke in men. In post-hoc analysis, we discovered statistically significant interactions between intake of fiber and saturated fat; these interactions also differed between men and women (p < 0.001). Conclusions: In this well-defined population, a high fiber intake was associated with lower risk of iCVD, but there were no robust associations between other macronutrients and iCVD risk. Judging from this study, gender-specific nutrient analysis may be preferable in epidemiology.	[Wallstrom, Peter; Drake, Isabel; Gullberg, Bo; Wirfalt, Elisabet] Lund Univ, Dept Clin Sci, Nutr Epidemiol Res Grp, Malmo, Sweden; [Hlebowicz, Joanna] Lund Univ, Dept Clin Sci, Expt Cardiovasc Res Unit, Malmo, Sweden; [Persson, Margaretha] Lund Univ, Dept Clin Sci, Internal Med Res Unit, Malmo, Sweden	Lund University; Lund University; Lund University	Wallstrom, P (corresponding author), Lund Univ, Dept Clin Sci, Nutr Epidemiol Res Grp, Malmo, Sweden.	peter.wallstrom@med.lu.se	Sonestedt, Emily/I-3814-2016	Sonestedt, Emily/0000-0002-0747-4562; Persson, Margaretha/0000-0001-8188-5792; Drake, Isabel/0000-0002-6500-6310; Ericson, Ulrika/0000-0003-4629-4318	Swedish governmental funds for clinical research (ALF); Heart-Lung Foundation, Region Skane; Skane University Hospital; Ernhold Lundstrom Foundation	Swedish governmental funds for clinical research (ALF); Heart-Lung Foundation, Region Skane; Skane University Hospital; Ernhold Lundstrom Foundation	This paper was funded by grants from Swedish governmental funds for clinical research (ALF), the Heart-Lung Foundation, Region Skane, the research funds of the Skane University Hospital and the Ernhold Lundstrom Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KK, 2009, STROKE, V40, P2068, DOI 10.1161/STROKEAHA.108.540112; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Bingham SA, 2006, INT J EPIDEMIOL, V35, P1022, DOI 10.1093/ije/dyl142; Byers T, 1997, AM J CLIN NUTR, V66, P1541; Cust AE, 2009, EUR J CLIN NUTR, V63, pS37, DOI 10.1038/ejcn.2009.74; Elmadfa I, 2009, ANN NUTR METAB, V55, P56, DOI 10.1159/000228996; Elmstahl S, 1996, EUR J CLIN NUTR, V50, P143; Elmstahl S, 1996, EUR J CLIN NUTR, V50, P134; Eshak ES, 2010, J NUTR, V140, P1445, DOI 10.3945/jn.110.122358; Food and Agriculture Organization/World Health Organization (FAO/WHO), 2010, 91 FAOWHO; Giugliano D, 2006, J AM COLL CARDIOL, V48, P677, DOI 10.1016/j.jacc.2006.03.052; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hlebowicz J, 2011, J INTERN MED, V270, P365, DOI 10.1111/j.1365-2796.2011.02382.x; Holme I, 2009, J INTERN MED, V265, P275, DOI 10.1111/j.1365-2796.2008.02016.x; Jacobs DR, 2007, NUTR REV, V65, P439, DOI [10.1111/j.1753-4887.2007.tb00269.x, 10.1301/nr.2007.oct.439-450]; Jakobsen MU, 2010, AM J CLIN NUTR, V91, P1764, DOI 10.3945/ajcn.2009.29099; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; JERNTORP P, 1992, STROKE, V23, P357, DOI 10.1161/01.STR.23.3.357; Leosdottir M, 2007, EUR J CARDIOV PREV R, V14, P701, DOI 10.1097/HJR.0b013e3282a56c45; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Macintyre S, 1997, DESIGN CONCEPTS NUTR, P273; Manjer J, 2001, EUR J CANCER PREV, V10, P489, DOI 10.1097/00008469-200112000-00003; Manjer J, 2002, SCAND J PUBLIC HEALT, V30, P103, DOI 10.1080/14034940210133771; Mattisson I, 2005, BRIT J NUTR, V94, P832, DOI 10.1079/BJN20051573; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Mohan KM, 2011, STROKE, V42, P1489, DOI 10.1161/STROKEAHA.110.602615; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; National Board of Health and Welfare, 2000, VARD DIAGN AK HJART; National Food Administration, 2010, T FAT; Pereira MA, 2004, ARCH INTERN MED, V164, P370, DOI 10.1001/archinte.164.4.370; Riboli E, 1997, INT J EPIDEMIOL, V26, pS161, DOI 10.1093/ije/26.suppl_1.S161; RICHARDSON MT, 1994, J CLIN EPIDEMIOL, V47, P271, DOI 10.1016/0895-4356(94)90008-6; Sieri S, 2010, ARCH INTERN MED, V170, P640, DOI 10.1001/archinternmed.2010.15; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P535, DOI 10.3945/ajcn.2009.27725; Skeaff CM, 2009, ANN NUTR METAB, V55, P173, DOI 10.1159/000229002; Sonestedt E, 2005, PUBLIC HEALTH NUTR, V8, P876, DOI 10.1079/PHN2005736; Sonestedt E, 2007, PUBLIC HEALTH NUTR, V10, P769, DOI 10.1017/S1368980007246646; Sonestedt E, 2011, EUR J EPIDEMIOL, V26, P609, DOI 10.1007/s10654-011-9589-y; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Thiebaut ACM, 2008, CANCER INVEST, V26, P68, DOI 10.1080/07357900701527918; Warensjo E, 2010, AM J CLIN NUTR, V92, P194, DOI 10.3945/ajcn.2009.29054; WHO, 1985, ENERGY PROTEIN REQUI; Willett W., 1998, NUTR EPIDEMIOL, V122, P101; Willett W.C., 1998, SAUPTIKAPARVAN MAHAB, DOI [10.1093/acprof:oso/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.003.11]; Wirfalt E, 2001, AM J EPIDEMIOL, V154, P1150, DOI 10.1093/aje/154.12.1150; Wirfalt E, 2002, NUTR J, V1, DOI 10.1186/1475-2891-1-3; World Health Organization, 2000, WHO TECHN REP SER, V894; Zakynthinos E, 2009, J CARDIOL, V53, P317, DOI 10.1016/j.jjcc.2008.12.007	49	47	51	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31637	10.1371/journal.pone.0031637	http://dx.doi.org/10.1371/journal.pone.0031637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384046	gold, Green Published, Green Submitted			2022-12-27	WOS:000302918500033
J	Yan, C; Ding, XC; Dasgupta, N; Wu, LY; Du, H				Yan, Cong; Ding, Xinchun; Dasgupta, Nupur; Wu, Lingyan; Du, Hong			Gene Profile of Myeloid-Derived Suppressive Cells from the Bone Marrow of Lysosomal Acid Lipase Knock-Out Mice	PLOS ONE			English	Article							MAMMALIAN PROTEIN; IMMUNE-SYSTEM; LAL(-/-) MICE; INFLAMMATION; CANCER; EXPRESSION; RAPAMYCIN; MTOR; LUNG; YEAST	Background: Lysosomal acid lipase (LAL) controls development and homeostasis of myeloid lineage cells. Loss of the lysosomal acid lipase (LAL) function leads to expansion of myeloid-derived suppressive cells (MDSCs) that cause myeloproliferative neoplasm. Methodology/Principal Findings: Affymetrix GeneChip microarray analysis identified detailed intrinsic defects in Ly6G(+) myeloid lineage cells of LAL knock-out (lal(-/-)) mice. Ingenuity Pathway Analysis revealed activation of the mammalian target of rapamycin (mTOR) signaling, which functions as a nutrient/energy/redox sensor, and controls cell growth, cell cycle entry, cell survival, and cell motility. Loss of the LAL function led to major alteration of large GTPase and small GTPase signal transduction pathways. lal(-/-) Ly6G(+) myeloid cells in the bone marrow showed substantial increase of cell proliferation in association with up-regulation of cyclin and cyclin-dependent kinase (cdk) genes. The epigenetic microenvironment was significantly changed due to the increased expression of multiple histone cluster genes, centromere protein genes and chromosome modification genes. Gene expression of bioenergetic pathways, including glycolysis, aerobic glycolysis, mitochondrial oxidative phosphorylation, and respiratory chain proteins, was also increased, while the mitochondrial function was impaired in lal(-/-) Ly6G(+) myeloid cells. The concentration of reactive oxygen species (ROS) was significantly increased accompanied by up-regulation of nitric oxide/ROS production genes in these cells. Conclusions/Significance: This comprehensive gene profile study for the first time identifies and defines important gene pathways involved in the myeloid lineage cells towards MDSCs using lal(-/-) mouse model.	[Yan, Cong; Ding, Xinchun; Wu, Lingyan] Indiana Univ, Sch Med, Ctr Immunobiol, Indianapolis, IN 46202 USA; [Yan, Cong; Ding, Xinchun; Wu, Lingyan; Du, Hong] Indiana Univ, Sch Med, IU Simon Canc Ctr, Indianapolis, IN USA; [Yan, Cong; Ding, Xinchun; Wu, Lingyan; Du, Hong] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA; [Dasgupta, Nupur] Cincinnati Childrens Hosp, Div Human Genet, Med Ctr, Cincinnati, OH USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Cincinnati Children's Hospital Medical Center	Yan, C (corresponding author), Indiana Univ, Sch Med, Ctr Immunobiol, Indianapolis, IN 46202 USA.	hongdu@iupui.edu	ding, xinchun/P-5490-2017		National Institutes of Health [CA138759, CA152099, HL087001]; NATIONAL CANCER INSTITUTE [R01CA152099, R01CA138759] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health Grants CA138759, CA152099 (CY) and HL087001 (HD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Du H, 1998, HUM MOL GENET, V7, P1347, DOI 10.1093/hmg/7.9.1347; Du H, 2001, J LIPID RES, V42, P489; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gavi S, 2006, TRENDS ENDOCRIN MET, V17, P46, DOI 10.1016/j.tem.2006.01.006; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Kaipparettu BA, 2011, ANN NY ACAD SCI, V1201, P137; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li Y, 2007, CANCER RES, V67, P8494, DOI 10.1158/0008-5472.CAN-07-0647; Lian XM, 2005, AM J PATHOL, V167, P813, DOI 10.1016/S0002-9440(10)62053-6; Lian XM, 2004, AM J PHYSIOL-LUNG C, V286, pL801, DOI 10.1152/ajplung.00335.2003; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Ovaa H, 2007, NAT REV CANCER, V7, P613, DOI 10.1038/nrc2128; Qu P, 2011, J IMMUNOL, V187, P3854, DOI 10.4049/jimmunol.1003358; Qu P, 2011, BLOOD, V117, P4476, DOI 10.1182/blood-2010-07-298380; Qu P, 2010, AM J PATHOL, V176, P2394, DOI 10.2353/ajpath.2010.091063; Qu P, 2009, J IMMUNOL, V182, P1648, DOI 10.4049/jimmunol.182.3.1648; Recher C, 2005, CELL CYCLE, V4, P1540; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Scheele JS, 2007, IMMUNOL REV, V218, P92, DOI 10.1111/j.1600-065X.2007.00530.x; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Wu L, 2011, AM J PATHOL; Wu L, 2011, BLOOD; Yan C, 2006, AM J PATHOL, V169, P916, DOI 10.2353/ajpath.2006.051327; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	36	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e30701	10.1371/journal.pone.0030701	http://dx.doi.org/10.1371/journal.pone.0030701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383970	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500014
J	Guo, F; Zhou, WJ; Zhang, JC; Xu, Q; Deng, XX				Guo, Fei; Zhou, Wenjing; Zhang, Jiancheng; Xu, Qiang; Deng, Xiuxin			Effect of the Citrus Lycopene beta-Cyclase Transgene on Carotenoid Metabolism in Transgenic Tomato Fruits	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; PHYTOENE SYNTHASE; GENETIC-VARIATION; EPSILON-CYCLASE; POTATO-TUBERS; PLANTS; PATHWAY; ACCUMULATION; MANIPULATION; EXPRESSION	Lycopene beta-cyclase (LYCB) is the key enzyme for the synthesis of beta-carotene, a valuable component of the human diet. In this study, tomato constitutively express Lycb-1 was engineered. The beta-carotene level of transformant increased 4.1 fold, and the total carotenoid content increased by 30% in the fruits. In the transgenic line, the downstream alpha-branch metabolic fluxes were repressed during the three developmental stages while alpha-carotene content increased in the ripe stage. Microarray analysis in the ripe stage revealed that the constitutive expression of Lycb-1 affected a number of pathways including the synthesis of fatty acids, flavonoids and phenylpropanoids, the degradation of limonene and pinene, starch and sucrose metabolism and photosynthesis. This study provided insight into the regulatory effect of Lycb-1 gene on plant carotenoid metabolism and fruit transcriptome.	[Guo, Fei; Zhou, Wenjing; Zhang, Jiancheng; Xu, Qiang; Deng, Xiuxin] Huazhong Agr Univ, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China; [Xu, Qiang; Deng, Xiuxin] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Guo, F (corresponding author), Huazhong Agr Univ, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China.	xxdeng@mail.hzau.edu.cn		Xiuxin, Deng/0000-0003-4490-4514	Ministry of Science and Technology of China [2011CB100601, 2011AA100205]; National Natural Science Foundation of China [30830078]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China (Nos.2011CB100601, 2011AA100205) and the National Natural Science Foundation of China (No.30830078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam AL, 2011, FEMS MICROBIOL LETT, V318, P76, DOI 10.1111/j.1574-6968.2011.02241.x; Apel W, 2009, PLANT PHYSIOL, V151, P59, DOI 10.1104/pp.109.140533; Auldridge ME, 2006, CURR OPIN PLANT BIOL, V9, P315, DOI 10.1016/j.pbi.2006.03.005; Bartolozzi F, 1997, J CHROMATOGR A, V758, P99, DOI 10.1016/S0021-9673(96)00709-1; BIRD CR, 1988, PLANT MOL BIOL, V11, P651, DOI 10.1007/BF00017465; Bouvier F, 2003, PLANT CELL, V15, P47, DOI 10.1105/tpc.006536; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; D'Ambrosio C, 2004, PLANT SCI, V166, P207, DOI 10.1016/j.plantsci.2003.09.015; Davuluri GR, 2004, PLANT J, V40, P344, DOI 10.1111/j.1365-313X.2004.02218.x; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; Diretto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000350; Diretto G, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-13; Ducreux LJM, 2005, J EXP BOT, V56, P81, DOI 10.1093/jxb/eri016; Enfissi EMA, 2005, PLANT BIOTECHNOL J, V3, P17, DOI 10.1111/j.1467-7652.2004.00091.x; Fester T, 2002, PLANT CELL PHYSIOL, V43, P256, DOI 10.1093/pcp/pcf029; Forcat S, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-16; Fraser PD, 2007, PLANT CELL, V19, P3194, DOI 10.1105/tpc.106.049817; Fraser PD, 2002, P NATL ACAD SCI USA, V99, P1092, DOI 10.1073/pnas.241374598; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Giuliano G, 2003, TRENDS PLANT SCI, V8, P145, DOI 10.1016/S1360-1385(03)00053-0; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Joung JG, 2009, PLANT PHYSIOL, V151, P1758, DOI 10.1104/pp.109.145169; Liu Q, 2007, J EXP BOT, V58, P4161, DOI 10.1093/jxb/erm273; Lu S, 2006, PLANT CELL, V18, P3594, DOI 10.1105/tpc.106.046417; Mayne ST, 1996, FASEB J, V10, P690, DOI 10.1096/fasebj.10.7.8635686; Milborrow BV, 2001, J EXP BOT, V52, P1145, DOI 10.1093/jexbot/52.359.1145; NAKAJIMA K, 1993, P NATL ACAD SCI USA, V90, P9591, DOI 10.1073/pnas.90.20.9591; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Pogson BJ, 2000, PHILOS T ROY SOC B, V355, P1395, DOI 10.1098/rstb.2000.0701; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Romer S, 2002, METAB ENG, V4, P263, DOI 10.1006/mben.2002.0234; Romer S, 2000, NAT BIOTECHNOL, V18, P666, DOI 10.1038/76523; Ronen G, 2000, P NATL ACAD SCI USA, V97, P11102, DOI 10.1073/pnas.190177497; Shewmaker CK, 1999, PLANT J, V20, P401, DOI 10.1046/j.1365-313x.1999.00611.x; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Wang F, 2007, BIOTECHNOL ADV, V25, P211, DOI 10.1016/j.biotechadv.2006.12.001; West CE, 2002, J NUTR, V132, p2920S, DOI 10.1093/jn/132.9.2920S; Wurbs D, 2007, PLANT J, V49, P276, DOI 10.1111/j.1365-313X.2006.02960.x; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhou XJ, 2011, PLANT CELL ENVIRON, V34, P1020, DOI 10.1111/j.1365-3040.2011.02301.x	42	21	24	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32221	10.1371/journal.pone.0032221	http://dx.doi.org/10.1371/journal.pone.0032221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384184	Green Submitted, Green Published, gold			2022-12-27	WOS:000302916800029
J	Abdouh, M; Chatoo, W; El Hajjar, J; David, J; Ferreira, J; Bernier, G				Abdouh, Mohamed; Chatoo, Wassim; El Hajjar, Jida; David, Jocelyn; Ferreira, Jose; Bernier, Gilbert			Bmi1 Is Down-Regulated in the Aging Brain and Displays Antioxidant and Protective Activities in Neurons	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; STAGE ALZHEIMERS-DISEASE; DNA-DAMAGE; OXIDATIVE STRESS; LIFE-SPAN; SUPEROXIDE-DISMUTASE; CELL RENEWAL; IN-VIVO; P53; PROLIFERATION	Aging increases the risk to develop several neurodegenerative diseases, although the underlying mechanisms are poorly understood. Inactivation of the Polycomb group gene Bmi1 in mice results in growth retardation, cerebellar degeneration, and development of a premature aging-like phenotype. This progeroid phenotype is characterized by formation of lens cataracts, apoptosis of cortical neurons, and increase of reactive oxygen species (ROS) concentrations, owing to p53-mediated repression of antioxidant response (AOR) genes. Herein we report that Bmi1 expression progressively declines in the neurons of aging mouse and human brains. In old brains, p53 accumulates at the promoter of AOR genes, correlating with a repressed chromatin state, down-regulation of AOR genes, and increased oxidative damages to lipids and DNA. Comparative gene expression analysis further revealed that aging brains display an up-regulation of the senescence-associated genes IL-6, p19(Arf) and p16(Ink4a), along with the pro-apoptotic gene Noxa, as seen in Bmi1-null mice. Increasing Bmi1 expression in cortical neurons conferred robust protection against DNA damage-induced cell death or mitochondrial poisoning, and resulted in suppression of ROS through activation of AOR genes. These observations unveil that Bmi1 genetic deficiency recapitulates aspects of physiological brain aging and that Bmi1 over-expression is a potential therapeutic modality against neurodegeneration.	[Abdouh, Mohamed; Chatoo, Wassim; El Hajjar, Jida; David, Jocelyn; Bernier, Gilbert] Hop Maison Neuve Rosemont, Dev Biol Lab, Montreal, PQ H1T 2M4, Canada; [Ferreira, Jose] Hop Maison Neuve Rosemont, Dept Pathol, Montreal, PQ H1T 2M4, Canada; [Bernier, Gilbert] Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Abdouh, M (corresponding author), Hop Maison Neuve Rosemont, Dev Biol Lab, Montreal, PQ H1T 2M4, Canada.	gbernier.hmr@ssss.gouv.qc.ca		Abdouh, Mohamed/0000-0003-0702-9335	Natural Science and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research (CIHR); Antoine-Turmel Foundation for Macular Degeneration Research	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Antoine-Turmel Foundation for Macular Degeneration Research	This work was supported by grants from the Natural Science and Engineering Research Council of Canada (NSERC), Canadian Institutes of Health Research (CIHR), and Antoine-Turmel Foundation for Macular Degeneration Research. Dr. Bernier is Chercheur Boursier from the Fonds de Recherche en Sante du Quebec (FRSQ). Dr. Chatoo is a Scholar from the Fonds de Recherche en Ophtalmologie de l'Universite de Montreal (FROUM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Best BP, 2009, REJUV RES, V12, P199, DOI 10.1089/rej.2009.0847; Bielas JH, 2000, P NATL ACAD SCI USA, V97, P11391, DOI 10.1073/pnas.190330997; Bielas JH, 2004, DNA REPAIR, V3, P711, DOI 10.1016/j.dnarep.2004.02.010; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Buege J A, 1978, Methods Enzymol, V52, P302; Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chatoo W, 2011, ANTIOXID REDOX SIGNA; Chatoo W, 2009, J NEUROSCI, V29, P529, DOI 10.1523/JNEUROSCI.5303-08.2009; Cregan SP, 2004, J NEUROSCI, V24, P10003, DOI 10.1523/JNEUROSCI.2114-04.2004; Cregan SP, 1999, J NEUROSCI, V19, P7860; Dorszewska J, 2004, RESP PHYSIOL NEUROBI, V139, P227, DOI 10.1016/j.resp.2003.10.005; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Faraonio R, 2006, J BIOL CHEM, V281, P39776, DOI 10.1074/jbc.M605707200; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016615; Kim J, 2009, J BIOL CHEM, V284, P14396, DOI 10.1074/jbc.M808116200; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lovell MA, 2007, NUCLEIC ACIDS RES, V35, P7497, DOI 10.1093/nar/gkm821; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Markesbery WR, 2006, ANTIOXID REDOX SIGN, V8, P2039, DOI 10.1089/ars.2006.8.2039; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Sahasrabuddhe AA, 2011, CELL CYCLE, V10, P1322, DOI 10.4161/cc.10.8.15372; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Sentman ML, 2006, J BIOL CHEM, V281, P6904, DOI 10.1074/jbc.M510764200; Shao C, 2008, FREE RADICAL BIO MED, V45, P813, DOI 10.1016/j.freeradbiomed.2008.06.003; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Shih AY, 2005, J BIOL CHEM, V280, P22925, DOI 10.1074/jbc.M414635200; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Slack RS, 1996, J CELL BIOL, V135, P1085, DOI 10.1083/jcb.135.4.1085; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tian F, 2009, REJUV RES, V12, P209, DOI 10.1089/rej.2009.0849; Unlu ES, 2007, ANN NY ACAD SCI, V1100, P505, DOI 10.1196/annals.1395.055; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Xiang H, 1996, J NEUROSCI, V16, P6753; Xiang H, 1998, J NEUROSCI, V18, P1363; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005	52	37	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31870	10.1371/journal.pone.0031870	http://dx.doi.org/10.1371/journal.pone.0031870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384090	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100036
J	Sanz, LM; Crespo, B; De-Cozar, C; Ding, XC; Llergo, JL; Burrows, JN; Garcia-Bustos, JF; Gamo, FJ				Sanz, Laura M.; Crespo, Benigno; De-Cozar, Cristina; Ding, Xavier C.; Llergo, Jose L.; Burrows, Jeremy N.; Garcia-Bustos, Jose F.; Gamo, Francisco-Javier			P. falciparum In Vitro Killing Rates Allow to Discriminate between Different Antimalarial Mode-of-Action	PLOS ONE			English	Article							MITOCHONDRIAL ELECTRON-TRANSPORT; SEMIAUTOMATED MICRODILUTION TECHNIQUE; PLASMODIUM-VIVAX MALARIA; DRUG-SENSITIVITY; ARTEMISININ RESISTANCE; SULFADOXINE-PYRIMETHAMINE; TREATMENT FAILURE; CHLOROQUINE; MECHANISM; PARASITE	Chemotherapy is still the cornerstone for malaria control. Developing drugs against Plasmodium parasites and monitoring their efficacy requires methods to accurately determine the parasite killing rate in response to treatment. Commonly used techniques essentially measure metabolic activity as a proxy for parasite viability. However, these approaches are susceptible to artefacts, as viability and metabolism are two parameters that are coupled during the parasite life cycle but can be differentially affected in response to drug actions. Moreover, traditional techniques do not allow to measure the speed-of-action of compounds on parasite viability, which is an essential efficacy determinant. We present here a comprehensive methodology to measure in vitro the direct effect of antimalarial compounds over the parasite viability, which is based on limiting serial dilution of treated parasites and re-growth monitoring. This methodology allows to precisely determine the killing rate of antimalarial compounds, which can be quantified by the parasite reduction ratio and parasite clearance time, which are key mode-of-action parameters. Importantly, we demonstrate that this technique readily permits to determine compound killing activities that might be otherwise missed by traditional, metabolism-based techniques. The analysis of a large set of antimalarial drugs reveals that this viability-based assay allows to discriminate compounds based on their antimalarial mode-of-action. This approach has been adapted to perform medium throughput screening, facilitating the identification of fast-acting antimalarial compounds, which are crucially needed for the control and possibly the eradication of malaria.	[Sanz, Laura M.; Crespo, Benigno; De-Cozar, Cristina; Llergo, Jose L.; Garcia-Bustos, Jose F.; Gamo, Francisco-Javier] GlaxoSmithKline, Dis Dev World, Tres Cantos, Madrid, Spain; [Ding, Xavier C.; Burrows, Jeremy N.] Med Malaria Venture, Geneva, Switzerland	GlaxoSmithKline	Sanz, LM (corresponding author), GlaxoSmithKline, Dis Dev World, Tres Cantos, Tres Cantos Med Dev Campus, Madrid, Spain.	francisco-javier.b.gamo@gsk.com		Garcia-Bustos, Jose/0000-0002-6310-796X				Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Barton V, 2010, CURR OPIN CHEM BIOL, V14, P440, DOI 10.1016/j.cbpa.2010.05.005; Burkhardt D, 2007, INT J PARASITOL, V37, P777, DOI 10.1016/j.ijpara.2006.12.010; Bustos DG, 1999, J INFECT DIS, V179, P1587, DOI 10.1086/314770; Codd A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-56; Dahl EL, 2007, ANTIMICROB AGENTS CH, V51, P3485, DOI 10.1128/AAC.00527-07; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Ding XC, 2011, TRENDS PARASITOL, V27, P73, DOI 10.1016/j.pt.2010.11.006; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dunne MW, 2005, AM J TROP MED HYG, V73, P1108; ELABBADI N, 1992, ANTIMICROB AGENTS CH, V36, P50, DOI 10.1128/AAC.36.1.50; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Frita R, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-74; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Gomes M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-39; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Gujjar R, 2009, J MED CHEM, V52, P1864, DOI 10.1021/jm801343r; HIEN TT, 1993, LANCET, V341, P603; Johnson JD, 2007, ANTIMICROB AGENTS CH, V51, P1926, DOI 10.1128/AAC.01607-06; Karl S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-294; Ketema T, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-177; KREMSNER PG, 1993, AM J TROP MED HYG, V49, P650, DOI 10.4269/ajtmh.1993.49.650; Looareesuwan S, 1996, AM J TROP MED HYG, V54, P62, DOI 10.4269/ajtmh.1996.54.62; MAKLER MT, 1993, AM J TROP MED HYG, V48, P205, DOI 10.4269/ajtmh.1993.48.205; Meshnick SR, 1996, MICROBIOL REV, V60, P301, DOI 10.1128/MMBR.60.2.301-315.1996; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Ndiaye D, 2010, AM J TROP MED HYG, V82, P228, DOI 10.4269/ajtmh.2010.09-0470; Noedl H, 2002, ANTIMICROB AGENTS CH, V46, P1658, DOI 10.1128/AAC.46.6.1658-1664.2002; Noedl H, 2003, TRENDS PARASITOL, V19, P175, DOI 10.1016/S1471-4922(03)00028-X; O'Neill PM, 2010, MOLECULES, V15, P1705, DOI 10.3390/molecules15031705; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Painter HJ, 2010, ANTIMICROB AGENTS CH, V54, P5281, DOI 10.1128/AAC.00937-10; Piper R, 1999, AM J TROP MED HYG, V60, P109, DOI 10.4269/ajtmh.1999.60.109; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Pukrittayakamee S, 2004, ANTIMICROB AGENTS CH, V48, P1329, DOI 10.1128/AAC.48.4.1329-1334.2004; RIECKMANN KH, 1978, LANCET, V1, P22; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Teuscher F, 2010, J INFECT DIS, V202, P1362, DOI 10.1086/656476; Thapa S, 2007, AM J TROP MED HYG, V77, P423, DOI 10.4269/ajtmh.2007.77.423; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Wein S, 2010, J CLIN MICROBIOL, V48, P1651, DOI 10.1128/JCM.02250-09; White NJ, 2010, LANCET, V376, P2051, DOI 10.1016/S0140-6736(10)61963-0; White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413, DOI 10.1128/AAC.41.7.1413; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Xiang H, 2006, J PHARM SCI-US, V95, P2657, DOI 10.1002/jps.20681; YOUNG RD, 1993, ANTIMICROB AGENTS CH, V37, P1102, DOI 10.1128/AAC.37.5.1102; ZHANEL GG, 1991, DICP ANN PHARMAC, V25, P153, DOI 10.1177/106002809102500210	48	125	127	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e30949	10.1371/journal.pone.0030949	http://dx.doi.org/10.1371/journal.pone.0030949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383983	Green Published, gold			2022-12-27	WOS:000302916100010
J	Dodson, ML; Walker, RC; Lloyd, RS				Dodson, M. L.; Walker, Ross C.; Lloyd, R. Stephen			Carbinolamine Formation and Dehydration in a DNA Repair Enzyme Active Site	PLOS ONE			English	Article							BASE EXCISION-REPAIR; FREE-ENERGY DIFFERENCES; MOLECULAR-DYNAMICS; PROTEIN; GLYCOSYLASE; SIMULATIONS; MECHANISMS; SUBSTRATE; CHARGES; COMPLEX	In order to suggest detailed mechanistic hypotheses for the formation and dehydration of a key carbinolamine intermediate in the T4 pyrimidine dimer glycosylase (T4PDG) reaction, we have investigated these reactions using steered molecular dynamics with a coupled quantum mechanics-molecular mechanics potential (QM/MM). We carried out simulations of DNA abasic site carbinolamine formation with and without a water molecule restrained to remain within the active site quantum region. We recovered potentials of mean force (PMF) from thirty replicate reaction trajectories using Jarzynski averaging. We demonstrated feasible pathways involving water, as well as those independent of water participation. The water-independent enzyme-catalyzed reaction had a bias-corrected Jarzynski-average barrier height of approximately 6.5 kcal mol(-1) (27.2 kJ mol(-1)) for the carbinolamine formation reaction and 44.5 kcal mol(-1) (186 kJ mol(-1)) for the reverse reaction at this level of representation. When the proton transfer was facilitated with an intrinsic quantum water, the barrier height was approximately 15 kcal mol(-1) (62.8 kJ mol(-1)) in the forward (formation) reaction and 19 kcal mol(-1) (79.5 kJ mol(-1)) for the reverse. In addition, two modes of unsteered (free dynamics) carbinolamine dehydration were observed: in one, the quantum water participated as an intermediate proton transfer species, and in the other, the active site protonated glutamate hydrogen was directly transferred to the carbinolamine oxygen. Water-independent unforced proton transfer from the protonated active site glutamate carboxyl to the unprotonated N-terminal amine was also observed. In summary, complex proton transfer events, some involving water intermediates, were studied in QM/MM simulations of T4PDG bound to a DNA abasic site. Imine carbinolamine formation was characterized using steered QM/MM molecular dynamics. Dehydration of the carbinolamine intermediate to form the final imine product was observed in free, unsteered, QM/MM dynamics simulations, as was unforced acid-base transfer between the active site carboxylate and the N-terminal amine.	[Dodson, M. L.] Act Site Dynam LLC, Houston, TX USA; [Walker, Ross C.] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Walker, Ross C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Oregon Health & Science University	Dodson, ML (corresponding author), Act Site Dynam LLC, Houston, TX USA.	mldodson@comcast.net		Lloyd, R. Stephen/0000-0001-7273-372X	National Science Foundation through TeraGrid Supercomputer resources; Purdue University Steele cluster; Advanced User Support; San Diego Supercomputer Center under TeraGrid [TG-MCB090181, TG-MCB090110]; National Science Foundation [NSF1047875]; University of California [09-LR-06-117792-WALR];  [R01-ES004091-20]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004091] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1047875] Funding Source: National Science Foundation	National Science Foundation through TeraGrid Supercomputer resources(National Science Foundation (NSF)); Purdue University Steele cluster; Advanced User Support; San Diego Supercomputer Center under TeraGrid; National Science Foundation(National Science Foundation (NSF)); University of California(University of California System); ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This research was supported in part by grant R01-ES004091-20 to RSL and a subcontract of that grant to Active Site Dynamics LLC (Limited Liability Company). This research was also supported in part by the National Science Foundation through TeraGrid Supercomputer resources provided by the Purdue University Steele cluster and Advanced User Support provided by the San Diego Supercomputer Center under TeraGrid grant numbers TG-MCB090181 and TG-MCB090110. RCW also acknowledges support in part by grants NSF1047875 from the National Science Foundation and 09-LR-06-117792-WALR from the University of California Lab Fees program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akola J, 2003, J PHYS CHEM B, V107, P11774, DOI 10.1021/jp035538g; [Anonymous], 2008, AMBER 10; Babin V, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2844595; Bhagwat M, 1996, BIOCHEMISTRY-US, V35, P659, DOI 10.1021/bi9522662; Bustamante C, 2005, PHYS TODAY, V58, P43, DOI 10.1063/1.2012462; Cerutti DS, 2008, J CHEM THEORY COMPUT, V4, P1669, DOI 10.1021/ct8002173; CORDES EH, 1962, J AM CHEM SOC, V84, P832, DOI 10.1021/ja00864a031; CORNELL WD, 1993, J AM CHEM SOC, V115, P9620, DOI 10.1021/ja00074a030; Crooks GE, 1999, PHYS REV E, V60, P2721, DOI 10.1103/PhysRevE.60.2721; Dodson ML, 2002, FREE RADICAL BIO MED, V32, P678, DOI 10.1016/S0891-5849(02)00767-0; Elstner M, 1998, PHYS REV B, V58, P7260, DOI 10.1103/PhysRevB.58.7260; Fuxreiter M, 1999, BIOCHEMISTRY-US, V38, P9577, DOI 10.1021/bi9901937; Golan G, 2006, J MOL BIOL, V362, P241, DOI 10.1016/j.jmb.2006.06.059; Guo H, 2001, P NATL ACAD SCI USA, V98, P9032, DOI 10.1073/pnas.141230998; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Isralewitz B, 2001, J MOL GRAPH MODEL, V19, P13, DOI 10.1016/S1093-3263(00)00133-9; Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P; Jarzynski C, 2001, P NATL ACAD SCI USA, V98, P3636, DOI 10.1073/pnas.081074598; Jarzynski C, 1997, PHYS REV E, V56, P5018, DOI 10.1103/PhysRevE.56.5018; Jencks W. P., 1987, CATALYSIS CHEM ENZYM; Kleinert H, 1995, PATH INTEGRALS QUANT; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kruger T, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1871913; Lloyd RS, 2005, MUTAT RES-FUND MOL M, V577, P77, DOI 10.1016/j.mrfmmm.2005.04.003; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; Meijer EJ, 1998, J AM CHEM SOC, V120, P6345, DOI 10.1021/ja972935u; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Park S, 2003, J CHEM PHYS, V119, P3559, DOI 10.1063/1.1590311; POREZAG D, 1995, PHYS REV B, V51, P12947, DOI 10.1103/PhysRevB.51.12947; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Seabra GD, 2007, J PHYS CHEM A, V111, P5655, DOI 10.1021/jp0700711; Senn HM, 2007, CURR OPIN CHEM BIOL, V11, P182, DOI 10.1016/j.cbpa.2007.01.684; VASSYLYEV DG, 1995, CELL, V83, P773, DOI 10.1016/0092-8674(95)90190-6; Walker RK, 2006, BIOCHEMISTRY-US, V45, P14192, DOI 10.1021/bi060802s; Walker RC, 2008, J COMPUT CHEM, V29, P1019, DOI 10.1002/jcc.20857; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Xiong H, 2006, THEOR CHEM ACC, V116, P338, DOI 10.1007/s00214-005-0072-2	39	6	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31377	10.1371/journal.pone.0031377	http://dx.doi.org/10.1371/journal.pone.0031377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384015	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500017
J	Ersland, KM; Christoforou, A; Stansberg, C; Espeseth, T; Mattheisen, M; Mattingsdal, M; Hardarson, GA; Hansen, T; Fernandes, CPD; Giddaluru, S; Breuer, R; Strohmaier, J; Djurovic, S; Nothen, MM; Rietschel, M; Lundervold, AJ; Werge, T; Cichon, S; Andreassen, OA; Reinvang, I; Steen, VM; Le Hellard, S				Ersland, Kari M.; Christoforou, Andrea; Stansberg, Christine; Espeseth, Thomas; Mattheisen, Manuel; Mattingsdal, Morten; Hardarson, Gudmundur A.; Hansen, Thomas; Fernandes, Carla P. D.; Giddaluru, Sudheer; Breuer, Rene; Strohmaier, Jana; Djurovic, Srdjan; Noethen, Markus M.; Rietschel, Marcella; Lundervold, Astri J.; Werge, Thomas; Cichon, Sven; Andreassen, Ole A.; Reinvang, Ivar; Steen, Vidar M.; Le Hellard, Stephanie			Gene-Based Analysis of Regionally Enriched Cortical Genes in GWAS Data Sets of Cognitive Traits and Psychiatric Disorders	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; CANDIDATE GENES; ROR-BETA; EXPRESSION; INTELLIGENCE; SCHIZOPHRENIA; IDENTIFICATION; POLYMORPHISM; MODULATION	Background: Despite its estimated high heritability, the genetic architecture leading to differences in cognitive performance remains poorly understood. Different cortical regions play important roles in normal cognitive functioning and impairment. Recently, we reported on sets of regionally enriched genes in three different cortical areas (frontomedial, temporal and occipital cortices) of the adult rat brain. It has been suggested that genes preferentially, or specifically, expressed in one region or organ reflect functional specialisation. Employing a gene-based approach to the analysis, we used the regionally enriched cortical genes to mine a genome-wide association study (GWAS) of the Norwegian Cognitive NeuroGenetics (NCNG) sample of healthy adults for association to nine psychometric tests measures. In addition, we explored GWAS data sets for the serious psychiatric disorders schizophrenia (SCZ) (n = 3 samples) and bipolar affective disorder (BP) (n = 3 samples), to which cognitive impairment is linked. Principal Findings: At the single gene level, the temporal cortex enriched gene RAR-related orphan receptor B (RORB) showed the strongest overall association, namely to a test of verbal intelligence (Vocabulary, P = 7.7E- 04). We also applied gene set enrichment analysis (GSEA) to test the candidate genes, as gene sets, for enrichment of association signal in the NCNG GWAS and in GWASs of BP and of SCZ. We found that genes differentially expressed in the temporal cortex showed a significant enrichment of association signal in a test measure of non-verbal intelligence (Reasoning) in the NCNG sample. Conclusion: Our gene-based approach suggests that RORB could be involved in verbal intelligence differences, while the genes enriched in the temporal cortex might be important to intellectual functions as measured by a test of reasoning in the healthy population. These findings warrant further replication in independent samples on cognitive traits.	[Ersland, Kari M.; Christoforou, Andrea; Stansberg, Christine; Fernandes, Carla P. D.; Giddaluru, Sudheer; Cichon, Sven; Steen, Vidar M.; Le Hellard, Stephanie] Univ Bergen, Dept Clin Med, Dr E Martens Res Grp Biol Psychiat, Bergen, Norway; [Ersland, Kari M.; Christoforou, Andrea; Stansberg, Christine; Fernandes, Carla P. D.; Giddaluru, Sudheer; Steen, Vidar M.; Le Hellard, Stephanie] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Espeseth, Thomas; Reinvang, Ivar] Univ Oslo, Dept Psychol, Ctr Study Human Cognit, Oslo, Norway; [Mattheisen, Manuel; Noethen, Markus M.; Cichon, Sven] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Mattheisen, Manuel] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Mattheisen, Manuel] Univ Bonn, IMBIE, Bonn, Germany; [Mattingsdal, Morten; Djurovic, Srdjan; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Mattingsdal, Morten] Sorlandet Hosp HF, Kristiansand, Norway; [Hardarson, Gudmundur A.; Hansen, Thomas; Werge, Thomas] Copenhagen Univ Hosp, Res Inst Biol Psychiat, iPSYCH, Roskilde, Denmark; [Breuer, Rene; Strohmaier, Jana; Rietschel, Marcella] Univ Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Mannheim, Germany; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Noethen, Markus M.; Cichon, Sven] Univ Bonn, Inst Human Genet, Bonn, Germany; [Noethen, Markus M.] German Ctr Neurodegenerat Disorders DZNE, Bonn, Germany; [Lundervold, Astri J.] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Lundervold, Astri J.] Haraldsplass Deaconesses Hosp, Kavli Res Ctr Aging & Dementia, Bergen, Norway; [Cichon, Sven] Res Ctr Juelich, Inst Neurosci & Med INM 1, Julich, Germany; [Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Oslo; University of Bonn; Harvard University; Harvard T.H. Chan School of Public Health; University of Bonn; University of Oslo; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Copenhagen; Central Institute of Mental Health; University of Mannheim; University of Oslo; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bergen; Helmholtz Association; Research Center Julich; University of Oslo	Ersland, KM (corresponding author), Univ Bergen, Dept Clin Med, Dr E Martens Res Grp Biol Psychiat, Bergen, Norway.	kari.ersland@med.uib.no	Andreassen, Ole A./AAY-7531-2020; Mattheisen, Manuel/S-3725-2019; Hansen, Thomas/GWZ-2858-2022; Mattingsdal, Morten/Q-9367-2016; Pillay, Nischalan/F-9536-2012; Cichon, Sven/B-9618-2014; Werge, Thomas/G-7263-2012; Lundervold, Astri/AAH-9796-2021; Cichon, Sven/H-8803-2013; Mattheisen, Manuel/B-4949-2012; Hansen, Thomas Folkmann/O-5965-2014	Mattheisen, Manuel/0000-0002-8442-493X; Mattingsdal, Morten/0000-0003-4440-0324; Cichon, Sven/0000-0002-9475-086X; Lundervold, Astri/0000-0002-6819-6164; Cichon, Sven/0000-0002-9475-086X; Mattheisen, Manuel/0000-0002-8442-493X; Hansen, Thomas Folkmann/0000-0001-6703-7762; Andreassen, Ole A./0000-0002-4461-3568; Ersland, Kari Merete/0000-0003-3674-4151; Djurovic, Srdjan/0000-0002-8140-8061; Nothen, Markus/0000-0002-8770-2464; Stansberg, Christine/0000-0002-3665-7843; Le Hellard, Stephanie/0000-0002-8085-051X	Bergen Research Foundation; University of Bergen; Research Council of Norway (incl. FUGE) [151904, 183327]; Psykisk Helse [175345]; Helse Vest RHF; Centre for Advanced Study (CAS) at the Norwegian Academy of Science and Letters in Oslo; NIH/NHLBI [U01 HL089856, RO1 MH087590, R01 MH081862]; German Federal Ministry of Education and Research (BMBF), within the context of the National Genome Research Network 2 (NGFN-2); National Genome Research Network plus (NGFNplus); Integrated Genome Research Network (IG) MooDS [01GS08144, 01GS08147]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087590, R01MH081862] Funding Source: NIH RePORTER	Bergen Research Foundation; University of Bergen; Research Council of Norway (incl. FUGE)(Research Council of Norway); Psykisk Helse; Helse Vest RHF; Centre for Advanced Study (CAS) at the Norwegian Academy of Science and Letters in Oslo; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); German Federal Ministry of Education and Research (BMBF), within the context of the National Genome Research Network 2 (NGFN-2)(Federal Ministry of Education & Research (BMBF)); National Genome Research Network plus (NGFNplus); Integrated Genome Research Network (IG) MooDS; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by a grant from the Bergen Research Foundation and the University of Bergen to SLH. The study was also supported by grants from the Research Council of Norway (incl. FUGE grant nos. 151904 and 183327, and Psykisk Helse grant no. 175345), Helse Vest RHF, Dr Einar Martens Fund and in part by the Centre for Advanced Study (CAS) at the Norwegian Academy of Science and Letters in Oslo. In addition this work was supported by NIH/NHLBI U01 HL089856, RO1 MH087590, R01 MH081862 and by the German Federal Ministry of Education and Research (BMBF), within the context of the National Genome Research Network 2 (NGFN-2); the National Genome Research Network plus (NGFNplus); and the Integrated Genome Research Network (IG) MooDS (grant 01GS08144 to S.C. and M.M.N., grant 01GS08147 to M.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, WESCHLER ABBREVIATED; Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; Bernstein HG, 2007, SCHIZOPHR RES, V96, P246, DOI 10.1016/j.schres.2007.05.038; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen CH, 2011, NEURON, V72, P537, DOI 10.1016/j.neuron.2011.08.021; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Cichon S, 2011, AM J HUM GENET, V88, P396, DOI [10.1016/j.ajhg.2011.01.017, 10.1016/j.ajhg.2011.03.001]; Davies G, 2011, MOL PSYCHIAT; Dean K, 2010, ARCH GEN PSYCHIAT, V67, P822, DOI 10.1001/archgenpsychiatry.2010.86; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4; Deary IJ, 2002, NATURE, V418, P932, DOI 10.1038/418932a; Delis D. C., 2001, D KEFS EXAMINERS MAN; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Djurovic S, 2010, J AFFECT DISORDERS, V126, P312, DOI 10.1016/j.jad.2010.04.007; Espeseth T, 2006, COGN AFFECT BEHAV NE, V6, P31, DOI 10.3758/CABN.6.1.31; Esslinger C, 2009, SCIENCE, V324, P605, DOI 10.1126/science.1167768; Fadel J, 2010, BRAIN RES, V1314, P112, DOI 10.1016/j.brainres.2009.08.046; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Gray JR, 2004, NAT REV NEUROSCI, V5, P471, DOI 10.1038/nrn1405; Grozeva D, 2010, ARCH GEN PSYCHIAT, V67, P318, DOI 10.1001/archgenpsychiatry.2010.25; Ingason A, 2011, MOL PSYCHIATR, V16, P17, DOI 10.1038/mp.2009.101; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Khaitovich P, 2004, GENOME RES, V14, P1462, DOI 10.1101/gr.2538704; KRUBITZER L, 1995, TRENDS NEUROSCI, V18, P408, DOI 10.1016/0166-2236(95)93938-T; Krubitzer L, 2007, NEURON, V56, P201, DOI 10.1016/j.neuron.2007.10.002; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Le Hellard S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007534; Le-Niculescu H, 2009, AM J MED GENET B, V150B, P155, DOI 10.1002/ajmg.b.30887; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lichtenstein P, 2006, PSYCHOL MED, V36, P1417, DOI 10.1017/S0033291706008385; Masana MI, 2007, AM J PHYSIOL-REG I, V292, pR2357, DOI 10.1152/ajpregu.00687.2006; McGrath CL, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-70; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Owen MJ, 2009, CURR OPIN GENET DEV, V19, P266, DOI 10.1016/j.gde.2009.02.008; Plomin R, 2004, MOL PSYCHIATR, V9, P582, DOI 10.1038/sj.mp.4001441; Posthuma D, 2002, NAT NEUROSCI, V5, P83, DOI 10.1038/nn0202-83; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rainero I, 2011, J AFFECT DISORDERS, V130, P487, DOI 10.1016/j.jad.2010.10.033; Rietschel M, 2011, MOL PSYCHIAT; Rimol LM, 2010, BIOL PSYCHIAT, V68, P41, DOI 10.1016/j.biopsych.2010.03.036; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Schaeren-Wiemers N, 1997, EUR J NEUROSCI, V9, P2687, DOI 10.1111/j.1460-9568.1997.tb01698.x; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stansberg C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-94; Stansberg C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-15; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Strand AD, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030059; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Tsai SJ, 2004, NEUROPSYCHOBIOLOGY, V49, P13, DOI 10.1159/000075333; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Winterer G, 2003, BRAIN RES REV, V43, P134, DOI 10.1016/S0165-0173(03)00205-4; Wu LLY, 2009, CELL ADHES MIGR, V3, P71, DOI 10.4161/cam.3.1.7511; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16	66	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31687	10.1371/journal.pone.0031687	http://dx.doi.org/10.1371/journal.pone.0031687			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384057	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500035
J	Lindorff-Larsen, K; Maragakis, P; Piana, S; Eastwood, MP; Dror, RO; Shaw, DE				Lindorff-Larsen, Kresten; Maragakis, Paul; Piana, Stefano; Eastwood, Michael P.; Dror, Ron O.; Shaw, David E.			Systematic Validation of Protein Force Fields against Experimental Data	PLOS ONE			English	Article							DYNAMICS; MECHANICS; UBIQUITIN; SIMULATIONS; EWALD	Molecular dynamics simulations provide a vehicle for capturing the structures, motions, and interactions of biological macromolecules in full atomic detail. The accuracy of such simulations, however, is critically dependent on the force field-the mathematical model used to approximate the atomic-level forces acting on the simulated molecular system. Here we present a systematic and extensive evaluation of eight different protein force fields based on comparisons of experimental data with molecular dynamics simulations that reach a previously inaccessible timescale. First, through extensive comparisons with experimental NMR data, we examined the force fields' abilities to describe the structure and fluctuations of folded proteins. Second, we quantified potential biases towards different secondary structure types by comparing experimental and simulation data for small peptides that preferentially populate either helical or sheet-like structures. Third, we tested the force fields' abilities to fold two small proteins-one alpha-helical, the other with beta-sheet structure. The results suggest that force fields have improved over time, and that the most recent versions, while not perfect, provide an accurate description of many structural and dynamical properties of proteins.	[Lindorff-Larsen, Kresten; Maragakis, Paul; Piana, Stefano; Eastwood, Michael P.; Dror, Ron O.; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Shaw, David E.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY USA	D. E. Shaw Research; Columbia University	Lindorff-Larsen, K (corresponding author), DE Shaw Res, New York, NY 10036 USA.	David.Shaw@DEShawResearch.com	Lindorff-Larsen, Kresten/K-6469-2014	Lindorff-Larsen, Kresten/0000-0002-4750-6039; Dror, Ron/0000-0002-6418-2793				Best RB, 2008, BIOPHYS J, V95, pL7, DOI 10.1529/biophysj.108.132696; Best RB, 2010, J PHYS CHEM B, V114, P8790, DOI 10.1021/jp102575b; Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t; Bowers KJ, 2007, J COMPUT PHYS, V221, P303, DOI 10.1016/j.jcp.2006.06.014; Fenwick RB, 2011, J AM CHEM SOC, V133, P10336, DOI 10.1021/ja200461n; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; Dror RO, 2009, P C HIGH PERF COMP N; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Faver JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018868; Fennell CJ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2206581; Freddolino PL, 2010, NAT PHYS, V6, P751, DOI 10.1038/NPHYS1713; Freddolino PL, 2009, BIOPHYS J, V96, P3772, DOI 10.1016/j.bpj.2009.02.033; Honda S, 2008, J AM CHEM SOC, V130, P15327, DOI 10.1021/ja8030533; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Kubelka J, 2006, J MOL BIOL, V359, P546, DOI 10.1016/j.jmb.2006.03.034; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Lange OF, 2010, BIOPHYS J, V99, P647, DOI 10.1016/j.bpj.2010.04.062; Lei HX, 2007, CURR OPIN STRUC BIOL, V17, P187, DOI 10.1016/j.sbi.2007.03.003; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARINARI E, 1992, EUROPHYS LETT, V19, P451, DOI 10.1209/0295-5075/19/6/002; Markwick PRL, 2007, J AM CHEM SOC, V129, P4724, DOI 10.1021/ja0687668; NORTHRUP SH, 1980, J CHEM PHYS, V73, P2700, DOI 10.1063/1.440484; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Piana S, 2011, J MOL BIOL, V405, P43, DOI 10.1016/j.jmb.2010.10.023; Prinz JH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3565032; SHALONGO W, 1994, J AM CHEM SOC, V116, P8288, DOI 10.1021/ja00097a039; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Stone JE, 2010, J MOL GRAPH MODEL, V29, P116, DOI 10.1016/j.jmgm.2010.06.010; Ulmer TS, 2003, J AM CHEM SOC, V125, P9179, DOI 10.1021/ja0350684; Vendruscolo M, 2011, CURR BIOL, V21, pR68, DOI 10.1016/j.cub.2010.11.062; Vogeli B, 2007, J AM CHEM SOC, V129, P9377, DOI 10.1021/ja070324o; Voter AF, 1998, PHYS REV B, V57, P13985, DOI 10.1103/PhysRevB.57.R13985; Wang AC, 1996, J AM CHEM SOC, V118, P2483, DOI 10.1021/ja9535524	42	444	445	4	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32131	10.1371/journal.pone.0032131	http://dx.doi.org/10.1371/journal.pone.0032131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384157	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500077
J	Adams, RA; Snode, ER; Shaw, JB				Adams, Rick A.; Snode, Emily R.; Shaw, Jason B.			Flapping Tail Membrane in Bats Produces Potentially Important Thrust during Horizontal Takeoffs and Very Slow Flight	PLOS ONE			English	Article							KINEMATICS; BIOMECHANICS; PERFORMANCE; UPSTROKE; LIFT	Historically, studies concerning bat flight have focused primarily on the wings. By analyzing high-speed video taken on 48 individuals of five species of vespertilionid bats, we show that the capacity to flap the tail-membrane (uropatagium) in order to generate thrust and lift during takeoffs and minimal-speed flight (< 1 m (s-1)) was largely underestimated. Indeed, bats flapped the tail-membrane by extensive dorso-ventral fanning motions covering as much as 135 degrees of arc consistent with thrust generation by air displacement. The degree of dorsal extension of the tail-membrane, and thus the potential amount of thrust generated during platform launches, was significantly correlated with body mass (P = 0.02). Adduction of the hind limbs during upstrokes collapsed the tail-membrane thereby reducing its surface area and minimizing negative lift forces. Abduction of the hind limbs during the downstroke fully expanded the tail-membrane as it was swept ventrally. The flapping kinematics of the tail-membrane is thus consistent with expectations for an airfoil. Timing offsets between the wings and tail-membrane during downstrokes was as much as 50%, suggesting that the tail-membrane was providing thrust and perhaps lift when the wings were retracting through the upstoke phase of the wing-beat cycle. The extent to which the tail-membrane was used during takeoffs differed significantly among four vespertilionid species (P = 0.01) and aligned with predictions derived from bat ecomorphology. The extensive fanning motion of the tail membrane by vespertilionid bats has not been reported for other flying vertebrates.	[Adams, Rick A.; Snode, Emily R.; Shaw, Jason B.] Univ No Colorado, Sch Biol Sci, Greeley, CO 80639 USA	University of Northern Colorado	Adams, RA (corresponding author), Univ No Colorado, Sch Biol Sci, Greeley, CO 80639 USA.	rick.adams@unco.edu			University of Northern Colorado	University of Northern Colorado	Research was funded by the Provost Research Fund at the University of Northern Colorado. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 1997, J ZOOL LONDON, V246, P165; Adams RA, 2008, CELLS TISSUES ORGANS, V187, P13, DOI 10.1159/000109960; ALDRIDGE HDJN, 1986, J EXP BIOL, V126, P479; [Anonymous], 1999, REV DOLPHIN HYDRODYN; Azuma A., 2006, BIOKINETICS FLYING S; Berg AM, 2010, J EXP BIOL, V213, P1651, DOI 10.1242/jeb.038109; Fish FE, 1996, AM ZOOL, V36, P628, DOI 10.1093/icb/36.6.628; Fish FE, 2000, PHYSIOL BIOCHEM ZOOL, V73, P683, DOI 10.1086/318108; Gardiner JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018214; GATESY SM, 1993, J EXP BIOL, V176, P55; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; HERMANSON JW, 1983, J MAMMAL, V64, P62, DOI 10.2307/1380751; HERMANSON JW, 1985, J ZOOL, V205, P157, DOI 10.1111/j.1469-7998.1985.tb03526.x; Kojeszewski T, 2007, J EXP BIOL, V210, P2411, DOI 10.1242/jeb.02790; MacAyeal LC, 2011, J EXP BIOL, V214, P786, DOI 10.1242/jeb.050195; Muijres FT, 2008, SCIENCE, V319, P1250, DOI 10.1126/science.1153019; Norberg U., 1990, VERTEBRATE FLIGHT ME; Norberg UML, 2006, J EXP BIOL, V209, P3887, DOI 10.1242/jeb.02446; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Rayner J.M.V., 1987, P23; RAYNER JMV, 1986, NATURE, V321, P162, DOI 10.1038/321162a0; Schutt WA, 1997, J EXP BIOL, V200, P3003; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Swartz SM, 2008, CELLS TISSUES ORGANS, V187, P59, DOI 10.1159/000109964; Swartz SM, 2003, BAT ECOLOGY, P257; Vaughan TA, 1970, BATS, P127; VAUGHAN TERRY A., 1959, UNIV KANSAS PUBL MUS NAT HIST, V12, P1; VIDELER J, 1985, J EXP BIOL, V119, P265	28	12	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32074	10.1371/journal.pone.0032074	http://dx.doi.org/10.1371/journal.pone.0032074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393378	Green Published, gold, Green Submitted			2022-12-27	WOS:000303003500031
J	Morgan, HP; Mertens, HDT; Guariento, M; Schmidt, CQ; Soares, DC; Svergun, DI; Herbert, AP; Barlow, PN; Hannan, JP				Morgan, Hugh P.; Mertens, Haydyn D. T.; Guariento, Mara; Schmidt, Christoph Q.; Soares, Dinesh C.; Svergun, Dmitri I.; Herbert, Andrew P.; Barlow, Paul N.; Hannan, Jonathan P.			Structural Analysis of the C-Terminal Region (Modules 18-20) of Complement Regulator Factor H (FH)	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; SMALL-ANGLE SCATTERING; TRANSLATIONAL MINIREVIEW SERIES; POLYANION BINDING-SITE; SYNCHROTRON X-RAY; MACULAR DEGENERATION; ALTERNATIVE PATHWAY; 3-DIMENSIONAL STRUCTURE; HOST RECOGNITION; PROTEIN BETA-1H	Factor H (FH) is a soluble regulator of the human complement system affording protection to host tissues. It selectively inhibits amplification of C3b, the activation-specific fragment of the abundant complement component C3, in fluid phase and on self-surfaces and accelerates the decay of the alternative pathway C3 convertase, C3bBb. We have determined the crystal structure of the three carboxyl-terminal complement control protein (CCP) modules of FH (FH18-20) that bind to C3b, and which additionally recognize polyanionic markers specific to self-surfaces. These CCPs harbour nearly 30 disease-linked missense mutations. We have also deployed small-angle X-ray scattering (SAXS) to investigate FH18-20 flexibility in solution using FH18-20 and FH19-20 constructs. In the crystal lattice FH18-20 adopts a "J"-shape: A similar to 122-degree tilt between the structurally highly similar modules 18 and 19 precedes an extended, linear arrangement of modules 19 and 20 as observed in previously determined structures of these two modules alone. However, under solution conditions FH18-20 adopts multiple conformations mediated by flexibility between CCPs 18 and 19. We also pinpoint the locations of disease-associated missense mutations on the module 18 surface and discuss our data in the context of the C3b: FH interaction.	[Morgan, Hugh P.; Hannan, Jonathan P.] Univ Edinburgh, Inst Struct & Mol Biol, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Mertens, Haydyn D. T.; Svergun, Dmitri I.] Hamburg Outstn, European Mol Biol Lab, Hamburg, Germany; [Guariento, Mara; Schmidt, Christoph Q.; Herbert, Andrew P.; Barlow, Paul N.] Univ Edinburgh, Sch Chem, EaStCHEM, Edinburgh Biomol NMR Unit, Edinburgh, Midlothian, Scotland; [Soares, Dinesh C.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Ctr Mol Med, Edinburgh, Midlothian, Scotland	University of Edinburgh; European Molecular Biology Laboratory (EMBL); University of Edinburgh; University of Edinburgh	Morgan, HP (corresponding author), Univ Edinburgh, Inst Struct & Mol Biol, Sch Biol Sci, Kings Bldg, Edinburgh, Midlothian, Scotland.	Jonathan.Hannan@ucdenver.edu	Herbert, Andrew P/C-4755-2008; Barlow, Paul N/G-2853-2011; Herbert, Andy P/F-6693-2010; Soares, Dinesh C/A-4425-2012	Herbert, Andrew P/0000-0002-4549-6965; Herbert, Andy P/0000-0002-4549-6965; Soares, Dinesh C/0000-0001-7557-0495; Hannan, Jonathan/0000-0003-3318-2341; Svergun, Dmitri/0000-0003-0830-5696; Mertens, Haydyn/0000-0002-5664-744X	School of Biological Sciences at the University of Edinburgh; Wellcome Trust [073131, 088179]; EMBL Interdisciplinary Postdocs programme (EIPOD); Scottish University Life Sciences Alliance; BBSRC; Medical Research Council [G0001089] Funding Source: researchfish; MRC [G0001089] Funding Source: UKRI	School of Biological Sciences at the University of Edinburgh(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EMBL Interdisciplinary Postdocs programme (EIPOD); Scottish University Life Sciences Alliance; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by start-up funding from the School of Biological Sciences at the University of Edinburgh to JPH, by Wellcome Trust grant 073131 to PNB, and by Wellcome Trust grant 088179 to DCS. HDTM was supported by a fellowship from the EMBL Interdisciplinary Postdocs programme (EIPOD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Use of the Protein Production and Biophysical Characterization Facilities at the University of Edinburgh was supported by The Wellcome Trust, the Scottish University Life Sciences Alliance and the BBSRC.	Aslam M, 2001, J MOL BIOL, V309, P1117, DOI 10.1006/jmbi.2001.4720; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bhattacharjee A, 2010, MOL IMMUNOL, V47, P1686, DOI 10.1016/j.molimm.2010.03.007; Blackmore TK, 1996, J IMMUNOL, V157, P5422; Blackmore TK, 1998, J IMMUNOL, V160, P3342; Boon CJE, 2008, AM J HUM GENET, V82, P516, DOI 10.1016/j.ajhg.2007.11.007; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fernando AN, 2007, J MOL BIOL, V368, P564, DOI 10.1016/j.jmb.2007.02.038; Ferreira VP, 2009, J IMMUNOL, V182, P7009, DOI 10.4049/jimmunol.0804031; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; GORDON DL, 1995, J IMMUNOL, V155, P348; Guigonis V, 2005, AM J KIDNEY DIS, V45, P588, DOI 10.1053/j.ajkd.2004.12.004; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Herbert AP, 2007, J BIOL CHEM, V282, P18960, DOI 10.1074/jbc.M609636200; Herbert AP, 2006, J BIOL CHEM, V281, P16512, DOI 10.1074/jbc.M513611200; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Kirkitadze MD, 1999, BIOCHEMISTRY-US, V38, P7019, DOI 10.1021/bi982453a; Kirkitadze MD, 1999, BIOCHEM J, V344, P167, DOI 10.1042/0264-6021:3440167; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lehtinen MJ, 2009, J BIOL CHEM, V284, P15650, DOI 10.1074/jbc.M900814200; Maleknia SD, 2001, ANAL BIOCHEM, V289, P103, DOI 10.1006/abio.2000.4910; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; MERI S, 1994, BIOCHEM BIOPH RES CO, V198, P52, DOI 10.1006/bbrc.1994.1008; Morgan HP, 2011, ACTA CRYSTALLOGR D, V67, P593, DOI 10.1107/S0907444911015423; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; Okemefuna AI, 2008, J MOL BIOL, V375, P80, DOI 10.1016/j.jmb.2007.09.026; Okemefuna AI, 2010, J BIOL CHEM, V285, P1053, DOI 10.1074/jbc.M109.044529; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; PANGBURN MK, 1991, J BIOL CHEM, V266, P16847; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; Pangburn MK, 2002, J IMMUNOL, V169, P4702, DOI 10.4049/jimmunol.169.9.4702; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; Pechtl IC, 2011, PROTEIN SCI, V12, P2012; Perkins SJ, 2002, J MOL BIOL, V316, P217, DOI 10.1006/jmbi.2001.5337; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Richards A, 2001, AM J HUM GENET, V68, P485, DOI 10.1086/318203; Ripoche J, 1988, BIOCHEM J, V249, P563; Saunders RE, 2006, HUM MUTAT, V27, P21, DOI 10.1002/humu.20268; Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Schmidt CQ, 2010, J MOL BIOL, V395, P105, DOI 10.1016/j.jmb.2009.10.010; Sharma AK, 1996, P NATL ACAD SCI USA, V93, P10996, DOI 10.1073/pnas.93.20.10996; Soares DC, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P19; Soares DC, 2005, PROTEIN ENG DES SEL, V18, P379, DOI 10.1093/protein/gzi039; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755	64	33	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32187	10.1371/journal.pone.0032187	http://dx.doi.org/10.1371/journal.pone.0032187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389686	Green Published, Green Submitted, gold			2022-12-27	WOS:000302999600024
J	Tozer, AJB; Forsythe, ID; Steinert, JR				Tozer, Adam J. B.; Forsythe, Ian D.; Steinert, Joern R.			Nitric Oxide Signalling Augments Neuronal Voltage-Gated L-Type (Ca(V)1) and P/Q-Type (Ca(V)2.1) Channels in the Mouse Medial Nucleus of the Trapezoid Body	PLOS ONE			English	Article							SENSITIVE CALCIUM-CHANNELS; CA2+ CHANNELS; S-NITROSYLATION; INTRINSIC EXCITABILITY; HIPPOCAMPAL-NEURONS; VOLUME TRANSMITTER; HAIR-CELLS; RAT; MODULATION; PATHWAY	Nitric Oxide (NO) is a diffusible second messenger that modulates ion channels, intrinsic excitability and mediates synaptic plasticity. In light of its activity-dependent generation in the principal neurons of the medial nucleus of the trapezoid body (MNTB), we have investigated its potential modulatory effects on native voltage-gated calcium channels (Ca-V) within this nucleus. Whole-cell patch recordings were made from brain slices from P13-15 CBA mice. Slices were incubated with the inhibitor of neuronal nitric oxide synthase (nNOS) 7-nitroindazole (10 mu M) and pharmacological blockers used to isolate Ca2+ current subtypes. Unpaired observations in the presence and absence of the NO-donors sodium nitroprusside (SNP, 100 mu M) or Diethyl-ammonium-nonoate (DEA, 100 mu M) were made to elucidate NO-dependent modulation of the expressed Ca-V subtypes. A differential effect of NO on the calcium channel subtypes was observed: Ca(V)1 and Ca(V)2.1 (L+R- and P/Q+R-type) conductances were potentiated, whereas N+R-type (Ca(V)2.2) and R-type (Ca(V)2.3) current amplitudes were unaffected. L+R-type currents increased from 0.36 +/- 0.04 nA to 0.64 +/- 0.11 nA and P/Q+R-type from 0.55 +/- 0.09 nA to 0.94 +/- 0.05 nA, thereby changing the balance and relative contribution of each subtype to the whole cell calcium current. In addition, N+R-type half-activation voltage was left shifted following NO exposure. NO-dependent modulation of P/Q+R and N+R-type, but not L+R-type, channels was removed by inhibition of soluble guanylyl cyclase (sGC) activity. This data demonstrates a differential effect of NO signalling on voltage-gated calcium entry, by distinct NO-dependent pathways.	[Tozer, Adam J. B.; Forsythe, Ian D.; Steinert, Joern R.] Univ Leicester, MRC Toxicol Unit, Leicester, Leics, England	University of Leicester	Tozer, AJB (corresponding author), Univ Leicester, MRC Toxicol Unit, Leicester, Leics, England.	js333@le.ac.uk	Steinert, Joern/A-6678-2008; Steinert, Joern R/AAI-2742-2020; Steinert, Joern/ABB-4561-2020	Steinert, Joern/0000-0003-1640-0845; Steinert, Joern R/0000-0003-1640-0845; Forsythe, Ian/0000-0001-8216-0419	Medical Research Council; MRC [MC_U132681855] Funding Source: UKRI; Medical Research Council [MC_U132681855] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (http://www.mrctox.le.ac.uk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern GP, 2002, TRENDS NEUROSCI, V25, P510, DOI 10.1016/S0166-2236(02)02254-3; Almanza A, 2007, J NEUROPHYSIOL, V97, P1188, DOI 10.1152/jn.00849.2006; Arroyo G, 2003, EUR J PHARMACOL, V475, P11, DOI 10.1016/S0014-2999(03)02084-3; Artinian L, 2010, J NEUROSCI, V30, P1699, DOI 10.1523/JNEUROSCI.4511-09.2010; BLATTER LA, 1994, CELL CALCIUM, V15, P122, DOI 10.1016/0143-4160(94)90051-5; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Chen JG, 2002, FREE RADICAL BIO MED, V32, P638, DOI 10.1016/S0891-5849(02)00748-7; D'Ascenzo M, 2002, J NEUROSCI, V22, P7485; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Fessenden JD, 1999, J COMP NEUROL, V404, P52; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jian KH, 2007, BIOCHEM BIOPH RES CO, V359, P481, DOI 10.1016/j.bbrc.2007.05.113; Leao RN, 2004, J PHYSIOL-LONDON, V559, P25, DOI 10.1113/jphysiol.2004.067421; Lewis SJ, 2005, EUR J PHARMACOL, V528, P144, DOI 10.1016/j.ejphar.2005.10.056; Li NZ, 2003, J NEUROSCI, V23, P10302; Lv P, 2010, J NEUROPHYSIOL, V103, P2494, DOI 10.1152/jn.00017.2010; Missiaen L, 2000, CELL CALCIUM, V28, P1, DOI 10.1054/ceca.2000.0131; O'Leary T, 2010, J PHYSIOL-LONDON, V588, P157, DOI 10.1113/jphysiol.2009.181024; Petzold GC, 2005, BRAIN RES, V1063, P9, DOI 10.1016/j.brainres.2005.09.048; RANDALL A, 1995, J NEUROSCI, V15, P2995; Randall A, 1999, MOL CELL NEUROSCI, V14, P255, DOI 10.1006/mcne.1999.0795; Scragg JL, 2008, J BIOL CHEM, V283, P24412, DOI 10.1074/jbc.M803037200; Steinert JR, 2011, NEURON, V71, P291, DOI 10.1016/j.neuron.2011.05.037; Steinert JR, 2010, NEUROSCIENTIST, V16, P435, DOI 10.1177/1073858410366481; Steinert JR, 2010, J PHYSIOL-LONDON, V588, P447, DOI 10.1113/jphysiol.2009.184317; Steinert JR, 2008, NEURON, V60, P642, DOI 10.1016/j.neuron.2008.08.025; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; Tong HX, 2010, J PHYSIOL-LONDON, V588, P1451, DOI 10.1113/jphysiol.2009.186676; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Willmott NJ, 2000, J NEUROSCI, V20, P1767; Wong AYC, 2003, J NEUROSCI, V23, P4868; WOOD J, 1994, NEUROPHARMACOLOGY, V33, P1235, DOI 10.1016/0028-3908(94)90022-1; Youssoufian M, 2005, J NEUROPHYSIOL, V94, P3168, DOI 10.1152/jn.00342.2005	36	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32256	10.1371/journal.pone.0032256	http://dx.doi.org/10.1371/journal.pone.0032256			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389692	Green Published, gold, Green Submitted			2022-12-27	WOS:000302999600030
J	Cruz-Martin, A; Crespo, M; Portera-Cailliau, C				Cruz-Martin, Alberto; Crespo, Michelle; Portera-Cailliau, Carlos			Glutamate Induces the Elongation of Early Dendritic Protrusions via mGluRs in Wild Type Mice, but Not in Fragile X Mice	PLOS ONE			English	Article							CRITICAL PERIOD; BARREL CORTEX; DEPENDENT PLASTICITY; SYNAPTIC PLASTICITY; IN-VIVO; SPINES; EXPERIENCE; FILOPODIA; MOTILITY; SYNAPTOGENESIS	Fragile X syndrome (FXS), the most common inherited from of autism and mental impairment, is caused by transcriptional silencing of the Fmr1 gene, resulting in the loss of the RNA-binding protein FMRP. Dendritic spines of cortical pyramidal neurons in affected individuals are abnormally immature and in Fmr1 knockout (KO) mice they are also abnormally unstable. This could result in defects in synaptogenesis, because spine dynamics are critical for synapse formation. We have previously shown that the earliest dendritic protrusions, which are highly dynamic and might serve an exploratory role to reach out for axons, elongate in response to glutamate. Here, we tested the hypothesis that this process is mediated by metabotropic glutamate receptors (mGluRs) and that it is defective in Fmr1 KO mice. Using time-lapse imaging with two-photon microscopy in acute brain slices from early postnatal mice, we find that early dendritic protrusions in layer 2/3 neurons become longer in response to application of glutamate or DHPG, a Group 1 mGluR agonist. Blockade of mGluR5 signaling, which reverses some adult phenotypes of KO mice, prevented the glutamate-mediated elongation of early protrusions. In contrast, dendritic protrusions from KO mice failed to respond to glutamate. Thus, absence of FMRP may impair the ability of cortical pyramidal neurons to respond to glutamate released from nearby pre-synaptic terminals, which may be a critical step to initiate synaptogenesis and stabilize spines.	[Portera-Cailliau, Carlos] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Cruz-Martin, Alberto; Crespo, Michelle; Portera-Cailliau, Carlos] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cruz-Martin, A (corresponding author), Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, San Diego, CA 92103 USA.	cpcailliau@mednet.ucla.edu	Cruz Martin, Alberto/ABE-7562-2021; Cruz-Martín, Alberto/AAO-5320-2020	Cruz-Martin, Alberto/0000-0002-3271-7220	NICHD/NIH [5R01HD054453]; Diversity Supplement; University of California; MARC U*STAR NIH/NIGMS; FRAXA; DANA Foundations; Fu-Hsing and Jyu-Yuan Chen Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD054453] Funding Source: NIH RePORTER	NICHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Diversity Supplement(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); MARC U*STAR NIH/NIGMS; FRAXA; DANA Foundations; Fu-Hsing and Jyu-Yuan Chen Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NICHD/NIH 5R01HD054453 (CPC) and a Diversity Supplement for that grant(ACM), The University of California President's Postdoctoral Fellowship Program (ACM), MARC U*STAR NIH/NIGMS (MC), and by the FRAXA (www.fraxa.org) and DANA Foundations (www.dana.org)(CPC), as well as by the generous support of the Fu-Hsing and Jyu-Yuan Chen Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; Antar LN, 2006, MOL CELL NEUROSCI, V32, P37, DOI 10.1016/j.mcn.2006.02.001; BAKKER CE, 1994, CELL, V78, P23; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Bureau I, 2008, J NEUROSCI, V28, P5178, DOI 10.1523/JNEUROSCI.1076-08.2008; Carroll FY, 2001, MOL PHARMACOL, V59, P965, DOI 10.1124/mol.59.5.965; CORNELLBELL AH, 1990, GLIA, V3, P322, DOI 10.1002/glia.440030503; Cruz-Martin A, 2010, J NEUROSCI, V30, P7793, DOI 10.1523/JNEUROSCI.0577-10.2010; Dailey ME, 1996, J NEUROSCI, V16, P2983; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; De Rubeis S, 2010, MOL CELL NEUROSCI, V43, P43, DOI 10.1016/j.mcn.2009.09.013; FOX K, 1992, J NEUROSCI, V12, P1826; Harlow EG, 2010, NEURON, V65, P385, DOI 10.1016/j.neuron.2010.01.024; Hays SA, 2011, J NEUROSCI, V31, P14223, DOI 10.1523/JNEUROSCI.3157-11.2011; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Kirov SA, 2004, NEUROSCIENCE, V127, P69, DOI 10.1016/j.neuroscience.2004.04.053; Kirov SA, 1999, J NEUROSCI, V19, P2876; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Luikart BW, 2008, J NEUROSCI, V28, P7006, DOI 10.1523/JNEUROSCI.0195-08.2008; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Maravall M, 2004, J NEUROPHYSIOL, V92, P144, DOI 10.1152/jn.00598.2003; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Meredith RM, 2007, NEURON, V54, P627, DOI 10.1016/j.neuron.2007.04.028; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Pan F, 2010, P NATL ACAD SCI US; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Pfeiffer BE, 2007, J NEUROSCI, V27, P3120, DOI 10.1523/JNEUROSCI.0054-07.2007; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Portera-Cailliau C, 2001, REV NEUROLOGIA, V33, P1158, DOI 10.33588/rn.3312.2001338; Portera-Cailliau C, 2011, NEUROSCIENTIST; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Scotto-Lomassese S, 2011, J NEUROSCI, V31, P2205, DOI 10.1523/JNEUROSCI.5514-10.2011; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; SMITH SJ, 1991, NERVE GROWTH CONE, P19; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	46	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32446	10.1371/journal.pone.0032446	http://dx.doi.org/10.1371/journal.pone.0032446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384253	Green Submitted, Green Published, gold			2022-12-27	WOS:000302918500091
J	Cuesta-Dominguez, A; Ortega, M; Ormazabal, C; Santos-Roncero, M; Galan-Diez, M; Steegmann, JL; Figuera, A; Arranz, E; Vizmanos, JL; Bueren, JA; Rio, P; Fernandez-Ruiz, E				Cuesta-Dominguez, Alvaro; Ortega, Mara; Ormazabal, Cristina; Santos-Roncero, Matilde; Galan-Diez, Marta; Luis Steegmann, Juan; Figuera, Angela; Arranz, Eva; Luis Vizmanos, Jose; Bueren, Juan A.; Rio, Paula; Fernandez-Ruiz, Elena			Transforming and Tumorigenic Activity of JAK2 by Fusion to BCR: Molecular Mechanisms of Action of a Novel BCR-JAK2 Tyrosine-Kinase	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; IN-VITRO; SIGNAL TRANSDUCER; RESIDUAL DISEASE; FUSES BCR; GENE; STAT5; MICE; EXPRESSION	Chromosomal translocations in tumors frequently produce fusion genes coding for chimeric proteins with a key role in oncogenesis. Recent reports described a BCR-JAK2 fusion gene in fatal chronic and acute myeloid leukemia, but the functional behavior of the chimeric protein remains uncharacterized. We used fluorescence in situ hybridization and reverse transcription polymerase chain reaction (RT-PCR) assays to describe a BCR-JAK2 fusion gene from a patient with acute lymphoblastic leukemia. The patient has been in complete remission for six years following treatment and autologous transplantation, and minimal residual disease was monitored by real-time RT-PCR. BCR-JAK2 codes for a protein containing the BCR oligomerization domain fused to the JAK2 tyrosine-kinase domain. In vitro analysis of transfected cells showed that BCR-JAK2 is located in the cytoplasm. Transduction of hematopoietic Ba/F3 cells with retroviral vectors carrying BCR-JAK2 induced IL-3-independent cell growth, constitutive activation of the chimeric protein as well as STAT5 phosphorylation and translocation to the nuclei, where Bcl-xL gene expression was elicited. Primary mouse progenitor cells transduced with BCR-JAK2 also showed increased proliferation and survival. Treatment with the JAK2 inhibitor TG101209 abrogated BCR-JAK2 and STAT5 phosphorylation, decreased Bcl-xL expression and triggered apoptosis of transformed Ba/F3 cells. Therefore, BCR-JAK2 is a novel tyrosine-kinase with transforming activity. It deregulates growth factor-dependent proliferation and cell survival, which can be abrogated by the TG101209 inhibitor. Moreover, transformed Ba/F3 cells developed tumors when injected subcutaneously into nude mice, thus proving the tumorigenic capacity of BCR-JAK2 in vivo. Together these findings suggest that adult and pediatric patients with BCR-ABL-negative leukemia and JAK2 overexpression may benefit from targeted therapies.	[Cuesta-Dominguez, Alvaro; Ortega, Mara; Santos-Roncero, Matilde; Galan-Diez, Marta; Fernandez-Ruiz, Elena] Hosp Univ Princesa, Mol Biol Unit, Inst Invest Sanitaria Princesa IP, Madrid, Spain; [Cuesta-Dominguez, Alvaro; Ortega, Mara; Santos-Roncero, Matilde; Galan-Diez, Marta; Fernandez-Ruiz, Elena] REIPI, Madrid, Spain; [Ormazabal, Cristina; Luis Vizmanos, Jose] Univ Navarra, Dept Genet, E-31080 Pamplona, Spain; [Luis Steegmann, Juan; Figuera, Angela; Arranz, Eva] Hosp Univ Princesa, Dept Hematol, Madrid, Spain; [Bueren, Juan A.; Rio, Paula] Ctr Invest Energeticas Medioambientales & Tecnol, Div Hematopoiesis & Gene Therapy, Madrid, Spain; [Bueren, Juan A.; Rio, Paula] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain	University of Navarra; Hospital de La Princesa; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Cuesta-Dominguez, A (corresponding author), Hosp Univ Princesa, Mol Biol Unit, Inst Invest Sanitaria Princesa IP, Madrid, Spain.	efernandez.hlpr@salud.madrid.org	Galan-Diez, Marta/A-7037-2019; Fernández-Ruiz, Elena/A-7971-2019; Bueren, Juan/L-6112-2014; Vizmanos, José L./G-2833-2012; Rio, Paula/G-8681-2015	Galan-Diez, Marta/0000-0002-2092-3414; Fernández-Ruiz, Elena/0000-0001-5380-1686; Bueren, Juan/0000-0002-3228-7013; Vizmanos, José L./0000-0001-7416-3679; Rio, Paula/0000-0002-5424-5543	Fundacion Mutua Madrilena and Ministerio de Ciencia e Innovacion (MIICIN); Instituto de Salud Carlos III (ISCIII) [PI05/1999, PI08/1772, PI04/0037, SAF2007-62473]; CIBERER; Fundacion Marcelino Botin; ISCIII; European Development Regional Fund; Spanish Network for the Research in Infectious Diseases [REIPI RD07/0008/2006]; Consejeria de Educacion de la Comunidad de Madrid; Fondo Social Europeo (FSE)	Fundacion Mutua Madrilena and Ministerio de Ciencia e Innovacion (MIICIN); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); CIBERER; Fundacion Marcelino Botin; ISCIII(Instituto de Salud Carlos III); European Development Regional Fund(European Commission); Spanish Network for the Research in Infectious Diseases; Consejeria de Educacion de la Comunidad de Madrid; Fondo Social Europeo (FSE)(European Social Fund (ESF)European Commission)	This work was partially supported by grants from Fundacion Mutua Madrilena and Ministerio de Ciencia e Innovacion (MIICIN), Instituto de Salud Carlos III (ISCIII) PI05/1999 and PI08/1772 awarded to E.F.-R., PI04/0037 and SAF2007-62473 awarded to J.L.V., and CIBERER and Fundacion Marcelino Botin awarded to J.A.B. and P.R. A.C.-D. was supported by ISCIII co-financed by European Development Regional Fund "A way to achieve Europe", Spanish Network for the Research in Infectious Diseases (REIPI RD07/0008/2006 awarded to E.F.-R.), and M.G.-D. by Consejeria de Educacion de la Comunidad de Madrid and Fondo Social Europeo (FSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarante-Mendes GP, 1998, ONCOGENE, V16, P1383, DOI 10.1038/sj.onc.1201664; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Baxter EJ, 2002, HUM MOL GENET, V11, P1391, DOI 10.1093/hmg/11.12.1391; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; BROOME HE, 1995, J IMMUNOL, V155, P2311; Carron C, 2000, BLOOD, V95, P3891; Cirmena G, 2008, CANCER GENET CYTOGEN, V183, P105, DOI 10.1016/j.cancergencyto.2008.02.005; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Demiroglu A, 2001, BLOOD, V98, P3778, DOI 10.1182/blood.V98.13.3778; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Griesinger F, 2005, GENE CHROMOSOME CANC, V44, P329, DOI 10.1002/gcc.20235; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; Hitoshi Y, 2010, INT J HEMATOL, V91, P189, DOI 10.1007/s12185-010-0531-y; Ho JMY, 1999, BLOOD, V93, P4354, DOI 10.1182/blood.V93.12.4354.412k30_4354_4364; Hoelbl A, 2006, BLOOD, V107, P4898, DOI 10.1182/blood-2005-09-3596; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; HOELZER D, 1993, NEW ENGL J MED, V329, P1343, DOI 10.1056/NEJM199310283291810; Horita M, 2000, J EXP MED, V191, P977, DOI 10.1084/jem.191.6.977; Lacronique V, 2000, BLOOD, V95, P2076, DOI 10.1182/blood.V95.6.2076; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Lane Steven W, 2008, Br J Haematol, V142, P503, DOI 10.1111/j.1365-2141.2008.07164.x; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; MCLAUGHLIN J, 1987, P NATL ACAD SCI USA, V84, P6558, DOI 10.1073/pnas.84.18.6558; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; Million RP, 2000, BLOOD, V96, P664; Mortuza FY, 2002, J CLIN ONCOL, V20, P1094, DOI 10.1200/JCO.20.4.1094; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Nebral K, 2009, LEUKEMIA, V23, P134, DOI 10.1038/leu.2008.306; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Pallis M, 1997, LEUKEMIA, V11, P945, DOI 10.1038/sj.leu.2400705; Pardanani A, 2008, LEUKEMIA, V22, P23, DOI 10.1038/sj.leu.2404948; Pardanani A, 2007, LEUKEMIA, V21, P1658, DOI 10.1038/sj.leu.2404750; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Peeters P, 1997, BLOOD, V90, P2535, DOI 10.1182/blood.V90.7.2535.2535_2535_2540; Poitras JL, 2008, GENE CHROMOSOME CANC, V47, P884, DOI 10.1002/gcc.20585; Prosch S, 1996, BIOL CHEM H-S, V377, P195, DOI 10.1515/bchm3.1996.377.3.195; Puttini M, 2006, CANCER RES, V66, P11314, DOI 10.1158/0008-5472.CAN-06-1199; Reiter A, 2005, CANCER RES, V65, P2662, DOI 10.1158/0008-5472.CAN-04-4263; Rio P, 2002, BLOOD, V100, P2032; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Schwaller J, 1998, EMBO J, V17, P5321, DOI 10.1093/emboj/17.18.5321; Silva M, 1999, J BIOL CHEM, V274, P22165, DOI 10.1074/jbc.274.32.22165; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Sternberg DW, 2004, J CLIN ONCOL, V22, P361, DOI 10.1200/JCO.2004.10.124; Tefferi A, 2007, CELL CYCLE, V6, P550, DOI 10.4161/cc.6.5.3919; Van Etten RA, 2001, CURR OPIN HEMATOL, V8, P224, DOI 10.1097/00062752-200107000-00008; Van Roosbroeck K, 2011, BLOOD, V117, P4056, DOI 10.1182/blood-2010-06-291310; VANRHEE F, 1995, LEUKEMIA, V9, P329; Warsch W, 2011, BLOOD, V117, P3409, DOI 10.1182/blood-2009-10-248211; Werning G, 2008, CANCER CELL, V13, P311, DOI 10.1016/j.ccr.2008.02.009; WilsonRawls J, 1996, CANCER RES, V56, P3426; Ye D, 2006, BLOOD, V107, P4917, DOI 10.1182/blood-2005-10-4110; Yoda A, 2010, P NATL ACAD SCI USA, V107, P252, DOI 10.1073/pnas.0911726107; Yoshimura A, 1996, EMBO J, V15, P1055, DOI 10.1002/j.1460-2075.1996.tb00443.x	55	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32451	10.1371/journal.pone.0032451	http://dx.doi.org/10.1371/journal.pone.0032451			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384256	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500092
J	Kaseva, N; Wehkalampi, K; Strang-Karlsson, S; Salonen, M; Pesonen, AK; Raikkonen, K; Tammelin, T; Hovi, P; Lahti, J; Heinonen, K; Jarvenpaa, AL; Andersson, S; Eriksson, JG; Kajantie, E				Kaseva, Nina; Wehkalampi, Karoliina; Strang-Karlsson, Sonja; Salonen, Minna; Pesonen, Anu-Katriina; Raikkonen, Katri; Tammelin, Tuija; Hovi, Petteri; Lahti, Jari; Heinonen, Kati; Jarvenpaa, Anna-Liisa; Andersson, Sture; Eriksson, Johan G.; Kajantie, Eero			Lower Conditioning Leisure-Time Physical Activity in Young Adults Born Preterm at Very Low Birth Weight	PLOS ONE			English	Article							BLOOD-PRESSURE; CARDIORESPIRATORY FITNESS; RISK-FACTORS; PERSONALITY; HELSINKI; EXERCISE; ADOLESCENCE; PERFORMANCE; COMPENDIUM; CAPACITY	Background: Adults born preterm at very low birth weight (VLBW, <1500 g) have elevated levels of risk factors for cardiovascular diseases and type 2 diabetes. Preliminary observations suggest that this could partly be explained by lower rates of physical activity. The aim of this study was to assess physical activity in healthy young adults born preterm at very low birth weight compared with term-born controls. Methodology/Principal Findings: We studied 94 unimpaired young adults, aged 21-29 years, born at VLBW and 101 age-, sex-, and birth hospital-matched term-born controls from one regional center in Southern Finland. The participants completed a validated 30-item 12-month physical activity questionnaire and the NEO-Personality Inventory based on the Big Five taxonomy, the most commonly used classification of personality traits. Yearly frequency, total time, total volume and energy expenditure of conditioning and non-conditioning leisure-time physical activity (LTPA) and commuting physical activity were compared between VLBW and term-born subjects. A subset of participants underwent dual-energy x-ray absorptiometry for body composition measurement. Data were analyzed by multiple linear regression. Compared with controls, VLBW participants had lower frequency [-38.5% (95% CI; -58.9, -7.7)], total time [-47.4% (95% CI; -71.2, -4.1)], total volume [-44.3% (95% CI; -65.8, -9.2)] and energy expenditure [-55.9% (95% CI; -78.6, -9.4)] of conditioning LTPA when adjusted for age, sex, body mass index, smoking, parental education and personality traits. Adjusting for lean body mass instead of body mass index attenuated the difference. There were no differences in non-conditioning LTPA or commuting physical activity. Conclusions/Significance: Compared with term-born controls, unimpaired VLBW adults undertake less frequent LTPA with lower total time and volume of exercise resulting in lower energy expenditure. Differences in personality that exist between the VLBW and term-born groups do not seem to explain this association.	[Kaseva, Nina; Wehkalampi, Karoliina; Strang-Karlsson, Sonja; Salonen, Minna; Hovi, Petteri; Eriksson, Johan G.; Kajantie, Eero] Natl Inst Hlth & Welf, Dept Chron Dis & Diabet Prevent, Helsinki, Finland; [Kaseva, Nina; Wehkalampi, Karoliina; Strang-Karlsson, Sonja; Hovi, Petteri; Jarvenpaa, Anna-Liisa; Andersson, Sture; Kajantie, Eero] Univ Helsinki, Childrens Hosp, Cent Hosp, Helsinki, Finland; [Pesonen, Anu-Katriina; Raikkonen, Katri; Lahti, Jari; Heinonen, Kati] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Tammelin, Tuija] LIKES Res Ctr Sport & Hlth Sci, Jyvaskyla, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Vaasa Central Hospital; Folkhalsan Research Center	Kaseva, N (corresponding author), Natl Inst Hlth & Welf, Dept Chron Dis & Diabet Prevent, Helsinki, Finland.	nina.kaseva@fimnet.fi	PAN, ZEQIANG/X-6341-2018; Kaseva, Nina/O-7918-2019; Lahti, Jari/P-7987-2018; Lahti, Jari/P-2283-2019	Lahti, Jari/0000-0002-4310-5297; Lahti, Jari/0000-0002-4310-5297; Pesonen, Anu-Katriina/0000-0002-0662-6261; Eriksson, Johan/0000-0002-2516-2060; Raikkonen, Katri/0000-0003-3124-3470; Heinonen, Kati/0000-0002-1262-5599	Vainio Foundation; Novo Nordisk Foundation; Paivikki and Sakari Sohlberg Foundation; University of Helsinki; Perklen Foundation; Research Foundation for the Orion Corporation; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Waldemar von Frenckell Foundation; Yrjo Jahnsson Foundation; Finnish Medical Foundation; Otto A. Malm Donation Fund; Finska Lakaresallskapet; Emil Aaltonen Foundation	Vainio Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Paivikki and Sakari Sohlberg Foundation; University of Helsinki; Perklen Foundation; Research Foundation for the Orion Corporation; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Waldemar von Frenckell Foundation; Yrjo Jahnsson Foundation; Finnish Medical Foundation; Otto A. Malm Donation Fund; Finska Lakaresallskapet; Emil Aaltonen Foundation	The grants previously received are from the following foundations: Vainio Foundation, the Novo Nordisk Foundation, the Paivikki and Sakari Sohlberg Foundation, University of Helsinki, the Perklen Foundation, the Research Foundation for the Orion Corporation, the Signe and Ane Gyllenberg Foundation, the Sigrid Juselius Foundation, the Waldemar von Frenckell Foundation, the Yrjo Jahnsson Foundation, the Finnish Medical Foundation, Otto A. Malm Donation Fund, Finska Lakaresallskapet and the Emil Aaltonen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Allin M, 2006, PEDIATRICS, V117, P309, DOI 10.1542/peds.2005-0539; Andersen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008192; Burns YR, 2009, DEV MED CHILD NEUROL, V51, P136, DOI 10.1111/j.1469-8749.2008.03118.x; Costa P.T., 1985, NEO PERSONALITY INVE; DEBACKER G, 1981, CARDIOLOGY, V67, P110, DOI 10.1159/000173235; Doyle LW, 2003, PEDIATRICS, V111, P252, DOI 10.1542/peds.111.2.252; Evensen KAI, 2009, EUR J PAEDIATR NEURO, V13, P47, DOI 10.1016/j.ejpn.2008.02.009; Hack M, 2005, PEDIATR RES, V58, P677, DOI 10.1203/01.PDR.0000180551.93470.56; Hack M, 2007, J PEDIATR-US, V151, P635, DOI 10.1016/j.jpeds.2007.04.063; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Hovi P, 2010, J PEDIATR-US, V156, P54, DOI 10.1016/j.jpeds.2009.07.022; Hovi P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000135; Irving RJ, 2000, LANCET, V355, P2135, DOI 10.1016/S0140-6736(00)02384-9; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Kaijser M, 2009, DIABETES, V58, P523, DOI 10.2337/db08-0558; Kajantie E, 2010, DIABETES CARE; Kajantie E, 2010, J PEDIAT; Keller H, 2000, MED SCI SPORT EXER, V32, P278, DOI 10.1097/00005768-200002000-00005; Kohrt WM, 2004, MED SCI SPORT EXER, V36, P1985, DOI 10.1249/01.MSS.0000142662.21767.58; Koupil I, 2005, J EPIDEMIOL COMMUN H, V59, P473, DOI 10.1136/jech.2004.026518; Laaksonen DE, 2003, DIABETES CARE, V26, P2156, DOI 10.2337/diacare.26.7.2156; Laaksonen DE, 2005, DIABETES, V54, P158, DOI 10.2337/diabetes.54.1.158; LAKKA TA, 1992, INT J EPIDEMIOL, V21, P467, DOI 10.1093/ije/21.3.467; LAKKA TA, 1993, J CLIN EPIDEMIOL, V46, P1119, DOI 10.1016/0895-4356(93)90111-D; Lawlor DA, 2006, DIABETOLOGIA, V49, P2614, DOI 10.1007/s00125-006-0408-z; Norman M, 2010, SEMIN PERINATOL, V34, P183, DOI 10.1053/j.semperi.2010.02.009; Orozco LJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003054.pub3; Pescatello LS, 2004, MED SCI SPORT EXER, V36, P533, DOI 10.1249/01.MSS.0000115224.88514.3A; Pesonen AK, 2008, J CHILD PSYCHOL PSYC, V49, P609, DOI 10.1111/j.1469-7610.2007.01874.x; Pianosi PT, 2000, PEDIATR RES, V47, P653, DOI 10.1203/00006450-200005000-00016; Pihkala J, 1989, Duodecim, V105, P1540; Pyhala R, 2010, J PEDIAT; Pyhala R, 2009, PEDIATRICS, V123, P731, DOI 10.1542/peds.2008-0277; Rhodes RE, 2006, BRIT J SPORT MED, V40, P958, DOI 10.1136/bjsm.2006.028860; Rogers M, 2005, PEDIATRICS, V116, pE58, DOI 10.1542/peds.2004-1603; Saigal S, 2007, PEDIATRICS, V119, pE562, DOI 10.1542/peds.2006-2328; Schmidt LA, 2008, PEDIATRICS, V122, pE181, DOI 10.1542/peds.2007-3747; Strang-Karlsson S, 2010, CHRONOBIOL INT, V27, P1829, DOI 10.3109/07420528.2010.512689; Vrijlandt EJLE, 2006, AM J RESP CRIT CARE, V173, P890, DOI 10.1164/rccm.200507-1140OC	42	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32430	10.1371/journal.pone.0032430	http://dx.doi.org/10.1371/journal.pone.0032430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384247	Green Submitted, Green Published, gold			2022-12-27	WOS:000302918500088
J	Khodja, NI; Chataigneau, T; Auger, C; Schini-Kerth, VB				Khodja, Noureddine Idris; Chataigneau, Thierry; Auger, Cyril; Schini-Kerth, Valerie B.			Grape-Derived Polyphenols Improve Aging-Related Endothelial Dysfunction in Rat Mesenteric Artery: Role of Oxidative Stress and the Angiotensin System	PLOS ONE			English	Article							RED WINE POLYPHENOLS; EDHF-MEDIATED RELAXATIONS; PORCINE CORONARY-ARTERIES; II-INDUCED HYPERTENSION; NITRIC-OXIDE SYNTHASE; HYPERPOLARIZING FACTOR; DEPENDENT RELAXATIONS; SUPEROXIDE-PRODUCTION; REDUCED EXPRESSION; ENZYME-INHIBITION	Aging is characterized by the development of an endothelial dysfunction, which affects both the nitric oxide (NO)- and the endothelium-derived hyperpolarizing factor (EDHF)-mediated relaxations, associated with vascular oxidative stress and the activation of the angiotensin system. This study investigated whether red wine polyphenols (RWPs), antioxidants and potent stimulators of NO-and EDHF-mediated relaxations improve aging-related endothelial dysfunction, and, if so, examined the underlying mechanism. Mesenteric artery reactivity was determined in organ chambers, vascular oxidative stress by dihydroethidine and MitoSOX staining, and expression of target proteins by immunohistochemical staining. Control young rats (16 weeks) received solvent (ethanol, 3% v/v), and middle-aged rats (46 weeks) either solvent or RWPs (100 mg/kg/day) in the drinking water. The acetylcholine-induced endothelium-dependent NO component was slightly reduced whereas the EDHF component was markedly blunted in rings of middle-aged rats compared to young rats. The endothelial dysfunction was associated with oxidative stress, an upregulation of angiotensin II and AT1 receptors and a down-regulation of SKCa, IKCa, and angiotensin converting enzyme. Intake of RWPs for either one or two weeks improved the NO and the EDHF components of the relaxation, and normalized oxidative stress, the expression of SKCa, IKCa and the components of the angiotensin system. The protective effect of the 2-week RWPs treatment persisted for one and two weeks following stopping intake of RWPs. Thus, intake of RWPs caused a persistent improvement of the endothelial function, particularly the EDHF component, in middle-aged rats and this effect seems to involve the normalization of the expression of SKCa, IKCa and the angiotensin system.	[Khodja, Noureddine Idris; Chataigneau, Thierry; Auger, Cyril; Schini-Kerth, Valerie B.] Univ Strasbourg, Fac Pharm, Lab Biophoton & Pharmacol, UMR CNRS 7213, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Khodja, NI (corresponding author), Univ Strasbourg, Fac Pharm, Lab Biophoton & Pharmacol, UMR CNRS 7213, Illkirch Graffenstaden, France.	valerie.schini-kerth@unistra.fr	Auger, Cyril/N-4702-2016		Office National Interprofessionnel des Fruits, des Legumes, des Vins et de l'Horticulture (Action Vin Sante, France)	Office National Interprofessionnel des Fruits, des Legumes, des Vins et de l'Horticulture (Action Vin Sante, France)	This work was supported, in part, by the Office National Interprofessionnel des Fruits, des Legumes, des Vins et de l'Horticulture (Action Vin & Sante, France). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aranda R, 2007, FREE RADICAL RES, V41, P1195, DOI 10.1080/10715760701481461; Armstead WM, 2003, ANESTHESIOLOGY, V98, P1378, DOI 10.1097/00000542-200306000-00012; ATKINSON J, 1994, AM J PHYSIOL, V267, pR136, DOI 10.1152/ajpregu.1994.267.1.R136; Briones A. M., 2005, Autonomic & Autacoid Pharmacology, V25, P155, DOI 10.1111/j.1474-8673.2005.00344.x; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0; Chen WG, 2010, BIOCHEMISTRY-US, V49, P3129, DOI 10.1021/bi9016632; Cosentino F, 2001, ARTERIOSCL THROM VAS, V21, P496, DOI 10.1161/01.ATV.21.4.496; Csiszar A, 2002, CIRC RES, V90, P1159, DOI 10.1161/01.RES.0000020401.61826.EA; Dal-Ros S, 2011, BIOCHEM BIOPH RES CO, V404, P743, DOI 10.1016/j.bbrc.2010.12.060; Dal-Ros S, 2010, GASTROENTEROLOGY, V138, P1574, DOI 10.1053/j.gastro.2009.10.040; Dal-Ros S, 2009, J PHARMACOL EXP THER, V328, P478, DOI 10.1124/jpet.108.145326; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; FRANKEL EN, 1993, LANCET, V341, P1103, DOI 10.1016/0140-6736(93)92472-6; Goto K, 2000, HYPERTENSION, V36, P581, DOI 10.1161/01.HYP.36.4.581; Goto K, 2004, CLIN EXP PHARMACOL P, V31, P650, DOI 10.1111/j.1440-1681.2004.04054.x; Hamilton CA, 2001, HYPERTENSION, V37, P529, DOI 10.1161/01.HYP.37.2.529; Hilgers RHP, 2007, AM J PHYSIOL-HEART C, V292, pH2275, DOI 10.1152/ajpheart.00949.2006; HONGO K, 1988, STROKE, V19, P892, DOI 10.1161/01.STR.19.7.892; Kansui Y, 2002, J HYPERTENS, V20, P439, DOI 10.1097/00004872-200203000-00019; Kawai Y, 2008, J BIOL CHEM, V283, P9424, DOI 10.1074/jbc.M706571200; KUNG CF, 1995, HYPERTENSION, V25, P194, DOI 10.1161/01.HYP.25.2.194; Lavrentyev EN, 2007, CIRC RES, V101, P455, DOI 10.1161/CIRCRESAHA.107.151852; Lemarie CA, 2010, J RENIN-ANGIO-ALDO S, V11, P19, DOI 10.1177/1470320309347785; Long DA, 2005, KIDNEY INT, V68, P2154, DOI 10.1111/j.1523-1755.2005.00671.x; Lorenz M, 2004, J BIOL CHEM, V279, P6190, DOI 10.1074/jbc.M309114200; Matz RL, 2000, BRIT J PHARMACOL, V131, P303, DOI 10.1038/sj.bjp.0703568; Modrick ML, 2009, AM J PHYSIOL-HEART C, V296, pH1914, DOI 10.1152/ajpheart.00300.2009; Mukai Y, 2002, ARTERIOSCL THROM VAS, V22, P1445, DOI 10.1161/01.ATV.0000029121.63691.CE; NAKASHIMA M, 1993, J CLIN INVEST, V92, P2867, DOI 10.1172/JCI116907; Ndiaye M, 2004, BRIT J PHARMACOL, V142, P1131, DOI 10.1038/sj.bjp.0705774; Ndiaye M, 2003, BIOCHEM BIOPH RES CO, V310, P371, DOI 10.1016/j.bbrc.2003.09.028; Negishi H, 2004, J NUTR, V134, P38, DOI 10.1093/jn/134.1.38; Newaz MA, 2006, J CARDIOVASC PHARM, V48, P88, DOI 10.1097/01.fjc.0000245402.62864.0a; Oudot A, 2006, FREE RADICAL BIO MED, V40, P2214, DOI 10.1016/j.freeradbiomed.2006.02.020; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sarr M, 2006, CARDIOVASC RES, V71, P794, DOI 10.1016/j.cardiores.2006.05.022; Schmidt TS, 2007, CLIN SCI, V113, P47, DOI 10.1042/CS20070108; Shimokawa H, 1996, J CARDIOVASC PHARM, V28, P703, DOI 10.1097/00005344-199611000-00014; Taddei S, 2001, HYPERTENSION, V38, P274, DOI 10.1161/01.HYP.38.2.274; Urakami-Harasawa L, 1997, J CLIN INVEST, V100, P2793, DOI 10.1172/JCI119826; van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731; Wong SL, 2009, CIRC RES, V104, P228, DOI 10.1161/CIRCRESAHA.108.179770; Wu SZ, 2007, GERONTOLOGY, V53, P234, DOI 10.1159/000100961; Yang YM, 2009, AM J PHYSIOL-HEART C, V297, pH1829, DOI 10.1152/ajpheart.00230.2009; Ying CJ, 2003, HYPERTENS RES, V26, P823, DOI 10.1291/hypres.26.823; Zhu JH, 2010, ASIAN J ANDROL, V12, P599, DOI 10.1038/aja.2009.97	48	42	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32039	10.1371/journal.pone.0032039	http://dx.doi.org/10.1371/journal.pone.0032039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384133	Green Submitted, Green Published, gold			2022-12-27	WOS:000302918500056
J	Branco, RCS; de Oliveira, JC; Grassiolli, S; Miranda, RA; Barella, LF; Gomes, RM; Bataglini, LA; Torrezan, R; Gravena, C; Mathias, PCD				Souto Branco, Renato Chaves; de Oliveira, Julio Cezar; Grassiolli, Sabrina; Miranda, Rosiane Aparecida; Barella, Luiz Felipe; Gomes, Rodrigo Mello; Bataglini, Luiz Augusto; Torrezan, Rosana; Gravena, Clarice; de Freitas Mathias, Paulo Cezar			Maternal Protein Malnutrition Does Not Impair Insulin Secretion from Pancreatic Islets of Offspring after Transplantation into Diabetic Rats	PLOS ONE			English	Article							BETA-CELL; EARLY LACTATION; ADULT-RATS; UNDERNUTRITION; METABOLISM; GROWTH; DIET; TERM; HYPERGLYCEMIA; DYSFUNCTION	Pancreatic islets from adult rats whose mothers were protein restricted during lactation undersecrete insulin. The current work analyzes whether this secretory dysfunction can be improved when the pancreatic islets are grafted into hyperglycemic diabetic rats. Two groups of rats were used: the adult offspring from dams that received a low protein diet (4%) during the initial 2/3 of lactation (LP) and, as a control, the adult offspring from dams that consumed a normal protein diet (23%) during the entire period of lactation (NP). Islets from NP- and LP-rats were transplanted into diabetic recipient rats, which were generated by streptozotocin treatment. The islets were transplanted via the portal vein under anesthesia. The fed blood glucose levels were monitored during the 4 days post-transplantation. Transplanted islets from LP-rats (T LP) decreased the fed glucose levels of diabetic rats 34% (21.37 +/- 0.24 mM, p < 0.05); however, the levels still remained 2-fold higher than those of the sham-operated controls (6.88 +/- 0.39 mM, p < 0.05). Grafts with NP-islets (T NP) produced the same effect as the LP-islets in diabetic rats. The high fasting blood glucose levels of diabetic rats were improved by the transplantations. Islet grafts from both rat groups recovered 50% of the retroperitoneal fat mass of the diabetic rats (0.55 +/- 0.08 g/100 g of body weight for T NP and 0.56 +/- 0.07 g/100 g of body weight for T LP, p, 0.05). Because pancreatic islets from both the NP- and LP-rats were able to regulate fasting blood glucose concentrations in hyperglycemic rats, we propose that the altered function of pancreatic islets from LP-rats is not permanent.	[Souto Branco, Renato Chaves; de Oliveira, Julio Cezar; Miranda, Rosiane Aparecida; Barella, Luiz Felipe; Gomes, Rodrigo Mello; Bataglini, Luiz Augusto; Torrezan, Rosana; Gravena, Clarice; de Freitas Mathias, Paulo Cezar] Univ Estadual Maringa, Lab Secret Cell Biol, Dept Cell Biol & Genet, Maringa, Parana, Brazil; [Grassiolli, Sabrina] Univ Estadual Ponta Grossa, Dev Biol Lab, Dept Biol, Ponta Grossa, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Ponta Grossa	Branco, RCS (corresponding author), Univ Estadual Maringa, Lab Secret Cell Biol, Dept Cell Biol & Genet, Maringa, Parana, Brazil.	pmathias@uem.br	Miranda, Rosiane Aparecida/C-1688-2019; Gomes, Rodrigo Mello/L-2639-2016; de Freitas Mathias, Paulo Cezar PCFM/O-6056-2015; Chaves Souto Branco, Renato/N-7198-2016; Barella, Luiz/C-1181-2014; de Oliveira, Júlio Cezar/G-8527-2012; Grassiolli, Sabrina/AAP-5934-2020; DE FREITAS MATHIAS, PAULO CEZAR/AAQ-9682-2021	Miranda, Rosiane Aparecida/0000-0003-0978-7949; Gomes, Rodrigo Mello/0000-0002-9012-3287; de Freitas Mathias, Paulo Cezar PCFM/0000-0001-6994-4585; Chaves Souto Branco, Renato/0000-0002-6886-7693; Barella, Luiz/0000-0003-2211-3842; de Oliveira, Júlio Cezar/0000-0002-6489-9348; Grassiolli, Sabrina/0000-0001-5647-7877; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; Fundacao Araucaria	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	This work was supported by the Brazilian Research Agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES and Fundacao Araucaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeghate E, 2002, TRANSPL IMMUNOL, V10, P73, DOI 10.1016/S0966-3274(02)00051-5; Barbosa FB, 1999, RES COMMUN MOL PATH, V106, P63; Barbosa FB, 2002, BRIT J NUTR, V87, P147, DOI 10.1079/BJN2001489; BARBOSA FB, 1993, BRAZ J MED BIOL RES, V26, P1355; Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649; Bernt E, 1974, METHOD ENZYMAT AN, P1105; Biarnes M, 2002, DIABETES, V51, P66, DOI 10.2337/diabetes.51.1.66; Caldeira JD, 2000, RES COMMUN MOL PATH, V108, P213; Cheng Y, 2007, WORLD J GASTROENTERO, V13, P2862, DOI 10.3748/wjg.v13.i20.2862; Da Costa CL, 2004, J NUTR BIOCHEM, V15, P236, DOI [10.1016/j.nutbio.2003.12.004, 10.1016/j.jnutbio.2003.12.004]; Mathias PCD, 2007, TRANSPL P, V39, P193, DOI 10.1016/j.transproceed.2006.10.218; de Oliveira JC, 2011, J NEUROENDOCRINOL, V23, P148, DOI 10.1111/j.1365-2826.2010.02095.x; Cunha ACDR, 2009, J NUTR BIOCHEM, V20, P435, DOI 10.1016/j.jnutbio.2008.05.002; Dong XY, 2010, PEPTIDES, V31, P2145, DOI 10.1016/j.peptides.2010.07.020; Dufer M, 2010, ISLETS, V2, P156, DOI 10.4161/isl.2.3.11412; Dumortier O, 2007, DIABETOLOGIA, V50, P2495, DOI 10.1007/s00125-007-0811-0; FISHER RS, 1988, J COMP NEUROL, V272, P489, DOI 10.1002/cne.902720404; Fontaine Magali J, 2003, Hepatobiliary Pancreat Dis Int, V2, P170; GELOEN A, 1989, AM J PHYSIOL, V257, pE547, DOI 10.1152/ajpendo.1989.257.4.E547; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; Gravena C, 2002, J ENDOCRINOL, V173, P73, DOI 10.1677/joe.0.1730073; Gravena C, 2007, NUTR NEUROSCI, V10, P79, DOI 10.1080/10284150701308693; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; HILLER WFA, 1991, DIABETES, V40, P134, DOI 10.2337/diabetes.40.1.134; Hoet J J, 1992, Bull Mem Acad R Med Belg, V147, P174; Kimani-Murage EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-158; Lamontagne J, 2009, ENDOCRINOLOGY, V150, P3465, DOI 10.1210/en.2008-1557; Lesage J, 2006, STRESS, V9, P183, DOI 10.1080/10253890601056192; Malaisse WJ, 2003, INT J MOL MED, V12, P911; Molendi-Coste O, 2009, NEUROENDOCRINOLOGY, V90, P54, DOI 10.1159/000209222; Morsiani E, 1997, CELL TRANSPLANT, V6, P17, DOI 10.1016/S0963-6897(96)00091-7; Moura AS, 1996, RES COMMUN MOL PATH, V92, P73; Moura AS, 1997, RES COMMUN MOL PATH, V96, P179; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Ong KKL, 2000, J PEDIATR ENDOCR MET, V13, P1419; Prestes-Carneiro LE, 2006, J NUTR SCI VITAMINOL, V52, P414, DOI 10.3177/jnsv.52.414; ROGERS P, 1980, BRIT J NUTR, V43, P83, DOI 10.1079/BJN19800066; SAWAYA AL, 2003, CAD SAUDE PUB S1, V19, P21; SCOTT AM, 1981, DIABETOLOGIA, V21, P470; SENER A, 1978, METABOLISM, V27, P1505, DOI 10.1016/S0026-0495(78)80023-7; Sullivan EL, 2010, FORUM NUTR, V63, P186, DOI 10.1159/000264406; Thompson RF, 2010, J BIOL CHEM, V285, P15111, DOI 10.1074/jbc.M109.095133; van Straten EME, 2010, AM J PHYSIOL-REG I, V298, pR275, DOI 10.1152/ajpregu.00413.2009	45	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e30685	10.1371/journal.pone.0030685	http://dx.doi.org/10.1371/journal.pone.0030685			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383969	gold, Green Published, Green Submitted			2022-12-27	WOS:000302918500013
J	Reading, CL; Frincke, JM; White, SK				Reading, Christopher L.; Frincke, James M.; White, Steven K.			Molecular Targets for 17 alpha-Ethynyl-5-Androstene-3 beta,7 beta,17 beta-Triol, an Anti-Inflammatory Agent Derived from the Human Metabolome	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-1; INSULIN-RESISTANCE; RHEUMATOID-ARTHRITIS; SYNTHETIC ANALOG; ORAL TREATMENT; RODENT MODELS; MICE; DISEASE; HE3286; CELLS	HE3286, 17 alpha-ethynyl-5-androstene-3 beta, 7 beta, 17 beta-triol, is a novel synthetic compound related to the endogenous sterol 5-androstene-3 beta, 7 beta, 17 beta-triol (beta-AET), a metabolite of the abundant adrenal steroid dehydroepiandrosterone (DHEA). HE3286 has shown efficacy in clinical studies in impaired glucose tolerance and type 2 diabetes, and in vivo models of types 1 and 2 diabetes, autoimmunity, and inflammation. Proteomic analysis of solid-phase HE3286-bound bead affinity experiments, using extracts from RAW 264.7 mouse macrophage cells, identified 26 binding partners. Network analysis revealed associations of these HE3286 target proteins with nodes in the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways for type 2 diabetes, insulin, adipokine, and adipocyte signaling. Binding partners included low density lipoprotein receptor-related protein (Lrp1), an endocytic receptor; mitogen activated protein kinases 1 and 3 (Mapk1, Mapk3), protein kinases involved in inflammation signaling pathways; ribosomal protein S6 kinase alpha-3 (Rsp6ka3), an intracellular regulatory protein; sirtuin-2 (Sirt2); and 17 beta-hydroxysteroid dehydrogenase 1 (Hsd17 beta 4), a sterol metabolizing enzyme.	[Reading, Christopher L.; Frincke, James M.] Harbor Biosci, Dept Sci Dev, San Diego, CA USA; [White, Steven K.] Harbor Biosci, Dept Med Chem, San Diego, CA USA		Reading, CL (corresponding author), Harbor Biosci, Dept Sci Dev, San Diego, CA USA.	swhite@harborbiosciences.com			Harbor Biosciences	Harbor Biosciences	The authors have read the journal's policy and have the following conflicts: All authors declare that they are employees of Harbor Biosciences who funded this study. All authors own stock in Harbor Biosciences. Harbor Biosciences owns US patent No. 7,776,845, which is related to HE3286. In addition, Dr. Frincke sits on the Board of Harbor Biosciences. HE3286 is in clinical development, but there is no marketed product to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ahlem C, 2009, ANN NY ACAD SCI, V1173, P781, DOI 10.1111/j.1749-6632.2009.04798.x; Ahlem CN, INT J CLIN EXP MED, V4, P119; Ahlem CN, STEROIDS, V76, P669; [Anonymous], BIOGRID DATABASE V 3; Auci D, 2007, ANN NY ACAD SCI, V1110, P630, DOI 10.1196/annals.1423.066; Auci DL, 2010, OBESITY SILVER SPRIN, DOI [10.1038/oby.2010.1204, DOI 10.1038/OBY.2010.1204]; Auci DL, 2010, INT J MOL MED, V25, P625, DOI 10.3892/ijmm_00000385; Auci DL, 2009, AUTOIMMUN REV, V8, P369, DOI 10.1016/j.autrev.2008.11.011; Baitsch D, ARTERIOSCLER THROMB, V31, P1160; Boucher P, BIOCH PHARM, V81, P1; Celec P, 2003, PHYSIOL RES, V52, P397; Ceschin DG, 2009, J CELL BIOCHEM, V106, P372, DOI 10.1002/jcb.22014; Chung SK, 2005, J BIOL CHEM, V280, P38445, DOI 10.1074/jbc.M508159200; Conrad D, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-52; Croy JE, 2004, BIOCHEMISTRY-US, V43, P7328, DOI 10.1021/bi036208p; Fleuren WW, NUCL ACIDS RES, V39, pW450; Gaultier A, 2008, BLOOD, V111, P5316, DOI 10.1182/blood-2007-12-127613; Gordts PLSM, 2009, ARTERIOSCL THROM VAS, V29, P1258, DOI 10.1161/ATVBAHA.109.192211; Harsha HC, 2008, NAT PROTOC, V3, P505, DOI 10.1038/nprot.2008.2; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Jager J, 2010, DIABETES, V59, P61, DOI 10.2337/db09-0470; Kosiewicz M, 2011, EUR J PHARM IN PRESS; Kuo LH, 2011, DIABETOLOGIA, V54, P168, DOI 10.1007/s00125-010-1931-5; Lee SJ, 2010, EMBO REP, V11, P226, DOI 10.1038/embor.2010.7; Li JH, 2005, J ORG CHEM, V70, P4393, DOI 10.1021/jo0503310; Loria RM, 1997, PSYCHONEUROENDOCRINO, V22, pS103, DOI 10.1016/S0306-4530(97)00005-X; Lu M, 2010, AM J PHYSIOL-ENDOC M, V298, pE1036, DOI 10.1152/ajpendo.00668.2009; Malik AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013566; Mann M, 2009, NAT METHODS, V6, P717, DOI 10.1038/nmeth1009-717; Muller C, 2006, J STEROID BIOCHEM, V99, P215, DOI 10.1016/j.jsbmb.2005.12.001; Offner H, 2002, J NEUROIMMUNOL, V130, P128, DOI 10.1016/S0165-5728(02)00214-X; Offner H, 2009, J PHARMACOL EXP THER, V329, P1100, DOI 10.1124/jpet.108.145086; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Reading C, 2011, OBESITY UNPUB; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Wang TL, 2010, J PHARMACOL EXP THER, V333, P70, DOI 10.1124/jpet.109.161182; Washburn MP, 2002, ANAL CHEM, V74, P1650, DOI 10.1021/ac015704l; Zhang HY, 2004, J BIOL CHEM, V279, P2221, DOI 10.1074/jbc.M310679200; KEGG PATHWAY	40	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32147	10.1371/journal.pone.0032147	http://dx.doi.org/10.1371/journal.pone.0032147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384159	gold, Green Published, Green Submitted			2022-12-27	WOS:000302916800026
J	De Sutter, J; van de Veire, NR; Struyf, S; Philippe, J; De Buyzere, M; Van Damme, J				De Sutter, Johan; van de Veire, Nico R.; Struyf, Sofie; Philippe, Jan; De Buyzere, Marc; Van Damme, Jo			PF-4var/CXCL4L1 Predicts Outcome in Stable Coronary Artery Disease Patients with Preserved Left Ventricular Function	PLOS ONE			English	Article							CXC-CHEMOKINE PLATELET-FACTOR-4; HUMAN MONOCYTES; VARIANT; DIFFERENTIATION; CXCL4L1; INHIBITION; RECEPTORS; RELEASE; GROWTH	Background: Platelet-derived chemokines are implicated in several aspects of vascular biology. However, for the chemokine platelet factor 4 variant (PF-4var/CXCL4L1), released by platelets during thrombosis and with different properties as compared to PF-4/CXCL4, its role in heart disease is not yet studied. We evaluated the determinants and prognostic value of the platelet-derived chemokines PF-4var, PF-4 and RANTES/CCL5 in patients with stable coronary artery disease (CAD). Methodology/Principal Findings: From 205 consecutive patients with stable CAD and preserved left ventricular (LV) function, blood samples were taken at inclusion and were analyzed for PF-4var, RANTES, platelet factor-4 and N-terminal pro-B-type natriuretic peptide (NT-proBNP). Patients were followed (median follow-up 2.5 years) for the combined endpoint of cardiac death, non-fatal acute myocardial infarction, stroke or hospitalization for heart failure. Independent determinants of PF-4var levels (median 10 ng/ml; interquartile range 8-16 ng/ml) were age, gender and circulating platelet number. Patients who experienced cardiac events (n = 20) during follow-up showed lower levels of PF-4var (8.5 [5.3-10] ng/ml versus 12 [8-16] ng/ml, p = 0.033). ROC analysis for events showed an area under the curve (AUC) of 0.82 (95% CI 0.73-0.90, p<0.001) for higher NT-proBNP levels and an AUC of 0.32 (95% CI 0.19-0.45, p = 0.009) for lower PF-4var levels. Cox proportional hazard analysis showed that PF-4var has an independent prognostic value on top of NT-proBNP. Conclusions: We conclude that low PF-4var/CXCL4L1 levels are associated with a poor outcome in patients with stable CAD and preserved LV function. This prognostic value is independent of NT-proBNP levels, suggesting that both neurohormonal and platelet-related factors determine outcome in these patients.	[De Sutter, Johan; van de Veire, Nico R.] AZ Maria Middelares Ghent, Dept Cardiol, Ghent, Belgium; [De Sutter, Johan; De Buyzere, Marc] Ghent Univ Hosp, Ctr Heart, Ghent, Belgium; [van de Veire, Nico R.] Free Univ Brussels, Fac Med & Pharm, Brussels, Belgium; [Struyf, Sofie; Van Damme, Jo] Univ Louvain, Rega Inst, Lab Mol Immunol, Louvain, Belgium; [Philippe, Jan] Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; Universite Libre de Bruxelles; Vrije Universiteit Brussel; KU Leuven; Ghent University	De Sutter, J (corresponding author), AZ Maria Middelares Ghent, Dept Cardiol, Ghent, Belgium.	jo.vandamme@rega.kuleuven.be	philippé, jan/AAG-8964-2019; Philippé, Jan/A-1027-2008; Struyf, Sofie/U-2455-2017	philippé, jan/0000-0003-4857-5746; Philippé, Jan/0000-0003-4857-5746; Struyf, Sofie/0000-0003-4558-0769; Van Damme, Jo/0000-0002-6707-1167	Fund for Scientific Research of Flanders (FWO-Vlaanderen, Brussels, Belgium) [G.0648.09]; Concerted Research Actions (G.O.A.) of the Regional Government of Flanders [GOA/2007/15]	Fund for Scientific Research of Flanders (FWO-Vlaanderen, Brussels, Belgium)(FWO); Concerted Research Actions (G.O.A.) of the Regional Government of Flanders	This work was supported by the Fund for Scientific Research of Flanders (FWO-Vlaanderen, Brussels, Belgium) (G.0648.09) and the Concerted Research Actions (G.O.A.) of the Regional Government of Flanders (GOA/2007/15) [principal recipient is JVD]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibbins-Domingo K, 2007, JAMA-J AM MED ASSOC, V297, P169, DOI 10.1001/jama.297.2.169; Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Coelho AL, 2005, CYTOKINE GROWTH F R, V16, P553, DOI 10.1016/j.cytogfr.2005.03.004; Fricke I, 2004, FASEB J, V18, P1588, DOI 10.1096/fj.03-1435fje; Gleissner CA, 2010, J IMMUNOL, V184, P4810, DOI 10.4049/jimmunol.0901368; Greinacher A, 2010, HAMOSTASEOLOGIE, V30, P17; HAN ZC, 1990, BRIT J HAEMATOL, V74, P395, DOI 10.1111/j.1365-2141.1990.tb06325.x; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Lambert MP, 2007, BLOOD, V110, P1153, DOI 10.1182/blood-2007-01-067116; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; Lasagni L, 2007, BLOOD, V109, P4127, DOI 10.1182/blood-2006-10-052035; Lazzeri E., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P109, DOI 10.2174/1568008053174723; Mueller A, 2008, J LEUKOCYTE BIOL, V83, P875, DOI 10.1189/jlb.1006645; Nesmelova IV, 2008, J BIOL CHEM, V283, P24155, DOI 10.1074/jbc.M803308200; Petersen F, 1998, J IMMUNOL, V161, P4347; Rudiger A, 2008, INT J CARDIOL, V126, P28, DOI 10.1016/j.ijcard.2007.03.108; Scheuerer B, 2000, BLOOD, V95, P1158, DOI 10.1182/blood.V95.4.1158.004k31_1158_1166; Schnabel RB, 2010, EUR HEART J, V31, P3024, DOI 10.1093/eurheartj/ehq322; Slungaard A, 2003, BLOOD, V102, P146, DOI 10.1182/blood-2002-11-3529; Struyf S, 2004, CIRC RES, V95, P855, DOI 10.1161/01.RES.0000146674.38319.07; Struyf S, 2007, CANCER RES, V67, P5940, DOI 10.1158/0008-5472.CAN-06-4682; Struyf S, 2011, BLOOD, V117, P480, DOI 10.1182/blood-2009-11-253591; Van de Veire NR, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.04.029; Vandercappellen J, 2007, J LEUKOCYTE BIOL, V82, P1519, DOI 10.1189/jlb.0407206; Vandercappellen J, 2011, CYTOKINE GROWTH F R, V22, P1, DOI 10.1016/j.cytogfr.2010.10.011; von Hundelshausen P, 2007, THROMB HAEMOSTASIS, V97, P704, DOI 10.1160/TH07-01-0066; Woller G, 2008, J LEUKOCYTE BIOL, V83, P936, DOI 10.1189/jlb.0907592; Xia CQ, 2003, INT IMMUNOL, V15, P1007, DOI 10.1093/intimm/dxg100	30	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31343	10.1371/journal.pone.0031343	http://dx.doi.org/10.1371/journal.pone.0031343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384011	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100018
J	Noda, S; Asano, Y; Akamata, K; Aozasa, N; Taniguchi, T; Takahashi, T; Ichimura, Y; Toyama, T; Sumida, H; Yanaba, K; Tada, Y; Sugaya, M; Kadono, T; Sato, S				Noda, Shinji; Asano, Yoshihide; Akamata, Kaname; Aozasa, Naohiko; Taniguchi, Takashi; Takahashi, Takehiro; Ichimura, Yohei; Toyama, Tetsuo; Sumida, Hayakazu; Yanaba, Koichi; Tada, Yayoi; Sugaya, Makoto; Kadono, Takafumi; Sato, Shinichi			A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CYSTEINE CATHEPSINS; BASEMENT-MEMBRANE; ANGIOGENESIS; ENDOSTATIN; FLI1; DEGRADATION; INHIBITOR; TRANSFORMING-GROWTH-FACTOR-BETA-1; PHOSPHORYLATION	Cathepsin B (CTSB) is a proteolytic enzyme potentially modulating angiogenic processes and extracellular matrix remodeling. While matrix metalloproteinases are shown to be implicated in tissue fibrosis and vasculopathy associated with systemic sclerosis (SSc), the role of cathepsins in this disease has not been well studied. The aim of this study is to evaluate the roles of CTSB in SSc. Serum pro-CTSB levels were determined by enzyme-linked immunosorbent assay in 55 SSc patients and 19 normal controls. Since the deficiency of transcription factor Fli1 in endothelial cells is potentially associated with the development of SSc vasculopathy, cutaneous CTSB expression was evaluated by immunostaining in Fli1(+/-) and wild type mice as well as in SSc and control subjects. The effects of Fli1 gene silencing and transforming growth factor-beta (TGF-beta) on CTSB expression were determined by real-time PCR in human dermal microvascular endothelial cells (HDMECs) and dermal fibroblasts, respectively. Serum pro-CTSB levels were significantly higher in limited cutaneous SSc (lcSSc) and late-stage diffuse cutaneous SSc (dcSSc) patients than in healthy controls. In dcSSc, patients with increased serum pro-CTSB levels showed a significantly higher frequency of digital ulcers than those with normal levels. CTSB expression in dermal blood vessels was increased in Fli1(+/-) mice compared with wild type mice and in SSc patients compared with healthy controls. Consistently, Fli1 gene silencing increased CTSB expression in HDMECs. In cultured dermal fibroblasts from early dcSSc, CTSB expression was decreased compared with normal fibroblasts and significantly reversed by TGF-beta 1 antisense oligonucleotide. In conclusion, up-regulation of endothelial CTSB due to Fli1 deficiency may contribute to the development of SSc vasculopathy, especially digital ulcers, while reduced expression of CTSB in lesional dermal fibroblasts is likely to be associated with skin sclerosis in early dcSSc.	[Noda, Shinji; Asano, Yoshihide; Akamata, Kaname; Aozasa, Naohiko; Taniguchi, Takashi; Takahashi, Takehiro; Ichimura, Yohei; Toyama, Tetsuo; Sumida, Hayakazu; Yanaba, Koichi; Tada, Yayoi; Sugaya, Makoto; Kadono, Takafumi; Sato, Shinichi] Univ Tokyo, Dept Dermatol, Grad Sch Med, Tokyo 113, Japan	University of Tokyo	Noda, S (corresponding author), Univ Tokyo, Dept Dermatol, Grad Sch Med, Tokyo 113, Japan.	yasano-tky@umin.ac.jp	菅谷, 誠/GWC-3786-2022	Sumida, Hayakazu/0000-0003-0531-559X	Japanese Ministry of Education	Japanese Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant for scientific research from the Japanese Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham DJ, 2009, RHEUMATOLOGY, V48, P3, DOI 10.1093/rheumatology/ken481; Akada H, 2010, BLOOD, V115, P3589, DOI 10.1182/blood-2009-04-215848; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Asano Y, 2006, AM J PATHOL, V168, P499, DOI 10.2353/ajpath.2006.041306; Asano Y, 2005, J IMMUNOL, V175, P7708, DOI 10.4049/jimmunol.175.11.7708; Asano Y, 2005, ARTHRITIS RHEUM-US, V52, P2897, DOI 10.1002/art.21246; Asano Y, 2004, J CLIN INVEST, V113, P253, DOI 10.1172/JCI200416269; Asano Y, 2010, AM J PATHOL, V176, P1983, DOI 10.2353/ajpath.2010.090593; Asano Y, 2009, MOL CELL BIOL, V29, P1882, DOI 10.1128/MCB.01320-08; Bujor AM, 2011, ARTHRITIS RHEUM-US, V63, P1729, DOI 10.1002/art.30284; Chang SH, 2009, CANCER RES, V69, P4537, DOI 10.1158/0008-5472.CAN-08-4539; CLEMENTS PJ, 1993, J RHEUMATOL, V20, P1892; Distler JHW, 2006, RHEUMATOLOGY, V45, P26, DOI 10.1093/rheumatology/kel295; Distler O, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar596; Dziadzio M, 2005, RHEUMATOLOGY, V44, P1518, DOI 10.1093/rheumatology/kei088; Dziankowska-Bartkowiak B, 2006, CLIN EXP RHEUMATOL, V24, P508; Dziankowska-Bartkowiak B, 2005, MEDIAT INFLAMM, P144, DOI 10.1155/MI.2005.144; Ferreras M, 2000, FEBS LETT, V486, P247, DOI 10.1016/S0014-5793(00)02249-3; Fleming JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001452; Hebbar M, 2000, ARTHRITIS RHEUM-US, V43, P889, DOI 10.1002/1529-0131(200004)43:4<889::AID-ANR21>3.0.CO;2-5; Herve-Grepinet V, 2008, FEBS LETT, V582, P1307, DOI 10.1016/j.febslet.2008.03.007; HOYLAND JA, 1993, BRIT J DERMATOL, V129, P384, DOI 10.1111/j.1365-2133.1993.tb03162.x; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Hummers LK, 2009, J RHEUMATOL, V36, P576, DOI 10.3899/jrheum.080516; Im E, 2005, MOL BIOL CELL, V16, P3488, DOI 10.1091/mbc.E04-11-1029; Kubo M, 2003, AM J PATHOL, V163, P571, DOI 10.1016/S0002-9440(10)63685-1; Kuroda K, 1997, ARCH DERMATOL RES, V289, P567, DOI 10.1007/s004030050241; LeRoy EC, 1996, RHEUM DIS CLIN N AM, V22, P675, DOI 10.1016/S0889-857X(05)70295-7; LEROY EC, 1988, J RHEUMATOL, V15, P202; Malla RR, 2011, CANCER GENE THER, V18, P419, DOI 10.1038/cgt.2011.9; Manetti M, 2010, J CELL MOL MED, V14, P1241, DOI 10.1111/j.1582-4934.2010.01027.x; Moles A, 2009, HEPATOLOGY, V49, P1297, DOI 10.1002/hep.22753; Noda S, 2011, J EUR ACAD DERMATOL; Obermajer N, 2008, CONNECT TISSUE RES, V49, P193, DOI 10.1080/03008200802143158; Ram M, 2006, J CLIN IMMUNOL, V26, P299, DOI 10.1007/s10875-006-9022-6; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Rhew Elisa Y, 2004, Curr Rheumatol Rep, V6, P129, DOI 10.1007/s11926-004-0057-5; SATO S, 1994, ARTHRITIS RHEUM, V37, P391, DOI 10.1002/art.1780370313; Spyropoulos DD, 2000, MOL CELL BIOL, V20, P5643, DOI 10.1128/MCB.20.15.5643-5652.2000; STEEN VD, 1988, ARTHRITIS RHEUM, V31, P196, DOI 10.1002/art.1780310207	40	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32272	10.1371/journal.pone.0032272	http://dx.doi.org/10.1371/journal.pone.0032272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384200	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100065
J	Tao, M; Xie, P; Chen, J; Qin, BQ; Zhang, DW; Niu, Y; Zhang, M; Wang, Q; Wu, LY				Tao, Min; Xie, Ping; Chen, Jun; Qin, Boqiang; Zhang, Dawen; Niu, Yuan; Zhang, Meng; Wang, Qing; Wu, Laiyan			Use of a Generalized Additive Model to Investigate Key Abiotic Factors Affecting Microcystin Cellular Quotas in Heavy Bloom Areas of Lake Taihu	PLOS ONE			English	Article							CYANOBACTERIUM MICROCYSTIS; TOXIC CYANOBACTERIA; MEILIANG BAY; HEPATOTOXIN PRODUCTION; ENVIRONMENTAL-FACTORS; AERUGINOSA; GROWTH; LIGHT; LR; DYNAMICS	Lake Taihu is the third largest freshwater lake in China and is suffering from serious cyanobacterial blooms with the associated drinking water contamination by microcystin (MC) for millions of citizens. So far, most studies on MCs have been limited to two small bays, while systematic research on the whole lake is lacking. To explain the variations in MC concentrations during cyanobacterial bloom, a large-scale survey at 30 sites across the lake was conducted monthly in 2008. The health risks of MC exposure were high, especially in the northern area. Both Microcystis abundance and MC cellular quotas presented positive correlations with MC concentration in the bloom seasons, suggesting that the toxic risks during Microcystis proliferations were affected by variations in both Microcystis density and MC production per Microcystis cell. Use of a powerful predictive modeling tool named generalized additive model (GAM) helped visualize significant effects of abiotic factors related to carbon fixation and proliferation of Microcystis (conductivity, dissolved inorganic carbon (DIC), water temperature and pH) on MC cellular quotas from recruitment period of Microcystis to the bloom seasons, suggesting the possible use of these factors, in addition to Microcystis abundance, as warning signs to predict toxic events in the future. The interesting relationship between macrophytes and MC cellular quotas of Microcystis (i.e., high MC cellular quotas in the presence of macrophytes) needs further investigation.	[Tao, Min; Xie, Ping; Chen, Jun; Zhang, Dawen; Niu, Yuan; Zhang, Meng; Wang, Qing; Wu, Laiyan] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol China, Donghu Expt Stn Lake Ecosyst, Wuhan, Peoples R China; [Qin, Boqiang] Chinese Acad Sci, Nanjing Inst Geog & Limnol, Nanjing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS	Tao, M (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol China, Donghu Expt Stn Lake Ecosyst, Wuhan, Peoples R China.	xieping@ihb.ac.cn	Qin, Boqiang/E-5900-2013; Xie, Ping/AAL-7532-2020		National Basic Research Program of China (973 Program) [2008CB418101]; Chinese Academy of Sciences [KZCX1-YW-14-6-1]; State Key Laboratory of Freshwater Ecology and Biotechnology [2011FBZ07]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences)	This study was jointly supported by the National Basic Research Program of China (973 Program) (2008CB418101), the Knowledge Innovation Project of the Chinese Academy of Sciences (KZCX1-YW-14-6-1) and State Key Laboratory of Freshwater Ecology and Biotechnology (2011FBZ07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, SAS PROCEDURE GUIDE; Azevedo SMFO, 2002, TOXICOLOGY, V181, P441, DOI 10.1016/S0300-483X(02)00491-2; CARMICHAEL WW, 1992, J APPL BACTERIOL, V72, P445, DOI 10.1111/j.1365-2672.1992.tb01858.x; Carmichael WW, 2001, HUM ECOL RISK ASSESS, V7, P1393, DOI 10.1080/20018091095087; Casanova MT, 1999, ENVIRON TOXICOL, V14, P97, DOI 10.1002/(SICI)1522-7278(199902)14:1<97::AID-TOX13>3.0.CO;2-3; Chen JZ, 2011, J HAZARD MATER, V190, P240, DOI 10.1016/j.jhazmat.2011.03.030; Chen J, 2009, SCI TOTAL ENVIRON, V407, P3317, DOI 10.1016/j.scitotenv.2009.02.005; Chen J, 2009, TOXICOL SCI, V108, P81, DOI 10.1093/toxsci/kfp009; Dai RH, 2009, J HAZARD MATER, V161, P730, DOI 10.1016/j.jhazmat.2008.04.015; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; Dittmann E, 1997, MOL MICROBIOL, V26, P779, DOI 10.1046/j.1365-2958.1997.6131982.x; Dong X, 2001, SUGI P; Furukawa K, 2006, J BIOSCI BIOENG, V102, P90, DOI 10.1263/jbb.102.90; Gerard C, 2009, ENVIRON POLLUT, V157, P609, DOI 10.1016/j.envpol.2008.08.017; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Greenberg A.E., 1984, P AWWA WAT QUAL TECH, P11; Halstvedt CB, 2008, J PLANKTON RES, V30, P607, DOI 10.1093/plankt/fbn025; Haney JF, 2000, 65 NEW HAMPS WAT RES; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Havens KE, 2003, ENVIRON POLLUT, V122, P379, DOI 10.1016/S0269-7491(02)00304-4; Hu HJ, FRESHWATER ALGAE CHI; Jahnichen S, 2007, APPL ENVIRON MICROB, V73, P6994, DOI 10.1128/AEM.01253-07; Jahnichen S, 2001, ARCH HYDROBIOL, V150, P177; Jang MH, 2004, AQUAT TOXICOL, V68, P51, DOI 10.1016/j.aquatox.2004.02.002; Jang MH, 2008, TOXICON, V51, P882, DOI 10.1016/j.toxicon.2007.12.015; Janse I, 2004, APPL ENVIRON MICROB, V70, P3979, DOI 10.1128/AEM.70.7.3979-3987.2004; Jiang JL, 2011, J HAZARD MATER, V190, P188, DOI 10.1016/j.jhazmat.2011.03.023; John DM., 2002, FRESHWATER ALGAL FLO; Joung SH, 2011, HARMFUL ALGAE, V10, P188, DOI 10.1016/j.hal.2010.09.005; Kaebernick M, 2000, APPL ENVIRON MICROB, V66, P3387, DOI 10.1128/AEM.66.8.3387-3392.2000; KAPLAN A, 1991, PLANT PHYSIOL, V97, P851, DOI 10.1104/pp.97.3.851; Kotak BG, 2000, CAN J FISH AQUAT SCI, V57, P1584, DOI 10.1139/cjfas-57-8-1584; KOTAK BG, 1995, J PHYCOL, V31, P248, DOI 10.1111/j.0022-3646.1995.00248.x; Kurmayer R, 2003, APPL ENVIRON MICROB, V69, P787, DOI 10.1128/AEM.69.2.787-795.2003; Lance E, 2010, ENVIRON POLLUT, V158, P674, DOI 10.1016/j.envpol.2009.10.025; LeBlanc S, 2005, ENVIRON TOXICOL, V20, P67, DOI 10.1002/tox.20079; Li S, 2007, B ENVIRON CONTAM TOX, V78, P226, DOI 10.1007/s00128-007-9116-8; Liu YQ, 2008, B ENVIRON CONTAM TOX, V80, P24, DOI 10.1007/s00128-007-9293-5; Ma Ronghua, 2008, Hupo Kexue, V20, P687; MILLER AG, 1984, J BACTERIOL, V159, P100, DOI 10.1128/JB.159.1.100-106.1984; NISHIWAKIMATSUSHIMA R, 1992, J CANCER RES CLIN, V118, P420, DOI 10.1007/BF01629424; Niu Y, 2011, WATER RES, V45, P4169, DOI 10.1016/j.watres.2011.05.022; Orr PT, 1998, LIMNOL OCEANOGR, V43, P1604, DOI 10.4319/lo.1998.43.7.1604; Ozawa K, 2005, ENVIRON TOXICOL, V20, P270, DOI 10.1002/tox.20117; Paerl H W, 2001, ScientificWorldJournal, V1, P76; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Pope CA, 2007, ENVIRON HEALTH PERSP, V115, P679, DOI 10.1289/ehp.9762; Sabart M, 2010, APPL ENVIRON MICROB, V76, P4750, DOI 10.1128/AEM.02531-09; SAS Institute, 2008, SAS STAT US GUID; Sevilla E, 2008, ENVIRON MICROBIOL, V10, P2476, DOI 10.1111/j.1462-2920.2008.01663.x; Shen PP, 2003, ENVIRON INT, V29, P641, DOI 10.1016/S0160-4120(03)00047-3; Shi Limei, 2009, Hupo Kexue, V21, P801; SIVONEN K, 1990, APPL ENVIRON MICROB, V56, P2658, DOI 10.1128/AEM.56.9.2658-2666.1990; Song Lirong, 1998, Phycological Research, V46, P19, DOI 10.1046/j.1440-1835.1998.00120.x; Te SH, 2011, HARMFUL ALGAE, V10, P319, DOI 10.1016/j.hal.2010.11.006; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; UTKILEN H, 1995, APPL ENVIRON MICROB, V61, P797, DOI 10.1128/AEM.61.2.797-800.1995; VANDERWESTHUIZEN AJ, 1985, PLANTA, V163, P55, DOI 10.1007/BF00395897; Vezie C, 2002, MICROB ECOL, V43, P443, DOI 10.1007/s00248-001-0041-9; Wang JX, 2007, ENVIRON RES, V103, P70, DOI 10.1016/j.envres.2006.05.013; Wang Q, 2010, THESCIENTIFICWORLDJO, V10, P1795, DOI 10.1100/tsw.2010.172; WATANABE MF, 1985, APPL ENVIRON MICROB, V49, P1342, DOI 10.1128/AEM.49.5.1342-1344.1985; Wiedner C, 2003, APPL ENVIRON MICROB, V69, P1475, DOI 10.1128/AEM.69.3.1475-1481.2003; Wilhelm SW, 2011, HARMFUL ALGAE, V10, P207, DOI 10.1016/j.hal.2010.10.001; Xie P, HIST DEV CYANOBACTER; Xu Y, 2008, ENVIRON POLLUT, V156, P162, DOI 10.1016/j.envpol.2007.12.027; Yang H, 2006, J FRESHWATER ECOL, V21, P721, DOI 10.1080/02705060.2006.9664136; Ye WJ, 2009, HARMFUL ALGAE, V8, P637, DOI 10.1016/j.hal.2008.10.010; YEE TW, 1991, J VEG SCI, V2, P587, DOI 10.2307/3236170; Yoshida M, 2007, FEMS MICROBIOL LETT, V266, P49, DOI 10.1111/j.1574-6968.2006.00496.x; Zhang DW, 2009, ECOTOX ENVIRON SAFE, V72, P466, DOI 10.1016/j.ecoenv.2008.05.014; Zhang M, 2011, CHEMOSPHERE, V82, P329, DOI 10.1016/j.chemosphere.2010.10.038; Zhu JY, 2010, AQUAT TOXICOL, V98, P196, DOI 10.1016/j.aquatox.2010.02.011	73	38	42	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32020	10.1371/journal.pone.0032020	http://dx.doi.org/10.1371/journal.pone.0032020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384128	gold, Green Submitted, Green Published			2022-12-27	WOS:000302916100045
J	Zhu, JY; Zhao, N; Yang, B				Zhu, Jia-Ying; Zhao, Ning; Yang, Bin			Global Transcriptome Profiling of the Pine Shoot Beetle, Tomicus yunnanensis (Coleoptera: Scolytinae)	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; GLUTATHIONE-S-TRANSFERASE; DE-NOVO CHARACTERIZATION; PINIPERDA COLEOPTERA; CRYSTAL-STRUCTURE; EXPRESSION; CLONING; EVOLUTION; CHAPERONE; FAMILY	Background: The pine shoot beetle Tomicus yunnanensis (Coleoptera: Scolytinae) is an economically important pest of Pinus yunnanensis in southwestern China. Developed resistance to insecticides due to chemical pesticides being used for a long time is a factor involved in its serious damage, which poses a challenge for management. In addition, highly efficient adaptation to divergent environmental ecologies results in this pest posing great potential threat to pine forests. However, the molecular mechanisms remain unknown as only limited nucleotide sequence data for this species is available. Methodology/Principal Findings: In this study, we applied next generation sequencing (Illumina sequencing) to sequence the adult transcriptome of T. yunnanensis. A total of 51,822,230 reads were obtained. They were assembled into 140,702 scaffolds, and 60,031 unigenes. The unigenes were further functionally annotated with gene descriptions, Gene Ontology (GO), Clusters of Orthologous Groups (COG), and Kyoto Encyclopedia of Genes and Genome (KEGG). In total, 80,932 unigenes were classified into GO, 13,599 unigenes were assigned to COG, and 33,875 unigenes were found in KO categories. A biochemical pathway database containing 219 predicted pathways was also created based on the annotations. In depth analysis of the data revealed a large number of genes related to insecticides resistance and heat shock protein genes associated with environmental stress. Conclusions/Significance: The results facilitate the investigations of molecular resistance mechanisms to insecticides and environmental stress. This study lays the foundation for future functional genomics studies of important biological questions of this pest.	[Zhu, Jia-Ying; Yang, Bin] SW Forestry Univ, Coll Forestry, Key Lab Forest Disaster Warning & Control Yunnan, Kunming, Peoples R China; [Zhao, Ning] SW Forestry Univ, Coll Life Sci, Kunming, Peoples R China		Zhu, JY (corresponding author), SW Forestry Univ, Coll Forestry, Key Lab Forest Disaster Warning & Control Yunnan, Kunming, Peoples R China.	jyzhu001@gmail.com; yangbin48053@yahoo.com.cn	Yang, Bin/AAW-9583-2021	Yang, Bin/0000-0002-9290-7288	Special Fund for Forest Scientific Research in the Public Interest of China [201004067]; Science Foundation for the Excellent Youth Academic and Technological Scholars of Yunnan Province of China [2007YP01-18]; Science Foundation of Southwest Forestry University [111128]; Key Subject of Forest Protection of Yunnan Province of China [XKZ200905]	Special Fund for Forest Scientific Research in the Public Interest of China; Science Foundation for the Excellent Youth Academic and Technological Scholars of Yunnan Province of China; Science Foundation of Southwest Forestry University; Key Subject of Forest Protection of Yunnan Province of China	This work was supported by the Special Fund for Forest Scientific Research in the Public Interest of China (201004067), Science Foundation for the Excellent Youth Academic and Technological Scholars of Yunnan Province of China (2007YP01-18), Science Foundation of Southwest Forestry University (111128), and the Key Subject of Forest Protection of Yunnan Province of China (XKZ200905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aevermann BD, 2008, GENETICA, V133, P307, DOI 10.1007/s10709-007-9215-9; Aparicio G, 2006, STUD HEALTH TECHNOL, V120, P194; Arya R, 2008, CELL STRESS CHAPERON, V13, P509, DOI 10.1007/s12192-008-0051-3; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Bass C, 2011, PEST MANAG SCI, V67, P886, DOI 10.1002/ps.2189; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Chen HY, 2006, BIOTECHNOL LETT, V28, P1089, DOI 10.1007/s10529-006-9058-y; Choresh O, 2004, CELL STRESS CHAPERON, V9, P38, DOI 10.1379/1466-1268(2004)009<0038:TMKHSP>2.0.CO;2; Clark MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015919; Clark MS, 2009, MAR GENOM, V2, P11, DOI 10.1016/j.margen.2009.03.003; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Ding YC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-35; Duan Y, 2004, HEREDITY, V93, P416, DOI 10.1038/sj.hdy.6800518; Eager TA, 2004, J ECON ENTOMOL, V97, P460, DOI 10.1603/0022-0493-97.2.460; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Faccoli M, 2008, J CHEM ECOL, V34, P1162, DOI 10.1007/s10886-008-9503-6; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R., 2005, P1; Friedman R, 2011, MOL PHYLOGENET EVOL, V61, P924, DOI 10.1016/j.ympev.2011.08.027; Gullipalli D, 2010, COMP BIOCHEM PHYS B, V156, P33, DOI 10.1016/j.cbpb.2010.01.016; Haack RA, 2000, J ECON ENTOMOL, V93, P342, DOI 10.1603/0022-0493-93.2.342; Hamajima F, 2002, J CELL BIOCHEM, V84, P401, DOI 10.1002/jcb.10029; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Hata M, 2000, BBA-GENE STRUCT EXPR, V1493, P208, DOI 10.1016/S0167-4781(00)00136-6; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Horn A, 2009, HEREDITY, V103, P238, DOI 10.1038/hdy.2009.48; Huang LH, 2007, INSECT MOL BIOL, V16, P491, DOI 10.1111/j.1365-2583.2007.00744.x; Jia Haibo, 2011, Int J Biochem Mol Biol, V2, P47; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kirkendall LR, 2008, ZOOTAXA, P25, DOI 10.11646/zootaxa.1819.1.2; Knowlton AA, 1996, J BIOSCIENCE, V21, P123, DOI 10.1007/BF02703103; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Li ZW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-215; Liu H, 2010, J ECON ENTOMOL, V103, P95, DOI 10.1603/EC09080; Michels AA, 1999, J BIOL CHEM, V274, P36757, DOI 10.1074/jbc.274.51.36757; Ohtsuka K, 2000, CELL STRESS CHAPERON, V5, P98, DOI 10.1379/1466-1268(2000)005<0098:MHDHCO>2.0.CO;2; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Sonoda S, 2006, ARCH INSECT BIOCHEM, V63, P36, DOI 10.1002/arch.20138; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tazir Y, 2009, MOL BIOCHEM PARASIT, V168, P149, DOI 10.1016/j.molbiopara.2009.07.007; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Wang HS, 2007, INSECT MOL BIOL, V16, P207, DOI 10.1111/j.1365-2583.2006.00715.x; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Waters ER, 2008, CELL STRESS CHAPERON, V13, P127, DOI 10.1007/s12192-008-0023-7; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yamamoto K, 2011, INSECT MOL BIOL, V20, P379, DOI 10.1111/j.1365-2583.2011.01073.x; Yang HY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-705; Zhou J, 2010, J INVERTEBR PATHOL, V103, P170, DOI 10.1016/j.jip.2009.12.006	59	39	46	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32291	10.1371/journal.pone.0032291	http://dx.doi.org/10.1371/journal.pone.0032291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384206	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100067
J	Baker, CCM; Dall, SRX; Rankin, DJ				Baker, Christopher C. M.; Dall, Sasha R. X.; Rankin, Daniel J.			Kin Selection and the Evolution of Social Information Use in Animal Conflict	PLOS ONE			English	Article							PUBLIC INFORMATION; GAME; COOPERATION; ALTRUISM; FITNESS; COMPETITION; ASSORTMENT; STRATEGIES; BEHAVIOR; SPITE	Animals often use social information about conspecifics in making decisions about cooperation and conflict. While the importance of kin selection in the evolution of intraspecific cooperation and conflict is widely acknowledged, few studies have examined how relatedness influences the evolution of social information use. Here we specifically examine how relatedness affects the evolution of a stylised form of social information use known as eavesdropping. Eavesdropping involves individuals escalating conflicts with rivals observed to have lost their last encounter and avoiding fights with those seen to have won. We use a game theoretical model to examine how relatedness affects the evolution of eavesdropping, both when strategies are discrete and when they are continuous or mixed. We show that relatedness influences the evolution of eavesdropping, such that information use peaks at intermediate relatedness. Our study highlights the importance of considering kin selection when exploring the evolution of complex forms of information use.	[Baker, Christopher C. M.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Dall, Sasha R. X.] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn, Cornwall, England; [Rankin, Daniel J.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Rankin, Daniel J.] Swiss Inst Bioinformat, Lausanne, Switzerland	Harvard University; University of Exeter; University of Zurich; Swiss Institute of Bioinformatics	Baker, CCM (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	ccmbaker@fas.harvard.edu	Dall, Sasha/B-2642-2010; Rankin, Daniel/E-4178-2013; Baker, Christopher/E-8768-2016	Dall, Sasha/0000-0001-9873-6507; Rankin, Daniel/0000-0001-7709-6926; Baker, Christopher/0000-0002-2675-1078	Department of Organismic and Evolutionary Biology at Harvard University; National Science Foundation (NSF) [SES-0750480]; European Science Foundation/European Collaborative Research (ESF/EUROCORES); Evolution of Cooperation and Trading (TECT); Swiss National Science Foundation [31003A-125457, PZ00P3-121800]; University of Zurich Forschungskredit; Natural Environment Research Council UK [NE/D014352/1]; Natural Environment Research Council [NE/D014352/1] Funding Source: researchfish; NERC [NE/D014352/1] Funding Source: UKRI	Department of Organismic and Evolutionary Biology at Harvard University; National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); European Science Foundation/European Collaborative Research (ESF/EUROCORES)(European Science Foundation (ESF)); Evolution of Cooperation and Trading (TECT); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich Forschungskredit; Natural Environment Research Council UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Dr. Baker was supported by a fellowship from the Department of Organismic and Evolutionary Biology at Harvard University, and by National Science Foundation (NSF) SES-0750480 and the European Science Foundation/European Collaborative Research (ESF/EUROCORES) program's support for the The Evolution of Cooperation and Trading (TECT) project. Dr. Rankin thanks the Swiss National Science Foundation (Grants 31003A-125457 and PZ00P3-121800) and the University of Zurich Forschungskredit, and Dr. Dall thanks the Natural Environment Research Council UK (NE/D014352/1) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briffa Mark, 2010, P246; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; Earley RL, 2002, P ROY SOC B-BIOL SCI, V269, P943, DOI 10.1098/rspb.2002.1973; ESHEL I, 1982, P NATL ACAD SCI-BIOL, V79, P1331, DOI 10.1073/pnas.79.4.1331; Gardner A, 2004, J EVOLUTION BIOL, V17, P1195, DOI 10.1111/j.1420-9101.2004.00775.x; Gardner A, 2007, AM NAT, V169, P207, DOI 10.1086/510602; Gavrilets S, 2006, P NATL ACAD SCI USA, V103, P16823, DOI 10.1073/pnas.0601428103; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; GRAFEN A, 1979, ANIM BEHAV, V27, P905, DOI 10.1016/0003-3472(79)90028-9; Hamilton W. D., 1975, BIOSOCIAL ANTHR, P133; Hamilton W.D., 1971, MAN BEAST COMP SOCIA, P57; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hirshleifer J., 1992, ANAL UNCERTAINTY INF; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Johnstone RA, 2002, PHILOS T R SOC B, V357, P1515, DOI 10.1098/rstb.2002.1072; Johnstone RA, 2001, P NATL ACAD SCI USA, V98, P9177, DOI 10.1073/pnas.161058798; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Marshall JAR, 2009, J THEOR BIOL, V260, P386, DOI 10.1016/j.jtbi.2009.07.008; Maynard Smith J., 1982, pi; McNamara JM, 2010, OIKOS, V119, P231, DOI 10.1111/j.1600-0706.2009.17509.x; Metz J, 1996, STOCHAST SPATIAL STR, P183; METZ JAJ, 1992, TRENDS ECOL EVOL, V7, P198, DOI 10.1016/0169-5347(92)90073-K; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Otto SP, 2007, BIOL GUIDE MATH MODE; QUELLER DC, 1984, BIOL J LINN SOC, V23, P133, DOI 10.1111/j.1095-8312.1984.tb00133.x; Rankin DJ, 2009, EVOLUTION, V63, P1913, DOI 10.1111/j.1558-5646.2009.00656.x; RAPOPORT A, 1966, AM BEHAV SCI, V10, P10, DOI 10.1177/000276426601000303; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; STEPHENS DW, 1989, AM NAT, V134, P128, DOI 10.1086/284969; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; West SA, 2001, NATURE, V409, P510, DOI 10.1038/35054057; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; West SA, 2010, SCIENCE, V327, P1341, DOI 10.1126/science.1178332; Whiten A, 2007, PHILOS T R SOC B, V362, P603, DOI 10.1098/rstb.2006.1998	42	0	0	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31664	10.1371/journal.pone.0031664	http://dx.doi.org/10.1371/journal.pone.0031664			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384051	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500031
J	Jiao, LR; Frampton, AE; Jacob, J; Pellegrino, L; Krell, J; Giamas, G; Tsim, N; Vlavianos, P; Cohen, P; Ahmad, R; Keller, A; Habib, NA; Stebbing, J; Castellano, L				Jiao, Long R.; Frampton, Adam E.; Jacob, Jimmy; Pellegrino, Loredana; Krell, Jonathan; Giamas, Georgios; Tsim, Nicole; Vlavianos, Panagiotis; Cohen, Patrizia; Ahmad, Raida; Keller, Andreas; Habib, Nagy A.; Stebbing, Justin; Castellano, Leandro			MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors	PLOS ONE			English	Article							MUCINOUS CYSTIC NEOPLASMS; DUCTAL ADENOCARCINOMA; CELL-PROLIFERATION; BREAST-CANCER; LUNG-CANCER; EXPRESSION; RAS; LET-7; SUPPRESSOR; KRAS	Background: MicroRNA (miRNA) expression profiles have been described in pancreatic ductal adenocarcinoma (PDAC), but these have not been compared with pre-malignant pancreatic tumors. We wished to compare the miRNA expression signatures in pancreatic benign cystic tumors (BCT) of low and high malignant potential with PDAC, in order to identify miRNAs deregulated during PDAC development. The mechanistic consequences of miRNA dysregulation were further evaluated. Methods: Tissue samples were obtained at a tertiary pancreatic unit from individuals with BCT and PDAC. MiRNA profiling was performed using a custom microarray and results were validated using RT-qPCR prior to evaluation of miRNA targets. Results: Widespread miRNA down-regulation was observed in PDAC compared to low malignant potential BCT. We show that amongst those miRNAs down-regulated, miR-16, miR-126 and let-7d regulate known PDAC oncogenes (targeting BCL2, CRK and KRAS respectively). Notably, miR-126 also directly targets the KRAS transcript at a "seedless" binding site within its 3'UTR. In clinical specimens, miR-126 was strongly down-regulated in PDAC tissues, with an associated elevation in KRAS and CRK proteins. Furthermore, miR-21, a known oncogenic miRNA in pancreatic and other cancers, was not elevated in PDAC compared to serous microcystic adenoma (SMCA), but in both groups it was up-regulated compared to normal pancreas, implicating early up-regulation during malignant change. Conclusions: Expression profiling revealed 21 miRNAs down-regulated in PDAC compared to SMCA, the most benign lesion that rarely progresses to invasive carcinoma. It appears that miR-21 up-regulation is an early event in the transformation from normal pancreatic tissue. MiRNA expression has the potential to distinguish PDAC from normal pancreas and BCT. Mechanistically the down-regulation of miR-16, miR-126 and let-7d promotes PDAC transformation by post-transcriptional up-regulation of crucial PDAC oncogenes. We show that miR-126 is able to directly target KRAS; re-expression has the potential as a therapeutic strategy against PDAC and other KRAS-driven cancers.	[Jiao, Long R.; Frampton, Adam E.; Tsim, Nicole; Habib, Nagy A.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Surg & Canc, Hepatopancreatobiliary Surg Unit, London, England; [Jacob, Jimmy; Pellegrino, Loredana; Krell, Jonathan; Giamas, Georgios; Stebbing, Justin; Castellano, Leandro] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Surg & Canc, Div Oncol, London, England; [Vlavianos, Panagiotis] Hammersmith Hosp, Imperial Coll NHS Trust, Dept Gastroenterol, London, England; [Cohen, Patrizia; Ahmad, Raida] Hammersmith Hosp, Imperial Coll NHS Trust, Dept Histopathol, London, England; [Keller, Andreas] Univ Saarland, Dept Human Genet, D-6650 Homburg, Saar, Germany	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Saarland University	Jiao, LR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Surg & Canc, Hepatopancreatobiliary Surg Unit, London, England.	l.castellano@imperial.ac.uk	Keller, Andreas/ABB-6412-2021; Castellano, Leandro/AAE-1366-2021; Giamas, Georgios/AAP-3487-2021	Keller, Andreas/0000-0002-5361-0895; Castellano, Leandro/0000-0002-3059-4829; Giamas, Georgios/0000-0002-4417-2707; Stebbing, Justin/0000-0002-1117-6947	Peel Medical Research Trust; Alliance Family Trust Foundation; MRC [G1100425] Funding Source: UKRI; Cancer Research UK [14549] Funding Source: researchfish; Medical Research Council [G1100425] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-053] Funding Source: researchfish; Worldwide Cancer Research [10-0510] Funding Source: researchfish	Peel Medical Research Trust; Alliance Family Trust Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Worldwide Cancer Research	The Peel Medical Research Trust and The Alliance Family Trust Foundation helped with funding herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2003, BRIT J CANCER, V89, P2104, DOI 10.1038/sj.bjc.6601391; Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Bartley AN, 2011, CLIN CANCER RES, V17, P7283, DOI 10.1158/1078-0432.CCR-11-1452; Bartsch D, 1998, ANN SURG, V228, P79, DOI 10.1097/00000658-199807000-00012; Basturk O, 2009, ARCH PATHOL LAB MED, V133, P423, DOI 10.1043/1543-2165-133.3.423; Bellizzi AM, 2009, ARCH PATHOL LAB MED, V133, P388, DOI 10.1043/1543-2165-133.3.388; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Brugge WR, 2004, NEW ENGL J MED, V351, P1218, DOI 10.1056/NEJMra031623; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Chua YJ, 2005, J CLIN ONCOL, V23, P4532, DOI 10.1200/JCO.2005.17.954; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Crawford M, 2008, BIOCHEM BIOPH RES CO, V373, P607, DOI 10.1016/j.bbrc.2008.06.090; Crippa S, 2010, CLIN GASTROENTEROL H, V8, P213, DOI 10.1016/j.cgh.2009.10.001; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; du Rieu MC, 2010, CLIN CHEM, V56, P603, DOI 10.1373/clinchem.2009.137364; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Galanis C, 2007, J GASTROINTEST SURG, V11, P820, DOI 10.1007/s11605-007-0157-4; Garcea G, 2008, PANCREATOLOGY, V8, P236, DOI 10.1159/000134279; Goggins M, 2007, SEMIN ONCOL, V34, P303, DOI 10.1053/j.seminoncol.2007.05.003; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Habbe N, 2009, CANCER BIOL THER, V8, P340, DOI 10.4161/cbt.8.4.7338; Hamada S, 2011, MOL CANC RES; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Ishikawa T, 1998, PANCREAS, V16, P40, DOI 10.1097/00006676-199801000-00007; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Keller A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-353; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Klimstra DS, 2009, ARCH PATHOL LAB MED, V133, P454, DOI 10.1043/1543-2165-133.3.454; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Li X, 2009, ONCOGENE, V28, P4272, DOI 10.1038/onc.2009.278; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mardin WA, 2009, ANN SURG ONCOLOGY; Matthaei H, 2011, NAT REV GASTRO HEPAT, V8, P141, DOI 10.1038/nrgastro.2011.2; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Meister J, 2010, THESCIENTIFICWORLDJO, V10, P2090, DOI 10.1100/tsw.2010.198; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mukherjee S, 2008, CLIN ONCOL-UK, V20, P535, DOI 10.1016/j.clon.2008.02.003; Oh JS, 2010, INT J RADIAT ONCOL, V76, P5, DOI 10.1016/j.ijrobp.2009.08.028; Ohuchida K, 2011, ANN SURG ONCOL; Paranjape T, 2011, LANCET ONCOL, V12, P377, DOI 10.1016/S1470-2045(11)70044-4; Reddy S, 2007, SURG CLIN N AM, V87, P1359, DOI 10.1016/j.suc.2007.08.009; Sahani Dushyant V, 2009, J Am Coll Radiol, V6, P376, DOI 10.1016/j.jacr.2008.10.004; Satoh K, 1991, Nihon Shokakibyo Gakkai Zasshi, V88, P2795; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Seux M, 2009, PANCREATOLOGY, V9, P66, DOI 10.1159/000178876; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Sinicrope FA, 1996, CLIN CANCER RES, V2, P2015; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Szafranska AE, 2008, CLIN CHEM, V54, P1716, DOI 10.1373/clinchem.2008.109603; Takeshita F, 2010, MOL THER, V18, P181, DOI 10.1038/mt.2009.207; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Torrisani J, 2009, HUM GENE THER, V20, P831, DOI 10.1089/hum.2008.134; Vorwerk S, 2008, NEW BIOTECHNOL, V25, P142, DOI 10.1016/j.nbt.2008.08.005; Wang H, 2007, RNA, V13, P151, DOI 10.1261/rna.234507; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Watanabe S, 2009, AM J PATHOL, V174, P854, DOI 10.2353/ajpath.2009.080523; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yoshizawa K, 2002, VIRCHOWS ARCH, V441, P437, DOI 10.1007/s00428-002-0645-6; Yu J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-169; Yu SN, 2010, CANCER RES, V70, P6015, DOI 10.1158/0008-5472.CAN-09-4531; Zhao WG, 2010, CARCINOGENESIS, V31, P1726, DOI 10.1093/carcin/bgq160	79	103	110	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32068	10.1371/journal.pone.0032068	http://dx.doi.org/10.1371/journal.pone.0032068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384141	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000302875500070
J	Xiao, Y; Xu, CH; Guan, JX; Ping, YY; Fan, HH; Li, YQ; Zhao, HY; Li, X				Xiao, Yun; Xu, Chaohan; Guan, Jinxia; Ping, Yanyan; Fan, Huihui; Li, Yiqun; Zhao, Hongying; Li, Xia			Discovering Dysfunction of Multiple MicroRNAs Cooperation in Disease by a Conserved MicroRNA Co-Expression Network	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; REGULATORY MODULES; COMBINATORIAL REGULATION; STEM-CELLS; EXPRESSION; CANCER; GENES; DEREGULATION; CLUSTER; FAMILY	MicroRNAs, a new class of key regulators of gene expression, have been shown to be involved in diverse biological processes and linked to many human diseases. To elucidate miRNA function from a global perspective, we constructed a conserved miRNA co-expression network by integrating multiple human and mouse miRNA expression data. We found that these conserved co-expressed miRNA pairs tend to reside in close genomic proximity, belong to common families, share common transcription factors, and regulate common biological processes by targeting common components of those processes based on miRNA targets and miRNA knockout/transfection expression data, suggesting their strong functional associations. We also identified several co-expressed miRNA sub-networks. Our analysis reveals that many miRNAs in the same sub-network are associated with the same diseases. By mapping known disease miRNAs to the network, we identified three cancer-related miRNA sub-networks. Functional analyses based on targets and miRNA knockout/transfection data consistently show that these sub-networks are significantly involved in cancer-related biological processes, such as apoptosis and cell cycle. Our results imply that multiple co-expressed miRNAs can cooperatively regulate a given biological process by targeting common components of that process, and the pathogenesis of disease may be associated with the abnormality of multiple functionally cooperative miRNAs rather than individual miRNAs. In addition, many of these co-expression relationships provide strong evidence for the involvement of new miRNAs in important biological processes, such as apoptosis, differentiation and cell cycle, indicating their potential disease links.	[Xiao, Yun; Xu, Chaohan; Guan, Jinxia; Ping, Yanyan; Fan, Huihui; Li, Yiqun; Zhao, Hongying; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Heilongjiang, Peoples R China	Harbin Medical University	Xiao, Y (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Heilongjiang, Peoples R China.	lixia@hrbmu.edu.cn	li, xia/HHZ-7468-2022; Xiao, Yun/A-8359-2013; Fan, Huihui/AGB-0221-2022	Fan, Huihui/0000-0003-4233-5389; Ping, Yanyan/0000-0002-1810-1200	National Natural Science Foundation of China [30871394, 30370798, 30571034]; National High Tech Development Project of China; 863 Program [2007AA02Z329]; National Basic Research Program of China; 973 Program [2008CB517302]; National Science Foundation of Heilongjiang Province [ZJG0501, 1055HG009, GB03C602-4, HCXB2009019, HCXS2010008, BMFH060044, 1155H012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Tech Development Project of China(National High Technology Research and Development Program of China); 863 Program(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); 973 Program(National Basic Research Program of China); National Science Foundation of Heilongjiang Province	This work was supported in part by the National Natural Science Foundation of China (Grant Nos. 30871394, 30370798 and 30571034), the National High Tech Development Project of China, the 863 Program (Grant Nos. 2007AA02Z329), the National Basic Research Program of China, the 973 Program (Grant Nos. 2008CB517302) and the National Science Foundation of Heilongjiang Province (Grant Nos. ZJG0501, 1055HG009, GB03C602-4, HCXB2009019, HCXS2010008, BMFH060044 and 1155H012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Saavedra E, 2010, CURR BIOL, V20, P367, DOI 10.1016/j.cub.2009.12.051; Antonov AV, 2009, NUCLEIC ACIDS RES, V37, pW323, DOI 10.1093/nar/gkp313; Bandyopadhyay Sanghamitra, 2010, Silence, V1, P6, DOI 10.1186/1758-907X-1-6; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Chen CY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S41; Dalmasso G, 2011, AM J PHYSIOL-GASTR L, V300, pG52, DOI 10.1152/ajpgi.00394.2010; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo CJ, 2009, J HEPATOL, V50, P766, DOI 10.1016/j.jhep.2008.11.025; Gusev Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S16; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Joung JG, 2007, BIOINFORMATICS, V23, P1141, DOI 10.1093/bioinformatics/btm045; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Liu B, 2010, BIOINFORMATICS, V26, P3105, DOI 10.1093/bioinformatics/btq576; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Matushansky I, 2003, ONCOGENE, V22, P4143, DOI 10.1038/sj.onc.1206484; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mestdagh P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr646; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Nayak RR, 2009, GENOME RES, V19, P1953, DOI 10.1101/gr.097600.109; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ritchie W, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000513; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Sengupta D, 2011, MOL BIOSYST; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Shigoka M, 2010, PATHOL INT, V60, P351, DOI 10.1111/j.1440-1827.2010.02526.x; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Su NF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-150; Tran DH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S5; Tsuchiya S, 2009, NUCLEIC ACIDS RES, V37, P3821, DOI 10.1093/nar/gkp255; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Xu J, 2010, NUCL ACIDS RES; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Yoon SR, 2005, BIOINFORMATICS, V21, P93, DOI 10.1093/bioinformatics/bti1116; Zhou YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-396	53	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32201	10.1371/journal.pone.0032201	http://dx.doi.org/10.1371/journal.pone.0032201			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384175	Green Submitted, Green Published, gold			2022-12-27	WOS:000302875500084
J	Hu, X; Li, JH; Lan, L; Wu, FF; Zhang, EP; Song, ZM; Huang, HC; Luo, FJ; Pan, CW; Tan, F				Hu, Xin; Li, Jiang-Hui; Lan, Lan; Wu, Fei-Fei; Zhang, Er-Peng; Song, Zeng-Mei; Huang, Hui-Cong; Luo, Fang-Jun; Pan, Chang-Wang; Tan, Feng			In Vitro Study of the Effects of Angiostrongylus cantonensis Larvae Extracts on Apoptosis and Dysfunction in the Blood-Brain Barrier (BBB)	PLOS ONE			English	Article							MURINE CEREBRAL MALARIA; CEREBROSPINAL-FLUID; ENDOTHELIAL-CELLS; EOSINOPHILIC MENINGOENCEPHALITIS; MATRIX METALLOPROTEINASES; MONONUCLEAR-CELLS; TISSUE INHIBITORS; MENINGITIS; INFECTION; ASTROCYTES	It has been hypothesized that blood-brain barrier (BBB) dysfunction in Angiostrongylus cantonensis infection might be due to the apoptosis of the hosts' BBB cells. Here, we evaluated this hypothesis through several methods, all based on an in vitro mouse BBB model consisting of primary culture brain microvascular endothelial cells (BMECs) and brain astrocytic cells (BACs). In the present study, a four-hour percolation and HRP permeability experiment showed that A. cantonensis larvae extracts can increase the permeability of the BBB. Apoptosis among BMECs and BACs after exposure to larvae extracts was monitored by TUNEL and annexin-V-FITC/PI double staining. A. cantonensis larvae extracts were found to induce apoptosis in both BMECs and BACs. For this reason, we concluded that the induction of apoptosis might participate in the BBB dysfunction observed during angiostrongyliasis. Improved fundamental understanding of how A. cantonensis induces apoptosis may lead to new approaches to the treatment or prevention of this parasitic disease.	[Hu, Xin] Wenzhou Med Coll, Sch Med Lab Sci, Wenzhou, Zhejiang, Peoples R China; [Hu, Xin] Wenzhou Med Coll, Sch Life Sci, Wenzhou, Zhejiang, Peoples R China; [Li, Jiang-Hui] Wenzhou Med Coll, Inst Hlth & Environm, Wenzhou, Zhejiang, Peoples R China; [Lan, Lan; Wu, Fei-Fei; Zhang, Er-Peng; Song, Zeng-Mei; Huang, Hui-Cong; Pan, Chang-Wang; Tan, Feng] Wenzhou Med Coll, Sch Basic Med Sci, Dept Parasitol, Wenzhou, Zhejiang, Peoples R China; [Luo, Fang-Jun] Zhuji Peoples Hosp, Dept Clin Lab, Zhuji, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Hu, X (corresponding author), Wenzhou Med Coll, Sch Med Lab Sci, Wenzhou, Zhejiang, Peoples R China.	tanfengsong@163.com			Natural Science Foundation of China [30800963, 30972575]; Wenzhou Science and Technology Bureau of China [Y20090001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Science and Technology Bureau of China	This work was supported by Natural Science Foundation of China (No. 30800963, http://www.nsfc.gov.cn) to F. Tan, Natural Science Foundation of China (No. 30972575) to H-C Huang, and grants from Social Development Program of Wenzhou Science and Technology Bureau of China (No. Y20090001, http://www.wzkj.gov.cn/) to C-W Pan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta RE, 2003, J LEUKOCYTE BIOL, V73, P127; Adamo SA, 2002, BRAIN BEHAV EVOLUT, V60, P370, DOI 10.1159/000067790; Aloisi F, 2000, IMMUNOL TODAY, V21, P141, DOI 10.1016/S0167-5699(99)01512-1; Balde AT, 2000, PARASITE IMMUNOL, V22, P307, DOI 10.1046/j.1365-3024.2000.00307.x; Brown HC, 2000, NEUROLOGY, V55, P104, DOI 10.1212/WNL.55.1.104; Deininger MH, 2002, EUR CYTOKINE NETW, V13, P173; Dorta-Contreras A, 1998, CLIN DIAGN LAB IMMUN, V5, P452, DOI 10.1128/CDLI.5.4.452-455.1998; El-Kowrany Samy I., 2001, Journal of the Egyptian Society of Parasitology, V31, P245; Gavrilescu LC, 2001, J IMMUNOL, V167, P902, DOI 10.4049/jimmunol.167.2.902; Girard M, 2003, INT J PARASITOL, V33, P713, DOI 10.1016/S0020-7519(03)00033-X; Gottfredsson M, 2000, SEMIN NEUROL, V20, P307, DOI 10.1055/s-2000-9394; Hunt NH, 2006, INT J PARASITOL, V36, P569, DOI 10.1016/j.ijpara.2006.02.016; Isobe I, 1996, NEUROCHEM INT, V28, P523, DOI 10.1016/0197-0186(95)00142-5; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Kolb SA, 1998, J NEUROIMMUNOL, V84, P143, DOI 10.1016/S0165-5728(97)00247-6; Lee JD, 2006, ACTA TROP, V97, P204, DOI 10.1016/j.actatropica.2005.11.003; Li JiangHui, 2008, Zhongguo Bingyuan Shengwuxue Zazhi / Journal of Pathogen Biology, V3, P894; Medana IM, 1996, GLIA, V16, P51, DOI 10.1002/(SICI)1098-1136(199601)16:1<51::AID-GLIA6>3.3.CO;2-2; Medana IM, 1997, GLIA, V19, P91, DOI 10.1002/(SICI)1098-1136(199702)19:2<91::AID-GLIA1>3.0.CO;2-C; Pien F D, 1999, Int J Infect Dis, V3, P161, DOI 10.1016/S1201-9712(99)90039-5; RISAU W, 1990, TRENDS NEUROSCI, V13, P174, DOI 10.1016/0166-2236(90)90043-A; Saikumar P, 1999, AM J MED, V107, P489, DOI 10.1016/S0002-9343(99)00259-4; Schluesener HJ, 1998, ACTA NEUROPATHOL, V96, P575, DOI 10.1007/s004010050938; Shapiro S, 2003, J NEUROL SCI, V206, P43, DOI 10.1016/S0022-510X(02)00317-9; Stiles JK, 2004, MOL BIOCHEM PARASIT, V133, P229, DOI 10.1016/j.molbiopara.2003.10.011; Stiles JK, 2001, ANN TROP MED PARASIT, V95, P797, DOI 10.1080/00034980120111145; ToureBalde A, 1996, INFECT IMMUN, V64, P744, DOI 10.1128/IAI.64.3.744-750.1996; Tsai HC, 2008, AM J TROP MED HYG, V78, P20, DOI 10.4269/ajtmh.2008.78.20; Tsai HC, 2007, AM J TROP MED HYG, V76, P592, DOI 10.4269/ajtmh.2007.76.592; TUNGKANAK R, 1972, AM J TROP MED HYG, V21, P415, DOI 10.4269/ajtmh.1972.21.415; Weidenfeller C, 2005, BRAIN RES, V1053, P162, DOI 10.1016/j.brainres.2005.06.049; Williams PL, 2002, J INFECT DIS, V186, P1692, DOI 10.1086/345365; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767; Zuniga E, 2000, CLIN EXP IMMUNOL, V119, P507, DOI 10.1046/j.1365-2249.2000.01150.x	35	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32161	10.1371/journal.pone.0032161	http://dx.doi.org/10.1371/journal.pone.0032161			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393387	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500040
J	Loebbermann, J; Schnoeller, C; Thornton, H; Durant, L; Sweeney, NP; Schuijs, M; O'Garra, A; Johansson, C; Openshaw, PJ				Loebbermann, Jens; Schnoeller, Corinna; Thornton, Hannah; Durant, Lydia; Sweeney, Nathan P.; Schuijs, Martijn; O'Garra, Anne; Johansson, Cecilia; Openshaw, Peter J.			IL-10 Regulates Viral Lung Immunopathology during Acute Respiratory Syncytial Virus Infection in Mice	PLOS ONE			English	Article							EFFECTOR T-CELLS; INTERLEUKIN-10; BRONCHIOLITIS; ASTHMA; INFLAMMATION; DISEASE; ACTIVATION; CHALLENGE; RESPONSES; SUBSETS	Interleukin (IL-) 10 is a pleiotropic cytokine with broad immunosuppressive functions, particularly at mucosal sites such as the intestine and lung. Here we demonstrate that infection of BALB/c mice with respiratory syncytial virus (RSV) induced IL-10 production by CD4(+) and CD8(+) T cells in the airways at later time points (e. g. day 8); a proportion of these cells also co-produced IFN-gamma. Furthermore, RSV infection of IL-10(-/-) mice resulted in more severe disease with enhanced weight loss, delayed recovery and greater cell infiltration of the respiratory tract without affecting viral load. In addition, IL-10(-/-) mice had a pronounced airway neutrophilia and heightened levels of pro-inflammatory cytokines and chemokines in the bronchoalveolar lavage fluid. Notably, the proportion of lung T cells producing IFN-gamma was enhanced, suggesting that IL-10 may act in an autocrine manner to dampen effector T cell responses. Similar findings were made in mice treated with antiIL-10R antibody and infected with RSV. Therefore, IL-10 inhibits disease and inflammation in mice infected with RSV, especially during recovery from infection.	[Loebbermann, Jens; Schnoeller, Corinna; Thornton, Hannah; Durant, Lydia; Sweeney, Nathan P.; Schuijs, Martijn; Johansson, Cecilia; Openshaw, Peter J.] Univ London Imperial Coll Sci Technol & Med, Ctr Resp Infect MRC, London, England; [Loebbermann, Jens; Schnoeller, Corinna; Thornton, Hannah; Durant, Lydia; Sweeney, Nathan P.; Schuijs, Martijn; Johansson, Cecilia; Openshaw, Peter J.] Univ London Imperial Coll Sci Technol & Med, Asthma UK Ctr, Natl Heart & Lung Inst, Fac Med, London, England; [O'Garra, Anne] MRC Natl Inst Med Res, Div Immunoregulat, London, England	Imperial College London; Imperial College London; MRC National Institute for Medical Research	Loebbermann, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Resp Infect MRC, London, England.	p.openshaw@imperial.ac.uk	Loebbermann, Jens/K-8327-2014; Johansson, Cecilia/ABF-6337-2021; Openshaw, Peter/AAL-9442-2020	Johansson, Cecilia/0000-0002-6607-5000; Openshaw, Peter/0000-0002-7220-2555; Durant, Lydia/0000-0002-5068-1479; O'Garra, Anne/0000-0001-9845-6134	Centre of Respiratory Infections (CRI); MRC & Asthma UK Centre in Allergic Mechanisms of Asthma; European Commission [UU-ER/2010/010744]; Wellcome Trust [087805/Z/08/Z]; MRC [G0800311]; Medical Research Council [G0800311, MC_U117565642, G1000758, G1000758B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish; Asthma UK [S06/001] Funding Source: researchfish; MRC [MC_U117565642] Funding Source: UKRI	Centre of Respiratory Infections (CRI); MRC & Asthma UK Centre in Allergic Mechanisms of Asthma(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Centre of Respiratory Infections (CRI), the MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, the Erasmus Placement grant (UU-ER/2010/010744, M.S.) from the European Commission Life Long Learning programme, the Wellcome Trust (Programme 087805/Z/08/Z, P.O.) and the MRC career development award (Grant G0800311, C.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bem RA, 2008, PEDIATR RES, V63, P650, DOI 10.1203/PDR.0b013e31816fdc32; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Castilow EM, 2008, J VIROL, V82, P2196, DOI 10.1128/JVI.01949-07; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Freymuth F, 2004, REV MAL RESPIR, V21, P35, DOI 10.1016/S0761-8425(04)71233-4; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; Hoebee B, 2004, J INFECT DIS, V189, P239, DOI 10.1086/380908; Jankovic D, 2010, MUCOSAL IMMUNOL, V3, P239, DOI 10.1038/mi.2010.8; Joetham A, 2007, J IMMUNOL, V178, P1433, DOI 10.4049/jimmunol.178.3.1433; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lee DC, 2010, J VIROL; Legg JP, 2003, AM J RESP CRIT CARE, V168, P633, DOI 10.1164/rccm.200210-1148OC; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; Mege JL, 2006, LANCET INFECT DIS, V6, P557, DOI 10.1016/S1473-3099(06)70577-1; Murai Hiroki, 2007, Allergol Int, V56, P157, DOI 10.2332/allergolint.O-06-454; Nagamatsu K, 2009, J EXP MED, V206, P3073, DOI 10.1084/jem.20090494; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; O'Garra A, 2009, NAT IMMUNOL, V10, P929, DOI 10.1038/ni0909-929; Pils MC, 2010, EUR J IMMUNOL, V40, P443, DOI 10.1002/eji.200939592; Pribul PK, 2008, J VIROL, V82, P4441, DOI 10.1128/JVI.02541-07; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schuurhof A, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-121; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Slobedman B, 2009, J VIROL, V83, P9618, DOI 10.1128/JVI.01098-09; Smyth RL, 2006, LANCET, V368, P312, DOI 10.1016/S0140-6736(06)69077-6; Stacey MA, 2011, J IMMUNOL, V187, P2944, DOI 10.4049/jimmunol.1101021; Sun J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002173; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Weiss KA, 2011, J IMMUNOL, V187, P3145, DOI 10.4049/jimmunol.1100764; Zeng RH, 2011, CYTOKINE, V53, P1, DOI 10.1016/j.cyto.2010.09.011	39	92	100	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32371	10.1371/journal.pone.0032371	http://dx.doi.org/10.1371/journal.pone.0032371			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393401	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500054
J	van der Helm, JJ; Sabajo, LOA; Grunberg, AW; Morre, SA; Speksnijder, AGCL; de Vries, HJC				van der Helm, Jannie J.; Sabajo, Leslie O. A.; Grunberg, Antoon W.; Morre, Servaas A.; Speksnijder, Arjen G. C. L.; de Vries, Henry J. C.			Point-of-Care Test for Detection of Urogenital Chlamydia in Women Shows Low Sensitivity. A Performance Evaluation Study in Two Clinics in Suriname	PLOS ONE			English	Article							COST-EFFECTIVENESS; TRACHOMATIS INFECTION; NEISSERIA-GONORRHOEAE; RAPID TESTS; DIAGNOSIS; DISEASES; ASSAY	Background: In general, point-of-care (POC) tests for Chlamydia trachomatis (Ct) show disappointing test performance, especially disappointing sensitivity results. However, one study sponsored by the manufacturer (Diagnostics for the Real World) reported over 80% sensitivity with their Chlamydia Rapid Test (CRT). We evaluated the performance of this CRT in a non-manufacturer-sponsored trial. Methods: Between July 2009 and February 2010, we included samples from 912 women in both high-and low-risk clinics for sexually transmitted infections (STIs) in Paramaribo, Suriname. Sensitivity, specificity, positive-and negative predictive values (PPV and NPV) for CRT compared to NAAT (Aptima, Gen-Probe) were determined. Quantitative Ct load and human cell load were determined in all CRT and/or NAAT positive samples. Results: CRT compared to NAAT showed a sensitivity and specificity of 41.2% (95% CI, 31.9%-50.9%) and 96.4% (95% CI, 95.0%-97.5%), respectively. PPV and NPV were 59.2% (95% CI, 47.5%-70.1%) and 92.9% (95% CI, 91.0%-94.5%), respectively. Quantitative Ct bacterial load was 73 times higher in NAAT-positive/CRT-positive samples compared to NAAT-positive/CRT-negative samples (p < 0.001). Human cell load did not differ between true-positive and false-negative CRT results (p = 0.835). Sensitivity of CRT in samples with low Ct load was 12.5% (95% CI, 5.2%-24.2%) and in samples with high Ct load 73.5% (95% CI, 59.9%-84.4%). Conclusions: The sensitivity of CRT for detecting urogenital Ct in this non-manufacturer-sponsored study did not meet the expectations as described previously. The CRT missed samples with a low Ct load. Improved POC are needed as meaningful diagnostic to reduce the disease burden of Ct.	[van der Helm, Jannie J.; de Vries, Henry J. C.] Publ Hlth Serv Amsterdam, STI Outpatient Clin, Amsterdam, Netherlands; [Sabajo, Leslie O. A.] Minist Hlth, Dermatol Serv, Paramaribo, Suriname; [Grunberg, Antoon W.] Lobi Fdn, Paramaribo, Suriname; [Morre, Servaas A.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Morre, Servaas A.] Univ Maastricht, Fac Hlth Med & Life Sci, Inst Publ Hlth Genom, Dept Genet & Cell Biol,Res Inst CAPHRI, Maastricht, Netherlands; [Morre, Servaas A.] Univ Maastricht, Fac Hlth Med & Life Sci, Inst Publ Hlth Genom, Dept Genet & Cell Biol,Res Inst GROW, Maastricht, Netherlands; [Speksnijder, Arjen G. C. L.] Publ Hlth Serv Amsterdam, Publ Hlth Lab, Amsterdam, Netherlands; [de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Henry J. C.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands	Public Health Service Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Maastricht University; Maastricht University; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands National Institute for Public Health & the Environment	van der Helm, JJ (corresponding author), Publ Hlth Serv Amsterdam, STI Outpatient Clin, Amsterdam, Netherlands.	h.j.devries@amc.uva.nl	de Vries, Henry/K-5963-2012; Speksnijder, Arjen/M-3406-2017	de Vries, Henry/0000-0001-9784-547X; Speksnijder, Arjen/0000-0002-1966-7265; van der Helm, Jannie/0000-0002-4288-9544	Municipal Health Service of Amsterdam [2369, 2371]; AGIS healthcare insurance [RVVZ] [1417000]	Municipal Health Service of Amsterdam; AGIS healthcare insurance [RVVZ]	This work was supported by the Research and Development fund of the Municipal Health Service of Amsterdam [project no 2369 and 2371] and AGIS healthcare insurance [RVVZ no 1417000]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch L, 2001, LETT APPL MICROBIOL, V33, P296, DOI 10.1046/j.1472-765X.2001.00999.x; Catsburg A, 2006, 11 INT S HUM CHLAM I, P521; Chernesky M, 2006, J CLIN MICROBIOL, V44, P400, DOI 10.1128/JCM.44.2.400-405.2006; Chin CD, 2011, NAT MED, V17, P1015, DOI 10.1038/nm.2408; Datta SD, 2007, ANN INTERN MED, V147, P89, DOI 10.7326/0003-4819-147-2-200707170-00007; Delaney KP, 2011, CLIN INFECT DIS, V52, P257, DOI 10.1093/cid/ciq068; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Gift TL, 1999, SEX TRANSM DIS, V26, P232, DOI 10.1097/00007435-199904000-00010; Harding-Esch EM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001234; Hislop J, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14290; Land JA, 2010, HUM REPROD UPDATE, V16, P189, DOI 10.1093/humupd/dmp035; Lowe P, 2006, J CLIN MICROBIOL, V44, P2619, DOI 10.1128/JCM.00476-06; Mahilum-Tapay L, 2007, BMJ-BRIT MED J, V335, P1190, DOI 10.1136/bmj.39402.463854.AE; Michel CEC, 2006, LANCET, V367, P1585, DOI 10.1016/S0140-6736(06)68695-9; Michel CEC, 2007, J CLIN MICROBIOL, V45, P1395, DOI 10.1128/JCM.00100-07; Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007; Peeling RW, 2006, SEX TRANSM INFECT, V82, pV1, DOI 10.1136/sti.2006.024265; Peeling RW, 2006, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro1569; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Pettifor A, 2000, SEX TRANSM DIS, V27, P371, DOI 10.1097/00007435-200008000-00002; Pospischil A, 2002, SWISS MED WKLY, V132, P64; Renault CA, 2011, SEX HEALTH, V8, P69, DOI 10.1071/SH10030; Saison F, 2007, J CLIN MICROBIOL, V45, P4011, DOI 10.1128/JCM.01343-07; Sanders GD, 2010, J GEN INTERN MED, V25, P556, DOI 10.1007/s11606-010-1265-5; van Dommelen L, 2010, SEX TRANSM INFECT, V86, P355, DOI 10.1136/sti.2010.042598; Vickerman P, 2003, SEX TRANSM INFECT, V79, P363, DOI 10.1136/sti.79.5.363; WHO World Health Organisation STD Statistics, 2001, GLOB PREV INC SEL CU; Whyte A, 1998, J INFECTION, V36, P245, DOI 10.1016/S0163-4453(98)80030-3	28	39	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32122	10.1371/journal.pone.0032122	http://dx.doi.org/10.1371/journal.pone.0032122			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393383	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500036
J	Becker, N; Jost, H; Ziegler, U; Eiden, M; Hoper, D; Emmerich, P; Fichet-Calvet, E; Ehichioya, DU; Czajka, C; Gabriel, M; Hoffmann, B; Beer, M; Tenner-Racz, K; Racz, P; Gunther, S; Wink, M; Bosch, S; Konrad, A; Pfeffer, M; Groschup, MH; Schmidt-Chanasit, J				Becker, Norbert; Joest, Hanna; Ziegler, Ute; Eiden, Martin; Hoeper, Dirk; Emmerich, Petra; Fichet-Calvet, Elisabeth; Ehichioya, Deborah U.; Czajka, Christina; Gabriel, Martin; Hoffmann, Bernd; Beer, Martin; Tenner-Racz, Klara; Racz, Paul; Guenther, Stephan; Wink, Michael; Bosch, Stefan; Konrad, Armin; Pfeffer, Martin; Groschup, Martin H.; Schmidt-Chanasit, Jonas			Epizootic Emergence of Usutu Virus in Wild and Captive Birds in Germany	PLOS ONE			English	Article							WEST-NILE-VIRUS; SEROLOGICAL EVIDENCE; AUSTRIA	This study aimed to identify the causative agent of mass mortality in wild and captive birds in southwest Germany and to gather insights into the phylogenetic relationship and spatial distribution of the pathogen. Since June 2011, 223 dead birds were collected and tested for the presence of viral pathogens. Usutu virus (USUV) RNA was detected by real-time RT-PCR in 86 birds representing 6 species. The virus was isolated in cell culture from the heart of 18 Blackbirds (Turdus merula). USUV-specific antigen was demonstrated by immunohistochemistry in brain, heart, liver, and lung of infected Blackbirds. The complete polyprotein coding sequence was obtained by deep sequencing of liver and spleen samples of a dead Blackbird from Mannheim (BH65/11-02-03). Phylogenetic analysis of the German USUV strain BH65/11-02-03 revealed a close relationship with strain Vienna that caused mass mortality among birds in Austria in 2001. Wild birds from lowland river valleys in southwest Germany were mainly affected by USUV, but also birds kept in aviaries. Our data suggest that after the initial detection of USUV in German mosquitoes in 2010, the virus spread in 2011 and caused epizootics among wild and captive birds in southwest Germany. The data also indicate an increased risk of USUV infections in humans in Germany.	[Becker, Norbert; Joest, Hanna; Czajka, Christina] German Mosquito Control Assoc KABS, Waldsee, Germany; [Becker, Norbert; Joest, Hanna; Czajka, Christina] Heidelberg Univ, Dept Zool, Heidelberg, Germany; [Joest, Hanna; Emmerich, Petra; Fichet-Calvet, Elisabeth; Ehichioya, Deborah U.; Czajka, Christina; Gabriel, Martin; Guenther, Stephan; Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, Dept Virol, Hamburg, Germany; [Ziegler, Ute; Eiden, Martin; Groschup, Martin H.] Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, Greifswald, Germany; [Hoeper, Dirk; Hoffmann, Bernd; Beer, Martin] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany; [Tenner-Racz, Klara; Racz, Paul] Bernhard Nocht Inst Trop Med, Dept Pathol, Hamburg, Germany; [Wink, Michael] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Bosch, Stefan] Nat & Biodivers Conservat Union NABU Baden Wurtte, Stuttgart, Germany; [Konrad, Armin] Avifauna Nordbaden De, Ornitholog Gesell Baden Wurttemberg OGBW Nordbade, Heidelberg, Germany; [Pfeffer, Martin] Univ Leipzig, Inst Anim Hyg & Vet Publ Hlth, Fac Vet Med, Leipzig, Germany	Ruprecht Karls University Heidelberg; Bernhard Nocht Institut fur Tropenmedizin; Friedrich Loeffler Institute; Friedrich Loeffler Institute; Bernhard Nocht Institut fur Tropenmedizin; Ruprecht Karls University Heidelberg; Leipzig University	Becker, N (corresponding author), German Mosquito Control Assoc KABS, Waldsee, Germany.	jonassi@gmx.de	Wink, Michael/E-3803-2012; Ehichioya, Deborah/AAR-7295-2020	Wink, Michael/0000-0002-7875-4510; Hoper, Dirk/0000-0001-8408-2274; Ehichioya, Deborah/0000-0002-5777-685X; Schmidt-Chanasit, Jonas/0000-0003-4433-0231; Eiden, Martin/0000-0002-1197-8288; Gunther, Stephan/0000-0002-6562-0230; Jost, Hanna/0000-0001-6947-8334	(European Virus Archive) from the European Community [228292]	(European Virus Archive) from the European Community	The study was supported by grant 228292 (European Virus Archive) from the European Community. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakonyi T, 2007, J CLIN MICROBIOL, V45, P3870, DOI 10.1128/JCM.01390-07; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Becker N, 2008, PARASITOL RES, V103, pS19, DOI 10.1007/s00436-008-1210-2; Bosch Stefan, 2005, Ornithologische Mitteilungen, V57, P192; Bosch Stefan, 2003, Ornithologische Mitteilungen, V55, P308; Brown C.R., 2011, ORNITHOL MONOGR, V71, P1, DOI [DOI 10.1525/0M.2011.71.1.1, 10.1525/om.2011.71.1.1.1, DOI 10.1525/OM.2011.71.1.1.1]; Buckley A, 2003, J GEN VIROL, V84, P2807, DOI 10.1099/vir.0.19341-0; Cavrini F, 2009, EURO SURVEILL, V14; Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06; Chvala S, 2004, J COMP PATHOL, V131, P176, DOI 10.1016/j.jcpa.2004.03.004; Einstein J, 2011, E COMMUNICATION; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Jost H, 2011, AM J TROP MED HYG, V85, P551, DOI 10.4269/ajtmh.2011.11-0248; Lissak W, E COMMUNICATION; Meister T, 2008, VET MICROBIOL, V127, P237, DOI 10.1016/j.vetmic.2007.08.023; Pecorari M, 2009, EURO SURVEILL, V14; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rubel F, 2008, PREV VET MED, V85, P166, DOI 10.1016/j.prevetmed.2008.01.006; Seidowski D, 2010, VECTOR-BORNE ZOONOT, V10, P639, DOI 10.1089/vbz.2009.0236; Weiss V, 2011, E COMMUNICATION; Weissenbock H, 2003, MICROBES INFECT, V5, P1132, DOI 10.1016/S1286-4579(03)00204-1; Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094; Ziegler U, 2012, MONITORING IN PRESS	23	123	125	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32604	10.1371/journal.pone.0032604	http://dx.doi.org/10.1371/journal.pone.0032604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389712	Green Published, gold			2022-12-27	WOS:000302999600051
J	Hurt, JK; Fitzpatrick, BJ; Norris-Drouin, J; Zylka, MJ				Hurt, Julie K.; Fitzpatrick, Brendan J.; Norris-Drouin, Jacqueline; Zylka, Mark J.			Secretion and N-Linked Glycosylation Are Required for Prostatic Acid Phosphatase Catalytic and Antinociceptive Activity	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; 3-DIMENSIONAL STRUCTURE; TYROSINE-PHOSPHATASE; CANCER; PAIN; ECTONUCLEOTIDASE; L(+)-TARTRATE; EXPRESSION; ADENOSINE; COMPLEX	Secretory human prostatic acid phosphatase (hPAP) is glycosylated at three asparagine residues (N62, N188, N301) and has potent antinociceptive effects when administered to mice. Currently, it is unknown if these N-linked residues are required for hPAP protein stability and activity in vitro or in animal models of chronic pain. Here, we expressed wild-type hPAP and a series of Asn to Gln point mutations in the yeast Pichia pastoris X33 then analyzed protein levels and enzyme activity in cell lysates and in conditioned media. Pichia secreted wild-type recombinant (r)-hPAP into the media (6-7 mg protein/L). This protein was as active as native hPAP in biochemical assays and in mouse models of inflammatory pain and neuropathic pain. In contrast, the N62Q and N188Q single mutants and the N62Q, N188Q double mutant were expressed at lower levels and were less active than wild-type r-hPAP. The purified N62Q, N188Q double mutant protein was also 1.9 fold less active in vivo. The N301Q mutant was not expressed, suggesting a critical role for this residue in protein stability. To explicitly test the importance of secretion, a construct lacking the signal peptide of hPAP was expressed in Pichia and assayed. This "cellular'' construct was not expressed at levels detectable by western blotting. Taken together, these data indicate that secretion and post-translational carbohydrate modifications are required for PAP protein stability and catalytic activity. Moreover, our findings indicate that recombinant hPAP can be produced in Pichia-a yeast strain that is used to generate biologics for therapeutic purposes.	[Hurt, Julie K.; Fitzpatrick, Brendan J.; Zylka, Mark J.] Univ N Carolina, Dept Cell & Mol Physiol, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Norris-Drouin, Jacqueline] Univ N Carolina, Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hurt, JK (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, Ctr Neurosci, Chapel Hill, NC 27599 USA.	zylka@med.unc.edu			NINDS [R01NS060725, R01NS067688]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060725, R01NS067688] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants to MJZ from NINDS (R01NS060725, R01NS067688). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter R, 2011, VACCINE, V29, P2272, DOI 10.1016/j.vaccine.2011.01.039; Chuang TD, 2010, J BIOL CHEM, V285, P23598, DOI 10.1074/jbc.M109.098301; Cox MMJ, 2009, BIOLOGICALS, V37, P182, DOI 10.1016/j.biologicals.2009.02.014; Fairbanks CA, 2003, ADV DRUG DELIVER REV, V55, P1007, DOI 10.1016/S0169-409X(03)00101-7; Gething M-J, 1985, CURRENT COMMUNICATIO; Gutman AB, 1938, J CLIN INVEST, V17, P473, DOI 10.1172/JCI100974; Hassan MI, 2010, EXPERT REV ANTICANC, V10, P1055, DOI 10.1586/ERA.10.46; Jakob CG, 2000, PROSTATE, V42, P211, DOI 10.1002/(SICI)1097-0045(20000215)42:3<211::AID-PROS7>3.0.CO;2-U; LaCount MW, 1998, J BIOL CHEM, V273, P30406, DOI 10.1074/jbc.273.46.30406; LEE H, 1991, BIOCHEM J, V277, P759, DOI 10.1042/bj2770759; LINDQVIST Y, 1993, J BIOL CHEM, V268, P20744; Meng TC, 1998, J BIOL CHEM, V273, P22096, DOI 10.1074/jbc.273.34.22096; MORRIS MF, 1989, CLIN CHIM ACTA, V182, P9, DOI 10.1016/0009-8981(89)90145-9; MRSA V, 1987, FEBS LETT, V217, P174, DOI 10.1016/0014-5793(87)80658-0; Murasugi Akira, 2010, Recent Pat Biotechnol, V4, P153; Ortlund E, 2003, BIOCHEMISTRY-US, V42, P383, DOI 10.1021/bi0265067; OSTANIN K, 1994, J BIOL CHEM, V269, P8971; OSTROWSKI WS, 1994, CLIN CHIM ACTA, V226, P121, DOI 10.1016/0009-8981(94)90209-7; PORVARI KS, 1994, J BIOL CHEM, V269, P22642; Quintero IB, 2007, CANCER RES, V67, P6549, DOI 10.1158/0008-5472.CAN-07-1651; RELJIC R, 1992, GLYCOCONJUGATE J, V9, P39, DOI 10.1007/BF00731176; RISLEY JM, 1987, ARCH BIOCHEM BIOPHYS, V258, P404, DOI 10.1016/0003-9861(87)90361-4; SCHNEIDER G, 1993, EMBO J, V12, P2609, DOI 10.1002/j.1460-2075.1993.tb05921.x; Shields SD, 2003, J PAIN, V4, P465, DOI 10.1067/S1526-5900(03)00781-8; Sowa NA, 2010, J NEUROSCI, V30, P10282, DOI 10.1523/JNEUROSCI.2162-10.2010; Sowa NA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004248; Street SE, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-80; Tolner B, 2007, EUR J CANCER, V43, P2515, DOI 10.1016/j.ejca.2007.08.027; VANETTEN RL, 1982, ANN NY ACAD SCI, V390, P27; Veeramani S, 2005, ENDOCR-RELAT CANCER, V12, P805, DOI 10.1677/erc.1.00950; VIHKO P, 1978, CLIN CHEM, V24, P466; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024; Zylka MJ, 2011, TRENDS MOL MED, V17, P188, DOI 10.1016/j.molmed.2010.12.006	34	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32741	10.1371/journal.pone.0032741	http://dx.doi.org/10.1371/journal.pone.0032741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389722	Green Published, gold, Green Submitted			2022-12-27	WOS:000302999600061
J	Levinson, P; Choi, RY; Cole, AL; Hirbod, T; Rhedin, S; Payne, B; Guthrie, BL; Bosire, R; Cole, AM; Farquhar, C; Broliden, K				Levinson, Pauline; Choi, Robert Y.; Cole, Amy L.; Hirbod, Taha; Rhedin, Samuel; Payne, Barbara; Guthrie, Brandon L.; Bosire, Rose; Cole, Alexander M.; Farquhar, Carey; Broliden, Kristina			HIV-Neutralizing Activity of Cationic Polypeptides in Cervicovaginal Secretions of Women in HIV-Serodiscordant Relationships	PLOS ONE			English	Article							LEUKOCYTE PROTEASE INHIBITOR; EXPOSED SERONEGATIVE INDIVIDUALS; VAGINAL FLUID; SEX WORKERS; ANTIMICROBIAL POLYPEPTIDES; BACTERIAL VAGINOSIS; ALPHA-DEFENSINS; INNATE IMMUNITY; GENITAL-TRACT; MUCOSAL	Background: HIV exposed seronegative (HESN) women represent the population most in need of a prophylactic antiviral strategy. Mucosal cationic polypeptides can potentially be regulated for this purpose and we here aimed to determine their endogenous expression and HIV neutralizing activity in genital secretions of women at risk of HIV infection. Methodology/Principal Findings: Cervicovaginal secretions (CVS) of Kenyan women in HIV-serodiscordant relationships (HESN, n = 164; HIV seropositive, n = 60) and low-risk controls (n = 72) were assessed for the cationic polypeptides HNP1-3, LL-37 and SLPI by ELISA and for HIV neutralizing activity by a PBMC-based assay using an HIV primary isolate. Median levels of HNP1-3 and LL-37 in CVS were similar across study groups. Neither HSV-2 serostatus, nor presence of bacterial vaginosis, correlated with levels of HNP1-3 or LL-37 in the HESN women. However, an association with their partner's viral load was observed. High viral load (>10,000 HIV RNA copies/ml plasma) correlated with higher levels of HNP1-3 and LL-37 (p = 0.04 and 0.03, respectively). SLPI was most abundant in the low-risk group and did not correlate with male partner's viral load in the HESN women. HIV neutralizing activity was found in CVS of all study groups. In experimental studies, selective depletion of cationic polypeptides from CVS rendered the remaining CVS fraction non-neutralizing, whereas the cationic polypeptide fraction retained the activity. Furthermore, recombinant HNP1-3 and LL-37 could induce neutralizing activity when added to CVS lacking intrinsic activity. Conclusions/Significance: These findings show that CVS from HESN, low-risk, and HIV seropositive women contain HIV neutralizing activity. Although several innate immune proteins, including HNP1-3 and LL-37, contribute to this activity these molecules can also have inflammatory properties. This balance is influenced by hormonal and environmental factors and in the present HIV serodiscordant couple cohort study we show that a partner's viral load is associated with levels of such molecules.	[Levinson, Pauline; Hirbod, Taha; Rhedin, Samuel; Broliden, Kristina] Karolinska Inst, Infect Dis Unit, Dept Med, Ctr Mol Med,Karolinska Univ Hosp, Stockholm, Sweden; [Choi, Robert Y.; Payne, Barbara; Bosire, Rose] Univ Nairobi, Dept Paediat & Child Hlth, Nairobi, Kenya; [Choi, Robert Y.; Payne, Barbara; Farquhar, Carey] Univ Washington, Dept Med, Seattle, WA USA; [Cole, Amy L.; Cole, Alexander M.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA; [Payne, Barbara; Farquhar, Carey] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Guthrie, Brandon L.; Farquhar, Carey] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Bosire, Rose] Kenya Govt Med Res Ctr, Ctr Publ Hlth Res, Nairobi, Kenya	Karolinska Institutet; Karolinska University Hospital; University of Nairobi; University of Washington; University of Washington Seattle; State University System of Florida; University of Central Florida; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kenya Medical Research Institute	Levinson, P (corresponding author), Karolinska Inst, Infect Dis Unit, Dept Med, Ctr Mol Med,Karolinska Univ Hosp, Stockholm, Sweden.	kristina.broliden@karolinska.se	Arthur Rhedin, Samuel/H-4653-2019	Arthur Rhedin, Samuel/0000-0001-5798-2875	Swedish Research Council; Swedish International Development Cooperation Agency; Swedish Physician against AIDS Foundation; Sven Gard's Foundation; University of Washington Center for AIDS Research (CFAR); National Institute of Health (NIH) [AI052017, AI082623, AI082693, AI NIH/NIAID R01 AI068431, K24 AI087399, K01 TW06080]; US funded program [P30 AI027757]; University of Washington (UW); NIH Fogarty International Center [D43 TW00007]; International Research Scientist Development Award [K01TW008406]; FOGARTY INTERNATIONAL CENTER [D43TW000007, K01TW008406, K01TW006080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082693, R56AI052017, R01AI068431, R01AI052017, P30AI027757, R33AI082693, U19AI082623, K24AI087399, T32AI007140] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency; Swedish Physician against AIDS Foundation; Sven Gard's Foundation; University of Washington Center for AIDS Research (CFAR); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US funded program; University of Washington (UW)(University of Washington); NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); International Research Scientist Development Award; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Swedish Research Council (KB), the Swedish International Development Cooperation Agency (KB), the Swedish Physician against AIDS Foundation (PL), and the Sven Gard's Foundation (PL) as well as the University of Washington Center for AIDS Research (CFAR), a National Institute of Health (NIH), US funded program (P30 AI027757). The studies were also funded in part by grants AI052017, AI082623 and AI082693 from the NIH (AMC and ALC) and by the NIH grant AI NIH/NIAID R01 AI068431. CF and BP received support from NIH grants K24 AI087399 (CF) and K01 TW06080 (BP). RB and BLG received training support from the University of Washington (UW) AIDS International Training and Research Program supported by the NIH Fogarty International Center grant D43 TW00007. RYC was supported by the International Research Scientist Development Award (K01TW008406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman P, 2007, CURR HIV RES, V5, P410; Broliden K, 2010, J INFECT DIS, V202, pS351, DOI 10.1086/655964; Burgener A, 2008, J PROTEOME RES, V7, P4446, DOI 10.1021/pr800406r; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Cole AM, 2008, AM J REPROD IMMUNOL, V59, P27, DOI 10.1111/j.1600-0897.2007.00561.x; Devito C, 2000, AIDS, V14, P1917, DOI 10.1097/00002030-200009080-00006; Emery S, 2000, J CLIN MICROBIOL, V38, P2688, DOI 10.1128/JCM.38.7.2688-2695.2000; Ghosh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011366; Guthrie BL, 2011, J ACQUIR IMMUNE DEFI; Hirbod T, 2008, AIDS, V22, P727, DOI 10.1097/QAD.0b013e3282f56b64; Iqbal SM, 2005, J INFECT DIS, V192, P728, DOI 10.1086/432482; Jendrysik MA, 2005, J INFECT DIS, V192, P630, DOI 10.1086/432071; Kaushic C, 2010, AM J REPROD IMMUNOL, V63, P566, DOI 10.1111/j.1600-0897.2010.00843.x; Kazmi SH, 2006, CLIN VACCINE IMMUNOL, V13, P1111, DOI 10.1128/CDLI.00426-05; Levinson P, 2009, AIDS, V23, P309, DOI 10.1097/QAD.0b013e328321809c; Lingappa JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012598; Ma G, 2004, J EXP MED, V200, P1337, DOI 10.1084/jem.20041115; Macaluso M, 1999, CONTRACEPTION, V59, P195, DOI 10.1016/S0010-7824(99)00013-X; Mackewicz CE, 2003, AIDS, V17, pF23, DOI 10.1097/00002030-200309260-00001; Mitchell CM, 2008, AIDS RES HUM RETROV, V24, P667, DOI [10.1089/aid.2007.0268, 10.1089/aid.2008.0268]; Novak RM, 2007, CLIN VACCINE IMMUNOL, V14, P1102, DOI 10.1128/CVI.00386-06; Pala P, 2009, MUCOSAL IMMUNOL, V2, P300, DOI 10.1038/mi.2009.23; Py B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005006; Sarker P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020637; Shattock RJ, 2011, SCIENCE, V333, P42, DOI 10.1126/science.1206399; Valore EV, 2006, INFECT IMMUN, V74, P5693, DOI 10.1128/IAI.00524-06; Valore EV, 2002, AM J OBSTET GYNECOL, V187, P561, DOI 10.1067/mob.2002.125280; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Wira CR, 2010, AM J REPROD IMMUNOL, V63, P544, DOI 10.1111/j.1600-0897.2010.00842.x	29	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e31996	10.1371/journal.pone.0031996	http://dx.doi.org/10.1371/journal.pone.0031996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389677	Green Published, Green Submitted, gold			2022-12-27	WOS:000302999600015
J	Elferink, MG; Megens, HJ; Vereijken, A; Hu, XX; Crooijmans, RPMA; Groenen, MAM				Elferink, Martin G.; Megens, Hendrik-Jan; Vereijken, Addie; Hu, Xiaoxiang; Crooijmans, Richard P. M. A.; Groenen, Martien A. M.			Signatures of Selection in the Genomes of Commercial and Non-Commercial Chicken Breeds	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SINGLE NUCLEOTIDE POLYMORPHISMS; GENETIC DIVERSITY; BODY-COMPOSITION; ASCITES SYNDROME; GROWTH; EXPRESSION; BIODIVERSITY; ASSOCIATIONS; BROILERS	Identifying genomics regions that are affected by selection is important to understand the domestication and selection history of the domesticated chicken, as well as understanding molecular pathways underlying phenotypic traits and breeding goals. While whole-genome approaches, either high-density SNP chips or massively parallel sequencing, have been successfully applied to identify evidence for selective sweeps in chicken, it has been difficult to distinguish patterns of selection and stochastic and breed specific effects. Here we present a study to identify selective sweeps in a large number of chicken breeds (67 in total) using a high-density (58 K) SNP chip. We analyzed commercial chickens representing all major breeding goals. In addition, we analyzed non-commercial chicken diversity for almost all recognized traditional Dutch breeds and a selection of representative breeds from China. Based on their shared history or breeding goal we in silico grouped the breeds into 14 breed groups. We identified 396 chromosomal regions that show suggestive evidence of selection in at least one breed group with 26 of these regions showing strong evidence of selection. Of these 26 regions, 13 were previously described and 13 yield new candidate genes for performance traits in chicken. Our approach demonstrates the strength of including many different populations with similar, and breed groups with different selection histories to reduce stochastic effects based on single populations.	[Elferink, Martin G.; Megens, Hendrik-Jan; Crooijmans, Richard P. M. A.; Groenen, Martien A. M.] Univ Wageningen & Res Ctr, Anim Breeding & Genom Ctr, Wageningen, Netherlands; [Vereijken, Addie] Hendrix Genet, Breeding Res & Technol Ctr, Boxmeer, Netherlands; [Hu, Xiaoxiang] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	Wageningen University & Research; China Agricultural University	Elferink, MG (corresponding author), Univ Wageningen & Res Ctr, Anim Breeding & Genom Ctr, Wageningen, Netherlands.	Martin.Elferink@wur.nl	Megens, Hendrik-Jan/M-5300-2019; Megens, Hendrik-Jan/E-9676-2010; Crooijmans, Richard PMA/E-2492-2012; Groenen, Martien/D-8408-2012	Megens, Hendrik-Jan/0000-0002-3619-7533; Megens, Hendrik-Jan/0000-0002-3619-7533; Groenen, Martien/0000-0003-0484-4545	Dutch Technology Foundation (STW) [07106]	Dutch Technology Foundation (STW)(Technologiestichting STW)	Martin Elferink was funded by the Dutch Technology Foundation (STW), project number 07106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amills M, 2003, POULTRY SCI, V82, P1485, DOI 10.1093/ps/82.10.1485; Ankra-Badu GA, 2010, ANIM GENET, V41, P400, DOI 10.1111/j.1365-2052.2009.02017.x; Baghbanzadeh A, 2008, AVIAN PATHOL, V37, P117, DOI 10.1080/03079450801902062; BAKER CMA, 1968, GENETICS, V58, P211; Balog JM, 2003, AVIAN POULT BIOL REV, V14, P99, DOI 10.3184/147020603783637490; BERRY AJ, 1991, GENETICS, V129, P1111; Bokui N, 2008, FEBS LETT, V582, P365, DOI 10.1016/j.febslet.2007.12.006; Burt DW, 2005, GENOME RES, V15, P1692, DOI 10.1101/gr.4141805; Crawford R.D, 1990, POULTRY BREEDING GEN; Crooijmans RPMA, 1998, NEDERLANDSE HOENDERR; Dana N, 2010, ANIMAL GENETICS, DOI 10.1111; Darwin CR., 1868, VARIATION ANIMALS PL, DOI DOI 10.1371/journal.pbio.0040088; Desai J, 2006, HUM MOL GENET, V15, P1329, DOI 10.1093/hmg/ddl053; Ding H, 2000, MECH DEVELOP, V96, P209, DOI 10.1016/S0925-4773(00)00425-1; Eding H, 2002, GENET SEL EVOL, V34, P613, DOI [10.1186/1297-9686-34-5-613, 10.1051/gse:2002027]; Elferink MG, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-11; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Fumihito A, 1996, P NATL ACAD SCI USA, V93, P6792, DOI 10.1073/pnas.93.13.6792; FUMIHITO A, 1994, P NATL ACAD SCI USA, V91, P12505, DOI 10.1073/pnas.91.26.12505; Gao Y, 2009, ANIM GENET, V40, P952, DOI 10.1111/j.1365-2052.2009.01911.x; Gerdin AK, 2006, BIOCHEM BIOPH RES CO, V349, P825, DOI 10.1016/j.bbrc.2006.08.103; Groenen MAM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-274; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; Havenstein GB, 2003, POULTRY SCI, V82, P1500, DOI 10.1093/ps/82.10.1500; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hillel J, 2003, GENET SEL EVOL, V35, P533, DOI [10.1051/gse:2003038, 10.1186/1297-9686-35-6-533]; Hoogendoorn B, 2000, HUM GENET, V107, P488, DOI 10.1007/s004390000397; Hu ZL, 2007, NUCLEIC ACIDS RES, V35, pD604, DOI 10.1093/nar/gkl946; Hutt F.B., 1949, GENETICS OF THE FOWL; Ikeobi CON, 2004, LIVEST PROD SCI, V87, P143, DOI 10.1016/j.livprodsci.2003.09.020; Julian RJ, 1998, POULTRY SCI, V77, P1773, DOI 10.1093/ps/77.12.1773; JULIAN RJ, 1993, AVIAN PATHOL, V22, P419, DOI 10.1080/03079459308418934; Kanginakudru S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-174; Liu YP, 2006, MOL PHYLOGENET EVOL, V38, P12, DOI 10.1016/j.ympev.2005.09.014; Megens HJ, 2008, GENET SEL EVOL, V40, P103, DOI 10.1051/gse:2007039; Megens HJ, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-86; Muira WM, 2008, P NATL ACAD SCI USA, V105, P17312, DOI 10.1073/pnas.0806569105; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Peiris BL, 2011, ANIM GENET, V42, P113, DOI 10.1111/j.1365-2052.2010.02077.x; Plant J, 1986, ORIGIN EVOLUTION H 3; Rabie TSKM, 2005, ANIM GENET, V36, P468, DOI 10.1111/j.1365-2052.2005.01346.x; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sharman PWA, 2007, CYTOGENET GENOME RES, V117, P296, DOI 10.1159/000103191; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Uutela M, 2001, CIRCULATION, V103, P2242; WEST B, 1988, J ARCHAEOL SCI, V15, P515, DOI 10.1016/0305-4403(88)90080-5; Whitehead CC, 2000, POULTRY SCI, V79, P1033, DOI 10.1093/ps/79.7.1033; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Zekarias B, 2002, VET RES, V33, P109, DOI 10.1051/vetres:2002001; Zhou H, 2007, POULTRY SCI, V86, P255, DOI 10.3382/ps.2007-00267; Zhou H, 2005, POULTRY SCI, V84, P212, DOI 10.1093/ps/84.2.212	54	48	51	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32720	10.1371/journal.pone.0032720	http://dx.doi.org/10.1371/journal.pone.0032720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384281	gold, Green Submitted, Green Published			2022-12-27	WOS:000302918500107
J	Frenkel, S; Kirzhner, V; Korol, A				Frenkel, Svetlana; Kirzhner, Valery; Korol, Abraham			Organizational Heterogeneity of Vertebrate Genomes	PLOS ONE			English	Article							HUMAN TRANSCRIPTOME MAP; DNA-SEQUENCE; CPG ISLANDS; GC-CONTENT; ULTRACONSERVED ELEMENTS; CHROMOSOME TERRITORIES; RECOMBINATION RATES; MAMMALIAN GENOMES; GENE-EXPRESSION; EVOLUTION	Genomes of higher eukaryotes are mosaics of segments with various structural, functional, and evolutionary properties. The availability of whole-genome sequences allows the investigation of their structure as "texts'' using different statistical and computational methods. One such method, referred to as Compositional Spectra (CS) analysis, is based on scoring the occurrences of fixed-length oligonucleotides (k-mers) in the target DNA sequence. CS analysis allows generating species- or region-specific characteristics of the genome, regardless of their length and the presence of coding DNA. In this study, we consider the heterogeneity of vertebrate genomes as a joint effect of regional variation in sequence organization superimposed on the differences in nucleotide composition. We estimated compositional and organizational heterogeneity of genome and chromosome sequences separately and found that both heterogeneity types vary widely among genomes as well as among chromosomes in all investigated taxonomic groups. The high correspondence of heterogeneity scores obtained on three genome fractions, coding, repetitive, and the remaining part of the noncoding DNA (the genome dark matter - GDM) allows the assumption that CS-heterogeneity may have functional relevance to genome regulation. Of special interest for such interpretation is the fact that natural GDM sequences display the highest deviation from the corresponding reshuffled sequences.	[Frenkel, Svetlana] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel	University of Haifa; University of Haifa	Frenkel, S (corresponding author), Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	korol@research.haifa.ac.il	Kirzhner, Valery/V-7775-2019		Israel Council for Higher Education; Israeli Ministry of Immigrant Absorption; Israeli Ministry of Absorption; Council for Higher Education	Israel Council for Higher Education; Israeli Ministry of Immigrant Absorption; Israeli Ministry of Absorption; Council for Higher Education	This work was supported by the Scholarship for Excellence in Converging Technologies Program of Israel Council for Higher Education (http://www.che.org.il/template/default_e.aspx?PageId = 286) and the Scholarship Program for Research Students of the Israeli Ministry of Immigrant Absorption (http://www.moia.gov.il/Moia_en/Scientists/ScholarshipProgram.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the anonymous reviewers for their helpful comments and suggestions, Dr. Zeev Frenkel for useful discussions and Alexander Frenkel for help in improving the scripts. This work was supported by the Israeli Ministry of Absorption (S.F. and V.K.). S.F. was also supported by a fellowship for excellence in Converging Technologies Program of The Council for Higher Education.	Abe T, 2003, GENOME RES, V13, P693, DOI 10.1101/gr.634603; Azad RK, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.031913; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bell SJ, 1999, J THEOR BIOL, V197, P51, DOI 10.1006/jtbi.1998.0857; Bell SJ, 1999, J THEOR BIOL, V197, P63, DOI 10.1006/jtbi.1998.0858; Bernardi G, 2000, GENE, V241, P3, DOI 10.1016/S0378-1119(99)00485-0; BERNARDI G, 1989, ANNU REV GENET, V23, P637, DOI 10.1146/annurev.genet.23.1.637; Bingham E, 2006, SOC IND MATH, V124; Buschiazzo E, 2010, GENOME BIOL EVOL, V2, P153, DOI 10.1093/gbe/evq007; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Carpena P, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.032903; Chapus C, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-63; Chen LA, 2005, BIOINFORMATICS, V21, P3951, DOI 10.1093/bioinformatics/bti651; Chubb JR, 2003, CELL, V112, P403, DOI 10.1016/S0092-8674(03)00078-3; Costantini M, 2008, P NATL ACAD SCI USA, V105, P13971, DOI 10.1073/pnas.0803916105; Costantini M, 2008, P NATL ACAD SCI USA, V105, P3433, DOI 10.1073/pnas.0710587105; Costantini M, 2007, GENE, V400, P9, DOI 10.1016/j.gene.2007.05.025; Costantini M, 2007, CHROMOSOMA, V116, P29, DOI 10.1007/s00412-006-0078-0; Costantini M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-146; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Csuros M, 2007, TRENDS GENET, V23, P543, DOI 10.1016/j.tig.2007.07.008; De S, 2010, CURR OPIN CELL BIOL, V22, P326, DOI 10.1016/j.ceb.2010.04.004; Deng B, 2007, ARXIV0704219118, P1; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; Dufraigne C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni004; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Eory L, 2010, MOL BIOL EVOL, V27, P177, DOI 10.1093/molbev/msp219; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Hattori M, 2000, AM J OPHTHALMOL, V130, P383, DOI [10.1016/S0002-9394(00)00695-4, DOI 10.1016/S0002-9394(00)00695-4]; Healy J, 2003, GENOME RES, V13, P2306, DOI 10.1101/gr.1350803; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Hillier LW, 2005, NATURE, V434, P724, DOI 10.1038/nature03466; Hohl M, 2007, SYST BIOL, V56, P206, DOI 10.1080/10635150701294741; Jabbari K, 1998, GENE, V224, P123, DOI 10.1016/S0378-1119(98)00474-0; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Jurka J, 2004, P NATL ACAD SCI USA, V101, P1268, DOI 10.1073/pnas.0308084100; KARLIN S, 1994, ANNU REV MICROBIOL, V48, P619, DOI 10.1146/annurev.mi.48.100194.003155; KARLIN S, 1994, P NATL ACAD SCI USA, V91, P12837, DOI 10.1073/pnas.91.26.12837; Karlin S, 2001, TRENDS MICROBIOL, V9, P335, DOI 10.1016/S0966-842X(01)02079-0; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Katzman S, 2011, GENOME BIOL EVOL, V3, P614, DOI 10.1093/gbe/evr058; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kirzhner V, 2007, J MOL EVOL, V64, P448, DOI 10.1007/s00239-006-0178-8; Kirzhner V, 2005, BIOSYSTEMS, V81, P208, DOI 10.1016/j.biosystems.2005.04.003; Kirzhner V, 2011, INFORM SCIENCES, V181, P1454, DOI 10.1016/j.ins.2010.12.009; Kirzhner VM, 2002, PHYSICA A, V312, P447, DOI 10.1016/S0378-4371(02)00843-9; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Lercher MJ, 2003, HUM MOL GENET, V12, P2411, DOI 10.1093/hmg/ddg251; Li WT, 2002, GENE, V300, P129, DOI 10.1016/S0378-1119(02)00847-8; Li WT, 1998, GENOME RES, V8, P916, DOI 10.1101/gr.8.9.916; Li WT, 2001, GENE, V276, P57, DOI 10.1016/S0378-1119(01)00672-2; Liao BY, 2004, BIOINFORMATICS, V20, P3156, DOI 10.1093/bioinformatics/bth380; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Malcom CM, 2003, MOL BIOL EVOL, V20, P1633, DOI 10.1093/molbev/msg178; Marino-Ramirez L, 2004, NUCLEIC ACIDS RES, V32, P949, DOI 10.1093/nar/gkh246; McLean C, 2008, GENOME RES, V18, P1743, DOI 10.1101/gr.080184.108; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Melodelima C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-632; Nekrutenko A, 2000, GENOME RES, V10, P1986, DOI 10.1101/gr.10.12.1986; Nusbaum C, 2005, NATURE, V437, P551, DOI 10.1038/nature03983; Nussinov R, 1980, NUCLEIC ACIDS RES, V378, DOI [10.1093/nar/gkn942, DOI 10.1093/NAR/GKN942]; Paz A, 2006, MOL BIOL EVOL, V23, P56, DOI 10.1093/molbev/msj007; PIETROKOVSKI S, 1990, J BIOMOL STRUCT DYN, V7, P1251, DOI 10.1080/07391102.1990.10508563; Ponting CP, 2006, HUM MOL GENET, V15, pR170, DOI 10.1093/hmg/ddl182; Porceddu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022855; Rosen Gail, 2008, Advances in Bioinformatics, V2008, P205969, DOI 10.1155/2008/205969; Rosen GL, 2011, BIOINFORMATICS, V27, P127, DOI 10.1093/bioinformatics/btq619; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Schmegner C, 2007, CYTOGENET GENOME RES, V116, P167, DOI 10.1159/000098182; Schmegner C, 2007, GENETICS, V175, P421, DOI 10.1534/genetics.106.064386; Sellis D, 2007, MOL BIOL EVOL, V24, P2385, DOI 10.1093/molbev/msm181; Semon M, 2005, HUM MOL GENET, V14, P421, DOI 10.1093/hmg/ddi038; Sims GE, 2009, P NATL ACAD SCI USA, V106, P2677, DOI 10.1073/pnas.0813249106; Sivaraman K, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-20; Smith AV, 2005, GENOME RES, V15, P1519, DOI 10.1101/gr.4421405; Touchon M, 2005, P NATL ACAD SCI USA, V102, P9836, DOI 10.1073/pnas.0500577102; Trifonov EN, 1986, GNOMIC DICT GENETIC; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Vinga S, 2003, BIOINFORMATICS, V19, P513, DOI 10.1093/bioinformatics/btg005; Vinogradov AE, 2005, TRENDS GENET, V21, P639, DOI 10.1016/j.tig.2005.09.002; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P5212, DOI 10.1093/nar/gkg699; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Woolfe A, 2008, ADV GENET, V61, P307, DOI 10.1016/S0065-2660(07)00012-0; Wu H, 2010, BIOSTATISTICS, V11, P499, DOI 10.1093/biostatistics/kxq005; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Zody MC, 2006, NATURE, V440, P1045, DOI 10.1038/nature04689	90	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32076	10.1371/journal.pone.0032076	http://dx.doi.org/10.1371/journal.pone.0032076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384143	Green Submitted, Green Published, gold			2022-12-27	WOS:000302918500058
J	Iglesias, MJ; Reilly, SJ; Emanuelsson, O; Sennblad, B; Najafabadi, MP; Folkersen, L; Malarstig, A; Lagergren, J; Eriksson, P; Hamsten, A; Odeberg, J				Iglesias, Maria Jesus; Reilly, Sarah-Jayne; Emanuelsson, Olof; Sennblad, Bengt; Najafabadi, Mohammad Pirmoradian; Folkersen, Lasse; Malarstig, Anders; Lagergren, Jens; Eriksson, Per; Hamsten, Anders; Odeberg, Jacob			Combined Chromatin and Expression Analysis Reveals Specific Regulatory Mechanisms within Cytokine Genes in the Macrophage Early Immune Response	PLOS ONE			English	Article							NF-KAPPA-B; HISTONE H3 ACETYLATION; PROMOTER STRUCTURE; TRANSCRIPTION; BINDING; RECRUITMENT; METHYLATION; ELONGATION; DOMAINS; MAPS	Macrophages play a critical role in innate immunity, and the expression of early response genes orchestrate much of the initial response of the immune system. Macrophages undergo extensive transcriptional reprogramming in response to inflammatory stimuli such as Lipopolysaccharide (LPS). To identify gene transcription regulation patterns involved in early innate immune responses, we used two genome-wide approaches - gene expression profiling and chromatin immunoprecipitation-sequencing (ChIP-seq) analysis. We examined the effect of 2 hrs LPS stimulation on early gene expression and its relation to chromatin remodeling (H3 acetylation; H3Ac) and promoter binding of Sp1 and RNA polymerase II phosphorylated at serine 5 (S5P RNAPII), which is a marker for transcriptional initiation. Our results indicate novel and alternative gene regulatory mechanisms for certain proinflammatory genes. We identified two groups of upregulated inflammatory genes with respect to chromatin modification and promoter features. One group, including highly up-regulated genes such as tumor necrosis factor (TNF), was characterized by H3Ac, high CpG content and lack of TATA boxes. The second group, containing inflammatory mediators (interleukins and CCL chemokines), was up-regulated upon LPS stimulation despite lacking H3Ac in their annotated promoters, which were low in CpG content but did contain TATA boxes. Genome-wide analysis showed that few H3Ac peaks were unique to either +/-LPS condition. However, within these, an unpacking/expansion of already existing H3Ac peaks was observed upon LPS stimulation. In contrast, a significant proportion of S5P RNAPII peaks (approx 40%) was unique to either condition. Furthermore, data indicated a large portion of previously unannotated TSSs, particularly in LPS-stimulated macrophages, where only 28% of unique S5P RNAPII peaks overlap annotated promoters. The regulation of the inflammatory response appears to occur in a very specific manner at the chromatin level for specific genes and this study highlights the level of fine-tuning that occurs in the immune response.	[Iglesias, Maria Jesus; Reilly, Sarah-Jayne; Sennblad, Bengt; Folkersen, Lasse; Malarstig, Anders; Eriksson, Per; Hamsten, Anders; Odeberg, Jacob] Karolinska Inst, Ctr Mol Med, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden; [Emanuelsson, Olof; Najafabadi, Mohammad Pirmoradian] KTH Royal Inst Technol, Sch Biotechnol, Div Gene Technol, Sci Life Lab, Stockholm, Sweden; [Lagergren, Jens] KTH Royal Inst Technol, Dept Computat Biol, Stockholm, Sweden; [Hamsten, Anders] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden; [Odeberg, Jacob] Karolinska Univ Hosp Solna, Ctr Hematol, Stockholm, Sweden; [Odeberg, Jacob] KTH Royal Inst Technol, Sch Biotechnol, Div Prote, Sci Life Lab, Stockholm, Sweden	Karolinska Institutet; Royal Institute of Technology; Royal Institute of Technology; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Royal Institute of Technology	Iglesias, MJ (corresponding author), Karolinska Inst, Ctr Mol Med, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden.	maria.iglesias@ki.se	Odeberg, Jacob O/O-3336-2014; Odeberg, Jacob/I-8314-2016	Odeberg, Jacob O/0000-0003-0996-1644; Odeberg, Jacob/0000-0003-0996-1644; Eriksson, Per/0000-0002-5635-2692; Folkersen, Lasse/0000-0003-0708-9530; Iglesias Mareque, Maria Jesus/0000-0003-4122-1945; Lagergren, Jens/0000-0002-4552-0240	European Community [LSHM-CT-2007-037273, PIEP-GA-2008-221346]; Swedish Research Council [8691, 80576801, 70374401]; Knut and Alice Wallenberg Foundation; Swedish Heart-Lung Foundation; Torsten and Ragnar Soderberg Foundation; Karolinska Institutet; Stockholm County Council; Foundation for Strategic Research; Uppsala University; Uppsala University Hospital, Science for Life Laboratory - Uppsala	European Community(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Torsten and Ragnar Soderberg Foundation; Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Foundation for Strategic Research; Uppsala University; Uppsala University Hospital, Science for Life Laboratory - Uppsala	This project was funded by European Community Sixth Framework Program (LSHM-CT-2007-037273), the Swedish Research Council (8691), the Knut and Alice Wallenberg Foundation (http://www.wallenberg.com/kaw/in_english/), the Swedish Heart-Lung Foundation, the Torsten and Ragnar Soderberg Foundation, the Strategic Cardiovascular Program of Karolinska Institutet and Stockholm County Council, the Foundation for Strategic Research and Stockholm County Council. The SNP & SEQ Technology Platform in Uppsala is supported by Uppsala University, Uppsala University Hospital, Science for Life Laboratory - Uppsala and the Swedish Research Council (80576801 and 70374401). MJI is a recipient of a Marie Curie Intra European Fellowship within the 7th European Community Framework Programme (PIEP-GA-2008-221346). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir-Zilberstein L, 2007, MOL CELL BIOL, V27, P5246, DOI 10.1128/MCB.00586-07; Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chen Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-544; Cheng CH, 2003, MOL CELL BIOL, V23, P1961, DOI 10.1128/MCB.23.6.1961-1967.2003; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hirose Y, 1999, GENE DEV, V13, P1234, DOI 10.1101/gad.13.10.1234; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kratz A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-257; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Monie TP, 2009, TRENDS BIOCHEM SCI, V34, P553, DOI 10.1016/j.tibs.2009.06.011; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Rada-Iglesias A, 2008, GENOME RES, V18, P380, DOI 10.1101/gr.6880908; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Schreiber J, 2006, P NATL ACAD SCI USA, V103, P5899, DOI 10.1073/pnas.0510996103; Valen E, 2011, TRENDS GENET, V27, P475, DOI 10.1016/j.tig.2011.08.001; van Heeringen SJ, 2011, GENOME RES, V21, P410, DOI 10.1101/gr.111724.110; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Whatling C, 2004, J LIPID RES, V45, P1768, DOI 10.1194/jlr.M400195-JLR200; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	34	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32306	10.1371/journal.pone.0032306	http://dx.doi.org/10.1371/journal.pone.0032306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384210	gold, Green Published, Green Submitted			2022-12-27	WOS:000302918500074
J	Kotzka, J; Knebel, B; Haas, J; Kremer, L; Jacob, S; Hartwig, S; Nitzgen, U; Muller-Wieland, D				Kotzka, Jorg; Knebel, Birgit; Haas, Jutta; Kremer, Lorena; Jacob, Sylvia; Hartwig, Sonja; Nitzgen, Ulrike; Muller-Wieland, Dirk			Preventing Phosphorylation of Sterol Regulatory Element-Binding Protein 1a by MAP-Kinases Protects Mice from Fatty Liver and Visceral Obesity	PLOS ONE			English	Article							SUBSTRATE RECOGNITION; CHOLESTEROL-SYNTHESIS; TRANSCRIPTION FACTOR; INSULIN-RESISTANCE; HEPATIC STEATOSIS; TRANSGENIC MICE; X-RECEPTOR; SREBP-1; EXPRESSION; IDENTIFICATION	The transcription factor sterol regulatory element binding protein (SREBP)-1a plays a pivotal role in lipid metabolism. Using the SREBP-1a expressing human hepatoma cell line HepG2 we have shown previously that human SREBP-1a is phosphorylated at serine 117 by ERK-mitogen-activated protein kinases (MAPK). Using a combination of cell biology and protein chemistry approach we show that SREBP-1a is also target of other MAPK-families, i.e. c-JUN N-terminal protein kinases (JNK) or p38 stress activated MAP kinases. Serine 117 is also the major phosphorylation site in SREBP-1a for JNK. In contrast to that the major phosphorylation sites of p38 MAPK family are serine 63 and threonine 426. Functional analyses reveal that phosphorylation of SREBP-1a does not alter protein/DNA interaction. The identified phosphorylation sites are specific for both kinase families also in cellular context. To provide direct evidence that phosphorylation of SREBP-1a is a regulatory principle of biological and clinical relevance, we generated transgenic mice expressing mature transcriptionally active N-terminal domain of human SREBP-1a variant lacking all identified phosphorylaton sites designed as alb-SREBP-1a Delta P and wild type SREBP-1a designed as alb-SREBP-1a liver specific under control of the albumin promoter and a liver specific enhancer. In contrast to alb-SREBP-1a mice the phosphorylation-deficient mice develop no enlarged fatty livers under normocaloric conditions. Phenotypical examination reveales a massive accumulation of adipose tissue in alb-SREBP-1a but not in the phosphorylation deficient alb-SREBP-1a Delta P mice. Moreover, preventing phosphorylation of SREBP-1a protects mice also from dyslipidemia. In conclusion, phosphorylation of SREBP-1a by ERK, JNK and p38 MAPK-families resembles a biological principle and plays a significant role, in vivo.	[Kotzka, Jorg; Knebel, Birgit; Kremer, Lorena; Jacob, Sylvia; Hartwig, Sonja; Nitzgen, Ulrike] Univ Dusseldorf, German Diabet Ctr, Inst Clin Biochem & Pathobiochem, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Haas, Jutta; Muller-Wieland, Dirk] Semmelweis Univ, Dept Gen Internal Med, Fac Med, Inst Diabet Res,Asklepios Clin St Georg, Hamburg, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Asklepios Klinik St. Georg; Semmelweis University	Kotzka, J (corresponding author), Univ Dusseldorf, German Diabet Ctr, Inst Clin Biochem & Pathobiochem, Leibniz Ctr Diabet Res, Dusseldorf, Germany.	d.mueller-wieland@asklepios.com		Kotzka, Jorg/0000-0003-1173-9372	Center for Molecular Medicine Cologne (TV1) and Norgenta; Center for Molecular Medicine Cologne (TV1); Norgenta; German Diabetes Center	Center for Molecular Medicine Cologne (TV1) and Norgenta; Center for Molecular Medicine Cologne (TV1); Norgenta; German Diabetes Center	The work was supported by the Center for Molecular Medicine Cologne (TV1) and Norgenta, a non-profit Life Sciences Agency of the federal state government of Hamburg and government of Schleswig-Holstein within the LiDia project and the German Diabetes Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; Arito M, 2008, J BIOL CHEM, V283, P15224, DOI 10.1074/jbc.M800910200; Barsyte-Lovejoy D, 2002, J BIOL CHEM, V277, P9896, DOI 10.1074/jbc.M108145200; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Bruning JC, 2003, J STEROID BIOCHEM, V86, P113, DOI 10.1016/S0960-0760(03)00263-2; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Day YJ, 2004, AM J PHYSIOL-GASTR L, V286, pG285, DOI 10.1152/ajpgi.00348.2003; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Harada N, 2008, BIOCHEM BIOPH RES CO, V368, P820, DOI 10.1016/j.bbrc.2008.02.004; Hawkins J, 2000, ARCH BIOCHEM BIOPHYS, V382, P310, DOI 10.1006/abbi.2000.2005; Herbach N, 2007, DIABETES, V56, P1268, DOI 10.2337/db06-0658; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HUA XX, 1995, J BIOL CHEM, V270, P29422, DOI 10.1074/jbc.270.49.29422; IZBAN MG, 1989, J BIOL CHEM, V264, P9171; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Kotzka J, 2000, J LIPID RES, V41, P99; Kotzka J, 2004, J BIOL CHEM, V279, P22404, DOI 10.1074/jbc.M401198200; Kotzka J, 2004, EXPERT OPIN THER TAR, V8, P141, DOI 10.1517/eott.8.2.141.30248; Kotzka J, 2011, ATHEROSCLEROSIS, V218, P134, DOI 10.1016/j.atherosclerosis.2011.05.008; Kotzka J, 2010, ATHEROSCLEROSIS, V213, P156, DOI 10.1016/j.atherosclerosis.2010.08.046; Lehr S, 2005, BIOCHEMISTRY-US, V44, P5117, DOI 10.1021/bi0479656; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mather K, 2009, AM J PHYSIOL-ENDOC M, V296, pE398, DOI 10.1152/ajpendo.90889.2008; Ndumele CE, 2011, ARTERIOSCL THROM VAS, V31, P1927, DOI 10.1161/ATVBAHA.111.228262; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; Plosch T, 2002, J BIOL CHEM, V277, P33870, DOI 10.1074/jbc.M206522200; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Roth G, 2000, J BIOL CHEM, V275, P33302, DOI 10.1074/jbc.M005425200; Schreuder TCMA, 2008, WORLD J GASTROENTERO, V14, P2474, DOI 10.3748/wjg.14.2474; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Shimano H, 2000, TRENDS CARDIOVAS MED, V10, P275, DOI 10.1016/S1050-1738(00)00079-7; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Shimomura I, 1997, P NATL ACAD SCI USA, V94, P12354, DOI 10.1073/pnas.94.23.12354; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Streicher R, 1996, J BIOL CHEM, V271, P7128, DOI 10.1074/jbc.271.12.7128; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Tilg H, 2006, GASTROENTEROLOGY, V131, P934, DOI 10.1053/j.gastro.2006.05.054; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Yoon YS, 2009, J BIOL CHEM, V284, P10446, DOI 10.1074/jbc.M900096200	54	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32609	10.1371/journal.pone.0032609	http://dx.doi.org/10.1371/journal.pone.0032609			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384276	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500103
J	Richards, BL; Williams, ID; Vetter, OJ; Williams, GJ				Richards, Benjamin L.; Williams, Ivor D.; Vetter, Oliver J.; Williams, Gareth J.			Environmental Factors Affecting Large-Bodied Coral Reef Fish Assemblages in the Mariana Archipelago	PLOS ONE			English	Article							REMOTE HAWAIIAN ATOLLS; MARINE PROTECTED AREAS; GREAT-BARRIER-REEF; LIFE-HISTORY; CARCHARHINUS-AMBLYRHYNCHOS; HABITAT ASSOCIATIONS; SPECIES RICHNESS; SPATIAL-PATTERNS; NEW-ZEALAND; MOVEMENTS	Large-bodied reef fishes represent an economically and ecologically important segment of the coral reef fish assemblage. Many of these individuals supply the bulk of the reproductive output for their population and have a disproportionate effect on their environment (e.g. as apex predators or bioeroding herbivores). Large-bodied reef fishes also tend to be at greatest risk of overfishing, and their loss can result in a myriad of either cascading (direct) or indirect trophic and other effects. While many studies have investigated habitat characteristics affecting populations of small-bodied reef fishes, few have explored the relationship between large-bodied species and their environment. Here, we describe the distribution of the large-bodied reef fishes in the Mariana Archipelago with an emphasis on the environmental factors associated with their distribution. Of the factors considered in this study, a negative association with human population density showed the highest relative influence on the distribution of large-bodied reef fishes; however, depth, water temperature, and distance to deep water also were important. These findings provide new information on the ecology of large-bodied reef fishes can inform discussions concerning essential fish habitat and ecosystem-based management for these species and highlight important knowledge gaps worthy of additional research.	[Richards, Benjamin L.] Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA; [Williams, Ivor D.; Vetter, Oliver J.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Richards, Benjamin L.] NOAA Fisheries Serv, Pacific Islands Fisheries Sci Ctr, Honolulu, HI USA; [Williams, Gareth J.] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92103 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California San Diego; Scripps Institution of Oceanography	Richards, BL (corresponding author), Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA.	benjamin.richards@noaa.gov	/AAZ-4417-2021	/0000-0001-9907-6221; Williams, Dr Gareth J./0000-0001-7837-1619; Williams, Ivor/0000-0002-9444-1020	National Marine Fisheries Service Office of Habitat Conservation; National Oceanic and Atmospheric Administration	National Marine Fisheries Service Office of Habitat Conservation; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	The National Marine Fisheries Service Office of Habitat Conservation and National Oceanic and Atmospheric Administration's Coral Reef Conservation Program provided funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardy T, 2011, MAR POLICY, V35, P226, DOI 10.1016/j.marpol.2010.10.006; Amesbury J.R., 1989, NATIVE FISHING RIGHT; Asakura Akira, 1994, Natural History Research Special Issue, V1, P1; Ault JS, 1998, FISH B-NOAA, V96, P395; Beger M, 2008, MAR ECOL PROG SER, V361, P1, DOI 10.3354/meps07481; BELLWOOD DR, 1990, ENVIRON BIOL FISH, V28, P189, DOI 10.1007/BF00751035; BELLWOOD DR, 1995, MAR BIOL, V121, P419, DOI 10.1007/BF00349451; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bigelow KA, 1999, FISH OCEANOGR, V8, P178, DOI 10.1046/j.1365-2419.1999.00105.x; Birkeland C, 2005, TRENDS ECOL EVOL, V20, P356, DOI 10.1016/j.tree.2005.03.015; Biro PA, 2009, TRENDS ECOL EVOL, V24, P66, DOI 10.1016/j.tree.2008.11.001; Bohnsack James A., 2003, Gulf and Caribbean Research, V14, P1; Bruggemann JH, 1996, MAR ECOL PROG SER, V134, P59, DOI 10.3354/meps134059; Burdick D, 2006, STATUS CORAL REEF EC; Cappo M, 2005, MAR FRESHWATER RES, V56, P713, DOI 10.1071/MF04218; Carpenter K.E., 1982, Proceedings of the International Coral Reef Symposium, P497; Caselle JE, 1996, ECOLOGY, V77, P2488, DOI 10.2307/2265748; Chabanet P, 1997, CORAL REEFS, V16, P93, DOI 10.1007/s003380050063; Chittaro PM, 2004, CORAL REEFS, V23, P235, DOI 10.1007/s00338-004-0376-z; Clarke KR, 2006, MAR ECOL PROG SER, V320, P11, DOI 10.3354/meps320011; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Coleman FC, 2000, FISHERIES, V25, P14, DOI 10.1577/1548-8446(2000)025<0014:LRF>2.0.CO;2; DAYTON PK, 1995, AQUAT CONSERV, V5, P205, DOI 10.1002/aqc.3270050305; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; DeMartini EE, 2007, B MAR SCI, V81, P139; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Flores T, 2006, OFFSHORE FISHERIES P; Flores T, 2006, INSHORE FISHERIES PA; Francis Malcolm P., 1993, Fisheries Oceanography, V2, P65, DOI 10.1111/j.1365-2419.1993.tb00121.x; Francis RC, 2007, FISHERIES, V32, P217, DOI 10.1577/1548-8446(2007)32[217:TCFBFS]2.0.CO;2; Friedlander A.M., 2001, AQUARIUM SCI CONSERV, V3, P135, DOI 10.1023/A:1011390729192; Friedlander AM, 2007, MAR ECOL PROG SER, V351, P221, DOI 10.3354/meps07112; Friedlander AM, 2010, MAR ECOL PROG SER, V410, P219, DOI 10.3354/meps08634; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Friedlander AM, 2005, NOAA TECHNICAL MEMOR, V23, P210; Gorley C.K., 2006, GETTING STARTED PRIM; Green A, 1997, 278 W PAC REG FISH M; GRIGG RW, 1994, MAR ECOL PROG SER, V103, P25, DOI 10.3354/meps103025; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Heithaus MR, 2009, LIMNOL OCEANOGR, V54, P472, DOI 10.4319/lo.2009.54.2.0472; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; Hixon Mark A., 1997, P230; HOBSON ES, 1978, FISH B-NOAA, V76, P133; Holland KN, 1996, FISH RES, V25, P279, DOI 10.1016/0165-7836(95)00442-4; Hopkins TE, 2003, ENVIRON BIOL FISH, V66, P279, DOI 10.1023/A:1023907121605; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Humston R, 2005, MAR ECOL PROG SER, V291, P237, DOI 10.3354/meps291237; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 1997, CORAL REEFS, V16, pS23, DOI 10.1007/s003380050238; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Jennings S, 2004, J ANIM ECOL, V73, P632, DOI 10.1111/j.0021-8790.2004.00839.x; Jennings S, 1999, J ANIM ECOL, V68, P617, DOI 10.1046/j.1365-2656.1999.00312.x; Jennings S, 1998, P ROY SOC B-BIOL SCI, V265, P333, DOI 10.1098/rspb.1998.0300; Jennings S., 2001, MARINE FISHERIES ECO; Jones R. S., 1968, Micronesica, V4, P309; Kemp JM, 1998, J BIOGEOGR, V25, P919, DOI 10.1046/j.1365-2699.1998.00249.x; Kenyon JC, 2006, COAST MANAGE, V34, P339, DOI 10.1080/08920750600686711; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; KOSLOW JA, 1988, MAR ECOL PROG SER, V43, P201, DOI 10.3354/meps043201; Kulbicki M, 2005, CYBIUM, V29, P235; Lange M., 2003, ENV MENTAL BIOL FISH, V66, P99; Leathwick JR, 2006, MAR ECOL PROG SER, V321, P267, DOI 10.3354/meps321267; LEVINS RICHARD, 1968; Lindberg WJ, 2006, ECOL APPL, V16, P731, DOI 10.1890/1051-0761(2006)016[0731:DHSAPB]2.0.CO;2; Long RA, 2009, J WILDLIFE MANAGE, V73, P294, DOI 10.2193/2008-052; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; Magnuson J.J., 1980, FISH BEHAV ITS USE C, P512; MARAGOS JE, 1993, COAST MANAGE, V21, P235, DOI 10.1080/08920759309362207; MCKIBBEN JN, 1986, B MAR SCI, V38, P89; Meekan MG, 2003, MAR ECOL PROG SER, V256, P193, DOI 10.3354/meps256193; Meyer CG, 2007, MAR BIOL, V151, P2133, DOI 10.1007/s00227-007-0647-7; Meyer CG, 2007, MAR ECOL PROG SER, V333, P13, DOI 10.3354/meps333013; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Myers RA, 1997, ECOL APPL, V7, P91, DOI 10.1890/1051-0761(1997)007[0091:WDFSCT]2.0.CO;2; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nakamura Y, 2004, FISHERIES SCI, V70, P788, DOI 10.1111/j.1444-2906.2004.00872.x; Newman SJ, 1996, ENVIRON BIOL FISH, V46, P123, DOI 10.1007/BF00005214; NOAA National Centers for Coastal Ocean Science [NCCOS], 2005, NOAA TECHN MEM NOS N, P8; Pacific Islands Benthic Habitat Mapping Center, 2010, COMM NO MAR ISL CNMI; Papastamatiou YP, 2006, MAR ECOL PROG SER, V320, P239, DOI 10.3354/meps320239; Pate FD, 2001, AUST ARCHAEOL, V52, P1; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pittman SJ, 2007, ECOL MODEL, V204, P9, DOI 10.1016/j.ecolmodel.2006.12.017; Pittman SJ, 2007, MAR ECOL PROG SER, V348, P273, DOI 10.3354/meps07052; Pittman SJ, 2004, MAR ECOL PROG SER, V283, P233, DOI 10.3354/meps283233; Plotkin JB, 2002, ECOLOGY, V83, P3344, DOI 10.1890/0012-9658(2002)083[3344:STSCOA]2.0.CO;2; R Core Team, 2020, R LANG ENV STAT COMP; RAINBIRD P, 1994, J WORLD PREHIST, V8, P293, DOI 10.1007/BF02221052; Reynolds JD, 2005, P ROY SOC B-BIOL SCI, V272, P2337, DOI 10.1098/rspb.2005.3281; Richards BL, 2011, B MAR SCI, V87, P55, DOI 10.5343/bms.2010.1019; Ridgeway G., GEN BOOSTED REGRESSI; Roberts C., 2007, UNNATURAL HIST SEA; Rohmann SO, 2005, CORAL REEFS, V24, P370, DOI 10.1007/s00338-005-0014-4; RUSS G, 1984, MAR ECOL PROG SER, V20, P23, DOI 10.3354/meps020023; Russ GR, 1998, CORAL REEFS, V17, P399, DOI 10.1007/s003380050146; RUSS GR, 1989, MAR ECOL PROG SER, V56, P13, DOI 10.3354/meps056013; SALE PF, 1972, ECOLOGY, V53, P753, DOI 10.2307/1934798; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sandin Stuart A., 2010, P71; Schroeder RE, 2003, P 10 INT COR REEF S, P1016; Sheppard C., 1995, MAR POLL B, V30, P766; Simpfendorfer CA, 2005, ESTUARIES, V28, P78, DOI 10.1007/BF02732755; Song LM, 2009, ENVIRON BIOL FISH, V85, P153, DOI 10.1007/s10641-009-9474-7; Sponaugle S, 2006, MAR ECOL PROG SER, V308, P1, DOI 10.3354/meps308001; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; SUDEKUM AE, 1991, FISH B-NOAA, V89, P493; THRESHER RE, 1986, B MAR SCI, V38, P253; Valesini FJ, 2004, ESTUAR COAST SHELF S, V60, P737, DOI 10.1016/j.ecss.2004.03.012; Western Pacific Regional Fishery Management Council, 2009, FISH EC PLAN MAR ARC; Wetherbee BM, 1997, MAR ECOL PROG SER, V151, P181, DOI 10.3354/meps151181; Williams GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009264; Williams ID, 2008, ENVIRON CONSERV, V35, P261, DOI 10.1017/S0376892908004876; Williams I.D., 2011, J MARINE BIOL, P14; Williaw GJ, 2008, NEW ZEAL J MAR FRESH, V42, P33, DOI 10.1080/00288330809509934; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399	121	34	35	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31374	10.1371/journal.pone.0031374	http://dx.doi.org/10.1371/journal.pone.0031374			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384014	gold, Green Published, Green Submitted			2022-12-27	WOS:000302918500023
J	Veatch, SL; Machta, BB; Shelby, SA; Chiang, EN; Holowka, DA; Baird, BA				Veatch, Sarah L.; Machta, Benjamin B.; Shelby, Sarah A.; Chiang, Ethan N.; Holowka, David A.; Baird, Barbara A.			Correlation Functions Quantify Super-Resolution Images and Estimate Apparent Clustering Due to Over-Counting	PLOS ONE			English	Article							FC-EPSILON-RI; CELL-MEMBRANES; MAST-CELLS; MODEL; HETEROGENEITY; MICROSCOPY; RECEPTOR; DOMAINS; IGE; LIGANDS	We present an analytical method using correlation functions to quantify clustering in super-resolution fluorescence localization images and electron microscopy images of static surfaces in two dimensions. We use this method to quantify how over-counting of labeled molecules contributes to apparent self-clustering and to calculate the effective lateral resolution of an image. This treatment applies to distributions of proteins and lipids in cell membranes, where there is significant interest in using electron microscopy and super-resolution fluorescence localization techniques to probe membrane heterogeneity. When images are quantified using pair auto-correlation functions, the magnitude of apparent clustering arising from over-counting varies inversely with the surface density of labeled molecules and does not depend on the number of times an average molecule is counted. In contrast, we demonstrate that over-counting does not give rise to apparent co-clustering in double label experiments when pair cross-correlation functions are measured. We apply our analytical method to quantify the distribution of the IgE receptor (Fc epsilon RI) on the plasma membranes of chemically fixed RBL-2H3 mast cells from images acquired using stochastic optical reconstruction microscopy (STORM/dSTORM) and scanning electron microscopy (SEM). We find that apparent clustering of Fc epsilon RI-bound IgE is dominated by over-counting labels on individual complexes when IgE is directly conjugated to organic fluorophores. We verify this observation by measuring pair cross-correlation functions between two distinguishably labeled pools of IgE-Fc epsilon RI on the cell surface using both imaging methods. After correcting for over-counting, we observe weak but significant self-clustering of IgE-Fc epsilon RI in fluorescence localization measurements, and no residual self-clustering as detected with SEM. We also apply this method to quantify IgE-Fc epsilon RI redistribution after deliberate clustering by crosslinking with two distinct trivalent ligands of defined architectures, and we evaluate contributions from both over-counting of labels and redistribution of proteins.	[Veatch, Sarah L.] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA; [Machta, Benjamin B.] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [Veatch, Sarah L.; Shelby, Sarah A.; Chiang, Ethan N.; Holowka, David A.; Baird, Barbara A.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA	University of Michigan System; University of Michigan; Cornell University; Cornell University	Veatch, SL (corresponding author), Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA.	sveatch@umich.edu	Veatch, Sarah L/G-9512-2016	Veatch, Sarah L/0000-0002-9317-2308; Shelby, Sarah/0000-0001-8484-8356	National Institutes of Health (NIH) [R00GM087810, R01AI18306]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM087810] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded through the National Institutes of Health (NIH) (SLV: R00GM087810; BAB: R01AI18306). http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibale P, 2010, J PHYS CHEM LETT, V1, P1506, DOI 10.1021/jz1003523; Baddeley D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020645; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Brewster R, 2009, BIOPHYS J, V97, P1087, DOI 10.1016/j.bpj.2009.05.051; Engelhardt J, 2011, NANO LETT, V11, P209, DOI 10.1021/nl103472b; ERICKSON J, 1987, BIOPHYS J, V52, P657, DOI 10.1016/S0006-3495(87)83258-7; GOMPPER G, 1990, PHYS REV B, V41, P9148, DOI 10.1103/PhysRevB.41.9148; Gosse JA, 2005, J IMMUNOL, V175, P2123, DOI 10.4049/jimmunol.175.4.2123; Hancock JF, 2005, METHODS, V37, P165, DOI 10.1016/j.ymeth.2005.05.018; Heilemann M, 2011, MOLECULES, V16, P3106; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Honerkamp-Smith AR, 2009, BBA-BIOMEMBRANES, V1788, P53, DOI 10.1016/j.bbamem.2008.09.010; Ji N, 2008, CURR OPIN NEUROBIOL, V18, P605, DOI 10.1016/j.conb.2009.03.009; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Kiskowski MA, 2009, BIOPHYS J, V97, P1095, DOI 10.1016/j.bpj.2009.05.039; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Kolin DL, 2007, CELL BIOCHEM BIOPHYS, V49, P141, DOI 10.1007/s12013-007-9000-5; Larson DR, 2005, J CELL BIOL, V171, P527, DOI 10.1083/jcb.200503110; Machta BB, 2011, BIOPHYS J, V100, P1668, DOI 10.1016/j.bpj.2011.02.029; MENDOZA G, 1976, NATURE, V264, P548, DOI 10.1038/264548a0; Onsager L, 1944, PHYS REV, V65, P117, DOI 10.1103/PhysRev.65.117; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Sethna JP, 2006, STAT MECH ENTROPY OR, Vxix; Sil D, 2007, ACS CHEM BIOL, V2, P674, DOI 10.1021/cb7001472; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Tanaka KAK, 2010, NAT METHODS, V7, P865, DOI 10.1038/nmeth.f.314; van de Linde S, 2010, J BIOTECHNOL, V149, P260, DOI 10.1016/j.jbiotec.2010.02.010; Veatch SL, 2008, ACS CHEM BIOL, V3, P287, DOI 10.1021/cb800012x; Wilson BS, 2000, J CELL BIOL, V149, P1131, DOI 10.1083/jcb.149.5.1131; Wilson BS, 2004, MOL BIOL CELL, V15, P2580, DOI 10.1091/mbc.E03-08-0574; Wilson BS, 2001, J CELL BIOL, V154, P645, DOI 10.1083/jcb.200104049; Wu M, 2004, P NATL ACAD SCI USA, V101, P13798, DOI 10.1073/pnas.0403835101	34	196	196	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31457	10.1371/journal.pone.0031457	http://dx.doi.org/10.1371/journal.pone.0031457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384026	Green Published, gold, Green Submitted			2022-12-27	WOS:000302918500026
J	Dalesman, S; Lukowiak, K				Dalesman, Sarah; Lukowiak, Ken			How Stress Alters Memory in 'Smart' Snails	PLOS ONE			English	Article							LONG-TERM-MEMORY; CENTRAL PATTERN GENERATOR; LYMNAEA-STAGNALIS; ENVIRONMENTAL CALCIUM; POPULATION DIFFERENCES; ANTIPREDATOR BEHAVIOR; PREDATION PRESSURE; LEARNING-ABILITY; LOCAL ADAPTATION; INTERMEDIATE	Cognitive ability varies within species, but whether this variation alters the manner in which memory formation is affected by environmental stress is unclear. The great pond snail, Lymnaea stagnalis, is commonly used as model species in studies of learning and memory. The majority of those studies used a single laboratory strain (i.e. the Dutch strain) originating from a wild population in the Netherlands. However, our recent work has identified natural populations that demonstrate significantly enhanced long-term memory (LTM) formation relative to the Dutch strain following operant conditioning of aerial respiratory behaviour. Here we assess how two populations with enhanced memory formation (i.e. 'smart' snails), one from Canada (Trans Canada 1: TC1) and one from the U. K. (Chilton Moor: CM) respond to ecologically relevant stressors. In control conditions the Dutch strain forms memory lasting 1-3 h following a single 0.5 h training session in our standard calcium pond water (80 mg/l [Ca2+]), whereas the TC1 and CM populations formed LTM lasting 5+ days following this training regime. Exposure to low environmental calcium pond water (20 mg/l [Ca2+]), which blocks LTM in the Dutch strain, reduced LTM retention to 24 h in the TC1 and CM populations. Crowding (20 snails in 100 ml) immediately prior to training blocks LTM in the Dutch strain, and also did so in TC1 and CM populations. Therefore, snails with enhanced cognitive ability respond to these ecologically relevant stressors in a similar manner to the Dutch strain, but are more robust at forming LTM in a low calcium environment. Despite the two populations (CM and TC1) originating from different continents, LTM formation was indistinguishable in both control and stressed conditions. This indicates that the underlying mechanisms controlling cognitive differences among populations may be highly conserved in L. stagnalis.	[Dalesman, Sarah; Lukowiak, Ken] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Calgary	Dalesman, S (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada.	sarah.dalesman@ucalgary.ca		Dalesman, Sarah/0000-0001-8548-3096	Alberta Heritage Foundation for Medical Research from Alberta Innovates - Health Solutions, Canada; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council	Alberta Heritage Foundation for Medical Research from Alberta Innovates - Health Solutions, Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	S.D. is supported by an Alberta Heritage Foundation for Medical Research postdoctoral fellowship from Alberta Innovates - Health Solutions, Canada (http://www.aihealthsolutions.ca/). K.L. is supported by grants from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) and the Natural Sciences and Engineering Research Council (http://www.nserc-crsng.gc.ca/Index_eng.asp). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abjornsson K, 2004, ECOLOGY, V85, P1859, DOI 10.1890/03-0074; Andrews JS, 1996, COGNITIVE BRAIN RES, V3, P251, DOI 10.1016/0926-6410(96)00011-0; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; Benjamin PR, 2000, LEARN MEMORY, V7, P124, DOI 10.1101/lm.7.3.124; Boycott AE, 1936, J ANIM ECOL, V5, P116, DOI 10.2307/1096; Braun MH, 2012, NEUROBIOL LEARN MEM, V97, P173, DOI 10.1016/j.nlm.2011.11.005; Braun MH, 2011, NEUROBIOL LEARN MEM, V96, P403, DOI 10.1016/j.nlm.2011.06.016; Brembs B, 2003, CURR OPIN NEUROBIOL, V13, P710, DOI 10.1016/j.conb.2003.10.002; Brydges NM, 2008, ANIM BEHAV, V75, P935, DOI 10.1016/j.anbehav.2007.08.005; COOPER RM, 1958, CAN J PSYCHOLOGY, V12, P159, DOI 10.1037/h0083747; Cousyn C, 2001, P NATL ACAD SCI USA, V98, P6256, DOI 10.1073/pnas.111606798; Dalesman S, 2006, ANIM BEHAV, V71, P789, DOI 10.1016/j.anbehav.2005.05.028; Dalesman S, 2007, ECOLOGY, V88, P2462, DOI 10.1890/07-0403.1; Dalesman S, 2007, FRESHWATER BIOL, V52, P2134, DOI 10.1111/j.1365-2427.2007.01843.x; Dalesman Sarah, 2011, Communicative & Integrative Biology, V4, P717; Dalesman S, 2011, ANIM BEHAV, V82, P311, DOI 10.1016/j.anbehav.2011.05.005; Dalesman S, 2011, J EXP BIOL, V214, P2528, DOI 10.1242/jeb.058024; Dalesman S, 2011, NEUROBIOL LEARN MEM, V95, P393, DOI 10.1016/j.nlm.2010.11.017; Dalesman S, 2010, FRESHWATER BIOL, V55, P2107, DOI 10.1111/j.1365-2427.2010.02470.x; Dalesman S, 2010, J EXP BIOL, V213, P1471, DOI 10.1242/jeb.040493; Dalesman S, 2010, ANIM BEHAV, V79, P173, DOI 10.1016/j.anbehav.2009.10.024; Dalesman S, 2009, EVOL ECOL, V23, P907, DOI 10.1007/s10682-008-9280-2; Dalesman S, 2009, ANIM BEHAV, V78, P987, DOI 10.1016/j.anbehav.2009.07.018; De Caigny P, 2008, J EXP BIOL, V211, P2678, DOI 10.1242/jeb.020347; Ebanks SC, 2010, J COMP PHYSIOL B, V180, P953, DOI 10.1007/s00360-010-0469-7; Ferrari MCO, 2006, BEHAV ECOL SOCIOBIOL, V60, P522, DOI 10.1007/s00265-006-0195-z; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Fitzpatrick MJ, 2007, NATURE, V447, P210, DOI 10.1038/nature05764; Griffiths SW, 2003, FISH FISH, V4, P256, DOI 10.1046/j.1467-2979.2003.00129.x; Healy SD, 2009, BEHAV PROCESS, V80, P288, DOI 10.1016/j.beproc.2008.10.002; Katsnelson E, 2011, P ROY SOC B-BIOL SCI, V278, P582, DOI 10.1098/rspb.2010.1151; Kelley JL, 2003, FISH FISH, V4, P216, DOI 10.1046/j.1467-2979.2003.00126.x; KEMENES G, 1989, BRAIN RES, V489, P163, DOI 10.1016/0006-8993(89)90019-X; Knezevic B, 2011, J EXP BIOL, V214, P2118, DOI 10.1242/jeb.054635; Koene JM, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-212; Kojima S, 1996, ZOOL SCI, V13, P803, DOI 10.2108/zsj.13.803; Leiser SF, 2010, MOL CELL BIOL, V30, P871, DOI 10.1128/MCB.01145-09; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Lukowiak K, 2000, LEARN MEMORY, V7, P140, DOI 10.1101/lm.7.3.140; Lukowiak K, 2003, J EXP BIOL, V206, P2097, DOI 10.1242/jeb.00374; Lukowiak K, 1996, J EXP BIOL, V199, P683; Lukowiak K, 2010, BEHAV BRAIN RES, V214, P18, DOI 10.1016/j.bbr.2010.05.011; MACAN TT, 1950, J ANIM ECOL, V19, P124, DOI 10.2307/1523; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; MCKILLOP WB, 1972, CAN J ZOOLOG, V50, P1433, DOI 10.1139/z72-192; Mery F, 2006, CHEM SENSES, V31, pE84; Mery F, 2007, P NATL ACAD SCI USA, V104, P13051, DOI 10.1073/pnas.0702923104; Munoz A, 2008, BEHAV ECOL SOCIOBIOL, V62, P913, DOI 10.1007/s00265-007-0515-y; Orr M, 2009, J EXP BIOL, V212, P3911, DOI 10.1242/jeb.024281; Orr MV, 2008, J EXP BIOL, V211, P2807, DOI 10.1242/jeb.020172; Orr MV, 2008, J NEUROSCI, V28, P2726, DOI 10.1523/JNEUROSCI.5132-07.2008; Orr MV, 2009, J EXP BIOL, V212, P2237, DOI 10.1242/jeb.031575; Parsons PA, 2003, BIOGERONTOLOGY, V4, P63, DOI 10.1023/A:1023308122587; Parvez K, 2006, CAN J NEUROL SCI, V33, P347, DOI 10.1017/S0317167100005291; Pravosudov VV, 2002, BEHAV NEUROSCI, V116, P515, DOI 10.1037//0735-7044.116.4.515; Rundle SD, 2004, P ROY SOC B-BIOL SCI, V271, pS67, DOI 10.1098/rsbl.2003.0106; Sangha S, 2003, J EXP BIOL, V206, P1605, DOI 10.1242/jeb.00301; Scheibenstock A, 2002, J NEUROPHYSIOL, V88, P1584, DOI 10.1152/jn.2002.88.4.1584; SELYE H, 1973, AM SCI, V61, P692; Shors TJ, 2004, LEARN MEMORY, V11, P137, DOI 10.1101/lm.66604; Skow CD, 2006, BEHAV ECOL, V17, P34, DOI 10.1093/beheco/ari094; Sokolowski MB, 1997, P NATL ACAD SCI USA, V94, P7373, DOI 10.1073/pnas.94.14.7373; SYED NI, 1992, ACTA BIOL HUNG, V43, P409; SYED NI, 1990, SCIENCE, V250, P282, DOI 10.1126/science.2218532; Tryon R. C., 1940, YEARBOOK NATIONAL SO, V39, P111; Vermeulen CJ, 2007, EXP GERONTOL, V42, P153, DOI 10.1016/j.exger.2006.09.014; Ward AJW, 2009, BEHAV ECOL, V20, P511, DOI 10.1093/beheco/arp025; WILLIAMS N V, 1970, Malacologia, V10, P153; YOUNG J O, 1975, Proceedings of the Malacological Society of London, V41, P429	69	21	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32334	10.1371/journal.pone.0032334	http://dx.doi.org/10.1371/journal.pone.0032334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384220	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916800036
J	Delisle, VC; Beck, AT; Dobson, KS; Dozois, DJA; Thombs, BD				Delisle, Vanessa C.; Beck, Aaron T.; Dobson, Keith S.; Dozois, David J. A.; Thombs, Brett D.			Revisiting Gender Differences in Somatic Symptoms of Depression: Much Ado about Nothing?	PLOS ONE			English	Article							SEX-DIFFERENCES; LIFETIME PREVALENCE; CLINICAL-FEATURES; MAJOR DEPRESSION; DISORDER; HEALTH; RISKS	Background: Women have a higher prevalence of Major Depressive Disorder (MDD) and report more severe depressive symptoms than men. Several studies have suggested that gender differences in depression may occur because women report higher levels of somatic symptoms than men. Those studies, however, have not controlled or matched for non-somatic symptoms. The objective of this study was to examine if women report relatively more somatic symptoms than men matched on cognitive/affective symptoms. Methods: Male and female patients receiving treatment for MDD in outpatient psychiatric clinics in New Jersey and Pennsylvania, USA were matched on Beck Depression Inventory-II (BDI-II) cognitive/affective symptom scores. Male and female BDI-II somatic symptom scores were compared using independent samples 2-tailed t-tests. Results: Of 472 male and 1,026 female patients, there were 470 male patients (mean age = 40.1 years, SD = 15.1) and 470 female patients (mean age = 43.1 years, SD = 17.2) successfully matched on BDI-II cognitive/affective symptom scores. Somatic symptoms accounted for 35% of total BDI-II scores for male patients versus 38% for matched female patients. Female patients had somatic symptom scores on average 1.3 points higher than males (p<.001), equivalent to 4% of the total BDI-II scores of female patients. Only 5% of male patients and 7% of female patients scored 2 or higher on all BDI-II somatic symptom items. Conclusions: Gender differences in somatic scores were very small. Thus, differences in the experience and reporting of somatic symptoms would not likely explain gender differences in depression rates and symptom severity.	[Delisle, Vanessa C.; Thombs, Brett D.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Sch Nursing, Montreal, PQ, Canada; [Delisle, Vanessa C.; Thombs, Brett D.] McGill Univ, Jewish Gen Hosp, Dept Psychiat, Montreal, PQ H3T 1E2, Canada; [Beck, Aaron T.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Dobson, Keith S.] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada; [Dozois, David J. A.] Univ Western Ontario, Dept Psychol, London, ON, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; University of Pennsylvania; University of Calgary; Western University (University of Western Ontario)	Delisle, VC (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.	brett.thombs@mcgill.ca		Dobson, Keith/0000-0001-9542-0822; Thombs, Brett D./0000-0002-5644-8432	Canadian Institutes of Health Research (CIHR); Fonds de la Recherche en Sante Quebec (FRSQ)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	Ms. Delisle is supported by Frederick Banting and Charles Best Canadian Graduate Scholarship-Master's Award from the Canadian Institutes of Health Research (CIHR). Dr. Thombs is supported by a New Investigator Award from the CIHR and an Etablissement de Jeunes Chercheurs award from the Fonds de la Recherche en Sante Quebec (FRSQ). There was no direct sponsorship of the study, and funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Angold A, 1999, PSYCHOL MED, V29, P1043, DOI 10.1017/S0033291799008946; Barnett Rosalind C., 1987, GENDER STRESS; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; BRESLAU N, 1995, PSYCHIAT RES, V58, P1, DOI 10.1016/0165-1781(95)02765-O; CLANCY K, 1974, AM J SOCIOL, V80, P205, DOI 10.1086/225767; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dekker J, 2007, WOMEN HEALTH, V46, P19, DOI 10.1300/J013v46n04_02; Dozois D.J., 2004, COMPREHENSIVE HDB PS; Edwards A, 2002, BMJ-BRIT MED J, V324, P827, DOI 10.1136/bmj.324.7341.827; ERNST C, 1992, EUR ARCH PSY CLIN N, V241, P222, DOI 10.1007/BF02190257; FRANK E, 1988, AM J PSYCHIAT, V145, P41; Gigerenzer G, 2003, BMJ-BRIT MED J, V327, P741, DOI 10.1136/bmj.327.7417.741; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Gigerenzer G, 2010, BMJ-BRIT MED J, V341, P787; Gold CH, 2002, J GERONTOL B-PSYCHOL, V57, pS168, DOI 10.1093/geronb/57.3.S168; HEDGES LV, 1982, PSYCHOL BULL, V92, P490, DOI 10.1037/0033-2909.92.2.490; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Joiner TE, 2005, PSYCHOL ASSESSMENT, V17, P267, DOI 10.1037/1040-3590.17.3.267; Kessler R.C., 2006, WOMEN DEPRESSION HDB, P22, DOI DOI 10.1017/CBO9780511841262.004; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Khan AA, 2002, AM J PSYCHIAT, V159, P1427, DOI 10.1176/appi.ajp.159.8.1427; Kockler M, 2002, INT J GERIATR PSYCH, V17, P65, DOI 10.1002/gps.521; Kornstein SG, 2000, J AFFECT DISORDERS, V60, P1, DOI 10.1016/S0165-0327(99)00158-5; Kroenke K, 1998, PSYCHOSOM MED, V60, P150, DOI 10.1097/00006842-199803000-00006; Ladwig KH, 2001, PSYCHOSOMATICS, V42, P511, DOI 10.1176/appi.psy.42.6.511; Marcus SM, 2008, COMPR PSYCHIAT, V49, P238, DOI 10.1016/j.comppsych.2007.06.012; Middeldorp CM, 2006, TWIN RES HUM GENET, V9, P632, DOI 10.1375/twin.9.5.632; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Nolen-Hoeksema S., 1990, SEX DIFFERENCES DEPR; Osman A, 2008, J CLIN PSYCHOL, V64, P83, DOI 10.1002/jclp.20433; Piccinelli M, 1997, PSYCHOL MED, V27, P433, DOI 10.1017/S0033291796004539; Romans SE, 2007, J NERV MENT DIS, V195, P905, DOI 10.1097/NMD.0b013e3181594cb7; Silverstein B, 1999, AM J PSYCHIAT, V156, P480; Silverstein B, 2002, AM J PSYCHIAT, V159, P1051, DOI 10.1176/appi.ajp.159.6.1051; Szadoczky E, 2002, INT J PSYCHIAT CLIN, V6, P31, DOI 10.1080/136515002753489399; TIBBLIN G, 1990, Scandinavian Journal of Primary Health Care, V8, P9, DOI 10.3109/02813439008994923; Uebelacker LA, 2009, PSYCHOL MED, V39, P591, DOI 10.1017/S0033291708003875; Ward LC, 2006, PSYCHOL ASSESSMENT, V18, P81, DOI 10.1037/1040-3590.18.1.81; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Wenzel A, 2005, J AFFECT DISORDERS, V89, P177, DOI 10.1016/j.jad.2005.06.009; YOUNG MA, 1990, J NERV MENT DIS, V178, P200, DOI 10.1097/00005053-199003000-00008; YOUNG MA, 1990, J AFFECT DISORDERS, V18, P187, DOI 10.1016/0165-0327(90)90035-7	43	36	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32490	10.1371/journal.pone.0032490	http://dx.doi.org/10.1371/journal.pone.0032490			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	927OG	22384260	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916800038
J	Enfield, KB; Schafer, K; Zlupko, M; Herasevich, V; Novicoff, WM; Gajic, O; Hoke, TR; Truwit, JD				Enfield, Kyle B.; Schafer, Katherine; Zlupko, Mike; Herasevich, Vitaly; Novicoff, Wendy M.; Gajic, Ognjen; Hoke, Tracey R.; Truwit, Jonathon D.			A Comparison of Administrative and Physiologic Predictive Models in Determining Risk Adjusted Mortality Rates in Critically Ill Patients	PLOS ONE			English	Article							CHRONIC HEALTH EVALUATION; QUALITY-OF-CARE; HOSPITAL MORTALITY; SEVERITY; ILLNESS; PERFORMANCE; APACHE; SYSTEM	Background: Hospitals are increasingly compared based on clinical outcomes adjusted for severity of illness. Multiple methods exist to adjust for differences between patients. The challenge for consumers of this information, both the public and healthcare providers, is interpreting differences in risk adjustment models particularly when models differ in their use of administrative and physiologic data. We set to examine how administrative and physiologic models compare to each when applied to critically ill patients. Methods: We prospectively abstracted variables for a physiologic and administrative model of mortality from two intensive care units in the United States. Predicted mortality was compared through the Pearsons Product coefficient and Bland-Altman analysis. A subgroup of patients admitted directly from the emergency department was analyzed to remove potential confounding changes in condition prior to ICU admission. Results: We included 556 patients from two academic medical centers in this analysis. The administrative model and physiologic models predicted mortalities for the combined cohort were 15.3% (95% CI 13.7%, 16.8%) and 24.6% (95% CI 22.7%, 26.5%) (t-test p-value<0.001). The r(2) for these models was 0.297. The Bland-Atlman plot suggests that at low predicted mortality there was good agreement; however, as mortality increased the models diverged. Similar results were found when analyzing a subgroup of patients admitted directly from the emergency department. When comparing the two hospitals, there was a statistical difference when using the administrative model but not the physiologic model. Unexplained mortality, defined as those patients who died who had a predicted mortality less than 10%, was a rare event by either model. Conclusions: In conclusion, while it has been shown that administrative models provide estimates of mortality that are similar to physiologic models in non-critically ill patients with pneumonia, our results suggest this finding can not be applied globally to patients admitted to intensive care units. As patients and providers increasingly use publicly reported information in making health care decisions and referrals, it is critical that the provided information be understood. Our results suggest that severity of illness may influence the mortality index in administrative models. We suggest that when interpreting "report cards" or metrics, health care providers determine how the risk adjustment was made and compares to other risk adjustment models.	[Enfield, Kyle B.; Schafer, Katherine; Truwit, Jonathon D.] Univ Virginia, Dept Med, Charlottesville, VA USA; [Zlupko, Mike] Cleveland Clin, Dept Med, Cleveland, OK USA; [Herasevich, Vitaly; Gajic, Ognjen] Mayo Clin, Dept Med, Rochester, MN USA; [Novicoff, Wendy M.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Hoke, Tracey R.] Univ Virginia, Dept Pediat, Childrens Hosp, Charlottesville, VA USA	University of Virginia; Cleveland Clinic Foundation; Mayo Clinic; University of Virginia; University of Virginia	Enfield, KB (corresponding author), Univ Virginia, Dept Med, Charlottesville, VA USA.	ke4z@virginia.edu	Herasevich, Vitaly/V-4000-2019; Enfield, Kyle/J-1840-2019	Herasevich, Vitaly/0000-0002-0214-0651; Enfield, Kyle/0000-0003-4624-0176; truwit, jonathon/0000-0001-7129-9300	NIAID NIH HHS [T32 AI007046] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007046] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; DESHARNAIS SI, 1988, MED CARE, V26, P1129, DOI 10.1097/00005650-198812000-00004; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Enfield KB, 2010, ATS 2010 A2412 NEW O; Glance LG, 2002, CRIT CARE MED, V30, P1976, DOI 10.1097/00003246-200209000-00005; GREEN J, 1990, JAMA-J AM MED ASSOC, V263, P241, DOI 10.1001/jama.263.2.241; Halpin LS, 2008, SEMIN CARDIOTHORAC V, V12, P191, DOI 10.1177/1089253208323412; Herasevich V, 2010, MAYO CLIN PROC, V85, P247, DOI 10.4065/mcp.2009.0479; HORN SD, 1991, MED CARE, V29, P305, DOI 10.1097/00005650-199104000-00001; Iezzoni LI, 1996, AM J PUBLIC HEALTH, V86, P1379, DOI 10.2105/AJPH.86.10.1379; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Kozower BD, 2009, J AM COLL SURGEONS, V209, P551, DOI 10.1016/j.jamcollsurg.2009.08.008; Kuzniewicz MW, 2008, CHEST, V133, P1319, DOI 10.1378/chest.07-3061; Lilford R, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2016; Lilford RJ, 2007, BMJ-BRIT MED J, V335, P648, DOI 10.1136/bmj.39317.641296.AD; Metnitz PGH, 1999, CRIT CARE MED, V27, P1486, DOI 10.1097/00003246-199908000-00014; Mukamel DB, 1998, MED CARE, V36, P945, DOI 10.1097/00005650-199807000-00002; Reid RO, 2010, ARCH INTERN MED, V170, P1442, DOI 10.1001/archinternmed.2010.307; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	21	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32286	10.1371/journal.pone.0032286	http://dx.doi.org/10.1371/journal.pone.0032286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384205	Green Submitted, Green Published, gold			2022-12-27	WOS:000302916800033
J	Byron, SA; Gartside, M; Powell, MA; Wellens, CL; Gao, F; Mutch, DG; Goodfellow, PJ; Pollock, PM				Byron, Sara A.; Gartside, Michael; Powell, Matthew A.; Wellens, Candice L.; Gao, Feng; Mutch, David G.; Goodfellow, Paul J.; Pollock, Pamela M.			FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features	PLOS ONE			English	Article							SYSTEMATIC PELVIC LYMPHADENECTOMY; TRANSMEMBRANE MUTATION; CARCINOMA; DNA; ACTIVATION; SURGERY; TRIAL	Mutations in multiple oncogenes including KRAS, CTNNB1, PIK3CA and FGFR2 have been identified in endometrial cancer. The aim of this study was to provide insight into the clinicopathological features associated with patterns of mutation in these genes, a necessary step in planning targeted therapies for endometrial cancer. 466 endometrioid endometrial tumors were tested for mutations in FGFR2, KRAS, CTNNB1, and PIK3CA. The relationships between mutation status, tumor microsatellite instability (MSI) and clinicopathological features including overall survival (OS) and disease-free survival (DFS) were evaluated using Kaplan-Meier survival analysis and Cox proportional hazard models. Mutations were identified in FGFR2 (48/466); KRAS (87/464); CTNNB1 (88/454) and PIK3CA (104/464). KRAS and FGFR2 mutations were significantly more common, and CTNNB1 mutations less common, in MSI positive tumors. KRAS and FGFR2 occurred in a near mutually exclusive pattern (p = 0.05) and, surprisingly, mutations in KRAS and CTNNB1 also occurred in a near mutually exclusive pattern (p = 0.0002). Multivariate analysis revealed that mutation in KRAS and FGFR2 showed a trend (p = 0.06) towards longer and shorter DFS, respectively. In the 386 patients with early stage disease (stage I and II), FGFR2 mutation was significantly associated with shorter DFS (HR = 3.24; 95% confidence interval, CI, 1.35-7.77; p = 0.008) and OS (HR = 2.00; 95% CI 1.09-3.65; p = 0.025) and KRAS was associated with longer DFS (HR = 0.23; 95% CI 0.05-0.97; p = 0.045). In conclusion, although KRAS and FGFR2 mutations share similar activation of the MAPK pathway, our data suggest very different roles in tumor biology. This has implications for the implementation of anti-FGFR or anti-MEK biologic therapies.	[Byron, Sara A.; Gartside, Michael; Wellens, Candice L.; Pollock, Pamela M.] Translat Genom Res Inst, Canc & Cell Biol Div, Phoenix, AZ USA; [Powell, Matthew A.; Gao, Feng; Mutch, David G.; Goodfellow, Paul J.] Siteman Canc Ctr, Div Gynecol Oncol, St Louis, MO USA; [Powell, Matthew A.; Gao, Feng; Mutch, David G.; Goodfellow, Paul J.] Siteman Canc Ctr, Div Biostat, St Louis, MO USA; [Powell, Matthew A.; Gao, Feng; Mutch, David G.; Goodfellow, Paul J.] Siteman Canc Ctr, Div Endocrine Oncol, St Louis, MO USA; [Powell, Matthew A.; Gao, Feng; Mutch, David G.; Goodfellow, Paul J.] Washington Univ, Sch Med, St Louis, MO USA	Translational Genomics Research Institute; Siteman Cancer Center; Siteman Cancer Center; Siteman Cancer Center; Washington University (WUSTL)	Byron, SA (corresponding author), Translat Genom Res Inst, Canc & Cell Biol Div, Phoenix, AZ USA.	pamela.pollock@qut.edu.au		Gao, Feng/0000-0002-1425-1623; Pollock, Pamela/0000-0001-8420-1026; Byron, Sara/0000-0003-0093-0374	American Cancer Society [PF-07-215-01-TBE]; V Foundation for Cancer Research; QUT;  [CA71754];  [P50 CA134254]; NATIONAL CANCER INSTITUTE [P50CA134254, R01CA071754] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); V Foundation for Cancer Research; QUT; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by PF-07-215-01-TBE from the American Cancer Society (SAB), A V Scholar Grant from The V Foundation for Cancer Research (PMP), CA71754 (PJG), P50 CA134254 (PJG) and a QUT Vice Chancellors' Fellowship (PMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton DPJ, 2009, INT J GYNECOL CANCER, V19, P1465, DOI 10.1111/IGC.0b013e3181b89f95; Bikkavilli Rama Kamesh, 2009, Commun Integr Biol, V2, P46; Byron SA, 2008, CANCER RES, V68, P6902, DOI 10.1158/0008-5472.CAN-08-0770; Catasus L, 2008, MODERN PATHOL, V21, P131, DOI 10.1038/modpathol.3800992; Cheung LWT, 2011, CANC DISCOVERY, P1; Cragun JM, 2005, J CLIN ONCOL, V23, P3668, DOI 10.1200/JCO.2005.04.144; Creutzberg CL, 2000, LANCET, V355, P1404, DOI 10.1016/S0140-6736(00)02139-5; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Engelsen IB, 2009, APMIS, V117, P693, DOI 10.1111/j.1600-0463.2009.02467.x; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Greulich H, 2011, TRENDS MOL MED, V17, P283, DOI 10.1016/j.molmed.2011.01.012; He LJ, 2008, J MOL BIOL, V384, P1130, DOI 10.1016/j.jmb.2008.10.036; Heiskanen M, 2001, ANAL CELL PATHOL, V22, P229, DOI 10.1155/2001/981218; Jang JH, 2001, CANCER RES, V61, P3541; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kang S, 2008, INT J GYNECOL CANCER, V18, P1339, DOI 10.1111/j.1525-1438.2007.01172.x; Keys HM, 2004, GYNECOL ONCOL, V92, P744, DOI 10.1016/j.ygyno.2003.11.048; Konopka B, 2011, HUMAN PATHOLOGY; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Lutman CV, 2006, GYNECOL ONCOL, V102, P92, DOI 10.1016/j.ygyno.2005.11.032; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Monsonego-Ornan E, 2000, MOL CELL BIOL, V20, P516, DOI 10.1128/MCB.20.2.516-522.2000; Mutch DG., 2009, GYNECOL ONCOL, V115, P325, DOI [10.1016/j.ygyno.2009.10.050, DOI 10.1016/J.YGYNO.2009.10.050, DOI 10.1016/J.YGYN0.2009.10.050]; Panici PB, 2008, JNCI-J NATL CANCER I, V100, P1707, DOI 10.1093/jnci/djn397; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Pollock PM, 2007, ONCOGENE; Rudd ML, 2011, CLIN CANCER RES, V17, P1331, DOI 10.1158/1078-0432.CCR-10-0540; Shin EY, 2000, J CANCER RES CLIN, V126, P519, DOI 10.1007/s004320000128; Susini T, 2007, CANCER-AM CANCER SOC, V109, P882, DOI 10.1002/cncr.22465; Swisher EM, 1999, CANCER-AM CANCER SOC, V85, P119, DOI 10.1002/(SICI)1097-0142(19990101)85:1<119::AID-CNCR17>3.0.CO;2-5; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; van Rhijn BWG, 2002, EUR J HUM GENET, V10, P819, DOI 10.1038/sj.ejhg.5200883; Zighelboim I, 2007, J CLIN ONCOL, V25, P2042, DOI 10.1200/JCO.2006.08.2107	36	117	120	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e30801	10.1371/journal.pone.0030801	http://dx.doi.org/10.1371/journal.pone.0030801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383975	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916100007
J	Fan, ZL; Wu, WH; Hildebrand, A; Kasuga, T; Zhang, RF; Xiong, XC				Fan, Zhiliang; Wu, Weihua; Hildebrand, Amanda; Kasuga, Takao; Zhang, Ruifu; Xiong, Xiaochao			A Novel Biochemical Route for Fuels and Chemicals Production from Cellulosic Biomass	PLOS ONE			English	Article							WHITE-ROT FUNGI; ENTNER-DOUDOROFF PATHWAY; NEUROSPORA-CRASSA; ESCHERICHIA-COLI; SPOROTRICHUM-PULVERULENTUM; CELLOBIOSE DEHYDROGENASE; BIOLOGICAL PRETREATMENT; ETHANOL-PRODUCTION; DEGRADATION; WOOD	The conventional biochemical platform featuring enzymatic hydrolysis involves five key steps: pretreatment, cellulase production, enzymatic hydrolysis, fermentation, and product recovery. Sugars are produced as reactive intermediates for subsequent fermentation to fuels and chemicals. Herein, an alternative biochemical route is proposed. Pretreatment, enzymatic hydrolysis and cellulase production is consolidated into one single step, referred to as consolidated aerobic processing, and sugar aldonates are produced as the reactive intermediates for biofuels production by fermentation. In this study, we demonstrate the viability of consolidation of the enzymatic hydrolysis and cellulase production steps in the new route using Neurospora crassa as the model microorganism and the conversion of cellulose to ethanol as the model system. We intended to prove the two hypotheses: 1) cellulose can be directed to produce cellobionate by reducing beta-glucosidase production and by enhancing cellobiose dehydrogenase production; and 2) both of the two hydrolysis products of cellobionate-glucose and gluconate-can be used as carbon sources for ethanol and other chemical production. Our results showed that knocking out multiple copies of beta-glucosidase genes led to cellobionate production from cellulose, without jeopardizing the cellulose hydrolysis rate. Simulating cellobiose dehydrogenase over-expression by addition of exogenous cellobiose dehydrogenase led to more cellobionate production. Both of the two hydrolysis products of cellobionate: glucose and gluconate can be used by Escherichia coli KO 11 for efficient ethanol production. They were utilized simultaneously in glucose and gluconate co-fermentation. Gluconate was used even faster than glucose. The results support the viability of the two hypotheses that lay the foundation for the proposed new route.	[Fan, Zhiliang; Wu, Weihua; Hildebrand, Amanda; Zhang, Ruifu; Xiong, Xiaochao] Univ Calif Davis, Biol & Agr Engn Dept, Davis, CA 95616 USA; [Kasuga, Takao] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Kasuga, Takao] ARS, USDA, Davis, CA USA; [Zhang, Ruifu] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangshu, Peoples R China	University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Agriculture (USDA); Nanjing Agricultural University	Fan, ZL (corresponding author), Univ Calif Davis, Biol & Agr Engn Dept, Davis, CA 95616 USA.	jzfan@ucdavis.edu	Zhang, Ruifu/HDN-0340-2022; Zhang, Ruifu/HDN-0417-2022		Agriculture and Food Research Initiative from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture [2011-67009-20060]; California Energy Commission [55779A/08-03]	Agriculture and Food Research Initiative from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture; California Energy Commission	This project was supported by Agriculture and Food Research Initiative Competitive Grant No. 2011-67009-20060 from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture and California Energy Commission grant 55779A/08-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aden A., 2002, LIGNOCELLULOSIC BIOM, DOI 10.2172/15001119; AKIN DE, 1993, APPL ENVIRON MICROB, V59, P4274, DOI 10.1128/AEM.59.12.4274-4282.1993; ANDER P, 1977, PHYSIOL PLANTARUM, V41, P239, DOI 10.1111/j.1399-3054.1977.tb04877.x; Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; BLANCHETTE RA, 1991, ANNU REV PHYTOPATHOL, V29, P381, DOI 10.1146/annurev.py.29.090191.002121; BRUCHMANN EE, 1969, H-S Z PHYSIOL CHEM, V350, P554, DOI 10.1515/bchm2.1969.350.1.554; BUSWELL JA, 1987, CRC CR REV BIOTECHN, V6, P1, DOI 10.3109/07388558709086984; Cameron MD, 2001, ENZYME MICROB TECH, V28, P129, DOI 10.1016/S0141-0229(00)00307-0; Cullen D, 1997, J BIOTECHNOL, V53, P273, DOI 10.1016/S0168-1656(97)01684-2; Davis RH, 2002, NAT REV GENET, V3, P397, DOI 10.1038/nrg797; EBERHART BM, 1973, J BACTERIOL, V116, P295, DOI 10.1128/JB.116.1.295-303.1973; EBERHART BM, 1977, J BACTERIOL, V130, P181, DOI 10.1128/JB.130.1.181-186.1977; ERIKSSON KE, 1980, HOLZFORSCHUNG, V34, P207, DOI 10.1515/hfsg.1980.34.6.207; ERIKSSON KE, 1974, FEBS LETT, V49, P282, DOI 10.1016/0014-5793(74)80531-4; FLIEGE R, 1992, APPL ENVIRON MICROB, V58, P3826, DOI 10.1128/AEM.58.12.3826-3829.1992; GOLD MH, 1989, ACS SYM SER, V389, P127; GOLD MH, 1993, MICROBIOL REV, V57, P605, DOI 10.1128/MMBR.57.3.605-622.1993; Harreither W, 2011, APPL ENVIRON MICROB, V77, P1804, DOI 10.1128/AEM.02052-10; Henriksson G, 2000, J BIOTECHNOL, V78, P93, DOI 10.1016/S0168-1656(00)00206-6; Kirk T. K., 1972, Wood and Fiber, V4, P72; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; Klemm P, 1996, J BACTERIOL, V178, P61, DOI 10.1128/jb.178.1.61-67.1996; Kurakake M, 2007, CURR MICROBIOL, V54, P424, DOI 10.1007/s00284-006-0568-6; Lee JW, 2007, J MICROBIOL, V45, P485; Luke AK, 2001, ENZYME MICROB TECH, V29, P348, DOI 10.1016/S0141-0229(01)00390-8; Lynd LR, 1999, BIOTECHNOL PROGR, V15, P777, DOI 10.1021/bp990109e; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; OHTA K, 1991, APPL ENVIRON MICROB, V57, P893, DOI 10.1128/AEM.57.4.893-900.1991; Ponce E, 2005, CAN J MICROBIOL, V51, P975, DOI 10.1139/w05-101; Porco A, 1997, J BACTERIOL, V179, P1584, DOI 10.1128/jb.179.5.1584-1590.1997; Romero MD, 1999, ENZYME MICROB TECH, V25, P244, DOI 10.1016/S0141-0229(99)00035-6; RUEL K, 1981, HOLZFORSCHUNG, V35, P157, DOI 10.1515/hfsg.1981.35.4.157; Singh OV, 2007, APPL MICROBIOL BIOT, V75, P713, DOI 10.1007/s00253-007-0851-x; STREAMER M, 1975, EUR J BIOCHEM, V59, P607, DOI 10.1111/j.1432-1033.1975.tb02489.x; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; Tian CG, 2007, EUKARYOT CELL, V6, P1018, DOI 10.1128/EC.00078-07; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; WESTERMARK U, 1975, SVEN PAPPERSTIDN, V78, P653; Wyman CE, 2007, TRENDS BIOTECHNOL, V25, P153, DOI 10.1016/j.tibtech.2007.02.009; YANG HH, 1980, BIOTECHNOL BIOENG, V22, P65, DOI 10.1002/bit.260220106; Zhang RF, 2011, PROTEIN EXPRES PURIF, V75, P63, DOI 10.1016/j.pep.2010.08.003	42	23	25	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31693	10.1371/journal.pone.0031693	http://dx.doi.org/10.1371/journal.pone.0031693			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384058	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916100028
J	Li, SC; Wang, SQ; Deng, QM; Zheng, AP; Zhu, J; Liu, HN; Wang, LX; Gao, FY; Zou, T; Huang, B; Cao, XM; Xu, LZ; Yu, C; Ai, P; Li, P				Li, Shuangcheng; Wang, Shiquan; Deng, Qiming; Zheng, Aiping; Zhu, Jun; Liu, Huainian; Wang, Lingxia; Gao, Fengyan; Zou, Ting; Huang, Bin; Cao, Xuemei; Xu, Lizhi; Yu, Chuang; Ai, Peng; Li, Ping			Identification of Genome-Wide Variations among Three Elite Restorer Lines for Hybrid-Rice	PLOS ONE			English	Article							GENE CONFERRING RESISTANCE; CYTOPLASMIC MALE-STERILITY; DRAFT SEQUENCE; GRAIN WIDTH; ENCODES; RESOURCE; WEIGHT; QTL	Rice restorer lines play an important role in three-line hybrid rice production. Previous research based on molecular tagging has suggested that the restorer lines used widely today have narrow genetic backgrounds. However, patterns of genetic variation at a genome-wide scale in these restorer lines remain largely unknown. The present study performed resequencing and genome-wide variation analysis of three important representative restorer lines, namely, IR24, MH63, and SH527, using the Solexa sequencing technology. With the genomic sequence of the Indica cultivar 9311 as the reference, the following genetic features were identified: 267,383 single-nucleotide polymorphisms (SNPs), 52,847 insertion/deletion polymorphisms (InDels), and 3,286 structural variations (SVs) in the genome of IR24; 288,764 SNPs, 59,658 InDels, and 3,226 SVs in MH63; and 259,862 SNPs, 55,500 InDels, and 3,127 SVs in SH527. Variations between samples were also determined by comparative analysis of authentic collections of SNPs, InDels, and SVs, and were functionally annotated. Furthermore, variations in several important genes were also surveyed by alignment analysis in these lines. Our results suggest that genetic variations among these lines, although far lower than those reported in the landrace population, are greater than expected, indicating a complicated genetic basis for the phenotypic diversity of the restorer lines. Identification of genome-wide variation and pattern analysis among the restorer lines will facilitate future genetic studies and the molecular improvement of hybrid rice.	[Li, Shuangcheng; Wang, Shiquan; Deng, Qiming; Zheng, Aiping; Zhu, Jun; Liu, Huainian; Wang, Lingxia; Xu, Lizhi; Yu, Chuang; Ai, Peng; Li, Ping] Sichuan Agr Univ, Rice Res Inst, Wenjiang, Sichuan, Peoples R China; [Li, Shuangcheng; Wang, Shiquan; Deng, Qiming; Zheng, Aiping; Zhu, Jun; Gao, Fengyan; Zou, Ting; Huang, Bin; Cao, Xuemei; Li, Ping] Sichuan Agr Univ, Minist Educ, Key Lab Crop Genet Resources & Improvement, Yaan, Sichuan, Peoples R China; [Li, Shuangcheng; Wang, Shiquan; Deng, Qiming; Li, Ping] Sichuan Agr Univ, State Key Lab Hybrid Rice, Chengdu, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Li, SC (corresponding author), Sichuan Agr Univ, Rice Res Inst, Wenjiang, Sichuan, Peoples R China.	liping6575@163.com			National Basic Research (973) Program of China [2011CB100101]; National Natural Science Foundation of China [30800084]; Special Programs for GM Crops Initiative of China [2008ZX08001-001]	National Basic Research (973) Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Programs for GM Crops Initiative of China	This work was supported by the National Basic Research (973) Program of China (2011CB100101), the National Natural Science Foundation of China (30800084), and the Special Programs for GM Crops Initiative of China (2008ZX08001-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadikhah A, 2006, PLANT BREEDING, V125, P363, DOI 10.1111/j.1439-0523.2006.01246.x; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Cheng ShiHua, 2000, Chinese Journal of Rice Science, V14, P165; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Du B, 2009, P NATL ACAD SCI USA, V106, P22163, DOI 10.1073/pnas.0912139106; Duan Shi-Hua, 2002, Acta Genetica Sinica, V29, P250; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Gao ZY, 2003, SCI CHINA SER C, V46, P661, DOI 10.1360/03yc0099; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Liu Shu, 2002, Chinese Journal of Rice Science, V16, P1; Liu WZ, 2009, PLANTA, V230, P649, DOI 10.1007/s00425-009-0975-6; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Qu S, 2006, GENETICS GENETICS; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang Q, 2007, PDS DATA PROCESSING; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang YuPing, 2004, Hybrid Rice, V19, P12; Wang ZH, 2006, PLANT CELL, V18, P676, DOI 10.1105/tpc.105.038240; Wang ZX, 1999, PLANT J, V19, P55, DOI 10.1046/j.1365-313X.1999.00498.x; Xie H, 1994, HYBRID RICE, V3, P31; Yoshimura S, 1998, P NATL ACAD SCI USA, V95, P1663, DOI 10.1073/pnas.95.4.1663; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhao WM, 2004, NUCLEIC ACIDS RES, V32, pD377, DOI 10.1093/nar/gkh085; Zhu YY, 2006, PLANT CELL, V18, P442, DOI 10.1105/tpc.105.038455	37	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e30952	10.1371/journal.pone.0030952	http://dx.doi.org/10.1371/journal.pone.0030952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383984	Green Submitted, Green Published, gold			2022-12-27	WOS:000302916100011
J	Cantacessi, C; Hofmann, A; Young, ND; Broder, U; Hall, RS; Loukas, A; Gasser, RB				Cantacessi, Cinzia; Hofmann, Andreas; Young, Neil D.; Broder, Ursula; Hall, Ross S.; Loukas, Alex; Gasser, Robin B.			Insights into SCP/TAPS Proteins of Liver Flukes Based on Large-Scale Bioinformatic Analyses of Sequence Datasets	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEIN; ANCYLOSTOMA-SECRETED PROTEIN; PROTEOMIC ANALYSIS; HUMAN HOOKWORM; VENOM ALLERGEN; NECATOR-AMERICANUS; FASCIOLA-HEPATICA; NA-ASP-2 PROTEIN; ADULT STAGE; GENE	Background: SCP/TAPS proteins of parasitic helminths have been proposed to play key roles in fundamental biological processes linked to the invasion of and establishment in their mammalian host animals, such as the transition from free-living to parasitic stages and the modulation of host immune responses. Despite the evidence that SCP/TAPS proteins of parasitic nematodes are involved in host-parasite interactions, there is a paucity of information on this protein family for parasitic trematodes of socio-economic importance. Methodology/Principal Findings: We conducted the first large-scale study of SCP/TAPS proteins of a range of parasitic trematodes of both human and veterinary importance (including the liver flukes Clonorchis sinensis, Opisthorchis viverrini, Fasciola hepatica and F. gigantica as well as the blood flukes Schistosoma mansoni, S. japonicum and S. haematobium). We mined all current transcriptomic and/or genomic sequence datasets from public databases, predicted secondary structures of full-length protein sequences, undertook systematic phylogenetic analyses and investigated the differential transcription of SCP/TAPS genes in O. viverrini and F. hepatica, with an emphasis on those that are up-regulated in the developmental stages infecting the mammalian host. Conclusions: This work, which sheds new light on SCP/TAPS proteins, guides future structural and functional explorations of key SCP/TAPS molecules associated with diseases caused by flatworms. Future fundamental investigations of these molecules in parasites and the integration of structural and functional data could lead to new approaches for the control of parasitic diseases.	[Cantacessi, Cinzia; Young, Neil D.; Hall, Ross S.; Gasser, Robin B.] Univ Melbourne, Dept Vet Sci, Parkville, Vic 3052, Australia; [Hofmann, Andreas; Broder, Ursula] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Loukas, Alex] James Cook Univ, Smithfield, Qld, Australia	University of Melbourne; Griffith University; James Cook University	Cantacessi, C (corresponding author), Univ Melbourne, Dept Vet Sci, Parkville, Vic 3052, Australia.	robinbg@unimelb.edu.au	Cantacessi, Cinzia/B-7356-2014; Gasser, Robin/ABH-6185-2020; Hofmann, Andreas/M-9870-2019; Young, Neil David/AAU-4572-2020; Hofmann, Andreas/B-9515-2008; Loukas, Alex/B-7355-2014	Cantacessi, Cinzia/0000-0001-6863-2950; Gasser, Robin/0000-0002-4423-1690; Hofmann, Andreas/0000-0003-4408-5467; Young, Neil David/0000-0001-8756-229X; Hofmann, Andreas/0000-0003-4408-5467; Loukas, Alex/0000-0002-0896-8441	Australian Research Council; Melbourne Water Corporation; National Health and Medical Research Council; Victorian Life Sciences Computation Initiative; IBM Collaboratory	Australian Research Council(Australian Research Council); Melbourne Water Corporation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Life Sciences Computation Initiative; IBM Collaboratory(International Business Machines (IBM))	The Gasser Lab is presently supported by funding from the Australian Research Council, Melbourne Water Corporation and the National Health and Medical Research Council (RBG). Support from the Victorian Life Sciences Computation Initiative and IBM Collaboratory is also acknowledged (RBG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1995, World Health Organ Tech Rep Ser, V849, P1; Asojo OA, 2005, ACTA CRYSTALLOGR F, V61, P391, DOI 10.1107/S1744309105007748; Asojo OA, 2005, J MOL BIOL, V346, P801, DOI 10.1016/j.jmb.2004.12.023; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Bethony J, 2005, FASEB J, V19, P1743, DOI 10.1096/fj.05-3936fje; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Bower MA, 2008, EXP PARASITOL, V118, P569, DOI 10.1016/j.exppara.2007.11.014; Cantacessi C, 2009, BIOTECHNOL ADV, V27, P376, DOI 10.1016/j.biotechadv.2009.02.005; Cantacessi C, 2011, BIOTECHNOL IN PRESS; Cass CL, 2007, MOL BIOCHEM PARASIT, V155, P84, DOI 10.1016/j.molbiopara.2007.06.002; Chalmers IW, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-89; Chen JF, 2010, PARASITOL RES, V106, P1413, DOI 10.1007/s00436-010-1817-y; Chen YJ, 2005, NUCLEIC ACIDS RES, V33, pD169; Choo KH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-249; Curwen RS, 2006, MOL CELL PROTEOMICS, V5, P835, DOI 10.1074/mcp.M500313-MCP200; Datu BJD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000130; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eberle HB, 2002, J CELL SCI, V115, P827; Eisenberg I, 2002, GENE, V293, P141, DOI 10.1016/S0378-1119(02)00703-5; Fernandez C, 1997, J MOL BIOL, V266, P576, DOI 10.1006/jmbi.1996.0772; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Gobert GN, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000469; Hagen J, 2011, PARASITE IM IN PRESS; Hansell E, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000262; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Hawdon JM, 1996, J BIOL CHEM, V271, P6672, DOI 10.1074/jbc.271.12.6672; Hawdon JM, 1999, MOL BIOCHEM PARASIT, V99, P149, DOI 10.1016/S0166-6851(99)00011-0; Hewitson JP, 2011, J PROTEOMICS, V74, P1573, DOI 10.1016/j.jprot.2011.06.002; Hotez PJ, 2003, INT J PARASITOL, V33, P1245, DOI 10.1016/S0020-7519(03)00158-9; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jalkanen J, 2005, BIOL REPROD, V72, P1268, DOI 10.1095/biolreprod.104.035758; Kaewkes S, 2003, ACTA TROP, V88, P177, DOI 10.1016/j.actatropica.2003.05.001; Kalinna BH, 2007, TRENDS PARASITOL, V23, P197, DOI 10.1016/j.pt.2007.03.007; KASAHARA M, 1989, GENOMICS, V5, P527, DOI 10.1016/0888-7543(89)90019-0; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewis F, 1998, CURRENT PROTOCOL S28; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Loukas A, 2006, LANCET INFECT DIS, V6, P733, DOI 10.1016/S1473-3099(06)70630-2; LU G, 1993, J IMMUNOL, V150, P2823; Mann VH, 2010, PARASITOLOGY, V137, P451, DOI 10.1017/S0031182009991211; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mendez S, 2008, PARASITE IMMUNOL, V30, P53, DOI 10.1111/j.1365-3024.2007.00994.x; Moreno Y, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000326; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moser JM, 2005, MOL BIOCHEM PARASIT, V143, P39, DOI 10.1016/j.molbiopara.2005.04.012; Mulcahy G, 1999, FASCIOLOSIS, P341; Mulvenna J, 2009, MOL CELL PROTEOMICS, V8, P109, DOI 10.1074/mcp.M800206-MCP200; Mulvenna J, 2010, PROTEOMICS, V10, P1063, DOI 10.1002/pmic.200900393; MURPHY EV, 1995, GENE, V159, P131, DOI 10.1016/0378-1119(95)00061-A; Nithikathkul C, 2007, J HELMINTHOL, V81, P39, DOI 10.1017/S0022149X07212106; Osman A, 2011, BIOTECHNOL IN PRESS; Page Roderic D M, 2002, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0602s01; Qian WF, 2011, P NATL ACAD SCI USA, V108, P8725, DOI 10.1073/pnas.1104695108; Rich T, 1996, GENE, V180, P125, DOI 10.1016/S0378-1119(96)00431-3; Robinson MW, 2009, MOL CELL PROTEOMICS, V8, P1891, DOI 10.1074/mcp.M900045-MCP200; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenzweig T, 2006, CANCER RES, V66, P4139, DOI 10.1158/0008-5472.CAN-05-2851; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SKRJABIN KI, 1991, KEYS PARASITIC NEMAT, V3, P230; Tchoubrieva EB, 2010, BIOTECHNOL GENET ENG, V26, P261; Tsai IJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r41; Van Galen J, 2010, MOL MEMBR BIOL, V27, P81, DOI 10.3109/09687680903507080; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wu XJ, 2009, MOL BIOCHEM PARASIT, V164, P32, DOI 10.1016/j.molbiopara.2008.11.005; Xiao S, 2008, EXP PARASITOL, V118, P32, DOI 10.1016/j.exppara.2007.05.010; Yamakawa T, 1998, BBA-GENE STRUCT EXPR, V1395, P202, DOI 10.1016/S0167-4781(97)00149-8; Young ND, 2011, NAT GENET IN PRESS; Young ND, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001004; Young ND, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000719; Young ND, 2010, BIOTECHNOL ADV, V28, P222, DOI 10.1016/j.biotechadv.2009.12.003; Zhan B, 2003, INT J PARASITOL, V33, P897, DOI 10.1016/S0020-7519(03)00111-5; Zhong WW, 2006, SCIENCE, V311, P1481, DOI 10.1126/science.1123287; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	80	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31164	10.1371/journal.pone.0031164	http://dx.doi.org/10.1371/journal.pone.0031164			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384000	Green Published, Green Accepted, gold			2022-12-27	WOS:000302875500013
J	David, HN; Haelewyn, B; Degoulet, M; Colomb, DG; Risso, JJ; Abraini, JH				David, Helene N.; Haelewyn, Benoit; Degoulet, Mickael; Colomb, Denis G., Jr.; Risso, Jean-Jacques; Abraini, Jacques H.			Ex Vivo and In Vivo Neuroprotection Induced by Argon When Given after an Excitotoxic or Ischemic Insult	PLOS ONE			English	Article							TRANSIENT CEREBRAL-ISCHEMIA; NITROUS-OXIDE; NOBLE-GASES; FOREBRAIN ISCHEMIA; ARTERY OCCLUSION; BRAIN-INJURY; XENON; RAT; STROKE; ISOFLURANE	In vitro studies have well established the neuroprotective action of the noble gas argon. However, only limited data from in vivo models are available, and particularly whether postexcitotoxic or postischemic argon can provide neuroprotection in vivo still remains to be demonstrated. Here, we investigated the possible neuroprotective effect of postexcitotoxic-postischemic argon both ex vivo in acute brain slices subjected to ischemia in the form of oxygen and glucose deprivation (OGD), and in vivo in rats subjected to an intrastriatal injection of N-methyl-D-aspartate (NMDA) or to the occlusion of middle-cerebral artery (MCAO). We show that postexcitotoxic-postischemic argon reduces OGD-induced cell injury in brain slices, and further reduces NMDA-induced brain damage and MCAO-induced cortical brain damage in rats. Contrasting with its beneficial effect at the cortical level, we show that postischemic argon increases MCAO-induced subcortical brain damage and provides no improvement of neurologic outcome as compared to control animals. These results extend previous data on the neuroprotective action of argon. Particularly, taken together with previous in vivo data that have shown that intraischemic argon has neuroprotective action at both the cortical and subcortical level, our findings on postischemic argon suggest that this noble gas could be administered during but not after ischemia, i.e. before but not after reperfusion has occurred, in order to provide cortical neuroprotection and to avoid increasing subcortical brain damage. Also, the effects of argon are discussed as regards to the oxygen-like chemical, pharmacological, and physical properties of argon.	[David, Helene N.; Abraini, Jacques H.] Univ Laval, Ctr Rech, Ctr Hosp Affilie Univ Hotel Dieu Levis, Levis, PQ, Canada; [Haelewyn, Benoit] Univ Caen Basse Normandie, CURB, Caen, France; [Haelewyn, Benoit; Degoulet, Mickael; Abraini, Jacques H.] Univ Caen Basse Normandie, UMR 6232, Caen, France; [Haelewyn, Benoit; Degoulet, Mickael; Abraini, Jacques H.] CNRS, UMR 6232, Caen, France; [Colomb, Denis G., Jr.] USN, Expt Diving Unit, Panama City, FL USA; [Risso, Jean-Jacques] Inst Rech Biomed Armees, Antenne Toulon, France; [Abraini, Jacques H.] Univ Laval, Ctr Rech, Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada	Laval University; Universite de Caen Normandie; Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); United States Department of Defense; United States Navy; Laval University	David, HN (corresponding author), Univ Laval, Ctr Rech, Ctr Hosp Affilie Univ Hotel Dieu Levis, Levis, PQ, Canada.	jh.abraini@gmail.com		Degoulet, Mickael/0000-0002-4268-5795	Direction Generale de l'Armement of the French Ministry of Defence; NNOXe Pharmaceuticals (Quebec City, QC, Canada)	Direction Generale de l'Armement of the French Ministry of Defence; NNOXe Pharmaceuticals (Quebec City, QC, Canada)	This work was supported by the Direction Generale de l'Armement of the French Ministry of Defence and NNOXe Pharmaceuticals (Quebec City, QC, Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abraini JH, 2005, ANN NY ACAD SCI, V1053, P289, DOI 10.1196/annals.1344.025; Abraini JH, 2005, ANESTH ANALG, V101, P614, DOI 10.1213/01.ANE.0000159020.86959.83; Abraini JH, 2003, ANESTH ANALG, V96, P746, DOI 10.1213/01.ANE.0000050282.14291.38; Abraini JH, 1998, BRAIN RES, V808, P300, DOI 10.1016/S0006-8993(98)00760-4; David HN, 2008, FASEB J, V22, P1275, DOI 10.1096/fj.07-9420com; David HN, 2010, J CEREBR BLOOD F MET, V30, P718, DOI 10.1038/jcbfm.2009.275; David HN, 2009, J CEREBR BLOOD F MET, V29, P1159, DOI 10.1038/jcbfm.2009.40; David HN, 2003, J CEREBR BLOOD F MET, V23, P1168, DOI 10.1097/01.WCB.0000087342.31689.18; Dingley J, 2006, STROKE, V37, P501, DOI 10.1161/01.STR.0000198867.31134.ac; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Goto T, 1998, BRIT J ANAESTH, V80, P255, DOI 10.1093/bja/80.2.255; Haelewyn B, 2008, EXP NEUROL, V213, P238, DOI 10.1016/j.expneurol.2008.05.012; Haelewyn B, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-2; Haelewyn B, 2011, ANESTHESIOLOGY, V115, P1044, DOI 10.1097/ALN.0b013e3182342860; Homi HM, 2003, ANESTHESIOLOGY, V99, P876, DOI 10.1097/00000542-200310000-00020; Istaphanous GK, 2011, ANESTHESIOLOGY, V114, P578, DOI 10.1097/ALN.0b013e3182084a70; Jawad N, 2009, NEUROSCI LETT, V460, P232, DOI 10.1016/j.neulet.2009.05.069; Lazar RM, 2010, J NEUROL SCI, V292, P72, DOI 10.1016/j.jns.2010.01.024; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; LEVY DI, 1990, NEUROSCI LETT, V110, P291, DOI 10.1016/0304-3940(90)90862-4; Lo EH, 2005, STROKE, V36, P189, DOI 10.1161/01.STR.0000153069.96296.fd; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; Ma DQ, 2003, ANESTHESIOLOGY, V98, P690, DOI 10.1097/00000542-200303000-00017; Massieu L, 2001, NEUROSCIENCE, V106, P669, DOI 10.1016/S0306-4522(01)00323-2; MICKEL HS, 1987, STROKE, V18, P426, DOI 10.1161/01.STR.18.2.426; Nasu I, 2006, ANESTH ANALG, V103, P413, DOI 10.1213/01.ane.0000223686.50202.38; Natale G, 2006, ANN NY ACAD SCI, V1074, P650, DOI 10.1196/annals.1369.063; Olney JW, 2000, ENVIRON HEALTH PERSP, V108, P383, DOI 10.2307/3454524; Pagel PS, 2007, ANESTH ANALG, V105, P562, DOI 10.1213/01.ane.0000278083.31991.36; Pavlov BN, 1997, HIGH PRESSURE BIOL M, P133; Petzelt C, 2003, LIFE SCI, V72, P1909, DOI 10.1016/S0024-3205(02)02439-6; Rizvi M, 2010, EXP BIOL MED, V235, P886, DOI 10.1258/ebm.2010.009366; Ryang YM, 2011, CRIT CARE MED, V39, P1448, DOI 10.1097/CCM.0b013e31821209be; Sanders RD, 2005, BEST PRACT RES-CLIN, V19, P461, DOI 10.1016/j.bpa.2005.01.005; Schwartz-Bloom RD, 2000, NEUROSCIENCE, V98, P471, DOI 10.1016/S0306-4522(00)00144-5; Semenov N, 1989, SHORT MOMENT TRIUMPH, P6; Singhal AB, 2002, NEUROLOGY, V58, P945, DOI 10.1212/WNL.58.6.945; Sucher N J, 1990, Neuroreport, V1, P29, DOI 10.1097/00001756-199009000-00009; Sugaya T, 1997, BRAIN RES BULL, V44, P307, DOI 10.1016/S0361-9230(97)00142-1; TAPPER D, 1974, J PEDIATR SURG, V9, P597, DOI 10.1016/0022-3468(74)90094-3; WHITE PF, 1974, ANESTHESIOLOGY, V40, P52, DOI 10.1097/00000542-197401000-00012; Wu KLH, 2007, J NEUROCHEM, V101, P1552, DOI 10.1111/j.1471-4159.2006.04445.x; Yamakura T, 2000, ANESTHESIOLOGY, V93, P1095, DOI 10.1097/00000542-200010000-00034; Yarin YM, 2005, HEARING RES, V201, P1, DOI 10.1016/j.heares.2004.09.015; Zhang F, 2007, NEUROSCIENCE, V150, P938, DOI 10.1016/j.neuroscience.2007.09.070	46	62	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e30934	10.1371/journal.pone.0030934	http://dx.doi.org/10.1371/journal.pone.0030934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22383981	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500006
J	Hurlbert, AH; Liang, ZF				Hurlbert, Allen H.; Liang, Zhongfei			Spatiotemporal Variation in Avian Migration Phenology: Citizen Science Reveals Effects of Climate Change	PLOS ONE			English	Article							SWALLOW HIRUNDO-RUSTICA; SPRING ARRIVAL DATES; BIRD MIGRATION; DEPARTURE DATES; MIGRANT BIRDS; LONG-TERM; DISTANCE; TRENDS; TEMPERATURE; RESPONSES	A growing number of studies have documented shifts in avian migratory phenology in response to climate change, and yet there is a large amount of unexplained variation in the magnitude of those responses across species and geographic regions. We use a database of citizen science bird observations to explore spatiotemporal variation in mean arrival dates across an unprecedented geographic extent for 18 common species in North America over the past decade, relating arrival dates to mean minimum spring temperature. Across all species and geographic locations, species shifted arrival dates 0.8 days earlier for every degrees C of warming of spring temperature, but it was common for some species in some locations to shift as much as 3-6 days earlier per degrees C. Species that advanced arrival dates the earliest in response to warming were those that migrate more slowly, short distance migrants, and species with broader climatic niches. These three variables explained 63% of the interspecific variation in phenological response. We also identify a latitudinal gradient in the average strength of phenological response, with species shifting arrival earlier at southern latitudes than northern latitudes for the same degree of warming. This observation is consistent with the idea that species must be more phenologically sensitive in less seasonal environments to maintain the same degree of precision in phenological timing.	[Hurlbert, Allen H.; Liang, Zhongfei] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Hurlbert, AH (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	hurlbert@bio.unc.edu		Hurlbert, Allen/0000-0002-5678-9907	University of North Carolina	University of North Carolina	This study was supported by institutional funds from the University of North Carolina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola M, 2004, GLOBAL CHANGE BIOL, V10, P1610, DOI 10.1111/j.1365-2486.2004.00823.x; [Anonymous], 2020, BIRDS N AM CORNELL L, DOI DOI 10.2173/BOW.ROSGOO.01; [Anonymous], 1988, BIRDERS HDB FIELD GU; Askeyev OV, 2009, CENT EUR J BIOL, V4, P595, DOI 10.2478/s11535-009-0046-9; Baillie SR, 2006, J ORNITHOL, V147, P254, DOI 10.1007/s10336-006-0062-8; Barrett RT, 2002, BIRD STUDY, V49, P270, DOI 10.1080/00063650209461275; Berthold P, 1998, NATURWISSENSCHAFTEN, V85, P350, DOI 10.1007/s001140050514; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Buse A, 1999, FUNCT ECOL, V13, P74, DOI 10.1046/j.1365-2435.1999.00010.x; Butler CJ, 2003, IBIS, V145, P484, DOI 10.1046/j.1474-919X.2003.00193.x; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; Faaborg J, 2010, ECOL MONOGR, V80, P3, DOI 10.1890/09-0395.1; Fink D, 2010, ECOL APPL, V20, P2131, DOI 10.1890/09-1340.1; Gordo O, 2007, CLIM RES, V35, P37, DOI 10.3354/cr00713; Gordo O, 2006, GLOBAL CHANGE BIOL, V12, P1993, DOI 10.1111/j.1365-2486.2006.01178.x; Gwinner E, 2003, CURR OPIN NEUROBIOL, V13, P770, DOI 10.1016/j.conb.2003.10.010; Huin N, 1998, BIRD STUDY, V45, P361, DOI 10.1080/00063659809461108; Huppop O, 2003, P ROY SOC B-BIOL SCI, V270, P233, DOI 10.1098/rspb.2002.2236; Hurlbert AH, 2007, GLOBAL ECOL BIOGEOGR, V16, P764, DOI 10.1111/j.1466-8238.2007.00335.x; Jones T, 2010, J ANIM ECOL, V79, P98, DOI 10.1111/j.1365-2656.2009.01610.x; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; Julliard R, 2004, GLOBAL CHANGE BIOL, V10, P148, DOI 10.1111/j.1365-2486.2003.00723.x; Kaufmann RK, 2011, P NATL ACAD SCI; Knudsen E, 2011, BIOL REV, V86, P928, DOI 10.1111/j.1469-185X.2011.00179.x; La Sorte FA, 2010, J EXP BIOL, V213, P862, DOI 10.1242/jeb.038356; Lehikoinen E, 2004, ADV ECOL RES, V35, P1, DOI 10.1016/S0065-2504(04)35001-4; MacMynowski DP, 2007, INT J BIOMETEOROL, V51, P361, DOI 10.1007/s00484-006-0084-1; Marra PP, 2005, OECOLOGIA, V142, P307, DOI 10.1007/s00442-004-1725-x; Marris E, 2010, NATURE, V466, P807, DOI 10.1038/466807a; Mearns L., 2007, N AM REGIONAL CLIMAT, DOI 10.5065/D6RN35ST; Miller-Rushing AJ, 2008, GLOBAL CHANGE BIOL, V14, P1959, DOI 10.1111/j.1365-2486.2008.01619.x; Mills AM, 2005, IBIS, V147, P259, DOI 10.1111/j.1474-919X.2005.00380.x; Moller AP, 2008, J EVOLUTION BIOL, V21, P213, DOI 10.1111/j.1420-9101.2007.01450.x; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Moller AP, 2001, P ROY SOC B-BIOL SCI, V268, P203; Moreau R. E., 1972, PALEARCTIC AFRICAN B; Murphy-Klassen HM, 2005, AUK, V122, P1130, DOI 10.1642/0004-8038(2005)122[1130:LTISAD]2.0.CO;2; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parry ML, 2007, CLIMATE CHANGE 2007; Pulido F, 2007, CLIM RES, V35, P5, DOI 10.3354/cr00711; Rubolini D, 2005, BIOL J LINN SOC, V85, P199, DOI 10.1111/j.1095-8312.2005.00484.x; Rubolini D, 2007, CLIM RES, V35, P135, DOI 10.3354/cr00720; Rubolini D, 2010, CLIM RES, V42, P45, DOI 10.3354/cr00862; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; SAUER JR, 2011, N AM BREEDING BIRD S; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Sparks TH, 2007, J ORNITHOL, V148, P503, DOI 10.1007/s10336-007-0193-6; Sparks T.H., 2001, Avian Ecology and Behaviour, V7, P75; Sparks TH, 1999, INT J BIOMETEOROL, V42, P134, DOI 10.1007/s004840050096; Sparks TH, 2005, GLOBAL CHANGE BIOL, V11, P22, DOI 10.1111/j.1365-2486.2004.00887.x; Sparks TH, 2001, INT J BIOMETEOROL, V45, P212, DOI 10.1007/s004840100095; Strode PK, 2003, GLOBAL CHANGE BIOL, V9, P1137, DOI 10.1046/j.1365-2486.2003.00664.x; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Swanson DL, 2009, J FIELD ORNITHOL, V80, P351, DOI 10.1111/j.1557-9263.2009.00241.x; Tottrup AP, 2010, INTEGRATIVE COMP BIO; Tryjanowski P, 2002, IBIS, V144, P62, DOI 10.1046/j.0019-1019.2001.00022.x; Tryjanowski P, 2001, INT J BIOMETEOROL, V45, P217, DOI 10.1007/s00484-001-0112-0; Vegvari Z, 2010, GLOBAL CHANGE BIOL, V16, P1, DOI 10.1111/j.1365-2486.2009.01876.x; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Wikelski M, 2008, PHILOS T R SOC B, V363, P411, DOI 10.1098/rstb.2007.2147	67	150	154	2	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31662	10.1371/journal.pone.0031662	http://dx.doi.org/10.1371/journal.pone.0031662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384050	gold, Green Published, Green Submitted			2022-12-27	WOS:000302875500030
J	McCarthy, MJ; Nievergelt, CM; Kelsoe, JR; Welsh, DK				McCarthy, Michael J.; Nievergelt, Caroline M.; Kelsoe, John R.; Welsh, David K.			A Survey of Genomic Studies Supports Association of Circadian Clock Genes with Bipolar Disorder Spectrum Illnesses and Lithium Response	PLOS ONE			English	Article							BRAIN MESSENGER-RNA; SCHIZOAFFECTIVE DISORDER; WIDE ASSOCIATION; I-DISORDER; EXPRESSION; RHYTHM; SUSCEPTIBILITY; PROLIFERATION; DEPRESSION; CARBONATE	Circadian rhythm abnormalities in bipolar disorder (BD) have led to a search for genetic abnormalities in circadian "clock genes" associated with BD. However, no significant clock gene findings have emerged from genome-wide association studies (GWAS). At least three factors could account for this discrepancy: complex traits are polygenic, the organization of the clock is more complex than previously recognized, and/or genetic risk for BD may be shared across multiple illnesses. To investigate these issues, we considered the clock gene network at three levels: essential "core" clock genes, upstream circadian clock modulators, and downstream clock controlled genes. Using relaxed thresholds for GWAS statistical significance, we determined the rates of clock vs. control genetic associations with BD, and four additional illnesses that share clinical features and/or genetic risk with BD (major depression, schizophrenia, attention deficit/hyperactivity). Then we compared the results to a set of lithium-responsive genes. Associations with BD-spectrum illnesses and lithium-responsiveness were both enriched among core clock genes but not among upstream clock modulators. Associations with BD-spectrum illnesses and lithium-responsiveness were also enriched among pervasively rhythmic clock-controlled genes but not among genes that were less pervasively rhythmic or non-rhythmic. Our analysis reveals previously unrecognized associations between clock genes and BD-spectrum illnesses, partly reconciling previously discordant results from past GWAS and candidate gene studies.	[McCarthy, Michael J.; Kelsoe, John R.; Welsh, David K.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [McCarthy, Michael J.; Nievergelt, Caroline M.; Kelsoe, John R.; Welsh, David K.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [McCarthy, Michael J.; Nievergelt, Caroline M.; Kelsoe, John R.; Welsh, David K.] Univ Calif San Diego, Ctr Chronobiol, La Jolla, CA 92093 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego	McCarthy, MJ (corresponding author), Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA.	mmccarthy@ucsd.edu	McCarthy, Michael/K-9302-2017	McCarthy, Michael/0000-0001-6219-4945; Nievergelt, Caroline/0000-0001-5766-8923	VA [1IK2BX001275, CX-09-008]; National Institute of Health [MH92758, MH078151, MH092758]; Veterans Affairs, NIH [1R01MH082945M]; NARSAD; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078151, R01MH082945, R01MH093500, U01MH092758] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000363, IK2BX001275] Funding Source: NIH RePORTER	VA(US Department of Veterans Affairs); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs, NIH; NARSAD(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Veterans Affairs(US Department of Veterans Affairs)	MM is supported by a VA Career Development Award (1IK2BX001275). JK receives support from National Institute of Health (MH92758 and MH078151), and a Veterans Affairs Merit Award (CX-09-008); DW from a Veterans Affairs Career Development Award, NIH grant 1R01MH082945M and a NARSAD Young Investigator Award; and CN from NIH (MH092758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Birmaher B, 2010, AM J PSYCHIAT, V167, P321, DOI 10.1176/appi.ajp.2009.09070977; Borgs L, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-30; Bosetti F, 2002, BRAIN RES BULL, V57, P205, DOI 10.1016/S0361-9230(01)00744-4; Bromundt V, 2011, BRIT J PSYCHIAT, V198, P269, DOI 10.1192/bjp.bp.110.078022; Chen G, 1999, J NEUROCHEM, V72, P879, DOI 10.1046/j.1471-4159.1999.720879.x; Chetcuti A, 2008, PSYCHIAT GENET, V18, P64, DOI 10.1097/YPG.0b013e3282fb0051; Doyle Alysa E, 2002, Curr Psychiatry Rep, V4, P146, DOI 10.1007/s11920-002-0049-y; Fatemi SH, 2009, BIOCHEM SOC T, V37, P1090, DOI 10.1042/BST0371090; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Garriock HA, 2010, BIOL PSYCHIAT, V67, P133, DOI 10.1016/j.biopsych.2009.08.029; Hirota T, 2008, P NATL ACAD SCI USA, V105, P20746, DOI 10.1073/pnas.0811410106; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; Kato M, 2008, HUM MOL GENET, V17, P577, DOI 10.1093/hmg/ddm332; Kelsoe JR, 2003, J AFFECT DISORDERS, V73, P183, DOI 10.1016/S0165-0327(02)00323-3; Kissling C, 2008, AM J MED GENET B, V147B, P333, DOI 10.1002/ajmg.b.30602; Klassen LJ, 2010, J AFFECT DISORDERS, V124, P1, DOI 10.1016/j.jad.2009.06.036; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Konneker T, 2008, AM J MED GENET B, V147B, P671, DOI 10.1002/ajmg.b.30802; Kripke Daniel F, 2009, J Circadian Rhythms, V7, P2, DOI 10.1186/1740-3391-7-2; KRIPKE DF, 1978, BIOL PSYCHIAT, V13, P335; KRIPKE DF, 1980, LIFE SCI, V26, P1319, DOI 10.1016/0024-3205(80)90091-0; KRIPKE DF, 1979, BIOL PSYCHIAT, V14, P545; Mansour HA, 2006, GENES BRAIN BEHAV, V5, P150, DOI 10.1111/j.1601-183X.2005.00147.x; Mansour HA, 2009, BIPOLAR DISORD, V11, P701, DOI 10.1111/j.1399-5618.2009.00756.x; McCarthy MJ, 2010, PHARMACOGENOMICS, V11, P1439, DOI [10.2217/pgs.10.127, 10.2217/PGS.10.127]; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; McGrath CL, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-70; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; McQuillin A, 2007, PHARMACOGENET GENOM, V17, P605, DOI 10.1097/FPC.0b013e328011b5b2; Mukherjee S, 2010, BIOL PSYCHIAT, V68, P503, DOI 10.1016/j.biopsych.2010.04.031; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; Nievergelt CM, 2006, AM J MED GENET B, V141B, P234, DOI 10.1002/ajmg.b.30252; Partonen T, 2007, ANN MED, V39, P229, DOI 10.1080/07853890701278795; Patel SD, 2010, AM J MED GENET B, V153B, P850, DOI 10.1002/ajmg.b.31087; Pechnick RN, 2008, P NATL ACAD SCI USA, V105, P1358, DOI 10.1073/pnas.0711030105; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; RAO ML, 1994, BIOL PSYCHIAT, V35, P151, DOI 10.1016/0006-3223(94)91147-9; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Saunders EFH, 2009, AM J MED GENET B, V150B, P1133, DOI 10.1002/ajmg.b.30937; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; Shi JJ, 2008, AM J MED GENET B, V147B, P1047, DOI 10.1002/ajmg.b.30714; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smith AV, 2005, GENOME RES, V15, P1519, DOI 10.1101/gr.4421405; Soria V, 2010, NEUROPSYCHOPHARMACOL, V35, P1279, DOI 10.1038/npp.2009.230; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Szabo ST, 2009, NEUROPHARMACOLOGY, V56, P47, DOI 10.1016/j.neuropharm.2008.08.015; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Van Veen MM, 2010, BIOL PSYCHIAT, V67, P1091, DOI 10.1016/j.biopsych.2009.12.032; Weber H, 2011, NEUROPSYCHOPHARMACOL, V36, P2076, DOI 10.1038/npp.2011.98; WELSH DK, 1990, BIOL PSYCHIAT, V28, P117, DOI 10.1016/0006-3223(90)90629-G; Williams HJ, 2011, HUM MOL GENET, V20, P387, DOI 10.1093/hmg/ddq471; Willour VL, 2009, MOL PSYCHIATR, V14, P261, DOI 10.1038/sj.mp.4002141; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	56	108	110	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32091	10.1371/journal.pone.0032091	http://dx.doi.org/10.1371/journal.pone.0032091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384149	Green Submitted, Green Published, gold			2022-12-27	WOS:000302875500074
J	Pourreyron, C; Reilly, L; Proby, C; Panteleyev, A; Fleming, C; McLean, K; South, AP; Foerster, J				Pourreyron, Celine; Reilly, Louise; Proby, Charlotte; Panteleyev, Andrey; Fleming, Colin; McLean, Kathleen; South, Andrew P.; Foerster, John			Wnt5a Is Strongly Expressed at the Leading Edge in Non-Melanoma Skin Cancer, Forming Active Gradients, while Canonical Wnt Signalling Is Repressed	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEINS; BETA-CATENIN; EPIGENETIC INACTIVATION; PROMOTER METHYLATION; INVASION; INHIBITION; PSORIASIS; ADHESION; PATHWAY; FRZA	Wnt5a is one of the so-called non-canonical Wnt ligands which do not act through beta-catenin. In normal development, Wnt5a is secreted and directs the migration of target cells along concentration gradients. The effect of Wnt5a on target cells is regulated by many factors, including the expression level of inhibitors and receptors. Dysregulated Wnt5a signalling facilitates invasion of multiple tumor types into adjacent tissue. However, the expression and distribution of Wnt5a in cutaneous squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), as well as the effect of Wnt5a on keratinocyte migration has not been studied in detail to date. We here report that Wnt5a is upregulated in SCC and BCC and localised to the leading edge of tumors, as well as tumor-associated fibroblasts. The Wnt5a-triggered bundling of its receptor Fzd3 provides evidence of Wnt5a concentration gradients projecting into the tumor. In vitro migration assays show that Wnt5a concentration gradients determine its effect on keratinoctye migration: While chemotactic migration is inhibited by Wnt5a present in homogenous concentrations, it is enhanced in the presence of a Wnt5a gradient. Expression profiling of the Wnt pathway shows that the upregulation of Wnt5a in SCC is coupled to repression of canonical Wnt signalling. This is confirmed by immunohistochemistry showing lack of nuclear beta-catenin, as well as absent accumulation of Axin2. Since both types of Wnt signalling act mutually antogonistically at multiple levels, the concurrent repression of canonical Wnt signalling suggests hyper-active Wnt5a signal transduction. Significantly, this combination of gene dysregulation is not observed in the benign hyperproliferative inflammatory skin disease psoriasis. Collectively, our data strongly suggest that Wnt5a signalling contributes to tissue invasion by non-melanoma skin cancer.	[Pourreyron, Celine; Reilly, Louise; Proby, Charlotte; Panteleyev, Andrey; South, Andrew P.] Univ Dundee, Coll Med Dent & Nursing, Med Res Inst, Dundee, Scotland; [Proby, Charlotte; Fleming, Colin; Foerster, John] Univ Dundee, Dept Dermatol, Coll Med Dent & Nursing, Dundee, Scotland; [Pourreyron, Celine; Reilly, Louise; Proby, Charlotte; Panteleyev, Andrey; McLean, Kathleen; South, Andrew P.] Univ Dundee, Coll Med Dent & Nursing, Canc Res UK Canc Ctr Dundee, Dundee, Scotland; [Fleming, Colin; Foerster, John] Univ Dundee, Coll Med Dent & Nursing, Educ Div, Dundee, Scotland; [McLean, Kathleen] Univ Dundee, Coll Med Dent & Nursing, Tayside Tissue Bank, Dundee, Scotland	University of Dundee; University of Dundee; University of Dundee; University of Dundee; University of Dundee	Pourreyron, C (corresponding author), Univ Dundee, Coll Med Dent & Nursing, Med Res Inst, Dundee, Scotland.	j.foerster@dundee.ac.uk	Panteleyev, Andrey A/R-9151-2016; Pourreyron, Celine/AAE-7362-2020	Panteleyev, Andrey A/0000-0002-8733-9183; Reilly, Louise/0000-0002-2224-1708	Cancer Research UK; DebRa International (Dystrophic Epidermolysis Bullosa Research Association); European Research Council (ERC); Cancer Research UK [13044] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); DebRa International (Dystrophic Epidermolysis Bullosa Research Association); European Research Council (ERC)(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK (C. Pourreyron, APS). C. Pourreyron was funded by DebRa International (Dystrophic Epidermolysis Bullosa Research Association) and the European Research Council (ERC) (APS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Chen YJ, 2004, INT J DEV BIOL, V48, P867, DOI 10.1387/ijdb.041882yc; Cheng YY, 2007, BRIT J CANCER, V97, P895, DOI 10.1038/sj.bjc.6603968; Chung MT, 2009, GYNECOL ONCOL, V112, P301, DOI 10.1016/j.ygyno.2008.10.004; Dennis S, 1999, J CELL SCI, V112, P3815; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Doglioni C, 2003, AM J PATHOL, V163, P2277, DOI 10.1016/S0002-9440(10)63585-7; Dufourcq P, 2002, CIRCULATION, V106, P3097, DOI 10.1161/01.CIR.0000039342.85015.5C; Dufourcq P, 2008, STEM CELLS, V26, P2991, DOI 10.1634/stemcells.2008-0372; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Enomoto M, 2009, ONCOGENE; Galli LM, 2006, DEV DYNAM, V235, P681, DOI 10.1002/dvdy.20681; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1849, DOI 10.1038/jid.2010.67; Hampton PJ, 2007, BRIT J DERMATOL, V157, P1168, DOI 10.1111/j.1365-2133.2007.08195.x; Hudson LG, 2010, MOL CARCINOGEN, V49, P619, DOI 10.1002/mc.20636; Jenei V, 2009, P NATL ACAD SCI USA, V106, P19473, DOI 10.1073/pnas.0909409106; Kang HY, 2011, J INVEST DERMATOL; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Li B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022920; Lin ZH, 2005, J CANCER RES CLIN, V131, P364, DOI 10.1007/s00432-004-0657-5; Matsumoto S, 2010, EMBO J, V29, P1192, DOI 10.1038/emboj.2010.26; McDonald SL, 2009, BRIT J CANCER, V101, P209, DOI 10.1038/sj.bjc.6605174; Medrek C, 2009, J BIOL CHEM, V284, P10968, DOI 10.1074/jbc.M804923200; Melkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636, DOI 10.1073/pnas.94.25.13636; Nishita M, 2010, TRENDS CELL BIOL, V20, P346, DOI 10.1016/j.tcb.2010.03.001; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; Pannone G, 2010, ONCOL REP, V24, P1035, DOI 10.3892/or_00000952; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Ren DY, 2011, GENES CELLS, V16, P304, DOI 10.1111/j.1365-2443.2011.01487.x; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; Romanowska M, 2008, J INVEST DERMATOL, V128, P110, DOI 10.1038/sj.jid.5700943; Romanowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009701; Romanowska M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005354; Rutberg SE, 2006, J INVEST DERMATOL, V126, P2583, DOI 10.1038/sj.jid.5700454; Sienknecht UJ, 2008, J COMP NEUROL, V510, P378, DOI 10.1002/cne.21791; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Verkaar F, 2010, FEBS LETT, V584, P3850, DOI 10.1016/j.febslet.2010.08.030; Villar J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023914; Watt SA, 2011, ONCOGENE; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250; Xu QH, 1998, DEVELOPMENT, V125, P4767; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Yamamoto H, 2009, GASTROENTEROLOGY, V137, P242, DOI 10.1053/j.gastro.2009.02.003; Yuzugullu H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-90	49	48	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31827	10.1371/journal.pone.0031827	http://dx.doi.org/10.1371/journal.pone.0031827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384081	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500046
J	Qu, XY; Du, J; Zhang, CY; Fu, WJ; Xi, H; Zou, JF; Hou, J				Qu, Xiaoyan; Du, Juan; Zhang, Chunyang; Fu, Weijun; Xi, Hao; Zou, Jianfeng; Hou, Jian			Arsenic Trioxide Exerts Antimyeloma Effects by Inhibiting Activity in the Cytoplasmic Substrates of Histone Deacetylase 6	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; KAPPA-B ACTIVATION; CELL APOPTOSIS; JNK ACTIVATION; HDAC6; PHOSPHORYLATION; GROWTH; CYTOSKELETON; ACETYLATION; P65	Arsenic trioxide (As2O3) has shown remarkable efficacy for the treatment of multiple myeloma (MM). Histone deacetylases (HDAC) play an important role in the control of gene expression, and their dysregulation has been linked to myeloma. Especially, HDAC6, a unique cytoplasmic member of class II, which mainly functions as alpha-tubulin deacetylase and Hsp90 deacetylase, has become a target for drug development to treat cancer due to its major contribution in oncogenic cell transformation. However, the mechanisms of action for As2O3 have not yet been defined. In this study, we investigated the effect of As2O3 on proliferation and apoptosis in human myeloma cell line and primary myeloma cells, and then we studied that As2O3 exerts antimyeloma effects by inhibiting activity in the alpha-tubulin and Hsp90 through western blot analysis and immunoprecipitation. We found that As2O3 acts directly on MM cells at relatively low concentrations of 0.5 similar to 2.5 mu M, which effects survival and apoptosis of MM cells. However, As2O3 inhibited HDAC activity at the relatively high concentration and dose-dependent manner (great than 4 mu M). Subsequently, we found that As2O3 treatment in a dose- and time-dependent fashion markedly increased the level of acetylated alpha-tubulin and acetylated Hsp90, and inhibited the chaperone association with IKK alpha activities and increased degradation of IKK alpha. Importantly, the loss of IKK alpha-associated Hsp90 occurred prior to any detectable loss in the levels of IKK alpha, indicating a novel pathway by which As2O3 down-regulates HDAC6 to destabilize IKK alpha protein via Hsp90 chaperone function. Furthermore, we observed the effect of As2O3 on TNF-alpha-induced NF-kappa B signaling pathway was to significantly reduced phosphorylation of Ser-536 on NF-kappa B p65. Therefore, our studies provide an important insight into the molecular mechanism of anti-myeloma activity of As2O3 in HDAC6-Hsp90-IKK alpha-NF kappa B signaling axis and the rationale for As2O3 can be extended readily using all the HDAC associated diseases.	[Qu, Xiaoyan; Du, Juan; Zhang, Chunyang; Fu, Weijun; Xi, Hao; Zou, Jianfeng; Hou, Jian] Second Mil Med Univ, Changzheng Hosp, Myeloma & Lymphoma Ctr, Dept Hematol, Shanghai, Peoples R China	Naval Medical University	Qu, XY (corresponding author), Second Mil Med Univ, Changzheng Hosp, Myeloma & Lymphoma Ctr, Dept Hematol, Shanghai, Peoples R China.	houjian167@sohu.com	qu, xiaoyan/HDN-3134-2022		National Natural Science Foundation of China [NFSC30670884, 30900643]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by the National Natural Science Foundation of China (NFSC30670884, 30900643), and no additional external funding was received for the additional part of the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Baysan A, 2007, INT J ONCOL, V30, P313; Beauchamp EM, 2011, J CLIN INVEST, V121, P148, DOI 10.1172/JCI42874; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Davison K, 2004, BLOOD, V103, P3496, DOI 10.1182/blood-2003-05-1412; dos Santos GAS, 2012, LEUKEMIA, V26, P451, DOI 10.1038/leu.2011.216; Drobna Z, 2002, FASEB J, V16, P67, DOI 10.1096/fj.02-0287fje; Emadi A, 2010, BLOOD REV, V24, P191, DOI 10.1016/j.blre.2010.04.001; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hayashi T, 2002, MOL CANCER THER, V1, P851; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hinz M, 2007, J BIOL CHEM, V282, P32311, DOI 10.1074/jbc.M705785200; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kajiguchi T, 2006, CANCER SCI, V97, P540, DOI 10.1111/j.1349-7006.2006.00199.x; Kapahi P, 2000, J BIOL CHEM, V275, P36062, DOI 10.1074/jbc.M007204200; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Lemoine M, 2010, DISCOV MED, V10, P462; Miller WH, 2002, CANCER RES, V62, P3893; Nasr R, 2003, BLOOD, V101, P4576, DOI 10.1182/blood-2002-09-2986; Qazilbash MH, 2008, BIOL BLOOD MARROW TR, V14, P1401, DOI 10.1016/j.bbmt.2008.09.019; Qing GL, 2006, CELL RES, V16, P895, DOI 10.1038/sj.cr.7310109; Roussel RR, 2000, ARCH BIOCHEM BIOPHYS, V377, P204, DOI 10.1006/abbi.2000.1770; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sanz MA, 2011, J CLIN ONCOL, V29, P495, DOI 10.1200/JCO.2010.32.1067; Sharma M, 2012, CANCER-AM CANCER SOC, V118, P2507, DOI 10.1002/cncr.26517; Sharma V, 2010, J CELL MOL MED, V14, P2151, DOI 10.1111/j.1582-4934.2009.00844.x; Thu YM, 2010, CYTOKINE GROWTH F R, V21, P213, DOI 10.1016/j.cytogfr.2010.06.002; Tokesi N, 2010, J BIOL CHEM, V285, P17896, DOI 10.1074/jbc.M109.096578; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Vey N, 2006, J CLIN ONCOL, V24, P2465, DOI 10.1200/JCO.2005.03.9503; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Waxman S, 2001, ONCOLOGIST, V6, P3, DOI 10.1634/theoncologist.6-suppl_2-3; Wen JG, 2008, BRIT J HAEMATOL, V140, P169, DOI 10.1111/j.1365-2141.2007.06895.x; Wu KL, 2006, HAEMATOLOGICA, V91, P1722; Yao YL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/146493; Zhou L, 2005, BLOOD, V105, P1198, DOI 10.1182/blood-2003-12-4299	42	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32215	10.1371/journal.pone.0032215	http://dx.doi.org/10.1371/journal.pone.0032215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384180	Green Submitted, Green Published, gold			2022-12-27	WOS:000302875500085
J	Angrisano, F; Riglar, DT; Sturm, A; Volz, JC; Delves, MJ; Zuccala, ES; Turnbull, L; Dekiwadia, C; Olshina, MA; Marapana, DS; Wong, W; Mollard, V; Bradin, CH; Tonkin, CJ; Gunning, PW; Ralph, SA; Whitchurch, CB; Sinden, RE; Cowman, AF; McFadden, GI; Baum, J				Angrisano, Fiona; Riglar, David T.; Sturm, Angelika; Volz, Jennifer C.; Delves, Michael J.; Zuccala, Elizabeth S.; Turnbull, Lynne; Dekiwadia, Chaitali; Olshina, Maya A.; Marapana, Danushka S.; Wong, Wilson; Mollard, Vanessa; Bradin, Clare H.; Tonkin, Christopher J.; Gunning, Peter W.; Ralph, Stuart A.; Whitchurch, Cynthia B.; Sinden, Robert E.; Cowman, Alan F.; McFadden, Geoffrey I.; Baum, Jake			Spatial Localisation of Actin Filaments across Developmental Stages of the Malaria Parasite	PLOS ONE			English	Article							HOST-CELL INVASION; PLASMODIUM-FALCIPARUM; TOXOPLASMA-GONDII; ERYTHROCYTE INVASION; GLIDING MOTILITY; MOVING JUNCTION; APICOMPLEXAN PARASITES; MAMMALIAN-CELLS; VIRULENCE GENES; PROTEINS	Actin dynamics have been implicated in a variety of developmental processes during the malaria parasite lifecycle. Parasite motility, in particular, is thought to critically depend on an actomyosin motor located in the outer pellicle of the parasite cell. Efforts to understand the diverse roles actin plays have, however, been hampered by an inability to detect microfilaments under native conditions. To visualise the spatial dynamics of actin we generated a parasite-specific actin antibody that shows preferential recognition of filamentous actin and applied this tool to different lifecycle stages (merozoites, sporozoites and ookinetes) of the human and mouse malaria parasite species Plasmodium falciparum and P. berghei along with tachyzoites from the related apicomplexan parasite Toxoplasma gondii. Actin filament distribution was found associated with three core compartments: the nuclear periphery, pellicular membranes of motile or invasive parasite forms and in a ring-like distribution at the tight junction during merozoite invasion of erythrocytes in both human and mouse malaria parasites. Localisation at the nuclear periphery is consistent with an emerging role of actin in facilitating parasite gene regulation. During invasion, we show that the actin ring at the parasite-host cell tight junction is dependent on dynamic filament turnover. Super-resolution imaging places this ring posterior to, and not concentric with, the junction marker rhoptry neck protein 4. This implies motor force relies on the engagement of dynamic microfilaments at zones of traction, though not necessarily directly through receptor-ligand interactions at sites of adhesion during invasion. Combined, these observations extend current understanding of the diverse roles actin plays in malaria parasite development and apicomplexan cell motility, in particular refining understanding on the linkage of the internal parasite gliding motor with the extra-cellular milieu.	[Angrisano, Fiona; Riglar, David T.; Volz, Jennifer C.; Zuccala, Elizabeth S.; Olshina, Maya A.; Marapana, Danushka S.; Wong, Wilson; Bradin, Clare H.; Tonkin, Christopher J.; Cowman, Alan F.; Baum, Jake] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Angrisano, Fiona; Riglar, David T.; Volz, Jennifer C.; Zuccala, Elizabeth S.; Olshina, Maya A.; Tonkin, Christopher J.; Cowman, Alan F.; Baum, Jake] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Sturm, Angelika; Sinden, Robert E.] Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia; [Delves, Michael J.; Mollard, Vanessa; McFadden, Geoffrey I.] Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London, England; [Turnbull, Lynne; Whitchurch, Cynthia B.] Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia; [Dekiwadia, Chaitali; Ralph, Stuart A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Gunning, Peter W.] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; Imperial College London; University of Technology Sydney; University of Melbourne; University of New South Wales Sydney	Angrisano, F (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	jake@wehi.edu.au	Zuccala, Elizabeth/HDM-5025-2022; McFadden, Geoffrey McFadden I/F-7667-2014; Tonkin, Christopher/K-6534-2019; Cowman, Alan F/C-7642-2013; Gunning, Peter W/E-9058-2010; Ralph, Stuart/C-8590-2014; Turnbull, Lynne/A-2605-2012; Whitchurch, Cynthia/A-5954-2008	McFadden, Geoffrey McFadden I/0000-0002-5351-1627; Tonkin, Christopher/0000-0002-7036-6222; Cowman, Alan F/0000-0001-5145-9004; Angrisano, Fiona/0000-0002-0457-5982; Baum, Jake/0000-0002-0275-352X; Ralph, Stuart/0000-0003-0114-7808; Delves, Michael/0000-0001-8526-4782; Wong, Wilson/0000-0003-1335-8047; Turnbull, Lynne/0000-0002-9255-9033; Whitchurch, Cynthia/0000-0003-2296-3791; Zuccala, Elizabeth/0000-0002-9189-9810; Gunning, Peter/0000-0003-0833-3128; Riglar, David/0000-0002-5004-4373	National Health and Medical Research Council of Australia (NHMRC [516747, 637341]; Pratt Foundation through the University of Melbourne; HFSP; NHMRC [575523]; University of Technology, Sydney; Australian Research Council (ARC) [FT0990350, FT100100112]	National Health and Medical Research Council of Australia (NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Pratt Foundation through the University of Melbourne; HFSP(Human Frontier Science Program); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Technology, Sydney; Australian Research Council (ARC)(Australian Research Council)	This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. Funding for the research came from the National Health and Medical Research Council of Australia (NHMRC Project Grants 516747 JB & CJT and 637341 JB & GIM). DTR is supported by a Pratt Foundation PhD scholarship through the University of Melbourne; JCV was initially supported by a HFSP long-term fellowship; CJT is supported by an NHMRC Career Development Award (575523); LT is supported by a Chancellor's Postdoctoral Fellowship from the University of Technology, Sydney; PWG was a Principal Research Fellow of the NHMRC; SAR is supported by an Australian Research Council (ARC) Future Fellowship (FT0990350); CBW is supported by a Senior Research Fellowship from the NHMRC; AFC is an Australia Fellow of the NHMRC. GIM is an ARC Federation Fellow with support from the NHMRC; JB is supported by an ARC Future Fellowship (FT100100112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; Angrisano F, 2012, MOL BIOCHEM PARASIT, V182, P93, DOI 10.1016/j.molbiopara.2011.11.008; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Baum J, 2008, TRENDS PARASITOL, V24, P557, DOI 10.1016/j.pt.2008.08.006; Baum J, 2008, CELL HOST MICROBE, V3, P188, DOI 10.1016/j.chom.2008.02.006; Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; Besteiro S, 2011, CELL MICROBIOL, V13, P797, DOI 10.1111/j.1462-5822.2011.01597.x; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Daher W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001132; Daher W, 2009, CURR OPIN MICROBIOL, V12, P408, DOI 10.1016/j.mib.2009.06.008; Dobrowolski JM, 1997, MOL MICROBIOL, V26, P163, DOI 10.1046/j.1365-2958.1997.5671913.x; Dobrowolski JM, 1997, CELL MOTIL CYTOSKEL, V37, P253, DOI 10.1002/(SICI)1097-0169(1997)37:3&lt;253::AID-CM7&gt;3.0.CO;2-7; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; ELMENDORF HG, 1993, EMBO J, V12, P4763, DOI 10.1002/j.1460-2075.1993.tb06165.x; FIELD SJ, 1993, CELL MOTIL CYTOSKEL, V25, P43, DOI 10.1002/cm.970250106; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gordon JL, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-179; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Green JL, 2006, J MOL BIOL, V355, P933, DOI 10.1016/j.jmb.2005.11.027; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Jones ML, 2006, MOL BIOCHEM PARASIT, V147, P74, DOI 10.1016/j.molbiopara.2006.01.009; Kudryashev Mikhail, 2010, PMC Biophys, V3, P6, DOI 10.1186/1757-5036-3-6; Lazarus MD, 2008, J CELL SCI, V121, P1937, DOI 10.1242/jcs.023150; MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172; Mizuno Y, 2002, PARASITOL RES, V88, P844, DOI 10.1007/s00436-002-0666-8; Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; Mota MM, 2002, NAT MED, V8, P1318, DOI 10.1038/nm785; Munter S, 2009, CELL HOST MICROBE, V6, P551, DOI 10.1016/j.chom.2009.11.007; Nebl T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002222; Percival JM, 2004, MOL BIOL CELL, V15, P268, DOI 10.1091/mbc.e03-03-0176; Pinder JC, 1998, J CELL SCI, V111, P1831; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Raibaud A, 2001, J STRUCT BIOL, V135, P47, DOI 10.1006/jsbi.2001.4396; Ralph SA, 2005, P NATL ACAD SCI USA, V102, P5414, DOI 10.1073/pnas.0408883102; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; RYNING FW, 1978, INFECT IMMUN, V20, P739, DOI 10.1128/IAI.20.3.739-743.1978; Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512; Schatten H, 2003, MICROSC MICROANAL, V9, P330, DOI 10.1017/S143192760030095; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Schmitz S, 2010, J BIOL CHEM, V285, P36577, DOI 10.1074/jbc.M110.142638; Shaw MK, 1999, P NATL ACAD SCI USA, V96, P9095, DOI 10.1073/pnas.96.16.9095; Sheiner L, 2010, MOL MICROBIOL; Siden-Kiamos I, 2006, MOL BIOCHEM PARASIT, V150, P308, DOI 10.1016/j.molbiopara.2006.09.003; Siden-Kiamos I, 2012, MOL BIOCHEM PARASIT, V181, P186, DOI 10.1016/j.molbiopara.2011.11.002; Sinden Robert E, 2002, Methods Mol Med, V72, P25, DOI 10.1385/1-59259-271-6:25; Skillman KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002280; Smythe WA, 2008, CELL MICROBIOL, V10, P452, DOI 10.1111/j.1462-5822.2007.01058.x; Spano F., 1996, Parassitologia (Rome), V38, P559; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Sukow C, 2003, BIOPHYS J, V85, P525, DOI 10.1016/S0006-3495(03)74497-X; TAYLOR KA, 1994, BIOPHYS J, V67, P1976, DOI 10.1016/S0006-3495(94)80680-0; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Tyler JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001282; VARMA M, 1987, EXP CELL RES, V173, P163, DOI 10.1016/0014-4827(87)90342-9; Visa N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000620; Vlachou D, 2006, CURR OPIN GENET DEV, V16, P384, DOI 10.1016/j.gde.2006.06.012; Volz JC, 2012, CELL HOST MICROBE, V11, P7, DOI 10.1016/j.chom.2011.11.011; Wetzel DM, 2003, MOL BIOL CELL, V14, P396, DOI 10.1091/mbc.E02-08-0458; WHO, 2010, WOR HEALT REP, P1; Wong W, 2011, P NATL ACAD SCI USA, V108, P9869, DOI 10.1073/pnas.1018927108; YOSHIDA N, 1980, SCIENCE, V207, P71, DOI 10.1126/science.6985745; Zhang QF, 2011, CELL HOST MICROBE, V10, P451, DOI 10.1016/j.chom.2011.09.013	72	53	54	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32188	10.1371/journal.pone.0032188	http://dx.doi.org/10.1371/journal.pone.0032188			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389687	Green Published, gold, Green Accepted			2022-12-27	WOS:000302999600025
J	Gallwitz, M; Enoksson, M; Thorpe, M; Hellman, L				Gallwitz, Maike; Enoksson, Mattias; Thorpe, Michael; Hellman, Lars			The Extended Cleavage Specificity of Human Thrombin	PLOS ONE			English	Article							MAST-CELL CHYMASE; SUBSTRATE RECOGNITION PROFILE; PHAGE DISPLAY; ANTITHROMBIN-III; SERINE PROTEASES; BRAIN-INJURY; AMINO-ACIDS; SITE; REVEALS; MOUSE	Thrombin is one of the most extensively studied of all proteases. Its central role in the coagulation cascade as well as several other areas has been thoroughly documented. Despite this, its consensus cleavage site has never been determined in detail. Here we have determined its extended substrate recognition profile using phage-display technology. The consensus recognition sequence was identified as, P2-Pro, P1-Arg, P1'-Ser/Ala/Gly/Thr, P2'-not acidic and P3'-Arg. Our analysis also identifies an important role for a P3'-arginine in thrombin substrates lacking a P2-proline. In order to study kinetics of this cooperative or additive effect we developed a system for insertion of various pre-selected cleavable sequences in a linker region between two thioredoxin molecules. Using this system we show that mutations of P2-Pro and P3'-Arg lead to an approximate 20-fold and 14-fold reduction, respectively in the rate of cleavage. Mutating both Pro and Arg results in a drop in cleavage of 200-400 times, which highlights the importance of these two positions for maximal substrate cleavage. Interestingly, no natural substrates display the obtained consensus sequence but represent sequences that show only 1-30% of the optimal cleavage rate for thrombin. This clearly indicates that maximal cleavage, excluding the help of exosite interactions, is not always desired, which may instead cause problems with dysregulated coagulation. It is likely exosite cooperativity has a central role in determining the specificity and rate of cleavage of many of these in vivo substrates. Major effects on cleavage efficiency were also observed for residues as far away as 4 amino acids from the cleavage site. Insertion of an aspartic acid in position P4 resulted in a drop in cleavage by a factor of almost 20 times.	[Gallwitz, Maike; Enoksson, Mattias; Thorpe, Michael; Hellman, Lars] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden	Uppsala University	Gallwitz, M (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden.	lars.hellman@icm.uu.se	Thorpe, Michael/P-6838-2015	Thorpe, Michael/0000-0002-4771-0080	Swedish National Research Counsil for Science and Technology [621-2008-3248]	Swedish National Research Counsil for Science and Technology	This work was supported by grants from the Swedish National Research Counsil for Science and Technology, number 621-2008-3248. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Andersson MK, 2008, MOL IMMUNOL, V45, P2548, DOI 10.1016/j.molimm.2008.01.012; Andersson MK, 2008, MOL IMMUNOL, V45, P766, DOI 10.1016/j.molimm.2007.06.360; Andersson MK, 2010, FEBS J, V277, P2255, DOI 10.1111/j.1742-4658.2010.07642.x; Andersson MK, 2009, INT IMMUNOL, V21, P95, DOI 10.1093/intimm/dxn128; Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642; Bianchini EP, 2002, J BIOL CHEM, V277, P20527, DOI 10.1074/jbc.M201139200; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Boffa MB, 2000, J BIOL CHEM, V275, P12868, DOI 10.1074/jbc.275.17.12868; CHANG GTG, 1994, THROMB HAEMOSTASIS, V72, P693; CHANG JY, 1985, EUR J BIOCHEM, V151, P225, DOI 10.1111/j.1432-1033.1985.tb09092.x; CHANG JY, 1985, EUR J BIOCHEM, V151, P217, DOI 10.1111/j.1432-1033.1985.tb09091.x; Cloutier SM, 2002, EUR J BIOCHEM, V269, P2747, DOI 10.1046/j.1432-1033.2002.02960.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Davie EW, 2006, SEMIN THROMB HEMOST, V32, P3, DOI 10.1055/s-2006-939550; de la Houssaye BA, 1999, J NEUROSCI, V19, P10843, DOI 10.1523/JNEUROSCI.19-24-10843.1999; Diamond SL, 2007, CURR OPIN CHEM BIOL, V11, P46, DOI 10.1016/j.cbpa.2006.11.021; Ebert RF, 1991, INDEX VARIANT HUMAN; Fang M, 2003, J PHYSIOL-LONDON, V549, P903, DOI 10.1113/jphysiol.2002.036384; Faraut B, 2003, J CELL PHYSIOL, V196, P105, DOI 10.1002/jcp.10280; Gallwitz M, 2007, IMMUNOGENETICS, V59, P391, DOI 10.1007/s00251-007-0202-1; Gallwitz M, 2010, INT IMMUNOL, V22, P421, DOI 10.1093/intimm/dxq021; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Hachem JP, 2005, J INVEST DERMATOL, V125, P510, DOI 10.1111/j.0022-202X.2005.23838.x; Harris JL, 1998, J BIOL CHEM, V273, P27364, DOI 10.1074/jbc.273.42.27364; HAWKINS RL, 1989, DEV BRAIN RES, V45, P203, DOI 10.1016/0165-3806(89)90039-4; Hills R, 2007, J BIOL CHEM, V282, P11101, DOI 10.1074/jbc.M611588200; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; Junge CE, 2003, P NATL ACAD SCI USA, V100, P13019, DOI 10.1073/pnas.2235594100; Karlson L, 2002, J BIOL CHEM, V277, P18579, DOI 10.1074/jbc.M110356200; Karlson U, 2003, J BIOL CHEM, V278, P39625, DOI 10.1074/jbc.M301512200; Karlson U., 2003, THESIS UPPSALA U UPP; KAWABATA SI, 1988, EUR J BIOCHEM, V172, P17, DOI 10.1111/j.1432-1033.1988.tb13849.x; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; LEBONNIEC BF, 1991, J BIOL CHEM, V266, P13796; LeBonniec BF, 1996, BIOCHEMISTRY-US, V35, P7114, DOI 10.1021/bi952701s; LIOTTA LA, 1981, CANCER RES, V41, P4629; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P539, DOI 10.1016/0167-4838(83)90272-8; Marque PE, 2000, J BIOL CHEM, V275, P809, DOI 10.1074/jbc.275.2.809; MAYER U, 1993, EUR J BIOCHEM, V217, P877, DOI 10.1111/j.1432-1033.1993.tb18316.x; McCarter JD, 2004, J BACTERIOL, V186, P5919, DOI 10.1128/JB.186.17.5919-5925.2004; Muszbek L, 1984, THROMBIN, P83; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Ng NMY, 2009, ARCH BIOCHEM BIOPHYS, V489, P48, DOI 10.1016/j.abb.2009.07.012; Ohnishi M, 2007, EXP NEUROL, V206, P43, DOI 10.1016/j.expneurol.2007.03.030; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; Pan WJ, 2003, J BIOL CHEM, V278, P27820, DOI 10.1074/jbc.M304436200; Petrassi HM, 2005, BIOORG MED CHEM LETT, V15, P3162, DOI 10.1016/j.bmcl.2005.04.019; POZSGAY M, 1981, EUR J BIOCHEM, V115, P491; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Ramos-Mandujano G, 2007, GLIA, V55, P917, DOI 10.1002/glia.20513; Reimer JM, 2008, MOL IMMUNOL, V45, P2116, DOI 10.1016/j.molimm.2007.10.015; Ribeiro MD, 2006, EXP NEUROL, V198, P199, DOI 10.1016/j.expneurol.2005.11.017; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHERAGA HA, 1958, NATURE, V182, P461, DOI 10.1038/182461a0; Sigle RO, 2004, J CELL SCI, V117, P4481, DOI 10.1242/jcs.01310; Southan C, 2001, DRUG DISCOV TODAY, V6, P681, DOI 10.1016/S1359-6446(01)01793-7; STEPHENS AW, 1988, J BIOL CHEM, V263, P15849; THEUNISSEN HJM, 1993, J BIOL CHEM, V268, P9035; Vindigni A, 1997, NAT BIOTECHNOL, V15, P891, DOI 10.1038/nbt0997-891; WELLS CM, 1992, BIOCHEMISTRY-US, V31, P11721, DOI 10.1021/bi00162a008; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x	62	80	94	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31756	10.1371/journal.pone.0031756	http://dx.doi.org/10.1371/journal.pone.0031756			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384068	gold, Green Published, Green Submitted			2022-12-27	WOS:000302918500037
J	Girgenti, MJ; LoTurco, JJ; Maher, BJ				Girgenti, Matthew J.; LoTurco, Joseph J.; Maher, Brady J.			ZNF804a Regulates Expression of the Schizophrenia-Associated Genes PRSS16, COMT, PDE4B, and DRD2	PLOS ONE			English	Article							COMMON VARIANTS; RISK	ZNF804a was identified by a genome-wide association study (GWAS) in which a single nucleotide polymorphism (SNP rs1344706) in ZNF804a reached genome-wide statistical significance for association with a combined diagnosis of schizophrenia (SZ) and bipolar disorder. Although the molecular function of ZNF804a is unknown, the amino acid sequence is predicted to contain a C2H2-type zinc-finger domain and suggests ZNF804a plays a role in DNA binding and transcription. Here, we confirm that ZNF804a directly contributes to transcriptional control by regulating the expression of several SZ associated genes and directly interacts with chromatin proximal to the promoter regions of PRSS16 and COMT, the two genes we find upregulated by ZNF804a. Using immunochemistry we establish that ZNF804a is localized to the nucleus of rat neural progenitor cells in culture and in vivo. We demonstrate that expression of ZNF804a results in a significant increase in transcript levels of PRSS16 and COMT, relative to GFP transfected controls, and a statistically significant decrease in transcript levels of PDE4B and DRD2. Furthermore, we show using chromatin immunoprecipitation assays (ChIP) that both epitope-tagged and endogenous ZNF804a directly interacts with the promoter regions of PRSS16 and COMT, suggesting a direct upregulation of transcription by ZNF804a on the expression of these genes. These results are the first to confirm that ZNF804a regulates transcription levels of four SZ associated genes, and binds to chromatin proximal to promoters of two SZ genes. These results suggest a model where ZNF804a may modulate a transcriptional network of SZ associated genes.	[Girgenti, Matthew J.; LoTurco, Joseph J.; Maher, Brady J.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Maher, Brady J.] Lieber Inst Brain Dev, Baltimore, MD USA	University of Connecticut	Girgenti, MJ (corresponding author), Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA.	brady.maher@libd.org	Maher, Brady/GPC-8697-2022; Girgenti, Matthew/ABV-9100-2022; Maher, Brady/L-8314-2016	Maher, Brady/0000-0001-5930-885X	 [K01MH086050];  [R01MH056524]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH086050, R01MH056524] Funding Source: NIH RePORTER	; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding was provided by K01MH086050 (BJM; www.nih.nimh.gov) and R01MH056524 (JJL; www.nih.nimh.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Bowlus CL, 1999, CELL IMMUNOL, V196, P80, DOI 10.1006/cimm.1999.1543; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Hill MJ, 2011, HUM MOL GENET; Hill MJ, 2011, MOL PSYCHIAT; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Riley B, 2010, MOL PSYCHIATR, V15, P29, DOI 10.1038/mp.2009.109; Sei Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010789; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steinberg S, 2011, MOL PSYCHIATR, V16, P59, DOI 10.1038/mp.2009.149; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Williams HJ, 2011, MOL PSYCHIATR, V16, P429, DOI 10.1038/mp.2010.36; Zhang FY, 2011, BIOL PSYCHIAT, V69, P914, DOI 10.1016/j.biopsych.2011.01.003; Zhang R, 2011, MOL PSYCHIATR, V16, P360, DOI 10.1038/mp.2010.55; Zhang R, 2011, SCHIZOPHR RES	18	80	85	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32404	10.1371/journal.pone.0032404	http://dx.doi.org/10.1371/journal.pone.0032404			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384243	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500086
J	Koshiol, J; Flores, R; Lam, TK; Taylor, PR; Weinstein, SJ; Virtamo, J; Albanes, D; Perez-Perez, G; Caporaso, NE; Blaser, MJ				Koshiol, Jill; Flores, Roberto; Lam, Tram K.; Taylor, Philip R.; Weinstein, Stephanie J.; Virtamo, Jarmo; Albanes, Demetrius; Perez-Perez, Guillermo; Caporaso, Neil E.; Blaser, Martin J.			Helicobacter pylori Seropositivity and Risk of Lung Cancer	PLOS ONE			English	Article							BETA-CAROTENE SUPPLEMENTS; SQUAMOUS-CELL CARCINOMA; ALPHA-TOCOPHEROL; CIGARETTE-SMOKING; PREVENTION; METAANALYSIS; INFECTION; POPULATION; INTENSITY; DISEASE	Lung cancer is the leading cause of cancer mortality worldwide. Helicobacter pylori (H. pylori) is a risk factor for distal stomach cancer, and a few small studies have suggested that H. pylori may be a potential risk factor for lung cancer. To test this hypothesis, we conducted a study of 350 lung adenocarcinoma cases, 350 squamous cell carcinoma cases, and 700 controls nested within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC) cohort of male Finnish smokers. Controls were one-to-one matched by age and date of baseline serum draw. Using enzyme-linked immunosorbent assays to detect immunoglobulin G antibodies against H. pylori whole-cell and cytotoxin-associated gene (CagA) antigens, we calculated odds ratios (ORs) and 95% confidence intervals (95% CIs) for associations between H. pylori seropositivity and lung cancer risk using conditional logistic regression. H. pylori seropositivity was detected in 79.7% of cases and 78.5% of controls. After adjusting for pack-years and cigarettes smoked per day, H. pylori seropositivity was not associated with either adenocarcinoma (OR: 1.1, 95% CI: 0.75-1.6) or squamous cell carcinoma (OR: 1.1, 95% CI: 0.77-1.7). Results were similar for CagA-negative and CagA-positive H. pylori seropositivity. Despite earlier small studies suggesting that H. pylori may contribute to lung carcinogenesis, H. pylori seropositivity does not appear to be associated with lung cancer.	[Koshiol, Jill; Flores, Roberto; Lam, Tram K.; Taylor, Philip R.; Weinstein, Stephanie J.; Albanes, Demetrius; Caporaso, Neil E.] NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Perez-Perez, Guillermo; Blaser, Martin J.] NYU, Sch Med, Dept Med, New York, NY USA; [Perez-Perez, Guillermo; Blaser, Martin J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Finland National Institute for Health & Welfare; New York University; New York University	Koshiol, J (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA.	koshiolj@mail.nih.gov	Weinstein, Stephanie J/P-1627-2017; Albanes, Demetrius/B-9749-2015; Perez, Guillermo Perez/AAJ-3761-2020; koshiol, Jill/L-8686-2014	Weinstein, Stephanie J/0000-0002-3834-1535; koshiol, Jill/0000-0002-3832-6204; Perez Perez, Guillermo/0000-0002-0131-5798	National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics	National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics)	This research was supported by General Funds from the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics. The Division of Cancer Epidemiology and Genetics reviewed and approved the ATBC study and cleared the manuscript for publication but had no role in the analysis, decision to publish, or preparation of the manuscript.	Albanes D, 1996, J NATL CANCER I, V88, P1560, DOI 10.1093/jnci/88.21.1560; ALBANES D, 1995, AM J CLIN NUTR, V62, P1427, DOI 10.1093/ajcn/62.6.1427S; Arnold IC, 2011, J CLIN INVEST, V121, P3088, DOI 10.1172/JCI45041; *ATBC CANC PREV ST, 1994, ANN EPIDEMIOL, V4, P1; Behroozian Ramin, 2010, Trop Gastroenterol, V31, P34; Brenner DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017479; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Chang YJ, 2011, J CLIN INVEST, V121, P57, DOI 10.1172/JCI44845; Chaturvedi AK, 2010, J CLIN ONCOL, V28, P2719, DOI 10.1200/JCO.2009.27.0454; Cook MB, 2010, CANCER EPIDEM BIOMAR, V19, P1966, DOI 10.1158/1055-9965.EPI-10-0270; Ece F, 2005, RESP MED, V99, P1258, DOI 10.1016/j.rmed.2005.02.038; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Engels EA, 2008, EXPERT REV ANTICANC, V8, P605, DOI 10.1586/14737140.8.4.605; Gillison ML, 2008, CANCER-AM CANCER SOC, V113, P3036, DOI 10.1002/cncr.23764; Gocyk W, 2000, Med Sci Monit, V6, P1085; GREENLAND S, 1998, MODERN EPIDEMIOLOGY, P218; IARC, 1994, IARC MONOGRAPHS EVAL, VVolume 61, P1; Islami F, 2008, CANCER PREV RES, V1, P329, DOI 10.1158/1940-6207.CAPR-08-0109; Janssen-Heijnen MLG, 2003, LUNG CANCER-J IASLC, V41, P245, DOI 10.1016/S0169-5002(03)00230-7; Kamangar F, 2006, JNCI-J NATL CANCER I, V98, P1445, DOI 10.1093/jnci/djj393; Kanbay M, 2007, RESP MED, V101, P203, DOI 10.1016/j.rmed.2006.04.022; Kohno T, 2011, J THORAC ONCOL, V6, P813, DOI 10.1097/JTO.0b013e3181ee80ef; Kohno T, 2010, CARCINOGENESIS, V31, P834, DOI 10.1093/carcin/bgq003; Korhonen P, 2002, ACTA ONCOL, V41, P381, DOI 10.1080/028418602760169442; Koshiol J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007380; Kosunen TU, 1997, EPIDEMIOL INFECT, V119, P29, DOI 10.1017/S0950268897007565; Limburg PJ, 2001, JNCI-J NATL CANCER I, V93, P226, DOI 10.1093/jnci/93.3.226; Lubin JH, 2008, AM J EPIDEMIOL, V167, P970, DOI 10.1093/aje/kwm392; Lubin JH, 2007, INT J EPIDEMIOL, V36, P236, DOI 10.1093/ije/dym043; Lubin JH, 2006, CANCER EPIDEM BIOMAR, V15, P517, DOI 10.1158/1055-9965.EPI-05-0863; Murphy G, 2011, J NATL CANCER I, V103, P1123, DOI 10.1093/jnci/djr194; Najafizadeh K, 2007, WORLD J GASTROENTERO, V13, P2349, DOI 10.3748/wjg.v13.i16.2349; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Philippou N, 2004, WORLD J GASTROENTERO, V10, P3342, DOI 10.3748/wjg.v10.i22.3342; Pine SR, 2011, JNCI-J NATL CANCER I, V103, P1112, DOI 10.1093/jnci/djr216; Reibman J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004060; Romero-Gallo J, 2002, CLIN DIAGN LAB IMMUN, V9, P1313, DOI 10.1128/CDLI.9.6.1313-1317.2002; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Stolzenberg-Solomon RZ, 2001, J NATL CANCER I, V93, P937, DOI 10.1093/jnci/93.12.937; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Thun MJ, 2002, ONCOGENE, V21, P7307, DOI 10.1038/sj.onc.1205807; World Health Organization, 1978, INT STAT CLASS DIS R; Zhuo WL, 2009, ARCH MED RES, V40, P406, DOI 10.1016/j.arcmed.2009.05.002	46	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32106	10.1371/journal.pone.0032106	http://dx.doi.org/10.1371/journal.pone.0032106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384154	gold, Green Submitted, Green Published			2022-12-27	WOS:000302916800024
J	Marsano, RM; Leronni, D; D'Addabbo, P; Viggiano, L; Tarasco, E; Caizzi, R				Marsano, Rene Massimiliano; Leronni, Daniela; D'Addabbo, Pietro; Viggiano, Luigi; Tarasco, Eustachio; Caizzi, Ruggiero			Mosquitoes LTR Retrotransposons: A Deeper View into the Genomic Sequence of Culex quinquefasciatus	PLOS ONE			English	Article							TERMINAL-REPEAT RETROTRANSPOSONS; TRANSFER-RNA; EVOLUTIONARY ANALYSES; ANOPHELES-GAMBIAE; AEDES-AEGYPTI; IDENTIFICATION; IMPACT; INSULATOR; ELEMENTS; PIPIENS	A set of 67 novel LTR-retrotransposon has been identified by in silico analyses of the Culex quinquefasciatus genome using the LTR_STRUC program. The phylogenetic analysis shows that 29 novel and putatively functional LTR-retrotransposons detected belong to the Ty3/gypsy group. Our results demonstrate that, by considering only families containing potentially autonomous LTR-retrotransposons, they account for about 1% of the genome of C. quinquefasciatus. In previous studies it has been estimated that 29% of the genome of C. quinquefasciatus is occupied by mobile genetic elements. The potential role of retrotransposon insertions strictly associated with host genes is described and discussed along with the possible origin of a retrotransposon with peculiar Primer Binding Site region. Finally, we report the presence of a group of 38 retrotransposons, carrying tandem repeated sequences but lacking coding potential, and apparently lacking "master copy" elements from which they could have originated. The features of the repetitive sequences found in these non-autonomous LTR retrotransposons are described, and their possible role discussed. These results integrate the existing data on the genomics of an important virus-borne disease vector.	[Marsano, Rene Massimiliano; Leronni, Daniela; D'Addabbo, Pietro; Viggiano, Luigi; Caizzi, Ruggiero] Univ Bari Aldo Moro, Sez Genet & Microbiol, Dipartimento Biol, Bari, Italy; [Tarasco, Eustachio] Univ Bari Aldo Moro, Dipartimento Biol & Chim Agroforestale & Ambienta, Sez Entomol & Zool, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Marsano, RM (corresponding author), Univ Bari Aldo Moro, Sez Genet & Microbiol, Dipartimento Biol, Bari, Italy.	r.marsano@biologia.uniba.it	Tarasco, Eustachio/T-8588-2019; D'Addabbo, Pietro/AAC-7731-2020; Leronni, Daniela/G-5795-2018; D'Addabbo, Pietro/D-8551-2016; Marsano, René Massimiliano/B-9640-2012	Leronni, Daniela/0000-0003-4878-9904; D'Addabbo, Pietro/0000-0003-3325-4931; Marsano, René Massimiliano/0000-0001-8450-1010; Caizzi, Ruggiero/0000-0002-4360-2808; Viggiano, Luigi/0000-0002-2067-5166; Tarasco, Eustachio/0000-0001-6310-186X	Fondazione Cassa di Risparmio di Puglia	Fondazione Cassa di Risparmio di Puglia	This work was funded by the Fondazione Cassa di Risparmio di Puglia (granted to RMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TEFAM DATABASE; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Bensaadi-Merchermek N, 1997, GENETICA, V100, P141, DOI 10.1023/A:1018321310567; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Biedler JK, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-112; Byarugaba W, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-14; Conte C, 2002, MOL CELL BIOL, V22, P1767, DOI 10.1128/MCB.22.6.1767-1777.2002; Coy MR, 2007, INSECT MOL BIOL, V16, P411, DOI 10.1111/j.1365-2583.2007.00735.x; Darboux I, 2007, CELL MICROBIOL, V9, P2022, DOI 10.1111/j.1462-5822.2007.00934.x; Deragon J. M., 2008, V4, P69, DOI 10.1159/000126007; Diao YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016743; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; Feschotte C, 2001, MOL BIOL EVOL, V18, P74, DOI 10.1093/oxfordjournals.molbev.a003721; Feschotte C, 2002, MOBILE DNA-UK, P1147, DOI DOI 10.1128/9781555817954.CH50; Finnegan DJ, 1992, CURR OPIN GENET DEV, V2, P861, DOI 10.1016/S0959-437X(05)80108-X; Ganko EW, 2001, GENOME RES, V11, P2066, DOI 10.1101/gr.196201; Gdula DA, 1996, P NATL ACAD SCI USA, V93, P9378, DOI 10.1073/pnas.93.18.9378; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; INOUYE S, 1986, NUCLEIC ACIDS RES, V14, P3031, DOI 10.1093/nar/14.7.3031; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kalendar R, 2004, GENETICS, V166, P1437, DOI 10.1534/genetics.166.3.1437; Kalendar R, 2011, HEREDITY, V106, P520, DOI 10.1038/hdy.2010.93; Kapitonov Vladimir V, 2008, Nat Rev Genet, V9, P411, DOI 10.1038/nrg2165-c1; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kholod NS, 1999, BIOCHEMISTRY-MOSCOW+, V64, P298; Kidwell MG, 2002, MOBILE DNA, P59; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; LOEHR JS, 1968, P NATL ACAD SCI USA, V61, P1115, DOI 10.1073/pnas.61.3.1115; Malik HS, 2000, GENOME RES, V10, P1307, DOI 10.1101/gr.145000; Malik HS, 1999, J VIROL, V73, P5186, DOI 10.1128/JVI.73.6.5186-5190.1999; Marsano RM, 2005, GENE, V357, P115, DOI [10.1016/j.gene.2005.06.010, 10.1016/j.gene.2005.06.005]; McCarthy EM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r14; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; Medstrand P, 2005, CYTOGENET GENOME RES, V110, P342, DOI 10.1159/000084966; MICHAILLE JJ, 1990, NUCLEIC ACIDS RES, V18, P674, DOI 10.1093/nar/18.3.674; Minervini CF, 2007, GENE, V393, P1, DOI 10.1016/j.gene.2006.12.028; Minervini CF, 2010, MOL GENET GENOMICS, V283, P503, DOI 10.1007/s00438-010-0529-4; Minervini CF, 2009, GENE, V440, P42, DOI 10.1016/j.gene.2009.03.021; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Pantazidis A, 1999, MOL BIOL EVOL, V16, P909, DOI 10.1093/oxfordjournals.molbev.a026180; RAO PN, 1990, HEREDITAS, V113, P139, DOI 10.1111/j.1601-5223.1990.tb00077.x; Sabot F, 2006, HEREDITY, V97, P381, DOI 10.1038/sj.hdy.6800903; Sanz-Alferez S, 2003, GENOME, V46, P745, DOI [10.1139/g03-061, 10.1139/G03-061]; Smit A, 1996, REPEATMASKER OPEN 30; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; SPANA C, 1988, GENE DEV, V2, P1414, DOI 10.1101/gad.2.11.1414; Syomin BV, 2002, MOL GENET GENOMICS, V267, P418, DOI 10.1007/s00438-002-0678-1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tubio JMC, 2005, MOL BIOL EVOL, V22, P29, DOI 10.1093/molbev/msh251; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Witte CP, 2001, P NATL ACAD SCI USA, V98, P13778, DOI 10.1073/pnas.241341898	54	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e30770	10.1371/journal.pone.0030770	http://dx.doi.org/10.1371/journal.pone.0030770			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22383973	Green Submitted, gold, Green Published			2022-12-27	WOS:000302916800007
J	Planer, D; Leibowitz, D; Hadid, A; Erlich, T; Sharon, N; Paltiel, O; Jacoby, E; Lotan, C; Moran, DS				Planer, David; Leibowitz, David; Hadid, Amir; Erlich, Tomer; Sharon, Nir; Paltiel, Ora; Jacoby, Elad; Lotan, Chaim; Moran, Daniel S.			The Effect of Prolonged Physical Activity Performed during Extreme Caloric Deprivation on Cardiac Function	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; OF-ECHOCARDIOGRAPHYS GUIDELINES; TROPONIN-T RELEASE; DIASTOLIC FUNCTION; VENTRICULAR DYSFUNCTION; STANDARDS COMMITTEE; ENDURANCE EXERCISE; STRENUOUS EXERCISE; MARATHON; RESTRICTION	Background: Endurance exercise may induce transient cardiac dysfunction. Data regarding the effect of caloric restriction on cardiac function is limited. We studied the effect of physical activity performed during extreme caloric deprivation on cardiac function. Methods: Thirty-nine healthy male soldiers (mean age 20+/-0.3 years) were studied during a field training exercise lasted 85-103 hours, with negligible food intake and unlimited water supply. Anthropometric measurements, echocardiographic examinations and blood and urine tests were performed before and after the training exercise. Results: Baseline VO2 max was 59+/-5.5 ml/kg/min. Participants' mean weight reduction was 5.7+/-0.9 kg. There was an increase in plasma urea (11.6+/-2.6 to 15.8+/-3.8 mmol/L, p<0.001) and urine osmolarity (692+/-212 to 1094+/-140 mmol/kg, p<0.001) and a decrease in sodium levels (140.5+/-1.0 to 136.6+/-2.1 mmol/L, p<0.001) at the end of the study. Significant alterations in diastolic parameters included a decrease in mitral E wave (93.6 to 83.5 cm/s; p = 0.003), without change in E/A and E/E' ratios, and an increase in iso-volumic relaxation time (73.9 to 82.9 ms, p = 0.006). There was no change in left or right ventricular systolic function, or pulmonary arterial pressure. Brain natriuretic peptide (BNP) levels were significantly reduced post-training (median 9 to 0 pg/ml, p<0.001). There was no elevation in Troponin T or CRP levels. On multivariate analysis, BNP reduction correlated with sodium levels and weight reduction (R = 0.8, p<0.001). Conclusions: Exposure to prolonged physical activity performed under caloric deprivation resulted in minor alterations of left ventricular diastolic function. BNP levels were significantly reduced due to negative water and sodium balance.	[Planer, David; Leibowitz, David; Lotan, Chaim] Hadassah Hebrew Univ Med Ctr, Inst Heart, Jerusalem, Israel; [Hadid, Amir; Erlich, Tomer; Jacoby, Elad; Moran, Daniel S.] Chaim Sheba Med Ctr, Heller Inst Med Res, IL-52621 Tel Hashomer, Israel; [Sharon, Nir; Paltiel, Ora] Hadassah Hebrew Univ Med Ctr, Brown Sch Publ Hlth, Jerusalem, Israel; [Planer, David] Columbia Univ, Dept Cardiol, Med Ctr, New York, NY USA	Hebrew University of Jerusalem; Chaim Sheba Medical Center; Hebrew University of Jerusalem; Columbia University	Planer, D (corresponding author), Hadassah Hebrew Univ Med Ctr, Inst Heart, Jerusalem, Israel.	davidplaner@gmail.com		Jacoby, Elad/0000-0003-1411-8942; ERLICH, TOMER/0000-0003-4151-0018				Alshaher M, 2007, ECHOCARDIOGR-J CARD, V24, P237, DOI 10.1111/j.1540-8175.2007.00380.x; Daneshrad Z, 2000, MOL CELL BIOCHEM, V210, P159, DOI 10.1023/A:1007137909171; DavilaRoman VG, 1997, J AM COLL CARDIOL, V30, P468, DOI 10.1016/S0735-1097(97)00179-4; Epstein Y, 2006, IND HEALTH, V44, P388, DOI 10.2486/indhealth.44.388; Fu F, 2009, INT J SPORTS MED, V30, P168, DOI 10.1055/s-0028-1104586; Gottdiener JS, 2004, J AM SOC ECHOCARDIOG, V17, P1086, DOI 10.1016/j.echo.2004.07.013; Hammer S, 2008, J CLIN ENDOCR METAB, V93, P497, DOI 10.1210/jc.2007-2015; Hart E, 2007, J AM SOC ECHOCARDIOG, V20, P1393, DOI 10.1016/j.echo.2007.04.032; Konig D, 2003, MED SCI SPORT EXER, V35, P1679, DOI 10.1249/01.MSS.0000089248.37173.E7; La Gerche A, 2008, HEART, V94, P860, DOI 10.1136/hrt.2006.101063; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lucia A, 1999, MED SCI SPORT EXER, V31, P1414; Meluzin J, 2001, EUR HEART J, V22, P340, DOI 10.1053/euhj.2000.2296; Middleton N, 2008, J AM COLL CARDIOL, V52, P1813, DOI 10.1016/j.jacc.2008.03.069; Middleton N, 2007, INT J CARDIOL, V122, P87, DOI 10.1016/j.ijcard.2006.11.042; Middleton N, 2007, MED SCI SPORT EXER, V39, P83, DOI 10.1249/01.mss.0000239395.93578.60; Neilan TG, 2006, CIRCULATION, V114, P2325, DOI 10.1161/CIRCULATIONAHA.106.647461; Neumayr G, 2005, AM J CARDIOL, V96, P732, DOI 10.1016/j.amjcard.2005.04.054; Ohba H, 2001, AM HEART J, V141, P751, DOI 10.1067/mhj.2001.114371; Scharhag J, 2005, AM HEART J, V150, P1128, DOI 10.1016/j.ahj.2005.01.051; Scharhag J, 2008, MED SCI SPORT EXER, V40, P1408, DOI 10.1249/MSS.0b013e318172cf22; Scharhag J, 2008, CLIN RES CARDIOL, V97, P62, DOI 10.1007/s00392-008-0601-9; Shave RE, 2002, INT J SPORTS MED, V23, P489, DOI 10.1055/s-2002-35069; Shave R, 2007, MED SCI SPORT EXER, V39, P2099, DOI 10.1249/mss.0b013e318153ff78; SHPILBERG O, 1990, EUR J APPL PHYSIOL O, V60, P305, DOI 10.1007/BF00379401; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Suzuki J, 2002, AM J PHYSIOL-ENDOC M, V283, pE94, DOI 10.1152/ajpendo.00017.2002; Tharion WJ, 2005, APPETITE, V44, P47, DOI 10.1016/j.appet.2003.11.010; van der Meer RW, 2007, DIABETES, V56, P2849, DOI 10.2337/db07-0768; Vidotto C, 2005, INT J SPORTS MED, V26, P645, DOI 10.1055/s-2004-830491	30	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31266	10.1371/journal.pone.0031266	http://dx.doi.org/10.1371/journal.pone.0031266			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384007	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916800011
J	Timpka, T; Eriksson, O; Spreco, A; Gursky, EA; Stromgren, M; Holm, E; Ekberg, J; Dahlstrom, O; Valter, L; Eriksson, H				Timpka, Toomas; Eriksson, Olle; Spreco, Armin; Gursky, Elin A.; Stromgren, Magnus; Holm, Einar; Ekberg, Joakim; Dahlstrom, Orjan; Valter, Lars; Eriksson, Henrik			Age as a Determinant for Dissemination of Seasonal and Pandemic Influenza: An Open Cohort Study of Influenza Outbreaks in Ostergotland County, Sweden	PLOS ONE			English	Article							SPREAD; VACCINATION; SURVEILLANCE; TRANSMISSION; POPULATION; CHILDREN; CLOSURE	An understanding of the occurrence and comparative timing of influenza infections in different age groups is important for developing community response and disease control measures. This study uses data from a Scandinavian county (population 427.000) to investigate whether age was a determinant for being diagnosed with influenza 2005-2010 and to examine if age was associated with case timing during outbreaks. Aggregated demographic data were collected from Statistics Sweden, while influenza case data were collected from a county-wide electronic health record system. A logistic regression analysis was used to explore whether case risk was associated with age and outbreak. An analysis of variance was used to explore whether day for diagnosis was also associated to age and outbreak. The clinical case data were validated against case data from microbiological laboratories during one control year. The proportion of cases from the age groups 10-19 (p<0.001) and 20-29 years old (p<0.01) were found to be larger during the A pH1N1 outbreak in 2009 than during the seasonal outbreaks. An interaction between age and outbreak was observed (p<0.001) indicating a difference in age effects between circulating virus types; this interaction persisted for seasonal outbreaks only (p<0.001). The outbreaks also differed regarding when the age groups received their diagnosis (p<0.001). A post-hoc analysis showed a tendency for the young age groups, in particular the group 10-19 year olds, led outbreaks with influenza type A H1 circulating, while A H3N2 outbreaks displayed little variations in timing. The validation analysis showed a strong correlation (r = 0.625; p<0.001) between the recorded numbers of clinically and microbiologically defined influenza cases. Our findings demonstrate the complexity of age effects underlying the emergence of local influenza outbreaks. Disentangling these effects on the causal pathways will require an integrated information infrastructure for data collection and repeated studies of well-defined communities.	[Timpka, Toomas; Ekberg, Joakim; Dahlstrom, Orjan; Valter, Lars] Ostergotland Cty Council, Dept Publ Hlth, Linkoping, Sweden; [Timpka, Toomas; Spreco, Armin; Ekberg, Joakim; Dahlstrom, Orjan; Valter, Lars] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Timpka, Toomas; Eriksson, Olle; Spreco, Armin; Ekberg, Joakim; Valter, Lars; Eriksson, Henrik] Linkoping Univ, Dept Comp & Informat Sci, S-58183 Linkoping, Sweden; [Gursky, Elin A.] ANSER Analyt Serv Inc, Natl Strategies Support Directorate, Arlington, VA USA; [Stromgren, Magnus; Holm, Einar] Umea Univ, Dept Social & Econ Geog, Umea, Sweden; [Dahlstrom, Orjan] Linkoping Univ, Dept Behav Sci, Swedish Inst Disabil Res, Linnaeus Ctr HEAD, Linkoping, Sweden	City Council Ostergotland; Linkoping University; Linkoping University; Umea University; Linkoping University	Timpka, T (corresponding author), Ostergotland Cty Council, Dept Publ Hlth, Linkoping, Sweden.	toomas.timpka@liu.se	Timpka, Toomas/E-8065-2018	Dahlstrom, Orjan/0000-0002-3955-0443; Spreco, Armin/0000-0003-0985-8209	Swedish Civil Contingencies Agency [2010-2788]; Swedish Science Council [2008-5252]	Swedish Civil Contingencies Agency; Swedish Science Council	This study was supported by grants from the Swedish Civil Contingencies Agency (2010-2788) and the Swedish Science Council (2008-5252). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguelin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017074; Basta Nicole E, 2009, Am J Epidemiol, V170, P679, DOI 10.1093/aje/kwp237; Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Charland KM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017207, 10.1371/journal.pone.0024047]; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cowling BJ, 2008, EMERG INFECT DIS, V14, P1660, DOI 10.3201/eid1410.080646; FLEMING DM, 2008, EPIDEMIOL INFECT, V136, P866, DOI DOI 10.1017/S0950268807009910; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; GLEZEN WP, 1991, AM J EPIDEMIOL, V133, P296, DOI 10.1093/oxfordjournals.aje.a115874; Halder N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022087; Karageorgopoulos DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021690; Miller WC, 2010, EPIDEMIOLOGY, V21, P593, DOI 10.1097/EDE.0b013e3181e942e2; Milne GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004005; MONTO AS, 1969, B WORLD HEALTH ORGAN, V41, P537; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Opatowski L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002225; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Schanzer D, 2011, AM J EPIDEMIOL, V174, P109, DOI 10.1093/aje/kwr037; Schanzer DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021471; Sebastian R, 2008, VACCINE, V26, P1397, DOI 10.1016/j.vaccine.2007.11.090; Timpka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017941; Timpka Toomas, 2010, AMIA Annu Symp Proc, V2010, P792; Timpka T, 2009, B WORLD HEALTH ORGAN, V87, P305, DOI 10.2471/BLT.07.050203; Tu WW, 2010, J VIROL, V84, P6527, DOI 10.1128/JVI.00519-10; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Wu JT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001103	30	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31746	10.1371/journal.pone.0031746	http://dx.doi.org/10.1371/journal.pone.0031746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384066	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100033
J	Li, XM; Liao, WJ; Wolfe, LM; Zhang, DY				Li, Xiao-Meng; Liao, Wan-Jin; Wolfe, Lorne M.; Zhang, Da-Yong			No Evolutionary Shift in the Mating System of North American Ambrosia artemisiifolia (Asteraceae) Following Its Introduction to China	PLOS ONE			English	Article							SELF-INCOMPATIBILITY; PROPAGULE PRESSURE; POLLEN LIMITATION; GENETIC-VARIATION; REPRODUCTIVE ASSURANCE; INVASIVE POPULATIONS; COMMON RAGWEED; LIFE-HISTORY; NATIVE RANGE; PLANT	The mating system plays a key role during the process of plant invasion. Contemporary evolution of uniparental reproduction (selfing or asexuality) can relieve the challenges of mate limitation in colonizing populations by providing reproductive assurance. Here we examined aspects of the genetics of colonization in Ambrosia artemisiifolia, a North American native that is invasive in China. This species has been found to possess a strong self-incompatibility system and have high outcrossing rates in North America and we examined whether there has been an evolutionary shift towards the dependence on selfing in the introduced range. Specifically, we estimated outcrossing rates in one native and five invasive populations and compared levels of genetic diversity between North America and China. Based on six microsatellite loci we found that, like the native North American population, all five Chinese populations possessed a completely outcrossing mating system. The estimates of paternity correlations were low, ranging from 0.028-0.122, which suggests that populations possessed similar to 8-36 pollen donor parents contributing to each maternal plant in the invasive populations. High levels of genetic diversity for both native and invasive populations were found with the unbiased estimate of gene diversity ranging from 0.262-0.289 for both geographic ranges based on AFLP markers. Our results demonstrate that there has been no evolutionary shift from outcrossing to selfing during A. artemisiifolia's invasion of China. Furthermore, high levels of genetic variation in North America and China indicate that there has been no erosion of genetic variance due to a bottleneck during the introduction process. We suggest that the successful invasion of A. artemisiifolia into Asia was facilitated by repeated introductions from multiple source populations in the native range creating a diverse gene pool within Chinese populations.	[Li, Xiao-Meng; Liao, Wan-Jin; Zhang, Da-Yong] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, MOE Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China; [Wolfe, Lorne M.] Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA	Beijing Normal University; University System of Georgia; Georgia Southern University	Li, XM (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, MOE Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China.	liaowj@bnu.edu.cn	Zhang, Da-Yong/B-3078-2011	Zhang, Da-Yong/0000-0003-1056-8735	State Key Basic Research and Development Plan [2009CB119201]; National Natural Science Foundation of China [31121003]; Beijing Normal University; USA National Science Foundation [DEB 0349553]	State Key Basic Research and Development Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Normal University; USA National Science Foundation(National Science Foundation (NSF))	This study was financially supported by the State Key Basic Research and Development Plan (2009CB119201), the National Natural Science Foundation of China (31121003), and Beijing Normal University. Dr. Wolfe's research is supported by the USA National Science Foundation (DEB 0349553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsellem L, 2000, MOL ECOL, V9, P443, DOI 10.1046/j.1365-294x.2000.00876.x; Amsellem L, 2001, AM J BOT, V88, P2243, DOI 10.2307/3558386; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; BAKER HG, 1967, EVOLUTION, V21, P853, DOI 10.1111/j.1558-5646.1967.tb03440.x; Barrett S. C. H., 1990, Plant population genetics, breeding, and genetic resources., P254; Barrett S. C. H., 1992, Applied population biology., P91; Barrett SCH, 1997, J HERED, V88, P277, DOI 10.1093/oxfordjournals.jhered.a023105; Barrett Spencer C. H., 1993, Plant Species Biology, V8, P141, DOI 10.1111/j.1442-1984.1993.tb00065.x; Barrett SCH, 2008, MOL ECOL, V17, P373, DOI 10.1111/j.1365-294X.2007.03503.x; Barrett SCH, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P195; BASSETT IJ, 1975, CAN J PLANT SCI, V55, P463, DOI 10.4141/cjps75-072; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Brown AHD, 1981, EVOLUTIONARY CHANGES, P351; BURD M, 1994, BOT REV, V60, P83, DOI 10.1007/BF02856594; Busch JW, 2008, TRENDS PLANT SCI, V13, P128, DOI 10.1016/j.tplants.2008.01.002; Cano L, 2008, AUST J BOT, V56, P539, DOI 10.1071/BT07100; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Cheptou PO, 2004, EVOLUTION, V58, P2613; Chun YJ, 2010, NEW PHYTOL, V185, P1100, DOI 10.1111/j.1469-8137.2009.03129.x; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Colautti RI, 2010, INT J PLANT SCI, V171, P158, DOI 10.1086/649023; Davis HG, 2005, EVOL ECOL, V19, P255, DOI 10.1007/s10682-005-0912-5; Davis HG, 2004, P NATL ACAD SCI USA, V101, P13804, DOI 10.1073/pnas.0405230101; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; DeWalt SJ, 2004, AM J BOT, V91, P1155, DOI 10.3732/ajb.91.8.1155; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Eckert C. G., 2006, ECOLOGY EVOLUTION FL, P183; Eckert CG, 1996, EVOLUTION, V50, P1512, DOI [10.1111/j.1558-5646.1996.tb03924.x, 10.2307/2410888]; ECKERT CG, 1994, HEREDITY, V72, P396, DOI 10.1038/hdy.1994.56; Estoup A, 2001, GENETICS, V159, P1671; Foxcroft LC, 2011, PERSPECT PLANT ECOL, V13, P89, DOI 10.1016/j.ppees.2011.03.004; Friedman J, 2008, ANN BOT-LONDON, V101, P1303, DOI 10.1093/aob/mcn039; Gaudeul M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017658; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; Groom MJ, 1998, AM NAT, V151, P487, DOI 10.1086/286135; Lafuma L, 2007, OIKOS, V116, P201, DOI 10.1111/j.0030-1299.2007.15220.x; Lande R., 2003, OXFORD SERIES ECOLOG; Larson BMH, 2000, BIOL J LINN SOC, V69, P503, DOI 10.1111/j.1095-8312.2000.tb01221.x; Leung B, 2004, ECOLOGY, V85, P1651, DOI 10.1890/02-0571; Lockwood JL, 2009, DIVERS DISTRIB, V15, P904, DOI 10.1111/j.1472-4642.2009.00594.x; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Morgan MT, 2005, AM NAT, V166, P169, DOI 10.1086/431317; Novak SJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P201; Olsson K, 2002, J EVOLUTION BIOL, V15, P983, DOI 10.1046/j.1420-9101.2002.00457.x; Pannell JR, 1998, EVOLUTION, V52, P657, DOI [10.2307/2411261, 10.1111/j.1558-5646.1998.tb03691.x]; Petanidou T, 2012, PERSPECTIVE IN PRESS; PRICE SC, 1981, OECOLOGIA, V49, P283, DOI 10.1007/BF00349202; Rambuda TD, 2004, DIVERS DISTRIB, V10, P409, DOI 10.1111/j.1366-9516.2004.00100.x; REINARTZ JA, 1984, J ECOL, V72, P897, DOI 10.2307/2259539; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Taylor CM, 2004, ECOLOGY, V85, P3254, DOI 10.1890/03-0640; Taylor DR, 2007, EVOLUTION, V61, P334, DOI 10.1111/j.1558-5646.2007.00037.x; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wan FH, 2009, RES BIOL INVASIONS C; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	62	9	11	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31935	10.1371/journal.pone.0031935	http://dx.doi.org/10.1371/journal.pone.0031935			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384104	gold, Green Published, Green Submitted			2022-12-27	WOS:000302875500053
J	Srinivasan, V; Gertz, RE; Shewmaker, PL; Patrick, S; Chitnis, AS; O'Connell, H; Benowitz, I; Patel, P; Guh, AY; Noble-Wang, J; Turabelidze, G; Beall, B				Srinivasan, Velusamy; Gertz, Robert E., Jr.; Shewmaker, Patricia L.; Patrick, Sarah; Chitnis, Amit S.; O'Connell, Heather; Benowitz, Isaac; Patel, Priti; Guh, Alice Y.; Noble-Wang, Judith; Turabelidze, George; Beall, Bernard			Using PCR-Based Detection and Genotyping to Trace Streptococcus salivarius Meningitis Outbreak Strain to Oral Flora of Radiology Physician Assistant	PLOS ONE			English	Article							IATROGENIC MENINGITIS; SPINAL-ANESTHESIA; MYELOGRAPHY; IDENTIFICATION	We recently investigated three cases of bacterial meningitis that were reported from a midwestern radiology clinic where facemasks were not worn during spinal injection of contrast agent during myelography procedures. Using pulsed field gel electrophoresis we linked a case strain of S. salivarius to an oral specimen of a radiology physician assistant (RPA). We also used a real-time PCR assay to detect S. salivarius DNA within a culture-negative cerebrospinal fluid (CSF) specimen. Here we extend this investigation through using a nested PCR/sequencing strategy to link the culture-negative CSF specimen to the case strain. We also provide validation of the real-time PCR assay used, demonstrating that it is not solely specific for Streptococcus salivarius, but is also highly sensitive for detection of the closely related oral species Streptococcus vestibularis. Through using multilocus sequence typing and 16S rDNA sequencing we further strengthen the link between the CSF case isolate and the RPA carriage isolate. We also demonstrate that the newly characterized strains from this study are distinct from previously characterized S. salivarius strains associated with carriage and meningitis.	[Srinivasan, Velusamy; Gertz, Robert E., Jr.; Shewmaker, Patricia L.; Beall, Bernard] Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial Dis, Atlanta, GA 30333 USA; [Patrick, Sarah; Turabelidze, George] Missouri Dept Hlth & Senior Serv, Sect Epidemiol Publ Hlth Practice, Div Community & Publ Hlth, St Louis, MO USA; [Chitnis, Amit S.; O'Connell, Heather; Benowitz, Isaac; Patel, Priti; Guh, Alice Y.; Noble-Wang, Judith] Ctr Dis Control & Prevent, Surveillance Branch, Div Healthcare Qual Promot, Atlanta, GA USA; [Chitnis, Amit S.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Srinivasan, V (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial Dis, Atlanta, GA 30333 USA.	BBEALL@CDC.GOV		Moulton-Meissner, Heather/0000-0002-0728-2552	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The Centers for Disease Control and Prevention funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, GUIDELINE ISOLATION; Baer ET, 2000, CLIN INFECT DIS, V31, P519, DOI 10.1086/313991; Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3; Chapman GH, 1944, J BACTERIOL, V48, P113, DOI 10.1128/JB.48.1.113-114.1944; Chitnis AS, 2011, J AM COLL R IN PRESS; de Fijter S., 2010, Morbidity and Mortality Weekly Report, V59, P65; DEJONG J, 1992, INFECT CONT HOSP EP, V13, P74; Delorme C, 2007, J BACTERIOL, V189, P1330, DOI 10.1128/JB.01058-06; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; FRENEY J, 1992, J CLIN MICROBIOL, V30, P2657, DOI 10.1128/JCM.30.10.2657-2661.1992; GELFAND MS, 1995, CLIN INFECT DIS, V20, P582, DOI 10.1093/clinids/20.3.582; Hebl JR, 2006, REGION ANESTH PAIN M, V31, P311, DOI 10.1016/j.rapm.2006.04.004; Kazor CE, 2003, J CLIN MICROBIOL, V41, P558, DOI 10.1128/JCM.41.2.558-563.2003; Nakanishi H, 2009, FORENSIC SCI INT, V183, P20, DOI 10.1016/j.forsciint.2008.10.003; Rubin L, 2007, INFECT CONT HOSP EP, V28, P1187, DOI 10.1086/520748; SCHLESINGER JJ, 1982, ARCH NEUROL-CHICAGO, V39, P576, DOI 10.1001/archneur.1982.00510210046010; Schneeberger PM, 1996, INFECTION, V24, P29, DOI 10.1007/BF01780647; Seow WK, 2009, INT J PAEDIATR DENT, V19, P406, DOI 10.1111/j.1365-263X.2009.01003.x; Shewmaker PL, 2010, J CLIN MICROBIOL, V48, P2589, DOI 10.1128/JCM.00426-10; VERINGA E, 1995, J HOSP INFECT, V29, P316, DOI 10.1016/0195-6701(95)90283-X; Wilson W, 2011, CLIN MED RES    0804	21	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32169	10.1371/journal.pone.0032169	http://dx.doi.org/10.1371/journal.pone.0032169			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384169	gold, Green Published, Green Submitted			2022-12-27	WOS:000302875500081
J	Tripathy, AS; Das, R; Rathod, SB; Arankalle, VA				Tripathy, Anuradha S.; Das, Rumki; Rathod, Sanjay B.; Arankalle, Vidya A.			Cytokine Profiles, CTL Response and T Cell Frequencies in the Peripheral Blood of Acute Patients and Individuals Recovered from Hepatitis E Infection	PLOS ONE			English	Article							VIRAL-HEPATITIS; MONONUCLEAR-CELLS; IMMUNE-RESPONSES; VIRUS; SERUM; RNA; DNA	Background: Hepatitis E is a major public health problem in the developing countries. Pathogenesis of hepatitis E virus (HEV) infection is poorly understood. Methods: This case-control study included 124 Hepatitis E patients (46 acute and 78 recovered), 9 with prior exposure to HEV and 71 anti-HEV negative healthy controls. HEV induced CTL response by Elispot, cytokines/chemokines quantitation by Milliplex assay and peripheral CD4+ & CD8+ T cell frequencies by flow cytometry were assessed. Results: Among the patient categories, HEV specific IFN-gamma responses as recorded by Elispot were comparable. Comparisons of cytokines/chemokines revealed significantly high levels of IL-1 alpha and sIL-2R alpha during acute phase. Circulating peripheral CD4/CD8+ T-cell subsets in acute and recovered individuals were comparable compared to controls, while among patient categories CD8+ T cell subset was significantly higher in recovered individuals. Conclusions: Our findings suggest that IL-1 alpha and sIL-2R alpha play a role in the pathogenesis of acute Hepatitis E infection. Lack of robust HEV ORF2-specific CTL response in the peripheral blood of HEV infected patients during the acute and recovered phases of the disease may be associated with involvement of innate immune cells/localization of the immune events at the site of infection.	[Tripathy, Anuradha S.; Das, Rumki; Rathod, Sanjay B.; Arankalle, Vidya A.] Natl Inst Virol, Hepatitis Grp, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Tripathy, AS (corresponding author), Natl Inst Virol, Hepatitis Grp, Pune, Maharashtra, India.	anuradhastripathy@hotmail.com	Rathod, Sanjay/AAT-2556-2021; Rathod, Sanjay/AAQ-6512-2020	Rathod, Sanjay/0000-0003-1755-8222; Arankalle, Vidya/0000-0002-9940-3437	Indian Council of Medical Research, New Delhi, India	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	This study was funded by the Indian Council of Medical Research, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arankalle VA, 2007, J VIRAL HEPATITIS, V14, P435, DOI 10.1111/j.1365-2893.2006.00801.x; Arankalle VA, 2009, VACCINE, V27, P1032, DOI 10.1016/j.vaccine.2008.11.097; BERTOLETTI A, 1991, P NATL ACAD SCI USA, V88, P10445, DOI 10.1073/pnas.88.23.10445; Blackard JT, 2005, J INFECT DIS, V192, P258, DOI 10.1086/430949; Chandra NS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-213; Deshmukh TM, 2007, VACCINE, V25, P4350, DOI 10.1016/j.vaccine.2007.03.040; FLEISCHER B, 1990, IMMUNOLOGY, V69, P14; Husain MM, 2011, J VIRAL HEPATITIS, V18, pE603, DOI 10.1111/j.1365-2893.2011.01489.x; Ippagunta SK, 2011, J VIRAL HEPATITIS, V18, P668, DOI 10.1111/j.1365-2893.2010.01351.x; Jaiswal SPB, 2001, INT J GYNECOL OBSTET, V72, P103, DOI 10.1016/S0020-7292(00)00264-2; Jilani N, 2007, J GASTROEN HEPATOL, V22, P676, DOI 10.1111/j.1440-1746.2007.04913.x; KHUROO MS, 1993, LANCET, V341, P1355; KOZIEL MJ, 1993, J VIROL, V67, P7522, DOI 10.1128/JVI.67.12.7522-7532.1993; Laskus T, 1999, J VIROL, V73, P1235, DOI 10.1128/JVI.73.2.1235-1238.1999; Navaneethan U, 2008, LIVER INT, V28, P1190, DOI 10.1111/j.1478-3231.2008.01840.x; Prabhu SB, 2011, J VIRAL HEPATITIS, V18, P587, DOI 10.1111/j.1365-2893.2010.01338.x; Saravanabalaji S, 2009, INTERVIROLOGY, V52, P78, DOI 10.1159/000214862; Schofield DJ, 2000, J VIROL, V74, P5548, DOI 10.1128/JVI.74.12.5548-5555.2000; Srivastava R, 2008, J VIRAL HEPATITIS, V15, P910, DOI 10.1111/j.1365-2893.2008.01036.x; Srivastava R, 2011, J GASTROEN HEPATOL, V26, P306, DOI 10.1111/j.1440-1746.2010.06356.x; TALIANI G, 1995, J MED VIROL, V47, P16, DOI 10.1002/jmv.1890470105; Taneja S, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-39; TORRE D, 1994, CLIN INFECT DIS, V18, P194, DOI 10.1093/clinids/18.2.194; TrehanPati N, 2011, J CLIN IMMUNOL, V31, P498, DOI 10.1007/s10875-010-9506-2; Tripathy AS, 2012, EUR J CLIN MICROBIOL, V31, P179, DOI 10.1007/s10096-011-1291-1; Tripathy AS, 2011, J VIRAL HEPATITIS, V18, pE415, DOI 10.1111/j.1365-2893.2011.01457.x; Wu T, 2008, INTERVIROLOGY, V51, P322, DOI 10.1159/000172627; YAMAGUCHI S, 1988, HEPATO-GASTROENTEROL, V35, P245	28	29	30	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31822	10.1371/journal.pone.0031822	http://dx.doi.org/10.1371/journal.pone.0031822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384080	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500045
J	Zhang, WQ; Ji, YL; Meng, J; Wu, XC; Xu, HY				Zhang, Weiqi; Ji, Yinglu; Meng, Jie; Wu, Xiaochun; Xu, Haiyan			Probing the Behaviors of Gold Nanorods in Metastatic Breast Cancer Cells Based on UV-vis-NIR Absorption Spectroscopy	PLOS ONE			English	Article							SURFACE-CHEMISTRY; CELLULAR UPTAKE; PHOTOTHERMAL THERAPY; NANOPARTICLES; MECHANISMS; TOXICITY; DELIVERY	In this work, behaviors of positively-charged AuNRs in a highly metastatic tumor cell line MDA-MB-231 are examined based on UV-vis-NIR absorption spectroscopy in combination with inductively coupled plasma mass spectrometry (ICP-MS), transmission electron microscopy (TEM) and dark-field microscopic observation. It is found that characteristic surface plasmon resonance (SPR) peaks of AuNRs can be detected using spectroscopic method within living cells that have taken up AuNRs. The peak area of transverse SPR band is shown to be proportionally related to the amount of AuNRs in the cells determined with ICP-MS, which suggests a facile and real time quantification method for AuNRs in living cells. The shape of longitudinal SPR band in UV-vis-NIR spectrum reflects the aggregation state of AuNRs in the cells during the incubation period, which is proved by TEM and microscopic observations. Experimental results reveal that AuNRs are internalized by the cells rapidly; the accumulation, distribution and aggregation of AuNRs in the cells compartments are time and dose dependent. The established spectroscopic analysis method can not only monitor the behaviors of AuNRs in living cells but may also be helpful in choosing the optimum laser stimulation wavelength for anti-tumor thermotherapy.	[Zhang, Weiqi; Meng, Jie; Xu, Haiyan] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Zhang, Weiqi; Meng, Jie; Xu, Haiyan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ji, Yinglu; Wu, Xiaochun] Natl Ctr Nanosci & Technol, CAS Key Lab Standardizat & Measurement Nanotechno, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China	Zhang, WQ (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China.	wuxc@nanoctr.cn; xuhy@pumc.edu.cn	Zhang, Weiqi/J-3974-2019	Zhang, Weiqi/0000-0003-4315-6809	National Key Program of China (973 program) [2011CB933504, 2010CB932802]; Natural Science Foundation of China (NSFC) [81000665]	National Key Program of China (973 program)(National Basic Research Program of China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research was supported by the National Key Program of China (973 program 2011CB933504 and 2010CB932802), and Natural Science Foundation of China (NSFC 81000665). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese A, 2011, ACS NANO, V5, P5478, DOI 10.1021/nn2007496; Alkilany AM, 2010, LANGMUIR, V26, P9328, DOI 10.1021/la100253k; Alkilany AM, 2009, SMALL, V5, P701, DOI 10.1002/smll.200801546; Alkilany AM, 2011, ADV DRUG DELIV REV, DOI [10.1016/j.addr.2011.03005, DOI 10.1016/J.ADDR.2011.03005]; Bachmeier B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020550; Bareford LA, 2007, ADV DRUG DELIVER REV, V59, P748, DOI 10.1016/j.addr.2007.06.008; Bartneck M, 2010, ACS NANO, V4, P3073, DOI 10.1021/nn100262h; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Bonoiu AC, 2009, P NATL ACAD SCI USA, V106, P5546, DOI 10.1073/pnas.0901715106; Bright NA, 1997, J CELL SCI, V110, P2027; Casals E, 2010, ACS NANO, V4, P3623, DOI 10.1021/nn901372t; Chen KM, 2011, BIOMACROMOLECULES, V12, P2552, DOI 10.1021/bm200374e; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Cho EC, 2011, NAT NANOTECHNOL, V6, P385, DOI [10.1038/NNANO.2011.58, 10.1038/nnano.2011.58]; Cho EC, 2010, ANGEW CHEM INT EDIT, V49, P1976, DOI 10.1002/anie.200906584; Errington RJ, 2010, CELL CYCLE, V9, P121, DOI 10.4161/cc.9.1.10246; Feng LL, 2008, CHEM-EUR J, V14, P9764, DOI 10.1002/chem.200800544; Grabinski C, 2011, ACS NANO, V5, P2870, DOI 10.1021/nn103476x; Hauck TS, 2008, SMALL, V4, P153, DOI 10.1002/smll.200700217; Huang HC, 2009, ACS NANO, V3, P2941, DOI 10.1021/nn900947a; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Huang XH, 2009, ADV MATER, V21, P4880, DOI 10.1002/adma.200802789; Huff TB, 2007, LANGMUIR, V23, P1596, DOI 10.1021/la062642r; Jain PK, 2006, J PHYS CHEM B, V110, P18243, DOI 10.1021/jp063879z; JORDAN GW, 1978, ANTIMICROB AGENTS CH, V13, P199, DOI 10.1128/AAC.13.2.199; Levy R, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.4889; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Monopoli MP, 2011, J AM CHEM SOC, V133, P2525, DOI 10.1021/ja107583h; Murphy CJ, 2008, ACCOUNTS CHEM RES, V41, P1721, DOI 10.1021/ar800035u; Nakayama S, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2231; Orendorff CJ, 2006, J PHYS CHEM B, V110, P3990, DOI 10.1021/jp0570972; Oyelere AK, 2007, BIOCONJUGATE CHEM, V18, P1490, DOI 10.1021/bc070132i; Pan B, 2012, INT J CANCER, V131, P70, DOI 10.1002/ijc.26341; Parab HJ, 2009, J PHYS CHEM C, V113, P7574, DOI 10.1021/jp9000169; Qiu Y, 2010, BIOMATERIALS, V31, P7606, DOI 10.1016/j.biomaterials.2010.06.051; Rayavarapu RG, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/14/145101; Russell MRG, 2006, CURR OPIN CELL BIOL, V18, P422, DOI 10.1016/j.ceb.2006.06.002; Sangiuolo Federica, 2002, BMC Med Genet, V3, P8, DOI 10.1186/1471-2350-3-8; Scheffer A, 2008, ANAL BIOANAL CHEM, V390, P249, DOI 10.1007/s00216-007-1576-5; Tong L, 2007, ADV MATER, V19, P3136, DOI 10.1002/adma.200701974; Tong L, 2009, PHOTOCHEM PHOTOBIOL, V85, P21, DOI 10.1111/j.1751-1097.2008.00507.x; Ungureanu C, 2011, NANO LETT, V11, P1887, DOI 10.1021/nl103884b; Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v; Wang LM, 2011, NANO LETT, V11, P772, DOI 10.1021/nl103992v; Wilson CG, 2009, J MATER CHEM, V19, P6332, DOI 10.1039/b902760b; Yi DK, 2010, BIOCONJUGATE CHEM, V21, P2173, DOI 10.1021/bc100308p; Zhang LW, 2009, TOXICOL SCI, V110, P138, DOI 10.1093/toxsci/kfp087; Zhang WQ, 2011, NANOSCALE, V3, P3923, DOI 10.1039/c1nr10573f; Zhou Y, 2010, J MICROSC-OXFORD, V237, P200, DOI 10.1111/j.1365-2818.2009.03324.x	49	22	23	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31957	10.1371/journal.pone.0031957	http://dx.doi.org/10.1371/journal.pone.0031957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384113	Green Submitted, gold, Green Published			2022-12-27	WOS:000302875500058
J	Zhang, XF; Ye, L; Hu, J; Tang, W; Liu, RX; Yang, ML; Hong, J; Wang, WQ; Ning, G; Gu, WQ				Zhang, Xiaofang; Ye, Lei; Hu, Jiong; Tang, Wei; Liu, Ruixin; Yang, Minglan; Hong, Jie; Wang, Weiqing; Ning, Guang; Gu, Weiqiong			Acute Response of Peripheral Blood Cell to Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetic Patient	PLOS ONE			English	Article							GENE-EXPRESSION; GRANZYME-A; PROTEIN; TOLERANCE; ALPHA	Objective: Autologous nonmyeloablative hematopoietic stem cell transplantation (AHST) was the first therapeutic approach that can improve beta cell function in type 1 diabetic (T1D) patients. This study was designed to investigate the potential mechanisms involved. Design and methods: We applied AHST to nine T1D patients diagnosed within six months and analyzed the acute responses in peripheral blood for lymphocyte subpopulation as well as for genomic expression profiling at the six-month follow-up. Results: We found six patients obtained insulin free (IF group) and three remained insulin dependent (ID group); C-peptide production was significantly higher in IF group compared to ID group. The acute responses in lymphocytes at six-month follow-up include declined CD3(+)CD4(+), CD3(+)CD8(+) T cell population and recovered B cell, NK cell population in both groups but with no significant differences between the two groups; most immune-related genes and pathways were up-regulated in peripheral blood mononuclear cell (PBMC) of both groups while none of transcription factors for immune regulatory component were significantly changed; the IF group demonstrated more AHST-modified genetic events than the ID group and distinct pattern of top pathways, co-expression network as well as 'hub' genes (eg, TCF7 and GZMA) were associated with each group. Conclusions: AHST could improve the islet function in newly diagnosed T1D patients and elimination of the islet specific autoreactive T cells might be one of the mechanisms involved; T1D patients responded differently to AHST possibly due to the distinct transcriptional events occurring in PBMC.	[Zhang, Xiaofang; Ye, Lei; Liu, Ruixin; Yang, Minglan; Hong, Jie; Wang, Weiqing; Ning, Guang; Gu, Weiqiong] Shanghai Jiao Tong Univ, Ruijin Hosp,Shanghai Key Lab Endocrine Tumors, Sch Med,Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis,Shanghai E In, Shanghai 200030, Peoples R China; [Ning, Guang] Shanghai Jiao Tong Univ, Chinese Acad Sci, Lab Endocrine & Metab Dis, Inst Hlth Sci,Shanghai Inst Biol Sci,Sch Med, Shanghai 200030, Peoples R China; [Hu, Jiong; Tang, Wei] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Hematol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, XF (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp,Shanghai Key Lab Endocrine Tumors, Sch Med,Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis,Shanghai E In, Shanghai 200030, Peoples R China.	weiqionggu@hotmail.com			National Key Technologies Research and Development Program [2008ZX09312-0191200]; Chinese National Natural Science Foundation [30725037]; Key Project of Shanghai Science and Technology [09DZ1950200]	National Key Technologies Research and Development Program(National Key Technology R&D Program); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Key Project of Shanghai Science and Technology	This study was supported by the grants from the National Key Technologies Research and Development Program (2008ZX09312-0191200), the Chinese National Natural Science Foundation (30725037) and the Key Project of Shanghai Science and Technology (09DZ1950200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander T, 2009, BLOOD, V113, P214, DOI 10.1182/blood-2008-07-168286; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS42; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Beard ME, 2002, DIABETES CARE, V25, P799, DOI 10.2337/diacare.25.4.799; Chatenoud L, 2003, NAT REV IMMUNOL, V3, P123, DOI 10.1038/nri1000; Couri CEB, 2009, JAMA-J AM MED ASSOC, V301, P1573, DOI 10.1001/jama.2009.470; de Kleer I, 2006, BLOOD, V107, P1696, DOI 10.1182/blood-2005-07-2800; Erlich HA, 2009, GENES IMMUN, V10, pS54, DOI 10.1038/gene.2009.92; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; HELD W, 1990, P NATL ACAD SCI USA, V87, P2239, DOI 10.1073/pnas.87.6.2239; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Marmont AM, 1997, LUPUS, V6, P545, DOI 10.1177/096120339700600613; Martinvalet D, 2008, CELL, V133, P681, DOI 10.1016/j.cell.2008.03.032; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Muraro PA, 2005, J EXP MED, V201, P805, DOI 10.1084/jem.20041679; Notkins AL, 2001, J CLIN INVEST, V108, P1247, DOI 10.1172/JCI200114257; Reynier F, 2010, GENES IMMUN, V11, P269, DOI 10.1038/gene.2009.112; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sosenko JM, 2004, DIABETES, V53, pA425; Suk K, 2001, J IMMUNOL, V166, P4481, DOI 10.4049/jimmunol.166.7.4481; Tsukamoto H, 2011, RHEUMATOLOGY, V50, P944, DOI 10.1093/rheumatology/keq414; Voltarelli JC, 2007, JAMA-J AM MED ASSOC, V297, P1568, DOI 10.1001/jama.297.14.1568; Voltarelli JC, 2008, ANN NY ACAD SCI, V1150, P220, DOI 10.1196/annals.1447.048; Wen YT, 2008, BIOCHEM BIOPH RES CO, V374, P282, DOI 10.1016/j.bbrc.2008.07.016; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	29	5	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31887	10.1371/journal.pone.0031887	http://dx.doi.org/10.1371/journal.pone.0031887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384093	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500050
J	Becker, EA; Petruno, S; Marler, CA				Becker, Elizabeth A.; Petruno, Sarah; Marler, Catherine A.			A Comparison of Scent Marking between a Monogamous and Promiscuous Species of Peromyscus: Pair Bonded Males Do Not Advertise to Novel Females	PLOS ONE			English	Article							VOLES MICROTUS-PENNSYLVANICUS; MEADOW VOLES; COMPETITIVE ABILITY; PATERNAL BEHAVIOR; SOCIAL EXPERIENCE; COUNTER-MARKING; CALIFORNIA MICE; PRAIRIE VOLES; OVER-MARKS; HOUSE MICE	Scent marking can provide behavioral and physiological information including territory ownership and mate advertisement. It is unknown how mating status and pair cohabitation influence marking by males from different social systems. We compared the highly territorial and monogamous California mouse (Peromyscus californicus) to the less territorial and promiscuous white-footed mouse (P. leucopus). Single and mated males of both species were assigned to one of the following arenas lined with filter paper: control (unscented arena), male scented (previously scent-marked by a male conspecific), or females present (containing females in small cages). As expected, the territorial P. californicus scent marked and overmarked an unfamiliar male conspecific's scent marks more frequently than P. leucopus. Species differences in responses to novel females were also found based on mating status. The presence of unfamiliar females failed to induce changes in scent marking in pair bonded P. californicus even though virgin males increased marking behavior. Pair bonding appears to reduce male advertisement for novel females. This is in contrast to P. leucopus males that continue to advertise regardless of mating status. Our data suggest that communication through scent-marking can diverge significantly between species based on mating system and that there are physiological mechanisms that can inhibit responsiveness of males to female cues.	[Becker, Elizabeth A.; Marler, Catherine A.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Marler, Catherine A.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Petruno, Sarah] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Diego	Becker, EA (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	eflorek@wisc.edu	Marler, Catherine/AAB-6883-2020	Marler, Catherine/0000-0002-2783-1029	National Science Foundation [IOB-0620042]; Wisconsin Alumni Research Foundation	National Science Foundation(National Science Foundation (NSF)); Wisconsin Alumni Research Foundation	This research was supported by National Science Foundation grant IOB-0620042 and the Wisconsin Alumni Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 2008, NEUROSCI BIOBEHAV R, V32, P1236, DOI 10.1016/j.neubiorev.2008.05.012; Arakawa H, 2009, BEHAV BRAIN RES, V205, P138, DOI 10.1016/j.bbr.2009.07.007; Bester-Meredith JK, 2003, ETHOLOGY, V109, P797, DOI 10.1046/j.0179-1613.2003.00917.x; Bester-Meredith JK, 2001, HORM BEHAV, V40, P51, DOI 10.1006/hbeh.2001.1666; Bester-Meredith JK, 1999, HORM BEHAV, V36, P25, DOI 10.1006/hbeh.1999.1522; Blanchard RJ, 2003, HORM BEHAV, V44, P161, DOI 10.1016/S0018-506X(03)00127-2; Brown R. E., 1985, SOCIAL ODOURS MAMMAL, V1-2; Brown RE, 1985, SOCIAL ODOURS MAMMAL, VII; CARTER CS, 1995, NEUROSCI BIOBEHAV R, V19, P303; DESJARDINS C, 1973, SCIENCE, V182, P939, DOI 10.1126/science.182.4115.939; DEWSBURY DA, 1983, AGGRESSIVE BEHAV, V9, P207, DOI 10.1002/1098-2337(1983)9:3<207::AID-AB2480090302>3.0.CO;2-8; Ferkin MH, 1999, ETHOLOGY, V105, P825, DOI 10.1046/j.1439-0310.1999.00460.x; Ferkin MH, 2004, ETHOLOGY, V110, P257, DOI 10.1111/j.1439-0310.2004.00961.x; Ferkin MH, 2001, BEHAVIOUR, V138, P1319, DOI 10.1163/156853901317367618; Ferkin Michael H., 2004, Acta Ethologica, V7, P1; Fuxjager MJ, 2011, ENDOCRINOLOGY, V152, P3422, DOI 10.1210/en.2011-1099; Fuxjager MJ, 2010, ANIM BEHAV, V80, P921, DOI 10.1016/j.anbehav.2010.08.018; Fuxjager MJ, 2010, BEHAV ECOL, V21, P37, DOI 10.1093/beheco/arp148; GORMAN ML, 1990, REV SUISSE ZOOL, V97, P3, DOI 10.5962/bhl.part.79722; Gorman ML, 1990, CHEM SIGNAL VERTEBRA, P5; Gosling L.M., 2001, Animal Behaviour Forum, V62, pF7, DOI 10.1006/anbe.2001.1802; Gosling LM, 2000, BEHAV ECOL SOCIOBIOL, V48, P328, DOI 10.1007/s002650000242; GOSLING LM, 1982, Z TIERPSYCHOL, V60, P89; Gosling LM, 1996, BEHAVIOUR, V133, P491, DOI 10.1163/156853996X00170; Gosling LM, 1990, CHEM SIGNAL VERTEBRA, P5; Gottfried BM, 1981, CAN J ZOOL, V60, P1660; Holldobler B., 1990, pi; Humphries RE, 1999, ANIM BEHAV, V58, P1177, DOI 10.1006/anbe.1999.1252; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; HURST JL, 1993, ANIM BEHAV, V45, P55, DOI 10.1006/anbe.1993.1007; Hurst JL, 1999, ADV CHEM COMMUNICATI; Janotova K, 2011, J CHEM ECOL, V37, P647, DOI 10.1007/s10886-011-9966-8; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; Johnston RE, 1997, ETHOLOGY, V103, P443; Johnston RE, 1997, ANIM BEHAV, V54, P679, DOI 10.1006/anbe.1997.0471; JOHNSTON RE, 1983, PHEROMONES REPROD MA; Kellie A, 2004, J COMP PHYSIOL A, V190, P429, DOI 10.1007/s00359-004-0507-6; Koivula M, 1999, J AVIAN BIOL, V30, P329, DOI 10.2307/3677362; Lisberg AE, 2011, ANIM BEHAV, V81, P757, DOI 10.1016/j.anbehav.2011.01.006; Malone N, 2005, CHEM SIGNALS VERTEBR, P10; Marler C, 2005, CURR DIR PSYCHOL SCI, V14, P163, DOI 10.1111/j.0963-7214.2005.00351.x; Marler CA, 2003, ADV STUDY BEHAV; Martin LB, 2007, GEN COMP ENDOCR, V151, P342, DOI 10.1016/j.ygcen.2007.02.001; Oyegbile TO, 2006, PHYSIOL BEHAV, V89, P171, DOI 10.1016/j.physbeh.2006.05.044; Oyegbile TO, 2005, HORM BEHAV, V48, P259, DOI 10.1016/j.yhbeh.2005.04.007; Probst R, 2002, J AVIAN BIOL, V33, P437, DOI 10.1034/j.1600-048X.2002.02760.x; RIBBLE DO, 1991, BEHAV ECOL SOCIOBIOL, V29, P161, DOI 10.1007/BF00166397; RIBBLE DO, 1990, THESIS U CALIFORNIA; Rich TJ, 1999, ANIM BEHAV, V58, P1027, DOI 10.1006/anbe.1999.1217; Rich TJ, 1998, ANIM BEHAV, V56, P727, DOI 10.1006/anbe.1998.0803; Roberts SC, 2001, BEHAV ECOL, V12, P698, DOI 10.1093/beheco/12.6.698; Roberts SC, 2000, BEHAV ECOL SOCIOBIOL, V47, P417, DOI 10.1007/s002650050685; ROTHMAN RJ, 1979, ANIM BEHAV, V27, P750, DOI 10.1016/0003-3472(79)90010-1; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Sorensen PW, 2004, NEW ZEAL J MAR FRESH, V38, P399, DOI 10.1080/00288330.2004.9517248; Thomas SA, 2002, ANIM BEHAV, V63, P1121, DOI 10.1006/anbe.2002.3014; Thomas SA, 2002, ETHOLOGY, V108, P51, DOI 10.1046/j.1439-0310.2002.00753.x; Trainor BC, 2004, HORM BEHAV, V45, P115, DOI 10.1016/j.yhbeh.2003.09.006; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wang ZX, 1997, BRAIN RES, V767, P321, DOI 10.1016/S0006-8993(97)00617-3; WOLFF JO, 1989, ANIM BEHAV, V38, P637, DOI 10.1016/S0003-3472(89)80009-0; WOLFF JO, 1983, BEHAV ECOL SOCIOBIOL, V12, P237, DOI 10.1007/BF00290776; Woodward RL, 2000, ETHOLOGY, V106, P979, DOI 10.1046/j.1439-0310.2000.00618.x; XIA XH, 1991, BEHAV ECOL SOCIOBIOL, V28, P171; Zala SM, 2004, BEHAV ECOL, V15, P338, DOI 10.1093/beheco/arh022; ZIEGLER TE, 1993, ANIM BEHAV, V45, P313, DOI 10.1006/anbe.1993.1036; [No title captured]	67	16	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32002	10.1371/journal.pone.0032002	http://dx.doi.org/10.1371/journal.pone.0032002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393377	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500030
J	Ma, J; Liu, WC; Yan, XH; Wang, QR; Zhao, QL; Xue, Y; Ren, H; Wu, L; Cheng, YX; Li, S; Miao, L; Yao, LB; Zhang, J				Ma, Ji; Liu, Wenchao; Yan, Xiaohong; Wang, Qianrong; Zhao, Qingli; Xue, Yan; Ren, Hui; Wu, Lin; Cheng, Yuanxiong; Li, Sen; Miao, Lu; Yao, Libo; Zhang, Jian			Inhibition of Endothelial Cell Proliferation and Tumor Angiogenesis by Up-Regulating NDRG2 Expression in Breast Cancer Cells	PLOS ONE			English	Article							GENE; HIF-1-ALPHA; INVASION; VEGF; MYC; P53; SUPPRESSION; SURVIVAL; CD24	The N-myc downstream-regulated gene 2 (NDRG2) is involved in tumor cell differentiation and apoptosis, but its function in tumor angiogenesis remains to be established. Here, we employed adenovirus overexpressing NDRG2 (Ad-NDRG2) to efficiently up-regulate target gene expression in the NDRG2-low-expressing, breast cancer cell line MCF-7. Moreover, VEGF secretion was decreased in MCF-7 cells infected by Ad-NDRG2, and medium conditioned by these infected cells could significantly inhibit the proliferation, tube formation and invasion of human umbilical vein endothelial cells (HUVECs). Further study indicated that the angiogenesis promoting factors VEGF and HIF-1 alpha were down-regulated, whereas the angiogenesis suppressing factors p53 and VHL were up-regulated in MCF-7 cells infected by Ad-NDRG2. Finally, in a nude mouse model, intratumoral injections of Ad-NDRG2 every 3 days for 20 days significantly inhibited the growth and angiogenesis of xenografted MCF-7 tumors. In summary, these data indicate that NDRG2 may be involved in angiogenesis by impacting the expression of angiogenesis related factors. Thus, specific overexpression of NDRG2 by adenovirus represents a promising approach for the treatment of tumor angiogenesis.	[Ma, Ji; Liu, Wenchao; Wang, Qianrong; Xue, Yan; Li, Sen] Fourth Mil Med Univ, Dept Oncol, Xijing Hosp, State Key Discipline Cell Biol, Xian 710032, Shaanxi Provinc, Peoples R China; [Ma, Ji; Wu, Lin; Yao, Libo; Zhang, Jian] Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Shaanxi Provinc, Peoples R China; [Ma, Ji; Zhao, Qingli; Ren, Hui] Lanzhou Gen Hosp CPLA, Dept Breast Surg, Lanzhou, Gansu, Peoples R China; [Yan, Xiaohong] Baoji Cent Hosp, Dept Oncol, Baoji, Shaanxi Provinc, Peoples R China; [Cheng, Yuanxiong] So Med Univ, Nanfang Hosp, Dept Resp, Guangzhou, Guangdong, Peoples R China; [Miao, Lu] Fourth Mil Med Univ, Sch Aerosp Med, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Southern Medical University - China; Air Force Military Medical University	Ma, J (corresponding author), Fourth Mil Med Univ, Dept Oncol, Xijing Hosp, State Key Discipline Cell Biol, Xian 710032, Shaanxi Provinc, Peoples R China.	xjcancer@fmmu.edu.cn; biozhangj@yahoo.com.cn			National Nature Science Foundation of China [30830054, 81172292, 81071894, 81072050, 30572100]; Nation Program on Key Basic Research Project [2009CB521704]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nation Program on Key Basic Research Project	This work was supported by grants from the National Nature Science Foundation of China (nos. 30830054, 81172292, 81071894, 81072050 and 30572100) and Nation Program on Key Basic Research Project (2009CB521704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek JH, 2000, ONCOGENE, V19, P4621, DOI 10.1038/sj.onc.1203814; Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Chen DL, 2003, J BIOL CHEM, V278, P13595, DOI 10.1074/jbc.C200694200; Choi SC, 2007, EXP MOL MED, V39, P705, DOI 10.1038/emm.2007.77; Deng YC, 2003, INT J CANCER, V106, P342, DOI 10.1002/ijc.11228; Dewhirst MW, 2009, RADIAT RES, V172, P653, DOI 10.1667/RR1926.1; Gao L, 2011, CANCER LETT, V310, P94, DOI 10.1016/j.canlet.2011.06.015; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Liu N, 2007, BIOCHEM BIOPH RES CO, V358, P164, DOI 10.1016/j.bbrc.2007.04.089; Lorentzen A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-14; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Nor JE, 1999, AM J PATHOL, V154, P375, DOI 10.1016/S0002-9440(10)65284-4; Pal S, 2001, CANCER RES, V61, P6952; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Ravi R, 2000, GENE DEV, V14, P34; Shon SK, 2009, BIOCHEM BIOPH RES CO, V385, P198, DOI 10.1016/j.bbrc.2009.05.038; Sikora S, 2004, PROTEIN SCI, V13, P786, DOI 10.1110/ps.03454904; Wang LF, 2008, CELL PHYSIOL BIOCHEM, V21, P239, DOI 10.1159/000113765; Wang YQ, 2004, BIOCHEM BIOPH RES CO, V317, P358, DOI 10.1016/j.bbrc.2004.03.050; Yang XM, 2009, INVEST OPHTH VIS SCI, V50, P1873, DOI 10.1167/iovs.08-2591; Yao LB, 2008, ACTA BIOCH BIOPH SIN, V40, P625, DOI 10.1111/j.1745-7270.2008.00434.x; Zhang J, 2006, J BIOL CHEM, V281, P39159, DOI 10.1074/jbc.M605820200; Zheng J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-251; Zheng J, 2010, ASIAN PAC J CANCER P, V11, P1817; Zhou RH, 2001, GENOMICS, V73, P86, DOI 10.1006/geno.2000.6496	25	23	27	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32368	10.1371/journal.pone.0032368	http://dx.doi.org/10.1371/journal.pone.0032368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393400	Green Published, gold, Green Submitted			2022-12-27	WOS:000303003500053
J	Skodda, S; Gronheit, W; Schlegel, U				Skodda, Sabine; Groenheit, Wenke; Schlegel, Uwe			Impairment of Vowel Articulation as a Possible Marker of Disease Progression in Parkinson's Disease	PLOS ONE			English	Article							SPEECH DISORDERS; SPEAKING RATE; INTELLIGIBILITY; DYSARTHRIA; LEVODOPA; DIADOCHOKINESIS; HYPOKINESIA; PERCEPTION; ACCURACY; SPACE	Purpose: The aim of the current study was to survey if vowel articulation in speakers with Parkinson's disease (PD) shows specific changes in the course of the disease. Method: 67 patients with PD (42 male) and 40 healthy speakers (20 male) were tested and retested after an average time interval of 34 months. Participants had to read a given text as source for subsequent calculation of the triangular vowel space area (tVSA) and vowel articulation index (VAI). Measurement of tVSA and VAI were based upon analysis of the first and second formant of the vowels /alpha/, /i/ and /u/ extracted from defined words within the text. Results: At first visit, VAI values were reduced in male and female PD patients as compared to the control group, and showed a further decrease at the second visit. Only in female Parkinsonian speakers, VAI was correlated to overall speech impairment based upon perceptual impression. VAI and tVSA were correlated to gait impairment, but no correlations were seen between VAI and global motor impairment or overall disease duration. tVSA showed a similar reduction in the PD as compared to the control group and was also found to further decline between first and second examination in female, but not in male speakers with PD. Conclusions: Measurement of VAI seems to be superior to tVSA in the description of impaired vowel articulation and its further decline in the course of the disease in PD. Since impairment of vowel articulation was found to be independent from global motor function but correlated to gait dysfunction, measurement of vowel articulation might have a potential to serve as a marker of axial disease progression.	[Skodda, Sabine; Groenheit, Wenke; Schlegel, Uwe] Ruhr Univ Bochum, Knappschaftskrankenhaus, Dept Neurol, Bochum, Germany	Ruhr University Bochum	Skodda, S (corresponding author), Ruhr Univ Bochum, Knappschaftskrankenhaus, Dept Neurol, Univ Str 150, Bochum, Germany.	sabine.skodda@kk-bochum.de						ACKERMANN H, 1995, FOLIA PHONIATR LOGO, V47, P15, DOI 10.1159/000266338; ACKERMANN H, 1989, FORTSCHR NEUROL PSYC, V57, P149, DOI 10.1055/s-2007-1000756; Alves G, 2005, NEUROLOGY, V65, P1436, DOI 10.1212/01.wnl.0000183359.50822.f2; Asgari M, 2010, IEEE ENG MED BIO, P5201, DOI 10.1109/IEMBS.2010.5626104; Blomgren B, 1998, J SPEECH LANG HEAR R, V41, P1042, DOI 10.1044/jslhr.4105.1042; Bradlow AR, 1996, SPEECH COMMUN, V20, P255, DOI 10.1016/S0167-6393(96)00063-5; Bunton K, 2001, J SPEECH LANG HEAR R, V44, P1215, DOI 10.1044/1092-4388(2001/095); BYRD D, 1994, SPEECH COMMUN, V15, P39, DOI 10.1016/0167-6393(94)90039-6; CALIGIURI MP, 1989, BRAIN LANG, V36, P493, DOI 10.1016/0093-934X(89)90080-1; CANTER GJ, 1965, J SPEECH HEAR DISORD, V30, P217, DOI 10.1044/jshd.3003.217; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; Ferguson SH, 2004, J ACOUST SOC AM, V116, P2365, DOI 10.1121/1.1788730; FORREST K, 1989, J ACOUST SOC AM, V85, P2608, DOI 10.1121/1.397755; Goberman A, 2002, J COMMUN DISORD, V35, P217, DOI 10.1016/S0021-9924(01)00072-7; Hilker R, 2005, ARCH NEUROL-CHICAGO, V62, P378, DOI 10.1001/archneur.62.3.378; Ho AK, 2008, MOVEMENT DISORD, V23, P574, DOI 10.1002/mds.21899; Ho AK, 1998, BEHAV NEUROL, V11, P131, DOI 10.1155/1999/327643; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; HUNKER CJ, 1982, NEUROLOGY, V32, P749, DOI 10.1212/WNL.32.7.749; Jankovic J, 2001, ARCH NEUROL-CHICAGO, V58, P1611, DOI 10.1001/archneur.58.10.1611; Kent RD, 2003, CLIN LINGUIST PHONET, V17, P427, DOI 10.1080/0269920031000086248; KLATT DH, 1990, J ACOUST SOC AM, V87, P820, DOI 10.1121/1.398894; Kwon HB, 2010, J ADV PROSTHODONT, V2, P71, DOI 10.4047/jap.2010.2.3.71; McRae PA, 2002, J SPEECH LANG HEAR R, V45, P35, DOI 10.1044/1092-4388(2002/003); Morrish PK, 1998, J NEUROL NEUROSUR PS, V64, P314, DOI 10.1136/jnnp.64.3.314; Neel AT, 2008, J SPEECH LANG HEAR R, V51, P574, DOI 10.1044/1092-4388(2008/041); Ramig Lorraine O, 2008, Expert Rev Neurother, V8, P297, DOI 10.1586/14737175.8.2.297; Robertson LT, 1996, J NEUROL NEUROSUR PS, V60, P41, DOI 10.1136/jnnp.60.1.41; Roy N, 2009, J COMMUN DISORD, V42, P124, DOI 10.1016/j.jcomdis.2008.10.001; Sapir S, 2010, J SPEECH LANG HEAR R, V53, P114, DOI 10.1044/1092-4388(2009/08-0184); Sendlmeier WF, FORMATENKARTEN DTSCH; Skodda S, 2011, J VOICE, V25, P467, DOI 10.1016/j.jvoice.2010.01.009; Skodda S, 2011, MOVEMENT DISORD, V26, P59, DOI 10.1002/mds.23382; Skodda S, 2011, J VOICE, V25, P76, DOI 10.1016/j.jvoice.2009.07.005; Skodda S, 2010, J NEURAL TRANSM, V117, P197, DOI 10.1007/s00702-009-0351-5; Skodda S, 2009, MOVEMENT DISORD, V24, P716, DOI 10.1002/mds.22430; Spielman J, 2011, J COMMUN DISORD; Titze IR, 1994, PRINCIPLES VOICE PRO; Tjaden K, 2004, J SPEECH LANG HEAR R, V47, P766, DOI 10.1044/1092-4388(2004/058); Tjaden K, 2011, CLIN LINGUIST PHONET, V25, P155, DOI 10.3109/02699206.2010.520185; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; TURNER GS, 1995, J SPEECH HEAR RES, V38, P1001, DOI 10.1044/jshr.3805.1001; Watson PJ, 2008, J ACOUST SOC AM, V124, pEL291, DOI 10.1121/1.2987464; Weenink D., 1996, PRAAT SYSTEM DOING P; Weismer G, 2001, FOLIA PHONIATR LOGO, V53, P1, DOI 10.1159/000052649	45	110	113	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32132	10.1371/journal.pone.0032132	http://dx.doi.org/10.1371/journal.pone.0032132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	928RC	22389682	Green Submitted, Green Published, gold			2022-12-27	WOS:000302999600020
J	Frankle, WG; Cho, RY; Mason, NS; Chen, CM; Himes, M; Walker, C; Lewis, DA; Mathis, CA; Narendran, R				Frankle, W. Gordon; Cho, Raymond Y.; Mason, N. Scott; Chen, Chi-Min; Himes, Michael; Walker, Christopher; Lewis, David A.; Mathis, Chester A.; Narendran, Rajesh			[C-11]flumazenil Binding Is Increased in a Dose-Dependent Manner with Tiagabine-Induced Elevations in GABA Levels	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; BENZODIAZEPINE-RECEPTORS; HUMAN-BRAIN; GAMMA-OSCILLATIONS; C-11 FLUMAZENIL; IN-VIVO; WORKING-MEMORY; RO 15-1788; HUMANS; NEURONS	Evidence indicates that synchronization of cortical activity at gamma-band frequencies, mediated through GABA-A receptors, is important for perceptual/cognitive processes. To study GABA signaling in vivo, we recently used a novel positron emission tomography (PET) paradigm measuring the change in binding of the benzodiazepine (BDZ) site radiotracer [C-11]flumazenil associated with increases in extracellular GABA induced via GABA membrane transporter (GAT1) blockade with tiagabine. GAT1 blockade resulted in significant increases in [C-11] flumazenil binding potential (BPND) over baseline in the major functional domains of the cortex, consistent with preclinical studies showing that increased GABA levels enhance the affinity of GABA-A receptors for BDZ ligands. In the current study we sought to replicate our previous results and to further validate this approach by demonstrating that the magnitude of increase in [C-11] flumazenil binding observed with PET is directly correlated with tiagabine dose. [C-11] flumazenil distribution volume (VT) was measured in 18 healthy volunteers before and after GAT1 blockade with tiagabine. Two dose groups were studied (n = 9 per group; Group I: tiagabine 0.15 mg/kg; Group II: tiagabine 0.25 mg/kg). GAT1 blockade resulted in increases in mean (+/-SD) [C-11]flumazenil VT in Group II in association cortices (6.8+/-0.8 mL g(-1) vs. 7.3+/-0.4 mL g(-1); p = 0.03), sensory cortices (6.7+/-0.8 mL g(-1) vs. 7.3+/-0.5 mL g(-1); p = 0.02) and limbic regions (5.2+/-0.6 mL g(-1) vs. 5.7+/-0.3 mL g(-1); p = 0.03). No change was observed at the low dose (Group I). Increased orbital frontal cortex binding of [C-11] flumazenil in Group II correlated with the ability to entrain cortical networks (r = 0.67, p = 0.05) measured via EEG during a cognitive control task. These data provide a replication of our previous study demonstrating the ability to measure in vivo, with PET, acute shifts in extracellular GABA.	[Frankle, W. Gordon; Cho, Raymond Y.; Chen, Chi-Min; Himes, Michael; Walker, Christopher; Lewis, David A.; Narendran, Rajesh] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; [Frankle, W. Gordon; Mason, N. Scott; Mathis, Chester A.; Narendran, Rajesh] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Lewis, David A.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Frankle, WG (corresponding author), Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA.	franklewg@upmc.edu	Cho, Raymond/P-3028-2014; Mathis, Chester A/A-8607-2009; Lewis, David A/G-4053-2014	Cho, Raymond/0000-0003-1331-1409; Mathis, Chester A/0000-0001-9811-0950; Lewis, David A/0000-0002-3225-6778; Walker, Christopher P/0000-0002-1042-075X; Frankle, William/0000-0003-0356-4197	Silvio O. Conte Center for the Neuroscience of Mental Disorders [MH51456]; United States National Institutes of Health (NIH)/NCRR; Montefiore University Hospital Clinical and Translational Research Center; GlaxoSmithKline, Inc.; Sunovion Pharmaceuticals, Inc.; Merck; Pfizer; Neuroptix; GE Healthcare; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	Silvio O. Conte Center for the Neuroscience of Mental Disorders; United States National Institutes of Health (NIH)/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Montefiore University Hospital Clinical and Translational Research Center; GlaxoSmithKline, Inc.(GlaxoSmithKline); Sunovion Pharmaceuticals, Inc.; Merck(Merck & Company); Pfizer(Pfizer); Neuroptix; GE Healthcare(General ElectricGE Healthcare); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	These data were generated with the support of a Silvio O. Conte Center for the Neuroscience of Mental Disorders (MH51456, PI: Lewis) and a United States National Institutes of Health (NIH)/NCRR Grant which funds the Montefiore University Hospital Clinical and Translational Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Frankle serves as a consultant for Sunovion Pharmaceuticals, Inc. and ONO Pharmaceuticals, Inc. Dr. Narendran has received grant support from GlaxoSmithKline, Inc. and Sunovion Pharmaceuticals, Inc. Dr. Mason serves as a consultant for Aposense Inc., Banner Good Samaritan Hospital (Phoenix, AZ), Janssen AI, and The Gollman Group (Dallas, TX). Dr. Lewis has served as a consultant for Bristol Meyer Squibb, Merck, Lilly, and Hoffman-LaRoche and received research grant support from Merck and Pfizer. Dr. Mathis receives royalty payments from the University of Pittsburgh for technology licensed to GE Healthcare and Neuroptix. He serves as a consultant for Elan, Pfizer, Takeda, Amgen, Baxter Scientific, Novartis, and GE Healthcare. He has received grant support from Neuroptix and GE Healthcare. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Dr. Cho, Ms. Chen, Mr. Himes and Mr. Walker have no conflict of interest to declare.	ABADIE P, 1992, EUR J PHARMACOL, V213, P107, DOI 10.1016/0014-2999(92)90239-Z; ABI-DARGHAM A, 1994, J NUCL MED, V35, P228; Adkins JC, 1998, DRUGS, V55, P437, DOI 10.2165/00003495-199855030-00013; BARRE L, 1991, APPL RADIAT ISOTOPES, V42, P435; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Belzung C, 2000, PSYCHOPHARMACOLOGY, V148, P24, DOI 10.1007/s002130050021; BERTRAND O, 1985, ELECTROEN CLIN NEURO, V62, P462, DOI 10.1016/0168-5597(85)90058-9; BRAESTRUP C, 1982, SCIENCE, V216, P1241, DOI 10.1126/science.6281892; BRAESTRUP C, 1977, NATURE, V269, P702, DOI 10.1038/269702a0; Cho RY, 2006, P NATL ACAD SCI USA, V103, P19878, DOI 10.1073/pnas.0609440103; DURING M, 1992, ANN M AM EP SOC SEAT; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; FINKJENSEN A, 1992, EUR J PHARMACOL, V220, P197, DOI 10.1016/0014-2999(92)90748-S; Frankle WG, 2009, NEUROPSYCHOPHARMACOL, V34, P624, DOI 10.1038/npp.2008.104; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Gerra G, 2002, ADDICT BIOL, V7, P385, DOI 10.1080/1355621021000005973; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; HALLDIN C, 1988, APPL RADIAT ISOTOPES, V39, P993; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Innis R, 2007, J CEREBRAL BLOOD FLO, V2007; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Johannessen CU, 2000, NEUROCHEM INT, V37, P103, DOI 10.1016/S0197-0186(00)00013-9; KAPCZINSKI F, 1994, PSYCHOPHARMACOLOGY, V114, P187, DOI 10.1007/BF02245463; KOE BK, 1987, EUR J PHARMACOL, V142, P373, DOI 10.1016/0014-2999(87)90076-8; KOEPPE RA, 1991, J CEREBR BLOOD F MET, V11, P735, DOI 10.1038/jcbfm.1991.130; LARUELLE M, 1994, J CEREBR BLOOD F MET, V14, P439, DOI 10.1038/jcbfm.1994.55; LASSEN NA, 1995, J CEREBR BLOOD F MET, V15, P152, DOI 10.1038/jcbfm.1995.17; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; LUTZENBERGER W, 1995, NEUROSCI LETT, V183, P39, DOI 10.1016/0304-3940(94)11109-V; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; MILLER LG, 1988, EUR J PHARMACOL, V148, P123, DOI 10.1016/0014-2999(88)90461-X; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; MINTUN MA, 1984, ANN NEUROL, V15, P217, DOI 10.1002/ana.410150302; MOHLER H, 1981, NATURE, V294, P763, DOI 10.1038/294763a0; Mohler H, 1977, SCIENCE, V198; PERSSON A, 1985, J PSYCHIAT RES, V19, P609, DOI 10.1016/0022-3956(85)90080-9; PRICE JC, 1993, J CEREBR BLOOD F MET, V13, P656, DOI 10.1038/jcbfm.1993.84; Price RB, 2009, BIOL PSYCHIAT, V65, P792, DOI 10.1016/j.biopsych.2008.10.025; Rao SG, 2000, J NEUROSCI, V20, P485, DOI 10.1523/JNEUROSCI.20-01-00485.2000; Richards DA, 1996, NEUROCHEM RES, V21, P135, DOI 10.1007/BF02529130; ROSENBERG HC, 1979, NEUROSCI LETT, V15, P277, DOI 10.1016/0304-3940(79)96126-3; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; SYBIRSKA E, 1993, NEUROPHARMACOLOGY, V32, P671, DOI 10.1016/0028-3908(93)90080-M; Talairach I., 1988, COPLANAR STEREOTACTI; TALLMAN JF, 1978, NATURE, V274, P383, DOI 10.1038/274383a0; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Uthman BM, 1998, ARCH NEUROL-CHICAGO, V55, P56, DOI 10.1001/archneur.55.1.56; VANVREESWIJK, 1994, J COMPUT NEUROSCI, V1, P313; Watson CC, 2000, IEEE T NUCL SCI, V47, P1587, DOI 10.1109/23.873020; Weiss M, 2002, NEUROCHEM RES, V27, P1605, DOI 10.1023/A:1021674708556; Yoon JH, 2010, J NEUROSCI, V30, P3777, DOI 10.1523/JNEUROSCI.6158-09.2010; ZEZULA J, 1988, NEUROSCIENCE, V25, P771, DOI 10.1016/0306-4522(88)90036-X; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	55	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32443	10.1371/journal.pone.0032443	http://dx.doi.org/10.1371/journal.pone.0032443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384252	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000302918500090
J	Ciborowski, M; Teul, J; Martin-Ventura, JL; Egido, J; Barbas, C				Ciborowski, Michal; Teul, Joanna; Luis Martin-Ventura, Jose; Egido, Jesus; Barbas, Coral			Metabolomics with LC-QTOF-MS Permits the Prediction of Disease Stage in Aortic Abdominal Aneurysm Based on Plasma Metabolic Fingerprint	PLOS ONE			English	Article							PATHOGENESIS; PERFORMANCE; CARNITINE	Abdominal aortic aneurysm (AAA) is a permanent and localized aortic dilation, defined as aortic diameter >= 3 cm. It is an asymptomatic but potentially fatal condition because progressive enlargement of the abdominal aorta is spontaneously evolving towards rupture. Biomarkers may help to explain pathological processes of AAA expansion, and allow us to find novel therapeutic strategies or to determine the efficiency of current therapies. Metabolomics seems to be a good approach to find biomarkers of AAA. In this study, plasma samples of patients with large AAA, small AAA, and controls were fingerprinted with LC-QTOF-MS. Statistical analysis was used to compare metabolic fingerprints and select metabolites that showed a significant change. Results presented here reveal that LC-QTOF-MS based fingerprinting of plasma from AAA patients is a very good technique to distinguish small AAA, large AAA, and controls. With the use of validated PLS-DA models it was possible to classify patients according to the disease stage and predict properly the stage of additional AAA patients. Identified metabolites indicate a role for sphingolipids, lysophospholipids, cholesterol metabolites, and acylcarnitines in the development and progression of AAA. Moreover, guanidinosuccinic acid, which mimics nitric oxide in terms of its vasodilatory action, was found as a strong marker of large AAA.	[Ciborowski, Michal; Teul, Joanna; Barbas, Coral] Univ CEU San Pablo, Fac Farm, CEMBIO Ctr Metabol & Bioanal, Madrid, Spain; [Ciborowski, Michal] Med Univ Bialystok, Dept Phys Chem, Bialystok, Poland; [Teul, Joanna] Med Univ Bialystok, Dept Pharmaceut Anal, Bialystok, Poland; [Luis Martin-Ventura, Jose; Egido, Jesus] IIS Fdn Jimenez Diaz, Vasc Res Lab, Madrid, Spain; [Luis Martin-Ventura, Jose; Egido, Jesus] Univ Autonoma Madrid, Madrid, Spain	San Pablo CEU University; Medical University of Bialystok; Medical University of Bialystok; Fundacion Jimenez Diaz; Autonomous University of Madrid	Ciborowski, M (corresponding author), Univ CEU San Pablo, Fac Farm, CEMBIO Ctr Metabol & Bioanal, Madrid, Spain.	cbarbas@ceu.es	Ciborowski, Michal/E-6728-2015; Barbas, Coral/K-3871-2014; MARTIN-VENTURA, JOSE LUIS/Z-2386-2019	Ciborowski, Michal/0000-0003-3729-0518; Barbas, Coral/0000-0003-4722-491X; MARTIN-VENTURA, JOSE LUIS/0000-0003-2090-8641	Comunidad Autonoma de Madrid (CAM) [S2006/GEN-0247]; European Community [HEALTH F2-2008-200647]; Spanish Ministerio de Ciencia y Tecnologia [SAF2010/21852, CTQ2008-03779]; Ministerio de Sanidad y Consumo; Instituto de Salud Carlos III; Redes Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares (RECAVA) [RD06/0014/0035]; European Aeronautic Defence and Space Company - Construcciones Aeronauticas Sociedad Anonima (EADSCASA);  [EUS2008-03565]	Comunidad Autonoma de Madrid (CAM)(Comunidad de Madrid); European Community(European Commission); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Redes Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares (RECAVA); European Aeronautic Defence and Space Company - Construcciones Aeronauticas Sociedad Anonima (EADSCASA); 	The paper has been supported by Comunidad Autonoma de Madrid (CAM) (S2006/GEN-0247), the European Community Fighting Aneurysmal Disease (FAD) project (FP-7, HEALTH F2-2008-200647), the Spanish Ministerio de Ciencia y Tecnologia (SAF2010/21852 and CTQ2008-03779), Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Redes Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares (RECAVA) (RD06/0014/0035), European Aeronautic Defence and Space Company - Construcciones Aeronauticas Sociedad Anonima (EADSCASA), and EUS2008-03565. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi K, 2001, KIDNEY INT, V59, pS93, DOI 10.1046/j.1523-1755.2001.59780093.x; Arsenian MA, 1997, PROG CARDIOVASC DIS, V40, P265, DOI 10.1016/S0033-0620(97)80037-0; Ciborowski M, 2011, J PROTEOME RES, V10, P1374, DOI 10.1021/pr101138m; Duan SZ, 2008, CIRC RES, V102, P283, DOI 10.1161/CIRCRESAHA.107.164384; Gamberi T, 2011, MOL BIOSYST, V7, P2855, DOI 10.1039/c1mb05107e; Gika HG, 2008, J CHROMATOGR B, V871, P299, DOI 10.1016/j.jchromb.2008.05.048; Gilmour RS, 2001, EXP BIOL MED, V226, P1; Golledge J, 2011, ATHEROSCLEROSIS, V216, P458, DOI 10.1016/j.atherosclerosis.2011.02.022; Hamblin M, 2010, J VASC SURG, V52, P984, DOI 10.1016/j.jvs.2010.05.089; Hurt-Camejo E, 2001, CIRC RES, V89, P298, DOI 10.1161/hh1601.095598; Klink A, 2011, NAT REV CARDIOL, V8, P338, DOI 10.1038/nrcardio.2011.1; Krishna SM, 2010, ATHEROSCLEROSIS, V212, P16, DOI 10.1016/j.atherosclerosis.2010.02.008; Levin David C, 2009, J Am Coll Radiol, V6, P506, DOI 10.1016/j.jacr.2009.02.003; Martinez-Pinna R, 2011, ARTERIOSCL THROM VAS, V31, P935, DOI 10.1161/ATVBAHA.110.214429; Michel JB, 2011, CARDIOVASC RES, V90, P18, DOI 10.1093/cvr/cvq337; Milne S, 2006, METHODS, V39, P92, DOI 10.1016/j.ymeth.2006.05.014; Miyake T, 2009, CARDIOVASC RES, V83, P436, DOI 10.1093/cvr/cvp155; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; Mosorin Martti, 2008, Interact Cardiovasc Thorac Surg, V7, P578, DOI 10.1510/icvts.2008.178103; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Rubingh CM, 2006, METABOLOMICS, V2, P53, DOI 10.1007/s11306-006-0022-6; Sayed-Ahmed MM, 2001, PHARMACOL RES, V44, P235, DOI 10.1006/phrs.2001.0852; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Shulaev V, 2006, BRIEF BIOINFORM, V7, P128, DOI 10.1093/bib/bbl012; Tosaka M, 2001, STROKE, V32, P2913, DOI 10.1161/hs1201.099525; Touat Z, 2006, AM J PATHOL, V168, P1022, DOI 10.2353/ajpath.2006.050868; Tsuji K, 2009, BIOORG MED CHEM LETT, V19, P1643, DOI 10.1016/j.bmcl.2009.02.004; van Raalte DH, 2004, PHARM RES-DORDR, V21, P1531, DOI 10.1023/B:PHAM.0000041444.06122.8d; Van Veldhoven PP, 2000, CELL SIGNAL, V12, P475, DOI 10.1016/S0898-6568(00)00092-9; Fokko ZA, 2007, BBA-MOL CELL BIOL L, V1771, P972, DOI 10.1016/j.bbalip.2007.04.021; Zhang FX, 2009, TALANTA, V79, P836, DOI 10.1016/j.talanta.2009.05.010	31	50	52	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31982	10.1371/journal.pone.0031982	http://dx.doi.org/10.1371/journal.pone.0031982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384120	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916800022
J	Valle-Casuso, JC; Gonzalez-Sanchez, A; Medina, JM; Tabernero, A				Carlos Valle-Casuso, Jose; Gonzalez-Sanchez, Ana; Medina, Jose M.; Tabernero, Arantxa			HIF-1 and c-Src Mediate Increased Glucose Uptake Induced by Endothelin-1 and Connexin43 in Astrocytes	PLOS ONE			English	Article							GAP-JUNCTIONAL COMMUNICATION; CULTURED ASTROCYTES; TERMINAL DOMAIN; GROWTH-FACTOR; UP-REGULATION; RAT NEURONS; EXPRESSION; PROTEIN; BRAIN; INHIBITION	In previous work we showed that endothelin-1 (ET-1) increases the rate of glucose uptake in astrocytes, an important aspect of brain function since glucose taken up by astrocytes is used to supply the neurons with metabolic substrates. In the present work we sought to identify the signalling pathway responsible for this process in primary culture of rat astrocytes. Our results show that ET-1 promoted an increase in the transcription factor hypoxia-inducible factor-1 alpha (HIF-1 alpha) in astrocytes, as shown in other cell types. Furthermore, HIF-1 alpha-siRNA experiments revealed that HIF-1 alpha participates in the effects of ET-1 on glucose uptake and on the expression of GLUT-1, GLUT-3, type I and type II hexokinase. We previously reported that these effects of ET-1 are mediated by connexin43 (Cx43), the major gap junction protein in astrocytes. Indeed, our results show that silencing Cx43 increased HIF-1 alpha and reduced the effect of ET-1 on HIF-1 alpha, indicating that the effect of ET-1 on HIF-1 alpha is mediated by Cx43. The activity of oncogenes such as c-Src can up-regulate HIF-1 alpha. Since Cx43 interacts with c-Src, we investigated the participation of c-Src in this pathway. Interestingly, both the treatment with ET-1 and with Cx43-siRNA increased c-Src activity. In addition, when c-Src activity was inhibited neither ET-1 nor silencing Cx43 were able to up-regulate HIF-1 alpha. In conclusion, our results suggest that ET-1 by down-regulating Cx43 activates c-Src, which in turn increases HIF-1 alpha leading to the up-regulation of the machinery required to take up glucose in astrocytes. Cx43 expression can be reduced in response not only to ET-1 but also to various physiological and pathological stimuli. This study contributes to the identification of the signalling pathway evoked after Cx43 down-regulation that results in increased glucose uptake in astrocytes. Interestingly, this is the first evidence linking Cx43 to HIF-1, which is a master regulator of glucose metabolism.	[Carlos Valle-Casuso, Jose; Gonzalez-Sanchez, Ana; Medina, Jose M.; Tabernero, Arantxa] Univ Salamanca, Dept Bioquim & Biol Mol, INCYL, E-37008 Salamanca, Spain	University of Salamanca	Valle-Casuso, JC (corresponding author), Univ Salamanca, Dept Bioquim & Biol Mol, INCYL, E-37008 Salamanca, Spain.	ataber@usal.es	Tabernero, Arantxa/K-5950-2014; Gonzalez-Sanchez, Ana/GWC-6092-2022; Casuso, Jose Carlos Valle/N-2502-2018	Tabernero, Arantxa/0000-0001-6302-6134; Casuso, Jose Carlos Valle/0000-0002-9637-7085	Ministerio de Educacion y Ciencia [BFU2010-22190, BFU2011-27602]; Junta de Castilla y Leon [SA043A09]	Ministerio de Educacion y Ciencia(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by the Ministerio de Educacion y Ciencia, FEDER BFU2010-22190, BFU2011-27602 and the Junta de Castilla y Leon SA043A09. JCVC and AGS were recipient of a fellowship from the Junta de Castilla y Leon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates DC, 2007, GLIA, V55, P1554, DOI 10.1002/glia.20569; Bento-Abreu A, 2008, J NEUROCHEM, V106, P1149, DOI 10.1111/j.1471-4159.2008.05462.x; Blomstrand F, 2006, J NEUROSCI RES, V83, P996, DOI 10.1002/jnr.20801; Blomstrand F, 2004, EUR J NEUROSCI, V19, P1005, DOI 10.1111/j.0953-816X.2004.03197.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan DA, 2002, J BIOL CHEM, V277, P40112, DOI 10.1074/jbc.M206922200; Chauhan A, 2007, FASEB J, V21, P777, DOI 10.1096/fj.06-7054com; Cina C, 2009, J NEUROSCI, V29, P2009, DOI 10.1523/JNEUROSCI.5025-08.2009; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Didier N, 2002, NEUROREPORT, V13, P1179, DOI 10.1097/00001756-200207020-00022; Du JY, 2009, NAT BIOTECHNOL, V27, P77, DOI 10.1038/nbt.1513; FUXE K, 1991, NEUROSCI LETT, V123, P107, DOI 10.1016/0304-3940(91)90169-T; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; GIAUME C, 1992, EUR J NEUROSCI, V4, P877, DOI 10.1111/j.1460-9568.1992.tb00198.x; Giaume C, 1996, TRENDS NEUROSCI, V19, P319, DOI 10.1016/0166-2236(96)10046-1; GIAUME C, 1991, NEURON, V6, P133, DOI 10.1016/0896-6273(91)90128-M; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Giepmans BNG, 2006, ADV CARDIOL, V42, P41, DOI 10.1159/000092561; Giepmans BNG, 2001, J BIOL CHEM, V276, P8544, DOI 10.1074/jbc.M005847200; Gilleron J, 2008, J CELL SCI, V121, P4069, DOI 10.1242/jcs.033373; Hama H, 1997, J NEUROSCI RES, V47, P590, DOI 10.1002/(SICI)1097-4547(19970315)47:6<590::AID-JNR4>3.0.CO;2-8; Hasselblatt M, 2003, GLIA, V42, P390, DOI 10.1002/glia.10224; Herrero-Gonzalez S, 2010, ONCOGENE, V29, P5712, DOI 10.1038/onc.2010.299; Herrero-Gonzalez S, 2009, GLIA, V57, P222, DOI 10.1002/glia.20748; Herve JC, 2007, PROG BIOPHYS MOL BIO, V94, P29, DOI 10.1016/j.pbiomolbio.2007.03.010; Huang RP, 1998, CANCER RES, V58, P5089; Huang RP, 1999, J SURG ONCOL, V70, P21, DOI 10.1002/(SICI)1096-9098(199901)70:1<21::AID-JSO4>3.3.CO;2-S; Kardami E, 2007, PROG BIOPHYS MOL BIO, V94, P245, DOI 10.1016/j.pbiomolbio.2007.03.009; Karni R, 2002, J BIOL CHEM, V277, P42919, DOI 10.1074/jbc.M206141200; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; Lee HY, 2011, CARCINOGENESIS, V32, P703, DOI 10.1093/carcin/bgr034; Li W, 2005, J BIOL CHEM, V280, P7941, DOI 10.1074/jbc.M410548200; Lin R, 2001, J CELL BIOL, V154, P815, DOI 10.1083/jcb.200102027; MACCUMBER MW, 1990, P NATL ACAD SCI USA, V87, P2359, DOI 10.1073/pnas.87.6.2359; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Nie XJ, 1996, REV NEUROSCIENCE, V7, P177; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Prochnow N, 2008, HISTOCHEM CELL BIOL, V130, P71, DOI 10.1007/s00418-008-0434-7; Pu PY, 2004, CLIN NEUROL NEUROSUR, V107, P49, DOI 10.1016/j.clineuro.2004.03.006; Rosano L, 2010, AM J PHYSIOL-REG I, V299, pR395, DOI 10.1152/ajpregu.00304.2010; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Rozyczka J, 2005, J NEUROSCI RES, V79, P303, DOI 10.1002/jnr.20355; Sanchez-Alvarez R, 2004, J NEUROCHEM, V89, P703, DOI 10.1046/j.1471-4159.2004.02398.x; Scemes E, 2008, GLIA, V56, P145, DOI 10.1002/glia.20598; Shinoura N, 1996, J NEUROSURG, V84, P839, DOI 10.3171/jns.1996.84.5.0839; SIMONSON MS, 1993, PHYSIOL REV, V73, P375, DOI 10.1152/physrev.1993.73.2.375; Soroceanu L, 2001, GLIA, V33, P107, DOI 10.1002/1098-1136(200102)33:2<107::AID-GLIA1010>3.0.CO;2-4; Spinella F, 2002, J BIOL CHEM, V277, P27850, DOI 10.1074/jbc.M202421200; Spinella F, 2007, CANCER RES, V67, P1725, DOI 10.1158/0008-5472.CAN-06-2606; Spinella F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011241; Stiles JD, 1997, J NEUROPATH EXP NEUR, V56, P435, DOI 10.1097/00005072-199704000-00012; SUPATTAPONE S, 1989, BIOCHEM BIOPH RES CO, V165, P1115, DOI 10.1016/0006-291X(89)92718-6; SWENSON KI, 1990, CELL REGUL, V1, P989, DOI 10.1091/mbc.1.13.989; Tabernero A, 2006, J NEUROCHEM, V96, P973, DOI 10.1111/j.1471-4159.2005.03623.x; Tabernero A, 1996, NEUROSCI RES, V24, P131, DOI 10.1016/0168-0102(95)00981-7; Tabernero A, 1996, GLIA, V16, P187, DOI 10.1002/(SICI)1098-1136(199603)16:3<187::AID-GLIA1>3.0.CO;2-#; Tabernero A, 2001, J NEUROCHEM, V78, P890, DOI 10.1046/j.1471-4159.2001.00476.x; TABERNERO A, 1993, BIOCHEM J, V294, P635, DOI 10.1042/bj2940635; Tabernero A, 2006, J NEUROCHEM, V99, P1049, DOI 10.1111/j.1471-4159.2006.04088.x; Teixeira A, 2000, J NEUROCHEM, V74, P1034, DOI 10.1046/j.1471-4159.2000.0741034.x; Tence M, 2012, CELL SIGNAL, V24, P86, DOI 10.1016/j.cellsig.2011.08.006; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Venance L, 1997, J NEUROSCI, V17, P1981; VICARIO C, 1993, PEDIATR RES, V34, P709, DOI 10.1203/00006450-199312000-00002; Wolf A, 2010, ONCOTARGET, V1, P552, DOI 10.18632/oncotarget.190; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yamashita K, 2000, CELL MOL NEUROBIOL, V20, P541, DOI 10.1023/A:1007007710703; YOSHIMOTO S, 1990, BRAIN RES, V508, P283, DOI 10.1016/0006-8993(90)90407-3; ZHANG WW, 1994, J NEUROL SCI, V122, P90, DOI 10.1016/0022-510X(94)90057-4; ZHU D, 1991, P NATL ACAD SCI USA, V88, P1883, DOI 10.1073/pnas.88.5.1883	72	35	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32448	10.1371/journal.pone.0032448	http://dx.doi.org/10.1371/journal.pone.0032448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384254	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100083
J	Lee, JS; Kim, YK; Kim, HJ; Hajar, S; Tan, YL; Kang, NY; Ng, SH; Yoon, CN; Chang, YT				Lee, Jun-Seok; Kim, Yun Kyung; Kim, Han Jo; Hajar, Siti; Tan, Yee Ling; Kang, Nam-Young; Ng, Shin Hui; Yoon, Chang No; Chang, Young-Tae			Identification of Cancer Cell-Line Origins Using Fluorescence Image-Based Phenomic Screening	PLOS ONE			English	Article							PHENOTYPES; MOLECULES; PATTERNS; LIBRARY; CONTEXT; PROBE	Universal phenotyping techniques that can discriminate among various states of biological systems have great potential. We applied 557 fluorescent library compounds to NCI's 60 human cancer cell-lines (NCI-60) to generate a systematic fluorescence phenotypic profiling data. By the kinetic fluorescence intensity analysis, we successfully discriminated the organ origin of all the 60 cell-lines.	[Lee, Jun-Seok; Yoon, Chang No] Korea Inst Sci & Technol, Biomol Funct Res Ctr, Seoul, South Korea; [Kim, Yun Kyung] Korea Inst Sci & Technol, Ctr Neuromed, Brain Sci Inst, Seoul, South Korea; [Kim, Han Jo; Chang, Young-Tae] Natl Univ Singapore, Dept Chem, Inst Life Sci, Singapore 117548, Singapore; [Kim, Han Jo; Chang, Young-Tae] Natl Univ Singapore, Med Chem Program, Inst Life Sci, Singapore 117548, Singapore; [Hajar, Siti; Tan, Yee Ling; Kang, Nam-Young; Ng, Shin Hui; Chang, Young-Tae] Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Bioimaging Probe Dev, Singapore, Singapore	Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST); National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC)	Lee, JS (corresponding author), Korea Inst Sci & Technol, Biomol Funct Res Ctr, Seoul, South Korea.	chmcyt@nus.edu.sg	Chang, Young-Tae/B-2780-2010; Lee, Jun-Seok/D-8428-2011	Chang, Young-Tae/0000-0002-1927-3688; Lee, Jun-Seok/0000-0003-3641-1728	Agency for Science, Technology and Research (A*STAR); Singapore Biomedical Research Council; A*STAR SSCC [SSCC10/024]; Ministry of Education, Science and Technology [2010K001410]; T. J. Park Science Fellowship	Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); A*STAR SSCC(Agency for Science Technology & Research (A*STAR)); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); T. J. Park Science Fellowship	This work was supported by an intramural funding from Agency for Science, Technology and Research (A*STAR), Singapore Biomedical Research Council and A*STAR SSCC Grant (SSCC10/024). This work was also supported by Converging Research Center Program through the Ministry of Education, Science and Technology (2010K001410). JSL is a recipient of T. J. Park Science Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YH, 2007, J AM CHEM SOC, V129, P4510, DOI 10.1021/ja068230m; Ayhan Y, 2011, MOL PSYCHIATR, V16, P293, DOI 10.1038/mp.2009.144; BELLOC F, 1994, CYTOMETRY, V17, P59, DOI 10.1002/cyto.990170108; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Fatrai S, 2011, J BIOL CHEM, V286, P6061, DOI 10.1074/jbc.M110.201848; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Gerlai R, 2002, TRENDS NEUROSCI, V25, P506, DOI 10.1016/S0166-2236(02)02250-6; Gmeiner WH, 2010, MOL CANCER THER, V9, P3105, DOI 10.1158/1535-7163.MCT-10-0674; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Im CN, 2010, ANGEW CHEM INT EDIT, V49, P7497, DOI 10.1002/anie.201002463; Korn K, 2007, CURR OPIN CHEM BIOL, V11, P503, DOI 10.1016/j.cbpa.2007.08.030; Lee JS, 2007, ANGEW CHEM INT EDIT, V46, P3616, DOI 10.1002/anie.200604972; Lee JS, 2011, CHEM COMMUN, V47, P2339, DOI 10.1039/c0cc04495d; Lee JS, 2009, J AM CHEM SOC, V131, P10077, DOI 10.1021/ja9011657; Ljosa V, 2008, TRENDS BIOTECHNOL, V26, P527, DOI 10.1016/j.tibtech.2008.06.008; MacKenzie DA, 2007, J BIOL CHEM, V282, P9696, DOI 10.1074/jbc.M604192200; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Shen L, 2010, NEUROIMAGE, V53, P1051, DOI 10.1016/j.neuroimage.2010.01.042; Vounou M, 2010, NEUROIMAGE, V53, P1147, DOI 10.1016/j.neuroimage.2010.07.002; Wagner BK, 2008, J AM CHEM SOC, V130, P4208, DOI 10.1021/ja077656d; Walter T, 2010, NAT METHODS, V7, pS26, DOI [10.1038/nmeth.1431, 10.1038/NMETH.1431]; WEINSTEIN JN, 1992, SCIENCE, V258, P447, DOI 10.1126/science.1411538; Zbuk KM, 2007, NAT REV CANCER, V7, P35, DOI 10.1038/nrc2037	26	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32096	10.1371/journal.pone.0032096	http://dx.doi.org/10.1371/journal.pone.0032096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384151	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100052
J	Han, M; Nagele, E; DeMarshall, C; Acharya, N; Nagele, R				Han, Min; Nagele, Eric; DeMarshall, Cassandra; Acharya, Nimish; Nagele, Robert			Diagnosis of Parkinson's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; CEREBROSPINAL-FLUID; RATING-SCALE; EPIDEMIOLOGY	Parkinson's disease (PD), hallmarked by a variety of motor disorders and neurological decline, is the second most common neurodegenerative disease worldwide. Currently, no diagnostic test exists to identify sufferers, and physicians must rely on a combination of subjective physical and neurological assessments to make a diagnosis. The discovery of definitive blood-borne biomarkers would be a major step towards early and reliable diagnosis. Despite attention devoted to this search, such biomarkers have remained elusive. In the present study, we used human protein microarrays to reveal serum autoantibodies that are differentially expressed among PD and control subjects. The diagnostic significance of each of these autoantibodies was evaluated, resulting in the selection of 10 autoantibody biomarkers that can effectively differentiate PD sera from control sera with a sensitivity of 93.1% and specificity of 100%. PD sera were also distinguishable from sera obtained from Alzheimer's disease, breast cancer, and multiple sclerosis patients with accuracies of 86.0%, 96.6%, and 100%, respectively. Results demonstrate that serum autoantibodies can be used as highly specific and accurate biomarkers for PD diagnosis throughout the course of the disease.	[Han, Min; DeMarshall, Cassandra; Acharya, Nimish] Univ Med & Dent New Jersey, Sch Osteopath Med, Grad Sch Biomed Sci, Stratford, NJ 08084 USA; [Han, Min; DeMarshall, Cassandra; Acharya, Nimish; Nagele, Robert] Univ Med & Dent New Jersey, New Jersey Inst Successful Aging, Stratford, NJ USA; [Nagele, Eric; Nagele, Robert] Durin Technol Inc, New Brunswick, NJ USA	Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Han, M (corresponding author), Univ Med & Dent New Jersey, Sch Osteopath Med, Grad Sch Biomed Sci, Stratford, NJ 08084 USA.	nagelero@umdnj.edu		Han, Min/0000-0002-8350-687X; Han, Min/0000-0002-7348-9121	Foundation Venture Capital Group, L.L.C.; New Jersey Health Foundation	Foundation Venture Capital Group, L.L.C.; New Jersey Health Foundation	The authors gratefully acknowledge financial support from the Foundation Venture Capital Group, L.L.C., an affiliate of the New Jersey Health Foundation. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aarsland D, 2010, BRAIN PATHOL, V20, P633, DOI 10.1111/j.1750-3639.2009.00369.x; Berendse HW, 2011, J NEUROL SC IN PRESS; BIRKMAYER W, 1961, Wien Klin Wochenschr, V73, P787; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dekosky ST, 2003, SCIENCE, V302, P830, DOI 10.1126/science.1090349; Ebersbach G, 2006, J NEUROL, V253, P32, DOI 10.1007/00415-006-4008-0; Gaig C, 2009, MOVEMENT DISORD, V24, pS656, DOI 10.1002/mds.22672; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Gerlach M, 2012, J NEURAL TRANSM, V119, P39, DOI 10.1007/s00702-011-0682-x; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Greffard S, 2006, ARCH NEUROL-CHICAGO, V63, P584, DOI 10.1001/archneur.63.4.584; Hilker R, 2005, ARCH NEUROL-CHICAGO, V62, P378, DOI 10.1001/archneur.62.3.378; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Hornykiewicz O, 2006, J NEURAL TRANSM-SUPP, P9; Hughes AJ, 2002, BRAIN, V125, P861, DOI 10.1093/brain/awf080; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Levin EC, 2010, BRAIN RES, V1345, P221, DOI 10.1016/j.brainres.2010.05.038; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Nagele E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023112; NAGELE RG, 2011, J ALZHEIMER IN PRESS; Ohrfelt A, 2009, NEUROSCI LETT, V450, P332, DOI 10.1016/j.neulet.2008.11.015; Stoessl AJ, 2011, NEUROTHERAPEUTICS, V8, P72, DOI 10.1007/s13311-010-0007-z; Strobel G, 2009, J ALZHEIMERS DIS, V18, P625, DOI [10.3233/JAD-2009-1250, 10.3233/JAD-2009-1234]; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Tolosa E, 2011, J NEUROL SC IN PRESS; Yanamandra K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018513	28	76	82	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32383	10.1371/journal.pone.0032383	http://dx.doi.org/10.1371/journal.pone.0032383			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384236	Green Published, gold			2022-12-27	WOS:000302875500099
J	Lin, JE; Snook, AE; Li, P; Stoecker, BA; Kim, GW; Magee, MS; Garcia, AVM; Valentino, MA; Hyslop, T; Schulz, S; Waldman, SA				Lin, Jieru Egeria; Snook, Adam Eugene; Li, Peng; Stoecker, Brian Arthur; Kim, Gilbert Won; Magee, Michael Sullivan; Garcia, Alex Vladimir Mejia; Valentino, Michael Anthony; Hyslop, Terry; Schulz, Stephanie; Waldman, Scott Arthur			GUCY2C Opposes Systemic Genotoxic Tumorigenesis by Regulating AKT-Dependent Intestinal Barrier Integrity	PLOS ONE			English	Article							GUANYLYL CYCLASE-C; INFLAMMATORY-BOWEL-DISEASE; GENE-EXPRESSION PROFILES; TIGHT JUNCTION BARRIER; MUCOSAL INFLAMMATION; COLORECTAL-CANCER; POLYP FORMATION; COLON-CANCER; CELLS; ENTEROTOXIN	The barrier separating mucosal and systemic compartments comprises epithelial cells, annealed by tight junctions, limiting permeability. GUCY2C recently emerged as an intestinal tumor suppressor coordinating AKT1-dependent crypt-villus homeostasis. Here, the contribution of GUCY2C to barrier integrity opposing colitis and systemic tumorigenesis is defined. Mice deficient in GUCY2C (Gucy2c(-/-)) exhibited barrier hyperpermeability associated with reduced junctional proteins. Conversely, activation of GUCY2C in mice reduced barrier permeability associated with increased junctional proteins. Further, silencing GUCY2C exacerbated, while activation reduced, chemical barrier disruption and colitis. Moreover, eliminating GUCY2C amplified, while activation reduced, systemic oxidative DNA damage. This genotoxicity was associated with increased spontaneous and carcinogen-induced systemic tumorigenesis in Gucy2c(-/-) mice. GUCY2C regulated barrier integrity by repressing AKT1, associated with increased junction proteins occludin and claudin 4 in mice and Caco2 cells in vitro. Thus, GUCY2C defends the intestinal barrier, opposing colitis and systemic genotoxicity and tumorigenesis. The therapeutic potential of this observation is underscored by the emerging clinical development of oral GUCY2C ligands, which can be used for chemoprophylaxis in inflammatory bowel disease and cancer.	[Lin, Jieru Egeria; Snook, Adam Eugene; Li, Peng; Stoecker, Brian Arthur; Kim, Gilbert Won; Magee, Michael Sullivan; Garcia, Alex Vladimir Mejia; Valentino, Michael Anthony; Schulz, Stephanie; Waldman, Scott Arthur] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA; [Hyslop, Terry] Thomas Jefferson Univ, Div Biostat, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Lin, JE (corresponding author), Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA.	Scott.Waldman@Jefferson.edu	Snook, Adam/P-2585-2015; Magee, Michael/L-8354-2013	Snook, Adam/0000-0001-9216-4560; Magee, Michael/0000-0002-0480-4618; Waldman, Scott/0000-0001-6619-175X	National Institutes of Health (NIH) [CA146033, 5T32 GM08562]; Pennsylvania Department of Health; Targeted Diagnostic and Therapeutics Inc.; NATIONAL CANCER INSTITUTE [RC1CA146033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008562] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; Targeted Diagnostic and Therapeutics Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by grants from the National Institutes of Health (NIH) (CA146033), the Pennsylvania Department of Health, and Targeted Diagnostic and Therapeutics Inc. The Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations or conclusions. Dr. Garcia and Dr. Li were supported by NIH 5T32 GM08562. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Failor KL, 2007, MOL ENDOCRINOL, V21, P2403, DOI 10.1210/me.2007-0143; Fasano A, 2005, NAT CLIN PRACT GASTR, V2, P416, DOI 10.1038/ncpgasthep0259; Fasano A, 2011, PHYSIOL REV, V91, P151, DOI 10.1152/physrev.00003.2008; FINK MP, 1990, CRIT CARE MED, V18, P579; Glebov OK, 2006, CANCER EPIDEM BIOMAR, V15, P2253, DOI 10.1158/1055-9965.EPI-05-0694; Gong R, 2011, SCIENCE; Han XN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016139; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Hollande Frederic, 2005, Sci STKE, V2005, ppe13, DOI 10.1126/stke.2772005pe13; Kemper K, 2010, ONCOTARGET, V1, P387, DOI 10.18632/oncotarget.173; Lembo AJ, 2011, NEW ENGL J MED, V365, P527, DOI 10.1056/NEJMoa1010863; Li P, 2007, AM J PATHOL, V171, P1847, DOI 10.2353/ajpath.2007.070198; Li P, 2007, GASTROENTEROLOGY, V133, P599, DOI 10.1053/j.gastro.2007.05.052; Lin JE, 2010, GASTROENTEROLOGY, V138, P241, DOI 10.1053/j.gastro.2009.08.064; Mann EA, 2005, INT J CANCER, V116, P500, DOI 10.1002/ijc.21119; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Mazumdar T, 2011, ONCOTARGET, V2, P638; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Nakazato M, 2001, J GASTROENTEROL, V36, P219, DOI 10.1007/s005350170106; Notterman DA, 2001, CANCER RES, V61, P3124; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Patel BB, 2011, ONCOTARGET, V2, P197, DOI 10.18632/oncotarget.241; Pedersen N, 2010, AM J GASTROENTEROL, V105, P1480, DOI 10.1038/ajg.2009.760; Pitari GM, 2007, CLIN PHARMACOL THER, V82, P441, DOI 10.1038/sj.clpt.6100325; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Shailubhai K, 2000, CANCER RES, V60, P5151; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Steinbrecher KA, 2011, J IMMUNOL, V186, P7205, DOI 10.4049/jimmunol.1002469; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Van Der Kraak L, 2010, ONCOTARGET, V1, P436; Wang WC, 2011, J CELL BIOCHEM, V112, P1544, DOI 10.1002/jcb.23067; Westbrook AM, 2009, CANCER RES, V69, P4827, DOI 10.1158/0008-5472.CAN-08-4416; Wu F, 2007, INFLAMM BOWEL DIS, V13, P807, DOI 10.1002/ibd.20110; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	38	97	98	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31686	10.1371/journal.pone.0031686	http://dx.doi.org/10.1371/journal.pone.0031686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384056	gold, Green Published, Green Submitted			2022-12-27	WOS:000302875500034
J	Przybycien-Szymanska, MM; Gillespie, RA; Pak, TR				Przybycien-Szymanska, Magdalena M.; Gillespie, Roberta A.; Pak, Toni R.			17 beta-Estradiol Is Required for the Sexually Dimorphic Effects of Repeated Binge-Pattern Alcohol Exposure on the HPA Axis during Adolescence	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; PITUITARY-ADRENAL AXIS; CORTICOTROPIN-RELEASING-FACTOR; ARGININE-VASOPRESSIN; MALE RATS; SEX-DIFFERENCES; USE DISORDERS; FEMALE RATS; GENDER-DIFFERENCE; SCHOOL-STUDENTS	Alcohol consumption during adolescence has long-term sexually dimorphic effects on anxiety behavior and mood disorders. We have previously shown that repeated binge-pattern alcohol exposure increased the expression of two critical central regulators of stress and anxiety, corticotrophin-releasing hormone (CRH) and arginine vasopressin (AVP), in adolescent male rats. By contrast, there was no effect of alcohol on these same genes in adolescent females. Therefore, we tested the hypothesis that 17 beta-estradiol (E-2), the predominant sex steroid hormone in females, prevents alcohol-induced changes in CRH and AVP gene expression in the paraventricular nucleus (PVN) of the hypothalamus. To test this hypothesis, postnatal day (PND) 26 females were ovariectomized and given E-2 replacement or cholesterol as a control. Next, they were given an alcohol exposure paradigm of 1) saline alone, 2) acute (single dose) or 3) a repeated binge-pattern. Our results showed that acute and repeated binge-pattern alcohol treatment increased plasma ACTH and CORT levels in both E-2- and Ch-treated groups, however habituation to repeated binge-pattern alcohol exposure was evident only in E-2- treated animals. Further, repeated binge-pattern alcohol exposure significantly decreased CRH and AVP mRNA in Ch-, but not E-2- treated animals, which was consistent with our previous observations in gonad intact females. We further tested the effects of E-2 and alcohol treatment on the activity of the wild type CRH promoter in a PVN-derived neuronal cell line. Alcohol increased CRH promoter activity in these cells and concomitant treatment with E-2 completely abolished the effect. Together our data suggest that E-2 regulates the reactivity of the HPA axis to a repeated stressor through modulation of the habituation response and further serves to maintain normal steady state mRNA levels of CRH and AVP in the PVN in response to a repeated alcohol stressor.				tpak@lumc.edu			National Institutes of Health [R21AA018398, T32 AA013527]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA018398, T32AA013527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Fundings sources: National Institutes of Health R21AA018398 and T32 AA013527. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen EQ, 2007, GAC SANIT, V21, P43, DOI 10.1157/13099120; Azcoitia I, 2001, J NEUROBIOL, V47, P318, DOI 10.1002/neu.1038; Becker JB, 2007, J NEUROSCI, V27, P11851, DOI 10.1523/JNEUROSCI.3565-07.2007; Bingham B, 2011, PSYCHONEUROENDOCRINO, V36, P249, DOI 10.1016/j.psyneuen.2010.07.015; BURGESS LH, 1993, MOL CELL NEUROSCI, V4, P191, DOI 10.1006/mcne.1993.1023; Cagnacci A, 2007, FERTIL STERIL, V88, P1603, DOI 10.1016/j.fertnstert.2007.01.039; Chen J, 2008, EXP NEUROL, V211, P529, DOI 10.1016/j.expneurol.2008.02.023; Chen J, 2009, J NEUROCHEM, V110, P1310, DOI 10.1111/j.1471-4159.2009.06219.x; Chung WCJ, 2007, J COMP NEUROL, V505, P249, DOI 10.1002/cne.21490; Conway KP, 2006, J CLIN PSYCHIAT, V67, P247, DOI 10.4088/JCP.v67n0211; Epstein EE, 2007, J WOMEN AGING, V19, P31, DOI 10.1300/J074v19n01_03; Field M, 2007, ADDICTION; Garcia-Segura LM, 1999, NEUROSCIENCE, V89, P567, DOI 10.1016/S0306-4522(98)00340-6; GUENNOUN R, 1995, MOL BRAIN RES, V30, P287, DOI 10.1016/0169-328X(95)00016-L; Handa RJ, 2007, NEUROSCI LETT, V425, P99, DOI 10.1016/j.neulet.2007.08.044; KETELSLEGERS JM, 1978, ENDOCRINOLOGY, V103, P212, DOI 10.1210/endo-103-1-212; Lauing K, 2008, ALCOHOL, V42, P649, DOI 10.1016/j.alcohol.2008.08.005; Li ZQ, 2005, MOL CELL NEUROSCI, V29, P345, DOI 10.1016/j.mcn.2005.04.002; Lund TD, 2005, ENDOCRINOLOGY, V146, P797, DOI 10.1210/en.2004-1158; Lund TD, 2006, J NEUROSCI, V26, P1448, DOI 10.1523/JNEUROSCI.3777-05.2006; Lunga P, 2004, J NEUROENDOCRINOL, V16, P776, DOI 10.1111/j.1365-2826.2004.01234.x; Malkoski SP, 1999, MOL ENDOCRINOL, V13, P1629, DOI 10.1210/me.13.10.1629; McCullough LD, 2003, J NEUROSCI, V23, P8701; Miller JW, 2007, PEDIATRICS, V119, P76, DOI 10.1542/peds.2006-1517; Ogilvie KM, 1997, BRAIN RES, V744, P83, DOI 10.1016/S0006-8993(96)01082-7; Ogilvie KM, 1996, ALCOHOL CLIN EXP RES, V20, P255, DOI 10.1111/j.1530-0277.1996.tb01637.x; Ogilvie KM, 1997, BRAIN RES, V766, P19, DOI 10.1016/S0006-8993(97)00525-8; Pak TR, 2007, ENDOCRINOLOGY, V148, P3371, DOI 10.1210/en.2007-0086; Pak TR, 2009, AM J PHYSIOL-ENDOC M, V296, pE1409, DOI 10.1152/ajpendo.00037.2009; Pak TR, 2003, AM J PHYSIOL-ENDOC M, V284, pE206, DOI 10.1152/ajpendo.00352.2002; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; Penland S, 2001, ALCOHOL, V24, P45, DOI 10.1016/S0741-8329(01)00142-2; Pietranera L, NEUROSCIENCE, V174, P151; Przybycien-Szymanska MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026647; Przybycien-Szymanska MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018350; Przybycien-Szymanska MM, 2010, AM J PHYSIOL-ENDOC M, V298, pE320, DOI 10.1152/ajpendo.00615.2009; RIVIER C, 1993, ALCOHOL CLIN EXP RES, V17, P854, DOI 10.1111/j.1530-0277.1993.tb00853.x; Saleh TM, 2005, NEUROSCIENCE, V135, P1141, DOI 10.1016/j.neuroscience.2005.06.061; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SENCARCUPOVIC I, 1976, MECH AGEING DEV, V5, P1, DOI 10.1016/0047-6374(76)90002-6; Sierra A, 2003, ENDOCRINE, V21, P43, DOI 10.1385/ENDO:21:1:43; Smith KL, 2008, OBESITY, V16, P2239, DOI 10.1038/oby.2008.366; SODERSTEN P, 1975, HORM BEHAV, V6, P307, DOI 10.1016/0018-506X(75)90001-X; SODERSTEN P, 1977, HORM BEHAV, V8, P320, DOI 10.1016/0018-506X(77)90006-X; Steckelbroeck S, 2004, J BIOL CHEM, V279, P10784, DOI 10.1074/jbc.M313308200; Tebar M, 1996, BIOL REPROD, V54, P1266, DOI 10.1095/biolreprod54.6.1266; Veiga S, 2005, NEUROREPORT, V16, P1599, DOI 10.1097/01.wnr.0000179081.39659.7d; Walker BM, 2009, PHARMACOL BIOCHEM BE, V91, P560, DOI 10.1016/j.pbb.2008.09.017; Weihua Z, 2002, P NATL ACAD SCI USA, V99, P13589, DOI 10.1073/pnas.162477299; Weiser MJ, 2009, NEUROSCIENCE, V159, P883, DOI 10.1016/j.neuroscience.2008.12.058; Witt ED, 2007, NEUROTOXICOL TERATOL, V29, P81, DOI 10.1016/j.ntt.2006.10.013; Zilberman ML, 2003, CAN J PSYCHIAT, V48, P5, DOI 10.1177/070674370304800103	52	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32263	10.1371/journal.pone.0032263	http://dx.doi.org/10.1371/journal.pone.0032263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384198	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500091
J	Wang, QZ; Xie, B; Wu, CH; Chen, G; Wang, ZW; Cui, J; Hu, TM; Wiatrak, P				Wang, Quanzhen; Xie, Bao; Wu, Chunhui; Chen, Guo; Wang, Zhengwei; Cui, Jian; Hu, Tianming; Wiatrak, Pawel			Models Analyses for Allelopathic Effects of Chicory at Equivalent Coupling of Nitrogen Supply and pH Level on F. arundinacea, T. repens and M. sativa	PLOS ONE			English	Article							ORGANIC-MATTER DECOMPOSITION; CICHORIUM-INTYBUS; ENZYME-ACTIVITY; PHENOLIC-ACIDS; L.; SOIL; GRASSLANDS; DEPOSITION; NITRATE; IDENTIFICATION	Alllelopathic potential of chicory was investigated by evaluating its effect on seed germination, soluble sugar, malondialdehyde (MDA) and the chlorophyll content of three target plants species (Festuca arundinacea, Trifolium repens and Medicago sativa). The secretion of allelochemicals was regulated by keeping the donor plant (chicory) separate from the three target plant species and using different pH and nitrogen levels. Leachates from donor pots with different pH levels and nitrogen concentrations continuously irrigated the target pots containing the seedlings. The allelopathic effects of the chicory at equivalent coupling of nitrogen supply and pH level on the three target plants species were explored via models analyses. The results suggested a positive effect of nitrogen supply and pH level on allelochemical secretion from chicory plants. The nitrogen supply and pH level were located at a rectangular area defined by 149 to 168 mg/l nitrogen supply combining 4.95 to 7.0 pH value and point located at nitrogen supply 177 mg/l, pH 6.33 when they were in equivalent coupling effects; whereas the inhibitory effects of equivalent coupling nitrogen supply and pH level were located at rectangular area defined by 125 to 131 mg/l nitrogen supply combining 6.71 to 6.88 pH value and two points respectively located at nitrogen supply 180 mg/l with pH 6.38 and nitrogen supply 166 mg/l with pH 7.59. Aqueous extracts of chicory fleshy roots and leaves accompanied by treatment at different sand pH values and nitrogen concentrations influenced germination, seedling growth, soluble sugar, MDA and chlorophyll of F. arundinacea, T. repens and M. sativa. Additionally, we determined the phenolics contents of root and leaf aqueous extracts, which were 0.104% and 0.044% on average, respectively.	[Wang, Quanzhen; Xie, Bao; Wu, Chunhui; Chen, Guo; Wang, Zhengwei; Hu, Tianming] NW A&F Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Yangling, Shaanxi Provinc, Peoples R China; [Cui, Jian] NW A&F Univ, Coll life Sci, Dept Plant Sci, Yangling, Shaanxi Provinc, Peoples R China; [Wiatrak, Pawel] Clemson Univ, Edisto Res & Educ Ctr, Blackville, SC USA	Northwest A&F University - China; Northwest A&F University - China; Clemson University	Wang, QZ (corresponding author), NW A&F Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Yangling, Shaanxi Provinc, Peoples R China.	wangquanzhen191@163.com			Ministry of Science and Technology of the Peoples Republic of China; International S and T Cooperation Research Project between China and Serbia [2011-1-7]; National Science and Technology Pillar Program of China [2011BAD17B05]	Ministry of Science and Technology of the Peoples Republic of China(Ministry of Science and Technology, China); International S and T Cooperation Research Project between China and Serbia; National Science and Technology Pillar Program of China	The Ministry of Science and Technology of the Peoples Republic of China, International S and T Cooperation Research Project between China and Serbia (grant number: 2011-1-7, (http://www.istcp.org.cn/), and The National Science and Technology Pillar Program of China (grant number: 2011BAD17B05, http://www.most.gov.cn/), funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMATO M, 1992, SOIL BIOL BIOCHEM, V24, P455, DOI 10.1016/0038-0717(92)90208-F; Barkosky RR, 2000, J CHEM ECOL, V26, P2095, DOI 10.1023/A:1005564315131; Barry TN, 1998, J AGR SCI, V131, P251, DOI 10.1017/S002185969800584X; Belesky DP, 1999, AGRON J, V91, P450, DOI 10.2134/agronj1999.00021962009100030015x; Cambui CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019211; CHAILLOU S, 1991, J EXP BOT, V42, P189, DOI 10.1093/jxb/42.2.189; Chatterjee S, 1977, REGRESSION ANAL EXAM; Chon SU, 2005, SCI HORTIC-AMSTERDAM, V106, P309, DOI 10.1016/j.scienta.2005.04.005; Chung RS, 2010, IND CROP PROD, V32, P650, DOI 10.1016/j.indcrop.2010.07.021; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; DELAUNE RD, 1981, SOIL BIOL BIOCHEM, V13, P533, DOI 10.1016/0038-0717(81)90045-6; Delfini R, 2010, PLANT GROWTH REGUL, V61, P153, DOI 10.1007/s10725-010-9461-1; DESHUSSES J, 1961, Mitt Geb Lebensmittelunters Hyg, V52, P428; Dong J, 2006, EUPHYTICA, V151, P71, DOI 10.1007/s10681-006-9129-0; Ens EJ, 2010, PLANT SOIL, V326, P403, DOI 10.1007/s11104-009-0021-2; Fang CX, 2010, PLANT GROWTH REGUL, V61, P277, DOI 10.1007/s10725-010-9475-8; Fang CX, 2009, PLANT GROWTH REGUL, V57, P163, DOI 10.1007/s10725-008-9333-0; Fitter A, 2003, SCIENCE, V301, P1337, DOI 10.1126/science.1089291; Gallo M, 2004, MICROB ECOL, V48, P218, DOI 10.1007/s00248-003-9001-x; GLASS ADM, 1974, PLANT PHYSIOL, V54, P855, DOI 10.1104/pp.54.6.855; Gregory S, 1978, STAT METHODS GEOGRAP; Hadacek F, 2002, CRIT REV PLANT SCI, V21, P273, DOI 10.1080/0735-260291044269; Hassan HA, 2010, FOOD CHEM TOXICOL, V48, P2163, DOI 10.1016/j.fct.2010.05.023; Hogh-Jensen H, 2006, EUR J AGRON, V24, P247, DOI 10.1016/j.eja.2005.10.007; Jung GA, 1996, AGRON J, V88, P104, DOI 10.2134/agronj1996.00021962008800010022x; Kato-Noguchi H, 2010, PLANT GROWTH REGUL, V60, P127, DOI 10.1007/s10725-009-9428-2; Kato-Noguchi H, 2009, PLANT GROWTH REGUL, V59, P153, DOI 10.1007/s10725-009-9398-4; Kidd PS, 2000, PLANT BIOLOGY, V2, P335, DOI 10.1055/s-2000-3706; Lattin J., 2003, ANAL MULTIVARIATE DA; LAWTON JH, 1994, OIKOS, V71, P367, DOI 10.2307/3545824; Le Thi H, 2008, PLANT GROWTH REGUL, V56, P1, DOI 10.1007/s10725-008-9289-0; Lea PJ, 2006, ANN APPL BIOL, V149, P243, DOI 10.1111/j.1744-7348.2006.00101.x; Levang-Brilz N, 2003, PLANT ECOL, V165, P117, DOI 10.1023/A:1021469210691; Mulabagal V, 2009, EUR FOOD RES TECHNOL, V230, P47, DOI 10.1007/s00217-009-1144-7; Nakano H, 2002, PLANT GROWTH REGUL, V37, P113, DOI 10.1023/A:1020579101938; Nasir H, 2005, J CHEM ECOL, V31, P2179, DOI 10.1007/s10886-005-6084-5; Oueslati O, 2005, J AGRON CROP SCI, V191, P249, DOI 10.1111/j.1439-037X.2005.00156.x; Parvez SS, 2004, PLANT GROWTH REGUL, V42, P245, DOI 10.1023/B:GROW.0000026493.95805.a5; Parvez SS, 2003, PLANT GROWTH REGUL, V41, P139, DOI 10.1023/A:1027387126878; Parvez SS, 2003, PLANT GROWTH REGUL, V40, P107, DOI 10.1023/A:1024237426416; Perry LG, 2005, J ECOL, V93, P1126, DOI 10.1111/j.1365-2745.2005.01044.x; Plumier W., 1972, Revue de l'Agriculture, V25, P567; Rice EL, 1984, ALLELOPATHY; Saiya-Cork KR, 2002, SOIL BIOL BIOCHEM, V34, P1309, DOI 10.1016/S0038-0717(02)00074-3; Salam MA, 2009, PLANT GROWTH REGUL, V58, P137, DOI 10.1007/s10725-009-9360-5; SAS-Institute-Inc, 1988, SAS STAT US GUID; Sinsabaugh RL, 2002, BIOGEOCHEMISTRY, V60, P1, DOI 10.1023/A:1016541114786; Sodaeizadeh H, 2009, PLANT GROWTH REGUL, V59, P227, DOI 10.1007/s10725-009-9408-6; Suriguga, 2008, XIBEI ZHIWU XUEBAO, V28, P1689; Turner KE, 1999, AGRON J, V91, P445, DOI 10.2134/agronj1999.00021962009100030014x; Van Waes C, 1998, J SCI FOOD AGR, V76, P107, DOI 10.1002/(SICI)1097-0010(199801)76:1&lt;107::AID-JSFA911&gt;3.0.CO;2-6; VESSEY JK, 1990, J PLANT NUTR, V13, P95, DOI 10.1080/01904169009364061; Viard-Cretat F, 2009, ANN BOT-LONDON, V103, P1271, DOI 10.1093/aob/mcp064; Wang QZ, 2011, AFR J BIOTECHNOL, V10, P1966; Yao HY, 2009, SOIL BIOL BIOCHEM, V41, P1425, DOI 10.1016/j.soilbio.2009.03.020; Zhang YL, 2011, PLANT GROWTH REGUL, V63, P235, DOI 10.1007/s10725-010-9520-7	56	4	4	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31670	10.1371/journal.pone.0031670	http://dx.doi.org/10.1371/journal.pone.0031670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384054	Green Published, gold			2022-12-27	WOS:000302875500033
J	Coster, A; Madsen, O; Heuven, HCM; Dibbits, B; Groenen, MAM; van Arendonk, JAM; Bovenhuis, H				Coster, Albart; Madsen, Ole; Heuven, Henri C. M.; Dibbits, Bert; Groenen, Martien A. M.; van Arendonk, Johan A. M.; Bovenhuis, Henk			The Imprinted Gene DIO3 Is a Candidate Gene for Litter Size in Pigs	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ORIGIN ALLELIC EXPRESSION; MEAT QUALITY; GENOME SCAN; EVOLUTIONARY CONSERVATION; SWINE CHROMOSOME-2; TYPE-3 DEIODINASE; MOUSE-BRAIN; MUSCLE MASS; IGF2 LOCUS	Genomic imprinting is an important epigenetic phenomenon, which on the phenotypic level can be detected by the difference between the two heterozygote classes of a gene. Imprinted genes are important in both the development of the placenta and the embryo, and we hypothesized that imprinted genes might be involved in female fertility traits. We therefore performed an association study for imprinted genes related to female fertility traits in two commercial pig populations. For this purpose, 309 SNPs in fifteen evolutionary conserved imprinted regions were genotyped on 689 and 1050 pigs from the two pig populations. A single SNP association study was used to detect additive, dominant and imprinting effects related to four reproduction traits; total number of piglets born, the number of piglets born alive, the total weight of the piglets born and the total weight of the piglets born alive. Several SNPs showed significant (q-value<0.10) additive and dominant effects and one SNP showed a significant imprinting effect. The SNP with a significant imprinting effect is closely linked to DIO3, a gene involved in thyroid metabolism. The imprinting effect of this SNP explained approximately 1.6% of the phenotypic variance, which corresponded to approximately 15.5% of the additive genetic variance. In the other population, the imprinting effect of this QTL was not significant (q-value>0.10), but had a similar effect as in the first population. The results of this study indicate a possible association between the imprinted gene DIO3 and female fertility traits in pigs.	[Coster, Albart; Madsen, Ole; Heuven, Henri C. M.; Dibbits, Bert; Groenen, Martien A. M.; van Arendonk, Johan A. M.; Bovenhuis, Henk] Wageningen Univ, Anim Breeding & Genom Grp, Wageningen, Netherlands	Wageningen University & Research	Coster, A (corresponding author), Wageningen Univ, Anim Breeding & Genom Grp, Wageningen, Netherlands.	albart@dairyconsult.nl	van Arendonk, Johan/E-2536-2011; Groenen, Martien/D-8408-2012; Bovenhuis, Henk/E-4750-2012; Madsen, Ole/E-3730-2012	van Arendonk, Johan/0000-0003-2592-3947; Groenen, Martien/0000-0003-0484-4545; Madsen, Ole/0000-0001-8082-7881	Technologiestichting STW	Technologiestichting STW(Technologiestichting STW)	The work was financially supported by Technologiestichting STW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S1; Butler MG, 2009, J ASSIST REPROD GEN, V26, P477, DOI 10.1007/s10815-009-9353-3; Charalambous M, 2010, DEV BIOL, V337, P1, DOI 10.1016/j.ydbio.2009.10.011; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; Dabney A, 2009, QVALUE Q VALUE ESTIM; Day T, 2004, GENETICS, V167, P1537, DOI 10.1534/genetics.103.026211; de Givry S, 2005, P WCB05 WORKSH CONST; de Koning DJ, 2000, P NATL ACAD SCI USA, V97, P7947, DOI 10.1073/pnas.140216397; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Garfield AS, 2011, NATURE, V469, P534, DOI 10.1038/nature09651; Gilmour AR, 2002, ASREML REFERENCE MAN; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Hagan JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004352; Hager R, 2008, GENETICS, V178, P1755, DOI 10.1534/genetics.107.080697; Hager R, 2009, EVOLUTION, V63, P1118, DOI 10.1111/j.1558-5646.2009.00638.x; Haig D, 2004, ANNU REV GENET, V38, P553, DOI 10.1146/annurev.genet.37.110801.142741; Hernandez A, 2006, J CLIN INVEST, V116, P476, DOI 10.1172/JCI26240; Hernandez A, 2005, THYROID, V15, P865, DOI 10.1089/thy.2005.15.865; Hernandez A, 2002, ENDOCRINOLOGY, V143, P4483, DOI 10.1210/en.2002-220800; Hirooka H, 2001, J ANIM SCI, V79, P2320; Holl JW, 2004, J ANIM SCI, V82, P3421; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Jeon JT, 1999, NAT GENET, V21, P157, DOI 10.1038/5938; Knott SA, 1998, GENETICS, V149, P1069; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; Lynch M., 1998, GENETICS ANAL QUANTI; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; Monk D, 2009, HUM MOL GENET, V18, P3066, DOI 10.1093/hmg/ddp248; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Munoz M, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-23; Nezer C, 1999, NAT GENET, V21, P155, DOI 10.1038/5935; Onteru S K, 2009, Soc Reprod Fertil Suppl, V66, P87; Qiao M, 2011, MOL BIOL REP, P1; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Renfree MB, 2008, REPRODUCTION, V136, P523, DOI 10.1530/REP-08-0264; Rohrer GA, 2006, ANIM GENET, V37, P17, DOI 10.1111/j.1365-2052.2005.01368.x; Royo H, 2008, BIOL CELL, V100, P149, DOI 10.1042/BC20070126; Sanchez M, 2008, CONSTRAINTS, V13, P130, DOI 10.1007/s10601-007-9029-5; Sandor C, 2008, GENETICS, V180, P1167, DOI 10.1534/genetics.108.092551; Santure AW, 2006, GENETICS, V173, P2297, DOI 10.1534/genetics.105.049494; Stearns TM, 2005, J ANIM SCI, V83, P2471; Stearns TM, 2005, J ANIM SCI, V83, P1481; StGermain DL, 1997, THYROID, V7, P655; Stinckens A, 2010, ANIM GENET; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thomsen H, 2004, J ANIM SCI, V82, P2213; Tsai CE, 2002, CURR BIOL, V12, P1221, DOI 10.1016/S0960-9822(02)00951-X; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Verona RI, 2003, ANNU REV CELL DEV BI, V19, P237, DOI 10.1146/annurev.cellbio.19.111401.092717; Wolf JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000091; Wolf JB, 2006, PLOS BIOL, V4, P2238, DOI 10.1371/journal.pbio.0040380; Wood AJ, 2006, PLOS GENET, V2, P1677, DOI 10.1371/journal.pgen.0020147; Yang ZL, 2009, AGR SCI CHINA, V8, P613, DOI 10.1016/S1671-2927(08)60253-9; Yevtodiyenko A, 2002, MAMM GENOME, V13, P633, DOI 10.1007/s00335-002-2208-1; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	58	26	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31825	10.1371/journal.pone.0031825	http://dx.doi.org/10.1371/journal.pone.0031825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393372	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500025
J	Schuller, D; Cardoso, F; Sousa, S; Gomes, P; Gomes, AC; Santos, MAS; Casal, M				Schuller, Dorit; Cardoso, Filipa; Sousa, Susana; Gomes, Paula; Gomes, Ana C.; Santos, Manuel A. S.; Casal, Margarida			Genetic Diversity and Population Structure of Saccharomyces cerevisiae Strains Isolated from Different Grape Varieties and Winemaking Regions	PLOS ONE			English	Article							WINE YEAST POPULATIONS; SPONTANEOUS FERMENTATION; NATURAL FERMENTATION; CONSECUTIVE YEARS; ECOLOGICAL SURVEY; MOLECULAR METHODS; IDENTIFICATION; VINEYARD; AREAS; SPAIN	We herein evaluate intraspecific genetic diversity of fermentative vineyard-associated S. cerevisiae strains and evaluate relationships between grape varieties and geographical location on populational structures. From the musts obtained from 288 grape samples, collected from two wine regions (16 vineyards, nine grape varieties), 94 spontaneous fermentations were concluded and 2820 yeast isolates were obtained that belonged mainly (92%) to the species S. cerevisiae. Isolates were classified in 321 strains by the use of ten microsatellite markers. A high strain diversity (8-43 strains per fermentation) was associated with high percentage (60-100%) of fermenting samples per vineyard, whereas a lower percentage of spontaneous fermentations (0-40%) corresponded to a rather low strain diversity (1-10 strains per fermentation). For the majority of the populations, observed heterozygosity (Ho) was about two to five times lower than the expected heterozygosity (He). The inferred ancestry showed a very high degree of admixture and divergence was observed between both grape variety and geographical region. Analysis of molecular variance showed that 81-93% of the total genetic variation existed within populations, while significant differentiation within the groups could be detected. Results from AMOVA analysis and clustering of allelic frequencies agree in the distinction of genetically more dispersed populations from the larger wine region compared to the less extended region. Our data show that grape variety is a driver of populational structures, because vineyards with distinct varieties harbor genetically more differentiated S. cerevisiae populations. Conversely, S. cerevisiae strains from vineyards in close proximity (5-10 km) that contain the same grape variety tend to be less divergent. Populational similarities did not correlate with the distance between vineyards of the two wine regions. Globally, our results show that populations of S. cerevisiae in vineyards may occur locally due to multi-factorial influences, one of them being the grape variety.	[Schuller, Dorit; Cardoso, Filipa; Casal, Margarida] Univ Minho, Ctr Mol & Environm Biol CBMA, Dept Biol, Braga, Portugal; [Sousa, Susana; Gomes, Paula; Gomes, Ana C.] Ctr Inovacao Biotecnol, BIOCANT, Cantanhede, Portugal; [Santos, Manuel A. S.] Univ Aveiro, RNA Biol Lab, Dept Biol, P-3800 Aveiro, Portugal	Universidade do Minho; Universidade de Aveiro	Schuller, D (corresponding author), Univ Minho, Ctr Mol & Environm Biol CBMA, Dept Biol, Braga, Portugal.	dschuller@bio.uminho.pt	Santos, Manuel/E-6704-2010; Schuller, Dorit/I-6649-2013; CASAL, MARGARIDA/B-6386-2009; Gomes, Ana Catarina/A-2628-2015	Santos, Manuel/0000-0002-0437-1146; CASAL, MARGARIDA/0000-0002-0143-9758; Gomes, Ana Catarina/0000-0002-4989-6026; Schuller, Dorit/0000-0001-6030-4602	European Community [232454, 289603]; program FEDER/COMPETE; Portuguese Science and Technology Foundation (Fundacao para a Ciencia e Tecnologia) [POCI/AGR/56102/2004, PTDC/BIABCM/64745/2006, PTDC/AGR-ALI/103392/2008, PTDC/AGR-ALI/098292/2008]; Fundação para a Ciência e a Tecnologia [PTDC/AGR-ALI/098292/2008, PTDC/AGR-ALI/103392/2008, PTDC/BIA-BCM/64745/2006] Funding Source: FCT	European Community(European Commission); program FEDER/COMPETE; Portuguese Science and Technology Foundation (Fundacao para a Ciencia e Tecnologia); Fundação para a Ciência e a Tecnologia	This study was financially supported by the European Community's Seventh Framework Programme under grant agreements no 232454 and 289603. Funding was also obtained by the program FEDER/COMPETE and the Portuguese Science and Technology Foundation (Fundacao para a Ciencia e Tecnologia) through the projects POCI/AGR/56102/2004, PTDC/BIABCM/64745/2006, PTDC/AGR-ALI/103392/2008 and PTDC/AGR-ALI/098292/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azumi M, 2001, YEAST, V18, P1145, DOI 10.1002/yea.767; Ben-Ari G, 2005, HEREDITY, V95, P493, DOI 10.1038/sj.hdy.6800759; Blanco P, 2006, ANTON LEEUW INT J G, V89, P351, DOI 10.1007/s10482-005-9038-6; Cavalieri D, 1998, FOOD TECHNOL BIOTECH, V36, P45; Chavan P, 2009, FOOD MICROBIOL, V26, P801, DOI 10.1016/j.fm.2009.05.005; Comi G, 2000, INT J FOOD MICROBIOL, V58, P117, DOI 10.1016/S0168-1605(00)00287-7; Constanti M, 1997, AM J ENOL VITICULT, V48, P339; Cordero-Bueso G, 2011, INT J FOOD MICROBIOL, V148, P23, DOI 10.1016/j.ijfoodmicro.2011.04.021; Cordero-Bueso G, 2011, INT J FOOD MICROBIOL, V145, P132, DOI 10.1016/j.ijfoodmicro.2010.11.040; Csoma H, 2010, INT J FOOD MICROBIOL, V140, P239, DOI 10.1016/j.ijfoodmicro.2010.03.024; Cubillos FA, 2009, FEMS MICROBIOL ECOL, V67, P162, DOI 10.1111/j.1574-6941.2008.00600.x; Esteve-Zarzoso B, 2000, FOOD MICROBIOL, V17, P553, DOI 10.1006/fmic.2000.0347; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Franco-Duarte R, 2011, ELECTROPHORESIS, V32, P1447, DOI 10.1002/elps.201000640; FREZIER V, 1992, AM J ENOL VITICULT, V43, P375; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Gayevskiy V, 2011, ISME J, P1; Goddard MR, 2010, ENVIRON MICROBIOL, V12, P63, DOI 10.1111/j.1462-2920.2009.02035.x; Granchi L, 1999, J APPL MICROBIOL, V87, P949, DOI 10.1046/j.1365-2672.1999.00600.x; Greig D, 2009, CURR BIOL, V19, pR886, DOI 10.1016/j.cub.2009.07.037; Gutierrez AR, 1999, LETT APPL MICROBIOL, V29, P411, DOI 10.1046/j.1472-765X.1999.00657.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Khan W., 2000, South African Journal of Enology and Viticulture, V21, P17; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Legras JL, 2005, INT J FOOD MICROBIOL, V102, P73, DOI 10.1016/j.ijfoodmicro.2004.12.007; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; LONGO E, 1991, AM J ENOL VITICULT, V42, P141; Lopandic K, 2007, FEMS YEAST RES, V7, P953, DOI 10.1111/j.1567-1364.2007.00240.x; Lopes CA, 2002, J APPL MICROBIOL, V93, P608, DOI 10.1046/j.1365-2672.2002.01738.x; Martini A, 1996, AM J ENOL VITICULT, V47, P435; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Mortimer R, 1999, RES MICROBIOL, V150, P199, DOI 10.1016/S0923-2508(99)80036-9; MORTIMER RK, 1994, YEAST, V10, P1543, DOI 10.1002/yea.320101203; Orlic S, 2010, WORLD J MICROB BIOT, V26, P1483, DOI 10.1007/s11274-010-0323-9; PARISH ME, 1985, AM J ENOL VITICULT, V36, P165; Pramateftaki PV, 2000, J APPL MICROBIOL, V89, P236, DOI 10.1046/j.1365-2672.2000.01102.x; Pretorius I. S., 1999, South African Journal of Enology and Viticulture, V20, P61; Rosini G., 1982, VIGNE VINI, V9, P43; Sabate J, 1998, LETT APPL MICROBIOL, V26, P452, DOI 10.1046/j.1472-765X.1998.00369.x; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; SCHNEIDER S, ARLEQUIN VER 2 000 S; Schuller D, 2005, FEMS MICROBIOL ECOL, V51, P167, DOI 10.1016/j.femsec.2004.08.003; Schuller D, 2004, FEMS MICROBIOL LETT, V231, P19, DOI 10.1016/S0378-1097(03)00928-5; Schuller D, 2007, YEAST, V24, P625, DOI 10.1002/yea.1496; Schuller D, 2007, ANTON LEEUW INT J G, V91, P137, DOI 10.1007/s10482-006-9104-8; SCHUTZ M, 1993, J APPL BACTERIOL, V75, P551, DOI 10.1111/j.1365-2672.1993.tb01594.x; Sipiczki M, 2001, ANTON LEEUW INT J G, V79, P97, DOI 10.1023/A:1010249408975; Sun HH, 2009, ANN MICROBIOL, V59, P69, DOI 10.1007/BF03175601; Torija MJ, 2001, ANTON LEEUW INT J G, V79, P345, DOI 10.1023/A:1012027718701; Valero E, 2007, FEMS YEAST RES, V7, P317, DOI 10.1111/j.1567-1364.2006.00161.x; van der Westhuizen T. J., 2000, South African Journal of Enology and Viticulture, V21, P10; van der Westhuizen T. J., 2000, South African Journal of Enology and Viticulture, V21, P3; VERSAVAUD A, 1995, SYST APPL MICROBIOL, V18, P303, DOI 10.1016/S0723-2020(11)80401-7; VERSAVAUD A, 1993, REV FR OENOL, V142, P20; VEZINHET F, 1992, AM J ENOL VITICULT, V43, P83; Wright S., 1978, EVOLUTION GENETICS P	57	65	69	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32507	10.1371/journal.pone.0032507	http://dx.doi.org/10.1371/journal.pone.0032507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393409	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500062
J	Graae, L; Karlsson, R; Paddock, S				Graae, Lisette; Karlsson, Robert; Paddock, Silvia			Significant Association of Estrogen Receptor Binding Site Variation with Bipolar Disorder in Females	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL TRANSFER PROTEINS; GENOME-WIDE ASSOCIATION; MENTAL-HEALTH SURVEY; GENE-EXPRESSION; TISSUE TRANSGLUTAMINASE; MAJOR DEPRESSION; SEX-DIFFERENCES; NEURODEGENERATIVE DISORDERS; RESPONSE ELEMENTS; MESSENGER-RNA	Major depression is nearly twice as prevalent in women compared to men. In bipolar disorder, depressive episodes have been reported to be more common amongst female patients. Furthermore, periods of depression often correlate with periods of hormonal fluctuations. A link between hormone signaling and these mood disorders has, therefore, been suggested to exist in many studies. Estrogen, one of the primary female sex hormones, mediates its effect mostly by binding to estrogen receptors (ERs). Nuclear ERs function as transcription factors and regulate gene transcription by binding to specific DNA sequences. A nucleotide change in the binding sequence might alter the binding efficiency, which could affect transcription levels of nearby genes. In order to investigate if variation in ER DNA-binding sequences may be involved in mood disorders, we conducted a genome-wide study of ER DNA-binding in patients diagnosed with major depression or bipolar disorder. Association studies were performed within each gender separately and the results were corrected for multiple testing by the Bonferroni method. In the female bipolar disorder material a significant association result was found for rs6023059 (corrected p-value = 0.023; odds ratio (OR) 0.681, 95% confidence interval (CI) 0.570-0.814), a single nucleotide polymorphism (SNP) placed downstream of the gene coding for transglutaminase 2 (TGM2). Thus, females with a specific genotype at this SNP may be more vulnerable to fluctuating estrogen levels, which may then act as a triggering factor for bipolar disorder.	[Graae, Lisette; Paddock, Silvia] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Karlsson, Robert] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Graae, L (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	graae.lisette@gmail.com		Karlsson, Robert/0000-0002-8949-2587	Swedish Research Council [2005-6929]; Swedish Foundation for Strategic Research [A3 05:207b]; Brain and Behavior Research Foundation; Karolinska Institutet Foundations; Center for Gender Medicine at Karolinska Institutet; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH046282, R01MH059567, R01MH059533, R01MH059548, R01MH059553, Z01MH002810, R01MH059545, R01MH059534, R01MH059535, R01MH060068, R01MH059556, U01MH046280, U01MH046274] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Brain and Behavior Research Foundation; Karolinska Institutet Foundations(Karolinska Institutet); Center for Gender Medicine at Karolinska Institutet(Karolinska Institutet); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Swedish Research Council (www.vr.se; Dnr. 2005-6929), the Swedish Foundation for Strategic Research (www.stratresearch.se; Dnr. A3 05:207b), a 'Young Investigator Grant' (to SP) from the Brain and Behavior Research Foundation (http://bbrfoundation.org/; formerly NARSAD), Karolinska Institutet Foundations (http://ki.se/ki/jsp/polopoly.jsp;jsessionid=a_3ahrCXd3144UH4Mk?l=en&d=20152), and the Center for Gender Medicine at Karolinska Institutet (http://ki.se/ki/jsp/polopoly.jsp?l=en&d=8993). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano K, 2008, PSYCHIAT GENET, V18, P1, DOI 10.1097/YPG.0b013e3281ac238e; Arevalo MA, 2010, BBA-GEN SUBJECTS, V1800, P1106, DOI 10.1016/j.bbagen.2009.10.002; Assisi L, 1999, EXP CELL RES, V247, P339, DOI 10.1006/excr.1998.4358; Bauersachs S, 2008, EXP CLIN ENDOCR DIAB, V116, P371, DOI 10.1055/s-2008-1076714; Benes FM, 2006, MOL PSYCHIATR, V11, P241, DOI 10.1038/sj.mp.4001758; Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P581, DOI 10.1007/s001270050097; Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Bradford M, 2009, AM J MED GENET B, V150B, P335, DOI 10.1002/ajmg.b.30813; Brietzke E, 2011, CNS SPECTRUMS; Campisi A, 2008, J NEUROSCI RES, V86, P1297, DOI 10.1002/jnr.21579; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chiu Chi-Tso, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P461, DOI 10.3969/j.issn.1672-7347.2011.06.001; Cockcroft S, 2007, BBA-MOL CELL BIOL L, V1771, P677, DOI 10.1016/j.bbalip.2007.03.009; Craddock N, 2009, TRENDS GENET, V25, P99, DOI 10.1016/j.tig.2008.12.002; Diflorio A, 2010, INT REV PSYCHIATR, V22, P437, DOI 10.3109/09540261.2010.514601; Driscoll MD, 1998, J BIOL CHEM, V273, P29321, DOI 10.1074/jbc.273.45.29321; DUBOVSKY SL, 1992, AM J PSYCHIAT, V149, P118; El Khoury A, 2002, PROG NEURO-PSYCHOPH, V26, P1063, DOI 10.1016/S0278-5846(02)00223-3; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Freeman MP, 2002, J CLIN PSYCHIAT, V63, P284, DOI 10.4088/JCP.v63n0403; Fujita K, 2006, NEUROCHEM RES, V31, P1059, DOI 10.1007/s11064-006-9114-y; Gigante AD, 2011, INT J NEUROPSYCHOPH, V14, P1075, DOI 10.1017/S146114571000146X; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Grigoriadis Sophie, 2002, Am J Ther, V9, P503, DOI 10.1097/00045391-200211000-00008; Gupta A, 2011, PHARMACOGENOMICS J; Habauzit D, 2011, J TOXICOL ENV HEAL B, V14, P300, DOI 10.1080/10937404.2011.578554; Hadjivassiliou M, 2008, ANN NEUROL, V64, P332, DOI 10.1002/ana.21450; Halbreich U, 2001, CNS DRUGS, V15, P797, DOI 10.2165/00023210-200115100-00005; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Herberth M, 2011, PROTEOMICS, V11, P94, DOI 10.1002/pmic.201000291; Hucho TB, 2006, EUR J NEUROSCI, V24, P527, DOI 10.1111/j.1460-9568.2006.04913.x; Iga J, 2006, NEUROSCI LETT, V400, P203, DOI 10.1016/j.neulet.2006.02.044; Kairouz R, 2005, J CELL PHYSIOL, V203, P85, DOI 10.1002/jcp.20199; Kealey C, 2001, PSYCHIAT GENET, V11, P223, DOI 10.1097/00041444-200112000-00008; Kendler KS, 2006, AM J PSYCHIAT, V163, P109, DOI 10.1176/appi.ajp.163.1.109; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kulakosky PC, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290137; Leibenluft E, 1996, AM J PSYCHIAT, V153, P163; Lesort M, 2000, PROG NEUROBIOL, V61, P439, DOI 10.1016/S0301-0082(99)00052-0; Li Q, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.33; LI XH, 1995, J NEUROCHEM, V65, P2500; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Mahon PB, 2009, AM J PSYCHIAT, V166, P1229, DOI 10.1176/appi.ajp.2009.09030417; McQuillin A, 2007, PHARMACOGENET GENOM, V17, P605, DOI 10.1097/FPC.0b013e328011b5b2; Middle F, 2003, AM J MED GENET B, V118B, P72, DOI 10.1002/ajmg.b.10021; Osterlund MK, 2005, ENDOCRINE, V28, P235, DOI 10.1385/ENDO:28:3:235; Ostlund H, 2003, ANN NY ACAD SCI, V1007, P54, DOI 10.1196/annals.1286.006; Pae CU, 2009, BIOMED PHARMACOTHER, V63, P228, DOI 10.1016/j.biopha.2008.03.010; Park KC, 2004, BIOCHEM BIOPH RES CO, V323, P1055, DOI 10.1016/j.bbrc.2004.08.204; Payne JL, 2003, INT REV PSYCHIATR, V15, P280, DOI 10.1080/0954026031000136893; Ruan QM, 2007, FRONT BIOSCI-LANDMRK, V12, P891, DOI 10.2741/2111; RUSINOL AE, 1989, J BIOL CHEM, V264, P6612; Samaroo D, 2009, SCHIZOPHR RES; Shadan S, 2008, TRAFFIC, V9, P1743, DOI 10.1111/j.1600-0854.2008.00794.x; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Squassina A, 2008, PHARMACOL RES, V57, P369, DOI 10.1016/j.phrs.2008.03.011; Squassina A, 2008, PSYCHIAT GENET, V18, P128, DOI 10.1097/YPG.0b013e3282fb003d; SULLIVAN PF, 2008, MOL PSYCHIAT; Tenenbaum M, 2007, J ENDOTOXIN RES, V13, P158, DOI 10.1177/0968051907080428; van Nas A, 2009, ENDOCRINOLOGY, V150, P1235, DOI 10.1210/en.2008-0563; Vegeto E, 2008, FRONT NEUROENDOCRIN, V29, P507, DOI 10.1016/j.yfrne.2008.04.001; Viguera AC., 2011, AM J PSYCHIAT; Wasserman MJ, 2004, NEUROPSYCHOPHARMACOL, V29, P759, DOI 10.1038/sj.npp.1300400; Weickert CS, 2008, HUM MOL GENET, V17, P2293, DOI 10.1093/hmg/ddn130; WEISSMAN MM, 1977, ARCH GEN PSYCHIAT, V34, P98; WEISSMAN MM, 1993, J AFFECT DISORDERS, V29, P77, DOI 10.1016/0165-0327(93)90025-F; WILHELM K, 1994, PSYCHOL MED, V24, P97, DOI 10.1017/S0033291700026878; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Zhao CY, 2010, CANCER RES, V70, P5174, DOI 10.1158/0008-5472.CAN-09-4407	71	7	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32304	10.1371/journal.pone.0032304	http://dx.doi.org/10.1371/journal.pone.0032304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389694	Green Submitted, gold, Green Published			2022-12-27	WOS:000302999600032
J	Pinto, P; Wang, QH; Chen, N; Dubovi, EJ; Daniels, JB; Millward, LM; Buonavoglia, C; Martella, V; Saif, LJ				Pinto, Pierfrancesco; Wang, Qiuhong; Chen, Ning; Dubovi, Edward J.; Daniels, Joshua B.; Millward, Laurie M.; Buonavoglia, Canio; Martella, Vito; Saif, Linda J.			Discovery and Genomic Characterization of Noroviruses from a Gastroenteritis Outbreak in Domestic Cats in the US	PLOS ONE			English	Article							NONSTRUCTURAL POLYPROTEIN; MURINE NOROVIRUS; END CDNA; INFECTION; PATHOGENESIS; STRAIN; AMPLIFICATION; ANTIBODY; NORWALK; FECES	Norovirus (NoV) RNA was detected in the stools of 6 out 14 (42.8%) 8-12-week-old cats with enteritis from a feline shelter, in New York State. Upon sequence analysis of the complete capsid, the six NoVs were found to be identical, suggesting the spread of a unique NoV strain in the shelter. The full-length genomic sequence (7839 nt) of one feline NoV, CU081210E/2010/US, was determined. In the capsid protein VP1 region, the virus displayed the highest amino acid identity to animal genogroup IV genotype 2 (GIV.2) NoVs: lion/Pistoia-387/06/IT (97.9%) and dog/Bari-170/07/IT (90.4%). These findings document the discovery of a novel feline calicivirus, different from vesiviruses, and extend the spectrum of NoV host range. Epidemiological studies using feline NoV-specific diagnostic tools and experimental infection of cats are required to understand whether NoVs have a pathogenic role in this species.	[Pinto, Pierfrancesco; Buonavoglia, Canio; Martella, Vito] Univ Bari Aldo Moro, Dept Vet Publ Hlth, Valenzano, Italy; [Wang, Qiuhong; Chen, Ning; Saif, Linda J.] Ohio State Univ, Dept Vet Prevent Med, Wooster, OH USA; [Dubovi, Edward J.] Cornell Univ, Dept Populat Med, Ithaca, NY USA; [Daniels, Joshua B.; Millward, Laurie M.] Ohio State Univ, Dept Vet Clin Sci, Columbus, OH 43210 USA	Universita degli Studi di Bari Aldo Moro; University System of Ohio; Ohio State University; Cornell University; University System of Ohio; Ohio State University	Pinto, P (corresponding author), Univ Bari Aldo Moro, Dept Vet Publ Hlth, Valenzano, Italy.	v.martella@veterinaria.uniba.it	Daniels, Joshua B/D-5200-2019; Martella, Vito/K-3146-2016	Martella, Vito/0000-0002-5740-6947	state and federal funds; Italian Government (Borse di studio a collaborazione internazionale, Regione Puglia e A.DI.S.U. Puglia) [2288/2009]; Italian Ministry of Health, Ricerca corrente; Italian Ministry for Education, University and Research; Scientific and technological collaboration Italy-Usa; Italian Ministry of Foreign Affairs (Mae)	state and federal funds; Italian Government (Borse di studio a collaborazione internazionale, Regione Puglia e A.DI.S.U. Puglia); Italian Ministry of Health, Ricerca corrente(Ministry of Health, Italy); Italian Ministry for Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Scientific and technological collaboration Italy-Usa; Italian Ministry of Foreign Affairs (Mae)(Ministry of Foreign Affairs and International Cooperation (Italy))	Salaries and research support were provided by state and federal funds provided to the Ohio Agricultural Research and Development Center (OARDC), The Ohio State University, US. P. Pinto was supported by the Italian Government (Borse di studio a collaborazione internazionale, Regione Puglia e A.DI.S.U. Puglia, delibera No 2288/2009). V. Martella was supported by the Italian Ministry of Health, Ricerca corrente 2009, project IZS VE 21/09 RC "Definizione di una procedura validata per la selezione di cani per programmi di Interventi Assistiti dagli Animali (IAA)''; by the Italian Ministry for Education, University and Research, grant PRIN 2008 "Calicivirus nei carnivori e nell'uomo: caratterizzazione molecolare, epidemiologia, implicazioni zoonosiche''; and by the grant Scientific and technological collaboration Italy-Usa 2010 by the Italian Ministry of Foreign Affairs (Mae) - "Assessing the impact of GIV-norovirus on human health: a molecular epidemiological investigation on environmental and clinical samples as a basis for the design of novel diagnostic tools for an emerging pathogen''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belliot G, 2003, J VIROL, V77, P10957, DOI 10.1128/JVI.77.20.10957-10974.2003; Cheetham S, 2006, J VIROL, V80, P10372, DOI 10.1128/JVI.00809-06; Di Martino B, 2010, CLIN VACCINE IMMUNOL, V17, P180, DOI 10.1128/CVI.00312-09; Green K. Y., 2007, FIELDS VIROLOGY, V1, P949; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HERBST W, 1987, J VET MED B, V34, P314, DOI 10.1111/j.1439-0450.1987.tb00402.x; Jiang X, 1999, J VIROL METHODS, V83, P145, DOI 10.1016/S0166-0934(99)00114-7; JOHNSON RP, 1983, CAN VET J, V24, P6; Karst SM, 2010, VIRUSES-BASEL, V2, P748, DOI 10.3390/v2030748; KENNEDY FA, 1993, J VET DIAGN INVEST, V5, P273, DOI 10.1177/104063879300500224; Kipar A, 2001, VET PATHOL, V38, P359, DOI 10.1354/vp.38-4-359; Kitajima M, 2009, LETT APPL MICROBIOL, V49, P655, DOI 10.1111/j.1472-765X.2009.02718.x; L'Homme Y, 2009, VIRUS GENES, V39, P66, DOI 10.1007/s11262-009-0360-3; La Rosa G, 2010, ARCH VIROL, V155, P589, DOI 10.1007/s00705-010-0619-y; Lindesmith LC, 2011, J VIROL, V85, P231, DOI 10.1128/JVI.01364-10; Lochridge VP, 2007, J VIROL, V81, P12316, DOI 10.1128/JVI.01254-07; LOVE DN, 1972, AUST VET J, V48, P643, DOI 10.1111/j.1751-0813.1972.tb05105.x; MARSHALL JA, 1987, AUST VET J, V64, P100, DOI 10.1111/j.1751-0813.1987.tb09638.x; Martella V, 2011, VET SMALL A IN PRESS; Martella V, 2008, EMERG INFECT DIS, V14, P1306, DOI 10.3201/eid1408.080062; Martella V, 2007, EMERG INFECT DIS, V13, P1071, DOI 10.3201/eid1307.070268; Martella V, 2009, J VIROL, V83, P11391, DOI 10.1128/JVI.01385-09; Mesquita JR, 2010, EMERG INFECT DIS, V16, P980, DOI 10.3201/eid1606.091861; MOCHIZUKI M, 1992, VET MICROBIOL, V31, P297, DOI 10.1016/0378-1135(92)90087-A; Ntafis V, 2010, J CLIN MICROBIOL, V48, P2605, DOI 10.1128/JCM.02528-09; Povey RC, 1974, J COMP PATHOL, V10, P1307; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Radford AD, 2009, J FELINE MED SURG, V11, P556, DOI 10.1016/j.jfms.2009.05.004; RICE M, 1993, NEW ZEAL VET J, V41, P96, DOI 10.1080/00480169.1993.35743; Scotto-Lavino E, 2006, NAT PROTOC, V1, P3056, DOI 10.1038/nprot.2006.479; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2742, DOI 10.1038/nprot.2006.481; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Sosnovtsev SV, 2006, J VIROL, V80, P7816, DOI 10.1128/JVI.00532-06; Souza M, 2008, J VIROL, V82, P1777, DOI 10.1128/JVI.01347-07; SPRADBROW PB, 1970, AUST VET J, V46, P105, DOI 10.1111/j.1751-0813.1970.tb15931.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WARDLEY RC, 1977, RES VET SCI, V23, P15, DOI 10.1016/S0034-5288(18)33215-6; Yun SI, 2010, VIRUS RES, V152, P137, DOI 10.1016/j.virusres.2010.06.018; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	39	54	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32739	10.1371/journal.pone.0032739	http://dx.doi.org/10.1371/journal.pone.0032739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389721	Green Published, gold, Green Submitted			2022-12-27	WOS:000302999600060
J	Hansen, M; Gerds, TA; Nielsen, OH; Seidelin, JB; Troelsen, JT; Olsen, J				Hansen, Morten; Gerds, Thomas Alexander; Nielsen, Ole Haagen; Seidelin, Jakob Benedict; Troelsen, Jesper Thorvald; Olsen, Jorgen			pcaGoPromoter - An R Package for Biological and Regulatory Interpretation of Principal Components in Genome-Wide Gene Expression Data	PLOS ONE			English	Article							MULTIVARIATE-ANALYSIS; MICROARRAY DATA; PROBE LEVEL; CELL-CYCLE; PROFILES; SERUM; IDENTIFICATION; BIOCONDUCTOR; REPLICATION; INTEGRATION	Analyzing data obtained from genome-wide gene expression experiments is challenging due to the quantity of variables, the need for multivariate analyses, and the demands of managing large amounts of data. Here we present the R package pcaGoPromoter, which facilitates the interpretation of genome-wide expression data and overcomes the aforementioned problems. In the first step, principal component analysis (PCA) is applied to survey any differences between experiments and possible groupings. The next step is the interpretation of the principal components with respect to both biological function and regulation by predicted transcription factor binding sites. The robustness of the results is evaluated using cross-validation, and illustrative plots of PCA scores and gene ontology terms are available. pcaGoPromoter works with any platform that uses gene symbols or Entrez IDs as probe identifiers. In addition, support for several popular Affymetrix GeneChip platforms is provided. To illustrate the features of the pcaGoPromoter package a serum stimulation experiment was performed and the genome-wide gene expression in the resulting samples was profiled using the Affymetrix Human Genome U133 Plus 2.0 chip. Array data were analyzed using pcaGoPromoter package tools, resulting in a clear separation of the experiments into three groups: controls, serum only and serum with inhibitor. Functional annotation of the axes in the PCA score plot showed the expected serum-promoted biological processes, e. g., cell cycle progression and the predicted involvement of expected transcription factors, including E2F. In addition, unexpected results, e. g., cholesterol synthesis in serum-depleted cells and NF-kB activation in inhibitor treated cells, were noted. In summary, the pcaGoPromoter R package provides a collection of tools for analyzing gene expression data. These tools give an overview of the input data via PCA, functional interpretation by gene ontology terms (biological processes), and an indication of the involvement of possible transcription factors.	[Hansen, Morten; Troelsen, Jesper Thorvald; Olsen, Jorgen] Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Gerds, Thomas Alexander] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark; [Nielsen, Ole Haagen; Seidelin, Jakob Benedict] Univ Copenhagen, Dept Gastroenterol, Med Sect, Herlev Hosp, Copenhagen, Denmark; [Troelsen, Jesper Thorvald] Univ Roskilde, Dept Sci Models & Syst, Roskilde, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Roskilde University	Hansen, M (corresponding author), Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark.	jolsen@sund.ku.dk	Olsen, Jørgen/K-5355-2019; Nielsen, Ole Haagen/AAK-2482-2021; Seidelin, Jakob/B-7879-2013; Troelsen, Jesper Thorvald T/B-6264-2013	Olsen, Jørgen/0000-0003-1974-6446; Nielsen, Ole Haagen/0000-0003-4612-8635; Seidelin, Jakob/0000-0003-3230-7966; Troelsen, Jesper Thorvald T/0000-0002-4177-3267; Gerds, Thomas Alexander/0000-0002-5955-816X	Lundbeck Foundation; Family Erichsen Memorial Foundation	Lundbeck Foundation(Lundbeckfonden); Family Erichsen Memorial Foundation	The project was supported by grants from the Lundbeck Foundation and the Family Erichsen Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Bruckskotten M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-336; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Busold CH, 2005, BIOINFORMATICS, V21, P2424, DOI 10.1093/bioinformatics/bti367; Csillag C, 2007, AM J PHYSIOL-GASTR L, V292, pG298, DOI 10.1152/ajpgi.00321.2006; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Fagan A, 2007, PROTEOMICS, V7, P2162, DOI 10.1002/pmic.200600898; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; GABRIEL KR, 1971, BIOMETRIKA, V58, P453, DOI 10.1093/biomet/58.3.453; Ganter B, 2008, PHARMACOGENOMICS, V9, P35, DOI 10.2217/14622416.9.1.35; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hauff KD, 2010, BIOCHEM CELL BIOL, V88, P595, DOI 10.1139/O09-186; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jeffery IB, 2007, BIOINFORMATICS, V23, P298, DOI 10.1093/bioinformatics/btl597; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Li YY, 2003, FEBS LETT, V544, P112, DOI 10.1016/S0014-5793(03)00485-X; Maeng YS, 2006, CELL SIGNAL, V18, P994, DOI 10.1016/j.cellsig.2005.08.007; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Notterman DA, 2001, CANCER RES, V61, P3124; Olsen J, 2009, INFLAMM BOWEL DIS, V15, P1032, DOI 10.1002/ibd.20879; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pedersen MB, 2007, J INVEST DERMATOL, V127, P2585, DOI 10.1038/sj.jid.5700902; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Pruitt KD, 2000, TRENDS GENET, V16, P44, DOI 10.1016/S0168-9525(99)01882-X; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Quackenbush J, 2006, METHOD INFORM MED, V45, P91; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Ringner M, 2002, PHARMACOGENOMICS, V3, P403, DOI 10.1517/14622416.3.3.403; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Stegmann A, 2006, PHYSIOL GENOMICS, V27, P141, DOI 10.1152/physiolgenomics.00314.2005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	49	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32394	10.1371/journal.pone.0032394	http://dx.doi.org/10.1371/journal.pone.0032394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384239	Green Published, gold, Green Submitted			2022-12-27	WOS:000302918500083
J	Hartter, J; Stampone, MD; Ryan, SJ; Kirner, K; Chapman, CA; Goldman, A				Hartter, Joel; Stampone, Mary D.; Ryan, Sadie J.; Kirner, Karen; Chapman, Colin A.; Goldman, Abraham			Patterns and Perceptions of Climate Change in a Biodiversity Conservation Hotspot	PLOS ONE			English	Article							EQUATORIAL EAST-AFRICA; HUMAN-POPULATION; RAINFALL VARIABILITY; TEMPORAL PATTERNS; PROTECTED AREAS; FUTURE CLIMATE; CHANGE IMPACTS; FOREST PARK; LAND-USE; UGANDA	Quantifying local people's perceptions to climate change, and their assessments of which changes matter, is fundamental to addressing the dual challenge of land conservation and poverty alleviation in densely populated tropical regions To develop appropriate policies and responses, it will be important not only to anticipate the nature of expected changes, but also how they are perceived, interpreted and adapted to by local residents. The Albertine Rift region in East Africa is one of the world's most threatened biodiversity hotspots due to dense smallholder agriculture, high levels of land and resource pressures, and habitat loss and conversion. Results of three separate household surveys conducted in the vicinity of Kibale National Park during the late 2000s indicate that farmers are concerned with variable precipitation. Many survey respondents reported that conditions are drier and rainfall timing is becoming less predictable. Analysis of daily rainfall data for the climate normal period 1981 to 2010 indicates that total rainfall both within and across seasons has not changed significantly, although the timing and transitions of seasons has been highly variable. Results of rainfall data analysis also indicate significant changes in the intra-seasonal rainfall distribution, including longer dry periods within rainy seasons, which may contribute to the perceived decrease in rainfall and can compromise food security. Our results highlight the need for fine-scale climate information to assist agro-ecological communities in developing effective adaptive management.	[Hartter, Joel; Stampone, Mary D.] Univ New Hampshire, Dept Geog, Durham, NH 03824 USA; [Ryan, Sadie J.] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Coll Environm Sci & Forestry, Syracuse, NY 13210 USA; [Ryan, Sadie J.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Kirner, Karen] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Chapman, Colin A.] McGill Univ, Dept Anthropol, Montreal, PQ, Canada; [Chapman, Colin A.] McGill Univ, McGill Sch Environm, Montreal, PQ, Canada; [Chapman, Colin A.] Wildlife Conservat Soc, Bronx, NY USA; [Goldman, Abraham] Univ Florida, Dept Geog, Gainesville, FL 32611 USA	University System Of New Hampshire; University of New Hampshire; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; State University System of Florida; University of Florida; McGill University; McGill University; Wildlife Conservation Society; State University System of Florida; University of Florida	Hartter, J (corresponding author), Univ New Hampshire, Dept Geog, Durham, NH 03824 USA.	joel.hartter@unh.edu	Ryan, Sadie/H-1595-2012; Chapman, Colin/S-1911-2019; Ryan, Sadie Jane/H-7488-2019	Chapman, Colin/0000-0002-8827-8140; Ryan, Sadie Jane/0000-0002-4308-6321; HARTTER, JOEL/0000-0002-2255-1845	National Science Foundation [0352008, 0624343, EF-0553768]; University of California, Santa Barbara; State of California; Natural Sciences and Engineering Research Council; Canada Research Chair; National Geographic Society	National Science Foundation(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); National Geographic Society(National Geographic Society)	AG, JH, and KK were funded through National Science Foundation grants (0352008, 0624343). SJR conducted this work while a Postdoctoral Associate at the National Center for Ecological Analysis and Synthesis, a Center funded by National Science Foundation (EF-0553768), the University of California, Santa Barbara, and the State of California. CAC's research was supported by Natural Sciences and Engineering Research Council, Canada Research Chair, and National Geographic Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 00849 IFPRI; [Anonymous], [No title captured]; Baird TD, 2009, HUM ECOL, V37, P463, DOI 10.1007/s10745-009-9264-z; Bartlein PJ, 1997, CONSERV BIOL, V11, P782, DOI 10.1046/j.1523-1739.1997.95383.x; BASALIRWA CPK, 1995, INT J CLIMATOL, V15, P1161, DOI 10.1002/joc.3370151008; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Brooks T, 2001, BIOSCIENCE, V51, P613, DOI 10.1641/0006-3568(2001)051[0613:TABFCI]2.0.CO;2; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Burgess N.D., 2004, TERRESTRIAL ECOREGIO; Byron N, 1999, WORLD DEV, V27, P789, DOI 10.1016/S0305-750X(99)00025-X; Camberlin P, 2009, THEOR APPL CLIMATOL, V98, P237, DOI 10.1007/s00704-009-0113-1; Chapman CA, 2005, J TROP ECOL, V21, P31, DOI 10.1017/S0266467404001993; Chapman CA, 2001, EVOL ANTHROPOL, V10, P16, DOI 10.1002/1520-6505(2001)10:1<16::AID-EVAN1010>3.0.CO;2-O; Chapman CA, 2006, AFR J ECOL, V44, P116, DOI 10.1111/j.1365-2028.2006.00636.x; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Conway D, 2005, PHILOS T ROY SOC A, V363, P49, DOI 10.1098/rsta.2004.1475; Cordeiro NJ, 2007, BIOL CONSERV, V134, P155, DOI 10.1016/j.biocon.2006.08.023; DeFries R, 2010, P NATL ACAD SCI USA, V107, P19627, DOI 10.1073/pnas.1011163107; DeFries RS, 2004, FRONT ECOL ENVIRON, V2, P249, DOI 10.1890/1540-9295(2004)002[0249:LCBHNA]2.0.CO;2; Easterling DR, 2000, B AM METEOROL SOC, V81, P417, DOI 10.1175/1520-0477(2000)081<0417:OVATIE>2.3.CO;2; Edwards CD, 1997, 972 COL STAT U; Fischer G, 2005, PHILOS T R SOC B, V360, P2067, DOI 10.1098/rstb.2005.1744; Fisher B, 2007, ECOL ECON, V62, P93, DOI 10.1016/j.ecolecon.2006.05.020; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2007, FRONT ECOL ENVIRON, V5, P25, DOI 10.1890/1540-9295(2007)5[25:ARFDAL]2.0.CO;2; GARBUTT DJ, 1981, ARCH METEOR GEOPHY B, V29, P137, DOI 10.1007/BF02278197; Gbetibouo G.A., 2009, UNDERSTANDING FARMER; Gearheard S, 2010, CLIMATIC CHANGE, V100, P267, DOI 10.1007/s10584-009-9587-1; Goldman A, 2008, SCIENCE AND CONSERVATION IN AFRICAN FORESTS: THE BENEFITS OF LONG-TERM RESEARCH, P129; Green D, 2010, CLIMATIC CHANGE, V100, P239, DOI 10.1007/s10584-010-9804-y; HANNA LW, 1971, J APPL ECOL, V8, P791, DOI 10.2307/2402684; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Hartter J., 2009, Human Dimensions of Wildlife, V14, P433, DOI 10.1080/10871200902911834; Hartter J.N., 2007, LANDSCAPE CHANGE KIB; Hartter J, 2011, LANDSCAPE ECOL, V26, P877, DOI 10.1007/s10980-011-9616-0; Hartter J, 2011, ORYX, V45, P60, DOI 10.1017/S0030605310000141; Hartter J, 2010, LAND USE POLICY, V27, P815, DOI 10.1016/j.landusepol.2009.11.001; Hartter J, 2010, SOC NATUR RESOUR, V23, P207, DOI 10.1080/08941920903360372; Hayes TM, 2006, WORLD DEV, V34, P2064, DOI 10.1016/j.worlddev.2006.03.002; Hill JL, 2003, J BIOGEOGR, V30, P1391, DOI 10.1046/j.1365-2699.2003.00930.x; Houghton J. T., 2001, CLIMATE CHANGE 2001; HUXLEY PA, 1965, EXP AGR, V1, P81, DOI 10.1017/S0014479700018640; Indeje M, 2000, INT J CLIMATOL, V20, P19, DOI [10.1002/(SICI)1097-0088(200001)20:1<19::AID-JOC449>3.0.CO;2-0, 10.1002/(SICI)1097-0088(200001)20:1&lt;19::AID-JOC449&gt;3.0.CO;2-0]; Kirner KE, 2010, AGR VARIATION CHANGE; Lepp A, 2006, SOC NATUR RESOUR, V19, P609, DOI 10.1080/08941920600742377; Li WH, 2008, PHILOS T R SOC B, V363, P1767, DOI 10.1098/rstb.2007.0022; Longobardi A, 2010, INT J CLIMATOL, V30, P1538, DOI 10.1002/joc.2001; Maddison DJ, 2007, 4308 WORLD BANK POL; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; MANNING HL, 1956, PROC R SOC SER B-BIO, V144, P460, DOI 10.1098/rspb.1956.0004; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; McKee JK, 2004, BIOL CONSERV, V115, P161, DOI 10.1016/S0006-3207(03)00099-5; MCKEE TB, 1995, NINTH CONFERENCE ON APPLIED CLIMATOLOGY, P233; McKee TB, 1993, 8 C APPL CLIM 17 JA, V17, P179, DOI DOI 10.1111/J.1467-7717.1988.TB00685; Mertz O, 2009, ENVIRON MANAGE, V43, P804, DOI 10.1007/s00267-008-9197-0; Midgley GF, 2003, BIOL CONSERV, V112, P87, DOI 10.1016/S0006-3207(02)00414-7; Moron V, 2007, J CLIMATE, V20, P5244, DOI 10.1175/2007JCLI1623.1; MYERS N, 1991, CLIMATIC CHANGE, V19, P3, DOI 10.1007/BF00142209; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Naughton-Treves L, 1998, J APPL ECOL, V35, P596, DOI 10.1046/j.1365-2664.1998.3540596.x; Naylor RL, 2007, P NATL ACAD SCI USA, V104, P7752, DOI 10.1073/pnas.0701825104; NICHOLSON SE, 1993, J CLIMATE, V6, P1463, DOI 10.1175/1520-0442(1993)006<1463:AOOARF>2.0.CO;2; Ntale HK, 2003, INT J CLIMATOL, V23, P1335, DOI 10.1002/joc.931; Nyong A., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P787, DOI 10.1007/s11027-007-9099-0; Odekunle TO, 2006, THEOR APPL CLIMATOL, V83, P193, DOI 10.1007/s00704-005-0166-8; OGALLO LJ, 1989, INT J CLIMATOL, V9, P145, DOI 10.1002/joc.3370090204; Ogallo LJ, 1980, STAT CLIMATOLOGY DEV, V13, P255; Ogutu JO, 2003, ECOL LETT, V6, P412, DOI 10.1046/j.1461-0248.2003.00447.x; Orlove B, 2010, CLIMATIC CHANGE, V100, P243, DOI 10.1007/s10584-009-9586-2; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Phillips J, 2000, INT J CLIMATOL, V20, P171, DOI 10.1002/(SICI)1097-0088(200002)20:2&lt;171::AID-JOC471&gt;3.0.CO;2-O; Plumptre A.J., 2003, BIODIVERSITY ALBERTI; PLUMPTRE AJ, 2002, EXTENT STATUS UNPUB; Plumptre AJ, 2007, BIOL CONSERV, V134, P178, DOI 10.1016/j.biocon.2006.08.021; Rebetez M, 1996, CLIMATIC CHANGE, V32, P495, DOI 10.1007/BF00140358; Rudnick DA, ISSUES ECOL UNPUB; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Smith K, 2000, WORLD DEV, V28, P1945, DOI 10.1016/S0305-750X(00)00053-X; Speranza CI, 2010, CLIMATIC CHANGE, V100, P295, DOI 10.1007/s10584-009-9713-0; Stampone M. D., 2011, Research Journal of Environmental and Earth Sciences, V3, P14; Terborgh J., 2002, MAKING PARKS WORK ST; Thomas DSG, 2007, CLIMATIC CHANGE, V83, P301, DOI 10.1007/s10584-006-9205-4; Thomas DSG, 2005, GLOBAL ENVIRON CHANG, V15, P115, DOI 10.1016/j.gloenvcha.2004.10.001; Thornton PK, 2009, GLOBAL ENVIRON CHANG, V19, P54, DOI 10.1016/j.gloenvcha.2008.08.005; Twinomugisha B., 2005, CONTENT ANAL REPORTS; Uganda Bureau of Statistics, 2005, 2002 UG POP HOUS CEN; [United Nations Department of Economics and Social Affairs Population division], 2009, WORLD POP PROSP 2008; Verschuren D, 2000, NATURE, V403, P410, DOI 10.1038/35000179; Weber EU, 2010, WIRES CLIM CHANGE, V1, P332, DOI 10.1002/wcc.41; White TCR, 2008, BIOL REV, V83, P227, DOI 10.1111/j.1469-185X.2008.00041.x; Willmott CJ, 2006, INT J GEOGR INF SCI, V20, P89, DOI 10.1080/13658810500286976; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; Zahran S, 2006, SOC NATUR RESOUR, V19, P771, DOI 10.1080/08941920600835528	93	68	70	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32408	10.1371/journal.pone.0032408	http://dx.doi.org/10.1371/journal.pone.0032408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	927OV	22384244	Green Published, gold, Green Submitted			2022-12-27	WOS:000302918500087
J	Kumar, AA; Shantha, GPS; Kahan, S; Samson, RJ; Boddu, ND; Cheskin, LJ				Kumar, Anita Ashok; Shantha, Ghanshyam Palamaner Subash; Kahan, Scott; Samson, Rohit Joshua; Boddu, Nelson David; Cheskin, Lawrence Jay			Intentional Weight Loss and Dose Reductions of Anti-Diabetic Medications - A Retrospective Cohort Study	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; LIFE-STYLE INTERVENTION; RISK-FACTORS; OBESITY; PREVALENCE; HEALTH	Background and Aim: Intentional weight loss, primarily by improving insulin resistance, is known to decrease the need for anti-diabetic medications. In this study, we assess the magnitude of weight loss that resulted in dose reductions or discontinuation of anti-diabetic medications in overweight or obese patients with type 2 diabetes (DM) undergoing weight loss treatment. Methods: Case records of 50 overweight or obese patients with DM who successfully decreased dosage or discontinued diabetes medications after losing weight via attendance at two University-based, outpatient weight management centers were analyzed. Follow-up visits, weight reduction interventions, and decisions for dose reductions or discontinuation of medications were individualized to patient needs by the treating physician. Results: Mean starting BMI was 35 kg/m(2), mean age 53.4 years, and 58% were male. All 50 used at least one anti-diabetic medication (30 metformin, 39 sulfonylureas, 31 insulin, 21 sitagliptin) to manage blood sugar. Mean duration of follow-up was 30.2 months. Mean weight loss was 10.864.1 kgs (11.1% of initial body weight 64.7%). 22/50 patients (44%) discontinued anti-diabetes medications (14 sulfonylureas [36%], 7 insulin [23%], 4 sitagliptin [19%]). The mean percentage weight loss achieved at the point of successful discontinuation of medication was 11.2% 63.5% (14% for sulphonylureas, 11% for insulin, and 7.1% for sitagliptin). Mean percentage weight loss of 5.6% 62.8% (5.1% for sulphonylureas, 4.3% for insulin, and 7.1% for sitagliptin) was required for initial dose reduction. For every 5% weight loss, predicted dose reductions were sulphonylureas, 39%; insulin, 42%; and any anti-diabetic medications, 49%. Conclusion: Among overweight or obese patients with type 2 diabetes, intentional weight loss of 7-14% was typically required for full discontinuation of at least one anti-diabetic medication. Discontinuation of insulin was achieved at a mean weight reduction of 11% of initial body weight.	[Kumar, Anita Ashok; Shantha, Ghanshyam Palamaner Subash] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Kahan, Scott] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Kahan, Scott] George Washington Univ, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC USA; [Kahan, Scott; Samson, Rohit Joshua; Boddu, Nelson David; Cheskin, Lawrence Jay] Johns Hopkins Univ, Johns Hopkins Weight Management Ctr, Baltimore, MD USA; [Cheskin, Lawrence Jay] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; George Washington University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kumar, AA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	lcheskin@jhsph.edu	Cheskin, Lawrence/AAM-1094-2021	Cheskin, Lawrence/0000-0003-0262-1030; Kahan, Scott/0000-0002-3080-0661				Ahamed A, 2008, J INDIAN MED ASSOC, V106, P588; Ahamed Anish, 2008, J Indian Med Assoc, V106, P583; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colditz GA, 1999, MED SCI SPORT EXER, V31, pS663, DOI 10.1097/00005768-199911001-00026; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Dixon JB, 2009, WORLD J SURG, V33, P2014, DOI 10.1007/s00268-009-0062-y; Espeland M, 2007, DIABETES CARE, V30, P1374; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Greenberg R.S.D.S., 2005, MED EPIDEMIOLOGY, Vfourth; Ismail-Beigi F, 2011, ANN INTERN MED, V154, P554, DOI 10.7326/0003-4819-154-8-201104190-00007; Ito H, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-83; Jeffrey SF, 2005, HARRISONS PRINCIPLES, V1, P422; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Nguyen NT, 2008, J AM COLL SURGEONS, V207, P928, DOI 10.1016/j.jamcollsurg.2008.08.022; Peyrot M, 2011, DIABETES TECHNOL THE, V13, P471, DOI 10.1089/dia.2010.0167; Ray NF, 1998, DIABETES CARE, V21, P296; Redmon JB, 2010, DIABETES CARE, V33, P1153, DOI 10.2337/dc09-2090; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; World Health Organization, 1995, PHYS STAT US INT ANT	23	16	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32395	10.1371/journal.pone.0032395	http://dx.doi.org/10.1371/journal.pone.0032395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384240	Green Submitted, Green Published, gold			2022-12-27	WOS:000302918500084
J	Li, CX; Shao, Y; Ng, KTP; Liu, XB; Ling, CC; Ma, YY; Geng, W; Fan, ST; Lo, CM; Man, K				Li, Chang Xian; Shao, Yan; Ng, Kevin T. P.; Liu, Xiao Bing; Ling, Chang Chun; Ma, Yuen Yuen; Geng, Wei; Fan, Sheung Tat; Lo, Chung Mau; Man, Kwan			FTY720 Suppresses Liver Tumor Metastasis by Reducing the Population of Circulating Endothelial Progenitor Cells	PLOS ONE			English	Article							BONE-MARROW; HEPATOCELLULAR-CARCINOMA; ISCHEMIA-REPERFUSION; ANGIOGENIC SWITCH; GRAFT INJURY; CANCER CELLS; STEM-CELLS; FACTOR-I; G-CSF; GROWTH	Background: Surgical procedures such as liver resection and liver transplantation are the first-line treatments for hepatocellular carcinoma (HCC) patients. However, the high incidence of tumor recurrence and metastasis after liver surgery remains a major problem. Recent studies have shown that hepatic ischemia-reperfusion (I/R) injury and endothelial progenitor cells (EPCs) contribute to tumor growth and metastasis. We aim to investigate the mechanism of FTY720, which was originally applied as an immunomodulator, on suppression of liver tumor metastasis after liver resection and partial hepatic I/R injury. Methodology/Principal Findings: An orthotopic liver tumor model in Buffalo rat was established using the hepatocellular carcinoma cell line McA-RH7777. Two weeks after orthotopic liver tumor implantation, the rats underwent liver resection for tumor-bearing lobe and partial hepatic I/R injury. FTY720 (2 mg/kg) was administered through the inferior caval vein before and after I/R injury. Blood samples were taken at days 0, 1, 3, 7, 14, 21 and 28 for detection of circulating EPCs (CD133+CD34+). Our results showed that intrahepatic and lung metastases were significantly inhibited together with less tumor angiogenesis by FTY720 treatment. The number of circulating EPCs was also significantly decreased by FTY720 treatment from day 7 to day 28. Hepatic gene expressions of CXCL10, VEGF, CXCR3, CXCR4 induced by hepatic I/R injury were down-regulated in the treatment group. Conclusions/Significance: FTY720 suppressed liver tumor metastasis after liver resection marred by hepatic I/R injury in a rat liver tumor model by attenuating hepatic I/R injury and reducing circulating EPCs.	[Li, Chang Xian] Univ Hong Kong, Dept Surg, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Li, CX (corresponding author), Univ Hong Kong, Dept Surg, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China.	kwanman@hkucc.hku.hk	Ng, Tak Pan/C-4698-2009; NG, Kevin Tak-Pan/J-1510-2018	NG, Kevin Tak-Pan/0000-0001-9822-1335	Research Grant Council Hong Kong [HKU5/CRF/08, HKU1/CRF10, HKU3/CRF11R]; Centre for Cancer Research-Strategy Research Theme of the University of Hong Kong	Research Grant Council Hong Kong(Hong Kong Research Grants Council); Centre for Cancer Research-Strategy Research Theme of the University of Hong Kong	This study was supported by the Collaborative Research Funds (HKU5/CRF/08, HKU1/CRF10 & HKU3/CRF11R) of the Research Grant Council Hong Kong, Small project funding and Seed funding of Centre for Cancer Research-Strategy Research Theme programme of the University of Hong Kong. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma H, 2002, CANCER RES, V62, P1410; Azuma H, 2003, J UROLOGY, V169, P2372, DOI 10.1097/01.ju.0000064938.32318.91; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; De Palma M, 2003, HUM GENE THER, V14, P1193, DOI 10.1089/104303403322168028; Doi K, 2002, J SURG RES, V105, P243, DOI 10.1006/jsre.2002.6356; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Ho JWY, 2006, HEPATOLOGY, V44, P836, DOI 10.1002/hep.21353; Kalka C, 2000, CIRC RES, V86, P1198, DOI 10.1161/01.RES.86.12.1198; Kiuchi M, 2000, J MED CHEM, V43, P2946, DOI 10.1021/jm000173z; Lee TK, 2005, CLIN CANCER RES, V11, P8458, DOI 10.1158/1078-0432.CCR-05-0447; Lemoli RM, 2006, STEM CELLS, V24, P2817, DOI 10.1634/stemcells.2006-0333; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Man K, 2005, AM J TRANSPLANT, V5, P40, DOI 10.1111/j.1600-6143.2004.00642.x; Man K, ANN SURG, V251, P1154; Man K, CLIN CANC RES, V16, P967; Man K, 2008, ANN SURG, V247, P1049, DOI 10.1097/SLA.0b013e31816ffab6XXX; Man K, 2007, LIVER TRANSPLANT, V13, P1669, DOI 10.1002/lt.21193; Mohle R, 1998, BLOOD, V91, P4523, DOI 10.1182/blood.V91.12.4523.412k04_4523_4530; Natori T, 2002, BIOCHEM BIOPH RES CO, V297, P1058, DOI 10.1016/S0006-291X(02)02335-5; Ng KT, 2007, INT J ONCOL, V30, P375; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Poon RTP, 2002, J CLIN ONCOL, V20, P1775, DOI 10.1200/JCO.2002.07.089; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Rookmaaker MB, 2002, BLOOD, V99, P1095, DOI 10.1182/blood.V99.3.1095; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Sato E, 2007, BRIT J CANCER, V96, P1735, DOI 10.1038/sj.bjc.6603790; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tian F, 2009, BLOOD, V113, P5352, DOI 10.1182/blood-2008-08-173773; van der Bilt JDW, 2005, HEPATOLOGY, V42, P165, DOI 10.1002/hep.20739; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yannaki E, 2005, EXP HEMATOL, V33, P108, DOI 10.1016/j.exphem.2004.09.005; Yu DC, 2007, CLIN CANCER RES, V13, P3814, DOI 10.1158/1078-0432.CCR-06-2594; Zhao Y, 2004, AM J TRANSPLANT, V4, P1399, DOI 10.1111/j.1600-6143.2004.00527.x; Zhou C, 2006, CANCER LETT, V233, P36, DOI 10.1016/j.canlet.2005.02.039	39	38	39	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32380	10.1371/journal.pone.0032380	http://dx.doi.org/10.1371/journal.pone.0032380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384233	gold, Green Published			2022-12-27	WOS:000302918500082
J	Zelic, G; Mottet, D; Lagarde, J				Zelic, Gregory; Mottet, Denis; Lagarde, Julien			Behavioral Impact of Unisensory and Multisensory Audio-Tactile Events: Pros and Cons for Interlimb Coordination in Juggling	PLOS ONE			English	Article							MULTIPLE TIME SCALES; OPTICAL INFORMATION; HAPTIC INFORMATION; MOVEMENT; DYNAMICS; INTEGRATION; PHASE; PERCEPTION; PATTERN; HUMANS	Recent behavioral neuroscience research revealed that elementary reactive behavior can be improved in the case of cross-modal sensory interactions thanks to underlying multisensory integration mechanisms. Can this benefit be generalized to an ongoing coordination of movements under severe physical constraints? We choose a juggling task to examine this question. A central issue well-known in juggling lies in establishing and maintaining a specific temporal coordination among balls, hands, eyes and posture. Here, we tested whether providing additional timing information about the balls and hands motions by using external sound and tactile periodic stimulations, the later presented at the wrists, improved the behavior of jugglers. One specific combination of auditory and tactile metronome led to a decrease of the spatiotemporal variability of the juggler's performance: a simple sound associated to left and right tactile cues presented antiphase to each other, which corresponded to the temporal pattern of hands movement in the juggling task. A contrario, no improvements were obtained in the case of other auditory and tactile combinations. We even found a degraded performance when tactile events were presented alone. The nervous system thus appears able to integrate in efficient way environmental information brought by different sensory modalities, but only if the information specified matches specific features of the coordination pattern. We discuss the possible implications of these results for the understanding of the neuronal integration process implied in audio-tactile interaction in the context of complex voluntary movement, and considering the well-known gating effect of movement on vibrotactile perception.	[Zelic, Gregory; Mottet, Denis; Lagarde, Julien] Univ Montpellier I, Montpellier, France	Universite de Montpellier	Zelic, G (corresponding author), Univ Montpellier I, Montpellier, France.	julien.lagarde@univ-montp1.fr	Mottet, Denis/J-3098-2012	Mottet, Denis/0000-0002-7564-5394; Lagarde, Julien/0000-0002-6353-8487	Commission of the European Community [035005]	Commission of the European Community(European Commission)	This research was supported by SKILLS, an Integrated Project (FP6-IST contract #035005) of the Commission of the European Community. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amazeen EL, 2001, ECOL PSYCHOL, V13, P71, DOI 10.1207/S15326969ECO1302_1; Amazeen EL, 1999, J MOTOR BEHAV, V31, P279, DOI 10.1080/00222899909600994; Assisi CG, 2005, BIOL CYBERN, V93, P6, DOI 10.1007/s00422-005-0558-y; Austin HA, 1976, THESIS DEP ELECT ENG; BEEK P J, 1989, Ecological Psychology, V1, P55, DOI 10.1207/s15326969eco0101_4; BEEK PJ, 1992, J EXP PSYCHOL HUMAN, V18, P934, DOI 10.1037/0096-1523.18.4.934; BEEK PJ, 1992, J MOTOR BEHAV, V24, P85, DOI 10.1080/00222895.1992.9941604; Bendat J.S., 2000, RANDOM DATA ANAL MEA; BERNSTEIN IH, 1970, J EXP PSYCHOL, V86, P196, DOI 10.1037/h0029958; Bernstein N, 1967, COORDINATION REGULAT; Bushara KO, 2003, NAT NEUROSCI, V6, P190, DOI 10.1038/nn993; BYBLOW WD, 1994, HUM MOVEMENT SCI, V13, P3, DOI 10.1016/0167-9457(94)90027-2; Calvert GA, 2004, J PHYSIOL-PARIS, V98, P191, DOI 10.1016/j.jphysparis.2004.03.018; CARSON RG, 1995, EXP BRAIN RES, V105, P465; Chapman CE, 2002, BEHAV BRAIN RES, V135, P225, DOI 10.1016/S0166-4328(02)00168-7; Dessing JC, 2007, J MOTOR BEHAV, V39, P433, DOI 10.3200/JMBR.39.5.433-448; Dhamala M, 2007, NEUROIMAGE, V34, P764, DOI 10.1016/j.neuroimage.2006.07.044; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Driver J, 2000, CURR BIOL, V10, pR731, DOI 10.1016/S0960-9822(00)00740-5; Dunlap K, 1910, PSYCHOL REV, V17, P399, DOI 10.1037/h0074736; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Fink PW, 2000, EXP BRAIN RES, V134, P9, DOI 10.1007/s002210000439; Foxe JJ, 2009, BRAIN TOPOGR, V21, P149, DOI 10.1007/s10548-009-0102-9; Fuchs A, 1996, BIOL CYBERN, V74, P21, DOI 10.1007/BF00199134; FUCHS A, 1994, J EXP PSYCHOL HUMAN, V20, P1088, DOI 10.1037/0096-1523.20.5.1088; Haibach PS, 2004, HUM MOVEMENT SCI, V23, P185, DOI 10.1016/j.humov.2004.07.002; HERSHENSON M, 1962, J EXP PSYCHOL, V63, P289, DOI 10.1037/h0039516; Ho C, 2005, TRANSPORT RES F-TRAF, V8, P397, DOI 10.1016/j.trf.2005.05.002; Howard IS, 2009, J NEUROPHYSIOL, V102, P1902, DOI 10.1152/jn.00013.2009; Huys R, 2004, HUM MOVEMENT SCI, V23, P315, DOI 10.1016/j.humov.2004.08.009; Huys R, 2004, MOTOR CONTROL, V8, P188, DOI 10.1123/mcj.8.2.188; Huys R, 2002, J SPORT SCI, V20, P171, DOI 10.1080/026404102317284745; Jeka JJ, 1997, EXP BRAIN RES, V113, P475, DOI 10.1007/PL00005600; Jirsa VK, 2000, J BIOL PHYS, V26, P85, DOI 10.1023/A:1005208122449; Jirsa VK, 2004, UND COM SYS, P243; Juravle G, 2011, EXP BRAIN RES, V213, P87, DOI 10.1007/s00221-011-2780-2; Juravle G, 2010, BEHAV BRAIN RES, V208, P391, DOI 10.1016/j.bbr.2009.12.009; Kay BA, 2001, BIOL CYBERN, V85, P89, DOI 10.1007/PL00008002; Kelso J. A. S., 1991, RHYTHMS PHYSL SYSTEM, P195; Kelso JAS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005749; KELSO JAS, 1990, ATTENTION PERFORM, P139; Kelso JAS, 2001, P ROY SOC B-BIOL SCI, V268, P1207; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kralemann B, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.055201; Lagarde J, 2006, EXP BRAIN RES, V173, P673, DOI 10.1007/s00221-006-0410-1; Lagarde J, 2005, J MOTOR BEHAV, V37, P418, DOI 10.3200/JMBR.37.6.418-424; Lagarde J, 2009, SKILLS09 INT C SKILL; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; LUTKENHONER B, 1991, ACTA OTO-LARYNGOL, P52; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; Meredith MA, 2002, COGNITIVE BRAIN RES, V14, P31, DOI 10.1016/S0926-6410(02)00059-9; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; NICKERSON RS, 1973, J EXP PSYCHOL, V98, P36, DOI 10.1037/h0034300; PEPER CE, 1995, HUM MOVEMENT SCI, V14, P217, DOI 10.1016/0167-9457(95)00010-P; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Post AA, 2000, BIOL CYBERN, V82, P143, DOI 10.1007/PL00007966; RAAB DH, 1962, SCIENCE, V135, P42, DOI 10.1126/science.135.3497.42; Rosengren K.S., 2003, DEV MOVEMENT COORDIN, V1st, P56; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; SCHONER G, 1986, BIOL CYBERN, V53, P247, DOI 10.1007/BF00336995; Schroeder CE, 2002, COGNITIVE BRAIN RES, V14, P187, DOI 10.1016/S0926-6410(02)00073-3; Sinnett S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013148; Sperdin HF, 2010, NEUROPSYCHOLOGIA, V48, P3696, DOI 10.1016/j.neuropsychologia.2010.09.001; Sperdin HF, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/neuro.01.009.2010; SPORNS O, 1993, CHILD DEV, V64, P960, DOI 10.2307/1131321; Swinnen SP, 2004, NEURO BEHAV DETERMIN; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Tass PA, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051909; Todd J.W., 1912, REACTION MULTIPLE ST; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tognoli E, 2007, P NATL ACAD SCI USA, V104, P8190, DOI 10.1073/pnas.0611453104; TULLER B, 1989, EXP BRAIN RES, V75, P306; TURVEY MT, 1990, AM PSYCHOL, V45, P938, DOI 10.1037/0003-066X.45.8.938; vanSantvoord AAM, 1996, ACTA PSYCHOL, V91, P131, DOI 10.1016/0001-6918(94)00044-1; VANSANTVOORD AAM, 1994, ECOL PSYCHOL, V6, P239, DOI 10.1207/s15326969eco0604_1; Von Holst E, 1973, COLLECTED PAPERS E V; Voss M, 2006, NAT NEUROSCI, V9, P26, DOI 10.1038/nn1592; Voss M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002866; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; Wallace MT, 1998, J NEUROPHYSIOL, V80, P1006, DOI 10.1152/jn.1998.80.2.1006; Warren WH, 2006, PSYCHOL REV, V113, P358, DOI 10.1037/0033-295X.113.2.358; Williams SR, 1998, J NEUROPHYSIOL, V79, P947, DOI 10.1152/jn.1998.79.2.947; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403	85	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32308	10.1371/journal.pone.0032308	http://dx.doi.org/10.1371/journal.pone.0032308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	927OV	22384211	Green Published, gold, Green Submitted			2022-12-27	WOS:000302918500075
J	Chen, Q; Xie, LX; Qing, ZR; Li, LJ; Luo, ZY; Lin, M; Zhang, SM; Chen, WZ; Lin, BZ; Lin, QL; Li, H; Chen, WP; Zheng, PY; Mao, LZ; Chen, CY; Yang, C; Zhan, YZ; Liu, XZ; Zheng, JK; Yang, LY				Chen, Qiang; Xie, Long-Xu; Qing, Zhi-Rong; Li, Lie-Jun; Luo, Zhao-Yun; Lin, Min; Zhang, Shi-Ming; Chen, Wen-Zhou; Lin, Bing-Zhong; Lin, Qi-Li; Li, Hui; Chen, Wei-Pian; Zheng, Pei-Yao; Mao, Ling-Zhi; Chen, Chan-Yu; Yang, Chun; Zhan, Yong-Zhong; Liu, Xiang-Zhi; Zheng, Jia-Kun; Yang, Li-Ye			Epidemiologic Characterization of Human Papillomavirus Infection in Rural Chaozhou, Eastern Guangdong Province of China	PLOS ONE			English	Article							RISK HUMAN-PAPILLOMAVIRUS; REPUBLIC-OF-CHINA; GENOTYPE DISTRIBUTION; CERVICAL-CANCER; POOLED ANALYSIS; PREVALENCE; WOMEN; DNA; VACCINE	Background: Human papilloma virus (HPV) infection was the main cause of cervical cancer. There were only a few reports and detailed data about epidemiological research of HPV infection in rural population of China. Materials and Methods: The cervical cells of rural Chaozhou women were collected, and multiplex real time PCR was firstly performed to detect high-risk HPV (HR-HPV) infection, which could detect 13 types of HR-HPV (types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68). Then, HPV-positive samples were typed by HPV GenoArray test. Results: HR-HPV DNA was detected by multiplex real time-PCR in 3830 of 48559 cases (7.89%). There was a peak incidence in age of 55-60 years group, and a lower incidence in who lived in plain group compared with suburban, mountain and seashore group. 3380 cases of HPV positive sample were genotyped, 11.01% (372/3380) cases could not be classified, among the typed 3008 cases, 101 cases were identified without HR-HPV type infection, 2907 cases were infected with one HR-HPV type at least, the 6 most common HR-HPV types in descending order of infection, were type 52 (33.4%, 16 (20.95%), 58 (15.93%), 33 (9.94%), 68 (9.22%) and 18 (8.36%). The combined prevalence of HPV types 16 and 18 accounted for 28.52% of total infection. However, type 52 plus 58 presented 48.23% of total infection. 2209/2907 cases were infected with a single HPV type and 698/2907 cases were infected with multiple types, and multiple infection constituent ratio increased with age, with a peak incidence in age 55-60 years group. Conclusions: Our findings showed low prevalence of HPV vaccine types (16 and 18) and relatively high prevalence of HPV-52 and -58, support the hypothesis that the second-generation HPV vaccines including HPV-52 and -58 may offer higher protection for women in rural Guangdong Province.	[Chen, Qiang; Luo, Zhao-Yun; Lin, Min; Zhan, Yong-Zhong; Liu, Xiang-Zhi; Zheng, Jia-Kun; Yang, Li-Ye] Chaozhou Cent Hosp, Cent Lab, Chaozhou, Guangdong, Peoples R China; [Chen, Qiang] Jilin Univ, Sch Publ Hlth, Dept Radiobiol, Changchun 130023, Peoples R China; [Xie, Long-Xu; Qing, Zhi-Rong; Li, Lie-Jun] Chaozhou Hybribio Ltd Corp, Chaozhou, Guangdong, Peoples R China; [Zhang, Shi-Ming; Chen, Wen-Zhou] Chaozhou Hlth Bur, Chaozhou, Guangdong, Peoples R China; [Lin, Bing-Zhong] Raoping Cty Peoples Hosp, Raoping Cty, Guangdong, Peoples R China; [Lin, Qi-Li] Chaozhou Peoples Hosp, Dept Gynecol & Obstet, Chaozhou, Guangdong, Peoples R China; [Li, Hui] Chaozhou Gynecol & Pediat Hosp, Dept Gynecol & Obstet, Chaozhou, Guangdong, Peoples R China; [Chen, Wei-Pian] Chaoan Cty Gynecol & Pediat Hosp, Chaoan Cty, Guangdong, Peoples R China; [Zheng, Pei-Yao] Fengxi Peoples Hosp, Chaozhou, Guangdong, Peoples R China; [Mao, Ling-Zhi] Guangdong Prov Women & Childrens Hosp, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China; [Chen, Chan-Yu; Yang, Chun] Chaozhou Cent Hosp, Dept Gynecol, Chaozhou, Guangdong, Peoples R China	Jilin University	Chen, Q (corresponding author), Chaozhou Cent Hosp, Cent Lab, Chaozhou, Guangdong, Peoples R China.	yangleeyee@sina.com			Medical Research Funds of Guangdong Province [A2011760]	Medical Research Funds of Guangdong Province	This work was supported by Medical Research Funds of Guangdong Province (A2011760). Reagent discounts and reagent gifts was from Hybribio Biotechnology Limited Corp.. The funders had no role in study design and data analysis, decision to publish, or reparation of the manuscript.	Bosch FX, 2007, DIS MARKERS, V23, P213, DOI 10.1155/2007/914823; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; [程娇影 Cheng Jiaoying], 2010, [临床检验杂志, Chinese Journal of Clinical Laboratory Science], V28, P113; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Dai M, 2006, BRIT J CANCER, V95, P96, DOI 10.1038/sj.bjc.6603208; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Goldie SJ, 2008, VACCINE, V26, P4080, DOI 10.1016/j.vaccine.2008.04.053; Herrero R, 2009, J INFECT DIS, V199, P919, DOI 10.1086/597308; Hildesheim A, 2002, VIRUS RES, V89, P229, DOI 10.1016/S0168-1702(02)00191-0; Inoue M, 2006, INT J GYNECOL CANCER, V16, P1007, DOI 10.1111/j.1525-1438.2006.00460.x; Jin Qiong, 2009, Zhonghua Fu Chan Ke Za Zhi, V44, P898; Kjaer SK, 2001, CANCER EPIDEM BIOMAR, V10, P101; Kjaer SK, 2009, CANCER PREV RES, V2, P868, DOI 10.1158/1940-6207.CAPR-09-0031; Klintschar M, 2000, J FORENSIC SCI, V45, P669; Li CD, 2010, CANCER EPIDEM BIOMAR, V19, P2655, DOI 10.1158/1055-9965.EPI-10-0212; Li LK, 2006, BRIT J CANCER, V95, P1593, DOI 10.1038/sj.bjc.6603450; Li Q, 2009, CHINESE NEOPLASIA, V18, P315; Lin M, 2008, AUST NZ J OBSTET GYN, V48, P189, DOI 10.1111/j.1479-828X.2008.00844.x; Liu SS, 2010, J CLIN MICROBIOL, V48, P758, DOI 10.1128/JCM.00989-09; Liu SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019244; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2009, LANCET, V373, P1949, DOI 10.1016/S0140-6736(09)60691-7; Paolini F, 2011, INT J IMMUNOPATH PH, V24, P127, DOI 10.1177/039463201102400115; SOLOMON D, 1989, J REPROD MED, V34, P779; Trottier H, 2009, PUBLIC HEALTH GENOM, V12, P291, DOI 10.1159/000214920; Wu Rui-fang, 2010, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V32, P90, DOI 10.3881/j.issn.1000-503X.2010.01.021; Ye J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-66; Yip YC, 2010, J MED VIROL, V82, P1724, DOI 10.1002/jmv.21826; Yoshikawa Hiroyuki, 2009, Virus (Nagoya), V59, P243; Zhao FH, 2010, LANCET ONCOL, V11, P1160, DOI 10.1016/S1470-2045(10)70256-4	31	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32149	10.1371/journal.pone.0032149	http://dx.doi.org/10.1371/journal.pone.0032149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384160	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916800027
J	Falanga, A; Tarallo, R; Vitiello, G; Vitiello, M; Perillo, E; Cantisani, M; D'Errico, G; Galdiero, M; Galdiero, S				Falanga, Annarita; Tarallo, Rossella; Vitiello, Giuseppe; Vitiello, Mariateresa; Perillo, Emiliana; Cantisani, Marco; D'Errico, Gerardino; Galdiero, Massimiliano; Galdiero, Stefania			Biophysical Characterization and Membrane Interaction of the Two Fusion Loops of Glycoprotein B from Herpes Simplex Type I Virus	PLOS ONE			English	Article							ELECTRON-SPIN-RESONANCE; CRYSTAL-STRUCTURE; PHOSPHOLIPID-MEMBRANES; FUSOGENIC DOMAINS; PROXIMAL REGION; PEPTIDE; GB; AGGREGATION; ASSOCIATION; VESICLES	The molecular mechanism of entry of herpesviruses requires a multicomponent fusion system. Cell invasion by Herpes simplex virus (HSV) requires four virally encoded glycoproteins: namely gD, gB and gH/gL. The role of gB has remained elusive until recently when the crystal structure of HSV-1 gB became available and the fusion potential of gB was clearly demonstrated. Although much information on gB structure/function relationship has been gathered in recent years, the elucidation of the nature of the fine interactions between gB fusion loops and the membrane bilayer may help to understand the precise molecular mechanism behind herpesvirus-host cell membrane fusion. Here, we report the first biophysical study on the two fusion peptides of gB, with a particular focus on the effects determined by both peptides on lipid bilayers of various compositions. The two fusion loops constitute a structural subdomain wherein key hydrophobic amino acids form a ridge that is supported on both sides by charged residues. When used together the two fusion loops have the ability to significantly destabilize the target membrane bilayer, notwithstanding their low bilayer penetration when used separately. These data support the model of gB fusion loops insertion into cholesterol enriched membranes.	[Falanga, Annarita; Tarallo, Rossella; Perillo, Emiliana; Cantisani, Marco; Galdiero, Stefania] Univ Naples Federico II, Dept Biol Sci, Div Biostruct, Naples, Italy; [Falanga, Annarita; Cantisani, Marco; Galdiero, Massimiliano; Galdiero, Stefania] Univ Naples Federico II, Ctr Interuniv Ric Peptidi Bioattivi, Naples, Italy; [Vitiello, Giuseppe; D'Errico, Gerardino] Univ Naples Federico II, Dept Chem, Naples, Italy; [Vitiello, Mariateresa] CSGI, Consorzio Studio Sistemi Grande Interfase, Naples, Italy; [Galdiero, Massimiliano] Univ Naples 2, Dept Expt Med, Naples, Italy; [Galdiero, Stefania] CNR, Ist Biostrutture & Bioimmagini, I-80125 Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR)	Falanga, A (corresponding author), Univ Naples Federico II, Dept Biol Sci, Div Biostruct, Naples, Italy.	massimiliano.galdiero@unina2.it; sgaldier@unina.it	Galdiero, Stefania/M-3225-2019; galdiero, stefania/B-1357-2010; D'Errico, Gerardino/ABC-9579-2020	Galdiero, Stefania/0000-0002-7849-7024; D'Errico, Gerardino/0000-0001-6383-8618; FALANGA, Annarita/0000-0001-6538-8585; Falanga, Anna/0000-0001-6906-9020; Galdiero, Massimiliano/0000-0002-1576-6290; VITIELLO, Giuseppe/0000-0003-3389-6942	MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca) [FIRB Prot. RBRN07BMCT]	MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR))	This work was supported by MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca) (FIRB Prot. RBRN07BMCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn A, 2002, J VIROL, V76, P3267, DOI 10.1128/JVI.76.7.3267-3275.2002; Akkarawongsa R, 2009, ANTIMICROB AGENTS CH, V53, P987, DOI 10.1128/AAC.00793-08; Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Atanasiu D, 2007, P NATL ACAD SCI USA, V104, P18718, DOI 10.1073/pnas.0707452104; Avitabile E, 2007, J VIROL, V81, P11532, DOI 10.1128/JVI.01343-07; Backovic M, 2009, P NATL ACAD SCI USA, V106, P2880, DOI 10.1073/pnas.0810530106; Bender FC, 2003, J VIROL, V77, P9542, DOI 10.1128/JVI.77.17.9542-9552.2003; BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P52, DOI 10.1021/bi00453a007; Chatterjee PK, 2002, J VIROL, V76, P12712, DOI 10.1128/JVI.76.24.12712-12722.2002; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chowdary TK, 2010, NAT STRUCT MOL BIOL, V17, P882, DOI 10.1038/nsmb.1837; Connolly SA, 2011, NAT REV MICROBIOL, V9, P369, DOI 10.1038/nrmicro2548; Cummings JE, 2007, BBA-BIOMEMBRANES, V1768, P1796, DOI 10.1016/j.bbamem.2007.04.016; Curtain C, 1999, EUR BIOPHYS J BIOPHY, V28, P427, DOI 10.1007/s002490050225; D'Errico G, 2008, BIOCHEMISTRY-US, V47, P5317, DOI 10.1021/bi7025062; D'Errico G, 2008, BBA-BIOMEMBRANES, V1778, P2710, DOI 10.1016/j.bbamem.2008.07.014; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; DEKROON AIP, 1990, BIOCHEMISTRY-US, V29, P8229, DOI 10.1021/bi00488a006; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; EFTINK MR, 1976, J PHYS CHEM-US, V80, P486, DOI 10.1021/j100546a014; ELLENS H, 1984, BIOCHEMISTRY-US, V23, P1532, DOI 10.1021/bi00302a029; Falanga A, 2011, NANOMED-NANOTECHNOL, V7, P925, DOI 10.1016/j.nano.2011.04.009; Falanga A, 2009, PROTEIN PEPTIDE LETT, V16, P751, DOI 10.2174/092986609788681760; Farnsworth A, 2007, P NATL ACAD SCI USA, V104, P10187, DOI 10.1073/pnas.0703790104; Fiske CH, 1925, J BIOL CHEM, V66, P375; Galdiero S, 2005, J BIOL CHEM, V280, P28632, DOI 10.1074/jbc.M505196200; Galdiero S, 2006, J GEN VIROL, V87, P1085, DOI 10.1099/vir.0.81794-0; Galdiero S, 2008, J BIOL CHEM, V283, P29993, DOI 10.1074/jbc.M803092200; Galdiero S, 2008, PEPTIDES, V29, P1461, DOI 10.1016/j.peptides.2008.04.022; Galdiero S, 2008, CHEMBIOCHEM, V9, P758, DOI 10.1002/cbic.200700457; Galdiero S, 2007, CHEMBIOCHEM, V8, P885, DOI 10.1002/cbic.200700044; Galdiero S, 2012, CURR DRUG METAB, V13, P93, DOI 10.2174/138920012798356961; Galdiero S, 2010, J BIOL CHEM, V285, P17123, DOI 10.1074/jbc.M110.114819; Galdiero S, 2010, BBA-BIOMEMBRANES, V1798, P579, DOI 10.1016/j.bbamem.2010.01.006; Galdiero S, 2009, PROTEIN PEPTIDE LETT, V16, P711, DOI 10.2174/092986609788681797; GORDON LM, 1992, BIOCHIM BIOPHYS ACTA, V1139, P257, DOI 10.1016/0925-4439(92)90099-9; Hannah BP, 2007, J VIROL, V81, P4858, DOI 10.1128/JVI.02755-06; Hannah BP, 2009, J VIROL, V83, P6825, DOI 10.1128/JVI.00301-09; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Kadlec J, 2008, NAT STRUCT MOL BIOL, V15, P1024, DOI 10.1038/nsmb.1484; KRISHNA YVSR, 1990, BIOCHIM BIOPHYS ACTA, V1024, P89; LANGE A, 1985, BIOCHEMISTRY-US, V24, P4383, DOI 10.1021/bi00337a020; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Marsh D, 2010, BBA-BIOMEMBRANES, V1798, P688, DOI 10.1016/j.bbamem.2009.12.027; Marsh D, 2008, METHODS, V46, P83, DOI 10.1016/j.ymeth.2008.07.001; Matsuura H, 2010, P NATL ACAD SCI USA, V107, P22641, DOI 10.1073/pnas.1011806108; MOSER M, 1989, BIOPHYS J, V55, P111, DOI 10.1016/S0006-3495(89)82784-5; PARENTE RA, 1990, BIOCHEMISTRY-US, V29, P8713, DOI 10.1021/bi00489a030; POUNY Y, 1992, BIOCHEMISTRY-US, V31, P12416, DOI 10.1021/bi00164a017; RAPAPORT D, 1991, J BIOL CHEM, V266, P23769; Roche S, 2008, CELL MOL LIFE SCI, V65, P1716, DOI 10.1007/s00018-008-7534-3; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; SCHWARZ G, 1986, BIOCHIM BIOPHYS ACTA, V861, P141, DOI 10.1016/0005-2736(86)90412-8; Spadaccini R, 2010, BBA-BIOMEMBRANES, V1798, P344, DOI 10.1016/j.bbamem.2009.10.018; STANKOWSKI S, 1990, BIOCHIM BIOPHYS ACTA, V1025, P164, DOI 10.1016/0005-2736(90)90094-5; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Sun X, 2008, J BIOL CHEM, V283, P6418, DOI 10.1074/jbc.M708955200; SWAMY MJ, 1994, BIOCHEMISTRY-US, V33, P11656, DOI 10.1021/bi00204a030; Tarallo R, 2011, CHEM-EUR J, V17, P12659, DOI 10.1002/chem.201101425; THIAUDIERE E, 1991, EUR J BIOCHEM, V195, P203, DOI 10.1111/j.1432-1033.1991.tb15696.x; Thoren PEG, 2005, BIOPHYS CHEM, V114, P169, DOI 10.1016/j.bpc.2004.11.016; Turner A, 1998, J VIROL, V72, P873, DOI 10.1128/JVI.72.1.873-875.1998; Vashishtha M, 1998, J CELL BIOL, V140, P91, DOI 10.1083/jcb.140.1.91; Vitiello G, 2011, BBA-BIOMEMBRANES, V1808, P2517, DOI 10.1016/j.bbamem.2011.07.012; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c	67	36	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32186	10.1371/journal.pone.0032186	http://dx.doi.org/10.1371/journal.pone.0032186			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384173	gold, Green Submitted, Green Published			2022-12-27	WOS:000302916100057
J	Henriques, J; Pujades-Rodriguez, M; McGuire, M; Szumilin, E; Iwaz, J; Etard, JF; Ecochard, R				Henriques, Julie; Pujades-Rodriguez, Mar; McGuire, Megan; Szumilin, Elisabeth; Iwaz, Jean; Etard, Jean-Francois; Ecochard, Rene			Comparison of Methods to Correct Survival Estimates and Survival Regression Analysis on a Large HIV African Cohort	PLOS ONE			English	Article							MEASUREMENT ERROR MODELS; FOLLOW-UP; PATIENTS LOST; ANTIRETROVIRAL TREATMENT; SCALE-UP; INFECTED PATIENTS; SOUTH-AFRICA; VITAL STATUS; MORTALITY; PROGRAMS	Objective: The evaluation of HIV treatment programs is generally based on an estimation of survival among patients receiving antiretroviral treatment (ART). In large HIV programs, loss to follow-up (LFU) rates remain high despite active patient tracing, which is likely to bias survival estimates and survival regression analyses. Methods: We compared uncorrected survival estimates derived from routine program data with estimates obtained by applying six correction methods that use updated outcome data by a field survey targeting LFU patients in a rural HIV program in Malawi. These methods were based on double-sampling and differed according to the weights given to survival estimates in LFU and non-LFU subpopulations. We then proposed a correction of the survival regression analysis. Results: Among 6,727 HIV-infected adults receiving ART, 9% were LFU after one year. The uncorrected survival estimates from routine data were 91% in women and 84% in men. According to increasing sophistication of the correction methods, the corrected survival estimates ranged from 89% to 85% in women and 82% to 77% in men. The estimates derived from uncorrected regression analyses were highly biased for initial tuberculosis mortality ratios (RR; 95% CI: 1.07; 0.76-1.50 vs. 2.06 to 2.28 with different correction weights), Kaposi sarcoma diagnosis (2.11; 1.61-2.76 vs. 2.64 to 3.9), and year of ART initiation (1.40; 1.17-1.66 vs. 1.29 to 1.34). Conclusions: In HIV programs with high LFU rates, the use of correction methods based on non-exhaustive double-sampling data are necessary to minimise the bias in survival estimates and survival regressions.	[Henriques, Julie; Iwaz, Jean; Ecochard, Rene] Hosp Civils Lyon, Serv Biostat, Lyon, France; [Henriques, Julie; Iwaz, Jean; Ecochard, Rene] Univ Lyon, Lyon, France; [Henriques, Julie; Iwaz, Jean; Ecochard, Rene] Univ Lyon 1, F-69622 Villeurbanne, France; [Henriques, Julie; Iwaz, Jean; Ecochard, Rene] CNRS, Equipe Biostat Sante, Unite Mixte Rech 5558, Lab Biometrie & Biol Evolut, Villeurbanne, France; [Pujades-Rodriguez, Mar; McGuire, Megan; Etard, Jean-Francois] Epicentre, Paris, France; [Szumilin, Elisabeth] Med Sans Frontieres, Paris, France; [Etard, Jean-Francois] Univ Montpellier, Inst Rech Dev, Unite Mixte Int TransVIHMI 233, F-34059 Montpellier, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; Doctors Without Borders; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Henriques, J (corresponding author), Hosp Civils Lyon, Serv Biostat, Lyon, France.	rene.ecochard@chu-lyon.fr	Etard, Jean François/A-9630-2008; Pujades-Rodriguez, Mar/G-4388-2014; Pujades-Rodriguez, Mar/T-1129-2018; Etard, Jean-Francois/V-4865-2019	Etard, Jean François/0000-0002-4873-0788; Pujades-Rodriguez, Mar/0000-0002-7778-3520; Pujades-Rodriguez, Mar/0000-0002-1375-1028; Etard, Jean-Francois/0000-0002-4873-0788	Hospices Civils de Lyon; Medecins Sans Frontieres	Hospices Civils de Lyon; Medecins Sans Frontieres	This work has been supported only by the institutional funds of Hospices Civils de Lyon and Medecins Sans Frontieres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An MW, 2009, BIOMETRICS, V65, P301, DOI 10.1111/j.1541-0420.2008.01043.x; Anglaret X, 2004, JAIDS-J ACQ IMM DEF, V35, P320, DOI 10.1097/00126334-200403010-00015; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Carroll RJ, 1996, J AM STAT ASSOC, V91, P242, DOI 10.2307/2291401; COOK JR, 1994, J AM STAT ASSOC, V89, P1314, DOI 10.2307/2290994; DEGRUTTOLA V, 1994, BIOMETRICS, V50, P1003, DOI 10.2307/2533439; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; Fox MP, 2010, TROP MED INT HEALTH, V15, P405, DOI 10.1111/j.1365-3156.2010.02473.x; Frangakis CE, 2001, BIOMETRICS, V57, P333, DOI 10.1111/j.0006-341X.2001.00333.x; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Geng EH, 2010, TROP MED INT HEALTH, V15, P63, DOI 10.1111/j.1365-3156.2010.02507.x; Lanoy E, 2009, HIV MED, V10, P236, DOI 10.1111/j.1468-1293.2008.00678.x; Lester RT, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-87; Lowrance DW, 2008, JAIDS-J ACQ IMM DEF, V49, P287, DOI 10.1097/QAI.0b013e3181893ef0; McGuire M, 2010, TROP MED INT HEALTH, V15, P55, DOI 10.1111/j.1365-3156.2010.02504.x; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Touloumi G, 2002, EPIDEMIOLOGY, V13, P347, DOI 10.1097/00001648-200205000-00017; Wu L, 2007, STAT MED, V26, P3342, DOI 10.1002/sim.2816; Yiannoutsos CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003843	21	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31706	10.1371/journal.pone.0031706	http://dx.doi.org/10.1371/journal.pone.0031706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384061	Green Published, gold			2022-12-27	WOS:000302916100030
J	Yuan, Y; Li, Q; Yu, H; Kong, LF				Yuan, Yang; Li, Qi; Yu, Hong; Kong, Lingfeng			The Complete Mitochondrial Genomes of Six Heterodont Bivalves (Tellinoidea and Solenoidea): Variable Gene Arrangements and Phylogenetic Implications	PLOS ONE			English	Article							TAXONOMIC DIVERSITY GRADIENTS; TRANSFER-RNA GENES; DNA-SEQUENCE; MOLECULAR PHYLOGENY; CONTROL REGION; MOLLUSCA-BIVALVIA; TANDEM REPEATS; COMPLETE MTDNA; MARINE REALM; EVOLUTION	Background: Taxonomy and phylogeny of subclass Heterodonta including Tellinoidea are long-debated issues and a complete agreement has not been reached yet. Mitochondrial (mt) genomes have been proved to be a powerful tool in resolving phylogenetic relationship. However, to date, only ten complete mitochondrial genomes of Heterodonta, which is by far the most diverse major group of Bivalvia, have been determined. In this paper, we newly sequenced the complete mt genomes of six species belonging to Heterodonta in order to resolve some problematical relationships among this subclass. Principal Findings: The complete mt genomes of six species vary in size from 16,352 bp to 18,182. Hairpin-like secondary structures are found in the largest non-coding regions of six freshly sequenced mt genomes, five of which contain tandem repeats. It is noteworthy that two species belonging to the same genus show different gene arrangements with three translocations. The phylogenetic analysis of Heterodonta indicates that Sinonovacula constricta, distant from the Solecurtidae belonging to Tellinoidea, is as a sister group with Solen grandis of family Solenidae. Besides, all five species of Tellinoidea cluster together, while Sanguinolaria diphos has closer relationship with Solecurtus divaricatus, Moerella iridescens and Semele scaba rather than with Sanguinolaria olivacea. Conclusions/Significance: By comparative study of gene order rearrangements and phylogenetic relationships of the five species belonging to Tellinoidea, our results support that comparisons of mt gene order rearrangements, to some extent, are a useful tool for phylogenetic studies. Based on phylogenetic analyses of multiple protein-coding genes, we prefer classifying the genus Sinonovacula within the superfamily Solenoidea and not the superfamily Tellinoidea. Besides, both gene order and sequence data agree that Sanguinolaria (Psammobiidae) is not monophyletic. Nevertheless, more studies based on more mt genomes via combination of gene order and phylogenetic analysis are needed to further understand the phylogenetic relationships in subclass Heterodonta.	[Yuan, Yang; Li, Qi; Yu, Hong; Kong, Lingfeng] Ocean Univ China, Coll Fisheries, Qingdao, Shandong, Peoples R China	Ocean University of China	Yuan, Y (corresponding author), Ocean Univ China, Coll Fisheries, Qingdao, Shandong, Peoples R China.	qili66@ouc.edu.cn	Kong, Lingfeng/AAJ-3402-2021; Kong, Lingfeng/AAG-2473-2019	Kong, Lingfeng/0000-0001-5263-1697	973 Program [2010CB126406]; National Natural Science Foundation of China [31072207]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the 973 Program (2010CB126406) and National Natural Science Foundation of China (31072207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Akasaki T, 2006, MOL PHYLOGENET EVOL, V38, P648, DOI 10.1016/j.ympev.2005.10.018; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bieler R, 2006, ZOOL J LINN SOC-LOND, V148, P223, DOI 10.1111/j.1096-3642.2006.00255.x; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 2004, MOL BIOL EVOL, V21, P1492, DOI 10.1093/molbev/msh090; Boore JL, 1999, MOL BIOL EVOL, V16, P410, DOI 10.1093/oxfordjournals.molbev.a026122; BOORE JL, 1994, GENETICS, V138, P423; BOORE JL, 1994, NAUTILUS, V108, P61; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; BRIDGE D, 1992, P NATL ACAD SCI USA, V89, P8750, DOI 10.1073/pnas.89.18.8750; Campbell DC, 2000, GEOL SOC SPEC PUBL, V177, P31, DOI 10.1144/GSL.SP.2000.177.01.03; Canapa A, 2001, MOL PHYLOGENET EVOL, V21, P156, DOI 10.1006/mpev.2001.0992; CANTATORE P, 1987, NATURE, V329, P853, DOI 10.1038/329853a0; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CHENG S, 1994, NATURE, V369, P684, DOI 10.1038/369684a0; Cope JCW, 1997, PALAEONTOLOGY, V40, P713; Crame JA, 2000, PALEOBIOLOGY, V26, P188; Crame JA, 2002, PALEOBIOLOGY, V28, P184; Curole JP, 1999, TRENDS ECOL EVOL, V14, P394, DOI 10.1016/S0169-5347(99)01660-2; Doucet-Beaupre H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-50; Dreyer H, 2003, ZOOL J LINN SOC-LOND, V139, P229, DOI 10.1046/j.1096-3642.2003.00065.x; Dreyer Hermann, 2006, Front Zool, V3, P13, DOI 10.1186/1742-9994-3-13; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Faber JE, 1998, MOL PHYLOGENET EVOL, V10, P310, DOI 10.1006/mpev.1998.0530; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Ghosh E., 1920, Records of the Indian Museum, V19; Giribet G, 2003, SM S COMP E, P45; Giribet G, 2002, INVERTEBR BIOL, V121, P271; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Grande C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-61; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Habe T., 1977, P1; He CB, 2011, MOL BIOL REP, V38, P3401, DOI 10.1007/s11033-010-0449-8; HEBERT PDN, 2002, P ROY SOC LOND B BIO, V270, P313; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kappner I, 2006, MOL PHYLOGENET EVOL, V40, P317, DOI 10.1016/j.ympev.2006.02.006; Keen AM, 1969, TREATISE INVERTEBRAT; Kilpert F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-241; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kumazawa Y, 1998, GENETICS, V150, P313; Kurabayashi A, 2000, MOL BIOL EVOL, V17, P266, DOI 10.1093/oxfordjournals.molbev.a026306; LAROCHE J, 1990, MOL BIOL EVOL, V7, P45; Lee T, 2003, ZOOL J LINN SOC-LOND, V137, P245, DOI 10.1046/j.1096-3642.2003.00047.x; Lewis TL, 2007, MAR ECOL PROG SER, V329, P131, DOI 10.3354/meps329131; Li Q, 2002, J SHELLFISH RES, V21, P811; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maynard BT, 2005, MAR BIOTECHNOL, V7, P645, DOI 10.1007/s10126-005-0013-z; Mikkelsen PM, 2006, ZOOL J LINN SOC-LOND, V148, P439, DOI 10.1111/j.1096-3642.2006.00262.x; MORITZ C, 1987, P NATL ACAD SCI USA, V84, P7183, DOI 10.1073/pnas.84.20.7183; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Mundy NI, 1996, J HERED, V87, P21, DOI 10.1093/oxfordjournals.jhered.a022948; NCBI (National Center for Biotechnology Information), BAS LOC AL SEARCH TO; NCBI Open Reading Frame Finder, NCBI OP READ FRAM FI; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Podsiadlowski L, 2008, MOL BIOL EVOL, V25, P42, DOI 10.1093/molbev/msm223; POHLO R, 1982, J MOLLUS STUD, V48, P245, DOI 10.1093/oxfordjournals.mollus.a065646; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prezant RS, 1998, MOLLUSCA SO SYNTHESI, V5, P289; Rawlings TA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-440; Ren JF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-394; Ren JF, 2010, J MOL EVOL, V70, P57, DOI 10.1007/s00239-009-9308-4; Ren JF, 2009, MITOCHONDR DNA, V20, P78, DOI 10.1080/19401730902964425; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russo CAM, 1996, MOL BIOL EVOL, V13, P525, DOI 10.1093/oxfordjournals.molbev.a025613; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; Schneider A, 2000, TRENDS CELL BIOL, V10, P509, DOI 10.1016/S0962-8924(00)01854-7; Serb JM, 2003, MOL BIOL EVOL, V20, P1854, DOI 10.1093/molbev/msg218; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simone LRL, 2008, RAFFLES B ZOOL, P151; SMITH MJ, 1993, J MOL EVOL, V36, P545, DOI 10.1007/BF00556359; Steiner G, 2000, GEOL SOC SPEC PUBL, V177, P11, DOI 10.1144/GSL.SP.2000.177.01.02; TAYLOR J D, 1973, Palaeontology (Oxford), V16, P519; Taylor JD, 2007, ZOOL SCR, V36, P587, DOI 10.1111/j.1463-6409.2007.00299.x; Taylor JD, 2007, J MAR BIOL ASSOC UK, V87, P565, DOI 10.1017/S0025315407054409; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trueman E. R., 1966, Proceedings of the Malacological Society of London, V37, P111; Uda K, 2011, GENE, V476, P27, DOI 10.1016/j.gene.2011.01.019; Vokes HE, 1980, GENERA BIVALVIA SYST; von Cosel R, 1990, BIVALVIA; Wang HX, 2010, COMP BIOCHEM PHYS D, V5, P256, DOI 10.1016/j.cbd.2010.07.003; Williams ST, 2004, J MOLLUS STUD, V70, P187, DOI 10.1093/mollus/70.2.187; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wu XY, 2010, MOL PHYLOGENET EVOL, V57, P448, DOI 10.1016/j.ympev.2010.05.029; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu KF, 2011, MOL BIOL REP, V38, P3067, DOI 10.1007/s11033-010-9974-8; Xu XD, 2010, GENOME, V53, P1041, DOI 10.1139/G10-096; YONGE CM, 1959, J MAR BIOL ASSOC UK, V38, P277, DOI 10.1017/S0025315400006081; YONGE CM, 1949, PHILOS T ROY SOC B, V234, P29, DOI 10.1098/rstb.1949.0006; Yu ZN, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-477; Yuan Y, 2012, MOL BIOL REP, V39, P1287, DOI 10.1007/s11033-011-0861-8; Zardoya R, 1996, MOL BIOL EVOL, V13, P933, DOI 10.1093/oxfordjournals.molbev.a025661; ZHANG DX, 1995, J MOL EVOL, V40, P382, DOI 10.1007/BF00164024	96	47	51	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32353	10.1371/journal.pone.0032353	http://dx.doi.org/10.1371/journal.pone.0032353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384227	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100073
J	Blood, AJ; Kuster, JK; Woodman, SC; Kirlic, N; Makhlouf, ML; Multhaupt-Buell, TJ; Makris, N; Parent, M; Sudarsky, LR; Sjalander, G; Breiter, H; Breiter, HC; Sharma, N				Blood, Anne J.; Kuster, John K.; Woodman, Sandra C.; Kirlic, Namik; Makhlouf, Miriam L.; Multhaupt-Buell, Trisha J.; Makris, Nikos; Parent, Martin; Sudarsky, Lewis R.; Sjalander, Greta; Breiter, Henry; Breiter, Hans C.; Sharma, Nutan			Evidence for Altered Basal Ganglia-Brainstem Connections in Cervical Dystonia	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TOXIN TYPE-A; FOCAL DYSTONIA; DYT1 DYSTONIA; PSYCHIATRIC COMORBIDITY; SPASMODIC TORTICOLLIS; ABNORMAL PLASTICITY; CEREBELLUM; CARRIERS; LESIONS	Background: There has been increasing interest in the interaction of the basal ganglia with the cerebellum and the brainstem in motor control and movement disorders. In addition, it has been suggested that these subcortical connections with the basal ganglia may help to coordinate a network of regions involved in mediating posture and stabilization. While studies in animal models support a role for this circuitry in the pathophysiology of the movement disorder dystonia, thus far, there is only indirect evidence for this in humans with dystonia. Methodology/Principal Findings: In the current study we investigated probabilistic diffusion tractography in DYT1-negative patients with cervical dystonia and matched healthy control subjects, with the goal of showing that patients exhibit altered microstructure in the connectivity between the pallidum and brainstem. The brainstem regions investigated included nuclei that are known to exhibit strong connections with the cerebellum. We observed large clusters of tractography differences in patients relative to healthy controls, between the pallidum and the brainstem. Tractography was decreased in the left hemisphere and increased in the right hemisphere in patients, suggesting a potential basis for the left/right white matter asymmetry we previously observed in focal dystonia patients. Conclusions/Significance: These findings support the hypothesis that connections between the basal ganglia and brainstem play a role in the pathophysiology of dystonia.	[Blood, Anne J.; Kuster, John K.; Woodman, Sandra C.; Kirlic, Namik; Makhlouf, Miriam L.; Sjalander, Greta; Breiter, Henry; Breiter, Hans C.] Massachusetts Gen Hosp, Mood & Motor Control Lab, Charlestown, MA 02129 USA; [Blood, Anne J.; Kuster, John K.; Kirlic, Namik; Breiter, Hans C.] Massachusetts Gen Hosp, Lab Neuroimaging & Genet, Charlestown, MA USA; [Makris, Nikos] Massachusetts Gen Hosp, Ctr Morphometr Anal, Charlestown, MA USA; [Blood, Anne J.; Kuster, John K.; Woodman, Sandra C.; Kirlic, Namik; Makhlouf, Miriam L.; Makris, Nikos; Sjalander, Greta; Breiter, Henry; Breiter, Hans C.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Blood, Anne J.; Kuster, John K.; Woodman, Sandra C.; Kirlic, Namik; Makris, Nikos; Breiter, Henry; Breiter, Hans C.] Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA; [Blood, Anne J.; Kuster, John K.; Multhaupt-Buell, Trisha J.; Sjalander, Greta; Sharma, Nutan] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Breiter, Hans C.] Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA USA; [Sudarsky, Lewis R.; Sharma, Nutan] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Blood, Anne J.; Makris, Nikos; Sudarsky, Lewis R.; Breiter, Hans C.; Sharma, Nutan] Harvard Univ, Sch Med, Boston, MA USA; [Kuster, John K.] Boston Univ, Sch Med, Div Grad Med Sci, Boston, MA 02118 USA; [Makhlouf, Miriam L.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Parent, Martin] Univ Laval, Fac Med, Ctr Rech Univ Laval Robert Giffard, Dept Psychiat & Neurosci, Quebec City, PQ G1K 7P4, Canada; [Breiter, Hans C.] NW Univ Feinberg, Warren Wright Adolescent Ctr, Sch Med, Dept Psychiat & Behav Sci, Chicago, IL USA; [Breiter, Hans C.] NW Univ Feinberg, Ctr Self Regulat, Chicago, IL USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; Massachusetts Institute of Technology (MIT); Laval University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Blood, AJ (corresponding author), Massachusetts Gen Hosp, Mood & Motor Control Lab, Charlestown, MA 02129 USA.	ablood@nmr.mgh.harvard.edu		Kirlic, Namik/0000-0003-4153-8774	National Institute of Neurological Disorders and Stroke [R01NS052368, NINP50NS037409]; Dystonia Medical Research Foundation; National Center for Research Resources [P41 RR14075, UL1 RR025758-01]; Mental Illness and Neuroscience Discovery (MIND) Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001066, UL1RR025758, P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS037409, P50NS037409, R01NS052368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA026002, R01DA027804] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Dystonia Medical Research Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Mental Illness and Neuroscience Discovery (MIND) Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute of Neurological Disorders and Stroke (grant number R01NS052368 to Dr. Blood, and grant number NINP50NS037409 to Dr. Breakefield with Dr. Sharma as PI of the clinical core), and a grant from the Dystonia Medical Research Foundation to Dr. Blood. The general infrastructure of the Martinos Center for Biomedical Imaging in which research on these grants was conducted, was supported by National Center for Research Resources (grant number P41 RR14075 to Dr. Rosen), and the Mental Illness and Neuroscience Discovery (MIND) Institute (Dr. Rosen). Prescreening and exams were conducted in the General Clinical Research Center, funded by National Center for Research Resources (grant number UL1 RR025758-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Argyelan M, 2009, J NEUROSCI, V29, P9740, DOI 10.1523/JNEUROSCI.2300-09.2009; Blood AJ, 2006, NEUROREPORT, V17, P1251, DOI 10.1097/01.wnr.0000230500.03330.01; Blood AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013945; Blood Anne J, 2008, Biosci Hypotheses, V1, P14, DOI 10.1016/j.bihy.2008.01.006; Bostan AC, 2010, NEUROPSYCHOL REV, V20, P261, DOI 10.1007/s11065-010-9143-9; Bostan AC, 2010, P NATL ACAD SCI USA, V107, P8452, DOI 10.1073/pnas.1000496107; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Brighina F, 2009, EXP BRAIN RES, V192, P651, DOI 10.1007/s00221-008-1572-9; Carbon M, 2010, EUR J NEUROL, V17, P58, DOI 10.1111/j.1468-1331.2010.03054.x; Carbon M, 2008, BRAIN, V131, P146, DOI 10.1093/brain/awm243; Carbon M, 2010, BRAIN, V133, P690, DOI 10.1093/brain/awq017; Colosimo C, 2005, J NEUROL NEUROSUR PS, V76, P1591, DOI 10.1136/jnnp.2004.056614; Curra A, 2004, MOVEMENT DISORD, V19, pS60, DOI 10.1002/mds.20011; Delmaire C, 2007, NEUROLOGY, V69, P376, DOI 10.1212/01.wnl.0000266591.49624.1a; Eidelberg D, 1998, ANN NEUROL, V44, P303, DOI 10.1002/ana.410440304; Fabbrini G, 2008, EUR J NEUROL, V15, P185, DOI 10.1111/j.1468-1331.2007.02034.x; Fabbrini G, 2010, MOVEMENT DISORD, V25, P459, DOI 10.1002/mds.22983; Finkelstein DI, 2000, NEUROSCIENCE, V97, P99, DOI 10.1016/S0306-4522(00)00009-9; Ghilardi MF, 2003, ANN NEUROL, V54, P102, DOI 10.1002/ana.10610; Gilio F, 2000, ANN NEUROL, V48, P20, DOI 10.1002/1531-8249(200007)48:1<20::AID-ANA5>3.0.CO;2-U; Gundel H, 2003, J NERV MENT DIS, V191, P465; Haaland KY, 2004, BRAIN, V127, P1145, DOI 10.1093/brain/awh133; Heiman GA, 2004, NEUROLOGY, V63, P631, DOI 10.1212/01.WNL.0000137113.39225.FA; Le Ber I, 2006, NEUROLOGY, V67, P1769, DOI 10.1212/01.wnl.0000244484.60489.50; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; LeDoux MS, 2003, MOVEMENT DISORD, V18, P60, DOI 10.1002/mds.10301; Lehericy S, 2004, NEUROREPORT, V15, P1887; Loher TJ, 2009, MOVEMENT DISORD, V24, P157, DOI 10.1002/mds.22196; Makris N, 2008, NEURON, V60, P174, DOI 10.1016/j.neuron.2008.08.011; McNaught KS, 2004, ANN NEUROL, V56, P540, DOI 10.1002/ana.20225; Neychev VK, 2008, BRAIN, V131, P2499, DOI 10.1093/brain/awn168; Ochs S, 1997, PROG NEUROBIOL, V52, P391, DOI 10.1016/S0301-0082(97)00022-1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parent A, 2000, TRENDS NEUROSCI, V23, pS20, DOI 10.1016/S1471-1931(00)00022-7; Parent A., 1996, CARPENTERS HUMAN NEU, V9th. Edn; Parent M, 2004, PARKINSONISM RELAT D, V10, P203, DOI 10.1016/j.parkreldis.2004.02.007; Parent M, 2001, J COMP NEUROL, V439, P162, DOI 10.1002/cne.1340; Pizoli CE, 2002, J NEUROSCI, V22, P7825; Quartarone A, 2008, J NEUROL NEUROSUR PS, V79, P985, DOI 10.1136/jnnp.2007.121632; Quartarone A, 2011, NEUROBIOL DIS, V42, P162, DOI 10.1016/j.nbd.2010.12.011; Ruge D, 2011, MOV DISORD; Ruge D, 2011, BRAIN, V134, P2106, DOI 10.1093/brain/awr122; Stavrinou LC, 2011, CEN EUR NEUROSURG; Stokely ME, 2005, J NEUROSCI RES, V79, P598, DOI 10.1002/jnr.20383; Tamura Y, 2009, BRAIN, V132, P749, DOI 10.1093/brain/awn348; Tan EK, 2005, J NEUROL SCI, V234, P109, DOI 10.1016/j.jns.2005.03.046; Teo JTH, 2009, J NEUROL NEUROSUR PS, V80, P80, DOI 10.1136/jnnp.2008.144626; Turkheimer FE, 2001, NEUROIMAGE, V13, P920, DOI 10.1006/nimg.2001.0764; van der Kouwe AJW, 2005, NEUROIMAGE, V27, P222, DOI 10.1016/j.neuroimage.2005.03.035; Wenzel T, 1998, J PSYCHOSOM RES, V44, P687, DOI 10.1016/S0022-3999(97)00229-8; White T, 2007, SCHIZOPHR RES, V90, P302, DOI 10.1016/j.schres.2006.09.032; Wu Chia-Lun, 1992, Journal of the Formosan Medical Association, V91, P1013; Zadro I, 2008, MOVEMENT DISORD, V23, P919, DOI 10.1002/mds.21981	54	55	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31654	10.1371/journal.pone.0031654	http://dx.doi.org/10.1371/journal.pone.0031654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384048	Green Submitted, Green Published, gold			2022-12-27	WOS:000302875500028
J	Fraser, EE; McGuire, LP; Eger, JL; Longstaffe, FJ; Fenton, MB				Fraser, Erin E.; McGuire, Liam P.; Eger, Judith L.; Longstaffe, Fred J.; Fenton, M. Brock			Evidence of Latitudinal Migration in Tri-colored Bats, Perimyotis subflavus	PLOS ONE			English	Article							PIPISTRELLE PIPISTRELLUS-SUBFLAVUS; FEMALE EASTERN PIPISTRELLES; MALE DAUBENTONS BATS; MYOTIS-LUCIFUGUS; REPRODUCTIVE CONDITION; STABLE HYDROGEN; BROWN BAT; CHIROPTERA; VESPERTILIONIDAE; HIBERNACULA	Background: Annual movements of tri-colored bats (Perimyotis subflavus) are poorly understood. While this species has been considered a regional migrant, some evidence suggests that it may undertake annual latitudinal migrations, similar to other long distance North American migratory bat species. Methodology/Principal Findings: We investigated migration in P. subflavus by conducting stable hydrogen isotope analyses of 184 museum specimen fur samples and comparing these results (delta D-fur) to published interpolated delta D values of collection site growing season precipitation (delta D-precip). Results suggest that the male molt period occurred between June 23 and October 16 and 33% of males collected during the presumed non-molt period were south of their location of fur growth. For the same time period, 16% of females were south of their location of fur growth and in general, had not travelled as far as migratory males. There were strong correlations between delta D-fur from the presumed molt period and both growing season delta D-precip (males - r(2) = 0.86;p<0.01; females - r(2) = 0.75; p<0.01), and latitude of collection (males - r(2) = 0.85; p<0.01; females - r(2) = 0.73; p<0.01). Most migrants were collected at the northern (>40 degrees N; males and females) and southern (<35 degrees N; males only) extents of the species' range. Conclusions/Significance: These results indicate a different pattern of migration for this species than previously documented, suggesting that some P. subflavus engage in annual latitudinal migrations and that migratory tendency varies with latitude and between sexes. We suggest that this species' hibernation ecology makes it particularly susceptible to long winters, making migration from the northern extent of the species' range to more southern hibernacula preferable for some individuals. Fur delta D values for some of the northern individuals may indicate an increase in the currently accepted northern range of this species. Sex-biased differences in migration may be the result of differences in reproductive pressures.	[Fraser, Erin E.; McGuire, Liam P.; Fenton, M. Brock] Univ Western Ontario, Dept Biol, London, ON, Canada; [Eger, Judith L.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Longstaffe, Fred J.] Univ Western Ontario, Dept Earth Sci, London, ON, Canada	Western University (University of Western Ontario); Royal Ontario Museum; Western University (University of Western Ontario)	Fraser, EE (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	efrase4@uwo.ca	McGuire, Liam/CAE-8434-2022; Longstaffe, Fred J/A-6843-2008		Natural Sciences and Engineering Research Council [s 3331-2010, 3890-2009]; Canadian Foundation for Innovation [2732]; Bat Conservation International	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Bat Conservation International	Funding for this research was provided by the Natural Sciences and Engineering Research Council (MBF, FJL, LPM, EEF; Discovery grant #s 3331-2010 (MBF); 3890-2009 (FJL)), The Canadian Foundation for Innovation (FJL; infrastructure grant # 2732), and Bat Conservation International (EEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A. A., 1921, Journal of Mammalogy, V2, P53, DOI 10.2307/1373683; [Anonymous], 2020, ECONOMIST 0326; ANTHONY ELP, 1977, ECOLOGY, V58, P775, DOI 10.2307/1936213; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Barbour R. W., 1969, BATS AM; BARCLAY RMR, 1989, BEHAV ECOL SOCIOBIOL, V24, P31, DOI 10.1007/BF00300115; Bisson IA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007504; Bowen GJ, 2005, RAPID COMMUN MASS SP, V19, P2371, DOI 10.1002/rcm.2069; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Bowen GJ, 2010, GRIDDED MAPS ISOTOPI; Boyles JG, 2008, FUNCT ECOL, V22, P632, DOI 10.1111/j.1365-2435.2008.01423.x; Boyles JG, 2009, J MAMMAL, V90, P9, DOI 10.1644/08-MAMM-A-205.1; Briggler JT, 2003, AM MIDL NAT, V149, P406, DOI 10.1674/0003-0031(2003)149[0406:SUASOC]2.0.CO;2; Britzke ER, 2009, J MAMMAL, V90, P743, DOI 10.1644/08-MAMM-A-211R2.1; Broders HG, 2001, NORTHEAST NAT, V8, P331; CONSTANTINE D. G., 1957, JOUR MAMMAL, V38, P461, DOI 10.2307/1376398; Cryan PM, 2009, J MAMMAL, V90, P1330, DOI 10.1644/09-MAMM-S-076R1.1; Cryan PM, 2004, J MAMMAL, V85, P995, DOI 10.1644/BRG-202; Cryan PM, 2003, J EXP BIOL, V206, P3381, DOI 10.1242/jeb.00574; Cryan PM, 2003, J MAMMAL, V84, P579, DOI 10.1644/1545-1542(2003)084<0579:SDOMTB>2.0.CO;2; Davis W. H., 1964, Journal of Mammalogy, V45, P645, DOI 10.2307/1377349; Davis W. H., 1965, Journal of Mammalogy, V46, P296, DOI 10.2307/1377850; DAVIS WAYNE H., 1959, JOUR MAMMAL, V40, P16, DOI 10.2307/1376111; Dietz M, 2006, J COMP PHYSIOL B, V176, P223, DOI 10.1007/s00360-005-0043-x; Dubois JE, 2007, CAN FIELD NAT, V121, P57, DOI 10.22621/cfn.v121i1.393; DWYER P. D., 1963, AUSTRALIAN JOUR ZOOL, V11, P290, DOI 10.1071/ZO9630290; Dzal Y, 2009, ACTA CHIROPTEROL, V11, P307, DOI 10.3161/150811009X485549; Encarnacao JA, 2004, MAMM BIOL, V69, P163, DOI 10.1078/1616-5047-00131; Encarnacao JA, 2006, FOLIA ZOOL, V55, P237; FENTON MB, 1969, CAN J ZOOLOG, V47, P597, DOI 10.1139/z69-103; Ferrara FJ, 2005, WILDLIFE SOC B, V33, P1113, DOI 10.2193/0091-7648(2005)33[1113:IOIDAT]2.0.CO;2; Findley J. S., 1964, Journal of Mammalogy, V45, P461, DOI 10.2307/1377421; Fleming TH, 2003, BAT ECOLOGY, P156; Fraser KC, 2010, BIOTROPICA, V42, P512, DOI 10.1111/j.1744-7429.2009.00608.x; FUJITA M S, 1984, Mammalian Species, P1, DOI 10.2307/3504021; Geluso K, 2005, WEST N AM NATURALIST, V65, P405; GOEHRING HH, 1954, J MAMMAL, V35, P434, DOI 10.2307/1375980; GRIFFIN DONALD R., 1940, JOUR MAMMAL, V21, P181, DOI 10.2307/1374974; Henry M, 2002, J MAMMAL, V83, P767, DOI 10.1644/1545-1542(2002)083<0767:FDAHRO>2.0.CO;2; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hobson KA, 2008, TERR ECOL SER, V2, P1, DOI 10.1016/S1936-7961(07)00001-2; Hoofer SR, 2006, J MAMMAL, V87, P981, DOI 10.1644/05-MAMM-A-425R1.1; Humphries MM, 2002, NATURE, V418, P313, DOI 10.1038/nature00828; Ibanez C, 2009, J MAMMAL, V90, P235, DOI 10.1644/08-MAMM-A-037.1; JONES C, 1973, J MAMMAL, V54, P962, DOI 10.2307/1379091; JONES C, 1968, J MAMMAL, V49, P134, DOI 10.2307/1377741; KNOWLES B, 1992, CAN FIELD NAT, V106, P252; KUNZ TH, 1995, OECOLOGIA, V101, P407, DOI 10.1007/BF00329419; KURTA A, 1989, PHYSIOL ZOOL, V62, P804, DOI 10.1086/physzool.62.3.30157928; KURTA A, 1994, AM MIDL NAT, V132, P410, DOI 10.2307/2426599; Kurta A, 2007, AM MIDL NAT, V157, P404, DOI 10.1674/0003-0031(2007)157[404:REACAO]2.0.CO;2; Langin KM, 2007, OECOLOGIA, V152, P449, DOI 10.1007/s00442-007-0669-3; LaVal RK, 1980, TERRESTRIAL SERIES; MCNAB BK, 1974, ECOLOGY, V55, P943, DOI 10.2307/1940347; MENU H, 1984, MAMMALIA, V48, P409, DOI 10.1515/mamm.1984.48.3.409; Paritte JM, 2009, AUK, V126, P165, DOI 10.1525/auk.2009.07187; Perry RW, 2007, J MAMMAL, V88, P974, DOI 10.1644/06-MAMM-A-215R.1; Poissant JA, 2010, ECOSCIENCE, V17, P372, DOI 10.2980/17-4-3352; Reynolds DS, 2006, J WILDLIFE MANAGE, V70, P1219, DOI 10.2193/0022-541X(2006)70[1219:MTPIOA]2.0.CO;2; Rivers NM, 2006, BIOL CONSERV, V127, P215, DOI 10.1016/j.biocon.2005.08.010; Rodrigues L, 2008, J ZOOL, V274, P116, DOI 10.1111/j.1469-7998.2007.00361.x; Sandel JK, 2001, J MAMMAL, V82, P173, DOI 10.1644/1545-1542(2001)082<0173:UASOWH>2.0.CO;2; Slider RM, 2011, NORTHEAST NAT, V18, P378; Speakman JR, 2003, BAT ECOLOGY, P430; THOMAS DW, 1983, CAN J ZOOL, V61, P2266, DOI 10.1139/z83-299; Tiunov MP, 2007, ACTA CHIROPTEROL, V9, P538, DOI 10.3161/1733-5329(2007)9[538:SMIMPC]2.0.CO;2; Torres-Dowdall J, 2009, WATERBIRDS, V32, P300, DOI 10.1675/063.032.0210; Trombulak SC, 2001, NORTHEAST NAT, V8, P51, DOI 10.2307/3858262; Veilleux JP, 2004, AM MIDL NAT, V152, P196, DOI 10.1674/0003-0031(2004)152[0196:IAIFTS]2.0.CO;2; Veilleux JP, 2003, J MAMMAL, V84, P1068, DOI 10.1644/BEM-021; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002; Wunder MB, 2008, TRACKING ANIMAL MIGR, P1	73	33	33	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31419	10.1371/journal.pone.0031419	http://dx.doi.org/10.1371/journal.pone.0031419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384019	gold, Green Published, Green Submitted			2022-12-27	WOS:000302875500018
J	Gadkari, RA; Srinivasan, N				Gadkari, Rupali A.; Srinivasan, Narayanaswamy			Protein-Protein Interactions in Clathrin Vesicular Assembly: Radial Distribution of Evolutionary Constraints in Interfaces	PLOS ONE			English	Article							COATED VESICLES; MEDIATED ENDOCYTOSIS; MAXIMUM-LIKELIHOOD; BETA-PROPELLER; CRYSTAL-STRUCTURE; MEMBRANE; DOMAIN; RECRUITMENT; RESOLUTION; ADAPTERS	In eukaryotic organisms clathrin-coated vesicles are instrumental in the processes of endocytosis as well as intracellular protein trafficking. Hence, it is important to understand how these vesicles have evolved across eukaryotes, to carry cargo molecules of varied shapes and sizes. The intricate nature and functional diversity of the vesicles are maintained by numerous interacting protein partners of the vesicle system. However, to delineate functionally important residues participating in protein-protein interactions of the assembly is a daunting task as there are no high-resolution structures of the intact assembly available. The two cryoEM structures closely representing intact assembly were determined at very low resolution and provide positions of C alpha atoms alone. In the present study, using the method developed by us earlier, we predict the protein-protein interface residues in clathrin assembly, taking guidance from the available low-resolution structures. The conservation status of these interfaces when investigated across eukaryotes, revealed a radial distribution of evolutionary constraints, i.e., if the members of the clathrin vesicular assembly can be imagined to be arranged in spherical manner, the cargo being at the center and clathrins being at the periphery, the detailed phylogenetic analysis of these members of the assembly indicated high-residue variation in the members of the assembly closer to the cargo while high conservation was noted in clathrins and in other proteins at the periphery of the vesicle. This points to the strategy adopted by the nature to package diverse proteins but transport them through a highly conserved mechanism.	[Gadkari, Rupali A.; Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Gadkari, RA (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	rupali@mbu.iisc.ernet.in			Department of Biotechnology, New Delhi, India; Mathematical Biology initiative of Department of Science and Technology, New Delhi, India; Microsoft Corporation; Department of Science and Technology, New Delhi, India	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); Mathematical Biology initiative of Department of Science and Technology, New Delhi, India; Microsoft Corporation(Microsoft); Department of Science and Technology, New Delhi, India(Department of Science & Technology (India))	This research is supported by the Department of Biotechnology, New Delhi, India, and also by the Mathematical Biology initiative of Department of Science and Technology, New Delhi, India. The fellowship to RG was initially provided by a grant to NS by Microsoft Corporation and is currently being funded by a research project to RG under the "Women Scientist Scheme WOS-A" of the Department of Science and Technology, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonazzi M, 2011, J CELL BIOL, V195, P525, DOI 10.1083/jcb.201105152; Boucrot E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010597; Brett TJ, 2002, STRUCTURE, V10, P797, DOI 10.1016/S0969-2126(02)00784-0; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conibear E, 2010, CURR OPIN CELL BIOL; DeLlano W, 2002, PYMOL MOL GRAPHICS S; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Fotin A, 2004, NATURE, V432, P649, DOI 10.1038/nature03078; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Gadkari RA, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-17; Gadkari RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004476; Glaser F, 2005, PROTEINS, V58, P610, DOI 10.1002/prot.20305; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Holzenspies J, 2010, REPRODUCTION    0603; Hubbard S. J., 1993, NACCESS; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; KEEN JH, 1979, CELL, V16, P303, DOI 10.1016/0092-8674(79)90007-2; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lewin DA, 1998, BBA-MOL CELL RES, V1401, P129, DOI 10.1016/S0167-4889(97)00130-4; Liu ZH, 2009, J CELL BIOL, V186, P473, DOI 10.1083/jcb.200902071; Miele AE, 2004, NAT STRUCT MOL BIOL, V11, P242, DOI 10.1038/nsmb736; Mills IG, 2007, SEMIN CELL DEV BIOL, V18, P459, DOI 10.1016/j.semcdb.2007.07.001; Moeller HB, 2008, KIDNEY INT; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; PEARSE BMF, 1987, ANNU REV BIOPHYS BIO, V16, P49, DOI 10.1146/annurev.bb.16.060187.000405; PEARSE BMF, 1987, EMBO J, V6, P2507, DOI 10.1002/j.1460-2075.1987.tb02536.x; PEARSE BMF, 1976, P NATL ACAD SCI USA, V73, P1255, DOI 10.1073/pnas.73.4.1255; Rekha N, 2005, PROTEINS, V58, P339, DOI 10.1002/prot.20319; ROTH TF, 1964, J CELL BIOL, V20, P313, DOI 10.1083/jcb.20.2.313; Saffarian S, 2008, BIOPHYS J, V94, P2333, DOI 10.1529/biophysj.107.117234; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCHWARTZ AL, 1990, ANNU REV IMMUNOL, V8, P195, DOI 10.1146/annurev.immunol.8.1.195; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Szymkiewicz I, 2004, BIOCHEM J, V383, P1, DOI 10.1042/BJ20040913; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; Ybe JA, 1999, NATURE, V399, P371, DOI 10.1038/20708; Young A, 2007, SEMIN CELL DEV BIOL, V18, P448, DOI 10.1016/j.semcdb.2007.07.006	53	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31445	10.1371/journal.pone.0031445	http://dx.doi.org/10.1371/journal.pone.0031445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384024	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000302875500019
J	Uchida, Y; Kudoh, D; Murakami, A; Honda, M; Kitazawa, S				Uchida, Yusuke; Kudoh, Daisuke; Murakami, Akira; Honda, Masaaki; Kitazawa, Shigeru			Origins of Superior Dynamic Visual Acuity in Baseball Players: Superior Eye Movements or Superior Image Processing	PLOS ONE			English	Article							MOTION; TASK; PERCEPTION; BALL	Dynamic visual acuity (DVA) is defined as the ability to discriminate the fine parts of a moving object. DVA is generally better in athletes than in non-athletes, and the better DVA of athletes has been attributed to a better ability to track moving objects. In the present study, we hypothesized that the better DVA of athletes is partly derived from better perception of moving images on the retina through some kind of perceptual learning. To test this hypothesis, we quantitatively measured DVA in baseball players and non-athletes using moving Landolt rings in two conditions. In the first experiment, the participants were allowed to move their eyes (free-eye-movement conditions), whereas in the second they were required to fixate on a fixation target (fixation conditions). The athletes displayed significantly better DVA than the non-athletes in the free-eye-movement conditions. However, there was no significant difference between the groups in the fixation conditions. These results suggest that the better DVA of athletes is primarily due to an improved ability to track moving targets with their eyes, rather than to improved perception of moving images on the retina.	[Uchida, Yusuke; Honda, Masaaki] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Kudoh, Daisuke; Murakami, Akira] Juntendo Univ, Sch Med, Dept Ophthalmol, Bunkyo Ku, Tokyo 113, Japan; [Kitazawa, Shigeru] Juntendo Univ, Sch Med, Dept Neurophysiol, Bunkyo Ku, Tokyo 113, Japan; [Kitazawa, Shigeru] Osaka Univ, Grad Sch Frontier Biosci, Dynam Brain Network Lab, Osaka, Japan; [Kitazawa, Shigeru] Osaka Univ, Grad Sch Med, Dept Brain Physiol, Osaka, Japan	Waseda University; Juntendo University; Juntendo University; Osaka University; Osaka University	Uchida, Y (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.	y-uchida@aoni.waseda.jp			Waseda University [2008A-899]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [KAKENHI: 23700685, KAKENHI: 21240029]; Grants-in-Aid for Scientific Research [23700685] Funding Source: KAKEN	Waseda University; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Waseda University Grant for Special Research Projects (2008A-899) and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to YU (KAKENHI: 23700685) and to SK (KAKENHI: 21240029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHILL AT, 1979, SCI AM, V240, P108, DOI 10.1038/scientificamerican0179-108; BAHILL AT, 1984, AM SCI, V72, P249; BALL K, 1981, J EXP PSYCHOL HUMAN, V7, P780, DOI 10.1037/0096-1523.7.4.780; BURG A, 1961, J APPL PSYCHOL, V45, P111, DOI 10.1037/h0044200; DAY RW, 1989, ECOL MONOGR, V59, P433, DOI 10.2307/1943075; DEMER JL, 1993, INVEST OPHTH VIS SCI, V34, P1894; GIBSON EJ, 1963, ANNU REV PSYCHOL, V14, P29, DOI 10.1146/annurev.ps.14.020163.000333; GIBSON JJ, 1955, PSYCHOL REV, V62, P32, DOI 10.1037/h0048826; ISHIGAKI H, 1993, PERCEPT MOTOR SKILL, V77, P835, DOI 10.2466/pms.1993.77.3.835; Jacob R, 2005, OPTOMETRY VISION SCI, V82, P1060, DOI 10.1097/01.opx.0000192346.84549.6a; Koyama S, 2004, PERCEPTION, V33, P1139, DOI 10.1068/p5195; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Linhart H., 1986, MODEL SELECTION; MILLER J W, 1962, Surv Ophthalmol, V7, P83; Millslagle DG, 2000, PERCEPT MOTOR SKILL, V90, P498, DOI 10.2466/PMS.90.2.498-504; MORRIS GSD, 1977, RES QUART, V48, P480; Rouse M W, 1988, J Am Optom Assoc, V59, P946; SANDERSON FH, 1974, J MOTOR BEHAV, V6, P87, DOI 10.1080/00222895.1974.10734984; SCHALEN L, 1980, ACTA OTO-LARYNGOL, V90, P404, DOI 10.3109/00016488009131742; Schneiders AG, 2010, PHYS THER SPORT, V11, P47, DOI 10.1016/j.ptsp.2010.01.001; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Seitz AR, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000028; Vaina LM, 1998, P NATL ACAD SCI USA, V95, P12657, DOI 10.1073/pnas.95.21.12657; Watanabe T, 2002, NAT NEUROSCI, V5, P1003, DOI 10.1038/nn915; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; WESTHEIMER G, 1975, J OPT SOC AM, V65, P847, DOI 10.1364/JOSA.65.000847	26	22	22	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31530	10.1371/journal.pone.0031530	http://dx.doi.org/10.1371/journal.pone.0031530			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZZ	22384033	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500024
J	Yuan, YY; Zhang, X; Huang, SS; Zuo, LJ; Zhang, GZ; Song, YS; Wang, GJ; Wang, HT; Huang, DL; Han, DY; Dai, P				Yuan, Yongyi; Zhang, Xun; Huang, Shasha; Zuo, Lujie; Zhang, Guozheng; Song, Yueshuai; Wang, Guojian; Wang, Hongtian; Huang, Deliang; Han, Dongyi; Dai, Pu			Common Molecular Etiologies Are Rare in Nonsyndromic Tibetan Chinese Patients with Hearing Impairment	PLOS ONE			English	Article							CONNEXIN-26 GJB2 GENE; MUTATION SPECTRUM; OXYGEN-SATURATION; PENDREDS-SYNDROME; HOMEOBOX GENE; DEAFNESS; EAR; POU3F4; MORPHOGENESIS; ADAPTATION	Background: Thirty thousand infants are born every year with congenital hearing impairment in mainland China. Racial and regional factors are important in clinical diagnosis of genetic deafness. However, molecular etiology of hearing impairment in the Tibetan Chinese population living in the Tibetan Plateau has not been investigated. To provide appropriate genetic testing and counseling to Tibetan families, we investigated molecular etiology of nonsyndromic deafness in this population. Methods: A total of 114 unrelated deaf Tibetan children from the Tibet Autonomous Region were enrolled. Five prominent deafness-related genes, GJB2, SLC26A4, GJB6, POU3F4, and mtDNA 12S rRNA, were analyzed. Inner ear development was evaluated by temporal CT. A total of 106 Tibetan hearing normal individuals were included as genetic controls. For radiological comparison, 120 patients, mainly of Han ethnicity, with sensorineural hearing loss were analyzed by temporal CT. Results: None of the Tibetan patients carried diallelic GJB2 or SLC26A4 mutations. Two patients with a history of aminoglycoside usage carried homogeneous mtDNA 12S rRNA A1555G mutation. Two controls were homozygous for 12S rRNA A1555G. There were no mutations in GJB6 or POU3F4. A diagnosis of inner ear malformation was made in 20.18% of the Tibetan patients and 21.67% of the Han deaf group. Enlarged vestibular aqueduct, the most common inner ear deformity, was not found in theTibetan patients, but was seen in 18.33% of the Han patients. Common molecular etiologies, GJB2 and SLC26A4 mutations, were rare in the Tibetan Chinese deaf population. Conclusion: The mutation spectrum of hearing loss differs significantly between Chinese Tibetan patients and Han patients. The incidence of inner ear malformation in Tibetans is almost as high as that in Han deaf patients, but the types of malformation vary greatly. Hypoxia and special environment in plateau may be one cause of developmental inner ear deformity in this population.	[Yuan, Yongyi; Huang, Shasha; Zuo, Lujie; Zhang, Guozheng; Song, Yueshuai; Wang, Guojian; Wang, Hongtian; Huang, Deliang; Han, Dongyi; Dai, Pu] Peoples Liberat Army Gen Hosp, Dept Otolaryngol, Beijing, Peoples R China; [Zhang, Xun; Zuo, Lujie; Zhang, Guozheng] Hebei Med Univ, Hosp 3, Dept Otolaryngol, Shijiazhuang, Hebei, Peoples R China; [Yuan, Yongyi; Wang, Guojian; Dai, Pu] Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Otolaryngol, Sanya, Peoples R China	Chinese People's Liberation Army General Hospital; Hebei Medical University; Chinese People's Liberation Army General Hospital	Yuan, YY (corresponding author), Peoples Liberat Army Gen Hosp, Dept Otolaryngol, Beijing, Peoples R China.	huangdl301@sina.com; hdy301@263.net; daipu301@vip.sina.com		Yuan, Yongyi/0000-0002-7936-4776	Beijing Nova programme [2009B34, 2010B081]; Chinese National Nature Science Foundation [30572015, 30728030, 31071109, 30801285, 81000415]; State 863 High Technology R&D Key Project of China [SQ2010AA0221634001]; Minister of Science and Technology [2012BAI09B02]	Beijing Nova programme(Beijing Municipal Science & Technology Commission); Chinese National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); State 863 High Technology R&D Key Project of China(National High Technology Research and Development Program of China); Minister of Science and Technology	This work was supported by Chinese National Nature Science Foundation Research Grant (30572015, 30728030, 31071109), State 863 High Technology R&D Key Project of China(SQ2010AA0221634001) and grant from the Minister of Science and Technology (2012BAI09B02) to Dr. Pu Dai, Chinese National Nature Science Foundation Research Grant (30801285) and Beijing Nova programme (2009B34) to Dr. Yongyi Yuan, Chinese National Nature Science Foundation Research Grant (81000415) and Beijing Nova programme (2010B081) to Dr. Guojian Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi O, 2008, GENET TEST, V12, P569, DOI 10.1089/gte.2008.0063; BEALL CM, 1994, AM J PHYS ANTHROPOL, V95, P271, DOI 10.1002/ajpa.1330950303; Beall CM, 1997, HUM BIOL, V69, P597; Beall CM, 1998, AM J PHYS ANTHROPOL, V106, P385, DOI 10.1002/(SICI)1096-8644(199807)106:3<385::AID-AJPA10>3.3.CO;2-6; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Bonyadi M, 2009, GENET TEST MOL BIOMA, V13, P689, DOI 10.1089/gtmb.2009.0026; Burton Q, 2004, DEV BIOL, V272, P161, DOI 10.1016/j.ydbio.2004.04.024; Camarero G, 2002, HEARING RES, V170, P2, DOI 10.1016/S0378-5955(02)00447-1; Cohen M. M., 1995, HEREDITARY HEARING L, P9; Dahl HHM, 2006, J MED GENET, V43, P850, DOI 10.1136/jmg.2006.042051; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Everett LA, 1999, P NATL ACAD SCI USA, V96, P9727, DOI 10.1073/pnas.96.17.9727; Fischel-Ghodsian N, 1998, P SOC EXP BIOL MED, V218, P1; Gabriel H, 2001, Hum Mutat, V17, P521, DOI 10.1002/humu.1138; Gualandi F, 2004, ACTA OTO-LARYNGOL, V124, P29, DOI 10.1080/03655230410017166; Han B, 2009, CHINESE MED J-PEKING, V122, P830, DOI 10.3760/cma.j.issn.0366-6999.2009.07.013; Han Dong-yi, 2010, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V45, P265; Han SH, 2008, J HUM GENET, V53, P1022, DOI 10.1007/s10038-008-0342-7; Hutchin TP, 2000, CELL MOL LIFE SCI, V57, P1927, DOI 10.1007/PL00000673; Hwa HL, 2003, GENET MED, V5, P161, DOI 10.1097/01.GIM.0000066796.11916.94; Karis A, 2001, J COMP NEUROL, V429, P615, DOI 10.1002/1096-9861(20010122)429:4<615::AID-CNE8>3.0.CO;2-F; Lee HK, 2009, CLIN GENET, V75, P572, DOI 10.1111/j.1399-0004.2009.01181.x; Lench N, 1998, LANCET, V351, P415, DOI 10.1016/S0140-6736(98)24006-2; Li JZ, 2010, J GENET GENOMICS, V37, P787, DOI 10.1016/S1673-8527(09)60096-5; Liu RC, 1982, CHIN J CARDIOL, V10, P241; Mahdieh N, 2011, GENET TEST MOL BIOMA, V15, P489, DOI 10.1089/gtmb.2010.0145; Merlo GR, 2002, DEV BIOL, V248, P157, DOI 10.1006/dbio.2002.0713; Minowa O, 1999, SCIENCE, V285, P1408, DOI 10.1126/science.285.5432.1408; Moraes F, 2005, MECH DEVELOP, V122, P199, DOI 10.1016/j.mod.2004.10.004; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; Morsli H, 2005, DEVELOPMENT, V126, P2235; Niermeyer S, 2001, HIGH ALTITUDE EXPLOR; Office of the 2ndnationwide survey of the disabled Chinese population, 2007, HDB MAJ DAT 2 NAT SU; Ohtsuka A, 2003, HUM GENET, V112, P329, DOI 10.1007/s00439-002-0889-x; Ozaki H, 2004, DEVELOPMENT, V131, P551, DOI 10.1242/dev.00943; Park HJ, 2000, LARYNGOSCOPE, V110, P1535, DOI 10.1097/00005537-200009000-00023; Phippard D, 1998, HEARING RES, V120, P77, DOI 10.1016/S0378-5955(98)00059-8; Rabionet R, 2000, HUM GENET, V106, P40, DOI 10.1007/s004390051007; Romand R, 2004, GENE EXPR PATTERNS, V4, P123, DOI 10.1016/j.modgep.2003.09.006; Roux Anne-Francoise, 2004, BMC Med Genet, V5, P5; Royaux IE, 2000, ENDOCRINOLOGY, V141, P839, DOI 10.1210/en.141.2.839; Ruszymah B H I, 2005, Med J Malaysia, V60, P269; Samanich J, 2007, AM J MED GENET A, V143A, P830, DOI 10.1002/ajmg.a.31668; Shi GZ, 2004, HEARING RES, V197, P19, DOI 10.1016/j.heares.2004.06.012; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Snoeckx RL, 2005, AM J HUM GENET, V77, P945, DOI 10.1086/497996; Stankovic KM, 2010, ANN OTO RHINOL LARYN, V119, P815, DOI 10.1177/000348941011901205; Tsukada K, 2010, CLIN GENET, V78, P464, DOI 10.1111/j.1399-0004.2010.01407.x; Wang J, 2002, TIBETAN SCI TECHNOL, V1, P12, DOI [10.3969/j.issn.1004-3403.2002.01.005, DOI 10.3969/J.ISSN.1004-3403.2002.01.005]; Wang WD, 2001, DEVELOPMENT, V128, P5017; Wattanasirichaigoon D, 2004, CLIN GENET, V66, P452, DOI 10.1111/j.1399-0004.2004.00325.x; Wilcox SA, 2000, HUM GENET, V106, P399, DOI 10.1007/s004390000273; Wu BL, 2002, GENET MED, V4, P279, DOI 10.1097/00125817-200207000-00006; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Yong AML, 2001, J CLIN ENDOCR METAB, V86, P3907, DOI 10.1210/jc.86.8.3907; Yuan Y, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-79; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133; Zlotogora J, 2006, GENET TEST, V10, P40, DOI 10.1089/gte.2006.10.40	59	17	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e30720	10.1371/journal.pone.0030720	http://dx.doi.org/10.1371/journal.pone.0030720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389666	Green Submitted, gold, Green Published			2022-12-27	WOS:000302999600003
J	Liu, QH; Zhang, Y; Mao, HP; Chen, W; Luo, N; Zhou, Q; Chen, WF; Yu, XQ				Liu, Qinghua; Zhang, Yu; Mao, Haiping; Chen, Wei; Luo, Ning; Zhou, Qin; Chen, Wenfang; Yu, Xueqing			A Crosstalk between the Smad and JNK Signaling in the TGF-beta-Induced Epithelial-Mesenchymal Transition in Rat Peritoneal Mesothelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PROTEIN-KINASE PATHWAYS; HEPATIC STELLATE CELLS; HUMAN LUNG FIBROBLASTS; PAI-1 GENE-EXPRESSION; MEDIATED TRANSCRIPTION; INDEPENDENT PATHWAYS; MESANGIAL CELLS; TGF-BETA-1; FIBROSIS	Transforming growth factor beta (TGF-beta) induces the process of epithelial-mesenchymal transition (EMT) through the Smad and JNK signaling. However, it is unclear how these pathways interact in the TGF-beta 1-induced EMT in rat peritoneal mesothelial cells (RPMCs). Here, we show that inhibition of JNK activation by introducing the dominant-negative JNK1 gene attenuates the TGF-beta 1-down-regulated E-cadherin expression, and TGF-beta 1-up-regulated alpha-SMA, Collagen I, and PAI-1 expression, leading to the inhibition of EMT in primarily cultured RPMCs. Furthermore, TGF-beta 1 induces a bimodal JNK activation with peaks at 10 minutes and 12 hours post treatment in RPMCs. In addition, the inhibition of Smad3 activation by introducing a Smad3 mutant mitigates the TGF-beta 1-induced second wave, but not the first wave, of JNK1 activation in RPMCs. Moreover, the inhibition of JNK1 activation prevents the TGF-beta 1-induced Smad3 activation and nuclear translocation, and inhibition of the TGF-gamma 1-induced second wave of JNK activation greatly reduced TGF-beta 1-induced EMT in RPMCs. These data indicate a crosstalk between the JNK1 and Samd3 pathways during the TGF-beta 1-induced EMT and fibrotic process in RPMCs. Therefore, our findings may provide new insights into understanding the regulation of the TGF-beta 1-related JNK and Smad signaling in the development of fibrosis.	[Liu, Qinghua; Zhang, Yu; Mao, Haiping; Chen, Wei; Luo, Ning; Zhou, Qin; Chen, Wenfang; Yu, Xueqing] Sun Yat Sen Univ, Dept Nephrol, Affiliated Hosp 1, Key Lab Nephrol,Minist Hlth, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Liu, QH (corresponding author), Sun Yat Sen Univ, Dept Nephrol, Affiliated Hosp 1, Key Lab Nephrol,Minist Hlth, Guangzhou 510275, Guangdong, Peoples R China.	yuxq@mail.sysu.edu.cn		Mao, Haiping/0000-0002-3608-3851; Zhou, Qin/0000-0002-7205-082X	Research Fund for the Doctoral Program of Higher Education of China [20100171120067]; Natural Science Foundation of Guangdong Province of China [10451008901005957]; Medical Scientific Research Foundation of Guangdong Province of China [A2010148]	Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Medical Scientific Research Foundation of Guangdong Province of China	This study was supported by Research Fund for the Doctoral Program of Higher Education of China (20100171120067), Natural Science Foundation of Guangdong Province of China (10451008901005957) and Medical Scientific Research Foundation of Guangdong Province of China (A2010148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2008, J CELL SCI, V121, P1036, DOI 10.1242/jcs.019455; Alcorn JF, 2009, AM J RESP CELL MOL, V40, P422, DOI 10.1165/rcmb.2008-0174OC; Arany PR, 2008, ONCOGENE, V27, P2507, DOI 10.1038/sj.onc.1210889; Aroeira LS, 2005, AM J KIDNEY DIS, V46, P938, DOI 10.1053/j.ajkd.2005.08.011; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Boyer B, 2000, BIOCHEM PHARMACOL, V60, P1091, DOI 10.1016/S0006-2952(00)00427-5; Chang Y, 2009, J INT MED RES, V37, P727, DOI 10.1177/147323000903700316; Chang Y, 2010, MOL CELL BIOCHEM, V335, P83, DOI 10.1007/s11010-009-0245-8; Dennler S, 2000, J BIOL CHEM, V275, P28858, DOI 10.1074/jbc.M910358199; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Frey RS, 1997, CANCER RES, V57, P628; Ge Q, 2010, J CELL PHYSIOL, V225, P846, DOI 10.1002/jcp.22295; Gokal R, 2002, J AM SOC NEPHROL, V13, pS104; Guo BL, 2005, KIDNEY INT, V68, P972, DOI 10.1111/j.1523-1755.2005.00491.x; Hashimoto S, 2001, AM J RESP CRIT CARE, V163, P152, DOI 10.1164/ajrccm.163.1.2005069; Hayashida T, 1999, KIDNEY INT, V56, P1710, DOI 10.1046/j.1523-1755.1999.00733.x; He S, 2010, BRIT J DERMATOL, V162, P538, DOI 10.1111/j.1365-2133.2009.09511.x; Higuchi C, 2005, THER APHER DIAL, V9, P173, DOI 10.1111/j.1774-9987.2005.00232.x; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Huang YF, 2003, J CLIN INVEST, V112, P379, DOI 10.1172/JCI200318038; Hung KY, 2003, NEPHROL DIAL TRANSPL, V18, P670, DOI 10.1093/ndt/gfg141; Imamichi Y, 2005, BIOL CHEM, V386, P225, DOI 10.1515/BC.2005.028; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; KEETON MR, 1991, J BIOL CHEM, V266, P23048; Kutz SM, 2001, J CELL SCI, V114, P3905; Lindert S, 2005, MATRIX BIOL, V24, P198, DOI 10.1016/j.matbio.2005.03.003; Liu QH, 2008, PERITON DIALYSIS INT, V28, pS88; Ma FY, 2007, J AM SOC NEPHROL, V18, P472, DOI 10.1681/ASN.2006060604; Margetts PJ, 2005, J AM SOC NEPHROL, V16, P425, DOI 10.1681/ASN.2004060436; Mori S, 2004, ONCOGENE, V23, P7416, DOI 10.1038/sj.onc.1207981; Nie J, 2007, KIDNEY INT, V72, P1336, DOI 10.1038/sj.ki.5002533; Oh KH, 2005, INT J ARTIF ORGANS, V28, P129, DOI 10.1177/039139880502800208; Patel P, 2010, KIDNEY INT, V77, P319, DOI 10.1038/ki.2009.436; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Santibanez JF, 2006, FEBS LETT, V580, P5385, DOI 10.1016/j.febslet.2006.09.003; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sun YY, 2009, AM J NEPHROL, V30, P84, DOI 10.1159/000203362; Utsugi M, 2003, AM J RESP CELL MOL, V28, P754, DOI 10.1165/rcmb.4892; Ventura JJ, 2004, MOL CELL, V15, P269, DOI 10.1016/j.molcel.2004.06.007; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Woodward RN, 2006, ATHEROSCLEROSIS, V186, P92, DOI 10.1016/j.atherosclerosis.2005.07.026; Xie SP, 2005, AM J PHYSIOL-LUNG C, V288, pL68, DOI 10.1152/ajplung.00156.2004; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yang AH, 2003, KIDNEY INT, V63, P1530, DOI 10.1046/j.1523-1755.2003.00861.x; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Yoshida K, 2005, AM J PATHOL, V166, P1029, DOI 10.1016/S0002-9440(10)62324-3	47	50	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32009	10.1371/journal.pone.0032009	http://dx.doi.org/10.1371/journal.pone.0032009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384127	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500053
J	Menezes, MR; Waisertreiger, ISR; Lopez-Bertoni, H; Luo, X; Pavlov, YI				Menezes, Miriam Rose; Waisertreiger, Irina S-R.; Lopez-Bertoni, Hernando; Luo, Xu; Pavlov, Youri I.			Pivotal Role of Inosine Triphosphate Pyrophosphatase in Maintaining Genome Stability and the Prevention of Apoptosis in Human Cells	PLOS ONE			English	Article							BASE ANALOG 6-N-HYDROXYLAMINOPURINE; ADVERSE DRUG-REACTIONS; ESCHERICHIA-COLI; CHROMOSOMAL FRAGMENTATION; MODIFIED PURINES; DNA-DAMAGE; GENE; MUTAGENESIS; REPAIR; SPECIFICITY	Pure nucleotide precursor pools are a prerequisite for high-fidelity DNA replication and the suppression of mutagenesis and carcinogenesis. ITPases are nucleoside triphosphate pyrophosphatases that clean the precursor pools of the non-canonical triphosphates of inosine and xanthine. The precise role of the human ITPase, encoded by the ITPA gene, is not clearly defined. ITPA is clinically important because a widespread polymorphism, 94C>A, leads to null ITPase activity in erythrocytes and is associated with an adverse reaction to thiopurine drugs. We studied the cellular function of ITPA in HeLa cells using the purine analog 6-N hydroxylaminopurine (HAP), whose triphosphate is also a substrate for ITPA. In this study, we demonstrate that ITPA knockdown sensitizes HeLa cells to HAP-induced DNA breaks and apoptosis. The HAP-induced DNA damage and cytotoxicity observed in ITPA knockdown cells are rescued by an overexpression of the yeast ITPase encoded by the HAM1 gene. We further show that ITPA knockdown results in elevated mutagenesis in response to HAP treatment. Our studies reveal the significance of ITPA in preventing base analog-induced apoptosis, DNA damage and mutagenesis in human cells. This implies that individuals with defective ITPase are predisposed to genome damage by impurities in nucleotide pools, which is drastically augmented by therapy with purine analogs. They are also at an elevated risk for degenerative diseases and cancer.	[Menezes, Miriam Rose; Waisertreiger, Irina S-R.; Lopez-Bertoni, Hernando; Luo, Xu; Pavlov, Youri I.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Menezes, MR (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	ypavlov@unmc.edu	Lopez, Hernando/AAY-7655-2020; Menezes, Miriam-Rose/I-8002-2019; Pavlov, Youri/T-7532-2017	Lopez, Hernando/0000-0001-6618-1092; Menezes, Miriam-Rose/0000-0001-6478-9600; Pavlov, Youri/0000-0003-1179-5796	Nebraska Department of Health and Human Services [LB506]; University of Nebraska Medical Center Eppley Cancer Center [010107]; National Institute of Cancer [R01 CA129925]; University of Nebraska Medical Center; NATIONAL CANCER INSTITUTE [R01CA129925] Funding Source: NIH RePORTER	Nebraska Department of Health and Human Services; University of Nebraska Medical Center Eppley Cancer Center; National Institute of Cancer; University of Nebraska Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an Nebraska Department of Health and Human Services LB506 Grant, by a University of Nebraska Medical Center Eppley Cancer Center 010107 Pilot Grant, and in part by the National Institute of Cancer Grant R01 CA129925 to Youri I. Pavlov. Miriam R. Menezes was supported by a University of Nebraska Medical Center graduate student fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULMASIH MT, 1986, J BIOL CHEM, V261, P2020; Abolhassani N, 2010, NUCLEIC ACIDS RES, V38, P2891, DOI 10.1093/nar/gkp1250; AMES BN, 1991, MUTAT RES, V250, P3, DOI 10.1016/0027-5107(91)90157-J; Bakker JA, 2011, NUCLEOS NUCLEOT NUCL, V30, P839, DOI 10.1080/15257770.2011.606789; BARRETT JC, 1981, P NATL ACAD SCI-BIOL, V78, P5685, DOI 10.1073/pnas.78.9.5685; Behmanesh M, 2009, CELL DEATH DIFFER, V16, P1315, DOI 10.1038/cdd.2009.53; Bierau J, 2007, PHARMACOGENOMICS, V8, P1221, DOI 10.2217/14622416.8.9.1221; BIESELE JJ, 1963, EXP CELL RES, P525; Bradshaw JS, 2003, MOL MICROBIOL, V48, P1711, DOI 10.1046/j.1365-2958.2003.03540.x; Brem R, 2010, ONCOGENE, V29, P3953, DOI 10.1038/onc.2010.140; Budke B, 2010, MOL MICROBIOL, V75, P230, DOI 10.1111/j.1365-2958.2009.06994.x; Burgis NE, 2003, J BACTERIOL, V185, P3101, DOI 10.1128/JB.185.10.3101-3110.2003; Burgis NE, 2007, J BIOL CHEM, V282, P3531, DOI 10.1074/jbc.M608708200; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Cariani E, 2011, CLIN CHEM LAB MED, V49, P1247, DOI 10.1515/CCLM.2011.618; Dalhus B, 2009, NAT STRUCT MOL BIOL, V16, P138, DOI 10.1038/nsmb.1538; DEMPLE B, 1986, P NATL ACAD SCI USA, V83, P7731, DOI 10.1073/pnas.83.20.7731; ELMORE E, 1983, CANCER RES, V43, P1650; Fowler RG, 1997, FEMS MICROBIOL REV, V21, P43, DOI 10.1111/j.1574-6976.1997.tb00344.x; FREESE E., 1959, PROC NATL ACAD SCI, V45, P622, DOI 10.1073/pnas.45.4.622; Friedberg EC, 2004, CURR OPIN GENET DEV, V14, P5, DOI 10.1016/j.gde.2003.11.001; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kamiya H, 2003, NUCLEIC ACIDS RES, V31, P517, DOI 10.1093/nar/gkg137; Karran P, 2008, NAT REV CANCER, V8, P24, DOI 10.1038/nrc2292; Karran P, 2006, BRIT MED BULL, V79-80, P153, DOI 10.1093/bmb/ldl020; Kouzminova EA, 2004, P NATL ACAD SCI USA, V101, P16262, DOI 10.1073/pnas.0405943101; Kow YW, 2002, FREE RADICAL BIO MED, V33, P886, DOI 10.1016/S0891-5849(02)00902-4; Kozmin SG, 1998, MUTAT RES-FUND MOL M, V402, P41, DOI 10.1016/S0027-5107(97)00280-7; Kozmin SG, 1998, ACTA BIOCHIM POL, V45, P645, DOI 10.18388/abp.1998_4202; Kozmin SG, 2000, J BACTERIOL, V182, P3361, DOI 10.1128/JB.182.12.3361-3367.2000; Kozmin SG, 2008, MOL MICROBIOL, V68, P51, DOI 10.1111/j.1365-2958.2008.06128.x; Lin SR, 2001, J BIOL CHEM, V276, P18695, DOI 10.1074/jbc.M011084200; Loeb LA, 2010, SEMIN CANCER BIOL, V20, P279, DOI 10.1016/j.semcancer.2010.10.006; Lopez H, 2010, J BIOL CHEM, V285, P15016, DOI 10.1074/jbc.M109.086231; Lukas L, 2006, GENETICS, V172, P1359, DOI 10.1534/genetics.105.051144; Marinaki AM, 2004, NUCLEOS NUCLEOT NUCL, V23, P1393, DOI 10.1081/NCN-200027639; Marinaki AM, 2004, PHARMACOGENETICS, V14, P181, DOI 10.1097/00008571-200403000-00006; Marsh S, 2004, J HUM GENET, V49, P579, DOI 10.1007/s10038-004-0183-y; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Moe A, 2003, NUCLEIC ACIDS RES, V31, P3893, DOI 10.1093/nar/gkg472; Mullen P, 2004, METH MOLEC MED, V88, P171; Nakabeppu Y, 2010, MUTAT RES-GEN TOX EN, V703, P51, DOI 10.1016/j.mrgentox.2010.06.006; Nakamura J, 2003, NUCLEIC ACIDS RES, V31, P1790, DOI 10.1093/nar/gkg263; Noskov VN, 1996, YEAST, V12, P17, DOI 10.1002/(SICI)1097-0061(199601)12:1<17::AID-YEA875>3.0.CO;2-I; Oka S, 2008, EMBO J, V27, P421, DOI 10.1038/sj.emboj.7601975; Oka S, 2011, CANCER SCI, V102, P677, DOI 10.1111/j.1349-7006.2011.01869.x; PAVLOV YI, 1986, GENETIKA+, V22, P2235; Pavlov YI, 1996, MUTAT RES-FUND MOL M, V357, P1, DOI 10.1016/0027-5107(96)00060-7; Porta J, 2006, ACTA CRYSTALLOGR F, V62, P1076, DOI 10.1107/S1744309106041790; Qian Y, 1998, MUTAT RES-GEN TOX EN, V418, P61, DOI 10.1016/S1383-5718(98)00108-9; Rotman E, 2007, J BACTERIOL, V189, P6976, DOI 10.1128/JB.00776-07; Sakumi K, 2010, MUTAT RES-GEN TOX EN, V703, P43, DOI 10.1016/j.mrgentox.2010.06.009; Sekiguchi M, 1992, Nucleic Acids Symp Ser, P101; Shcherbakova PV, 1996, MUTAT RES-GENET TOX, V369, P33, DOI 10.1016/S0165-1218(96)90045-2; SHCHERBAKOVA PV, 1993, MUTAGENESIS, V8, P417, DOI 10.1093/mutage/8.5.417; Shipkova M, 2006, CLIN CHEM, V52, P240, DOI 10.1373/clinchem.2005.059501; Stepchenkova EI, 2009, RUSS J GENET+, V45, P409, DOI 10.1134/S1022795409040048; Stepchenkova EI, 2009, J MOL BIOL, V392, P602, DOI 10.1016/j.jmb.2009.07.051; SZMIGIERO L, 1988, ANAL BIOCHEM, V168, P88, DOI 10.1016/0003-2697(88)90014-0; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; TSUTSUI T, 1985, MUTAT RES, V148, P107, DOI 10.1016/0027-5107(85)90213-1; Tsuzuki T, 2001, P NATL ACAD SCI USA, V98, P11456, DOI 10.1073/pnas.191086798; Vallur AC, 2005, DNA REPAIR, V4, P1088, DOI 10.1016/j.dnarep.2005.05.008; VERHOEF VL, 1980, BIOCHEM GENET, V18, P235, DOI 10.1007/BF00484239; Waisertreiger ISR, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/872180; Xiong H, 2010, FUND CLIN PHARMACOL, V24, P393, DOI 10.1111/j.1472-8206.2009.00770.x	68	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32313	10.1371/journal.pone.0032313	http://dx.doi.org/10.1371/journal.pone.0032313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384212	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500076
J	Mwai, L; Diriye, A; Masseno, V; Muriithi, S; Feltwell, T; Musyoki, J; Lemieux, J; Feller, A; Mair, GR; Marsh, K; Newbold, C; Nzila, A; Carret, CK				Mwai, Leah; Diriye, Abdi; Masseno, Victor; Muriithi, Steven; Feltwell, Theresa; Musyoki, Jennifer; Lemieux, Jacob; Feller, Avi; Mair, Gunnar R.; Marsh, Kevin; Newbold, Chris; Nzila, Alexis; Carret, Celine K.			Genome Wide Adaptations of Plasmodium falciparum in Response to Lumefantrine Selective Drug Pressure	PLOS ONE			English	Article							RESISTANCE-ASSOCIATED PROTEIN; PFMDR1 COPY NUMBER; VACUOLAR H+-ATPASE; MALARIA PARASITE; ARTEMETHER-LUMEFANTRINE; MEFLOQUINE RESISTANCE; ANTIMALARIAL-DRUGS; GENE-EXPRESSION; PLASMODIUM-FALCIPARUM-PFMDR1 ALLELES; SACCHAROMYCES-CEREVISIAE	The combination therapy of the Artemisinin-derivative Artemether (ART) with Lumefantrine (LM) (CoartemH) is an important malaria treatment regimen in many endemic countries. Resistance to Artemisinin has already been reported, and it is feared that LM resistance (LMR) could also evolve quickly. Therefore molecular markers which can be used to track CoartemH efficacy are urgently needed. Often, stable resistance arises from initial, unstable phenotypes that can be identified in vitro. Here we have used the Plasmodium falciparum multidrug resistant reference strain V1S to induce LMR in vitro by culturing the parasite under continuous drug pressure for 16 months. The initial IC50 (inhibitory concentration that kills 50% of the parasite population) was 24 nM. The resulting resistant strain V1S(LM), obtained after culture for an estimated 166 cycles under LM pressure, grew steadily in 378 nM of LM, corresponding to 15 times the IC50 of the parental strain. However, after two weeks of culturing V1SLM in drug-free medium, the IC50 returned to that of the initial, parental strain V1S. This transient drug tolerance was associated with major changes in gene expression profiles: using the PFSANGER Affymetrix custom array, we identified 184 differentially expressed genes in V1SLM. Among those are 18 known and putative transporters including the multidrug resistance gene 1 (pfmdr1), the multidrug resistance associated protein and the V-type H+ pumping pyrophosphatase 2 (pfvp2) as well as genes associated with fatty acid metabolism. In addition we detected a clear selective advantage provided by two genomic loci in parasites grown under LM drug pressure, suggesting that all, or some of those genes contribute to development of LM tolerance - they may prove useful as molecular markers to monitor P. falciparum LM susceptibility.	[Mwai, Leah; Diriye, Abdi; Masseno, Victor; Muriithi, Steven; Musyoki, Jennifer; Marsh, Kevin; Nzila, Alexis] Kenya Govt Med Res Ctr, Welcome Trust Res Programme, Kilifi, Kenya; [Mwai, Leah; Marsh, Kevin; Nzila, Alexis] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England; [Feltwell, Theresa] Welcome Trust Sanger Inst, Pathogen Microarrays Grp, Cambridge, England; [Feller, Avi] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Lemieux, Jacob; Newbold, Chris] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Mair, Gunnar R.; Carret, Celine K.] Inst Mol Med, Mol Parasitol Unit, Lisbon, Portugal	Kenya Medical Research Institute; University of Oxford; Wellcome Trust Sanger Institute; University of Oxford; University of Oxford; Universidade de Lisboa	Mwai, L (corresponding author), Kenya Govt Med Res Ctr, Welcome Trust Res Programme, Kilifi, Kenya.	ccarret@fm.ul.pt		Newbold, Chris/0000-0002-9274-3789; Feller, Avi/0000-0001-7319-5468; Mair, Gunnar/0000-0002-5187-3691	European and Developing Country Clinical Trial Partnership (EDCTP); KEMRI-Wellcome Trust; Portuguese FCT [PTDC_SAU-GMG_104392_2008, PTDC_BIA-BCM_105610_2008]; EDCTP	European and Developing Country Clinical Trial Partnership (EDCTP); KEMRI-Wellcome Trust(Wellcome Trust); Portuguese FCT(Portuguese Foundation for Science and Technology); EDCTP	This study was supported by the European and Developing Country Clinical Trial Partnership (EDCTP) and the KEMRI-Wellcome Trust Programme. LM is an EDCTP funded PhD student. GRM and CKC are supported by Portuguese FCT grants PTDC_SAU-GMG_104392_2008 and PTDC_BIA-BCM_105610_2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2000, CANCER RES, V60, P5761; Almagro-Garcia J, 2009, BIOINFORMATICS, V25, P2732, DOI 10.1093/bioinformatics/btp488; Biagini GA, 2003, TRENDS PARASITOL, V19, P479, DOI 10.1016/j.pt.2003.09.011; BIGGS BA, 1989, P NATL ACAD SCI USA, V86, P2428, DOI 10.1073/pnas.86.7.2428; Blackhall WJ, 1998, EXP PARASITOL, V90, P42, DOI 10.1006/expr.1998.4316; Carret CK, 2005, MOL BIOCHEM PARASIT, V144, P177, DOI 10.1016/j.molbiopara.2005.08.010; Chakraborti PK, 1999, BIOSCIENCE REP, V19, P293, DOI 10.1023/A:1020598324663; Chakravorty SJ, 2007, INT J PARASITOL, V37, P975, DOI 10.1016/j.ijpara.2007.02.006; CHEVLI R, 1982, ANTIMICROB AGENTS CH, V21, P581, DOI 10.1128/AAC.21.4.581; Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107; COWMAN AF, 1994, P NATL ACAD SCI USA, V91, P1143, DOI 10.1073/pnas.91.3.1143; Dahl EL, 2006, ANTIMICROB AGENTS CH, V50, P3124, DOI 10.1128/AAC.00394-06; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dent JA, 2000, P NATL ACAD SCI USA, V97, P2674, DOI 10.1073/pnas.97.6.2674; Dokomajilar C, 2006, ANTIMICROB AGENTS CH, V50, P1893, DOI 10.1128/AAC.50.5.1893-1895.2006; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Duraisingh MT, 2005, MOL MICROBIOL, V57, P874, DOI 10.1111/j.1365-2958.2005.04748.x; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fitch CD, 2004, LIFE SCI, V74, P1957, DOI 10.1016/j.lfs.2003.10.003; FOOTE SJ, 1989, CELL, V57, P921, DOI 10.1016/0092-8674(89)90330-9; Ganesan K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000214; GEORGE RCS, 1984, BIOCHIM BIOPHYS ACTA, V803, P174, DOI 10.1016/0167-4889(84)90007-7; GINSBURG H, 1983, BIOCHIM BIOPHYS ACTA, V732, P316, DOI 10.1016/0005-2736(83)90219-5; GINSBURG H, 1984, CHEM PHYS LIPIDS, V35, P331, DOI 10.1016/0009-3084(84)90076-8; Gunasekera AM, 2003, MOL MICROBIOL, V50, P1229, DOI 10.1046/j.1365-2958.2003.03787.x; Gunasekera AM, 2007, EXP PARASITOL, V117, P87, DOI 10.1016/j.exppara.2007.03.001; Happi CT, 2006, AM J TROP MED HYG, V75, P155, DOI 10.4269/ajtmh.2006.75.155; Happi CT, 2009, ANTIMICROB AGENTS CH, V53, P888, DOI 10.1128/AAC.00968-08; Hastings IM, 2005, J INFECT DIS, V192, P1303, DOI 10.1086/432554; Hayashi M, 2000, J BIOL CHEM, V275, P34353, DOI 10.1074/jbc.M003323200; Horrocks P, 1998, MOL BIOCHEM PARASIT, V95, P171, DOI 10.1016/S0166-6851(98)00110-8; Hu GA, 2010, NAT BIOTECHNOL, V28, P91, DOI 10.1038/nbt.1597; Humphreys GS, 2007, ANTIMICROB AGENTS CH, V51, P991, DOI 10.1128/AAC.00875-06; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JACOBS GH, 1987, AM J TROP MED HYG, V36, P9, DOI 10.4269/ajtmh.1987.36.9; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; Jiang HY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-398; Jiang HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002484; Klokouzas A, 2004, BIOCHEM BIOPH RES CO, V321, P197, DOI 10.1016/j.bbrc.2004.06.135; Kokwaro G, 2007, EXPERT OPIN PHARMACO, V8, P75, DOI 10.1517/14656566.8.1.75; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Leek JT, 2006, BIOINFORMATICS, V22, P507, DOI 10.1093/bioinformatics/btk005; Lemieux JE, 2009, P NATL ACAD SCI USA, V106, P7559, DOI 10.1073/pnas.0811829106; Lim P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-11; Mackinnon MJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000644; Madeira L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001889; Makanga M, 2005, PROTEOMICS, V5, P1849, DOI 10.1002/pmic.200401076; Marchesini N, 2005, J BIOL CHEM, V280, P36841, DOI 10.1074/jbc.M507727200; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; McIntosh MT, 2002, INT J PARASITOL, V32, P1, DOI 10.1016/S0020-7519(01)00325-3; Mu JB, 2003, MOL MICROBIOL, V49, P977, DOI 10.1046/j.1365-2958.2003.03627.x; Mwai L, 2009, ANTIMICROB AGENTS CH, V53, P5069, DOI 10.1128/AAC.00638-09; Myrick A, 2003, MOL MICROBIOL, V49, P671, DOI 10.1046/j.1365-2958.2003.03597.x; Natalang O, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-388; Nelson AL, 2005, AM J TROP MED HYG, V72, P586, DOI 10.4269/ajtmh.2005.72.586; Nzila A, 2003, ANTIMICROB AGENTS CH, V47, P2108, DOI 10.1128/AAC.47.7.2108-2112.2003; Nzila A, 2010, J ANTIMICROB CHEMOTH, V65, P390, DOI 10.1093/jac/dkp449; OLLIARO P, 1989, MICROBIOLOGICA, V12, P15; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Ouellette Marc, 1994, Trends in Microbiology, V2, P407, DOI 10.1016/0966-842X(94)90620-3; PEEL SA, 1993, AM J TROP MED HYG, V48, P385, DOI 10.4269/ajtmh.1993.48.385; PEEL SA, 1994, AM J TROP MED HYG, V51, P648, DOI 10.4269/ajtmh.1994.51.648; POLOGE LG, 1988, CELL, V55, P869, DOI 10.1016/0092-8674(88)90142-0; Porcar I, 2003, J PHARM SCI, V92, P45, DOI 10.1002/jps.10254; Price RN, 1999, ANTIMICROB AGENTS CH, V43, P2943, DOI 10.1128/AAC.43.12.2943; Price RN, 2006, CLIN INFECT DIS, V42, P1570, DOI 10.1086/503423; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Raj DK, 2009, J BIOL CHEM, V284, P7687, DOI 10.1074/jbc.M806944200; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Schlitzer M, 2007, CHEMMEDCHEM, V2, P944, DOI 10.1002/cmdc.200600240; Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115; Sisowath C, 2005, J INFECT DIS, V191, P1014, DOI 10.1086/427997; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; TANARIYA P, 1988, EXP PARASITOL, V67, P129, DOI 10.1016/0014-4894(88)90060-4; Tonkin CJ, 2009, PLOS BIOL, V7, P771, DOI 10.1371/journal.pbio.1000084; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Uhlemann AC, 2007, J INFECT DIS, V195, P134, DOI 10.1086/509809; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833; Witkowski B, 2010, ANTIMICROB AGENTS CH, V54, P1872, DOI 10.1128/AAC.01636-09	80	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31623	10.1371/journal.pone.0031623	http://dx.doi.org/10.1371/journal.pone.0031623			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384044	Green Submitted, Green Published, gold			2022-12-27	WOS:000302918500031
J	Padhi, AK; Kumar, H; Vasaikar, SV; Jayaram, B; Gomes, J				Padhi, Aditya K.; Kumar, Hirdesh; Vasaikar, Suhas V.; Jayaram, Bhyravabhotla; Gomes, James			Mechanisms of Loss of Functions of Human Angiogenin Variants Implicated in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; PROTEIN-LIGAND COMPLEXES; MOLECULAR-DYNAMICS; HEXANUCLEOTIDE REPEAT; ENDOTHELIAL-CELLS; ANG GENE; ALS-FTD; MUTATIONS; IDENTIFICATION; DOCKING	Background: Mutations in the coding region of angiogenin (ANG) gene have been found in patients suffering from Amyotrophic Lateral Sclerosis (ALS). Neurodegeneration results from the loss of angiogenic ability of ANG (protein coded by ANG). In this work, we performed extensive molecular dynamics (MD) simulations of wild-type ANG and disease associated ANG variants to elucidate the mechanism behind the loss of ribonucleolytic activity and nuclear translocation activity, functions needed for angiogenesis. Methodology/Principal Findings: MD simulations were carried out to study the structural and dynamic differences in the catalytic site and nuclear localization signal residues between WT-ANG (Wild-type ANG) and six mutants. Variants K17I, S28N, P112L and V113I have confirmed association with ALS, while T195C and A238G single nucleotide polymorphisms (SNPs) encoding L35P and K60E mutants respectively, have not been associated with ALS. Our results show that loss of ribonucleolytic activity in K17I is caused by conformational switching of the catalytic residue His114 by 99 degrees. The loss of nuclear translocation activity of S28N and P112L is caused by changes in the folding of the residues (RRR33)-R-31 that result in the reduction in solvent accessible surface area (SASA). Consequently, we predict that V113I will exhibit loss of angiogenic properties by loss of nuclear translocation activity and L35P by loss of both ribonucleolytic activity and nuclear translocation activity. No functional loss was inferred for K60E. The MD simulation results were supported by hydrogen bond interaction analyses and molecular docking studies. Conclusions/Significance: Conformational switching of catalytic residue His114 seems to be the mechanism causing loss of ribonucleolytic activity and reduction in SASA of nuclear localization signal residues (RRR33)-R-31 results in loss of nuclear translocation activity in ANG mutants. Therefore, we predict that L35P mutant, would exhibit loss of angiogenic functions, and hence would correlate with ALS while K60E would not show any loss.	[Padhi, Aditya K.; Kumar, Hirdesh; Vasaikar, Suhas V.; Jayaram, Bhyravabhotla; Gomes, James] Indian Inst Technol, Sch Biol Sci, New Delhi, India; [Jayaram, Bhyravabhotla] Indian Inst Technol, Dept Chem, New Delhi 110016, India; [Jayaram, Bhyravabhotla] Indian Inst Technol, Supercomp Facil Bioinformat & Computat Biol, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Padhi, AK (corresponding author), Indian Inst Technol, Sch Biol Sci, New Delhi, India.	jgomes@bioschool.iitd.ac.in	Kumar, Hirdesh/I-6843-2016; Vasaikar, Suhas/AAJ-5885-2020; Jayaram, B/G-9130-2011	Kumar, Hirdesh/0000-0002-8488-3001; Jayaram, B/0000-0002-5495-2213; Vasaikar, Suhas/0000-0001-9763-3899; Padhi, Aditya Kumar/0000-0001-6732-2547	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Programme support to the Supercomputing Facility for Bioinformatics & Computational Biology, Indian Institute of Technology Delhi from the Department of Biotechnology (http://dbtindia.nic.in/index.asp), Government of India is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bento-Abreu A, 2010, EUR J NEUROSCI, V31, P2247, DOI 10.1111/j.1460-9568.2010.07260.x; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bikadi Z, 2007, ARCH BIOCHEM BIOPHYS, V461, P225, DOI 10.1016/j.abb.2007.02.020; Conforti FL, 2008, NEUROMUSCULAR DISORD, V18, P68, DOI 10.1016/j.nmd.2007.07.003; Crabtree B, 2007, BIOCHEMISTRY-US, V46, P11810, DOI 10.1021/bi701333h; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; CURRAN TP, 1993, BIOCHEMISTRY-US, V32, P2307, DOI 10.1021/bi00060a023; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fernandez-Santiago R, 2009, J NEUROL, V256, P1337, DOI 10.1007/s00415-009-5124-4; Gao XW, 2008, ACTA BIOCH BIOPH SIN, V40, P619, DOI 10.1111/j.1745-7270.2008.00442.x; Gellera C, 2008, NEUROGENETICS, V9, P33, DOI 10.1007/s10048-007-0111-3; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Greenway MJ, 2004, NEUROLOGY, V63, P1936, DOI 10.1212/01.WNL.0000144344.39103.F6; Gupta A, 2007, PROTEIN PEPTIDE LETT, V14, P632; HARPER JW, 1988, P NATL ACAD SCI USA, V85, P7139, DOI 10.1073/pnas.85.19.7139; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jain T, 2005, FEBS LETT, V579, P6659, DOI 10.1016/j.febslet.2005.10.031; Jenkins JL, 2003, BIOCHEMISTRY-US, V42, P6674, DOI 10.1021/bi034164e; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lee PH, 2009, BIOINFORMATICS, V25, P1048, DOI 10.1093/bioinformatics/btp103; Leonidas DD, 1999, J MOL BIOL, V285, P1209, DOI 10.1006/jmbi.1998.2378; MOROIANU J, 1994, P NATL ACAD SCI USA, V91, P1677, DOI 10.1073/pnas.91.5.1677; MOROIANU J, 1994, BIOCHEM BIOPH RES CO, V203, P1765, DOI 10.1006/bbrc.1994.2391; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Paubel A, 2008, ARCH NEUROL-CHICAGO, V65, P1333, DOI 10.1001/archneur.65.10.1333; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schuyler AD, 2009, J PHYS CHEM B, V113, P6613, DOI 10.1021/jp808736c; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHAPIRO R, 1989, BIOCHEMISTRY-US, V28, P7401, DOI 10.1021/bi00444a038; SHAPIRO R, 1989, BIOCHEMISTRY-US, V28, P1726, DOI 10.1021/bi00430a045; Shapiro R, 1998, BIOCHEMISTRY-US, V37, P6847, DOI 10.1021/bi9800146; Shaw PJ, 2005, J NEUROL NEUROSUR PS, V76, P1046, DOI 10.1136/jnnp.2004.048652; Singh T, 2011, J CHEM INF MODEL, V51, P2515, DOI 10.1021/ci200193z; Sleegers K, 2008, NEUROLOGY, V71, P253, DOI 10.1212/01.wnl.0000289191.54852.75; Subramanian V, 2008, HUM MOL GENET, V17, P130, DOI 10.1093/hmg/ddm290; Ueki M, 2008, CELL BIOCHEM FUNCT, V26, P718, DOI 10.1002/cbf.1498; van Es MA, 2009, NEUROLOGY, V72, P287, DOI 10.1212/01.wnl.0000339487.84908.00; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Wu D, 2007, ANN NEUROL, V62, P609, DOI 10.1002/ana.21221; Xu ZP, 2002, BIOCHEM BIOPH RES CO, V294, P287, DOI 10.1016/S0006-291X(02)00479-5	53	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32479	10.1371/journal.pone.0032479	http://dx.doi.org/10.1371/journal.pone.0032479			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384259	gold, Green Published			2022-12-27	WOS:000302918500095
J	Schaub, MT; Delvenne, JC; Yaliraki, SN; Barahona, M				Schaub, Michael T.; Delvenne, Jean-Charles; Yaliraki, Sophia N.; Barahona, Mauricio			Markov Dynamics as a Zooming Lens for Multiscale Community Detection: Non Clique-Like Communities and the Field-of-View Limit	PLOS ONE			English	Article								In recent years, there has been a surge of interest in community detection algorithms for complex networks. A variety of computational heuristics, some with a long history, have been proposed for the identification of communities or, alternatively, of good graph partitions. In most cases, the algorithms maximize a particular objective function, thereby finding the 'right' split into communities. Although a thorough comparison of algorithms is still lacking, there has been an effort to design benchmarks, i.e., random graph models with known community structure against which algorithms can be evaluated. However, popular community detection methods and benchmarks normally assume an implicit notion of community based on clique-like subgraphs, a form of community structure that is not always characteristic of real networks. Specifically, networks that emerge from geometric constraints can have natural non clique-like substructures with large effective diameters, which can be interpreted as long-range communities. In this work, we show that long-range communities escape detection by popular methods, which are blinded by a restricted 'field-of-view' limit, an intrinsic upper scale on the communities they can detect. The field-of-view limit means that long-range communities tend to be overpartitioned. We show how by adopting a dynamical perspective towards community detection [1,2], in which the evolution of a Markov process on the graph is used as a zooming lens over the structure of the network at all scales, one can detect both clique-or non clique-like communities without imposing an upper scale to the detection. Consequently, the performance of algorithms on inherently low-diameter, clique-like benchmarks may not always be indicative of equally good results in real networks with local, sparser connectivity. We illustrate our ideas with constructive examples and through the analysis of real-world networks from imaging, protein structures and the power grid, where a multiscale structure of non clique-like communities is revealed.	[Schaub, Michael T.; Barahona, Mauricio] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England; [Schaub, Michael T.; Yaliraki, Sophia N.] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AY, England; [Delvenne, Jean-Charles] Catholic Univ Louvain, Dept Appl Math, B-1348 Louvain, Belgium	Imperial College London; Imperial College London; Universite Catholique Louvain	Schaub, MT (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England.	michael.schaub09@imperial.ac.uk; m.barahona@imperial.ac.uk	Schaub, Michael T./AAV-4668-2020; Barahona, Mauricio/M-9747-2019; Barahona, Mauricio/C-3638-2008	Schaub, Michael T./0000-0003-2426-6404; Barahona, Mauricio/0000-0002-1089-5675; Barahona, Mauricio/0000-0002-1089-5675	EPSRC (Engineering and Physical Sciences Research Council) of the UK; Office of Naval Research (ONR) of the US; Belgian Programme of Interuniversity Attraction Poles; Action de Recherche Concertee (ARC) of the French Community of Belgium; EPSRC [EP/I017267/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I017267/1] Funding Source: researchfish	EPSRC (Engineering and Physical Sciences Research Council) of the UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Office of Naval Research (ONR) of the US(Office of Naval Research); Belgian Programme of Interuniversity Attraction Poles; Action de Recherche Concertee (ARC) of the French Community of Belgium; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work has been supported by a grant from the EPSRC (Engineering and Physical Sciences Research Council) of the UK under the Mathematics underpinning the Digital Economy program and by the Office of Naval Research (ONR) of the US. J.-C.D. is supported by the Belgian Programme of Interuniversity Attraction Poles and an Action de Recherche Concertee (ARC) of the French Community of Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barahona M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.054101; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boguna Marian, 2010, Nat Commun, V1, P62, DOI 10.1038/ncomms1063; Browet A, 2011, LECT NOTES COMPUT SC, V6636, P358, DOI 10.1007/978-3-642-21073-0_32; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Danon L, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/11/P11010; Delmotte A, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/5/055010; Delvenne JC, 2010, P NATL ACAD SCI USA, V107, P12755, DOI 10.1073/pnas.0903215107; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fraigniaud P, 2008, IEEE INFOCOM SER, P1759; Gupta A, 2003, ANN IEEE SYMP FOUND, P534, DOI 10.1109/SFCS.2003.1238226; Karrer B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016107; Lambiotte Renaud, 2010, 2010 8th International Symposium on Modeling and Optimization in Mobile, Ad Hoc and Wireless Networks (WiOpt), P546; LAMBIOTTE R, 2008, ARXIV08121770; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Lancichinetti A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066122; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016118; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Reichardt J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.218701; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Ronhovde P, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016109; Rosas-Casals M, 2007, INT J BIFURCAT CHAOS, V17, P2465, DOI 10.1142/S0218127407018531; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104; Rosvall M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018209; Schaub MT, 2011, CODING MARKOV DYNAMI; Sole RV, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026102; Taylor A, 2009, ACM T MATH SOFTWARE, V35, DOI 10.1145/1462173.1462175; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Traag VA, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016114; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	38	91	98	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32210	10.1371/journal.pone.0032210	http://dx.doi.org/10.1371/journal.pone.0032210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384178	Green Published, gold, Green Submitted			2022-12-27	WOS:000302918500065
J	Bergboer, JGM; Umicevic-Mirkov, M; Fransen, J; den Heijer, M; Franke, B; van Riel, PLCM; Schalkwijk, J; Coenen, MJH				Bergboer, Judith G. M.; Umicevic-Mirkov, Masa; Fransen, Jaap; den Heijer, Martin; Franke, Barbara; van Riel, Piet L. C. M.; Schalkwijk, Joost; Coenen, Marieke J. H.		Nijmegen Biomed Study Principal	A Replication Study of the Association between Rheumatoid Arthritis and Deletion of the Late Cornified Envelope Genes LCE3B and LCE3C	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COPY NUMBER; SUSCEPTIBILITY; PSORIASIS; POLYMORPHISM; LCE3C-LCE3B; POPULATION	Objective: Two recent studies, in a Spanish and a Chinese population, point to an association between rheumatoid arthritis (RA) risk and the deletion of the Late Cornified Envelope (LCE) 3B and 3C genes (LCE3C_LCE3B-del), a known risk factor for psoriasis. We aimed to replicate these studies in a large Dutch cohort. Methods: 1039 RA cases and 759 controls were genotyped for LCE3C_LCE3B-del. Association analysis was performed for the complete cohort and after stratification for the serologic markers anti-cyclic citrullinated peptide and rheumatoid factor. A meta-analysis was performed combining our data with the Spanish and Chinese datasets, resulting in an analysis including 2466 RA cases and 2438 controls. Results: In the Dutch cohort we did not observe a significant association of LCE3C_LCE3B-del (p = 0.093) with RA risk. A stratified analysis for the serologic positive and negative group did not show an association between the genetic variant and disease risk, either. The meta-analysis, however, confirmed a significant association (p<0.0001, OR = 1.31, 95% confidence interval 1.16-1.47). Conclusion: Our meta-analysis confirms the association of the LCE3 deletion with RA, suggesting that LCE3C_LCE3B-del is a common risk factor for (auto)immune diseases.	[Bergboer, Judith G. M.; Schalkwijk, Joost] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Dermatol, NL-6525 ED Nijmegen, Netherlands; [Umicevic-Mirkov, Masa; Franke, Barbara; Coenen, Marieke J. H.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Fransen, Jaap; van Riel, Piet L. C. M.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands; [den Heijer, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, NL-6525 ED Nijmegen, Netherlands; [den Heijer, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Bergboer, JGM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Dermatol, NL-6525 ED Nijmegen, Netherlands.	m.coenen@antrg.umcn.nl	Fransen, J./L-4310-2015; Coenen, Marieke/A-2159-2010; van Riel, P.L.C.M./H-8082-2014; Schalkwijk, Joost/R-7509-2019; Schalkwijk, Joost/N-1774-2013; Franke, Barbara/D-4836-2009; den Heijer, Martin/J-8036-2015	Coenen, Marieke/0000-0001-8796-2031; Schalkwijk, Joost/0000-0002-1308-1319; Franke, Barbara/0000-0003-4375-6572; den Heijer, Martin/0000-0003-3620-5617	Netherlands Organisation for Scientific Research [916.76.020]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by a personal grant to MC from the Netherlands Organisation for Scientific Research (grant 916.76.020, www.nwo.nl/nwohome.nsf/pages/SPPD_5R2QE7_Eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergboer JGM, 2011, AM J PATHOL, V178, P1470, DOI 10.1016/j.ajpath.2010.12.017; Bergboer JGM, 2010, J INVEST DERMATOL, V130, P2057, DOI 10.1038/jid.2010.88; Bowes J, 2010, ANN RHEUM DIS, V69, P2199, DOI 10.1136/ard.2010.130575; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Docampo E, 2011, ARTHRITIS RHEUM-US, V63, P1860, DOI 10.1002/art.30340; Docampo E, 2010, ARTHRITIS RHEUM-US, V62, P1246, DOI 10.1002/art.27381; Hoogendoorn EH, 2006, CLIN CHEM, V52, P104, DOI 10.1373/clinchem.2005.055194; Huffmeier U, 2010, J INVEST DERMATOL, V130, P979, DOI 10.1038/jid.2009.385; Jackson B, 2005, J INVEST DERMATOL, V124, P1062, DOI 10.1111/j.0022-202X.2005.23699.x; Lu XL, 2011, ANN RHEUM DIS, V70, P1648, DOI 10.1136/ard.2010.148072; Marshall D, 2001, P NATL ACAD SCI USA, V98, P13031, DOI 10.1073/pnas.231489198; McKinney C, 2008, ANN RHEUM DIS, V67, P409, DOI 10.1136/ard.2007.075028; McKinney C, 2010, ANN RHEUM DIS, V69, P1711, DOI 10.1136/ard.2009.123588; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Riveira-Munoz E, 2011, J INVEST DERMATOL, V131, P1105, DOI 10.1038/jid.2010.350; Toonen EJM, 2008, ANN RHEUM DIS, V67, P1174, DOI 10.1136/ard.2008.088138; Uddin M, 2011, J RHEUMATOL, V38, P797, DOI 10.3899/jrheum.100758; Wagener FADTG, 2008, ARTHRITIS RHEUM, V58, P3388, DOI 10.1002/art.23970; Yim SH, 2011, MOL IMMUNOL, V48, P1338, DOI 10.1016/j.molimm.2010.11.009; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310	22	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32045	10.1371/journal.pone.0032045	http://dx.doi.org/10.1371/journal.pone.0032045			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384135	Green Submitted, Green Published, gold			2022-12-27	WOS:000302916100047
J	Pan, HP; Li, XC; Ge, DQ; Wang, SL; Wu, QJ; Xie, W; Jiao, XG; Chu, D; Liu, BM; Xu, BY; Zhang, YJ				Pan, Huipeng; Li, Xianchun; Ge, Daqing; Wang, Shaoli; Wu, Qingjun; Xie, Wen; Jiao, Xiaoguo; Chu, Dong; Liu, Baiming; Xu, Baoyun; Zhang, Youjun			Factors Affecting Population Dynamics of Maternally Transmitted Endosymbionts in Bemisia tabaci	PLOS ONE			English	Article							HOST-PLANT SPECIALIZATION; PEA APHID; CYTOPLASMIC INCOMPATIBILITY; BACTERIAL ENDOSYMBIONTS; VERTICAL TRANSMISSION; FACULTATIVE SYMBIONTS; NATURAL-POPULATIONS; SECONDARY SYMBIONTS; INFECTION DENSITY; LOW-TEMPERATURES	While every individual of Bemisia tabaci (Hemiptera: Aleyrodidae) harbors the primary symbiont (P-symbiont) Portiera, the infection frequencies of the six secondary symbionts (S-symbionts) including Hamiltonella, Arsenophonus, Cardinium, Wolbachia, Rickettsia and Fritschea vary greatly among different populations. To characterize the factors influencing the infection dynamics of the six S-symbionts in B. tabaci, gene-specific PCR were conducted to screen for the presence of the P-symbiont Portiera and the six S-symbionts in 61 (17 B and 44 Q biotypes) field populations collected from different plant species and locations in China. All individuals of the 61 populations hosted the P-symbiont Portiera, but none of them harbored Arsenophonus and Fritschea. The presence and infection rates of Hamiltonella, Cardinium, Rickettsia, Wolbachia and their co-infections Rickettsia + Hamiltonella (RH), Rickettsia + Cardinium (RC), Hamiltonella + Cardinium (HC) and Rickettsia + Hamiltonella + Cardinium (RHC) varied significantly among the 61 field populations; and the observed variations can be explained by biotypes, sexes, host plants and geographical locations of these field populations. Taken together, at least three factors including biotype, host plant and geographical location affect the infection dynamics of S-symbionts in B. tabaci.	[Pan, Huipeng; Ge, Daqing; Wang, Shaoli; Wu, Qingjun; Xie, Wen; Jiao, Xiaoguo; Liu, Baiming; Xu, Baoyun; Zhang, Youjun] Chinese Acad Agr Sci, Dept Plant Protect, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Li, Xianchun] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Li, Xianchun] Univ Arizona, Inst BIO5, Tucson, AZ USA; [Chu, Dong] Shandong Acad Agr Sci, High Tech Res Ctr, Jinan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; University of Arizona; University of Arizona; Shandong Academy of Agricultural Sciences	Pan, HP (corresponding author), Chinese Acad Agr Sci, Dept Plant Protect, Inst Vegetables & Flowers, Beijing 100193, Peoples R China.	lxc@email.arizona.edu; zhangyj@mail.caas.net.cn	CHU, DONG/AAI-1892-2020; Zhang, Youjun/AAY-7948-2020; Chu, Dong/AAS-3914-2020	Zhang, Youjun/0000-0003-3508-6695; Chu, Dong/0000-0001-5716-4979	National Science Fund for Distinguished Young Scholars [31025020]; 973 Program [2009 CB119200]; National Natural Science Foundation of China [30900153]; Key Laboratory of Vegetable Genetics and Physiology, Ministry of Agriculture	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Vegetable Genetics and Physiology, Ministry of Agriculture	This study was supported by the National Science Fund for Distinguished Young Scholars (31025020), the 973 Program (2009 CB119200), the National Natural Science Foundation of China (No. 30900153), and the Key Laboratory of Vegetable Genetics and Physiology, Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MZ, 2009, J APPL ENTOMOL, V133, P733, DOI 10.1111/j.1439-0418.2009.01442.x; Ahmed MZ, 2010, CURR MICROBIOL, V61, P322, DOI 10.1007/s00284-010-9614-5; Anbutsu H, 2008, APPL ENVIRON MICROB, V74, P6053, DOI 10.1128/AEM.01503-08; Arthofer W, 2009, ENVIRON MICROBIOL, V11, P1923, DOI 10.1111/j.1462-2920.2009.01914.x; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Charlat S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-64; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chu D, 2011, B ENTOMOL RES, V101, P477, DOI 10.1017/S0007485311000083; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Elbaz M, 2010, B ENTOMOL RES, V100, P581, DOI 10.1017/S0007485309990630; Everett KDE, 2005, INT J SYST EVOL MICR, V55, P1581, DOI 10.1099/ijs.0.63454-0; Ferrari J, 2004, ECOL ENTOMOL, V29, P60, DOI 10.1111/j.1365-2311.2004.00574.x; Goto S, 2006, APPL ENVIRON MICROB, V72, P4805, DOI 10.1128/AEM.00416-06; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; Hunter MS, 2003, P ROY SOC B-BIOL SCI, V270, P2185, DOI 10.1098/rspb.2003.2475; Inbar M, 2008, ANNU REV ENTOMOL, V53, P431, DOI 10.1146/annurev.ento.53.032107.122456; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Koga R, 2003, P ROY SOC B-BIOL SCI, V270, P2543, DOI 10.1098/rspb.2003.2537; Leonardo TE, 2003, P ROY SOC B-BIOL SCI, V270, pS209, DOI 10.1098/rsbl.2003.0064; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Majerus TMO, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000987; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Oliver KM, 2006, P ROY SOC B-BIOL SCI, V273, P1273, DOI 10.1098/rspb.2005.3436; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Osaka R, 2008, CURR MICROBIOL, V57, P335, DOI 10.1007/s00284-008-9199-4; Perring TM, 2001, CROP PROT, V20, P725, DOI 10.1016/S0261-2194(01)00109-0; Sandstrom JP, 2001, PHYSIOL ENTOMOL, V26, P202, DOI 10.1046/j.0307-6962.2001.00235.x; Shatters RG, 2009, J ECON ENTOMOL, V102, P750, DOI 10.1603/029.102.0236; Simon JC, 2003, P ROY SOC B-BIOL SCI, V270, P1703, DOI 10.1098/rspb.2003.2430; Skaljac M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-142; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Thao MLL, 2004, CURR MICROBIOL, V48, P140, DOI 10.1007/s00284-003-4157-7; Toju H, 2011, MOL ECOL, V20, P853, DOI 10.1111/j.1365-294X.2010.04980.x; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; Tsuchida T, 2002, MOL ECOL, V11, P2123, DOI 10.1046/j.1365-294X.2002.01606.x; Vautrin E, 2009, TRENDS MICROBIOL, V17, P95, DOI 10.1016/j.tim.2008.12.002; Weeks AR, 2003, P ROY SOC B-BIOL SCI, V270, P1857, DOI 10.1098/rspb.2003.2425; Wernegreen JJ, 2004, PLOS BIOL, V2, P307, DOI 10.1371/journal.pbio.0020068; White JA, 2009, HEREDITY, V102, P483, DOI 10.1038/hdy.2009.5; Wilkinson TL, 2001, J EXP BIOL, V204, P3027; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Zchori-Fein E, 2002, ANN ENTOMOL SOC AM, V95, P711, DOI 10.1603/0013-8746(2002)095[0711:DOPAWB]2.0.CO;2; Zhang LP, 2005, J APPL ENTOMOL, V129, P121, DOI 10.1111/j.1439-0418.2005.00950.x; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	51	74	86	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e30760	10.1371/journal.pone.0030760	http://dx.doi.org/10.1371/journal.pone.0030760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383972	Green Submitted, gold, Green Published			2022-12-27	WOS:000302916100005
J	Pareja, M; Qvarfordt, E; Webster, B; Mayon, P; Pickett, J; Birkett, M; Glinwood, R				Pareja, Martin; Qvarfordt, Erika; Webster, Ben; Mayon, Patrick; Pickett, John; Birkett, Michael; Glinwood, Robert			Herbivory by a Phloem-Feeding Insect Inhibits Floral Volatile Production	PLOS ONE			English	Article							LEAF HERBIVORY; PLANT DEFENSE; BRASSICA-NAPUS; APHID; ARABIDOPSIS; RESPONSES; ECOLOGY; POLLINATION; SPECIALIST; SALICYLATE	There is extensive knowledge on the effects of insect herbivory on volatile emission from vegetative tissue, but little is known about its impact on floral volatiles. We show that herbivory by phloem-feeding aphids inhibits floral volatile emission in white mustard Sinapis alba measured by gas chromatographic analysis of headspace volatiles. The effect of the Brassica specialist aphid Lipaphis erysimi was stronger than the generalist aphid Myzus persicae and feeding by chewing larvae of the moth Plutella xylostella caused no reduction in floral volatile emission. Field observations showed no effect of L. erysimi-mediated floral volatile emission on the total number of flower visits by pollinators. Olfactory bioassays suggested that although two aphid natural enemies could detect aphid inhibition of floral volatiles, their olfactory orientation to infested plants was not disrupted. This is the first demonstration that phloem-feeding herbivory can affect floral volatile emission, and that the outcome of interaction between herbivory and floral chemistry may differ depending on the herbivore's feeding mode and degree of specialisation. The findings provide new insights into interactions between insect herbivores and plant chemistry.	[Pareja, Martin] Univ Fed Lavras, Dept Entomol, Lavras, Brazil; [Qvarfordt, Erika; Webster, Ben; Glinwood, Robert] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Mayon, Patrick; Pickett, John; Birkett, Michael] Rothamsted Res, Dept Biol Chem, Harpenden, Herts, England	Universidade Federal de Lavras; Swedish University of Agricultural Sciences; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Pareja, M (corresponding author), Univ Fed Lavras, Dept Entomol, Lavras, Brazil.	robert.glinwood@slu.se	Webster, Ben/K-6860-2012; Pareja, Martin/A-9982-2012	Webster, Ben/0000-0002-0437-9826; Glinwood, Robert/0000-0001-5082-5076; Birkett, Michael/0000-0002-3302-2025	Carl Tryggers Stiftelse; Mistra; Stiftelsen Tornspiran; Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom; Biotechnology and Biological Sciences Research Council [BB/J020281/1, BBS/E/C/00005194] Funding Source: researchfish; BBSRC [BBS/E/C/00005194, BB/J020281/1] Funding Source: UKRI	Carl Tryggers Stiftelse; Mistra; Stiftelsen Tornspiran; Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a grant from Carl Tryggers Stiftelse to Martin Pareja and by Mistra through the PlantComMistra program. Funding for equipment from Stiftelsen Tornspiran is acknowledged. Rothamsted Research receives grant-aided support from the Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2001, ECOLOGY, V82, P2032, DOI 10.1890/0012-9658(2001)082[2032:DAIEOA]2.0.CO;2; Adler LS, 2006, ECOL LETT, V9, P960, DOI 10.1111/j.1461-0248.2006.00944.x; Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; Armbruster WS, 1997, ECOLOGY, V78, P1661; Bernasconi ML, 1998, ENTOMOL EXP APPL, V87, P133, DOI 10.1023/A:1003200108763; Blande JD, 2007, J CHEM ECOL, V33, P767, DOI 10.1007/s10886-007-9264-7; Blight MM, 1997, J CHEM ECOL, V23, P1715, DOI 10.1023/B:JOEC.0000006446.21160.c1; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; Bridges M, 2002, P ROY SOC B-BIOL SCI, V269, P187, DOI 10.1098/rspb.2001.1861; Bruce TJA, 2008, P NATL ACAD SCI USA, V105, P4553, DOI 10.1073/pnas.0710305105; CHOU TS, 1984, J CHEM SOC CHEM COMM, P1323, DOI 10.1039/c39840001323; DAWSON GW, 1993, PESTIC SCI, V39, P271, DOI 10.1002/ps.2780390404; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Dudareva N, 2006, BIOL FLORAL SCENT; Dudareva N, 2006, BIOLOGY OF FLORAL SCENT, P55; DUKAS R, 1989, OIKOS, V54, P281, DOI 10.2307/3565286; Effmert U, 2008, PLANT PHYSIOL, V146, P1996, DOI 10.1104/pp.107.112326; GAONI Y, 1977, TETRAHEDRON LETT, P947; Girling RD, 2008, J EXP BOT, V59, P3077, DOI 10.1093/jxb/ern163; Glinwood R, 2011, OECOLOGIA, V166, P637, DOI 10.1007/s00442-010-1892-x; Glinwood R, 2009, ARTHROPOD-PLANT INTE, V3, P215, DOI 10.1007/s11829-009-9072-9; Han BY, 2002, J AGR FOOD CHEM, V50, P2571, DOI 10.1021/jf010681x; Hare JD, 2011, ANNU REV ENTOMOL, V56, P161, DOI 10.1146/annurev-ento-120709-144753; Heil M, 2008, PROG BOT, P360; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Hodek I., 1996, ECOLOGY COCCINELLIDA; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; Kazana E, 2007, P ROY SOC B-BIOL SCI, V274, P2271, DOI 10.1098/rspb.2007.0237; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler D, 2008, SCIENCE, V321, P1200, DOI 10.1126/science.1160072; Kessler D, 2011, CURR OPIN PLANT BIOL, V14, P429, DOI 10.1016/j.pbi.2011.03.023; Kessler D, 2010, CURR BIOL, V20, P237, DOI 10.1016/j.cub.2009.11.071; Knudsen JT, 2006, BOT REV, V72, P1, DOI 10.1663/0006-8101(2006)72[1:DADOFS]2.0.CO;2; Kusnierczyk A, 2007, J EXP BOT, V58, P2537, DOI 10.1093/jxb/erm043; Leopold E.J., 1986, ORG SYNTH, V64, P164, DOI DOI 10.1002/0471264180.0S064.25; Lucas-Barbosa D, 2011, PHYTOCHEMISTRY, V72, P1647, DOI 10.1016/j.phytochem.2011.03.013; Pettersson J, 2008, APPL ENTOMOL ZOOL, V43, P315, DOI 10.1303/aez.2008.315; Raguso RA, 2008, ENTOMOL EXP APPL, V128, P196, DOI 10.1111/j.1570-7458.2008.00683.x; Raguso RA, 2009, FUNCT ECOL, V23, P837, DOI 10.1111/j.1365-2435.2009.01643.x; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; Sarmento RA, 2011, ECOL LETT, V14, P229, DOI 10.1111/j.1461-0248.2010.01575.x; Smith JL, 2009, PEST MANAG SCI, V65, P497, DOI 10.1002/ps.1714; Strauss SY, 1997, ECOLOGY, V78, P1617; Theis N, 2006, J CHEM ECOL, V32, P917, DOI 10.1007/s10886-006-9051-x; Theis N, 2009, AM J BOT, V96, P897, DOI 10.3732/ajb.0800300; Tholl D, 2006, PLANT J, V45, P540, DOI 10.1111/j.1365-313X.2005.02612.x; Thompson GA, 2006, J EXP BOT, V57, P755, DOI 10.1093/jxb/erj135; van Eck L, 2010, PLANT BIOTECHNOL J, V8, P1023, DOI 10.1111/j.1467-7652.2010.00539.x; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Zhu JW, 2005, J CHEM ECOL, V31, P1733, DOI 10.1007/s10886-005-5923-8	54	39	42	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31971	10.1371/journal.pone.0031971	http://dx.doi.org/10.1371/journal.pone.0031971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384116	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000302916100042
J	Ramanadhan, S; Salhi, C; Achille, E; Baril, N; D'Entremont, K; Grullon, M; Judge, C; Oppenheimer, S; Reeves, C; Savage, C; Viswanath, K				Ramanadhan, Shoba; Salhi, Carmel; Achille, Erline; Baril, Nashira; D'Entremont, Kerrie; Grullon, Milagro; Judge, Christine; Oppenheimer, Sarah; Reeves, Chrasandra; Savage, Clara; Viswanath, Kasisomayajula			Addressing Cancer Disparities via Community Network Mobilization and Intersectoral Partnerships: A Social Network Analysis	PLOS ONE			English	Article							HEALTH-PROMOTION; PARTICIPATORY RESEARCH; COLLABORATION; CAPACITY; STRATEGY; COALITIONS; FRAMEWORK	Community mobilization and collaboration among diverse partners are vital components of the effort to reduce and eliminate cancer disparities in the United States. We studied the development and impact of intersectoral connections among the members of the Massachusetts Community Network for Cancer Education, Research, and Training (MassCONECT). As one of the Community Network Program sites funded by the National Cancer Institute, this infrastructure-building initiative utilized principles of Community-based Participatory Research (CBPR) to unite community coalitions, researchers, policymakers, and other important stakeholders to address cancer disparities in three Massachusetts communities: Boston, Lawrence, and Worcester. We conducted a cross-sectional, sociometric network analysis four years after the network was formed. A total of 38 of 55 members participated in the study (69% response rate). Over four years of collaboration, the number of intersectoral connections reported by members (intersectoral out-degree) increased, as did the extent to which such connections were reported reciprocally (intersectoral reciprocity). We assessed relationships between these markers of intersectoral collaboration and three intermediate outcomes in the effort to reduce and eliminate cancer disparities: delivery of community activities, policy engagement, and grants/publications. We found a positive and statistically significant relationship between intersectoral out-degree and community activities and policy engagement (the relationship was borderline significant for grants/publications). We found a positive and statistically significant relationship between intersectoral reciprocity and community activities and grants/publications (the relationship was borderline significant for policy engagement). The study suggests that intersectoral connections may be important drivers of diverse intermediate outcomes in the effort to reduce and eliminate cancer disparities. The findings support investment in infrastructure-building and intersectoral mobilization in addressing disparities and highlight the benefits of using CBPR approaches for such work.	[Ramanadhan, Shoba; Viswanath, Kasisomayajula] Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA; [Salhi, Carmel] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Achille, Erline; Baril, Nashira] Boston Publ Hlth Commiss, New England Ctr Excellence Eliminat Dispar, Boston, MA USA; [D'Entremont, Kerrie; Grullon, Milagro] City Lawrence, Mayors Hlth Task Force, Lawrence, MA USA; [Judge, Christine; Oppenheimer, Sarah] Harvard Univ, Sch Publ Hlth, Div Publ Hlth Practice, Boston, MA 02115 USA; [Reeves, Chrasandra] Boston Alliance Community Hlth, Boston, MA USA; [Savage, Clara] Common Pathways, Worcester, MA USA; [Viswanath, Kasisomayajula] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Ramanadhan, S (corresponding author), Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA.	shoba_ramanadhan@dfci.harvard.edu			National Cancer Institute [5 U01 CA114644]; NATIONAL CANCER INSTITUTE [U01CA114644] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Cancer Institute (Grant#: 5 U01 CA114644, Viswanath, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One co-author, Milagro Grullon, currently works for a commercial enterprise, but was employed by the City of Lawrence Mayor's Health Task Force at the time this work was conducted and the work was not funded or impacted by Lawrence Community Connections.	Borgatti S. P., 2005, UCINET WINDOWS SOFTW; Bracht N., 1990, HEALTH PROMOT INT, V5, P199, DOI [10.1093/heapro/5.3.199, DOI 10.1093/HEAPRO/5.3.199]; Burt R.S., 1992, STRUCTURAL HOLES SOC, DOI DOI 10.1016/J.JET.2007.01.006; Butterfoss FD, 1996, HEALTH EDUC QUART, V23, P65, DOI 10.1177/109019819602300105; Dyer JH, 1998, ACAD MANAGE REV, V23, P660, DOI 10.2307/259056; Emmons KM, 2008, AM J PREV MED, V35, pS204, DOI 10.1016/j.amepre.2008.05.009; FREEMAN H, 1991, J NATL CANCER I, V83, P526, DOI 10.1093/jnci/83.8.526; Giachello AL, 2003, PUBLIC HEALTH REP, V118, P309, DOI 10.1016/S0033-3549(04)50255-8; Goerzen A, 2005, STRATEGIC MANAGE J, V26, P333, DOI 10.1002/smj.447; Griffith DM, 2010, J PRIM PREV, V31, P31, DOI 10.1007/s10935-010-0202-z; Hanneman R.A., 2005, INTRO SOCIAL NETWORK; Hansen MT, 1999, ADMIN SCI QUART, V44, P82, DOI 10.2307/2667032; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; KANTER RM, 1994, HARVARD BUS REV, V72, P96; Koelen MA, 2001, J EPIDEMIOL COMMUN H, V55, P257, DOI 10.1136/jech.55.4.257; Koh H, 2009, MASSCONECT YEA UNPUB; Koh HK, 2010, AM J PUBLIC HEALTH, V100, pS72, DOI 10.2105/AJPH.2009.167353; KRACKHARDT D, 1988, SOC NETWORKS, V10, P359, DOI 10.1016/0378-8733(88)90004-4; Lasker RD, 2001, MILBANK Q, V79, P179, DOI 10.1111/1468-0009.00203; Lavery SH, 2005, AM J PUBLIC HEALTH, V95, P611, DOI 10.2105/AJPH.2004.047704; Luke DA, 2007, ANNU REV PUBL HEALTH, V28, P69, DOI 10.1146/annurev.publhealth.28.021406.144132; Luque JS, 2011, ANN ANTHROPL PRACT, V35, P112, DOI 10.1111/j.2153-9588.2011.01085.x; Luque J, 2010, J COMMUNITY PSYCHOL, V38, P656, DOI 10.1002/jcop.20386; Maibach EW, 2006, PREVENTING CHRONIC D, V3; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Minkler M, 2008, HLTH BEHAV HLTH ED T, P287; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Powell WW, 1996, ADMIN SCI QUART, V41, P116, DOI 10.2307/2393988; Powell WW, 1999, NETWORKS ORG, V16; Provan KG, 2005, PUBLIC ADMIN REV, V65, P603, DOI 10.1111/j.1540-6210.2005.00487.x; Provan KG, 2003, HEALTH EDUC BEHAV, V30, P646, DOI 10.1177/1090198103255366; Ramanadhan S, 2010, AM J HEALTH PROMOT, V25, P12, DOI 10.4278/ajhp.080826-QUAN-163; Ramanadhan S, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-17; Roussos ST, 2000, ANNU REV PUBL HEALTH, V21, P369, DOI 10.1146/annurev.publhealth.21.1.369; Sandoval JA, 2011, HLTH ED RES; Scott J., 2000, SOCIAL STRUCTURE, V2nd; Shults RA, 2009, AM J PREV MED, V37, P360, DOI 10.1016/j.amepre.2009.07.005; Simons-Morton B, 2011, BEHAV THEORY HLTH PR; Tourangeau Roger, 2000, PSYCHOL SURVEY RESPO; Trans-HHS Cancer Health Disparities Progress Review Group, 2004, MAK CANC HLTH UNPUB; Valente T.W., 2005, MODELS METHODS SOCIA, VVolume 28, P98, DOI DOI 10.1017/CBO9780511811395.006; Valente TW, 2007, AM J PUBLIC HEALTH, V97, P880, DOI 10.2105/AJPH.2005.063644; Valente TW, 2010, AM J PUBLIC HEALTH, V100, P1319, DOI 10.2105/AJPH.2009.171116; Valente TW, 2008, EVAL PROGRAM PLANN, V31, P392, DOI 10.1016/j.evalprogplan.2008.06.002; Valente TW, 2010, SOCIAL NETWORKS MODE; Van Duyn MAS, 2006, CANCER, V107, P1945, DOI 10.1002/cncr.22165; Varda D, 2011, AM J PUBLIC HLTH; Viswanath K, 2006, EXAMINING HLTH DISPA, P215; Viswanathan M, 2004, Evid Rep Technol Assess (Summ), P1; Wallerstein N, 2010, AM J PUBLIC HEALTH, V100, pS40, DOI 10.2105/AJPH.2009.184036; Wallerstein NB, 2006, HEALTH PROMOT PRACT, V7, P312, DOI 10.1177/1524839906289376; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Williams DR, 2008, J PUBLIC HLTH MANA S, V14; Zenk SN, 2005, METHODS COMMUNITY BA	55	23	23	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32130	10.1371/journal.pone.0032130	http://dx.doi.org/10.1371/journal.pone.0032130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	927NZ	22384156	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916100053
J	Kosir, R; Juvan, P; Perse, M; Budefeld, T; Majdic, G; Fink, M; Sassone-Corsi, P; Rozman, D				Kosir, Rok; Juvan, Peter; Perse, Martina; Budefeld, Tomaz; Majdic, Gregor; Fink, Martina; Sassone-Corsi, Paolo; Rozman, Damjana			Novel Insights into the Downstream Pathways and Targets Controlled by Transcription Factors CREM in the Testis	PLOS ONE			English	Article							RESPONSIVE-ELEMENT MODULATOR; LANOSTEROL 14-ALPHA-DEMETHYLASE CYP51; CAMP EARLY REPRESSOR; GERM-CELL APOPTOSIS; GENE-EXPRESSION; BINDING PROTEIN; CIRCADIAN-RHYTHMS; MASTER-SWITCH; CYCLIC-AMP; MOUSE	The essential role of the Crem gene in normal sperm development is widely accepted and is confirmed by azoospermia in male mice lacking the Crem gene. The exact number of genes affected by Crem absence is not known, however a large difference has been observed recently between the estimated number of differentially expressed genes found in Crem knock-out (KO) mice compared to the number of gene loci bound by CREM. We therefore re-examined global gene expression in male mice lacking the Crem gene using whole genome transcriptome analysis with Affymetrix microarrays and compared the lists of differentially expressed genes from Crem(-/-) mice to a dataset of genes where binding of CREM was determined by Chip-seq. We determined the global effect of CREM on spermatogenesis as well as distinguished between primary and secondary effects of the CREM absence. We demonstrated that the absence of Crem deregulates over 4700 genes in KO testis. Among them are 101 genes associated with spermatogenesis 41 of which are bound by CREM and are deregulated in Crem KO testis. Absence of several of these genes in mouse models has proven their importance for normal spermatogenesis and male fertility. Our study showed that the absence of Crem plays a more important role on different aspects of spermatogenesis as estimated previously, with its impact ranging from apoptosis induction to deregulation of major circadian clock genes, steroidogenesis and the cell-cell junction dynamics. Several new genes important for normal spermatogenesis and fertility are down-regulated in KO testis and are therefore possible novel targets of CREM.	[Kosir, Rok; Juvan, Peter; Rozman, Damjana] Univ Ljubljana, Fac Med, Inst Biochem, Ctr Funct Genom & Biochips, Ljubljana 61000, Slovenia; [Perse, Martina] Univ Ljubljana, Fac Med, Inst Pathol, Ctr Med Expt, Ljubljana, Slovenia; [Budefeld, Tomaz; Majdic, Gregor] Univ Ljubljana, Fac Vet, Ctr Anim Genom, Ljubljana, Slovenia; [Fink, Martina] Univ Med Ctr Ljubljana, Dept Haematol, Ljubljana, Slovenia; [Majdic, Gregor] Univ Maribor, Fac Med, Inst Physiol, SLO-2000 Maribor, Slovenia; [Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Kosir, Rok] Diagenomi Ltd, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana; University of Ljubljana; University Medical Centre Ljubljana; University of Maribor; University of California System; University of California Irvine	Kosir, R (corresponding author), Univ Ljubljana, Fac Med, Inst Biochem, Ctr Funct Genom & Biochips, Ljubljana 61000, Slovenia.	damjana.rozman@mf.uni-lj.si	Perse, Martina/AAS-2898-2020; Majdic, Gregor/A-7107-2008; Kosir, Rok/AAT-2901-2020	Majdic, Gregor/0000-0001-9620-2683; Kosir, Rok/0000-0002-1197-9627; Juvan, Peter/0000-0003-2873-5247; Rozman, Damjana/0000-0002-6501-2163	Slovenian Research Agency [J1-9438, P1-0527]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The work was supported by the Slovenian Research Agency Grants J1-9438 and P1-0527. Rok Kosir was supported by the fellowship from the Slovenian Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acimovic J, 2008, BIOCHEM BIOPH RES CO, V376, P206, DOI 10.1016/j.bbrc.2008.08.126; Alvarez JD, 2008, J BIOL RHYTHM, V23, P26, DOI 10.1177/0748730407311254; Beardsley A, 2003, BIOL REPROD, V68, P1299, DOI 10.1095/biolreprod.102.009811; Behr R, 2001, INT J ANDROL, V24, P126, DOI 10.1046/j.1365-2605.2001.00277.x; Beissbarth T, 2003, MOL CELL ENDOCRINOL, V212, P29, DOI 10.1016/j.mce.2003.09.023; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bettegowda A, 2010, PHILOS T R SOC B, V365, P1637, DOI 10.1098/rstb.2009.0196; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Burton KA, 2007, PHYSIOLOGY, V22, P40, DOI 10.1152/physiol.00034.2006; Calvel P, 2010, PHILOS T R SOC B, V365, P1481, DOI 10.1098/rstb.2009.0294; Carreau Serge, 2003, Reprod Biol Endocrinol, V1, P35, DOI 10.1186/1477-7827-1-35; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; Cheng CY, 2010, PHILOS T R SOC B, V365, P1459, DOI 10.1098/rstb.2010.0024; Cheng CY, 2005, CONTRACEPTION, V72, P251, DOI 10.1016/j.contraception.2005.03.008; Claustrat B, 2005, SLEEP MED REV, V9, P11, DOI 10.1016/j.smrv.2004.08.001; Cos S, 2008, CURR CANCER DRUG TAR, V8, P691, DOI 10.2174/156800908786733469; Cotman M, 2004, ENDOCRINOLOGY, V145, P1419, DOI 10.1210/en.2003-1332; Daniel PB, 2000, ENDOCRINOLOGY, V141, P3923, DOI 10.1210/en.141.11.3923; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; De Cesare D, 2000, J ENDOCRINOL INVEST, V23, P592, DOI 10.1007/BF03343781; Debeljak N, 1999, WHY IS CHOLESTEROGEN; DELMAS V, 1993, MOL ENDOCRINOL, V7, P1502, DOI 10.1210/me.7.11.1502; DELMAS V, 1992, P NATL ACAD SCI USA, V89, P4226, DOI 10.1073/pnas.89.10.4226; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; Foulkes NS, 1997, BIOL CELL, V89, P487, DOI 10.1016/S0248-4900(98)80004-X; Foulkes NS, 1996, P NATL ACAD SCI USA, V93, P14140, DOI 10.1073/pnas.93.24.14140; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; FOULKES NS, 1993, NATURE, V362, P264, DOI 10.1038/362264a0; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Frungieri NB, 2005, ENDOCRINOLOGY, V146, P1541, DOI 10.1210/en.2004-0990; Fulton DL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r29; Gellersen B, 2002, MOL HUM REPROD, V8, P965, DOI 10.1093/molehr/8.11.965; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; Hurst S, 1998, MOL REPROD DEV, V49, P81, DOI 10.1002/(SICI)1098-2795(199801)49:1&lt;81::AID-MRD9&gt;3.0.CO;2-K; Jamsai D, 2011, ASIAN J ANDROL, V13, P139, DOI 10.1038/aja.2010.101; Kennaway DJ, 2002, AM J PHYSIOL-REG I, V282, pR358, DOI 10.1152/ajpregu.00360.2001; Kopera IA, 2010, PHILOS T R SOC B, V365, P1593, DOI 10.1098/rstb.2009.0251; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; LAOIDE BM, 1993, EMBO J, V12, P1179, DOI 10.1002/j.1460-2075.1993.tb05759.x; Lee NPY, 2009, CURR MED CHEM, V16, P906, DOI 10.2174/092986709787549262; Lie PPY, 2010, PHILOS T R SOC B, V365, P1581, DOI 10.1098/rstb.2009.0261; Manfredini R, 2005, CHRONOBIOL INT, V22, P417, DOI 10.1081/CBI-200062927; Martianov I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-530; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; MEYER TE, 1993, ENDOCR REV, V14, P269, DOI 10.1210/er.14.3.269; MONACO L, 1995, P NATL ACAD SCI USA, V92, P10673, DOI 10.1073/pnas.92.23.10673; Mongrain V, 2008, GENES CELLS, V13, P1197, DOI 10.1111/j.1365-2443.2008.01237.x; Morales V, 2003, J ENDOCRINOL, V179, P417, DOI 10.1677/joe.0.1790417; Morse D, 2003, MOL ENDOCRINOL, V17, P141, DOI 10.1210/me.2002-0184; Mruk DD, 2010, PHILOS T R SOC B, V365, P1621, DOI 10.1098/rstb.2010.0010; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Nantel Francois, 1996, Frontiers in Bioscience (online), V1, pD266; O'Bryan MK, 2006, INT J ANDROL, V29, P76, DOI 10.1111/j.1365-2605.2005.00614.x; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; OLIVA R, 1991, ANN NY ACAD SCI, V637, P289, DOI 10.1111/j.1749-6632.1991.tb27316.x; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Pauley SM, 2004, MED HYPOTHESES, V63, P588, DOI 10.1016/j.mehy.2004.03.020; REHFUSS RP, 1991, J BIOL CHEM, V266, P18431; Rozman D, 1999, MOL ENDOCRINOL, V13, P1951, DOI 10.1210/me.13.11.1951; Rozman D, 1998, DRUG METAB DISPOS, V26, P1199; Russell LD, 1993, SERTOLI CELL, P365; Ruwanpura SM, 2010, J ENDOCRINOL, V205, P117, DOI 10.1677/JOE-10-0025; Sassone-Corsi P, 2000, MOL REPROD DEV, V56, P228, DOI 10.1002/(SICI)1098-2795(200006)56:2+<228::AID-MRD2>3.0.CO;2-B; SassoneCorsi P, 1997, CELL, V88, P163, DOI 10.1016/S0092-8674(00)81834-6; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Schmidt EE, 1997, J BIOL CHEM, V272, P5326, DOI 10.1074/jbc.272.8.5326; SCHMIDT EE, 1995, DEVELOPMENT, V121, P2373; Shaha C, 2010, PHILOS T R SOC B, V365, P1501, DOI 10.1098/rstb.2009.0124; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Shiraishi K, 2000, BIOL REPROD, V63, P1538, DOI 10.1095/biolreprod63.5.1538; SKINNER MK, 1991, ENDOCR REV, V12, P45, DOI 10.1210/edrv-12-1-45; Steger K, 1999, J ANDROL, V20, P747; ULISSE S, 1994, ENDOCRINOLOGY, V135, P2479, DOI 10.1210/en.135.6.2479; Verhoeven G, 2010, PHILOS T R SOC B, V365, P1537, DOI 10.1098/rstb.2009.0117; Vouk K, 2005, MOL HUM REPROD, V11, P567, DOI 10.1093/molehr/gah209; Walker WH, 1998, MOL CELL ENDOCRINOL, V143, P167, DOI 10.1016/S0303-7207(98)00082-3; Walker WH, 2010, PHILOS T R SOC B, V365, P1557, DOI 10.1098/rstb.2009.0258; Xiao P, 2008, BIOL PHARM BULL, V31, P201, DOI 10.1248/bpb.31.201; Yao PL, 2007, J BIOL CHEM, V282, P5420, DOI 10.1074/jbc.M609068200; Zhou YD, 1996, P NATL ACAD SCI USA, V93, P12262, DOI 10.1073/pnas.93.22.12262	83	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31798	10.1371/journal.pone.0031798	http://dx.doi.org/10.1371/journal.pone.0031798			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384077	Green Published, gold			2022-12-27	WOS:000302875500043
J	Schock, L; Dyck, M; Demenescu, LR; Edgar, JC; Hertrich, I; Sturm, W; Mathiak, K				Schock, Lisa; Dyck, Miriam; Demenescu, Liliana R.; Edgar, J. Christopher; Hertrich, Ingo; Sturm, Walter; Mathiak, Klaus			Mood Modulates Auditory Laterality of Hemodynamic Mismatch Responses during Dichotic Listening	PLOS ONE			English	Article							WHOLE-HEAD MAGNETOENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS; SUPERIOR TEMPORAL GYRUS; RIGHT-HEMISPHERE; EMOTIONAL CONTEXT; FACIAL EXPRESSIONS; NEGATIVITY MMN; STIMULUS APPLICATION; MAJOR DEPRESSION; INDUCTION	Hemodynamic mismatch responses can be elicited by deviant stimuli in a sequence of standard stimuli even during cognitive demanding tasks. Emotional context is known to modulate lateralized processing. Right-hemispheric negative emotion processing may bias attention to the right and enhance processing of right-ear stimuli. The present study examined the influence of induced mood on lateralized pre-attentive auditory processing of dichotic stimuli using functional magnetic resonance imaging (fMRI). Faces expressing emotions (sad/happy/neutral) were presented in a blocked design while a dichotic oddball sequence with consonant-vowel (CV) syllables in an event-related design was simultaneously administered. Twenty healthy participants were instructed to feel the emotion perceived on the images and to ignore the syllables. Deviant sounds reliably activated bilateral auditory cortices and confirmed attention effects by modulation of visual activity. Sad mood induction activated visual, limbic and right prefrontal areas. A lateralization effect of emotion-attention interaction was reflected in a stronger response to right-ear deviants in the right auditory cortex during sad mood. This imbalance of resources may be a neurophysiological correlate of laterality in sad mood and depression. Conceivably, the compensatory right-hemispheric enhancement of resources elicits increased ipsilateral processing.	[Schock, Lisa; Dyck, Miriam; Demenescu, Liliana R.; Mathiak, Klaus] Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Schock, Lisa; Sturm, Walter; Mathiak, Klaus] Rhein Westfal TH Aachen, Sch Med, Interdisciplinary Ctr Clin Res, Aachen, Germany; [Schock, Lisa; Dyck, Miriam; Demenescu, Liliana R.; Mathiak, Klaus] Julich Aachen Res Alliance JARA Translat Brain Me, Aachen, Germany; [Edgar, J. Christopher] Childrens Hosp Philadelphia, Dept Radiol, Philadelphia, PA USA; [Hertrich, Ingo] Univ Tubingen, Dept Gen Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany; [Sturm, Walter] Rhein Westfal TH Aachen, Sch Med, Dept Neurol, Aachen, Germany; [Mathiak, Klaus] Forschungszentrum Julich, Inst Neurosci & Med, INM 1, D-52425 Julich, Germany	RWTH Aachen University; RWTH Aachen University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; RWTH Aachen University; Helmholtz Association; Research Center Julich	Schock, L (corresponding author), Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany.	lisa.schock@rwth-aachen.de	Demenescu, Liliana Ramona/C-4884-2014; Hertrich, Ingo/T-1154-2018	Demenescu, Liliana Ramona/0000-0002-8770-0725; Hertrich, Ingo/0000-0001-8965-6249	"Interdisciplinary Centre for Clinical Research (IZKF) Aachen'' of the Faculty of Medicine at RWTH Aachen University; German Research Foundation (Deutsche Forschungsgemeinschaft DFG, IRTG) [1328, MA2631/4-1]	"Interdisciplinary Centre for Clinical Research (IZKF) Aachen'' of the Faculty of Medicine at RWTH Aachen University; German Research Foundation (Deutsche Forschungsgemeinschaft DFG, IRTG)(German Research Foundation (DFG))	This research project was supported by the "Interdisciplinary Centre for Clinical Research (IZKF) Aachen'' of the Faculty of Medicine at RWTH Aachen University and the German Research Foundation (Deutsche Forschungsgemeinschaft DFG, IRTG 1328 and MA2631/4-1). The funders had no role in study design, data collection and analysis, decision to punlish, or preparation of the manuscript.	Adolphs R, 1996, J NEUROSCI, V16, P7678; Alexandrov YI, 2007, INT J PSYCHOPHYSIOL, V65, P261, DOI 10.1016/j.ijpsycho.2007.05.004; Alho K, 1998, PSYCHOPHYSIOLOGY, V35, P211, DOI 10.1111/1469-8986.3520211; BANICH MT, 1992, NEUROPSY NEUROPSY BE, V5, P20; Bruder GE, 1999, J ABNORM PSYCHOL, V108, P233, DOI 10.1037/0021-843X.108.2.233; Della Penna S, 2007, CEREB CORTEX, V17, P2303, DOI 10.1093/cercor/bhl139; Demaree Heath A, 2005, Behav Cogn Neurosci Rev, V4, P3, DOI 10.1177/1534582305276837; Dominguez-Borras J, 2008, EUR J NEUROSCI, V28, P1199, DOI 10.1111/j.1460-9568.2008.06411.x; Dominguez-Borras J, 2008, NEUROREPORT, V19, P503, DOI 10.1097/WNR.0b013e3282f85bec; Dominguez-Borras J, 2009, CEREB CORTEX, V19, P1521, DOI 10.1093/cercor/bhn188; Dyck M, 2011, NEUROIMAGE, V54, P2503, DOI 10.1016/j.neuroimage.2010.10.013; Gadea M, 2005, PSYCHONEUROENDOCRINO, V30, P129, DOI 10.1016/j.psyneuen.2004.06.005; Gerber AJ, 2008, NEUROPSYCHOLOGIA, V46, P2129, DOI 10.1016/j.neuropsychologia.2008.02.032; Gur RC, 2002, J NEUROSCI METH, V115, P137, DOI 10.1016/S0165-0270(02)00006-7; Habel U, 2005, NEUROIMAGE, V26, P206, DOI 10.1016/j.neuroimage.2005.01.014; Heilman KM, 1990, PSYCHOL BIOL APPROAC; Heller W, 1998, CURR DIR PSYCHOL SCI, V7, P26, DOI 10.1111/1467-8721.ep11521823; Hertrich I, 2002, NEUROPSYCHOLOGIA, V40, P1902, DOI 10.1016/S0028-3932(02)00063-5; Ikezawa S, 2008, INT J PSYCHOPHYSIOL, V68, P41, DOI 10.1016/j.ijpsycho.2008.01.006; Jancke L, 2002, NEUROLOGY, V58, P736, DOI 10.1212/WNL.58.5.736; Kaiser J, 2000, NEUROREPORT, V11, P2889, DOI 10.1097/00001756-200009110-00012; Kasai K, 2002, COGNITIVE BRAIN RES, V13, P305, DOI 10.1016/S0926-6410(01)00125-2; Killgore WDS, 2007, SOC COGN AFFECT NEUR, V2, P240, DOI 10.1093/scan/nsm020; KIMURA D, 1961, CAN J PSYCHOLOGY, V15, P166, DOI 10.1037/h0083219; Koster EHW, 2005, EMOTION, V5, P446, DOI 10.1037/1528-3542.5.4.446; Koster Ernst H W, 2009, Depress Anxiety, V26, pE16, DOI 10.1002/da.20420; LADAVAS E, 1984, NEUROPSYCHOLOGIA, V22, P479, DOI 10.1016/0028-3932(84)90042-3; Lang PJ, 1980, TECHNOLOGY MENTAL HL; Lehrl S., 2005, MULTIPLE CHOICE VOCA; Liotti M, 2001, J CLIN EXP NEUROPSYC, V23, P121, DOI 10.1076/jcen.23.1.121.1223; LIOTTI M, 1992, BRAIN COGNITION, V18, P138, DOI 10.1016/0278-2626(92)90075-W; Lipski SC, 2007, NEUROSCI LETT, V415, P90, DOI 10.1016/j.neulet.2007.01.001; Mathiak K, 2000, COGNITIVE BRAIN RES, V10, P125, DOI 10.1016/S0926-6410(00)00035-5; Mathiak K, 2002, HUM BRAIN MAPP, V16, P190, DOI 10.1002/hbm.10041; Mathiak K, 2002, NEUROPSYCHOLOGIA, V40, P585, DOI 10.1016/S0028-3932(01)00159-2; Mneimne M, 2010, BRAIN COGNITION, V74, P10, DOI 10.1016/j.bandc.2010.05.011; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 2004, CLIN NEUROPHYSIOL, V115, P140, DOI 10.1016/j.clinph.2003.04.001; NAATANEN R, 1989, NEUROSCI LETT, V98, P217, DOI 10.1016/0304-3940(89)90513-2; NAATANEN R, 1995, EAR HEARING, V16, P6; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Phillips C, 2000, J COGNITIVE NEUROSCI, V12, P1038, DOI 10.1162/08989290051137567; Pine DS, 2000, PSYCHIAT RES, V93, P135, DOI 10.1016/S0165-1781(00)00101-3; Pulvermuller F, 2006, PROG NEUROBIOL, V79, P49, DOI 10.1016/j.pneurobio.2006.04.004; Rosburg T, 2005, BRAIN, V128, P819, DOI 10.1093/brain/awh442; Rotenberg VS, 2004, PROG NEURO-PSYCHOPH, V28, P1, DOI 10.1016/S0278-5846(03)00163-5; SAMS M, 1985, ELECTROEN CLIN NEURO, V62, P437, DOI 10.1016/0168-5597(85)90054-1; Schneider F, 1998, SCHIZOPHR RES, V34, P133, DOI 10.1016/S0920-9964(98)00085-1; Schneider F, 1995, PSYCHIAT RES-NEUROIM, V61, P265, DOI 10.1016/0925-4927(95)02678-Q; SCHNEIDER F, 1994, PSYCHIAT RES, V51, P19, DOI 10.1016/0165-1781(94)90044-2; Schock L, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-78; Schonwiesner M, 2007, J NEUROPHYSIOL, V97, P2075, DOI 10.1152/jn.01083.2006; Seidel EM, 2010, J EXP PSYCHOL HUMAN, V36, P500, DOI 10.1037/a0018169; Sequeira SD, 2010, LATERALITY, V15, P577, DOI 10.1080/13576500903045082; SILBERMAN EK, 1986, BRAIN COGNITION, V5, P322, DOI 10.1016/0278-2626(86)90035-7; Sturm W, 2006, EXP BRAIN RES, V171, P16, DOI 10.1007/s00221-005-0253-1; Surakka V, 1998, COGNITIVE BRAIN RES, V7, P159, DOI 10.1016/S0926-6410(98)00021-4; Thimm M, 2006, NEUROPSYCHOLOGIA, V44, P1230, DOI 10.1016/j.neuropsychologia.2005.09.008; VELTEN E, 1968, BEHAV RES THER, V6, P473, DOI 10.1016/0005-7967(68)90028-4; Westerhausen R, 2010, NEUROPSYCHOLOGIA, V48, P2075, DOI 10.1016/j.neuropsychologia.2010.03.028; Wittchen HU, 1997, STRUCTURED CLIN INTE	61	9	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31936	10.1371/journal.pone.0031936	http://dx.doi.org/10.1371/journal.pone.0031936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZZ	22384105	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500054
J	Kudo, K; Takasaki, J; Manabe, T; Uryu, H; Yamada, R; Kuroda, E; Kobayashi, N; Matsushita, T				Kudo, Koichiro; Takasaki, Jin; Manabe, Toshie; Uryu, Hideko; Yamada, Ritsuko; Kuroda, Emi; Kobayashi, Nobuyuki; Matsushita, Takeji			Systemic Corticosteroids and Early Administration of Antiviral Agents for Pneumonia with Acute Wheezing due to Influenza A(H1N1)pdm09 in Japan	PLOS ONE			English	Article							A H1N1	Background: Pneumonia patients with wheezing due to influenza A(H1N1)pdm09 were frequently treated with systemic corticosteroids in Japan although systemic corticosteroid for critically ill patients with pneumonia caused by influenza A(H1N1) pdm09 has been controversial. Applicability of systemic corticosteroid treatment needs to be evaluated. Methods/Principal Findings: We retrospectively reviewed 89 subjects who were diagnosed with influenza A(H1N1) pdm09 and admitted to a national hospital, Tokyo during the pandemic period. The median age of subjects (45 males) was 8 years (range, 0-71). All subjects were treated with antiviral agents and the median time from symptom onset to initiation of antiviral agents was 2 days (range, 0-7). Subjects were classified into four groups: upper respiratory tract infection, wheezing illness, pneumonia with wheezing, and pneumonia without wheezing. The characteristics of each group was evaluated. A history of asthma was found more frequently in the wheezing illness (55.6%) and pneumonia with wheezing (43.3%) groups than in the other two groups (p = 0.017). Corticosteroid treatment was assessed among subjects with pneumonia. Oxygen saturation was lower in subjects receiving corticosteroids (steroid group) than in subjects not receiving corticosteroids (no-steroid group) (p < 0.001). The steroid group required greater oxygen supply than the no-steroid group (p < 0.001). No significant difference was found by the Kaplan-Meier method between the steroid and the no-steroid groups in hours to fever alleviation from the initiation of antiviral agents and hospitalization days. In logistic regression analysis, wheezing, pneumonia and oxygen saturation were independent factors associated with using systemic corticosteroids. Conclusion: Patients with wheezing and a history of asthma were frequently found in the study subjects. Systemic corticosteroids together with early administration of antiviral agents to pneumonia with wheezing and possibly without wheezing did not result in negative clinical outcomes and may prevent progression to severe pneumonia in this study population.	[Kudo, Koichiro; Takasaki, Jin; Manabe, Toshie; Uryu, Hideko; Yamada, Ritsuko; Kuroda, Emi; Kobayashi, Nobuyuki; Matsushita, Takeji] Natl Ctr Global Hlth & Med, Tokyo, Japan	National Center for Global Health & Medicine - Japan	Kudo, K (corresponding author), Natl Ctr Global Hlth & Med, Tokyo, Japan.	kudo@dcc.go.jp			Ministry of Health, Labour and Welfare [H22-emerging infectious diseases and influenza-002]	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	The work was supported by the Ministry of Health, Labour and Welfare for the proggram No. H22-emerging infectious diseases and influenza-002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Brun-Buisson C, 2011, AM J RESP CRIT CARE, V183, P1200, DOI 10.1164/rccm.201101-0135OC; Corneli HM, 2007, NEW ENGL J MED, V357, P331, DOI 10.1056/NEJMoa071255; Iglesias ALH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021838; Infectious Disease Surveillance Center, 2009, PAND INFL A H1N1 SIT; Jaian S, 2009, NEW ENGL J MED, V302, P1896; Japanese Society of Allergoology, 2009, ASTHM PREV MAN GUIDL, P113; Kil HR, 2011, CRIT CARE, V15, DOI 10.1186/cc10082; Kim SH, 2011, AM J RESP CRIT CARE, V183, P1207, DOI 10.1164/rccm.201101-0110OC; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; National Asthma Education and Prevention Program, 2007, HYPERLIPIDAEMIA; Panickar J, 2009, NEW ENGL J MED, V360, P329, DOI 10.1056/NEJMoa0804897; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Riquelme R, 2011, INT J TUBERC LUNG D, V15, P542, DOI 10.5588/ijtld.10.0539; The Global Initiative for Asthma(GINA), 2010, GLOB START ASTHM MAN; The Ministry of Health Labour and Welfare, 2011, TREND PAND H1N1 2009; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; World Health Organization, 2010, WHO GUIDL PHARM MAN	18	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32280	10.1371/journal.pone.0032280	http://dx.doi.org/10.1371/journal.pone.0032280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393395	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500048
J	Seixas, S; Ivanova, N; Ferreira, Z; Rocha, J; Victor, BL				Seixas, Susana; Ivanova, Nevyana; Ferreira, Zelia; Rocha, Jorge; Victor, Bruno L.			Loss and Gain of Function in SERPINB11: An Example of a Gene under Selection on Standing Variation, with Implications for Host-Pathogen Interactions	PLOS ONE			English	Article							AMINO-ACID SITES; DETECTING POSITIVE SELECTION; INFLAMMATORY-BOWEL-DISEASE; CODON-SUBSTITUTION MODELS; HUMAN GENOME; LINKAGE DISEQUILIBRIUM; HAPLOTYPE RECONSTRUCTION; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; STATISTICAL-METHOD	Serine protease inhibitors (SERPINs) are crucial in the regulation of diverse biological processes including inflammation and immune response. SERPINB11, located in the 18q21 gene cluster, is a polymorphic gene/pseudogene coding for a non-inhibitory SERPIN. In a genome-wide scan for recent selection, SERPINB11 was identified as a potential candidate gene for adaptive evolution in Yoruba. The present study sought a better understanding of the evolutionary history of SERPINB11, with special focus on evaluating its selective signature. Through the resequencing of coding and noncoding regions of SERPINB11 in 20 Yorubans and analyzing primate orthologous sequences, we identified a full-length SERPINB11 variant encoding a non-inhibitory SERPIN as the putative candidate of selection - probably driven to higher frequencies by an adaptive response using preexisting variation. In addition, we detected contrasting evolutionary features of SERPINB11 in primates: While primate phylogeny as a whole is under purifying selection, the human lineage shows evidence of positive selection in a few codons, all associated with the active SERPINB11. Comparative modeling studies suggest that positively selected codons reduce SERPINB11's ability to undergo the conformational changes typical of inhibitory SERPINs suggesting that it is evolving towards a new non-inhibitory function in humans. Significant correlations between SERPINB11 variants and the environmental variables, pastoralism and pathogen richness, have led us to propose a selective advantage through host-pathogen interactions, possibly linked to an adaptive response combating the emergence of infectious diseases in recent human evolution. This work represents the first description of a resurrected gene in humans, and may well exemplify selection on standing variation triggered by drastic ecological shifts.	[Seixas, Susana; Ivanova, Nevyana; Ferreira, Zelia; Rocha, Jorge] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Ferreira, Zelia; Rocha, Jorge] Univ Porto, Dept Zool & Anthropol, Fac Sci, P-4100 Oporto, Portugal; [Victor, Bruno L.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal	Universidade do Porto; Universidade do Porto; Universidade Nova de Lisboa	Seixas, S (corresponding author), Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal.	sseixas@ipatimup.pt	Victor, Bruno L./L-2649-2016; Seixas, Susana/I-5084-2013	Victor, Bruno L./0000-0002-6472-5700; Seixas, Susana/0000-0002-7035-7422; rocha, jorge/0000-0001-5460-7615; Worman, Zelia/0000-0002-7619-7466	Portuguese Foundation for Science and Technology (FCT) [PTDC/SAU-GMG/64043/2006, SFRH/BD/45907/2008, SFRH/BPD/29708/2006]; POPH-QREN - Promotion of scientific employment; Ministry of Science, Technology and Higher Education	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); POPH-QREN - Promotion of scientific employment; Ministry of Science, Technology and Higher Education	This work was supported by the Portuguese Foundation for Science and Technology (FCT), project grant to S. Seixas - PTDC/SAU-GMG/64043/2006. Z. Ferreira and B.L. Victor are supported by fellowships SFRH/BD/45907/2008 and SFRH/BPD/29708/2006, respectively, from FCT, supported by POPH-QREN - Promotion of scientific employment, supported by the European Social Fund and national funds of the Ministry of Science, Technology and Higher Education. S. Seixas is supported by POPH-QREN - Promotion of scientific employment, supported by the European Social Fund and national funds of the Ministry of Science, Technology and Higher Education. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Askew DJ, 2007, J BIOL CHEM, V282, P24948, DOI 10.1074/jbc.M703182200; Atchley WR, 2001, MOL BIOL EVOL, V18, P1502, DOI 10.1093/oxfordjournals.molbev.a003936; Barnich N, 2007, WORLD J GASTROENTERO, V13, P5571, DOI 10.3748/wjg.v13.i42.5571; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Bekpen C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000403; Benarafa C, 2005, P NATL ACAD SCI USA, V102, P11367, DOI 10.1073/pnas.0502934102; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Bots M, 2008, J LEUKOCYTE BIOL, V84, P1238, DOI 10.1189/jlb.0208140; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ferreira Z, 2011, MOL BIOL EVOL, V28, P2811, DOI 10.1093/molbev/msr106; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Fulton KF, 2005, J BIOL CHEM, V280, P8435, DOI 10.1074/jbc.M410206200; Fumagalli M, 2009, GENOME RES, V19, P199, DOI 10.1101/gr.082768.108; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garrigan D, 2005, GENETICS, V170, P1849, DOI 10.1534/genetics.105.041095; Garrigan D, 2006, NAT REV GENET, V7, P669, DOI 10.1038/nrg1941; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; Hayakawa T, 2006, GENETICS, V172, P1139, DOI 10.1534/genetics.105.046995; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Hudson RR, 2001, GENETICS, V159, P1805; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Irving JA, 2007, MOL CELLULAR ASPECTS, P1; Izuhara K, 2008, CELL MOL LIFE SCI, V65, P2541, DOI 10.1007/s00018-008-8049-7; Kaiserman D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-167; Kim HL, 2008, GENETICS, V178, P1505, DOI 10.1534/genetics.107.083691; Knight P, 2008, BRIT MED BULL, V88, P95, DOI 10.1093/bmb/ldn038; Koda Y, 2000, J MOL EVOL, V50, P243, DOI 10.1007/s002399910028; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Kudaravalli S, 2009, MOL BIOL EVOL, V26, P649, DOI 10.1093/molbev/msn289; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Magalon H, 2008, EUR J HUM GENET, V16, P243, DOI 10.1038/sj.ejhg.5201963; Malmstrom E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000698; Mangan MSJ, 2008, TISSUE ANTIGENS, V72, P1, DOI 10.1111/j.1399-0039.2008.01059.x; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Nachman MW, 2000, GENETICS, V156, P297; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nielsen R, 1998, GENETICS, V148, P929; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Orr HA, 2001, GENETICS, V157, P875; Patin E, 2006, HUM MUTAT, V27, P720, DOI 10.1002/humu.9438; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Pellegrini A, 2004, BBA-GEN SUBJECTS, V1672, P76, DOI 10.1016/j.bbagen.2004.02.010; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; Ragg H, 2001, MOL BIOL EVOL, V18, P577, DOI 10.1093/oxfordjournals.molbev.a003838; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; REMOLDODONNELL E, 1993, FEBS LETT, V315, P105, DOI 10.1016/0014-5793(93)81143-N; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Scheinfeldt LB, 2009, MOL BIOL EVOL, V26, P1357, DOI 10.1093/molbev/msp045; Seixas S, 2007, MOL BIOL EVOL, V24, P587, DOI 10.1093/molbev/msl187; Silva LM, 2010, GLYCOCONJUGATE J, V27, P61, DOI 10.1007/s10719-009-9255-8; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Stajich JE, 2005, MOL BIOL EVOL, V22, P63, DOI 10.1093/molbev/msh252; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Wall JD, 2000, GENETICS, V155, P1865; Wang XX, 2006, PLOS BIOL, V4, P366, DOI 10.1371/journal.pbio.0040052; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Xue YL, 2006, AM J HUM GENET, V78, P659, DOI 10.1086/503116; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	95	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32518	10.1371/journal.pone.0032518	http://dx.doi.org/10.1371/journal.pone.0032518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393410	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500063
J	Cao, HJ; Li, X; Liu, JP				Cao, Huijuan; Li, Xun; Liu, Jianping			An Updated Review of the Efficacy of Cupping Therapy	PLOS ONE			English	Review							BACK	Background: Since 1950, traditional Chinese medicine (TCM) cupping therapy has been applied as a formal modality in hospitals throughout China and elsewhere in the world. Based on a previous systematic literature review of clinical studies on cupping therapy, this study presents a thorough review of randomized controlled trials (RCTs) to evaluate the therapeutic effect of cupping therapy. Method: Six databases were searched for articles published through 2010. RCTs on cupping therapy for various diseases were included. Studies on cupping therapy combined with other TCM treatments versus non-TCM therapies were excluded. Results: 135 RCTs published from 1992 through 2010 were identified. The studies were generally of low methodological quality. Diseases for which cupping therapy was commonly applied were herpes zoster, facial paralysis (Bell palsy), cough and dyspnea, acne, lumbar disc herniation, and cervical spondylosis. Wet cupping was used in most trials, followed by retained cupping, moving cupping, and flash cupping. Meta-analysis showed cupping therapy combined with other TCM treatments was significantly superior to other treatments alone in increasing the number of cured patients with herpes zoster, facial paralysis, acne, and cervical spondylosis. No serious adverse effects were reported in the trials. Conclusions: Numerous RCTs on cupping therapy have been conducted and published during the past decades. This review showed that cupping has potential effect in the treatment of herpes zoster and other specific conditions. However, further rigorously designed trials on its use for other conditions are warranted.	[Cao, Huijuan] Univ Western Sydney, Ctr Complementary Med Res, Penrith, NSW 1797, Australia; [Cao, Huijuan; Li, Xun; Liu, Jianping] Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China	Western Sydney University; Beijing University of Chinese Medicine	Liu, JP (corresponding author), Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China.	Jianping_l@hotmail.com		Li, Xun/0000-0002-3513-5904; Liu, Jianping/0000-0002-0320-061X	international cooperation project [2009DFA31460]; 111 Project from China [B08006]; National Center for Complementary and Alternative Medicine (NCCAM) of the US National Institutes of Health [R24 AT001293]; National Center for Complementary & Integrative Health [R24AT001293] Funding Source: NIH RePORTER	international cooperation project; 111 Project from China(Ministry of Education, China - 111 Project); National Center for Complementary and Alternative Medicine (NCCAM) of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Huijuan Cao and Jianping Liu were supported by the grant of international cooperation project (No. 2009DFA31460) and the 111 Project (B08006) from China. Jianping Liu was in part supported by the Grant Number R24 AT001293 from the National Center for Complementary and Alternative Medicine (NCCAM) of the US National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CHIN GEN PRACT; [Anonymous], LIAONING J TRADIT CH; [Anonymous], TIANJIN PHARM; [Anonymous], COCHRANE HDB SYSTEMA; [Anonymous], J EXTERN THER TRADIT; [Anonymous], 1999, TRADITIONAL CHINESE; [Anonymous], J CLIN ACUPUNCT MOXI, DOI DOI 10.3969/J.ISSN.1005-0779.2006.08.028; [Anonymous], 2004, PRACTICAL CUPPING TH; [Anonymous], 2007, J ACUPUNCT MOXIBUST; [Anonymous], J MED THEORY PRACT; [Anonymous], SHANXI J TRADIT CHIN; [Anonymous], SHANGHAI J ACUPUNCT; Bu Tong-wen, 2007, Zhongguo Zhen Jiu, V27, P337; Cao HJ, 2010, ALTERN THER HEALTH M, V16, P48; Cao HJ, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-70; Cao RL, 2009, SHANXI J TRADITIONAL, V30, P74; Chen J, 1993, CHINESE J DERMATOVEN, V5, P252; Chen JJ, 2009, JCAM, V25, P27; Chen LA, 2010, JIANGXI J TRADITIONA, V41, P62; Chen MX, 2000, THESIS CHENGDU U TRA; Chen YL, 2008, JIANGSU J TRADIT CHI, V40, P47; Cheng G, 2000, J CLIN ACUPUNCTURE M, V6, P33; Chi FL, 1987, CHINESE PRIMARY HLTH, V1, P24; Ci HF, 2010, MODERN MED HLTH, V26, P1550; *CONSORT GROUP, CONSORT STAT 2001 CH; Dai JY, 2006, SHANGHAI J ACUPUNCTU, V25, P13; Fang X, 2006, MODERN J INTEGRATED, V15, P734; Farhadi K, 2009, COMPLEMENT THER MED, V17, P9, DOI 10.1016/j.ctim.2008.05.003; Feng WM, 2004, CHINESE J TRADITIONA, V11, P180; Fu CA, 2004, J YANAN U MED SCI, V2, P59; Fu L, 2009, SHANGHAI J ACUPUNCTU, V28, P132; Fu Y, 2005, THESIS TIANJIN U TRA; Gao BB, 2010, CHINA J GUANG MING C, V25, P1244; Gao YJ, 2009, J EXTERNAL THERAPY T, V18, P34; Ge JJ, 2003, CHINESE J PRACTICAL, V3, P823; Guo JM, 1997, SHANDONG J TRADITION, V16, P74; Guo XL, 1992, ZHEN JIU XUE BAO, P34; Han LX, 1998, TIANJIN J TRADITIONA, V15, P122; [洪永锋 HONG Yongfeng], 2006, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V21, P340; Huang GQ, 2004, CHINESE J CURRENT CL, V2, P1680; Huang J, 2010, CHINA BIOBEAUTY, V1, P19; Huang J, 2008, J LIAONING U TRADITI, V10, P168; Huang LP, 2010, SHANXI J TRADITIONAL, V31, P473; Huang LP, 2009, SHANXI J TRADITIONAL, V30, P597; Huang Z-F, 2006, SHANGHAI J ACUPUNTUR, V25, P14; Ji J, 1992, CHINESE ACUPUNCTURE, V12, P11; Jiang H, 2006, J NURSING SCI, V21, P48; Jiang XY, 2008, J NURS SCI, V23, P37; Kang HQ, 2005, J EMERGENCY TRADITIO, V14, P51; Kim JI, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep035; Kwon Young Dal, 2007, [Journal of Physiology & Pathology in Korean Medicine, 동의생리병리학회지], V21, P789; Laine C, 2007, NEW ENGL J MED, V356, P2734, DOI 10.1056/NEJMe078110; Lee MS, 2011, J ACUPUNCT MERIDIAN, V4, P1, DOI 10.1016/S2005-2901(11)60001-0; Lee MS, 2010, ACUPUNCT MED, V28, P200, DOI 10.1136/aim.2010.002329; Lee MS, 2010, CLIN EXP HYPERTENS, V32, P423, DOI 10.3109/10641961003667955; Lee MS, 2010, J NEUROL SCI, V294, P70, DOI 10.1016/j.jns.2010.03.033; Li HT, 2005, J CHINESE INTEGRATED, V3, P69; Li Huang-Tong, 2005, Zhong Xi Yi Jie He Xue Bao, V3, P69; Li JC, 2008, SHANGHAI J ACUPUNCTU, V27, P8; Li KZ, 2009, J QIQIHAR MED COLL, V30, P3091; Li P, 2010, J SHANXI COLL TRADIT, V33, P83; Li Wei-Hong, 2005, Zhongguo Zhen Jiu, V25, P765; Li X, 2006, PRACTICAL NEW MED, V7, P702; Liang SY, 2009, FUJIAN J TRADITIONAL, V40, P28; Liang YL, 2009, NURSING PRACTICE RES, V6, P79; Liao FR, 2009, SHANGHAI J ACUPUNCTU, V28, P399; Lin SZ, 2005, TRADITIONAL CHINESE, V18, P47; Liu BX, 2008, CHINESE J REHABILITA, V14, P572; Liu BX, 2010, J ZHEJIANG U TRADITI, V34, P409; Liu H., 2009, LIAONING J TRAD CHIN, V36, P1395; Liu J, 2005, CHINESE J CLIN REHAB, V9, P135; Liu L, 2003, CHINESE J PRACTICAL, V3, P1088; Liu L, 2006, J HEBEI TRADITIONAL, V21, P30; Liu YZ, 2009, CHINA FOREIGN MED TR, V2, P113; Lu HM, 2009, J PRACTICAL TRADITIO, V25, P320; Lu J, 2007, J CLIN ACUPUNCTURE M, V23, P16; Lu JC, 2010, CHINA HIGHER MED ED, V10, P136; Lu ZX, 2009, J ZHEJIANG COLL TRAD, V33, P862; Ludtke R, 2006, COMPLEMENT THER MED, V14, P247, DOI 10.1016/j.ctim.2006.07.004; Luo XX, 2010, CHINESE J INFORM TCM, V17, P75; Ma CT, 2006, THESIS BEIJING U CHI; MacPherson H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000261; Michalsen A, 2009, J PAIN, V10, P601, DOI 10.1016/j.jpain.2008.12.013; Ni ML, 2010, HEILONGJIANG MED J, V23, P453; Ou XH, 2009, J CHENGDU U TRADITIO, V32, P37; Qiu JZ, 2003, CHINA J MODERN MED, V13, P146; Ren YJ, 2006, SHANXI J TRADITIONAL, V27, P480; Rui XG, 2010, SHANGHAI J ACUPUNCTU, V29, P515; Shao M, 2003, SHANGHAI J ACUPUNCTU, V22, P20; Sun HW, 2010, CHINA J GUANG MING C, V25, P1674; Sun LJ, 2007, CHINA PRACTICAL MED, V2, P138; Sun SY, 2006, J THORAC ONCOL, V1, P109, DOI 10.1097/01243894-200602000-00002; Tang CR, 2003, SICHUAN J TRADITIONA, V21, P89; Tao Q, 2007, J CLIN ACUPUNCTURE M, V23, P46; Viergever RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014701; Wan Xue-wen, 2005, Zhongguo Zhen Jiu, V25, P551; Wan XW, 2007, J ACUPUNCTURE TUINA, V5, P345, DOI DOI 10.1007/S11726-007-0345-5; Wang J, 2010, CHINA SCI TECHNOLOGY, V15, P176; Wang L, 2010, CHINESE GEN NURSING, V8, P2574; Wang LR, 2010, SICHUAN J TRADITIONA, V8, P110; Wang PL, 2010, CLIN J CHINESE MED, V9, P15; Wang Q., 2007, SHANGHAI J ACUPUNCT, V26, P20; Wang SP, 2009, GUIDING J TRADITIONA, V15, P56; Wang XM, 2004, SHANXI J TRADITIONAL, V25, P60; Wu FF, 2010, J QIQIHAR MED COLL, V31, P1596; Wu PX, 2010, GUIDING J TRADITIONA, V16, P79; Wu Y., 2008, J PRACTICAL TRADITIO, V22, P61; Xiao W, 2010, J ANHUI COLL TRADITI, V29, P37; Xiao W, 2009, CHINESE J TRADITIONA, V21, P420; Xin KP, 2006, JIANGXI J TRADITIONA, V37, P53; Xiong JF, 2010, J EXTERNAL THERAPY T, V19, P28; Xiong SY, 2007, J NURSES TRAINING, V22, P948; Xu M, 2009, LIAONING J TRADITION, V36, P1007; Xu MY, 2006, LIAONING J TRADITION, V33, P719; Xu SW, 2008, SHANGHAI J ACUPUNCTU, V27, P11; Xu SX, 1999, CHINESE J DERMATONEU, V21, P21; Xu Y, 2010, CLIN J CHINESE MED, V10, P70; Xue WH, 2005, LIAONING J TRADITION, V32, P826; Yang JH, 2007, GUIDING J TRADITIONA, V13, P57; Yao X, 2006, JILIN MED J, V27, P1403; Yin GZ, 2009, XINJIANG CHIN MED, V27, P13; You Y, 2006, CHINESE J REHABILITA, V12, P1037; You Y, 2006, CHINESE J CONVALESCE, V15, P14; Zeng HW, 2007, SHANGHAI J ACUPUNCTU, V26, P8; Zha BG, 2005, HUNAN J TRADITIONAL, V21, P81; Zhang DD, 2009, JILIN J TRADITIONAL, V29, P796; Zhang FY, 2006, J EXTERNAL THERAPY T, V15, P42; Zhang HB, 2010, SHANXI J TRADITIONAL, V26, P28; Zhang HX., 2009, J EMERG TRADIT CHIN, V18, P1979; Zhang JX, 2007, CHINESE MAGAZINE CLI, V13, P3444; Zhang KX, 2008, WORLD HLTH DIGEST, V5, P193; Zhang QL, 2009, ACTA CHINESE MED PHA, V37, P79; Zhang XY, 2009, J CHINESE ACUPUNCTUR, V25, P45; Zhang YB, 2010, GUANGXI J TRADITIONA, V33, P17; Zhang YC, 2004, J QILU NURSING, V10, P28; Zhang YD, 2005, J EXTERNAL THERAPY T, V14, P40; Zhao J, 2010, SHANXI J TRADITIONAL, V26, P34; Zhao NX, 2010, J GUIYANG COLL TRADI, V32, P72; [赵兴全 Zhao Xingquan], 2003, [中国针灸, Chinese Acupuncture and Moxibustion], V23, P75; Zhao YS, 2010, CHINA MODERN MED, V17, P19; Zheng L., 2008, CHINESE J TRADITIONA, V16, P27; Zheng ZH, 1999, HEBEI J TRADITIONAL, V14, P29; Zhou LW, 2007, CLIN J TRADITIONAL C, V19, P170; Zhou Y, 2010, J GUIYANG COLL TRADI, V32, P54; Zhou YM, 1994, CHINESE ACUPUNCTURE, V14, P292; Zhu F, 2009, J EMERGENCY TRADITIO, V18, P702; Zhu Y, 2010, SHANXI J TRADITIONAL, V31, P476; Zhu Y, 2009, CHINESE MED MODERN D, V7, P97; Zou LY, 2009, HENAN TRADITIONAL CH, V29, P802; Zou R, 2010, CHINESE J REHABILITA, V25, P205; 王映辉, 2009, [中国中医基础医学杂志, Chinese Journal of Basic Medicine in Traditional Chinese Medicine], V15, P774	151	98	101	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e31793	10.1371/journal.pone.0031793	http://dx.doi.org/10.1371/journal.pone.0031793			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389674	gold, Green Submitted, Green Published			2022-12-27	WOS:000302999600011
J	Colinet, H; Renault, D; Charoy-Guevel, B; Com, E				Colinet, Herve; Renault, David; Charoy-Guevel, Blandine; Com, Emmanuelle			Metabolic and Proteomic Profiling of Diapause in the Aphid Parasitoid Praon volucre	PLOS ONE			English	Article							NORTHERN HOUSE MOSQUITO; HEAT-SHOCK PROTEINS; GENE-EXPRESSION; FLESH FLY; INSECT DIAPAUSE; COTTON BOLLWORM; COLD TOLERANCE; PIPECOLIC ACID; STRESS; SORBITOL	Background: Diapause, a condition of developmental arrest and metabolic depression exhibited by a wide range of animals is accompanied by complex physiological and biochemical changes that generally enhance environmental stress tolerance and synchronize reproduction. Even though some aspects of diapause have been well characterized, very little is known about the full range of molecular and biochemical modifications underlying diapause in non-model organisms. Methodology/Principal Findings: In this study we focused on the parasitic wasp, Praon volucre that exhibits a pupal diapause in response to environmental signals. System-wide metabolic changes occurring during diapause were investigated using GC-MS metabolic fingerprinting. Moreover, proteomic changes were studied in diapausing versus nondiapausing phenotypes using a combination of two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry. We found a reduction of Krebs cycle intermediates which most likely resulted from the metabolic depression. Glycolysis was galvanized, probably to favor polyols biosynthesis. Diapausing parasitoids accumulated high levels of cryoprotective polyols, especially sorbitol. A large set of proteins were modulated during diapause and these were involved in various functions such as remodeling of cytoskeleton and cuticle, stress tolerance, protein turnover, lipid metabolism and various metabolic enzymes. Conclusions/Significance: The results presented here provide some first clues about the molecular and biochemical events that characterize the diapause syndrome in aphid parasitoids. These data are useful for probing potential commonality of parasitoids diapause with other taxa and they will help creating a general understanding of diapause underpinnings and a background for future interpretations.	[Colinet, Herve; Renault, David] Univ Rennes 1, CNRS, UMR 6553, Rennes, France; [Colinet, Herve] Catholic Univ Louvain, Earth & Life Inst, Biodivers Res Ctr BDIV, B-3000 Louvain, Belgium; [Charoy-Guevel, Blandine; Com, Emmanuelle] Univ Rennes 1, Prote Core Facil Biogenouest, IRSET, INSERM,U1085, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes; Universite Catholique Louvain; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Colinet, H (corresponding author), Univ Rennes 1, CNRS, UMR 6553, Bat 14A, Rennes, France.	herve.colinet@uclouvain.be	, Protim/C-4687-2012; Colinet, hervé/B-3677-2019; Com, Emmanuelle/AAD-2312-2020; Com, Emmanuelle/E-8656-2011; colinet, hervé/K-8768-2019	Colinet, hervé/0000-0002-8806-3107; Com, Emmanuelle/0000-0002-7401-817X; Com, Emmanuelle/0000-0002-7401-817X; GUEVEL, Blandine/0000-0002-4592-603X; RENAULT, David/0000-0003-3644-1759	Fonds de la Recherche Scientifique - FNRS in Belgium	Fonds de la Recherche Scientifique - FNRS in Belgium(Fonds de la Recherche Scientifique - FNRS)	This study was supported by Fonds de la Recherche Scientifique - FNRS in Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; AYMESOUTHGATE A, 1989, J CELL BIOL, V108, P521, DOI 10.1083/jcb.108.2.521; Baker DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-242; Bao B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-224; BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; BLOCK W, 1990, PHILOS T ROY SOC B, V326, P613, DOI 10.1098/rstb.1990.0035; Brocker C, 2010, J BIOL CHEM, V285, P18452, DOI 10.1074/jbc.M109.077925; Bundy JG, 2009, METABOLOMICS, V5, P3, DOI 10.1007/s11306-008-0152-0; Cai XJ, 2006, MOL BIOL EVOL, V23, P550, DOI 10.1093/molbev/msj056; Chen LZ, 2010, J INSECT PHYSIOL, V56, P247, DOI 10.1016/j.jinsphys.2009.10.008; ChristiansenWeniger P, 1997, ENTOMOPHAGA, V42, P165, DOI 10.1007/BF02769894; Colinet H, 2010, ANN APPL BIOL, V156, P147, DOI 10.1111/j.1744-7348.2009.00374.x; Colinet H, 2007, INSECT BIOCHEM MOLEC, V37, P1177, DOI 10.1016/j.ibmb.2007.07.004; Colinet H, 2011, BIOL CONTROL, V58, P83, DOI 10.1016/j.biocontrol.2011.04.014; Colinet H, 2010, PHYSIOL ENTOMOL, V35, P301, DOI 10.1111/j.1365-3032.2010.00743.x; Com E, 2003, MOL CELL PROTEOMICS, V2, P248, DOI 10.1074/mcp.M300010-MCP200; Com E, 2011, METHODS MOL BIOL, V691, P187, DOI 10.1007/978-1-60761-849-2_11; Cornman RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-22; Courant F, 2009, ANALYST, V134, P1637, DOI 10.1039/b901813a; Dana AN, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-5; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Denlinger DL., 2004, COMP MOL INSECT SCI, V3, P615; DENLINGER DL, 2000, CE MO RE ST, V1, P259; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Flannagan RD, 1998, P NATL ACAD SCI USA, V95, P5616, DOI 10.1073/pnas.95.10.5616; GEKKO K, 1981, J BIOCHEM-TOKYO, V90, P1633, DOI 10.1093/oxfordjournals.jbchem.a133638; GOUESBET G, 1994, MICROBIOL-SGM, V140, P2415, DOI 10.1099/13500872-140-9-2415; Gouffi K, 2000, APPL ENVIRON MICROB, V66, P2358, DOI 10.1128/AEM.66.6.2358-2364.2000; Hahn DA, 2007, J INSECT PHYSIOL, V53, P760, DOI 10.1016/j.jinsphys.2007.03.018; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Hayward SAL, 2005, J INSECT PHYSIOL, V51, P631, DOI 10.1016/j.jinsphys.2004.11.009; Hodkova M, 2004, EUR J ENTOMOL, V101, P445, DOI 10.14411/eje.2004.064; Kankare Maaria, 2010, BMC Ecology, V10, P3, DOI 10.1186/1472-6785-10-3; Kim M, 2006, J INSECT PHYSIOL, V52, P1226, DOI 10.1016/j.jinsphys.2006.09.007; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2004, J INSECT PHYSIOL, V50, P303, DOI 10.1016/j.jinsphys.2004.01.006; Kostal V, 2001, COMP BIOCHEM PHYS B, V130, P365, DOI 10.1016/S1096-4959(01)00441-9; Langer A, 2000, J INSECT PHYSIOL, V46, P671, DOI 10.1016/S0022-1910(99)00155-9; Lee KY, 1998, J INSECT PHYSIOL, V44, P221, DOI 10.1016/S0022-1910(97)00173-X; Leon A, 1999, MOL BIOL CELL, V10, P3825, DOI 10.1091/mbc.10.11.3825; Li AQ, 2007, J INSECT PHYSIOL, V53, P385, DOI 10.1016/j.jinsphys.2007.01.003; Li AQ, 2009, J MED ENTOMOL, V46, P1382, DOI 10.1603/033.046.0618; Lu YX, 2010, J PROTEOME RES, V9, P5053, DOI 10.1021/pr100356t; MacRae TH, 2010, CELL MOL LIFE SCI, V67, P2405, DOI 10.1007/s00018-010-0311-0; Michaud MR, 2007, J COMP PHYSIOL B, V177, P753, DOI 10.1007/s00360-007-0172-5; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Muffat J, 2008, P NATL ACAD SCI USA, V105, P7088, DOI 10.1073/pnas.0800896105; Munoz-Torres MC, 2011, NUCLEIC ACIDS RES, V39, pD658, DOI 10.1093/nar/gkq1145; Pavlides SC, 2011, J INSECT PHYSIOL, V57, P635, DOI 10.1016/j.jinsphys.2011.03.022; Pinter M, 1998, INSECT BIOCHEM MOLEC, V28, P91, DOI 10.1016/S0965-1748(97)00095-7; Polgar LA, 2000, ENTOMOL EXP APPL, V97, P21, DOI 10.1023/A:1004004801807; PULLIN AS, 1992, J INSECT PHYSIOL, V38, P319, DOI 10.1016/0022-1910(92)90056-J; Pullin AS, 1996, EUR J ENTOMOL, V93, P121; Qiu Z, 2007, MECH DEVELOP, V124, P856, DOI 10.1016/j.mod.2007.09.001; Ragland GJ, 2010, P NATL ACAD SCI USA, V107, P14909, DOI 10.1073/pnas.1007075107; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Renaut J, 2006, PHYSIOL PLANTARUM, V126, P97, DOI 10.1111/j.1399-3054.2006.00617.x; Reynolds JA, 2009, J EXP BIOL, V212, P2074, DOI 10.1242/jeb.027367; Rinehart JP, 2010, J INSECT PHYSIOL, V56, P603, DOI 10.1016/j.jinsphys.2009.12.007; Robich RM, 2007, J INSECT PHYSIOL, V53, P235, DOI 10.1016/j.jinsphys.2006.08.008; SALT RW, 1961, ANNU REV ENTOMOL, V6, P55, DOI 10.1146/annurev.en.06.010161.000415; Salvucci ME, 2000, J THERM BIOL, V25, P353, DOI 10.1016/S0306-4565(99)00107-2; Sladek NE, 2003, J BIOCHEM MOL TOXIC, V17, P7, DOI 10.1002/jbt.10057; Soares-Costa A, 2011, J INSECT PHYSIOL, V57, P462, DOI 10.1016/j.jinsphys.2011.01.006; Storey J. M., 2005, FUNCTIONAL METABOLIS, P473; STOREY KB, 1983, CRYOBIOLOGY, V20, P365, DOI 10.1016/0011-2240(83)90025-1; STORY JM, 1983, J COMP PHYSIOL, V149, P495, DOI 10.1007/BF00690008; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Tanaka K, 2007, INSECT BIOCHEM MOLEC, V37, P338, DOI 10.1016/j.ibmb.2006.12.006; TATSUKA M, 1992, NATURE, V359, P333, DOI 10.1038/359333a0; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Thiele H, 2008, J PROTEOM BIOINFORM, V1, P485, DOI DOI 10.4172/jpb.1000056; Thiele H, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-141; Waller M, 2007, LC GC N AM, P39; Wolfe GR, 1998, J INSECT PHYSIOL, V44, P597, DOI 10.1016/S0022-1910(98)00035-3; Wolschin F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006394; YAGINUMA T, 1978, J INSECT PHYSIOL, V24, P347, DOI 10.1016/0022-1910(78)90074-4; Yocum GD, 2005, J INSECT PHYSIOL, V51, P621, DOI 10.1016/j.jinsphys.2004.11.008; Yocum GD, 2009, EUR J ENTOMOL, V106, P471, DOI 10.14411/eje.2009.059; Zhang QR, 2011, P NATL ACAD SCI USA, V108, P16922, DOI 10.1073/pnas.1113863108; Zhou Q, 2008, MAR BIOTECHNOL, V10, P438, DOI 10.1007/s10126-007-9079-0	82	49	57	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32606	10.1371/journal.pone.0032606	http://dx.doi.org/10.1371/journal.pone.0032606			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389713	Green Published, gold			2022-12-27	WOS:000302999600052
J	Habibi, R; Khurana, B				Habibi, Ruth; Khurana, Beena			Spontaneous Gender Categorization in Masking and Priming Studies: Key for Distinguishing Jane from John Doe but Not Madonna from Sinatra	PLOS ONE			English	Article							FACE RECOGNITION; RACE; PERCEPTION; IDENTITY; ROUTE; SEX	Facial recognition is key to social interaction, however with unfamiliar faces only generic information, in the form of facial stereotypes such as gender and age is available. Therefore is generic information more prominent in unfamiliar versus familiar face processing? In order to address the question we tapped into two relatively disparate stages of face processing. At the early stages of encoding, we employed perceptual masking to reveal that only perception of unfamiliar face targets is affected by the gender of the facial masks. At the semantic end; using a priming paradigm, we found that while to-be-ignored unfamiliar faces prime lexical decisions to gender congruent stereotypic words, familiar faces do not. Our findings indicate that gender is a more salient dimension in unfamiliar relative to familiar face processing, both in early perceptual stages as well as later semantic stages of person construal.	[Habibi, Ruth; Khurana, Beena] Univ Sussex, Sch Psychol, Brighton, E Sussex, England	University of Sussex	Habibi, R (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.	r.m.habibi@sussex.ac.uk		Habibi, Ruth/0000-0002-8928-1210	Economic and Social Research Council [PTA-031-2005-00100]	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was funded by RH's DPhil funding from the Economic and Social Research Council: award PTA-031-2005-00100 (http://www.esrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann T, 2005, PERCEPTION, V34, P139, DOI 10.1068/p5344b; Bar-Haim Y, 2006, PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-9280.2006.01679.x; Blair IV, 1996, J PERS SOC PSYCHOL, V70, P1142, DOI 10.1037/0022-3514.70.6.1142; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; BURTON AM, 1990, BRIT J PSYCHOL, V81, P361, DOI 10.1111/j.2044-8295.1990.tb02367.x; CALIS GJJ, 1984, ACTA PSYCHOL, V55, P215, DOI 10.1016/0001-6918(84)90042-8; Clutterbuck R, 2004, PERCEPTION, V33, P159, DOI 10.1068/p5115; COSTEN NP, 1994, VIS COGN, V1, P227, DOI DOI 10.1080/13506289408402301; Dux PE, 2005, PSYCHOL SCI, V16, P775, DOI 10.1111/j.1467-9280.2005.01613.x; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Ganel T, 2002, J EXP PSYCHOL HUMAN, V28, P854, DOI 10.1037//0096-1523.28.4.854; Goshen-Gottstein Y, 2000, J EXP PSYCHOL LEARN, V26, P1198, DOI 10.1037//0278-7393.26.5.1198; Ito TA, 2005, COGN AFFECT BEHAV NE, V5, P21, DOI 10.3758/CABN.5.1.21; Ito TA, 2003, J PERS SOC PSYCHOL, V85, P616, DOI 10.1037/0022-3514.85.4.616; Lebrecht S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004215; Loffler G, 2005, VISION RES, V45, P2287, DOI 10.1016/j.visres.2005.02.009; Macrae CN, 2007, EUR J SOC PSYCHOL, V37, P793, DOI 10.1002/ejsp.406; Macrae CN, 2005, J PERS SOC PSYCHOL, V89, P686, DOI 10.1037/0022-3514.89.5.686; Macrae CN, 2000, ANNU REV PSYCHOL, V51, P93, DOI 10.1146/annurev.psych.51.1.93; Macrae CN, 2002, PSYCHOL SCI, V13, P460, DOI 10.1111/1467-9280.00481; Moore CM, 2007, VISION RES, V47, P1624, DOI 10.1016/j.visres.2007.01.030; Mouchetant-Rostaing Y, 2003, J COGNITIVE NEUROSCI, V15, P900, DOI 10.1162/089892903322370816; Mouchetant-Rostaing Y, 2000, EUR J NEUROSCI, V12, P303, DOI 10.1046/j.1460-9568.2000.00888.x; Reiss JE, 2007, VIS COGN, V15, P789, DOI 10.1080/13506280701307035; Stone A, 2004, PSYCHON B REV, V11, P469, DOI 10.3758/BF03196597; Stone A, 2007, COGNITION, V104, P535, DOI 10.1016/j.cognition.2006.07.014; Wilson HR, 2002, VISION RES, V42, P2909, DOI 10.1016/S0042-6989(02)00362-0	27	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32377	10.1371/journal.pone.0032377	http://dx.doi.org/10.1371/journal.pone.0032377			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	928RC	22389697	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000302999600035
J	Shalapour, S; Deiser, K; Kuhl, AA; Glauben, R; Krug, SM; Fischer, A; Sercan, O; Chappaz, S; Bereswill, S; Heimesaat, MM; Loddenkemper, C; Fromm, M; Finke, D; Hammerling, GJ; Arnold, B; Siegmund, B; Schuler, T				Shalapour, Shabnam; Deiser, Katrin; Kuehl, Anja A.; Glauben, Rainer; Krug, Susanne M.; Fischer, Andre; Sercan, Oezen; Chappaz, Stephane; Bereswill, Stefan; Heimesaat, Markus M.; Loddenkemper, Christoph; Fromm, Michael; Finke, Daniela; Haemmerling, Guenter J.; Arnold, Bernd; Siegmund, Britta; Schueler, Thomas			Interleukin-7 Links T Lymphocyte and Intestinal Epithelial Cell Homeostasis	PLOS ONE			English	Article							CHRONIC COLITIS; TRANSGENIC MICE; BETA-CATENIN; IN-VIVO; IL-7; INNATE; INFLAMMATION; RECEPTOR; DIFFERENTIATION; PROLIFERATION	Interleukin-7 (IL-7) is a major survival factor for mature T cells. Therefore, the degree of IL-7 availability determines the size of the peripheral T cell pool and regulates T cell homeostasis. Here we provide evidence that IL-7 also regulates the homeostasis of intestinal epithelial cells (IEC), colon function and the composition of the commensal microflora. In the colon of T cell-deficient, lymphopenic mice, IL-7-producing IEC accumulate. IEC hyperplasia can be blocked by IL-7-consuming T cells or the inactivation of the IL-7/IL-7R signaling pathway. However, the blockade of the IL-7/IL-7R signaling pathway renders T cell-deficient mice more sensitive to chemically-induced IEC damage and subsequent colitis. In summary, our data demonstrate that IL-7 promotes IEC hyperplasia under lymphopenic conditions. Under non-lymphopenic conditions, however, T cells consume IL-7 thereby limiting IEC expansion and survival. Hence, the degree of IL-7 availability regulates both, T cell and IEC homeostasis.	[Shalapour, Shabnam; Deiser, Katrin; Sercan, Oezen; Schueler, Thomas] Charite, Inst Immunol, D-13353 Berlin, Germany; [Kuehl, Anja A.; Loddenkemper, Christoph] Charite, Res Ctr ImmunoSci, Inst Pathol, D-13353 Berlin, Germany; [Glauben, Rainer; Siegmund, Britta] Charite, Dept Gastroenterol Infectiol & Rheumatol, D-13353 Berlin, Germany; [Krug, Susanne M.; Fromm, Michael] Charite, Inst Clin Physiol, D-13353 Berlin, Germany; [Fischer, Andre; Bereswill, Stefan; Heimesaat, Markus M.] Charite, Inst Microbiol & Hyg, D-13353 Berlin, Germany; [Sercan, Oezen; Haemmerling, Guenter J.; Arnold, Bernd; Schueler, Thomas] German Canc Res Ctr, Dept Mol Immunol, D-6900 Heidelberg, Germany; [Chappaz, Stephane; Finke, Daniela] Univ Basel, Div Dev Immunol, Dept Biomed, Basel, Switzerland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); University of Basel	Shalapour, S (corresponding author), Charite, Inst Immunol, Campus Benjamin Franklin, D-13353 Berlin, Germany.	thomas.schueler@charite.de	Fromm, Michael/K-6203-2013; Krug, Susanne M/AAY-6221-2020; Siegmund, Britta/E-6929-2018	Fromm, Michael/0000-0003-4497-7983; Krug, Susanne M/0000-0002-1293-2484; Siegmund, Britta/0000-0002-0055-958X; Kuhl, Anja/0000-0003-2293-5387; Chappaz, Stephane/0000-0003-0574-7544; Heimesaat, Markus/0000-0001-6399-651X; Sercan Alp, Oezen/0000-0001-5150-3618; Shalapour, Shabnam/0000-0002-4743-3706	Deutsche Forschungsgemeinschaft [SFB 405, SFB-TR36/TPB7, SFB633/TPA7/TPB6/TPB15, FOR721]; Swiss National Science Foundation (SNF) [PP00A-116894/1]; European Union [DIAGNOSIS-FP6/WP5]; Fritz-Thyssen-Foundation [Az. 10.05.2.194]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); European Union(European Commission); Fritz-Thyssen-Foundation	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 405, SFB-TR36/TPB7, SFB633/TPA7/TPB6/TPB15, and FOR721), the Swiss National Science Foundation (SNF) (PP00A-116894/1), the European Union (DIAGNOSIS-FP6/WP5), and the Fritz-Thyssen-Foundation (Az. 10.05.2.194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Boyman O, 2008, J IMMUNOL, V180, P7265, DOI 10.4049/jimmunol.180.11.7265; Buckley RH, 2004, ANNU REV IMMUNOL, V22, P625, DOI 10.1146/annurev.immunol.22.012703.104614; Feng T, 2010, J EXP MED, V207, P1321, DOI 10.1084/jem.20092253; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Guimond M, 2009, NAT IMMUNOL, V10, P149, DOI 10.1038/ni.1695; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Jiang Q, 2005, CYTOKINE GROWTH F R, V16, P513, DOI 10.1016/j.cytogfr.2005.05.004; Khaled AR, 2002, NAT REV IMMUNOL, V2, P817, DOI 10.1038/nri931; Kieper WC, 2002, J EXP MED, V195, P1533, DOI 10.1084/jem.20020067; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Li Y, 2003, CANCER BIOL THER, V2, P187, DOI 10.4161/cbt.2.2.282; MERTSCHING E, 1995, INT IMMUNOL, V7, P401, DOI 10.1093/intimm/7.3.401; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Ponchel F, 2011, CLIN CHIM ACTA, V412, P7, DOI 10.1016/j.cca.2010.09.002; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Sawa S, 2006, J EXP MED, V203, P1459, DOI 10.1084/jem.20052187; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Shalapour S, 2010, EUR J IMMUNOL, V40, P2391, DOI 10.1002/eji.201040441; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sportes C, 2009, ANN NY ACAD SCI, V1182, P28, DOI 10.1111/j.1749-6632.2009.05075.x; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tomita T, 2008, J IMMUNOL, V180, P383, DOI 10.4049/jimmunol.180.1.383; Totsuka T, 2007, J IMMUNOL, V178, P4737, DOI 10.4049/jimmunol.178.8.4737; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Watanabe M, 1998, J EXP MED, V187, P389, DOI 10.1084/jem.187.3.389; Watanabe Mamoru, 2003, Current Drug Targets - Inflammation and Allergy, V2, P119, DOI 10.2174/1568010033484269; Weitzmann MN, 2002, J CLIN INVEST, V110, P1643, DOI 10.1172/JCI200215687; Wilcox CM, 2008, GUT, V57, P861, DOI 10.1136/gut.2006.103432; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; Yamazaki M, 2003, J IMMUNOL, V171, P1556, DOI 10.4049/jimmunol.171.3.1556; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208	41	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31939	10.1371/journal.pone.0031939	http://dx.doi.org/10.1371/journal.pone.0031939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384106	Green Published, gold, Green Accepted			2022-12-27	WOS:000302918500048
J	Sohle, J; Machuy, N; Smailbegovic, E; Holtzmann, U; Gronniger, E; Wenck, H; Stab, F; Winnefeld, M				Soehle, Joern; Machuy, Nikolaus; Smailbegovic, Elma; Holtzmann, Ursula; Groenniger, Elke; Wenck, Horst; Staeb, Franz; Winnefeld, Marc			Identification of New Genes Involved in Human Adipogenesis and Fat Storage	PLOS ONE			English	Article							ADIPOCYTE DIFFERENTIATION; RNA INTERFERENCE; EXPRESSION; OBESITY; TRANSPORT; SWITCH	Since the worldwide increase in obesity represents a growing challenge for health care systems, new approaches are needed to effectively treat obesity and its associated diseases. One prerequisite for advances in this field is the identification of genes involved in adipogenesis and/or lipid storage. To provide a systematic analysis of genes that regulate adipose tissue biology and to establish a target-oriented compound screening, we performed a high throughput siRNA screen with primary (pre)adipocytes, using a druggable siRNA library targeting 7,784 human genes. The primary screen showed that 459 genes affected adipogenesis and/or lipid accumulation after knock-down. Out of these hits, 333 could be validated in a secondary screen using independent siRNAs and 110 genes were further regulated on the gene expression level during adipogenesis. Assuming that these genes are involved in neutral lipid storage and/or adipocyte differentiation, we performed InCell-Western analysis for the most striking hits to distinguish between the two phenotypes. Beside well known regulators of adipogenesis and neutral lipid storage (i.e. PPAR gamma, RXR, Perilipin A) the screening revealed a large number of genes which have not been previously described in the context of fatty tissue biology such as axonemal dyneins. Five out of ten axonemal dyneins were identified in our screen and quantitative RT-PCR-analysis revealed that these genes are expressed in preadipocytes and/or maturing adipocytes. Finally, to show that the genes identified in our screen are per se druggable we performed a proof of principle experiment using an antagonist for HTR2B. The results showed a very similar phenotype compared to knock-down experiments proofing the "druggability''. Thus, we identified new adipogenesis-associated genes and those involved in neutral lipid storage. Moreover, by using a druggable siRNA library the screen data provides a very attractive starting point to identify anti-obesity compounds targeting the adipose tissue.	[Soehle, Joern; Smailbegovic, Elma; Holtzmann, Ursula; Groenniger, Elke; Wenck, Horst; Staeb, Franz; Winnefeld, Marc] Beiersdorf AG, Res & Dev, Hamburg, Germany; [Machuy, Nikolaus] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany	Beiersdorf AG; Max Planck Society	Sohle, J (corresponding author), Beiersdorf AG, Res & Dev, Hamburg, Germany.	marc.winnefeld@beiersdorf.com						Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gregoire FM, 2001, EXP BIOL MED, V226, P997, DOI 10.1177/153537020122601106; Gronniger E, 2010, CELL BIOL INT, V34, P737, DOI 10.1042/CBI20090299; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lindemann CB, 2010, J CELL SCI, V123, P519, DOI 10.1242/jcs.051326; Nagayama M, 2007, J LIPID RES, V48, P9, DOI 10.1194/jlr.M600155-JLR200; Olofsson SO, 2009, BBA-MOL CELL BIOL L, V1791, P448, DOI 10.1016/j.bbalip.2008.08.001; Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Rosen ED, 2000, GENE DEV, V14, P1293; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Sohle J, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-20; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Tummala P, 2010, CELL MOL BIOENG, V3, P207, DOI 10.1007/s12195-010-0127-x; Tuschl Thomas, 2002, Mol Interv, V2, P158, DOI 10.1124/mi.2.3.158; Vetter ML, 2010, NAT REV ENDOCRINOL, V6, P578, DOI 10.1038/nrendo.2010.121; Welte MA, 2009, BIOCHEM SOC T, V37, P991, DOI 10.1042/BST0370991; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; World Health Organization, 2000, WHO TECHN REP SER, V894; Xu Y, 2006, EXP CELL RES, V312, P1856, DOI 10.1016/j.yexcr.2006.02.016; Yan C, 2011, J BIOL CHEM     1206	36	36	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31193	10.1371/journal.pone.0031193	http://dx.doi.org/10.1371/journal.pone.0031193			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384002	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500021
J	Bouteille, M; Rolland, G; Balsera, C; Loudet, O; Muller, B				Bouteille, Marie; Rolland, Gaelle; Balsera, Crispulo; Loudet, Olivier; Muller, Bertrand			Disentangling the Intertwined Genetic Bases of Root and Shoot Growth in Arabidopsis	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; QTL CONTROLLING ROOT; SYSTEM ARCHITECTURE; MAPPING QTLS; NATURAL VARIATION; ELONGATION RATE; EPISTASIS; IDENTIFICATION; AVAILABILITY; DISSECTION	Root growth and architecture are major components of plant nutrient and water use efficiencies and these traits are the matter of extensive genetic analysis in several crop species. Because root growth relies on exported assimilate from the shoot, and changes in assimilate supply are known to alter root architecture, we hypothesized (i) that the genetic bases of root growth could be intertwined with the genetic bases of shoot growth and (ii) that the link could be either positive, with alleles favouring shoot growth also favouring root growth, or negative, because of competition for assimilates. We tested these hypotheses using a quantitative genetics approach in the model species Arabidopsis thaliana and the Bay-0 x Shahdara recombinant inbred lines population. In accordance with our hypothesis, root and shoot growth traits were strongly correlated and most root growth quantitative trait loci (QTLs) colocalized with shoot growth QTLs with positive alleles originating from either the same or the opposite parent. In order to identify regions that could be responsible for root growth independently of the shoot, we generated new variables either based on root to shoot ratios, residuals of root to shoot correlations or coordinates of principal component analysis. These variables showed high heritability allowing genetic analysis. They essentially all yielded similar results pointing towards two regions involved in the root - shoot balance. Using Heterogeneous Inbred Families (a kind of near-isogenic lines), we validated part of the QTLs present in these two regions for different traits. Our study thus highlights the difficulty of disentangling intertwined genetic bases of root and shoot growth and shows that this difficulty can be overcome by using simple statistical tools.	[Bouteille, Marie; Rolland, Gaelle; Balsera, Crispulo; Muller, Bertrand] INRA, Lab Ecophysiol Plantes Stress Environm, UMR759, SupAgro, F-34060 Montpellier, France; [Loudet, Olivier] INRA, Inst Jean Pierre Bourgin, UMR1318, F-78026 Versailles, France; [Loudet, Olivier] AgroParisTech, Inst Jean Pierre Bourgin, UMR1318, Versailles, France	INRAE; Institut Agro; Montpellier SupAgro; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Bouteille, M (corresponding author), INRA, Lab Ecophysiol Plantes Stress Environm, UMR759, SupAgro, F-34060 Montpellier, France.	muller@supagro.inra.fr	Loudet, Olivier/CAF-7559-2022; Muller, Bertrand/AAP-3575-2020; Loudet, Olivier/K-8266-2012	Muller, Bertrand/0000-0001-6387-9460; Loudet, Olivier/0000-0003-3717-0137	ANR (Agence Nationale de la Recherche) [DNV, GPLA 06014G]; ERAPG (ARABRAS) [06-ERAPG-003-01]; Max Planck Institute for developmental biology at Tubingen; French ministry of foreign affairs	ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); ERAPG (ARABRAS); Max Planck Institute for developmental biology at Tubingen; French ministry of foreign affairs	This study was funded by ANR (Agence Nationale de la Recherche (DNV, GPLA 06014G)) and ERAPG (ARABRAS, 06-ERAPG-003-01 http://www.erapg.org/publicpage.m?key=everyone&trail=/everyone). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MB thanks D Weigel and the Max Planck Institute for developmental biology at Tubingen for contributing to her PhD fellowship and the French ministry of foreign affairs for EGIDE/PHC - Procope grant for travels. C Granier, D Vile and S Tisne are acknowledged for a critical reading of an earlier draft of the manuscript.	AGUIRREZABAL LAN, 1994, PLANT CELL ENVIRON, V17, P443, DOI 10.1111/j.1365-3040.1994.tb00313.x; Balasubramanian S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004318; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; BINGHAM IJ, 1993, PHYSIOL PLANTARUM, V88, P149, DOI 10.1111/j.1399-3054.1993.tb01772.x; BROUWER R., 1962, NETHERLANDS JOUR AGRIC SCI, V10, P361; Bruce WB, 2002, J EXP BOT, V53, P13, DOI 10.1093/jexbot/53.366.13; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Chase K, 1997, THEOR APPL GENET, V94, P724, DOI 10.1007/s001220050471; Chevalier F, 2003, PLANT CELL ENVIRON, V26, P1839, DOI 10.1046/j.1365-3040.2003.01100.x; Cooper M, 2009, CURR OPIN PLANT BIOL, V12, P231, DOI 10.1016/j.pbi.2009.01.006; Courtois B, 2000, MOL BREEDING, V6, P55, DOI 10.1023/A:1009652326121; Cui KH, 2008, PHYSIOL PLANTARUM, V132, P53, DOI 10.1111/j.1399-3054.2007.00991.x; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; de Dorlodot S, 2007, TRENDS PLANT SCI, V12, P474, DOI 10.1016/j.tplants.2007.08.012; El-Lithy ME, 2004, PLANT PHYSIOL, V135, P444, DOI 10.1104/pp.103.036822; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; FARRAR JF, 1986, NEW PHYTOL, V102, P513, DOI 10.1111/j.1469-8137.1986.tb00827.x; Freixes S, 2002, PLANT CELL ENVIRON, V25, P1357, DOI 10.1046/j.1365-3040.2002.00912.x; Gerald JNF, 2006, GENETICS, V172, P485, DOI 10.1534/genetics.105.047555; Giuliani S, 2005, J EXP BOT, V56, P3061, DOI 10.1093/jxb/eri303; Guo DL, 2004, OECOLOGIA, V140, P450, DOI 10.1007/s00442-004-1596-1; Hammer GL, 2009, CROP SCI, V49, P299, DOI 10.2135/cropsci2008.03.0152; Hebert Y, 2001, CROP SCI, V41, P363, DOI 10.2135/cropsci2001.412363x; Hochholdinger F, 2009, CURR OPIN PLANT BIOL, V12, P172, DOI 10.1016/j.pbi.2008.12.002; Huang XQ, 2011, P NATL ACAD SCI USA, V108, P4488, DOI 10.1073/pnas.1100465108; Hummel I, 2010, PLANT PHYSIOL, V154, P357, DOI 10.1104/pp.110.157008; Hund A, 2004, THEOR APPL GENET, V109, P618, DOI 10.1007/s00122-004-1665-1; Iwata H, 2010, MOL BREEDING, V25, P203, DOI 10.1007/s11032-009-9319-2; Juenger TE, 2005, GENETICA, V123, P87, DOI 10.1007/s10709-003-2717-1; Kamoshita A, 2002, THEOR APPL GENET, V104, P880, DOI 10.1007/s00122-001-0837-5; Kenis K, 2007, MOL BREEDING, V19, P193, DOI 10.1007/s11032-006-9022-5; Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; Langlade NB, 2005, P NATL ACAD SCI USA, V102, P10221, DOI 10.1073/pnas.0504210102; Laperche A, 2006, THEOR APPL GENET, V113, P1131, DOI 10.1007/s00122-006-0373-4; Li B, 1998, OECOLOGIA, V115, P293, DOI 10.1007/s004420050519; Li JZ, 2009, J GENET GENOMICS, V36, P173, DOI 10.1016/S1673-8527(08)60104-6; Liao H, 2004, FUNCT PLANT BIOL, V31, P959, DOI 10.1071/FP03255; Loudet O, 2005, THEOR APPL GENET, V110, P742, DOI 10.1007/s00122-004-1900-9; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; MacMillan K, 2006, THEOR APPL GENET, V113, P977, DOI 10.1007/s00122-006-0356-5; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Malmberg RL, 2005, GENETICS, V171, P2013, DOI 10.1534/genetics.105.046078; Manschadi AM, 2008, PLANT SOIL, V303, P115, DOI 10.1007/s11104-007-9492-1; McConnaughay KDM, 1998, PLANT SOIL, V202, P201, DOI 10.1023/A:1004341731703; MCMICHAEL BL, 1991, ENVIRON EXP BOT, V31, P461, DOI 10.1016/0098-8472(91)90045-P; Mouchel CF, 2004, GENE DEV, V18, P700, DOI 10.1101/gad.1187704; Muller B, 1998, PLANT CELL ENVIRON, V21, P149, DOI 10.1046/j.1365-3040.1998.00263.x; Ochoa IE, 2006, CROP SCI, V46, P1609, DOI 10.2135/cropsci2005.12-0446; Ostonen I, 2007, PLANT BIOSYST, V141, P426, DOI 10.1080/11263500701626069; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P595, DOI 10.1071/PP99173; Poorter H, 2005, OECOLOGIA, V142, P360, DOI 10.1007/s00442-004-1705-1; Price AH, 1997, THEOR APPL GENET, V95, P143, DOI 10.1007/s001220050542; Rauh BL, 2002, THEOR APPL GENET, V104, P743, DOI 10.1007/s00122-001-0815-y; REITER RS, 1991, THEOR APPL GENET, V82, P561, DOI 10.1007/BF00226791; Reymond M, 2006, PLANT CELL ENVIRON, V29, P115, DOI 10.1111/j.1365-3040.2005.01405.x; ROBINSON D, 1986, ANN BOT-LONDON, V58, P841, DOI 10.1093/oxfordjournals.aob.a087266; Roumet C, 2006, NEW PHYTOL, V170, P357, DOI 10.1111/j.1469-8137.2006.01667.x; Rowe HC, 2008, GENETICS, V180, P2237, DOI 10.1534/genetics.108.091439; Ryser P, 2000, AM J BOT, V87, P402, DOI 10.2307/2656636; Sanguineti MC, 2007, ANN APPL BIOL, V151, P291, DOI 10.1111/j.1744-7348.2007.00198.x; Sebastian RL, 2002, THEOR APPL GENET, V104, P601, DOI 10.1007/s001220100743; Sergeeva LI, 2006, P NATL ACAD SCI USA, V103, P2994, DOI 10.1073/pnas.0511015103; SIDDIQUE KHM, 1990, PLANT SOIL, V121, P89, DOI 10.1007/BF00013101; Svistoonoff S, 2007, NAT GENET, V39, P792, DOI 10.1038/ng2041; Thaler P, 1998, PLANT SOIL, V201, P307, DOI 10.1023/A:1004380021699; Thaler P, 1996, PHYSIOL PLANTARUM, V97, P365, DOI 10.1034/j.1399-3054.1996.970222.x; Tisne S, 2010, PLANT CELL ENVIRON, V33, P1875, DOI 10.1111/j.1365-3040.2010.02191.x; Van Rijn CPE, 2000, NEW PHYTOL, V146, P471, DOI 10.1046/j.1469-8137.2000.00670.x; Vlad D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000945; WARDLAW IF, 1990, NEW PHYTOL, V116, P341, DOI 10.1111/j.1469-8137.1990.tb00524.x; Xiong LM, 2006, PLANT PHYSIOL, V142, P1065, DOI 10.1104/pp.106.084632; Zhang WP, 2001, THEOR APPL GENET, V103, P118, DOI 10.1007/s001220100561; Zhu JM, 2006, THEOR APPL GENET, V113, P1, DOI 10.1007/s00122-006-0260-z	75	35	35	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32319	10.1371/journal.pone.0032319	http://dx.doi.org/10.1371/journal.pone.0032319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384215	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916800035
J	Tezuka, A; Matsushima, N; Nemoto, Y; Akashi, HD; Kawata, M; Makino, T				Tezuka, Ayumi; Matsushima, Noe; Nemoto, Yoriko; Akashi, Hiroshi D.; Kawata, Masakado; Makino, Takashi			Comprehensive Primer Design for Analysis of Population Genetics in Non-Sequenced Organisms	PLOS ONE			English	Article							CLIMATE-CHANGE; PHYLOGENETIC ANALYSIS; EMERGING DISEASE; AVIAN GENOME; MARKERS; EVOLUTION; ALIGNMENT; CONSERVATION; FREQUENCY; SELECTION	Nuclear sequence markers are useful tool for the study of the history of populations and adaptation. However, it is not easy to obtain multiple nuclear primers for organisms with poor or no genomic sequence information. Here we used the genomes of organisms that have been fully sequenced to design comprehensive sets of primers to amplify polymorphic genomic fragments of multiple nuclear genes in non-sequenced organisms. First, we identified a large number of candidate polymorphic regions that were flanked on each side by conserved regions in the reference genomes. We then designed primers based on these conserved sequences and examined whether the primers could be used to amplify sequences in target species, montane brown frog (Rana ornativentris), anole lizard (Anolis sagrei), guppy (Poecilia reticulata), and fruit fly (Drosophila melanogaster), for population genetic analysis. We successfully obtained polymorphic markers for all target species studied. In addition, we found that sequence identities of the regions between the primer sites in the reference genomes affected the experimental success of DNA amplification and identification of polymorphic loci in the target genomes, and that exonic primers had a higher success rate than intronic primers in amplifying readable sequences. We conclude that this comparative genomic approach is a time-and cost-effective way to obtain polymorphic markers for non-sequenced organisms, and that it will contribute to the further development of evolutionary ecology and population genetics for non-sequenced organisms, aiding in the understanding of the genetic basis of adaptation.	[Tezuka, Ayumi; Matsushima, Noe; Nemoto, Yoriko; Akashi, Hiroshi D.; Kawata, Masakado; Makino, Takashi] Tohoku Univ, Grad Sch Sci, Dept Ecol & Evolutionary Biol, Sendai, Miyagi 980, Japan	Tohoku University	Tezuka, A (corresponding author), Tohoku Univ, Grad Sch Sci, Dept Ecol & Evolutionary Biol, Sendai, Miyagi 980, Japan.	kawata@m.tohoku.ac.jp; tamakino@m.tohoku.ac.jp	Makino, Takashi/AAC-5181-2019; Kawata, Masakado/E-3962-2012	Makino, Takashi/0000-0003-4600-9353; Kawata, Masakado/0000-0001-8716-5438; Akashi, Hiroshi/0000-0001-5053-3292	Japan Society for the Promotion of Science [21370007, 23128501]; Ministry of Education, Culture, Sports, Science and Technology of Japan [J03]; Grants-in-Aid for Scientific Research [22657004] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	MK and TM were supported by a Grant-in-Aid for Scientific Research (21370007 and 23128501, respectively) from the Japan Society for the Promotion of Science, and in part by the Global COE Program "Centre for ecosystem management adapting to global change" (J03) of the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backstroem N, 2008, MOL ECOL, V17, P964, DOI 10.1111/j.1365-294X.2007.03551.x; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Balanya J, 2006, SCIENCE, V313, P1773, DOI 10.1126/science.1131002; Doyle J. J., 1987, PHYTOCHEM B, P11; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Hoffmann AA, 2007, ECOL LETT, V10, P63, DOI 10.1111/j.1461-0248.2006.00985.x; Hohenlohe PA, 2010, INT J PLANT SCI, V171, P1059, DOI 10.1086/656306; Jump AS, 2006, MOL ECOL, V15, P3469, DOI 10.1111/j.1365-294X.2006.03027.x; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Lee JY, 2008, EVOLUTION, V62, P3117, DOI 10.1111/j.1558-5646.2008.00543.x; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Ouborg NJ, 2007, J ECOL, V95, P8, DOI 10.1111/j.1365-2745.2006.01197.x; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Primmer CR, 1997, GENOME RES, V7, P471, DOI 10.1101/gr.7.5.471; Prychitko TM, 2003, MOL BIOL EVOL, V20, P762, DOI 10.1093/molbev/msg080; Puechmaille SJ, 2011, TRENDS ECOL EVOL, V26, P570, DOI 10.1016/j.tree.2011.06.013; Putta S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-54; Rambaut A., 1996, SEQUENCE ALIGNMENT E; Ranwez V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-241; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rosenblum EB, 2007, MOL ECOL NOTES, V7, P113, DOI 10.1111/j.1471-8286.2006.01547.x; Stinchcombe JR, 2008, HEREDITY, V100, P158, DOI 10.1038/sj.hdy.6800937; Storfer A, 2009, BIOSCIENCE, V59, P559, DOI 10.1525/bio.2009.59.7.7; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomson RC, 2010, MOL ECOL, V19, P2184, DOI 10.1111/j.1365-294X.2010.04650.x; Townsend TM, 2008, MOL PHYLOGENET EVOL, V47, P129, DOI 10.1016/j.ympev.2008.01.008; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523; Willing EM, 2011, BIOINFORMATICS, V27, P2187, DOI 10.1093/bioinformatics/btr346; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455	33	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32314	10.1371/journal.pone.0032314	http://dx.doi.org/10.1371/journal.pone.0032314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22393396	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916800034
J	Huang, EY; Bi, Y; Jiang, W; Luo, XJ; Yang, K; Gao, JL; Gao, YH; Luo, Q; Shi, Q; Kim, SH; Liu, X; Li, M; Hu, N; Liu, H; Cui, J; Zhang, WW; Li, RD; Chen, X; Shen, JK; Kong, YH; Zhang, JY; Wang, JH; Luo, JY; He, BC; Wang, HC; Reid, RR; Luu, HH; Haydon, RC; Yang, L; He, TC				Huang, Enyi; Bi, Yang; Jiang, Wei; Luo, Xiaoji; Yang, Ke; Gao, Jian-Li; Gao, Yanhong; Luo, Qing; Shi, Qiong; Kim, Stephanie H.; Liu, Xing; Li, Mi; Hu, Ning; Liu, Hong; Cui, Jing; Zhang, Wenwen; Li, Ruidong; Chen, Xiang; Shen, Jikun; Kong, Yuhan; Zhang, Jiye; Wang, Jinhua; Luo, Jinyong; He, Bai-Cheng; Wang, Huicong; Reid, Russell R.; Luu, Hue H.; Haydon, Rex C.; Yang, Li; He, Tong-Chuan			Conditionally Immortalized Mouse Embryonic Fibroblasts Retain Proliferative Activity without Compromising Multipotent Differentiation Potential	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE MORPHOGENETIC PROTEINS; MARROW STROMAL CELLS; HEPATIC PROGENITOR CELLS; SUPPRESSES TUMOR-GROWTH; LARGE T-ANTIGEN; OSTEOGENIC DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; HUMAN OSTEOSARCOMA; RECOMBINANT ADENOVIRUSES	Mesenchymal stem cells (MSCs) are multipotent cells which reside in many tissues and can give rise to multiple lineages including bone, cartilage and adipose. Although MSCs have attracted significant attention for basic and translational research, primary MSCs have limited life span in culture which hampers MSCs' broader applications. Here, we investigate if mouse mesenchymal progenitors can be conditionally immortalized with SV40 large T antigen and maintain long-term cell proliferation without compromising their multipotency. Using the system which expresses SV40 large T antigen flanked with Cre/loxP sites, we demonstrate that mouse embryonic fibroblasts (MEFs) can be efficiently immortalized by SV40 large T antigen. The conditionally immortalized MEFs (iMEFs) exhibit an enhanced proliferative activity and maintain long-term cell proliferation, which can be reversed by Cre recombinase. The iMEFs express most MSC markers and retain multipotency as they can differentiate into osteogenic, chondrogenic and adipogenic lineages under appropriate differentiation conditions in vitro and in vivo. The removal of SV40 large T reduces the differentiation potential of iMEFs possibly due to the decreased progenitor expansion. Furthermore, the iMEFs are apparently not tumorigenic when they are subcutaneously injected into athymic nude mice. Thus, the conditionally immortalized iMEFs not only maintain long-term cell proliferation but also retain the ability to differentiate into multiple lineages. Our results suggest that the reversible immortalization strategy using SV40 large T antigen may be an efficient and safe approach to establishing long-term cell culture of primary mesenchymal progenitors for basic and translational research, as well as for potential clinical applications.	[Huang, Enyi; Wang, Huicong; Yang, Li] Chongqing Univ, Sch Bioengn, Chongqing 630044, Peoples R China; [Huang, Enyi; Bi, Yang; Jiang, Wei; Luo, Xiaoji; Yang, Ke; Gao, Jian-Li; Gao, Yanhong; Luo, Qing; Shi, Qiong; Kim, Stephanie H.; Liu, Xing; Li, Mi; Hu, Ning; Liu, Hong; Cui, Jing; Zhang, Wenwen; Li, Ruidong; Chen, Xiang; Shen, Jikun; Kong, Yuhan; Zhang, Jiye; Wang, Jinhua; Luo, Jinyong; He, Bai-Cheng; Reid, Russell R.; Luu, Hue H.; Haydon, Rex C.; He, Tong-Chuan] Univ Chicago, Med Ctr, Dept Surg, Mol Oncol Lab, Chicago, IL 60637 USA; [Bi, Yang; Luo, Qing; Liu, Xing; Li, Mi; He, Tong-Chuan] Chongqing Med Univ, Childrens Hosp, Stem Cell Biol & Therapy Lab, Key Lab Pediat Codesignated,Chinese Minist Educ, Chongqing, Peoples R China; [Bi, Yang; Luo, Qing; Liu, Xing; Li, Mi; He, Tong-Chuan] Chongqing Med Univ, Childrens Hosp, Chongqing Bur Educ, Chongqing, Peoples R China; [Luo, Xiaoji; Shi, Qiong; Hu, Ning; Liu, Hong; Cui, Jing; Zhang, Wenwen; Li, Ruidong; Kong, Yuhan; Zhang, Jiye; Wang, Jinhua; Luo, Jinyong; He, Bai-Cheng; He, Tong-Chuan] Chongqing Med Univ, Key Lab Diagnost Med Designated, Chinese Minist Educ, Chongqing, Peoples R China; [Luo, Xiaoji; Shi, Qiong; Hu, Ning; Liu, Hong; Cui, Jing; Zhang, Wenwen; Li, Ruidong; Kong, Yuhan; Zhang, Jiye; Wang, Jinhua; Luo, Jinyong; He, Bai-Cheng; He, Tong-Chuan] Chongqing Med Univ, Affiliated Hosp, Chongqing, Peoples R China; [Yang, Ke] Third Mil Med Univ, Dept Cell Biol, Chongqing, Peoples R China; [Gao, Jian-Li] Zhejiang Chinese Med Univ, Inst Mat Med, Hangzhou, Zhejiang, Peoples R China; [Gao, Yanhong] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Geriatr, Shanghai 200030, Peoples R China; [Chen, Xiang] Fourth Mil Med Univ, Affiliated Tangdu Hosp, Dept Orthopaed Surg, Xian 710032, Peoples R China	Chongqing University; University of Chicago; University of Chicago Medical Center; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Army Medical University; Zhejiang Chinese Medical University; Shanghai Jiao Tong University; Air Force Military Medical University	Huang, EY (corresponding author), Chongqing Univ, Sch Bioengn, Chongqing 630044, Peoples R China.	yangli@cqu.edu.cn; tche@surgery.bsd.uchicago.edu	GAO, JianLi/J-4997-2017	GAO, JianLi/0000-0002-5977-0021; HUANG, ENYI/0000-0003-1163-5282; Chen, Xiang/0000-0001-7628-516X	American Cancer Society; Orthopaedic Research and Education Foundation; National Institutes of Health; China Scholarship Council	American Cancer Society(American Cancer Society); Orthopaedic Research and Education Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council)	The reported work was supported, in part, by research grants from the American Cancer Society (TCH and HHL), the Orthopaedic Research and Education Foundation (RCH and HHL), and the National Institutes of Health (RCH, TCH and HHL). EH was a recipient of the Predoctoral Fellowship from China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON SA, 1968, J CELL PHYSIOL, V72, P141, DOI 10.1002/jcp.1040720208; ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P17734, DOI 10.1073/pnas.0508440102; Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Chan JL, 2006, BLOOD, V107, P4817, DOI 10.1182/blood-2006-01-0057; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; GEE CJ, 1979, J CELL SCI, V36, P223; Geserick C, 2006, ONCOGENE, V25, P4310, DOI 10.1038/sj.onc.1209465; Haydon RC, 2002, CLIN CANCER RES, V8, P1288; He BC, 2011, MOL PHARMACOL, V79, P211, DOI 10.1124/mol.110.068668; He BC, 2010, CLIN CANCER RES, V16, P2235, DOI 10.1158/1078-0432.CCR-09-2499; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; HOWELL N, 1982, CYTOGENET CELL GENET, V34, P215, DOI 10.1159/000131809; Huang JY, 2009, LIVER INT, V29, P1569, DOI 10.1111/j.1478-3231.2009.02111.x; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; KAHN P, 1983, VIROLOGY, V126, P348, DOI 10.1016/0042-6822(83)90484-1; Kang Mo K, 2007, Methods Mol Biol, V371, P151; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Keilhoff G, 2006, EUR J CELL BIOL, V85, P11, DOI 10.1016/j.ejcb.2005.09.021; Lee MK, 2005, J CELL SCI, V118, P819, DOI 10.1242/jcs.01673; Liu Z, 2004, J NEUROTRAUM, V21, P1479, DOI 10.1089/neu.2004.21.1479; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98; Luther G, 2011, CURR GENE THER, V11, P229; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Nitta M, 2001, GYNECOL ONCOL, V81, P10, DOI 10.1006/gyno.2000.6084; Noel Daniele, 2002, Curr Opin Investig Drugs, V3, P1000; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; PRIVES C, 1990, CELL, V61, P735, DOI 10.1016/0092-8674(90)90179-I; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rastegar Farbod, 2010, World J Stem Cells, V2, P67, DOI 10.4252/wjsc.v2.i4.67; Rastegar F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014182; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ringe J, 2008, J TISSUE ENG REGEN M, V2, P136, DOI 10.1002/term.75; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Shenaq DS, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/519028; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Sinanan ACM, 2004, BIOTECHNOL APPL BIOC, V40, P25, DOI 10.1042/BA20030185; Su Y, 2011, ONCOGENE, V30, P3907, DOI 10.1038/onc.2011.97; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614; vom Brocke J, 2006, CARCINOGENESIS, V27, P2141, DOI 10.1093/carcin/bg1101; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Westerman KA, 1996, P NATL ACAD SCI USA, V93, P8971, DOI 10.1073/pnas.93.17.8971; Wislet-Gendebien S, 2005, BRAIN RES BULL, V68, P95, DOI 10.1016/j.brainresbull.2005.08.016; Zhang WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011917; Zhu GH, 2009, DIFFERENTIATION, V78, P195, DOI 10.1016/j.diff.2009.06.001; ZHU JY, 1991, J VIROL, V65, P6872, DOI 10.1128/JVI.65.12.6872-6880.1991; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	71	88	92	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32428	10.1371/journal.pone.0032428	http://dx.doi.org/10.1371/journal.pone.0032428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384246	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916100079
J	Li, YY; Lenaghan, SC; Zhang, MJ				Li, YuanYuan; Lenaghan, Scott C.; Zhang, Mingjun			A Data-Driven Predictive Approach for Drug Delivery Using Machine Learning Techniques	PLOS ONE			English	Article							GIARDIA-LAMBLIA; IN-VITRO; RESISTANT TUBERCULOSIS; METRONIDAZOLE; BENZIMIDAZOLES; INTESTINALIS; ALBENDAZOLE; TINIDAZOLE; INVITRO	In drug delivery, there is often a trade-off between effective killing of the pathogen, and harmful side effects associated with the treatment. Due to the difficulty in testing every dosing scenario experimentally, a computational approach will be helpful to assist with the prediction of effective drug delivery methods. In this paper, we have developed a data-driven predictive system, using machine learning techniques, to determine, in silico, the effectiveness of drug dosing. The system framework is scalable, autonomous, robust, and has the ability to predict the effectiveness of the current drug treatment and the subsequent drug-pathogen dynamics. The system consists of a dynamic model incorporating both the drug concentration and pathogen population into distinct states. These states are then analyzed using a temporal model to describe the drug-cell interactions over time. The dynamic drug-cell interactions are learned in an adaptive fashion and used to make sequential predictions on the effectiveness of the dosing strategy. Incorporated into the system is the ability to adjust the sensitivity and specificity of the learned models based on a threshold level determined by the operator for the specific application. As a proof-of-concept, the system was validated experimentally using the pathogen Giardia lamblia and the drug metronidazole in vitro.	[Li, YuanYuan; Lenaghan, Scott C.; Zhang, Mingjun] Univ Tennessee, Mech Aerosp & Biomed Engn Dept, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Li, YY (corresponding author), Univ Tennessee, Mech Aerosp & Biomed Engn Dept, Knoxville, TN 37996 USA.	mjzhang@utk.edu		Lenaghan, Scott/0000-0002-7539-1726				Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Belhassen S, 2010, MED PHYS, V37, P1309, DOI 10.1118/1.3301610; Bezdek J, ADV APPL PATTERN REC; Blaas SH, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-60; BOREHAM PFL, 1988, T ROY SOC TROP MED H, V82, P104, DOI 10.1016/0035-9203(88)90278-7; Cedillo-Rivera R, 2002, J EUKARYOT MICROBIOL, V49, P201, DOI 10.1111/j.1550-7408.2002.tb00523.x; CEDILLORIVERA R, 1992, J MED MICROBIOL, V37, P221, DOI 10.1099/00222615-37-3-221; Citron DM, 2005, ANAEROBE, V11, P315, DOI 10.1016/j.anaerobe.2005.04.005; Craun GF, 1996, WATERBORNE OUTBREAKS; Dasenbrook EC, 2010, AM J RESP CRIT CARE, V181; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; EDLIND TD, 1990, J INFECT DIS, V162, P1408, DOI 10.1093/infdis/162.6.1408; Erah PO, 1997, J ANTIMICROB CHEMOTH, V39, P5, DOI 10.1093/jac/39.1.5; Gardner TB, 2001, CLIN MICROBIOL REV, V14, P114, DOI 10.1128/CMR.14.1.114-128.2001; GARDUNOESPINOSA J, 1992, REV INVEST CLIN, V44, P235; Green CE, 2009, AM J DRUG ALCOHOL AB, V35, P95, DOI 10.1080/00952990802647503; Harari O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000862; Ibrahim KH, 2004, PHARMACODYNAMICS PUL; KATELARIS PH, 1994, ALIMENT PHARM THERAP, V8, P187, DOI 10.1111/j.1365-2036.1994.tb00277.x; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Kempker RR, 2010, J INFECTION, V61, P372, DOI 10.1016/j.jinf.2010.09.021; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kramer M H, 1996, MMWR CDC Surveill Summ, V45, P1; Locarnini S, 2010, J GASTROEN HEPATOL, V25, P649, DOI 10.1111/j.1440-1746.2010.06255.x; MELONI BP, 1990, T ROY SOC TROP MED H, V84, P375, DOI 10.1016/0035-9203(90)90324-8; Mohamed NA, 1999, INT CONF ACOUST SPEE, P3429, DOI 10.1109/ICASSP.1999.757579; Nelson R, 2010, AM J NURS, V110, P55, DOI 10.1097/01.NAJ.0000389678.80144.cb; Ron D, 1996, MACH LEARN, V25, P117, DOI 10.1007/BF00114008; Saritas I, 2009, J INTELL MANUF, V20, P169, DOI 10.1007/s10845-008-0226-x; Sun JK, 2010, DRUG DELIV, V17, P164, DOI 10.3109/10717541003667764; Tomasetti C, 2010, MATH BIOSCI ENG, V7, P905, DOI 10.3934/mbe.2010.7.905; UPCROFT JA, 1993, PARASITOL TODAY, V9, P187, DOI 10.1016/0169-4758(93)90144-5; Upcroft P, 2001, CLIN MICROBIOL REV, V14, P150, DOI 10.1128/CMR.14.1.150-164.2001	33	9	9	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31724	10.1371/journal.pone.0031724	http://dx.doi.org/10.1371/journal.pone.0031724			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384063	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100031
J	Velasco, RP; Praditsitthikorn, N; Wichmann, K; Mohara, A; Kotirum, S; Tantivess, S; Vallenas, C; Harmanci, H; Teerawattananon, Y				Velasco, Roman Perez; Praditsitthikorn, Naiyana; Wichmann, Kamonthip; Mohara, Adun; Kotirum, Surachai; Tantivess, Sripen; Vallenas, Constanza; Harmanci, Hande; Teerawattananon, Yot			Systematic Review of Economic Evaluations of Preparedness Strategies and Interventions against Influenza Pandemics	PLOS ONE			English	Review							COST-EFFECTIVENESS; VACCINATION STRATEGIES; UNITED-STATES; H1N1 2009; PROPHYLAXIS; SIMULATION; SCENARIOS; SINGAPORE; EPIDEMIC; IMPACT	Background: Although public health guidelines have implications for resource allocation, these issues were not explicitly considered in previous WHO pandemic preparedness and response guidance. In order to ensure a thorough and informed revision of this guidance following the H1N1 2009 pandemic, a systematic review of published and unpublished economic evaluations of preparedness strategies and interventions against influenza pandemics was conducted. Methods: The search was performed in September 2011 using 10 electronic databases, 2 internet search engines, reference list screening, cited reference searching, and direct communication with relevant authors. Full and partial economic evaluations considering both costs and outcomes were included. Conversely, reviews, editorials, and studies on economic impact or complications were excluded. Studies were selected by 2 independent reviewers. Results: 44 studies were included. Although most complied with the cost effectiveness guidelines, the quality of evidence was limited. However, the data sources used were of higher quality in economic evaluations conducted after the 2009 H1N1 pandemic. Vaccination and drug regimens were varied. Pharmaceutical plus non-pharmaceutical interventions are relatively cost effective in comparison to vaccines and/or antivirals alone. Pharmaceutical interventions vary from cost saving to high cost effectiveness ratios. According to ceiling thresholds (Gross National Income per capita), the reduction of nonessential contacts and the use of pharmaceutical prophylaxis plus the closure of schools are amongst the cost effective strategies for all countries. However, quarantine for household contacts is not cost effective even for low and middle income countries. Conclusion: The available evidence is generally inconclusive regarding the cost effectiveness of preparedness strategies and interventions against influenza pandemics. Studies on their effectiveness and cost effectiveness should be readily implemented in forthcoming events that also involve the developing world. Guidelines for assessing the impact of disease and interventions should be drawn up to facilitate these studies.	[Velasco, Roman Perez; Praditsitthikorn, Naiyana; Wichmann, Kamonthip; Mohara, Adun; Kotirum, Surachai; Tantivess, Sripen; Teerawattananon, Yot] Minist Publ Hlth, Dept Hlth, Hlth Intervent & Technol Assessment Program, Muang, Nonthaburi, Thailand; [Vallenas, Constanza; Harmanci, Hande] WHO, Global Influenza Program, CH-1211 Geneva, Switzerland	Ministry of Public Health - Thailand; World Health Organization	Velasco, RP (corresponding author), Minist Publ Hlth, Dept Hlth, Hlth Intervent & Technol Assessment Program, Muang, Nonthaburi, Thailand.	romanperezvelasco@gmail.com		Teerawattananon, Yot/0000-0003-2217-2930; Harmanci, Hande/0000-0001-9750-6304; Perez Velasco, Roman/0000-0003-4651-3285	Thai Health Promotion Foundation; Health System Research Institute; National Health Security Office; Bureau of Health Policy and Strategy, Ministry of Public Health; World Health Organization	Thai Health Promotion Foundation; Health System Research Institute; National Health Security Office; Bureau of Health Policy and Strategy, Ministry of Public Health; World Health Organization(World Health Organization)	The Health Intervention and Technology Assessment Program is funded by the Thai Health Promotion Foundation, the Health System Research Institute, the National Health Security Office and the Bureau of Health Policy and Strategy, Ministry of Public Health. This study was specifically funded by the Global Influenza Programme, World Health Organization. The authors independently from the funders carried out study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R., 2010, EVIDENCE BASED DECIS; Andradottir S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S1; Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Balicer RD, 2005, EMERG INFECT DIS, V11, P1280; Beigi RH, 2009, CLIN INFECT DIS, V49, P1784, DOI 10.1086/649013; Brouwers L, 2009, EUROSURVEILLANCE, V14, P5; Brown ST, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-353; Brunovsky P, 2009, EKON CAS, V57, P163; Carrasco LR, 2011, J R SOC INTERFACE, V8, P1307, DOI 10.1098/rsif.2010.0715; Congressional Budget Office of the US, 2006, POT INFL PAND POSS M; Cooper Nicola, 2005, J Health Serv Res Policy, V10, P245, DOI 10.1258/135581905774414187; Dan YY, 2009, EMERG INFECT DIS, V15, P1909, DOI 10.3201/eid1512.090902; Deuffic-Burban S, 2009, PLOS CURR-TREE LIFE, V1; Doyle A, 2006, J EPIDEMIOL COMMUN H, V60, P399, DOI 10.1136/jech.2005.034082; Drummond M., METHODS EC EVALUATIO; Drummond M, 2009, VALUE HEALTH, V12, P409, DOI 10.1111/j.1524-4733.2008.00489.x; Durbin A, 2011, J INFECT DIS IMMUN, V3, P40; Dutta A., 2008, EFFECTIVENESS POLICI; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Gonzalez-Canudas J, 2011, REV PANAM SALUD PUBL, V29, P1; Halder N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022087; Jonung Lars., 2006, EC PAPERS EUROPEAN C, V251, P3, DOI [10.2139/ssrn.920851, DOI 10.2139/SSRN.920851]; Khazeni N, 2009, ANN INTERN MED, V151, P829, DOI [10.7326/0000605-200912150-00157, 10.7326/0003-4819-151-12-200912150-00157]; Khazeni N, 2009, ANN INTERN MED, V151, P840, DOI [10.7326/0000605-200912150-00156, 10.7326/0003-4819-151-12-200912150-00156]; Lee BY, 2011, AM J MANAG CARE, V17, P693; Lee BY, 2011, VACCINE, V29, P2149, DOI 10.1016/j.vaccine.2010.12.078; Lee BY, 2010, VACCINE, V28, P4875, DOI 10.1016/j.vaccine.2010.05.002; Lee BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011284; Lee BY, 2009, OBSTET GYNECOL, V114, P971, DOI 10.1097/AOG.0b013e3181bdbfed; Lee VJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007108; Lee VJ, 2006, EMERG INFECT DIS, V12, P95; Lu CJ, 2010, CHIN J INTEGR MED, V16, P493, DOI 10.1007/s11655-010-0563-4; Lugner AK, 2010, COST EFFECTIVENESS C, P15; Lugner Anna K, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P547, DOI 10.1586/erp.09.56; Lugner AK, 2010, HEALTH ECON, V19, P518, DOI 10.1002/hec.1485; Lugner AK, 2009, EUR J PUBLIC HEALTH, V19, P516, DOI 10.1093/eurpub/ckp119; Medema JK, 2004, VIRUS RES, V103, P9, DOI 10.1016/j.virusres.2004.02.006; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Mota NVYVP, 2011, EMERG INFECT DIS, V17, P1421, DOI 10.3201/eid1708.101546; Newall AT, 2010, EMERG INFECT DIS, V16, P224, DOI 10.3201/eid1602.090571; Perlroth DJ, 2010, CLIN INFECT DIS, V50, P165, DOI 10.1086/649867; Piercy J, 2003, EC PANDEMIC INFLUENZ; Prosser LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022308; Sander B, 2006, PHARMACOECONOMICS, V24, P373, DOI 10.2165/00019053-200624040-00007; Sander B, 2009, PLOS CURR, V1; Sander B, 2010, VACCINE, V28, P6210, DOI 10.1016/j.vaccine.2010.07.010; Sander B, 2009, VALUE HEALTH, V12, P226, DOI 10.1111/j.1524-4733.2008.00437.x; Siddiqui MR, 2008, EMERG INFECT DIS, V14, P267, DOI 10.3201/eid1402.070478; Smetanin P, 2010, H1N1 2009 PANDEMIC A; Smetanin PKP, 2009, CONTRAST PROPHYLACTI; Teerawattananon Y, 2007, PHARMACOECONOMICS, V25, P467, DOI 10.2165/00019053-200725060-00003; The World Bank, 2011, DAT WE CLASS COUNTR; Tracht SM, 2011, EC ANAL USE FACEMASK; Walker DG, 2010, VACCINE, V28, P2356, DOI 10.1016/j.vaccine.2009.06.035; World Health Organization, 2009, PAND INFL PREP RESP; World Health Organization, 2005, WHO CHECKL INFL PAND; Yarmand H, 2010, THESIS N CAROLINA ST	58	44	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e30333	10.1371/journal.pone.0030333	http://dx.doi.org/10.1371/journal.pone.0030333			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	928SI	22393352	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500005
J	Nakazono, Y; Hara, K; Kashiwagi, T; Hamada, N; Watanabe, H				Nakazono, Yoko; Hara, Koyu; Kashiwagi, Takahito; Hamada, Nobuyuki; Watanabe, Hiroshi			The RNA Polymerase PB2 Subunit of Influenza A/HongKong/156/1997 (H5N1) Restrict the Replication of Reassortant Ribonucleoprotein Complexes	PLOS ONE			English	Article							N-TERMINAL REGION; VIRUS POLYMERASE; PA SUBUNIT; IN-VITRO; CONSERVED MOTIFS; CAP-BINDING; H1N1 VIRUS; A VIRUSES; NUCLEOPROTEIN; PROTEIN	Background: Genetic reassortment plays a critical role in the generation of pandemic strains of influenza virus. The influenza virus RNA polymerase, composed of PB1, PB2 and PA subunits, has been suggested to influence the efficiency of genetic reassortment. However, the role of the RNA polymerase in the genetic reassortment is not well understood. Methodology/Principal Findings: Here, we reconstituted reassortant ribonucleoprotein (RNP) complexes, and demonstrated that the PB2 subunit of A/HongKong/156/1997 (H5N1) [HK PB2] dramatically reduced the synthesis of mRNA, cRNA and vRNA when introduced into the polymerase of other influenza strains of H1N1 or H3N2. The HK PB2 had no significant effect on the assembly of the polymerase trimeric complex, or on promoter binding activity or replication initiation activity in vitro. However, the HK PB2 was found to remarkably impair the accumulation of RNP. This impaired accumulation and activity of RNP was fully restored when four amino acids at position 108, 508, 524 and 627 of the HK PB2 were mutated. Conclusions/Significance: Overall, we suggest that the PB2 subunit of influenza polymerase might play an important role for the replication of reassortant ribonucleoprotein complexes.	[Nakazono, Yoko; Hara, Koyu; Kashiwagi, Takahito; Hamada, Nobuyuki; Watanabe, Hiroshi] Kurume Univ, Div Infect Dis, Dept Infect Med, Sch Med, Fukuoka, Japan	Kurume University	Nakazono, Y (corresponding author), Kurume Univ, Div Infect Dis, Dept Infect Med, Sch Med, Fukuoka, Japan.	koyu@med.kurume-u.ac.jp			Ishibashi Foundation for the Promotion of Science; Ministry of Education, Science, Sports and Culture, Japan [21791015]; Grants-in-Aid for Scientific Research [24591590] Funding Source: KAKEN	Ishibashi Foundation for the Promotion of Science; Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Ishibashi Foundation for the Promotion of Science and the Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Young Scientists (B), 21791015, 2009-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAN WJ, 1984, VIROLOGY, V133, P438, DOI 10.1016/0042-6822(84)90410-0; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; BISWAS SK, 1994, J VIROL, V68, P1819, DOI 10.1128/JVI.68.3.1819-1826.1994; Bradel-Tretheway BG, 2008, J GEN VIROL, V89, P2923, DOI 10.1099/vir.0.2008/006254-0; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Deng T, 2005, J VIROL, V79, P8669, DOI 10.1128/JVI.79.13.8669-8674.2005; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Engelhardt OG, 2005, J VIROL, V79, P5812, DOI 10.1128/JVI.79.9.5812-5818.2005; Engelhardt OG, 2006, REV MED VIROL, V16, P329, DOI 10.1002/rmv.512; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Fislova T, 2010, J VIROL, V84, P8691, DOI 10.1128/JVI.00813-10; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hara K, 2001, GENES CELLS, V6, P87, DOI 10.1046/j.1365-2443.2001.00399.x; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hemerka JN, 2009, J VIROL, V83, P3944, DOI 10.1128/JVI.02300-08; Hirayama E, 2004, J VIROL, V78, P1263, DOI 10.1128/JVI.78.3.1263-1270.2004; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jorba N, 2008, PROTEOMICS, V8, P2077, DOI 10.1002/pmic.200700508; Jung TE, 2006, J GEN VIROL, V87, P679, DOI 10.1099/vir.0.81453-0; Kashiwagi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015140; Kashiwagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005473; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Lee MTM, 2002, NUCLEIC ACIDS RES, V30, P429, DOI 10.1093/nar/30.2.429; Leung BW, 2010, VIROLOGY, V401, P96, DOI 10.1016/j.virol.2010.01.036; Li CJ, 2010, P NATL ACAD SCI USA, V107, P4687, DOI 10.1073/pnas.0912807107; Li CJ, 2008, J VIROL, V82, P11880, DOI 10.1128/JVI.01445-08; Li OTW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005658; Maier HJ, 2008, VIROLOGY, V370, P194, DOI 10.1016/j.virol.2007.08.029; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Momose F, 2002, J BIOL CHEM, V277, P45306, DOI 10.1074/jbc.M206822200; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Octaviani CP, 2011, J VIROL, V85, P8449, DOI 10.1128/JVI.05054-11; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Poole E, 2004, VIROLOGY, V321, P120, DOI 10.1016/j.virol.2003.12.022; Rameix-Welti MA, 2009, J VIROL, V83, P1320, DOI 10.1128/JVI.00977-08; Resa-Infante P, 2011, RNA BIOL, V8, P207, DOI 10.4161/rna.8.2.14513; SanzEzquerro JJ, 1996, J VIROL, V70, P1905, DOI 10.1128/JVI.70.3.1905-1911.1996; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; SNYDER MH, 1987, J VIROL, V61, P2857, DOI 10.1128/JVI.61.9.2857-2863.1987; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Toyoda T, 1996, J GEN VIROL, V77, P2149, DOI 10.1099/0022-1317-77-9-2149; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004	49	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32634	10.1371/journal.pone.0032634	http://dx.doi.org/10.1371/journal.pone.0032634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389716	Green Published, gold, Green Submitted			2022-12-27	WOS:000302999600055
J	Owen, C; Czopek, A; Agouni, A; Grant, L; Judson, R; Lees, EK; Mcilroy, GD; Goransson, O; Welch, A; Bence, KK; Kahn, BB; Neel, BG; Mody, N; Delibegovic, M				Owen, Carl; Czopek, Alicja; Agouni, Abdelali; Grant, Louise; Judson, Robert; Lees, Emma K.; Mcilroy, George D.; Goransson, Olga; Welch, Andy; Bence, Kendra K.; Kahn, Barbara B.; Neel, Benjamin G.; Mody, Nimesh; Delibegovic, Mirela			Adipocyte-Specific Protein Tyrosine Phosphatase 1B Deletion Increases Lipogenesis, Adipocyte Cell Size and Is a Minor Regulator of Glucose Homeostasis	PLOS ONE			English	Article							LIVER-SPECIFIC DELETION; INSULIN-RESISTANCE; ENDOPLASMIC-RETICULUM; ENERGY-EXPENDITURE; 3T3-L1 ADIPOCYTES; ADIPOSE-TISSUE; PTP1B; EXPRESSION; OBESITY; TRANSPORT	Protein tyrosine phosphatase 1B (PTP1B), a key negative regulator of leptin and insulin signaling, is positively correlated with adiposity and contributes to insulin resistance. Global PTP1B deletion improves diet-induced obesity and glucose homeostasis via enhanced leptin signaling in the brain and increased insulin signaling in liver and muscle. However, the role of PTP1B in adipocytes is unclear, with studies demonstrating beneficial, detrimental or no effect(s) of adipose-PTP1B-deficiency on body mass and insulin resistance. To definitively establish the role of adipocyte-PTP1B in body mass regulation and glucose homeostasis, adipocyte-specific-PTP1B knockout mice (adip-crePTP1B(-/-)) were generated using the adiponectin-promoter to drive Cre-recombinase expression. Chow-fed adip-crePTP1B(-/-) mice display enlarged adipocytes, despite having similar body weight/adiposity and glucose homeostasis compared to controls. High-fat diet (HFD)-fed adip-crePTP1B(-/-) mice display no differences in body weight/adiposity but exhibit larger adipocytes, increased circulating glucose and leptin levels, reduced leptin sensitivity and increased basal lipogenesis compared to controls. This is associated with decreased insulin receptor (IR) and Akt/PKB phosphorylation, increased lipogenic gene expression and increased hypoxia-induced factor-1-alpha (Hif-1 alpha) expression. Adipocyte-specific PTP1B deletion does not beneficially manipulate signaling pathways regulating glucose homeostasis, lipid metabolism or adipokine secretion in adipocytes. Moreover, PTP1B does not appear to be the major negative regulator of the IR in adipocytes.	[Owen, Carl; Judson, Robert; Welch, Andy] Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland; [Goransson, Olga] Lund Univ, Dept Expt Med Sci, Prot Phosphorylat Unit, Lund, Sweden; [Bence, Kendra K.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Kahn, Barbara B.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Neel, Benjamin G.] Univ Toronto, Ontario Canc Inst, Campbell Family Canc Res Inst, Princess Margaret Hosp, Toronto, ON, Canada	University of Aberdeen; Lund University; University of Pennsylvania; Harvard University; Beth Israel Deaconess Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Owen, C (corresponding author), Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland.	m.delibegovic@abdn.ac.uk	Mody, Nimesh/J-9602-2019; Agouni, Abdelali/AAP-5298-2020	Mody, Nimesh/0000-0002-2215-7952; Agouni, Abdelali/0000-0002-8363-1582; Delibegovic, Mirela/0000-0001-6193-3152; Mcilroy, George/0000-0003-4230-4355; Lees, Emma/0000-0001-8911-4351; Goransson, Olga/0000-0002-7209-8022; Bence, Kendra/0000-0002-5879-4726	British Heart Foundation [PG/09/048/27675, PG/11/8/28703]; Diabetes UK [BDA/RD08/0003597]; STINT; Swedish Foundation for International Cooperation in Research and Higher Education; BBSRC; Biotechnology and Biological Sciences Research Council [1091530] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK043051] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); Diabetes UK(Diabetes UK); STINT; Swedish Foundation for International Cooperation in Research and Higher Education; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the British Heart Foundation project grant awarded to MD (PG/09/048/27675 and PG/11/8/28703) and the Diabetes UK project grant awarded to MD. (BDA/RD08/0003597). This work was also supported by a STINT grant awarded to OG; Institutional Grant for Young Researchers, from The Swedish Foundation for International Cooperation in Research and Higher Education. CO is the recipient of a BBSRC postgraduate studentship; NM is the recipient of a British Heart Foundation intermediate basic research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2011, BIOCHEM J, V438, P369, DOI 10.1042/BJ20110373; Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Arya G, 2010, VET MICROBIOL, V141, P332, DOI 10.1016/j.vetmic.2009.09.030; Bai YL, 1996, J BIOL CHEM, V271, P13939, DOI 10.1074/jbc.271.24.13939; Banno R, 2010, J CLIN INVEST, V120, P720, DOI 10.1172/JCI39620; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bence Kendra K, 2010, J Clin Metab Diabetes, V1, P27; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Delibegovic M, 2007, MOL CELL BIOL, V27, P7727, DOI 10.1128/MCB.00959-07; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Dorrestijn J, 1998, ARCH PHYSIOL BIOCHEM, V106, P269, DOI 10.1076/apab.106.4.269.4369; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fine JB, 1997, INT J OBESITY, V21, P764, DOI 10.1038/sj.ijo.0800469; FOLEY JE, 1980, DIABETOLOGIA, V19, P234, DOI 10.1007/BF00275275; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; HAMILTON BS, 1995, NAT MED, V1, P953, DOI 10.1038/nm0995-953; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kahn BB, 1996, DIABETES, V45, P1644, DOI 10.2337/diabetes.45.11.1644; Katsuki A, 2001, DIABETES CARE, V24, P362, DOI 10.2337/diacare.24.2.362; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kobayashi K, 2005, CURR DRUG TARGETS, V6, P525, DOI 10.2174/1389450054021972; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Lonnqvist F, 1997, J CLIN INVEST, V99, P2398, DOI 10.1172/JCI119422; Mao JQ, 2009, P NATL ACAD SCI USA, V106, P17576, DOI 10.1073/pnas.0909055106; Matsuo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016446; Miranda S, 2010, CELL SIGNAL, V22, P645, DOI 10.1016/j.cellsig.2009.11.019; MOODY AJ, 1974, HORM METAB RES, V6, P12, DOI 10.1055/s-0028-1093895; Muthusamy VS, 2008, CHEM-BIOL INTERACT, V174, P69, DOI 10.1016/j.cbi.2008.04.016; Perez C, 2004, DIABETES, V53, P347, DOI 10.2337/diabetes.53.2.347; Rondinone CM, 2002, DIABETES, V51, P2405, DOI 10.2337/diabetes.51.8.2405; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Ruffolo SC, 2007, J BIOL CHEM, V282, P30423, DOI 10.1074/jbc.M700697200; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shimizu S, 2003, J BIOL CHEM, V278, P43095, DOI 10.1074/jbc.M306880200; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Suwaki N, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002004; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Venable CL, 2000, J BIOL CHEM, V275, P18318, DOI 10.1074/jbc.M908392199; Wang MY, 1999, J BIOL CHEM, V274, P17541, DOI 10.1074/jbc.274.25.17541; Wang YC, 2006, J NUCL MED, V47, P1891; Wang ZV, 2010, ENDOCRINOLOGY, V151, P2933, DOI 10.1210/en.2010-0136; Waring JF, 2003, MOL CELL ENDOCRINOL, V203, P155, DOI 10.1016/S0303-7207(03)00008-X; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401; Yip SC, 2010, TRENDS BIOCHEM SCI, V35, P442, DOI 10.1016/j.tibs.2010.03.004; Zinker BA, 2002, P NATL ACAD SCI USA, V99, P11357, DOI 10.1073/pnas.142298199	56	41	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32700	10.1371/journal.pone.0032700	http://dx.doi.org/10.1371/journal.pone.0032700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389718	Green Published, gold, Green Submitted			2022-12-27	WOS:000302999600057
J	Kim, S; Joo, DH; Lee, JB; Shim, BS; Cheon, IS; Jang, JE; Song, HH; Kim, KH; Song, MK; Chang, J				Kim, Sol; Joo, Dong-Hyun; Lee, Jee-Boong; Shim, Byoung-Shik; Cheon, In Su; Jang, Ji-Eun; Song, Ho-Hyun; Kim, Kyung-Hyo; Song, Man Ki; Chang, Jun			Dual Role of Respiratory Syncytial Virus Glycoprotein Fragment as a Mucosal Immunogen and Chemotactic Adjuvant	PLOS ONE			English	Article							ATTACHMENT G GLYCOPROTEIN; G-PROTEIN; PROTECTIVE IMMUNITY; CHOLERA-TOXIN; PULMONARY EOSINOPHILIA; MONOCLONAL-ANTIBODIES; DENDRITIC CELLS; RESPONSES; INFECTION; VACCINE	Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract disease in infancy and early childhood. Despite its importance as a pathogen, there is no licensed vaccine to prevent RSV infection. The G glycoprotein of RSV, a major attachment protein, is a potentially important target for protective antiviral immune responses and has been shown to exhibit chemotactic activity through CX3C mimicry. Here, we show that sublingual or intranasal immunization of a purified G protein fragment of amino acids from 131 to 230, designated Gcf, induces strong serum IgG and mucosal IgA responses. Interestingly, these antibody responses could be elicited by Gcf even in the absence of any adjuvant, indicating a novel self-adjuvanting property of our vaccine candidate. Gcf exhibited potent chemotactic activity in in vitro cell migration assay and cysteine residues are necessary for chemotactic activity and self-adjuvanticity of Gcf in vivo. Mucosal immunization with Gcf also provides protection against RSV challenge without any significant lung eosinophilia or vaccine-induced weight loss. Together, our data demonstrate that mucosal administration of Gcf vaccine elicits beneficial protective immunity and represents a promising vaccine regimen preventing RSV infection.	[Kim, Sol; Lee, Jee-Boong; Chang, Jun] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea; [Joo, Dong-Hyun; Shim, Byoung-Shik; Cheon, In Su; Jang, Ji-Eun; Song, Ho-Hyun; Song, Man Ki] Int Vaccine Inst, Div Sci Lab, Seoul, South Korea; [Kim, Kyung-Hyo] Ewha Womans Univ, Sch Med, Dept Pediat, Seoul, South Korea	Ewha Womans University; International Vaccine Institute; Ewha Womans University	Kim, S (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea.	songmk@ivi.int; tcell@ewha.ac.kr	kim, sol/I-2198-2019	CHANG, JUN/0000-0002-8423-5987	Korea Health Industry Development Institute; Korean Government [A084555]; Korea Science & Engineering Foundation through the Center for Cell Signaling & Drug Discovery Research at Ewha Womans University [R15-2006-020]; government of the Republic of Korea; government of the Republic of Sweden; government of the Republic of Kuwait; Korea Research Institute of Bioscience Biotechnology [KGM3110912]; Ministry of Science Technology	Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); Korean Government(Korean Government); Korea Science & Engineering Foundation through the Center for Cell Signaling & Drug Discovery Research at Ewha Womans University; government of the Republic of Korea(Korean Government); government of the Republic of Sweden; government of the Republic of Kuwait; Korea Research Institute of Bioscience Biotechnology; Ministry of Science Technology	This work was supported by the Korea Health Industry Development Institute Grant funded by the Korean Government (A084555), by the grant R15-2006-020 from the National Core Research Center program of the Ministry of Science & Technology and the Korea Science & Engineering Foundation through the Center for Cell Signaling & Drug Discovery Research at Ewha Womans University. Man Ki Song was supported by the governments of the Republic of Korea, Sweden, and Kuwait, and by the grant from Korea Research Institute of Bioscience & Biotechnology (KGM3110912). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis Mubeccel, 2008, Clin Allergy Immunol, V21, P71; ALWAN WH, 1994, J EXP MED, V179, P81, DOI 10.1084/jem.179.1.81; Armstrong ME, 2005, J INFECT DIS, V192, P1628, DOI 10.1086/491739; Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; Bohle B, 2007, J ALLERGY CLIN IMMUN, V120, P707, DOI 10.1016/j.jaci.2007.06.013; Brandtzaeg P, 2003, INT J MED MICROBIOL, V293, P3, DOI 10.1078/1438-4221-00241; Carretero-Ortega J, 2010, MOL PHARMACOL, V77, P435, DOI 10.1124/mol.109.060400; Cuburu N, 2007, VACCINE, V25, P8598, DOI 10.1016/j.vaccine.2007.09.073; Falsey AR, 1998, VACCINE, V16, P1775, DOI 10.1016/S0264-410X(98)00142-X; Feldman SA, 1999, J VIROL, V73, P6610, DOI 10.1128/JVI.73.8.6610-6617.1999; Fujihashi K, 2002, VACCINE, V20, P2431, DOI 10.1016/S0264-410X(02)00155-X; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Glezen WP, 2000, JAMA-J AM MED ASSOC, V283, P499, DOI 10.1001/jama.283.4.499; Gorman JJ, 1997, PROTEIN SCI, V6, P1308, DOI 10.1002/pro.5560060619; Han LL, 1999, J INFECT DIS, V179, P25, DOI 10.1086/314567; Hancock GE, 1996, J VIROL, V70, P7783, DOI 10.1128/JVI.70.11.7783-7791.1996; Harcourt J, 2006, J IMMUNOL, V176, P1600, DOI 10.4049/jimmunol.176.3.1600; Huang Y, 2009, J CLIN VIROL, V44, P287, DOI 10.1016/j.jcv.2009.01.009; JOHNSON PR, 1987, J VIROL, V61, P3163, DOI 10.1128/JVI.61.10.3163-3166.1987; Johnson TR, 1998, J VIROL, V72, P2871, DOI 10.1128/JVI.72.4.2871-2880.1998; KAMMANN M, 1989, NUCLEIC ACIDS RES, V17, P5404, DOI 10.1093/nar/17.13.5404; Lemiale F, 2003, J VIROL, V77, P10078, DOI 10.1128/JVI.77.18.10078-10087.2003; LEVINE S, 1987, J GEN VIROL, V68, P2521, DOI 10.1099/0022-1317-68-9-2521; Martinez I, 1998, J GEN VIROL, V79, P2215, DOI 10.1099/0022-1317-79-9-2215; Martinez I, 1997, J GEN VIROL, V78, P2419, DOI 10.1099/0022-1317-78-10-2419; OPENSHAW PJM, 1992, INT IMMUNOL, V4, P493, DOI 10.1093/intimm/4.4.493; Plotnicky-Gilquin H, 1999, J VIROL, V73, P5637, DOI 10.1128/JVI.73.7.5637-5645.1999; Power UF, 2003, VACCINE, V22, P168, DOI 10.1016/S0264-410X(03)00570-X; Power UF, 1997, VIROLOGY, V230, P155, DOI 10.1006/viro.1997.8465; Sparer TE, 1998, J EXP MED, V187, P1921, DOI 10.1084/jem.187.11.1921; Srikiatkhachorn A, 1997, J EXP MED, V186, P421, DOI 10.1084/jem.186.3.421; Stevens WW, 2007, J IMMUNOL METHODS, V327, P63, DOI 10.1016/j.jim.2007.07.011; TAYLOR G, 1984, IMMUNOLOGY, V52, P137; Tebbey PW, 1998, J EXP MED, V188, P1967, DOI 10.1084/jem.188.10.1967; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675; van Ginkel FW, 2000, J IMMUNOL, V165, P4778, DOI 10.4049/jimmunol.165.9.4778; WITT DP, 1994, CURR BIOL, V4, P394, DOI 10.1016/S0960-9822(00)00088-9; Yamamoto S, 1997, P NATL ACAD SCI USA, V94, P5267, DOI 10.1073/pnas.94.10.5267; Yu JR, 2008, J VIROL, V82, P2350, DOI 10.1128/JVI.02372-07; Zhang W, J VIROL, V84, P1148	40	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32226	10.1371/journal.pone.0032226	http://dx.doi.org/10.1371/journal.pone.0032226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384186	Green Submitted, Green Published, gold			2022-12-27	WOS:000302918500068
J	Kulik, MC; Nusselder, WJ; Boshuizen, HC; Lhachimi, SK; Fernandez, E; Baili, P; Bennett, K; Mackenbach, JP; Smit, HA				Kulik, Margarete C.; Nusselder, Wilma J.; Boshuizen, Hendriek C.; Lhachimi, Stefan K.; Fernandez, Esteve; Baili, Paolo; Bennett, Kathleen; Mackenbach, Johan P.; Smit, H. A.			Comparison of Tobacco Control Scenarios: Quantifying Estimates of Long-Term Health Impact Using the DYNAMO-HIA Modeling Tool	PLOS ONE			English	Article							SMOKING-CESSATION; INTERVENTIONS; SIMULATION	Background: There are several types of tobacco control interventions/policies which can change future smoking exposure. The most basic intervention types are 1) smoking cessation interventions 2) preventing smoking initiation and 3) implementation of a nationwide policy affecting quitters and starters simultaneously. The possibility for dynamic quantification of such different interventions is key for comparing the timing and size of their effects. Methods and Results: We developed a software tool, DYNAMO-HIA, which allows for a quantitative comparison of the health impact of different policy scenarios. We illustrate the outcomes of the tool for the three typical types of tobacco control interventions if these were applied in the Netherlands. The tool was used to model the effects of different types of smoking interventions on future smoking prevalence and on health outcomes, comparing these three scenarios with the business-as-usual scenario. The necessary data input was obtained from the DYNAMO-HIA database which was assembled as part of this project. All smoking interventions will be effective in the long run. The population-wide strategy will be most effective in both the short and long term. The smoking cessation scenario will be second-most effective in the short run, though in the long run the smoking initiation scenario will become almost as effective. Interventions aimed at preventing the initiation of smoking need a long time horizon to become manifest in terms of health effects. The outcomes strongly depend on the groups targeted by the intervention. Conclusion: We calculated how much more effective the population-wide strategy is, in both the short and long term, compared to quit smoking interventions and measures aimed at preventing the initiation of smoking. By allowing a great variety of user-specified choices, the DYNAMO-HIA tool is a powerful instrument by which the consequences of different tobacco control policies and interventions can be assessed.	[Kulik, Margarete C.; Nusselder, Wilma J.; Lhachimi, Stefan K.; Mackenbach, Johan P.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Kulik, Margarete C.; Smit, H. A.] Natl Inst Publ Hlth & Environm RIVM, Ctr Prevent & Hlth Serv Res PZO, Bilthoven, Netherlands; [Boshuizen, Hendriek C.; Lhachimi, Stefan K.] Natl Inst Publ Hlth & Environm RIVM, Dept Stat & Math Modeling, Bilthoven, Netherlands; [Boshuizen, Hendriek C.] Wageningen Univ, Dept Human Nutr, Wageningen, Netherlands; [Fernandez, Esteve] Inst Catala Oncol IDIBELL, Tobacco Control Unit, Barcelona, Spain; [Fernandez, Esteve] Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain; [Baili, Paolo] Fdn IRCCS Ist Nazl Tumori, Descript Studies & Hlth Planning Unit, Milan, Italy; [Bennett, Kathleen] St James Hosp, Trinity Ctr Hlth Sci, Dept Pharmacol & Therapeut, Dublin, Ireland; [Smit, H. A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Wageningen University & Research; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Fondazione IRCCS Istituto Nazionale Tumori Milan; Trinity College Dublin; Utrecht University; Utrecht University Medical Center	Kulik, MC (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	m.kulik@erasmusmc.nl	Boshuizen, Hendriek C/B-3718-2014; Baili, Paolo/J-7422-2016; Boshuizen, Hendriek/M-3415-2014; Fernandez, Esteve/A-9750-2008; Lhachimi, Stefan K/D-9227-2014	Baili, Paolo/0000-0003-0335-2418; Boshuizen, Hendriek/0000-0002-3916-9095; Fernandez, Esteve/0000-0003-4239-723X; Lhachimi, Stefan K/0000-0001-8597-0935; Bennett, Kathleen/0000-0002-2861-7665	EU of the European Commission's Directorate General for Health and Consumer Affairs (DG SANCO); Erasmus Medical Center Rotterdam; Institute of Public Health and the Environment in the Netherlands; Catalan Institute of Oncology; International Obesity task force; London School for Hygiene and Tropical Medicine; Haughton Institute in Dublin; Instituto Tumori in Milan; Thematic Network of Cooperative Research on Cancer from the Instituto de Salud Carlos III, Government of Spain [RD06/0020/0089]; Ministry of Universities and Research, Government of Catalonia [2009SGR192]	EU of the European Commission's Directorate General for Health and Consumer Affairs (DG SANCO); Erasmus Medical Center Rotterdam; Institute of Public Health and the Environment in the Netherlands; Catalan Institute of Oncology; International Obesity task force; London School for Hygiene and Tropical Medicine; Haughton Institute in Dublin; Instituto Tumori in Milan; Thematic Network of Cooperative Research on Cancer from the Instituto de Salud Carlos III, Government of Spain; Ministry of Universities and Research, Government of Catalonia	The DYNAMO-HIA project was funded by the EU Public Health Programme 2003-2008 of the European Commission's Directorate General for Health and Consumer Affairs (DG SANCO), with co-financing from the Erasmus Medical Center Rotterdam, the Institute of Public Health and the Environment in the Netherlands, the Catalan Institute of Oncology, the International Obesity task force, the London School for Hygiene and Tropical Medicine, the Haughton Institute in Dublin and the Instituto Tumori in Milan. E. Fernandez was also partly supported by the Thematic Network of Cooperative Research on Cancer (RD06/0020/0089) from the Instituto de Salud Carlos III, Government of Spain; and by the Ministry of Universities and Research (2009SGR192), Government of Catalonia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Boshuizen HC, 2012, DEMOGRAPHY, V49, P1259, DOI 10.1007/s13524-012-0122-z; CBS - Permanent Onderzoek Leefsituatie (POLS) website, PERM OND LEEFS POLS; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P842; Feenstra TL, 2005, VALUE HEALTH, V8, P178, DOI 10.1111/j.1524-4733.2005.04008.x; Hoogenveen R, 3 CDM; Lancaster T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001292.pub2, 10.1002/14651858.CD001292.pub3]; Levy David T, 2004, J Public Health Manag Pract, V10, P338; Levy DT, 2010, AM J PUBLIC HEALTH, V100, P1253, DOI 10.2105/AJPH.2009.166785; Levy DT, 2000, AM J PUBLIC HEALTH, V90, P1311, DOI 10.2105/AJPH.90.8.1311; Lhachimi SK, 2011, DYNAMIC POPULATION H, V63; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Stead LF, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002850.pub2; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Stead LF, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001007.PUB2; Thomas R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001293.pub2; Valery L, 2008, EUR J CANCER PREV, V17, P535, DOI 10.1097/CEJ.0b013e3282f75e48; van den Berg M, 2010, EFFECTEN PREVENTIEVE; Wiehe SE, 2005, J ADOLESCENT HEALTH, V36, P162, DOI 10.1016/j.jadohealth.2004.12.003; World Health Organization, 2008, WHO REP GLOB TOB EP; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; WorldBank, 2003, TOB CONTR GLANC	22	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32363	10.1371/journal.pone.0032363	http://dx.doi.org/10.1371/journal.pone.0032363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384230	Green Published, gold			2022-12-27	WOS:000302916100074
J	Mende, DR; Waller, AS; Sunagawa, S; Jarvelin, AI; Chan, MM; Arumugam, M; Raes, J; Bork, P				Mende, Daniel R.; Waller, Alison S.; Sunagawa, Shinichi; Jaervelin, Aino I.; Chan, Michelle M.; Arumugam, Manimozhiyan; Raes, Jeroen; Bork, Peer			Assessment of Metagenomic Assembly Using Simulated Next Generation Sequencing Data	PLOS ONE			English	Article							GENOME; MICROBIOME; ACCESS; SETS; TOOL	Due to the complexity of the protocols and a limited knowledge of the nature of microbial communities, simulating metagenomic sequences plays an important role in testing the performance of existing tools and data analysis methods with metagenomic data. We developed metagenomic read simulators with platform-specific (Sanger, pyrosequencing, Illumina) base-error models, and simulated metagenomes of differing community complexities. We first evaluated the effect of rigorous quality control on Illumina data. Although quality filtering removed a large proportion of the data, it greatly improved the accuracy and contig lengths of resulting assemblies. We then compared the quality-trimmed Illumina assemblies to those from Sanger and pyrosequencing. For the simple community (10 genomes) all sequencing technologies assembled a similar amount and accurately represented the expected functional composition. For the more complex community (100 genomes) Illumina produced the best assemblies and more correctly resembled the expected functional composition. For the most complex community (400 genomes) there was very little assembly of reads from any sequencing technology. However, due to the longer read length the Sanger reads still represented the overall functional composition reasonably well. We further examined the effect of scaffolding of contigs using paired-end Illumina reads. It dramatically increased contig lengths of the simple community and yielded minor improvements to the more complex communities. Although the increase in contig length was accompanied by increased chimericity, it resulted in more complete genes and a better characterization of the functional repertoire. The metagenomic simulators developed for this research are freely available.	[Mende, Daniel R.; Waller, Alison S.; Sunagawa, Shinichi; Jaervelin, Aino I.; Arumugam, Manimozhiyan; Bork, Peer] European Mol Biol Lab, Heidelberg, Germany; [Chan, Michelle M.] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Raes, Jeroen] Vrije Univ Brussel VIB, B-1050 Brussels, Belgium; [Bork, Peer] Max Delbruck Ctr Mol Med, Berlin, Germany	European Molecular Biology Laboratory (EMBL); Massachusetts Institute of Technology (MIT); Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Mende, DR (corresponding author), European Mol Biol Lab, Heidelberg, Germany.	bork@embl.de	Mende, Daniel R/I-3662-2019; Bork, Peer/F-1813-2013; Arumugam, Manimozhiyan/AAJ-2394-2020; raes, jeroen/D-7835-2018; Sunagawa, Shinichi/Q-5950-2019; Arumugam, Manimozhiyan/E-1211-2011	Mende, Daniel R/0000-0001-6831-4557; Bork, Peer/0000-0002-2627-833X; Arumugam, Manimozhiyan/0000-0002-0886-9101; raes, jeroen/0000-0002-1337-041X; Sunagawa, Shinichi/0000-0003-3065-0314; Arumugam, Manimozhiyan/0000-0002-0886-9101	MetaHIT; Natural Sciences and Engineering Research Council of Canada; European Molecular Biology Laboratory	MetaHIT; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); European Molecular Biology Laboratory	This research received funding from MetaHIT, the Natural Sciences and Engineering Research Council of Canada (funding A. S. W.) and European Molecular Biology Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulencia CB, 2006, APPL ENVIRON MICROB, V72, P3291, DOI 10.1128/AEM.72.5.3291-3301.2006; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Arumugam M, 2010, BIOINFORMATICS, V26, P2977, DOI 10.1093/bioinformatics/btq536; Chivian D, 2008, SCIENCE, V322, P275, DOI 10.1126/science.1155495; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Glenn TC, 2011, MOL ECOLOGY; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goll J, 2010, BIOINFORMATICS, V26, P2631, DOI 10.1093/bioinformatics/btq455; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Harrington ED, 2007, P NATL ACAD SCI USA, V104, P13913, DOI 10.1073/pnas.0702636104; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pignatelli M, 2011, PLOS ONE, V6, pe19984; Pop M, 2004, GENOME RES, V14, P149; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; R Development Core Team, 2011, R LAND ENV STAT COMP; Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935; Raes J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.6; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schoenfeld T, 2008, APPL ENVIRON MICROB, V74, P4164, DOI 10.1128/AEM.02598-07; Singh AH, 2009, J BACTERIOL, V191, P32, DOI 10.1128/JB.01084-08; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Wu D, 2011, PLOS ONE, V6, pe18011; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	50	148	154	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31386	10.1371/journal.pone.0031386	http://dx.doi.org/10.1371/journal.pone.0031386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384016	Green Accepted, Green Published, gold			2022-12-27	WOS:000302916100020
J	Pasiakos, SM; Karl, JP; Lutz, LJ; Murphy, NE; Margolis, LM; Rood, JC; Cable, SJ; Williams, KW; Young, AJ; McClung, JP				Pasiakos, Stefan M.; Karl, J. Philip; Lutz, Laura J.; Murphy, Nancy E.; Margolis, Lee M.; Rood, Jennifer C.; Cable, Sonya J.; Williams, Kelly W.; Young, Andrew J.; McClung, James P.			Cardiometabolic Risk in US Army Recruits and the Effects of Basic Combat Training	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PLACEBO-CONTROLLED TRIAL; PREDICTING BODY DENSITY; INTIMA-MEDIA THICKNESS; CARDIOVASCULAR RISK; UNITED-STATES; PHYSICAL-ACTIVITY; NATIONAL-HEALTH; BLOOD-LIPIDS; YOUNG-ADULTS	Background: Cardiometabolic disease risk in US military recruits and the effects of military training have not been determined. This study examined lifestyle factors and biomarkers associated with cardiometabolic risk in US Army recruits (209; 118 male, 91 female, 23 +/- 5 yr) before, during, and after basic combat training (BCT). Methodology/Principal Findings: Anthropometrics; fasting total (TC), high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol; triglycerides (TG); glucose; and insulin were measured at baseline and every 3 wks during the 10 wk BCT course. At baseline, 14% of recruits were obese (BMI>30 kg/m(2)), 27% were cigarette smokers, 37% were sedentary, and 34% reported a family history of cardiometabolic disease. TC was above recommended levels in 8%, LDL in 39%, TG in 5%, and glucose in 8% of recruits, and HDL was below recommended levels in 33% of recruits at baseline. By week 9, TC decreased 8%, LDL 10%, TG 13%, glucose 6% and homeostasis model assessment of insulin resistance (HOMA-IR) 40% in men (P<0.05). In women, TC, LDL, glucose and HOMA-IR were decreased from baseline at weeks 3 and 6 (P<0.05), but were not different from baseline levels at week 9. During BCT, body weight declined in men but not women, while body fat percentage declined in both men and women (P<0.05). Conclusions/Significance: At the start of military service, the prevalence of cardiometabolic risk in US military recruits is comparable to that reported in similar, college-aged populations. Military training appears to be an effective strategy that may mitigate risk in young people through improvements in lipid profiles and glycemic control.	[Pasiakos, Stefan M.; Karl, J. Philip; Lutz, Laura J.; Murphy, Nancy E.; Margolis, Lee M.; Young, Andrew J.; McClung, James P.] USA, Environm Med Res Inst, Mil Nutr Div, Natick, MA 01760 USA; [Rood, Jennifer C.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Cable, Sonya J.; Williams, Kelly W.] Directorate Basic Combat Training, Ft Jackson, SC USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Pasiakos, SM (corresponding author), USA, Environm Med Res Inst, Mil Nutr Div, Natick, MA 01760 USA.	james.mcclung@amedd.army.mil	Pasiakos, Stefan M/E-6295-2014; Rood, Jennifer/N-1989-2017; McClung, James P/A-1989-2009	Pasiakos, Stefan M/0000-0002-5378-5820; Rood, Jennifer/0000-0001-5848-2987; Karl, J. Philip/0000-0002-5871-2241; , Lee/0000-0002-0652-1304; Margolis, Lee/0000-0003-1697-825X	United States Army Medical Research and Materiel Command	United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was funded by the United States Army Medical Research and Materiel Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2006, ACSMS GUIDELINES EXE, P55; Benjamin RM, 2011, PUBLIC HEALTH REP, V126, P310, DOI 10.1177/003335491112600302; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; BLOCK G, 1990, J CLIN EPIDEMIOL, V43, P1327, DOI 10.1016/0895-4356(90)90099-B; Bray RM, 2009, 2008 DEP DEFENSE SUR; Burke JD, 2009, J AM DIET ASSOC, V109, P1751, DOI 10.1016/j.jada.2009.07.005; Carroll MD, 2011, AM J CARDIOL, V107, P1868, DOI 10.1016/j.amjcard.2011.03.047; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; Department of the Army, 2006, 6009 AR DEP ARM, V600, P9; Department of the Army, 2007, 40501 AR DEP ARM, P40; Department of the Army, 2001, 4025 AR DEP ARM, P40; Department of the Army, 2005, 3022 AR DEP ARM, P30; Dugas LR, 2011, OBESITY, V19, P2099, DOI 10.1038/oby.2011.52; Durstine JL, 2001, SPORTS MED, V31, P1033, DOI 10.2165/00007256-200131150-00002; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2006, CURR OPIN CARDIOL, V21, P1, DOI 10.1097/01.hco.0000200416.65370.a0; Halbert JA, 1999, EUR J CLIN NUTR, V53, P514, DOI 10.1038/sj.ejcn.1600784; Harris JR, 2011, J OCCUP ENVIRON MED, V53, P132, DOI 10.1097/JOM.0b013e3182045f2c; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Heyward VH, 1996, SPORTS MED, V22, P146, DOI 10.2165/00007256-199622030-00002; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175; Karl JP, 2010, AM J CLIN NUTR, V92, P93, DOI 10.3945/ajcn.2010.29185; Keenan Nora L., 2011, Morbidity and Mortality Weekly Report, V60, P62; Knapik JJ, 2007, INT J SPORTS MED, V28, P106, DOI 10.1055/s-2006-924147; Knapik JJ, 2006, SPORTS MED, V36, P613, DOI 10.2165/00007256-200636070-00005; Kuklina EV, 2010, ANN FAM MED, V8, P327, DOI 10.1370/afm.1137; Leon AS, 2001, MED SCI SPORT EXER, V33, pS502, DOI 10.1097/00005768-200106001-00021; Li CY, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-46; Liao Youlian, 2011, Morbidity and Mortality Weekly Report, V60, P1; Luke A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-387; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McClung JP, 2009, AM J CLIN NUTR, V90, P124, DOI 10.3945/ajcn.2009.27774; McCracken Melissa, 2007, Prev Chronic Dis, V4, pA25; McGill HC, 2000, CIRCULATION, V102, P374; McGraw LK, 2008, J CARDIOVASC NURS, V23, P338, DOI 10.1097/01.JCN.0000317437.75081.e7; McMahan CA, 2005, ARCH INTERN MED, V165, P883, DOI 10.1001/archinte.165.8.883; Okosun IS, 2010, J CLIN HYPERTENS, V12, P636, DOI 10.1111/j.1751-7176.2010.00338.x; Oren A, 2003, ARCH INTERN MED, V163, P1787, DOI 10.1001/archinte.163.15.1787; Paeratakul S, 2002, INT J OBESITY, V26, P1205, DOI 10.1038/sj.ijo.0802026; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Rodriguez NR, 2009, MED SCI SPORT EXER, V41, P709, DOI 10.1249/MSS.0b013e31890eb86; Sacheck JM, 2010, MED SCI SPORT EXER, V42, P1039, DOI 10.1249/MSS.0b013e3181c9216b; Srinivasan SR, 2006, PEDIATRICS, V118, P201, DOI 10.1542/peds.2005-1856; Steinberg D, 2006, J LIPID RES, V47, P1339, DOI 10.1194/jlr.R600009-JLR200; Tambalis K, 2009, ANGIOLOGY, V60, P614, DOI 10.1177/0003319708324927; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; Zhao GX, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-130; Zhao GX, 2011, J AM GERIATR SOC, V59, P132, DOI 10.1111/j.1532-5415.2010.03236.x	52	27	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31222	10.1371/journal.pone.0031222	http://dx.doi.org/10.1371/journal.pone.0031222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384004	gold, Green Submitted, Green Published			2022-12-27	WOS:000302916100016
J	Zhu, R; Yang, YT; Tian, Y; Bai, JY; Zhang, X; Li, XH; Peng, ZH; He, YH; Chen, L; Pan, Q; Fang, DC; Chen, WS; Qian, C; Bian, XW; Wang, RQ				Zhu, Rong; Yang, Yongtao; Tian, Yin; Bai, Jianying; Zhang, Xin; Li, Xiaohuan; Peng, Zhihong; He, Yonghong; Chen, Lei; Pan, Qiong; Fang, Dianchun; Chen, Wensheng; Qian, Chen; Bian, Xiuwu; Wang, Rongquan			Ascl2 Knockdown Results in Tumor Growth Arrest by miRNA-302b-Related Inhibition of Colon Cancer Progenitor Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; INITIATING CELLS; SELF-RENEWAL; HEMATOPOIETIC STEM; SIGNALING PATHWAYS; TUMORIGENICITY; EXPRESSION; MIR-34; P53	Background: Achaete scute-like 2 (Ascl2), a basic helix-loop-helix (bHLH) transcription factor, controls the fate of intestinal stem cells. However, the role of Ascl2 in colon cancer progenitor cells remains unknown. The cell line HT-29 (47.5-95% of CD133(+) population) and LS174T (0.45% of CD133(+) population) were chosen for functional evaluation of Ascl2 in colon cancer progenitor cells after gene knockdown by RNA interference. Methodology/Principal Findings: Immunohistochemistry demonstrated that Ascl2 was significantly increased in colorectal adenocarcinomas. Downregulation of Ascl2 using RNA interference in cultured colonic adenocarcinoma HT-29 and LS174T cells reduced cellular proliferation, colony-forming ability, invasion and migration in vitro, and resulted in the growth arrest of tumor xenografts in vivo. The Ascl2 protein level in CD133(+) HT-29 cells was significantly higher than in CD133(-) HT-29 cells. Ascl2 blockade via shRNA interference in HT-29 cells (shRNA-Ascl2/HT-29 cells) resulted in 26.2% of cells staining CD133(+) compared with 54.7% in control shRNA-Ctr/HT-29 cells. The levels of 'stemness' associated genes, such as CD133, Sox2, Oct4, Lgr5, Bmi1, and C-myc, were significantly decreased in shRNA-Ascl2/HT-29 and shRNA-Ascl2/LS174T cells in vitro as well as in the corresponding tumor xenograft (CD133 was not performed in shRNA-Ascl2/LS174T cells). The shRNA-Ascl2/HT-29 cells had inhibited abilities to form tumorspheres compared with control. The microRNA (miRNAs) microarrays, identified 26 up-regulated miRNAs and 58 down-regulated miRNAs in shRNA-Ascl2/HT-29 cells. Expression levels of let-7b, miRNA-124, miRNA-125b, miRNA-17, miRNA-20a and miRNA-302b, involved in the regulation of 'stemness', were quantified with qPCR, which confirmed their identities. Restoration of miRNA-302b, via its mimic, led to the restoration of shRNA-Ascl2/HT-29 'stemness' characteristics, including tumorsphere formation and 'stemness' associated genes levels, and the recovery of cellular behaviors, including colony-forming ability, invasion and migration in vitro. Conclusions/Significance: Ascl2 may be a potential target for the inhibition of colon cancer progenitor cells, and functions through a miR-302b-related mechanism.	[Zhu, Rong; Yang, Yongtao; Tian, Yin; Bai, Jianying; Zhang, Xin; Li, Xiaohuan; Peng, Zhihong; He, Yonghong; Chen, Lei; Pan, Qiong; Fang, Dianchun; Chen, Wensheng; Wang, Rongquan] Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Chongqing, Peoples R China; [Qian, Chen; Bian, Xiuwu] Third Mil Med Univ, Southwest Hosp, Dept Pathol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Zhu, R (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Chongqing, Peoples R China.	rongquanw@hotmail.com	Bian, Xiu-Wu/D-4736-2017	Bian, Xiu-Wu/0000-0003-4383-0197; Wang, Rongquan/0000-0001-5307-0086	State Foundation for the Natural Sciences of the People's Republic of China [81000154]; Natural Science Foundation of CQ CSTC [2008BA5034]	State Foundation for the Natural Sciences of the People's Republic of China; Natural Science Foundation of CQ CSTC(Natural Science Foundation Project of CQ CSTC)	This work was supported by the State Foundation for the Natural Sciences of the People's Republic of China 81000154 (to Y.Y.) and the Natural Science Foundation Project of CQ CSTC 2008BA5034 (to R.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; de Sousa EMF, 2011, CLIN CANCER RES, V17, P647, DOI 10.1158/1078-0432.CCR-10-1204; Dickstein J, 2010, P NATL ACAD SCI USA, V107, P9783, DOI 10.1073/pnas.1004297107; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Elsaba TMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010714; Gal H, 2008, BIOCHEM BIOPH RES CO, V376, P86, DOI 10.1016/j.bbrc.2008.08.107; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Haraguchi N, 2008, ANN SURG ONCOL, V15, P2927, DOI 10.1245/s10434-008-0074-0; Huang EH, 2008, TRENDS MOL MED, V14, P503, DOI 10.1016/j.molmed.2008.09.005; Ieta K, 2008, ANN SURG ONCOL, V15, P638, DOI 10.1245/s10434-007-9605-3; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Jubb AM, 2006, ONCOGENE, V25, P3445, DOI 10.1038/sj.onc.1209382; Jubb AM, 2010, GUT; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Lee NS, 2008, BIOCHEM BIOPH RES CO, V377, P434, DOI 10.1016/j.bbrc.2008.09.159; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Solozobova V, 2010, EXP CELL RES, V316, P2434, DOI 10.1016/j.yexcr.2010.06.006; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Tabatabai G, 2011, CELL TISSUE RES, V343, P459, DOI 10.1007/s00441-010-1123-0; Takebe N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2876; Tan BT, 2006, LAB INVEST, V86, P1203, DOI 10.1038/labinvest.3700488; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van der Flier LG, 2010, GUT, V59, P1236; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wang J, 2010, DEV CELL, V19, P903, DOI 10.1016/j.devcel.2010.10.022; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	36	59	71	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32170	10.1371/journal.pone.0032170	http://dx.doi.org/10.1371/journal.pone.0032170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384170	Green Submitted, Green Published, gold			2022-12-27	WOS:000302916100056
J	Cesqui, B; d'Avella, A; Portone, A; Lacquaniti, F				Cesqui, Benedetta; d'Avella, Andrea; Portone, Alessandro; Lacquaniti, Francesco			Catching a Ball at the Right Time and Place: Individual Factors Matter	PLOS ONE			English	Article							HITTING MOVING-OBJECTS; ARM MOVEMENTS; MANUAL INTERCEPTION; ONLINE CONTROL; COORDINATION; TARGETS; MODEL; SPEED; INFORMATION; HAND	Intercepting a moving object requires accurate spatio-temporal control. Several studies have investigated how the CNS copes with such a challenging task, focusing on the nature of the information used to extract target motion parameters and on the identification of general control strategies. In the present study we provide evidence that the right time and place of the collision is not univocally specified by the CNS for a given target motion; instead, different but equally successful solutions can be adopted by different subjects when task constraints are loose. We characterized arm kinematics of fourteen subjects and performed a detailed analysis on a subset of six subjects who showed comparable success rates when asked to catch a flying ball in three dimensional space. Balls were projected by an actuated launching apparatus in order to obtain different arrival flight time and height conditions. Inter-individual variability was observed in several kinematic parameters, such as wrist trajectory, wrist velocity profile, timing and spatial distribution of the impact point, upper limb posture, trunk motion, and submovement decomposition. Individual idiosyncratic behaviors were consistent across different ball flight time conditions and across two experimental sessions carried out at one year distance. These results highlight the importance of a systematic characterization of individual factors in the study of interceptive tasks.	[Cesqui, Benedetta; d'Avella, Andrea; Portone, Alessandro; Lacquaniti, Francesco] IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy; [Portone, Alessandro; Lacquaniti, Francesco] Univ Roma Tor Vergata, Dept Syst Med, Neurosci Sect, Rome, Italy; [Lacquaniti, Francesco] Univ Roma Tor Vergata, Ctr Space Biomed, Rome, Italy	IRCCS Santa Lucia; University of Rome Tor Vergata; University of Rome Tor Vergata	Cesqui, B (corresponding author), IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy.	davella@hsantalucia.it	d'Avella, Andrea/K-6856-2018; Lacquaniti, Francesco/J-9842-2016	d'Avella, Andrea/0000-0002-3393-4956; Lacquaniti, Francesco/0000-0003-0896-7315	European Union [248311]; Italian Ministry of Health; Italian University Ministry; Italian Space Agency	European Union(European Commission); Italian Ministry of Health(Ministry of Health, Italy); Italian University Ministry(Ministry of Education, Universities and Research (MIUR)); Italian Space Agency(Agenzia Spaziale Italiana (ASI))	Research was supported by grants from the European Union FP7-ICT program (Adaptive Modular Architectures for Rich Motor skills, AMARSI, Grant 248311), the Italian Ministry of Health, the Italian University Ministry (PRIN project), and Italian Space Agency (CRUSOE grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JA, 1987, PSYCHOL BULL, V101, P41, DOI 10.1037/0033-2909.101.1.41; ATKESON CG, 1985, J NEUROSCI, V5, P2318; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bartletti R, 2007, SPORT BIOMECH, V6, P224, DOI 10.1080/14763140701322994; Beek PJ, 2003, PHILOS T R SOC B, V358, P1511, DOI 10.1098/rstb.2003.1343; Bernstein N, 1967, COORDINATION REGULAT; Berret B, 2011, J NEUROPHYSIOL; Bianchi L, 1998, PFLUG ARCH EUR J PHY, V436, P343, DOI 10.1007/s004240050642; Brenner E, 2005, HUMAN VISION ELECT I; Brouwer AM, 2000, EXP BRAIN RES, V133, P242, DOI 10.1007/s002210000371; Brouwer AM, 2006, VISION RES, V46, P382, DOI 10.1016/j.visres.2005.09.002; Brouwer AM, 2003, EXP BRAIN RES, V152, P368, DOI 10.1007/s00221-003-1556-8; Brouwer AM, 2002, EXP BRAIN RES, V143, P198, DOI 10.1007/s00221-001-0980-x; BULLOCK D, 1988, PSYCHOL REV, V95, P49, DOI 10.1037/0033-295X.95.1.49; Button C, 2002, ACTA PSYCHOL, V109, P75, DOI 10.1016/S0001-6918(01)00052-X; CHAPMAN S, 1968, AM J PHYS, V36, P868, DOI 10.1119/1.1974297; d'Avella A, 2011, J NEUROSCI METH, V196, P264, DOI 10.1016/j.jneumeth.2011.01.013; de Lussanet MHE, 2004, EXP BRAIN RES, V157, P181, DOI 10.1007/s00221-004-1832-2; Dessing JC, 2002, NEURAL NETWORKS, V15, P163, DOI 10.1016/S0893-6080(01)00136-8; Faisal AA, 2009, J NEUROPHYSIOL, V101, P1901, DOI 10.1152/jn.90974.2008; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Ganesh G, 2010, J NEUROPHYSIOL, V104, P382, DOI 10.1152/jn.01058.2009; Gray R, 2005, J EXP PSYCHOL HUMAN, V31, P1004, DOI 10.1037/0096-1523.31.5.1004; Hoffman L, 2007, BEHAV RES METHODS, V39, P101, DOI 10.3758/BF03192848; KELSO JAS, 1991, EXP BRAIN RES, V85, P432; LACQUANITI F, 1994, J NEUROPHYSIOL, V72, P1496, DOI 10.1152/jn.1994.72.4.1496; LACQUANITI F, 1993, J NEUROPHYSIOL, V69, P1443, DOI 10.1152/jn.1993.69.5.1443; LACQUANITI F, 1986, NEUROSCIENCE, V17, P313, DOI 10.1016/0306-4522(86)90249-6; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; LAURENT M, 1994, EXP BRAIN RES, V101, P314, DOI 10.1007/BF00228752; Lee D, 1997, EXP BRAIN RES, V116, P421, DOI 10.1007/PL00005770; LEE DN, 1983, Q J EXP PSYCHOL-A, V35, P333, DOI 10.1080/14640748308402138; Liu CK, 2005, LEARNING PHYS BASED; Liu D, 2007, J NEUROSCI, V27, P9354, DOI 10.1523/JNEUROSCI.1110-06.2007; Locker L, 2007, BEHAV RES METHODS, V39, P723, DOI 10.3758/BF03192962; Mazyn LIN, 2007, J MOTOR BEHAV, V39, P491, DOI 10.3200/JMBR.39.6.491-502; Mazyn LIN, 2007, ACTA PSYCHOL, V126, P59, DOI 10.1016/j.actpsy.2006.10.001; Mazyn LIN, 2006, MOTOR CONTROL, V10, P143, DOI 10.1123/mcj.10.2.143; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; MCLEOD P, 1993, NATURE, V362, P23, DOI 10.1038/362023a0; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Mrotek LA, 2007, J NEUROSCI, V27, P7297, DOI 10.1523/JNEUROSCI.2046-07.2007; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; PEPER L, 1994, J EXP PSYCHOL HUMAN, V20, P591, DOI 10.1037/0096-1523.20.3.591; Port NL, 1997, EXP BRAIN RES, V116, P406, DOI 10.1007/PL00005769; REGAN D, 1979, VISION RES, V19, P1331, DOI 10.1016/0042-6989(79)90205-0; Rohrer B, 2006, BIOL CYBERN, V94, P409, DOI 10.1007/s00422-006-0055-y; Rohrer B, 2004, MOTOR CONTROL, V8, P472, DOI 10.1123/mcj.8.4.472; Savelsbergh G, 2002, INTERCEPTIVE ACTION; SAVELSBERGH GJP, 1992, EXP BRAIN RES, V89, P223; SAVELSBERGH GJP, 1991, J EXP PSYCHOL HUMAN, V17, P315, DOI 10.1037/0096-1523.17.2.315; Saville BR, 2009, BIOMETRICS, V65, P369, DOI 10.1111/j.1541-0420.2008.01107.x; Scholz JP, 2000, EXP BRAIN RES, V135, P382, DOI 10.1007/s002210000540; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; SMEETS JBJ, 1995, BIOL CYBERN, V73, P519, DOI 10.1007/BF00199544; STRAM DO, 1994, BIOMETRICS, V50, P1171, DOI 10.2307/2533455; Tijtgat P, 2010, EXP BRAIN RES, V201, P875, DOI 10.1007/s00221-009-2102-0; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tresilian JR, 2009, BRAIN RES, V1250, P202, DOI 10.1016/j.brainres.2008.11.001; Tresilian JR, 1999, PERCEPT PSYCHOPHYS, V61, P515, DOI 10.3758/BF03211970; Tresilian JR, 2005, PERCEPT PSYCHOPHYS, V67, P129, DOI 10.3758/BF03195017; Tresilian JR, 2002, EXP BRAIN RES, V142, P193, DOI 10.1007/s00221-001-0920-9; Trommershauser J, 2005, J NEUROSCI, V25, P7169, DOI 10.1523/JNEUROSCI.1906-05.2005; Vuillerme N, 2001, NEUROSCI LETT, V311, P73, DOI 10.1016/S0304-3940(01)02147-4; Vuillerme N, 2001, NEUROSCI LETT, V303, P83, DOI 10.1016/S0304-3940(01)01722-0; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672; Zago M, 2005, J NEUROPHYSIOL, V93, P1055, DOI 10.1152/jn.00833.2004; Zago M, 2008, VISION RES, V48, P1532, DOI 10.1016/j.visres.2008.04.005; Zago M, 2009, EXP BRAIN RES, V192, P571, DOI 10.1007/s00221-008-1691-3	70	44	44	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31770	10.1371/journal.pone.0031770	http://dx.doi.org/10.1371/journal.pone.0031770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384072	Green Submitted, Green Published, gold			2022-12-27	WOS:000302875500040
J	Falivene, J; Zajac, MPD; Pascutti, MF; Rodriguez, AM; Maeto, C; Perdiguero, B; Gomez, CE; Esteban, M; Calamante, G; Gherardi, MM				Falivene, Juliana; Del Medico Zajac, Maria Paula; Pascutti, Maria Fernanda; Maria Rodriguez, Ana; Maeto, Cynthia; Perdiguero, Beatriz; Gomez, Carmen E.; Esteban, Mariano; Calamante, Gabriela; Magdalena Gherardi, Maria			Improving the MVA Vaccine Potential by Deleting the Viral Gene Coding for the IL-18 Binding Protein	PLOS ONE			English	Article							VIRUS ANKARA MVA; IFN-GAMMA PRODUCTION; T-CELL DETERMINANTS; ATTENUATED MVA; SMALLPOX VACCINE; STRAIN MVA; IMMUNOGENICITY; INFECTION; RECEPTOR; MEMORY	Background: Modified Vaccinia Ankara (MVA) is an attenuated strain of Vaccinia virus (VACV) currently employed in many clinical trials against HIV/AIDS and other diseases. MVA still retains genes involved in host immune response evasion, enabling its optimization by removing some of them. The aim of this study was to evaluate cellular immune responses (CIR) induced by an IL-18 binding protein gene (C12L) deleted vector (MVA Delta C12L). Methodology/Principal Findings: BALB/c and C57BL/6 mice were immunized with different doses of MVA Delta C12L or MVA wild type (MVAwt), then CIR to VACV epitopes in immunogenic proteins were evaluated in spleen and draining lymph nodes at acute and memory phases (7 and 40 days post-immunization respectively). Compared with parental MVAwt, MVA Delta C12L immunization induced a significant increase of two to three-fold in CD8(+) and CD4(+) T-cell responses to different VACV epitopes, with increased percentage of anti-VACV cytotoxic CD8(+) T-cells (CD107a/b(+)) during the acute phase of the response. Importantly, the immunogenicity enhancement was also observed after MVA Delta C12L inoculation with different viral doses and by distinct routes (systemic and mucosal). Potentiation of MVA's CIR was also observed during the memory phase, in correlation with a higher protection against an intranasal challenge with VACV WR. Of note, we could also show a significant increase in the CIR against HIV antigens such as Env, Gag, Pol and Nef from different subtypes expressed from two recombinants of MVA Delta C12L during heterologous DNA prime/MVA boost vaccination regimens. Conclusions/Significance: This study demonstrates the relevance of IL-18 bp contribution in the immune response evasion during MVA infection. Our findings clearly show that the deletion of the viral IL-18 bp gene is an effective approach to increase MVA vaccine efficacy, as immunogenicity improvements were observed against vector antigens and more importantly to HIV antigens.	[Falivene, Juliana; Pascutti, Maria Fernanda; Maria Rodriguez, Ana; Maeto, Cynthia; Magdalena Gherardi, Maria] Univ Buenos Aires, Fac Med, Ctr Nacl Referencia SIDA, Buenos Aires, DF, Argentina; [Del Medico Zajac, Maria Paula; Calamante, Gabriela] CICVyA INTA Castelar, Inst Biotecnol, Buenos Aires, DF, Argentina; [Perdiguero, Beatriz; Gomez, Carmen E.; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Dept Biol Mol & Celular, Madrid, Spain	University of Buenos Aires; Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Falivene, J (corresponding author), Univ Buenos Aires, Fac Med, Ctr Nacl Referencia SIDA, Buenos Aires, DF, Argentina.	mgherardi@fmed.uba.ar	Gomez, Carmen Elena/K-1940-2014; Perdiguero, Beatriz/K-6587-2017; Esteban, Mariano/ABG-5375-2020	Gomez, Carmen Elena/0000-0002-5414-7935; Perdiguero, Beatriz/0000-0001-6276-7766; Esteban, Mariano/0000-0003-0846-2827; Pascutti, Maria Fernanda/0000-0003-3212-780X; Falivene, Juliana/0000-0003-3437-4863	Argentinean Agency for the Promotion of Science and Technology (ANPCYT) [2008-0459]; AECID-PCI of Spain [A/031560/10]; AERG (Area Estrategica de Regursos Geneticos) from National Institute of Agricultural Technology (INTA), Argentina [232152]; Argentinean National Research Council (CONICET)	Argentinean Agency for the Promotion of Science and Technology (ANPCYT)(ANPCyT); AECID-PCI of Spain; AERG (Area Estrategica de Regursos Geneticos) from National Institute of Agricultural Technology (INTA), Argentina; Argentinean National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research has been funded by the Argentinean Agency for the Promotion of Science and Technology (ANPCYT, Grant No 2008-0459), the AECID-PCI of Spain (Grant No A/031560/10) and Grant AERG (Area Estrategica de Regursos Geneticos) No 232152 from National Institute of Agricultural Technology (INTA), Argentina. Juliana Falivene and Cynthia Maeto were supported by the Argentinean National Research Council (CONICET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008159; ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; Alejo A, 2006, P NATL ACAD SCI USA, V103, P5995, DOI 10.1073/pnas.0510462103; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Badovinac VP, 2006, IMMUNOL REV, V211, P67, DOI 10.1111/j.0105-2896.2006.00384.x; Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Blanchard TJ, 1998, J GEN VIROL, V79, P1159, DOI 10.1099/0022-1317-79-5-1159; Born TL, 2000, J IMMUNOL, V164, P3246, DOI 10.4049/jimmunol.164.6.3246; Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845; Clark RH, 2006, J GEN VIROL, V87, P29, DOI 10.1099/vir.0.81417-0; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Cox MA, TRENDS IMMUNOL, V32, P180; Dai KF, 2008, VACCINE, V26, P5062, DOI 10.1016/j.vaccine.2008.06.011; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Earl PL, 1998, CURRENT PROTOCOLS MO; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Ferrer M. F., 2007, Rev. argent. microbiol., V39, P138; Ferrer MF, VIRAL IMMUNOL, V24, P331; Garcia-Arriaza J, PLOS ONE, V5; Garcia-Arriaza J, PLOS ONE, V6, pe24244; Gherardi MM, 2005, J GEN VIROL, V86, P2925, DOI 10.1099/vir.0.81181-0; Gherardi MM, 2004, J IMMUNOL, V172, P6209, DOI 10.4049/jimmunol.172.10.6209; Gherardi MM, 2003, J GEN VIROL, V84, P1961, DOI 10.1099/vir.0.19120-0; Gherardi MM, 1999, J IMMUNOL, V162, P6724; Gomez CE, 2007, J GEN VIROL, V88, P2473, DOI 10.1099/vir.0.83018-0; Gomez CE, CURR GENE THER, V11, P189; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Hand TW, P NATL ACAD SCI US, V107, P16601; Haring JS, 2009, INFECT IMMUN, V77, P1894, DOI 10.1128/IAI.01315-08; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Iwai Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002404; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Manrique M, 2009, MUCOSAL IMMUNOL, V2, P536, DOI 10.1038/mi.2009.103; MAYR A, 1978, ZBL BAKT MIK HYG B, V167, P375; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Moorthy VS, 2004, PLOS MED, V1, P128, DOI 10.1371/journal.pmed.0010033; Moutaftsi M, 2007, J IMMUNOL, V178, P6814, DOI 10.4049/jimmunol.178.11.6814; Mwau M, 2004, J GEN VIROL, V85, P911, DOI 10.1099/vir.0.19701-0; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; Reading PC, 2003, J VIROL, V77, P9960, DOI 10.1128/JVI.77.18.9960-9968.2003; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rodriguez AM, 2009, VIRUS RES, V146, P1, DOI 10.1016/j.virusres.2009.08.004; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Saubi N, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/516219; Smith CL, 2005, INT J CANCER, V113, P259, DOI 10.1002/ijc.20569; Smith VP, 2000, J GEN VIROL, V81, P1223, DOI 10.1099/0022-1317-81-5-1223; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Staib C, 2005, J GEN VIROL, V86, P1997, DOI 10.1099/vir.0.80646-0; STICKL H, 1974, DEUT MED WOCHENSCHR, V99, P2386, DOI 10.1055/s-0028-1108143; SUTTER G, 1992, P NATL ACAD SCI USA, V89, P10847, DOI 10.1073/pnas.89.22.10847; Symons JA, 2002, J GEN VIROL, V83, P2833, DOI 10.1099/0022-1317-83-11-2833; Tscharke DC, 2006, J VIROL, V80, P6318, DOI 10.1128/JVI.00427-06; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Wilck MB, J INFECT DIS, V201, P1361; Yoshimoto T, 1998, J IMMUNOL, V161, P3400	60	46	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32220	10.1371/journal.pone.0032220	http://dx.doi.org/10.1371/journal.pone.0032220			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384183	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500087
J	Jachowski, DS; Slotow, R; Millspaugh, JJ				Jachowski, David S.; Slotow, Rob; Millspaugh, Joshua J.			Physiological Stress and Refuge Behavior by African Elephants	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; SEXUAL SEGREGATION; HABITAT SELECTION; GAME RESERVE; CONSERVATION; CORTICOSTERONE; POPULATION; HETEROGENEITY; MOVEMENTS; DOMINANCE	Physiological stress responses allow individuals to adapt to changes in their status or surroundings, but chronic exposure to stressors could have detrimental effects. Increased stress hormone secretion leads to short-term escape behavior; however, no studies have assessed the potential of longer-term escape behavior, when individuals are in a chronic physiological state. Such refuge behavior is likely to take two forms, where an individual or population restricts its space use patterns spatially (spatial refuge hypothesis), or alters its use of space temporally (temporal refuge hypothesis). We tested the spatial and temporal refuge hypotheses by comparing space use patterns among three African elephant populations maintaining different fecal glucocorticoid metabolite (FGM) concentrations. In support of the spatial refuge hypothesis, the elephant population that maintained elevated FGM concentrations (iSimangaliso) used 20% less of its reserve than did an elephant population with lower FGM concentrations (Pilanesberg) in a reserve of similar size, and 43% less than elephants in the smaller Phinda reserve. We found mixed support for the temporal refuge hypothesis; home range sizes in the iSimangaliso population did not differ by day compared to nighttime, but elephants used areas within their home ranges differently between day and night. Elephants in all three reserves generally selected forest and woodland habitats over grasslands, but elephants in iSimangaliso selected exotic forest plantations over native habitat types. Our findings suggest that chronic stress is associated with restricted space use and altered habitat preferences that resemble a facultative refuge behavioral response. Elephants can maintain elevated FGM levels for >= 6 years following translocation, during which they exhibit refuge behavior that is likely a result of human disturbance and habitat conditions. Wildlife managers planning to translocate animals, or to initiate other management activities that could result in chronic stress responses, should consider the potential for, and consequences of, refuge behavior.	[Jachowski, David S.; Millspaugh, Joshua J.] Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO 65201 USA; [Slotow, Rob] Univ KwaZulu Natal, Sch Life Sci, Amarula Elephant Res Programme, Durban, South Africa	University of Missouri System; University of Missouri Columbia; University of Kwazulu Natal	Jachowski, DS (corresponding author), Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO 65201 USA.	djachowski@gmail.com	Slotow, Rob/AAM-9053-2020	Slotow, Rob/0000-0001-9469-1508	University of Missouri; University of KwaZulu-Natal and Amarula (Distell (PTY) Ltd); Wildlands Conservation Trust; U.S. Fish & Game African Elephant Conservation Fund [98210-2-G419]; National Research Foundation [2053623, FA2006032300024]	University of Missouri; University of KwaZulu-Natal and Amarula (Distell (PTY) Ltd); Wildlands Conservation Trust; U.S. Fish & Game African Elephant Conservation Fund; National Research Foundation	Funding for this research was provided by the University of Missouri, the University of KwaZulu-Natal and Amarula (Distell (PTY) Ltd), Wildlands Conservation Trust, U.S. Fish & Game African Elephant Conservation Fund (98210-2-G419), and National Research Foundation (2053623 and FA2006032300024). D.S. Jachowski was supported by the Brown Fellowship of the University of Missouri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Ahlering MA, 2010, ANIMAL CONSERVATION, V14, P124; Archie EA, 2006, ANIM BEHAV, V71, P117, DOI 10.1016/j.anbehav.2005.03.023; ASTHEIMER LB, 1992, ORNIS SCAND, V23, P355, DOI 10.2307/3676661; Barg JJ, 2005, J ANIM ECOL, V74, P139, DOI 10.1111/j.1365-2656.2004.00906.x; Bingham RL, 2004, J WILDLIFE MANAGE, V68, P206, DOI 10.2193/0022-541X(2004)068[0206:COTIER]2.0.CO;2; Bradshaw GA, 2007, ETHOLOGY, V113, P426, DOI 10.1111/j.1439-0310.2007.01333.x; Bradshaw GA, 2005, NATURE, V433, P807, DOI 10.1038/433807a; Breuner CW, 2003, HORM BEHAV, V43, P115, DOI 10.1016/S0018-506X(02)00020-X; Breuner CW, 1998, GEN COMP ENDOCR, V111, P386, DOI 10.1006/gcen.1998.7128; Brockett BH, 1993, WOODY VEGETATION STA; Burke T, 2005, THESIS U KWAZULU NAT; Burke T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002417; Codron J, 2006, J MAMMAL, V87, P27, DOI 10.1644/05-MAMM-A-017R1.1; de Knegt HJ, 2011, J ANIM ECOL, V80, P270, DOI 10.1111/j.1365-2656.2010.01764.x; Dickens MJ, 2010, BIOL CONSERV, V143, P1329, DOI 10.1016/j.biocon.2010.02.032; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Druce HC, 2008, BIOL CONSERV, V141, P3127, DOI 10.1016/j.biocon.2008.09.024; Elliott JM, 2000, J FISH BIOL, V56, P938, DOI 10.1111/j.1095-8649.2000.tb00883.x; Foley CAH, 2001, CONSERV BIOL, V15, P1134, DOI 10.1046/j.1523-1739.2001.0150041134.x; Garai Marion E., 2004, Pachyderm, V37, P28; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; Graham MD, 2009, ANIM CONSERV, V12, P445, DOI 10.1111/j.1469-1795.2009.00272.x; Grant C.C., 2008, P329; Grobler Douw G., 2008, P241; Hart BL, 2008, NEUROSCI BIOBEHAV R, V32, P86, DOI 10.1016/j.neubiorev.2007.05.012; Hayward MW, 2009, BIOL CONSERV, V142, P1, DOI 10.1016/j.biocon.2008.09.022; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; Hoare RE, 1999, CONSERV BIOL, V13, P633, DOI 10.1046/j.1523-1739.1999.98035.x; Kauffman MJ, 2007, ECOL LETT, V10, P690, DOI 10.1111/j.1461-0248.2007.01059.x; Kerley GIH, 2008, ELEPHANT MANAGEMENT, P84; LAWS RM, 1970, OIKOS, V21, P1, DOI 10.2307/3543832; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; Low AB, 1996, VEGETATION S AFRICAN; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Millspaugh JJ, 2000, J WILDLIFE MANAGE, V64, P994, DOI 10.2307/3803209; Millspaugh JJ, 2003, WILDLIFE SOC B, V31, P399; Millspaugh JJ, 2007, J WILDLIFE MANAGE, V71, P1257, DOI 10.2193/2006-015; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; Millspaugh JSJ, 2004, WILDLIFE SOC B, V32, P148, DOI 10.2193/0091-7648(2004)32[148:COTATT]2.0.CO;2; Mutinda Hamisi, 2011, P246; Ngene SM, 2010, AFR J ECOL, V48, P386, DOI 10.1111/j.1365-2028.2009.01125.x; Owen-Smith N.R., 1988, MEGAHERBIVORES INFLU; Poole Joyce H., 2011, P109; Pretorius Y, 2004, THESIS U NATAL DURBA; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Romero LM, 2007, INT J COMP PSYCHOL, V20, P85; Seidel K., 1992, STAT PROPERTIES APPL; Shannon G, 2008, J MAMMAL, V89, P467, DOI 10.1644/07-MAMM-A-132R.1; Shannon G, 2006, AFR ZOOL, V41, P37, DOI 10.3377/1562-7020(2006)41[37:AEHRAH]2.0.CO;2; Shannon G, 2010, AUSTRAL ECOL, V35, P731, DOI 10.1111/j.1442-9993.2009.02080.x; Skarpe C, 2004, AMBIO, V33, P276, DOI 10.1639/0044-7447(2004)033[0276:TROTGE]2.0.CO;2; Slotow R, 2000, NATURE, V408, P425, DOI 10.1038/35044191; Slotow R, 2005, S AFR J WILDL RES, V35, P23; Slotow R, 2012, FENCING FOR CONSERVATION: RESTRICTION OF EVOLUTIONARY POTENTIAL OR A RIPOSTE TO THREATENING PROCESSES?, P91, DOI 10.1007/978-1-4614-0902-1_6; Smit IPJ, 2007, DIVERS DISTRIB, V13, P225, DOI 10.1111/j.1472-4642.2007.00318.x; Smith RK, 2004, J APPL ECOL, V41, P1092, DOI 10.1111/j.0021-8901.2004.00976.x; Teixeira CP, 2007, ANIM BEHAV, V73, P1, DOI 10.1016/j.anbehav.2006.06.002; Theuerkauf J, 2003, J WILDLIFE MANAGE, V67, P706, DOI 10.2307/3802677; Twine Wayne, 2008, P206; Ultsch GR, 2006, BIOL REV, V81, P339, DOI 10.1017/S1464793106007032; van Winkle W, 1975, J WILDLIFE MANAGE, V54, P322; Vanak AT, 2010, BIOL CONSERV, V143, P2631, DOI 10.1016/j.biocon.2010.07.005; Viijoen JJ, 2008, S AFR J WILDL RES, V38, P146; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; Wingfield JC, 1997, ARDEA, V85, P155; Wittemyer G, 2007, BEHAV ECOL SOCIOBIOL, V61, P1919, DOI 10.1007/s00265-007-0432-0; Woolley LA, 2009, J WILDLIFE MANAGE, V73, P827, DOI 10.2193/2008-412; Woolley LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003233; Wrege PH, 2010, CONSERV BIOL, V24, P1578, DOI 10.1111/j.1523-1739.2010.01559.x	72	50	50	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31818	10.1371/journal.pone.0031818	http://dx.doi.org/10.1371/journal.pone.0031818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384079	Green Submitted, gold, Green Published			2022-12-27	WOS:000302875500044
J	Shapiro, RL; Souda, S; Parekh, N; Binda, K; Kayembe, M; Lockman, S; Svab, P; Babitseng, O; Powis, K; Jimbo, W; Creek, T; Makhema, J; Essex, M; Roberts, DJ				Shapiro, Roger L.; Souda, Sajini; Parekh, Natasha; Binda, Kelebogile; Kayembe, Mukendi; Lockman, Shahin; Svab, Petr; Babitseng, Orphinah; Powis, Kathleen; Jimbo, William; Creek, Tracy; Makhema, Joseph; Essex, Max; Roberts, Drucilla J.			High Prevalence of Hypertension and Placental Insufficiency, but No In Utero HIV Transmission, among Women on HAART with Stillbirths in Botswana	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; GESTATIONAL HYPERTENSION; INCREASED RISK; PREGNANCY; INFECTION; OUTCOMES; PREECLAMPSIA; DELIVERY	Background: Increased stillbirth rates occur among HIV-infected women, but no studies have evaluated the pathological basis for this increase, or whether highly active antiretroviral therapy (HAART) influences the etiology of stillbirths. It is also unknown whether HIV infection of the fetus is associated with stillbirth. Methods: HIV-infected women and a comparator group of HIV-uninfected women who delivered stillbirths were enrolled at the largest referral hospital in Botswana between January and November 2010. Obstetrical records, including antiretroviral use in pregnancy, were extracted at enrollment. Verbal autopsies; maternal HIV, CD4 and HIV RNA testing; stillbirth HIV PCR testing; and placental pathology (blinded to HIV and treatment status) were performed. Results: Ninety-nine stillbirths were evaluated, including 62 from HIV-infected women (34% on HAART from conception, 8% on HAART started in pregnancy, 23% on zidovudine started in pregnancy, and 35% on no antiretrovirals) and 37 from a comparator group of HIV-uninfected women. Only 2 (3.7%) of 53 tested stillbirths from HIV-infected women were HIV PCR positive, and both were born to women not receiving HAART. Placental insufficiency associated with hypertension accounted for most stillbirths. Placental findings consistent with chronic hypertension were common among HIV-infected women who received HAART and among HIV-uninfected women (65% vs. 54%, p = 0.37), but less common among HIV-infected women not receiving HAART (28%, p = 0.003 vs. women on HAART). Conclusions: In utero HIV infection was rarely associated with stillbirths, and did not occur among women receiving HAART. Hypertension and placental insufficiency were associated with most stillbirths in this tertiary care setting.	[Shapiro, Roger L.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Shapiro, Roger L.; Lockman, Shahin; Powis, Kathleen; Makhema, Joseph; Essex, Max] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Shapiro, Roger L.; Souda, Sajini; Parekh, Natasha; Binda, Kelebogile; Lockman, Shahin; Powis, Kathleen; Makhema, Joseph; Essex, Max] Botswana Harvard Sch Publ Hlth, AIDS Inst Partnership HIV Res & Educ, Boston, MA 02115 USA; [Kayembe, Mukendi] Minist Hlth, Botswana Natl Hlth Lab, Gaborone, Botswana; [Lockman, Shahin] Brigham & Womens Hosp, Infect Dis Unit, Boston, MA 02115 USA; [Svab, Petr; Babitseng, Orphinah] Princess Marina Hosp, Minist Hlth, Gaborone, Botswana; [Powis, Kathleen] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Powis, Kathleen] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Jimbo, William; Creek, Tracy] Ctr Dis Control & Prevent, Atlanta, GA USA; [Roberts, Drucilla J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Centers for Disease Control & Prevention - USA; Harvard University; Massachusetts General Hospital	Shapiro, RL (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA.	rshapiro@hsph.harvard.edu	Roberts, Drucilla/AAB-6379-2022; Powis, Kathleen/AAU-5123-2021		Centers for Disease Control and Prevention [U2GPS000941]; Doris Duke Charitable Research Foundation; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U2GPS000941] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Doris Duke Charitable Research Foundation(Doris Duke Charitable Foundation (DDCF)); National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by a grant from the Centers for Disease Control and Prevention (U2GPS000941), and by a Research Fellowship from the Doris Duke Charitable Research Foundation (N.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalos E, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002252.pub3; BACKE E, 1994, AM J PERINAT, V11, P326, DOI 10.1055/s-2007-994545; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; Buchbinder A, 2002, AM J OBSTET GYNECOL, V186, P66, DOI 10.1067/mob.2002.120080; Cotter AM, 2006, J INFECT DIS, V193, P1195, DOI 10.1086/503045; D'costa Grace Francis, 2007, Indian J Pathol Microbiol, V50, P515; GICHANGI PB, 1993, E AFR MED J, V70, P85; Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8; Hauth JC, 2000, OBSTET GYNECOL, V95, P24, DOI 10.1016/S0029-7844(99)00462-7; Ladner J, 1998, J ACQ IMMUN DEF SYND, V18, P293, DOI 10.1097/00042560-199807010-00015; LANGSTON C, 1995, J INFECT DIS, V172, P1451, DOI 10.1093/infdis/172.6.1451; Leroy V, 1998, AIDS, V12, P643, DOI 10.1097/00002030-199806000-00014; Pinar H, 2010, CLIN OBSTET GYNECOL, V53, P656, DOI 10.1097/GRF.0b013e3181eb68fe; Rollins NC, 2007, JAIDS-J ACQ IMM DEF, V44, P321, DOI 10.1097/QAI.0b013e31802ea4b0; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; STLOUIS ME, 1993, JAMA-J AM MED ASSOC, V269, P2853, DOI 10.1001/jama.269.22.2853; Suy A, 2006, AIDS, V20, P59, DOI 10.1097/01.aids.0000198090.70325.bd; TEMMERMAN M, 1990, AIDS, V4, P1087, DOI 10.1097/00002030-199011000-00006; Townsend CL, 2007, AIDS, V21, P1019, DOI 10.1097/QAD.0b013e328133884b; Tuomala RE, 2002, NEW ENGL J MED, V346, P1863, DOI 10.1056/NEJMoa991159; Tuomala RK, 2005, JAIDS-J ACQ IMM DEF, V38, P449, DOI 10.1097/01.qai.0000139398.38236.4d; Wabwire-Mangen F, 1999, J ACQ IMMUN DEF SYND, V22, P379; Wimalasundera RC, 2002, LANCET, V360, P1152, DOI 10.1016/S0140-6736(02)11195-0	23	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31580	10.1371/journal.pone.0031580	http://dx.doi.org/10.1371/journal.pone.0031580			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384039	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500026
J	Zuercher, E; Butticaz, C; Wyniger, J; Martinez, R; Battegay, M; El Amari, EB; Dang, T; Egger, JF; Fehr, J; Mueller-Garamvogyi, E; Parini, A; Schaefer, SC; Schoeni-Affolter, F; Thurnheer, C; Tinguely, M; Telenti, A; Rothenberger, S				Zuercher, Emilie; Butticaz, Christophe; Wyniger, Josiane; Martinez, Raquel; Battegay, Manuel; El Amari, Emmanuelle Boffi; Thanh Dang; Egger, Jean-Francois; Fehr, Jan; Mueller-Garamvoegyi, Esther; Parini, Andrea; Schaefer, Stephan C.; Schoeni-Affolter, Franziska; Thurnheer, Christine; Tinguely, Marianne; Telenti, Amalio; Rothenberger, Sylvia		Swiss HIV Cohort Study	Genetic Diversity of EBV-Encoded LMP1 in the Swiss HIV Cohort Study and Implication for NF-Kb Activation	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; LATENT MEMBRANE-PROTEIN; KAPPA-B; NASOPHARYNGEAL CARCINOMA; HODGKIN LYMPHOMA; BNLF-1 GENE; WILD-TYPE; SEQUENCE; VARIANTS; MEMBRANE-PROTEIN-1	Epstein-Barr virus (EBV) is associated with several types of cancers including Hodgkin's lymphoma (HL) and nasopharyngeal carcinoma (NPC). EBV-encoded latent membrane protein 1 (LMP1), a multifunctional oncoprotein, is a powerful activator of the transcription factor NF-kappa B, a property that is essential for EBV-transformed lymphoblastoid cell survival. Previous studies reported LMP1 sequence variations and induction of higher NF-kappa B activation levels compared to the prototype B95-8 LMP1 by some variants. Here we used biopsies of EBV-associated cancers and blood of individuals included in the Swiss HIV Cohort Study (SHCS) to analyze LMP1 genetic diversity and impact of sequence variations on LMP1-mediated NF-kappa B activation potential. We found that a number of variants mediate higher NF-kappa B activation levels when compared to B95-8 LMP1 and mapped three single polymorphisms responsible for this phenotype: F106Y, I124V and F144I. F106Y was present in all LMP1 isolated in this study and its effect was variant dependent, suggesting that it was modulated by other polymorphisms. The two polymorphisms I124V and F144I were present in distinct phylogenetic groups and were linked with other specific polymorphisms nearby, I152L and D150A/L151I, respectively. The two sets of polymorphisms, I124V/I152L and F144I/D150A/L151I, which were markers of increased NF-kappa B activation in vitro, were not associated with EBV-associated HL in the SHCS. Taken together these results highlighted the importance of single polymorphisms for the modulation of LMP1 signaling activity and demonstrated that several groups of LMP1 variants, through distinct mutational paths, mediated enhanced NF-kappa B activation levels compared to B95-8 LMP1.	[Zuercher, Emilie; Butticaz, Christophe; Wyniger, Josiane; Martinez, Raquel; Telenti, Amalio; Rothenberger, Sylvia] Univ Lausanne Hosp, Inst Microbiol, Lausanne, Switzerland; [Zuercher, Emilie; Butticaz, Christophe; Wyniger, Josiane; Martinez, Raquel; Thanh Dang; Schaefer, Stephan C.; Schoeni-Affolter, Franziska; Telenti, Amalio; Rothenberger, Sylvia] Univ Lausanne, Lausanne, Switzerland; [Battegay, Manuel] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland; [El Amari, Emmanuelle Boffi] Univ Hosp Geneva, Univ Clin Infect Dis, Geneva, Switzerland; [Thanh Dang] Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland; [Egger, Jean-Francois] Lab Viollier Weintraub SA, Pathol, Geneva, Switzerland; [Fehr, Jan; Tinguely, Marianne] Univ Zurich, Zurich, Switzerland; [Fehr, Jan] Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, CH-8091 Zurich, Switzerland; [Mueller-Garamvoegyi, Esther; Thurnheer, Christine] Univ Bern, Bern, Switzerland; [Mueller-Garamvoegyi, Esther] Univ Hosp Bern, Inst Pathol, CH-3010 Bern, Switzerland; [Parini, Andrea] Osped Regionale, Med Serv, Lugano, Switzerland; [Schaefer, Stephan C.] Univ Lausanne Hosp, Inst Pathol, Lausanne, Switzerland; [Schoeni-Affolter, Franziska] Univ Lausanne Hosp, Swiss HIV Cohort Study Data Ctr, Lausanne, Switzerland; [Thurnheer, Christine] Univ Hosp Bern, Div Infect Dis, CH-3010 Bern, Switzerland; [Tinguely, Marianne] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Basel; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zurich; University of Zurich; University Zurich Hospital; University of Bern; University of Bern; University Hospital of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University Hospital of Bern; University of Zurich; University Zurich Hospital	Zuercher, E (corresponding author), Univ Lausanne Hosp, Inst Microbiol, Lausanne, Switzerland.	sylvia.rothenberger-aubert@chuv.ch	Telenti, Amalio/AAY-1674-2021; Pantaleo, Giuseppe/K-6163-2016; Fehr, Jan S/V-7499-2017; Thurnheer, Christine/CAH-0185-2022	Fehr, Jan S/0000-0003-1113-9895; Thurnheer, Christine/0000-0003-1357-0347; Rothenberger, Sylvia/0000-0001-8633-2994	Foundation VELUX; Fondation Emma Muschamp; Fondation Pierre Mercier pour la Science; University of Lausanne; Swiss HIV Cohort Study; Swiss National Science Foundation [FN 3100A0-120250]	Foundation VELUX(Velux Fonden); Fondation Emma Muschamp; Fondation Pierre Mercier pour la Science; University of Lausanne; Swiss HIV Cohort Study; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Foundation VELUX, the Fondation Emma Muschamp, the Fondation Pierre Mercier pour la Science, the University of Lausanne, the Swiss HIV Cohort Study and the Swiss National Science Foundation (grant FN 3100A0-120250 to Stefan Kunz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAICHWAL VR, 1988, ONCOGENE, V2, P461; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Biggar RJ, 2006, BLOOD, V108, P3786, DOI 10.1182/blood-2006-05-024109; Blake SMS, 2001, VIROLOGY, V282, P278, DOI 10.1006/viro.2001.0828; Cahir-McFarland ED, 2004, J VIROL, V78, P4108, DOI 10.1128/JVI.78.8.4108-4119.2004; Cahir-McFarland ED, 2000, P NATL ACAD SCI USA, V97, P6055, DOI 10.1073/pnas.100119497; Carbone A, 1999, BLOOD, V93, P2319; Carbone A, 2009, BLOOD, V113, P1213, DOI 10.1182/blood-2008-09-180315; Chang CM, 2009, VIRUS RES, V143, P209, DOI 10.1016/j.virusres.2009.07.005; Cheung ST, 1998, INT J CANCER, V76, P399, DOI 10.1002/(SICI)1097-0215(19980504)76:3<399::AID-IJC18>3.0.CO;2-6; Clifford GM, 2009, BLOOD, V113, P5737, DOI 10.1182/blood-2009-02-204172; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Correa RM, 2007, J MED VIROL, V79, P401, DOI 10.1002/jmv.20782; DAWSON CW, 1990, NATURE, V344, P777, DOI 10.1038/344777a0; Dirmeier U, 2003, CANCER RES, V63, P2982; Dolcetti R, 1997, BLOOD, V89, P1723, DOI 10.1182/blood.V89.5.1723.1723_1723_1731; Dolcetti R, 2001, EUR J CANCER, V37, P1276, DOI 10.1016/S0959-8049(01)00105-8; Edwards RH, 2004, J VIROL, V78, P868, DOI 10.1128/JVI.78.2.868-881.2004; Edwards RH, 1999, VIROLOGY, V261, P79, DOI 10.1006/viro.1999.9855; Farrell K, 2011, HISTOPATHOLOGY, V58, P15, DOI 10.1111/j.1365-2559.2010.03705.x; Faumont N, 2001, J GEN VIROL, V82, P1169, DOI 10.1099/0022-1317-82-5-1169; FENNEWALD S, 1984, J VIROL, V51, P411, DOI 10.1128/JVI.51.2.411-419.1984; Fielding CA, 2001, J VIROL, V75, P9129, DOI 10.1128/JVI.75.19.9129-9141.2001; Gasser O, 2007, PLOS MED, V4, P556, DOI 10.1371/journal.pmed.0040096; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HAMMARSKJOLD ML, 1992, J VIROL, V66, P6496; He ZM, 2000, CANCER RES, V60, P1845; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; HU LF, 1991, J GEN VIROL, V72, P2399, DOI 10.1099/0022-1317-72-10-2399; HU LF, 1993, ONCOGENE, V8, P1575; Izumi KM, 1997, P NATL ACAD SCI USA, V94, P1447, DOI 10.1073/pnas.94.4.1447; Jen KY, 2005, VIRUS GENES, V30, P223, DOI 10.1007/s11262-004-5630-5; Johnson RJ, 1998, J VIROL, V72, P4038, DOI 10.1128/JVI.72.5.4038-4048.1998; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; Keller SA, 2006, BLOOD, V107, P3295, DOI 10.1182/blood-2005-07-2730; Kilger E, 1998, EMBO J, V17, P1700, DOI 10.1093/emboj/17.6.1700; KNECHT H, 1995, ONCOGENE, V10, P523; KNECHT H, 1993, BLOOD, V82, P2937; Kuppers Ralf, 2009, Hematology Am Soc Hematol Educ Program, P491, DOI 10.1182/asheducation-2009.1.491; Mainou BA, 2006, J VIROL, V80, P6458, DOI 10.1128/JVI.00135-06; Miller WE, 1998, ONCOGENE, V16, P1869, DOI 10.1038/sj.onc.1201696; MITCHELL T, 1995, J VIROL, V69, P2968, DOI 10.1128/JVI.69.5.2968-2976.1995; Nagamine M, 2007, VIRUS GENES, V34, P47, DOI 10.1007/s11262-006-0008-5; Nguyen-Van D, 2008, VIRUS GENES, V37, P273, DOI 10.1007/s11262-008-0262-9; Nicholls J, 2004, J VIROL METHODS, V116, P79, DOI 10.1016/j.jviromet.2003.10.015; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Rezk SA, 2007, HUM PATHOL, V38, P1293, DOI 10.1016/j.humpath.2007.05.020; Rothenberger S, 2002, CELL MOL LIFE SCI, V59, P171, DOI 10.1007/s00018-002-8413-y; SAMPLE J, 1990, J VIROL, V64, P4084, DOI 10.1128/JVI.64.9.4084-4092.1990; Sandvej K, 1997, BLOOD, V90, P323; Schmitz R, 2009, ANNU REV PATHOL-MECH, V4, P151, DOI 10.1146/annurev.pathol.4.110807.092209; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; Spina M, 2011, ADV HEMATOL; Tang YL, 2008, BRAZ J MED BIOL RES, V41, P110, DOI 10.1590/S0100-879X2008000200006; TELENTI A, 1993, EUR J CLIN MICROBIOL, V12, P601, DOI 10.1007/BF01973638; TIRELLI U, 1995, AIDS, V9, P99; Walling DM, 1999, J INFECT DIS, V179, P763, DOI 10.1086/314672; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556	60	16	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32168	10.1371/journal.pone.0032168	http://dx.doi.org/10.1371/journal.pone.0032168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384168	Green Published, Green Accepted, gold			2022-12-27	WOS:000302875500080
J	Liu, Y; Zhang, YX; Wen, J; Liu, L; Zhai, XJ; Liu, JB; Pan, SD; Chen, JG; Shen, HB; Hu, ZB				Liu, Yao; Zhang, Yixin; Wen, Juan; Liu, Li; Zhai, Xiangjun; Liu, Jibin; Pan, Shandong; Chen, Jianguo; Shen, Hongbing; Hu, Zhibin			A Genetic Variant in the Promoter Region of miR-106b-25 Cluster and Risk of HBV Infection and Hepatocellular Carcinoma	PLOS ONE			English	Article							GASTRIC-CANCER; MICRORNA EXPRESSION; IDENTIFICATION; PROGRESSION; GROWTH; LIVER; SRY	Background: MiR-106b-25 cluster, hosted in intron 13 of MCM7, may play integral roles in diverse processes including immune response and tumorigenesis. A single nucleotide polymorphism (SNP), rs999885, is located in the promoter region of MCM7. Methods: We performed a case-control study including 1300 HBV-positive hepatocellular carcinoma (HCC) cases, 1344 HBV persistent carriers and 1344 subjects with HBV natural clearance to test the association between rs999885 and the risk of HBV persistent infection and HCC. We also investigated the genotype-expression correlation between rs999885 and miR-106b-25 cluster in 25 pairs of HCC and adjacent non-tumor liver tissues. Results: Compared with the HBV natural clearance subjects carrying rs999885 AA genotype, those with AG/GG genotypes had a decreased risk of chronic HBV infection with an adjusted odds ratio (OR) of 0.79 [95% confidence intervals (CIs) = 0.67-0.93]. However, the AG/GG genotypes were significantly associated with an increased HCC risk in HBV persistent carriers (adjusted OR = 1.25, 95% CIs = 1.06-1.47). Expression analysis revealed that the expression level of miR-106b-25 cluster was significantly higher in AG/GG carriers than those in AA carriers in non-tumor liver tissues. Conclusions: These findings indicate that the A to G base change of rs999885 may provide a protective effect against chronic HBV infection but an increased risk for HCC in HBV persistent carriers by altering the expression of the miR-106b-25 cluster.	[Liu, Yao; Wen, Juan; Pan, Shandong; Shen, Hongbing; Hu, Zhibin] Nanjing Med Univ, Sch Publ Hlth, MOE Key Lab Modern Toxicol, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Zhang, Yixin; Liu, Li; Liu, Jibin] Nantong Tumor Hosp, Dept Hepatobiliary Surg, Nantong, Peoples R China; [Zhang, Yixin; Liu, Li; Liu, Jibin] Nanjing Med Univ, Affiliated Hosp 2, Inst Digest Endoscopy, Nanjing, Jiangsu, Peoples R China; [Liu, Li] Nanjing Med Univ, Affiliated Hosp 2, Med Ctr Digest Dis, Nanjing, Jiangsu, Peoples R China; [Zhai, Xiangjun] Jiangsu Prov Ctr Dis Prevent & Control, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China; [Chen, Jianguo] Qidong Liver Canc Res Inst, Qidong, Peoples R China; [Shen, Hongbing; Hu, Zhibin] Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Clin Epidemiol Sect, Nanjing, Jiangsu, Peoples R China; [Shen, Hongbing; Hu, Zhibin] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Liu, Y (corresponding author), Nanjing Med Univ, Sch Publ Hlth, MOE Key Lab Modern Toxicol, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	zhibin_hu@njmu.edu.cn	, 雷克思/ABG-3956-2020	, 雷克思/0000-0003-4102-8934	Priority Academic Program Development of Jiangsu Higher Education Institutions; Foundation for the Author of National Excellent Doctoral Dissertation [201081]; National Natural Science Foundation of China [30800946, 81072344]; Natural Science Foundation Jiangsu Ministry of Health [H200957]; Program for New Century Excellent Talents in University [NCET-10-0178]; National Major ST Projects [2011ZX10004-902]	Priority Academic Program Development of Jiangsu Higher Education Institutions; Foundation for the Author of National Excellent Doctoral Dissertation(Foundation for the Author of National Excellent Doctoral Dissertation of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Jiangsu Ministry of Health; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Major ST Projects	This work was supported in part by Priority Academic Program Development of Jiangsu Higher Education Institutions, Foundation for the Author of National Excellent Doctoral Dissertation (Grants No.: 201081), National Natural Science Foundation of China (Grants No.: 30800946, 81072344), Natural Science Foundation Jiangsu Ministry of Health (Grant No.: H200957), the Program for New Century Excellent Talents in University (NCET-10-0178) and National Major S&T Projects(Grant No.: 2011ZX10004-902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chuang SC, 2009, CANCER LETT, V286, P9, DOI 10.1016/j.canlet.2008.10.040; De Santis G, 2010, J NEUROIMMUNOL, V226, P165, DOI 10.1016/j.jneuroim.2010.06.009; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Gao P, 2011, J HEPATOL, V54, P1177, DOI 10.1016/j.jhep.2010.09.023; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Hu L., 2011, HEPATOLOGY; Hu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016221; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Kan T, 2009, CURR OPIN PHARMACOL, V9, P727, DOI 10.1016/j.coph.2009.08.009; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kuper H, 2000, INT J CANCER, V85, P498, DOI 10.1002/(SICI)1097-0215(20000215)85:4&lt;498::AID-IJC9&gt;3.0.CO;2-F; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JP, 2011, BIOCHEM BIOPH RES CO, V406, P70, DOI 10.1016/j.bbrc.2011.01.111; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Ohe K, 2002, P NATL ACAD SCI USA, V99, P1146, DOI 10.1073/pnas.022645899; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Phillips NB, 2004, BIOCHEMISTRY-US, V43, P7066, DOI 10.1021/bi049920a; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Spierings DC, 2011, BLOOD, V117, P5340, DOI 10.1182/blood-2010-10-316034; Toffanin S, 2011, GASTROENTEROLOGY, V140, P1618, DOI 10.1053/j.gastro.2011.02.009; Zeiner GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008742; Zhu Zhong-zheng, 2003, Zhonghua Gan Zang Bing Za Zhi, V11, P574	30	56	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32230	10.1371/journal.pone.0032230	http://dx.doi.org/10.1371/journal.pone.0032230			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393390	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500043
J	Markowitz, J; Cao, YQ; Grossberg, S				Markowitz, Jeffrey; Cao, Yongqiang; Grossberg, Stephen			From Retinal Waves to Activity-Dependent Retinogeniculate Map Development	PLOS ONE			English	Article							VISUAL-SYSTEM DEVELOPMENT; NICOTINIC ACETYLCHOLINE-RECEPTOR; PRENATAL DEVELOPMENT; MAMMALIAN RETINA; MICE LACKING; CIRCUITS; NETWORK; PATHWAY; MODEL; SEGREGATION	A neural model is described of how spontaneous retinal waves are formed in infant mammals, and how these waves organize activity-dependent development of a topographic map in the lateral geniculate nucleus, with connections from each eye segregated into separate anatomical layers. The model simulates the spontaneous behavior of starburst amacrine cells and retinal ganglion cells during the production of retinal waves during the first few weeks of mammalian postnatal development. It proposes how excitatory and inhibitory mechanisms within individual cells, such as Ca2+-activated K+ channels, and cAMP currents and signaling cascades, can modulate the spatiotemporal dynamics of waves, notably by controlling the after-hyperpolarization currents of starburst amacrine cells. Given the critical role of the geniculate map in the development of visual cortex, these results provide a foundation for analyzing the temporal dynamics whereby the visual cortex itself develops.	[Markowitz, Jeffrey; Cao, Yongqiang; Grossberg, Stephen] Boston Univ, Ctr Adapt Syst, Dept Cognit & Neural Syst, Boston, MA 02215 USA; [Markowitz, Jeffrey; Cao, Yongqiang; Grossberg, Stephen] Boston Univ, Ctr Excellence Learning Educ Sci & Technol, Boston, MA 02215 USA	Boston University; Boston University	Markowitz, J (corresponding author), Boston Univ, Ctr Adapt Syst, Dept Cognit & Neural Syst, 111 Cummington St, Boston, MA 02215 USA.	steve@bu.edu	Markowitz, Jeffrey/GQP-3708-2022		CELEST (Center of Excellence for Learning in Education, Science and Technology); National Science Foundation Science of Learning Center [SBE-0354379]; DARPA (Defense Advanced Research Projects Agency) [HR0011-09-C-397 0001]	CELEST (Center of Excellence for Learning in Education, Science and Technology)(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Science Foundation Science of Learning Center(National Science Foundation (NSF)NSF - Office of the Director (OD)); DARPA (Defense Advanced Research Projects Agency)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported in part by CELEST (Center of Excellence for Learning in Education, Science and Technology), a National Science Foundation Science of Learning Center (SBE-0354379), and by the SyNAPSE program of DARPA (Defense Advanced Research Projects Agency), HR0011-09-C-397 0001). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal A, 2000, J NEUROSCI, V20, P7672; Beggs JM, 2003, J NEUROSCI, V23, P11167; Blankenship AG, 2009, NEURON, V62, P230, DOI 10.1016/j.neuron.2009.03.015; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; BURGI PY, 1994, J NEUROSCI, V14, P7426; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Eglen SJ, 1999, PHILOS T ROY SOC B, V354, P497, DOI 10.1098/rstb.1999.0400; Elliott T, 1999, J NEUROSCI, V19, P7951; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 2002, J NEUROBIOL, V53, P556, DOI 10.1002/neu.10140; Feller MB, 1997, NEURON, V19, P293, DOI 10.1016/S0896-6273(00)80940-X; Firth SI, 2005, CELL CALCIUM, V37, P425, DOI 10.1016/j.ceca.2005.01.010; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Godfrey KB, 2007, PLOS COMPUT BIOL, V3, P2408, DOI 10.1371/journal.pcbi.0030245; Grossberg S, 1999, VISION RES, V39, P1385, DOI 10.1016/S0042-6989(98)00250-8; Grossberg S, 2003, CEREB CORTEX, V13, P852, DOI 10.1093/cercor/13.8.852; Grossberg S, 2001, CEREB CORTEX, V11, P37, DOI 10.1093/cercor/11.1.37; Haith G. L, 1998, MODELING ACTIVITY DE, DOI [10.5555/927417, DOI 10.5555/927417]; Hennig MH, 2009, J NEUROSCI, V29, P1077, DOI 10.1523/JNEUROSCI.4880-08.2009; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2007, CURR OPIN NEUROBIOL, V17, P73, DOI 10.1016/j.conb.2007.01.005; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Mcallister KA, 1996, NEURON, V17, P1057; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; O'Leary DDM, 2005, PROG BRAIN RES, V147, P43, DOI 10.1016/S0079-6123(04)47005-8; RIDDLE DR, 1995, NATURE, V378, P189, DOI 10.1038/378189a0; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Sernagor E, 2000, J NEUROSCI, V20, part. no.; SHATZ CJ, 1983, J NEUROSCI, V3, P482; SRETAVAN DW, 1987, J COMP NEUROL, V255, P386, DOI 10.1002/cne.902550306; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Stafford BK, 2009, NEURON, V64, P200, DOI 10.1016/j.neuron.2009.09.021; Stellwagen D, 1999, NEURON, V24, P673, DOI 10.1016/S0896-6273(00)81121-6; Sun C, 2008, P NATL ACAD SCI USA, V105, P13638, DOI 10.1073/pnas.0807178105; Torborg CL, 2005, PROG NEUROBIOL, V76, P213, DOI 10.1016/j.pneurobio.2005.09.002; UDIN SB, 1988, ANNU REV NEUROSCI, V11, P289, DOI 10.1146/annurev.ne.11.030188.001445; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Zheng JJ, 2006, NAT NEUROSCI, V9, P363, DOI 10.1038/nn1644; Zheng JJ, 2004, NEURON, V44, P851, DOI 10.1016/j.neuron.2004.11.015; Zhou Z J, 2001, Prog Brain Res, V131, P599	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e31553	10.1371/journal.pone.0031553	http://dx.doi.org/10.1371/journal.pone.0031553			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389669	Green Published, Green Submitted, gold			2022-12-27	WOS:000302999600006
J	Marzetti, E; Lees, HA; Manini, TM; Buford, TW; Aranda, JM; Calvani, R; Capuani, G; Marsiske, M; Lott, DJ; Vandenborne, K; Bernabei, R; Pahor, M; Leeuwenburgh, C; Wohlgemuth, SE				Marzetti, Emanuele; Lees, Hazel A.; Manini, Todd M.; Buford, Thomas W.; Aranda, Juan M., Jr.; Calvani, Riccardo; Capuani, Giorgio; Marsiske, Michael; Lott, Donovan J.; Vandenborne, Krista; Bernabei, Roberto; Pahor, Marco; Leeuwenburgh, Christiaan; Wohlgemuth, Stephanie E.			Skeletal Muscle Apoptotic Signaling Predicts Thigh Muscle Volume and Gait Speed in Community-Dwelling Older Persons: An Exploratory Study	PLOS ONE			English	Article							MITOCHONDRIAL-DNA MUTATIONS; LOWER-EXTREMITY FUNCTION; PHYSICAL PERFORMANCE; CALORIE RESTRICTION; SARCOPENIA; AGE; CASPASE-3; SUPPLEMENTATION; DYSFUNCTION; ACTIVATION	Background: Preclinical studies strongly suggest that accelerated apoptosis in skeletal myocytes may be involved in the pathogenesis of sarcopenia. However, evidence in humans is sparse. In the present study, we investigated whether apoptotic signaling in the skeletal muscle was associated with indices of muscle mass and function in older persons. Methodology/Principal Findings: Community-dwelling older adults were categorized into high-functioning (HF) or low-functioning (LF) groups according to their short physical performance battery (SPPB) summary score. Participants underwent an isokinetic knee extensor strength test and 3-dimensional magnetic resonance imaging of the thigh. Vastus lateralis muscle samples were obtained by percutaneous needle biopsy and assayed for the expression of a set of apoptotic signaling proteins. Age, sex, number of comorbid conditions and medications as well as knee extensor strength were not different between groups. HF participants displayed greater thigh muscle volume compared with LF persons. Multivariate partial least squares (PLS) regressions showed significant correlations between caspase-dependent apoptotic signaling proteins and the muscular percentage of thigh volume (R-2 = 0.78; Q(2) = 0.61) as well as gait speed (R-2 = 0.81; Q(2) = 0.56). Significant variables in the PLS model of percent muscle volume were active caspase-8, cleaved caspase-3, cytosolic cytochrome c and mitochondrial Bak. The regression model of gait speed was mainly described by cleaved caspase-3 and mitochondrial Bax and Bak. PLS predictive apoptotic variables did not differ between functional groups. No correlation was determined between apoptotic signaling proteins and muscle strength or quality (strength per unit volume). Conclusions/Significance: Data from this exploratory study show for the first time that apoptotic signaling is correlated with indices of muscle mass and function in a cohort of community-dwelling older persons. Future larger-scale studies are needed to corroborate these preliminary findings and determine if down-regulation of apoptotic signaling in skeletal myocytes will provide improvements in the muscle mass and functional status of older persons.	[Marzetti, Emanuele; Lees, Hazel A.; Manini, Todd M.; Buford, Thomas W.; Pahor, Marco; Leeuwenburgh, Christiaan; Wohlgemuth, Stephanie E.] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL 32611 USA; [Marzetti, Emanuele] Univ Cattolica Sacro Cuore, Dept Orthoped & Traumatol, Inst Orthoped, I-00168 Rome, Italy; [Aranda, Juan M., Jr.] Univ Florida, Coll Med, Dept Med, Gainesville, FL USA; [Calvani, Riccardo] Inst Crystallog, Natl Res Council CNR, Bari, Italy; [Calvani, Riccardo; Bernabei, Roberto] Univ Cattolica Sacro Cuore, Dept Gerontol Geriatr & Physiatr, Inst Internal Med & Geriatr, I-00168 Rome, Italy; [Capuani, Giorgio] Univ Roma La Sapienza, Dept Chem, I-00185 Rome, Italy; [Marsiske, Michael] Univ Florida, Dept Clin & Hlth Psychol, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Lott, Donovan J.; Vandenborne, Krista] Univ Florida, Dept Phys Therapy, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA	State University System of Florida; University of Florida; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; State University System of Florida; University of Florida; Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Marzetti, E (corresponding author), Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL 32611 USA.	emarzetti@live.com; cleeuwen@ufl.edu	Buford, Thomas W/B-1111-2011; Marzetti, Emanuele/A-9430-2010; Calvani, Riccardo/K-2011-2018; Capuani, Giorgio/B-7738-2015; Bernabei, Roberto/AAB-2704-2019; Capuani, Giorgio/Y-4099-2019	Buford, Thomas W/0000-0002-9541-4358; Marzetti, Emanuele/0000-0001-9567-6983; Calvani, Riccardo/0000-0001-5472-2365; Capuani, Giorgio/0000-0002-6992-2578; Bernabei, Roberto/0000-0002-9197-004X; Capuani, Giorgio/0000-0002-6992-2578; Marsiske, Michael/0000-0001-5973-2116; Leeuwenburgh, Christiaan/0000-0003-0826-4257	University of Florida's Institute on Aging; Claude D. Pepper Older Americans Independence Center [1P30AG028740]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	University of Florida's Institute on Aging; Claude D. Pepper Older Americans Independence Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the University of Florida's Institute on Aging and Claude D. Pepper Older Americans Independence Center (1P30AG028740). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GF, 2000, HEALTH AFFAIR, V19, P191, DOI 10.1377/hlthaff.19.3.191; Buford TW, 2012, EXP GERONTOL, V47, P38, DOI 10.1016/j.exger.2011.10.001; Carter CS, 2011, AGE, V33, P167, DOI 10.1007/s11357-010-9196-y; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Cesari M, 2011, JAMA-J AM MED ASSOC, V305, P93, DOI 10.1001/jama.2010.1970; Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dirks AJ, 2004, FREE RADICAL BIO MED, V36, P27, DOI 10.1016/j.freeradbiomed.2003.10.003; Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Dupont-Versteegden EE, 2005, EXP GERONTOL, V40, P473, DOI 10.1016/j.exger.2005.04.003; Eriksson L, 2006, MOL DIVERS, V10, P169, DOI 10.1007/s11030-006-9024-6; Galvao DA, 2005, J AM GERIATR SOC, V53, P2090, DOI 10.1111/j.1532-5415.2005.00494.x; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Kovacheva EL, 2010, ENDOCRINOLOGY, V151, P628, DOI 10.1210/en.2009-1177; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Malmgren LT, 2001, OTOLARYNG HEAD NECK, V125, P34, DOI 10.1067/mhn.2001.116449; Maly MR, 2005, PHYS THER, V85, P1318, DOI 10.1093/ptj/85.12.1318; Manton KG, 2006, P NATL ACAD SCI USA, V103, P18374, DOI 10.1073/pnas.0608483103; Martens H, 2001, CHEMOMETR INTELL LAB, V58, P151, DOI 10.1016/S0169-7439(01)00157-5; Marzetti E, 2008, MECH AGEING DEV, V129, P542, DOI 10.1016/j.mad.2008.05.005; Marzetti E, 2008, AM J PHYSIOL-REG I, V294, pR558, DOI 10.1152/ajpregu.00620.2007; Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011; Marzetti E, 2010, BBA-GEN SUBJECTS, V1800, P235, DOI 10.1016/j.bbagen.2009.05.007; Marzetti E, 2010, THESCIENTIFICWORLDJO, V10, P340, DOI 10.1100/tsw.2010.27; Marzetti E, 2009, MECH AGEING DEV, V130, P272, DOI 10.1016/j.mad.2008.12.008; Murphy KT, 2010, FASEB J, V24, P4433, DOI 10.1096/fj.10-159608; Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004; Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje; Roubenoff R, 2007, NUTR REV, V65, pS208, DOI 10.1111/j.1753-4887.2007.tb00364.x; Ruetten H, 2001, J AM COLL CARDIOL, V38, P2063, DOI 10.1016/S0735-1097(01)01670-9; Seo AY, 2008, AGING CELL, V7, P706, DOI 10.1111/j.1474-9726.2008.00418.x; Song W, 2006, ANTIOXID REDOX SIGN, V8, P517, DOI 10.1089/ars.2006.8.517; Stadelmann C, 2000, CELL TISSUE RES, V301, P19, DOI 10.1007/s004410000203; Strasser H, 1999, LANCET, V354, P918, DOI 10.1016/S0140-6736(99)02588-X; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Sun YF, 2001, J BIOL CHEM, V276, P16240, DOI 10.1074/jbc.M010419200; Vasunilashorn S, 2009, J GERONTOL A-BIOL, V64, P223, DOI 10.1093/gerona/gln022; Walston J, 2008, J GERONTOL A-BIOL, V63, P391, DOI 10.1093/gerona/63.4.391; Wannamethee SG, 2007, AM J CLIN NUTR, V86, P1339, DOI 10.1093/ajcn/86.5.1339; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Whitman SA, 2005, PFLUG ARCH EUR J PHY, V450, P437, DOI 10.1007/s00424-005-1473-8; Wohlgemuth SE, 2011, REJUV RES, V14, P315, DOI 10.1089/rej.2010.1132; Wohlgemuth SE, 2010, EXP GERONTOL, V45, P138, DOI 10.1016/j.exger.2009.11.002; Wu MZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006430	50	62	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32829	10.1371/journal.pone.0032829	http://dx.doi.org/10.1371/journal.pone.0032829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389725	Green Published, gold, Green Submitted			2022-12-27	WOS:000302999600064
J	Witt, CM; Manheimer, E; Hammerschlag, R; Ludtke, R; Lao, LX; Tunis, SR; Berman, BM				Witt, Claudia M.; Manheimer, Eric; Hammerschlag, Richard; Luedtke, Rainer; Lao, Lixing; Tunis, Sean R.; Berman, Brian M.			How Well Do Randomized Trials Inform Decision Making: Systematic Review Using Comparative Effectiveness Research Measures on Acupuncture for Back Pain	PLOS ONE			English	Review							COMPLEMENTARY THERAPIES; CLINICAL-TRIALS; USUAL CARE; CHALLENGES; MEDICINE	Background: For Comparative Effectiveness Research (CER) there is a need to develop scales for appraisal of available clinical research. Aims were to 1) test the feasibility of applying the pragmatic-explanatory continuum indicator summary tool and the six CER defining characteristics of the Institute of Medicine to RCTs of acupuncture for treatment of low back pain, and 2) evaluate the extent to which the evidence from these RCTs is relevant to clinical and health policy decision making. Methods: We searched Medline, the AcuTrials (TM) Database to February 2011 and reference lists and included full-report randomized trials in English that compared needle acupuncture with a conventional treatment in adults with non-specific acute and/or chronic low back pain and restricted to those with >= 30 patients in the acupuncture group. Papers were evaluated by 5 raters. Principal Findings: From 119 abstracts, 44 full-text publications were screened and 10 trials (4,901 patients) were evaluated. Due to missing information and initial difficulties in operationalizing the scoring items, the first scoring revealed inter-rater and inter-item variance (intraclass correlations 0.02-0.60), which improved after consensus discussions to 0.20-1.00. The 10 trials were found to cover the efficacy-effectiveness continuum; those with more flexible acupuncture and no placebo control scored closer to effectiveness. Conclusion: Both instruments proved useful, but need further development. In addition, CONSORT guidelines for reporting pragmatic trials should be expanded. Most studies in this review already reflect the movement towards CER and similar approaches can be taken to evaluate comparative effectiveness relevance of RCTs for other treatments.	[Witt, Claudia M.; Manheimer, Eric; Lao, Lixing; Berman, Brian M.] Univ Maryland, Sch Med, Ctr Integrat Med, Baltimore, MD 21201 USA; [Witt, Claudia M.] Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany; [Hammerschlag, Richard] Oregon Coll Oriental Med, Res Dept, Portland, OR USA; [Luedtke, Rainer] Carstens Fdn, Essen, Germany; [Tunis, Sean R.] Ctr Med Technol Policy, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Witt, CM (corresponding author), Univ Maryland, Sch Med, Ctr Integrat Med, Baltimore, MD 21201 USA.	claudia.witt@charite.de	Lao, Lixing/P-9107-2019; Witt, Claudia M./AAX-2370-2021; Lao, Lixing/I-7979-2013	Lao, Lixing/0000-0003-0198-9714; Witt, Claudia M./0000-0002-5440-7805; 	Institute for Integrative Health a non-profit organization, Baltimore, United States of America; National Center for Complementary & Integrative Health [R24AT001293] Funding Source: NIH RePORTER	Institute for Integrative Health a non-profit organization, Baltimore, United States of America; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	CMW received a travel grant by the Institute for Integrative Health a non-profit organization, Baltimore, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Barnes Patricia M, 2004, Adv Data, P1; Berman BM, 2010, NEW ENGL J MED, V363, P454, DOI 10.1056/NEJMct0806114; Cherkin Daniel C, 2002, J Am Board Fam Pract, V15, P463; Cherkin DC, 2009, ARCH INTERN MED, V169, P858, DOI 10.1001/archinternmed.2009.65; Cherkin DC, 2001, ARCH INTERN MED, V161, P1081, DOI 10.1001/archinte.161.8.1081; Committee on Comparative Effectiveness Research Priorization, 2009, IN NAT PRIOR COMP EF, P37; Conway PH, 2009, NEW ENGL J MED, V361, P328, DOI 10.1056/NEJMp0905631; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Eisenberg DM, 2007, SPINE, V32, P151, DOI 10.1097/01.brs.0000252697.07214.65; Eisenberg DM, 2001, ANN INTERN MED, V135, P344, DOI 10.7326/0003-4819-135-5-200109040-00011; Fineberg H, 2009, INITIAL NATL PRIORIT; Godwin Marshall, 2003, BMC Med Res Methodol, V3, P28, DOI 10.1186/1471-2288-3-28; Haake M, 2007, ARCH INTERN MED, V167, P1892, DOI 10.1001/archinte.167.17.1892; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Koppenaal T, 2011, J CLIN EPIDEMIOL; Last JM., 2001, DICT EPIDEMIOLOGY, V4th; Leibing E, 2002, PAIN, V96, P189, DOI 10.1016/S0304-3959(01)00444-4; Luo X, 1976, SPINE, V29, P79; MacPherson H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000261; Mason S, 2002, BRIT MED J, V325, P832, DOI 10.1136/bmj.325.7368.832; Meng CF, 2003, RHEUMATOLOGY, V42, P1508, DOI 10.1093/rheumatology/keg405; Molsberger A, 2002, DTSCH ARZTEBLATT, V99, P1539; Oregon College of Oriental Medicine, 2011, ACUTRIALS DAT; Rubinstein SM, 2010, EUR SPINE J, V19, P1213, DOI 10.1007/s00586-010-1356-3; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Strom BL, 2007, MED CARE, V45, pS13, DOI 10.1097/MLR.0b013e318041f752; Szczurko O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000919; Thomas KJ, 2006, BMJ-BRIT MED J, V333, P623, DOI 10.1136/bmj.38878.907361.7C; Thorpe KE, 2009, CAN MED ASSOC J, V180, pE47, DOI 10.1503/cmaj.090523; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Witt CM, 2006, AM J EPIDEMIOL, V164, P487, DOI 10.1093/aje/kwj224; Witt CM, 2011, CLIN J PAIN, V27, P550, DOI 10.1097/AJP.0b013e31820dfbf5; Witt CM, 2011, INTEGRATING E ASIAN; Yuan J, 2008, SPINE, V33, pE887, DOI 10.1097/BRS.0b013e318186b276; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	37	37	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32399	10.1371/journal.pone.0032399	http://dx.doi.org/10.1371/journal.pone.0032399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389699	Green Published, Green Submitted, gold			2022-12-27	WOS:000302999600037
J	Abhold, EL; Kiang, A; Rahimy, E; Kuo, SZ; Wang-Rodriguez, J; Lopez, JP; Blair, KJ; Yu, MA; Haas, M; Brumund, KT; Altuna, X; Patel, A; Weisman, RA; Ongkeko, WM				Abhold, Eric L.; Kiang, Alan; Rahimy, Elham; Kuo, Selena Z.; Wang-Rodriguez, Jessica; Lopez, Jay Patrick; Blair, Katherine J.; Yu, Michael Andrew; Haas, Martin; Brumund, Kevin T.; Altuna, Xabier; Patel, Andrew; Weisman, Robert A.; Ongkeko, Weg M.			EGFR Kinase Promotes Acquisition of Stem Cell-Like Properties: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma Stem Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SELF-RENEWAL; CANCER; RESISTANCE; CHEMOTHERAPY; EXPRESSION; CONFERS; COMMON	Members of the EGFR/ErbB family of tyrosine kinases are found to be highly expressed and deregulated in many cancers, including head and neck squamous cell carcinoma (HNSCC). The ErbB family, including EGFR, has been demonstrated to play key roles in metastasis, tumorigenesis, cell proliferation, and drug resistance. Recently, these characteristics have been linked to a small subpopulation of cells classified as cancer stem cells (CSCs) which are believed to be responsible for tumor initiation and maintenance. In this study, we investigated the possible role of EGFR as a regulator of "stemness" in HNSCC cells. Activation of EGFR by the addition of EGF ligand or ectopic expression of EGFR in two established HNSCC cell lines (UMSCC-22B and HN-1) resulted in the induction of CD44, BMI-1, Oct-4, NANOG, CXCR4, and SDF-1. Activation of EGFR also resulted in increased tumorsphere formation, a characteristic ability of cancer stem cells. Conversely, treatment with the EGFR kinase inhibitor, Gefinitib (Iressa), resulted in decreased expression of the aforementioned genes, and loss of tumorsphere-forming ability. Similar trends were observed in a 99.9% CD44 positive stem cell culture derived from a fresh HNSCC tumor, confirming our findings for the cell lines. Additionally, we found that these putative cancer stem cells, when treated with Gefitinib, possessed a lower capacity to invade and became more sensitive to cisplatin-induced death in vitro. These results suggest that EGFR plays critical roles in the survival, maintenance, and function of cancer stem cells. Drugs that target EGFR, perhaps administered in combination with conventional chemotherapy, might be an effective treatment for HNSCC.	[Abhold, Eric L.; Kiang, Alan; Rahimy, Elham; Kuo, Selena Z.; Lopez, Jay Patrick; Blair, Katherine J.; Yu, Michael Andrew; Brumund, Kevin T.; Patel, Andrew; Weisman, Robert A.; Ongkeko, Weg M.] Univ Calif San Diego, Dept Surg, Div Otolaryngol Head & Neck Surg, San Diego, CA 92103 USA; [Wang-Rodriguez, Jessica] Univ Calif San Diego, Vet Adm Med Ctr, San Diego, CA 92103 USA; [Wang-Rodriguez, Jessica] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Haas, Martin] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA; [Altuna, Xabier] Hosp Univ Donostia, San Sebastian, Spain	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Diego; University of California System; University of California San Diego	Abhold, EL (corresponding author), Univ Calif San Diego, Dept Surg, Div Otolaryngol Head & Neck Surg, San Diego, CA 92103 USA.	wongkeko@ucsd.edu		Rahimy, Elham/0000-0001-7356-3996; Lopez, Jay/0000-0002-7645-1620; ALTUNA, XABIER/0000-0002-3453-5017	AAOHNSF	AAOHNSF	The authors' work was funded by AAOHNSF grant (AAOHNSF.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MALS, 2008, CANCER SCI, V99, P1589, DOI 10.1111/j.1349-7006.2008.00861.x; Boockvar JA, 2003, MOL CELL NEUROSCI, V24, P1116, DOI 10.1016/j.mcn.2003.09.011; Chen XM, 2000, BIOCHEM BIOPH RES CO, V277, P757, DOI 10.1006/bbrc.2000.3731; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hama T, 2009, ONCOLOGIST, V14, P900, DOI 10.1634/theoncologist.2009-0058; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Ivkovic S, 2008, J NEUROSCI, V28, P914, DOI 10.1523/JNEUROSCI.4327-07.2008; JETTEN AM, 1990, INT J CANCER, V45, P195, DOI 10.1002/ijc.2910450135; KHAZAIE K, 1993, CANCER METAST REV, V12, P255, DOI 10.1007/BF00665957; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MIYAGUCHI M, 1991, CLIN OTOLARYNGOL, V16, P466, DOI 10.1111/j.1365-2273.1991.tb01041.x; Nemunaitis J, 2002, EXPERT OPIN BIOL TH, V2, P177, DOI 10.1517/14712598.2.2.177; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Pardal R, 2005, COLD SH Q B, V70, P177, DOI 10.1101/sqb.2005.70.057; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schmidt C, 2008, J NATL CANCER I, V100, P694, DOI 10.1093/jnci/djn168; SCHWACHOFER JHM, 1990, ANTICANCER RES, V10, P805; Sok JC, 2006, CLIN CANCER RES, V12, P5064, DOI 10.1158/1078-0432.CCR-06-0913; Wheeler SE, 2010, ONCOGENE; Yarden Y, 2001, EUR J CANCER, V37, pS3	26	69	70	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32459	10.1371/journal.pone.0032459	http://dx.doi.org/10.1371/journal.pone.0032459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384257	Green Published, gold, Green Submitted			2022-12-27	WOS:000302918500093
J	Parrilla, M; Lillo, C; Herrero-Turrion, MJ; Arevalo, R; Aijon, J; Lara, JM; Velasco, A				Parrilla, Marta; Lillo, Concepcion; Javier Herrero-Turrion, M.; Arevalo, Rosario; Aijon, Jose; Lara, Juan M.; Velasco, Almudena			Characterization of Pax2 Expression in the Goldfish Optic Nerve Head during Retina Regeneration	PLOS ONE			English	Article							ASTROCYTE PRECURSOR CELLS; GLIAL-CELLS; VISUAL-SYSTEM; MULLER CELLS; GENE; EYE; PROTEINS; FAMILY; AXONS; FISH	The Pax2 transcription factor plays a crucial role in axon-guidance and astrocyte differentiation in the optic nerve head (ONH) during vertebrate visual system development. However, little is known about its function during regeneration. The fish visual system is in continuous growth and can regenerate. Muller cells and astrocytes of the retina and ONH play an important role in these processes. We demonstrate that pax2a in goldfish is highly conserved and at least two pax2a transcripts are expressed in the optic nerve. Moreover, we show two different astrocyte populations in goldfish: Pax2(+) astrocytes located in the ONH and S100(+) astrocytes distributed throughout the retina and the ONH. After peripheral growth zone (PGZ) cryolesion, both Pax2(+) and S100(+) astrocytes have different responses. At 7 days after injury the number of Pax2(+) cells is reduced and coincides with the absence of young axons. In contrast, there is an increase of S100(+) astrocytes in the retina surrounding the ONH and S100(+) processes in the ONH. At 15 days post injury, the PGZ starts to regenerate and the number of S100(+) astrocytes increases in this region. Moreover, the regenerating axons reach the ONH and the pax2a gene expression levels and the number of Pax2(+) cells increase. At the same time, S100(+)/GFAP(+)/GS(+) astrocytes located in the posterior ONH react strongly. In the course of the regeneration, Muller cell vitreal processes surrounding the ONH are primarily disorganized and later increase in number. During the whole regenerative process we detect a source of Pax2(+)/PCNA(+) astrocytes surrounding the posterior ONH. We demonstrate that pax2a expression and the Pax2(+) astrocyte population in the ONH are modified during the PGZ regeneration, suggesting that they could play an important role in this process.	[Parrilla, Marta; Lillo, Concepcion; Javier Herrero-Turrion, M.; Arevalo, Rosario; Aijon, Jose; Lara, Juan M.; Velasco, Almudena] Univ Salamanca, Inst Neurosci Castilla & Leon, E-37008 Salamanca, Spain	University of Salamanca	Parrilla, M (corresponding author), Univ Salamanca, Inst Neurosci Castilla & Leon, E-37008 Salamanca, Spain.	malmu@usal.es	Lara, Juan/L-5590-2014; Arévalo, Rosario/L-5649-2014; Lillo, Concepcion/A-6321-2009; Herrero-Turrión, M. Javier/D-9419-2019	Lara, Juan/0000-0001-5389-3592; Arévalo, Rosario/0000-0001-5849-1736; Lillo, Concepcion/0000-0001-5814-9826; Herrero-Turrión, M. Javier/0000-0003-3350-2608; Velasco, Almudena/0000-0002-7442-3255	Ministerio Espanol de Ciencia e Innovacion [BFU-2009-11179]; Grupos de Excelencia de Castilla y Leon [GR-183]	Ministerio Espanol de Ciencia e Innovacion(Spanish Government); Grupos de Excelencia de Castilla y Leon	This work was funded by Ministerio Espanol de Ciencia e Innovacion (BFU-2009-11179) and Grupos de Excelencia de Castilla y Leon (GR-183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balczarek KA, 1997, MOL BIOL EVOL, V14, P829, DOI 10.1093/oxfordjournals.molbev.a025824; Becker CG, 2007, J NEUROSCI RES, V85, P2793, DOI 10.1002/jnr.21121; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Boije H, 2010, DEV DYNAM, V239, P1858, DOI 10.1002/dvdy.22309; BUNT SM, 1982, J COMP NEUROL, V206, P209, DOI 10.1002/cne.902060302; Busse A, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-36; Cai Y, 2003, EMBO J, V22, P5522, DOI 10.1093/emboj/cdg536; Cai Y, 2002, J BIOL CHEM, V277, P1217, DOI 10.1074/jbc.M109663200; Chan-Ling T, 2004, INVEST OPHTH VIS SCI, V45, P2020, DOI 10.1167/iovs.03-1169; Chan-Ling T, 2009, GLIA, V57, P39, DOI 10.1002/glia.20733; Chu Y, 2001, FASEB J, V15, P2013, DOI 10.1096/fj.00-0868fje; Chun MH, 2000, BRAIN RES, V868, P358, DOI 10.1016/S0006-8993(00)02305-2; Cid E, 2006, PARTICIPACION POBLAC; Clemente D, 2008, ARCH ITAL BIOL, V146, P35; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Dorfler P, 1996, EMBO J, V15, P1971, DOI 10.1002/j.1460-2075.1996.tb00548.x; Dressler GR, 1999, INT J DEV BIOL, V43, P463; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Fu WM, 1997, GENE DEV, V11, P2066, DOI 10.1101/gad.11.16.2066; Fu WM, 1998, DEVELOPMENT, V125, P2943; Fujita Y, 2000, TISSUE CELL, V32, P293, DOI 10.1054/tice.2000.0115; Garcia DM, 2009, COMP BIOCHEM PHYS A, V152, P135, DOI 10.1016/j.cbpa.2008.09.026; Goode DK, 2009, DEV DYNAM, V238, P2951, DOI 10.1002/dvdy.22146; Heller N, 1997, MECH DEVELOP, V69, P83, DOI 10.1016/S0925-4773(97)00158-5; Hitchcock P, 2004, PROG RETIN EYE RES, V23, P183, DOI 10.1016/j.preteyeres.2004.01.001; Jimeno D, 1999, BRAIN RES, V816, P175, DOI 10.1016/S0006-8993(98)01170-6; JOHNS PR, 1977, J COMP NEUROL, V176, P331, DOI 10.1002/cne.901760303; Kirsch M, 2010, GLIA, V58, P768, DOI 10.1002/glia.20961; Koriyama Y, 2006, ADV EXP MED BIOL, V572, P333; Lillo C, 2002, J HISTOCHEM CYTOCHEM, V50, P1289, DOI 10.1177/002215540205001002; Lillo C, 2001, J NEUROCYTOL, V30, P475, DOI 10.1023/A:1015684932550; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lun K, 1998, DEVELOPMENT, V125, P3049; Macdonald R, 1996, CURR OPIN NEUROBIOL, V6, P49, DOI 10.1016/S0959-4388(96)80008-0; Macdonald R, 1997, DEVELOPMENT, V124, P2397; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Matsukawa T, 2004, BIOL PHARM BULL, V27, P445, DOI 10.1248/bpb.27.445; Meri S, 2001, BIOMOL ENG, V18, P213, DOI 10.1016/S1389-0344(01)00106-X; Mi HY, 1999, J NEUROSCI, V19, P1049; Morcillo J, 2006, DEVELOPMENT, V133, P3179, DOI 10.1242/dev.02493; MURRAY M, 1982, J COMP NEUROL, V209, P352, DOI 10.1002/cne.902090405; Nagashima M, 2009, NEUROCHEM INT, V54, P229, DOI 10.1016/j.neuint.2008.11.007; Oster SF, 2004, SEMIN CELL DEV BIOL, V15, P125, DOI 10.1016/j.semcdb.2003.09.006; Parrilla M, 2009, BRAIN RES, V1255, P75, DOI 10.1016/j.brainres.2008.12.010; Petrausch B, 2000, MOL CELL NEUROSCI, V16, P350, DOI 10.1006/mcne.2000.0877; Pfeffer PL, 1998, DEVELOPMENT, V125, P3063; Phelps DE, 1996, J BIOL CHEM, V271, P7978, DOI 10.1074/jbc.271.14.7978; Rodger J, 2006, NEUROSCIENCE, V142, P1043, DOI 10.1016/j.neuroscience.2006.07.057; Sanyanusin P, 1996, GENOMICS, V35, P258, DOI 10.1006/geno.1996.0350; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwarz M, 2000, DEVELOPMENT, V127, P4325; Soukkarieh C, 2007, DEV BIOL, V303, P800, DOI 10.1016/j.ydbio.2006.11.016; Stanke J, 2010, J COMP NEUROL, V518, P2316, DOI 10.1002/cne.22335; Stuermer CAO, 2000, PROG NEUROBIOL, V62, P197, DOI 10.1016/S0301-0082(00)00012-5; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Tavassoli K, 1997, HUM GENET, V101, P371, DOI 10.1007/s004390050644; Thanos S, 2004, J NEUROBIOL, V59, P8, DOI 10.1002/neu.20001; Thanos S, 2001, BRAIN RES REV, V35, P205, DOI 10.1016/S0165-0173(01)00049-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torres MA, 1996, DEVELOPMENT, V122, P3381; Vecino E, 1997, MICROSC RES TECHNIQ, V36, P17; Velasco A, 1997, BRAIN RES BULL, V43, P327, DOI 10.1016/S0361-9230(97)00014-2; Wehr R, 1996, INT J DEV BIOL, V40, P369; Wohl SG, 2009, EXP NEUROL, V219, P175, DOI 10.1016/j.expneurol.2009.05.008; Ziman MR, 2001, HISTOL HISTOPATHOL, V16, P239, DOI 10.14670/HH-16.239	69	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32348	10.1371/journal.pone.0032348	http://dx.doi.org/10.1371/journal.pone.0032348			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384226	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500079
J	Shasmal, M; Sengupta, J				Shasmal, Manidip; Sengupta, Jayati			Structural Diversity in Bacterial Ribosomes: Mycobacterial 70S Ribosome Structure Reveals Novel Features	PLOS ONE			English	Article							ACID-FAST BACILLI; MESSENGER-RNA; ESCHERICHIA-COLI; DELAYED-HYPERSENSITIVITY; ANGSTROM RESOLUTION; TRANSLATION INITIATION; ANTIBIOTIC-RESISTANCE; ELECTRON-MICROSCOPY; 80S RIBOSOME; SUBUNIT	Here we present analysis of a 3D cryo-EM map of the 70S ribosome from Mycobacterium smegmatis, a saprophytic cousin of the etiological agent of tuberculosis in humans, Mycobacterium tuberculosis. In comparison with the 3D structures of other prokaryotic ribosomes, the density map of the M. smegmatis 70S ribosome reveals unique structural features and their relative orientations in the ribosome. Dramatic changes in the periphery due to additional rRNA segments and extra domains of some of the peripheral ribosomal proteins like S3, S5, S16, L17, L25, are evident. One of the most notable features appears in the large subunit near L1 stalk as a long helical structure next to helix 54 of the 23S rRNA. The sharp upper end of this structure is located in the vicinity of the mRNA exit channel. Although the M. smegmatis 70S ribosome possesses conserved core structure of bacterial ribosome, the new structural features, unveiled in this study, demonstrates diversity in the 3D architecture of bacterial ribosomes. We postulate that the prominent helical structure related to the 23S rRNA actively participates in the mechanisms of translation in mycobacteria.	[Shasmal, Manidip; Sengupta, Jayati] CSIR, Indian Inst Chem Biol, Struct Biol & Bioinformat Div, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Shasmal, M (corresponding author), CSIR, Indian Inst Chem Biol, Struct Biol & Bioinformat Div, Kolkata, W Bengal, India.	jayati@iicb.res.in			Indian Institute of Chemical Biology, Kolkata, India; Council of Scientific and Industrial Research, Government of India	Indian Institute of Chemical Biology, Kolkata, India; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Indian Institute of Chemical Biology, Kolkata, India. MS has been awarded a senior research fellowship from the Council of Scientific and Industrial Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER R, 1979, INT ARCH ALLER A IMM, V59, P328, DOI 10.1159/000232277; BAKER RE, 1973, INFECT IMMUN, V8, P236, DOI 10.1128/IAI.8.2.236-244.1973; BAKER RE, 1972, INFECT IMMUN, V6, P258, DOI 10.1128/IAI.6.3.258-265.1972; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Berk V, 2006, P NATL ACAD SCI USA, V103, P15830, DOI 10.1073/pnas.0607541103; Bruell CM, 2008, BIOCHEMISTRY-US, V47, P8828, DOI 10.1021/bi800527k; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Das B, 1996, EUR J BIOCHEM, V235, P613, DOI 10.1111/j.1432-1033.1996.00613.x; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frank J, 2007, P NATL ACAD SCI USA, V104, P19671, DOI 10.1073/pnas.0708517104; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gao HX, 2005, P NATL ACAD SCI USA, V102, P10206, DOI 10.1073/pnas.0500926102; HONORE N, 1994, ANTIMICROB AGENTS CH, V38, P238, DOI 10.1128/AAC.38.2.238; Jenner L, 2005, SCIENCE, V308, P120, DOI 10.1126/science.1105639; Korostelev A, 2008, CURR OPIN CHEM BIOL, V12, P674, DOI 10.1016/j.cbpa.2008.08.037; LOECHEL S, 1991, NUCLEIC ACIDS RES, V19, P6905, DOI 10.1093/nar/19.24.6905; LOGE RV, 1974, INFECT IMMUN, V9, P489, DOI 10.1128/IAI.9.3.489-496.1974; LONNROTH I, 1985, FEMS MICROBIOL LETT, V26, P113, DOI 10.1016/0378-1097(85)90134-X; LONNROTH I, 1985, FEMS MICROBIOL LETT, V27, P203, DOI 10.1016/0378-1097(85)90314-3; MARTIN C, 1990, NATURE, V345, P739, DOI 10.1038/345739a0; Marzi S, 2008, BIOL CHEM, V389, P585, DOI 10.1515/BC.2008.055; Marzi S, 2007, CELL, V130, P1019, DOI 10.1016/j.cell.2007.07.008; McCutcheon JP, 1999, P NATL ACAD SCI USA, V96, P4301, DOI 10.1073/pnas.96.8.4301; Morgan DG, 2000, J MOL BIOL, V301, P301, DOI 10.1006/jmbi.2000.3947; NEEFS JM, 1993, NUCLEIC ACIDS RES, V21, P3025, DOI 10.1093/nar/21.13.3025; Nguyen L, 2006, TRENDS MICROBIOL, V14, P304, DOI 10.1016/j.tim.2006.05.005; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; Poehlsgaard J, 2005, NAT REV MICROBIOL, V3, P870, DOI 10.1038/nrmicro1265; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Reblova K, 2010, NUCLEIC ACIDS RES, V38, P1325, DOI 10.1093/nar/gkp1057; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Sorensen MA, 1998, J MOL BIOL, V280, P561, DOI 10.1006/jmbi.1998.1909; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; SURYANARAYANA T, 1984, BIOCHEMISTRY-US, V23, P1047, DOI 10.1021/bi00301a002; Tenson T, 2006, MOL MICROBIOL, V59, P1664, DOI 10.1111/j.1365-2958.2006.05063.x; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Villa E, 2009, P NATL ACAD SCI US; WAGENKNECHT T, 1988, J MOL BIOL, V199, P137, DOI 10.1016/0022-2836(88)90384-1; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281	46	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31742	10.1371/journal.pone.0031742	http://dx.doi.org/10.1371/journal.pone.0031742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384065	Green Submitted, gold, Green Published			2022-12-27	WOS:000302916800018
J	Sexton, T; Hitchcook, LJ; Rodgers, DW; Bradley, LH; Hersh, LB				Sexton, Travis; Hitchcook, Lisa J.; Rodgers, David W.; Bradley, Luke H.; Hersh, Louis B.			Active Site Mutations Change the Cleavage Specificity of Neprilysin	PLOS ONE			English	Article							ENDOPEPTIDASE 24.11 ENKEPHALINASE; NEUTRAL ENDOPEPTIDASE; AMYLOID BURDEN; PURIFICATION; DEGRADATION; EXPRESSION; INHIBITOR; PATHOLOGY; MEMBRANE; ENZYME	Neprilysin (NEP), a member of the M13 subgroup of the zinc-dependent endopeptidase family is a membrane bound peptidase capable of cleaving a variety of physiological peptides. We have generated a series of neprilysin variants containing mutations at either one of two active site residues, Phe(563) and Ser(546). Among the mutants studied in detail we observed changes in their activity towards leucine(5)-enkephalin, insulin B chain, and amyloid beta(1-40). For example, NEPF563I displayed an increase in preference towards cleaving leucine(5)-enkephalin relative to insulin B chain, while mutant NEPS546E was less discriminating than neprilysin. Mutants NEPF563L and NEPS546E exhibit different cleavage site preferences than neprilysin with insulin B chain and amyloid beta(1-40) as substrates. These data indicate that it is possible to alter the cleavage site specificity of neprilysin opening the way for the development of substrate specific or substrate exclusive forms of the enzyme with enhanced therapeutic potential.	[Sexton, Travis; Hitchcook, Lisa J.; Rodgers, David W.; Hersh, Louis B.] Univ Kentucky, Struct Biol Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA; [Bradley, Luke H.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Sexton, T (corresponding author), Univ Kentucky, Struct Biol Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA.	lhersh@uky.edu		Bradley, Luke/0000-0003-1870-0796	Alzheimer's Association; National Institutes of Health [RO1DA02243, T32DA016176, P2ORR020171]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA016176, R01DA002243] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by grants from the Alzheimer's Association (DR. Rodgers, Dr. Bradley, Dr. Hersh), and the National Institutes of Health RO1DA02243 (Dr. Hersh), T32DA016176 (Dr. Sexton), and P2ORR020171 (DR. Rodgers, Dr. Bradley, Dr. Hersh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012793; Bradley LH, 2005, PROTEIN ENG DES SEL, V18, P201, DOI 10.1093/protein/gzi020; Bradley LH, 2011, PROTEIN EXPRES PURIF, V75, P186, DOI 10.1016/j.pep.2010.08.007; CAMERON CE, 1994, J BIOL CHEM, V269, P11170; CRAIK CS, 1985, SCIENCE, V228, P291, DOI 10.1126/science.3838593; ERDOS EG, 1989, FASEB J, V3, P145, DOI 10.1096/fasebj.3.2.2521610; GEE NS, 1985, BIOCHEM J, V228, P119, DOI 10.1042/bj2280119; Guan H, 2009, J NEUROSCI RES, V87, P1462, DOI 10.1002/jnr.21944; HERSH LB, 1986, J BIOL CHEM, V261, P6433; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; Jeffrey JL, 2003, J BIOL CHEM, V278, P18971, DOI 10.1074/jbc.M210113200; KERR MA, 1974, BIOCHEM J, V137, P477, DOI 10.1042/bj1370477; Lee CC, 2005, PLASMID, V54, P80, DOI 10.1016/j.plasmid.2004.12.001; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; LI CW, 1995, METHOD ENZYMOL, V248, P253; Liu YX, 2009, MOL THER, V17, P1381, DOI 10.1038/mt.2009.115; MALFROY B, 1978, NATURE, V276, P523, DOI 10.1038/276523a0; Marr RA, 2003, J NEUROSCI, V23, P1992; MATSAS R, 1983, P NATL ACAD SCI-BIOL, V80, P3111, DOI 10.1073/pnas.80.10.3111; Oefner C, 2000, J MOL BIOL, V296, P341, DOI 10.1006/jmbi.1999.3492; PAINTER RG, 1988, J BIOL CHEM, V263, P9456; Poirier R, 2006, NEUROBIOL DIS, V24, P475, DOI 10.1016/j.nbd.2006.08.003; ROQUES BP, 1993, PHARMACOL REV, V45, P87; Spengler J, 1998, J CHEM SOC PERK T 1, P2091, DOI 10.1039/a801052h; Thanawala V, 2008, CURR DRUG TARGETS, V9, P887, DOI 10.2174/138945008785909356; Thompson MW, 2003, PEPTIDES, V24, P1359, DOI 10.1016/j.peptides.2003.07.012; Turner AJ, 1997, FASEB J, V11, P355, DOI 10.1096/fasebj.11.5.9141502; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; VIJAYARAGHAVAN J, 1990, BIOCHEMISTRY-US, V29, P8052, DOI 10.1021/bi00487a009; Wang DS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/58406; Wayman CP, 2010, BRIT J PHARMACOL, V160, P51, DOI 10.1111/j.1476-5381.2010.00691.x; WOLZ RL, 1991, BIOCHEMISTRY-US, V30, P8488, DOI 10.1021/bi00098a029	33	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32343	10.1371/journal.pone.0032343	http://dx.doi.org/10.1371/journal.pone.0032343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384224	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916100072
J	Zhao, JY; Sun, JW; Gu, ZY; Wang, J; Wang, EL; Yang, XY; Qiao, B; Duan, WY; Huang, GY; Wang, HY				Zhao, Jian-Yuan; Sun, Jing-Wei; Gu, Zhuo-Ya; Wang, Jue; Wang, Er-Li; Yang, Xue-Yan; Qiao, Bin; Duan, Wen-Yuan; Huang, Guo-Ying; Wang, Hong-Yan			Genetic Polymorphisms of the TYMS Gene Are Not Associated with Congenital Cardiac Septal Defects in a Han Chinese Population	PLOS ONE			English	Article							THYMIDYLATE SYNTHASE GENE; HEART-DEFECTS; RISK; FOLATE; HOMOCYSTEINE; MULTIVITAMIN; DETERMINANT; SUPPLEMENTS; INTRON	Background: Clinical research indicates that periconceptional administration of folic acid can reduce the occurrence of congenital cardiac septal defects (CCSDs). The vital roles of folate exhibits in three ways: the unique methyl donor for DNA expression regulation, the de novo biosynthesis of purine and pyrimidine for DNA construction, and the serum homocysteine removal. Thymidylate synthase (TYMS) is the solo catalysis enzyme for the de novo synthesis of dTMP, which is the essential precursor of DNA biosynthesis and repair process. To examine the role of TYMS in Congenital Cardiac Septal Defects (CCSDs) risk, we investigated whether genetic polymorphisms in the TYMS gene associated with the CCSDs in a Han Chinese population. Method: Polymorphisms in the noncoding region of TYMS were identified via direct sequencing in 32 unrelated individuals composed of half CCSDs and half control subjects. Nine SNPs and two insertion/deletion polymorphisms were genotyped from two independent case-control studies involving a total of 529 CCSDs patients and 876 healthy control participants. The associations were examined by both single polymorphism and haplotype tests using logistic regression. Result: We found that TYMS polymorphisms were not related to the altered CCSDs risk, and even to the changed risk of VSDs subgroup, when tested in both studied groups separately or in combination. In the haplotype analysis, there were no haplotypes significantly associated with risks for CCSDs either. Conclusion: Our results show no association between common genetic polymorphisms of the regulatory region of the TYMS gene and CCSDs in the Han Chinese population.	[Zhao, Jian-Yuan; Sun, Jing-Wei; Gu, Zhuo-Ya; Wang, Jue; Wang, Er-Li; Yang, Xue-Yan; Wang, Hong-Yan] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhao, Jian-Yuan; Sun, Jing-Wei; Gu, Zhuo-Ya; Wang, Jue; Wang, Er-Li; Yang, Xue-Yan; Wang, Hong-Yan] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Qiao, Bin; Duan, Wen-Yuan] Jinan Mil Reg, Gen Hosp, Inst Cardiovasc Dis, Jinan, Peoples R China; [Huang, Guo-Ying] Fudan Univ, Shanghai Childrens Hosp, Shanghai 200433, Peoples R China; [Wang, Hong-Yan] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Zhao, Jian-Yuan] Adm Sports Anhui Prov, Inst Sports Sci & Technol, Hefei, Peoples R China	Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University; Fudan University	Zhao, JY (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	wanghy@fudan.edu.cn	Zhao, Jianyuan/G-8483-2012	Zhao, Jian-Yuan/0000-0001-9861-0330	National Science Fund for Distinguished Young Scholars [81025003]; 973 Program [2010CB529601, 2007CB500902]; National Natural Science Foundation of China [30872129]; Ministry of Education of China [20110071110026, 20090071120037]; Program for Innovative Research Team in University [IRT1010]; Commission for Science and Technology of Shanghai Municipality [10JC1401300, 11XD1400900]; Scientific Research Foundation for Returned Scholars; Natural Science Foundation of Shanghai Municipality [09ZR1404400]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Program for Innovative Research Team in University; Commission for Science and Technology of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Scientific Research Foundation for Returned Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Natural Science Foundation of Shanghai Municipality(Natural Science Foundation of Shanghai)	This work was supported by the grants from the National Science Fund for Distinguished Young Scholars (81025003), the 973 Program (2010CB529601, 2007CB500902), the National Natural Science Foundation of China (30872129), the Doctoral Fund of Ministry of Education of China (20110071110026), the Program for Innovative Research Team in University (IRT1010) and the Commission for Science and Technology of Shanghai Municipality (10JC1401300, 11XD1400900) to HYW, grants from the Scientific Research Foundation for Returned Scholars and Doctoral Fund of Ministry of Education of China (20090071120037) and the Natural Science Foundation of Shanghai Municipality (09ZR1404400) to XYY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYUSAWA D, 1986, J MOL BIOL, V190, P559, DOI 10.1016/0022-2836(86)90241-X; Bailey LB, 2005, AM J CLIN NUTR, V81, p1213S; Blanton SH, 2011, BIRTH DEFECTS RES A, V91, P50, DOI 10.1002/bdra.20740; Botto LD, 2004, AM J MED GENET C, V125C, P12, DOI 10.1002/ajmg.c.30004; Botto LD, 1996, PEDIATRICS, V98, P911; Botto LD, 2003, AM J MED GENET A, V121A, P95, DOI 10.1002/ajmg.a.20132; Hernandez-Diaz S, 2000, NEW ENGL J MED, V343, P1608, DOI 10.1056/NEJM200011303432204; Hobbs CA, 2010, OBSTET GYNECOL, V116, P316, DOI 10.1097/AOG.0b013e3181e80979; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Huhta JC, 2006, CURR OPIN PEDIATR, V18, P484, DOI 10.1097/01.mop.0000245347.45336.d7; Huhta JC, 2005, FETAL PEDIATR PATHOL, V24, P71, DOI 10.1080/15227950591008240; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; KANEDA S, 1992, SOMAT CELL MOLEC GEN, V18, P409, DOI 10.1007/BF01233080; KANEDA S, 1990, J BIOL CHEM, V265, P20277; Kawate H, 2002, J BIOL CHEM, V277, P36304, DOI 10.1074/jbc.M204956200; Kim SR, 2006, DRUG METAB PHARMACOK, V21, P509, DOI 10.2133/dmpk.21.509; Lupo PJ, 2011, BIRTH DEFECTS RES A, V91, P61, DOI 10.1002/bdra.20745; Shaw GM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-49; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; TAKAYANAGI A, 1992, NUCLEIC ACIDS RES, V20, P4021, DOI 10.1093/nar/20.15.4021; Trinh BN, 2002, HUM GENET, V111, P299, DOI 10.1007/s00439-002-0779-2; Ulrich CM, 2002, CANCER RES, V62, P3361; van Beynum IM, 2006, EUR HEART J, V27, P981, DOI 10.1093/eurheartj/ehi815; van Beynum IM, 2006, CLIN CHEM LAB MED, V44, P1317, DOI 10.1515/CCLM.2006.254; Volcik KA, 2003, BIRTH DEFECTS RES A, V67, P924, DOI 10.1002/bdra.10029; Wilding CS, 2004, BIRTH DEFECTS RES A, V70, P483, DOI 10.1002/bdra.20038	26	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31644	10.1371/journal.pone.0031644	http://dx.doi.org/10.1371/journal.pone.0031644			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384047	gold, Green Submitted, Green Published			2022-12-27	WOS:000302916100027
J	Eva, R; Bouyoucef-Cherchalli, D; Patel, K; Cullen, PJ; Banting, G				Eva, Richard; Bouyoucef-Cherchalli, Dalila; Patel, Kalpana; Cullen, Peter J.; Banting, George			IP3 3-Kinase Opposes NGF Driven Neurite Outgrowth	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE; NERVE GROWTH-FACTOR; B-CELL SELECTION; PC12 CELLS; DENDRITIC SPINES; SIGNALING PATHWAYS; SIGMA-1 RECEPTORS; 1,3,4,5-TETRAKISPHOSPHATE; EXPRESSION; POTENTIATION	The inositol (1,4,5) trisphosphate 3-kinases comprise a family of enzymes (A, B, and C) that phosphorylate the calcium mobilising molecule inositol (1,4,5) trisphosphate (IP3) to generate inositol (1,3,4,5) tetrakisphosphate. This molecule can function as a second messenger, but its roles are not completely understood. The A isoform of inositol (1,4,5) trisphosphate 3-kinase localises to filamentous actin within dendritic spines in the hippocampus and is implicated in the regulation of spine morphology and long term potentiation, however the mechanisms through which it signals in neuronal cells are not completely understood. We have used NGF driven neurite outgrowth from PC12 cells as a platform to examine the impact of signaling via inositol (1,4,5) trisphosphate 3-kinase activity in a neuronal cell. We have found that the catalytic activity of the enzyme opposes neurite outgrowth, whilst pharmacological inhibition of inositol (1,4,5) trisphosphate 3-kinase leads to a significant increase in neurite outgrowth, and we show that the reduction in neurite outgrowth in response to inositol (1,4,5) trisphosphate 3-kinase activity correlates with reduced ERK activity as determined by western blotting using phosphorylation-specific antibodies. Our findings suggest a novel neuronal signaling pathway linking metabolism of IP3 to signaling via ERK.	[Eva, Richard; Bouyoucef-Cherchalli, Dalila; Cullen, Peter J.] Univ Bristol, Sch Med Sci, Dept Biochem, Henry Wellcome Integrated Signalling Labs, Bristol BS8 1TD, Avon, England; [Patel, Kalpana] GlaxoSmithKline Inc, Dept High Throughput Biol Cell Physiol, Harlow, Essex, England	University of Bristol; GlaxoSmithKline	Eva, R (corresponding author), Univ Bristol, Sch Med Sci, Dept Biochem, Henry Wellcome Integrated Signalling Labs, Bristol BS8 1TD, Avon, England.	g.banting@bristol.ac.uk	Eva, Richard/J-7865-2017	Eva, Richard/0000-0003-0305-0452; Banting, George/0000-0001-8249-1621; Cullen, Peter/0000-0002-9070-8349	BBSRC; CASE Studentship; GlaxoSmithKline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CASE Studentship; GlaxoSmithKline(GlaxoSmithKline)	This work was supported by funding from the BBSRC and CASE Studentship with GlaxoSmithKline (www.bbsrc.ac.uk, www.gsk.co.uk). The BBSRC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GSK contributed to a small percentage of the funding. Kalpana Patel was employed by GSK at the time and contributed to the design of the study. The design of the study on the part of GSK was to investigate the use of fluorescent reporter constructs in PC12 cells for high throughput screening. The decision to pursue investigations of the role of inositol (1,4,5) trisphosphate 3-kinase A in PC12 cell differentiation was not part of the original study design regarding GSK. GSK did not design the study as presented here, however some data was collected and analysed on GSK equipment by Richard Eva. Specifically, neurite outgrowth quantification and analysis was performed on GSK equipment by Richard Eva, who was at the time a PhD student at the University of Bristol. All the data presented in figures 4, 5 and 6 was acquired at the University of Bristol. GSK had no role in the decision to publish or preparation of the manuscript. Kalpana Patel was employed by GSK at the time the data was acquired, but not at the time of the drafting of the manuscript. Cells expressing GFP tagged Inositol (1,4,5) trisphosphate 3-kinase A were sorted for expression levels by Rob Jepras on a FACS machine at GSK. Rob Jepras had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; Chang YT, 2002, CHEMBIOCHEM, V3, P897, DOI 10.1002/1439-7633(20020902)3:9<897::AID-CBIC897>3.0.CO;2-B; CONTRERAS ML, 1993, J NEUROCHEM, V61, P1035, DOI 10.1111/j.1471-4159.1993.tb03617.x; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; GO M, 1993, NEUROSCI LETT, V158, P135, DOI 10.1016/0304-3940(93)90247-I; Huang YH, 2007, SCIENCE, V316, P886, DOI 10.1126/science.1138684; Irvine RF, 1999, CHEM PHYS LIPIDS, V98, P49, DOI 10.1016/S0009-3084(99)00017-1; Irvine RF, 2006, ADV ENZYME REGUL, V46, P314, DOI 10.1016/j.advenzreg.2006.01.009; Ishima T, 2008, PROG NEURO-PSYCHOPH, V32, P1656, DOI 10.1016/j.pnpbp.2008.06.011; Iwashita S, 2007, J BIOL CHEM, V282, P3413, DOI 10.1074/jbc.C600293200; Jia YH, 2008, P NATL ACAD SCI USA, V105, P4739, DOI 10.1073/pnas.0800218105; Jia YH, 2007, IMMUNITY, V27, P453, DOI 10.1016/j.immuni.2007.07.016; Johnson HW, 2009, MOL BIOL CELL, V20, P5166, DOI 10.1091/mbc.E09-01-0083; Jun KS, 1998, LEARN MEMORY, V5, P317; Kim IH, 2004, MOL BRAIN RES, V124, P12, DOI 10.1016/j.molbrainres.2003.12.016; Kim IH, 2009, J NEUROSCI, V29, P14039, DOI 10.1523/JNEUROSCI.2483-09.2009; Kupzig S, 2006, J BIOL CHEM, V281, P9891, DOI 10.1074/jbc.M512802200; Marechal Y, 2007, P NATL ACAD SCI USA, V104, P13978, DOI 10.1073/pnas.0704312104; Mayr GW, 2005, J BIOL CHEM, V280, P13229, DOI 10.1074/jbc.M500545200; Miller AT, 2008, CELL CYCLE, V7, P463, DOI 10.4161/cc.7.4.5518; Miller AT, 2007, NAT IMMUNOL, V8, P514, DOI 10.1038/ni1458; Miller AT, 2009, J IMMUNOL, V182, P4696, DOI 10.4049/jimmunol.0802850; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; Nash MS, 2002, J BIOL CHEM, V277, P35947, DOI 10.1074/jbc.M205622200; Nishimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002558; Pattni K, 2004, CELL SIGNAL, V16, P643, DOI 10.1016/j.cellsig.2003.10.009; Pouillon V, 2003, NAT IMMUNOL, V4, P1136, DOI 10.1038/ni980; Rong R, 2003, J BIOL CHEM, V278, P52497, DOI 10.1074/jbc.M306744200; Schell MJ, 2010, CELL MOL LIFE SCI, V67, P1755, DOI 10.1007/s00018-009-0238-5; Schell MJ, 2001, J BIOL CHEM, V276, P37537, DOI 10.1074/jbc.M104101200; Szinyei C, 1999, J PHYSIOL-LONDON, V516, P855, DOI 10.1111/j.1469-7793.1999.0855u.x; Togashi S, 1997, BIOCHEM J, V326, P221, DOI 10.1042/bj3260221; VANWEYENBERG V, 1995, BIOCHEM J, V306, P429, DOI 10.1042/bj3060429; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Wen BG, 2004, P NATL ACAD SCI USA, V101, P5604, DOI 10.1073/pnas.0306907101; Woodring PJ, 1997, J BIOL CHEM, V272, P30447, DOI 10.1074/jbc.272.48.30447; YAMADA M, 1993, BRAIN RES, V606, P335, DOI 10.1016/0006-8993(93)91004-C; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	38	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32386	10.1371/journal.pone.0032386	http://dx.doi.org/10.1371/journal.pone.0032386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384237	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500100
J	Goransson, J; Ke, RQ; Nong, RY; Howell, WM; Karman, A; Grawe, J; Stenberg, J; Granberg, M; Elgh, M; Herthnek, D; Wikstrom, P; Jarvius, J; Nilsson, M				Goransson, Jenny; Ke, Rongqin; Nong, Rachel Yuan; Howell, W. Mathias; Karman, Anna; Grawe, Jan; Stenberg, Johan; Granberg, Malin; Elgh, Magnus; Herthnek, David; Wikstrom, Per; Jarvius, Jonas; Nilsson, Mats			Rapid Identification of Bio-Molecules Applied for Detection of Biosecurity Agents Using Rolling Circle Amplification	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; FRANCISELLA-TULARENSIS; PROXIMITY LIGATION; MAGNETIC BIOSENSOR; PROTEIN-DETECTION; YERSINIA-PESTIS; PADLOCK PROBES; IN-SITU; ASSAYS; PCR	Detection and identification of pathogens in environmental samples for biosecurity applications are challenging due to the strict requirements on specificity, sensitivity and time. We have developed a concept for quick, specific and sensitive pathogen identification in environmental samples. Target identification is realized by padlock- and proximity probing, and reacted probes are amplified by RCA (rolling-circle amplification). The individual RCA products are labeled by fluorescence and enumerated by an instrument, developed for sensitive and rapid digital analysis. The concept is demonstrated by identification of simili biowarfare agents for bacteria (Escherichia coli and Pantoea agglomerans) and spores (Bacillus atrophaeus) released in field.	[Goransson, Jenny; Ke, Rongqin; Nong, Rachel Yuan; Howell, W. Mathias; Herthnek, David; Jarvius, Jonas; Nilsson, Mats] Uppsala Univ, SciLifeLab, Dept Immunol Genet & Pathol, Rudbeck Lab, Uppsala, Sweden; [Karman, Anna] Dag Hammarskjolds Vag, Olink AB, Uppsala, Sweden; [Goransson, Jenny; Karman, Anna; Grawe, Jan; Stenberg, Johan; Elgh, Magnus; Jarvius, Jonas] Dag Hammarskjolds, Q Linea AB, Uppsala, Sweden; [Granberg, Malin; Wikstrom, Per] Swedish Def Res Agcy, Umea, Sweden	SciLifeLab; Uppsala University; Saab Group	Goransson, J (corresponding author), Uppsala Univ, SciLifeLab, Dept Immunol Genet & Pathol, Rudbeck Lab, Uppsala, Sweden.	mats.nilsson@igp.uu.se	Ke, Rongqin/P-2701-2019; Nong, Rachel Yuan/AAM-1591-2020	Ke, Rongqin/0000-0002-9868-3713; 	Wallenberg Foundation; Swedish Research Council; EU; Swedish Defense Nanotechnology Program	Wallenberg Foundation(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); EU(European Commission); Swedish Defense Nanotechnology Program	This work was supported by grants from the Wallenberg Foundation, the Swedish Research Council, the EU FP7 project "READNA" and the Swedish Defense Nanotechnology Program. Q-linea and Olink funded this study through the employment of JG, AK, J Gr, JS, ME, JJ. The contributions of these authors are listed in the author contribution section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baner J, 1998, NUCLEIC ACIDS RES, V26, P5073, DOI 10.1093/nar/26.22.5073; BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; Campbell GA, 2007, ANAL CHEM, V79, P1145, DOI 10.1021/ac060982b; Conze T, 2009, ANNU REV ANAL CHEM, V2, P215, DOI 10.1146/annurev-anchem-060908-155239; Dahl F, 2004, P NATL ACAD SCI USA, V101, P4548, DOI 10.1073/pnas.0400834101; Darmanis S, 2010, MOL CELL PROTEOMICS, V9, P327, DOI 10.1074/mcp.M900248-MCP200; DelVecchio VG, 2006, APPL ENVIRON MICROB, V72, P6355, DOI 10.1128/AEM.00455-06; Derzelle S, 2011, J CLIN MICROBIOL, V49, P4286, DOI 10.1128/JCM.05439-11; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Fredriksson S, 2008, CLIN CHEM, V54, P582, DOI 10.1373/clinchem.2007.093195; Fredriksson S, 2007, NAT METHODS, V4, P327, DOI 10.1038/NMETH1020; Garnier L, 2009, APPL ENVIRON MICROB, V75, P1614, DOI 10.1128/AEM.02120-08; Janse I, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-314; Jarvius J, 2006, NAT METHODS, V3, P725, DOI 10.1038/NMETH916; Kamali-Moghaddam M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-124; Kane SR, 2009, J MICROBIOL METH, V76, P278, DOI 10.1016/j.mimet.2008.12.005; Landegren U, 2003, COMP FUNCT GENOM, V4, P525, DOI 10.1002/cfg.326; LANDEGREN U, 1988, SCIENCE, V241, P1077, DOI 10.1126/science.3413476; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; Lundberg M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004978; Matero P, 2011, CLIN MICROBIOL INFEC, V17, P34, DOI 10.1111/j.1469-0691.2010.03178.x; Meyer MHF, 2007, J MAGN MAGN MATER, V311, P259, DOI 10.1016/j.jmmm.2006.10.1175; Meyer MHF, 2007, J MICROBIOL METH, V68, P218, DOI 10.1016/j.mimet.2006.08.004; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Nilsson M, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf065; Okinaka R, 2006, PLOS PATHOG, V2, P1025, DOI 10.1371/journal.ppat.0020122; Opel KL, 2010, J FORENSIC SCI, V55, P25, DOI 10.1111/j.1556-4029.2009.01245.x; Pedero M, 2011, ELECTROANAL, V22, P1; Pohl G, 2004, EXPERT REV MOL DIAGN, V4, P41, DOI 10.1586/14737159.4.1.41; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Trung TT, 2011, APPL ENVIRON MICROB, V77, P6486, DOI 10.1128/AEM.00735-11; Velusamy V, 2010, BIOTECHNOL ADV, V28, P232, DOI 10.1016/j.biotechadv.2009.12.004; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Vogler AJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001319; Vogler AJ, 2009, J BACTERIOL, V191, P2474, DOI 10.1128/JB.01786-08; Walt DR, 2000, ANAL CHEM, V72, p738A, DOI 10.1021/ac003002a	36	39	41	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31068	10.1371/journal.pone.0031068	http://dx.doi.org/10.1371/journal.pone.0031068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22383994	gold, Green Published, Green Submitted			2022-12-27	WOS:000302875500012
J	Hsu, CJ; Hsieh, WT; Waldman, A; Clarke, F; Huseby, ES; Burkhardt, JK; Baumgart, T				Hsu, Chih-Jung; Hsieh, Wan-Ting; Waldman, Abraham; Clarke, Fiona; Huseby, Eric S.; Burkhardt, Janis K.; Baumgart, Tobias			Ligand Mobility Modulates Immunological Synapse Formation and T Cell Activation	PLOS ONE			English	Article							SUPPORTED LIPID-BILAYERS; FC-EPSILON-RI; RECEPTOR MICROCLUSTERS; IMMUNE SYNAPSE; MEMBRANE DYNAMICS; ANTIGEN RECEPTOR; LATERAL MOBILITY; DENDRITIC CELLS; PROTEIN; ACTIN	T cell receptor (TCR) engagement induces clustering and recruitment to the plasma membrane of many signaling molecules, including the protein tyrosine kinase zeta-chain associated protein of 70 kDa (ZAP70) and the adaptor SH2 domain-containing leukocyte protein of 76 kDa (SLP76). This molecular rearrangement results in formation of the immunological synapse (IS), a dynamic protein array that modulates T cell activation. The current study investigates the effects of apparent long-range ligand mobility on T cell signaling activity and IS formation. We formed stimulatory lipid bilayers on glass surfaces from binary lipid mixtures with varied composition, and characterized these surfaces with respect to diffusion coefficient and fluid connectivity. Stimulatory ligands coupled to these surfaces with similar density and orientation showed differences in their ability to activate T cells. On less mobile membranes, central supramolecular activation cluster (cSMAC) formation was delayed and the overall accumulation of CD3f at the IS was reduced. Analysis of signaling microcluster (MC) dynamics showed that ZAP70 MCs exhibited faster track velocity and longer trajectories as a function of increased ligand mobility, whereas movement of SLP76 MCs was relatively insensitive to this parameter. Actin retrograde flow was observed on all surfaces, but cell spreading and subsequent cytoskeletal contraction were more pronounced on mobile membranes. Finally, increased tyrosine phosphorylation and persistent elevation of intracellular Ca2+ were observed in cells stimulated on fluid membranes. These results point to ligand mobility as an important parameter in modulating T cell responses.	[Hsu, Chih-Jung; Hsieh, Wan-Ting; Waldman, Abraham; Baumgart, Tobias] Univ Penn, Childrens Hosp Philadelphia, Dept Chem, Philadelphia, PA 19104 USA; [Hsu, Chih-Jung; Hsieh, Wan-Ting; Waldman, Abraham; Clarke, Fiona; Burkhardt, Janis K.; Baumgart, Tobias] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Clarke, Fiona; Burkhardt, Janis K.] Univ Penn, Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Huseby, Eric S.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Massachusetts System; University of Massachusetts Worcester	Hsu, CJ (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Dept Chem, Philadelphia, PA 19104 USA.	jburkhar@mail.med.upenn.edu; baumgart@sas.upenn.edu		Burkhardt, Janis/0000-0002-8176-1375	NIH [R21AI073409, R01GM097552, R01AI065644]; University of Pennsylvania Nano/Bio Interface Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065644, R21AI073409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097552] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Nano/Bio Interface Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R21AI073409 and R01GM097552 to TB, NIH grant R01AI065644 to JKB, and an Innovation Award from the University of Pennsylvania Nano/Bio Interface Center to TB and JKB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Baker RG, 2009, MOL CELL BIOL, V29, P5578, DOI 10.1128/MCB.00283-09; Balagopalan L, 2011, NAT REV IMMUNOL, V11, P21, DOI 10.1038/nri2903; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Barr VA, 2006, TRAFFIC, V7, P1143, DOI 10.1111/j.1600-0854.2006.00464.x; BERRYMAN JG, 1983, PHYS REV A, V27, P1053, DOI 10.1103/PhysRevA.27.1053; Borg C, 2004, BLOOD, V104, P3267, DOI 10.1182/blood-2004-01-0380; Bouma G, 2011, BLOOD, V118, P2492, DOI 10.1182/blood-2011-03-340265; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2006, MOL CELL BIOL, V26, P7155, DOI 10.1128/MCB.00507-06; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Carrizosa E, 2009, J IMMUNOL, V183, P7352, DOI 10.4049/jimmunol.0900973; Carroll-Portillo A, 2010, J IMMUNOL, V184, P1328, DOI 10.4049/jimmunol.0903071; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Forstner MB, 2006, J AM CHEM SOC, V128, P15221, DOI 10.1021/ja064093h; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; Giocondi MC, 2001, LANGMUIR, V17, P1653, DOI 10.1021/la0012135; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hartman NC, 2009, P NATL ACAD SCI USA, V106, P12729, DOI 10.1073/pnas.0902621106; Hashimoto-Tane A, 2011, IMMUNITY, V34, P919, DOI 10.1016/j.immuni.2011.05.012; Horton MR, 2007, LANGMUIR, V23, P6263, DOI 10.1021/la063690e; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; JACOBS R, 1979, BIOCHEMISTRY-US, V18, P3280, DOI 10.1021/bi00582a013; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; LEE SB, 1990, PHYS REV A, V41, P5338, DOI 10.1103/PhysRevA.41.5338; Lou C, 2007, LANGMUIR, V23, P9752, DOI 10.1021/la701399s; MABREY S, 1976, P NATL ACAD SCI USA, V73, P3862, DOI 10.1073/pnas.73.11.3862; Manz BN, 2010, NAT REV MOL CELL BIO, V11, P342, DOI 10.1038/nrm2883; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; Purbhoo MA, 2010, SCI SIGNAL, V3, P10; Ratanabanangkoon P, 2002, LANGMUIR, V18, P4270, DOI 10.1021/la025568v; Ratto TV, 2002, BIOPHYS J, V83, P3380, DOI 10.1016/S0006-3495(02)75338-1; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Seantier B, 2004, NANO LETT, V4, P5, DOI [10.1021/nl034590l, 10.1021/nl0345901]; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; Spendier K, 2010, BIOPHYS J, V99, P388, DOI 10.1016/j.bpj.2010.04.029; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; VAZ WLC, 1989, BIOPHYS J, V56, P869, DOI 10.1016/S0006-3495(89)82733-X; VAZ WLC, 1990, BIOPHYS J, V58, P273, DOI 10.1016/S0006-3495(90)82373-0; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yokosuka T, 2009, IMMUNOL REV, V229, P27, DOI 10.1111/j.1600-065X.2009.00779.x	46	45	46	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32398	10.1371/journal.pone.0032398	http://dx.doi.org/10.1371/journal.pone.0032398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384241	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500101
J	Schaue, D; Ratikan, JA; Iwamoto, KS				Schaue, Doerthe; Ratikan, Josephine A.; Iwamoto, Keisuke S.			Cellular Autofluorescence following Ionizing Radiation	PLOS ONE			English	Article							LASER-INDUCED FLUORESCENCE; OXIDATIVE PHOSPHORYLATION; CANCER-CELLS; NADH; DNA; SPECTROSCOPY; FIBROBLASTS; RESPONSES; REVEALS; NAD(P)H	Cells often autofluoresce in response to UV radiation excitation and this can reflect critical aspects of cellular metabolism. Here we report that many different human and murine cell types respond to ionizing radiation with a striking rise in autofluorescence that is dependent on dose and time. There was a highly reproducible fluorescent shift at various wavelengths, which was mirrored by an equally reproducible rise in the vital intracellular metabolic co-factors FAD and NADH. It appears that mitochondria, metabolism and Ca2+ homeostasis are important for this to occur as cells without mitochondria or cells unable to alter calcium levels did not behave in this way. We believe these radiation-induced changes are of biological importance and that autofluorescence may even provide us with a tool to monitor radiation responses in the clinic.	[Schaue, Doerthe; Ratikan, Josephine A.; Iwamoto, Keisuke S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Schaue, D (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	dschaue@mednet.ucla.edu			Department of Defense [PC060403, BC094391]; National Institute of Allergy and Infectious Diseases [2U19 AI-67769]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067769] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Department of Defense PC060403 (DS), the Department of Defense BC094391 (DS), and a National Institute of Allergy and Infectious Diseases Seed grant 2U19 AI-67769 (DS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFANO RR, 1984, IEEE J QUANTUM ELECT, V20, P1507, DOI 10.1109/JQE.1984.1072322; Andersson H, 1998, J MICROSC-OXFORD, V191, P1; Andrews BJ, 2006, J BIOL CHEM, V281, P13596, DOI 10.1074/jbc.M512787200; AUBIN JE, 1979, J HISTOCHEM CYTOCHEM, V27, P36, DOI 10.1177/27.1.220325; Backman SA, 2002, CURR OPIN NEUROBIOL, V12, P516, DOI 10.1016/S0959-4388(02)00354-9; BENSON RC, 1979, J HISTOCHEM CYTOCHEM, V27, P44, DOI 10.1177/27.1.438504; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; Croce AC, 1999, PHOTOCHEM PHOTOBIOL, V69, P364, DOI 10.1562/0031-8655(1999)069<0364:DOFAPO>2.3.CO;2; DaCosta RS, 2005, J CLIN PATHOL, V58, P766, DOI 10.1136/jcp.2004.023804; DESJARDINS P, 1985, MOL CELL BIOL, V5, P1163, DOI 10.1128/MCB.5.5.1163; Fujibayashi Y, 1997, RADIAT RES, V147, P729, DOI 10.2307/3579487; JAMIESON D, 1966, NATURE, V209, P361, DOI 10.1038/209361a0; KUNZ WS, 1994, ANAL BIOCHEM, V216, P322, DOI 10.1006/abio.1994.1048; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lee C, 2004, CANCER RES, V64, P6906, DOI 10.1158/0008-5472.CAN-04-1767; Levitt JM, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2401149; Ohshima Y, BIOCH BIOPHYS ACTA, V1800, P40; ORD MG, 1955, BRIT J RADIOL, V28, P279, DOI 10.1259/0007-1285-28-329-279; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pan MH, 2008, MOL IMAGING BIOL, V10, P325, DOI 10.1007/s11307-008-0158-z; Patterson GH, 2000, P NATL ACAD SCI USA, V97, P5203, DOI 10.1073/pnas.090098797; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Pellerin L, 2004, SCIENCE, V305, P50, DOI 10.1126/science.1100428; RichardsKortum R, 1996, ANNU REV PHYS CHEM, V47, P555, DOI 10.1146/annurev.physchem.47.1.555; ROEDERER M, 1986, CYTOMETRY, V7, P558, DOI 10.1002/cyto.990070610; Shen ZH, 1997, J IMMUNOL, V158, P2723; Silveira L, 2008, J FLUORESC, V18, P35, DOI 10.1007/s10895-007-0232-y; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; THOMSON JF, 1966, RADIAT RES, V29, P121, DOI 10.2307/3572096; VISTICA DT, 1991, CANCER RES, V51, P2515; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672	32	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32062	10.1371/journal.pone.0032062	http://dx.doi.org/10.1371/journal.pone.0032062			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384140	Green Submitted, Green Published, gold			2022-12-27	WOS:000302875500069
J	Tanabe, LM; Martin, C; Dauer, WT				Tanabe, Lauren M.; Martin, Caitlin; Dauer, William T.			Genetic Background Modulates the Phenotype of a Mouse Model of DYT1 Dystonia	PLOS ONE			English	Article							EARLY-ONSET DYSTONIA; TORSION DYSTONIA; IDIOPATHIC DYSTONIA; NUCLEAR-ENVELOPE; PROTEIN; MICE; ABNORMALITIES; PENETRANCE; GENOTYPE; MUTATION	DYT1 dystonia is a debilitating neurological disease characterized by involuntary twisting movements. The disease is caused by an in-frame deletion (GAG, "Delta E") mutation in the TOR1A gene that encodes the torsinA protein. Intriguingly, only 30% of mutation carriers exhibit motor symptoms despite the fact that functional brain imaging studies show abnormal brain metabolism in all carriers. Because genetic modifiers may be a determinant of this reduced penetrance, we examined the genetic contribution of three different inbred strains of mice on the DYT1 mutation in animals that are homozygous (Tor1a(Delta E/Delta E)) or heterozygous (Tor1a(Delta E/+); disease state) for the disease-causing Delta E mutation. We find that the DBA/2J, C57BL/6J, and CD1-ICR contribution of genes significantly alter lifespan in Tor1a(Delta E/Delta E) mice, which die during the first few days of life on the 129S6/SvEvTac (129) background. The C57BL/6J (B6) strain significantly decreases life expectancy of Tor1a(Delta E/Delta E) animals but, like 129S6/SvEvTac Tor1a(Delta E/+) mice, congenic C57BL/6J Tor1a(Delta E/+) mice do not exhibit any motor abnormalities. In contrast, the DBA/2J (D2) strain significantly increases life expectancy. This effect was not present in congenic DBA/2J Tor1a(Delta E/Delta E) mice, indicating that the extended lifespan of F2 129/D2 mice was due to a combination of homozygous and heterozygous allelic effects. Our observations suggest that genetic modifiers may alter the penetrance of the DE mutation, and that mapping these modifiers may provide fresh insight into the torsinA molecular pathway.	[Tanabe, Lauren M.; Dauer, William T.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI 48109 USA; [Martin, Caitlin] Emory Univ, Sch Med, Atlanta, GA USA; [Dauer, William T.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; Emory University; University of Michigan System; University of Michigan	Tanabe, LM (corresponding author), Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI 48109 USA.	dauer@med.umich.edu		Dauer, William/0000-0003-1775-7504; Tanabe, Lauren/0000-0003-1760-3468	Dystonia Medical Research Foundation	Dystonia Medical Research Foundation	These experiments were funded by the Dystonia Medical Research Foundation. The link for this foundation can be found at http://www.dystonia-foundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyelan M, 2009, J NEUROSCI, V29, P9740, DOI 10.1523/JNEUROSCI.2300-09.2009; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bressman SB, 2007, PARKINSONISM RELAT D, V13, pS347, DOI 10.1016/S1353-8020(08)70029-4; Carbon M, 2004, NEUROLOGY, V62, P1384, DOI 10.1212/01.WNL.0000120541.97467.FE; Clarimon J, 2005, ANN NEUROL, V57, P765, DOI 10.1002/ana.20485; Cookson MR, 2005, NEURON, V48, P875, DOI 10.1016/j.neuron.2005.12.006; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; Eidelberg D, 1998, ANN NEUROL, V44, P303, DOI 10.1002/ana.410440304; Giles LM, 2009, J BIOL CHEM, V284, P21765, DOI 10.1074/jbc.M109.004838; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Grundmann K, 2007, NEUROBIOL DIS, V27, P190, DOI 10.1016/j.nbd.2007.04.015; Kamm C, 2006, NEUROLOGY, V67, P1857, DOI 10.1212/01.wnl.0000244423.63406.17; Kearney JA, 2011, CURR OPIN GENET DEV, V21, P349, DOI 10.1016/j.gde.2010.12.007; Kim CE, 2010, P NATL ACAD SCI USA, V107, P9861, DOI 10.1073/pnas.0912877107; Leung JC, 2001, NEUROGENETICS, V3, P133, DOI 10.1007/s100480100111; Martella G, 2009, BRAIN, V132, P2336, DOI 10.1093/brain/awp194; Nadeau JH, 2005, NEW ENGL J MED, V352, P1598, DOI 10.1056/NEJMe058054; Napolitano F, 2010, J NEUROSCI, V30, P11043, DOI 10.1523/JNEUROSCI.1682-10.2010; Niethammer M, 2011, NEUROBIOL DIS, V42, P202, DOI 10.1016/j.nbd.2010.10.010; OZELIUS L, 1989, NEURON, V2, P1427, DOI 10.1016/0896-6273(89)90188-8; Ozelius LJ, 1999, GENOMICS, V62, P377, DOI 10.1006/geno.1999.6039; Pisani A, 2006, NEUROBIOL DIS, V24, P318, DOI 10.1016/j.nbd.2006.07.006; Risch NJ, 2007, AM J HUM GENET, V80, P1188, DOI 10.1086/518427; Shakkottai VG, 2011, J NEUROSCI, V31, P13002, DOI 10.1523/JNEUROSCI.2789-11.2011; Sharma N, 2005, J NEUROSCI, V25, P5351, DOI 10.1523/JNEUROSCI.0855-05.2005; Shashidharan P, 2005, HUM MOL GENET, V14, P125, DOI 10.1093/hmg/ddi012; Tanabe LM, 2009, NAT REV NEUROL, V5, P598, DOI 10.1038/nrneurol.2009.160; Trost M, 2002, ANN NEUROL, V52, P853, DOI 10.1002/ana.10418; Ulug AM, 2011, P NATL ACAD SCI USA, V108, P6638, DOI 10.1073/pnas.1016445108	31	38	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32245	10.1371/journal.pone.0032245	http://dx.doi.org/10.1371/journal.pone.0032245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393392	Green Submitted, Green Published, gold			2022-12-27	WOS:000303003500045
J	Totir, M; Echols, N; Nanao, M; Gee, CL; Moskaleva, A; Gradia, S; Iavarone, AT; Berger, JM; May, AP; Zubieta, C; Alber, T				Totir, Monica; Echols, Nathaniel; Nanao, Max; Gee, Christine L.; Moskaleva, Alisa; Gradia, Scott; Iavarone, Anthony T.; Berger, James M.; May, Andrew P.; Zubieta, Chloe; Alber, Tom			Macro-to-Micro Structural Proteomics: Native Source Proteins for High-Throughput Crystallization	PLOS ONE			English	Article							ALDO-KETO REDUCTASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; MOLECULAR-REPLACEMENT; PHOSPHOGLUCOSE ISOMERASE; MASS-SPECTROMETRY; REFINEMENT; RESOLUTION; DENSITY; COMPLEX	Structural biology and structural genomics projects routinely rely on recombinantly expressed proteins, but many proteins and complexes are difficult to obtain by this approach. We investigated native source proteins for high-throughput protein crystallography applications. The Escherichia coli proteome was fractionated, purified, crystallized, and structurally characterized. Macro-scale fermentation and fractionation were used to subdivide the soluble proteome into 408 unique fractions of which 295 fractions yielded crystals in microfluidic crystallization chips. Of the 295 crystals, 152 were selected for optimization, diffraction screening, and data collection. Twenty-three structures were determined, four of which were novel. This study demonstrates the utility of native source proteins for high-throughput crystallography.	[Totir, Monica; Echols, Nathaniel; Gee, Christine L.; Moskaleva, Alisa; Berger, James M.; Zubieta, Chloe; Alber, Tom] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Nanao, Max] European Mol Biol Lab, F-38042 Grenoble, France; [Gradia, Scott; Iavarone, Anthony T.] QB3 Inst, Berkeley, CA USA; [May, Andrew P.] Fluidigm Corp, San Francisco, CA USA	University of California System; University of California Berkeley; European Molecular Biology Laboratory (EMBL)	Totir, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	zubieta@esrf.fr; tom@ucxray.berkeley.edu	Nanao, Max/ABA-9292-2021	Gee, Christine/0000-0002-2632-6418; Nanao, Max/0000-0002-6340-1376; Zubieta, Chloe/0000-0003-4558-9333	University of California Office of the President UC [bio06583]; W.M. Keck Foundation; National Institutes of Health (NIH) [P01 AI068135]; Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, of the US Department of Energy (DOE) at Lawrence Berkeley National Laboratory [DE-AC03-76SF00098]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068135] Funding Source: NIH RePORTER	University of California Office of the President UC(University of California System); W.M. Keck Foundation(W.M. Keck Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, of the US Department of Energy (DOE) at Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the University of California Office of the President UC Discovery Grant matched by the Fluidigm Corporation (bio06583; T.A.), a grant from the W.M. Keck Foundation (T.A. and J.M.B.) and National Institutes of Health (NIH) P01 AI068135 (T.A. and J.M.B.). The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, of the US Department of Energy (DOE) under Contract No. DE-AC03-76SF00098 at Lawrence Berkeley National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine P., 2005, CCP4 NEWSLETTER, V42; Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Babnigg Gyoergy, 2010, Journal of Structural and Functional Genomics, V11, P71, DOI 10.1007/s10969-010-9080-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker MG, 2011, J INFECT; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Chen YJ, 1999, RAPID COMMUN MASS SP, V13, P1907, DOI 10.1002/(SICI)1097-0231(19991015)13:19<1907::AID-RCM732>3.0.CO;2-T; Das R, 2009, ACTA CRYSTALLOGR D, V65, P169, DOI 10.1107/S0907444908020039; Davies C, 2002, PROTEINS, V49, P577, DOI 10.1002/prot.10255; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fox BG, 2008, NAT METHODS, V5, P129, DOI 10.1038/nmeth0208-129; Grant AW, 2003, FEMS MICROBIOL LETT, V218, P93, DOI 10.1111/j.1574-6968.2003.tb11503.x; Hansen CL, 2006, J AM CHEM SOC, V128, P3142, DOI 10.1021/ja0576637; Hansen CL, 2002, P NATL ACAD SCI USA, V99, P16531, DOI 10.1073/pnas.262485199; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; HUDSON JI, 1993, JAMA-J AM MED ASSOC, V269, P3108, DOI 10.1001/jama.269.24.3108; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jin XY, 1999, RAPID COMMUN MASS SP, V13, P2327, DOI 10.1002/(SICI)1097-0231(19991215)13:23<2327::AID-RCM792>3.0.CO;2-2; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Khatib F, 2011, NAT STRUCT MOL BIOL, V18, P1175, DOI 10.1038/nsmb.2119; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee WH, 2009, MOL CELL ENDOCRINOL, V301, P199, DOI 10.1016/j.mce.2008.09.042; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Li L, 2010, ANNU REV BIOPHYS, V39, P139, DOI 10.1146/annurev.biophys.050708.133630; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mujacic M, 2004, MOL MICROBIOL, V51, P849, DOI 10.1046/j.1365-2958.2003.03871.x; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nanao MH, 2005, ACTA CRYSTALLOGR D, V61, P1227, DOI 10.1107/S0907444905019360; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Ravelli RBG, 2005, J SYNCHROTRON RADIAT, V12, P276, DOI 10.1107/S0909049505003286; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Rodriguez DD, 2009, NAT METHODS, V6, P651, DOI [10.1038/NMETH.1365, 10.1038/nmeth.1365]; SAKAMOTO N, 1975, J BACTERIOL, V124, P775, DOI 10.1128/JB.124.2.775-783.1975; Schwarzenbacher R, 2008, ACTA CRYSTALLOGR D, V64, P133, DOI 10.1107/S0907444907050111; Shen YF, 2001, J CHROMATOGR A, V914, P257, DOI 10.1016/S0021-9673(01)00579-9; Sigdel Tara K, 2004, J Biomol Tech, V15, P199; Solomons JTG, 2004, J MOL BIOL, V342, P847, DOI 10.1016/j.jmb.2004.07.085; Stokes-Rees I, 2010, P NATL ACAD SCI USA, V107, P21476, DOI 10.1073/pnas.1012095107; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tartaglia GG, 2009, J MOL BIOL, V388, P381, DOI 10.1016/j.jmb.2009.03.002; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Zwart PH, 2004, ACTA CRYSTALLOGR D, V60, P2230, DOI 10.1107/S0907444904012995	52	24	32	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32498	10.1371/journal.pone.0032498	http://dx.doi.org/10.1371/journal.pone.0032498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393408	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500061
J	Yuan, Y; Chen, HY; Ma, G; Cao, XF; Liu, ZH				Yuan, Yi; Chen, Hongyan; Ma, Gang; Cao, Xiaofeng; Liu, Zhihua			Reelin Is Involved in Transforming Growth Factor-beta 1-Induced Cell Migration in Esophageal Carcinoma Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; GENE-EXPRESSION; TGF-BETA; BREAST-CANCER; METASTASIS; REPRESSOR; PHOSPHORYLATION; MORPHOGENESIS; PATHWAY	Reelin (RELN), which is a glycoprotein secreted by Cajal-Retzius cells of the developing cerebral cortex, plays an important role in neuronal migration, but its role in cell migration and cancer metastasis is largely unclear. Here, we showed that cell motility was significantly increased in KYSE-510 cells by TGF-beta 1 treatment. Moreover, TGF-beta 1 decreased RELN mRNA expression and overexpression of Reelin at least partly reversed TGF-beta 1-induced cell migration in KYSE-30 cells. Furthermore, this negative regulation of Reelin expression by TGF-beta 1 was through Snail, one transcription factor which was induced by TGF-beta 1 in KYSE-510 cells. RELN promoter activity was reduced in parallel with the induction of Snail after TGF-beta 1 treatment and Snail suppressed both RELN promoter activity and expression through binding to E-box sequences in the RELN promoter region in ESCC cells. Knockdown of RELN induced cell migration in KYSE-510 cells, together with the increase of mesenchymal markers expression. Taken together, Reelin is an essential negative regulator in the TGF-beta 1-induced cell migration process, and is suppressed by TGF-beta pathway at the transcriptional level through Snail regulation. Therefore, the correlation of Reelin and TGF-beta pathway was critical in cancer metastasis, and Reelin could be one potential anti-metastasis target in future clinical practice.	[Yuan, Yi; Chen, Hongyan; Ma, Gang; Liu, Zhihua] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Yuan, Yi; Chen, Hongyan; Ma, Gang; Liu, Zhihua] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yuan, Yi; Cao, Xiaofeng] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Key Lab Plant Genom, Beijing, Peoples R China; [Yuan, Yi; Cao, Xiaofeng] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Plant Gene Res, Beijing, Peoples R China; [Yuan, Yi] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yuan, Y (corresponding author), Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100730, Peoples R China.	liuzh@cicams.ac.cn			National Basic Research Program of China [2011CB504205]; National Natural Science Foundation of China [81021061]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2011CB504205) and National Natural Science Foundation of China (81021061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen Y, 2002, NUCLEIC ACIDS RES, V30, P2930, DOI 10.1093/nar/gkf401; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; Dohi O, 2010, INT J ONCOL, V36, P85, DOI 10.3892/ijo_00000478; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gov NS, 2007, P NATL ACAD SCI USA, V104, P15970, DOI 10.1073/pnas.0708037104; Grayson DR, 2006, PHARMACOL THERAPEUT, V111, P272, DOI 10.1016/j.pharmthera.2005.01.007; Han Yaling, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P455; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Ikeda Y, 1997, DEV DYNAM, V210, P157, DOI 10.1002/(SICI)1097-0177(199710)210:2<157::AID-AJA8>3.0.CO;2-F; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; KANDA Y, 1994, INT J CANCER, V58, P291, DOI 10.1002/ijc.2910580224; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lehmann U, 2001, METHODS, V25, P409, DOI 10.1006/meth.2001.1263; Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Okamura Y, 2010, ANN SURG ONCOL; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perrone G, 2007, MODERN PATHOL, V20, P344, DOI 10.1038/modpathol.3800743; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sato N, 2006, GASTROENTEROLOGY, V130, P548, DOI 10.1053/j.gastro.2005.11.008; Sato Y, 2010, AM J PATHOL, V177, P141, DOI 10.2353/ajpath.2010.090747; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Smalheiser NR, 2000, P NATL ACAD SCI USA, V97, P1281, DOI 10.1073/pnas.97.3.1281; Stein T, 2010, AM J PATHOL, V177, P2323, DOI 10.2353/ajpath.2010.100209; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Wang Q, 2002, CANCER LETT, V179, P71, DOI 10.1016/S0304-3835(01)00846-1; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	47	51	52	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31802	10.1371/journal.pone.0031802	http://dx.doi.org/10.1371/journal.pone.0031802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393371	gold, Green Submitted, Green Published			2022-12-27	WOS:000303003500024
J	Bousbia, S; Papazian, L; Saux, P; Forel, JM; Auffray, JP; Martin, C; Raoult, D; La Scola, B				Bousbia, Sabri; Papazian, Laurent; Saux, Pierre; Forel, Jean Marie; Auffray, Jean-Pierre; Martin, Claude; Raoult, Didier; La Scola, Bernard			Repertoire of Intensive Care Unit Pneumonia Microbiota	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; BRONCHOALVEOLAR LAVAGE FLUID; MOLECULAR ANALYSIS; DENTAL PLAQUE; DIAGNOSIS; BACTERIA; CYTOMEGALOVIRUS; IDENTIFICATION; INFECTIONS; PATHOGENS	Despite the considerable number of studies reported to date, the causative agents of pneumonia are not completely identified. We comprehensively applied modern and traditional laboratory diagnostic techniques to identify microbiota in patients who were admitted to or developed pneumonia in intensive care units (ICUs). During a three-year period, we tested the bronchoalveolar lavage (BAL) of patients with ventilator-associated pneumonia, community-acquired pneumonia, non-ventilator ICU pneumonia and aspiration pneumonia, and compared the results with those from patients without pneumonia (controls). Samples were tested by amplification of 16S rDNA, 18S rDNA genes followed by cloning and sequencing and by PCR to target specific pathogens. We also included culture, amoeba co-culture, detection of antibodies to selected agents and urinary antigen tests. Based on molecular testing, we identified a wide repertoire of 160 bacterial species of which 73 have not been previously reported in pneumonia. Moreover, we found 37 putative new bacterial phylotypes with a 16S rDNA gene divergence >= 98% from known phylotypes. We also identified 24 fungal species of which 6 have not been previously reported in pneumonia and 7 viruses. Patients can present up to 16 different microorganisms in a single BAL (mean +/- SD; 3.77 +/- 2.93). Some pathogens considered to be typical for ICU pneumonia such as Pseudomonas aeruginosa and Streptococcus species can be detected as commonly in controls as in pneumonia patients which strikingly highlights the existence of a core pulmonary microbiota. Differences in the microbiota of different forms of pneumonia were documented.	[Bousbia, Sabri; Raoult, Didier; La Scola, Bernard] CNRS IRD UMR 6236, Fac Med, URMITE, Marseille, France; [Papazian, Laurent; Forel, Jean Marie; Auffray, Jean-Pierre] Hop Nord Marseille, Serv Reanimat Med, Marseille, France; [Saux, Pierre] Hop Enfants La Timone, Dept Anesthesie Reanimat, Marseille, France; [Martin, Claude] Hop Nord Marseille, Dept Anesthesie Reanimat, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Bousbia, S (corresponding author), CNRS IRD UMR 6236, Fac Med, URMITE, Marseille, France.	bernard.lascola@univmed.fr	LA SCOLA, Bernard/P-6477-2016; RAOULT, Didier/A-8434-2008	LA SCOLA, Bernard/0000-0001-8006-7704; RAOULT, Didier/0000-0002-0633-5974	Programme Hospitalier de Recherche Clinique	Programme Hospitalier de Recherche Clinique	This work was supported by a grant from the Programme Hospitalier de Recherche Clinique 2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Armougom F, 2009, EUR J CLIN MICROBIOL, V28, P1151, DOI 10.1007/s10096-009-0749-x; Bahrani-Mougeot FK, 2007, J CLIN MICROBIOL, V45, P1588, DOI 10.1128/JCM.01963-06; BERDAL BP, 1979, J CLIN MICROBIOL, V9, P575; Berger P, 2006, EMERG INFECT DIS, V12, P248; Bittar F, 2008, EMERG INFECT DIS, V14, P997, DOI 10.3201/eid1406.071236; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Bousbia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011298; Bousbia S, 2010, EMERG INFECT DIS, V16, P258, DOI 10.3201/eid1602.090610; Bouza E, 2010, J CRIT CARE; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Chiche L, 2009, CRIT CARE MED, V37, P1850, DOI 10.1097/CCM.0b013e31819ffea6; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Drancourt M, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000083; DUPONT HT, 1994, CLIN DIAGN LAB IMMUN, V1, P189, DOI 10.1128/CDLI.1.2.189-196.1994; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Esperatti M, 2010, AM J RESP CRIT CARE; Fournier PE, 2002, CLIN DIAGN LAB IMMUN, V9, P795, DOI 10.1128/CDLI.9.4.795-801.2002; Fourrier F, 1998, CRIT CARE MED, V26, P301, DOI 10.1097/00003246-199802000-00032; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Haider S, 2008, FEMS MICROBIOL LETT, V281, P198, DOI 10.1111/j.1574-6968.2008.01099.x; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Heo SM, 2008, CLIN INFECT DIS, V47, P1562, DOI 10.1086/593193; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hoffman LR, 2006, P NATL ACAD SCI USA, V103, P19890, DOI 10.1073/pnas.0606756104; Kawanami T, 2009, J CLIN MICROBIOL, V47, P496, DOI 10.1128/JCM.01429-08; Khlif M, 2009, CLIN MICROBIOL INFEC, V15, P656, DOI 10.1111/j.1469-0691.2009.02762.x; La Scola B, 2000, FEMS MICROBIOL ECOL, V34, P129, DOI 10.1016/S0168-6496(00)00084-2; La Scola B, 2003, EMERG INFECT DIS, V9, P815, DOI 10.3201/eid0907.030065; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; Luyt CE, 2008, CURR OPIN CRIT CARE, V14, P605, DOI 10.1097/MCC.0b013e32830f1e12; Mailman Timothy L, 2005, Can J Infect Dis Med Microbiol, V16, P245; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; Munson MA, 2002, J DENT RES, V81, P761, DOI 10.1177/154405910208101108; Murray PR., 2007, MANUAL CLIN MICROBIO, P1004; Papazian L, 1996, ANESTHESIOLOGY, V84, P280, DOI 10.1097/00000542-199602000-00005; Peleg AY, 2008, P NATL ACAD SCI USA, V105, P14585, DOI 10.1073/pnas.0805048105; POTGIETER PD, 1992, CHEST, V101, P199, DOI 10.1378/chest.101.1.199; Qin ZQ, 2009, MICROBIOL-SGM, V155, P2148, DOI 10.1099/mic.0.028001-0; Roux D, 2009, CRIT CARE MED, V37, P1062, DOI 10.1097/CCM.0b013e31819629d2; Sakamoto M, 2006, ORAL MICROBIOL IMMUN, V21, P112, DOI 10.1111/j.1399-302X.2006.00270.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torres A, 2000, CHEST, V117, p198S, DOI 10.1378/chest.117.4_suppl_2.198S; Vial L, 2008, J BACTERIOL, V190, P5339, DOI 10.1128/JB.00400-08; Vincent A, 2009, CRIT CARE MED, V37, P111, DOI 10.1097/CCM.0b013e318192fa8b; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; ZURAVLEFF JJ, 1983, JAMA-J AM MED ASSOC, V250, P1981, DOI 10.1001/jama.250.15.1981	49	76	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32486	10.1371/journal.pone.0032486	http://dx.doi.org/10.1371/journal.pone.0032486			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389704	Green Submitted, gold, Green Published			2022-12-27	WOS:000302999600042
J	Jiang, BC; Nie, JH; Zhou, Z; Zhang, J; Tong, J; Cao, Y				Jiang, Bingcheng; Nie, Jihua; Zhou, Zhen; Zhang, Jie; Tong, Jian; Cao, Yi			Adaptive Response in Mice Exposed to 900 MHz Radiofrequency Fields: Primary DNA Damage	PLOS ONE			English	Article							RAT-BRAIN CELLS; HUMAN-LYMPHOCYTES; MICROWAVE-RADIATION; IONIZING-RADIATION; GAMMA-RAYS; VARIABILITY; REPAIR; BREAKS	The phenomenon of adaptive response (AR) in animal and human cells exposed to ionizing radiation is well documented in scientific literature. We have examined whether such AR could be induced in mice exposed to non-ionizing radiofrequency fields (RF) used for wireless communications. Mice were pre-exposed to 900 MHz RF at 120 mu W/cm(2) power density for 4 hours/day for 1, 3, 5, 7 and 14 days and then subjected to an acute dose of 3 Gy gamma-radiation. The primary DNA damage in the form of alkali labile base damage and single strand breaks in the DNA of peripheral blood leukocytes was determined using the alkaline comet assay. The results indicated that the extent of damage in mice which were pre-exposed to RF for 1 day and then subjected to gamma-radiation was similar and not significantly different from those exposed to gamma-radiation alone. However, mice which were pre-exposed to RF for 3, 5, 7 and 14 days showed progressively decreased damage and was significantly different from those exposed to gamma-radiation alone. Thus, the data indicated that RF pre-exposure is capable of inducing AR and suggested that the pre-exposure for more than 4 hours for 1 day is necessary to elicit such AR.	[Jiang, Bingcheng; Nie, Jihua; Zhou, Zhen; Zhang, Jie; Tong, Jian; Cao, Yi] Soochow Univ, Sch Publ Hlth, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Jiang, BC (corresponding author), Soochow Univ, Sch Publ Hlth, Suzhou, Jiangsu, Peoples R China.	yicao@suda.edu.cn			National Natural Science Foundation of China [81020108028, 81001257]; China Ministry of Science and Technology [2011CB503700]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Ministry of Science and Technology(Ministry of Science and Technology, China); Priority Academic Program Development of Jiangsu Higher Education Institutions	This research is supported by funding from the National Natural Science Foundation of China (nos. 81020108028 and 81001257), 973 project grant from China Ministry of Science and Technology (2011CB503700) and The Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in designing the experiments, data collection and analysis, preparation of the manuscript, and decision to publish the results.	BOSI A, 1989, MUTAT RES, V211, P13, DOI 10.1016/0027-5107(89)90102-4; Cao Y, 2011, INT J RADIAT BIOL, V87, P720, DOI 10.3109/09553002.2010.550981; Cao Y, 2010, J TOXICOL ENV HEAL A, V73, P507, DOI 10.1080/15287390903523451; Heynick LN, 2003, BIOELECTROMAGNETICS, pS74, DOI 10.1002/bem.10162; ICNIRP, 2009, EXP HIGH FREQ EL FIE; Ikushima T, 1996, MUTAT RES-FUND MOL M, V358, P193, DOI 10.1016/S0027-5107(96)00120-0; Kim JH, 1996, J RADIAT RES, V37, P161, DOI 10.1269/jrr.37.161; Kleczkowska HE, 1996, MUTAT RES-FUND MOL M, V358, P215, DOI 10.1016/S0027-5107(96)00123-6; Krishnaja AP, 2008, MUTAGENESIS, V23, P77, DOI 10.1093/mutage/gem045; Lai H, 1996, INT J RADIAT BIOL, V69, P513, DOI 10.1080/095530096145814; LAI H, 1995, BIOELECTROMAGNETICS, V16, P207, DOI 10.1002/bem.2250160309; Lai H., 2007, EVIDENCE GENOTOXIC E; Malyapa RS, 1998, RADIAT RES, V149, P637, DOI 10.2307/3579911; Meltz ML, 2003, BIOELECTROMAGNETICS, pS196, DOI 10.1002/bem.10176; Mortazavi SMJ, 2011, IRAN J RADIAT RES, V9, P9; Moulder JE, 1999, RADIAT RES, V151, P513, DOI 10.2307/3580028; Sannino A, 2011, INT J RADIAT BIOL, V87, P1; Sannino A, 2009, RADIAT RES, V171, P735, DOI 10.1667/RR1687.1; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Verschaeve, 2005, TOXICOL APPL PHARM, V207, pS336, DOI 10.1016/j.taap.2005.03.028; Verschaeve L, 2010, MUTAT RES-REV MUTAT, V705, P252, DOI 10.1016/j.mrrev.2010.10.001; Vijayalaxmi, 2004, RADIAT RES, V162, P481, DOI 10.1667/RR3252; VIJAYALAXMI, 1995, MUTAT RES LETT, V348, P45, DOI 10.1016/0165-7992(95)90020-9; VIJAYALAXMI, 1989, MUTAGENESIS, V4, P187, DOI 10.1093/mutage/4.3.187; Vijayalaxmi, 2008, RADIAT RES, V169, P561, DOI 10.1667/RR0987.1; WIENCKE JK, 1986, MUTAGENESIS, V1, P375, DOI 10.1093/mutage/1.5.375; YOUNGBLOM JH, 1989, MUTAT RES, V227, P257, DOI 10.1016/0165-7992(89)90107-3; ZHANG LZ, 1995, MUTAT RES-ENVIR MUTA, V334, P33, DOI 10.1016/0165-1161(95)90028-4	28	33	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32040	10.1371/journal.pone.0032040	http://dx.doi.org/10.1371/journal.pone.0032040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389679	gold, Green Published, Green Submitted			2022-12-27	WOS:000302999600017
J	Kaitu'u-Lino, TJ; Whitehead, CL; Ngian, GL; Permezel, M; Tong, S				Kaitu'u-Lino, Tu'uhevaha J.; Whitehead, Clare L.; Ngian, Gene-Lyn; Permezel, Michael; Tong, Stephen			Serum Concentrations of Soluble Flt-1 Are Decreased among Women with a Viable Fetus and No Symptoms of Miscarriage Destined for Pregnancy Loss	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OXIDATIVE STRESS; EXPRESSION; OXYGEN; RISK; VASCULARIZATION	Miscarriage is the most common complication of pregnancy. Pre-clinical miscarriage has an estimated incidence of 30%, whilst clinical miscarriage has an incidence of 12-15%. Two thirds of pregnancies lost to miscarriage are believed to be attributable to defective placentation, thus a number of studies have sought to identify markers of defective placentation that could be used as clinical biomarkers of miscarriage. Decreased soluble FMS-like tyrosine kinase-1 (sFlt1), placental growth factor (PlGF), and soluble endoglin (sEng) in the maternal circulation during the first trimester have recently been proposed as potential markers of pregnancy loss. However, in these studies clinical samples were only obtained once women had presented with symptoms of miscarriage. In this study we prospectively screened serum samples collected from asymptomatic women with a viable fetus. We assessed maternal serum levels of sFlt1, PlGF and sEng across the first trimester of normal pregnancy and compared levels between women who continued to a live birth, to those who subsequently miscarried. Both sFlt1 and PlGF significantly (p <= 0.05) increased across gestation in normal pregnancy with serum levels rising from 0.65 +/- 0.12 ng/ml at 6 weeks to 1.85 +/- 0.24 ng/ml at 12 weeks for sFlt1, and 57.2 +/- 19.2 pg/ml to 106 +/- 22.7 pg/ml for PlGF. sEng remained unchanged throughout the the first trimester. Importantly we detected a significant (35%, p <= 0.05) decrease in sFlt1 levels between our control and miscarriage cohort, however there was significant overlap between cases and controls, suggesting serum sFlt1 is unlikely to be useful as a clinical biomarker in asymptomatic women. Nevertheless, our data suggests a dysregulation of angiogenic factors may be involved in the pathophysiology of miscarriage.	[Kaitu'u-Lino, Tu'uhevaha J.; Whitehead, Clare L.; Tong, Stephen] Univ Melbourne, Translat Obstet Grp, Mercy Hosp Women, Heidelberg, Vic, Australia; [Kaitu'u-Lino, Tu'uhevaha J.; Whitehead, Clare L.; Ngian, Gene-Lyn; Permezel, Michael; Tong, Stephen] Univ Melbourne, Dept Obstet & Gynaecol, Mercy Hosp Women, Heidelberg, Vic, Australia	University of Melbourne; University of Melbourne	Kaitu'u-Lino, TJ (corresponding author), Univ Melbourne, Translat Obstet Grp, Mercy Hosp Women, Heidelberg, Vic, Australia.	t.klino@unimelb.edu.au		Kaitu'u-Lino, Tu'uhevaha/0000-0001-6233-9737; Tong, Stephen/0000-0002-2319-0586	Victorian Government; National Health and Medical Research Council of Australia [490970, 490995]	Victorian Government; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Victorian Government's Operational Infrastructure Support Program. The National Health and Medical Research Council of Australia provided salary support (#490970 to S. T.; #490995 to T. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED A, 1995, GROWTH FACTORS, V12, P235, DOI 10.3109/08977199509036883; Burton Graham J, 2003, Reprod Biomed Online, V6, P84; Calleja-Agius J, HUM REPROD; Daponte A, 2011, J CLIN ENDOCRINOL ME; Jauniaux E, 2003, PLACENTA, V24, pS86, DOI 10.1053/plac.2002.0932; Jauniaux E, 2003, AM J PATHOL, V162, P115, DOI 10.1016/S0002-9440(10)63803-5; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Muttukrishna S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018041; Muttukrishna S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002302; Nagamatsu T, 2004, ENDOCRINOLOGY, V145, P4838, DOI 10.1210/en.2004-0533; Plaisier M, 2009, HUM REPROD, V24, P185, DOI 10.1093/humrep/den296; Plaisier M, 2007, FERTIL STERIL, V88, P176, DOI 10.1016/j.fertnstert.2006.11.102; REGAN L, 1989, BRIT MED J, V299, P541, DOI 10.1136/bmj.299.6698.541; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Schiettecatte J, 2001, CLIN BIOCHEM, V43, P768; Smith GCS, 2007, OBSTET GYNECOL, V109, P1316, DOI 10.1097/01.AOG.0000265804.09161.0d; Taylor RN, 2003, AM J OBSTET GYNECOL, V188, P177, DOI 10.1067/mob.2003.111; Tong S, 2008, OBSTET GYNECOL, V111, P710, DOI 10.1097/AOG.0b013e318163747c; Welch PC, 2006, AM J OBSTET GYNECOL, V194, P1625, DOI 10.1016/j.ajog.2006.01.012; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401	22	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32509	10.1371/journal.pone.0032509	http://dx.doi.org/10.1371/journal.pone.0032509			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389705	Green Published, gold			2022-12-27	WOS:000302999600043
J	Lloyd, AH; Wang, D; Timmis, JN				Lloyd, Andrew H.; Wang, Dong; Timmis, Jeremy N.			Single Molecule PCR Reveals Similar Patterns of Non-Homologous DSB Repair in Tobacco and Arabidopsis	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA END; LIGASE-IV; CHLOROPLAST DNA; FLORAL DIP; GENOME; PLANTS; THALIANA; METHYLATION; INTEGRATION	DNA double strand breaks (DSBs) occur constantly in eukaryotes. These potentially lethal DNA lesions are repaired efficiently by two major DSB repair pathways: homologous recombination and non-homologous end joining (NHEJ). We investigated NHEJ in Arabidopsis thaliana and tobacco (Nicotiana tabacum) by introducing DNA double-strand breaks through inducible expression of I-SceI, followed by amplification of individual repair junction sequences by single-molecule PCR. Using this process over 300 NHEJ repair junctions were analysed in each species. In contrast to previously published variation in DSB repair between Arabidopsis and tobacco, the two species displayed similar DSB repair profiles in our experiments. The majority of repair events resulted in no loss of sequence and small (1-20 bp) deletions occurred at a minority (25-45%) of repair junctions. Approximately similar to 1.5% of the observed repair events contained larger deletions (. 20 bp) and a similar percentage contained insertions. Strikingly, insertion events in tobacco were associated with large genomic deletions at the site of the DSB that resulted in increased micro-homology at the sequence junctions suggesting the involvement of a non-classical NHEJ repair pathway. The generation of DSBs through inducible expression of I-SceI, in combination with single molecule PCR, provides an effective and efficient method for analysis of individual repair junctions and will prove a useful tool in the analysis of NHEJ.	[Lloyd, Andrew H.; Wang, Dong; Timmis, Jeremy N.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	University of Adelaide	Lloyd, AH (corresponding author), INRA Ctr Versailles Grignon, INRA AgroParisTech UMR1318, Inst Jean Pierre Bourgin, Versailles, France.	andrew.lloyd@versailles.inra.fr	Wang, Dong/AAF-2406-2020	Wang, Dong/0000-0003-4278-2728; Lloyd, Andrew/0000-0001-7871-6621	Australian Research Council [DP0986973]	Australian Research Council(Australian Research Council)	This research was supported under the Australian Research Council's (www.arc.gov.au) Discovery Projects funding scheme (project number DP0986973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Yehezkel T, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn457; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Caddick MX, 1998, NAT BIOTECHNOL, V16, P177, DOI 10.1038/nbt0298-177; Chen HH, 2011, RADIAT RES, V175, P214, DOI 10.1667/RR2323.1; Chhibber A, 2008, ANAL BIOCHEM, V377, P46, DOI 10.1016/j.ab.2008.02.026; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davidson D, 2011, INVEST NEW DRUGS, DOI [10.1007/s10637-10010-19626-10639, DOI 10.1007/S10637-10010-19626-10639]; Della-Maria J, 2011, J BIOL CHEM, DOI [10.1074/jbc.M1111.274159, DOI 10.1074/JBC.M1111.274159]; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Erikson O, 2004, NAT BIOTECHNOL, V22, P455, DOI 10.1038/nbt946; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Friesner J, 2003, PLANT J, V34, P427, DOI 10.1046/j.1365-313X.2003.01738.x; Gorbunova V, 1997, NUCLEIC ACIDS RES, V25, P4650, DOI 10.1093/nar/25.22.4650; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Hall AE, 2006, GENOME RES, V16, P355, DOI 10.1101/gr.4399206; Harrison SJ, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-19; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Huang CY, 2004, P NATL ACAD SCI USA, V101, P9710, DOI 10.1073/pnas.0400853101; Huang CY, 2003, NATURE, V422, P72, DOI 10.1038/nature01435; Kirik A, 2000, EMBO J, V19, P5562, DOI 10.1093/emboj/19.20.5562; Kohli A, 2003, PLANT MOL BIOL, V52, P247, DOI 10.1023/A:1023941407376; Kongruttanachok N, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-70; Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809; Kraytsberg Y, 2009, METHODS MOL BIOL, V554, P329, DOI 10.1007/978-1-59745-521-3_21; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Liang L, 2008, NUCLEIC ACIDS RES, V36, P3297, DOI 10.1093/nar/gkn184; Lieber MR, 2008, CELL RES, V18, P125, DOI 10.1038/cr.2007.108; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Lloyd AH, 2011, MOL BIOL EVOL, V28, P2019, DOI 10.1093/molbev/msr021; Ma JL, 2003, MOL CELL BIOL, V23, P8820, DOI 10.1128/MCB.23.23.8820-8828.2003; Marie A, 2010, NUCLEIC ACIDS RES, V38, P5706, DOI 10.1093/nar/gkq379; Mathis NL, 1994, PLANT MOL BIOL MAN B, P1; Matsuo M, 2005, PLANT CELL, V17, P665, DOI 10.1105/tpc.104.027706; Mazon G, 2010, CELL, V142, DOI 10.1016/j.cell.2010.08.006; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakano M, 2003, J BIOTECHNOL, V102, P117, DOI 10.1016/S0168-1656(03)00023-3; OHSHIMA K, 1994, J MOL BIOL, V243, P25, DOI 10.1006/jmbi.1994.1627; Orel N, 2003, PLANT MOL BIOL, V51, P523, DOI 10.1023/A:1022324205661; Pace JK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000469; Pallotta MA, 2000, THEOR APPL GENET, V101, P1100, DOI 10.1007/s001220051585; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; Puchta H, 1996, P NATL ACAD SCI USA, V93, P5055, DOI 10.1073/pnas.93.10.5055; Rahal EA, 2010, CELL CYCLE, V9, P2866, DOI 10.4161/cc.9.14.12408; Salomon S, 1998, EMBO J, V17, P6086, DOI 10.1093/emboj/17.20.6086; Salter MG, 1998, PLANT J, V16, P127, DOI 10.1046/j.1365-313x.1998.00281.x; Schmuths H, 2004, ANN BOT-LONDON, V93, P317, DOI 10.1093/aob/mch037; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Tanaka S, 2010, BIOCHEM BIOPH RES CO, V396, P289, DOI 10.1016/j.bbrc.2010.04.082; Taylor EM, 2010, NUCLEIC ACIDS RES, V38, P441, DOI 10.1093/nar/gkp905; van den Bosch M, 2002, BIOL CHEM, V383, P873; Wang HC, 2003, NUCLEIC ACIDS RES, V31, P5377, DOI 10.1093/nar/gkg728; Windels P, 2003, PLANT PHYSIOL, V133, P2061, DOI 10.1104/pp.103.027532; Wright DA, 2005, PLANT J, V44, P693, DOI 10.1111/j.1365-313X.2005.02551.x; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Yang YN, 2011, CANCER LETT, V309, P110, DOI 10.1016/j.canlet.2011.05.023	59	27	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32255	10.1371/journal.pone.0032255	http://dx.doi.org/10.1371/journal.pone.0032255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389691	Green Published, gold, Green Submitted			2022-12-27	WOS:000302999600029
J	Lodola, A; Branduardi, D; De Vivo, M; Capoferri, L; Mor, M; Piomelli, D; Cavalli, A				Lodola, Alessio; Branduardi, Davide; De Vivo, Marco; Capoferri, Luigi; Mor, Marco; Piomelli, Daniele; Cavalli, Andrea			A Catalytic Mechanism for Cysteine N-Terminal Nucleophile Hydrolases, as Revealed by Free Energy Simulations	PLOS ONE			English	Article							HYDROLYZING ACID AMIDASE; BILE-SALT HYDROLASE; SCC-DFTB METHOD; MOLECULAR-DYNAMICS SIMULATIONS; HYBRID QM/MM SIMULATIONS; PENICILLIN-V-ACYLASE; CRYSTAL-STRUCTURE; ENZYME CATALYSIS; 20S PROTEASOME; CERAMIDASE	The N-terminal nucleophile (Ntn) hydrolases are a superfamily of enzymes specialized in the hydrolytic cleavage of amide bonds. Even though several members of this family are emerging as innovative drug targets for cancer, inflammation, and pain, the processes through which they catalyze amide hydrolysis remains poorly understood. In particular, the catalytic reactions of cysteine Ntn-hydrolases have never been investigated from a mechanistic point of view. In the present study, we used free energy simulations in the quantum mechanics/molecular mechanics framework to determine the reaction mechanism of amide hydrolysis catalyzed by the prototypical cysteine Ntn-hydrolase, conjugated bile acid hydrolase (CBAH). The computational analyses, which were confirmed in water and using different CBAH mutants, revealed the existence of a chair-like transition state, which might be one of the specific features of the catalytic cycle of Ntn-hydrolases. Our results offer new insights on Ntn-mediated hydrolysis and suggest possible strategies for the creation of therapeutically useful inhibitors.	[Lodola, Alessio; Capoferri, Luigi; Mor, Marco] Univ Parma, Dept Pharmaceut, I-43100 Parma, Italy; [Branduardi, Davide; De Vivo, Marco; Piomelli, Daniele; Cavalli, Andrea] Italian Inst Technol, Genoa, Italy; [Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Cavalli, Andrea] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy	University of Parma; Istituto Italiano di Tecnologia - IIT; University of California System; University of California Irvine; University of Bologna	Lodola, A (corresponding author), Univ Parma, Dept Pharmaceut, I-43100 Parma, Italy.	andrea.cavalli@iit.it	De Vivo, Marco/A-7525-2012; Lodola, Alessio/H-9078-2013; Branduardi, Davide/B-2473-2010; Mor, Marco/D-2394-2009	De Vivo, Marco/0000-0003-4022-5661; Lodola, Alessio/0000-0002-8675-1002; Mor, Marco/0000-0003-0199-1849; CAVALLI, ANDREA/0000-0002-6370-1176	University of Parma; Univeristy of Bologna; Italian Institute of Technology	University of Parma; Univeristy of Bologna; Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT)	The present work is supported by: University of Parma, Univeristy of Bologna and Italian Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokhove M, 2010, STRUCTURE, V18, P301, DOI 10.1016/j.str.2010.01.005; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Branduardi D, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2432340; Branduardi D, 2011, J CHEM THEORY COMPUT, V7, P539, DOI 10.1021/ct100547a; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Capoferri L, 2011, J MOL MODEL, V17, P2375, DOI 10.1007/s00894-011-0981-z; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cavalli A, 2006, CHEM REV, V106, P3497, DOI 10.1021/cr050579p; Crespo A, 2005, J AM CHEM SOC, V127, P6940, DOI 10.1021/ja0452830; Cui Q, 2001, J PHYS CHEM B, V105, P569, DOI 10.1021/jp0029109; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Elstner M, 2006, THEOR CHEM ACC, V116, P316, DOI 10.1007/s00214-005-0066-0; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; GOPALSRIVASTAVA R, 1988, J LIPID RES, V29, P1079; Groll M, 2006, STRUCTURE, V14, P451, DOI 10.1016/j.str.2005.11.019; Harrison MJ, 1997, J AM CHEM SOC, V119, P12285, DOI 10.1021/ja9711472; He XX, 2003, J BIOL CHEM, V278, P32978, DOI 10.1074/jbc.M301936200; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Ke ZH, 2011, J PHYS CHEM B, V115, P3725, DOI 10.1021/jp200843s; Kumar RS, 2006, J BIOL CHEM, V281, P32516, DOI 10.1074/jbc.M604172200; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lee YS, 2000, J BIOL CHEM, V275, P39200, DOI 10.1074/jbc.M002504200; Li GH, 2003, J AM CHEM SOC, V125, P15028, DOI 10.1021/ja0367851; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lonsdale R, 2010, CHEM COMMUN, V46, P2354, DOI 10.1039/b925647d; Ma S, 2007, J AM CHEM SOC, V129, P13633, DOI 10.1021/ja074222+; Mladenovic M, 2008, J AM CHEM SOC, V130, P8696, DOI 10.1021/ja711043x; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; Ovchinnikov V, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3544209; Perakyla M, 1996, CHEM-EUR J, V2, P1548, DOI 10.1002/chem.19960021212; Rossocha M, 2005, BIOCHEMISTRY-US, V44, P5739, DOI 10.1021/bi0473206; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Seabra GD, 2007, J PHYS CHEM A, V111, P5655, DOI 10.1021/jp0700711; Senn HM, 2009, ANGEW CHEM INT EDIT, V48, P1198, DOI 10.1002/anie.200802019; Shtraizent N, 2008, J BIOL CHEM, V283, P11253, DOI 10.1074/jbc.M709166200; Solorzano C, 2010, J MED CHEM, V53, P5770, DOI 10.1021/jm100582w; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; Suresh CG, 1999, NAT STRUCT BIOL, V6, P414, DOI 10.1038/8213; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; Tsuboi K, 2007, CHEM BIODIVERS, V4, P1914, DOI 10.1002/cbdv.200790159; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Walker RC, 2008, J COMPUT CHEM, V29, P1019, DOI 10.1002/jcc.20857; Warshel A, 2003, ANNU REV BIOPH BIOM, V32, P425, DOI 10.1146/annurev.biophys.32.110601.141807; WARSHEL A, 1972, J AM CHEM SOC, V94, P5612, DOI 10.1021/ja00771a014; Xu Q, 2010, J PHYS CHEM B, V114, P10594, DOI 10.1021/jp102785s; Zeidan YH, 2008, CURR DRUG TARGETS, V9, P653, DOI 10.2174/138945008785132358; Zhiryakova D, 2009, FEBS J, V276, P2589, DOI 10.1111/j.1742-4658.2009.06987.x	49	51	51	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32397	10.1371/journal.pone.0032397	http://dx.doi.org/10.1371/journal.pone.0032397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389698	Green Published, gold, Green Submitted			2022-12-27	WOS:000302999600036
J	Braccini, M; Van Rijn, J; Frick, L				Braccini, Matias; Van Rijn, Jay; Frick, Lorenz			High Post-Capture Survival for Sharks, Rays and Chimaeras Discarded in the Main Shark Fishery of Australia?	PLOS ONE			English	Article							GILL-NET CAPTURE; POSTRELEASE SURVIVORSHIP; MORTALITY; BYCATCH; CAUGHT; CHONDRICHTHYANS; CONSEQUENCES; IMPAIRMENT; MANAGEMENT	Most sharks, rays and chimaeras (chondrichthyans) taken in commercial fisheries are discarded (i.e. returned to the ocean either dead or alive). Quantifying the post-capture survival (PCS) of discarded species is therefore essential for the improved management and conservation of this group. For all chondrichthyans taken in the main shark fishery of Australia, we quantified the immediate PCS of individuals reaching the deck of commercial shark gillnet fishing vessels and applied a risk-based method to semi-quantitatively determine delayed and total PCS. Estimates of immediate, delayed and total PCS were consistent, being very high for the most commonly discarded species (Port Jackson shark, Australian swellshark, and spikey dogfish) and low for the most important commercial species (gummy and school sharks). Increasing gillnet soak time or water temperature significantly decreased PCS. Chondrichthyans with bottom-dwelling habits had the highest PCS whereas those with pelagic habits had the lowest PCS. The risk-based approach can be easily implemented as a standard practice of on-board observing programs, providing a convenient first-step assessment of the PCS of all species taken in commercial fisheries.	[Braccini, Matias] Marine & Freshwater Fisheries Res Inst, Dept Primary Ind Queenscliff Ctr, Queenscliff, Vic, Australia; [Van Rijn, Jay; Frick, Lorenz] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Monash University		Matias.Braccini@fish.wa.gov.au			Australian Fisheries Management Authority [R2006/823]	Australian Fisheries Management Authority	This project was funded through an Australian Fisheries Management Authority grant (R2006/823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, CASE STUDIES MANAGEM; Baremore IE, 2007, NOAA TECH MEMO NMFS, V565, P1; Bonfil R., 1994, FAO FISHERIES TECHNI, V341, P119; Braccini J. M., 2009, GHATF SHARK SURVEY P; Braccini JM, 2006, CAN J FISH AQUAT SCI, V63, P2456, DOI 10.1139/F06-141; Branstetter S., 1999, FAO (Food and Agriculture Organization of the United Nations) Fisheries Technical Paper, V378, P109; Broadhurst MK, 2006, FISH FISH, V7, P180, DOI 10.1111/j.1467-2979.2006.00213.x; Brown IW, 2008, NATL STRATEGY SURVIV; Campana SE, 2009, MAR ECOL PROG SER, V387, P241, DOI 10.3354/meps08109; Carlson JK, 2004, CRC MAR BIOL SER, P203; Compagno L.J.V., 1984, FAO FISH SYNOP, V125, P250, DOI DOI 10.1071/MF9920109; Compagno LJV., 1984, FAO FISH SYNOP, P20; Davis MW, 2006, FISH RES, V82, P1, DOI 10.1016/j.fishres.2006.09.004; Davis MW, 2010, FISH FISH, V11, P1, DOI 10.1111/j.1467-2979.2009.00331.x; Davis MW, 2005, J FISH BIOL, V66, P254, DOI 10.1111/j.0022-1112.2005.00602.x; Davis MW, 2002, CAN J FISH AQUAT SCI, V59, P1834, DOI 10.1139/F02-139; Food and Agriculture Organization (FAO), 2000, FISH MANAGE, V4; Francis MP, 1998, MAR FRESHWATER RES, V49, P579, DOI 10.1071/MF97076; FRANCIS RIC, 1992, CAN J FISH AQUAT SCI, V49, P922, DOI 10.1139/f92-102; Frick LH, 2011, COMP BIOC A IN PRESS; Frick LH, 2010, FISH RES, V106, P344, DOI 10.1016/j.fishres.2010.08.016; Frick LH, 2010, J EXP MAR BIOL ECOL, V385, P29, DOI 10.1016/j.jembe.2010.01.013; Frick LH, 2009, N AM J FISH MANAGE, V29, P127, DOI 10.1577/M08-031.1; Gurshin CWD, 2004, J FISH BIOL, V65, P973, DOI 10.1111/j.0022-1112.2004.00501.x; Hight BV, 2007, MAR FRESHWATER RES, V58, P145, DOI 10.1071/MF05260; HILBORN R, 1992; Hobday A.J., 2007, R041072 AUSTR FISH M; HOLDEN M J, 1973, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V164, P360; Hueter R.E., 1994, BYCATCH CATCH RELEAS; Hueter RE, 2006, T AM FISH SOC, V135, P500, DOI 10.1577/T05-065.1; KAISER MJ, 1995, MAR ECOL PROG SER, V126, P31, DOI 10.3354/meps126031; KIRKWOOD GP, 1986, AUST J MAR FRESH RES, V37, P689; KOOPMAN M, 2006, INTEGRATED SCI MONIT; Laptikhovsky VV, 2004, FISH B-NOAA, V102, P757; Last PR, 1994, SHARKS RAYS AUSTR, DOI 10.2307/1446735; Mandelman JW, 2007, FISH RES, V83, P238, DOI 10.1016/j.fishres.2006.10.001; Manire C, 2001, T AM FISH SOC, V130, P1038, DOI 10.1577/1548-8659(2001)130&lt;1038:SCAWGN&gt;2.0.CO;2; McAuley RB, 2007, ICES J MAR SCI, V64, P1702, DOI 10.1093/icesjms/fsm136; Mora O, 2006, COL VOL SCI PAP ICCA, V59, P599; Moyes CD, 2006, T AM FISH SOC, V135, P1389, DOI 10.1577/T05-224.1; PAN-Tiburones, 2015, PLAN ACC NAC CONS MA; Revill AS, 2005, FISH RES, V71, P121, DOI 10.1016/j.fishres.2004.07.006; Rulifson RA, 2007, N AM J FISH MANAGE, V27, P279, DOI 10.1577/M06-071.1; Simpfendorfer CA, 2011, MAR FRESHWATER RES, V62, P518, DOI 10.1071/MF11086; Skomal GB, 2007, FISHERIES MANAG ECOL, V14, P81, DOI 10.1111/j.1365-2400.2007.00528.x; Skomal G, 2010, CRC MAR BIOL SER, P459; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Stobutzki IC, 2002, FISH B-NOAA, V100, P800; Van Rijn J, 2009, THESIS MONASH U; Walker Terence I., 2005, Journal of Northwest Atlantic Fishery Science, V35, P505; Walker TI, 1998, MAR FRESHWATER RES, V49, P553, DOI 10.1071/MF98017	51	66	68	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32547	10.1371/journal.pone.0032547	http://dx.doi.org/10.1371/journal.pone.0032547			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384270	gold, Green Submitted, Green Published			2022-12-27	WOS:000302918500098
J	Chatham, CH; Claus, ED; Kim, A; Curran, T; Banich, MT; Munakata, Y				Chatham, Christopher H.; Claus, Eric D.; Kim, Albert; Curran, Tim; Banich, Marie T.; Munakata, Yuko			Cognitive Control Reflects Context Monitoring, Not Motoric Stopping, in Response Inhibition	PLOS ONE			English	Article							INFERIOR FRONTAL-CORTEX; PREFRONTAL CORTEX; EXECUTIVE FUNCTIONS; PREMOTOR CORTEX; ATTENTION; TASK; MEMORY; BRAIN; STIMULATION; SYSTEM	The inhibition of unwanted behaviors is considered an effortful and controlled ability. However, inhibition also requires the detection of contexts indicating that old behaviors may be inappropriate - in other words, inhibition requires the ability to monitor context in the service of goals, which we refer to as context-monitoring. Using behavioral, neuroimaging, electrophysiological and computational approaches, we tested whether motoric stopping per se is the cognitively-controlled process supporting response inhibition, or whether context-monitoring may fill this role. Our results demonstrate that inhibition does not require control mechanisms beyond those involved in context-monitoring, and that such control mechanisms are the same regardless of stopping demands. These results challenge dominant accounts of inhibitory control, which posit that motoric stopping is the cognitively-controlled process of response inhibition, and clarify emerging debates on the frontal substrates of response inhibition by replacing the centrality of controlled mechanisms for motoric stopping with context-monitoring.	[Chatham, Christopher H.] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA; [Claus, Eric D.] Mind Res Network, Albuquerque, NM USA; [Kim, Albert; Curran, Tim; Munakata, Yuko] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Banich, Marie T.] Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA	Brown University; Lovelace Respiratory Research Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Chatham, CH (corresponding author), Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA.	chathach@gmail.com	Claus, Eric/AAQ-5035-2021	BANICH, MARIE/0000-0001-9373-9194; MUNAKATA, YUKO/0000-0001-8192-5379	National Institute of Mental Health; P50 center [079485-02]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH079485] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); P50 center; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the National Institute of Mental Health (http://www.nimh.nih.gov) with a P50 center grant (079485-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisa B, 2008, NEURAL NETWORKS, V21, P1146, DOI 10.1016/j.neunet.2008.06.016; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Aron AR, 2004, BRAIN, V127, P1561, DOI 10.1093/brain/awh169; Aron AR, 2010, BIOL PSYCHIAT, P55; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; Beatty J., 2000, HDB PSYCHOPHYSIOL, V2, P142; Cai WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020840; Castellanos FX, 2006, TRENDS COGN SCI, V10, P117, DOI 10.1016/j.tics.2006.01.011; Chambers CD, 2006, J COGNITIVE NEUROSCI, V18, P444, DOI 10.1162/jocn.2006.18.3.444; Chikazoe J, 2007, J COGNITIVE NEUROSCI, V19, P69, DOI 10.1162/jocn.2007.19.1.69; Chikazoe J, 2009, CEREB CORTEX, V19, P146, DOI 10.1093/cercor/bhn065; Civardi C, 2001, NEUROIMAGE, V14, P1444, DOI 10.1006/nimg.2001.0918; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Dodds CM, 2011, CEREB CORTEX, V21, P1155, DOI 10.1093/cercor/bhq187; Ferrier D, 1876, FUNCTIONS BRAIN; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Jahfari S, 2010, J COGNITIVE NEUROSCI, V22, P1479, DOI 10.1162/jocn.2009.21307; Junghofer M, 1999, CLIN NEUROPHYSIOL, V110, P1149, DOI 10.1016/S1388-2457(99)00044-9; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; Lim SL, 2009, P NATL ACAD SCI USA, V106, P16841, DOI 10.1073/pnas.0904551106; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Lovero KL, 2009, NEUROIMAGE, V45, P976, DOI 10.1016/j.neuroimage.2008.12.070; MacLeod CM, 2003, PSYCHOL LEARN MOTIV, V43, P163, DOI 10.1016/S0079-7421(03)01014-4; Michael GA, 2006, BEHAV NEUROSCI, V120, P447, DOI 10.1037/0735-7044.120.2.447; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nambu A, 1997, NEUROSCI LETT, V239, P13, DOI 10.1016/S0304-3940(97)00877-X; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Neubert FX, 2010, P NATL ACAD SCI USA, V107, P13240, DOI 10.1073/pnas.1000674107; O'Reilly RC, 2010, TRENDS NEUROSCI, V33, P355, DOI 10.1016/j.tins.2010.05.002; Ratcliff R, 2009, PSYCHOL REV, V116, P59, DOI 10.1037/a0014086; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Shilling VM, 2002, NEUROPSYCHOLOGIA, V40, P605, DOI 10.1016/S0028-3932(01)00157-9; Smith JL, 2008, CLIN NEUROPHYSIOL, V119, P704, DOI 10.1016/j.clinph.2007.11.042; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Thorell LB, 2009, DEVELOPMENTAL SCI, V12, P106, DOI 10.1111/j.1467-7687.2008.00745.x; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Verbruggen F, 2005, EXP PSYCHOL, V52, P125, DOI 10.1027/1618-3169.52.2.125; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; Verbruggen V, 2009, J EXP PSYCHOL, V137, P649	48	112	115	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31546	10.1371/journal.pone.0031546	http://dx.doi.org/10.1371/journal.pone.0031546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	927OV	22384038	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500029
J	Pichancourt, JB; van Klinken, RD				Pichancourt, Jean-Baptiste; van Klinken, Rieks D.			Phenotypic Plasticity Influences the Size, Shape and Dynamics of the Geographic Distribution of an Invasive Plant	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; SEEDLING SURVIVAL; CLIMATE-CHANGE; EVOLUTION; ECOLOGY; MODELS; SEEDS; ADAPTATION; RESPONSES; SELECTION	Phenotypic plasticity has long been suspected to allow invasive species to expand their geographic range across large-scale environmental gradients. We tested this possibility in Australia using a continental scale survey of the invasive tree Parkinsonia aculeata (Fabaceae) in twenty-three sites distributed across four climate regions and three habitat types. Using tree-level responses, we detected a trade-off between seed mass and seed number across the moisture gradient. Individual trees plastically and reversibly produced many small seeds at dry sites or years, and few big seeds at wet sites and years. Bigger seeds were positively correlated with higher seed and seedling survival rates. The trade-off, the relation between seed mass, seed and seedling survival, and other fitness components of the plant life-cycle were integrated within a matrix population model. The model confirms that the plastic response resulted in average fitness benefits across the life-cycle. Plasticity resulted in average fitness being positively maintained at the wet and dry range margins where extinction risks would otherwise have been high ("Jack-of-all-Trades" strategy JT), and fitness being maximized at the species range centre where extinction risks were already low ("Master-of-Some" strategy MS). The resulting hybrid "Jack-and-Master" strategy (JM) broadened the geographic range and amplified average fitness in the range centre. Our study provides the first empirical evidence for a JM species. It also confirms mechanistically the importance of phenotypic plasticity in determining the size, the shape and the dynamic of a species distribution. The JM allows rapid and reversible phenotypic responses to new or changing moisture conditions at different scales, providing the species with definite advantages over genetic adaptation when invading diverse and variable environments. Furthermore, natural selection pressure acting on phenotypic plasticity is predicted to result in maintenance of the JT and strengthening of the MS, further enhancing the species invasiveness in its range centre.	[Pichancourt, Jean-Baptiste; van Klinken, Rieks D.] CSIRO Ecosyst Sci EcoSci Precinct, Dutton Pk, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Pichancourt, JB (corresponding author), CSIRO Ecosyst Sci EcoSci Precinct, Dutton Pk, Qld, Australia.	jean-baptiste.pichancourt@csiro.au	van Klinken, Rieks D/B-1772-2009; Pichancourt, Jean-Baptiste/J-7715-2016	van Klinken, Rieks D/0000-0002-7578-8977; Pichancourt, Jean-Baptiste/0000-0002-9760-0007; Pichancourt, Jean-Baptiste/0000-0002-9276-8628	Defeating the Weed Menace program	Defeating the Weed Menace program	This study was funded by the Defeating the Weed Menace program (http://lwa.gov.au/programs/defeating-weed-menace). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Angert AL, 2009, P NATL ACAD SCI USA, V106, P19693, DOI 10.1073/pnas.0901652106; Baker H. G., 1965, The genetics of colonizing species., P147; Brzek P, 2011, J EXP BIOL, V214, P2755, DOI 10.1242/jeb.058727; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; Callahan HS, 2002, ECOLOGY, V83, P1965, DOI 10.1890/0012-9658(2002)083[1965:SIPAIE]2.0.CO;2; Caswell, 2000, MATRIX POPULATION MO; CASWELL H, 1983, AM ZOOL, V23, P35; Charlesworth B, EVOLUTION AGE STRUCT; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Dansereau P, 1957, BIOGEOGRAPHY ECOLOGI, P86; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; DeWitt TJ, PHENOTYIC PLASTICIT; Dyer AR, 2010, EVOL APPL, V3, P179, DOI 10.1111/j.1752-4571.2010.00118.x; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ellers J, 2010, EVOL ECOL, V24, P523, DOI 10.1007/s10682-010-9375-4; Fisher RA, 1930, GENETICAL THEORY NAT; Funk JL, 2008, J ECOL, V96, P1162, DOI 10.1111/j.1365-2745.2008.01435.x; Gabriel W, 2005, J EVOLUTION BIOL, V18, P873, DOI 10.1111/j.1420-9101.2005.00959.x; Gabriel W, 2005, AM NAT, V166, P339, DOI 10.1086/432558; Galloway LF, 2007, SCIENCE, V318, P1134, DOI 10.1126/science.1148766; Gaston KJ, 2009, P ROY SOC B-BIOL SCI, V276, P1391, DOI [10.1098/rspb.2009.0100, 10.1098/rspb.2008.1480]; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Hawkins JA, 2007, NEW PHYTOL, V175, P575, DOI 10.1111/j.1469-8137.2007.02125.x; Hoverman JT, 2007, ECOLOGY, V88, P693, DOI 10.1890/05-1697; Hulme PE, 2008, FUNCT ECOL, V22, P3, DOI 10.1111/j.1365-2435.2007.01369.x; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Jongejans E, 2010, EVOL ECOL, V24, P585, DOI 10.1007/s10682-009-9340-2; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; LANDE R, 1982, ECOLOGY, V63, P607, DOI 10.2307/1936778; Lloret F, 1999, FUNCT ECOL, V13, P210, DOI 10.1046/j.1365-2435.1999.00309.x; Matesanz S, 2010, ANN NY ACAD SCI, V1206, P35, DOI 10.1111/j.1749-6632.2010.05704.x; McMahon SM, 2007, ECOL LETT, V10, P437, DOI 10.1111/j.1461-0248.2007.01036.x; Moles AT, 2004, J ECOL, V92, P384, DOI 10.1111/j.0022-0477.2004.00880.x; Moles AT, 2006, OIKOS, V113, P91, DOI 10.1111/j.0030-1299.2006.14194.x; Moles AT, 2004, J ECOL, V92, P372, DOI 10.1111/j.0022-0477.2004.00884.x; Moles AT, 2004, ECOL LETT, V7, P911, DOI 10.1111/j.1461-0248.2004.00647.x; Mondor EB, 2004, ECOL LETT, V7, P941, DOI 10.1111/j.1461-0248.2004.00650.x; Muth NZ, 2007, J ECOL, V95, P1001, DOI 10.1111/j.1365-2745.2007.01268.x; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Nicotra AB, 2010, FUNCT PLANT BIOL, V37, P117, DOI 10.1071/FP09139; Nilsson-Ehle H, 1914, PFLANZENZUECHTUNG, V2, P153; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Paul-Victor C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006917; Pigliucci M, 2003, ECOL LETT, V6, P265, DOI 10.1046/j.1461-0248.2003.00428.x; Pigliucci M, PHENOTYPIC PLASTICIT; Pohlman CL, 2005, J BIOGEOGR, V32, P341, DOI 10.1111/j.1365-2699.2004.01181.x; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Richards CL, 2010, ESTUAR COAST, V33, P840, DOI 10.1007/s12237-009-9186-4; Sadras VO, 2009, FIELD CROP RES, V110, P242, DOI 10.1016/j.fcr.2008.09.004; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Santamaria L, 2003, ECOLOGY, V84, P2454, DOI 10.1890/02-0431; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stauffer, 1975, CHARLES DARWINS NATU; Sultan SE, 2001, ECOLOGY, V82, P328, DOI 10.1890/0012-9658(2001)082[0328:PPFFCI]2.0.CO;2; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Sutherst RW, 1999, CLIMEX PREDICTING EF; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Tuljapurkar S, 2000, ECOL MODEL, V133, P143, DOI 10.1016/S0304-3800(00)00288-X; Valladares F, 2006, J ECOL, V94, P1103, DOI 10.1111/j.1365-2745.2006.01176.x; van der Werf J, ADAPTATION FITNESS A; van Klinken RD, 2005, WEED SCI, V53, P663, DOI 10.1614/WS-05-008R.1; Van Klinken RD, 2008, ANN BOT-LONDON, V102, P255, DOI 10.1093/aob/mcn087; van Klinken RD, 2009, GLOBAL ECOL BIOGEOGR, V18, P688, DOI 10.1111/j.1466-8238.2009.00483.x; van Klinken Rieks Dekker, 2009, Plant Protection Quarterly, V24, P100	70	53	55	0	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32323	10.1371/journal.pone.0032323	http://dx.doi.org/10.1371/journal.pone.0032323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384216	gold, Green Published, Green Submitted			2022-12-27	WOS:000302918500077
J	Regulski, K; Courtin, P; Meyrand, M; Claes, IJJ; Lebeer, S; Vanderleyden, J; Hols, P; Guillot, A; Chapot-Chartier, MP				Regulski, Krzysztof; Courtin, Pascal; Meyrand, Mickael; Claes, Ingmar J. J.; Lebeer, Sarah; Vanderleyden, Jos; Hols, Pascal; Guillot, Alain; Chapot-Chartier, Marie-Pierre			Analysis of the Peptidoglycan Hydrolase Complement of Lactobacillus casei and Characterization of the Major gamma-D-Glutamyl-L-Lysyl-Endopeptidase	PLOS ONE			English	Article							LACTOCOCCUS-LACTIS; BACTERIAL-PEPTIDOGLYCAN; CELL-WALL; TRANSFORMATION; EXPRESSION; PROTEINS; BL23; ELECTROPORATION; IDENTIFICATION; AUTOLYSIN	Peptidoglycan (PG) is the major component of Gram positive bacteria cell wall and is essential for bacterial integrity and shape. Bacteria synthesize PG hydrolases (PGHs) which are able to cleave bonds in their own PG and play major roles in PG remodelling required for bacterial growth and division. Our aim was to identify the main PGHs in Lactobacillus casei BL23, a lactic acid bacterium with probiotic properties. The PGH complement was first identified in silico by amino acid sequence similarity searches of the BL23 genome sequence. Thirteen PGHs were detected with different predicted hydrolytic specificities. Transcription of the genes was confirmed by RT-PCR. A proteomic analysis combining the use of SDS-PAGE and LC-MS/MS revealed the main seven PGHs synthesized during growth of L. casei BL23. Among these PGHs, LCABL_02770 (renamed Lc-p75) was identified as the major one. This protein is the homolog of p75 (Msp1) major secreted protein of Lactobacillus rhamnosus GG, which was shown to promote survival and growth of intestinal epithelial cells. We identified its hydrolytic specificity on PG and showed that it is a gamma-D-glutamyl-L-lysyl-endopeptidase. It has a marked specificity towards PG tetrapeptide chains versus tripeptide chains and for oligomers rather than monomers. Immunofluorescence experiments demonstrated that Lc-p75 localizes at cell septa in agreement with its role in daughter cell separation. It is also secreted under an active form as detected in zymogram. Comparison of the muropeptide profiles of wild type and Lc-p75-negative mutant revealed a decrease of the amount of disaccharide-dipeptide in the mutant PG in agreement with Lc-p75 activity. As a conclusion, Lc-p75 is the major L. casei BL23 PGH with endopeptidase specificity and a key role in daughter cell separation. Further studies will aim at investigating the role of Lc-p75 in the anti-inflammatory potential of L. casei BL23.	[Regulski, Krzysztof; Courtin, Pascal; Meyrand, Mickael; Guillot, Alain; Chapot-Chartier, Marie-Pierre] INRA, Micalis UMR1319, Jouy En Josas, France; [Regulski, Krzysztof; Courtin, Pascal; Meyrand, Mickael; Guillot, Alain; Chapot-Chartier, Marie-Pierre] AgroParisTech, UMR Micalis, Jouy En Josas, France; [Claes, Ingmar J. J.; Lebeer, Sarah; Vanderleyden, Jos] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Louvain, Belgium; [Hols, Pascal] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; KU Leuven; Universite Catholique Louvain	Regulski, K (corresponding author), INRA, Micalis UMR1319, Jouy En Josas, France.	Marie-Pierre.Chapot@jouy.inra.fr	Lebeer, Sarah/S-9951-2019; Claes, Ingmar/AAI-1910-2019; Lebeer, Sarah/D-5156-2014	Lebeer, Sarah/0000-0002-9400-6918; Claes, Ingmar/0000-0003-4209-4116; Lebeer, Sarah/0000-0002-9400-6918; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519	Institut National de la Recherche Agronomique (INRA); Marie Curie FP7 Initial Training Network Cross Talk [21553-2]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); Research Department of the Communaute Francaise de Belgique (Concerted Research Action)	Institut National de la Recherche Agronomique (INRA); Marie Curie FP7 Initial Training Network Cross Talk; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Department of the Communaute Francaise de Belgique (Concerted Research Action)	The work of MPCC was supported by Institut National de la Recherche Agronomique (INRA) (Jeune Equipe grant). KR was the recipient of a fellowship from INRA. KR's PhD project received financial support as an associated project from the Marie Curie FP7 Initial Training Network Cross Talk (grant agreement no21553-2, starting date: October, 1st, 2008). IC holds a PhD grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen). SL is a postdoctoral researcher of the FWO-Vlaanderen. Work of PH was supported by the Research Department of the Communaute Francaise de Belgique (Concerted Research Action), and PH is Research Associate of the National Fund for Scientific Research, Walloon, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asong J, 2009, J BIOL CHEM, V284, P8634, DOI 10.1074/jbc.M806633200; Aukrust T W, 1995, Methods Mol Biol, V47, P201; Bauerl C, 2010, J MOL MICROB BIOTECH, V19, P231, DOI 10.1159/000322233; Beganovic J, 2010, J PROTEOME RES, V9, P677, DOI 10.1021/pr9000866; Bernard E, 2011, J BIOL CHEM, V286, P23950, DOI 10.1074/jbc.M111.241414; Bryan EM, 2000, PLASMID, V44, P183, DOI 10.1006/plas.2000.1484; Chapot-Chartier MP, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P383, DOI 10.1007/978-3-642-05062-6_13; Chaput C, 2006, PLOS PATHOG, V2, P844, DOI 10.1371/journal.ppat.0020097; Claes IJJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031588; Corthesy B, 2007, J NUTR, V137, p781S, DOI 10.1093/jn/137.3.781S; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fernandez EM, 2011, GUT, V60, P1050, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Fontaine L, 2010, APPL ENVIRON MICROB, V76, P7870, DOI 10.1128/AEM.01671-10; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Huard C, 2003, MICROBIOL-SGM, V149, P695, DOI 10.1099/mic.0.25875-0; Humann J, 2007, J IMMUNOL, V178, P2407, DOI 10.4049/jimmunol.178.4.2407; Humann J, 2009, J INNATE IMMUN, V1, P88, DOI 10.1159/000181181; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Lambert JM, 2007, APPL ENVIRON MICROB, V73, P1126, DOI 10.1128/AEM.01473-06; Layec S, 2008, RES MICROBIOL, V159, P507, DOI 10.1016/j.resmic.2008.06.008; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Maze A, 2010, J BACTERIOL, V192, P2647, DOI 10.1128/JB.00076-10; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; NAGAOKA M, 1990, J BIOCHEM-TOKYO, V108, P568, DOI 10.1093/oxfordjournals.jbchem.a123243; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Rochat T, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-22; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Seth A, 2008, AM J PHYSIOL-GASTR L, V294, pG1060, DOI 10.1152/ajpgi.00202.2007; Shida K, 2009, IMMUNOLOGY, V128, pe858, DOI 10.1111/j.1365-2567.2009.03095.x; Sperandio B, 2005, J BACTERIOL, V187, P3762, DOI 10.1128/JB.187.11.3762-3778.2005; Steen A, 2003, J BIOL CHEM, V278, P23874, DOI 10.1074/jbc.M211055200; Veiga P, 2006, MOL MICROBIOL, V62, P1713, DOI 10.1111/j.1365-2958.2006.05474.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Whisstock JC, 1999, TRENDS BIOCHEM SCI, V24, P132, DOI 10.1016/S0968-0004(99)01366-3; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022	41	36	39	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32301	10.1371/journal.pone.0032301	http://dx.doi.org/10.1371/journal.pone.0032301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384208	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500073
J	Cruceanu, C; Alda, M; Grof, P; Rouleau, GA; Turecki, G				Cruceanu, Cristiana; Alda, Martin; Grof, Paul; Rouleau, Guy A.; Turecki, Gustavo			Synapsin II Is Involved in the Molecular Pathway of Lithium Treatment in Bipolar Disorder	PLOS ONE			English	Article							PROPHYLACTIC TREATMENT; NONNEURONAL CELLS; GENE-EXPRESSION; VALPROIC ACID; SUICIDE RISK; SCHIZOPHRENIA; FAMILY; LYMPHOBLASTS; ASSOCIATION; ILLNESS	Bipolar disorder (BD) is a debilitating psychiatric condition with a prevalence of 1-2% in the general population that is characterized by severe episodic shifts in mood ranging from depressive to manic episodes. One of the most common treatments is lithium (Li), with successful response in 30-60% of patients. Synapsin II (SYN2) is a neuronal phosphoprotein that we have previously identified as a possible candidate gene for the etiology of BD and/or response to Li treatment in a genome-wide linkage study focusing on BD patients characterized for excellent response to Li prophylaxis. In the present study we investigated the role of this gene in BD, particularly as it pertains to Li treatment. We investigated the effect of lithium treatment on the expression of SYN2 in lymphoblastoid cell lines from patients characterized as excellent Li-responders, non-responders, as well as non-psychiatric controls. Finally, we sought to determine if Li has a cell-type-specific effect on gene expression in neuronal-derived cell lines. In both in vitro models, we found SYN2 to be modulated by the presence of Li. By focusing on Li-responsive BD we have identified a potential mechanism for Li response in some patients.	[Cruceanu, Cristiana; Turecki, Gustavo] McGill Univ, Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada; [Alda, Martin] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada; [Grof, Paul] Mood Disorders Ctr Ottawa, Ottawa, ON, Canada; [Rouleau, Guy A.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Rouleau, Guy A.] Univ Montreal, CHUM Res Ctr, Ctr Excellence Neur, Montreal, PQ, Canada	McGill University; Dalhousie University; University of Ottawa; Universite de Montreal; Universite de Montreal	Cruceanu, C (corresponding author), McGill Univ, Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada.	gustavo.turecki@mcgill.ca	Turecki, Gustavo/K-5100-2015; Cruceanu, Cristiana/AAK-2885-2021; Alda, Martin/F-5812-2010	Cruceanu, Cristiana/0000-0002-7799-5531; Alda, Martin/0000-0001-9544-3944; Turecki, Gustavo/0000-0003-4075-2736	Canadian Institute of Health Research (CIHR) [64410]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institute of Health Research (CIHR) grant 64410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alda M, 2001, J AFFECT DISORDERS, V65, P117, DOI 10.1016/S0165-0327(00)00166-X; Alda M, 2009, ANN MED, V41, P186, DOI 10.1080/07853890802409489; Baldessarini RJ, 2000, ARCH GEN PSYCHIAT, V57, P187, DOI 10.1001/archpsyc.57.2.187; Baldessarini RJ, 1996, J CLIN PSYCHIAT, V57, P441, DOI 10.4088/JCP.v57n1001; Baldessarini RJ, 2006, BIPOLAR DISORD, V8, P625, DOI 10.1111/j.1399-5618.2006.00344.x; Benedetti F, 2005, NEUROSCI LETT, V376, P51, DOI 10.1016/j.neulet.2004.11.022; Bhangu PS, 2001, BONE, V29, P16, DOI 10.1016/S8756-3282(01)00482-3; BROWNING MD, 1987, J NEUROSCI, V7, P847; Bustos R, 2001, J CELL SCI, V114, P3695; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Chen HM, 2009, INT J NEUROPSYCHOPH, V12, P975, DOI 10.1017/S1461145709000029; Chen Q, 2004, AM J HUM GENET, V75, P873, DOI 10.1086/425588; Cipriani A, 2005, AM J PSYCHIAT, V162, P1805, DOI 10.1176/appi.ajp.162.10.1805; de Lara CL, 2010, INT J NEUROPSYCHOPH, V13, P1397, DOI 10.1017/S1461145710000714; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; Garnham J, 2007, J AFFECT DISORDERS, V104, P185, DOI 10.1016/j.jad.2007.03.003; Goodwin FK, 2003, JAMA-J AM MED ASSOC, V290, P1467, DOI 10.1001/jama.290.11.1467; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; GREBB JA, 1990, ARCH GEN PSYCHIAT, V47, P1149; GROF P, 1994, J AFFECT DISORDERS, V32, P85, DOI 10.1016/0165-0327(94)90066-3; HAYCOCK JW, 1988, J NEUROSCI, V8, P3233; Hurley SL, 2004, BIOCHEM BIOPH RES CO, V317, P16, DOI 10.1016/j.bbrc.2004.03.008; Kile BM, 2010, J NEUROSCI, V30, P9762, DOI 10.1523/JNEUROSCI.2071-09.2010; Lakhan R, SYNAPSE, V64, P403; Lee HJ, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-15; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Maienschein V, 1999, GLIA, V26, P233, DOI 10.1002/(SICI)1098-1136(199905)26:3<233::AID-GLIA5>3.0.CO;2-2; Mamdani F, 2008, AM J MED GENET B, V147B, P500, DOI 10.1002/ajmg.b.30617; MATOVCIK LM, 1994, EUR J CELL BIOL, V65, P327; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; MULLEROERLINGHAUSEN B, 1992, J AFFECT DISORDERS, V25, P261, DOI 10.1016/0165-0327(92)90084-J; PETERSOHN D, 1995, J BIOL CHEM, V270, P24361, DOI 10.1074/jbc.270.41.24361; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Rao JS, 2005, NEUROPSYCHOPHARMACOL, V30, P2006, DOI 10.1038/sj.npp.1300740; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Saviouk V, 2007, SCHIZOPHR RES, V96, P100, DOI 10.1016/j.schres.2007.07.031; SCHOU M, 1983, NERVENARZT, V54, P331; Smoller JW, 2003, AM J MED GENET C, V123C, P48, DOI 10.1002/ajmg.c.20013; Sun XJ, 2004, NEUROPSYCHOPHARMACOL, V29, P799, DOI 10.1038/sj.npp.1300383; ThiesFlechtner K, 1996, PHARMACOPSYCHIATRY, V29, P103, DOI 10.1055/s-2007-979553; Turecki G, 2001, MOL PSYCHIATR, V6, P570, DOI 10.1038/sj.mp.4000888; ULLRICH B, 1995, NEUROPHARMACOLOGY, V34, P1371, DOI 10.1016/0028-3908(95)00132-P; VALTORTA F, 1992, J BIOL CHEM, V267, P7195; Vawter MP, 2002, MOL PSYCHIATR, V7, P571, DOI 10.1038/sj.mp.4001158; Wang YB, 2009, PSYCHIAT RES, V169, P167, DOI 10.1016/j.psychres.2008.12.005; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131	46	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32680	10.1371/journal.pone.0032680	http://dx.doi.org/10.1371/journal.pone.0032680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384280	Green Submitted, Green Published, gold			2022-12-27	WOS:000302916800043
J	Irvine, IC; Brigham, CA; Suding, KN; Martiny, JBH				Irvine, Irina C.; Brigham, Christy A.; Suding, Katharine N.; Martiny, Jennifer B. H.			The Abundance of Pink-Pigmented Facultative Methylotrophs in the Root Zone of Plant Species in Invaded Coastal Sage Scrub Habitat	PLOS ONE			English	Article							BACTERIA; METHYLOBACTERIUM; PHYLLOSPHERE; COMMUNITY; GROWTH; DIVERSITY; INVASION; L.; METHANOTROPHS; POPULATIONS	Pink-pigmented facultative methylotrophic bacteria (PPFMs) are associated with the roots, leaves and seeds of most terrestrial plants and utilize volatile C-1 compounds such as methanol generated by growing plants during cell division. PPFMs have been well studied in agricultural systems due to their importance in crop seed germination, yield, pathogen resistance and drought stress tolerance. In contrast, little is known about the PPFM abundance and diversity in natural ecosystems, let alone their interactions with non-crop species. Here we surveyed PPFM abundance in the root zone soil of 5 native and 5 invasive plant species along ten invasion gradients in Southern California coastal sage scrub habitat. PPFMs were present in every soil sample and ranged in abundance from 10(2) to 10(5) CFU/g dry soil. This abundance varied significantly among plant species. PPFM abundance was 50% higher in the root zones of annual or biennial species (many invasives) than perennial species (all natives). Further, PPFM abundance appears to be influenced by the plant community beyond the root zone; pure stands of either native or invasive species had 50% more PPFMs than mixed species stands. In sum, PPFM abundance in the root zone of coastal sage scrub plants is influenced by both the immediate and surrounding plant communities. The results also suggest that PPFMs are a good target for future work on plant-microorganism feedbacks in natural ecosystems.	[Irvine, Irina C.; Martiny, Jennifer B. H.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Irvine, Irina C.; Brigham, Christy A.] Natl Pk Serv, Santa Monica Mt Natl Recreat Area, Thousand Oaks, CA USA; [Suding, Katharine N.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Irvine; United States Department of the Interior; University of California System; University of California Berkeley	Irvine, IC (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	Irina_Irvine@NPS.gov	Suding, Katharine/O-6290-2017; Martiny, Jennifer/AAB-9323-2019	Suding, Katharine/0000-0002-5357-0176; Martiny, Jennifer/0000-0002-2415-1247	University of California; National Science Foundation [MCB-0701494]	University of California(University of California System); National Science Foundation(National Science Foundation (NSF))	University of California Irvine graduate student support (teaching assistantships, graduate student researcher stipends). National Science Foundation grant number MCB-0701494. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2006, SOIL BIOL BIOCHEM, V38, P1537, DOI 10.1016/j.soilbio.2005.11.008; Bains G, 2009, PLANT PHYSIOL, V151, P2145, DOI 10.1104/pp.109.146407; Bais HP, 2005, NATURE, V434, P217, DOI 10.1038/nature03356; Balachandar D, 2008, WORLD J MICROB BIOT, V24, P2087, DOI 10.1007/s11274-008-9713-7; Balachandar D, 2008, BRAZ J MICROBIOL, V39, P68, DOI [10.1590/S1517-83822008000100017, 10.1590/S1517-838220080001000017]; Bowler PA, 2000, ENVIRON MANAGE, V26, pS85; Burlage RS, 1998, TECHNIQUES MICROBIAL, P480; Chanprame S, 1996, PLANT CELL REP, V16, P222, DOI 10.1007/BF01890872; CORPE WA, 1989, FEMS MICROBIOL ECOL, V62, P243, DOI 10.1111/j.1574-6968.1989.tb03698.x; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Doronina NV, 2002, MICROBIOLOGY+, V71, P116, DOI 10.1023/A:1017966820382; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Hawkes CV, 2005, ECOL LETT, V8, P976, DOI 10.1111/j.1461-0248.2005.00802.x; Irvine IC, 2011, RESTORATION ECOLOGY, DOI [10.1111/j.1526-100X.2011.00850x, DOI 10.1111/J.1526-100X.2011.00850X]; Kalyaeva MA, 2001, RUSS J PLANT PHYSL+, V48, P514, DOI 10.1023/A:1016715800238; Knief C, 2008, APPL ENVIRON MICROB, V74, P2218, DOI 10.1128/AEM.02532-07; Lidstrom ME, 2006, AEROBIC METHYLOTROPH, P618, DOI DOI 10.1007/0-387-30742-7_20; Madhaiyan M, 2006, CURR MICROBIOL, V53, P270, DOI 10.1007/s00284-005-0452-9; Madhaiyan M, 2005, BIOL FERT SOILS, V41, P350, DOI 10.1007/s00374-005-0838-7; Madhaiyan M, 2004, BOT BULL ACAD SINICA, V45, P315; Madhaiyan M, 2007, J MICROBIOL BIOTECHN, V17, P1645; Mangla S, 2008, J ECOL, V96, P58, DOI 10.1111/j.1365-2745.2007.01312.x; McDonald IR, 1997, APPL ENVIRON MICROB, V63, P3218, DOI 10.1128/AEM.63.8.3218-3224.1997; Omer ZS, 2004, FEMS MICROBIOL ECOL, V47, P319, DOI 10.1016/S0168-6496(04)00003-0; Pirttila AM, 2005, TREE PHYSIOL, V25, P289, DOI 10.1093/treephys/25.3.289; Raja P, 2008, BIOL FERT SOILS, V45, P45, DOI 10.1007/s00374-008-0306-2; Reeburgh W. S., 1993, P1; Reynolds HL, 2003, ECOLOGY, V84, P2281, DOI 10.1890/02-0298; Romanovskaya V. A., 1996, Mikrobiolohichnyi Zhurnal, V58, P3; Schauer S, 2008, THEOR BIOSCI, V127, P23, DOI 10.1007/s12064-007-0020-x; Thorpe AS, 2009, J ECOL, V97, P641, DOI 10.1111/j.1365-2745.2009.01520.x; Trotsenko YA, 2001, MICROBIOLOGY+, V70, P623, DOI 10.1023/A:1013167612105; Trotsenko YA, 2008, ADV APPL MICROBIOL, V63, P183, DOI 10.1016/S0065-2164(07)00005-6; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601; Vogelsang KM, 2009, ECOLOGY, V90, P399, DOI 10.1890/07-2144.1; Weidenhamer JD, 2010, J CHEM ECOL, V36, P59, DOI 10.1007/s10886-009-9735-0	36	4	7	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31026	10.1371/journal.pone.0031026	http://dx.doi.org/10.1371/journal.pone.0031026			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22383990	Green Submitted, Green Published, gold			2022-12-27	WOS:000302916800009
J	Liao, BY; Chang, AYF				Liao, Ben-Yang; Chang, Andrew Ying-Fei			Mammalian Genes Preferentially Co-Retained in Radiation Hybrid Panels Tend to Avoid Coexpression	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; EXPRESSION PROFILES; LINKED GENES; CONSERVATION; NETWORK; MOUSE; ORDER	Coexpression has been frequently used to explore modules of functionally related genes in eukaryotic genomes. However, we found that genetically interacting mammalian genes identified through radiation hybrid (RH) genotypes tend not to be coexpressed across tissues. This pattern remained unchanged after controlling for potential confounding factors, including chromosomal linkage, chromosomal distance, and gene duplication. Because >99.9% of the genetically interacting genes were identified according to the higher co-retention frequencies, our observation implies that coexpression is not necessarily an indication of the need for the co-presence of two genes in the genome, which is a prerequisite for cofunctionality of their coding proteins in the cell. Therefore, coexpression information must be applied cautiously to the exploration of the functional relatedness of genes in a genome.	[Liao, Ben-Yang; Chang, Andrew Ying-Fei] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Miaoli County, Taiwan	National Health Research Institutes - Taiwan	Liao, BY (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Miaoli County, Taiwan.	liaoby@nhri.org.tw	Chang, Andrew Ying-Fei/M-5745-2019; Liao, Ben-Yang/AAH-5974-2019; Liao, Ben-Yang/AAX-6318-2021; Liao, Ben-Yang/E-3940-2010; Chang, Andrew Ying-Fei/K-4127-2012	Liao, Ben-Yang/0000-0003-1163-3113; Chang, Andrew Ying-Fei/0000-0001-5949-9836	National Health Research Institutes, Taiwan; National Science Council, Taiwan [NSC 99-2311-B-400-003-MY2]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by intramural funding from the National Health Research Institutes, Taiwan, and research grant (NSC 99-2311-B-400-003-MY2) from the National Science Council, Taiwan, to BYL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batada NN, 2007, TRENDS GENET, V23, P480, DOI 10.1016/j.tig.2007.08.003; Bjorklund AK, 2008, PROTEOMICS, V8, P4657, DOI 10.1002/pmic.200800150; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Garcia-Sanz JA, 1998, FASEB J, V12, P299, DOI 10.1096/fasebj.12.3.299; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lercher MJ, 2003, GENOME RES, V13, P238, DOI 10.1101/gr.553803; Liao BY, 2008, MOL BIOL EVOL, V25, P1555, DOI 10.1093/molbev/msn101; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Lin A, 2010, GENOME RES, V20, P1122, DOI 10.1101/gr.104216.109; Navratil V, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-13; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; Shi ZA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-74; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; van Noort V, 2003, TRENDS GENET, V19, P238, DOI 10.1016/S0168-9525(03)00056-8; Weber CC, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r23; Yanai I, 2006, TRENDS GENET, V22, P132, DOI 10.1016/j.tig.2006.01.006; Yanai I, 2009, GENOME RES, V19, P2214, DOI 10.1101/gr.093815.109	21	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32284	10.1371/journal.pone.0032284	http://dx.doi.org/10.1371/journal.pone.0032284			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384204	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916800032
J	Dvoriantchikova, G; Ivanov, D; Barakat, D; Grinberg, A; Wen, R; Slepak, VZ; Shestopalov, VI				Dvoriantchikova, Galina; Ivanov, Dmitry; Barakat, David; Grinberg, Alexander; Wen, Rong; Slepak, Vladlen Z.; Shestopalov, Valery I.			Genetic Ablation of Pannexin1 Protects Retinal Neurons from Ischemic Injury	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; CELL-DEATH; GANGLION-CELLS; NITRIC-OXIDE; ATP RELEASE; TNF-ALPHA; INFLAMMASOME; HEMICHANNELS; FAMILY; REPERFUSION	Pannexin1 (Panx1) forms large nonselective membrane channel that is implicated in paracrine and inflammatory signaling. In vitro experiments suggested that Panx1 could play a key role in ischemic death of hippocampal neurons. Since retinal ganglion cells (RGCs) express high levels of Panx1 and are susceptible to ischemic induced injury, we hypothesized that Panx1 contributes to rapid and selective loss of these neurons in ischemia. To test this hypothesis, we induced experimental retinal ischemia followed by reperfusion in live animals with the Panx1 channel genetically ablated either in the entire mouse (Panx1 KO), or only in neurons using the conditional knockout (Panx1 CKO) technology. Here we report that two distinct neurotoxic processes are induced in RGCs by ischemia in the wild type mice but are inactivated in Panx1KO and Panx1 CKO animals. First, the post-ischemic permeation of RGC plasma membranes is suppressed, as assessed by dye transfer and calcium imaging assays ex vivo and in vitro. Second, the inflammasome-mediated activation of caspase-1 and the production of interleukin-1 beta in the Panx1 KO retinas are inhibited. Our findings indicate that post-ischemic neurotoxicity in the retina is mediated by previously uncharacterized pathways, which involve neuronal Panx1 and are intrinsic to RGCs. Thus, our work presents the in vivo evidence for neurotoxicity elicited by neuronal Panx1, and identifies this channel as a new therapeutic target in ischemic pathologies.	[Dvoriantchikova, Galina; Ivanov, Dmitry; Barakat, David; Wen, Rong; Shestopalov, Valery I.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA; [Ivanov, Dmitry] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Grinberg, Alexander] NICHD, NIH, Bethesda, MD USA; [Slepak, Vladlen Z.] Univ Miami, Miller Sch Med, Dept Mol Pharmacol, Miami, FL 33136 USA; [Shestopalov, Valery I.] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA	Bascom Palmer Eye Institute; University of Miami; Russian Academy of Sciences; Vavilov Institute of General Genetics; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Miami; University of Miami	Dvoriantchikova, G (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA.	vshestopalov@med.miami.edu	Shestopalov, Valery/AAE-9838-2020	Ivanov, Dmitry/0000-0002-5573-4402; Barakat, David/0000-0001-7057-178X; Shestopalov, Valery/0000-0002-1568-6637	Research to Prevent Blindness Foundation; National Institutes of Health (NIH) [R01EY017991, R21EY020613, RO1EY018666, R01EY018586]; NIH center [P30 EY014801]; NATIONAL EYE INSTITUTE [R21EY017991, R01EY018666, R01EY021517, P30EY014801, R01EY018586, R21EY020613] Funding Source: NIH RePORTER	Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by a Career Development Award from the Research to Prevent Blindness Foundation (VIS), National Institutes of Health (NIH) grants R01EY017991 (VIS), R21EY020613 (DI), RO1EY018666 (VZS), R01EY018586 (RW), NIH center grant P30 EY014801 and an unrestricted grant from the Research to Prevent Blindness Foundation to the Department of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulafia DP, 2009, J CEREBR BLOOD F MET, V29, P534, DOI 10.1038/jcbfm.2008.143; Akuzawa S, 2008, J VASC SURG, V48, P694, DOI 10.1016/j.jvs.2008.04.011; Arai J, 2006, JPN J OPHTHALMOL, V50, P417, DOI 10.1007/s10384-006-0352-y; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Barbe MT, 2006, PHYSIOLOGY, V21, P103, DOI 10.1152/physiol.00048.2005; Bargiotas P, 2011, P NATL ACAD SCI USA, V108, P20772, DOI 10.1073/pnas.1018262108; Bargiotas P, 2009, CURR MOL MED, V9, P186, DOI 10.2174/156652409787581646; BENARI Y, 1990, EUR J NEUROSCI, V2, P62, DOI 10.1111/j.1460-9568.1990.tb00381.x; Berger S, 2008, INVEST OPHTH VIS SCI, V49, P3605, DOI 10.1167/iovs.07-0817; Bodar EJ, 2009, NETH J MED, V67, P302; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Carlson NG, 1999, J IMMUNOL, V163, P3963; Chakraborty S, 2010, J NEUROSCI RES, V88, P1615, DOI 10.1002/jnr.22343; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Daugeliene L, 2000, INVEST OPHTH VIS SCI, V41, P2743; Dvoriantchikova G, 2006, FEBS LETT, V580, P2178, DOI 10.1016/j.febslet.2006.03.026; Dvoriantchikova G, 2011, INVEST OPHTHALMOL VI; Dvoriantchikova G, 2006, MOL VIS, V12, P1417; Dvoriantchikova G, 2010, MOL VIS, V16, P2882; Dvoriantchikova G, 2010, MOL VIS, V16, P1907; Emsley HCA, 2005, J NEUROL NEUROSUR PS, V76, P1366, DOI 10.1136/jnnp.2004.054882; Froger N, 2010, MOL CELL NEUROSCI, V45, P37, DOI 10.1016/j.mcn.2010.05.007; Goldbach-Mansky R, 2009, ANN NY ACAD SCI, V1182, P111, DOI 10.1111/j.1749-6632.2009.05159.x; Hamann M, 2005, BRAIN, V128, P2408, DOI 10.1093/brain/awh619; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hansen JD, 2011, DEV COMP IMMUNOL, V35, P886, DOI 10.1016/j.dci.2011.01.008; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Ivanov D, 2006, FEBS LETT, V580, P331, DOI 10.1016/j.febslet.2005.12.017; Ivanov D, 2008, J NEUROSCI METH, V174, P10, DOI 10.1016/j.jneumeth.2008.06.016; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Katai N, 1999, INVEST OPHTH VIS SCI, V40, P2697; Kawai S, 2001, FASEB J, V15, P1285, DOI 10.1096/fj.00-0666fje; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Macvicar BA, 2009, NON JUNCTION FUNCTIO; Madry C, 2010, BRAIN, V133, P3755, DOI 10.1093/brain/awq284; Maher JJ, 2009, J CLIN INVEST, V119, P246, DOI 10.1172/JCI38178; Mandrup-Poulsen T, 2010, NAT REV ENDOCRINOL, V6, P158, DOI 10.1038/nrendo.2009.271; Neufeld AH, 2002, EXP EYE RES, V75, P521, DOI 10.1006/exer.2002.2042; Orellana JA, 2009, ANTIOXID REDOX SIGN, V11, P369, DOI 10.1089/ars.2008.2130; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Plesnila N, 2001, P NATL ACAD SCI USA, V98, P15318, DOI 10.1073/pnas.261323298; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Roth S, 1997, CURR EYE RES, V16, P875, DOI 10.1076/ceyr.16.9.875.5045; Ryskamp DA, 2011, J NEUROSCI, V31, P7089, DOI 10.1523/JNEUROSCI.0359-11.2011; Sandiford SL, 2009, BIOCHEMISTRY-US, V48, P2282, DOI 10.1021/bi801989c; Sappington RM, 2009, INVEST OPHTH VIS SCI, V50, P717, DOI 10.1167/iovs.08-2321; Scemes E, 2007, NEURON GLIA BIOL, V3, P199, DOI 10.1017/S1740925X08000069; Seki M, 2008, PROG BRAIN RES, V173, P495, DOI 10.1016/S0079-6123(08)01134-5; SellesNavarro I, 1996, INVEST OPHTH VIS SCI, V37, P2002; Seminario-Vidal L, 2011, J BIOL CHEM, V286, P26277, DOI 10.1074/jbc.M111.260562; Shestopalov VI, 2008, CELL MOL LIFE SCI, V65, P376, DOI 10.1007/s00018-007-7200-1; Shiose S, 2011, J BIOL CHEM, V286, P15543, DOI 10.1074/jbc.M111.228551; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Trendelenburg G, 2008, J CEREBR BLOOD F MET, V28, P867, DOI 10.1038/sj.jcbfm.9600609; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; WEINBERG JM, 1985, J CLIN INVEST, V76, P1193, DOI 10.1172/JCI112075; Yoneda S, 2001, EXP EYE RES, V73, P661, DOI 10.1006/exer.2001.1072; Zappala A, 2007, NEUROSCIENCE, V148, P653, DOI 10.1016/j.neuroscience.2007.06.028; Zhang L, 2008, J NEUROSCI RES, V86, P2281, DOI 10.1002/jnr.21675; Zhang X, 2004, EXP EYE RES, V78, P849, DOI 10.1016/j.exer.2003.10.018	71	85	86	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31991	10.1371/journal.pone.0031991	http://dx.doi.org/10.1371/journal.pone.0031991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384122	Green Published, gold			2022-12-27	WOS:000302916100043
J	Flores, H; van Franeker, JA; Siegel, V; Haraldsson, M; Strass, V; Meesters, EH; Bathmann, U; Wolff, WJ				Flores, Hauke; van Franeker, Jan Andries; Siegel, Volker; Haraldsson, Matilda; Strass, Volker; Meesters, Erik Hubert; Bathmann, Ulrich; Wolff, Willem Jan			The Association of Antarctic Krill Euphausia superba with the Under-Ice Habitat	PLOS ONE			English	Article							NW WEDDELL SEA; PACK-ICE; LAZAREV SEA; TROPHIC RELATIONSHIPS; COMMUNITY STRUCTURE; FORAGING BEHAVIOR; ELEPHANT ISLAND; ENERGY BUDGETS; SOUTH SHETLAND; FATTY-ACIDS	The association of Antarctic krill Euphausia superba with the under-ice habitat was investigated in the Lazarev Sea (Southern Ocean) during austral summer, autumn and winter. Data were obtained using novel Surface and Under Ice Trawls (SUIT), which sampled the 0-2 m surface layer both under sea ice and in open water. Average surface layer densities ranged between 0.8 individuals m(-2) in summer and autumn, and 2.7 individuals m(-2) in winter. In summer, under-ice densities of Antarctic krill were significantly higher than in open waters. In autumn, the opposite pattern was observed. Under winter sea ice, densities were often low, but repeatedly far exceeded summer and autumn maxima. Statistical models showed that during summer high densities of Antarctic krill in the 0-2 m layer were associated with high ice coverage and shallow mixed layer depths, among other factors. In autumn and winter, density was related to hydrographical parameters. Average under-ice densities from the 0-2 m layer were higher than corresponding values from the 0-200 m layer collected with Rectangular Midwater Trawls (RMT) in summer. In winter, under-ice densities far surpassed maximum 0-200 m densities on several occasions. This indicates that the importance of the ice-water interface layer may be under-estimated by the pelagic nets and sonars commonly used to estimate the population size of Antarctic krill for management purposes, due to their limited ability to sample this habitat. Our results provide evidence for an almost year-round association of Antarctic krill with the under-ice habitat, hundreds of kilometres into the ice-covered area of the Lazarev Sea. Local concentrations of postlarval Antarctic krill under winter sea ice suggest that sea ice biota are important for their winter survival. These findings emphasise the susceptibility of an ecological key species to changing sea ice habitats, suggesting potential ramifications on Antarctic ecosystems induced by climate change.	[Flores, Hauke; van Franeker, Jan Andries; Meesters, Erik Hubert] Inst Marine Resources & Ecosyst Studies IMARES, Texel, Netherlands; [Siegel, Volker] Johann Heinrich von Thunen Inst Sea Fisheries, Hamburg, Germany; [Haraldsson, Matilda] Univ Gothenburg, Dept Marine Ecol, Fiskebackskil, Sweden; [Flores, Hauke; Strass, Volker; Bathmann, Ulrich] Alfred Wegener Inst Polar & Marine Res AWI, Bremerhaven, Germany; [Wolff, Willem Jan] Univ Groningen, Ctr Ecol & Evolutionary Studies, Haren, Netherlands	Wageningen University & Research; Johann Heinrich von Thunen Institute; University of Gothenburg; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Groningen	Flores, H (corresponding author), Alfred Wegener Inst Polar & Marine Res AWI, Bremerhaven, Germany.	hauke.flores@awi.de	Flores, Hauke/ABD-1888-2020	Flores, Hauke/0000-0003-1617-5449; Strass, Volker/0000-0002-7539-1400; Meesters, Erik/0000-0002-3877-1164	Netherlands AntArctic Programme (NAAP) [851.20.011]; Dutch Ministry for Economic Affairs, Agriculture and Innovation [WOT-04-003-002]; German LAKRIS [BMBF MGS 03F046A]	Netherlands AntArctic Programme (NAAP); Dutch Ministry for Economic Affairs, Agriculture and Innovation; German LAKRIS	This study was supported by the Netherlands AntArctic Programme (NAAP Project nr. 851.20.011), the Dutch Ministry for Economic Affairs, Agriculture and Innovation (Statutory Research Tasks Nature and Environment, Project no WOT-04-003-002), and the German LAKRIS project (BMBF MGS 03F046A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINLEY DG, 1986, SCIENCE, V232, P847, DOI 10.1126/science.232.4752.847; Ainley DG, 2003, CONDOR, V105, P95, DOI 10.1650/0010-5422(2003)105[95:SATVOD]2.0.CO;2; AINLEY DG, 1992, MAR ECOL PROG SER, V90, P207, DOI 10.3354/meps090207; Atkinson A, 2008, MAR ECOL PROG SER, V362, P1, DOI 10.3354/meps07498; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Atkinson A, 2002, LIMNOL OCEANOGR, V47, P953, DOI 10.4319/lo.2002.47.4.0953; Atkinson A, 2009, DEEP-SEA RES PT I, V56, P727, DOI 10.1016/j.dsr.2008.12.007; Brierley AS, 2002, SCIENCE, V295, P1890, DOI 10.1126/science.1068574; Brierley AS, 2002, ADV MAR BIOL, V43, P171, DOI 10.1016/S0065-2881(02)43005-2; Cisewski B, 2005, DEEP-SEA RES PT II, V52, P1087, DOI 10.1016/j.dsr2.2005.01.010; Cisewski B, 2011, DEEP-SEA RES PT I, V58, P186, DOI 10.1016/j.dsr.2010.12.001; Cisewski B, 2010, DEEP-SEA RES PT I, V57, P78, DOI 10.1016/j.dsr.2009.10.005; Clarke A, 2008, CURR BIOL, V18, P282, DOI 10.1016/j.cub.2008.01.059; Connan M, 2007, MAR BIOL, V152, P95, DOI 10.1007/s00227-007-0664-6; Croxall JP, 2004, ANTARCT SCI, V16, P569, DOI 10.1017/S0954102004002330; Daly KL, 2004, DEEP-SEA RES PT II, V51, P2139, DOI 10.1016/j.dsr2.2004.07.010; de la Mare W., 1994, CCAMLR SCI, V1, P55; Donnelly J, 2006, POLAR BIOL, V29, P280, DOI 10.1007/s00300-005-0051-z; Everson I., 2000, KRILL BIOL ECOLOGY F, P63; Fisher EC, 2004, MAR BIOL, V144, P345, DOI 10.1007/s00227-003-1177-6; Flores H, 2004, POLAR BIOL, V27, P119, DOI 10.1007/s00300-003-0570-4; Flores H, MARINE ECOL IN PRESS; Flores H, 2008, MAR ECOL PROG SER, V367, P271, DOI 10.3354/meps07530; Flores H, 2011, DEEP-SEA RES PT II, V58, P1948, DOI 10.1016/j.dsr2.2011.01.010; GUTT J, 1994, DEEP-SEA RES PT I, V41, P169, DOI 10.1016/0967-0637(94)90031-0; Hamner W.M., 1982, Antarctic Journal of the United States, V17, P165; Hardy A. C., 1935, PLANKTON S GEORGIA W; Hastie T, 1990, GENERALIZED ADDITIVE, P14; Hewitt Roger P., 2000, Reviews in Fisheries Science, V8, P235, DOI 10.1080/10641260091129224; Hunt BPV, 2008, PROG OCEANOGR, V78, P193, DOI 10.1016/j.pocean.2008.06.001; Hunt BPV, 2011, DEEP-SEA RES PT II, V58, P1662, DOI 10.1016/j.dsr2.2010.11.016; Kaufmann RS, 1995, MAR BIOL, V124, P387, DOI 10.1007/BF00363912; Kawaguchi K., 1986, MEMOIRS NATL INSTIT, V44, P67; Kawaguchi S, 2009, FISHERIES MANAG ECOL, V16, P424, DOI 10.1111/j.1365-2400.2009.00686.x; Lancraft TM, 2004, DEEP-SEA RES PT II, V51, P2247, DOI 10.1016/j.dsr2.2004.07.004; Lawson GL, 2008, DEEP-SEA RES PT II, V55, P432, DOI 10.1016/j.dsr2.2007.11.014; Lawson GL, 2004, DEEP-SEA RES PT II, V51, P2041, DOI 10.1016/j.dsr2.2004.07.022; Lizotte MP, 2001, AM ZOOL, V41, P57, DOI 10.1668/0003-1569(2001)041[0057:TCOSIA]2.0.CO;2; Luque SP, 2007, MAR BIOL, V152, P213, DOI 10.1007/s00227-007-0677-1; Lynnes AS, 2004, POLAR BIOL, V27, P544, DOI 10.1007/s00300-004-0617-1; MARSCHALL HP, 1988, POLAR BIOL, V9, P129, DOI 10.1007/BF00442041; Meyer B, 2002, LIMNOL OCEANOGR, V47, P943, DOI 10.4319/lo.2002.47.4.0943; Meyer B, 2011, POLAR BIOL IN PRESS; Meyer B, 2010, MAR ECOL PROG SER, V398, P1, DOI 10.3354/meps08371; Meyer B, 2009, LIMNOL OCEANOGR, V54, P1595, DOI 10.4319/lo.2009.54.5.1595; Nicol S, 2006, BIOSCIENCE, V56, P111, DOI 10.1641/0006-3568(2006)056[0111:KCASIE]2.0.CO;2; Nicol S, 2012, FISH FISH, V13, P30, DOI 10.1111/j.1467-2979.2011.00406.x; NORDHAUSEN W, 1994, MAR ECOL PROG SER, V109, P131, DOI 10.3354/meps109131; O'Brien C, 2011, DEEP-SEA RES PT II, V58, P1211, DOI 10.1016/j.dsr2.2010.11.001; OBRIEN DP, 1987, J CRUSTACEAN BIOL, V7, P437, DOI 10.2307/1548293; Osman LP, 2004, POLAR BIOL, V27, P92, DOI 10.1007/s00300-003-0555-3; Pakhomov EA, 1998, J MARINE SYST, V17, P313, DOI 10.1016/S0924-7963(98)00046-3; Phleger CF, 2002, COMP BIOCHEM PHYS B, V131, P733, DOI 10.1016/S1096-4959(02)00021-0; PIATKOWSKI U, 1985, MEERESFORSCHUNG, V30, P264; QUETIN LB, 1991, AM ZOOL, V31, P49; Quinn G.P., 2002, EXPT DESIGN DATA ANA, P539; ROE HSJ, 1980, MAR BIOL, V56, P247, DOI 10.1007/BF00645349; Ross RM, 1998, J MARINE SYST, V17, P261, DOI 10.1016/S0924-7963(98)00042-6; Schiermeier Q, 2010, NATURE, V467, P15, DOI 10.1038/467015a; Schmidt K, 2003, LIMNOL OCEANOGR, V48, P277, DOI 10.4319/lo.2003.48.1.0277; Schmidt K, DEEP SEA 2 IN PRESS; Schmidt K, 2006, LIMNOL OCEANOGR, V51, P2409, DOI 10.4319/lo.2006.51.5.2409; Schmidt K, 2011, LIMNOL OCEANOGR, V56, P1411, DOI 10.4319/lo.2011.56.4.1411; Schnack-Schiel S.B., 2003, SEA ICE INTRO ITS PH, P211; Scripps Oceanographic Institution, 2006, GLOB TOP MEAS EST SE; Siegel V, 2005, POLAR BIOL, V29, P1, DOI 10.1007/s00300-005-0058-5; SIEGEL V, 1987, MAR BIOL, V96, P483, DOI 10.1007/BF00397966; SIEGEL V, 1995, MAR ECOL PROG SER, V123, P45, DOI 10.3354/meps123045; SIEGEL V, 1990, POLAR BIOL, V10, P549; SIEGEL V, 1992, POLAR BIOL, V12, P15; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; STRETCH JJ, 1988, MAR ECOL PROG SER, V44, P131, DOI 10.3354/meps044131; TORRES JJ, 1994, MAR ECOL PROG SER, V113, P221, DOI 10.3354/meps113221; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Van de Putte A, 2006, POLAR BIOL, V29, P1045, DOI 10.1007/s00300-006-0148-z; van Franeker J.A., 2009, THESIS, P181; van Franeker J.A., 2001, MIRRORS ICE; VanFraneker JA, 1997, DEEP-SEA RES PT II, V44, P435, DOI 10.1016/S0967-0645(96)00078-1; Wood SN, 2017, GEN ADDITIVE MODELS, V2; ZHOU M, 1994, DEEP-SEA RES PT I, V41, P1425, DOI 10.1016/0967-0637(94)90106-6	80	80	87	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31775	10.1371/journal.pone.0031775	http://dx.doi.org/10.1371/journal.pone.0031775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384073	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100034
J	Honeybul, S; Ho, K; Hanlon, SO				Honeybul, Stephen; Ho, Kwok; Hanlon, Susan O'			Access to Reliable Information about Long-Term Prognosis Influences Clinical Opinion on Use of Lifesaving Intervention	PLOS ONE			English	Article							CEREBRAL-ARTERY INFARCTION; TRAUMATIC BRAIN-INJURY; OF-LIFE DECISIONS; DECOMPRESSIVE CRANIECTOMY; SURGICAL DECOMPRESSION; HEMICRANIECTOMY; ATTITUDES; CARE; MULTICENTER; NEUROTRAUMA	Background: Decompressive craniectomy has been traditionally used as a lifesaving rescue treatment in severe traumatic brain injury (TBI). This study assessed whether objective information on long-term prognosis would influence healthcare workers' opinion about using decompressive craniectomy as a lifesaving procedure for patients with severe TBI. Method: A two-part structured interview was used to assess the participants' opinion to perform decompressive craniectomy for three patients who had very severe TBI. Their opinion was assessed before and after knowing the predicted and observed risks of an unfavourable long-term neurological outcome in various scenarios. Results: Five hundred healthcare workers with a wide variety of clinical backgrounds participated. The participants were significantly more likely to recommend decompressive craniectomy for their patients than for themselves (mean difference in visual analogue scale [VAS] -1.5, 95% confidence interval -1.3 to -1.6), especially when the next of kin of the patients requested intervention. Patients' preferences were more similar to patients who had advance directives. The participants' preferences to perform the procedure for themselves and their patients both significantly reduced after knowing the predicted risks of unfavourable outcomes, and the changes in attitude were consistent across different specialties, amount of experience in caring for similar patients, religious backgrounds, and positions in the specialty of the participants. Conclusions: Access to objective information on risk of an unfavourable long-term outcome influenced healthcare workers' decision to recommend decompressive craniectomy, considered as a lifesaving procedure, for patients with very severe TBI.	[Honeybul, Stephen; Hanlon, Susan O'] Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia; [Ho, Kwok] Royal Perth Hosp, Dept Intens Care Med, Perth, WA, Australia; [Ho, Kwok] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia	University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia	Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia.	stephen.honeybul@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004				Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Azoulay E, 2009, AM J RESP CRIT CARE, V180, P853, DOI 10.1164/rccm.200810-1614OC; Barbour KA, 2006, CHEST, V129, P1367, DOI 10.1378/chest.129.5.1367; Burns JP, 2001, CRIT CARE MED, V29, P658, DOI 10.1097/00003246-200103000-00036; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Gillett GR, 2010, J MED ETHICS, V36, P727, DOI 10.1136/jme.2010.037424; Granja C, 2001, INTENS CARE MED, V27, P555, DOI 10.1007/s001340100852; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Ho KM, 2005, INTENS CARE MED, V31, P668, DOI 10.1007/s00134-005-2613-5; Ho KM, 2004, ANAESTH INTENS CARE, V32, P781, DOI 10.1177/0310057X0403200609; Ho KM, 2011, J TRAUMA, V71, P1637, DOI 10.1097/TA.0b013e31823a08f1; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Holtkamp M, 2001, J NEUROL NEUROSUR PS, V70, P226, DOI 10.1136/jnnp.70.2.226; Honeybul S, 2011, J MED ETHICS, V37, P707, DOI 10.1136/medethics-2011-100081; Honeybul S, 2011, ACTA NEUROCHIR, V153, P1105, DOI 10.1007/s00701-011-0974-9; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Honeybul S, 2011, J NEUROTRAUM, V28, P13, DOI 10.1089/neu.2010.1584; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2010, ACTA NEUROCHIR, V152, P959, DOI 10.1007/s00701-010-0626-5; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kelly AG, 2010, NEUROLOGY, V75, P682, DOI 10.1212/WNL.0b013e3181eee273; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Koh MS, 2000, SURG NEUROL, V53, P225, DOI 10.1016/S0090-3019(00)00163-4; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Pugh EJ, 2009, PALLIATIVE MED, V23, P158, DOI 10.1177/0269216308100248; Pusic A, 2007, OTOLARYNG HEAD NECK, V136, P525, DOI 10.1016/j.otohns.2006.12.006; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sanoff HK, 2007, CLIN COLORECTAL CANC, V6, P700, DOI 10.3816/CCC.2007.n.039; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Servadei F, 2011, NEW ENGL J MED, V364, P1558, DOI 10.1056/NEJMe1102998; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Uhl E, 2004, J NEUROL NEUROSUR PS, V75, P270; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235	36	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32375	10.1371/journal.pone.0032375	http://dx.doi.org/10.1371/journal.pone.0032375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384231	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100075
J	Molloy, TJ; Roepman, P; Naume, B; van't Veer, LJ				Molloy, Timothy J.; Roepman, Paul; Naume, Bjorn; van't Veer, Laura J.			A Prognostic Gene Expression Profile That Predicts Circulating Tumor Cell Presence in Breast Cancer Patients	PLOS ONE			English	Article							BONE-MARROW MICROMETASTASIS; MARKER GENES; SURVIVAL; SIGNATURE; RECOMMENDATIONS; CARCINOMAS; RECURRENCE; TAMOXIFEN; SUBTYPES	The detection of circulating tumor cells (CTCs) in the peripheral blood and microarray gene expression profiling of the primary tumor are two promising new technologies able to provide valuable prognostic data for patients with breast cancer. Meta-analyses of several established prognostic breast cancer gene expression profiles in large patient cohorts have demonstrated that despite sharing few genes, their delineation of patients into "good prognosis" or "poor prognosis" are frequently very highly correlated, and combining prognostic profiles does not increase prognostic power. In the current study, we aimed to develop a novel profile which provided independent prognostic data by building a signature predictive of CTC status rather than outcome. Microarray gene expression data from an initial training cohort of 72 breast cancer patients for which CTC status had been determined in a previous study using a multimarker QPCR-based assay was used to develop a CTC-predictive profile. The generated profile was validated in two independent datasets of 49 and 123 patients and confirmed to be both predictive of CTC status, and independently prognostic. Importantly, the "CTC profile" also provided prognostic information independent of the well-established and powerful '70-gene' prognostic breast cancer signature. This profile therefore has the potential to not only add prognostic information to currently-available microarray tests but in some circumstances even replace blood-based prognostic CTC tests at time of diagnosis for those patients already undergoing testing by multigene assays.	[Molloy, Timothy J.; van't Veer, Laura J.] Netherlands Canc Inst, Div Expt Therapy, NL-1066 CX Amsterdam, Netherlands; [Roepman, Paul; van't Veer, Laura J.] Agendia BV, Amsterdam, Netherlands; [Naume, Bjorn] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Oncol, Oslo, Norway	Netherlands Cancer Institute; Agendia; University of Oslo	Molloy, TJ (corresponding author), Netherlands Canc Inst, Div Expt Therapy, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	l.vt.veer@nki.nl			European Commission [LSHC-CT-2005-018911]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Sixth Framework Program of the European Commission as part of the international DISMAL collaboration for research into disseminated epithelial malignancies (Project LSHC-CT-2005-018911). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosma AJ, 2002, CLIN CANCER RES, V8, P1871; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Molloy TJ, 2008, BREAST CANCER RES TR, V112, P297, DOI 10.1007/s10549-007-9872-5; Molloy TJ, 2011, BRIT J CANC; Molloy TJ, 2011, BREAST CANC IN PRESS; Naume B, 2007, MOL ONCOL, V1, P160, DOI 10.1016/j.molonc.2007.03.004; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Reyal F, 2011, ANN ONCOL, V22, P1458, DOI 10.1093/annonc/mdr144; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; Roepman P, 2009, CLIN CANCER RES, V15, P284, DOI 10.1158/1078-0432.CCR-08-1258; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weigelt B, 2003, BRIT J CANCER, V88, P1091, DOI 10.1038/sj.bjc.6600868; Wiedswang G, 2003, J CLIN ONCOL, V21, P3469, DOI 10.1200/JCO.2003.02.009; Wiedswang G, 2006, INT J CANCER, V118, P2013, DOI 10.1002/ijc.21576; Wikman H, 2008, APMIS, V116, P754, DOI 10.1111/j.1600-0463.2008.01033.x; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Xenidis N, 2009, J CLIN ONCOL, V27, P2177, DOI 10.1200/JCO.2008.18.0497	30	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32426	10.1371/journal.pone.0032426	http://dx.doi.org/10.1371/journal.pone.0032426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384245	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916100078
J	Rosello-Lleti, E; Calabuig, JR; Morillas, P; Cortes, R; Martinez-Dolz, L; Almenar, L; Gonzalez-Juanatey, JR; Lauwers, C; Salvador, A; Portoles, M; Bertomeu, V; Rivera, M				Rosello-Lleti, Esther; Calabuig, Jose R.; Morillas, Pedro; Cortes, Raquel; Martinez-Dolz, Luis; Almenar, Luis; Gonzalez-Juanatey, Jose R.; Lauwers, Catheline; Salvador, Antonio; Portoles, Manuel; Bertomeu, Vicente; Rivera, Miguel			Variability of NT-proBNP and Its Relationship with Inflammatory Status in Patients with Stable Essential Hypertension: A 2-Year Follow-Up Study	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; LEFT-VENTRICULAR HYPERTROPHY; CHRONIC HEART-FAILURE; MYOCARDIAL-INFARCTION; BIOLOGICAL VARIATION; TERMINAL PROBNP; PLASMA; EXPRESSION; BNP; ACTIVATION	Background: The variability of NT-proBNP levels has been studied in heart failure, yet no data exist on these changes over time in hypertensive patients. Furthermore, studies on the relationship between natriuretic peptides and inflammatory status are limited. Methodology/Principal Findings: 220 clinically and functionally asymptomatic stable patients (age 59613, 120 male) out of 252 patients with essential hypertension were followed up, and NT-proBNP was measured at baseline, 12 and 24 months. No differences in NT-proBNP were found with respect to the basal stage in the hypertrophic group, but significant changes were found in non-hypertrophic subjects. The reproducibility of NT-proBNP measurements was better in patients with hypertrophy than in the non-hypertrophic group for the three intervals (stage I-basal; stage II-stage I; stage II-basal) with a reference change value of 34%, 35% and 41%, respectively, in the hypertrophic group. A more elevated coefficient of correlation was obtained in the hypertrophic group than in patients without hypertrophy: basal versus stage I (r = 0.79, p<0.0001 and r = 0.59, p<0.0001) and stage I versus stage II (r = 0.86, p<0.0001 and r = 0.56, p<0.0001). Finally, levels of NT-proBNP significantly correlated with sTNF-R1 (p<0.0001) and IL-6 (p<0.01) during follow-up. A multivariate linear regression analysis showed that sTNF-R1 is an independent factor of NT-proBNP. Conclusions/Significance: This work shows that there is good stability in NT-proBNP levels in a follow-up study of asymptomatic patients with stable hypertension and left ventricular hypertrophy. As a consequence, assessment of NT-proBNP concentrations may be a useful tool for monitoring the follow-up of hypertensive patients with hypertrophy. Measured variations in peptide levels, exceeding 35% in a 12-month follow-up and 41% in a 24-month follow-up, may indicate an increase in cardiovascular risk, and therefore implies adjustment in the medical treatment. In addition, this study shows a link between neurohormonal and inflammatory activation in these patients.	[Rosello-Lleti, Esther; Cortes, Raquel; Rivera, Miguel] Hosp Univ La Fe, Cardiocirculatory Unit, Res Ctr, Valencia, Spain; [Morillas, Pedro; Bertomeu, Vicente] Hosp Univ San Juan, Cardiol Unit, Alicante, Spain; [Martinez-Dolz, Luis; Almenar, Luis; Salvador, Antonio] Hosp Univ la Fe, Cardiol Unit, Valencia, Spain; [Gonzalez-Juanatey, Jose R.] Hosp Clin, Cardiol Unit, Santiago De Compostela, Spain; [Lauwers, Catheline] Hosp San Francesc de Borja, Cardiol Unit, Gandia, Spain; [Portoles, Manuel] Hosp Univ La Fe, Cell Biol & Pathol Unit, Res Ctr, Valencia, Spain	Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Complexo Hospitalario Universitario de Santiago de Compostela; Hospital Universitari i Politecnic La Fe	Rosello-Lleti, E (corresponding author), Hosp Univ La Fe, Cardiocirculatory Unit, Res Ctr, Valencia, Spain.	rivera_jmi@gva.es	Roselló Lletí, Esther/ABG-8503-2020; Cortes, Raquel/GQH-6347-2022; Roselló-Lletí, Esther/B-2695-2017; CORTES, RAQUEL/K-2777-2014; Dolz, Luis Martinez/X-4627-2018; PORTOLES, MANUEL/B-4789-2009	Roselló Lletí, Esther/0000-0003-2627-6104; Cortes, Raquel/0000-0001-9607-997X; Roselló-Lletí, Esther/0000-0003-2627-6104; CORTES, RAQUEL/0000-0001-9607-997X; Dolz, Luis Martinez/0000-0001-5145-8191; PORTOLES, MANUEL/0000-0002-4415-7160; BERTOMEU MARTINEZ, VICENTE/0000-0002-3553-0963; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388	United States National Institutes of Health "Fondo de Investigaciones Sanitarias del Instituto Carlos III" [REDINSCOR 06/0003/1001]	United States National Institutes of Health "Fondo de Investigaciones Sanitarias del Instituto Carlos III"	This work was supported by grants from the United States National Institutes of Health "Fondo de Investigaciones Sanitarias del Instituto Carlos III," (REDINSCOR 06/0003/1001 and FIS Project (PI)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bruins S, 2004, CLIN CHEM, V50, P2052, DOI 10.1373/clinchem.2004.038752; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cortes R, 2008, AM J HYPERTENS, V21, P820, DOI 10.1038/ajh.2008.173; Cortes R, 2007, HEART, V93, P957, DOI 10.1136/hrt.2006.096891; d'Eril GVM, 2003, CLIN CHEM, V49, P1554; deBold AJ, 1996, CARDIOVASC RES, V31, P7, DOI 10.1016/S0008-6363(95)00121-2; Deten A, 2002, CARDIOVASC RES, V55, P329, DOI 10.1016/S0008-6363(02)00413-3; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Frankenstein L, 2009, CLIN CHEM, V55, P923, DOI 10.1373/clinchem.2008.112052; Garcia MJ, 1998, J AM COLL CARDIOL, V32, P865, DOI 10.1016/S0735-1097(98)00345-3; Harada M, 1998, J CARDIOVASC PHARM, V31, pS357, DOI 10.1097/00005344-199800001-00100; HASEGAWA K, 1993, CIRCULATION, V88, P372, DOI 10.1161/01.CIR.88.2.372; Hildebrandt P, 2004, EUR J HEART FAIL, V6, P313, DOI 10.1016/j.ejheart.2004.01.001; Hopkins WE, 2004, CIRCULATION, V109, P2872, DOI 10.1161/01.CIR.0000129305.25115.80; Isnard R, 2008, ARCH CARDIOVASC DIS, V101, P295, DOI 10.1016/j.acvd.2008.05.004; Jankowska EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014506; Jernberg T, 2003, J AM COLL CARDIOL, V42, P1909, DOI 10.1016/j.jacc.2003.07.015; Jourdain P, 2007, J AM COLL CARDIOL, V49, P1733, DOI 10.1016/j.jacc.2006.10.081; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mayosi BM, 2002, EUR HEART J, V23, P1963, DOI 10.1053/euhj.2002.3288; McKie PM, 2006, HYPERTENSION, V47, P874, DOI 10.1161/01.HYP.0000216794.24161.8c; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Niethammer M, 2008, INT J CARDIOL, V129, P111, DOI 10.1016/j.ijcard.2007.05.061; Nishigaki K, 1996, J AM COLL CARDIOL, V28, P1234, DOI 10.1016/S0735-1097(96)00277-X; Olsen MH, 2005, J HYPERTENS, V23, P1083, DOI 10.1097/01.hjh.0000166851.18463.85; Olsen MH, 2004, J HYPERTENS, V22, P1597, DOI 10.1097/01.hjh.0000125451.28861.2a; Paget V, 2011, HYPERTENSION, V57, P702, DOI 10.1161/HYPERTENSIONAHA.110.163550; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Rosello-Lleti E, 2009, AM J HYPERTENS, V22, P444, DOI 10.1038/ajh.2008.369; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Schou M, 2007, EUR HEART J, V28, P177, DOI 10.1093/eurheartj/ehl449; Sievers B, 2005, AM HEART J, V150, P737, DOI 10.1016/j.ahj.2004.11.017; Talens-Visconti R, 2006, ECHOCARDIOGR-J CARD, V23, P295, DOI 10.1111/j.1540-8175.2006.00205.x; Toda K, 2010, J CLIN LAB ANAL, V24, P12, DOI 10.1002/jcla.20366; Troughton RW, 2000, LANCET, V355, P1126, DOI 10.1016/S0140-6736(00)02060-2; Tsutamoto T, 2001, J AM COLL CARDIOL, V38, P2132, DOI 10.1016/S0735-1097(01)01646-1; Valgimigli M, 2005, CIRCULATION, V111, P863, DOI 10.1161/01.CIR.0000155614.35441.69; Wu AHB, 2003, AM J CARDIOL, V92, P628, DOI 10.1016/S0002-9149(03)00741-0	42	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31189	10.1371/journal.pone.0031189	http://dx.doi.org/10.1371/journal.pone.0031189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384001	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100015
J	Edmond, K; Scott, S; Korczak, V; Ward, C; Sanderson, C; Theodoratou, E; Clark, A; Griffiths, U; Rudan, I; Campbell, H				Edmond, Karen; Scott, Susana; Korczak, Viola; Ward, Catherine; Sanderson, Colin; Theodoratou, Evropi; Clark, Andrew; Griffiths, Ulla; Rudan, Igor; Campbell, Harry			Long Term Sequelae from Childhood Pneumonia; Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RESPIRATORY-TRACT INFECTION; LUNG-FUNCTION; MYCOPLASMA-PNEUMONIAE; BIRTH-WEIGHT; CHILDREN; BRONCHIECTASIS; EPIDEMIOLOGY; PREDICTORS; MORBIDITY; HYPOXEMIA	Background: The risks of long term sequelae from childhood pneumonia have not been systematically assessed. The aims of this study were to: (i) estimate the risks of respiratory sequelae after pneumonia in children under five years; (ii) estimate the distribution of the different types of respiratory sequelae; and (iii) compare sequelae risk by hospitalisation status and pathogen. Methods: We systematically reviewed published papers from 1970 to 2011. Standard global burden of disease categories (restrictive lung disease, obstructive lung disease, bronchiectasis) were labelled as major sequelae. 'Minor' sequelae (chronic bronchitis, asthma, other abnormal pulmonary function, other respiratory disease), and multiple impairments were also included. Thirteen papers were selected for inclusion. Synthesis was by random effects meta-analysis and meta-regression. Results: Risk of at least one major sequelae was 5.5% (95% confidence interval [95% CI] 2.8-8.3%) in non hospitalised children and 13.6% [6.2-21.1%]) in hospitalised children. Adenovirus pneumonia was associated with the highest sequelae risk (54.8% [39.2-70.5%]) but children hospitalised with no pathogen isolated also had high risk (17.6% [10.9-24.3%]). The most common type of major sequela was restrictive lung disease (5.4% [2.5-10.2%]). Potential confounders such as loss to follow up and median age at infection were not associated with sequelae risk in the final models. Conclusions: All children with pneumonia diagnosed by a health professional should be considered at risk of long term sequelae. Evaluation of childhood pneumonia interventions should include potential impact on long term respiratory sequelae.	[Edmond, Karen; Scott, Susana] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Korczak, Viola; Griffiths, Ulla] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Ward, Catherine; Theodoratou, Evropi] Univ Edinburgh, Dept Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Sanderson, Colin; Clark, Andrew; Rudan, Igor; Campbell, Harry] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Edinburgh; University of London; London School of Hygiene & Tropical Medicine	Edmond, K (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England.	karen.edmond@lshtm.ac.uk	Sanderson, Colin F/O-9877-2014; Rudan, Igor/I-1467-2012; Theodoratou, Evropi/C-3430-2014; Campbell, Harry/E-2959-2010	Rudan, Igor/0000-0001-6993-6884; Theodoratou, Evropi/0000-0001-5887-9132; Campbell, Harry/0000-0002-6169-6262; Korczak, Viola/0000-0002-5031-4126; Sanderson, Colin/0000-0002-4838-6112				BARKER DJP, 1991, BRIT MED J, V303, P671, DOI 10.1136/bmj.303.6804.671; BRITTEN N, 1987, BRIT MED J, V294, P1317, DOI 10.1136/bmj.294.6583.1317; Bruchhaus J D, 1998, Curr Opin Pulm Med, V4, P180; BUCHER U., 1961, THORAX, V16, P207, DOI 10.1136/thx.16.3.207; CERUTI E, 1971, AM J DIS CHILD, V122, P386, DOI 10.1001/archpedi.1971.02110050056004; Chang AB, 2003, PEDIATR PULM, V35, P477, DOI 10.1002/ppul.10289; Chang AB, 2002, MED J AUSTRALIA, V177, P200, DOI 10.5694/j.1326-5377.2002.tb04733.x; Chang AB, 2010, MED J AUSTRALIA, V193, P356, DOI 10.5694/j.1326-5377.2010.tb03949.x; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Eastham KM, 2008, ARCH DIS CHILD, V93, P755, DOI 10.1136/adc.2007.128900; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; GLEZEN WP, 1973, NEW ENGL J MED, V288, P498, DOI 10.1056/NEJM197303082881005; Johnston IDA, 1998, NEW ENGL J MED, V338, P581, DOI 10.1056/NEJM199802263380904; Johnston IDA, 1999, J PEDIATR-US, V135, pS33; Kim CK, 2000, PEDIATRICS, V105, P372, DOI 10.1542/peds.105.2.372; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; McEachern R, 1998, INFECT DIS CLIN N AM, V12, P761, DOI 10.1016/S0891-5520(05)70209-9; MOK JYQ, 1979, ACTA PAEDIATR SCAND, V68, P833; Piippo-Savolainen E, 2004, ARCH PEDIAT ADOL MED, V158, P1070, DOI 10.1001/archpedi.158.11.1070; Ritchie LMP, 2009, INT J TUBERC LUNG D, V13, P527; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; SABATO AR, 1984, ARCH DIS CHILD, V59, P1034, DOI 10.1136/adc.59.11.1034; SAMET JM, 1983, AM REV RESPIR DIS, V127, P508, DOI 10.1164/arrd.1983.127.4.508; SHAHEEN SO, 1994, AM J RESP CRIT CARE, V149, P616, DOI 10.1164/ajrccm.149.3.8118627; Shaheen SO, 1998, THORAX, V53, P549, DOI 10.1136/thx.53.7.549; SIMILA S, 1981, CHEST, V80, P127, DOI 10.1378/chest.80.2.127; SLY PD, 1984, ARCH DIS CHILD, V59, P935, DOI 10.1136/adc.59.10.935; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P155, DOI 10.1093/ije/dyq032; THURLBECK WM, 1982, THORAX, V37, P564, DOI 10.1136/thx.37.8.564; Usen S, 1999, BMJ-BRIT MED J, V318, P86, DOI 10.1136/bmj.318.7176.86; Weber MW, 1997, ARCH DIS CHILD, V76, P310, DOI 10.1136/adc.76.4.310; WEISS SG, 1986, J PEDIATR-US, V108, P659, DOI 10.1016/S0022-3476(86)81037-X; Wells G.A., NEWCASTLE OTTAWA SCA; WESLEY AG, 1984, S AFR MED J, V66, P325; WESLEY AG, 1991, S AFR MED J, V79, P73; West TE, 1999, B WORLD HEALTH ORGAN, V77, P144; World Health Organization, 2001, GLOB BURD DIS COMPR; World Health Organization Collaborating Centres for Classification of Diseases, 1992, INT STAT CLASS DIS R, V1	42	102	106	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31239	10.1371/journal.pone.0031239	http://dx.doi.org/10.1371/journal.pone.0031239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384005	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000302875500015
J	Gregory, JM; Barros, TP; Meehan, S; Dobson, CM; Luheshi, LM				Gregory, Jenna M.; Barros, Teresa P.; Meehan, Sarah; Dobson, Christopher M.; Luheshi, Leila M.			The Aggregation and Neurotoxicity of TDP-43 and Its ALS-Associated 25 kDa Fragment Are Differentially Affected by Molecular Chaperones in Drosophila	PLOS ONE			English	Article							HSP90 INHIBITOR; PROTEIN; MODEL; NEURODEGENERATION; DEGENERATION; NUCLEAR; DETERMINANTS; INCLUSIONS; EXPRESSION; INDUCTION	Almost all cases of sporadic amyotrophic lateral sclerosis (ALS), and some cases of the familial form, are characterised by the deposition of TDP-43, a member of a family of heteronuclear ribonucleoproteins (hnRNP). Although protein misfolding and deposition is thought to be a causative feature of many of the most prevalent neurodegenerative diseases, a link between TDP-43 aggregation and the dysfunction of motor neurons has yet to be established, despite many correlative neuropathological studies. We have investigated this relationship in the present study by probing the effect of altering TDP-43 aggregation behaviour in vivo by modulating the levels of molecular chaperones in a Drosophila model. More specifically, we quantify the effect of either pharmacological upregulation of the heat shock response or specific genetic upregulation of a small heat shock protein, CG14207, on the neurotoxicity of both TDP-43 and of its disease associated 25 kDa fragment (TDP-25) in a Drosophila model. Inhibition of the aggregation of TDP-43 by either method results in a partial reduction of its neurotoxic effects on both photoreceptor and motor neurons, whereas inhibition of the aggregation of TDP-25 results not only in a complete suppression of its toxicity but also its clearance from the brain in both neuronal subtypes studied. The results demonstrate, therefore, that aggregation plays a crucial role in mediating the neurotoxic effects of both full length and truncated TDP-43, and furthermore reveal that the in vivo propensity of these two proteins to aggregate and their susceptibility to molecular chaperone mediated clearance are quite distinct.	[Gregory, Jenna M.; Barros, Teresa P.; Meehan, Sarah; Dobson, Christopher M.; Luheshi, Leila M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Gregory, Jenna M.; Barros, Teresa P.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	University of Cambridge; University of Cambridge	Gregory, JM (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	lml25@cam.ac.uk	Barros, Teresa/F-7706-2013	Barros, Teresa/0000-0003-4889-1597; Gregory, Jenna/0000-0003-3337-4079	International Journal of Experimental Pathology; James Baird Fund; Royal Society; Biotechnology and Biological Sciences Research Council; Medical Research Council [G0700990, MC_G1000734] Funding Source: researchfish; MRC [G0700990, MC_G1000734] Funding Source: UKRI	International Journal of Experimental Pathology; James Baird Fund; Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the International Journal of Experimental Pathology (JMG), which is a non-profit-making institution; the James Baird Fund (JMG); the Royal Society (SM); and the Biotechnology and Biological Sciences Research Council (LML, TPB, and CMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2010, NEUROPATHOLOGY, V30, P170, DOI 10.1111/j.1440-1789.2009.01089.x; Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bilen J, 2007, PLOS GENET, V3, P1950, DOI 10.1371/journal.pgen.003177; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Carra S, 2010, J BIOL CHEM, V285, P37811, DOI 10.1074/jbc.M110.127498; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Crippa V, 2010, HUM MOL GENET, V19, P3440, DOI 10.1093/hmg/ddq257; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Fujikake N, 2008, J BIOL CHEM, V283, P26188, DOI 10.1074/jbc.M710521200; Hostein I, 2001, CANCER RES, V61, P4003; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Marsh JL, 2006, NEURON, V52, P169, DOI 10.1016/j.neuron.2006.09.025; Neef DW, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000291; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Riedel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008753; Voigt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012247; Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Waudby CA, 2010, BIOPHYS J, V98, P843, DOI 10.1016/j.bpj.2009.10.056; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Zhang T, 2011, HUM MOL GENET, V20, P1952, DOI 10.1093/hmg/ddr076; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007	40	43	44	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31899	10.1371/journal.pone.0031899	http://dx.doi.org/10.1371/journal.pone.0031899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384095	gold, Green Submitted, Green Published			2022-12-27	WOS:000302875500051
J	Olivry, T; Linder, KE; Wang, P; Bizikova, P; Bernstein, JA; Dunston, SM; Paps, JS; Casal, ML				Olivry, Thierry; Linder, Keith E.; Wang, Ping; Bizikova, Petra; Bernstein, Joseph A.; Dunston, Stanley M.; Paps, Judy S.; Casal, Margret L.			Deficient Plakophilin-1 Expression Due to a Mutation in PKP1 Causes Ectodermal Dysplasia-Skin Fragility Syndrome in Chesapeake Bay Retriever Dogs	PLOS ONE			English	Article							DESMOSOMAL PROTEIN PLAKOPHILIN-1; SPLICE-SITE MUTATIONS; EPIDERMOLYSIS-BULLOSA; GENE; FAMILIES; ADHESION	In humans, congenital and hereditary skin diseases associated with epidermal cell-cell separation (acantholysis) are very rare, and spontaneous animal models of these diseases are exceptional. Our objectives are to report a novel congenital acantholytic dermatosis that developed in Chesapeake Bay retriever dogs. Nine affected puppies in four different litters were born to eight closely related clinically normal dogs. The disease transmission was consistent with an autosomal recessive mode of inheritance. Clinical signs occurred immediately after birth with superficial epidermal layers sloughing upon pressure. At three month of age, dogs exhibited recurrent superficial skin sloughing and erosions at areas of friction and mucocutaneous junctions; their coat was also finer than normal and there were patches of partial hair loss. At birth, histopathology revealed severe suprabasal acantholysis, which became less severe with ageing. Electron microscopy demonstrated a reduced number of partially formed desmosomes with detached and aggregated keratin intermediate filaments. Immunostaining for desmosomal adhesion molecules revealed a complete lack of staining for plakophilin-1 and anomalies in the distribution of desmoplakin and keratins 10 and 14. Sequencing revealed a homozygous splice donor site mutation within the first intron of PKP1 resulting in a premature stop codon, thereby explaining the inability to detect plakophilin-1 in the skin. Altogether, the clinical and pathological findings, along with the PKP1 mutation, were consistent with the diagnosis of ectodermal dysplasia-skin fragility syndrome with plakophilin-1 deficiency. This is the first occurrence of ectodermal dysplasia-skin fragility syndrome in an animal species. Controlled mating of carrier dogs would yield puppies that could, in theory, be tested for gene therapy of this rare but severe skin disease of children.	[Olivry, Thierry; Bizikova, Petra; Dunston, Stanley M.; Paps, Judy S.] N Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27607 USA; [Olivry, Thierry] N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Raleigh, NC USA; [Linder, Keith E.] N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC USA; [Wang, Ping; Casal, Margret L.] Univ Penn, Sch Vet Med, Med Genet Sect, Philadelphia, PA 19104 USA; [Bernstein, Joseph A.] Long Green Anim Dermatol Ctr, Baldwin, MD USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Pennsylvania	Olivry, T (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27607 USA.	tolivry@ncsu.edu	Olivry, Thierry/AAV-7869-2021; Olivry, Thierry/E-3289-2013	Olivry, Thierry/0000-0003-1399-0034; 	National Institutes of Health (NIH)-National Center for Research Resources [RR02512]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER	National Institutes of Health (NIH)-National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was in part provided by the National Institutes of Health (NIH)-National Center for Research Resources (RR02512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding from NIH was used for the genetic part of the study. Otherwise, no additional external funding was received for this study.	Bergman R, 2005, AM J DERMATOPATH, V27, P333, DOI 10.1097/01.dad.0000157451.46657.a6; Bizikova P, 2011, VET DERMATOL, V22, P132, DOI 10.1111/j.1365-3164.2010.00924.x; Ersoy-Evans S, 2006, J AM ACAD DERMATOL, V55, P157, DOI 10.1016/j.jaad.2005.10.002; Fine JD, 2008, J AM ACAD DERMATOL, V58, P931, DOI 10.1016/j.jaad.2008.02.004; Hamada T, 2002, EXP DERMATOL, V11, P107, DOI 10.1034/j.1600-0625.2002.110202.x; Hartmann L, 2008, FRONT BIOSCI-LANDMRK, V13, P3252; Hatzfeld M, 2007, BBA-MOL CELL RES, V1773, P69, DOI 10.1016/j.bbamcr.2006.04.009; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; JOLLY RD, 1973, VET PATHOL, V10, P473, DOI 10.1177/030098587301000601; McGrath JA, 1999, BRIT J DERMATOL, V140, P297; McGrath JA, 1997, NAT GENET, V17, P240, DOI 10.1038/ng1097-240; McGrath JA, 2010, DERMATOL CLIN, V28, P131, DOI 10.1016/j.det.2009.10.015; McGrath JA, 2010, DERMATOL CLIN, V28, P125, DOI 10.1016/j.det.2009.10.014; McMillan JR, 2003, J INVEST DERMATOL, V121, P96, DOI 10.1046/j.1523-1747.2003.12324.x; Nel S, 2011, VET PATHOL, V48, P276, DOI 10.1177/0300985810374843; Olivry T, 2009, VET DERMATOL, V20, P313, DOI 10.1111/j.1365-3164.2009.00821.x; RIETCORREA F, 1994, VET PATHOL, V31, P450, DOI 10.1177/030098589403100407; Sprecher E, 2004, J INVEST DERMATOL, V122, P647, DOI 10.1111/j.0022-202X.2004.22335.x; Steijlen PM, 2004, J INVEST DERMATOL, V122, P1321, DOI 10.1111/j.0022-202X.2003.22302.x; Tanaka A, 2009, BRIT J DERMATOL, V160, P692, DOI 10.1111/j.1365-2133.2008.08900.x; Wessagowit V, 2005, ACTA DERM-VENEREOL, V85, P386, DOI 10.1080/00015550510011763; Whittock NV, 2000, J INVEST DERMATOL, V115, P368, DOI 10.1046/j.1523-1747.2000.00082.x	22	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32072	10.1371/journal.pone.0032072	http://dx.doi.org/10.1371/journal.pone.0032072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384142	gold, Green Published, Green Submitted			2022-12-27	WOS:000302875500071
J	Thomas, CM; Hong, T; van Pijkeren, JP; Hemarajata, P; Trinh, DV; Hu, WD; Britton, RA; Kalkum, M; Versalovic, J				Thomas, Carissa M.; Hong, Teresa; van Pijkeren, Jan Peter; Hemarajata, Peera; Trinh, Dan V.; Hu, Weidong; Britton, Robert A.; Kalkum, Markus; Versalovic, James			Histamine Derived from Probiotic Lactobacillus reuteri Suppresses TNF via Modulation of PKA and ERK Signaling	PLOS ONE			English	Article							NF-KAPPA-B; GASTROINTESTINAL-TRACT; GENE-EXPRESSION; DENDRITIC CELL; T-CELL; IDENTIFICATION; H-2-RECEPTOR; MAPK; MATURATION; RESPONSES	Beneficial microbes and probiotic species, such as Lactobacillus reuteri, produce biologically active compounds that can modulate host mucosal immunity. Previously, immunomodulatory factors secreted by L. reuteri ATCC PTA 6475 were unknown. A combined metabolomics and bacterial genetics strategy was utilized to identify small compound(s) produced by L. reuteri that were TNF-inhibitory. Hydrophilic interaction liquid chromatography-high performance liquid chromatography (HILIC-HPLC) separation isolated TNF-inhibitory compounds, and HILIC-HPLC fraction composition was determined by NMR and mass spectrometry analyses. Histamine was identified and quantified in TNF-inhibitory HILIC-HPLC fractions. Histamine is produced from L-histidine via histidine decarboxylase by some fermentative bacteria including lactobacilli. Targeted mutagenesis of each gene present in the histidine decarboxylase gene cluster in L. reuteri 6475 demonstrated the involvement of histidine decarboxylase pyruvoyl type A (hdcA), histidine/histamine antiporter (hdcP), and hdcB in production of the TNF-inhibitory factor. The mechanism of TNF inhibition by L. reuteri-derived histamine was investigated using Toll-like receptor 2 (TLR2)-activated human monocytoid cells. Bacterial histamine suppressed TNF production via activation of the H-2 receptor. Histamine from L. reuteri 6475 stimulated increased levels of cAMP, which inhibited downstream MEK/ERK MAPK signaling via protein kinase A (PKA) and resulted in suppression of TNF production by transcriptional regulation. In summary, a component of the gut microbiome, L. reuteri, is able to convert a dietary component, L-histidine, into an immunoregulatory signal, histamine, which suppresses pro-inflammatory TNF production. The identification of bacterial bioactive metabolites and their corresponding mechanisms of action with respect to immunomodulation may lead to improved anti-inflammatory strategies for chronic immune-mediated diseases.	[Thomas, Carissa M.] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA; [Hong, Teresa; Trinh, Dan V.; Hu, Weidong; Kalkum, Markus] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA USA; [van Pijkeren, Jan Peter; Britton, Robert A.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Hemarajata, Peera] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Versalovic, James] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Versalovic, James] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA	Baylor College of Medicine; City of Hope; Beckman Research Institute of City of Hope; Michigan State University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Thomas, CM (corresponding author), Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA.	jamesv@bcm.edu	Hemarajata, Peera/F-8268-2018; van Pijkeren, Jan-Peter/H-5333-2019	Hemarajata, Peera/0000-0001-6182-9136; Kalkum, Markus/0000-0002-9506-671X; Thomas, Carissa/0000-0003-0765-5731	National Institutes of Health; National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) [R01 DK065075, P30 DK56338]; National Center for Complementary and Alternative Medicine (NCCAM) [R01 AT004326]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, R01DK065075] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health including the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) (R01 DK065075) and the National Center for Complementary and Alternative Medicine (NCCAM) (R01 AT004326). The Texas Medical Center Digestive Disease Center receives support from NIDDK (P30 DK56338). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlFaleh K, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005496.pub2, 10.1097/AOG.0b013e3181726f2f]; Alifano P, 1996, MICROBIOL REV, V60, P44, DOI 10.1128/MMBR.60.1.44-69.1996; Andou A, 2009, GASTROENTEROLOGY, V136, P564, DOI 10.1053/j.gastro.2008.09.062; Aschenbach JR, 2009, INFLAMM RES, V58, P269, DOI 10.1007/s00011-008-8091-9; Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Bron PA, 2004, J BACTERIOL, V186, P5721, DOI 10.1128/JB.186.17.5721-5729.2004; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Clarke MB, 2005, AM J PHYSIOL-GASTR L, V288, pG1105, DOI 10.1152/ajpgi.00572.2004; Coeffier M, 2010, INFLAMM BOWEL DIS, V16, P518, DOI 10.1002/ibd.21017; Corthier G, 1998, APPL ENVIRON MICROB, V64, P2721; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DOHLSTEN M, 1988, SCAND J IMMUNOL, V27, P527, DOI 10.1111/j.1365-3083.1988.tb02379.x; Drouault S, 2002, APPL ENVIRON MICROB, V68, P938, DOI 10.1128/AEM.68.2.938-941.2002; Elenkov IJ, 1998, J IMMUNOL, V161, P2586; FAO WHO, 2001, REP JOINT FAO WHO EX, DOI DOI 10.1201/9781420009613.CH16; Fernandez EM, 2011, GUT, V60, P1050, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Frese SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001314; Fuller MF, 1998, ANNU REV NUTR, V18, P385, DOI 10.1146/annurev.nutr.18.1.385; Funaki C, 2010, INVEST OPHTH VIS SCI, V51, P6321, DOI 10.1167/iovs.10-5690; Gionchetti P, 2007, DIS COLON RECTUM, V50, P2075, DOI 10.1007/s10350-007-9068-4; Gosetti F, 2007, J CHROMATOGR A, V1149, P151, DOI 10.1016/j.chroma.2007.02.097; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Guillet R, 2006, PEDIATRICS, V117, pE137, DOI 10.1542/peds.2005-1543; Guma M, 2011, J EXP MED, V208, P1889, DOI 10.1084/jem.20110242; Handley SA, 2006, P NATL ACAD SCI USA, V103, P9268, DOI 10.1073/pnas.0510414103; Hungerford JM, 2010, TOXICON, V56, P231, DOI 10.1016/j.toxicon.2010.02.006; Iyer C, 2008, CELL MICROBIOL, V10, P1442, DOI 10.1111/j.1462-5822.2008.01137.x; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones SE, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-35; Jutel M, 2002, CURR OPIN IMMUNOL, V14, P735, DOI 10.1016/S0952-7915(02)00395-3; Jutel M, 2001, NATURE, V413, P420, DOI 10.1038/35096564; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Klaassens ES, 2009, APPL ENVIRON MICROB, V75, P2668, DOI 10.1128/AEM.02492-08; Konstantinov SR, 2008, P NATL ACAD SCI USA, V105, P19474, DOI 10.1073/pnas.0810305105; Koyama J, 2011, ANAL BIOANAL CHEM, V401, P1385, DOI 10.1007/s00216-011-5200-3; Lin YP, 2008, INFLAMM BOWEL DIS, V14, P1068, DOI 10.1002/ibd.20448; Lucas PM, 2005, APPL ENVIRON MICROB, V71, P1417, DOI 10.1128/AEM.71.3.1417-1424.2005; Martin MC, 2005, MICROBIOL-SGM, V151, P1219, DOI 10.1099/mic.0.27459-0; Masaki T, 2005, FASEB J, V19, P1245, DOI 10.1096/fj.04-3195com; Morita H, 2008, DNA RES, V15, P151, DOI 10.1093/dnares/dsn009; Murzyn A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012050; Nakamura T, 1997, EUR J PHARMACOL, V322, P83, DOI 10.1016/S0014-2999(96)00987-9; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nuutinen S, 2010, ADV EXP MED BIOL, V709, P95; Pena JA, 2009, INFLAMM BOWEL DIS, V15, P248, DOI 10.1002/ibd.20744; Pena JA, 2005, INFECT IMMUN, V73, P912, DOI 10.1128/IAI.73.2.912-920.2005; Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072; Reuter G, 2001, Curr Issues Intest Microbiol, V2, P43; Sander LE, 2006, GUT, V55, P498, DOI 10.1136/gut.2004.061762; Saulnier DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018783; SHAKA AJ, 1988, J MAGN RESON, V77, P274, DOI 10.1016/0022-2364(88)90178-3; Singh SK, 2011, MICROB CELL FACT, V10, DOI [10.1186/1475-2859-10-114, 10.1186/1475-2859-10-55]; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Son DO, 2005, FEBS LETT, V579, P4671, DOI 10.1016/j.febslet.2005.07.038; Spinler JK, 2008, ANAEROBE, V14, P166, DOI 10.1016/j.anaerobe.2008.02.001; TAFFET SM, 1989, CELL IMMUNOL, V120, P291, DOI 10.1016/0008-8749(89)90198-6; Takahasi HK, 2003, CLIN IMMUNOL, V108, P274, DOI 10.1016/S1521-6616(03)00140-2; Thomas CM, 2010, GUT MICROBES, V1, P148, DOI 10.4161/gmic.1.3.11712; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; Trip H, 2011, MOL MICROBIOL, V79, P861, DOI 10.1111/j.1365-2958.2010.07492.x; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; VANNIER E, 1991, J EXP MED, V174, P281, DOI 10.1084/jem.174.1.281; Wall T, 2007, APPL ENVIRON MICROB, V73, P3924, DOI 10.1128/AEM.01502-06; Walter J, 2003, APPL ENVIRON MICROB, V69, P2044, DOI 10.1128/AEM.69.4.2044-2051.2003; Waltereit R, 2003, MOL NEUROBIOL, V27, P99, DOI 10.1385/MN:27:1:99; Wang L, 1996, AM J PHYSIOL-GASTR L, V271, pG613, DOI 10.1152/ajpgi.1996.271.4.G613; Watanabe T, 2009, AM J PHYSIOL-GASTR L, V297, pG506, DOI 10.1152/ajpgi.90553.2008; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Xia JG, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-507; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yang XD, 2011, NAT MED, V17, P87, DOI 10.1038/nm.2278; ZHU G, 1990, J MAGN RESON, V90, P405, DOI 10.1016/0022-2364(90)90150-8	76	262	291	9	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31951	10.1371/journal.pone.0031951	http://dx.doi.org/10.1371/journal.pone.0031951			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384111	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500057
J	Wey, MCY; Fernandez, E; Martinez, PA; Sullivan, P; Goldstein, DS; Strong, R				Wey, Margaret Chia-Ying; Fernandez, Elizabeth; Martinez, Paul Anthony; Sullivan, Patricia; Goldstein, David S.; Strong, Randy			Neurodegeneration and Motor Dysfunction in Mice Lacking Cytosolic and Mitochondrial Aldehyde Dehydrogenases: Implications for Parkinson's Disease	PLOS ONE			English	Article							HUMAN ALPHA-SYNUCLEIN; ENDOGENOUS DOPAMINERGIC NEUROTOXIN; AMYOTROPHIC-LATERAL-SCLEROSIS; ONSET ALZHEIMERS-DISEASE; STRIDE LENGTH REGULATION; TREADMILL GAIT ANALYSIS; L-DOPA; HYDROGEN-PEROXIDE; 3,4-DIHYDROXYPHENYLACETALDEHYDE; SEROTONIN	Previous studies have reported elevated levels of biogenic aldehydes in the brains of patients with Parkinson's disease (PD). In the brain, aldehydes are primarily detoxified by aldehyde dehydrogenases (ALDH). Reduced ALDH1 expression in surviving midbrain dopamine neurons has been reported in brains of patients who died with PD. In addition, impaired complex I activity, which is well documented in PD, reduces the availability of the NAD(+) co-factor required by multiple ALDH isoforms to catalyze the removal of biogenic aldehydes. We hypothesized that chronically decreased function of multiple aldehyde dehydrogenases consequent to exposure to environmental toxins and/or reduced ALDH expression, plays an important role in the pathophysiology of PD. To address this hypothesis, we generated mice null for Aldh1a1 and Aldh2, the two isoforms known to be expressed in substantia nigra dopamine neurons. Aldh1a1(-/-) xAldh2(-/-) mice exhibited age-dependent deficits in motor performance assessed by gait analysis and by performance on an accelerating rotarod. Intraperitoneal administration of L-DOPA plus benserazide alleviated the deficits in motor performance. We observed a significant loss of neurons immunoreactive for tyrosine hydroxylase (TH) in the substantia nigra and a reduction of dopamine and metabolites in the striatum of Aldh1a1(-/-) xAldh2(-/-) mice. We also observed significant increases in biogenic aldehydes reported to be neurotoxic, including 4-hydroxynonenal (4-HNE) and the aldehyde intermediate of dopamine metabolism, 3,4-dihydroxyphenylacetaldehyde (DOPAL). These results support the hypothesis that impaired detoxification of biogenic aldehydes may be important in the pathophysiology of PD and suggest that Aldh1a1(-/-) xAldh2(-/-) mice may be a useful animal model of PD.	[Wey, Margaret Chia-Ying; Fernandez, Elizabeth; Strong, Randy] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Wey, Margaret Chia-Ying; Fernandez, Elizabeth; Martinez, Paul Anthony; Strong, Randy] Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Fernandez, Elizabeth; Strong, Randy] S Texas Vet Hlth Care Network, Ctr Geriatr Res Educ & Clin, San Antonio, TX USA; [Sullivan, Patricia; Goldstein, David S.] Natl Inst Neurol Disorders & Stroke, Clin Neurocardiol Sect, Clin Neurosci Program, Div Intramural Res, Bethesda, MD USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wey, MCY (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA.	FernandezE@uthscsa.edu; Strong@uthscsa.edu			Veteran Affairs Office of Research Development; National Institute of Aging [T32 AG021890-08]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG021890] Funding Source: NIH RePORTER	Veteran Affairs Office of Research Development; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Veteran Affairs Office of Research & Development (to E.F. and R.S.) and the National Institute of Aging predoctoral training grant T32 AG021890-08 (to M.C.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amende Ivo, 2005, J Neuroeng Rehabil, V2, P20, DOI 10.1186/1743-0003-2-20; Anderson DW, 2011, BRAIN RES, V1408, P81, DOI 10.1016/j.brainres.2011.06.051; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Burke WJ, 2008, ACTA NEUROPATHOL, V115, P193, DOI 10.1007/s00401-007-0303-9; Burke WJ, 2004, NEUROTOXICOLOGY, V25, P101, DOI 10.1016/S0161-813X(03)00090-1; Burke WJ, 2003, BRAIN RES, V989, P205, DOI 10.1016/S0006-8993(03)03354-7; CANAVAN AGM, 1990, NEUROPSYCHOLOGIA, V28, P969, DOI 10.1016/0028-3932(90)90112-2; CARLSSON A, 1957, NATURE, V180, P1200, DOI 10.1038/1801200a0; Center for Drug Evaluation and Research, 2005, EST SAF START DOS CL; Chen JB, 2009, INVEST OPHTH VIS SCI, V50, P936, DOI 10.1167/iovs.08-2439; Duester G, 2001, CHEM-BIOL INTERACT, V130, P469, DOI 10.1016/S0009-2797(00)00292-1; Fernandez E, 2006, ALCOHOL CLIN EXP RES, V30, P1650, DOI 10.1111/j.1530-0277.2006.00200.x; Fleming SM, 2006, NEUROSCIENCE, V142, P1245, DOI 10.1016/j.neuroscience.2006.07.005; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Galter D, 2003, NEUROBIOL DIS, V14, P637, DOI 10.1016/j.nbd.2003.09.001; Gispert S, 2003, MOL CELL NEUROSCI, V24, P419, DOI 10.1016/S1044-7431(03)00198-2; Goldstein DS, 2011, EUR J NEUROL, V18, P703, DOI 10.1111/j.1468-1331.2010.03246.x; Grunblatt E, 2010, J NEURAL TRANSM, V117, P1387, DOI 10.1007/s00702-010-0509-1; Guillot TS, 2008, J MOTOR BEHAV, V40, P568, DOI 10.3200/JMBR.40.6.568-577; Hampton TG, 2010, J MOTOR BEHAV, V42, P1, DOI 10.1080/00222890903272025; Hao PP, 2011, CAN J NEUROL SCI, V38, P500, DOI 10.1017/S0317167100011938; Jinsmaa Y, 2011, CHEM-BIOL INTERACT, V192, P118, DOI 10.1016/j.cbi.2011.01.006; Jubault T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006154; Kamino K, 2000, BIOCHEM BIOPH RES CO, V273, P192, DOI 10.1006/bbrc.2000.2923; Kerenyi L, 2003, ARCH NEUROL-CHICAGO, V60, P1223, DOI 10.1001/archneur.60.9.1223; Kish SJ, 2008, BRAIN, V131, P120, DOI 10.1093/brain/awm239; LAMBERTY Y, 1993, PHYSIOL BEHAV, V54, P339, DOI 10.1016/0031-9384(93)90120-5; Lamensdorf I, 2000, J NEUROSCI RES, V60, P552, DOI 10.1002/(SICI)1097-4547(20000515)60:4<552::AID-JNR14>3.0.CO;2-U; LEES AJ, 1986, Q J MED, V59, P535; Lewis GN, 2000, BRAIN, V123, P2077, DOI 10.1093/brain/123.10.2077; Li SW, 2001, MOL BRAIN RES, V93, P1, DOI 10.1016/S0169-328X(01)00120-6; Maetzler W, 2009, LANCET NEUROL, V8, P1158, DOI 10.1016/S1474-4422(09)70291-1; Marchitti SA, 2007, PHARMACOL REV, V59, P125, DOI 10.1124/pr.59.2.1; MATTAMMAL MB, 1993, J CHROMATOGR-BIOMED, V614, P205, DOI 10.1016/0378-4347(93)80310-Z; MATTAMMAL MB, 1995, NEURODEGENERATION, V4, P271, DOI 10.1016/1055-8330(95)90016-0; MAYEUX R, 1988, MOVEMENT DISORD, V3, P237, DOI 10.1002/mds.870030308; MCCAFFERY P, 1994, P NATL ACAD SCI USA, V91, P7772, DOI 10.1073/pnas.91.16.7772; MCNAMARA RK, 1993, BRAIN RES REV, V18, P33, DOI 10.1016/0165-0173(93)90006-L; Meredith GE, 2006, MOVEMENT DISORD, V21, P1595, DOI 10.1002/mds.21010; Morris ME, 1996, BRAIN, V119, P551, DOI 10.1093/brain/119.2.551; OWEN AM, 1995, NEUROPSYCHOLOGY, V9, P126, DOI 10.1037/0894-4105.9.1.126; Panneton WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015251; Pavese N, 2010, BRAIN, V133, P3434, DOI 10.1093/brain/awq268; Picklo MJ, 2001, J NEUROPATH EXP NEUR, V60, P686, DOI 10.1093/jnen/60.7.686; Pinheiro J., 2011, NLME LINEAR NONLINEA; Qin ZJ, 2007, J BIOL CHEM, V282, P5862, DOI 10.1074/jbc.M608126200; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rozas G, 1998, J NEUROSCI METH, V83, P165, DOI 10.1016/S0165-0270(98)00078-8; SCATTON B, 1983, BRAIN RES, V275, P321, DOI 10.1016/0006-8993(83)90993-9; SCHAPIRA AHV, 1990, MOVEMENT DISORD, V5, P294, DOI 10.1002/mds.870050406; SCHNEIDER JS, 1990, BRAIN RES, V519, P122, DOI 10.1016/0006-8993(90)90069-N; Schulz JB, 2008, J NEUROL, V255, P3, DOI 10.1007/s00415-008-5011-4; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stolze H, 2001, J NEUROL NEUROSUR PS, V70, P289, DOI 10.1136/jnnp.70.3.289; Tanila H, 1998, BRAIN RES BULL, V45, P577, DOI 10.1016/S0361-9230(97)00452-8; Team R. D. C, 2011, R LANG ENV STAT COMP; TRUGMAN JM, 1991, BRAIN, V114, P1429, DOI 10.1093/brain/114.3.1429; Vasiliou Vasilis, 2005, Human Genomics, V2, P138; Wang BB, 2008, J NEUROL SCI, V268, P172, DOI 10.1016/j.jns.2007.12.006; Westerlund M, 2005, CELL TISSUE RES, V322, P227, DOI 10.1007/s00441-005-0038-7; Wood PL, 2007, BRAIN RES, V1145, P150, DOI 10.1016/j.brainres.2006.10.004; Wood PL, 2006, BRAIN RES, V1095, P190, DOI 10.1016/j.brainres.2006.04.038; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696; Zgaljardic DJ, 2004, J NEURAL TRANSM, V111, P1287, DOI 10.1007/s00702-004-0178-z; Zhou W, 2008, J BIOL CHEM, V283, P9863, DOI 10.1074/jbc.M710232200	65	114	116	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31522	10.1371/journal.pone.0031522	http://dx.doi.org/10.1371/journal.pone.0031522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384032	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500023
J	Authie, CN; Mestre, DR				Authie, Colas N.; Mestre, Daniel R.			Path Curvature Discrimination: Dependence on Gaze Direction and Optical Flow Speed	PLOS ONE			English	Article							EYE-MOVEMENTS; SELF-MOTION; OCULAR RESPONSES; PERCEPTION; COORDINATION; INFORMATION; LOCOMOTION; VISION	Many experimental approaches to the control of steering rely on the tangent point (TP) as major source of information. The TP is a good candidate to control self-motion. It corresponds to a singular and salient point in the subject's visual field, and its location depends on the road geometry, the direction of self-motion relative to the road and the position of the driver on the road. However, the particular status of the TP in the optical flow, as a local minimum of flow speed, has often been left aside. We therefore assume that the TP is actually an optimal location in the dynamic optical array to perceive a change in the trajectory curvature. In this study, we evaluated the ability of human observers to detect variations in their path curvature from optical flow patterns, as a function of their gaze direction in a virtual environment. We simulated curvilinear self-motion parallel to a ground plane. Using random-dot optic flow stimuli of brief duration and a two-alternative forced-choice adaptive procedure, we determined path curvature discrimination thresholds, as a function of gaze direction. The discrimination thresholds are minimal for a gaze directed toward a local minimum of optical flow speed. A model based on Weber fraction of the foveal velocities (Delta V/V) correctly predicts the relationship between experimental thresholds and local flow velocities. This model was also tested for an optical flow computation integrating larger circular areas in central vision. Averaging the flow over five degrees leads to an even better fit of the model to experimental thresholds. We also found that the minimal optical flow speed direction corresponds to a maximal sensitivity of the visual system, as predicted by our model. The spontaneous gazing strategies observed during driving might thus correspond to an optimal selection of relevant information in the optical flow field.	[Authie, Colas N.; Mestre, Daniel R.] Aix Marseille Univ, Inst Sci Mouvement, UMR 7287, Marseille, France; [Authie, Colas N.; Mestre, Daniel R.] CNRS, Inst Sci Mouvement, UMR 7287, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Authie, CN (corresponding author), Aix Marseille Univ, Inst Sci Mouvement, UMR 7287, Marseille, France.	colas.authie@gmail.com	Mestre, Daniel R/J-9526-2015	Mestre, Daniel R/0000-0002-0399-4747; Colas Nils, Authie/0000-0002-5017-9614	French Ministere de l'Enseignement Superieur et de la Recherche	French Ministere de l'Enseignement Superieur et de la Recherche	This work was funded by a grant from the French Ministere de l'Enseignement Superieur et de la Recherche (C.N. Authie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Authie CN, 2011, VISION RES, V51, P1791, DOI 10.1016/j.visres.2011.06.010; Banks MS, 1996, VISION RES, V36, P431, DOI 10.1016/0042-6989(95)00122-0; Chattington M, 2007, EXP BRAIN RES, V180, P1, DOI 10.1007/s00221-006-0839-2; Coutton Jean C, 2009, BEHAVIOUR, V12, P483; CROWELL J A, 1990, Investigative Ophthalmology and Visual Science, V31, P522; CROWELL JA, 1993, PERCEPT PSYCHOPHYS, V53, P325, DOI 10.3758/BF03205187; Cutting J.E., 1986, PERCEPTION EYE MOTIO, VVolume 1; Gibson J, 1950, PERCEPTION VISUAL WO, V2; GIBSON J J, 1955, Am J Psychol, V68, P372, DOI 10.2307/1418521; GIBSON JJ, 1954, PSYCHOL REV, V61, P304, DOI 10.1037/h0061885; GODTHELP H, 1986, HUM FACTORS, V28, P211, DOI 10.1177/001872088602800209; GORDON DA, 1966, PUBLIC ROADS, V34, P53; Holst E. von, 1950, Naturwissenschaften Berlin, V37, P464; Kandil FI, 2009, J VISION, V9, DOI 10.1167/9.1.11; Land M, VISUAL CONTROL STEER, P163; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Lappe M, 1998, J NEUROPHYSIOL, V79, P1461, DOI 10.1152/jn.1998.79.3.1461; Lappe M, 1999, TRENDS COGN SCI, V3, P329, DOI 10.1016/S1364-6613(99)01364-9; Lee D. N., 1978, MODES PERCEIVING PRO, P159; MacDougall HG, 2005, OPTOMETRY VISION SCI, V82, P706, DOI 10.1097/01.opx.0000175623.86611.03; MCKEE SP, 1984, VISION RES, V24, P25, DOI 10.1016/0042-6989(84)90140-8; MCKEE SP, 1981, VISION RES, V21, P491, DOI 10.1016/0042-6989(81)90095-X; Mestre DR, 1997, VISION RES, V37, P1627, DOI 10.1016/S0042-6989(96)00314-8; Miles FA, 1998, EUR J NEUROSCI, V10, P811, DOI 10.1046/j.1460-9568.1998.00112.x; MILES FA, 2004, OPTIC FLOW, P79; Niemann T, 1999, VISION RES, V39, P1359, DOI 10.1016/S0042-6989(98)00236-3; ROYDEN CS, 1994, VISION RES, V34, P3197, DOI 10.1016/0042-6989(94)90084-1; Rushton SK, 2001, TRENDS COGN SCI, V5, P6, DOI 10.1016/S1364-6613(00)01562-X; Salvucci DD, 2004, PERCEPTION, V33, P1233, DOI 10.1068/p5343; TAYLOR MM, 1967, J ACOUST SOC AM, V41, P782, DOI 10.1121/1.1910407; VANDENBERG AV, 1993, NATURE, V365, P497, DOI 10.1038/365497a0; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; WARREN WH, 1988, J EXP PSYCHOL HUMAN, V14, P646, DOI 10.1037/0096-1523.14.4.646; WARREN WH, 1992, PERCEPT PSYCHOPHYS, V51, P443, DOI 10.3758/BF03211640; WARREN WH, 1990, J OPT SOC AM A, V7, P160, DOI 10.1364/JOSAA.7.000160; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; WARREN WH, 1991, J EXP PSYCHOL HUMAN, V17, P28, DOI 10.1037/0096-1523.17.1.28; Weber E, HANDWORTERBUCH PHY 2, V3, P481; Wilkie R, 2003, J EXP PSYCHOL HUMAN, V29, P363, DOI 10.1037/0096-1523.29.2.363; Wilkie RM, 2006, J EXP PSYCHOL HUMAN, V32, P88, DOI 10.1037/0096-1523.32.1.88; Wilson M, 2007, EXP BRAIN RES, V176, P397, DOI 10.1007/s00221-006-0623-3	41	22	22	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31479	10.1371/journal.pone.0031479	http://dx.doi.org/10.1371/journal.pone.0031479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	928SI	22393363	Green Published, gold, Green Submitted			2022-12-27	WOS:000303003500016
J	Hyslop, L; Prathalingam, N; Nowak, L; Fenwick, J; Harbottle, S; Byerley, S; Rhodes, J; Watson, B; Henderson, R; Murdoch, A; Herbert, M				Hyslop, Louise; Prathalingam, Nilendran; Nowak, Lynne; Fenwick, Jeanette; Harbottle, Steve; Byerley, Samantha; Rhodes, John; Watson, Bruce; Henderson, Robin; Murdoch, Alison; Herbert, Mary			A Novel Isolator-Based System Promotes Viability of Human Embryos during Laboratory Processing	PLOS ONE			English	Article							INTRACELLULAR PH REGULATION; IN-VITRO FERTILIZATION; OXYGEN CONCENTRATION; MOUSE EMBRYOS; HUMAN OOCYTE; DIRECTED DIFFERENTIATION; BLASTOCYST YIELD; SIBLING OOCYTES; BOVINE EMBRYOS; STEM-CELLS	In vitro fertilisation (IVF) and related technologies are arguably the most challenging of all cell culture applications. The starting material is a single cell from which one aims to produce an embryo capable of establishing a pregnancy eventually leading to a live birth. Laboratory processing during IVF treatment requires open manipulations of gametes and embryos, which typically involves exposure to ambient conditions. To reduce the risk of cellular stress, we have developed a totally enclosed system of interlinked isolator-based workstations designed to maintain oocytes and embryos in a physiological environment throughout the IVF process. Comparison of clinical and laboratory data before and after the introduction of the new system revealed that significantly more embryos developed to the blastocyst stage in the enclosed isolator-based system compared with conventional open-fronted laminar flow hoods. Moreover, blastocysts produced in the isolator-based system contained significantly more cells and their development was accelerated. Consistent with this, the introduction of the enclosed system was accompanied by a significant increase in the clinical pregnancy rate and in the proportion of embryos implanting following transfer to the uterus. The data indicate that protection from ambient conditions promotes improved development of human embryos. Importantly, we found that it was entirely feasible to conduct all IVF-related procedures in the isolator-based workstations.	[Hyslop, Louise; Nowak, Lynne; Fenwick, Jeanette; Harbottle, Steve; Byerley, Samantha; Murdoch, Alison; Herbert, Mary] Int Ctr Life, Newcastle Fertil Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Prathalingam, Nilendran; Herbert, Mary] Newcastle Univ, Ctr Life, Newcastle Fertil Ctr, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Rhodes, John] Univ Hosp N Tees, Stockton Qual Control Lab, Stockton On Tees, England; [Watson, Bruce] Northumbria Univ, Sch Design, Ctr Design Res, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Henderson, Robin] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; University Hospital of North Tees; Northumbria University; Newcastle University - UK	Hyslop, L (corresponding author), Int Ctr Life, Newcastle Fertil Ctr, Newcastle Upon Tyne, Tyne & Wear, England.	mary.herbert@ncl.ac.uk	Hyslop, Louise/AAJ-2583-2021	Herbert, Mary/0000-0002-8488-2770	Medical Research Council [G0601157, GO400232]; One North East; RegeNer8; MRC [G0601157] Funding Source: UKRI; Medical Research Council [G0400232] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); One North East; RegeNer8; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding received from the Medical Research Council (G0601157 and GO400232), One North East, and RegeNer8. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida PA, 1995, ZYGOTE, V3, P357, DOI 10.1017/S0967199400002793; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BOWMAN P, 1970, J EMBRYOL EXP MORPH, V24, P203; BRINSTER RL, 1965, J EXP ZOOL, V158, P49, DOI 10.1002/jez.1401580105; BUSTER JE, 1985, AM J OBSTET GYNECOL, V153, P211, DOI 10.1016/0002-9378(85)90116-4; Caprino L, 1998, ENVIRON HEALTH PERSP, V106, P115, DOI 10.2307/3434312; Ciray HN, 2009, FERTIL STERIL, V91, P1459, DOI 10.1016/j.fertnstert.2008.07.1707; Cockburn K, 2010, J CLIN INVEST, V120, P995, DOI 10.1172/JCI41229; Cohen J, 1997, HUM REPROD, V12, P1742, DOI 10.1093/humrep/12.8.1742; Coleman CA, 2003, TOXICOL LETT, V142, P133, DOI 10.1016/S0378-4274(03)00020-1; Dale B, 1998, HUM REPROD, V13, P964, DOI 10.1093/humrep/13.4.964; DAVIDSON A, 1988, FERTIL STERIL, V49, P516; Dumoulin JCM, 1999, HUM REPROD, V14, P465, DOI 10.1093/humrep/14.2.465; Goldstein AH, 2007, ENVIRON SCI TECHNOL, V41, P1514, DOI 10.1021/es072476p; Sobrinho DBG, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-143; Griffiths TA, 2000, HUM REPROD, V15, P1592, DOI 10.1093/humrep/15.7.1592; Hall J, 1998, HUM REPROD, V13, P146, DOI 10.1093/humrep/13.suppl_4.146; Harton GL, 2011, HUM REPROD, V26, P41, DOI 10.1093/humrep/deq265; JOHN DP, 1988, FERTIL STERIL, V49, P150; Karagenc L, 2004, REPROD BIOMED ONLINE, V9, P409, DOI 10.1016/S1472-6483(10)61276-X; Kea B, 2007, FERTIL STERIL, V87, P213, DOI 10.1016/j.fertnstert.2006.05.066; Kovacic B, 2008, REPROD BIOMED ONLINE, V17, P229, DOI 10.1016/S1472-6483(10)60199-X; Kues WA, 2008, P NATL ACAD SCI USA, V105, P19768, DOI 10.1073/pnas.0805616105; Lane M, 1999, MOL REPROD DEV, V54, P396, DOI 10.1002/(SICI)1098-2795(199912)54:4&lt;396::AID-MRD10&gt;3.0.CO;2-6; Lane M, 1999, BIOL REPROD, V61, P452, DOI 10.1095/biolreprod61.2.452; Leese HJ, 1998, HUM REPROD, V13, P184, DOI 10.1093/humrep/13.suppl_4.184; Maher ER, 2003, HUM REPROD, V18, P2508, DOI 10.1093/humrep/deg486; Mantzouratou A, 2011, CYTOGENET GENOME RES, V133, P141, DOI 10.1159/000323794; Midcalf B, 2004, PHARM ISOLATORS; Molhave L., 1991, INDOOR AIR, V1, P357, DOI DOI 10.1111/J.1600-0668.1991.00001.X; Morgan HD, 2008, BIOL REPROD, V79, P618, DOI 10.1095/biolreprod.108.068213; Niemann H, 2000, THERIOGENOLOGY, V53, P21, DOI 10.1016/S0093-691X(99)00237-X; Phillips KP, 1999, DEV BIOL, V208, P392, DOI 10.1006/dbio.1999.9199; Phillips KP, 2000, HUM REPROD, V15, P896, DOI 10.1093/humrep/15.4.896; PICKERING SJ, 1990, FERTIL STERIL, V54, P102; PLANTE L, 1994, J ASSIST REPROD GEN, V11, P515, DOI 10.1007/BF02216032; Rivera RM, 2008, HUM MOL GENET, V17, P1, DOI 10.1093/hmg/ddm280; Rizos D, 2002, MOL REPROD DEV, V61, P234, DOI 10.1002/mrd.1153; Swain JE, 2010, REPROD BIOMED ONLINE, V21, P6, DOI 10.1016/j.rbmo.2010.03.012; Tillett L, 1999, AM J HEALTH-SYST PH, V56, P1433, DOI 10.1093/ajhp/56.14.1433; Veraitch FS, 2008, BIOTECHNOL BIOENG, V99, P1216, DOI 10.1002/bit.21673; Wang WH, 2001, HUM REPROD, V16, P2374, DOI 10.1093/humrep/16.11.2374; Xie Y, 2008, MOL REPROD DEV, V75, P689, DOI 10.1002/mrd.20787; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769	44	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31010	10.1371/journal.pone.0031010	http://dx.doi.org/10.1371/journal.pone.0031010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393356	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000303003500009
J	Imamovic, L; Muniesa, M				Imamovic, Lejla; Muniesa, Maite			Characterizing RecA-Independent Induction of Shiga toxin2-Encoding Phages by EDTA Treatment	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; TOXIN 2-ENCODING BACTERIOPHAGE; ETHYLENEDIAMINETETRAACETIC ACID; CONVERTING BACTERIOPHAGES; GENE; STRAINS; EXPRESSION; TRANSDUCTION; PROPHAGES; VIRULENCE	Background: The bacteriophage life cycle has an important role in Shiga toxin (Stx) expression. The induction of Shiga toxin-encoding phages (Stx phages) increases toxin production as a result of replication of the phage genome, and phage lysis of the host cell also provides a means of Stx toxin to exit the cell. Previous studies suggested that prophage induction might also occur in the absence of SOS response, independently of RecA. Methodology/Principal Findings: The influence of EDTA on RecA-independent Stx2 phage induction was assessed, in laboratory lysogens and in EHEC strains carrying Stx2 phages in their genome, by Real-Time PCR. RecA-independent mechanisms described for phage lambda induction (RcsA and DsrA) were not involved in Stx2 phage induction. In addition, mutations in the pathway for the stress response of the bacterial envelope to EDTA did not contribute to Stx2 phage induction. The effect of EDTA on Stx phage induction is due to its chelating properties, which was also confirmed by the use of citrate, another chelating agent. Our results indicate that EDTA affects Stx2 phage induction by disruption of the bacterial outer membrane due to chelation of Mg2+. In all the conditions evaluated, the pH value had a decisive role in Stx2 phage induction. Conclusions/Significance: Chelating agents, such as EDTA and citrate, induce Stx phages, which raises concerns due to their frequent use in food and pharmaceutical products. This study contributes to our understanding of the phenomenon of induction and release of Stx phages as an important factor in the pathogenicity of Shiga toxin-producing Escherichia coli (STEC) and in the emergence of new pathogenic strains.	[Imamovic, Lejla; Muniesa, Maite] Univ Barcelona, Dept Microbiol, Barcelona, Spain	University of Barcelona	Imamovic, L (corresponding author), Univ Barcelona, Dept Microbiol, Barcelona, Spain.	mmuniesa@ub.edu	Muniesa, Maite/K-4577-2014; Imamovic, Lejla/C-2612-2015; Imamovic, Lejla/ABB-7301-2021	Muniesa, Maite/0000-0001-5549-1394; Imamovic, Lejla/0000-0003-1662-9447; 	Generalitat de Catalunya [2009SGR1043]; Spanish Ministry of Education and Science [AGL2009-07576, FPI 20060054361]; Xarxa de Referencia en Biotecnologia (XeRBa)	Generalitat de Catalunya(Generalitat de Catalunya); Spanish Ministry of Education and Science(Spanish Government); Xarxa de Referencia en Biotecnologia (XeRBa)	This study was supported by the Generalitat de Catalunya (grant 2009SGR1043), by the Spanish Ministry of Education and Science (grant AGL2009-07576), and by the Xarxa de Referencia en Biotecnologia (XeRBa). L. Imamovic is a recipient of a grant from the Spanish Ministry of Education and Science (grant FPI 20060054361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ali GS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010167; Acheson DWK, 1998, INFECT IMMUN, V66, P4496; Aertsen A, 2005, APPL ENVIRON MICROB, V71, P1155, DOI 10.1128/AEM.71.3.1155-1162.2005; Allison HE, 2003, INFECT IMMUN, V71, P3409, DOI 10.1128/IAI.71.6.3409-3418.2003; Allison HE, 2007, FUTURE MICROBIOL, V2, P165, DOI 10.2217/17460913.2.2.165; Asahara T, 2004, INFECT IMMUN, V72, P2240, DOI 10.1128/IAI.72.4.2240-2247.2004; BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; Blanusa M, 2005, CURR MED CHEM, V12, P2771, DOI 10.2174/092986705774462987; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Boland JS, 2003, J FOOD PROTECT, V66, P1783, DOI 10.4315/0362-028X-66.10.1783; Branen JK, 2004, INT J FOOD MICROBIOL, V90, P63, DOI 10.1016/S0168-1605(03)00172-7; Bucheli-Witschel M, 2001, FEMS MICROBIOL REV, V25, P69, DOI 10.1111/j.1574-6976.2001.tb00572.x; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Caprioli A, 2005, VET RES, V36, P289, DOI 10.1051/vetres:2005002; Crane JK, 2011, INFECT IMMUN, V79, P1696, DOI 10.1128/IAI.01099-10; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Sablet T, 2008, MICROBIOL-SGM, V154, P176, DOI 10.1099/mic.0.2007/009704-0; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Fuchs S, 1999, MICROB PATHOGENESIS, V27, P13, DOI 10.1006/mpat.1999.0279; Ghosh D, 2009, APPL ENVIRON MICROB, V75, P7142, DOI 10.1128/AEM.00950-09; HEINDORFF K, 1983, MUTAT RES, V115, P149, DOI 10.1016/0165-1110(83)90001-5; Imamovic L, 2010, APPL ENVIRON MICROB, V76, P5693, DOI 10.1128/AEM.00107-10; James CE, 2001, APPL ENVIRON MICROB, V67, P4335, DOI 10.1128/AEM.67.9.4335-4337.2001; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kimmitt PT, 2000, EMERG INFECT DIS, V6, P458, DOI 10.3201/eid0605.000503; Koudelka AP, 2004, J BACTERIOL, V186, P7659, DOI 10.1128/JB.186.22.7659-7669.2004; LITTLE JW, 1984, P NATL ACAD SCI-BIOL, V81, P1375, DOI 10.1073/pnas.81.5.1375; Little JW, 1999, EMBO J, V18, P4299, DOI 10.1093/emboj/18.15.4299; Livny J, 2004, MOL MICROBIOL, V51, P1691, DOI 10.1111/j.1365-2958.2003.03934.x; Los JM, 2009, MICROB PATHOGENESIS, V47, P289, DOI 10.1016/j.micpath.2009.09.006; Los M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-13; McGannon CM, 2010, ANTIMICROB AGENTS CH, V54, P3790, DOI 10.1128/AAC.01783-09; Muhldorfer I, 1996, INFECT IMMUN, V64, P495; Muniesa M, 2004, MICROBIOL-SGM, V150, P2959, DOI 10.1099/mic.0.27188-0; Muniesa M, 1998, APPL ENVIRON MICROB, V64, P2443; Muniesa M, 2004, ENVIRON MICROBIOL, V6, P716, DOI 10.1111/j.1462-2920.2004.00604.x; Muniesa M, 2003, INFECT IMMUN, V71, P4554, DOI 10.1128/IAI.71.8.4554-4562.2003; Mustard JA, 2000, J BACTERIOL, V182, P1659, DOI 10.1128/JB.182.6.1659-1670.2000; OBRIEN AD, 1984, SCIENCE, V226, P694, DOI 10.1126/science.6387911; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Plunkett G, 1999, J BACTERIOL, V181, P1767, DOI 10.1128/JB.181.6.1767-1778.1999; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Ritchie JM, 2003, APPL ENVIRON MICROB, V69, P1059, DOI 10.1128/AEM.69.2.1059-1066.2003; Rozanov DV, 1998, J BACTERIOL, V180, P6306; Sambrook J., 2001, MOL CLONING LAB MANU; Schmidt H, 1999, APPL ENVIRON MICROB, V65, P3855; Serra-Moreno R, 2008, J BACTERIOL, V190, P4722, DOI 10.1128/JB.00069-08; Serra-Moreno R, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-31; Shimizu T, 2009, INFECT IMMUN, V77, P2813, DOI 10.1128/IAI.00060-09; Shkilnyj P, 2007, J BACTERIOL, V189, P3115, DOI 10.1128/JB.01857-06; SLEDJESKI D, 1995, P NATL ACAD SCI USA, V92, P2003, DOI 10.1073/pnas.92.6.2003; Toth I, 2003, APPL ENVIRON MICROB, V69, P7242, DOI 10.1128/AEM.69.12.7242-7247.2003; Tyler JS, 2004, J BACTERIOL, V186, P7670, DOI 10.1128/JB.186.22.7670-7679.2004; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Wagner PL, 1999, INFECT IMMUN, V67, P6710; Wagner PL, 2001, J BACTERIOL, V183, P2081, DOI 10.1128/JB.183.6.2081-2085.2001; Wagner PL, 2001, INFECT IMMUN, V69, P1934, DOI 10.1128/IAI.69.3.1934-1937.2001	59	56	57	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32393	10.1371/journal.pone.0032393	http://dx.doi.org/10.1371/journal.pone.0032393			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393404	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500057
J	Shehzad, W; McCarthy, TM; Pompanon, F; Purevjav, L; Coissac, E; Riaz, T; Taberlet, P				Shehzad, Wasim; McCarthy, Thomas Michael; Pompanon, Francois; Purevjav, Lkhagvajav; Coissac, Eric; Riaz, Tiayyba; Taberlet, Pierre			Prey Preference of Snow Leopard (Panthera uncia) in South Gobi, Mongolia	PLOS ONE			English	Article							ARGALI OVIS-AMMON; SCAT-DETECTION DOGS; LARGE CARNIVORES; DNA; CONSERVATION; LIVESTOCK; CONFLICT; DIET; IDENTIFICATION; PREDATORS	Accurate information about the diet of large carnivores that are elusive and inhabit inaccessible terrain, is required to properly design conservation strategies. Predation on livestock and retaliatory killing of predators have become serious issues throughout the range of the snow leopard. Several feeding ecology studies of snow leopards have been conducted using classical approaches. These techniques have inherent limitations in their ability to properly identify both snow leopard feces and prey taxa. To examine the frequency of livestock prey and nearly-threatened argali in the diet of the snow leopard, we employed the recently developed DNA-based diet approach to study a snow leopard population located in the Tost Mountains, South Gobi, Mongolia. After DNA was extracted from the feces, a region of similar to 100 bp long from mitochondrial 12S rRNA gene was amplified, making use of universal primers for vertebrates and a blocking oligonucleotide specific to snow leopard DNA. The amplicons were then sequenced using a next-generation sequencing platform. We observed a total of five different prey items from 81 fecal samples. Siberian ibex predominated the diet (in 70.4% of the feces), followed by domestic goat (17.3%) and argali sheep (8.6%). The major part of the diet was comprised of large ungulates (in 98.8% of the feces) including wild ungulates (79%) and domestic livestock (19.7%). The findings of the present study will help to understand the feeding ecology of the snow leopard, as well as to address the conservation and management issues pertaining to this wild cat.	[Shehzad, Wasim; Pompanon, Francois; Coissac, Eric; Riaz, Tiayyba; Taberlet, Pierre] Univ Grenoble 1, CNRS, Lab Ecol Alpine, Unite Mixte Rech 5553, Grenoble, France; [Purevjav, Lkhagvajav] Snow Leopard Conservat Fund, Ulaanbaatar, Mongolia; [McCarthy, Thomas Michael] Panthera, Snow Leopard Program, New York, NY USA	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie	Shehzad, W (corresponding author), Univ Grenoble 1, CNRS, Lab Ecol Alpine, Unite Mixte Rech 5553, Grenoble, France.	pierre.taberlet@ujf-grenoble.fr	Pompanon, François/D-3459-2009; Taberlet, Pierre/D-1178-2010; Coissac, Éric/AAE-8735-2019	Pompanon, François/0000-0003-4600-0172; Taberlet, Pierre/0000-0002-3554-5954; Coissac, Éric/0000-0001-7507-6729	Laboratoire d'Ecologie Alpine, Centre National de la Recherche Scientifique, France [UMR 5553]; Snow Leopard Conservation Grant Program; Higher Education Commission (HEC) of Pakistan	Laboratoire d'Ecologie Alpine, Centre National de la Recherche Scientifique, France; Snow Leopard Conservation Grant Program; Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan)	This work was funded by Laboratoire d'Ecologie Alpine, UMR 5553, Centre National de la Recherche Scientifique, France. Partial funding was provided by Snow Leopard Conservation Grant Program for 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.; We thank Rana Bayrakci for a critical review of the manuscript and for providing numerous helpful suggestions. We also extend our thanks to Alice Valentini, Christian Miquel, Carole Poillot, Delphine Rioux and Ludovic Gielly for their valuable comments and suggestions throughout the course of this study. Wasim Shehzad and Tiayyba Riaz are supported by the Higher Education Commission (HEC) of Pakistan.	Allen P, 2002, CONSERVATION PANTHER; Anwar MB, 2011, EUR J WILDLIFE RES, V57, P1077, DOI 10.1007/s10344-011-0521-2; Bagchi S, 2006, J ZOOL, V268, P217, DOI 10.1111/j.1469-7998.2005.00030.x; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Chundawat RS, 1994, INT SNOW LEOPARD TRU, P127; Davison A, 2002, J ZOOL, V257, P141, DOI 10.1017/S0952836902000730; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Fox J, 1994, P 7 INT SNOW LEOP S, P3; Fox J.L, 1989, REV STATUS ECOLOGY S; Gronberg E, 2011, MOVEMENT PATTERNS SN; Hansen MM, 1999, J ZOOL, V247, P177, DOI 10.1111/j.1469-7998.1999.tb00981.x; Hussain S, 2003, ORYX, V37, P26, DOI 10.1017/S0030605303000085; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Jackson RM, THESIS U LONDON; Jackson Rodney, 2001, Endangered Species Update, V18, P138; Jackson RM, 2006, WILDLIFE SOC B, V34, P772, DOI 10.2193/0091-7648(2006)34[772:ESLPAU]2.0.CO;2; Jackson Rodney M., 2010, P417; JALANKA HH, 1989, J ZOO WILDLIFE MED, V20, P154; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; Khatoon R, THESIS ARID AGR U PA; Long RA, 2007, J WILDLIFE MANAGE, V71, P2007, DOI 10.2193/2006-230; Lovari S, 2009, ANIM CONSERV, V12, P559, DOI 10.1111/j.1469-1795.2009.00285.x; Macdonald David W., 2010, P3; Magnuson VL, 1996, BIOTECHNIQUES, V21, P700, DOI 10.2144/96214rr03; Maroney RL, 2005, BIOL CONSERV, V121, P231, DOI 10.1016/j.biocon.2004.04.024; McCarthy T, THESIS U MASSACHUSET; McCarthy T, 2003, SNOW LEOPARD SURVIVA; McCarthy Tom, 2010, Cat News, V53, P15; Mishra C, 2006, ORYX, V40, P29, DOI 10.1017/S0030605306000032; Mishra C, 1997, ENVIRON CONSERV, V24, P338, DOI 10.1017/S0376892997000441; Namgail T, 2004, J ZOOL, V262, P57, DOI 10.1017/S0952836903004394; Namgail T, 2007, ENVIRON MANAGE, V39, P490, DOI 10.1007/s00267-005-0178-2; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; OLI MK, 1993, J ZOOL, V231, P71, DOI 10.1111/j.1469-7998.1993.tb05354.x; OLI MK, 1993, J ZOOL, V231, P365, DOI 10.1111/j.1469-7998.1993.tb01924.x; Pegard A, 2009, J AGR FOOD CHEM, V57, P5700, DOI 10.1021/jf803680c; Piggott MP, 2003, WILDLIFE RES, V30, P1, DOI 10.1071/WR02077; PUTMAN RJ, 1984, MAMMAL REV, V14, P79, DOI 10.1111/j.1365-2907.1984.tb00341.x; Radloff FGT, 2004, J ANIM ECOL, V73, P410, DOI 10.1111/j.0021-8790.2004.00817.x; Reading RP, 1997, ORYX, V31, P285, DOI 10.1046/j.1365-3008.1997.d01-17.x; Reading RP, 1999, BIODIVERS CONSERV, V8, P1115, DOI 10.1023/A:1008900427566; Rege JEO, 2000, P 3 INT C YAK PROD C, P69; Riaz T, 2011, NUCLEIC ACIDS RES, V39, P11; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; Shrestha R, 2006, RANGELAND ECOL MANAG, V59, P512, DOI 10.2111/06-022R2.1; Spiering PA, 2009, CONSERV GENET, V10, P2005, DOI 10.1007/s10592-009-9880-6; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; Vynne C, 2011, CONSERV BIOL, V25, P154, DOI 10.1111/j.1523-1739.2010.01581.x	53	77	85	1	174	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32104	10.1371/journal.pone.0032104	http://dx.doi.org/10.1371/journal.pone.0032104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393381	Green Published, gold			2022-12-27	WOS:000303003500034
J	Doyle, ME; Perley, JP; Skalak, TC				Doyle, Megan E.; Perley, Jeffrey P.; Skalak, Thomas C.			Bone Marrow-Derived Progenitor Cells Augment Venous Remodeling in a Mouse Dorsal Skinfold Chamber Model	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; IN-VIVO; COLLATERAL PERFUSION; INTERFERON-GAMMA; STROMAL CELLS; BLOOD-FLOW; RAT MODEL; ANGIOGENESIS; PROLIFERATION	The delivery of bone marrow-derived cells (BMDCs) has been widely used to stimulate angiogenesis and arteriogenesis. We identified a progenitor-enriched subpopulation of BMDCs that is able to augment venular remodeling, a generally unexplored area in microvascular research. Two populations of BMDCs, whole bone marrow (WBM) and Lin(-)/Sca-1(+) progenitor cells, were encapsulated in sodium alginate and delivered to a mouse dorsal skinfold chamber model. Upon observation that encapsulated Sca-1(+) progenitor cells enhance venular remodeling, the cells and tissue were analyzed on structural and molecular levels. Venule walls were thickened and contained more nuclei after Sca-1(+) progenitor cell delivery. In addition, progenitors expressed mRNA transcript levels of chemokine (C-X-C motif) ligand 2 (CXCL2) and interferon gamma (IFN gamma) that are over 5-fold higher compared to WBM. Tissues that received progenitors expressed significantly higher protein levels of vascular endothelial growth factor (VEGF), monocyte chemotactic protein-1 (MCP-1), and platelet derived growth factor-BB (PDGF-BB) compared to tissues that received an alginate control construct. Nine days following cell delivery, tissue from progenitor recipients contained 39% more CD45(+) leukocytes, suggesting that these cells may enhance venular remodeling through the modulation of the local immune environment. Results show that different BMDC populations elicit different microvascular responses. In this model, Sca-1(+) progenitor cell-derived CXCL2 and IFN gamma may mediate venule enlargement via modulation of the local inflammatory environment.	[Doyle, Megan E.; Perley, Jeffrey P.; Skalak, Thomas C.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA	University of Virginia	Doyle, ME (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA.	meg6u@virginia.edu			National Institutes of Health [HL-065958]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065958] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support for this work was provided by the National Institutes of Health (HL-065958). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles D, 2006, J VASC SURG, V44, P863, DOI 10.1016/j.jvs.2006.05.043; ADAIR TH, 1995, AM J PHYSIOL-HEART C, V269, pH717, DOI 10.1152/ajpheart.1995.269.2.H717; Al-Khaldi A, 2003, ANN THORAC SURG, V75, P204, DOI 10.1016/S0003-4975(02)04291-1; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Aranguren XL, 2008, J CLIN INVEST, V118, P505, DOI [10.1172/JC131153, 10.1172/JCI31153]; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Baggiolini M, 1995, Clin Exp Immunol, V101 Suppl 1, P5; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; Bobis S, 2006, FOLIA HISTOCHEM CYTO, V44, P215; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Dorfmuller P, 2007, HUM PATHOL, V38, P893, DOI 10.1016/j.humpath.2006.11.022; FIERS W, 1991, FEBS LETT, V285, P199, DOI 10.1016/0014-5793(91)80803-B; FRANK S, 1995, J BIOL CHEM, V270, P12607, DOI 10.1074/jbc.270.21.12607; Fuchs S, 2001, J AM COLL CARDIOL, V37, P1726, DOI 10.1016/S0735-1097(01)01200-1; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Goodell MA, 2001, ANN NY ACAD SCI, V938, P208; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hood JD, 1998, AM J PHYSIOL-HEART C, V274, pH1054; Ichioka S, 2005, BRIT J PLAST SURG, V58, P1124, DOI 10.1016/j.bjps.2005.04.054; Iwase T, 2005, CARDIOVASC RES, V66, P543, DOI 10.1016/j.cardiores.2005.02.006; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Kalka C, 2000, CIRC RES, V86, P1198, DOI 10.1161/01.RES.86.12.1198; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Komai Y, 2005, CLIN HEMORHEOL MICRO, V32, P247; Kwei S, 2004, AM J PATHOL, V164, P81, DOI 10.1016/S0002-9440(10)63099-4; Laham RJ, 2003, ANN VASC SURG, V17, P245, DOI 10.1007/s10016-001-0299-x; Lamb DJ, 2004, ATHEROSCLEROSIS, V176, P21, DOI 10.1016/j.atherosclerosis.2004.04.012; Li ZS, 2008, J BIOMED MATER RES A, V86A, P552, DOI 10.1002/jbm.a.31596; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Morris CE, 2007, J APPL PHYSIOL, V103, P629, DOI 10.1152/japplphysiol.01133.2006; NAGAOKA I, 1992, COMP BIOCHEM PHYS B, V103, P349, DOI 10.1016/0305-0491(92)90303-9; Nickerson MM, 2006, FASEB J, V20, pA709; Nugent HM, 2007, J VASC SURG, V46, P548, DOI 10.1016/j.jvs.2007.04.074; Price RJ, 1996, AM J PHYSIOL-HEART C, V271, pH752, DOI 10.1152/ajpheart.1996.271.2.H752; PRICE RJ, 1994, MICROVASC RES, V47, P188, DOI 10.1006/mvre.1994.1015; Scapini P, 2004, J IMMUNOL, V172, P5034, DOI 10.4049/jimmunol.172.8.5034; Schaper W, 2003, ARTERIOSCL THROM VAS, V23, P1143, DOI 10.1161/01.ATV.0000069625.11230.96; Schatteman GC, 2000, J CLIN INVEST, V106, P571, DOI 10.1172/JCI9087; Schatteman GC, 2006, STEM CELLS, V24, P717, DOI 10.1634/stemcells.2005-0214; SCHREIBER RD, 1986, ANN INST PASTEUR IMM, VC137, P203, DOI 10.1016/S0771-050X(86)80028-6; Shintani S, 2001, CIRCULATION, V103, P897, DOI 10.1161/01.CIR.103.6.897; Sivan-Loukianova E, 2003, J VASC RES, V40, P368, DOI 10.1159/000072701; Stepanovic V, 2003, CIRC RES, V92, P1247, DOI 10.1161/01.RES.0000074906.98021.55; Sun J, 2009, AM J PHYSIOL-HEART C, V296, pH43, DOI 10.1152/ajpheart.00613.2008; Tang YL, 2005, ANN THORAC SURG, V80, P229, DOI 10.1016/j.athoracsur.2005.02.072; Van Huyen JPD, 2008, MODERN PATHOL, V21, P837, DOI 10.1038/modpathol.2008.48; Van Overstraeten-Schloegel N, 2006, EUR J HAEMATOL, V76, P488, DOI 10.1111/j.1600-0609.2006.00633.x; Wang YN, 2007, CIRC RES, V101, P560, DOI 10.1161/CIRCRESAHA.107.151068; Wragg A, 2008, J MOL MED, V86, P1221, DOI 10.1007/s00109-008-0390-7; Xiong M, 1998, AM J PATHOL, V153, P587, DOI 10.1016/S0002-9440(10)65601-5; Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289; Zhang Hong-kun, 2005, Zhonghua Wai Ke Za Zhi, V43, P1275; Ziegelhoeffer T, 2004, CIRC RES, V94, P230, DOI 10.1161/01.RES.0000110419.50982.1C	56	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32815	10.1371/journal.pone.0032815	http://dx.doi.org/10.1371/journal.pone.0032815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389724	Green Submitted, gold, Green Published			2022-12-27	WOS:000302999600063
J	Fritah, A; Steel, JH; Parker, N; Nikolopoulou, E; Christian, M; Carling, D; Parker, MG				Fritah, Asmaa; Steel, Jennifer H.; Parker, Nadeene; Nikolopoulou, Evanthia; Christian, Mark; Carling, David; Parker, Malcolm G.			Absence of RIP140 Reveals a Pathway Regulating glut4-Dependent Glucose Uptake in Oxidative Skeletal Muscle through UCP1-Mediated Activation of AMPK	PLOS ONE			English	Article							TRANSCRIPTIONAL COREPRESSOR RIP140; RECEPTOR-INTERACTING PROTEIN-140; BROWN ADIPOSE-TISSUE; NUCLEAR RECEPTOR; GENE-EXPRESSION; SIGNALING PATHWAYS; INSULIN-RESISTANCE; ENERGY-METABOLISM; WHITE ADIPOCYTES; KINASE	Skeletal muscle constitutes the major site of glucose uptake leading to increased removal of glucose from the circulation in response to insulin. Type 2 diabetes and obesity are often associated with insulin resistance that can be counteracted by exercise or the use of drugs increasing the relative proportion of oxidative fibers. RIP140 is a transcriptional coregulator with a central role in metabolic tissues and we tested the effect of modulating its level of expression on muscle glucose and lipid metabolism in two mice models. Here, we show that although RIP140 protein is expressed at the same level in both oxidative and glycolytic muscles, it inhibits both fatty acid and glucose utilization in a fiber-type dependent manner. In RIP140-null mice, fatty acid utilization increases in the extensor digitorum longus and this is associated with elevated expression of genes implicated in fatty acid binding and transport. In the RIP140-null soleus, depletion of RIP140 leads to increased GLUT4 trafficking and glucose uptake with no change in Akt activity. AMPK phosphorylation/activity is inhibited in the soleus of RIP140 transgenic mice and increased in RIP140-null soleus. This is associated with increased UCP1 expression and mitochondrial uncoupling revealing the existence of a signaling pathway controlling insulin-independent glucose uptake in the soleus of RIP140-null mice. In conclusion, our findings reinforce the participation of RIP140 in the maintenance of energy homeostasis by acting as an inhibitor of energy production and particularly point to RIP140 as a promising therapeutic target in the treatment of insulin resistance.	[Fritah, Asmaa; Steel, Jennifer H.; Nikolopoulou, Evanthia; Christian, Mark; Parker, Malcolm G.] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Parker, Nadeene] UCL, Dept Cell & Dev Biol, London, England; [Carling, David] Univ London Imperial Coll Sci Technol & Med, Fac Med, Med Res Councils Clin Sci Ctr, London, England	Imperial College London; University of London; University College London; Imperial College London	Fritah, A (corresponding author), Ecole Normale Super Lyon, Lab Biol Mol Cellule, F-69364 Lyon, France.	asmaa.fritah@ens-lyon.fr	Parker, Nadeene/C-1562-2008; Steel, Jennifer/B-4737-2013; Carling, David/F-1943-2014	Steel, Jennifer/0000-0003-4439-0090; Carling, David/0000-0002-2316-1830; Christian, Mark/0000-0002-1616-4179	Wellcome Trust [079200/Z/06/Z]; Medical Research Council [MC_U120027537] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Wellcome Trust, Reference 079200/Z/06/Z (AF and JHS). http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Baldwin KM, 2001, J APPL PHYSIOL, V90, P345, DOI 10.1152/jappl.2001.90.1.345; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Carroll AM, 2004, BIOCHEM SOC T, V32, P1066, DOI 10.1042/BST0321066; Castet A, 2006, MOL ENDOCRINOL, V20, P1035, DOI 10.1210/me.2005-0227; Chen W, 2010, P NATL ACAD SCI USA, V107, P10196, DOI 10.1073/pnas.1005626107; Christian M, 2005, MOL CELL BIOL, V25, P9383, DOI 10.1128/MCB.25.21.9383-9391.2005; Dzamko N, 2008, J PHYSIOL-LONDON, V586, P5819, DOI 10.1113/jphysiol.2008.159814; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Fritah A, 2010, AM J PHYSIOL-ENDOC M, V299, pE335, DOI 10.1152/ajpendo.00243.2010; Fritah A, 2010, CARDIOVASC RES, V86, P443, DOI 10.1093/cvr/cvp418; Fritah A, 2009, APPL PHYSIOL NUTR ME, V34, P362, DOI 10.1139/H09-026; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Hallberg M, 2008, MOL CELL BIOL, V28, P6785, DOI 10.1128/MCB.00504-08; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Herzog B, 2007, MOL ENDOCRINOL, V21, P2687, DOI 10.1210/me.2007-0213; Ho PC, 2009, CELL METAB, V10, P516, DOI 10.1016/j.cmet.2009.09.012; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; Kiskinis E, 2007, EMBO J, V26, P4831, DOI 10.1038/sj.emboj.7601908; KLAUS S, 1991, INT J BIOCHEM, V23, P791, DOI 10.1016/0020-711X(91)90062-R; LARSSON L, 1991, AM J PHYSIOL, V261, pC93, DOI 10.1152/ajpcell.1991.261.1.C93; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; LHorset F, 1996, MOL CELL BIOL, V16, P6029; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Nautiyal J, 2010, ENDOCRINOLOGY, V151, P2923, DOI 10.1210/en.2010-0081; Neschen S, 2008, PHYSIOL GENOMICS, V33, P333, DOI 10.1152/physiolgenomics.00226.2007; Nielsen JN, 2003, J APPL PHYSIOL, V94, P631, DOI 10.1152/japplphysiol.00642.2002; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Russell RR, 1999, AM J PHYSIOL-HEART C, V277, pH643, DOI 10.1152/ajpheart.1999.277.2.H643; Rytinki MM, 2008, J BIOL CHEM, V283, P11586, DOI 10.1074/jbc.M709359200; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seth A, 2007, CELL METAB, V6, P236, DOI 10.1016/j.cmet.2007.08.004; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Treuter E, 1998, MOL ENDOCRINOL, V12, P864, DOI 10.1210/me.12.6.864; Tsai NP, 2009, BIOCHEM J, V424, P411, DOI 10.1042/BJ20090915; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; White R, 2000, NAT MED, V6, P1368, DOI 10.1038/82183; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wojtaszewski JFP, 2005, J PHYSIOL-LONDON, V564, P563, DOI 10.1113/jphysiol.2005.082669; Wu H, 2003, J MUSCLE RES CELL M, V24, P587, DOI 10.1023/B:JURE.0000009968.60331.86; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693; Zschiedrich I, 2008, BLOOD, V112, P264, DOI 10.1182/blood-2007-11-121699	61	24	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32520	10.1371/journal.pone.0032520	http://dx.doi.org/10.1371/journal.pone.0032520			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389706	Green Published, gold, Green Submitted			2022-12-27	WOS:000302999600044
J	Froeschke, G; Sommer, S				Froeschke, Goetz; Sommer, Simone			Insights into the Complex Associations Between MHC Class II DRB Polymorphism and Multiple Gastrointestinal Parasite Infestations in the Striped Mouse	PLOS ONE			English	Article							GENETIC DIVERSITY; HELMINTH-PARASITES; SELECTION; POPULATION; RESISTANCE; ALLELES; MICE; INFECTION; LOAD; MICROSATELLITES	Differences in host susceptibility to different parasite types are largely based on the degree of matching between immune genes and parasite antigens. Specifically the variable genes of the major histocompatibility complex (MHC) play a major role in the defence of parasites. However, underlying genetic mechanisms in wild populations are still not well understood because there is a lack of studies which deal with multiple parasite infections and their competition within. To gain insights into these complex associations, we implemented the full record of gastrointestinal nematodes from 439 genotyped individuals of the striped mouse, Rhabdomys pumilio. We used two different multivariate approaches to test for associations between MHC class II DRB genotype and multiple nematodes with regard to the main pathogen-driven selection hypotheses maintaining MHC diversity and parasite species-specific co-evolutionary effects. The former includes investigations of a `heterozygote advantage', or its specific form a `divergent-allele advantage' caused by highly dissimilar alleles as well as possible effects of specific MHC-alleles selected by a `rare allele advantage' (= negative `frequency-dependent selection'). A combination of generalized linear mixed models (GLMMs) and co-inertia (COIA) analyses made it possible to consider multiple parasite species despite the risk of type I errors on the population and on the individual level. We could not find any evidence for a `heterozygote' advantage but support for `divergent-allele' advantage and infection intensity. In addition, both approaches demonstrated high concordance of positive as well as negative associations between specific MHC alleles and certain parasite species. Furthermore, certain MHC alleles were associated with more than one parasite species, suggesting a many-to-many gene-parasite co-evolution. The most frequent allele Rhpu-DRB*38 revealed a pleiotropic effect, involving three nematode species. Our study demonstrates the co-existence of specialist and generalist MHC alleles in terms of parasite detection which may be an important feature in the maintenance of MHC polymorphism.	[Froeschke, Goetz; Sommer, Simone] Leibniz Inst Zoo & Wildlife Res IZW, Berlin, Germany	Leibniz Institut fur Zoo und Wildtierforschung	Froeschke, G (corresponding author), Leibniz Inst Zoo & Wildlife Res IZW, Berlin, Germany.	sommer@izw-berlin.de			Hansische Universitatsstiftung; German Academic Exchange Service (DAAD); Stellenbosch University; Leibniz-Institute for Zoo and Wildlife Research/Berlin	Hansische Universitatsstiftung; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Stellenbosch University; Leibniz-Institute for Zoo and Wildlife Research/Berlin	The study was financed by the Hansische Universitatsstiftung, the German Academic Exchange Service (DAAD), the Stellenbosch University and the Leibniz-Institute for Zoo and Wildlife Research/Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2010, MOL ECOL, V19, P3842, DOI 10.1111/j.1365-294X.2010.04772.x; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Altuvia Y, 2004, METHODS, V34, P454, DOI 10.1016/j.ymeth.2004.06.008; Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Apps P., 2000, SMITHERS MAMMALS SO; Arkush KD, 2002, CAN J FISH AQUAT SCI, V59, P966, DOI 10.1139/F02-066; Axtner J, 2011, INFECT GENET EVOL, V11, P2063, DOI 10.1016/j.meegid.2011.09.020; Behnke JM, 2008, PARASITOLOGY, V135, P751, DOI 10.1017/S0031182008000334; BEHNKE J.M., 2001, PARASITOLOGY, V122, P39; Behnke JM, 2005, J ANIM ECOL, V74, P982, DOI 10.1111/j.1365-2656.2005.00995.x; BEHNKE JM, 1973, PARASITOLOGY, V67, P157, DOI 10.1017/S0031182000046382; Bonneaud C, 2006, EVOLUTION, V60, P383, DOI 10.1111/j.0014-3820.2006.tb01114.x; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Brooks DR, 2006, J PARASITOL, V92, P426, DOI 10.1645/GE-711R.1; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Cattadori IM, 2006, MICROMAMMALS AND MACROPARASITES: FROM EVOLUTIONARY ECOLOGY TO MANAGEMENT, P349, DOI 10.1007/978-4-431-36025-4_18; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; CLARKE B, 1966, NATURE, V211, P999, DOI 10.1038/211999a0; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; Crawley M.J., 2007, R BOOK; de Bellocq JG, 2008, J EVOLUTION BIOL, V21, P1144, DOI 10.1111/j.1420-9101.2008.01538.x; De Graaff G., 1981, RODENTS SO AFRICA; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Deter J, 2008, INFECT GENET EVOL, V8, P450, DOI 10.1016/j.meegid.2007.07.003; Dionne M, 2009, PHILOS T R SOC B, V364, P1555, DOI 10.1098/rstb.2009.0011; Doherty P C, 1975, Nature, V256, P50; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Evans ML, 2009, MOL ECOL, V18, P4716, DOI 10.1111/j.1365-294X.2009.04374.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ezenwa VO, 2010, AM NAT, V176, P613, DOI 10.1086/656496; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Frank S. A., 2002, IMMUNOLOGY EVOLUTION, P33; Froeschke G, 2005, MOL BIOL EVOL, V22, P1254, DOI 10.1093/molbev/msi112; Froeschke G, 2010, OIKOS, V119, P1029, DOI 10.1111/j.1600-0706.2009.18124.x; Fumagalli M, 2009, J EXP MED, V206, P1395, DOI 10.1084/jem.20082779; Goncalves L, 1998, MEM I OSWALDO CRUZ, V93, P121, DOI 10.1590/S0074-02761998000100023; Goudet J., FSTAT PROGRAM ESTIMA; GREGORY RD, 1990, J ANIM ECOL, V59, P363, DOI 10.2307/5178; Harf R, 2005, MOL ECOL, V14, P85, DOI 10.1111/j.1365-294X.2004.02402.x; HAYUNGA EG, 1991, J PARASITOL, V77, P865, DOI 10.2307/3282734; HUGHEE AL, 1992, GENETICS, V132, P863; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; KLEIN J, 1986, NATURAL HIST MAJOR H; Lello J, 2004, NATURE, V428, P840, DOI 10.1038/nature02490; Lenz TL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-269; Loiseau C, 2008, ECOL LETT, V11, P258, DOI 10.1111/j.1461-0248.2007.01141.x; Mas-Coma S, 2008, REV SCI TECH OIE, V27, P443, DOI 10.20506/rst.27.2.1822; McClelland EE, 2003, INFECT IMMUN, V71, P2079, DOI 10.1128/IAI.71.4.2079-2086.2003; Meyer-Lucht Y, 2005, MOL ECOL, V14, P2233, DOI 10.1111/j.1365-294X.2005.02557.x; Meyer-Lucht Y, 2009, EVOL ECOL RES, V11, P1085; Meyer-Lucht Y, 2010, CONSERV GENET, V11, P2001, DOI 10.1007/s10592-010-0093-9; Michels C, 2006, INFECT IMMUN, V74, P5926, DOI 10.1128/IAI.00207-06; Nwosu CO, 2007, VET PARASITOL, V144, P118, DOI 10.1016/j.vetpar.2006.09.004; Oliver MK, 2009, P ROY SOC B-BIOL SCI, V276, P1119, DOI 10.1098/rspb.2008.1525; Pearce Edward J., 2002, P39; Perrigoue JG, 2008, CELL MICROBIOL, V10, P1757, DOI 10.1111/j.1462-5822.2008.01174.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; R Core Team, 2021, R LANGUAGE ENV STAT; Schad J, 2004, CONSERV GENET, V5, P299, DOI 10.1023/B:COGE.0000031137.50239.d3; Schwensow N, 2011, INFECT GENET EVOL, V11, P23, DOI 10.1016/j.meegid.2010.10.017; Schwensow N, 2010, INFECT GENET EVOL, V10, P662, DOI 10.1016/j.meegid.2010.03.012; SINGLETON GR, 1985, AUST WILDLIFE RES, V12, P437; Skorping A, 2004, TRENDS ECOL EVOL, V19, P219, DOI 10.1016/j.tree.2004.02.006; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Stear MJ, 1997, NATURE, V389, P27, DOI 10.1038/37895; Summers K, 2003, BIOL REV, V78, P639, DOI 10.1017/S146479310300616X; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Tellier A, 2007, P R SOC B, V274, P809, DOI 10.1098/rspb.2006.0281; Tollenaere C, 2008, J EVOLUTION BIOL, V21, P1307, DOI 10.1111/j.1420-9101.2008.01563.x; Vali U, 2008, MOL ECOL, V17, P3808, DOI 10.1111/j.1365-294X.2008.03876.x; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; WAKELAND EK, 1990, IMMUNOL RES, V9, P115, DOI 10.1007/BF02918202; Wegner KM, 2008, J FISH BIOL, V73, P2110, DOI 10.1111/j.1095-8649.2008.02051.x; Wegner KM, 2003, J EVOLUTION BIOL, V16, P224, DOI 10.1046/j.1420-9101.2003.00519.x; Weil ZM, 2006, MICROMAMMALS AND MACROPARASITES: FROM EVOLUTIONARY ECOLOGY TO MANAGEMENT, P443, DOI 10.1007/978-4-431-36025-4_21; Wilson K., 2001, ECOLOGY WILDLIFE DIS, P6; Zuur Alain F., 2009, P1	84	36	36	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e31820	10.1371/journal.pone.0031820	http://dx.doi.org/10.1371/journal.pone.0031820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389675	Green Submitted, Green Published, gold			2022-12-27	WOS:000302999600013
J	Churchill, NW; Yourganov, G; Oder, A; Tam, F; Graham, SJ; Strother, SC				Churchill, Nathan W.; Yourganov, Grigori; Oder, Anita; Tam, Fred; Graham, Simon J.; Strother, Stephen C.			Optimizing Preprocessing and Analysis Pipelines for Single-Subject fMRI: 2. Interactions with ICA, PCA, Task Contrast and Inter-Subject Heterogeneity	PLOS ONE			English	Article							FUNCTIONAL MRI; ARTIFACT REMOVAL; REPRODUCIBILITY; MOTOR; STROKE; NPAIRS; TRAIL; BRAIN; SEPARATION; EFFICIENCY	A variety of preprocessing techniques are available to correct subject-dependant artifacts in fMRI, caused by head motion and physiological noise. Although it has been established that the chosen preprocessing steps (or "pipeline'') may significantly affect fMRI results, it is not well understood how preprocessing choices interact with other parts of the fMRI experimental design. In this study, we examine how two experimental factors interact with preprocessing: between-subject heterogeneity, and strength of task contrast. Two levels of cognitive contrast were examined in an fMRI adaptation of the Trail-Making Test, with data from young, healthy adults. The importance of standard preprocessing with motion correction, physiological noise correction, motion parameter regression and temporal detrending were examined for the two task contrasts. We also tested subspace estimation using Principal Component Analysis (PCA), and Independent Component Analysis (ICA). Results were obtained for Penalized Discriminant Analysis, and model performance quantified with reproducibility (R) and prediction metrics (P). Simulation methods were also used to test for potential biases from individual-subject optimization. Our results demonstrate that (1) individual pipeline optimization is not significantly more biased than fixed preprocessing. In addition, (2) when applying a fixed pipeline across all subjects, the task contrast significantly affects pipeline performance; in particular, the effects of PCA and ICA models vary with contrast, and are not by themselves optimal preprocessing steps. Also, (3) selecting the optimal pipeline for each subject improves within-subject (P, R) and between-subject overlap, with the weaker cognitive contrast being more sensitive to pipeline optimization. These results demonstrate that sensitivity of fMRI results is influenced not only by preprocessing choices, but also by interactions with other experimental design factors. This paper outlines a quantitative procedure to denoise data that would otherwise be discarded due to artifact; this is particularly relevant for weak signal contrasts in single-subject, small-sample and clinical datasets.	[Churchill, Nathan W.; Graham, Simon J.; Strother, Stephen C.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Churchill, Nathan W.; Yourganov, Grigori; Oder, Anita; Tam, Fred; Graham, Simon J.; Strother, Stephen C.] Baycrest, Rotman Res Inst, Toronto, ON, Canada; [Yourganov, Grigori] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Tam, Fred; Graham, Simon J.] Sunnybrook Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Churchill, NW (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	nchurchill@rotman-baycrest.on.ca	Strother, Stephen C/D-6752-2011; Strother, Stephen/ABF-3371-2021	Strother, Stephen C/0000-0002-3198-217X; Strother, Stephen/0000-0002-3198-217X	Canadian Institute of Health Research [MOP 84483]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	Funded by the Canadian Institute of Health Research, MOP 84483 to P.I., S. Strother. URL: www.cihr-irsc.gc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2007, FOOD QUAL PREFER, V18, P627, DOI 10.1016/j.foodqual.2006.09.003; Abdi H, 2009, NEUROIMAGE, V45, P89, DOI 10.1016/j.neuroimage.2008.11.008; Beall EB, 2010, J NEUROSCI METH, V187, P216, DOI 10.1016/j.jneumeth.2010.01.013; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bennett C, 2009, P ICB; Birn RM, 2009, NEUROIMAGE, V47, P1092, DOI 10.1016/j.neuroimage.2009.05.030; Biswal BB, 1999, J COMPUT ASSIST TOMO, V23, P265, DOI 10.1097/00004728-199903000-00016; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Calautti C, 2003, STROKE, V34, P1553, DOI 10.1161/01.STR.0000071761.36075.A6; Carey JR, 2002, BRAIN, V125, P773, DOI 10.1093/brain/awf091; Churchill NW, NEURO IMAGE IN PRESS; Churchill NW, HUM BRAIN M IN PRESS; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; De Martino F, 2007, NEUROIMAGE, V34, P177, DOI 10.1016/j.neuroimage.2006.08.041; Della-Maggiore V, 2002, NEUROIMAGE, V17, P19, DOI 10.1006/nimg.2002.1113; Dong Y, 2006, STROKE, V37, P1552, DOI 10.1161/01.STR.0000221281.69373.4e; Douglas EA, 2006, CURR MED IMAGING, V2, P105, DOI 10.2174/157340506775541712; Fernandez G, 2003, NEUROLOGY, V60, P969, DOI 10.1212/01.WNL.0000049934.34209.2E; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Kastner S, 2000, J NEUROPHYSIOL, V83, P2453, DOI 10.1152/jn.2000.83.4.2453; Kay KN, 2008, HUM BRAIN MAPP, V29, P142, DOI 10.1002/hbm.20379; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; LaConte S, 2003, NEUROIMAGE, V18, P10, DOI 10.1006/nimg.2002.1300; Levy CE, 2001, AM J PHYS MED REHAB, V80, P4, DOI 10.1097/00002060-200101000-00003; Liu TT, 2001, NEUROIMAGE, V13, P759, DOI 10.1006/nimg.2000.0728; Liu TT, 2004, NEUROIMAGE, V21, P387, DOI 10.1016/j.neuroimage.2003.09.030; Lukic AS, 2002, ARTIF INTELL MED, V25, P69, DOI 10.1016/S0933-3657(02)00009-X; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Menon RS, 2002, MAGNET RESON MED, V47, P1, DOI 10.1002/mrm.10041; Morgan VL, 2007, COMPUT MED IMAG GRAP, V31, P436, DOI 10.1016/j.compmedimag.2007.04.002; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perlbarg V, 2007, MAGN RESON IMAGING, V25, P35, DOI 10.1016/j.mri.2006.09.042; Poline JB, 2006, HUM BRAIN MAPP, V27, P351, DOI 10.1002/hbm.20268; Rasmussen PM, 2011, MODEL SPARS IN PRESS; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; Seto E, 2001, NEUROIMAGE, V14, P284, DOI 10.1006/nimg.2001.0829; Shaw ME, 2003, NEUROIMAGE, V19, P988, DOI 10.1016/S1053-8119(03)00116-2; Strother S, 2004, NEUROIMAGE, V23, pS196, DOI 10.1016/j.neuroimage.2004.07.022; Strother SC, 2006, IEEE ENG MED BIOL, V25, P27, DOI 10.1109/MEMB.2006.1607667; Strother S, 2010, COMPSTAT'2010: 19TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL STATISTICS, P111, DOI 10.1007/978-3-7908-2604-3_10; Strothert SC, 2002, NEUROIMAGE, V15, P747, DOI 10.1006/nimg.2001.1034; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; Tam F, 2011, HUM BRAIN MAPP, V32, P240, DOI 10.1002/hbm.21013; Tanabe J, 2002, NEUROIMAGE, V15, P902, DOI 10.1006/nimg.2002.1053; Tegeler C, 1999, HUM BRAIN MAPP, V7, P267, DOI 10.1002/(SICI)1097-0193(1999)7:4<267::AID-HBM5>3.0.CO;2-3; Tohka J, 2008, NEUROIMAGE, V39, P1227, DOI 10.1016/j.neuroimage.2007.10.013; Woods RP, 1999, HUM BRAIN MAPP, V8, P73, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<73::AID-HBM1>3.0.CO;2-7; Worsley K.J., 2001, FUNCTIONAL MRI AN IN, P251, DOI [10.1093/acprof:oso/ 9780192630711.003.0014, DOI 10.1093/ACPROF:OSO/9780192630711.003.0014]; Yourganov G, 2011, NEUROIMAGE, V56, P531, DOI 10.1016/j.neuroimage.2010.09.034; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013; Zhang J, 2008, NEUROINFORMATICS, V6, P123, DOI 10.1007/s12021-008-9014-1; Zhang J, 2009, MAGN RESON IMAGING, V27, P264, DOI 10.1016/j.mri.2008.05.021; Zou QH, 2009, NEUROIMAGE, V48, P515, DOI 10.1016/j.neuroimage.2009.07.006	63	42	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31147	10.1371/journal.pone.0031147	http://dx.doi.org/10.1371/journal.pone.0031147			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383999	gold, Green Submitted, Green Published			2022-12-27	WOS:000302918500020
J	Gulati, AS; Shanahan, MT; Arthur, JC; Grossniklaus, E; von Furstenberg, RJ; Kreuk, L; Henning, SJ; Jobin, C; Sartor, RB				Gulati, Ajay S.; Shanahan, Michael T.; Arthur, Janelle C.; Grossniklaus, Emily; von Furstenberg, Richard J.; Kreuk, Lieselotte; Henning, Susan J.; Jobin, Christian; Sartor, R. Balfour			Mouse Background Strain Profoundly Influences Paneth Cell Function and Intestinal Microbial Composition	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INNATE IMMUNITY; CROHNS-DISEASE; INTERLEUKIN-10-DEFICIENT MICE; BACTERICIDAL LECTIN; ALPHA-DEFENSINS; EPITHELIUM; EXPRESSION; COLITIS; SOX9	Background: Increasing evidence supports the central role of Paneth cells in maintaining intestinal host-microbial homeostasis. However, the direct impact of host genotype on Paneth cell function remains unclear. Here, we characterize key differences in Paneth cell function and intestinal microbial composition in two widely utilized, genetically distinct mouse strains (C57BL/6 and 129/SvEv). In doing so, we demonstrate critical influences of host genotype on Paneth cell activity and the enteric microbiota. Methodology and Principal Findings: Paneth cell numbers were determined by flow cytometry. Antimicrobial peptide (AMP) expression was evaluated using quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR), acid urea-polyacrylamide gel electrophoresis, and mass spectrometry. Effects of mouse background on microbial composition were assessed by reciprocal colonization of germ-free mice from both background strains, followed by compositional analysis of resultant gut bacterial communities using terminal restriction fragment length polymorphism analysis and 16 S qPCR. Our results revealed that 129/SvEv mice possessed fewer Paneth cells and a divergent AMP profile relative to C57BL/6 counterparts. Novel 129/SvEv a-defensin peptides were identified, including Defa2/18v, Defa11, Defa16, and Defa18. Host genotype profoundly affected the global profile of the intestinal microbiota, while both source and host factors were found to influence specific bacterial groups. Interestingly, ileal a-defensins from 129/SvEv mice displayed attenuated antimicrobial activity against pro-inflammatory E. coli strains, a bacterial species found to be expanded in these animals. Conclusions and Significance: This work establishes the important impact of host genotype on Paneth cell function and the composition of the intestinal microbiota. It further identifies specific AMP and microbial alterations in two commonly used inbred mouse strains that have varying susceptibilities to a variety of disorders, ranging from obesity to intestinal inflammation. This will be critical for future studies utilizing these murine backgrounds to study the effects of Paneth cells and the intestinal microbiota on host health and disease.	[Gulati, Ajay S.; Shanahan, Michael T.; Arthur, Janelle C.; Grossniklaus, Emily; von Furstenberg, Richard J.; Kreuk, Lieselotte; Henning, Susan J.; Jobin, Christian; Sartor, R. Balfour] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27515 USA; [Gulati, Ajay S.] Univ N Carolina, Div Gastroenterol & Hepatol, Dept Pediat, Chapel Hill, NC USA; [Shanahan, Michael T.; Arthur, Janelle C.; Grossniklaus, Emily; von Furstenberg, Richard J.; Kreuk, Lieselotte; Henning, Susan J.; Jobin, Christian; Sartor, R. Balfour] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Henning, Susan J.] Univ N Carolina, Dept Cellular & Mol Physiol, Chapel Hill, NC USA; [Jobin, Christian] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Sartor, R. Balfour] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gulati, AS (corresponding author), Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27515 USA.	agulati@med.unc.edu	, Proteomics Core UNC/AFQ-7201-2022	Arthur, Janelle/0000-0002-4796-0207	United States National Institutes of Health (NIH) [KL2 RR025746]; NASPGHAN Foundation/Crohn's and Colitis Foundation of America; Global Probiotics Council; NIH [R01 DK53347, P40 RR018603, T32 DK007737, U01 DK085547, P30 DK34987]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR018603, KL2RR025746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, T32DK007737, R01DK053347, U01DK085547] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASPGHAN Foundation/Crohn's and Colitis Foundation of America; Global Probiotics Council; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by grants United States National Institutes of Health (NIH) KL2 RR025746 (Marshall S. Runge, PI), a Career Development Award from the NASPGHAN Foundation/Crohn's and Colitis Foundation of America (ASG), a Young Investigator Award from the Global Probiotics Council (ASG), NIH R01 DK53347 (RBS), NIH P40 RR018603 (RBS), NIH T32 DK007737 (RBS), NIH U01 DK085547 (SJH), and NIH P30 DK34987 (Robert S. Sandler, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Biswas A, 2010, P NATL ACAD SCI USA, V107, P14739, DOI 10.1073/pnas.1003363107; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Carvalho FA, 2009, J EXP MED, V206, P2179, DOI 10.1084/jem.20090741; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Crissey MAS, 2011, GASTROENTEROLOGY, V140, P517, DOI 10.1053/j.gastro.2010.11.033; Esworthy RS, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/986046; Formeister EJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1108, DOI 10.1152/ajpgi.00004.2009; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Huynh D, 2009, GASTROENTEROLOGY, V137, P136, DOI 10.1053/j.gastro.2009.03.004; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2011, GASTROENTEROLOGY, V140, P1738, DOI 10.1053/j.gastro.2011.02.048; Keshav S, 2006, J LEUKOCYTE BIOL, V80, P500, DOI 10.1189/jlb.1005556; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Koslowski MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004496; Kovacs A, 2011, MICROB ECOL, V61, P423, DOI 10.1007/s00248-010-9787-2; Mahler M, 1999, GENOMICS, V55, P147, DOI 10.1006/geno.1998.5636; Mastroianni JR, 2009, J BIOL CHEM, V284, P27848, DOI 10.1074/jbc.M109.050773; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Ouellette AJ, 2010, CURR OPIN GASTROEN, V26, P547, DOI 10.1097/MOG.0b013e32833dccde; Pena JA, 2009, INFLAMM BOWEL DIS, V15, P248, DOI 10.1002/ibd.20744; Reuter G, 2001, Curr Issues Intest Microbiol, V2, P43; Rolhion N, 2007, INFLAMM BOWEL DIS, V13, P1277, DOI 10.1002/ibd.20176; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Shanahan MT, 2011, INFECT IMMUN, V79, P459, DOI 10.1128/IAI.00996-10; Shirafuji Y, 2003, J BIOL CHEM, V278, P7910, DOI 10.1074/jbc.M210600200; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; von Furstenberg RJ, 2011, AM J PHYSIOL-GASTR L, V300, pG409, DOI 10.1152/ajpgi.00453.2010; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wehkamp J, 2007, J IMMUNOL, V179, P3109, DOI 10.4049/jimmunol.179.5.3109; Wehkamp J, 2010, J CROHNS COLITIS, V4, P523, DOI 10.1016/j.crohns.2010.05.010; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113	45	58	62	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32403	10.1371/journal.pone.0032403	http://dx.doi.org/10.1371/journal.pone.0032403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384242	gold, Green Submitted, Green Published			2022-12-27	WOS:000302918500085
J	Iserbyt, A; Van Gossum, H; Stoks, R				Iserbyt, Arne; Van Gossum, Hans; Stoks, Robby			Biogeographical Survey Identifies Consistent Alternative Physiological Optima and a Minor Role for Environmental Drivers in Maintaining a Polymorphism	PLOS ONE			English	Article							FEMALE COLOR POLYMORPHISM; FREQUENCY-DEPENDENT SELECTION; MORPH FREQUENCIES; IMMUNE FUNCTION; LIFE-HISTORY; EVOLUTIONARY DYNAMICS; NEHALENNIA-IRENE; CLINAL VARIATION; CORRELATIONAL SELECTION; GEOGRAPHIC-VARIATION	The contribution of adaptive mechanisms in maintaining genetic polymorphisms is still debated in many systems. To understand the contribution of selective factors in maintaining polymorphism, we investigated large-scale (>1000 km) geographic variation in morph frequencies and fitness-related physiological traits in the damselfly Nehalennia irene. As fitness-related physiological traits, we investigated investment in immune function (phenoloxidase activity), energy storage and fecundity (abdomen protein and lipid content), and flight muscles (thorax protein content). In the first part of the study, our aim was to identify selective agents maintaining the large-scale spatial variation in morph frequencies. Morph frequencies varied considerably among populations, but, in contrast to expectation, in a geographically unstructured way. Furthermore, frequencies co-varied only weakly with the numerous investigated ecological parameters. This suggests that spatial frequency patterns are driven by stochastic processes, or alternatively, are consequence of highly variable and currently unidentified ecological conditions. In line with this, the investigated ecological parameters did not affect the fitness-related physiological traits differently in both morphs. In the second part of the study, we aimed at identifying tradeoffs between fitness-related physiological traits that may contribute to the local maintenance of both colour morphs by defining alternative phenotypic optima, and test the spatial consistency of such trade-off patterns. The female morph with higher levels of phenoloxidase activity had a lower thorax protein content, and vice versa, suggesting a trade-off between investments in immune function and in flight muscles. This physiological trade-off was consistent across the geographical scale studied and supports widespread correlational selection, possibly driven by male harassment, favouring alternative trait combinations in both female morphs.	[Iserbyt, Arne; Van Gossum, Hans] Univ Antwerp, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium; [Stoks, Robby] Univ Leuven, Lab Aquat Ecol & Evolutionary Biol, Louvain, Belgium	University of Antwerp; KU Leuven	Iserbyt, A (corresponding author), Univ Antwerp, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium.	arne.iserbyt@ua.ac.de	Stoks, Robby/AAK-1227-2020	Iserbyt, Arne/0000-0002-6414-6688; Stoks, Robby/0000-0003-4130-0459	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); University of Antwerp (BOF-NOI) [2401]; Fund for Scientific Research Flanders (FWO); University of Leuven	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); University of Antwerp (BOF-NOI); Fund for Scientific Research Flanders (FWO)(FWO); University of Leuven(KU Leuven)	This study was funded by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen research grant to AI: http://www.iwt.be), research grants from the University of Antwerp (BOF-NOI, project number: 2401 to HVG: http://www.ua.ac.be), and the Fund for Scientific Research Flanders (FWO: http://www.fwo.be) and the University of Leuven (http://www.kuleuven.be) to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JK, 2008, MOL ECOL, V17, P1597, DOI 10.1111/j.1365-294X.2007.03641.x; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Andres JA, 2000, EVOLUTION, V54, P2156, DOI 10.1111/j.0014-3820.2000.tb01258.x; Andres JA, 2002, ANIM BEHAV, V63, P677, DOI 10.1006/anbe.2001.1948; Antoniazza S, 2010, EVOLUTION, V64, P1944, DOI 10.1111/j.1558-5646.2010.00969.x; Berwaerts K, 2004, OECOLOGIA, V141, P536, DOI 10.1007/s00442-004-1661-9; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bots J, 2008, PHYSIOL ENTOMOL, V33, P138, DOI 10.1111/j.1365-3032.2008.00616.x; Bots J, 2009, BIOL J LINN SOC, V97, P545, DOI 10.1111/j.1095-8312.2009.01238.x; Boughton RK, 2011, FUNCT ECOL, V25, P81, DOI 10.1111/j.1365-2435.2010.01817.x; Bouton N, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.11201; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calsbeek B, 2010, J EVOLUTION BIOL, V23, P1138, DOI 10.1111/j.1420-9101.2010.01978.x; Calsbeek R, 2008, J ANIM ECOL, V77, P103, DOI 10.1111/j.1365-2656.2007.01320.x; Calsbeek R, 2010, EVOLUTION, V64, P116, DOI 10.1111/j.1558-5646.2009.00808.x; Conrad KF, 2002, ECOGRAPHY, V25, P439, DOI 10.1034/j.1600-0587.2002.250406.x; Cooper IA, 2010, AM NAT, V176, P566, DOI 10.1086/656491; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Cordero Rivera A, 1998, ETOLOGIA, V6, P71; Cordoba-Aguilar A, 2009, BEHAV ECOL SOCIOBIOL, V63, P751, DOI 10.1007/s00265-009-0709-6; Corl A, 2010, P NATL ACAD SCI USA, V107, P4254, DOI 10.1073/pnas.0909480107; Cornwallis CK, 2010, TRENDS ECOL EVOL, V25, P145, DOI 10.1016/j.tree.2009.09.008; De Block M, 2008, ECOL ENTOMOL, V33, P796, DOI 10.1111/j.1365-2311.2008.01024.x; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Endler J.A., 1977, Monographs in Population Biology, pi; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; FARRAR DE, 1967, REV ECON STAT, V49, P92, DOI 10.2307/1937887; Fielding DJ, 2008, PHYSIOL ENTOMOL, V33, P264, DOI 10.1111/j.1365-3032.2008.00619.x; Fincke OM, 2004, ANIM BEHAV, V67, P833, DOI 10.1016/j.anbehav.2003.04.017; Forbes MR, 1997, CAN J ZOOL, V75, P253, DOI 10.1139/z97-032; FORBES MRL, 1995, ECOSCIENCE, V2, P28, DOI 10.1080/11956860.1995.11682265; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Gonzalez-Tokman D, 2011, ANIM BEHAV, V81, P1185, DOI 10.1016/j.anbehav.2011.02.027; Gosden TP, 2011, BIOL J LINN SOC, V102, P775, DOI 10.1111/j.1095-8312.2011.01619.x; Gosden TP, 2009, AM NAT, V173, P709, DOI 10.1086/598491; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; Hammers M, 2008, ANIM BEHAV, V76, P1403, DOI 10.1016/j.anbehav.2008.06.021; HINNEKINT BON, 1987, HYDROBIOLOGIA, V146, P3, DOI 10.1007/BF00007574; Hoffman EA, 2000, BIOL J LINN SOC, V70, P633, DOI 10.1006/bijl.1999.0421; HOLM S, 1979, SCAND J STAT, V6, P65; Hubert M, 2003, J CHEMOMETR, V17, P537, DOI 10.1002/cem.822; Iserbyt A, 2010, J ZOOL, V282, P256, DOI 10.1111/j.1469-7998.2010.00735.x; Iserbyt A, 2012, THESIS ANTWERP U ANT; Iserbyt A, 2011, P ROY SOC B-BIOL SCI, V278, P3116, DOI 10.1098/rspb.2011.0126; Iserbyt A, 2009, ANIM BEHAV, V78, P1463, DOI 10.1016/j.anbehav.2009.09.031; Iserbyt A, 2009, ANIM BIOL, V59, P313, DOI 10.1163/157075609X454944; JONES JS, 1977, ANNU REV ECOL SYST, V8, P109, DOI 10.1146/annurev.es.08.110177.000545; Joop G, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-19; Karl I, 2011, GLOBAL CHANGE BIOL, V17, P676, DOI 10.1111/j.1365-2486.2010.02277.x; King EG, 2011, J EVOLUTION BIOL, V24, P256, DOI 10.1111/j.1420-9101.2010.02160.x; Koenig WD, 1999, TRENDS ECOL EVOL, V14, P22, DOI 10.1016/S0169-5347(98)01533-X; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; Kunte K, 2009, ANIM BEHAV, V78, P1029, DOI 10.1016/j.anbehav.2009.08.013; Lam E., 2004, DAMSELFLIES NE GUIDE; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; Lease HM, 2011, PHYSIOL ENTOMOL, V36, P29, DOI 10.1111/j.1365-3032.2010.00767.x; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Li BB, 2002, CHEMOMETR INTELL LAB, V64, P79, DOI 10.1016/S0169-7439(02)00051-5; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Locklin JL, 2010, PARASITOL RES, V107, P75, DOI 10.1007/s00436-010-1836-8; Magurran AE, 2005, EVOLUTIONARY ECOLOGY, P224; Marden JH, 2000, ANNU REV PHYSIOL, V62, P157, DOI 10.1146/annurev.physiol.62.1.157; MARDEN JH, 1989, PHYSIOL ZOOL, V62, P505, DOI 10.1086/physzool.62.2.30156182; McKinnon JS, 2010, MOL ECOL, V19, P5101, DOI 10.1111/j.1365-294X.2010.04846.x; Millstein RL, 2002, BIOL PHILOS, V17, P33, DOI 10.1023/A:1012990800358; Mucklow PT, 2004, P ROY SOC B-BIOL SCI, V271, P1175, DOI 10.1098/rspb.2004.2707; Mullen LM, 2008, EVOLUTION, V62, P1555, DOI 10.1111/j.1558-5646.2008.00425.x; Nakamoto A, 2011, POPUL ECOL, V53, P241, DOI 10.1007/s10144-010-0214-9; Nosil P, 2006, AM NAT, V167, pE66, DOI 10.1086/499383; Ohsaki N, 2005, J ANIM ECOL, V74, P728, DOI 10.1111/j.1365-2656.2005.00972.x; Olsson K, 2002, J EVOLUTION BIOL, V15, P983, DOI 10.1046/j.1420-9101.2002.00457.x; Parkash R, 2009, J INSECT PHYSIOL, V55, P358, DOI 10.1016/j.jinsphys.2009.01.008; Phifer-Rixey M, 2008, J EVOLUTION BIOL, V21, P966, DOI 10.1111/j.1420-9101.2008.01549.x; Pujol B, 2008, MOL ECOL, V17, P4782, DOI 10.1111/j.1365-294X.2008.03958.x; Punzalan D, 2010, CURR BIOL, V20, pR972, DOI 10.1016/j.cub.2010.09.067; ROBERTSON HM, 1985, ANIM BEHAV, V33, P805, DOI 10.1016/S0003-3472(85)80013-0; Rolff J, 2004, P ROY SOC B-BIOL SCI, V271, P2157, DOI 10.1098/rspb.2004.2859; Rolff J, 2004, AM NAT, V164, P559, DOI 10.1086/423715; Saccheri IJ, 2008, P NATL ACAD SCI USA, V105, P16212, DOI 10.1073/pnas.0803785105; Sanchez-Guillen RA, 2011, HEREDITY, V107, P513, DOI 10.1038/hdy.2011.36; Sanchez-Guillen RA, 2005, BIOL J LINN SOC, V85, P471, DOI 10.1111/j.1095-8312.2005.00506.x; Schmid-Hempel P, 2005, BIOESSAYS, V27, P1026, DOI 10.1002/bies.20282; Silvertown J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018927; Sinervo B, 2002, HEREDITY, V89, P329, DOI 10.1038/sj.hdy.6800148; Sinervo B, 2001, EVOLUTION, V55, P2040; Sinervo B, 1998, OIKOS, V83, P432, DOI 10.2307/3546671; Siva-Jothy MT, 2002, PHYSIOL ENTOMOL, V27, P206, DOI 10.1046/j.1365-3032.2002.00286.x; SLATKIN M, 1973, GENETICS, V75, P733; Stapley J, 2011, J HERED, V102, P118, DOI 10.1093/jhered/esq104; Stearns S.C., 2000, EVOLUTION INTRO; Stoks R, 2006, ECOLOGY, V87, P809, DOI 10.1890/0012-9658(2006)87[809:TCMPPI]2.0.CO;2; Stoks R, 2012, ANNU REV ENTOMOL, V57, P249, DOI 10.1146/annurev-ento-120710-100557; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Svensson E, 2001, P NATL ACAD SCI USA, V98, P12561, DOI 10.1073/pnas.211071298; Svensson EI, 2005, J EVOLUTION BIOL, V18, P1503, DOI 10.1111/j.1420-9101.2005.00946.x; Svensson EI, 2005, AM NAT, V165, P567, DOI 10.1086/429278; Svensson EI, 2009, EVOL ECOL, V23, P93, DOI 10.1007/s10682-007-9208-2; Takahashi Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-256; Takahashi Y, 2010, EVOLUTION, V64, P3620, DOI 10.1111/j.1558-5646.2010.01083.x; Van Gossum H, 2008, CAN J ZOOL, V86, P1131, DOI 10.1139/Z08-091; Van Gossum H, 2001, BEHAV ECOL SOCIOBIOL, V51, P69; Van Gossum H, 2008, ECOL MODEL, V210, P212, DOI 10.1016/j.ecolmodel.2007.07.023; Van Gossum H, 2007, BIOL J LINN SOC, V90, P501, DOI 10.1111/j.1095-8312.2007.00740.x; Van Gossum Hans, 2008, P219; WESTFALL MJ, 1996, DAMSELFLIES N AM; Wheeler D, 1996, ANNU REV ENTOMOL, V41, P407, DOI 10.1146/annurev.en.41.010196.002203; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x; Wong A, 2003, MOL ECOL, V12, P3505, DOI 10.1046/j.1365-294X.2003.02002.x; Xu MZ, 2011, BEHAV ECOL SOCIOBIOL, V65, P1215, DOI 10.1007/s00265-010-1134-6; Zhao Z, 2006, J INSECT PHYSIOL, V52, P646, DOI 10.1016/j.jinsphys.2006.03.003; Zheng HF, 2009, AGR ECOSYST ENVIRON, V132, P98, DOI 10.1016/j.agee.2009.03.004; Ziegler R, 2006, INSECT BIOCHEM MOLEC, V36, P264, DOI 10.1016/j.ibmb.2006.01.014	113	11	11	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32648	10.1371/journal.pone.0032648	http://dx.doi.org/10.1371/journal.pone.0032648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384278	Green Published, gold, Green Submitted			2022-12-27	WOS:000302918500105
J	Falsafi, SK; Deli, A; Hoger, H; Pollak, A; Lubec, G				Falsafi, Soheil Keihan; Deli, Alev; Hoeger, Harald; Pollak, Arnold; Lubec, Gert			Scopolamine Administration Modulates Muscarinic, Nicotinic and NMDA Receptor Systems	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ACETYLCHOLINE-RECEPTOR; CHOLINERGIC SYSTEM; WATER MAZE; INHIBITORY AVOIDANCE; SYNAPTIC PLASTICITY; BINDING-PROPERTIES; CEREBRAL-CORTEX; MESSENGER-RNAS; WORKING-MEMORY	Studies on the effect of scopolamine on memory are abundant but so far only regulation of the muscarinic receptor (M1) has been reported. We hypothesized that levels of other cholinergic brain receptors as the nicotinic receptors and the N-methyl-D-aspartate (NMDA) receptor, known to be involved in memory formation, would be modified by scopolamine administration. C57BL/6J mice were used for the experiments and divided into four groups. Two groups were given scopolamine 1 mg/kg i.p. (the first group was trained and the second group untrained) in the multiple T-maze (MTM), a paradigm for evaluation of spatial memory. Likewise, vehicle-treated mice were trained or untrained thus serving as controls. Hippocampal levels of M1, nicotinic receptor alpha 4 (Nic4) and 7 (Nic7) and subunit NR1containing complexes were determined by immunoblotting on blue native gel electrophoresis. Vehicle-treated trained mice learned the task and showed memory retrieval on day 8, while scopolamine-treatment led to significant impairment of performance in the MTM. At the day of retrieval, hippocampal levels for M1, Nic7 and NR1 were higher in the scopolamine treated groups than in vehicle-treated groups. The concerted action, i.e. the pattern of four brain receptor complexes regulated by the anticholinergic compound scopolamine, is shown. Insight into probable action mechanisms of scopolamine at the brain receptor complex level in the hippocampus is provided. Scopolamine treatment is a standard approach to test cognitive enhancers and other psychoactive compounds in pharmacological studies and therefore knowledge on mechanisms is of pivotal interest.	[Falsafi, Soheil Keihan; Deli, Alev; Pollak, Arnold; Lubec, Gert] Med Univ Vienna, Dept Pediat, Vienna, Austria; [Hoeger, Harald] Med Univ Vienna, Div Lab Anim Sci & Genet, Core Unit Biomed Res, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Falsafi, SK (corresponding author), Med Univ Vienna, Dept Pediat, Vienna, Austria.	gert.lubec@meduniwien.ac.at		Lubec, Gert/0000-0002-6333-9461				Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; Barak S, 2009, INT J NEUROPSYCHOPH, V12, P227, DOI 10.1017/S1461145708009176; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; BERMUDEZRATTONI F, 1987, PHARMACOL BIOCHEM BE, V26, P553, DOI 10.1016/0091-3057(87)90165-1; BLOKLAND A, 1992, PSYCHOPHARMACOLOGY, V109, P373, DOI 10.1007/BF02245886; BODDEKE EWGM, 1992, EUR J PHARMACOL, V222, P21, DOI 10.1016/0014-2999(92)90457-F; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; BOREN JJ, 1959, J EXP ANAL BEHAV, V2, P107, DOI 10.1901/jeab.1959.2-107; BRITO GNO, 1983, PSYCHOPHARMACOLOGY, V81, P315, DOI 10.1007/BF00427569; Broide RS, 1999, MOL NEUROBIOL, V20, P1, DOI 10.1007/BF02741361; Buccafusco JJ, 2008, PSYCHOPHARMACOLOGY, V199, P481, DOI 10.1007/s00213-007-0887-8; BUCKLEY NJ, 1988, J NEUROSCI, V8, P4646; BURESOVA O, 1986, BEHAV NEUROSCI, V100, P476, DOI 10.1037/0735-7044.100.4.476; BURGARD EC, 1990, NEUROSCI LETT, V116, P34, DOI 10.1016/0304-3940(90)90382-J; Cain DP, 1998, NEUROSCI BIOBEHAV R, V22, P181, DOI 10.1016/S0149-7634(97)00005-5; Calabresi P, 1998, EUR J NEUROSCI, V10, P2887, DOI 10.1111/j.1460-9568.1998.00294.x; Calabresi P, 1999, NEUROPHARMACOLOGY, V38, P323, DOI 10.1016/S0028-3908(98)00199-3; CARLTON PL, 1963, PSYCHOL REV, V70, P19, DOI 10.1037/h0045063; CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B; Chen P, 2006, J NEUROCHEM, V98, P1126, DOI 10.1111/j.1471-4159.2006.03934.x; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P148, DOI 10.1016/j.tips.2008.12.002; Cordero-Erausquin M, 2000, TRENDS PHARMACOL SCI, V21, P211, DOI 10.1016/S0165-6147(00)01489-9; Cunha GMA, 2008, EXP NEUROL, V210, P776, DOI 10.1016/j.expneurol.2007.11.013; DECKER MW, 1990, BRAIN RES, V513, P81, DOI 10.1016/0006-8993(90)91091-T; Doralp S, 2008, NEUROBIOL LEARN MEM, V90, P382, DOI 10.1016/j.nlm.2008.05.013; ECKERMAN DA, 1980, PHARMACOL BIOCHEM BE, V12, P595, DOI 10.1016/0091-3057(80)90194-X; Fornari RV, 2000, LEARN MEMORY, V7, P287, DOI 10.1101/lm.34900; Ghafari M, 2011, BRAIN STRUC IN PRESS, DOI [10.1007/s00429-00011-00335-00428, DOI 10.1007/S00429-00011-00335-00428]; Ghafari M, 2011, BEHAV BRAIN RES, V221, P142, DOI 10.1016/j.bbr.2011.02.042; GODDING PR, 1982, PHARMACOL BIOCHEM BE, V16, P919, DOI 10.1016/0091-3057(82)90045-4; Harrison FE, 2009, BEHAV BRAIN RES, V205, P550, DOI 10.1016/j.bbr.2009.08.017; HARVEY J, 1993, NEUROSCI LETT, V162, P165, DOI 10.1016/0304-3940(93)90586-A; HEARST E, 1959, J PHARMACOL EXP THER, V126, P349; Hogg RC, 2003, REV PHYSIOL BIOCH P, V147, P1, DOI 10.1007/s10254-003-0005-1; HULME EC, 1978, MOL PHARMACOL, V14, P737; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Jones S, 1999, TRENDS NEUROSCI, V22, P555, DOI 10.1016/S0166-2236(99)01471-X; JONES SVP, 1993, LIFE SCI, V52, P457, DOI 10.1016/0024-3205(93)90302-J; Kamsler A, 2010, P NATL ACAD SCI USA, V107, P1618, DOI 10.1073/pnas.0912540107; Kang SU, 2008, J PROTEOME RES, V7, P3498, DOI 10.1021/pr800236u; Kenney JW, 2008, MOL NEUROBIOL, V38, P101, DOI 10.1007/s12035-008-8037-9; Kimura Y, 1999, BRAIN RES, V834, P6, DOI 10.1016/S0006-8993(99)01526-7; Klinkenberg I, 2011, PSYCHOPHARMACOLOGY, V215, P549, DOI 10.1007/s00213-011-2171-1; Soares JCK, 2006, NEUROBIOL LEARN MEM, V86, P188, DOI 10.1016/j.nlm.2006.02.006; Le Novere N, 2002, P NATL ACAD SCI USA, V99, P3210, DOI 10.1073/pnas.042699699; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Lena C, 1998, J PHYSIOL-PARIS, V92, P63, DOI 10.1016/S0928-4257(98)80140-X; LEVEY AI, 1991, J NEUROSCI, V11, P3218; Li HB, 1996, BRAIN RES, V725, P268, DOI 10.1016/0006-8993(96)00404-0; Lieben CKJ, 2005, NEUROPSYCHOPHARMACOL, V30, P2169, DOI 10.1038/sj.npp.1300777; Liu LW, 2006, J NEUROSCI, V26, P11588, DOI 10.1523/JNEUROSCI.2102-06.2006; Loiseau F, 2008, PSYCHOPHARMACOLOGY, V196, P93, DOI 10.1007/s00213-007-0934-5; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; Marino MJ, 1998, P NATL ACAD SCI USA, V95, P11465, DOI 10.1073/pnas.95.19.11465; MARKS MJ, 1982, MOL PHARMACOL, V22, P554; McGehee DS, 1999, ANN NY ACAD SCI, V868, P565, DOI 10.1111/j.1749-6632.1999.tb11330.x; MESSER WS, 1987, BRAIN RES, V407, P37, DOI 10.1016/0006-8993(87)91217-0; MRZLJAK L, 1993, P NATL ACAD SCI USA, V90, P5194, DOI 10.1073/pnas.90.11.5194; Ohno M, 1996, EUR J PHARMACOL, V318, P267, DOI 10.1016/S0014-2999(96)00907-7; Ovsepian SV, 2004, EUR J NEUROSCI, V20, P1267, DOI 10.1111/j.1460-9568.2004.03582.x; Park SJ, 2010, FOOD CHEM TOXICOL, V48, P1671, DOI 10.1016/j.fct.2010.03.042; Patil SS, 2009, BEHAV BRAIN RES, V198, P58, DOI 10.1016/j.bbr.2008.10.029; PERALTA EG, 1987, EMBO J, V6, P3923, DOI 10.1002/j.1460-2075.1987.tb02733.x; Perry DC, 2002, J NEUROCHEM, V82, P468, DOI 10.1046/j.1471-4159.2002.00951.x; Renner UD, 2005, THER DRUG MONIT, V27, P655, DOI 10.1097/01.ftd.0000168293.48226.57; RIEKKINEN P, 1990, BEHAV NEURAL BIOL, V54, P204, DOI 10.1016/0163-1047(90)91436-F; Robinson L, 2004, BEHAV BRAIN RES, V151, P277, DOI 10.1016/j.bbr.2003.09.001; Rogers DC, 1999, BEHAV BRAIN RES, V105, P207, DOI 10.1016/S0166-4328(99)00072-8; Roldan G, 1997, NEUROSCI LETT, V230, P93, DOI 10.1016/S0304-3940(97)00489-8; Rush R, 2002, MOL PHARMACOL, V61, P1416, DOI 10.1124/mol.61.6.1416; Salminen O, 2004, MOL PHARMACOL, V65, P1526, DOI 10.1124/mol.65.6.1526; Salminen O, 2007, MOL PHARMACOL, V71, P1563, DOI 10.1124/mol.106.031492; Sase A, 2011, AMINO ACIDS IN PRESS, DOI [10.1007/s00726-00011-01130-00729, DOI 10.1007/S00726-00011-01130-00729]; Saucier D, 1996, BEHAV NEUROSCI, V110, P103, DOI 10.1037/0735-7044.110.1.103; SCHMELLER T, 1995, PHARMAZIE, V50, P493; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; Thouvarecq R, 2007, PHYSIOL BEHAV, V90, P155, DOI 10.1016/j.physbeh.2006.09.024; Thouvarecq R, 2001, BEHAV BRAIN RES, V118, P209, DOI 10.1016/S0166-4328(00)00330-2; Vaisman N, 2009, PROG NEURO-PSYCHOPH, V33, P952, DOI 10.1016/j.pnpbp.2009.04.021; Volpicelli LA, 2004, PROG BRAIN RES, V145, P59, DOI 10.1016/S0079-6123(03)45003-6; WATTS J, 1981, PHYSIOL BEHAV, V26, P845, DOI 10.1016/0031-9384(81)90108-6; WEI J, 1994, J NEUROCHEM, V63, P815; WEINER DM, 1990, P NATL ACAD SCI USA, V87, P7050, DOI 10.1073/pnas.87.18.7050; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Wezenberg E, 2005, PSYCHOPHARMACOLOGY, V181, P582, DOI 10.1007/s00213-005-0083-7; Whiteaker P, 1999, EUR J NEUROSCI, V11, P2689, DOI 10.1046/j.1460-9568.1999.00685.x; WIENER NI, 1973, BEHAV BIOL, V9, P227, DOI 10.1016/S0091-6773(73)80157-9; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4; Zheng JF, 2009, J PROTEOME RES, V8, P4479, DOI 10.1021/pr9002596	90	69	70	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32082	10.1371/journal.pone.0032082	http://dx.doi.org/10.1371/journal.pone.0032082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384146	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100050
J	Semplice, M; Veglio, A; Naldi, G; Serini, G; Gamba, A				Semplice, Matteo; Veglio, Andrea; Naldi, Giovanni; Serini, Guido; Gamba, Andrea			A Bistable Model of Cell Polarity	PLOS ONE			English	Article							MITOTIC SPINDLE ORIENTATION; TUMOR-SUPPRESSOR PTEN; DICTYOSTELIUM CELLS; PLASMA-MEMBRANE; EPITHELIAL MORPHOGENESIS; SIGNAL-TRANSDUCTION; ACTIN CYTOSKELETON; POSITIVE FEEDBACK; RAS; CHEMOTAXIS	Ultrasensitivity, as described by Goldbeter and Koshland, has been considered for a long time as a way to realize bistable switches in biological systems. It is not as well recognized that when ultrasensitivity and reinforcing feedback loops are present in a spatially distributed system such as the cell plasmamembrane, they may induce bistability and spatial separation of the system into distinct signaling phases. Here we suggest that bistability of ultrasensitive signaling pathways in a diffusive environment provides a basic mechanism to realize cell membrane polarity. Cell membrane polarization is a fundamental process implicated in several basic biological phenomena, such as differentiation, proliferation, migration and morphogenesis of unicellular and multicellular organisms. We describe a simple, solvable model of cell membrane polarization based on the coupling of membrane diffusion with bistable enzymatic dynamics. The model can reproduce a broad range of symmetry-breaking events, such as those observed in eukaryotic directional sensing, the apico-basal polarization of epithelium cells, the polarization of budding and mating yeast, and the formation of Ras nanoclusters in several cell types.	[Semplice, Matteo] Univ Insubria, Dept Math & Phys, Como, Italy; [Veglio, Andrea] Inst Pasteur, Genomes & Genet Dept, Unit Phys Biol Syst, Paris, France; [Naldi, Giovanni] Univ Milan, Dept Math F Enriques, Milan, Italy; [Serini, Guido] Univ Turin, Sch Med, Inst Canc Res & Treatment, Lab Cell Adhes Dynam, Candiolo, Italy; [Serini, Guido] Univ Turin, Sch Med, Dept Oncol Sci, Candiolo, Italy; [Gamba, Andrea] Politecn Torino, Dept Math, I-10128 Turin, Italy; [Gamba, Andrea] Inst Canc Res & Treatment, Lab Syst Biol, Candiolo, Italy; [Gamba, Andrea] Ist Nazl Fis Nucl, I-10125 Turin, Italy	University of Insubria; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Milan; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; University of Turin; Polytechnic University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; Istituto Nazionale di Fisica Nucleare (INFN)	Semplice, M (corresponding author), Univ Insubria, Dept Math & Phys, Como, Italy.	giovanni.naldi@unimi.it	GAMBA, ANDREA ANTONIO/B-9097-2008; GAMBA, ANDREA ANTONIO/AAJ-3203-2021; Serini, Guido/AAF-2873-2021; Naldi, Giovanni/F-2935-2012	GAMBA, ANDREA ANTONIO/0000-0002-2591-2722; GAMBA, ANDREA ANTONIO/0000-0002-2591-2722; Serini, Guido/0000-0002-3502-8367; Naldi, Giovanni/0000-0001-9191-6003	Italian government; AIRC; FPRC; MIUR (Italy)	Italian government; AIRC(Fondazione AIRC per la ricerca sul cancro); FPRC; MIUR (Italy)(Ministry of Education, Universities and Research (MIUR))	This work was partially supported for GN and MS by the Italian government funding program PRIN "Advanced Numerical Methods for Partial Differential Equations"; this work was supported by AIRC to AG and GS; AG acknowledges financial support from FPRC and MIUR 5x1000 (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Arai Y, 2010, P NATL ACAD SCI USA, V107, P12399, DOI 10.1073/pnas.0908278107; Bahler J, 2000, FR MOLEC B, V28, P21; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Beta C, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/8/083015; BRAY AJ, 1994, ADV PHYS, V43, P357, DOI 10.1080/00018739400101505; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Calvez V, 2010, CR MATH, V348, P629, DOI 10.1016/j.crma.2010.04.009; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Carracedo A, 2011, CANCER RES, V71, P629, DOI 10.1158/0008-5472.CAN-10-2488; Ciliberto A, 2007, PLOS COMPUT BIOL, V3, P463, DOI 10.1371/journal.pcbi.0030045; Clarke B. L., 1980, ADV CHEM PHYS, V43, P1; Comer FI, 2007, CELL, V128, P239, DOI 10.1016/j.cell.2007.01.010; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; Das J, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3149861; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Datta A, 2011, CURR BIOL, V21, pR126, DOI 10.1016/j.cub.2010.12.003; de Candia Antonio, 2007, Sci STKE, V2007, ppl1, DOI 10.1126/stke.3782007pl1; Desai R. C., 2009, DYNAMICS SELF ORG SE; Evans LC, 1996, PARTIAL DIFFERENTIAL; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Flanders H., 1989, DIFFERENTIAL FORMS A; Freedman TS, 2006, P NATL ACAD SCI USA, V103, P16692, DOI 10.1073/pnas.0608127103; Gamba A, 2005, P NATL ACAD SCI USA, V102, P16927, DOI 10.1073/pnas.0503974102; Gamba A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.158101; Gamba A, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/02/P02019; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goehring NW, 2011, SCIENCE; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Gurry T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006148; Hairer E, 2010, SOLVING ORDINARY DIF, VII; Hawkins RJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.040903; Hecht I, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.158301; Iglesias PA, 2007, CURR OPIN CELL BIOL, V20, P1; Iijima M, 2004, J BIOL CHEM, V279, P16606, DOI 10.1074/jbc.M312098200; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Janetopoulos C, 2004, P NATL ACAD SCI USA, V101, P8951, DOI 10.1073/pnas.0402152101; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Kortholt A, 2008, CELL SIGNAL, V20, P1415, DOI 10.1016/j.cellsig.2008.02.006; Kriebel PW, 2003, CELL, V112, P549, DOI 10.1016/S0092-8674(03)00081-3; Krishnan J, 2004, J THEOR BIOL, V229, P85, DOI 10.1016/j.jtbi.2004.03.005; Landau L.D., 1980, COURSE THEORETICAL P, V5; LIFSHITZ IM, 1961, J PHYS CHEM SOLIDS, V19, P35, DOI 10.1016/0022-3697(61)90054-3; Ma L, 2004, BIOPHYS J, V87, P3764, DOI 10.1529/biophysj.104.045484; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Meier-Schellersheim M, 2006, PLOS COMPUT BIOL, V2, P710, DOI 10.1371/journal.pcbi.0020082; Meili R, 2002, NAT CELL BIOL, V4, pE171, DOI 10.1038/ncb0702-e171; Mori Y, 2008, BIOPHYS J, V94, P3684, DOI [10.1529/biophysj.107.120824, 10.1529/biophysj.107.120827]; Onsum M, 2007, PLOS COMPUT BIOL, V3, P436, DOI 10.1371/journal.pcbi.0030036; Otsuji M, 2007, PLOS COMPUT BIOL, V3, P1040, DOI 10.1371/journal.pcbi.0030108; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Postma M, 2003, MOL BIOL CELL, V14, P5019, DOI 10.1091/mbc.E03-08-0566; Postma M, 2004, J CELL SCI, V117, P2925, DOI 10.1242/jcs.01143; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Rotblat B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011991; Scholl E, 2000, LECT NOTE PHYS, V557; Skupsky R, 2005, BIOPHYS J, V89, P2806, DOI 10.1529/biophysj.105.061564; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Veglio A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031919; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wedlich-Soldner R, 2003, NAT CELL BIOL, V5, P267, DOI 10.1038/ncb0403-267; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Wilhelm T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-90; Yap AS, 2003, J CELL BIOL, V160, P11, DOI 10.1083/jcb.200208156; Yoshida S, 2008, EMBO REP, V9, P39, DOI 10.1038/sj.embor.7401142; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021	76	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e30977	10.1371/journal.pone.0030977	http://dx.doi.org/10.1371/journal.pone.0030977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383986	gold, Green Published, Green Submitted			2022-12-27	WOS:000302916100012
J	Christensen, B; Lundby, C; Jessen, N; Nielsen, TS; Vestergaard, PF; Moller, N; Pilegaard, H; Pedersen, SB; Kopchick, JJ; Jorgensen, JOL				Christensen, Britt; Lundby, Carsten; Jessen, Niels; Nielsen, Thomas S.; Vestergaard, Poul F.; Moller, Niels; Pilegaard, Henriette; Pedersen, Steen B.; Kopchick, John J.; Jorgensen, Jens Otto L.			Evaluation of Functional Erythropoietin Receptor Status in Skeletal Muscle In Vivo: Acute and Prolonged Studies in Healthy Human Subjects	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; KINASE LYN; ACTIVATION; PHOSPHORYLATION; EXPRESSION; DIFFERENTIATION; PROLIFERATION; ANTIBODIES; TISSUE	Background: Erythropoietin receptors have been identified in human skeletal muscle tissue, but downstream signal transduction has not been investigated. We therefore studied in vivo effects of systemic erythropoietin exposure in human skeletal muscle. Methodology/Principal Findings: The protocols involved 1) acute effects of a single bolus injection of erythropoietin followed by consecutive muscle biopsies for 1-10 hours, and 2) a separate study with prolonged administration for 16 days with biopsies obtained before and after. The presence of erythropoietin receptors in muscle tissue as well as activation of Epo signalling pathways (STAT5, MAPK, Akt, IKK) were analysed by western blotting. Changes in muscle protein profiles after prolonged erythropoietin treatment were evaluated by 2D gel-electrophoresis and mass spectrometry. The presence of the erythropoietin receptor in skeletal muscle was confirmed, by the M20 but not the C20 antibody. However, no significant changes in phosphorylation of the Epo-R, STAT5, MAPK, Akt, Lyn, IKK, and p70S6K after erythropoietin administration were detected. The level of 8 protein spots were significantly altered after 16 days of rHuEpo treatment; one isoform of myosin light chain 3 and one of desmin/actin were decreased, while three isoforms of creatine kinase and two of glyceraldehyd-3-phosphate dehydrogenase were increased. Conclusions/Significance: Acute exposure to recombinant human erythropoietin is not associated by detectable activation of the Epo-R or downstream signalling targets in human skeletal muscle in the resting situation, whereas more prolonged exposure induces significant changes in the skeletal muscle proteome. The absence of functional Epo receptor activity in human skeletal muscle indicates that the long-term effects are indirect and probably related to an increased oxidative capacity in this tissue.	[Christensen, Britt; Vestergaard, Poul F.; Moller, Niels; Pedersen, Steen B.; Jorgensen, Jens Otto L.] Aarhus Univ Hosp, NBG THG, Dept Endocrinol & Internal Med, DK-8000 Aarhus, Denmark; [Lundby, Carsten] Univ Zurich, Inst Physiol, Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Jessen, Niels] Aarhus Univ Hosp, Dept Clin Pharmacol, DK-8000 Aarhus, Denmark; [Kopchick, John J.] Ohio Univ, Dept Biomed Sci, Edison Biotechnol Inst, Athens, OH 45701 USA; [Christensen, Britt; Jessen, Niels; Nielsen, Thomas S.; Vestergaard, Poul F.; Moller, Niels] Univ Aarhus, Med Res Labs, Aarhus, Denmark; [Pilegaard, Henriette] Univ Copenhagen, Dept Biol, Ctr Inflammat & Metab, Copenhagen, Denmark; [Pilegaard, Henriette] Univ Copenhagen, Dept Biol, Copenhagen Muscle Res Ctr, Copenhagen, Denmark	Aarhus University; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Aarhus University; University System of Ohio; Ohio University; Aarhus University; University of Copenhagen; University of Copenhagen	Christensen, B (corresponding author), Aarhus Univ Hosp, NBG THG, Dept Endocrinol & Internal Med, DK-8000 Aarhus, Denmark.	britt.christensen@ki.au.dk	Pilegaard, Henriette/M-2315-2014; Pedersen, Steen B./AAB-3331-2019; Jorgensen, Jens Otto Lunde/O-8003-2019; Moller, Niels/E-5091-2011; Jessen, Niels/E-1731-2011	Pilegaard, Henriette/0000-0002-1071-0327; Pedersen, Steen B./0000-0002-7838-8063; Moller, Niels/0000-0001-5627-7322; Jorgensen, Jens Otto Lunde/0000-0001-7408-1526; Jessen, Niels/0000-0001-5613-7274; Nielsen, Thomas Svava/0000-0002-9457-8000	Danish Council of Independent Research in Medical Sciences, Denmark [271-08-0647]	Danish Council of Independent Research in Medical Sciences, Denmark	This study was supported by The Danish Council of Independent Research in Medical Sciences (271-08-0647), Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bittorf T, 2001, CELL SIGNAL, V13, P673, DOI 10.1016/S0898-6568(01)00189-9; Boudot C, 2003, BIOCHEM BIOPH RES CO, V300, P437, DOI 10.1016/S0006-291X(02)02866-8; Cayla JL, 2008, INT J SPORTS MED, V29, P460, DOI 10.1055/s-2007-965359; Chin H, 1998, BLOOD, V91, P3734; Chong Zhao Zhong, 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P141, DOI 10.2174/1568006033481483; Christensen B, 2011, J APPL PHYSIOL, V110, P149, DOI 10.1152/japplphysiol.00665.2010; Constantinescu SN, 1999, TRENDS ENDOCRIN MET, V10, P18, DOI 10.1016/S1043-2760(98)00101-5; Elliott S, 2006, BLOOD, V107, P1892, DOI 10.1182/blood-2005-10-4066; Erbayraktar Serhat, 2003, Curr Hematol Rep, V2, P465; Feng QP, 2006, CARDIOVASC RES, V71, P615, DOI 10.1016/j.cardiores.2006.07.001; Fisher JW, 2003, EXP BIOL MED, V228, P1; Hagstrom L, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/137817; Hojman P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005894; Jegalian AG, 2002, J INTERF CYTOK RES, V22, P853, DOI 10.1089/107999002760274863; Jelkmann W, 2004, INTERNAL MED, V43, P649, DOI 10.2169/internalmedicine.43.649; Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x; Jorgensen JOL, 2006, AM J PHYSIOL-ENDOC M, V291, pE899, DOI 10.1152/ajpendo.00024.2006; Juel C, 2007, EUR J APPL PHYSIOL, V102, P41, DOI 10.1007/s00421-007-0567-8; Kirkeby A, 2007, J NEUROSCI METH, V164, P50, DOI 10.1016/j.jneumeth.2007.03.026; Lappin TR, 2002, STEM CELLS, V20, P485, DOI 10.1634/stemcells.20-6-485; Launay T, 2010, CELL PROLIFERAT, V43, P1, DOI 10.1111/j.1365-2184.2009.00648.x; LeBaron MJ, 2007, ENDOCRINOLOGY, V148, P989, DOI 10.1210/en.2006-1219; Lundby C, 2008, J APPL PHYSIOL, V104, P1154, DOI 10.1152/japplphysiol.01211.2007; Lundby C, 2011, J PHYSIOL-LONDON, V589, P1265, DOI 10.1113/jphysiol.2010.195917; Marzo F, 2008, J THROMB THROMBOLYS, V26, P183, DOI 10.1007/s11239-008-0212-3; Ogilvie M, 2000, J BIOL CHEM, V275, P39754, DOI 10.1074/jbc.M004999200; Okumura N, 2005, PROTEOMICS, V5, P2896, DOI 10.1002/pmic.200401181; Ramakrishnan R, 2004, J CLIN PHARMACOL, V44, P991, DOI 10.1177/0091270004268411; REN CL, 1994, J EXP MED, V179, P673, DOI 10.1084/jem.179.2.673; Rotter R, 2008, J ORTHOP RES, V26, P1618, DOI 10.1002/jor.20692; Rundqvist H, 2009, EUR J ENDOCRINOL, V161, P427, DOI 10.1530/EJE-09-0342; Schmidt EK, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-7; Shi ZZ, 2010, MOL CANCER RES, V8, P615, DOI 10.1158/1541-7786.MCR-09-0264; STARON RS, 1993, COMP BIOCHEM PHYS B, V106, P463, DOI 10.1016/0305-0491(93)90120-T; Tilbrook PA, 2001, ARCH BIOCHEM BIOPHYS, V396, P128, DOI 10.1006/abbi.2001.2577; Tilbrook PA, 1999, INT J BIOCHEM CELL B, V31, P1001, DOI 10.1016/S1357-2725(99)00071-0; Wright GL, 2004, FASEB J, V18, P1031, DOI 10.1096/fj.03-1289fje	37	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31857	10.1371/journal.pone.0031857	http://dx.doi.org/10.1371/journal.pone.0031857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384088	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000302875500049
J	Castro, LFC; Monroig, O; Leaver, MJ; Wilson, J; Cunha, I; Tocher, DR				Costa Castro, Luis Filipe; Monroig, Oscar; Leaver, Michael J.; Wilson, Jonathan; Cunha, Isabel; Tocher, Douglas R.			Functional Desaturase Fads1 (Delta 5) and Fads2 (Delta 6) Orthologues Evolved before the Origin of Jawed Vertebrates	PLOS ONE			English	Article							FATTY-ACID DESATURASE; ALPHA-LINOLENIC ACID; TELEOST FISH; CAENORHABDITIS-ELEGANS; ACYL DESATURASES; ATLANTIC SALMON; MARINE FISH; FRESH-WATER; EVOLUTION; METABOLISM	Long-chain polyunsaturated fatty acids (LC-PUFAs) such as arachidonic (ARA), eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids are essential components of biomembranes, particularly in neural tissues. Endogenous synthesis of ARA, EPA and DHA occurs from precursor dietary essential fatty acids such as linoleic and alpha-linolenic acid through elongation and Delta 5 and Delta 6 desaturations. With respect to desaturation activities some noteworthy differences have been noted in vertebrate classes. In mammals, the Delta 5 activity is allocated to the Fads1 gene, while Fads2 is a Delta 6 desaturase. In contrast, teleosts show distinct combinations of desaturase activities (e.g. bifunctional or separate Delta 5 and Delta 6 desaturases) apparently allocated to Fads2-type genes. To determine the timing of Fads1-Delta 5 and Fads2-Delta 6 evolution in vertebrates we used a combination of comparative and functional genomics with the analysis of key phylogenetic species. Our data show that Fads1 and Fads2 genes with Delta 5 and Delta 6 activities respectively, evolved before gnathostome radiation, since the catshark Scyliorhinus canicula has functional orthologues of both gene families. Consequently, the loss of Fads1 in teleosts is a secondary episode, while the existence of D5 activities in the same group most likely occurred through independent mutations into Fads2 type genes. Unexpectedly, we also establish that events of Fads1 gene expansion have taken place in birds and reptiles. Finally, a fourth Fads gene (Fads4) was found with an exclusive occurrence in mammalian genomes. Our findings enlighten the history of a crucially important gene family in vertebrate fatty acid metabolism and physiology and provide an explanation of how observed lineage-specific gene duplications, losses and diversifications might be linked to habitat-specific food web structures in different environments and over geological timescales.	[Costa Castro, Luis Filipe; Wilson, Jonathan; Cunha, Isabel] Univ Porto, CIMAR Associate Lab, CIIMAR Interdisciplinary Ctr Marine & Environm Re, P-4100 Oporto, Portugal; [Monroig, Oscar] CSIC, IATS, Castellon de La Plana, Spain; [Leaver, Michael J.; Tocher, Douglas R.] Univ Stirling, Inst Aquaculture, Sch Nat Sci, Stirling FK9 4LA, Scotland	Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); University of Stirling	Castro, LFC (corresponding author), Univ Porto, CIMAR Associate Lab, CIIMAR Interdisciplinary Ctr Marine & Environm Re, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	filipe.castro@ciimar.up.pt	Castro, Filipe/AAA-2197-2022; Tocher, Douglas R/C-5652-2011; Wilson, Jonathan/I-6071-2012; Monroig, Oscar/K-9117-2014; Wilson, Jonathan Mark/AAG-6481-2019; Leaver, Michael/B-5518-2012	Castro, Filipe/0000-0001-7697-386X; Tocher, Douglas R/0000-0002-8603-9410; Wilson, Jonathan/0000-0003-3681-1166; Monroig, Oscar/0000-0001-8712-0440; Wilson, Jonathan Mark/0000-0003-3681-1166; Leaver, Michael/0000-0002-3155-0844; Cunha, Isabel/0000-0002-6149-9840	Fundacao para a Ciencia e a Tecnologia; European Community [PERG08-GA-2010-276916]; Ministerio de Ciencia e Innovacion, Spanish Government;  [PTDC/MAR/68885/2006]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Community(European Commission); Ministerio de Ciencia e Innovacion, Spanish Government(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); 	This research was financed by the Fundacao para a Ciencia e a Tecnologia Plurianual Program and partially by the Project PTDC/MAR/68885/2006. OM was supported by a Marie Curie Reintegration Grant within the 7th European Community Framework Programme (PERG08-GA-2010-276916, LONGFA) and a Juan de la Cierva postdoctoral contract from the Ministerio de Ciencia e Innovacion, Spanish Government. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Agaba M, 2004, MAR BIOTECHNOL, V6, P251, DOI 10.1007/s10126-003-0029-1; Alonso DL, 2003, BIOCHEM SYST ECOL, V31, P1111, DOI 10.1016/S0305-1978(03)00041-3; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Blanchard H, 2011, BIOCHIMIE, V93, P87, DOI 10.1016/j.biochi.2010.03.002; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; Castro LFC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-132; Cook HW, BIOCH LIPIDS LIPOPRO, P181; Evans H, 2008, PHYSIOL GENOMICS, V35, P18, DOI 10.1152/physiolgenomics.90266.2008; GILLAN FT, 1984, PHYTOCHEMISTRY, V23, P2817, DOI 10.1016/0031-9422(84)83021-6; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hastings N, 2004, MAR BIOTECHNOL, V6, P463, DOI 10.1007/s10126-004-3002-8; Hastings N, 2001, P NATL ACAD SCI USA, V98, P14304, DOI 10.1073/pnas.251516598; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Knoll HA, 2007, EVOLUTION PRIMARY PR; Leaver MJ, 2008, REV FISH SCI, V16, P73, DOI 10.1080/10641260802325278; Li YY, 2010, P NATL ACAD SCI USA, V107, P16840, DOI 10.1073/pnas.1008429107; Marquardt A, 2000, GENOMICS, V66, P175, DOI 10.1006/geno.2000.6196; Michaelson LV, 1998, FEBS LETT, V439, P215, DOI 10.1016/S0014-5793(98)01385-4; Monroig O, 2011, COMP BIOCHEM PHYS B, V159, P206, DOI 10.1016/j.cbpb.2011.04.007; Napier JA, 1998, BIOCHEM J, V330, P611; Park WJ, 2009, J LIPID RES, V50, P1195, DOI 10.1194/jlr.M800630-JLR200; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; RIVERS JPW, 1975, NATURE, V258, P171, DOI 10.1038/258171a0; Sargent J.R., 1995, Journal of Marine Biotechnology, V3, P26; Sargent JR, 1989, FISH NUTR, Vsecond, P153; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; SINCLAIR AJ, 1981, BRIT J NUTR, V46, P93, DOI 10.1079/BJN19810012; SINCLAIR AJ, 1979, LIPIDS, V14, P932, DOI 10.1007/BF02533508; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Tocher DR, 2006, LIPIDS, V41, P1003, DOI 10.1007/s11745-006-5051-4; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Vanhercke T, 2011, J BIOL CHEM, V286, P12860, DOI 10.1074/jbc.M110.191098; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Zheng X, 2004, COMP BIOCHEM PHYS B, V139, P269, DOI 10.1016/j.cbpc.2004.08.003; Zheng XZ, 2009, AQUACULTURE, V290, P122, DOI 10.1016/j.aquaculture.2009.02.010; Zheng XZ, 2005, LIPIDS, V40, P13, DOI 10.1007/s11745-005-1355-7	44	99	100	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31950	10.1371/journal.pone.0031950	http://dx.doi.org/10.1371/journal.pone.0031950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384110	gold, Green Published, Green Submitted			2022-12-27	WOS:000302875500056
J	Mohebbi, I; Saadat, S; Aghassi, M; Shekari, M; Matinkhah, M; Sehat, S				Mohebbi, Iraj; Saadat, Soheil; Aghassi, Mohammadreza; Shekari, Mahsa; Matinkhah, Maghsuod; Sehat, Shadi			Prevalence of Metabolic Syndrome in Iranian Professional Drivers: Results from a Population Based Study of 12,138 Men	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; RISK-FACTORS; WAIST CIRCUMFERENCE; CIGARETTE-SMOKING; UNITED-STATES; MORTALITY; HEALTH; IMPACT; EAST	Background: It is evident that professional driving is associated with substantial changes in lifestyle habits. Professional drivers are prone to metabolic syndrome (MetS) and its complications because their working environment is characterized by numerous stress factors such as lack of physical activity due to working in a fixed position, disruption in diet, and irregular sleep habits. The aim of the present study was to estimate the prevalence of MetS among long distance drivers residing in West Azerbaijan province in Iran. Materials: To assess the prevalence of metabolic syndrome among professional long distance drivers, 12138 participants were enrolled in this cross sectional study. The MetS was defined using International Diabetes Federation criteria. Results: Among 12138 participants, 3697 subjects found to be MetS. The crude and age-adjusted rates of MetS were 30.5% and 32.4% respectively. Based on Body mass index (BMI), 5027 subjects (41.4%) were overweight (BMI >= 25.01-30 kg/m2), and 2592 (21.3%) were obese (BMI >= 30.01 kg/m2). The presence of central obesity was more common than other components. The associations of MetS with BMI, pack-year smoking, age, weekly driving duration and driving experiences were significant in the logistic regression. By increasing BMI, pack-year smoking, age, weekly driving duration and driving experiences, odds ratio of MetS was increased. Conclusion: The study suggests that MetS has become a noteworthy health problem among Iranian long distance drivers. This might be due to the following facts: sitting in a fixed position for long hours while working, cigarette smoking, job stress, unhealthy diet and lack of physical activity. Educational programs should be established for promoting healthy lifestyle and also for early detection and appropriate interventions	[Mohebbi, Iraj; Shekari, Mahsa; Matinkhah, Maghsuod; Sehat, Shadi] Urmia Univ Med Sci, Occupat Med Ctr, Orumiyeh, Iran; [Saadat, Soheil] Med Sci Univ Tehran, Sina Hosp, Sina Trauma Res Ctr, Tehran, Iran; [Aghassi, Mohammadreza] Urmia Univ Med Sci, Dept Endocrinol, Orumiyeh, Iran	Urmia University of Medical Sciences; Tehran University of Medical Sciences; Urmia University of Medical Sciences	Mohebbi, I (corresponding author), Urmia Univ Med Sci, Occupat Med Ctr, Orumiyeh, Iran.	irajmohebbi@umsu.ac.ir	Brunner, Paul H/A-9690-2013; ONeill, Susan/B-1761-2010; De Robbio, Antonella/G-6496-2010; Mohebbi, Iraj/G-1494-2017; Saadat, Soheil/J-1595-2014	Brunner, Paul H/0000-0003-0091-8236; De Robbio, Antonella/0000-0001-6617-444X; Saadat, Soheil/0000-0002-2744-7983; Mohebbi, Iraj/0000-0001-9158-5742				Ahmad OB, 2001, WHO DISCUSSION PAPER; [Anonymous], INT DIAB FED IDF CON; Azizi F, 2003, DIABETES RES CLIN PR, V61, P29, DOI 10.1016/S0168-8227(03)00066-4; Bonora E, 2003, DIABETES CARE, V26, P1251, DOI 10.2337/diacare.26.4.1251; Borch-Johnsen K, 2007, DAN MED BULL, V54, P157; Branth S, 2007, NUTR METAB CARDIOVAS, V17, P427, DOI 10.1016/j.numecd.2006.03.001; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; Chen CC, 2008, METABOLISM, V57, P544, DOI 10.1016/j.metabol.2007.11.018; Dekker JM, 2005, CIRCULATION, V112, P666, DOI 10.1161/CIRCULATIONAHA.104.516948; Delavari A, 2009, DIABETES CARE, V32, P1092, DOI 10.2337/dc08-1800; Eapen D, 2009, VASC HEALTH RISK MAN, V5, P731; Eberly LE, 2006, DIABETES CARE, V29, P123, DOI 10.2337/diacare.29.01.06.dc05-1320; Emdad R, 1998, PSYCHOTHER PSYCHOSOM, V67, P226, DOI 10.1159/000012285; Enas Enas A, 2007, J Cardiometab Syndr, V2, P267, DOI 10.1111/j.1559-4564.2007.07392.x; Ford ES, 2004, ATHEROSCLEROSIS, V173, P309, DOI 10.1016/j.atherosclerosis.2003.12.022; FRENCH SA, 1994, INT J OBESITY, V18, P145; HARTVIG P, 1983, INT ARCH OCC ENV HEA, V52, P353, DOI 10.1007/BF02226900; Kompier M.A.J., 1996, BUS DRIVERS OCCUPATI; Kurosaka K, 2000, IND HEALTH, V38, P15, DOI 10.2486/indhealth.38.15; Lee WY, 2005, DIABETES RES CLIN PR, V67, P70, DOI 10.1016/j.diabres.2004.05.006; Lorenzo C, 2003, DIABETES CARE, V26, P3153, DOI 10.2337/diacare.26.11.3153; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Misra A, 2009, BRIT J NUTR, V101, P465, DOI 10.1017/S0007114508073649; Miyatake N, 2006, INTERNAL MED, V45, P1039, DOI 10.2169/internalmedicine.45.1850; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; MORRIS JN, 1953, LANCET, V265, P1053; MORRIS JN, 1953, LANCET, V265, P1111; Nakamura K, 1998, OCCUP MED-OXFORD, V48, P169, DOI 10.1093/occmed/48.3.169; Nestel P, 2007, ASIA PAC J CLIN NUTR, V16, P362; Saberi HR, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-8; Sharifi F, 2009, EXP DIABETES RES, DOI 10.1155/2009/136501; Wang PD, 2001, PUBLIC HEALTH, V115, P261, DOI 10.1016/S0033-3506(01)00456-5; Zabetian A, 2007, DIABETES RES CLIN PR, V77, P251, DOI 10.1016/j.diabres.2006.12.001	34	29	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31790	10.1371/journal.pone.0031790	http://dx.doi.org/10.1371/journal.pone.0031790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384075	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500041
J	Winder, VL; Emslie, SD				Winder, Virginia L.; Emslie, Steven D.			Mercury in Nelson's Sparrow Subspecies at Breeding Sites	PLOS ONE			English	Article							SWALLOWS TACHYCINETA-BICOLOR; NORTHEASTERN UNITED-STATES; SHARP-TAILED SPARROWS; SALT-MARSH SPARROWS; REPRODUCTIVE SUCCESS; EXPOSURE; PATTERNS; CAUDACUTUS; BLOOD	Background: Mercury is a persistent, biomagnifying contaminant that can cause negative effects on ecosystems. Marshes are often areas of relatively high mercury methylation and bioaccumulation. Nelson's Sparrows (Ammodramus nelsoni) use marsh habitats year-round and have been documented to exhibit tissue mercury concentrations that exceed negative effects thresholds. We sought to further characterize the potential risk of Nelson's Sparrows to mercury exposure by sampling individuals from sites within the range of each of its subspecies. Methodology/Principal Findings: From 2009 to 2011, we captured adult Nelson's Sparrows at sites within the breeding range of each subspecies (A. n. nelsoni: Grand Forks and Upham, North Dakota; A. n. alterus: Moosonee, Ontario; and A. n. subvirgatus: Grand Manan Island, New Brunswick) and sampled breast feathers, the first primary feather (P1), and blood for total mercury analysis. Mean blood mercury in nelsoni individuals captured near Grand Forks ranged from 0.84 +/- 0.37 to 1.65 +/- 1.02 SD ppm among years, between 2.0 and 4.9 times as high as concentrations at the other sites (P<0.01). Breast feather mercury did not vary among sites within a given sampling year (site means ranged from 0.98 +/- 0.69 to 2.71 +/- 2.93 ppm). Mean P1 mercury in alterus (2.96 +/- 1.84 ppm fw) was significantly lower than in any other sampled population (5.25 +/- 2.24-6.77 +/- 3.51 ppm; P <= 0.03). Conclusions/Significance: Our study further characterized mercury in Nelson's Sparrows near Grand Forks; we documented localized and potentially harmful mercury concentrations, indicating that this area may represent a biological mercury hotspot. This finding warrants further research to determine if wildlife populations of conservation or recreational interest in this area may be experiencing negative effects due to mercury exposure. We present preliminary conclusions about the risk of each sampled population to mercury exposure.	[Winder, Virginia L.; Emslie, Steven D.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA	University of North Carolina; University of North Carolina Wilmington	Winder, VL (corresponding author), Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA.	vlw3056@uncw.edu			National Oceanic and Atmospheric Administration (NOAA); Ralph Brauer Fellowship, Sigma Xi; Eastern Bird Banding Association; North Carolina SeaGrant; James and Francis Parnell Fellowship; Department of Biology and Marine Biology at the University of North Carolina Wilmington	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); Ralph Brauer Fellowship, Sigma Xi; Eastern Bird Banding Association; North Carolina SeaGrant; James and Francis Parnell Fellowship; Department of Biology and Marine Biology at the University of North Carolina Wilmington	Funding and support for this project were provided by National Oceanic and Atmospheric Administration (NOAA) through a National Estuary Research Reserve System Graduate Research Fellowship (http://www.nerrs.noaa.gov/), Ralph Brauer Fellowship, Sigma Xi Grants in Aid of Research (http://www.sigmaxi.org/), Eastern Bird Banding Association (http://www.frontiernet.net/similar to bpbird/index.htm), North Carolina SeaGrant (http://www.ncseagrant.org/), the James and Francis Parnell Fellowship, and the Department of Biology and Marine Biology at the University of North Carolina Wilmington (http://www.uncw.edu/bio/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayard TS, 2011, AUK, V128, P393, DOI 10.1525/auk.2011.10178; Bearhop S, 2000, ENVIRON TOXICOL CHEM, V19, P1638, DOI [10.1002/etc.5620190622, 10.1897/1551-5028(2000)019&lt;1638:DOMIBA&gt;2.3.CO;2]; Bechard MJ, 2009, B ENVIRON CONTAM TOX, V83, P698, DOI 10.1007/s00128-009-9848-8; Bodaly RA, 2004, ENVIRON SCI TECHNOL, V38, p346A, DOI 10.1021/es040614u; Brasso RL, 2008, ECOTOXICOLOGY, V17, P133, DOI 10.1007/s10646-007-0163-z; Brigham ME, 2002, WATER AIR SOIL POLL, V138, P61, DOI 10.1023/A:1015573621474; Burger J, 1996, AUK, V113, P339; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Cristol DA, 2008, SCIENCE, V320, P335, DOI 10.1126/science.1154082; Cristol DA, 2011, ECOTOXICOLOGY, V20, P1773, DOI 10.1007/s10646-011-0710-5; Custer TW, 2008, ENVIRON POLLUT, V155, P217, DOI 10.1016/j.envpol.2007.12.003; Driscoll CT, 2007, BIOSCIENCE, V57, P17, DOI 10.1641/B570106; Evers DC, 2008, ECOTOXICOLOGY, V17, P69, DOI 10.1007/s10646-007-0168-7; Evers DC, 2007, BIOSCIENCE, V57, P29, DOI 10.1641/B570107; Evers DC, 2011, ECOTOXICOLOGY, V20, P1487, DOI 10.1007/s10646-011-0784-0; Evers DC, 2005, ECOTOXICOLOGY, V14, P193, DOI 10.1007/s10646-004-6269-7; Evers DC, 2004, ASSESSING IMPACTS ME, P69; Greenlaw JS, 2007, WILSON J ORNITHOL, V119, P361, DOI 10.1676/05-152.1; Jackson AK, 2011, AUK, V128, P759, DOI 10.1525/auk.2011.11106; Kahle S, 1999, CHEMOSPHERE, V39, P2451, DOI 10.1016/S0045-6535(99)00154-X; Lane OP, 2011, ECOTOXICOLOGY, V20, P1984, DOI 10.1007/s10646-011-0740-z; Lane OP, 2006, METHYLMERCURY AVAILA, P27; Marvin-DiPasquale MC, 2003, ENVIRON GEOL, V43, P260, DOI 10.1007/s00254-002-0623-y; RICH TD, 2004, PARTNERS FLIGHT N AM; Sando SK, 2007, 20075219 US GEOL SUR, P66; Shriver W. Gregory, 2006, Environmental Bioindicators, V1, P129, DOI 10.1080/15555270600695734; Snodgrass JW, 2000, CAN J FISH AQUAT SCI, V57, P171, DOI 10.1139/cjfas-57-1-171; U.S. EPA, 2007, 7473 US EPA; *US FISH WILDL SER, 2002, BIRDS CONS CONC 2002; WILLIAMS TP, 1994, MAR POLLUT BULL, V28, P277, DOI 10.1016/0025-326X(94)90152-X; Winder VL, 2011, ECOTOXICOLOGY, V20, P218, DOI 10.1007/s10646-010-0573-1; Winder VL, 2011, ECOTOXICOLO IN PRESS; WOLFE MF, 2003, ECOSYSTEM RESPONSES, P123	33	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32257	10.1371/journal.pone.0032257	http://dx.doi.org/10.1371/journal.pone.0032257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384194	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500090
J	De la Fuente, IM; Cortes, JM				De la Fuente, Ildefonso M.; Cortes, Jesus M.			Quantitative Analysis of the Effective Functional Structure in Yeast Glycolysis	PLOS ONE			English	Article							CHAOS; INFORMATION; OSCILLATIONS; ORGANIZATION; SUBSTRATE; PATHWAYS; DYNAMICS; EXTRACTS; ROUTE; MODEL	The understanding of the effective functionality that governs the enzymatic self-organized processes in cellular conditions is a crucial topic in the post-genomic era. In recent studies, Transfer Entropy has been proposed as a rigorous, robust and self-consistent method for the causal quantification of the functional information flow among nonlinear processes. Here, in order to quantify the functional connectivity for the glycolytic enzymes in dissipative conditions we have analyzed different catalytic patterns using the technique of Transfer Entropy. The data were obtained by means of a yeast glycolytic model formed by three delay differential equations where the enzymatic rate equations of the irreversible stages have been explicitly considered. These enzymatic activity functions were previously modeled and tested experimentally by other different groups. The results show the emergence of a new kind of dynamical functional structure, characterized by changing connectivity flows and a metabolic invariant that constrains the activity of the irreversible enzymes. In addition to the classical topological structure characterized by the specific location of enzymes, substrates, products and feedback-regulatory metabolites, an effective functional structure emerges in the modeled glycolytic system, which is dynamical and characterized by notable variations of the functional interactions. The dynamical structure also exhibits a metabolic invariant which constrains the functional attributes of the enzymes. Finally, in accordance with the classical biochemical studies, our numerical analysis reveals in a quantitative manner that the enzyme phosphofructokinase is the key-core of the metabolic system, behaving for all conditions as the main source of the effective causal flows in yeast glycolysis.	[De la Fuente, Ildefonso M.] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [De la Fuente, Ildefonso M.] Inst Invest Sanitarias Biocruces, Baracaldo, Spain; [Cortes, Jesus M.] Univ Granada, DECSAI Dept Ciencias Comp & Inteligencia Artifici, Granada, Spain; [Cortes, Jesus M.] Univ Granada, CITIC, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Granada; University of Granada	De la Fuente, IM (corresponding author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain.	mtpmadei@ehu.es	Cortes, Jesus/D-9949-2012; , Ivan/D-6804-2012	Cortes, Jesus/0000-0002-9059-8194; De la Fuente, Ildefonso/0000-0001-6548-7583; , Ivan/0000-0002-3108-058X	Consejo Superior Investigaciones Cientificas (CSIC) [201020I026]; Ministerio de Ciencia e Innovacion (MICINN), CEI BioTIC GENIL [PYR-2010-14]; Ministerio de Ciencia e Innovacion (MICINN); Junta de Andalucia [P09-FQM-4682, P07-FQM-02725]	Consejo Superior Investigaciones Cientificas (CSIC); Ministerio de Ciencia e Innovacion (MICINN), CEI BioTIC GENIL(Ministry of Science and Innovation, Spain (MICINN)); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia)	Consejo Superior Investigaciones Cientificas (CSIC), Ref. 201020I026. Ministerio de Ciencia e Innovacion (MICINN), CEI BioTIC GENIL, Ref. PYR-2010-14. Ministerio de Ciencia e Innovacion (MICINN), programa Ramon y Cajal. Junta de Andalucia, Refs. P09-FQM-4682 and P07-FQM-02725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaas E, 2005, PLOS COMPUT BIOL, V1, P557, DOI 10.1371/journal.pcbi.0010068; Almeida A, 2010, P NATL ACAD SCI USA, V107, P738, DOI 10.1073/pnas.0913668107; Bagheri S, 2006, P NATL ACAD SCI USA, V103, P11306, DOI 10.1073/pnas.0510085103; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; Bertschinger N, 2004, NEURAL COMPUT, V16, P1413, DOI 10.1162/089976604323057443; BOITEUX A, 1975, P NATL ACAD SCI USA, V72, P3829, DOI 10.1073/pnas.72.10.3829; CHANCE B, 1964, BIOCHEM BIOPH RES CO, V16, P182, DOI 10.1016/0006-291X(64)90358-4; Colussi C, 2006, FASEB J, V14; Cover T. M., 1991, ELEMENTS INFORM THEO; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; De la Fuente IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027224; De la Fuente IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009484; De la Fuente IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007510; De La Fuente IM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003100; De La Fuente IM, 1999, B MATH BIOL, V61, P573, DOI 10.1006/bulm.1999.0103; De la Fuente IM, 1999, BIOSYSTEMS, V50, P83, DOI 10.1016/S0303-2647(98)00094-X; DelaFuente IM, 1996, BIOSYSTEMS, V39, P87, DOI 10.1016/0303-2647(95)01603-1; delaFuente IM, 1996, BIOPHYS J, V71, P2375, DOI 10.1016/S0006-3495(96)79431-6; DUYSENS LNM, 1957, BIOCHIM BIOPHYS ACTA, V24, P19, DOI 10.1016/0006-3002(57)90141-5; Ebeling W, 1986, SELFORGANIZATION NON; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Fujita A, 2007, BIOINFORMATICS, V23, P1623, DOI 10.1093/bioinformatics/btm151; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; GERSTEIN GL, 1969, SCIENCE, V164, P828, DOI 10.1126/science.164.3881.828; GOLDBETER A, 1972, BIOPHYS J, V12, P1302, DOI 10.1016/S0006-3495(72)86164-2; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Goldbeter A, 2007, ADV CHEM PHYS, V135, P253; GOLDBETT.A, 1973, P NATL ACAD SCI USA, V70, P3255, DOI 10.1073/pnas.70.11.3255; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Heinisch JJ, 1996, J BIOL CHEM, V271, P15928, DOI 10.1074/jbc.271.27.15928; KAUFFMAN SA, 1991, J THEOR BIOL, V149, P467, DOI 10.1016/S0022-5193(05)80094-3; MARKUS M, 1985, BER BUNSEN PHYS CHEM, V89, P651, DOI 10.1002/bbpc.19850890617; MARKUS M, 1984, FEBS LETT, V172, P235, DOI 10.1016/0014-5793(84)81132-1; MARKUS M, 1980, BIOCHEM J, V189, P421, DOI 10.1042/bj1890421; MARKUS M, 1985, BIOPHYS CHEM, V22, P95, DOI 10.1016/0301-4622(85)80030-2; Mukhopadhyay ND, 2007, BIOINFORMATICS, V23, P442, DOI 10.1093/bioinformatics/btl598; Nicolis G, 1977, SELF ORG NONEQUILIBR; Olsen L, 2009, BIOPHYS J, V96; Pahle J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-139; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; PRIGOGINE I, 1977, P NATL ACAD SCI USA, V74, P4152, DOI 10.1073/pnas.74.10.4152; RUELLE D, 1971, COMMUN MATH PHYS, V20, P167, DOI 10.1007/BF01646553; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Serrano G, 1989, YEASTS; Sorensen P, 2005, FEBS J, V272; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; Termonia Y, 1981, P NATL ACAD SCI USA, V78; VIOLA RE, 1982, BIOCHEMISTRY-US, V21, P1295, DOI 10.1021/bi00535a029; Vlassenkoa A, 2010, P NATL ACAD SCI US; Wolf J, 2000, BIOPHYS J, V78, P1145, DOI 10.1016/S0006-3495(00)76672-0	52	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e30162	10.1371/journal.pone.0030162	http://dx.doi.org/10.1371/journal.pone.0030162			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393350	gold, Green Published, Green Submitted			2022-12-27	WOS:000303003500003
J	Lemons, D; Pare, A; McGinnis, W				Lemons, Derek; Pare, Adam; McGinnis, William			Three Drosophila Hox Complex microRNAs Do Not Have Major Effects on Expression of Evolutionarily Conserved Hox Gene Targets during Embryogenesis	PLOS ONE			English	Article							MESSENGER-RNAS; ABDOMINAL-B; POSTTRANSCRIPTIONAL REGULATION; BITHORAX-COMPLEX; TRANSCRIPTION; SPECIFICITY; PREDICTION; MIR-196; IMPACT; IDENTIFICATION	The discovery of microRNAs has resulted in a major expansion of the number of molecules known to be involved in gene regulation. Elucidating the functions of animal microRNAs has posed a significant challenge as their target interactions with messenger RNAs do not adhere to simple rules. Of the thousands of known animal microRNAs, relatively few microRNA: messenger RNA regulatory interactions have been biologically validated in an normal organismal context. Here we present evidence that three microRNAs from the Hox complex in Drosophila (miR-10-5p, miR-10-3p, miR-iab-4-5p) do not have significant effects during embryogenesis on the expression of Hox genes that contain high confidence microRNAs target sites in the 39 untranslated regions of their messenger RNAs. This is significant, in that it suggests that many predicted microRNA-target interactions may not be biologically relevant, or that the outcomes of these interactions may be so subtle that mutants may only show phenotypes in specific contexts, such as in environmental stress conditions, or in combinations with other microRNA mutations.	[Lemons, Derek; Pare, Adam; McGinnis, William] Univ Calif San Diego, Div Biol Sci, Sect Cellular & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Lemons, D (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cellular & Dev Biol, La Jolla, CA 92093 USA.	wmcginnis@ucsd.edu			NIH [HD28315, T32GM007240]; family of Herbert Stern; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD028315] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); family of Herbert Stern; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH Grant HD28315 (to W.M.), National Institutes of Health Training Grant T32GM007240 (to D.L. and A.P.), and funds from the family of Herbert Stern. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 1999, DEVELOPMENT, V126, P1121; Akbari OS, 2006, DEV BIOL, V293, P294, DOI 10.1016/j.ydbio.2006.02.015; Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Alvarez-Saavedra E, 2010, CURR BIOL, V20, P367, DOI 10.1016/j.cub.2009.12.051; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Asli NS, 2010, DEV BIOL, V344, P857, DOI 10.1016/j.ydbio.2010.06.003; Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Bae E, 2002, P NATL ACAD SCI USA, V99, P16847, DOI 10.1073/pnas.222671299; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bender W, 2008, GENE DEV, V22, P14, DOI 10.1101/gad.1614208; BERGSON C, 1990, EMBO J, V9, P4287, DOI 10.1002/j.1460-2075.1990.tb07877.x; BERMINGHAM JR, 1990, DEVELOPMENT, V109, P553; Brend T, 2003, DEVELOPMENT, V130, P2717, DOI 10.1242/dev.00471; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; DELORENZI M, 1990, DEVELOPMENT, V108, P323; Didiano D, 2008, RNA, V14, P1297, DOI 10.1261/rna.1082708; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Drewell RA, 2002, P NATL ACAD SCI USA, V99, P16853, DOI 10.1073/pnas.222671199; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; He XJ, 2011, DEV BIOL, V357, P463, DOI 10.1016/j.ydbio.2011.07.014; Ho MCW, 2009, INT J DEV BIOL, V53, P459, DOI 10.1387/ijdb.082647mh; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; KUZIORA MA, 1988, EMBO J, V7, P3233, DOI 10.1002/j.1460-2075.1988.tb03190.x; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 1998, DEVELOPMENT, V125, P4077; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; McGlinn E, 2009, P NATL ACAD SCI USA, V106, P18610, DOI 10.1073/pnas.0910374106; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Pare A, 2009, CURR BIOL, V19, P2037, DOI 10.1016/j.cub.2009.10.028; Pasquinelli AE, 2003, EVOL DEV, V5, P372, DOI 10.1046/j.1525-142X.2003.03044.x; PATTATUCCI AM, 1991, GENETICS, V129, P423; Pederson JD, 1996, DEV BIOL, V180, P131, DOI 10.1006/dbio.1996.0290; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; Stark A, 2008, GENE DEV, V22, P8, DOI 10.1101/gad.1613108; Thomsen S, 2010, DEVELOPMENT, V137, P2951, DOI 10.1242/dev.047324; TIONG S, 1985, MOL GEN GENET, V200, P335, DOI 10.1007/BF00425445; Tyler DM, 2008, GENE DEV, V22, P26, DOI 10.1101/gad.1615208; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Wu CI, 2009, GENOME RES, V19, P734, DOI 10.1101/gr.084640.108; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhao Z, 2010, PLOS GENET, V6, P9; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	80	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31365	10.1371/journal.pone.0031365	http://dx.doi.org/10.1371/journal.pone.0031365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393361	Green Published, Green Submitted, gold			2022-12-27	WOS:000303003500014
J	Ahmadpour, F; Ghirlando, R; De Jong, AT; Gloyd, M; Shin, JA; Guarne, A				Ahmadpour, Faraz; Ghirlando, Rodolfo; De Jong, Antonia T.; Gloyd, Melanie; Shin, Jumi A.; Guarne, Alba			Crystal Structure of the Minimalist Max-E47 Protein Chimera	PLOS ONE			English	Article							DOMAIN-DNA COMPLEX; ANALYTICAL ULTRACENTRIFUGATION; INDUCED-DIFFERENTIATION; SEDIMENTATION-VELOCITY; COGNATE DNA; C-MYC; TRANSCRIPTION; BINDING; MAX; HELIX	Max-E47 is a protein chimera generated from the fusion of the DNA-binding basic region of Max and the dimerization region of E47, both members of the basic region/helix-loop-helix (bHLH) superfamily of transcription factors. Like native Max, Max-E47 binds with high affinity and specificity to the E-box site, 5'-CACGTG, both in vivo and in vitro. We have determined the crystal structure of Max-E47 at 1.7 angstrom resolution, and found that it associates to form a well-structured dimer even in the absence of its cognate DNA. Analytical ultracentrifugation confirms that Max-E47 is dimeric even at low micromolar concentrations, indicating that the Max-E47 dimer is stable in the absence of DNA. Circular dichroism analysis demonstrates that both non-specific DNA and the E-box site induce similar levels of helical secondary structure in Max-E47. These results suggest that Max-E47 may bind to the E-box following the two-step mechanism proposed for other bHLH proteins. In this mechanism, a rapid step where protein binds to DNA without sequence specificity is followed by a slow step where specific protein: DNA interactions are fine-tuned, leading to sequence-specific recognition. Collectively, these results show that the designed Max-E47 protein chimera behaves both structurally and functionally like its native counterparts.	[Ahmadpour, Faraz; Gloyd, Melanie; Guarne, Alba] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Ghirlando, Rodolfo] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [De Jong, Antonia T.; Shin, Jumi A.] Univ Toronto, Dept Chem, Mississauga, ON L5L 1C6, Canada	McMaster University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Toronto; University Toronto Mississauga	Ahmadpour, F (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	guarnea@mcmaster.ca		Ahmadpour, Faraz/0000-0002-3861-1224	National Sciences and Engineering Research Council; Canadian Institutes of Health Research [MOP-67189]; National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033007] Funding Source: NIH RePORTER	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Discovery Grants from the National Sciences and Engineering Research Council (http://www.nserc-crsng.gc.ca/) to JAS and AG, by an Operating Grant (MOP-67189) from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/) to AG and by the intramural research program of the National Institutes of Health to RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine P., 2005, CCP4 NEWSLETTER, V42; Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balbo A., 2005, PROTEIN PROTEIN INTE; Banerjee A, 2006, BIOCHEMISTRY-US, V45, P2333, DOI 10.1021/bi0522551; Bird GH, 2002, ANAL CHEM, V74, P219, DOI 10.1021/ac010683g; Blackwood EM, 1992, CURR OPIN GENET DEV, V2, P227, DOI 10.1016/S0959-437X(05)80278-3; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Brownlie P, 1997, STRUCTURE, V5, P509, DOI 10.1016/S0969-2126(97)00207-4; Cave JW, 2000, PROTEIN SCI, V9, P2354, DOI 10.1110/ps.9.12.2354; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; COHEN SL, 1995, PROTEIN SCI, V4, P1088, DOI 10.1002/pro.5560040607; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; Fairman R, 1997, PROTEIN SCI, V6, P175; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; HURLIN PJ, 1994, COLD SPRING HARB SYM, V59, P109, DOI 10.1101/SQB.1994.059.01.014; Kohler JJ, 1999, P NATL ACAD SCI USA, V96, P11735, DOI 10.1073/pnas.96.21.11735; Kunne AGE, 1998, BIOCHEMISTRY-US, V37, P4217, DOI 10.1021/bi9725374; Larsson LG, 1997, ONCOGENE, V15, P737, DOI 10.1038/sj.onc.1201390; LARSSON LG, 1994, ONCOGENE, V9, P1247; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Longo A, 2008, BIOCHEMISTRY-US, V47, P218, DOI 10.1021/bi701527r; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luscher B, 2001, GENE, V277, P1, DOI 10.1016/S0378-1119(01)00697-7; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McArthur GA, 1998, COLD SPRING HARB SYM, V63, P423, DOI 10.1101/sqb.1998.63.423; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEIERHANS D, 1995, BIOCHEMISTRY-US, V34, P11026, DOI 10.1021/bi00035a008; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Podust LM, 2001, J BIOL CHEM, V276, P505, DOI 10.1074/jbc.M005594200; Ponzielli R, 2005, EUR J CANCER, V41, P2485, DOI 10.1016/j.ejca.2005.08.017; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; Sauve S, 2007, J MOL BIOL, V365, P1163, DOI 10.1016/j.jmb.2006.10.044; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SHA M, 1995, J BIOL CHEM, V270, P19325, DOI 10.1074/jbc.270.33.19325; Soucek L, 1998, ONCOGENE, V17, P2463, DOI 10.1038/sj.onc.1202199; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Wendt H, 1998, J BIOL CHEM, V273, P5735, DOI 10.1074/jbc.273.10.5735; Xu J, 2009, J AM CHEM SOC, V131, P7839, DOI 10.1021/ja901306q	46	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32136	10.1371/journal.pone.0032136	http://dx.doi.org/10.1371/journal.pone.0032136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389683	Green Published, Green Submitted, gold			2022-12-27	WOS:000302999600021
J	Maan, NS; Maan, S; Belaganahalli, MN; Ostlund, EN; Johnson, DJ; Nomikou, K; Mertens, PPC				Maan, Narender S.; Maan, Sushila; Belaganahalli, Manjunatha N.; Ostlund, Eileen N.; Johnson, Donna J.; Nomikou, Kyriaki; Mertens, Peter P. C.			Identification and Differentiation of the Twenty Six Bluetongue Virus Serotypes by RT-PCR Amplification of the Serotype-Specific Genome Segment 2	PLOS ONE			English	Article							COMPLETE SEQUENCE; UNITED-STATES; EPIDEMIOLOGY; ORBIVIRUS; EUROPE; NEUTRALIZATION; CATTLE; SHEEP; VP2; EMERGENCE	Bluetongue (BT) is an arthropod-borne viral disease, which primarily affects ruminants in tropical and temperate regions of the world. Twenty six bluetongue virus (BTV) serotypes have been recognised worldwide, including nine from Europe and fifteen in the United States. Identification of BTV serotype is important for vaccination programmes and for BTV epidemiology studies. Traditional typing methods (virus isolation and serum or virus neutralisation tests (SNT or VNT)) are slow (taking weeks, depend on availability of reference virus-strains or antisera) and can be inconclusive. Nucleotide sequence analyses and phylogenetic comparisons of genome segment 2 (Seg-2) encoding BTV outer-capsid protein VP2 (the primary determinant of virus serotype) were completed for reference strains of BTV-1 to 26, as well as multiple additional isolates from different geographic and temporal origins. The resulting Seg-2 database has been used to develop rapid (within 24 h) and reliable RT-PCR-based typing assays for each BTV type. Multiple primer-pairs (at least three designed for each serotype) were widely tested, providing an initial identification of serotype by amplification of a cDNA product of the expected size. Serotype was confirmed by sequencing of the cDNA amplicons and phylogenetic comparisons to previously characterised reference strains. The results from RT-PCR and sequencing were in perfect agreement with VNT for reference strains of all 26 BTV serotypes, as well as the field isolates tested. The serotype-specific primers showed no cross-amplification with reference strains of the remaining 25 serotypes, or multiple other isolates of the more closely related heterologous BTV types. The primers and RT-PCR assays developed in this study provide a rapid, sensitive and reliable method for the identification and differentiation of the twenty-six BTV serotypes, and will be updated periodically to maintain their relevance to current BTV distribution and epidemiology (http://www.reoviridae.org/dsRNA_virus_proteins/ReoID/rt-pcr-primers.htm).	[Maan, Narender S.; Maan, Sushila; Belaganahalli, Manjunatha N.; Nomikou, Kyriaki; Mertens, Peter P. C.] Inst Anim Hlth, Vector Borne Viral Dis Programme, Arbovirus Mol Res Grp, Woking, Surrey, England; [Ostlund, Eileen N.; Johnson, Donna J.] Anim & Plant Hlth Inspect Serv, Natl Vet Serv Labs, Vet Serv, USDA, Ames, IA USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; United States Department of Agriculture (USDA)	Maan, NS (corresponding author), LLR Univ Vet & Anim Sci, Dept Anim Biotechnol, Hisar, Haryana, India.	peter.mertens@iah.ac.uk	Nomikou, Kyriaki/Q-5555-2016; Belaganahalli, Manjunatha N/I-1688-2019; Nomikou, Kyriaki/P-1840-2018	Nomikou, Kyriaki/0000-0002-7013-1853; Belaganahalli, Manjunatha N/0000-0003-3401-5799; Nomikou, Kyriaki/0000-0002-7013-1853; Mertens, Peter/0000-0002-3438-3738	Biotechnology and Biological Sciences Research Council (BBSRC); European Union (EU) [SANCO/940/2002]; Department for Environment, Food and Rural Affairs (Defra) [SE2617]; Wellcome BTV; Commonwealth Scholarship Commission; U.S. Department of Agriculture	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union (EU)(CGIAREuropean Commission); Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Wellcome BTV; Commonwealth Scholarship Commission; U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This work was partly funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the European Union (EU) (SANCO/940/2002) awarded to NSM and PM. This work was also partly funded by the Department for Environment, Food and Rural Affairs (Defra)(SE2617) awarded to SM; KN was involved in this study and is funded by a Wellcome BTV Programme grant (http://www.wellcome.ac.uk/). For some of this work, MB was funded by the Commonwealth Scholarship Commission (http://cscuk.dfid.gov.uk/), and EO and DJ were funded by the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Batten CA, 2008, VET MICROBIOL, V129, P80, DOI 10.1016/j.vetmic.2007.11.005; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Brenner J, 2010, EMERG INFECT DIS, V16, P2003, DOI 10.3201/eid1612.100239; Cetre-Sossah C, 2010, RES VET SCI; DAVIES FG, 1992, VET MICROBIOL, V31, P25, DOI 10.1016/0378-1135(92)90138-J; De Clercq K, 2009, TRANSBOUND EMERG DIS, V56, P355, DOI 10.1111/j.1865-1682.2009.01092.x; DeMaula CD, 2000, VIRUS RES, V67, P59, DOI 10.1016/S0168-1702(00)00130-1; Erasmus B. J., 1990, Virus infections of ruminants., P227; Eschbaumer M, 2011, VACCINE; Eschbaumer M, 2009, VACCINE, V27, P4169, DOI 10.1016/j.vaccine.2009.04.056; Fernandez-Pacheco P, 2008, VET REC, V162, P659, DOI 10.1136/vr.162.20.659; Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-48; GARD GP, 1985, AUST VET J, V62, P203, DOI 10.1111/j.1751-0813.1985.tb07302.x; GIBBS EPJ, 1994, COMP IMMUNOL MICROB, V17, P207, DOI 10.1016/0147-9571(94)90044-2; Hamblin C, 2004, Vet Ital, V40, P538; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; HOWELL P G, 1970, Onderstepoort Journal of Veterinary Research, V37, P59; JEGGO MH, 1986, RES VET SCI, V40, P386, DOI 10.1016/S0034-5288(18)30556-3; JEGGO MH, 1983, RES VET SCI, V34, P205, DOI 10.1016/S0034-5288(18)32261-6; Johnson DJ, 2007, P ANN C AM ASS VET L; Listes E, 2009, VET MICROBIOL, V138, P92, DOI 10.1016/j.vetmic.2009.03.011; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026147; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Maan S, 2009, BIOL ANIM INFECT, P135, DOI 10.1016/B978-012369368-6.50011-3; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; MacLachlan NJ, 2007, VIRUS RES, V129, P236, DOI 10.1016/j.virusres.2007.07.009; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; MCCOLL KA, 1991, VIRUS RES, V21, P19, DOI 10.1016/0168-1702(91)90069-8; Mellor PS, 2009, BIOL ANIM INFECT, P235, DOI 10.1016/B978-012369368-6.50015-0; Mellor PS, 2002, VET J, V164, P20, DOI 10.1053/tvjl.2002.0713; Mertens PPC, 2007, J GEN VIROL, V88, P2811, DOI 10.1099/vir.0.83023-0; MERTENS PPC, 1984, VIROLOGY, V135, P207, DOI 10.1016/0042-6822(84)90131-4; MERTENS PPC, 1987, VIROLOGY, V161, P438, DOI 10.1016/0042-6822(87)90137-1; Mertens PPC., 2005, VIRUS TAXONOMY, P466; Mertens PPC, 2011, RNAS PROTEINS DSRNA; NAMP, 2009, NAT ARB MON PROGR NA; OIE, 2008, 6964 OIE; Orru G, 2006, J VIROL METHODS, V137, P34, DOI 10.1016/j.jviromet.2006.05.028; PIERCE CM, 1995, VIROLOGY, V209, P263, DOI 10.1006/viro.1995.1253; Planzer J, 2011, RES VET SCI; Prasad G., 1999, Indian Journal of Experimental Biology, V37, P1255; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Rodriguez-Sanchez B, 2010, EMERG INFECT DIS, V16, P518, DOI 10.3201/eid1603.090626; Roy P, 1990, FEMS Microbiol Immunol, V2, P223; ROY P, 1992, J GEN VIROL, V73, P3051, DOI 10.1099/0022-1317-73-12-3051; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Shaw AE, 2007, J VIROL METHODS, V145, P115, DOI 10.1016/j.jviromet.2007.05.014; STGEORGE TD, 1978, AUST VET J, V54, P153, DOI 10.1111/j.1751-0813.1978.tb05539.x; STGEORGE TD, 1980, AUST VET J, V56, P562, DOI 10.1111/j.1751-0813.1980.tb02598.x; Tabachnick WJ, 1996, ANNU REV ENTOMOL, V41, P23, DOI 10.1146/annurev.en.41.010196.000323; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; WILSON WC, 1993, J VIROL METHODS, V45, P39, DOI 10.1016/0166-0934(93)90138-H; World Organization for Animal Health (OIE), 2000, MAN STAND DIAGN TEST, P178; YAMAGUCHI S, 1988, NUCLEIC ACIDS RES, V16, P2725, DOI 10.1093/nar/16.6.2725; YAMAGUCHI S, 1988, VIRUS RES, V11, P49, DOI 10.1016/0168-1702(88)90066-4; Zientara S, 2010, EXPERT REV VACCINES, V9, P989, DOI 10.1586/ERV.10.97	62	111	131	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32601	10.1371/journal.pone.0032601	http://dx.doi.org/10.1371/journal.pone.0032601			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389711	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000302999600050
J	Mudge, JF; Baker, LF; Edge, CB; Houlahan, JE				Mudge, Joseph F.; Baker, Leanne F.; Edge, Christopher B.; Houlahan, Jeff E.			Setting an Optimal alpha That Minimizes Errors in Null Hypothesis Significance Tests	PLOS ONE			English	Article							STATISTICAL SIGNIFICANCE; EFFECT SIZE; INSIGNIFICANCE	Null hypothesis significance testing has been under attack in recent years, partly owing to the arbitrary nature of setting alpha (the decision-making threshold and probability of Type I error) at a constant value, usually 0.05. If the goal of null hypothesis testing is to present conclusions in which we have the highest possible confidence, then the only logical decision-making threshold is the value that minimizes the probability (or occasionally, cost) of making errors. Setting alpha to minimize the combination of Type I and Type II error at a critical effect size can easily be accomplished for traditional statistical tests by calculating the alpha associated with the minimum average of alpha and beta at the critical effect size. This technique also has the flexibility to incorporate prior probabilities of null and alternate hypotheses and/or relative costs of Type I and Type II errors, if known. Using an optimal alpha results in stronger scientific inferences because it estimates and minimizes both Type I errors and relevant Type II errors for a test. It also results in greater transparency concerning assumptions about relevant effect size(s) and the relative costs of Type I and II errors. By contrast, the use of alpha = 0.05 results in arbitrary decisions about what effect sizes will likely be considered significant, if real, and results in arbitrary amounts of Type II error for meaningful potential effect sizes. We cannot identify a rationale for continuing to arbitrarily use alpha = 0.05 for null hypothesis significance tests in any field, when it is possible to determine an optimal alpha.	[Mudge, Joseph F.; Baker, Leanne F.; Edge, Christopher B.; Houlahan, Jeff E.] Univ New Brunswick, Dept Biol, St John, NB E2L 4L5, Canada	University of New Brunswick	Mudge, JF (corresponding author), Univ New Brunswick, Dept Biol, St John, NB E2L 4L5, Canada.	joe.mudge@unb.ca	Edge, Christopher/E-8003-2012; Baker, Leanne F./D-2694-2012; Mudge, Joseph/B-9706-2012	Mudge, Joseph/0000-0001-6091-2966; Baker, Leanne/0000-0003-3339-7123; Edge, Christopher/0000-0002-4713-0035	NSERC; Canadian Rivers Institute at the University of New Brunswick Saint John; Canadian Department of Defence; Natural Resources Canada-Canadian Forest Services; Environment Canada	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Rivers Institute at the University of New Brunswick Saint John; Canadian Department of Defence; Natural Resources Canada-Canadian Forest Services(Natural Resources CanadaCanadian Forest Service); Environment Canada(CGIAR)	The authors are supported by an NSERC Strategic Grant, the Canadian Rivers Institute at the University of New Brunswick Saint John, the Canadian Department of Defence, Natural Resources Canada-Canadian Forest Services, and Environment Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; CARVER RP, 1993, J EXP EDUC, V61, P287, DOI 10.1080/00220973.1993.10806591; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Crawley M.J., 2007, R BOOK; Dupont P., 1977, REND SEM MAT U POLIT, V36, P125; Field SA, 2004, ECOL LETT, V7, P669, DOI 10.1111/j.1461-0248.2004.00625.x; Gill J, 1999, POLIT RES QUART, V52, P647, DOI 10.1177/106591299905200309; Huberty CJ, 2002, EDUC PSYCHOL MEAS, V62, P227, DOI 10.1177/0013164402062002002; Johnson DH, 1999, J WILDLIFE MANAGE, V63, P763, DOI 10.2307/3802789; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Munkittrick KR, 2009, ENVIRON TOXICOL CHEM, V28, P1361, DOI 10.1897/08-376.1; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; POWER M, 1995, ENVIRON MANAGE, V19, P629, DOI 10.1007/BF02471945; ROYALL RM, 1986, AM STAT, V40, P313, DOI 10.2307/2684616; Shrader-Frechette K. S., 1991, RISK RATIONALITY PHI; Steidl RJ, 1997, J WILDLIFE MANAGE, V61, P270, DOI 10.2307/3802582; Suter GW, 1996, HUM ECOL RISK ASSESS, V2, P331, DOI 10.1080/10807039609383611; Vredenburg VT, 2004, P NATL ACAD SCI USA, V101, P7646, DOI 10.1073/pnas.0402321101	18	97	100	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32734	10.1371/journal.pone.0032734	http://dx.doi.org/10.1371/journal.pone.0032734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389720	Green Published, Green Submitted, gold			2022-12-27	WOS:000302999600059
J	Cui, W; Zhang, J; Lian, HY; Wang, HL; Miao, DQ; Zhang, CX; Luo, MJ; Tan, JH				Cui, Wei; Zhang, Jie; Lian, Hua-Yu; Wang, Hui-Li; Miao, De-Qiang; Zhang, Chuan-Xin; Luo, Ming-Jiu; Tan, Jing-He			Roles of MAPK and Spindle Assembly Checkpoint in Spontaneous Activation and MIII Arrest of Rat Oocytes	PLOS ONE			English	Article							METAPHASE-II ARREST; PROTEIN-KINASE-II; MOUSE OOCYTES; MEIOTIC MATURATION; NUCLEAR-TRANSFER; VERTEBRATE EGGS; CYCLIN B1; IN-VITRO; PARTHENOGENETIC ACTIVATION; MICROTUBULE ORGANIZATION	Rat oocytes are well known to undergo spontaneous activation (SA) after leaving the oviduct, but the SA is abortive with oocytes being arrested in metaphase III (MIII) instead of forming pronuclei. This study was designed to investigate the mechanism causing SA and MIII arrest. Whereas few oocytes collected from SD rats at 13 h after hCG injection that showed 100% of mitogen-activated protein kinase (MAPK) activities activated spontaneously, all oocytes recovered 19 h post hCG with MAPK decreased to below 75% underwent SA during in vitro culture. During SA, MAPK first declined to below 45% and then increased again to 80%; the maturation-promoting factor (MPF) activity fluctuated similarly but always began to change ahead of the MAPK activity. In SA oocytes with 75% of MAPK activities, microtubules were disturbed with irregularly pulled chromosomes dispersed over the spindle and the spindle assembly checkpoint (SAC) was activated. When MAPK decreased to 45%, the spindle disintegrated and chromosomes surrounded by microtubules were scattered in the ooplasm. SA oocytes entered MIII and formed several spindle-like structures by 6 h of culture when the MAPK activity re-increased to above 80%. While SA oocytes showed one Ca2+ rise, Sr2+-activated oocytes showed several. Together, the results suggested that SA stimuli triggered SA in rat oocytes by inducing a premature MAPK inactivation, which led to disturbance of spindle microtubules. The microtubule disturbance impaired pulling of chromosomes to the spindle poles, caused spindle disintegration and activated SAC. The increased SAC activity reactivated MPF and thus MAPK, leading to MIII arrest.	[Cui, Wei; Zhang, Jie; Lian, Hua-Yu; Wang, Hui-Li; Miao, De-Qiang; Zhang, Chuan-Xin; Luo, Ming-Jiu; Tan, Jing-He] Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Cui, W (corresponding author), Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China.	tanjh@sdau.edu.cn	wang, hui/GRS-4730-2022; Miao, Deqiang/F-1226-2015; Cui, Wei/F-2192-2016; Luo, Mingjiu/AAU-8570-2021; wang, huimin/HDM-8421-2022	Miao, Deqiang/0000-0001-9731-9322; Cui, Wei/0000-0001-7281-3471; 	National Basic Research Program of China [2012CB944403, 2007CB947403]; China National Natural Science Foundation [30972096, 30771556]	National Basic Research Program of China(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Basic Research Program of China (Nos. 2012CB944403 and 2007CB947403) and the China National Natural Science Foundation (Nos. 30972096 and 30771556). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunet S, 2003, REPRODUCTION, V126, P443, DOI 10.1530/rep.0.1260443; Chang HY, 2004, J CELL SCI, V117, P6289, DOI 10.1242/jcs.01567; Chaube SK, 2007, CLONING STEM CELLS, V9, P608, DOI 10.1089/clo.2007.0001; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Choi TS, 1996, P NATL ACAD SCI USA, V93, P7032, DOI 10.1073/pnas.93.14.7032; COLLEDGE WH, 1994, NATURE, V370, P65, DOI 10.1038/370065a0; Goto S, 2002, MOL REPROD DEV, V63, P388, DOI 10.1002/mrd.90022; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; HASHIMOTO N, 1994, NATURE, V370, P68, DOI 10.1038/370068a0; Hatch KR, 2001, MOL REPROD DEV, V58, P69, DOI 10.1002/1098-2795(200101)58:1&lt;69::AID-MRD10&gt;3.0.CO;2-O; Hayes E, 2001, PHYSIOL GENOMICS, V5, P193, DOI 10.1152/physiolgenomics.2001.5.4.193; Hirabayashi M, 2003, CLONING STEM CELLS, V5, P35, DOI 10.1089/153623003321512148; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Huang TS, 2000, APOPTOSIS, V5, P235, DOI 10.1023/A:1009652412399; Iannaccone P, 2001, ZYGOTE, V9, P135, DOI 10.1017/S0967199401001149; Ito J, 2005, REPRODUCTION, V129, P171, DOI 10.1530/rep.1.00431; Ito J, 2007, THERIOGENOLOGY, V67, P475, DOI 10.1016/j.theriogenology.2006.08.012; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Jones KT, 2005, REPRODUCTION, V130, P813, DOI 10.1530/rep.1.00710; Josefsberg LBY, 2003, BIOL REPROD, V68, P1282, DOI 10.1095/biolreprod.102.006882; Kalab P, 1996, DEVELOPMENT, V122, P1957; KEEFER CL, 1982, J EXP ZOOL, V224, P371, DOI 10.1002/jez.1402240310; Klebig C, 2009, J CELL BIOL, V185, P841, DOI 10.1083/jcb.200902128; KUBIAK JZ, 1989, DEV BIOL, V136, P537, DOI 10.1016/0012-1606(89)90279-0; Lee J, 2000, ZYGOTE, V8, P119, DOI 10.1017/S0967199400000897; Li JJ, 2012, ZYGOTE, V20, P291, DOI 10.1017/S0967199411000219; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Li Y, 1997, P NATL ACAD SCI USA, V94, P12431, DOI 10.1073/pnas.94.23.12431; Ling YH, 1998, INT J CANCER, V75, P925, DOI 10.1002/(SICI)1097-0215(19980316)75:6<925::AID-IJC16>3.0.CO;2-1; Madgwick S, 2005, J CELL SCI, V118, P3849, DOI 10.1242/jcs.02506; Madgwick S, 2006, J CELL BIOL, V174, P791, DOI 10.1083/jcb.200604140; Markoulaki S, 2004, DEV BIOL, V272, P15, DOI 10.1016/j.ydbio.2004.04.008; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; Miyoshi K, 1997, BIOL REPROD, V56, P180, DOI 10.1095/biolreprod56.1.180; Nixon VL, 2002, CURR BIOL, V12, P746, DOI 10.1016/S0960-9822(02)00811-4; Oh SH, 1998, BIOL REPROD, V59, P884, DOI 10.1095/biolreprod59.4.884; Paronetto MP, 2004, EMBO J, V23, P4649, DOI 10.1038/sj.emboj.7600448; Phillips KP, 2002, DEV BIOL, V247, P210, DOI 10.1006/dbio.2002.0680; Reimann JDR, 2002, NATURE, V416, P850, DOI 10.1038/416850a; Ross PJ, 2006, CLONING STEM CELLS, V8, P275, DOI 10.1089/clo.2006.8.275; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Sterthaus O, 2009, CLONING STEM CELLS, V11, P463, DOI 10.1089/clo.2009.0014; Sun SC, 2008, MOL REPROD DEV, V75, P1542, DOI 10.1002/mrd.20891; Tomioka I, 2007, J REPROD DEVELOP, V53, P835, DOI 10.1262/jrd.18144; Tong C, 2003, CELL RES, V13, P375, DOI 10.1038/sj.cr.7290183; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; VERLHAC MH, 1993, DEV BIOL, V158, P330, DOI 10.1006/dbio.1993.1192; VERLHAC MH, 1994, DEVELOPMENT, V120, P1017; Verlhac MH, 1996, DEVELOPMENT, V122, P815; Vogt E, 2008, MUTAT RES-GEN TOX EN, V651, P14, DOI 10.1016/j.mrgentox.2007.10.015; Yin S, 2006, CELL CYCLE, V5, P2130, DOI 10.4161/cc.5.18.3170; Yoo JG, 2007, BIOCHEM BIOPH RES CO, V359, P854, DOI 10.1016/j.bbrc.2007.05.181; Zan YH, 2003, NAT BIOTECHNOL, V21, P645, DOI 10.1038/nbt830; ZERNICKAGOETZ M, 1991, MOL REPROD DEV, V28, P169, DOI 10.1002/mrd.1080280210; ZERNICKAGOETZ M, 1993, MOL REPROD DEV, V35, P165, DOI 10.1002/mrd.1080350210	55	30	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32044	10.1371/journal.pone.0032044	http://dx.doi.org/10.1371/journal.pone.0032044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384134	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500057
J	Marin, RM; Vanicek, J				Marin, Ray M.; Vanicek, Jiri			Optimal Use of Conservation and Accessibility Filters in MicroRNA Target Prediction	PLOS ONE			English	Article							SITE ACCESSIBILITY; PROTEIN; IDENTIFICATION; POPULATION; IMPACT; GENES	It is generally accepted that filtering microRNA (miRNA) target predictions by conservation or by accessibility can reduce the false discovery rate. However, these two strategies are usually not exploited in a combined and flexible manner. Here, we introduce PACCMIT, a flexible method that filters miRNA binding sites by their conservation, accessibility, or both. The improvement in performance obtained with each of these three filters is demonstrated on the prediction of targets for both i) highly and ii) weakly conserved miRNAs, i.e., in two scenarios in which the miRNA-target interactions are subjected to different evolutionary pressures. We show that in the first scenario conservation is a better filter than accessibility (as both sensitivity and precision are higher among the top predictions) and that the combined filter improves performance of PACCMIT even further. In the second scenario, on the other hand, the accessibility filter performs better than both the conservation and combined filters, suggesting that the site conservation is not equally effective in rejecting false positive predictions for all miRNAs. Regarding the quality of the ranking criterion proposed by Robins and Press and used in PACCMIT, it is shown that top ranking interactions correspond to more downregulated proteins than do the lower ranking interactions. Comparison with several other target prediction algorithms shows that the ranking of predictions provided by PACCMIT is at least as good as the ranking generated by other conservation-based methods and considerably better than the energy-based ranking used in other accessibility-based methods.	[Marin, Ray M.; Vanicek, Jiri] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, Lab Theoret Phys Chem, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Marin, RM (corresponding author), Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, Lab Theoret Phys Chem, Lausanne, Switzerland.	jiri.vanicek@epfl.ch	Marin, Ray/C-5515-2013; Vanicek, Jiri/I-6479-2013	Marin, Ray/0000-0002-5648-0731; Vanicek, Jiri/0000-0002-2080-4378	Ecole Polytechnique Federale de Lausanne	Ecole Polytechnique Federale de Lausanne	This research was supported by Ecole Polytechnique Federale de Lausanne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Busch A, 2008, BIOINFORMATICS, V24, P2849, DOI 10.1093/bioinformatics/btn544; Chen K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005681; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; Hammell M, 2010, SEMIN CELL DEV BIOL, V21, P738, DOI 10.1016/j.semcdb.2010.01.004; Hausser J, 2009, GENOME RES, V19, P2009, DOI 10.1101/gr.091181.109; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-476; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Marin RM, 2011, NUCLEIC ACIDS RES, V39, P19, DOI 10.1093/nar/gkq768; Mendes ND, 2009, NUCLEIC ACIDS RES, V37, P2419, DOI 10.1093/nar/gkp145; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Muckstein U, 2006, BIOINFORMATICS, V22, P1177, DOI 10.1093/bioinformatics/btl024; Murphy E, 2008, P NATL ACAD SCI USA, V105, P5453, DOI 10.1073/pnas.0711910105; Orom UA, 2010, GENE, V451, P1, DOI 10.1016/j.gene.2009.11.008; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Robins H, 2005, P NATL ACAD SCI USA, V102, P15557, DOI 10.1073/pnas.0507443102; Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Wen JY, 2011, RNA, V17, P820, DOI 10.1261/rna.2387911; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851	43	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32208	10.1371/journal.pone.0032208	http://dx.doi.org/10.1371/journal.pone.0032208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384176	Green Published, gold			2022-12-27	WOS:000302918500064
J	Sakai, A; Takasu, K; Sawada, M; Suzuki, H				Sakai, Atsushi; Takasu, Kumiko; Sawada, Makoto; Suzuki, Hidenori			Hemokinin-1 Gene Expression Is Upregulated in Microglia Activated by Lipopolysaccharide through NF-kappa B and p38 MAPK Signaling Pathways	PLOS ONE			English	Article							MAMMALIAN TACHYKININ PEPTIDE; SUBSTANCE-P; RAT/MOUSE HEMOKININ-1; SUPRASPINAL LEVEL; MESSENGER-RNA; NK1 RECEPTOR; KINASE; CELLS; PAIN; MICE	The mammalian tachykinins, substance P (SP) and hemokinin-1 (HK-1), are widely distributed throughout the nervous system and/or peripheral organs, and function as neurotransmitters or chemical modulators by activating their cognate receptor NK1. The TAC1 gene encoding SP is highly expressed in the nervous system, while the TAC4 gene encoding HK-1 is uniformly expressed throughout the body, including a variety of peripheral immune cells. Since TAC4 mRNA is also expressed in microglia, the resident immune cells in the central nervous system, HK-1 may be involved in the inflammatory processes mediated by these cells. In the present study, we found that TAC4, rather than TAC1, was the predominant tachykinin gene expressed in primary cultured microglia. TAC4 mRNA expression was upregulated in the microglia upon their activation by lipopolysaccharide, a well-characterized Toll-like receptor 4 agonist, while TAC1 mRNA expression was downregulated. Furthermore, both nuclear factor-kappa B and p38 mitogen-activated protein kinase intracellular signaling pathways were required for the upregulation of TAC4 mRNA expression, but not for the downregulation of TAC1 mRNA expression. These findings suggest that HK-1, rather than SP, plays dominant roles in the pathological conditions associated with microglial activation, such as neurodegenerative and neuroinflammatory disorders.	[Sakai, Atsushi; Takasu, Kumiko; Suzuki, Hidenori] Nippon Med Sch, Dept Pharmacol, Tokyo 113, Japan; [Sawada, Makoto] Nagoya Univ, Environm Med Res Inst, Dept Brain Funct, Nagoya, Aichi 4648601, Japan	Nippon Medical School; Nagoya University	Sakai, A (corresponding author), Nippon Med Sch, Dept Pharmacol, 1-1-5 Sendagi, Tokyo 113, Japan.	hsuzuki@nms.ac.jp		Sakai, Atsushi/0000-0002-3996-8022	Japan Society for the Promotion of Science [22791457]; Ministry of Education, Culture, Sports, Science and Technology, Japan [S0801035]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Encouragement of Young Scientists (B) (22791457 to AS) from the Japan Society for the Promotion of Science and a grant (S0801035 to HS) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger A, 2007, J NEUROIMMUNOL, V187, P83, DOI 10.1016/j.jneuroim.2007.04.019; Berger A, 2010, BLOOD, V116, P3792, DOI 10.1182/blood-2010-06-291062; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Duffy RA, 2003, NEUROPHARMACOLOGY, V45, P242, DOI 10.1016/S0028-3908(03)00150-3; Endo D, 2006, NEUROSCI LETT, V392, P114, DOI 10.1016/j.neulet.2005.09.005; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Fu CY, 2007, BEHAV BRAIN RES, V184, P39, DOI 10.1016/j.bbr.2007.06.019; Fu CY, 2006, BEHAV BRAIN RES, V170, P293, DOI 10.1016/j.bbr.2006.03.007; Grassin-Delyle S, 2011, PEPTIDES, V32, P1027, DOI 10.1016/j.peptides.2011.02.012; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Klassert TE, 2008, J NEUROIMMUNOL, V196, P27, DOI 10.1016/j.jneuroim.2008.02.010; Kurtz MM, 2002, GENE, V296, P205, DOI 10.1016/S0378-1119(02)00861-2; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Liu L, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2011.01685.x; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mantyh PW, 2002, J CLIN PSYCHIAT, V63, P6; Matsumura T, 2008, BRIT J PHARMACOL, V155, P767, DOI 10.1038/bjp.2008.301; Metwali A, 2004, J IMMUNOL, V172, P6528, DOI 10.4049/jimmunol.172.11.6528; Naono-Nakayama R, 2010, NEUROPEPTIDES, V44, P57, DOI 10.1016/j.npep.2009.10.002; Nelson DA, 2004, J NEUROIMMUNOL, V155, P94, DOI 10.1016/j.jneuroim.2004.06.005; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Page NM, 2004, CELL MOL LIFE SCI, V61, P1652, DOI 10.1007/s00018-004-4035-x; Pocock JM, 2007, TRENDS NEUROSCI, V30, P527, DOI 10.1016/j.tins.2007.07.007; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; SAWADA M, 1990, BRAIN RES, V509, P119, DOI 10.1016/0006-8993(90)90317-5; Sunakawa N, 2010, NEUROPEPTIDES, V44, P273, DOI 10.1016/j.npep.2010.01.003; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Tran AH, 2009, NEUROPEPTIDES, V43, P1, DOI 10.1016/j.npep.2008.10.002; Trang T, 2009, J NEUROSCI, V29, P3518, DOI 10.1523/JNEUROSCI.5714-08.2009; Wang W, 2010, J IMMUNOL, V184, P3590, DOI 10.4049/jimmunol.0901278; Watanabe C, 2010, PEPTIDES, V31, P1613, DOI 10.1016/j.peptides.2010.04.025; Zhang Y, 2000, NAT IMMUNOL, V1, P392, DOI 10.1038/80826	37	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32268	10.1371/journal.pone.0032268	http://dx.doi.org/10.1371/journal.pone.0032268			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384199	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500070
J	Xue, FZ; Li, SX; Luan, JA; Yuan, ZS; Luben, RN; Khaw, KT; Wareham, NJ; Loos, RJF; Zhao, JH				Xue, Fuzhong; Li, Shengxu; Luan, Jian'an; Yuan, Zhongshang; Luben, Robert N.; Khaw, Kay-Tee; Wareham, Nicholas J.; Loos, Ruth J. F.; Zhao, Jing Hua			A Latent Variable Partial Least Squares Path Modeling Approach to Regional Association and Polygenic Effect with Applications to a Human Obesity Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCI; DISEASE; RISK; GENE; MARKERS; SUSCEPTIBILITY; POPULATION; PARTICIPANTS; REGRESSION	Genetic association studies are now routinely used to identify single nucleotide polymorphisms (SNPs) linked with human diseases or traits through single SNP-single trait tests. Here we introduced partial least squares path modeling (PLSPM) for association between single or multiple SNPs and a latent trait that can involve single or multiple correlated measurement(s). Furthermore, the framework naturally provides estimators of polygenic effect by appropriately weighting trait-attributing alleles. We conducted computer simulations to assess the performance via multiple SNPs and human obesity-related traits as measured by body mass index (BMI), waist and hip circumferences. Our results showed that the associate statistics had type I error rates close to nominal level and were powerful for a range of effect and sample sizes. When applied to 12 candidate regions in data (N = 2,417) from the European Prospective Investigation of Cancer (EPIC)-Norfolk study, a region in FTO was found to have stronger association (rs7204609 similar to rs9939881 at the first intron P = 4.29 x 10(-7)) than single SNP analysis (all with P>10(-4)) and a latent quantitative phenotype was obtained using a subset sample of EPIC-Norfolk(N = 12,559). We believe our method is appropriate for assessment of regional association and polygenic effect on a single or multiple traits.	[Xue, Fuzhong; Yuan, Zhongshang] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Peoples R China; [Xue, Fuzhong; Luan, Jian'an; Wareham, Nicholas J.; Loos, Ruth J. F.; Zhao, Jing Hua] MRC Epidemiol Unit, Cambridge, England; [Xue, Fuzhong; Luan, Jian'an; Wareham, Nicholas J.; Loos, Ruth J. F.; Zhao, Jing Hua] Inst Metab Sci, Cambridge, England; [Li, Shengxu] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Luben, Robert N.] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge, England; [Khaw, Kay-Tee] Univ Cambridge, Sch Clin Med, Clin Gerontol Unit, Cambridge, England	Shandong University; University of Cambridge; Tulane University; University of Cambridge; University of Cambridge	Xue, FZ (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Peoples R China.	jinghua.zhao@mrc-epid.cam.ac.uk	Loos, Ruth J F/Q-2862-2016; Luben, Robert N/H-5519-2015; Li, Shengxu/D-8915-2012; Khaw, Kay-Tee/AAZ-3209-2021; Xue, Fuzhong/AAG-4808-2020; Loos, Ruth/GON-5877-2022; Yuan, Zhongshang/GVT-8351-2022	Loos, Ruth J F/0000-0002-8532-5087; Luben, Robert N/0000-0002-5088-6343; Xue, Fuzhong/0000-0003-0378-7956	Cancer Research UK; Medical Research Council; National Natural Science Foundation of China [30171155]; China Scholarship Council; Medical Research Council [G0401527, MC_U106179471, G1000143] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The EPIC-Norfolk study is supported by research programme grant funding from Cancer Research UK and the Medical Research Council. FX was supported by grants from National Natural Science Foundation of China (30171155) and China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyene J, 2009, GENET EPIDEMIOL, V33, pS105, DOI 10.1002/gepi.20481; Chun HH, 2011, GENET EPIDEMIOL, V35, P479, DOI 10.1002/gepi.20596; Coin LJM, 2010, NAT METHODS, V7, P541, DOI [10.1038/NMETH.1466, 10.1038/nmeth.1466]; Day N, 1999, BRIT J CANCER, V80, P95; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Esposito VV, 2010, HDB PARTIAL LEAST SQ; Glaz J, 2008, SCAN STAT METHODS ST; Harlaar N, 2005, J CHILD PSYCHOL PSYC, V46, P1097, DOI 10.1111/j.1469-7610.2005.01515.x; Henseler J, 2009, ADV INT MARKETING, V20, P277, DOI 10.1108/S1474-7979(2009)0000020014; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoh J, 2000, P NATL ACAD SCI USA, V97, P9615, DOI 10.1073/pnas.170179197; Jiang R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S65; Jones, 2017, J S CAROLINA WATER R, V4, P21, DOI [10.34068/JSCWR.04.03, DOI 10.34068/JSCWR.04.03]; Kao CH, 1999, GENETICS, V152, P1203; Khoury MJ, 2004, GENET MED, V6, P38, DOI 10.1097/01.GIM.0000105751.71430.79; LAPIDUS L, 1984, BMJ-BRIT MED J, V289, P1257, DOI 10.1136/bmj.289.6454.1257; Li HZ, 2010, BIOSTATISTICS, V11, P139, DOI 10.1093/biostatistics/kxp043; Li J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-44; Li MY, 2009, BIOINFORMATICS, V25, P497, DOI 10.1093/bioinformatics/btn641; Li SX, 2010, AM J CLIN NUTR, V91, P184, DOI 10.3945/ajcn.2009.28403; Lin JD, 2002, J CLIN EPIDEMIOL, V55, P757, DOI 10.1016/S0895-4356(02)00433-X; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Peng QQ, 2010, EUR J HUM GENET, V18, P582, DOI 10.1038/ejhg.2009.223; Peng QQ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-6; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; RIMM AA, 1988, J CLIN EPIDEMIOL, V41, P459, DOI 10.1016/0895-4356(88)90047-9; Setakis E, 2006, GENOME RES, V16, P290, DOI 10.1101/gr.4346306; Sun YV, 2009, COMPUT STAT DATA AN, V53, P1794, DOI 10.1016/j.csda.2008.04.013; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Walsh Patty, 2004, Diabetes Forecast, V57, P73; WALTON C, 1995, AM J MED, V99, P459, DOI 10.1016/S0002-9343(99)80220-4; Wells JCK, 2007, AM J CLIN NUTR, V85, P419, DOI 10.1093/ajcn/85.2.419; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Yang HC, 2009, BMC P S7, V3, pS135; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; ZENG ZB, 1994, GENETICS, V136, P1457	44	10	12	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31927	10.1371/journal.pone.0031927	http://dx.doi.org/10.1371/journal.pone.0031927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384102	Green Submitted, gold, Green Published			2022-12-27	WOS:000302918500047
J	Dakin, SG; Werling, D; Hibbert, A; Abayasekara, DRE; Young, NJ; Smith, RKW; Dudhia, J				Dakin, Stephanie Georgina; Werling, Dirk; Hibbert, Andrew; Abayasekara, Dilkush Robert Ephrem; Young, Natalie Jayne; Smith, Roger Kenneth Whealands; Dudhia, Jayesh			Macrophage Sub-Populations and the Lipoxin A(4) Receptor Implicate Active Inflammation during Equine Tendon Repair	PLOS ONE			English	Article							ACHILLES-TENDON; LIPID MEDIATORS; ALTERNATIVE ACTIVATION; FLEXOR TENDINITIS; ASPIRIN TREATMENT; HUMAN-LEUKOCYTES; GENE-EXPRESSION; IN-VIVO; TENDINOPATHY; RESOLUTION	Macrophages (M phi) orchestrate inflammatory and reparatory processes in injured connective tissues but their role during different phases of tendon healing is not known. We investigated the contribution of different M phi subsets in an equine model of naturally occurring tendon injury. Post mortem tissues were harvested from normal (uninjured), sub-acute (3-6 weeks post injury) and chronically injured (>3 months post injury) superficial digital flexor tendons. To determine if inflammation was present in injured tendons, M phi sub-populations were quantified based on surface antigen expression of CD172a (pan M phi), CD14(high) CD206(low) (pro-inflammatory M1M phi), and CD206(high) (anti-inflammatory M2M phi) to assess potential polarised phenotypes. In addition, the Lipoxin A(4) receptor (FPR2/ALX) was used as marker for resolving inflammation. Normal tendons were negative for both M phi and FPR2/ALX. In contrast, M1M phi predominated in sub-acute injury, whereas a potential phenotype-switch to M2M phi polarity was seen in chronic injury. Furthermore, FPR2/ALX expression by tenocytes was significantly upregulated in sub-acute but not chronic injury. Expression of the FPR2/ALX ligand Annexin A1 was also significantly increased in sub-acute and chronic injuries in contrast to low level expression in normal tendons. The combination of reduced FPR2/ALX expression and persistence of the M2M phi phenotype in chronic injury suggests a potential mechanism for incomplete resolution of inflammation after tendon injury. To investigate the effect of pro-inflammatory mediators on lipoxin A(4) (LXA(4)) production and FPR2/ALX expression in vitro, normal tendon explants were stimulated with interleukin-1 beta and prostaglandin E-2. Stimulation with either mediator induced LXA(4) release and maximal upregulation of FPR2/ALX expression after 72 hours. Taken together, our data suggests that although tenocytes are capable of mounting a protective mechanism to counteract inflammatory stimuli, this appears to be of insufficient duration and magnitude in natural tendon injury, which may potentiate chronic inflammation and fibrotic repair, as indicated by the presence of M2M phi.	[Dakin, Stephanie Georgina; Smith, Roger Kenneth Whealands; Dudhia, Jayesh] Univ London, Royal Vet Coll, Dept Vet Clin Sci, Hatfield, Herts, England; [Werling, Dirk] Univ London, Royal Vet Coll, Dept Pathol & Infect Dis, Hatfield, Herts, England; [Hibbert, Andrew; Abayasekara, Dilkush Robert Ephrem] Univ London Royal Vet Coll, Dept Vet Basic Sci, London, England; [Young, Natalie Jayne] Natl Inst Biol Stand & Controls, Dept Biotherapeut, S Mimms, Herts, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; National Institute for Biological Standards & Control	Dakin, SG (corresponding author), Univ London, Royal Vet Coll, Dept Vet Clin Sci, Hatfield, Herts, England.	sdakin@rvc.ac.uk	Werling, Dirk/F-5555-2013	Werling, Dirk/0000-0001-5411-4044; Dudhia, Jayesh/0000-0002-2503-697X; Dakin, Stephanie Georgina/0000-0003-2470-1031	Biotechnology and Biological Sciences Research Council (BBSRC) UK; Ceva (France) [BB/F018258/1]; Biotechnology and Biological Sciences Research Council [BB/D524883/1] Funding Source: researchfish; BBSRC [BB/D524883/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ceva (France); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research article was funded by Biotechnology and Biological Sciences Research Council (BBSRC) UK and Ceva (France) grant number BB/F018258/1. The funders had no role in study design, data collection and analysis, decision to publish or manuscript preparation.	Alfredson H, 2002, CURR DRUG TARGETS, V3, P43, DOI 10.2174/1389450023348028; Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; ASTROM M, 1995, CLIN ORTHOP RELAT R, P151; Avella CS, 2009, EQUINE VET J, V41, P449, DOI 10.2746/042516409X391042; BOMSZTYK K, 1990, J BIOL CHEM, V265, P9413; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; BOURNE HR, 1974, SCIENCE, V184, P19, DOI 10.1126/science.184.4132.19; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Crevier-Denoix N, 1997, Equine Vet J Suppl, P23; Dahlgren LA, 2002, J ORTHOP RES, V20, P910, DOI 10.1016/S0736-0266(02)00009-8; DiezRoux G, 1997, DEVELOPMENT, V124, P3633; Dowling BA, 2000, EQUINE VET J, V32, P369, DOI 10.2746/042516400777591138; Dudhia J, 2007, AGING CELL, V6, P547, DOI 10.1111/j.1474-9726.2007.00307.x; Gavins FNE, 2005, PROSTAG LEUKOTR ESS, V73, P211, DOI 10.1016/j.plefa.2005.05.008; Gilroy DW, 2010, INT J BIOCHEM CELL B, V42, P524, DOI 10.1016/j.biocel.2009.12.013; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gronert K, 1998, J EXP MED, V187, P1285, DOI 10.1084/jem.187.8.1285; Herrmann-Hoesing LM, 2010, VET PATHOL, V47, P518, DOI 10.1177/0300985809359605; Ibrahim S, 2007, VET IMMUNOL IMMUNOP, V119, P63, DOI 10.1016/j.vetimm.2007.06.034; Jarvinen M, 1997, SCAND J MED SCI SPOR, V7, P86; JOZSA L, 1990, ARCH ORTHOP TRAUM SU, V110, P15, DOI 10.1007/BF00431359; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P1507, DOI 10.2106/00004623-199173100-00009; Ker RF, 2000, J EXP BIOL, V203, P1317; Khan MH, 2005, CLIN J SPORT MED, V15, P27, DOI 10.1097/00042752-200501000-00006; Kujala UM, 2005, CLIN J SPORT MED, V15, P133, DOI 10.1097/01.jsm.0000165347.55638.23; Langberg H, 1999, J PHYSIOL-LONDON, V515, P919, DOI 10.1111/j.1469-7793.1999.919ab.x; Lawrence T, 2007, INT J EXP PATHOL, V88, P85, DOI 10.1111/j.1365-2613.2006.00507.x; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Leedom AJ, 2010, AM J PATHOL, V176, P74, DOI 10.2353/ajpath.2010.090678; Leibovich S J, 1988, Prog Clin Biol Res, V266, P131; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Lui PPY, 2011, SCAND J MED SCI SPOR, V21, P3, DOI 10.1111/j.1600-0838.2010.01164.x; Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x; Maffulli N, 1999, CLIN J SPORT MED, V9, P157, DOI 10.1097/00042752-199907000-00007; Magra M, 2006, CLIN J SPORT MED, V16, P1, DOI 10.1097/01.jsm.0000194764.27819.5d; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Marsolais D, 2003, LAB INVEST, V83, P991, DOI 10.1097/01.LAB.0000078688.07696.AC; Marsolais D, 2001, J ORTHOPAED RES, V19, P1203, DOI 10.1016/S0736-0266(01)00031-6; Millar NL, 2010, AM J SPORT MED, V38, P2085, DOI 10.1177/0363546510372613; Moller A, 1996, ACTA ORTHOP SCAND, V67, P479, DOI 10.3109/17453679608996672; Morris T, 2010, P NATL ACAD SCI USA, V107, P8842, DOI 10.1073/pnas.1000373107; Nagaoka T, 2000, AM J PATHOL, V157, P237, DOI 10.1016/S0002-9440(10)64534-8; NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815; Parente L, 2004, INFLAMM RES, V53, P125, DOI 10.1007/s00011-003-1235-z; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; Perretti M, 1996, NAT MED, V2, P1259, DOI 10.1038/nm1196-1259; Peters T, 2005, EMBO J, V24, P3400, DOI 10.1038/sj.emboj.7600809; RAIFE TJ, 1994, AM J CLIN PATHOL, V101, P296, DOI 10.1093/ajcp/101.3.296; Romijn HJ, 1999, J HISTOCHEM CYTOCHEM, V47, P229, DOI 10.1177/002215549904700211; Satoh N, 2010, DIABETES CARE, V33, pe7; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan Charles N, 2002, ScientificWorldJournal, V2, P169; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; SERHAN CN, 1984, P NATL ACAD SCI-BIOL, V81, P5335, DOI 10.1073/pnas.81.17.5335; Serhan CN, 2000, AM J RESP CRIT CARE, V161, pS95, DOI 10.1164/ajrccm.161.supplement_1.ltta-19; Silver I A, 1983, Equine Vet J Suppl, P1; SIMS JE, 1993, P NATL ACAD SCI USA, V90, P6155, DOI 10.1073/pnas.90.13.6155; Smeekens SP, 2011, EUR J IMMUNOL, V41, P2915, DOI 10.1002/eji.201141418; Smith R, 2003, IN PRACTICE, V25, P529; Smith RKW, 2008, VET CLIN N AM-EQUINE, V24, P37, DOI 10.1016/j.cveq.2007.11.005; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; STROCCHI R, 1991, FOOT ANKLE, V12, P100, DOI 10.1177/107110079101200207; Thampatty BP, 2007, GENE, V386, P154, DOI 10.1016/j.gene.2006.08.027; Tsuzaki M, 2003, J ORTHOP RES, V21, P256, DOI 10.1016/S0736-0266(02)00141-9; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; WELSH RP, 1980, CAN MED ASSOC J, V122, P193; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; WILLIAMS IF, 1984, RES VET SCI, V36, P326, DOI 10.1016/S0034-5288(18)31954-4; Wilson AM, 2001, NATURE, V414, P895, DOI 10.1038/414895a; Wong JKF, 2009, AM J PATHOL, V175, P1938, DOI 10.2353/ajpath.2009.090380; Yang D, 2001, J IMMUNOL, V166, P4092, DOI 10.4049/jimmunol.166.6.4092; Yang GG, 2005, GENE, V363, P166, DOI 10.1016/j.gene.2005.08.006; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zeyda M, 2007, INT J OBESITY, V31, P1420, DOI 10.1038/sj.ijo.0803632	82	57	59	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32333	10.1371/journal.pone.0032333	http://dx.doi.org/10.1371/journal.pone.0032333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384219	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500096
J	Haas, S; Jahnke, HG; Moerbt, N; von Bergen, M; Aharinejad, S; Andrukhova, O; Robitzki, AA				Haas, Sina; Jahnke, Heinz-Georg; Moerbt, Nora; von Bergen, Martin; Aharinejad, Seyedhossein; Andrukhova, Olena; Robitzki, Andrea A.			DIGE Proteome Analysis Reveals Suitability of Ischemic Cardiac In Vitro Model for Studying Cellular Response to Acute Ischemia and Regeneration	PLOS ONE			English	Article							OXIDATIVE STRESS; HEART-FAILURE; REPERFUSION INJURY; ENERGY-METABOLISM; APOPTOSIS; CELLS; CARDIOMYOCYTES; VIVO; TRANSPLANTATION; NUCLEOPHOSMIN	Proteomic analysis of myocardial tissue from patient population is suited to yield insights into cellular and molecular mechanisms taking place in cardiovascular diseases. However, it has been limited by small sized biopsies and complicated by high variances between patients. Therefore, there is a high demand for suitable model systems with the capability to simulate ischemic and cardiotoxic effects in vitro, under defined conditions. In this context, we established an in vitro ischemia/reperfusion cardiac disease model based on the contractile HL-1 cell line. To identify pathways involved in the cellular alterations induced by ischemia and thereby defining disease-specific biomarkers and potential target structures for new drug candidates we used fluorescence 2D-difference gel electrophoresis. By comparing spot density changes in ischemic and reperfusion samples we detected several protein spots that were differentially abundant. Using MALDI-TOF/TOF-MS and ESI-MS the proteins were identified and subsequently grouped by functionality. Most prominent were changes in apoptosis signalling, cell structure and energy-metabolism. Alterations were confirmed by analysis of human biopsies from patients with ischemic cardiomyopathy. With the establishment of our in vitro disease model for ischemia injury target identification via proteomic research becomes independent from rare human material and will create new possibilities in cardiac research.	[Haas, Sina; Jahnke, Heinz-Georg; Robitzki, Andrea A.] Univ Leipzig, Ctr Biotechnol & Biomed, Div Mol Biol Biochem Proc Technol, Leipzig, Germany; [Moerbt, Nora; von Bergen, Martin] UFZ Helmholtz Ctr Environm Res, Dept Prote, Leipzig, Germany; [von Bergen, Martin] UFZ Helmholtz Ctr Environm Res, Dept Metabol, Leipzig, Germany; [Aharinejad, Seyedhossein] Med Univ Vienna, Dept Cardiac Surg, Ctr Anat & Cell Biol, Vienna, Austria; [Aharinejad, Seyedhossein; Andrukhova, Olena] Med Univ Vienna, Dept Cardiovasc Res, Ctr Anat & Cell Biol, Vienna, Austria; [Andrukhova, Olena] Univ Vet Med, Inst Pathophysiol, Dept Biomed Sci, Vienna, Austria	Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Medical University of Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna	Haas, S (corresponding author), Univ Leipzig, Ctr Biotechnol & Biomed, Div Mol Biol Biochem Proc Technol, Leipzig, Germany.	andrea.robitzki@bbz.uni-leipzig.de	von Bergen, Martin/D-7960-2011	von Bergen, Martin/0000-0003-2732-2977; Jahnke, Heinz-Georg/0000-0001-6615-7092	European Union [CWB 266753]; BuildMoNa Graduate School of Leipzig	European Union(European Commission); BuildMoNa Graduate School of Leipzig	This work was funded by the European Union (FP6, Project: CWB 266753) and the BuildMoNa Graduate School of Leipzig. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharinejad S, 2007, AM J TRANSPLANT, V7, P2012, DOI 10.1111/j.1600-6143.2007.01875.x; Aharinejad S, 2001, TRANSPLANTATION, V72, P1043, DOI 10.1097/00007890-200109270-00011; Anderson L, 2005, J PHYSIOL-LONDON, V563, P23, DOI 10.1113/jphysiol.2004.080473; Anversa P, 1998, BASIC RES CARDIOL, V93, P8; Ay H, 2002, STROKE, V33, P286, DOI 10.1161/hs0102.101544; Bansal A, 2010, J PROTEOMICS, V73, P2041, DOI 10.1016/j.jprot.2010.06.009; Bjorhall K, 2005, PROTEOMICS, V5, P307, DOI 10.1002/pmic.200400900; Brscic E, 2000, AM HEART J, V139, P979, DOI 10.1067/mhj.2000.106165; Cicconi S, 2003, J CELL PHYSIOL, V195, P27, DOI 10.1002/jcp.10219; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cleutjens JPM, 1999, CARDIOVASC RES, V44, P232, DOI 10.1016/S0008-6363(99)00212-6; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; COSTANZO MR, 1995, CIRCULATION, V92, P3593, DOI 10.1161/01.CIR.92.12.3593; De Celle T, 2004, EXP PHYSIOL, V89, P605, DOI 10.1113/expphysiol.2004.027649; Dhar SK, 2009, J BIOL CHEM, V284, P16409, DOI 10.1074/jbc.M109.005736; DRIEDZIC WR, 1994, PHYSIOL REV, V74, P221, DOI 10.1152/physrev.1994.74.1.221; Feuerstein GZ, 1999, CARDIOVASC DRUG THER, V13, P289, DOI 10.1023/A:1007735413477; FLAHERTY JT, 1988, FREE RADICAL BIO MED, V5, P409, DOI 10.1016/0891-5849(88)90115-3; FOWLER NO, 1976, AM J CARDIOL, V37, P223, DOI 10.1016/0002-9149(76)90316-7; GANOTE C, 1993, CARDIOVASC RES, V27, P1387, DOI 10.1093/cvr/27.8.1387; Gu L, 2008, LEUKEMIA, V22, P2091, DOI 10.1038/leu.2008.204; Hasenfuss G, 2002, J MOL CELL CARDIOL, V34, P951, DOI 10.1006/jmcc.2002.2037; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Inserte J, 2000, AM J PHYSIOL-HEART C, V278, pH94, DOI 10.1152/ajpheart.2000.278.1.H94; Jehmlich N, 2008, ISME J, V2, P1122, DOI 10.1038/ismej.2008.64; Karwatowska-Prokopczuk E, 1998, CIRC RES, V82, P1139, DOI 10.1161/01.RES.82.11.1139; Kim KS, 2002, BIOCHIMIE, V84, P625, DOI 10.1016/S0300-9084(02)01435-9; Krinke D, 2009, BIOSENS BIOELECTRON, V24, P2798, DOI 10.1016/j.bios.2009.02.006; Lainscak M, 2009, HERZ, V34, P589, DOI 10.1007/s00059-009-3316-4; Liang BT, 1998, P NATL ACAD SCI USA, V95, P6995, DOI 10.1073/pnas.95.12.6995; McGregor E, 2003, HUM MOL GENET, V12, pR135, DOI 10.1093/hmg/ddg278; Morbt N, 2011, J PROTEOME RES, V10, P363, DOI 10.1021/pr1005718; Morbt N, 2009, PROTEOMICS, V9, P4920, DOI 10.1002/pmic.200800836; Muscari A, 1995, Cardiologia, V40, P507; Olivetti, 1997, Adv Clin Path, V1, P137; Sakai J, 2003, PROTEOMICS, V3, P1318, DOI 10.1002/pmic.200300432; Santos PM, 2007, OMICS, V11, P233, DOI 10.1089/omi.2007.0009; Sawicki G, 2004, PROTEOMICS, V4, P2195, DOI 10.1002/pmic.200300746; Schwertz H, 2002, PROTEOMICS, V2, P988, DOI 10.1002/1615-9861(200208)2:8<988::AID-PROT988>3.0.CO;2-#; Steel LF, 2003, MOL CELL PROTEOMICS, V2, P262, DOI 10.1074/mcp.M300026-MCP200; Stempfer R, 2008, ELECTROPHORESIS, V29, P4316, DOI 10.1002/elps.200800211; Takemura G, 1998, CIRC RES, V82, P1130, DOI 10.1161/01.RES.82.11.1130; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Vilahur G, 2011, J MOL CELL CARDIOL, V50, P522, DOI 10.1016/j.yjmcc.2010.12.021; Weekes J, 2003, ALCOHOL ALCOHOLISM, V38, P103, DOI 10.1093/alcalc/agg037; Wei YJ, 2009, MOL CELL BIOCHEM, V332, P103, DOI 10.1007/s11010-009-0179-1; Young J B, 1999, Curr Cardiol Rep, V1, P67, DOI 10.1007/s11886-999-0044-6; Zamilpa R, 2010, PROTEOMICS, V10, P2214, DOI 10.1002/pmic.200900587	48	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31669	10.1371/journal.pone.0031669	http://dx.doi.org/10.1371/journal.pone.0031669			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384053	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500032
J	Hu, ZH; Liu, C; Shi, PC; Liu, HF				Hu, Zhenghui; Liu, Cong; Shi, Pengcheng; Liu, Huafeng			Exploiting Magnetic Resonance Angiography Imaging Improves Model Estimation of BOLD Signal	PLOS ONE			English	Article							CONTROLLED RANDOM SEARCH; HEMODYNAMIC-RESPONSE; OXYGEN DELIVERY; BLOOD-FLOW; ACTIVATION; FMRI	The change of BOLD signal relies heavily upon the resting blood volume fraction (V-0) associated with regional vasculature. However, existing hemodynamic data assimilation studies pretermit such concern. They simply assign the value in a physiologically plausible range to get over ill-conditioning of the assimilation problem and fail to explore actual V-0. Such performance might lead to unreliable model estimation. In this work, we present the first exploration of the influence of V-0 on fMRI data assimilation, where actual V-0 within a given cortical area was calibrated by an MR angiography experiment and then was augmented into the assimilation scheme. We have investigated the impact of V-0 on single-region data assimilation and multi-region data assimilation (dynamic cause modeling, DCM) in a classical flashing checkerboard experiment. Results show that the employment of an assumed V-0 in fMRI data assimilation is only suitable for fMRI signal reconstruction and activation detection grounded on this signal, and not suitable for estimation of unobserved states and effective connectivity study. We thereby argue that introducing physically realistic V-0 in the assimilation process may provide more reliable estimation of physiological information, which contributes to a better understanding of the underlying hemodynamic processes. Such an effort is valuable and should be well appreciated.	[Hu, Zhenghui; Liu, Cong; Liu, Huafeng] Zhejiang Univ, State Key Lab Modern Opt Instrumentat, Hangzhou 310003, Zhejiang, Peoples R China; [Shi, Pengcheng] Rochester Inst Technol, B Thomas Golisano Coll Comp & Informat Sci, Rochester, NY 14623 USA; [Shi, Pengcheng] Univ Rochester, Med Ctr, Rochester, NY 14642 USA	Zhejiang University; Rochester Institute of Technology; University of Rochester	Hu, ZH (corresponding author), Zhejiang Univ, State Key Lab Modern Opt Instrumentat, Hangzhou 310003, Zhejiang, Peoples R China.	zhenghui@zju.edu.cn; liuhf@zju.edu.cn	Hu, Zhenghui/F-1959-2015; LIU, CONG/J-3588-2016; Liu, Cong/E-9762-2012	Hu, Zhenghui/0000-0002-5775-0481; LIU, CONG/0000-0002-2106-202X; 	National Basic Research Program of China [2010CB732500]; National Natural Science Foundation of China [30800250]; Ministry of Education of China [200803351022]; Zhejiang Provincial Natural Science Foundation of China [Y2080281]; Zhejiang Provincial Qianjiang Talent Plan [2009R10042]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Qianjiang Talent Plan	This work is supported in part by the National Basic Research Program of China under grant 2010CB732500 (http://most.gov.cn/), in part by the National Natural Science Foundation of China under grant 30800250 (http://www.nsfc.gov.cn), in part by Doctoral Fund of Ministry of Education of China under grant 200803351022 (http://www.moe.edu.cn/), in part by Zhejiang Provincial Natural Science Foundation of China under grant Y2080281 (http://www.zjnsf.gov.cn), and in part by Zhejiang Provincial Qianjiang Talent Plan under grant 2009R10042 (http://www.zjkjt.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MM, 1997, J GLOBAL OPTIM, V11, P377, DOI 10.1023/A:1008236920512; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buxton RB, 1997, J CEREBR BLOOD F MET, V17, P64, DOI 10.1097/00004647-199701000-00009; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Deneux T, 2006, NEUROIMAGE, V32, P1669, DOI 10.1016/j.neuroimage.2006.03.006; Friston KJ, 2008, NEUROIMAGE, V41, P849, DOI 10.1016/j.neuroimage.2008.02.054; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; Friston KJ, 2000, NEUROIMAGE, V12, P466, DOI 10.1006/nimg.2000.0630; Friston KJ, 2002, NEUROIMAGE, V16, P513, DOI 10.1006/nimg.2001.1044; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Hettiarachchi IT, 2010, IEEE ENG MED BIO, P2391, DOI 10.1109/IEMBS.2010.5627400; Hu ZH, 2007, LECT NOTES COMPUT SC, V4792, P734; Hu ZH, 2010, IEEE T MED IMAGING, V29, P1870, DOI 10.1109/TMI.2010.2053044; Hu ZH, 2009, I S BIOMED IMAGING, P706, DOI 10.1109/ISBI.2009.5193145; Hu ZH, 2009, EURASIP J ADV SIG PR, DOI 10.1155/2009/215409; Jiao L, 2010, NATURE, V327, P931; Johnston LA, 2008, NEUROIMAGE, V40, P504, DOI 10.1016/j.neuroimage.2007.11.024; Johnston LA, 2006, LECT NOTES COMPUT SC, V4191, P292; Li XF, 2010, MED IMAGE ANAL, V14, P30, DOI 10.1016/j.media.2009.09.005; Lu HZ, 2005, MAGN RESON MED, V54, P1403, DOI 10.1002/mrm.20705; Mechelli A, 2003, J COGNITIVE NEUROSCI, V15, P925, DOI 10.1162/089892903770007317; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Riera JJ, 2004, NEUROIMAGE, V21, P547, DOI 10.1016/j.neuroimage.2003.09.052; Stephan KE, 2008, NEUROIMAGE, V42, P649, DOI 10.1016/j.neuroimage.2008.04.262; Tsoulos IG, 2006, COMPUT PHYS COMMUN, V174, P152, DOI 10.1016/j.cpc.2005.09.007; Worsley K., 2001, FUNCTIONAL MRI INTRO, V61; Zheng Y, 2005, NEUROIMAGE, V28, P925, DOI 10.1016/j.neuroimage.2005.06.042; Zheng Y, 2002, NEUROIMAGE, V16, P617, DOI 10.1006/nimg.2002.1078; Zhenghui Hu, 2007, Proceedings 2007 IEEE International Conference on Image Processing, ICIP 2007, P145	30	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31612	10.1371/journal.pone.0031612	http://dx.doi.org/10.1371/journal.pone.0031612			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384043	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500027
J	Mizuguchi, Y; Specht, S; Lunz, JG; Isse, K; Corbitt, N; Takizawa, T; Demetris, AJ				Mizuguchi, Yoshiaki; Specht, Susan; Lunz, John G., III; Isse, Kumiko; Corbitt, Natasha; Takizawa, Toshihiro; Demetris, Anthony J.			Cooperation of p300 and PCAF in the Control of MicroRNA 200c/141 Transcription and Epithelial Characteristics	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; SIGNALING PATHWAYS; DOWN-REGULATION; MIR-200 FAMILY; CANCER-CELLS; E-CADHERIN; PROTEIN; EXPRESSION; ZEB1; CBP	Epithelial to mesenchymal transition (EMT) not only occurs during embryonic development and in response to injury, but is an important element in cancer progression. EMT and its reverse process, mesenchymal to epithelial transition (MET) is controlled by a network of transcriptional regulators and can be influenced by posttranscriptional and posttranslational modifications. EMT/MET involves many effectors that can activate and repress these transitions, often yielding a spectrum of cell phenotypes. Recent studies have shown that the miR-200 family and the transcriptional suppressor ZEB1 are important contributors to EMT. Our previous data showed that forced expression of SPRR2a was a powerful inducer of EMT and supports the findings by others that SPRR gene members are highly upregulated during epithelial remodeling in a variety of organs. Here, using SPRR2a cells, we characterize the role of acetyltransferases on the microRNA-200c/141 promoter and their effect on the epithelial/mesenchymal status of the cells. We show that the deacetylase inhibitor TSA as well as P300 and PCAF can cause a shift towards epithelial characteristics in HUCCT-1-SPRR2a cells. We demonstrate that both P300 and PCAF act as cofactors for ZEB1, forming a P300/PCAF/ZEB1 complex on the miR200c/141 promoter. This binding results in lysine acetylation of ZEB1 and a release of ZEB1 suppression on miR-200c/141 transcription. Furthermore, disruption of P300 and PCAF interactions dramatically down regulates miR-200c/141 promoter activity, indicating a PCAF/P300 cooperative function in regulating the transcriptional suppressor/activator role of ZEB1. These data demonstrate a novel mechanism of miRNA regulation in mediating cell phenotype.	[Mizuguchi, Yoshiaki; Specht, Susan; Lunz, John G., III; Isse, Kumiko; Corbitt, Natasha; Demetris, Anthony J.] Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15260 USA; [Mizuguchi, Yoshiaki; Specht, Susan; Lunz, John G., III; Isse, Kumiko; Corbitt, Natasha; Demetris, Anthony J.] Univ Pittsburgh, Dept Pathol, Med Ctr, Pittsburgh, PA USA; [Lunz, John G., III] Univ Pittsburgh, Dept Surg, Med Ctr, Pittsburgh, PA USA; [Takizawa, Toshihiro] Nippon Med Sch, Dept Mol Anat & Med, Tokyo 113, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nippon Medical School	Mizuguchi, Y (corresponding author), Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15260 USA.	demetrisaj@upmc.edu			Thomas E. Starzl Professor of Pathology Endowment Fund; Ministry of Education, Science, Sports, and Culture of Japan	Thomas E. Starzl Professor of Pathology Endowment Fund; Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Thomas E. Starzl Professor of Pathology Endowment Fund. It was also supported by the Ministry of Education, Science, Sports, and Culture of Japan and Grants-in-Aid for Scientific Research, Research Fellowships for young scientists and the Core Research Project for Private University: matching fund subsidy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2007, CURR OPIN IMMUNOL, V19, P694, DOI 10.1016/j.coi.2007.07.016; Bai L, 2007, FEBS LETT, V581, P5904, DOI 10.1016/j.febslet.2007.11.072; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Cereseto A, 2005, EMBO J, V24, P3070, DOI 10.1038/sj.emboj.7600770; Chan HM, 2001, J CELL SCI, V114, P2363; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Demetris AJ, 2008, J HEPATOL, V48, P276, DOI 10.1016/j.jhep.2007.09.019; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Eckner R, 1996, MOL CELL BIOL, V16, P3454; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Han C, 2004, J BIOL CHEM, V279, P44344, DOI 10.1074/jbc.M404852200; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Karamouzis MV, 2007, CELL RES, V17, P324, DOI 10.1038/cr.2007.10; Krubasik D, 2006, BRIT J CANCER, V94, P1326, DOI 10.1038/sj.bjc.6603101; Liu YN, 2005, ONCOGENE, V24, P8277, DOI 10.1038/sj.onc.1208991; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Neves R, BMC RES NOTES, V3, P219; Pena C, 2006, INT J CANCER, V119, P2098, DOI 10.1002/ijc.22083; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Postigo AA, 1997, EMBO J, V16, P3935, DOI 10.1093/emboj/16.13.3935; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tryndyak VP, 2009, MOL CARCINOGEN, V48, P479, DOI 10.1002/mc.20484; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0	32	47	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e32449	10.1371/journal.pone.0032449	http://dx.doi.org/10.1371/journal.pone.0032449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384255	Green Accepted, Green Published, gold			2022-12-27	WOS:000302875500102
J	Watmuff, B; Pouton, CW; Haynes, JM				Watmuff, Bradley; Pouton, Colin W.; Haynes, John M.			In Vitro Maturation of Dopaminergic Neurons Derived from Mouse Embryonic Stem Cells: Implications for Transplantation	PLOS ONE			English	Article							INTRACELLULAR CHLORIDE; PARKINSONS-DISEASE; GABAERGIC NEURONS; PROGENITOR CELLS; CA2+ REGULATION; DRUG DISCOVERY; RAT MODEL; GABA; MIDBRAIN; SURVIVAL	The obvious motor symptoms of Parkinson's disease result from a loss of dopaminergic neurons from the substantia nigra. Embryonic stem cell-derived neural progenitor or precursor cells, adult neurons and fetal midbrain tissue have all been used to replace dying dopaminergic neurons. Transplanted cell survival is compromised by factors relating to the new environment, for example; hypoxia, mechanical trauma and excitatory amino acid toxicity. In this study we investigate, using live-cell fluorescence Ca2+ and Cl- imaging, the functional properties of catecholaminergic neurons as they mature. We also investigate whether GABA has the capacity to act as a neurotoxin early in the development of these neurons. From day 13 to day 21 of differentiation [Cl-](i) progressively dropped in tyrosine hydroxylase positive (TH+) neurons from 56.0 ( 95% confidence interval, 55.1, 56.9) mM to 6.9 (6.8, 7.1) mM. At days 13 and 15 TH+ neurons responded to GABA (30 mu M) with reductions in intracellular Cl- ([Cl-](i)); from day 21 the majority of neurons responded to GABA (30 mu M) with elevations of [Cl-](i). As [Cl-](i) reduced, the ability of GABA (30 mu M) to elevate intracellular Ca2+ ([Ca2+](i)) did also. At day 13 of differentiation a three hour exposure to GABA (30 mu M) or L-glutamate (30 mu M) increased the number of midbrain dopaminergic (TH+ and Pitx3(+)) neurons labeled with the membrane-impermeable nuclear dye TOPRO-3. By day 23 cultures were resistant to the effects of both GABA and L-glutamate. We believe that neuronal susceptibility to amino acid excitotoxicity is dependent upon neuronal maturity, and this should be considered when isolating cells for transplantation studies.	[Watmuff, Bradley; Pouton, Colin W.; Haynes, John M.] Monash Univ, Monash Inst Pharmaceut Sci, Stem Cell Biol Grp, Parkville, Vic, Australia	Monash University	Watmuff, B (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Stem Cell Biol Grp, Parkville, Vic, Australia.	colin.pouton@monash.edu; john.haynes@monash.edu	Pouton, Colin W/M-2049-2016	Pouton, Colin W/0000-0003-0224-3308; , john/0000-0003-3075-1553	Australian Research Council [LP0455327]; Australian Postgraduate Award	Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government)	This work was funded by the Australian Research Council (LP0455327). BW was the recipient of an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annett LE, 1997, CELL TRANSPLANT, V6, P557, DOI 10.1016/S0963-6897(97)00079-1; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Ben-Hur T, 2004, STEM CELLS, V22, P1246, DOI 10.1634/stemcells.2004-0094; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Brundin P, 2000, CELL TRANSPLANT, V9, P179, DOI 10.1177/096368970000900205; Cai J, 2009, STEM CELLS DEV; Cordero-Erausquin M, 2005, J NEUROSCI, V25, P9613, DOI 10.1523/JNEUROSCI.1488-05.2005; Cucchiaroni ML, 2011, EUR J NEUROSCI; Dayanithi G, 2006, CELL CALCIUM, V39, P237, DOI 10.1016/j.ceca.2005.10.011; DIPORZIO U, 1993, EXP NEUROL, V120, P202, DOI 10.1006/exnr.1993.1055; Gaillard A, 2011, TRENDS NEUROSCI; Goren MZ, 2001, NEUROL SCI, V22, P297, DOI 10.1007/s10072-001-8171-x; GRODEN DL, 1991, CELL CALCIUM, V12, P279, DOI 10.1016/0143-4160(91)90002-V; Gruol DL, 2005, CEREBELLUM, V4, P128, DOI 10.1080/14734220510007969; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hahn M, 2009, J NEUROSCI RES, V87, P2006, DOI 10.1002/jnr.22031; Han SSW, 2011, NEURON, V70, P626, DOI 10.1016/j.neuron.2011.05.003; He J, 2005, CELL PHYSIOL BIOCHEM, V16, P69, DOI 10.1159/000087733; Ibanez-Sandoval O, 2007, J NEUROPHYSIOL, V98, P2311, DOI 10.1152/jn.00620.2007; Inglefield JR, 1999, METHODS, V18, P197, DOI 10.1006/meth.1999.0772; Jonsson ME, 2009, EXP NEUROL, V219, P341, DOI 10.1016/j.expneurol.2009.06.006; Khaira SK, 2011, NEUROCHEM INT, V59, P413, DOI 10.1016/j.neuint.2011.02.016; Khaira SK, 2009, BRIT J PHARMACOL, V158, P1922, DOI 10.1111/j.1476-5381.2009.00479.x; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Klimanskaya I, 2008, NAT REV DRUG DISCOV, V7, P131, DOI 10.1038/nrd2403; KRAPF R, 1988, BIOPHYS J, V53, P955, DOI 10.1016/S0006-3495(88)83176-X; Lang RJ, 2004, EUR J NEUROSCI, V20, P3209, DOI 10.1111/j.1460-9568.2004.03782.x; Liu Jia, 2007, Neurosci Bull, V23, P377, DOI 10.1007/s12264-007-0056-4; Lobb CJ, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00025; Lobb CJ, 2011, J NEUROPHYSIOL, V105, P2501, DOI 10.1152/jn.01076.2010; Malmersjo S, 2010, STEM CELLS DEV, V19, P1355, DOI 10.1089/scd.2009.0436; McNeish J, 2004, NAT REV DRUG DISCOV, V3, P70, DOI 10.1038/nrd1281; Meredith GE, 2009, EXP NEUROL, V219, P334, DOI 10.1016/j.expneurol.2009.06.005; Morizane A, 2008, CELL TISSUE RES, V331, P323, DOI 10.1007/s00441-007-0541-0; Nishimura F, 2003, STEM CELLS, V21, P171, DOI 10.1634/stemcells.21-2-171; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Nunez JL, 2003, EXP NEUROL, V181, P258, DOI 10.1016/S0014-4886(03)00053-0; Owens DF, 1996, J NEUROSCI, V16, P6414; Pignatelli A, 2009, PFLUG ARCH EUR J PHY, V457, P899, DOI 10.1007/s00424-008-0535-0; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Pouton CW, 2007, NAT REV DRUG DISCOV, V6, P605, DOI 10.1038/nrd2194; Preston A, 2003, BRIT J PHARMACOL, V138, P218, DOI 10.1038/sj.bjp.0705021; Raye WS, 2007, EUR J NEUROSCI, V25, P1961, DOI 10.1111/j.1460-9568.2007.05489.x; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Santhakumar V, 2010, NEUROSCIENCE, V167, P644, DOI 10.1016/j.neuroscience.2010.02.048; Stein V, 2004, J COMP NEUROL, V468, P57, DOI 10.1002/cne.10983; Steiner B, 2008, J NEUROSCI METH, V169, P128, DOI 10.1016/j.jneumeth.2007.11.032; Storch A, 2003, J CHEM NEUROANAT, V26, P133, DOI 10.1016/S0891-0618(03)00067-X; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x	51	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31999	10.1371/journal.pone.0031999	http://dx.doi.org/10.1371/journal.pone.0031999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384125	gold, Green Submitted, Green Published			2022-12-27	WOS:000302875500065
J	Wright, DB; Skagerberg, EM				Wright, Daniel B.; Skagerberg, Elin M.			Measuring Empathizing and Systemizing with a Large US Sample	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; SPECTRUM QUOTIENT AQ; PSYCHOMETRIC ANALYSIS; ASPERGER-SYNDROME; ADULTS; VALIDATION	A large number of people completed one of two versions of the empathizing quotient (EQ) and systemizing quotient (SQ). One version had the negatively phrased items all re-worded. These re-worded items were answered more rapidly than the original items, and for the SQ produced a more reliable scale. Subjects gave self-assessments of empathizing and systemizing, and these were moderately correlated, r approximate to.6, with their respective quotients. Females had on average higher empathizing scores and males had on average higher systemizing scores. If a female-male pair was chosen at random, the female would have the higher empathizing score about two-thirds of the time, and the males would have the higher systemizing score about two-thirds of the time.	[Wright, Daniel B.] Florida Int Univ, Dept Psychol, Miami, FL 33199 USA; [Skagerberg, Elin M.] Tavistock & Portman NHS Fdn Trust, Gender Ident Dev Serv, London, England	State University System of Florida; Florida International University	Wright, DB (corresponding author), Florida Int Univ, Dept Psychol, Miami, FL 33199 USA.	dwright@fiu.edu			Florida International University	Florida International University	This study was funded by a start up grant awarded to the first from Florida International University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison C, 2011, PERS INDIV DIFFER, V51, P829, DOI 10.1016/j.paid.2011.07.005; Asperger H, 1944, ARCH PSYCHIAT NERVEN, V117, P76, DOI 10.1007/BF01837709; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S., 2003, ESSENTIAL DIFFERENCE; Baron-Cohen S., 2011, ZERO DEGREES EMPATHY; Baron-Cohen S, 2006, PROG NEURO-PSYCHOPH, V30, P865, DOI 10.1016/j.pnpbp.2006.01.010; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Baron-Cohen S, 2009, ANN NY ACAD SCI, V1156, P68, DOI 10.1111/j.1749-6632.2009.04467.x; Bonett DG, 2003, APPL PSYCH MEAS, V27, P72, DOI 10.1177/0146621602239477; Cattaneo L, 2007, P NATL ACAD SCI USA, V104, P17825, DOI 10.1073/pnas.0706273104; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dinstein I, 2010, NEURON, V66, P461, DOI 10.1016/j.neuron.2010.03.034; Feldt LS, 2006, EDUC PSYCHOL MEAS, V66, P589, DOI 10.1177/0013164405282488; Frith U, 1991, AUTISM ASPERGERS SYN; Goldenfeld N, 2005, CLIN NEUROPSYCHIATR, V2, P338; Hare R.D, 2003, MANUAL REVISED PSYCH, V2nd; Hoekstra RA, 2011, J AUTISM DEV DISORD, V41, P589, DOI 10.1007/s10803-010-1073-0; Iacoboni M., 2008, MIRRORING PEOPLE SCI; Keysers C., 2011, EMPATHIC BRAIN DISCO; Lepage JF, 2009, CAN J BEHAV SCI, V41, P272, DOI 10.1037/a0016248; Ling J, 2009, BRIT J PSYCHOL, V100, P539, DOI 10.1348/000712608X368261; Ramachandran VS, 2006, SCI AM, V295, P62, DOI 10.1038/scientificamerican1106-62; Rizopoulos D, 2006, J STAT SOFTW, V17; Schuman H., 1981, QUESTIONS ANSWERS AT; Wakabayashi A, 2007, J AUTISM DEV DISORD, V37, P1823, DOI 10.1007/s10803-006-0316-6; Wheelwright S, 2006, BRAIN RES, V1079, P47, DOI 10.1016/j.brainres.2006.01.012	27	36	36	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31661	10.1371/journal.pone.0031661	http://dx.doi.org/10.1371/journal.pone.0031661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZZ	22384049	gold, Green Published, Green Accepted			2022-12-27	WOS:000302875500029
J	Knorr, U; Vinberg, M; Mortensen, EL; Winkel, P; Gluud, C; Wetterslev, J; Gether, U; Kessing, LV				Knorr, Ulla; Vinberg, Maj; Mortensen, Erik Lykke; Winkel, Per; Gluud, Christian; Wetterslev, Jorn; Gether, Ulrik; Kessing, Lars Vedel			Effect of Chronic Escitalopram versus Placebo on Personality Traits in Healthy First-Degree Relatives of Patients with Depression: A Randomized Trial	PLOS ONE			English	Article							MAJOR DEPRESSION; DRUG-TREATMENT; INTERVENTION; INVENTORY; DESIGN; MODEL	Introduction: The serotonergic neurotransmitter system is closely linked to depression and personality traits. It is not known if selective serotonin reuptake inhibitors (SSRI) have an effect on neuroticism that is independent of their effect on depression. Healthy individuals with a genetic liability for depression represent a group of particular interest when investigating if intervention with SSRIs affects personality. The present trial is the first to test the hypothesis that escitalopram may reduce neuroticism in healthy first-degree relatives of patients with major depressive disorder (MD). Methods: The trial used a randomized, blinded, placebo-controlled parallel-group design. We examined the effect of four weeks escitalopram 10 mg daily versus matching placebo on personality in 80 people who had a biological parent or sibling with a history of MD. The outcome measure on personality traits was change in self-reported neuroticism scores on the Revised Neuroticism-Extroversion-Openness-Personality Inventory (NEO-PI-R) and the Eysenck Personality Inventory (EPQ) from entry until end of four weeks of intervention. Results: When compared with placebo, escitalopram did not significantly affect self-reported NEO-PI-R and EPQ neuroticism and extroversion, EPQ psychoticism, NEO-PI-R openness, or NEO-PI-R conscientiousness (p all above 0.05). However, escitalopram increased NEO-PI-R agreeableness scores significantly compared with placebo (mean; SD) (2.38; 8.09) versus (-1.32; 7.94), p = 0.046), but not following correction for multiplicity. A trend was shown for increased conscientiousness (p = 0.07). There was no significant effect on subclinical depressive symptoms (p = 0.6). Conclusion: In healthy first-degree relatives of patients with MD, there is no effect of escitalopram on neuroticism, but it is possible that escitalopram may increase the personality traits of agreeableness and conscientiousness.	[Knorr, Ulla; Vinberg, Maj; Kessing, Lars Vedel] Univ Copenhagen Hosp, Rigshosp, Psychiat Ctr Copenhagen, DK-2100 Copenhagen, Denmark; [Knorr, Ulla; Mortensen, Erik Lykke] Univ Copenhagen Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, DK-2100 Copenhagen, Denmark; [Winkel, Per; Gluud, Christian; Wetterslev, Jorn] Univ Copenhagen, Dept Hlth Psychol, Copenhagen, Denmark; [Knorr, Ulla; Gether, Ulrik] Univ Copenhagen, Ctr Pharmacogen, Dept Neurosci & Pharmacol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Knorr, U (corresponding author), Univ Copenhagen Hosp, Rigshosp, Psychiat Ctr Copenhagen, DK-2100 Copenhagen, Denmark.	ulla.knorr@regionh.dk	Gluud, Christian/HGB-3191-2022; Gluud, Christian/AAY-1027-2021; Wetterslev, Jørn/ABF-1251-2020; Vinberg/ABC-7493-2021	Gluud, Christian/0000-0002-8861-0799; Wetterslev, Jørn/0000-0001-7778-1771; Vinberg/0000-0002-5982-1335; Kessing, Lars/0000-0001-9377-9436; Knorr, Ulla/0000-0002-1222-1527; Mortensen, Erik Lykke/0000-0002-6985-451X; Gether, Ulrik/0000-0002-0020-3807	Center for Pharmacogenomics, University of Copenhagen (Danish Research Councils) [2052-03-0025]; Lundbeck Foundation; Eli Larsen Foundation; Jeppe Juhl Foundation; Geert Jorgensen Foundation; Ivan Nielsen Foundation; Lundbeck Foundation [R17-2007-1798] Funding Source: researchfish	Center for Pharmacogenomics, University of Copenhagen (Danish Research Councils)(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Eli Larsen Foundation; Jeppe Juhl Foundation; Geert Jorgensen Foundation; Ivan Nielsen Foundation; Lundbeck Foundation(Lundbeckfonden)	The trial was supported by Center for Pharmacogenomics, University of Copenhagen (Danish Research Councils 2052-03-0025). The AGENDA trial has received non-restricted grants from non-profit and for-profit organizations. The Danish Psychological Publishers are thanked for providing the NEO-PI-R free of charge. H. Lundbeck A/S supplied the study drug and placebo free of charge. The Lundbeck Foundation, The Eli Larsen Foundation, The Jeppe Juhl Foundation, The Geert Jorgensen Foundation and The Ivan Nielsen Foundation gave unrestricted economical support. None of the grant contributors had any involvement in the design, organization, analysis, or preparation for publication of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce E, 2008, PSYCHOPHARMACOLOGY, V196, P661, DOI 10.1007/s00213-007-1004-8; Barnett JH, 2011, PSYCHOL MED, V41, P1593, DOI 10.1017/S0033291710002333; Bech P, 2006, PHARMACOPSYCHIATRY, V39, P128, DOI 10.1055/s-2006-946702; BECH P, 1986, ACTA PSYCHIAT SCAND, V73, P1; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Christensen MV, 2006, NORD J PSYCHIAT, V60, P79, DOI 10.1080/08039480600600300; Costa PT, 1997, J PERS ASSESS, V68, P86, DOI 10.1207/s15327752jpa6801_7; Du LS, 2002, J AFFECT DISORDERS, V71, P235, DOI 10.1016/S0165-0327(01)00370-6; Ekselius L, 1999, BRIT J PSYCHIAT, V174, P444, DOI 10.1192/bjp.174.5.444; Eysenck H.J., 1975, MANUAL EYSENCK PERSO; Frokjaer VG, 2009, NEUROIMAGE, V46, P360, DOI 10.1016/j.neuroimage.2009.02.008; Harmer CJ, 2009, BRIT J PSYCHIAT, V195, P102, DOI 10.1192/bjp.bp.108.051193; Harmer CJ, 2006, BIOL PSYCHIAT, V59, P816, DOI 10.1016/j.biopsych.2005.10.015; Huezo-Diaz Patricia, 2005, Curr Psychiatry Rep, V7, P117, DOI 10.1007/s11920-005-0008-5; Kendler KS, 2010, PSYCHOL MED, V40, P801, DOI 10.1017/S0033291709991140; Kendler KS, 2006, ARCH GEN PSYCHIAT, V63, P1113, DOI 10.1001/archpsyc.63.10.1113; Knorr U, 2011, THER ADV PSYCHOPHARM, V1, P133, DOI 10.1177/2045125311422591; Knorr U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021224; Knorr U, 2010, NORD J PSYCHIAT, V64, P153, DOI 10.3109/08039480903511381; Knorr U, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-66; Knutson B, 1998, AM J PSYCHIAT, V155, P373, DOI 10.1176/ajp.155.3.373; Lindstrom E, 2001, NORD J PSYCHIAT, V55, P5, DOI 10.1080/080394801317084428; Nemoto H, 2003, NEUROREPORT, V14, P791, DOI 10.1097/00001756-200305060-00003; Norbury R, 2011, MOL PSYCHIAT; Quilty LC, 2006, J AFFECT DISORDERS, V111, P67; Quitkin FM, 1999, AM J PSYCHIAT, V156, P829, DOI 10.1176/ajp.156.6.829; Rothen S, 2009, J AFFECT DISORDERS, V113, P133, DOI 10.1016/j.jad.2008.05.013; Skovdahl-Hansen H., 2004, DOKUMENTATION DANSKE; Takano A, 2007, BIOL PSYCHIAT, V62, P588, DOI 10.1016/j.biopsych.2006.11.007; Tang TZ, 2009, ARCH GEN PSYCHIAT, V66, P1322, DOI 10.1001/archgenpsychiatry.2009.166; Tse WS, 2002, PSYCHOPHARMACOLOGY, V161, P324, DOI 10.1007/s00213-002-1049-7; Tse WS, 2001, J PSYCHOPHARMACOL, V15, P195, DOI 10.1177/026988110101500313; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	35	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31980	10.1371/journal.pone.0031980	http://dx.doi.org/10.1371/journal.pone.0031980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393376	Green Published, gold, Green Submitted			2022-12-27	WOS:000303003500029
J	Queiroz, N; Humphries, NE; Noble, LR; Santos, AM; Sims, DW				Queiroz, Nuno; Humphries, Nicolas E.; Noble, Leslie R.; Santos, Antonio M.; Sims, David W.			Spatial Dynamics and Expanded Vertical Niche of Blue Sharks in Oceanographic Fronts Reveal Habitat Targets for Conservation	PLOS ONE			English	Article							WESTERN NORTH-ATLANTIC; TUNA THUNNUS-THYNNUS; PELAGIC SHARKS; PRIONACE-GLAUCA; SEASONAL MOVEMENTS; DIVING BEHAVIOR; XIPHIAS-GLADIUS; BASKING SHARKS; PACIFIC-OCEAN; MIGRATION	Dramatic population declines among species of pelagic shark as a result of overfishing have been reported, with some species now at a fraction of their historical biomass. Advanced telemetry techniques enable tracking of spatial dynamics and behaviour, providing fundamental information on habitat preferences of threatened species to aid conservation. We tracked movements of the highest pelagic fisheries by-catch species, the blue shark Prionace glauca, in the North-east Atlantic using pop-off satellite-linked archival tags to determine the degree of space use linked to habitat and to examine vertical niche. Overall, blue sharks moved south-west of tagging sites (English Channel; southern Portugal), exhibiting pronounced site fidelity correlated with localized productive frontal areas, with estimated space-use patterns being significantly different from that of random walks. Tracked female sharks displayed behavioural variability in diel depth preferences, both within and between individuals. Diel depth use ranged from normal DVM (nDVM; dawn descent, dusk ascent), to reverse DVM (rDVM; dawn ascent, dusk descent), to behavioural patterns where no diel differences were apparent. Results showed that blue sharks occupy some of the most productive marine zones for extended periods and structure diel activity patterns across multiple spatio-temporal scales in response to particular habitat types. In so doing, sharks occupied an extraordinarily broad vertical depth range for their size (1.0-2.0 m fork length), from the surface into the bathypelagic realm (max. dive depth, 1160 m). The space-use patterns of blue sharks indicated they spend much of the time in areas where pelagic longlining activities are often highest, and in depth zones where these fisheries particularly target other species, which could account for the rapid declines recently reported for blue sharks in many parts of the world's oceans. Our results provide habitat targets for blue shark conservation that may also be relevant to other pelagic species.	[Queiroz, Nuno; Humphries, Nicolas E.; Sims, David W.] Marine Biol Assoc United Kingdom Lab, Plymouth PL1 2PB, Devon, England; [Queiroz, Nuno; Santos, Antonio M.] Ctr Invest Biodiversidade & Recursos Genet, CIBIO UP, Vairao, Portugal; [Noble, Leslie R.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Humphries, Nicolas E.] Univ Plymouth, Sch Marine Sci & Engn, Inst Marine, Plymouth PL4 8AA, Devon, England; [Sims, David W.] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [Sims, David W.] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England	Marine Biological Association United Kingdom; Universidade do Porto; University of Aberdeen; University of Plymouth; NERC National Oceanography Centre; University of Southampton; University of Southampton	Queiroz, N (corresponding author), Marine Biol Assoc United Kingdom Lab, Citadel Hill, Plymouth PL1 2PB, Devon, England.	dws@mba.ac.uk	Humphries, Nick/AAE-7170-2019; Santos, António M/M-3515-2013; Queiroz, Nuno/G-3850-2010	Humphries, Nick/0000-0003-3741-1594; Santos, António M/0000-0002-0417-8813; Queiroz, Nuno/0000-0002-3860-7356; Sims, David/0000-0002-0916-7363; Noble, leslie/0000-0003-3076-0759	Save Our Seas Foundation; Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/MAR/100345/2008, SFRH/BPD/70070/2010]; UK Natural Environment Research Council (NERC); NERC [mba010004] Funding Source: UKRI; Natural Environment Research Council [mba010004] Funding Source: researchfish	Save Our Seas Foundation; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was received from the Save Our Seas Foundation (www.saveourseas.org), Fundacao para a Ciencia e a Tecnologia (FCT) Grant PTDC/MAR/100345/2008 and Scholarship SFRH/BPD/70070/2010 (www.fct.pt), and the UK Natural Environment Research Council (NERC) Oceans 2025 Strategic Research Programme (Theme 6, Science for Sustainable Marine Resources) (www.oceans2025.org) through grant awards to DWS and NQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird RW, 2008, MAR MAMMAL SCI, V24, P630, DOI 10.1111/j.1748-7692.2008.00211.x; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bigelow K, 2006, FISH RES, V77, P173, DOI 10.1016/j.fishres.2005.10.010; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Bolle LJ, 2005, ICES J MAR SCI, V62, P236, DOI 10.1016/j.icesjms.2004.11.010; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; Buencuerpo V, 1998, FISH B-NOAA, V96, P667; Campana SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016854; CAREY FG, 1990, MAR BIOL, V106, P329, DOI 10.1007/BF01344309; De Robertis A, 2002, LIMNOL OCEANOGR, V47, P925, DOI 10.4319/lo.2002.47.4.0925; Dupont N, 2009, LIMNOL OCEANOGR, V54, P1765, DOI 10.4319/lo.2009.54.5.1765; Field I, 2001, ANTARCT SCI, V13, P371, DOI 10.1017/S0954102001000529; Fitzmaurice P., 2005, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V58, P1171; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Hays GC, 2003, HYDROBIOLOGIA, V503, P163, DOI 10.1023/B:HYDR.0000008476.23617.b0; Hays GC, 2004, NATURE, V429, P522, DOI 10.1038/429522a; Hays GC, 2009, J EXP MAR BIOL ECOL, V370, P134, DOI 10.1016/j.jembe.2008.12.009; Horodysky AZ, 2007, FISH OCEANOGR, V16, P240, DOI 10.1111/j.1365-2419.2007.00419.x; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Kaartvedt S, 2007, LIMNOL OCEANOGR, V52, P975, DOI 10.4319/lo.2007.52.3.0975; Kohler NE, 2001, ENVIRON BIOL FISH, V60, P191, DOI 10.1023/A:1007679303082; Labat JP, 2009, DEEP-SEA RES PT I, V56, P1742, DOI 10.1016/j.dsr.2009.05.013; LEFEVRE J, 1986, ADV MAR BIOL, V23, P163; Litvinov F.F, 2006, J ICHTHYOL, V46, P613, DOI DOI 10.1134/S0032945206080091; Lopez-Mendilaharsu M, 2009, J EXP MAR BIOL ECOL, V378, P31, DOI 10.1016/j.jembe.2009.07.010; Lutcavage ME, 2000, MAR BIOL, V137, P347, DOI 10.1007/s002270000302; Manly BFJ, 1997, RANDOMIZATION BOOTST, P455; Marchesiello P, 2009, INT J EARTH SCI, V98, P299, DOI 10.1007/s00531-007-0235-6; Markaida U, 2005, FISH B-NOAA, V103, P219; McGregor HV, 2007, SCIENCE, V315, P637, DOI 10.1126/science.1134839; Mucientes GR, 2009, BIOL LETTERS, V5, P156, DOI 10.1098/rsbl.2008.0761; Neat FC, 2006, MAR BIOL, V148, P643, DOI 10.1007/s00227-005-0110-6; Olson D., 1994, OCEANOGRAPHY, V7, P52, DOI DOI 10.5670/OCEANOG.1994.03; Pade NG, 2009, J EXP MAR BIOL ECOL, V370, P64, DOI 10.1016/j.jembe.2008.12.002; PODESTA GP, 1993, CONT SHELF RES, V13, P253, DOI 10.1016/0278-4343(93)90109-B; Queiroz N, 2005, J MAR BIOL ASSOC UK, V85, P1107, DOI 10.1017/S0025315405012154; Queiroz N, 2010, MAR ECOL PROG SER, V406, P265, DOI 10.3354/meps08500; RINGELBERG J, 1995, J MAR BIOL ASSOC UK, V75, P15, DOI 10.1017/S0025315400015162; Rogan E, 2007, FISH RES, V86, P6, DOI 10.1016/j.fishres.2007.02.013; Schaefer KM, 2009, REV-METHODS TECHNOL, V9, P121, DOI 10.1007/978-1-4020-9640-2_8; Scheuerell MD, 2003, ECOLOGY, V84, P1713, DOI 10.1890/0012-9658(2003)084[1713:DVMBJS]2.0.CO;2; Sedberry GR, 2001, MAR BIOL, V139, P355; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Shaffer SA, 2009, MAR ECOL PROG SER, V391, P209, DOI 10.3354/meps07932; Simpfendorfer CA, 2002, FISH RES, V55, P175; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; Sims DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007351; Sims DW, 2005, J ANIM ECOL, V74, P755, DOI 10.1111/j.1365-2656.2005.00971.x; Sims DW, 2006, J ANIM ECOL, V75, P176, DOI 10.1111/j.1365-2656.2005.01033.x; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Sims DW, 2003, MAR ECOL PROG SER, V248, P187, DOI 10.3354/meps248187; Sims DW, 2003, J MAR BIOL ASSOC UK, V83, P643, DOI 10.1017/S0025315403007598h; STEVENS JD, 1976, J MAR BIOL ASSOC UK, V56, P929, DOI 10.1017/S002531540002097X; STEVENS JD, 1990, J MAR BIOL ASSOC UK, V70, P707, DOI 10.1017/S0025315400058999; STEVENS JD, 1973, J MAR BIOL ASSOC UK, V53, P357, DOI 10.1017/S0025315400022323; Turchin Peter, 1998; Walli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006151; Ward P, 2005, ECOLOGY, V86, P835, DOI 10.1890/03-0746; Ward P, 2005, CAN J FISH AQUAT SCI, V62, P1130, DOI 10.1139/F05-021; Weimerskirch H, 2008, MAR ECOL PROG SER, V362, P291, DOI 10.3354/meps07424; Weng KC, 2009, J FISH BIOL, V74, P1434, DOI 10.1111/j.1095-8649.2009.02209.x; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616; Weng KC, 2004, FISH B-NOAA, V102, P221; Weng KC, 2008, MAR ECOL PROG SER, V372, P253, DOI 10.3354/meps07706; West GJ, 2001, ENVIRON BIOL FISH, V60, P283, DOI 10.1023/A:1007697816642; WOLANSKI E, 1988, SCIENCE, V241, P177, DOI 10.1126/science.241.4862.177; Zainuddin M, 2006, DEEP-SEA RES PT II, V53, P419, DOI 10.1016/j.dsr2.2006.01.007	68	60	60	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32374	10.1371/journal.pone.0032374	http://dx.doi.org/10.1371/journal.pone.0032374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393403	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000303003500056
J	Ehrentraut, H; Westrich, JA; Eltzschig, HK; Clambey, ET				Ehrentraut, Heidi; Westrich, Joseph A.; Eltzschig, Holger K.; Clambey, Eric T.			Adora2b Adenosine Receptor Engagement Enhances Regulatory T Cell Abundance during Endotoxin-Induced Pulmonary Inflammation	PLOS ONE			English	Article							ACUTE LUNG INJURY; CUTTING EDGE; DEAMINASE DEFICIENCY; AIRWAY INFLAMMATION; DEPENDENT INDUCTION; IMMUNE-RESPONSE; DENDRITIC CELLS; HYPOXIA; PROTECTION; MICE	Anti-inflammatory signals play an essential role in constraining the magnitude of an inflammatory response. Extracellular adenosine is a critical tissue-protective factor, limiting the extent of inflammation. Given the potent anti-inflammatory effects of extracellular adenosine, we sought to investigate how extracellular adenosine regulates T cell activation and differentiation. Adenosine receptor activation by a pan adenosine-receptor agonist enhanced the abundance of murine regulatory T cells (Tregs), a cell type critical in constraining inflammation. Gene expression studies in both naive CD4 T cells and Tregs revealed that these cells expressed multiple adenosine receptors. Based on recent studies implicating the Adora2b in endogenous anti-inflammatory responses during acute inflammation, we used a pharmacologic approach to specifically activate Adora2b. Indeed, these studies revealed robust enhancement of Treg differentiation in wild-type mice, but not in Adora2b(-/-) T cells. Finally, when we subjected Adora2b-deficient mice to endotoxin-induced pulmonary inflammation, we found that these mice experienced more severe inflammation, characterized by increased cell recruitment and increased fluid leakage into the airways. Notably, Adora2b-deficient mice failed to induce Tregs after endotoxin-induced inflammation and instead had an enhanced recruitment of pro-inflammatory effector T cells. In total, these data indicate that the Adora2b adenosine receptor serves a potent anti-inflammatory role, functioning at least in part through the enhancement of Tregs, to limit inflammation.	[Ehrentraut, Heidi; Westrich, Joseph A.; Eltzschig, Holger K.; Clambey, Eric T.] Univ Colorado Denver, Mucosal Inflammat Program, Dept Anesthesiol, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Ehrentraut, H (corresponding author), Univ Colorado Denver, Mucosal Inflammat Program, Dept Anesthesiol, Aurora, CO 80045 USA.	eric.clambey@ucdenver.edu		Westrich, Joseph/0000-0003-2406-6891	National Institutes of Health [R01-HL0921, R01-DK083385, R01HL098294]; Crohn's and Colitis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092188, R01HL098294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by National Institutes of Health grants R01-HL0921, R01-DK083385, R01HL098294, and by a Crohn's and Colitis Foundation grant to HKE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne CM, 2011, GUT             0803; Belikoff BG, 2011, J IMMUNOL, V186, P2444, DOI 10.4049/jimmunol.1001567; Blackburn Michael R, 2009, Handb Exp Pharmacol, P215, DOI 10.1007/978-3-540-89615-9_8; Blackburn MR, 2000, J EXP MED, V192, P159, DOI 10.1084/jem.192.2.159; Blackburn MR, 2005, ADV IMMUNOL, V86, P1, DOI 10.1016/S0065-2776(04)86001-2; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Csoka B, 2010, J IMMUNOL, V185, P542, DOI 10.4049/jimmunol.0901295; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Dai YB, 2011, J AM SOC NEPHROL, V22, P890, DOI 10.1681/ASN.2010080890; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Du GJ, 2009, CANCER RES, V69, P3205, DOI 10.1158/0008-5472.CAN-08-3393; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Ernst PB, 2010, J IMMUNOL, V185, P1993, DOI 10.4049/jimmunol.1000108; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Frick JS, 2009, J IMMUNOL, V182, P4957, DOI 10.4049/jimmunol.0801324; Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137; Grenz A, 2011, ANTIOXID REDOX SIGN, V15, P2221, DOI 10.1089/ars.2010.3665; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Hart ML, 2009, J IMMUNOL, V182, P3965, DOI 10.4049/jimmunol.0802193; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Joetham A, 2009, J IMMUNOL, V183, P1821, DOI 10.4049/jimmunol.0900303; Keely S, 2009, FASEB J, V23, P1338, DOI 10.1096/fj.08-125344; Khoury J, 2007, J CLIN INVEST, V117, P703, DOI 10.1172/JCI30049; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Liu FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015404; Mirakaj V, 2010, AM J RESP CRIT CARE, V181, P815, DOI 10.1164/rccm.200905-0717OC; Mustafa SJ, 2007, J PHARMACOL EXP THER, V320, P1246, DOI 10.1124/jpet.106.112250; Naganuma M, 2006, J IMMUNOL, V177, P2765, DOI 10.4049/jimmunol.177.5.2765; Nakatsukasa H, 2011, BIOCHEM BIOPH RES CO, V409, P114, DOI 10.1016/j.bbrc.2011.04.125; Nemeth ZH, 2005, J IMMUNOL, V175, P8260, DOI 10.4049/jimmunol.175.12.8260; Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; Sitkovsky MV, 2008, CLIN CANCER RES, V14, P5947, DOI 10.1158/1078-0432.CCR-08-0229; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Szymczak-Workman AL, 2009, J IMMUNOL, V182, P5188, DOI 10.4049/jimmunol.0803123; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wilson JM, 2011, J IMMUNOL, V186, P6746, DOI 10.4049/jimmunol.1100117; Wilson JM, 2009, J IMMUNOL, V182, P4616, DOI 10.4049/jimmunol.0801279; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Zaynagetdinov R, 2010, AM J RESP CELL MOL, V42, P564, DOI 10.1165/rcmb.2008-0391OC; Zeng M, 2011, J CLIN INVEST, V121, P998, DOI 10.1172/JCI45157; Zhang YJ, 2011, NAT MED, V17, P79, DOI 10.1038/nm.2280; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou Y, 2011, J IMMUNOL, V186, P1097, DOI 10.4049/jimmunol.1002907; Zhou Y, 2009, J IMMUNOL, V182, P8037, DOI 10.4049/jimmunol.0900515	60	66	66	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32416	10.1371/journal.pone.0032416	http://dx.doi.org/10.1371/journal.pone.0032416			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389701	Green Published, Green Submitted, gold			2022-12-27	WOS:000302999600039
J	Atencio, CA; Schreiner, CE				Atencio, Craig A.; Schreiner, Christoph E.			Spectrotemporal Processing in Spectral Tuning Modules of Cat Primary Auditory Cortex	PLOS ONE			English	Article							FREQUENCY RESOLVING POWER; FUNCTIONAL-ORGANIZATION; VISUAL-CORTEX; RECEPTIVE-FIELDS; CORTICAL-NEURONS; THALAMOCORTICAL SYSTEM; INTRINSIC CONNECTIONS; FEATURE SELECTIVITY; COCHLEAR IMPLANT; NORMAL-HEARING	Spectral integration properties show topographical order in cat primary auditory cortex (AI). Along the iso-frequency domain, regions with predominantly narrowly tuned (NT) neurons are segregated from regions with more broadly tuned (BT) neurons, forming distinct processing modules. Despite their prominent spatial segregation, spectrotemporal processing has not been compared for these regions. We identified these NT and BT regions with broad-band ripple stimuli and characterized processing differences between them using both spectrotemporal receptive fields (STRFs) and nonlinear stimulus/firing rate transformations. The durations of STRF excitatory and inhibitory subfields were shorter and the best temporal modulation frequencies were higher for BT neurons than for NT neurons. For NT neurons, the bandwidth of excitatory and inhibitory subfields was matched, whereas for BT neurons it was not. Phase locking and feature selectivity were higher for NT neurons. Properties of the nonlinearities showed only slight differences across the bandwidth modules. These results indicate fundamental differences in spectrotemporal preferences - and thus distinct physiological functions for neurons in BT and NT spectral integration modules. However, some global processing aspects, such as spectrotemporal interactions and nonlinear input/output behavior, appear to be similar for both neuronal subgroups. The findings suggest that spectral integration modules in AI differ in what specific stimulus aspects are processed, but they are similar in the manner in which stimulus information is processed.	[Atencio, Craig A.; Schreiner, Christoph E.] Univ Calif San Francisco, UCSF Ctr Integrat Neurosci, Dept Otolaryngol HNS, Coleman Mem Lab, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Atencio, CA (corresponding author), Univ Calif San Francisco, UCSF Ctr Integrat Neurosci, Dept Otolaryngol HNS, Coleman Mem Lab, San Francisco, CA 94143 USA.	craig@phy.ucsf.edu		Schreiner, Christoph/0000-0002-4571-4328	National Institutes of Health [DC02260, MH077970]; Coleman Memorial Fund; Hearing Research Inc.; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coleman Memorial Fund; Hearing Research Inc.; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health (DC02260, MH077970), the Coleman Memorial Fund, and Hearing Research Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTSEN AMHJ, 1981, BIOL CYBERN, V42, P133, DOI 10.1007/BF00336731; Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Atencio CA, 2008, NEURON, V58, P956, DOI 10.1016/j.neuron.2008.04.026; Atencio CA, 2008, J NEUROSCI, V28, P3897, DOI 10.1523/JNEUROSCI.5366-07.2008; Atencio CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009521; Atencio CA, 2010, J NEUROPHYSIOL, V103, P192, DOI 10.1152/jn.00624.2009; Atencio CA, 2009, P NATL ACAD SCI USA, V106, P21894, DOI 10.1073/pnas.0908383106; Bizley JK, 2005, CEREB CORTEX, V15, P1637, DOI 10.1093/cercor/bhi042; Brenner N, 2000, NEURAL COMPUT, V12, P1531, DOI 10.1162/089976600300015259; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; Cheung SW, 2001, J NEUROPHYSIOL, V85, P1732, DOI 10.1152/jn.2001.85.4.1732; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; Ehret G, 1997, J COMP PHYSIOL A, V181, P635, DOI 10.1007/s003590050146; Ehret G, 2000, HEARING RES, V141, P107, DOI 10.1016/S0378-5955(99)00213-0; Escabi MA, 2005, J NEUROSCI, V25, P9524, DOI 10.1523/JNEUROSCI.1804-05.2005; Escabi MA, 2002, J NEUROSCI, V22, P4114, DOI 10.1523/JNEUROSCI.22-10-04114.2002; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1985, VISION RES, V25, P365, DOI 10.1016/0042-6989(85)90061-6; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Good PI., 2005, RESAMPLING METHODS P, V3rd ed.; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Henry BA, 2005, J ACOUST SOC AM, V118, P1111, DOI 10.1121/1.1944567; Henry BA, 2003, J ACOUST SOC AM, V113, P2861, DOI 10.1121/1.1561900; Imaizumi K, 2004, J NEUROPHYSIOL, V92, P444, DOI 10.1152/jn.01173.2003; Imaizumi K, 2007, J NEUROPHYSIOL, V98, P2933, DOI 10.1152/jn.00511.2007; IMIG TJ, 1977, BRAIN RES, V138, P241, DOI 10.1016/0006-8993(77)90743-0; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; Langner G, 1997, ACTA OTO-LARYNGOL, P68; Langner G, 1997, J COMP PHYSIOL A, V181, P665, DOI 10.1007/s003590050148; Lee CC, 2005, CEREB CORTEX, V15, P1804, DOI 10.1093/cercor/bhi057; LEWICKI MS, 1994, NEURAL COMPUT, V6, P1005, DOI 10.1162/neco.1994.6.5.1005; Mendelson JR, 1997, J COMP PHYSIOL A, V181, P615, DOI 10.1007/s003590050145; MERZENICH MM, 1975, J NEUROPHYSIOL, V38, P231, DOI 10.1152/jn.1975.38.2.231; Mesgarani N, 2008, J ACOUST SOC AM, V123, P899, DOI 10.1121/1.2816572; MIDDLEBROOKS JC, 1980, BRAIN RES, V181, P31, DOI 10.1016/0006-8993(80)91257-3; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Miller LM, 2001, J NEUROSCI, V21, P8136, DOI 10.1523/JNEUROSCI.21-20-08136.2001; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; Miller LM, 2000, J NEUROSCI, V20, P7011, DOI 10.1523/JNEUROSCI.20-18-07011.2000; Ojima H, 1991, CEREB CORTEX, V1, P80, DOI 10.1093/cercor/1.1.80; PHILLIPS DP, 1992, CEREB CORTEX, V2, P425, DOI 10.1093/cercor/2.5.425; Polley DB, 2007, J NEUROPHYSIOL, V97, P3621, DOI 10.1152/jn.01298.2006; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1998, AUDIOL NEURO-OTOL, V3, P86, DOI 10.1159/000013784; Read HL, 2008, NEUROSCIENCE, V152, P151, DOI 10.1016/j.neuroscience.2007.11.026; Read HL, 2001, P NATL ACAD SCI USA, V98, P8042, DOI 10.1073/pnas.131591898; Read HL, 2011, HEARING RES, DOI [10.1016/ j.heares.2010.1011.1010, DOI 10.1016/J.HEARES.2010.1011.1010]; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; Recanzone GH, 1999, J COMP NEUROL, V415, P460, DOI 10.1002/(SICI)1096-9861(19991227)415:4<460::AID-CNE4>3.0.CO;2-F; Ringach DL, 2007, J NEUROSCI, V27, P7673, DOI 10.1523/JNEUROSCI.1048-07.2007; Rodriguez FA, 2010, J NEUROPHYSIOL, V103, P887, DOI 10.1152/jn.00813.2009; ROUILLER EM, 1991, EXP BRAIN RES, V86, P483, DOI 10.1007/BF00230523; Schreiner C.E., 1994, AUDIT NEUROSCI, V1, P39; SCHREINER CE, 1988, HEARING RES, V32, P49, DOI 10.1016/0378-5955(88)90146-3; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; SCHREINER CE, 1992, EXP BRAIN RES, V92, P105; Schreiner CE, 1998, AUDIOL NEURO-OTOL, V3, P104, DOI 10.1159/000013785; SCHREINER CE, 1990, J NEUROPHYSIOL, V64, P1442, DOI 10.1152/jn.1990.64.5.1442; SCHREINER CE, 1992, J NEUROPHYSIOL, V68, P1487, DOI 10.1152/jn.1992.68.5.1487; Schreiner CE, 2007, NEURON, V56, P356, DOI 10.1016/j.neuron.2007.10.013; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; SUPIN AY, 1994, HEARING RES, V78, P31, DOI 10.1016/0378-5955(94)90041-8; SUPIN AY, 1994, NEUROSCI LETT, V165, P195, DOI 10.1016/0304-3940(94)90743-9; SUTTER ML, 1991, J NEUROPHYSIOL, V65, P1207, DOI 10.1152/jn.1991.65.5.1207; Sutter ML, 1999, J NEUROPHYSIOL, V82, P2358, DOI 10.1152/jn.1999.82.5.2358; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; TSO DY, 1986, J NEUROSCI, V6, P1160; WINER JA, 1992, MAMMALIAN AUDITORY P, P222; Wise KD, 2005, IEEE ENG MED BIOL, V24, P22, DOI 10.1109/MEMB.2005.1511497; Woolley SMN, 2009, J NEUROSCI, V29, P2780, DOI 10.1523/JNEUROSCI.2042-08.2009; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536; Yuan KX, 2011, J NEUROSCI, V31, P13333, DOI 10.1523/JNEUROSCI.1000-11.2011	75	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31537	10.1371/journal.pone.0031537	http://dx.doi.org/10.1371/journal.pone.0031537			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384036	Green Submitted, gold, Green Published			2022-12-27	WOS:000302918500028
J	Bigini, P; Diana, V; Barbera, S; Fumagalli, E; Micotti, E; Sitia, L; Paladini, A; Bisighini, C; De Grada, L; Coloca, L; Colombo, L; Manca, P; Bossolasco, P; Malvestiti, F; Fiordaliso, F; Forloni, G; Morbidelli, M; Salmona, M; Giardino, D; Mennini, T; Moscatelli, D; Silani, V; Cova, L				Bigini, Paolo; Diana, Valentina; Barbera, Sara; Fumagalli, Elena; Micotti, Edoardo; Sitia, Leopoldo; Paladini, Alessandra; Bisighini, Cinzia; De Grada, Laura; Coloca, Laura; Colombo, Laura; Manca, Pina; Bossolasco, Patrizia; Malvestiti, Francesca; Fiordaliso, Fabio; Forloni, Gianluigi; Morbidelli, Massimo; Salmona, Mario; Giardino, Daniela; Mennini, Tiziana; Moscatelli, Davide; Silani, Vincenzo; Cova, Lidia			Longitudinal Tracking of Human Fetal Cells Labeled with Super Paramagnetic Iron Oxide Nanoparticles in the Brain of Mice with Motor Neuron Disease	PLOS ONE			English	Article							STEM-CELLS; TRANSFECTION AGENT; MOUSE MODEL; IN-VIVO; SCLEROSIS; CORD; DIFFERENTIATION; TRANSPLANTATION; EXPRESSION	Stem Cell (SC) therapy is one of the most promising approaches for the treatment of Amyotrophic Lateral Sclerosis (ALS). Here we employed Super Paramagnetic Iron Oxide nanoparticles (SPIOn) and Hoechst 33258 to track human Amniotic Fluid Cells (hAFCs) after transplantation in the lateral ventricles of wobbler (a murine model of ALS) and healthy mice. By in vitro, in vivo and ex vivo approaches we found that: 1) the main physical parameters of SPIOn were maintained over time; 2) hAFCs efficiently internalized SPIOn into the cytoplasm while Hoechst 33258 labeled nuclei; 3) SPIOn internalization did not alter survival, cell cycle, proliferation, metabolism and phenotype of hAFCs; 4) after transplantation hAFCs rapidly spread to the whole ventricular system, but did not migrate into the brain parenchyma; 5) hAFCs survived for a long time in the ventricles of both wobbler and healthy mice; 6) the transplantation of double-labeled hAFCs did not influence mice survival.	[Bigini, Paolo; Barbera, Sara; Fumagalli, Elena; Micotti, Edoardo; Sitia, Leopoldo; Paladini, Alessandra; Bisighini, Cinzia; Colombo, Laura; Fiordaliso, Fabio; Forloni, Gianluigi; Salmona, Mario; Mennini, Tiziana] Mario Negri Inst Pharmacol Res, Milan, Italy; [De Grada, Laura; Coloca, Laura; Manca, Pina; Malvestiti, Francesca; Giardino, Daniela] ISCCR Ist Auxol Italiano, Lab Citogenet, Cusano Milanino, Italy; [Bossolasco, Patrizia] Univ Milan, Dipartimento Farmacol Chemioterapia & Tossicol Me, Fdn Matarelli, Milan, Italy; [Morbidelli, Massimo] ETH, Inst Chem & Bioengn, Zurich, Switzerland; [Moscatelli, Davide] Politecn Milan, Dipartimento Chim Mat & Ingn Chim G Natta, I-20133 Milan, Italy; [Silani, Vincenzo] Univ Milan, Dept Neurol, Ctr Dino Ferrari, IRCCS Ist Auxol Italiano, Milan, Italy; [Silani, Vincenzo] Univ Milan, Neurosci Lab, Ctr Dino Ferrari, IRCCS Ist Auxol Italiano, Milan, Italy; [Diana, Valentina; Silani, Vincenzo; Cova, Lidia] IRCCS Ist Auxol Italiano, Neurosci Lab, Cusano Milanino, Italy; [Diana, Valentina; Silani, Vincenzo; Cova, Lidia] IRCCS Ist Auxol Italiano, Dept Neurol, Cusano Milanino, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS Istituto Auxologico Italiano; University of Milan; Swiss Federal Institutes of Technology Domain; ETH Zurich; Polytechnic University of Milan; IRCCS Istituto Auxologico Italiano; University of Milan; IRCCS Istituto Auxologico Italiano; University of Milan; IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano	Bigini, P (corresponding author), Mario Negri Inst Pharmacol Res, Milan, Italy.	l.cova@auxologico.it	Silani, Vincenzo/P-4421-2017; Micotti, Edoardo/J-9359-2018; Bossolasco, Patrizia/AAA-5275-2020; Cova, Lidia/K-6459-2016; colombo, laura/AAA-6716-2020; DE GRADA, LAURA/AAA-5224-2020; salmona, mario/AAA-7116-2020; Forloni, Gianluigi/AAB-2115-2020; moscatelli, davide/G-8795-2013; salmona, mario/ABI-4066-2020; Sitia, Leopoldo/K-4017-2016; Bigini, Paolo/AAB-2901-2020; Fiordaliso, Fabio/AAA-7161-2020	Silani, Vincenzo/0000-0002-7698-3854; Micotti, Edoardo/0000-0002-5995-2992; Bossolasco, Patrizia/0000-0002-1596-7818; Cova, Lidia/0000-0002-1504-1556; colombo, laura/0000-0002-3243-0270; DE GRADA, LAURA/0000-0001-6662-0999; salmona, mario/0000-0002-9098-9873; Forloni, Gianluigi/0000-0001-5374-3914; moscatelli, davide/0000-0003-2759-9781; Sitia, Leopoldo/0000-0002-7268-4056; Bigini, Paolo/0000-0002-0239-9532; Fiordaliso, Fabio/0000-0002-0172-4030; Morbidelli, Massimo/0000-0002-0112-414X; Giardino, Daniela/0000-0003-2615-0026				Albani D, 2009, J NEUROCHEM, V110, P1445, DOI 10.1111/j.1471-4159.2009.06228.x; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Arbab AS, 2003, TRANSPLANTATION, V76, P1123, DOI 10.1097/01.TP.0000089237.39220.83; Berman SMC, 2011, WIRES NANOMED NANOBI, V3, P343, DOI 10.1002/wnan.140; Bigini P, 2011, REJUVENATIO IN PRESS; Bigini P, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-71; Bigini P, 2007, NEUROSCI LETT, V426, P106, DOI 10.1016/j.neulet.2007.08.057; Bossolasco P, 2006, CELL RES, V16, P329, DOI 10.1038/sj.cr.7310043; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Bulte JWM, 2004, METHOD ENZYMOL, V386, P275; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Cova L, 2010, STEM CELLS CLONING, V3, P145, DOI 10.2147/SCCAA.S8662; Diana V, 2010, EXP NEUROL, V225, P163, DOI 10.1016/j.expneurol.2010.06.008; DUCHEN LW, 1968, J NEUROL NEUROSUR PS, V31, P535, DOI 10.1136/jnnp.31.6.535; Flexman JA, 2011, MOL IMAGING BIOL, V13, P104, DOI 10.1007/s11307-010-0311-3; Focke A, 2008, MAGN RESON MED, V60, P1321, DOI 10.1002/mrm.21745; Garbuzova-Davis S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002494; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Hedlund E, 2007, EUR J NEUROSCI, V26, P1721, DOI 10.1111/j.1460-9568.2007.05780.x; Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248; Kim H, 2010, NEUROSCI LETT, V468, P190, DOI 10.1016/j.neulet.2009.10.074; Liu W, 2009, EUR J RADIOL, V70, P258, DOI 10.1016/j.ejrad.2008.09.021; Lohrke J, 2008, NANOMEDICINE-UK, V3, P437, DOI 10.2217/17435889.3.4.437; Magnitsky S, 2005, NEUROIMAGE, V26, P744, DOI 10.1016/j.neuroimage.2005.02.029; Mailander V, 2009, BIOMACROMOLECULES, V10, P2379, DOI 10.1021/bm900266r; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Mazzini L, 2011, CYTOTHERAPY; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Mohorko N, 2005, HUM EXP TOXICOL, V24, P573, DOI 10.1191/0960327105ht570oa; Nieman BJ, 2010, NEUROIMAGE, V50, P456, DOI 10.1016/j.neuroimage.2009.12.107; Paxinos G., MOUSE BRAIN STEREOTA; Pioro EP, 1998, NEUROREPORT, V9, P3041, DOI 10.1097/00001756-199809140-00023; Rathke-Hartlieb S, 1999, NEUROREPORT, V10, P3411, DOI 10.1097/00001756-199911080-00028; Schmitt-John T, 2005, NAT GENET, V37, P1213, DOI 10.1038/ng1661; Silani V, 2010, CNS NEUROL DISORD-DR, V9, P314, DOI 10.2174/187152710791292666; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba; Zhang C, 2009, CYTOTHERAPY, V11, P299, DOI 10.1080/14653240902806986	37	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e32326	10.1371/journal.pone.0032326	http://dx.doi.org/10.1371/journal.pone.0032326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384217	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500078
J	Zichel, R; Chearwae, W; Pandey, GS; Golding, B; Sauna, ZE				Zichel, Ran; Chearwae, Wanida; Pandey, Gouri Shankar; Golding, Basil; Sauna, Zuben E.			Aptamers as a Sensitive Tool to Detect Subtle Modifications in Therapeutic Proteins	PLOS ONE			English	Article							FACTOR-VIII; HUMAN THROMBIN; BIOSIMILARS; COMPARABILITY; INHIBITORS; AGENTS	Therapeutic proteins are derived from complex expression/production systems, which can result in minor conformational changes due to preferential codon usage in different organisms, post-translational modifications, etc. Subtle conformational differences are often undetectable by bioanalytical methods but can sometimes profoundly impact the safety, efficacy and stability of products. Numerous bioanalytical methods exist to characterize the primary structure of proteins, post translational modifications; protein-substrate/protein/protein interactions and functional bioassays are available for most proteins that are developed as products. There are however few analytical techniques to detect changes in the tertiary structure of proteins suitable for use during drug development and quality control. For example, x-ray crystallography and NMR are impractical for routine use and do not capture the heterogeneity of the product. Conformation-sensitive antibodies can be used to map proteins. However the development of antibodies to represent sufficient epitopes can be challenging. Other limitations of antibodies include limited supply, high costs, heterogeneity and batch to batch variations in titer. Here we provide proof-of-principle that DNA aptamers to thrombin can be used as surrogate antibodies to characterize conformational changes. We show that aptamers can be used in assays using either an ELISA or a label-free platform to characterize different thrombin products. In addition we replicated a heat-treatment procedure that has previously been shown to not affect protein activity but can result in conformational changes that have serious adverse consequences. We demonstrate that a panel of aptamers (but not an antibody) can detect changes in the proteins even when specific activity is unaffected. Our results indicate a novel approach to monitor even small changes in the conformation of proteins which can be used in a routine drug-development and quality control setting. The technique can provide an early warning of structural changes during the manufacturing process that could have consequential outcomes downstream.	[Zichel, Ran; Chearwae, Wanida; Pandey, Gouri Shankar; Sauna, Zuben E.] US FDA, Ctr Biol Evaluat & Res, Div Hematol, Lab Hemostasis, Bethesda, MD 20014 USA; [Golding, Basil] US FDA, Ctr Biol Evaluat & Res, Div Hematol, Lab Plasma Derivat, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Zichel, R (corresponding author), Israel Inst Biol Res, Dept Biotechnol, IL-70450 Ness Ziona, Israel.	zuben.sauna@fda.hhs.gov	Sauna, Zuben E./AAA-7149-2019		Laboratory of Hemostasis; Center for Biologics Evaluation and Research, Food and Drug Administration's Modernization of Science	Laboratory of Hemostasis; Center for Biologics Evaluation and Research, Food and Drug Administration's Modernization of Science	This work was supported by funds from the Laboratory of Hemostasis and the Center for Biologics Evaluation and Research, Food and Drug Administration's Modernization of Science program (ZES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, REC PACK INS; [Anonymous], 2007, EV PACK INS; [Anonymous], 2007, THROMB JMI PACK INS; [Anonymous], 2006, GUIDELINE SIMILAR BI; BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; Belsey MJ, 2006, NAT REV DRUG DISCOV, V5, P535, DOI 10.1038/nrd2093; Byeon JY, 2010, LANGMUIR, V26, P15430, DOI 10.1021/la1021824; Carothers JM, 2004, J AM CHEM SOC, V126, P5130, DOI 10.1021/ja031504a; Chapman WC, 2007, J AM COLL SURGEONS, V205, P252, DOI 10.1016/j.jamcollsurg.2007.03.020; Chirino AJ, 2004, NAT BIOTECHNOL, V22, P1383, DOI 10.1038/nbt1030; Concepcion J, 2009, COMB CHEM HIGH T SCR, V12, P791, DOI 10.2174/138620709789104915; DAWES J, 1984, THROMB RES, V36, P397, DOI 10.1016/0049-3848(84)90296-2; Dichtelmuller H, 1996, BIOLOGICALS, V24, P125, DOI 10.1006/biol.1996.0016; Doria C, 2008, CURR MED RES OPIN, V24, P785, DOI 10.1185/030079908X273426; Famulok M, 2005, CURR OPIN MOL THER, V7, P137; Iliuk AB, 2011, ANAL CHEM, V83, P4440, DOI 10.1021/ac201057w; Jhaveri S, 2000, NAT BIOTECHNOL, V18, P1293, DOI 10.1038/82414; Kessler CM, 2009, THROMB HAEMOSTASIS, V102, P15, DOI 10.1160/TH09-01-0034; Kozlowski S, 2011, NEW ENGL J MED, V365, P385, DOI 10.1056/NEJMp1107285; Lomax C, 2009, PHARMACOTHERAPY, V29, p8S, DOI 10.1592/phco.29.pt2.8S; MACAYA RF, 1993, P NATL ACAD SCI USA, V90, P3745, DOI 10.1073/pnas.90.8.3745; Modesti PA, 2009, ANESTHESIOLOGY, V111, P844, DOI 10.1097/ALN.0b013e3181b1607f; Peerlinck K, 1997, THROMB HAEMOSTASIS, V77, P80; PIZZI E, 1995, BIOPOLYMERS, V36, P675, DOI 10.1002/bip.360360513; Rathore AS, 2009, TRENDS BIOTECHNOL, V27, P698, DOI 10.1016/j.tibtech.2009.09.004; Rathore AS, 2009, NAT BIOTECHNOL, V27, P26, DOI 10.1038/nbt0109-26; Raut S, 1998, THROMB HAEMOSTASIS, V80, P624; Rentmeister A, 2007, NUCLEIC ACIDS RES, V35, P3713, DOI 10.1093/nar/gkm300; Rockberg J, 2008, NAT METHODS, V5, P1039, DOI 10.1038/nmeth.1272; Roger SD, 2010, EXPERT OPIN BIOL TH, V10, P1011, DOI 10.1517/14712591003796553; Ruigrok VJB, 2011, BIOCHEM J, V436, P1, DOI 10.1042/BJ20101860; Schellekens H, 2005, NEPHROL DIAL TRANSPL, V20, P3, DOI 10.1093/ndt/gfh1092; Schellekens H, 2004, TRENDS BIOTECHNOL, V22, P406, DOI 10.1016/j.tibtech.2004.06.003; Schellekens H, 2010, NAT BIOTECHNOL, V28, P28, DOI 10.1038/nbt0110-28; Schneider CK, 2008, NAT BIOTECHNOL, V26, P985, DOI 10.1038/nbt0908-985; Schoenecker JG, 2003, J AM COLL SURGEONS, V197, P580, DOI 10.1016/S1072-7515(03)00670-7; Shankar G, 2007, NAT BIOTECHNOL, V25, P555, DOI 10.1038/nbt1303; Soukup GA, 1999, TRENDS BIOTECHNOL, V17, P469, DOI 10.1016/S0167-7799(99)01383-9; Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275; Tombelli S, 2009, CURR OPIN MOL THER, V11, P179; TSIANG M, 1995, J BIOL CHEM, V270, P16854, DOI 10.1074/jbc.270.28.16854; Vinkenborg JL, 2011, NAT CHEM BIOL, V7, P519, DOI [10.1038/NCHEMBIO.609, 10.1038/nchembio.609]	42	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31948	10.1371/journal.pone.0031948	http://dx.doi.org/10.1371/journal.pone.0031948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384109	Green Published			2022-12-27	WOS:000302918500050
J	Kiselev, Y; Eriksen, TE; Forsdahl, S; Lan, HTN; Mikkola, I				Kiselev, Yury; Eriksen, Tonje Engevik; Forsdahl, Siri; Lan Huong Thi Nguyen; Mikkola, Ingvild			3T3 Cell Lines Stably Expressing Pax6 or Pax6(5a) - A New Tool Used for Identification of Common and Isoform Specific Target Genes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR PAX6; CELL-ADHESION MOLECULE; TISSUE GROWTH-FACTOR; PAIRED DOMAIN; DNA-BINDING; LENS; SEQUENCE; ROLES; ANIRIDIA; FAMILY	Pax6 and Pax6(5a) are two isoforms of the evolutionary conserved Pax6 gene often co-expressed in specific stochiometric relationship in the brain and the eye during development. The Pax6(5a) protein differs from Pax6 by having a 14 amino acid insert in the paired domain, causing the two proteins to have different DNA binding specificities. Difference in functions during development is proven by the fact that mutations in the 14 amino acid insertion for Pax6(5a) give a slightly different eye phenotype than the one described for Pax6. Whereas quite many Pax6 target genes have been published during the last years, few Pax6(5a) specific target genes have been reported on. However, target genes identified by Pax6 knockout studies can probably be Pax6(5a) targets as well, since this isoform also will be affected by the knockout. In order to identify new Pax6 target genes, and to try to distinguish between genes regulated by Pax6 and Pax6(5a), we generated FlpIn-3T3 cell lines stably expressing Pax6 or Pax6(5a). RNA was harvested from these cell lines and used in gene expression microarrays where we identified a number of genes differentially regulated by Pax6 and Pax6(5a). A majority of these were associated with the extracellular region. By qPCR we verified that Ncam1, Ngef, Sphk1, Dkk3 and Crtap are Pax6(5a) specific target genes, while Tgfbi, Vegfa, EphB2, Klk8 and Edn1 were confirmed as Pax6 specific target genes. Nbl1, Ngfb and seven genes encoding different glycosyl transferases appeared to be regulated by both. Direct binding to the promoters of Crtap, Ctgf, Edn1, Dkk3, Pdgfb and Ngef was verified by ChIP. Furthermore, a change in morphology of the stably transfected Pax6 and Pax6(5a) cells was observed, and the Pax6 expressing cells were shown to have increased proliferation and migration capacities.	[Kiselev, Yury; Eriksen, Tonje Engevik; Forsdahl, Siri; Lan Huong Thi Nguyen; Mikkola, Ingvild] Univ Tromso, Dept Pharm, Res Grp Pharmacol, Tromso, Norway	UiT The Arctic University of Tromso	Kiselev, Y (corresponding author), Univ Tromso, Dept Pharm, Res Grp Pharmacol, Tromso, Norway.	ingvild.mikkola@uit.no		Mikkola, Ingvild/0000-0001-6442-7626; Kiselev, Yury/0000-0002-6753-8572	Norwegian Research Council [160293]; Research School for Molecular and Structural Biology, University of Tromso; University of Tromso	Norwegian Research Council(Research Council of NorwayEuropean Commission); Research School for Molecular and Structural Biology, University of Tromso; University of Tromso	This work was supported by the Norwegian Research Council, grant # 160293 for I. M., and by the Research School for Molecular and Structural Biology, University of Tromso, with a Ph.D grant for Y.K. S. F. has a Ph.D grant from the University of Tromso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi A, 2008, RHEUMATOLOGY, V47, P760, DOI 10.1093/rheumatology/ken081; Assimacopoulos S, 2003, J NEUROSCI, V23, P6399; Azuma N, 1999, AM J HUM GENET, V65, P656, DOI 10.1086/302529; Azuma N, 2005, HUM MOL GENET, V14, P735, DOI 10.1093/hmg/ddi069; Beisvag V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-470; Caric D, 1997, DEVELOPMENT, V124, P5087; Cartier L, 2006, J NEUROBIOL, V66, P421, DOI 10.1002/neu.20225; CHALEPAKIS G, 1994, DNA CELL BIOL, V13, P891, DOI 10.1089/dna.1994.13.891; Chauhan BK, 2002, J BIOL CHEM, V277, P11539, DOI 10.1074/jbc.M110531200; Chauhan BK, 2004, NUCLEIC ACIDS RES, V32, P1696, DOI 10.1093/nar/gkh334; Chauhan BK, 2002, GENES CELLS, V7, P1267, DOI 10.1046/j.1365-2443.2002.00602.x; CZERNY T, 1995, MOL CELL BIOL, V15, P2858; Davis LK, 2008, HUM GENET, V123, P371, DOI 10.1007/s00439-008-0484-x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duncan MK, 2000, J CELL SCI, V113, P3173; Duncan MK, 1998, MOL CELL BIOL, V18, P5579, DOI 10.1128/MCB.18.9.5579; Duparc RH, 2006, DEV BIOL, V300, P647, DOI 10.1016/j.ydbio.2006.07.045; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; El Nakamura R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-52; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; Estivill-Torrus G, 2001, MECH DEVELOP, V109, P215, DOI 10.1016/S0925-4773(01)00527-5; Faber SC, 2002, DEVELOPMENT, V129, P3727; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; Gerlach-Bank LM, 2002, DEV DYNAM, V224, P109, DOI 10.1002/dvdy.10079; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Holst BD, 1997, P NATL ACAD SCI USA, V94, P1465, DOI 10.1073/pnas.94.4.1465; Huang DW, 2008, BIOINFORMATION, V2, P428; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Kim AS, 2003, DEV BRAIN RES, V145, P159, DOI 10.1016/S0165-3806(03)00213-X; Kozmik Z, 1997, EMBO J, V16, P6793, DOI 10.1093/emboj/16.22.6793; Kucerova R, 2006, INVEST OPHTH VIS SCI, V47, P5276, DOI 10.1167/iovs.06-0581; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Machon O, 2010, GENESIS, V48, P86, DOI 10.1002/dvg.20583; Martin CC, 2004, J BIOL CHEM, V279, P34277, DOI 10.1074/jbc.M404830200; Mikkola I, 1999, J BIOL CHEM, V274, P15115, DOI 10.1074/jbc.274.21.15115; Mitchell TN, 2003, ANN NEUROL, V53, P658, DOI 10.1002/ana.10576; Nagase T, 2001, DEV GROWTH DIFFER, V43, P683; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Numayama-Tsuruta K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-6; Olakowski M, 2009, FOLIA HISTOCHEM CYTO, V47, P249, DOI 10.2478/v10042-009-0031-1; OsumiYamashita N, 1997, DEV GROWTH DIFFER, V39, P53; OZAKI T, 1994, CANCER RES, V54, P646; Petros TJ, 2010, DEV NEUROBIOL, V70, P781, DOI 10.1002/dneu.20821; PHILIPPE J, 1988, MOL CELL BIOL, V8, P4877, DOI 10.1128/MCB.8.11.4877; Pinson J, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-13; Pinson J, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-25; PLAZA S, 1993, CELL GROWTH DIFFER, V4, P1041; Pras E, 2004, INVEST OPHTH VIS SCI, V45, P1940, DOI 10.1167/iovs.03-1117; PRITCHARD DJ, 1974, EXP EYE RES, V19, P335, DOI 10.1016/0014-4835(74)90018-9; PUSCHEL AW, 1992, DEVELOPMENT, V114, P643; Ramaesh T, 2006, INVEST OPHTH VIS SCI, V47, P1911, DOI 10.1167/iovs.05-1028; Rodrigues NR, 2000, GENOMICS, V65, P53, DOI 10.1006/geno.2000.6138; Rozen S, 2000, Methods Mol Biol, V132, P365; Rungger-Brandle E, 2010, DEV NEUROBIOL, V70, P764, DOI 10.1002/dneu.20816; Sakai M, 2001, NUCLEIC ACIDS RES, V29, P1228, DOI 10.1093/nar/29.5.1228; Samarakoon R, 2010, CELL SIGNAL, V22, P1413, DOI 10.1016/j.cellsig.2010.03.020; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shimizu N, 2009, BIOL PHARM BULL, V32, P999, DOI 10.1248/bpb.32.999; Singh S, 2002, P NATL ACAD SCI USA, V99, P6812, DOI 10.1073/pnas.102691299; Sivak JM, 2000, DEV BIOL, V222, P41, DOI 10.1006/dbio.2000.9694; Skala-Rubinson H, 2002, J BIOL CHEM, V277, P47190, DOI 10.1074/jbc.M209349200; Sugioka K, 2010, TOHOKU J EXP MED, V222, P45, DOI 10.1620/tjem.222.45; Takahashi Hiroshi, 2006, Birth Defects Research, V78, P256, DOI 10.1002/bdrc.20077; Takahashi M, 2009, CARBOHYD RES, V344, P1387, DOI 10.1016/j.carres.2009.04.031; Talamillo A, 2003, DEV BIOL, V255, P151, DOI 10.1016/S0012-1606(02)00046-5; Tang HK, 1998, J BIOL CHEM, V273, P7210, DOI 10.1074/jbc.273.13.7210; Vadas M, 2008, BBA-MOL CELL BIOL L, V1781, P442, DOI 10.1016/j.bbalip.2008.06.007; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Visel A, 2007, PLOS GENET, V3, P1867, DOI 10.1371/journal.pgen.0030178; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wolf LV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004159; Yao JG, 2008, DEV BIOL, V315, P535, DOI 10.1016/j.ydbio.2007.12.037; Yasuda T, 2002, DIABETES, V51, P224, DOI 10.2337/diabetes.51.1.224; Zhang WY, 2001, MOL VIS, V7, P1; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x; Zhou YH, 2003, CLIN CANCER RES, V9, P3369; Zhou YH, 2010, J NEURO-ONCOL, V96, P191, DOI 10.1007/s11060-009-9963-8	83	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31915	10.1371/journal.pone.0031915	http://dx.doi.org/10.1371/journal.pone.0031915			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384097	Green Submitted, gold, Green Published			2022-12-27	WOS:000302916100038
J	Rest, JS; Bullaughey, K; Morris, GP; Li, WH				Rest, Joshua S.; Bullaughey, Kevin; Morris, Geoffrey P.; Li, Wen-Hsiung			Contribution of Transcription Factor Binding Site Motif Variants to Condition-Specific Gene Expression Patterns in Budding Yeast	PLOS ONE			English	Article							DNA-BINDING; SACCHAROMYCES-CEREVISIAE; IN-VIVO; PROTEIN; SEQUENCES; GENOME; CIS; EVOLUTION; ELEMENT; INFERENCE	It is now experimentally well known that variant sequences of a cis transcription factor binding site motif can contribute to differential regulation of genes. We characterize the relationship between motif variants and gene expression by analyzing expression microarray data and binding site predictions. To accomplish this, we statistically detect motif variants with effects that differ among environments. Such environmental specificity may be due to either affinity differences between variants or, more likely, differential interactions of TFs bound to these variants with cofactors, and with differential presence of cofactors across environments. We examine conservation of functional variants across four Saccharomyces species, and find that about a third of transcription factors have target genes that are differentially expressed in a condition-specific manner that is correlated with the nucleotide at variant motif positions. We find good correspondence between our results and some cases in the experimental literature (Reb1, Sum1, Mcm1, and Rap1). These results and growing consensus in the literature indicates that motif variants may often be functionally distinct, that this may be observed in genomic data, and that variants play an important role in condition-specific gene regulation.	[Rest, Joshua S.; Bullaughey, Kevin; Morris, Geoffrey P.; Li, Wen-Hsiung] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Rest, JS (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.	Joshua.Rest@StonyBrook.edu; whli@uchicago.edu		Li, Wen-Hsiung/0000-0003-1086-1456; Rest, Joshua/0000-0002-9582-1041; Morris, Geoffrey Preston/0000-0002-3067-3359	National Institutes of Health [GM30998, GM081724]; International Balzan Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030998, R01GM081724, R01GM030998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Balzan Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health (www.nih.gov) grants (GM30998 and GM081724) and the International Balzan Foundation (www.balzan.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton TB, 1997, MOL CELL BIOL, V17, P1881, DOI 10.1128/MCB.17.4.1881; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Buck MJ, 2006, NAT GENET, V38, P1446, DOI 10.1038/ng1917; Chan SK, 1997, DEVELOPMENT, V124, P2007; Chechik G, 2008, NAT BIOTECHNOL, V26, P1251, DOI 10.1038/nbt.1499; Chen K, 2010, GENOME BIOL EVOL, V2, P697, DOI 10.1093/gbe/evq054; CHEN W, 1988, P NATL ACAD SCI USA, V85, P2691, DOI 10.1073/pnas.85.8.2691; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dos Santos C, 2009, DIABETES, V58, P489, DOI 10.2337/db08-0587; Erb I, 2006, IEEE P 1 INT C COMP; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Fuchs J, 2009, NEUROBIOL AGING, V30, P731, DOI 10.1016/j.neurobiolaging.2007.08.014; Gaudet J, 2004, PLOS BIOL, V2, P1828, DOI 10.1371/journal.pbio.0020352; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Giordano M, 2006, MOL CELL ENDOCRINOL, V249, P51, DOI 10.1016/j.mce.2006.01.006; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; HARBURY PAB, 1989, MOL CELL BIOL, V9, P5298, DOI 10.1128/MCB.9.12.5298; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Ihmels J, 2005, PLOS GENET, V1, P380, DOI 10.1371/journal.pgen.0010039; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; Karczewski KJ, 2011, P NATL ACAD SCI USA, V108, P13353, DOI 10.1073/pnas.1103105108; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kim HD, 2008, NAT STRUCT MOL BIOL, V15, P1192, DOI 10.1038/nsmb.1500; Kristensen VN, 2006, P NATL ACAD SCI USA, V103, P7735, DOI 10.1073/pnas.0601893103; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Landa I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000637; Laumen H, 2009, DIABETES, V58, P984, DOI 10.2337/db07-1646; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; LIAW PCY, 1994, YEAST, V10, P771, DOI 10.1002/yea.320100608; Lim FL, 2003, MOL CELL BIOL, V23, P450, DOI 10.1128/MCB.23.2.450-461.2003; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; McCord RP, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100140; Michal L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000018; Miller JA, 2003, MOL CELL BIOL, V23, P1623, DOI 10.1128/MCB.23.5.1623-1632.2003; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857; Papatsenko D, 2005, P NATL ACAD SCI USA, V102, P4966, DOI 10.1073/pnas.0409414102; Pierce M, 2003, MOL CELL BIOL, V23, P4814, DOI 10.1128/MCB.23.14.4814-4825.2003; Ren YQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000523; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Ronald J, 2005, GENOME RES, V15, P284, DOI 10.1101/gr.2850605; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; Seldeen KL, 2009, BIOCHEMISTRY-US, V48, P1975, DOI 10.1021/bi802068s; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Singh J, 2005, APPL ENVIRON MICROB, V71, P8752, DOI 10.1128/AEM.71.12.8752-8763.2005; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; STRUHL K, 1986, MOL CELL BIOL, V6, P3847, DOI 10.1128/MCB.6.11.3847; Swamy KBS, 2009, NUCLEIC ACIDS RES, V37, P6991, DOI 10.1093/nar/gkp743; Takagi Y, 2005, MOL CELL, V18, P237, DOI 10.1016/j.molcel.2005.03.007; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Tanay A, 2004, GENOME RES, V14, P829, DOI 10.1101/gr.2064404; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Tremblay JJ, 2000, NEUROENDOCRINOLOGY, V71, P277, DOI 10.1159/000054547; Wade C, 2001, MOL CELL BIOL, V21, P8638, DOI 10.1128/MCB.21.24.8638-8650.2001; WEFALD FC, 1990, NATURE, V344, P260, DOI 10.1038/344260a0; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; WYNNE J, 1992, NUCLEIC ACIDS RES, V20, P3297, DOI 10.1093/nar/20.13.3297; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zheng W, 2010, NATURE, V464, P1187, DOI 10.1038/nature08934; Zhong HL, 1999, GENOME RES, V9, P1040, DOI 10.1101/gr.9.11.1040; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607	71	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32274	10.1371/journal.pone.0032274	http://dx.doi.org/10.1371/journal.pone.0032274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384202	Green Submitted, gold, Green Published			2022-12-27	WOS:000302916100066
J	Bertrand, Y; Topel, M; Elvang, A; Melik, W; Johansson, M				Bertrand, Yann; Topel, Mats; Elvang, Annelie; Melik, Wessam; Johansson, Magnus			First Dating of a Recombination Event in Mammalian Tick-Borne Flaviviruses	PLOS ONE			English	Article							LOUPING ILL VIRUS; PHYLOGENETIC TREE SELECTION; MULTIPLE SEQUENCE ALIGNMENT; ENCEPHALITIS-VIRUS; RNA VIRUSES; POPULATION-DYNAMICS; PURIFYING SELECTION; MOLECULAR CLOCK; DENGUE VIRUS; DNA VIRUSES	The mammalian tick-borne flavivirus group (MTBFG) contains viruses associated with important human and animal diseases such as encephalitis and hemorrhagic fever. In contrast to mosquito-borne flaviviruses where recombination events are frequent, the evolutionary dynamic within the MTBFG was believed to be essentially clonal. This assumption was challenged with the recent report of several homologous recombinations within the Tick-borne encephalitis virus (TBEV). We performed a thorough analysis of publicly available genomes in this group and found no compelling evidence for the previously identified recombinations. However, our results show for the first time that demonstrable recombination (i.e., with large statistical support and strong phylogenetic evidences) has occurred in the MTBFG, more specifically within the Louping ill virus lineage. Putative parents, recombinant strains and breakpoints were further tested for statistical significance using phylogenetic methods. We investigated the time of divergence between the recombinant and parental strains in a Bayesian framework. The recombination was estimated to have occurred during a window of 282 to 76 years before the present. By unravelling the temporal setting of the event, we adduce hypotheses about the ecological conditions that could account for the observed recombination.	[Bertrand, Yann; Topel, Mats] Univ Gothenburg, Dept Plant & Environm Sci, Gothenburg, Sweden; [Elvang, Annelie; Melik, Wessam; Johansson, Magnus] Sodertorn Univ, Sch Life Sci, Huddinge, Sweden; [Melik, Wessam] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden	University of Gothenburg; Sodertorn University; Stockholm University	Bertrand, Y (corresponding author), Univ Gothenburg, Dept Plant & Environm Sci, Gothenburg, Sweden.	yann.bertrand@sh.se	Bertrand, Yann/R-5850-2018	Bertrand, Yann/0000-0001-6593-6959; Topel, Mats/0000-0001-7989-696X	Foundation for Baltic and East European studies	Foundation for Baltic and East European studies	This work was supported by grants to MJ by the Foundation for Baltic and East European studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chare ER, 2004, J GEN VIROL, V85, P3149, DOI 10.1099/vir.0.80134-0; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Dzhioev YP, 2011, VOP VIRUSOL+, V56, P14; Ecker M, 1999, J GEN VIROL, V80, P179, DOI 10.1099/0022-1317-80-1-179; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elvang A, 2011, VECTOR-BORNE ZOONOT, V11, P649, DOI 10.1089/vbz.2010.0105; Firth C, 2010, MOL BIOL EVOL, V27, P2038, DOI 10.1093/molbev/msq088; Gao GF, 1997, ACTA VIROL, V41, P259; GAO GF, 1993, J GEN VIROL, V74, P109, DOI 10.1099/0022-1317-74-1-109; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; GONZALEZ L, 1987, VET REC, V121, P12, DOI 10.1136/vr.121.1.12; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; Gubser C, 2004, J GEN VIROL, V85, P105, DOI 10.1099/vir.0.19565-0; Heinz F. X., 1990, Archives of Virology, Supplementum, P125; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Hon CC, 2008, J VIROL, V82, P1819, DOI 10.1128/JVI.01926-07; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes AL, 2007, GENE, V404, P117, DOI 10.1016/j.gene.2007.09.013; Hughes AL, 2010, INFECT GENET EVOL, V10, P50, DOI 10.1016/j.meegid.2009.10.001; Jensen Per M, 2004, Ugeskr Laeger, V166, P2563; Kovalev SY, 2009, J GEN VIROL, V90, P2884, DOI 10.1099/vir.0.012419-0; Mandl CW, 1998, J VIROL, V72, P2132, DOI 10.1128/JVI.72.3.2132-2140.1998; Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0; MARIN MS, 1995, RES VET SCI, V58, P11, DOI 10.1016/0034-5288(95)90081-0; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, PLOS GENET, V1, P475, DOI 10.1371/journal.pgen.0010051; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; McGuire K, 1998, J GEN VIROL, V79, P981, DOI 10.1099/0022-1317-79-5-981; Nylander J.A.A., 2004, MRAIC PL; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Randolph SE, 1996, PARASITOL TODAY, V12, P472, DOI 10.1016/S0169-4758(96)10072-7; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Skarphedinsson S, 2005, EMERG INFECT DIS, V11, P1055, DOI 10.3201/eid1107.041265; SMITH JM, 1992, J MOL EVOL, V34, P126; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suzuki Y, 2007, GENES GENET SYST, V82, P187, DOI 10.1266/ggs.82.187; Swofford D.L., 2002, PHYLOGENETIC ANAL US; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Twiddy SS, 2003, J GEN VIROL, V84, P429, DOI 10.1099/vir.0.18660-0; Waldenstrom J, 2007, EMERG INFECT DIS, V13, P1215, DOI 10.3201/eid1308.061416; WALLNER G, 1995, VIROLOGY, V213, P169, DOI 10.1006/viro.1995.1557; Woelk CH, 2002, MOL BIOL EVOL, V19, P2333, DOI 10.1093/oxfordjournals.molbev.a004059; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Yang ZH, 2000, GENETICS, V155, P431; Yun S-M, VIRUS GENES, V42, P307; ZANOTTO PMD, 1995, VIROLOGY, V210, P152, DOI 10.1006/viro.1995.1326; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548; Zlobin V. I., 2001, Voprosy Virusologii, V46, P17	61	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31981	10.1371/journal.pone.0031981	http://dx.doi.org/10.1371/journal.pone.0031981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384119	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500062
J	Peters, JL; Roberts, TE; Winker, K; McCracken, KG				Peters, Jeffrey L.; Roberts, Trina E.; Winker, Kevin; McCracken, Kevin G.			Heterogeneity in Genetic Diversity among Non-Coding Loci Fails to Fit Neutral Coalescent Models of Population History	PLOS ONE			English	Article							MULTILOCUS PHYLOGEOGRAPHY; DEMOGRAPHIC HISTORY; LINKAGE DISEQUILIBRIUM; CONTRASTING PATTERNS; STATISTICAL-METHOD; NATURAL-SELECTION; NORTH-AMERICA; MULTIPLE LOCI; DNA; DIVERGENCE	Inferring aspects of the population histories of species using coalescent analyses of non-coding nuclear DNA has grown in popularity. These inferences, such as divergence, gene flow, and changes in population size, assume that genetic data reflect simple population histories and neutral evolutionary processes. However, violating model assumptions can result in a poor fit between empirical data and the models. We sampled 22 nuclear intron sequences from at least 19 different chromosomes (a genomic transect) to test for deviations from selective neutrality in the gadwall (Anas strepera), a Holarctic duck. Nucleotide diversity among these loci varied by nearly two orders of magnitude (from 0.0004 to 0.029), and this heterogeneity could not be explained by differences in substitution rates alone. Using two different coalescent methods to infer models of population history and then simulating neutral genetic diversity under these models, we found that the observed among-locus heterogeneity in nucleotide diversity was significantly higher than expected for these simple models. Defining more complex models of population history demonstrated that a pre-divergence bottleneck was also unlikely to explain this heterogeneity. However, both selection and interspecific hybridization could account for the heterogeneity observed among loci. Regardless of the cause of the deviation, our results illustrate that violating key assumptions of coalescent models can mislead inferences of population history.	[Peters, Jeffrey L.] Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA; [Roberts, Trina E.] Univ Iowa, Museum Nat Hist, Iowa City, IA USA; [Winker, Kevin; McCracken, Kevin G.] Univ Alaska Fairbanks, Univ Alaska Museum, Fairbanks, AK USA; [McCracken, Kevin G.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA	University System of Ohio; Wright State University Dayton; University of Iowa; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	Peters, JL (corresponding author), Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA.	jeffrey.peters@wright.edu	Winker, Kevin/M-2042-2014; Peters, Jeffrey/I-5116-2012	Winker, Kevin/0000-0002-8985-8104; Peters, Jeffrey/0000-0002-5920-7976	NSF [DEB-0926162]; Alaska EPSCoR (NSF) [EPS-0346770]; Institute of Arctic Biology, University of Alaska Fairbanks; Department of Biological Sciences, Wright State University; Division Of Environmental Biology [0926162] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Alaska EPSCoR (NSF)(National Science Foundation (NSF)NSF - Office of the Director (OD)); Institute of Arctic Biology, University of Alaska Fairbanks; Department of Biological Sciences, Wright State University; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by grants provided by NSF (DEB-0926162), Alaska EPSCoR (NSF EPS-0346770), the Institute of Arctic Biology, University of Alaska Fairbanks, and the Department of Biological Sciences, Wright State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Axelsson E, 2005, GENOME RES, V15, P120, DOI 10.1101/gr.3021305; Bachtrog D, 2006, GENETICS, V174, P2045, DOI 10.1534/genetics.106.062760; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Becquet C, 2007, GENOME RES, V17, P1505, DOI 10.1101/gr.6409707; Becquet C, 2009, EVOLUTION, V63, P2547, DOI 10.1111/j.1558-5646.2009.00662.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bensch S, 2006, MOL ECOL, V15, P161, DOI 10.1111/j.1365-294X.2005.02766.x; BIERER BE, 1989, ANNU REV IMMUNOL, V7, P579, DOI 10.1146/annurev.immunol.7.1.579; Borge T, 2005, GENETICS, V171, P1861, DOI 10.1534/genetics.105.045120; Burt DW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S2-S5; Carling MD, 2008, GENETICS, V178, P363, DOI 10.1534/genetics.107.076422; Carneiro M, 2010, EVOLUTION, V64, P3443, DOI 10.1111/j.1558-5646.2010.01092.x; Casillas S, 2007, MOL BIOL EVOL, V24, P2222, DOI 10.1093/molbev/msm150; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edwards SV, 2000, EVOLUTION, V54, P1839; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fain MG, 2004, EVOLUTION, V58, P2558; Fedorova L, 2003, GENETICA, V118, P123, DOI 10.1023/A:1024145407467; Flot JF, 2010, MOL ECOL RESOUR, V10, P162, DOI 10.1111/j.1755-0998.2009.02732.x; Galtier N, 2000, GENETICS, V155, P981; Gillespie JH, 2000, GENETICS, V155, P909; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Haddrill PR, 2008, MOL BIOL EVOL, V25, P1825, DOI 10.1093/molbev/msn125; Haddrill PR, 2005, GENOME RES, V15, P790, DOI 10.1101/gr.3541005; Halligan DL, 2004, GENOME RES, V14, P273, DOI 10.1101/gr.1329204; Hamblin MT, 2006, GENETICS, V173, P953, DOI 10.1534/genetics.105.054312; Hammer MF, 2004, GENETICS, V167, P1841, DOI 10.1534/genetics.103.025361; Harlin-Cognato AD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-131; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hudson RR, 2007, J MOL EVOL, V64, P702, DOI 10.1007/s00239-006-0261-1; HUDSON RR, 1987, GENETICS, V116, P153; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hughes AL, 2007, HEREDITY, V99, P364, DOI 10.1038/sj.hdy.6801031; JOHNSGARD PAUL A., 1960, CONDOR, V62, P25, DOI 10.2307/1365656; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kimball RT, 2009, MOL PHYLOGENET EVOL, V50, P654, DOI 10.1016/j.ympev.2008.11.018; Kimura M., 1983, NEUTRAL THEORY MOL E; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Knowles LL, 2009, ANNU REV ECOL EVOL S, V40, P593, DOI 10.1146/annurev.ecolsys.38.091206.095702; Knowles LL, 2001, MOL ECOL, V10, P691, DOI 10.1046/j.1365-294x.2001.01206.x; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Lee JY, 2008, EVOLUTION, V62, P3117, DOI 10.1111/j.1558-5646.2008.00543.x; LEWONTIN RC, 1973, GENETICS, V74, P175; Luhtala M, 1998, POULTRY SCI, V77, P1858, DOI 10.1093/ps/77.12.1858; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; McCracken KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023173; McCracken KG, 2009, AM NAT, V174, P631, DOI 10.1086/606020; McCracken KG, 2009, MOL BIOL EVOL, V26, P815, DOI 10.1093/molbev/msp007; McCracken KG, 2005, SYST BIOL, V54, P35, DOI 10.1080/10635150590910249; MENG XL, 1994, ANN STAT, V22, P1142, DOI 10.1214/aos/1176325622; Olson MS, 2010, NEW PHYTOL, V186, P526, DOI 10.1111/j.1469-8137.2009.03174.x; Ometto L, 2006, BIOL LETT-UK, V2, P604, DOI 10.1098/rsbl.2006.0521; Peters JL, 2008, EVOLUTION, V62, P1469, DOI 10.1111/j.1558-5646.2008.00372.x; Peters JL, 2007, EVOLUTION, V61, P1992, DOI 10.1111/j.1558-5646.2007.00149.x; Peters JL, 2007, AUK, V124, P444, DOI 10.1642/0004-8038(2007)124[444:PSAMPI]2.0.CO;2; Peters JL, 2005, MOL PHYLOGENET EVOL, V35, P209, DOI 10.1016/j.ympev.2004.12.017; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Pritchard JK, 2000, GENETICS, V155, P945; R Development Team, 2009, R LANG ENV STAT COMP; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Ross-Ibarra J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002411; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Sonsthagen SA, 2011, J BIOGEOGR, V38, P1368, DOI 10.1111/j.1365-2699.2011.02492.x; Sorenson MD, 2003, MOL BIOL EVOL, V20, P1484, DOI 10.1093/molbev/msg157; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strasburg JL, 2008, EVOLUTION, V62, P1936, DOI 10.1111/j.1558-5646.2008.00415.x; Strasburg JL, 2011, MOL ECOL, V20, P2353, DOI 10.1111/j.1365-294X.2011.05048.x; Strasburg JL, 2010, MOL BIOL EVOL, V27, P297, DOI 10.1093/molbev/msp233; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tubaro PL, 2002, BIOL J LINN SOC, V77, P193, DOI 10.1046/j.1095-8312.2002.00096.x; VEILLETTE A, 1991, EUR J IMMUNOL, V21, P397, DOI 10.1002/eji.1830210222; Vucetich JA, 1997, EVOLUTION, V51, P2017, DOI 10.1111/j.1558-5646.1997.tb05123.x; Wall JD, 2000, GENETICS, V155, P1865; Wallis JW, 2004, NATURE, V432, P761, DOI 10.1038/nature03030; Woerner AE, 2007, BIOINFORMATICS, V23, P1851, DOI 10.1093/bioinformatics/btm253; WRIGHT S., 1938, Science (Washington), V87, P430; Wright SI, 2008, ANNU REV ECOL EVOL S, V39, P193, DOI 10.1146/annurev.ecolsys.39.110707.173342; Yuri T, 2008, MOL BIOL EVOL, V25, P352, DOI 10.1093/molbev/msm260	93	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31972	10.1371/journal.pone.0031972	http://dx.doi.org/10.1371/journal.pone.0031972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384117	Green Published, gold			2022-12-27	WOS:000302875500061
J	Hu, YC; Li, YP; Lin, HF; Yang, ZH; Cheng, LX				Hu, Yuncui; Li, Yanpeng; Lin, Hongfei; Yang, Zhihao; Cheng, Liangxi			Integrating Various Resources for Gene Name Normalization	PLOS ONE			English	Article							KNOWLEDGE	The recognition and normalization of gene mentions in biomedical literature are crucial steps in biomedical text mining. We present a system for extracting gene names from biomedical literature and normalizing them to gene identifiers in databases. The system consists of four major components: gene name recognition, entity mapping, disambiguation and filtering. The first component is a gene name recognizer based on dictionary matching and semi-supervised learning, which utilizes the co-occurrence information of a large amount of unlabeled MEDLINE abstracts to enhance feature representation of gene named entities. In the stage of entity mapping, we combine the strategies of exact match and approximate match to establish linkage between gene names in the context and the EntrezGene database. For the gene names that map to more than one database identifiers, we develop a disambiguation method based on semantic similarity derived from the Gene Ontology and MEDLINE abstracts. To remove the noise produced in the previous steps, we design a filtering method based on the confidence scores in the dictionary used for NER. The system is able to adjust the trade-off between precision and recall based on the result of filtering. It achieves an F-measure of 83% (precision: 82.5% recall: 83.5%) on BioCreative II Gene Normalization (GN) dataset, which is comparable to the current state-of-the-art.	[Hu, Yuncui; Li, Yanpeng; Lin, Hongfei; Yang, Zhihao] Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Liaoning, Peoples R China; [Cheng, Liangxi] Dalian Univ Technol, Dept Biomed Engn, Dalian, Liaoning, Peoples R China	Dalian University of Technology; Dalian University of Technology	Hu, YC (corresponding author), Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Liaoning, Peoples R China.	huyuncui@mail.dlut.edu.cn			Natural Science Foundation of China [60673039, 61070098]; National High Tech Research and Development Plan of China [2006AA01Z151]; Fundamental Research Funds for the Central Universities [DUT10JS09]; Liaoning Province Doctor Startup Fund [20091015]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Tech Research and Development Plan of China(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Liaoning Province Doctor Startup Fund	This work was supported by grant from the Natural Science Foundation of China (No. 60673039 and 61070098)(http://www.nsfc.gov.cn/Portal0/default124.htm), the National High Tech Research and Development Plan of China (No. 2006AA01Z151)(http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm), the Fundamental Research Funds for the Central Universities (No. DUT10JS09) and Liaoning Province Doctor Startup Fund (No. 20091015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando RK, 2007, P 2 BIOCREATIVE CHAL, V23, P101; Carpenter B, 2004, P 13 ANN TEXT RETR C; Cohen AM, 2005, BRIEF BIOINFORM, V6, P57, DOI 10.1093/bib/6.1.57; Cohen AM, 2007, P 2 BIOCREATIVE CHAL, P169; Fang H. R., 2006, P BIONLP WORKSH LINK, P41; Fluck J., 2007, P 2 BIOCREATIVE CHAL, P149; Fundel K, 2007, P 2 BIOCREATIVE CHAL, P153; Ganchev K., 2007, P 2 BIOCREATIVE CHAL, P119; Gonzalez G, 2007, P 2 BIOCREATIVE CHAL, P227; Grover C., 2007, P 2 BIOCREATIVE CHAL, P273; Hakenberg J, 2011, BIOINFORMATICS; Hakenberg J., 2007, P 2 BIOCREATIVE CHAL, P141; Hakenberg J, 2008, BIOINFORMATICS, V24, pI126, DOI 10.1093/bioinformatics/btn299; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S1; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S11; Huang HS, 2007, P 2 BIOCREATIVE CHAL, P109; Huang ML, 2011, BIOINFORMATICS, V27, P1032, DOI 10.1093/bioinformatics/btr042; Klinger R., 2007, P 2 BIOCREATIVE CHAL, P89; Kuo CJ, 2007, P 2 BIOCREATIVE CHAL; Kuo CJ, 2007, P 2 BIOCREATIVE CHAL, P105; Lau W, 2007, P 2 BIOCR CHALL EV W, P165; Li YP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-223; Luong T, 2007, P 2 BIOCREATIVE CHAL, P145; Morgan AA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S3; Nakov P, 2007, P 2 BIOCR CHALL EV W, P297; Neves ML, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-157; Schuemie M.J., 2007, P 2 BIOCREATIVE CHAL, P131; Settles B, 2005, BIOINFORMATICS, V21, P3191, DOI 10.1093/bioinformatics/bti475; Smith L, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s2, 10.1186/gb-2008-9-S2-S2]; Sparck-Jones K, 2000, INFORM PROCESS MANAG, V36, P779, DOI 10.1016/S0306-4573(00)00015-7; SPARCKJONES K, 1972, J DOC, V28, P11, DOI 10.1108/eb026526; Wermter J, 2009, BIOINFORMATICS, V25, P815, DOI 10.1093/bioinformatics/btp071; Xu H, 2007, BIOINFORMATICS, V23, P1015, DOI 10.1093/bioinformatics/btm056	33	106	113	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43558	10.1371/journal.pone.0043558	http://dx.doi.org/10.1371/journal.pone.0043558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22384115	Green Published, gold			2022-12-27	WOS:000308738500017
J	Wang, X; Zhang, AX; Liu, Y; Chen, S; Feng, ZQ; Shang, WB; Maziarz, M; Radtke, J; Hampe, CS				Wang, Xin; Zhang, Aixia; Liu, Yu; Chen, Shi; Feng, Zhenqing; Shang, Wenbin; Maziarz, Marlena; Radtke, Jared; Hampe, Christiane S.			Anti-Idiotypic Antibody Specific to GAD65 Autoantibody Prevents Type 1 Diabetes in the NOD Mouse	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTIRIBOSOMAL P AUTOANTIBODIES; ANTIGEN-PRESENTING CELLS; ACID DECARBOXYLASE GAD; GRAVES-DISEASE; DNA ANTIBODIES; B-LYMPHOCYTES; MONOCLONAL-ANTIBODIES; IDIOTYPIC ANTIBODIES; NETWORK THEORY	Overt autoantibodies to the smaller isoform of glutamate decarboxylase (GAD65Ab) are a characteristic in patients with Type 1 diabetes (T1D). Anti-idiotypic antibodies (anti-Id) directed to GAD65Ab effectively prevent the binding of GAD65 to GAD65Ab in healthy individuals. Levels of GAD65Ab-specific anti-Id are significantly lower in patients with T1D, leading to overt GAD65Ab in these patients. To determine the possible protective role of GAD65Ab-specific anti-Id in T1D pathogenesis, we developed the monoclonal anti-Id MAb 8E6G4 specifically targeting human monoclonal GAD65Ab b96.11. MAb 8E6G4 was demonstrated as a specific anti-Id directed to the antigen binding site of b96.11. MAb 8E6G4 recognized human antibodies in sera from healthy individuals, T2D patients, and T1D patients as established by ELISA. We confirmed these MAb 8E6G4-bound human antibodies to contain GAD65Ab by testing the eluted antibodies for binding to GAD65 in radioligand binding assays. These findings confirm that GAD65Ab are present in sera of individuals, who test GAD65Ab-negative in conventional detection assays. To test our hypothesis that GAD65Ab-specific anti-Id have an immune modulatory role in T1D, we injected young Non Obese Diabetic (NOD) mice with MAb 8E6G4. The animals were carefully monitored for development of T1D for 40 weeks. Infiltration of pancreatic islets by mononuclear cells (insulitis) was determined to establish the extent of an autoimmune attack on the pancreatic islets. Administration of MAb 8E6G4 significantly reduced the cumulative incidence rate of T1D and delayed the time of onset. Insulitis was significantly less severe in animals that received MAb 8E6G4 as compared to control animals. These results support our hypothesis that anti-Id specific to GAD65Ab have a protective role in T1D.	[Wang, Xin; Chen, Shi] Jiangsu Prov Hosp TCM, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Zhang, Aixia] Nanjing Med Univ, Sch Pharm, Nanjing, Jiangsu, Peoples R China; [Liu, Yu] Jilin Univ, Hosp 2, Dept Endocrinol, Changchun 130023, Jilin, Peoples R China; [Feng, Zhenqing] Nanjing Med Univ, Minist Hlth, Key Lab Antibody Technol, Nanjing, Jiangsu, Peoples R China; [Shang, Wenbin] Nanjing Univ Chinese Med, Coll Clin Med 1, Med Res Ctr, Nanjing, Jiangsu, Peoples R China; [Maziarz, Marlena; Radtke, Jared; Hampe, Christiane S.] Univ Washington, Seattle, WA 98195 USA	Nanjing University of Chinese Medicine; Nanjing Medical University; Jilin University; Nanjing Medical University; Nanjing University of Chinese Medicine; University of Washington; University of Washington Seattle	Wang, X (corresponding author), Jiangsu Prov Hosp TCM, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.	drwangxin@gmail.com; champe@u.washington.edu	Maziarz, Marlena/F-1746-2019; Maziarz, Marlena/AAL-3798-2021; Hampe, Christiane Susanne/GSD-7679-2022; Maziarz, Marlena/N-4255-2018; Shang, Wenbin/E-6682-2011; Wallinga, Jacco/C-4382-2018	Maziarz, Marlena/0000-0003-1417-6050; Maziarz, Marlena/0000-0003-1417-6050; Maziarz, Marlena/0000-0003-1417-6050; Shang, Wenbin/0000-0002-0317-5928; Bogaert, Debby/0000-0003-2651-7000; Trzcinski, Krzysztof/0000-0002-5433-8846; Wallinga, Jacco/0000-0003-1725-5627; Hampe, Christiane/0000-0001-9111-6671	National Institutes of Health [DK26190, DK17047, DK53456]; American Diabetes Association [1-09-RA-64]; Ministry of Science and Technology of China [2006BAI04A03]; Natural Science Foundation of China [NSF-C 81100555/H0707]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Institutes of Health (www2.niddk.nih.gov/) (grant numbers DK26190, DK17047, and DK53456), a basic science grant from the American Diabetes Association (www.diabetes.org)/(1-09-RA-64 to CSH), grant 2006BAI04A03 of the Ministry of Science and Technology of China (www.most.cn/eng/), and a grant from the Natural Science Foundation of China (www.nsfc.gov.cn/Portal0/default106.htm) NSF-C 81100555/H0707. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOU NI, 1989, J CLIN IMMUNOL, V9, P16, DOI 10.1007/BF00917123; ABDOU NI, 1981, J CLIN INVEST, V67, P1297, DOI 10.1172/JCI110158; Aly Theresa, 2005, Am J Ther, V12, P481, DOI 10.1097/01.mjt.0000178782.97413.79; Anderson CJ, 1998, ARTHRITIS RHEUM, V41, P33, DOI 10.1002/1529-0131(199801)41:1<33::AID-ART5>3.0.CO;2-5; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Bach JF, 2002, ARTHRITIS RES THER, V4, DOI 10.1186/ar554; Brooks-Worrell B, 2012, CLIN EXP IMMUNOL, V167, P40, DOI 10.1111/j.1365-2249.2011.04501.x; DWYER DS, 1983, NATURE, V301, P611, DOI 10.1038/301611a0; ERTL HCJ, 1988, VACCINE, V6, P80, DOI 10.1016/S0264-410X(88)80003-3; Falcone M, 1998, J IMMUNOL, V161, P1163; Goudy KS, 2005, INT REV IMMUNOL, V24, P307, DOI 10.1080/08830180500379721; Hall TR, 2008, IMMUNOLOGY, V123, P547, DOI 10.1111/j.1365-2567.2007.02724.x; Hampe CS, 2000, J CLIN ENDOCR METAB, V85, P4671, DOI 10.1210/jc.85.12.4671; Hampe CS, 2001, J NEUROIMMUNOL, V113, P63, DOI 10.1016/S0165-5728(00)00423-9; Harbers SO, 2007, J CLIN INVEST, V117, P1361, DOI 10.1172/JCI29470; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; KIM J, 1993, DIABETES, V42, P1799, DOI 10.2337/diabetes.42.12.1799; Knip M, 2008, AUTOIMMUN REV, V7, P550, DOI 10.1016/j.autrev.2008.04.008; NILSON BHK, 1992, J BIOL CHEM, V267, P2234; O'Neill SK, 2009, CURR OPIN ENDOCRINOL, V16, P293, DOI 10.1097/MED.0b013e32832e06a7; Oak S, 2008, P NATL ACAD SCI USA, V105, P5471, DOI 10.1073/pnas.0800578105; Padoa CJ, 2003, DIABETES, V52, P2689, DOI 10.2337/diabetes.52.11.2689; Pan ZJ, 1998, J CLIN INVEST, V102, P215, DOI 10.1172/JCI1969; PASCHKE R, 1990, J AUTOIMMUN, V3, P441, DOI 10.1016/S0896-8411(05)80011-3; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Quinn A, 1996, J AUTOIMMUN, V9, P365, DOI 10.1006/jaut.1996.0049; Raju R, 2005, J IMMUNOL, V175, P7755, DOI 10.4049/jimmunol.175.11.7755; Routsias JG, 2003, J AUTOIMMUN, V21, P17, DOI 10.1016/S0896-8411(03)00063-5; Sanjeevi CB, 1996, DIABETES NUTR METAB, V9, P167; Sapir T, 2005, CLIN REV ALLERG IMMU, V29, P185, DOI 10.1385/CRIAI:29:3:185; Serreze DV, 1998, J IMMUNOL, V161, P3912; SIKORSKA HM, 1986, J IMMUNOL, V137, P3786; Silveira PA, 2002, EUR J IMMUNOL, V32, P3657, DOI 10.1002/1521-4141(200212)32:12<3657::AID-IMMU3657>3.0.CO;2-E; SILVESTRIS F, 1984, ARTHRITIS RHEUM, V27, P1387, DOI 10.1002/art.1780271209; STAFFORD HA, 1995, J IMMUNOL, V155, P2754; Tada H, 2001, ENDOCR J, V48, P703, DOI 10.1507/endocrj.48.703; TANIGUCHI O, 1984, J RHEUMATOL, V11, P291; Tremble J, 1997, J CLIN ENDOCR METAB, V82, P2664, DOI 10.1210/jc.82.8.2664; Usuki S, 2010, J NEUROSCI RES, V88, P1651, DOI 10.1002/jnr.22330; VALDERRAMA R, 1988, J NEUROIMMUNOL, V20, P269, DOI 10.1016/0165-5728(88)90174-9; WILLIAMS RC, 1995, J RHEUMATOL, V22, P1075; Williams WM, 1998, LUPUS, V7, P164, DOI 10.1191/096120398678919958; Zekzer D, 1998, J CLIN INVEST, V101, P68, DOI 10.1172/JCI119878; ZOUALI M, 1983, CELL IMMUNOL, V76, P137, DOI 10.1016/0008-8749(83)90356-8	44	78	85	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32515	10.1371/journal.pone.0032515	http://dx.doi.org/10.1371/journal.pone.0032515			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	23189192	Green Submitted, gold, Green Published			2022-12-27	WOS:000302916800042
J	Sharaf, MR; Aldawood, AS				Sharaf, Mostafa R.; Aldawood, Abdulrahman S.			Ants of the Genus Solenopsis Westwood 1840 (Hymenoptera: Formicidae) in the Arabian Peninsula with Description of a New Species, Solenopsis elhawagryi	PLOS ONE			English	Article								Ants of the genus Solenopsis Westwood in the Arabian Peninsula are revised. Six species are treated: Solenopsis elhawagryi Sharaf & Aldawood sp. n., S. geminata (Fabricius, 1804), S. omana Collingwood & Agosti, 1996, S. saudiensis Sharaf & Aldawood, 2011, S. sumara Collingwood & Agosti, 1996, and S. zingibara Collingwood & Agosti, 1996. Solenopsis elhawagryi is described from Beljorashi Governorate, Al Baha Province, Saudi Arabia, based on worker castes and the queen with notes on this species biology and ecology. Solenopsis sumara workers are redescribed and illustrated for the first time and a lectotype is designated. An identification key to the Arabian and Egyptian species is provided with scanning electron micrographs to facilitate species recognition.	[Sharaf, Mostafa R.; Aldawood, Abdulrahman S.] King Saud Univ, Coll Food & Agr Sci, Dept Plant Protect, Riyadh, Saudi Arabia	King Saud University	Sharaf, MR (corresponding author), King Saud Univ, Coll Food & Agr Sci, Dept Plant Protect, Riyadh, Saudi Arabia.	antsharaf@gmail.com	Aldawood, Abdulrahman Saad/M-3657-2019	Aldawood, Abdulrahman Saad/0000-0003-0721-6632	NPST program (King Saud University) [11-BIO1974-02]	NPST program (King Saud University)(King Saud University)	Funding for the research was provided by NPST program (King Saud University) Project No. 11-BIO1974-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolton B., 1987, Bulletin of the British Museum (Natural History) Entomology, V54, P263; Bolton B., 1994, Identification guide to the ant genera of the world.; BOLTON B., 2007, BOLTONS CATALOGUE AN; Brown William L. Jr, 2000, P45; Collingwood CA, 1997, J ARID ENVIRON, V37, P505, DOI 10.1006/jare.1997.0309; Collingwood Cedric A., 1996, Fauna of Saudi Arabia, V15, P300; CREIGHTON W. S., 1950, BULL MUS COMP ZOOL HARVARD UNIV, V104, P1; Creighton WS, 1930, P AM ACAD ARTS SCI, V66, P39, DOI 10.2307/20026320; ETTERSHANK G., 1966, AUSTRALIAN J ZOOL, V14, P73, DOI 10.1071/ZO9660073; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Mayr G., 1863, VERHANDLUNGEN KAISER, V13, P385; McGlynn TP, 1999, J BIOGEOGR, V26, P535, DOI 10.1046/j.1365-2699.1999.00310.x; Pacheco JA, 2006, THESIS U TEXAS EL PA, P543; Sharaf MR, 2011, ANN SOC ENTOMOL FR, V47, P474, DOI 10.1080/00379271.2011.10697738; Sharaf MR, 2011, T AM ENTOMOL SOC, V137, P203, DOI 10.3157/061.137.0113; Sharaf MR, 2009, ZOOTAXA, P49, DOI 10.11646/zootaxa.2004.1.4; TRAGER JC, 1991, J NEW YORK ENTOMOL S, V99, P141; West-Wood J. O., 1840, ANN MAGAZINE NATURAL, V6, P81, DOI [10.1080/03745484009443610, DOI 10.1080/03745484009443610]; Wetterer JK, 2011, MYRMECOL NEWS, V14, P21	19	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49485	10.1371/journal.pone.0049485	http://dx.doi.org/10.1371/journal.pone.0049485			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23226211	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100020
J	Hu, Y; Duan, JH; Zhan, QM; Wang, FD; Lu, X; Yang, XD				Hu, Yan; Duan, Jinhong; Zhan, Qimin; Wang, Fengdan; Lu, Xin; Yang, Xian-Da			Novel MUC1 Aptamer Selectively Delivers Cytotoxic Agent to Cancer Cells In Vitro	PLOS ONE			English	Article							TARGETED DRUG-DELIVERY; EXPRESSION; DESIGN; ACID	Chemotherapy is a primary treatment for cancer, but its efficacy is often limited by the adverse effects of cytotoxic agents. Targeted drug delivery may reduce the non-specific toxicity of chemotherapy by selectively directing anticancer drugs to tumor cells. MUC1 protein is an attractive target for tumor-specific drug delivery owning to its overexpression in most adenocarcinomas. In this study, a novel MUC1 aptamer is exploited as the targeting ligand for carrying doxorubicin (Dox) to cancer cells. We developed an 86-base DNA aptamer (MA3) that bound to a peptide epitope of MUC1 with a K-d of 38.3 nM and minimal cross reactivity to albumin. Using A549 lung cancer and MCF-7 breast cancer cells as MUC1-expressing models, MA3 was found to preferentially bind to MUC1-positive but not MUC1-negative cells. An aptamer-doxorubicin complex (Apt-Dox) was formulated by intercalating doxorubicin into the DNA structure of MA3. Apt-Dox was found capable of carrying doxorubicin into MUC1-positive tumor cells, while significantly reducing the drug intake by MUC1-negative cells. Moreover, Apt-Dox retained the efficacy of doxorubicin against MUC1-positive tumor cells, but lowered the toxicity to MUC1-negative cells (P<0.01). The results suggest that the MUC1 aptamer may have potential utility as a targeting ligand for selective delivery of cytotoxic agent to MUC1-expressing tumors.	[Hu, Yan; Duan, Jinhong; Yang, Xian-Da] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Hu, Yan; Duan, Jinhong; Zhan, Qimin; Wang, Fengdan; Lu, Xin; Yang, Xian-Da] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhan, Qimin] Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China; [Wang, Fengdan; Lu, Xin] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Hu, Y (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China.	ayangmd@gmail.com			Chinese Ministry of Science and Technology [2011CB933504, 2011CB911004, 2011CB911003]; Natural Science Foundation of China [81071870]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from the Chinese Ministry of Science and Technology (2011CB933504, 2011CB911004, 2011CB911003) and the Natural Science Foundation of China (81071870).	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Brown KC, 2010, CURR PHARM DESIGN, V16, P1040, DOI 10.2174/138161210790963788; Burchell JM, 2001, J MAMMARY GLAND BIOL, V6, P355, DOI 10.1023/A:1011331809881; Cao Y, 1999, VIRCHOWS ARCH, V434, P503, DOI 10.1007/s004280050375; Croce MV, 2001, BREAST CANCER RES TR, V69, P1, DOI 10.1023/A:1012220902991; Dassie JP, 2009, NAT BIOTECHNOL, V27, P839, DOI 10.1038/nbt.1560; Davis KA, 1996, NUCLEIC ACIDS RES, V24, P702, DOI 10.1093/nar/24.4.702; Dhar S, 2008, P NATL ACAD SCI USA, V105, P17356, DOI 10.1073/pnas.0809154105; Farokhzad OC, 2004, CANCER RES, V64, P7668, DOI 10.1158/0008-5472.CAN-04-2550; Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103; Farokhzad OC, 2006, EXPERT OPIN DRUG DEL, V3, P311, DOI 10.1517/17425247.3.3.311; Ferreira CSM, 2006, TUMOR BIOL, V27, P289, DOI 10.1159/000096085; Ferreira CSM, 2009, NUCLEIC ACIDS RES, V37, P866, DOI 10.1093/nar/gkn967; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Haj HTB, 2003, CHEM-BIOL INTERACT, V145, P349, DOI 10.1016/S0009-2797(03)00061-9; Huang YF, 2009, CHEMBIOCHEM, V10, P862, DOI 10.1002/cbic.200800805; Lee Y, 2008, BIOCONJUGATE CHEM, V19, P525, DOI 10.1021/bc700382z; Levy-Nissenbaum E, 2008, TRENDS BIOTECHNOL, V26, P442, DOI 10.1016/j.tibtech.2008.04.006; Murray A, 1998, J PEPT RES, V52, P375; Osborne SE, 1997, CURR OPIN CHEM BIOL, V1, P5, DOI 10.1016/S1367-5931(97)80102-0; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Ren LF, 1997, CHEM-BIOL INTERACT, V104, P55, DOI 10.1016/S0009-2797(97)03767-8; SENTER PD, 1995, BIOCONJUGATE CHEM, V6, P389, DOI 10.1021/bc00034a008; Sudimack J, 2000, ADV DRUG DELIVER REV, V41, P147, DOI 10.1016/S0169-409X(99)00062-9; Taylor-Papadimitriou J, 1999, BBA-MOL BASIS DIS, V1455, P301, DOI 10.1016/S0925-4439(99)00055-1; Vasir JK, 2005, TECHNOL CANCER RES T, V4, P363, DOI 10.1177/153303460500400405; Vogel CL, 2009, J CLIN ONCOL, V27; Ye Xin, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P206	28	106	113	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31970	10.1371/journal.pone.0031970	http://dx.doi.org/10.1371/journal.pone.0031970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384115	Green Published, Green Submitted, gold			2022-12-27	WOS:000302875500060
J	Song, XF; Ren, H; Andreasen, A; Thomsen, JS; Zhai, XY				Song, Xiao-Feng; Ren, Hao; Andreasen, Arne; Thomsen, Jesper Skovhus; Zhai, Xiao-Yue			Expression of Bcl-2 and Bax in Mouse Renal Tubules during Kidney Development	PLOS ONE			English	Article							CYTOCHROME-C; PROXIMAL TUBULE; APOPTOSIS; DEATH; FAMILY; CELLS; MITOCHONDRIA; PROTEINS; RELEASE; MEMBERS	Bcl-2 and Bax play an important role in apoptosis regulation, as well as in cell adhesion and migration during kidney morphogenesis, which is structurally and functionally related to mitochondria. In order to elucidate the role of Bcl-2 and Bax during kidney development, it is essential to establish the exact location of their expression in the kidney. The present study localized their expression during kidney development. Kidneys from embryonic (E) 16-, 17-, 18-day-old mouse fetuses, and postnatal (P) 1-, 3-, 5-, 7-, 14-, 21-day-old pups were embedded in Epon. Semi-thin serial sections from two E17 kidneys underwent computer assisted 3D tubule tracing. The tracing was combined with a newly developed immunohistochemical technique, which enables immunohistochemistry on glutaraldehyde fixated plastic embedded sections. Thereby, the microstructure could be described in detail, and the immunochemistry can be performed using exactly the same sections. The study showed that Bcl-2 and Bax were strongly expressed in mature proximal convoluted tubules at all time points, less strongly expressed in proximal straight tubules, and only weakly in immature proximal tubules and distal tubules. No expression was detected in ureteric bud and other earlier developing structures, such as comma bodies, S shaped bodies, glomeruli, etc. Tubules expressing Bcl-2 only were occasionally observed. The present study showed that, during kidney development, Bcl-2 and Bax are expressed differently in the proximal and distal tubules, although these two tubule segments are almost equally equipped with mitochondria. The functional significance of the different expression of Bcl-2 and Bax in proximal and distal tubules is unknown. However, the findings of the present study suggest that the mitochondrial function differs between mature proximal tubules and in the rest of the tubules. The function of Bcl-2 and Bax during tubulogenesis still needs to be investigated.	[Song, Xiao-Feng; Ren, Hao; Zhai, Xiao-Yue] China Med Univ, Dept Histol & Embryol, Inst Pathol & Pathophysiol, Shenyang, Liao Ning, Peoples R China; [Andreasen, Arne; Thomsen, Jesper Skovhus] Aarhus Univ, Dept Anat, Dept Biomed, Aarhus, Denmark; [Song, Xiao-Feng] Liao Ning Med Coll, Dept Histol & Embryol, Jin Zhou, Liao Ning, Peoples R China; [Zhai, Xiao-Yue] China Med Univ, Inst Nephropathol, Shenyang, Liao Ning, Peoples R China	China Medical University; Aarhus University; China Medical University	Song, XF (corresponding author), China Med Univ, Dept Histol & Embryol, Inst Pathol & Pathophysiol, Shenyang, Liao Ning, Peoples R China.	zhaixy@mail.cmu.edu.cn		Thomsen, Jesper Skovhus/0000-0001-9386-6679	National Natural Science Foundation of China [30871313, 31171400]; China Postdoctoral Science Special Foundation [200801399]; Research Fund for the Doctoral Program of Higher Education of China [200801590016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Special Foundation; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported mainly by grants of National Natural Science Foundation of China (contract no. 30871313 and 31171400, http://isisn.nsfc.gov.cn/egrantweb), in part by China Postdoctoral Science Special Foundation (contract no. 200801399) and Research Fund for the Doctoral Program of Higher Education of China (contract no. 200801590016). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen A, 2003, J NEUROSCI METH, V122, P157, DOI 10.1016/S0165-0270(02)00317-5; Arany I, 2008, KIDNEY INT, V74, P261, DOI 10.1038/ki.2008.221; Autret A, 2009, MOL CELL, V36, P355, DOI 10.1016/j.molcel.2009.10.011; Basile DP, 1997, AM J PHYSIOL-RENAL, V272, pF640, DOI 10.1152/ajprenal.1997.272.5.F640; Carev D, 2006, PEDIATR NEPHROL, V21, P627, DOI 10.1007/s00467-006-0057-y; CHEN BY, 1994, TERATOLOGY, V50, P1, DOI 10.1002/tera.1420500102; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Costantini F, 2006, DIFFERENTIATION, V74, P402, DOI 10.1111/j.1432-0436.2006.00106.x; Erkan E, 2007, J AM SOC NEPHROL, V18, P1199, DOI 10.1681/ASN.2006040407; Fedorov LM, 2006, MECH AGEING DEV, V127, P600, DOI 10.1016/j.mad.2006.02.009; Foley JGD, 2002, J ANAT, V201, P477, DOI 10.1046/j.1469-7580.2002.00114.x; Hall AM, 2009, J AM SOC NEPHROL, V20, P1293, DOI 10.1681/ASN.2008070759; Hammerman MR, 1998, CURR OPIN NEPHROL HY, V7, P419, DOI 10.1097/00041552-199807000-00012; Hayashi M, 2002, NEPHROL DIAL TRANSPL, V17, P8, DOI 10.1093/ndt/17.suppl_9.8; KELLENBERGER E, 1987, J HISTOCHEM CYTOCHEM, V35, P959, DOI 10.1177/35.9.3302020; Kim YJ, 2009, J AGR FOOD CHEM, V57, P8793, DOI 10.1021/jf9019745; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; Messaris E, 2008, SURG INFECT, V9, P377, DOI 10.1089/sur.2006.018; Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200; NOVACK DV, 1994, AM J PATHOL, V145, P61; Patschan D, 2007, KIDNEY INT, V71, P744, DOI 10.1038/sj.ki.5002102; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Rolland SG, 2010, CURR OPIN CELL BIOL, V22, P852, DOI 10.1016/j.ceb.2010.07.014; RUEGG CE, 1990, AM J PHYSIOL, V259, pF176, DOI 10.1152/ajprenal.1990.259.1.F176; Saikumar P, 1998, ONCOGENE, V17, P3401, DOI 10.1038/sj.onc.1202590; Sheibani N, 2007, J CELL PHYSIOL, V210, P616, DOI 10.1002/jcp.20858; Sorenson CM, 2004, BBA-MOL CELL RES, V1644, P169, DOI 10.1016/j.bbamcr.2003.08.010; Torchinsky A, 1995, TERATOGEN CARCIN MUT, V15, P179, DOI 10.1002/tcm.1770150404; UCHIDA S, 1988, AM J PHYSIOL, V255, pF977, DOI 10.1152/ajprenal.1988.255.5.F977; Walker KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018723; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wyllie AH, 2010, MOL NEUROBIOL, V42, P4, DOI 10.1007/s12035-010-8125-5; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zhai XY, 2007, KIDNEY INT, V72, P731, DOI 10.1038/sj.ki.5002403; Zhai XY, 2006, J AM SOC NEPHROL, V17, P77, DOI 10.1681/ASN.2005080796; Ziehr J, 2004, AM J PHYSIOL-RENAL, V287, pF1154, DOI 10.1152/ajprenal.00129.2004	39	28	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32771	10.1371/journal.pone.0032771	http://dx.doi.org/10.1371/journal.pone.0032771			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389723	gold, Green Published			2022-12-27	WOS:000302999600062
J	Sharaf, MR; Aldawood, AS; Taylor, B				Sharaf, Mostafa R.; Aldawood, Abdulrahman S.; Taylor, Brian			A New Ant Species of the Genus Tetramorium Mayr, 1855 (Hymenoptera: Formicidae) from Saudi Arabia, with a Revised Key to the Arabian Species	PLOS ONE			English	Article							COMPLEX HYMENOPTERA; REGION; FOREST; FAUNA; USSR	Tetramorium amalae sp. n. is described and illustrated from Saudi Arabia based on two worker caste specimens collected in Al Bahah region. The new species belongs to the T. shilohense group and appears to be closely related to T. dysderke Bolton from Nigeria. T. amalae is distinguished by having well-developed frontal carinae, smaller eyes, greater head length and width, greater pronotal width, and the petiole node is longer than broad. Tetramorium latinode Collingwood & Agosti is recorded for the first time from Saudi Arabia and for only the second time since the original description. The worker caste of T. latinode is redescribed and illustrated using scanning electron micrographs to facilitate recognition and the gyne is described for the first time with observations given on species relationships, biology and habitat. A revised key to the nineteen Tetramorium species recorded from Arabian Peninsula based on worker castes is provided. Tetramorium bicarinatum (Nylander) is recorded for the first time from Saudi Arabia. It is suggested that T. amalae and T. latinode are endemic to the Arabian Peninsula.	[Sharaf, Mostafa R.; Aldawood, Abdulrahman S.] King Saud Univ, Dept Plant Protect, Coll Food & Agr Sci, Riyadh, Saudi Arabia	King Saud University	Sharaf, MR (corresponding author), King Saud Univ, Dept Plant Protect, Coll Food & Agr Sci, Riyadh, Saudi Arabia.	antsharaf@yahoo.com; aldawood88@yahoo.com	Aldawood, Abdulrahman Saad/M-3657-2019	Aldawood, Abdulrahman Saad/0000-0003-0721-6632	King Saud University, Deanship of Scientific Research, College of Food and Agricultural Sciences, Research Center	King Saud University, Deanship of Scientific Research, College of Food and Agricultural Sciences, Research Center	This project was supported by King Saud University, Deanship of Scientific Research, College of Food and Agricultural Sciences, Research Center. The authors express their debt and gratitude to Mr. Barry Bolton and Dr. Brian Fisher for useful and valuable comments, which much improved the manuscript. Actually, without their continuous help this study could not have been completed. Special thanks are due to Prof. Boris Kondratieff for critical reading of the manuscript. We are indebted to Dr. Stephen Judd, Director of the World Museum Liverpool and Mr. Guy Knight, Head of Zoology and Curator of Invertebrates, for allowing the senior author to examine Tetramorium material. Thanks go to Dr. Richard Pyle for providing the first Formicidae LSID for the new species. We are grateful for two anonymous reviewers for their comments which greatly improved the manuscript. We also thank Mr. Hassan Badri for technical assistance and Dr. Omer Hamed for taking SEM images. Special thanks go to Prof. Magdi Elhawagry and Mr. Mohammed Metwally for help in expedition to Baha region and Mr. Mohammed Sallam for helping with the photography of T. latinode. The senior author expresses his gratitude to his wife Amal El Saadany, for her joyful assistance and appreciated help with specimens mounting, to Mr. Cedric Collingwood, for his continuous encouragements and wonderful hospitality, and to Tony van Harten, Mr. Salah Montaser (the Egyptian Journalist, Al Ahram Newspaper), Prof. Hoda Farid (Ain Shams University), Dr. Mahmoud Eldera'a and Mr. Ismail Fareed for their encouragement.	Arnold G., 1926, Annals of the South African Museum, V23, P191; Bodenheimer FS, 1937, P LINN SOC LONDON, V148, P47; BOLTON B, 1995, J NAT HIST, V29, P1037, DOI 10.1080/00222939500770411; Bolton B., 1979, Bulletin of the British Museum (Natural History) Entomology, V38, P129; BOLTON B, 1985, J NAT HIST, V19, P243, DOI 10.1080/00222938500770191; Bolton B., 1977, Bulletin Br Mus nat Hist (Ent), V36, P67; Bolton B., 1976, Bulletin of the British Museum (Natural History), Entomology, V34, P281; Bolton B., 1980, Bulletin of the British Museum (Natural History) Entomology, V40, P193; Bolton B., 1994, IDENTIFICATION GUIDE; Brown WL, 2000, BIOL DIVERSITY HDB S; Collingwood C.A., 1985, Fauna of Saudi Arabia, V7, P230; Collingwood CA, 1997, J ARID ENVIRON, V37, P505, DOI 10.1006/jare.1997.0309; Collingwood Cedric A., 2005, Zoology in the Middle East, V35, P73; Collingwood Cedric A., 1996, Fauna of Saudi Arabia, V15, P300; Collingwood Cedric A., 2004, V20, P473; Csosz S, 2007, ZOOTAXA, P1; Csosz S, 2010, ZOOTAXA, P1; Garcia FH, 2010, ZOOTAXA, P1; Garcia FH, 2011, ZOOTAXA, P1; Garcia Francisco Hita, 2010, Bonn Zoological Bulletin, V57, P359; Garcia FH, 2010, MYRMECOL NEWS, V13, P141; Nayman J, 1972, ATLAS WILDLIFE; RADCHENKO AG, 1992, ZOOL ZH, V71, P39; RADCHENKO AG, 1992, ZOOL ZH, V71, P50; Taylor B., 1980, COCOA RES I NIGERIA, V7, P1; Yamane Seiki, 2011, Insecta Matsumurana, V67, P61	26	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e30811	10.1371/journal.pone.0030811	http://dx.doi.org/10.1371/journal.pone.0030811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	23226211	Green Published, gold			2022-12-27	WOS:000302999600004
J	Chen, F; Zhang, W; Liang, Y; Huang, JL; Li, K; Green, CD; Liu, JC; Zhang, GJ; Zhou, B; Yi, X; Wang, W; Liu, H; Xu, XH; Shen, F; Qu, N; Wang, YD; Gao, GY; San, A; JiangBai, LS; Sang, H; Fang, XD; Kristiansen, K; Yang, HM; Wang, J; Han, JDJ; Wang, J				Chen, Fang; Zhang, Wei; Liang, Yu; Huang, Jialiang; Li, Kui; Green, Christopher D.; Liu, Jiancheng; Zhang, Guojie; Zhou, Bing; Yi, Xin; Wang, Wei; Liu, Hang; Xu, Xiaohong; Shen, Feng; Qu, Ning; Wang, Yading; Gao, Guoyi; San, A.; JiangBai, LuoSang; Sang, Hua; Fang, Xiangdong; Kristiansen, Karsten; Yang, Huanming; Wang, Jun; Han, Jing-Dong J.; Wang, Jian			Transcriptome and Network Changes in Climbers at Extreme Altitudes	PLOS ONE			English	Article							EXPRESSION DATA; STEM-CELLS; HYPOXIA; ADAPTATION; EVEREST; ILLNESS; PROTEIN; OCT4	Extreme altitude can induce a range of cellular and systemic responses. Although it is known that hypoxia underlies the major changes and that the physiological responses include hemodynamic changes and erythropoiesis, the molecular mechanisms and signaling pathways mediating such changes are largely unknown. To obtain a more complete picture of the transcriptional regulatory landscape and networks involved in extreme altitude response, we followed four climbers on an expedition up Mount Xixiabangma (8,012 m), and collected blood samples at four stages during the climb for mRNA and miRNA expression assays. By analyzing dynamic changes of gene networks in response to extreme altitudes, we uncovered a highly modular network with 7 modules of various functions that changed in response to extreme altitudes. The erythrocyte differentiation module is the most prominently up-regulated, reflecting increased erythrocyte differentiation from hematopoietic stem cells, probably at the expense of differentiation into other cell lineages. These changes are accompanied by coordinated down-regulation of general translation. Network topology and flow analyses also uncovered regulators known to modulate hypoxia responses and erythrocyte development, as well as unknown regulators, such as the OCT4 gene, an important regulator in stem cells and assumed to only function in stem cells. We predicted computationally and validated experimentally that increased OCT4 expression at extreme altitude can directly elevate the expression of hemoglobin genes. Our approach established a new framework for analyzing the transcriptional regulatory network from a very limited number of samples.	[Chen, Fang; Zhang, Guojie; Yi, Xin; Wang, Wei; Liu, Hang; Xu, Xiaohong; Shen, Feng; Qu, Ning; Wang, Yading; San, A.; JiangBai, LuoSang; Sang, Hua; Yang, Huanming; Wang, Jun; Wang, Jian] BGI Shenzhen, Shenzhen, Peoples R China; [Zhang, Wei; Huang, Jialiang; Green, Christopher D.; Liu, Jiancheng; Zhou, Bing; Han, Jing-Dong J.] Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai, Peoples R China; [Chen, Fang; Liang, Yu; Li, Kui; Yi, Xin; San, A.; Fang, Xiangdong] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Zhang, Wei; Huang, Jialiang; Liu, Jiancheng; Zhou, Bing] Chinese Acad Sci, Ctr Mol Syst Biol, Inst Genet & Dev Biol, Beijing, Peoples R China; [Chen, Fang; Zhang, Wei; Liang, Yu; Huang, Jialiang; Li, Kui; Liu, Jiancheng; Zhou, Bing; Yi, Xin; San, A.] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Gao, Guoyi] Hosp XiShuangBanNa Dai Nationalities Autonomous, Jinghong, Peoples R China; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Copenhagen	Chen, F (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	wangj@genomics.org.cn; jdhan@picb.ac.cn; wangjian@genomics.org.cn	Zhou, Bing/J-3281-2015; Kristiansen, Karsten/J-5148-2014; Zhang, Guojie/B-6188-2014; Zhang, Guojie/J-7273-2019; Wang, Jun/A-7261-2013; Zhang, Wei/K-4276-2016; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Kristiansen, Karsten/0000-0002-6024-0917; Zhang, Guojie/0000-0001-6860-1521; Zhang, Guojie/0000-0001-6860-1521; Zhang, Wei/0000-0002-0942-1245; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; Wang, Dao Wen/0000-0002-9774-3980; , Chen/0000-0001-5080-9383	China National Science Foundation [30890033, 30588001, 30620120433]; Chinese Ministry of Science and Technology [2006CB910700, 2006CB504103]; Chinese Academy of Sciences [KSCX1-YW-R-40, KSCX2-YW-R-76]; Science and Technology Plan of the Tibet Autonomous Region [2007-2-18]	China National Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Plan of the Tibet Autonomous Region	This work was supported by grants from the China National Science Foundation (Grant # 30890033, # 30588001 and # 30620120433), Chinese Ministry of Science and Technology (973 program, Grant # 2006CB910700, # 2006CB504103) and Chinese Academy of Sciences (# KSCX1-YW-R-40, # KSCX2-YW-R-76), Science and Technology Plan of the Tibet Autonomous Region (# 2007-2-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; BERGLUND B, 1992, SPORTS MED, V14, P289, DOI 10.2165/00007256-199214050-00002; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Clerici C, 2009, AM J PHYSIOL-LUNG C, V296, pL267, DOI 10.1152/ajplung.90528.2008; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Grocott MPW, 2009, NEW ENGL J MED, V360, P140, DOI 10.1056/NEJMoa0801581; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Hartmann G, 2000, CYTOKINE, V12, P246, DOI 10.1006/cyto.1999.0533; Hochachka PW, 2003, BIOESSAYS, V25, P515, DOI 10.1002/bies.10261; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Koeppen M, 2011, CURR OPIN ANESTHESIO, V24, P363, DOI 10.1097/ACO.0b013e32834873fd; Lengner CJ, 2008, CELL CYCLE, V7, P725, DOI 10.4161/cc.7.6.5573; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEEHAN RT, 1987, ANN EMERG MED, V16, P974, DOI 10.1016/S0196-0644(87)80743-6; Michael P, 2000, HIGH ALTITUDE MED PH; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Reverter A, 2010, BIOINFORMATICS, V26, P896, DOI 10.1093/bioinformatics/btq051; Richalet JP, 1999, ADV EXP MED BIOL, V474, P297; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUTTON JR, 1988, J APPL PHYSIOL, V64, P1309, DOI 10.1152/jappl.1988.64.4.1309; Torkamani A, 2009, BIOINFORMATICS, V25, P2222, DOI 10.1093/bioinformatics/btp388; Wang X, 2009, STEM CELLS, V27, P1265, DOI 10.1002/stem.58; Xia K, 2006, PLOS COMPUT BIOL, V2, P1482, DOI 10.1371/journal.pcbi.0020145; Xia K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-508; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	32	127	132	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e31645	10.1371/journal.pone.0031645	http://dx.doi.org/10.1371/journal.pone.0031645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22393366	gold, Green Published, Green Submitted			2022-12-27	WOS:000303003500019
